"c_reference_id","c_pathogen_id","c_reference_name","c_reference_type","c_authors","c_title","c_year","c_volume","c_issue","c_pages","c_journal_book_name","c_publisher","c_publisher_location","c_book_editors","c_isbn","c_university","c_university_location","c_degree","c_pmid","c_url","c_file_name","c_gene_id","c_curation_flag","c_vaxjo_id","c_dv_plasmid_id","c_vaxvec_id","t_referencecol","c_vaxanimodel_id","c_comment"
19,7,"Brey, 2005",journal,Brey RN,Molecular basis for improved anthrax vaccines,"2005 Jun 17","57","9","1266-92",Advanced drug delivery reviews,"","","","","","","","15935874","",,0,10,0,0,0,,,
18,7,"CDC, 2000",website,Centers for Disease Control and Prevention,Use of anthrax vaccine in the United States: recommendations of the Advisory Committee on Immunization Practices (ACIP),MMWR 2000;49(No. RR-15),"","","","","","","","","","","","",http://www.cdc.gov/mmwr/PDF/rr/rr4915.pdf,,0,10,0,0,0,,,
16,7,"Hirsh et al, 2004",book,"Hirsh DC, Biberstrein EL.",Bacillus. ,"2004","","","170-174.","Veterinary Microbiology, 2nd Ed.",Blackwell Publishing,"Ames, Iowa..","","","","","","","",,0,10,0,0,0,,,
17,7,"Smith et al., 2006",journal,"Smith ME, Koser M, Xiao S, Siler C, McGettigan JP, Calkins C, Pomerantz RJ, Dietzschold B, Schnell MJ",Rabies virus glycoprotein as a carrier for anthrax protective antigen,"2006 Sep 30","353","2","344-56",Virology,"","","","","","","","16820183","",,0,10,0,0,0,,,
15,7,"Hanna et al., 1999",journal,"Hanna PC, Ireland JA",Understanding Bacillus anthracis pathogenesis,"1999 May","7","5","180-2",Trends in microbiology,"","","","","","","","10383221","",,0,10,0,0,0,,,
14,8,"Vemulapalli et al., 2000a",journal,"Vemulapalli R, He Y, Cravero S, Sriranganathan N, Boyle SM, Schurig GG",Overexpression of protective antigen as a novel approach to enhance vaccine efficacy of Brucella abortus strain RB51,"2000 Jun","68","6","3286-9",Infection and immunity,"","","","","","","","10816475","",,0,10,0,0,0,,,
11,8,"Schurig et al., 2002",journal,"Schurig GG, Sriranganathan N, Corbel MJ","Brucellosis vaccines: past, present and future","2002 Dec 20","90","1-4","479-96",Veterinary microbiology,"","","","","","","","12414166","",,0,10,0,0,0,,,
12,8,"Schurig et al., 1991",journal,"Schurig GG, Roop RM 2nd, Bagchi T, Boyle S, Buhrman D, Sriranganathan N",Biological properties of RB51; a stable rough strain of Brucella abortus,"1991 Jul","28","2","171-88",Veterinary microbiology,"","","","","","","","1908158","",,0,10,0,0,0,,,
13,8,"He et al., 2001",journal,"He Y, Vemulapalli R, Zeytun A, Schurig GG",Induction of specific cytotoxic lymphocytes in mice vaccinated with Brucella abortus RB51,"2001 Sep","69","9","5502-8",Infection and immunity,"","","","","","","","11500423 ","",,0,10,0,0,0,,,
21,7,"Flick-Smith et al., 2002",journal,"Flick-Smith HC, Walker NJ, Gibson P, Bullifent H, Hayward S, Miller J, Titball RW, Williamson ED",A recombinant carboxy-terminal domain of the protective antigen of Bacillus anthracis protects mice against anthrax infection,"2002 Mar","70","3","1653-6",Infection and immunity,"","","","","","","","11854261","",,0,10,0,0,0,,,
22,7,"Klaschik et al., 2007",journal,"Klaschik S, Gursel I, Klinman DM",CpG-mediated changes in gene expression in murine spleen cells identified by microarray analysis,"2007 Feb","44","6","1095-104",Molecular immunology,"","","","","","","","16930709","",,0,10,0,0,0,,,
23,7,"Coeshott et al., 2004",journal,"Coeshott CM, Smithson SL, Verderber E, Samaniego A, Blonder JM, Rosenthal GJ, Westerink MA",Pluronic F127-based systemic vaccine delivery systems,"2004 Jun 23","22","19","2396-405",Vaccine,"","","","","","","","15193401","",,0,10,0,0,0,,,
24,7,"Ribot et al., 2006",journal,"Ribot WJ, Powell BS, Ivins BE, Little SF, Johnson WM, Hoover TA, Norris SL, Adamovicz JJ, Friedlander AM, Andrews GP",Comparative vaccine efficacy of different isoforms of recombinant protective antigen against Bacillus anthracis spore challenge in rabbits,"2006 Apr 24","24","17","3469-76",Vaccine,"","","","","","","","16519970","",,0,10,0,0,0,,,
25,7,"Gu et al., 1999",journal,"Gu ML, Leppla SH, Klinman DM",Protection against anthrax toxin by vaccination with a DNA plasmid encoding anthrax protective antigen,"1999 Jan 28","17","4","340-4",Vaccine,"","","","","","","","9987172","",,0,10,0,0,0,,,
26,7,"Rhie et al., 2003",journal,"Rhie GE, Roehrl MH, Mourez M, Collier RJ, Mekalanos JJ, Wang JY",A dually active anthrax vaccine that confers protection against both bacilli and toxins,"2003 Sep 16","100","19","10925-30",Proceedings of the National Academy of Sciences of the United States of America,"","","","","","","","12960361","",,0,10,0,0,0,,,
27,7,"Leppla et al., 2002",journal,"Leppla SH, Robbins JB, Schneerson R, Shiloach J",Development of an improved vaccine for anthrax,"2002 Jul","110","2","141-4",The Journal of clinical investigation,"","","","","","","","12122102","",,0,10,0,0,0,,,
28,7,"Wang et al., 2004",journal,"Wang TT, Fellows PF, Leighton TJ, Lucas AH",Induction of opsonic antibodies to the gamma-D-glutamic acid capsule of Bacillus anthracis by immunization with a synthetic peptide-carrier protein conjugate,"2004 Apr 9","40","3","231-7",FEMS immunology and medical microbiology,"","","","","","","","15039099","",,0,10,0,0,0,,,
29,7,"Chabot et al., 2004",journal,"Chabot DJ, Scorpio A, Tobery SA, Little SF, Norris SL, Friedlander AM",Anthrax capsule vaccine protects against experimental infection,"2004 Nov 15","23","1","43-7",Vaccine,"","","","","","","","15519706","",,0,10,0,0,0,,,
30,7,"Schneerson et al., 2003",journal,"Schneerson R, Kubler-Kielb J, Liu TY, Dai ZD, Leppla SH, Yergey A, Backlund P, Shiloach J, Majadly F, Robbins JB",Poly(gamma-D-glutamic acid) protein conjugates induce IgG antibodies in mice to the capsule of Bacillus anthracis: a potential addition to the anthrax vaccine,"2003 Jul 22","100","15","8945-50",Proceedings of the National Academy of Sciences of the United States of America,"","","","","","","","12857944","",,0,10,0,0,0,,,
44,7,"Cui et al., 2006",journal,"Cui Z, Sloat BR",Topical immunization onto mouse skin using a microemulsion incorporated with an anthrax protective antigen protein-encoding plasmid,"2006 Jul 24","317","2","187-91",International journal of pharmaceutics,"","","","","","","","16730934 ","",,0,10,0,0,0,,,
32,7,"Price et al., 2001",journal,"Price BM, Liner AL, Park S, Leppla SH, Mateczun A, Galloway DR",Protection against anthrax lethal toxin challenge by genetic immunization with a plasmid encoding the lethal factor protein,"2001 Jul","69","7","4509-15",Infection and immunity,"","","","","","","","11401993","",,0,10,0,0,0,,,
33,7,"Hahn et al., 2004",journal,"Hahn UK, Alex M, Czerny CP, Bohm R, Beyer W",Protection of mice against challenge with Bacillus anthracis STI spores after DNA vaccination,"2004 Jul","294","1","35-44",International journal of medical microbiology : IJMM,"","","","","","","","15293452","",,0,10,0,0,0,,,
34,7,"Hermanson et al., 2004",journal,"Hermanson G, Whitlow V, Parker S, Tonsky K, Rusalov D, Ferrari M, Lalor P, Komai M, Mere R, Bell M, Brenneman K, Mateczun A, Evans T, Kaslow D, Galloway D, Hobart P",A cationic lipid-formulated plasmid DNA vaccine confers sustained antibody-mediated protection against aerosolized anthrax spores,"2004 Sep 14","101","37","13601-6",Proceedings of the National Academy of Sciences of the United States of America,"","","","","","","","15342913","",,0,10,0,0,0,,,
35,7,"Galloway et al., 2004",journal,"Galloway D, Liner A, Legutki J, Mateczun A, Barnewall R, Estep J",Genetic immunization against anthrax,"2004 Apr 16","22","13-14","1604-8",Vaccine,"","","","","","","","15068841","",,0,10,0,0,0,,,
36,7,"Pittman et al., 2006",journal,"Pittman PR, Norris SL, Barrera Oro JG, Bedwell D, Cannon TL, McKee KT Jr",Patterns of antibody response in humans to the anthrax vaccine adsorbed (AVA) primary (six-dose) series,"2006 Apr 24","24","17","3654-60",Vaccine,"","","","","","","","16497418","",,0,10,0,0,0,,,
37,7,"Klinman et al., 2004",journal,"Klinman DM, Xie H, Little SF, Currie D, Ivins BE",CpG oligonucleotides improve the protective immune response induced by the anthrax vaccination of rhesus macaques,"2004 Jul 29","22","21-22","2881-6",Vaccine,"","","","","","","","15246624 ","",,0,10,0,0,0,,,
40,7,"Little et al., 1986",journal,"Little SF, Knudson GB",Comparative efficacy of Bacillus anthracis live spore vaccine and protective antigen vaccine against anthrax in the guinea pig,"1986 May","52","2","509-12",Infection and immunity,"","","","","","","","3084385","",,0,10,0,0,0,,,
42,7,"Coker et al., 2003",journal,"Coker PR, Smith KL, Fellows PF, Rybachuck G, Kousoulas KG, Hugh-Jones ME",Bacillus anthracis virulence in Guinea pigs vaccinated with anthrax vaccine adsorbed is linked to plasmid quantities and clonality,"2003 Mar","41","3","1212-8",Journal of clinical microbiology,"","","","","","","","12624053","",,0,10,0,0,0,,,
43,7,"Xie et al., 2005",journal,"Xie H, Gursel I, Ivins BE, Singh M, O'Hagan DT, Ulmer JB, Klinman DM",CpG oligodeoxynucleotides adsorbed onto polylactide-co-glycolide microparticles improve the immunogenicity and protective activity of the licensed anthrax vaccine,"2005 Feb","73","2","828-33",Infection and immunity,"","","","","","","","15664922","",,0,10,0,0,0,,,
45,11,"Chiuchiolo et al., 2006",journal,"Chiuchiolo MJ, Boyer JL, Krause A, Senina S, Hackett NR, Crystal RG",Protective Immunity against Respiratory Tract Challenge with Yersinia pestis in Mice Immunized with an Adenovirus-Based Vaccine Vector Expressing V Antigen,"2006 Nov 1","194","9","1249-57",The Journal of infectious diseases,"","","","","","","","17041851","",,0,10,0,0,0,,,
46,12,"Isherwood et al., 2005",journal,"Isherwood KE, Titball RW, Davies DH, Felgner PL, Morrow WJ",Vaccination strategies for Francisella tularensis,"2005 Jun 17","57","9","1403-14",Advanced drug delivery reviews,"","","","","","","","15919131","",,0,10,0,0,0,,,
47,11,"Cornelis, 2002",journal,Cornelis GR,Yersinia type III secretion: send in the effectors,"2002 Aug 5","158","3","401-8",The Journal of cell biology,"","","","","","","","12163464","",,0,10,0,0,0,,,
49,11,"Perry et al., 1997",journal,"Perry RD, Fetherston JD",Yersinia pestis--etiologic agent of plague,"1997 Jan","10","1","35-66",Clinical microbiology reviews,"","","","","","","","8993858","",,0,10,0,0,0,,,
50,11,"Palin et al., 2006",journal,"Palin A, Chattopadhyay A, Park S, Delmas G, Suresh R, Senina S, Perlin DS, Rose JK","An optimized vaccine vector based on recombinant vesicular stomatitis virus gives high-level, long-term protection against Yersinia pestis challenge","2006 Aug 22","","","",Vaccine,"","","","","","","","16959385","",,0,10,0,0,0,,,
51,11,"Titball et al., 2004",journal,"Titball RW, Williamson ED",Yersinia pestis (plague) vaccines,"2004 Jun","4","6","965-73",Expert opinion on biological therapy,"","","","","","","","15174978","",,0,10,0,0,0,,,
52,11,"Jones et al., 2003",journal,"Jones SM, Griffin KF, Hodgson I, Williamson ED",Protective efficacy of a fully recombinant plague vaccine in the guinea pig,"2003 Sep 8","21","25-26","3912-8",Vaccine,"","","","","","","","12922126","",,0,10,0,0,0,,,
53,11,"Titball et al., 2001",journal,"Titball RW, Williamson ED",Vaccination against bubonic and pneumonic plague,"2001 Jul 20","19","30","4175-84",Vaccine,"","","","","","","","11457543","",,0,10,0,0,0,,,
54,11,"Williamson et al., 2000",journal,"Williamson ED, Eley SM, Stagg AJ, Green M, Russell P, Titball RW",A single dose sub-unit vaccine protects against pneumonic plague,"2000 Oct 15","19","4-5","566-71",Vaccine,"","","","","","","","11027822","",,0,10,0,0,0,,,
55,11,"Welkos et al., 2002",journal,"Welkos S, Pitt ML, Martinez M, Friedlander A, Vogel P, Tammariello R",Determination of the virulence of the pigmentation-deficient and pigmentation-/plasminogen activator-deficient strains of Yersinia pestis in non-human primate and mouse models of pneumonic plague,"2002 May 22","20","17-18","2206-14",Vaccine,"","","","","","","","12009274","",,0,10,0,0,0,,,
56,12,"Rohmer et al., 2006",journal,"Rohmer L, Brittnacher M, Svensson K, Buckley D, Haugen E, Zhou Y, Chang J, Levy R, Hayden H, Forsman M, Olson M, Johansson A, Kaul R, Miller SI",Potential source of Francisella tularensis live vaccine strain attenuation determined by genome comparison,"2006 Sep 25","","","",Infection and immunity,"","","","","","","","17000723","",,0,10,0,0,0,,,
64,12,"Bakshi et al., 2006",journal,"Bakshi CS, Malik M, Regan K, Melendez JA, Metzger DW, Pavlov VM, Sellati TJ",Superoxide dismutase B gene (sodB)-deficient mutants of Francisella tularensis demonstrate hypersensitivity to oxidative stress and attenuated virulence,"2006 Sep","188","17","6443-8",Journal of bacteriology,"","","","","","","","16923916","",,0,10,0,0,0,,,
58,12,"Elkins et al., 1996",journal,"Elkins KL, Rhinehart-Jones TR, Culkin SJ, Yee D, Winegar RK",Minimal requirements for murine resistance to infection with Francisella tularensis LVS,"1996 Aug","64","8","3288-93",Infection and immunity,"","","","","","","","8757866","",,0,10,0,0,0,,,
59,11,"Elvin et al., 2006",journal,"Elvin SJ, Eyles JE, Howard KA, Ravichandran E, Somavarappu S, Alpar HO, Williamson ED",Protection against bubonic and pneumonic plague with a single dose microencapsulated sub-unit vaccine,"2006 May 15","24","20","4433-9",Vaccine,"","","","","","","","16546306","",,0,10,0,0,0,,,
60,11,"DeBord et al., 2006",journal,"DeBord KL, Anderson DM, Marketon MM, Overheim KA, DePaolo RW, Ciletti NA, Jabri B, Schneewind O","Immunogenicity and protective immunity against bubonic plague and pneumonic plague by immunization of mice with the recombinant V10 antigen, a variant of LcrV","2006 Aug","74","8","4910-4",Infection and immunity,"","","","","","","","16861680","",,0,10,0,0,0,,,
61,11,"Williamson et al., 2005",journal,"Williamson ED, Flick-Smith HC, Lebutt C, Rowland CA, Jones SM, Waters EL, Gwyther RJ, Miller J, Packer PJ, Irving M",Human immune response to a plague vaccine comprising recombinant F1 and V antigens,"2005 Jun","73","6","3598-608",Infection and immunity,"","","","","","","","15908389","",,0,10,0,0,0,,,
62,11,"Jones et al., 2000",journal,"Jones SM, Day F, Stagg AJ, Williamson ED",Protection conferred by a fully recombinant sub-unit vaccine against Yersinia pestis in male and female mice of four inbred strains,"2000 Sep 15","19","2-3","358-66",Vaccine,"","","","","","","","10930691","",,0,10,0,0,0,,,
63,12,"Hepburn et al., 2006",journal,"Hepburn MJ, Purcell BK, Lawler JV, Coyne SR, Petitt PL, Sellers KD, Norwood DA, Ulrich MP",Live vaccine strain Francisella tularensis is detectable at the inoculation site but not in blood after vaccination against tularemia,"2006 Sep 15","43","6","711-6",Clinical infectious diseases : an official publication of the Infectious Diseases Society of America,"","","","","","","","16912944","",,0,10,0,0,0,,,
65,12,"Twine et al., 2005",journal,"Twine S, Bystrom M, Chen W, Forsman M, Golovliov I, Johansson A, Kelly J, Lindgren H, Svensson K, Zingmark C, Conlan W, Sjostedt A",A mutant of Francisella tularensis strain SCHU S4 lacking the ability to express a 58-kilodalton protein is attenuated for virulence and is an effective live vaccine,"2005 Dec","73","12","8345-52",Infection and immunity,"","","","","","","","16299332 ","",,0,10,0,0,0,,,
66,11,"Leary et al., 1995",journal,"Leary SE, Williamson ED, Griffin KF, Russell P, Eley SM, Titball RW",Active immunization with recombinant V antigen from Yersinia pestis protects mice against plague,"1995 Aug","63","8","2854-8",Infection and immunity,"","","","","","","","7622205","",,0,10,0,0,0,,,
67,11,"Une et al., 1984",journal,"Une T, Brubaker RR",Roles of V antigen in promoting virulence and immunity in yersiniae,"1984 Oct","133","4","2226-30","Journal of immunology (Baltimore, Md. : 1950)","","","","","","","","6381597","",,0,10,0,0,0,,,
68,12,"Tempel et al., 2006",journal,"Tempel R, Lai XH, Crosa L, Kozlowicz B, Heffron F",Attenuated Francisella novicida transposon mutants protect mice against wild-type challenge,"2006 Sep","74","9","5095-105",Infection and immunity,"","","","","","","","16926401","",,0,10,0,0,0,,,
70,12,"Dreisbach et al., 2000",journal,"Dreisbach VC, Cowley S, Elkins KL",Purified lipopolysaccharide from Francisella tularensis live vaccine strain (LVS) induces protective immunity against LVS infection that requires B cells and gamma interferon,"2000 Apr","68","4","1988-96",Infection and immunity,"","","","","","","","10722593","",,0,10,0,0,0,,,
71,12,"Pammit et al., 2006",journal,"Pammit MA, Raulie EK, Lauriano CM, Klose KE, Arulanandam BP",Intranasal vaccination with a defined attenuated Francisella novicida strain induces gamma interferon-dependent antibody-mediated protection against tularemia,"2006 Apr","74","4","2063-71",Infection and immunity,"","","","","","","","16552035","",,0,10,0,0,0,,,
72,11,"Russell et al., 1995",journal,"Russell P, Eley SM, Hibbs SE, Manchee RJ, Stagg AJ, Titball RW","A comparison of Plague vaccine, USP and EV76 vaccine induced protection against Yersinia pestis in a murine model","1995 Nov","13","16","1551-6",Vaccine,"","","","","","","","8578841","",,0,10,0,0,0,,,
73,11,"Anderson et al., 1996",journal,"Anderson GW Jr, Leary SE, Williamson ED, Titball RW, Welkos SL, Worsham PL, Friedlander AM",Recombinant V antigen protects mice against pneumonic and bubonic plague caused by F1-capsule-positive and -negative strains of Yersinia pestis,"1996 Nov","64","11","4580-5",Infection and immunity,"","","","","","","","8890210","",,0,10,0,0,0,,,
76,13,"Sullivan et al., 2003a",journal,"Sullivan N, Yang ZY, Nabel GJ",Ebola virus pathogenesis: implications for vaccines and therapies,"2003 Sep","77","18","9733-7",Journal of virology,"","","","","","","","12941881","",,0,10,0,0,0,,,
77,13,"Sullivan et al., 2003b",journal,"Sullivan NJ, Geisbert TW, Geisbert JB, Xu L, Yang ZY, Roederer M, Koup RA, Jahrling PB, Nabel GJ",Accelerated vaccination for Ebola virus haemorrhagic fever in non-human primates,"2003 Aug 7","424","6949","681-4",Nature,"","","","","","","","12904795","",,0,10,0,0,0,,,
75,11,"Robinson et al., 2005",journal,"Robinson VL, Oyston PC, Titball RW",A dam mutant of Yersinia pestis is attenuated and induces protection against plague,"2005 Nov 15","252","2","251-6",FEMS microbiology letters,"","","","","","","","16188402","",,0,10,0,0,0,,,
78,13,"Feldmann et al., 2003",journal,"Feldmann H, Jones S, Klenk HD, Schnittler HJ",Ebola virus: from discovery to vaccine,"2003 Aug","3","8","677-85",Nature reviews. Immunology,"","","","","","","","12974482","",,0,10,0,0,0,,,
79,13,"Sullivan et al., 2000",journal,"Sullivan NJ, Sanchez A, Rollin PE, Yang ZY, Nabel GJ",Development of a preventive vaccine for Ebola virus infection in primates,"2000 Nov 30","408","6812","605-9",Nature,"","","","","","","","11117750","",,0,10,0,0,0,,,
80,11,"Wang et al., 2004",journal,"Wang S, Heilman D, Liu F, Giehl T, Joshi S, Huang X, Chou TH, Goguen J, Lu S",A DNA vaccine producing LcrV antigen in oligomers is effective in protecting mice from lethal mucosal challenge of plague,"2004 Sep 3","22","25-26","3348-57",Vaccine,"","","","","","","","15308359 ","",,0,10,0,0,0,,,
81,11,"Motin et al., 1994",journal,"Motin VL, Nakajima R, Smirnov GB, Brubaker RR",Passive immunity to yersiniae mediated by anti-recombinant V antigen and protein A-V antigen fusion peptide,"1994 Oct","62","10","4192-201",Infection and immunity,"","","","","","","","7927675","",,0,10,0,0,0,,,
111,11,"Andrews et al., 1999",journal,"Andrews GP, Strachan ST, Benner GE, Sample AK, Anderson GW Jr, Adamovicz JJ, Welkos SL, Pullen JK, Friedlander AM",Protective efficacy of recombinant Yersinia outer proteins against bubonic plague caused by encapsulated and nonencapsulated Yersinia pestis,"1999 Mar","67","3","1533-7",Infection and immunity,"","","","","","","","10024607 ","",,0,10,0,0,0,,,
83,11,"Williamson et al., 2002",journal,"Williamson ED, Bennett AM, Perkins SD, Beedham RJ, Miller J, Baillie LW",Co-immunisation with a plasmid DNA cocktail primes mice against anthrax and plague,"2002 Jul 26","20","23-24","2933-41",Vaccine,"","","","","","","","12126905","",,0,10,0,0,0,,,
84,11,"Andrews et al., 1996",journal,"Andrews GP, Heath DG, Anderson GW Jr, Welkos SL, Friedlander AM",Fraction 1 capsular antigen (F1) purification from Yersinia pestis CO92 and from an Escherichia coli recombinant strain and efficacy against lethal plague challenge,"1996 Jun","64","6","2180-7",Infection and immunity,"","","","","","","","8675324","",,0,10,0,0,0,,,
87,11,"Nakajima et al., 1995",journal,"Nakajima R, Motin VL, Brubaker RR",Suppression of cytokines in mice by protein A-V antigen fusion peptide and restoration of synthesis by active immunization,"1995 Aug","63","8","3021-9",Infection and immunity,"","","","","","","","7622225","",,0,10,0,0,0,,,
86,13,"Geisbert et al., 2002",journal,"Geisbert TW, Pushko P, Anderson K, Smith J, Davis KJ, Jahrling PB",Evaluation in nonhuman primates of vaccines against Ebola virus,"2002 May","8","5","503-7",Emerging infectious diseases,"","","","","","","","11996686","",,0,10,0,0,0,,,
88,13,"Wilson et al., 2001",journal,"Wilson JA, Bray M, Bakken R, Hart MK","Vaccine potential of Ebola virus VP24, VP30, VP35, and VP40 proteins","2001 Aug 1","286","2","384-90",Virology,"","","","","","","","11485406","",,0,10,0,0,0,,,
89,13,"Pushko et al., 2000",journal,"Pushko P, Bray M, Ludwig GV, Parker M, Schmaljohn A, Sanchez A, Jahrling PB, Smith JF",Recombinant RNA replicons derived from attenuated Venezuelan equine encephalitis virus protect guinea pigs and mice from Ebola hemorrhagic fever virus,"2000 Aug 15","19","1","142-53",Vaccine,"","","","","","","","10924796","",,0,10,0,0,0,,,
90,13,"Vanderzanden et al., 1998",journal,"Vanderzanden L, Bray M, Fuller D, Roberts T, Custer D, Spik K, Jahrling P, Huggins J, Schmaljohn A, Schmaljohn C",DNA vaccines expressing either the GP or NP genes of Ebola virus protect mice from lethal challenge,"1998 Jun 20","246","1","134-44",Virology,"","","","","","","","9657001","",,0,10,0,0,0,,,
91,11,"Price et al., 1989",journal,"Price SB, Leung KY, Barve SS, Straley SC","Molecular analysis of lcrGVH, the V antigen operon of Yersinia pestis","1989 Oct","171","10","5646-53",Journal of bacteriology,"","","","","","","","2477361","",,0,10,0,0,0,,,
92,11,"Carr et al., 1999",journal,"Carr S, Miller J, Leary SE, Bennett AM, Ho A, Williamson ED","Expression of a recombinant form of the V antigen of Yersinia pestis, using three different expression systems","1999 Aug 20","18","1-2","153-9",Vaccine,"","","","","","","","10501245","",,0,10,0,0,0,,,
106,11,"Montminy et al., 2006",journal,"Montminy SW, Khan N, McGrath S, Walkowicz MJ, Sharp F, Conlon JE, Fukase K, Kusumoto S, Sweet C, Miyake K, Akira S, Cotter RJ, Goguen JD, Lien E",Virulence factors of Yersinia pestis are overcome by a strong lipopolysaccharide response,"2006 Oct","7","10","1066-73",Nature immunology,"","","","","","","","16980981 ","",,0,10,0,0,0,,,
107,14,"Byrne et al., 1998",journal,"Byrne MP, Smith TJ, Montgomery VA, Smith LA","Purification, potency, and efficacy of the botulinum neurotoxin type A binding domain from Pichia pastoris as a recombinant vaccine candidate","1998 Oct","66","10","4817-22",Infection and immunity,"","","","","","","","9746584","",,0,10,0,0,0,,,
118,14,"Lee et al., 2006",journal,"Lee JS, Groebner JL, Hadjipanayis AG, Negley DL, Schmaljohn AL, Welkos SL, Smith LA, Smith JF",Multiagent vaccines vectored by Venezuelan equine encephalitis virus replicon elicits immune responses to Marburg virus and protection against anthrax and botulinum neurotoxin in mice,"2006 Nov 17","24","47-48","6886-92",Vaccine,"","","","","","","","16828936","",,0,10,0,0,0,,,
109,14,"Byrne et al., 2000",journal,"Byrne MP, Smith LA",Development of vaccines for prevention of botulism,"2000 Sep-Oct","82","9-10","955-66",Biochimie,"","","","","","","","11086225","",,0,10,0,0,0,,,
110,14,"Boles et al., 2006",journal,"Boles J, West M, Montgomery V, Tammariello R, Pitt ML, Gibbs P, Smith L, LeClaire RD",Recombinant C fragment of botulinum neurotoxin B serotype (rBoNTB (HC)) immune response and protection in the rhesus monkey,"2006 Jun 15","47","8","877-84",Toxicon : official journal of the International Society on Toxinology,"","","","","","","","16730042 ","",,0,10,0,0,0,,,
103,13,"Xu et al., 1998",journal,"Xu L, Sanchez A, Yang Z, Zaki SR, Nabel EG, Nichol ST, Nabel GJ",Immunization for Ebola virus infection,"1998 Jan","4","1","37-42",Nature medicine,"","","","","","","","9427604","",,0,10,0,0,0,,,
104,11,"Meyer, 1970",journal,Meyer KF,Effectiveness of live or killed plague vaccines in man,"1970","42","5","653-66",Bulletin of the World Health Organization,"","","","","","","","4988692","",,0,10,0,0,0,,,
105,11,"Williams et al., 1979",journal,"Williams JE, Cavanaugh DC",Measuring the efficacy of vaccination in affording protection against plague,"1979","57","2","309-13",Bulletin of the World Health Organization,"","","","","","","","312163","",,0,10,0,0,0,,,
101,14,PathPort,website,"Sobral B., Dickerman A., Crasta O., Kenyon R.",Virginia Bioinformatics Institute,"","","","","","","","","","","","","",http://pathport.vbi.vt.edu/pathinfo/pathogens/Clostridium_botulinum_Info.shtml,,0,10,0,0,0,,,
102,14,"Lohenry et al., 2006",journal,"Lohenry K, Foulke K","Botulism: rare, but deadly","2006 Nov","19","11","41-5",JAAPA : official journal of the American Academy of Physician Assistants,"","","","","","","","17124790 ","",,0,10,0,0,0,,,
112,11,"Palin et al., 2007",journal,"Palin A, Chattopadhyay A, Park S, Delmas G, Suresh R, Senina S, Perlin DS, Rose JK","An optimized vaccine vector based on recombinant vesicular stomatitis virus gives high-level, long-term protection against Yersinia pestis challenge","2007 Jan 8","25","4","741-50",Vaccine,"","","","","","","","16959385","",,0,10,0,0,0,,,
113,11,"Matson et al., 2005",journal,"Matson JS, Durick KA, Bradley DS, Nilles ML",Immunization of mice with YscF provides protection from Yersinia pestis infections,"2005 Jun 24","5","1","38",BMC microbiology,"","","","","","","","15978133","",,0,10,0,0,0,,,
114,11,"Makoveichuk et al., 2003",journal,"Makoveichuk E, Cherepanov P, Lundberg S, Forsberg A, Olivecrona G",pH6 antigen of Yersinia pestis interacts with plasma lipoproteins and cell membranes,"2003 Feb","44","2","320-30",Journal of lipid research,"","","","","","","","12576514 ","",,0,10,0,0,0,,,
115,7,PathPort,website,"",Virginia Bioinformatics Institute,"","","","","","","","","","","","","",http://pathport.vbi.vt.edu/pathinfo/pathogens/Bacillus-anthracis_Info.shtml,,0,10,0,0,0,,,
116,17,"Fisher-Hoch et al., 2001",journal,"Fisher-Hoch SP, McCormick JB",Towards a human Lassa fever vaccine,"2001 Sep-Oct","11","5","331-41",Reviews in medical virology,"","","","","","","","11590670","",,0,10,0,0,0,,,
117,7,"Chekanov et al., 2006",journal,"Chekanov AV, Remacle AG, Golubkov VS, Akatov VS, Sikora S, Savinov AY, Fugere M, Day R, Rozanov DV, Strongin AY",Both PA63 and PA83 are endocytosed within an anthrax protective antigen mixed heptamer: a putative mechanism to overcome a furin deficiency,"2006 Feb 1","446","1","52-9",Archives of biochemistry and biophysics,"","","","","","","","16384550","",,0,10,0,0,0,,,
133,14,"Martinez et al., 1999",journal,"Martinez R, Wobeser G",Immunization of ducks for type C botulism,"1999 Oct","35","4","710-5",Journal of wildlife diseases,"","","","","","","","10574530 ","",,0,10,0,0,0,,,
134,18,PathPort,website,"",Virginia Bioinformatics Institute,"","","","","","","","","","","","","",http://pathport.vbi.vt.edu/pathinfo/pathogens/Clostridium_botulinum_Info.shtml,,0,10,0,0,0,,,
120,14,"Arnon et al., 2001",journal,"Arnon SS, Schechter R, Inglesby TV, Henderson DA, Bartlett JG, Ascher MS, Eitzen E, Fine AD, Hauer J, Layton M, Lillibridge S, Osterholm MT, O'Toole T, Parker G, Perl TM, Russell PK, Swerdlow DL, Tonat K",Botulinum toxin as a biological weapon: medical and public health management,"2001 Feb 28","285","8","1059-70",JAMA : the journal of the American Medical Association,"","","","","","","","11209178 ","",,0,10,0,0,0,,,
138,18,"Hooper et al., 2004",journal,"Hooper JW, Thompson E, Wilhelmsen C, Zimmerman M, Ichou MA, Steffen SE, Schmaljohn CS, Schmaljohn AL, Jahrling PB",Smallpox DNA vaccine protects nonhuman primates against lethal monkeypox,"2004 May","78","9","4433-43",Journal of virology,"","","","","","","","15078924","",,0,10,0,0,0,,,
136,17,"Geisbert et al., 2005",journal,"Geisbert TW, Jones S, Fritz EA, Shurtleff AC, Geisbert JB, Liebscher R, Grolla A, Stroher U, Fernando L, Daddario KM, Guttieri MC, Mothe BR, Larsen T, Hensley LE, Jahrling PB, Feldmann H",Development of a new vaccine for the prevention of Lassa fever,"2005 Jun","2","6",e183,PLoS medicine,"","","","","","","","15971954","",,0,10,0,0,0,,,
135,18,"Parrino et al., 2006",journal,"Parrino J, Graham BS","Smallpox vaccines: Past, present, and future","2006 Dec","118","6","1320-6",The Journal of allergy and clinical immunology,"","","","","","","","17157663 ","",,0,10,0,0,0,,,
124,14,"Jathoul et al., 2004",journal,"Jathoul AP, Holley JL, Garmory HS",Efficacy of DNA vaccines expressing the type F botulinum toxin Hc fragment using different promoters,"2004 Sep 28","22","29-30","3942-6",Vaccine,"","","","","","","","15364442","",,0,10,0,0,0,,,
125,14,"Arimitsu et al., 2004",journal,"Arimitsu H, Lee JC, Sakaguchi Y, Hayakawa Y, Hayashi M, Nakaura M, Takai H, Lin SN, Mukamoto M, Murphy T, Oguma K",Vaccination with recombinant whole heavy chain fragments of Clostridium botulinum Type C and D neurotoxins,"2004 May","11","3","496-502",Clinical and diagnostic laboratory immunology,"","","","","","","","15138174","",,0,10,0,0,0,,,
137,17,"Bredenbeek et al., 2006",journal,"Bredenbeek PJ, Molenkamp R, Spaan WJ, Deubel V, Marianneau P, Salvato MS, Moshkoff D, Zapata J, Tikhonov I, Patterson J, Carrion R, Ticer A, Brasky K, Lukashevich IS",A recombinant Yellow Fever 17D vaccine expressing Lassa virus glycoproteins,"2006 Feb 20","345","2","299-304",Virology,"","","","","","","","16412488","",,0,10,0,0,0,,,
127,14,"Bennett et al., 2003",journal,"Bennett AM, Perkins SD, Holley JL",DNA vaccination protects against botulinum neurotoxin type F,"2003 Jul 4","21","23","3110-7",Vaccine,"","","","","","","","12804837 ","",,0,10,0,0,0,,,
128,17,"Fisher-Hoch et al., 2000",journal,"Fisher-Hoch SP, Hutwagner L, Brown B, McCormick JB",Effective vaccine for lassa fever,"2000 Aug","74","15","6777-83",Journal of virology,"","","","","","","","10888616","",,0,10,0,0,0,,,
129,14,"Siegel, 1988",journal,Siegel LS,Human immune response to botulinum pentavalent (ABCDE) toxoid determined by a neutralization test and by an enzyme-linked immunosorbent assay,"1988 Nov","26","11","2351-6",Journal of clinical microbiology,"","","","","","","","3235662","",,0,10,0,0,0,,,
130,17,"Lukashevich et al., 2005",journal,"Lukashevich IS, Patterson J, Carrion R, Moshkoff D, Ticer A, Zapata J, Brasky K, Geiger R, Hubbard GB, Bryant J, Salvato MS",A live attenuated vaccine for Lassa fever made by reassortment of Lassa and Mopeia viruses,"2005 Nov","79","22","13934-42",Journal of virology,"","","","","","","","16254329","",,0,10,0,0,0,,,
131,17,"Auperin et al., 1988",journal,"Auperin DD, Esposito JJ, Lange JV, Bauer SP, Knight J, Sasso DR, McCormick JB",Construction of a recombinant vaccinia virus expressing the Lassa virus glycoprotein gene and protection of guinea pigs from a lethal Lassa virus infection,"1988 Feb","9","2-3","233-48",Virus research,"","","","","","","","3354260","",,0,10,0,0,0,,,
132,17,"Botten et al., 2006",journal,"Botten J, Alexander J, Pasquetto V, Sidney J, Barrowman P, Ting J, Peters B, Southwood S, Stewart B, Rodriguez-Carreno MP, Mothe B, Whitton JL, Sette A, Buchmeier MJ",Identification of protective Lassa virus epitopes that are restricted by HLA-A2,"2006 Sep","80","17","8351-61",Journal of virology,"","","","","","","","16912286","",,0,10,0,0,0,,,
139,18,"Casey et al., 2005",journal,"Casey CG, Iskander JK, Roper MH, Mast EE, Wen XJ, Torok TJ, Chapman LE, Swerdlow DL, Morgan J, Heffelfinger JD, Vitek C, Reef SE, Hasbrouck LM, Damon I, Neff L, Vellozzi C, McCauley M, Strikas RA, Mootrey G","Adverse events associated with smallpox vaccination in the United States, January-October 2003","2005 Dec 7","294","21","2734-43",JAMA : the journal of the American Medical Association,"","","","","","","","16333009 ","",,0,10,0,0,0,,,
140,18,"Grabenstein et al., 2003",journal,"Grabenstein JD, Winkenwerder W Jr",US military smallpox vaccination program experience,"2003 Jun 25","289","24","3278-82",JAMA : the journal of the American Medical Association,"","","","","","","","12824209 ","",,0,10,0,0,0,,,
141,18,"Greenberg et al., 2005",journal,"Greenberg RN, Kennedy JS, Clanton DJ, Plummer EA, Hague L, Cruz J, Ennis FA, Blackwelder WC, Hopkins RJ","Safety and immunogenicity of new cell-cultured smallpox vaccine compared with calf-lymph derived vaccine: a blind, single-centre, randomised controlled trial","2005 Jan 29-Feb 4","365","9457","398-409",Lancet,"","","","","","","","15680454 ","",,0,10,0,0,0,,,
142,18,"Weltzin et al., 2003",journal,"Weltzin R, Liu J, Pugachev KV, Myers GA, Coughlin B, Blum PS, Nichols R, Johnson C, Cruz J, Kennedy JS, Ennis FA, Monath TP",Clonal vaccinia virus grown in cell culture as a new smallpox vaccine,"2003 Sep","9","9","1125-30",Nature medicine,"","","","","","","","12925845 ","",,0,10,0,0,0,,,
143,18,"Empig et al., 2006",journal,"Empig C, Kenner JR, Perret-Gentil M, Youree BE, Bell E, Chen A, Gurwith M, Higgins K, Lock M, Rice AD, Schriewer J, Sinangil F, White E, Buller RM, Dermody TS, Isaacs SN, Moyer RW",Highly attenuated smallpox vaccine protects rabbits and mice against pathogenic orthopoxvirus challenge,"2006 Apr 24","24","17","3686-94",Vaccine,"","","","","","","","16430997 ","",,0,10,0,0,0,,,
144,18,"Monath et al., 2004",journal,"Monath TP, Caldwell JR, Mundt W, Fusco J, Johnson CS, Buller M, Liu J, Gardner B, Downing G, Blum PS, Kemp T, Nichols R, Weltzin R",ACAM2000 clonal Vero cell culture vaccinia virus (New York City Board of Health strain)--a second-generation smallpox vaccine for biological defense,"2004 Oct","8 Suppl 2","",S31-44,International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases,"","","","","","","","15491873","",,0,10,0,0,0,,,
146,18,"Ober et al., 2002",journal,"Ober BT, Bruhl P, Schmidt M, Wieser V, Gritschenberger W, Coulibaly S, Savidis-Dacho H, Gerencer M, Falkner FG",Immunogenicity and safety of defective vaccinia virus lister: comparison with modified vaccinia virus Ankara,"2002 Aug","76","15","7713-23",Journal of virology,"","","","","","","","12097585","",,0,10,0,0,0,,,
147,14,"Johnson, 1997",journal,Johnson S,Antibody responses to clostridial infection in humans,"1997 Sep","25 Suppl 2","",S173-7,Clinical infectious diseases : an official publication of the Infectious Diseases Society of America,"","","","","","","","9310668","",,0,10,0,0,0,,,
148,14,"Rubin et al., 1982",journal,"Rubin LG, Dezfulian M, Yolken RH",Serum antibody response to Clostridium botulinum toxin in infant botulism,"1982 Oct","16","4","770-1",Journal of clinical microbiology,"","","","","","","","7153329","",,0,10,0,0,0,,,
149,18,"Fogg et al., 2004",journal,"Fogg C, Lustig S, Whitbeck JC, Eisenberg RJ, Cohen GH, Moss B",Protective immunity to vaccinia virus induced by vaccination with multiple recombinant outer membrane proteins of intracellular and extracellular virions,"2004 Oct","78","19","10230-7",Journal of virology,"","","","","","","","15367588 ","",,0,10,0,0,0,,,
150,18,"Henderson, 1999",journal,Henderson DA,Smallpox: clinical and epidemiologic features,"1999 Jul-Aug","5","4","537-9",Emerging infectious diseases,"","","","","","","","10458961","",,0,10,0,0,0,,,
151,18,"Franz et al., 1997",journal,"Franz DR, Jahrling PB, Friedlander AM, McClain DJ, Hoover DL, Bryne WR, Pavlin JA, Christopher GW, Eitzen EM Jr",Clinical recognition and management of patients exposed to biological warfare agents,"1997 Aug 6","278","5","399-411",JAMA : the journal of the American Medical Association,"","","","","","","","9244332","",,0,10,0,0,0,,,
152,18,"Hassett, 2003",journal,Hassett DE,"Smallpox infections during pregnancy, lessons on pathogenesis from nonpregnant animal models of infection","2003 Oct","60","1","13-24",Journal of reproductive immunology,"","","","","","","","14568674","",,0,10,0,0,0,,,
153,18,"McFadden, 2005",journal,McFadden G,Poxvirus tropism,"2005 Mar","3","3","201-13",Nature reviews. Microbiology,"","","","","","","","15738948","",,0,10,0,0,0,,,
154,18,"Slifka, 2004",journal,Slifka MK,Immunological memory to viral infection,"2004 Aug","16","4","443-50",Current opinion in immunology,"","","","","","","","15245737","",,0,10,0,0,0,,,
155,18,"Earl et al., 2004",journal,"Earl PL, Americo JL, Wyatt LS, Eller LA, Whitbeck JC, Cohen GH, Eisenberg RJ, Hartmann CJ, Jackson DL, Kulesh DA, Martinez MJ, Miller DM, Mucker EM, Shamblin JD, Zwiers SH, Huggins JW, Jahrling PB, Moss B",Immunogenicity of a highly attenuated MVA smallpox vaccine and protection against monkeypox,"2004 Mar 11","428","6979","182-5",Nature,"","","","","","","","15014500","",,0,10,0,0,0,,,
156,18,"Meseda et al., 2005",journal,"Meseda CA, Garcia AD, Kumar A, Mayer AE, Manischewitz J, King LR, Golding H, Merchlinsky M, Weir JP",Enhanced immunogenicity and protective effect conferred by vaccination with combinations of modified vaccinia virus Ankara and licensed smallpox vaccine Dryvax in a mouse model,"2005 Sep 1","339","2","164-75",Virology,"","","","","","","","15993917 ","",,0,10,0,0,0,,,
157,18,"Vollmar et al., 2006",journal,"Vollmar J, Arndtz N, Eckl KM, Thomsen T, Petzold B, Mateo L, Schlereth B, Handley A, King L, Hulsemann V, Tzatzaris M, Merkl K, Wulff N, Chaplin P","Safety and immunogenicity of IMVAMUNE, a promising candidate as a third generation smallpox vaccine","2006 Mar 15","24","12","2065-70",Vaccine,"","","","","","","","16337719","",,0,10,0,0,0,,,
158,7,"Kutsenko et al., 2002",journal,"Kutsenko AS, Gizatullin RZ, Al-Amin AN, Wang F, Kvasha SM, Podowski RM, Matushkin YG, Gyanchandani A, Muravenko OV, Levitsky VG, Kolchanov NA, Protopopov AI, Kashuba VI, Kisselev LL, Wasserman W, Wahlestedt C, Zabarovsky ER",NotI flanking sequences: a tool for gene discovery and verification of the human genome,"2002 Jul 15","30","14","3163-70",Nucleic acids research,"","","","","","","","12136098","",,0,10,0,0,0,,,
159,18,"Stittelaar et al., 2005",journal,"Stittelaar KJ, van Amerongen G, Kondova I, Kuiken T, van Lavieren RF, Pistoor FH, Niesters HG, van Doornum G, van der Zeijst BA, Mateo L, Chaplin PJ, Osterhaus AD",Modified vaccinia virus Ankara protects macaques against respiratory challenge with monkeypox virus,"2005 Jun","79","12","7845-51",Journal of virology,"","","","","","","","15919938 ","",,0,10,0,0,0,,,
163,18,"Vilesova et al., 1985",journal,"Vilesova IS, Gurvich EB, Dzagurov SG, Grigor'eva LV, Abel H",[Changes in the properties of the vaccinia virus isolated in postvaccinal encephalitis],"1985 Jul-Aug","30","4","477-82",Voprosy virusologii,"","","","","","","","2865855","",,0,10,0,0,0,,,
164,18,"Edghill-Smith et al., 2003",journal,"Edghill-Smith Y, Venzon D","Modeling a safer smallpox vaccination regimen, for human immunodeficiency virus type 1-infected patients, in immunocompromised macaques","2003 Oct 15","188","8","1181-91",The Journal of infectious diseases,"","","","","","","", 14551889 ,"",,0,10,0,0,0,,,
162,18,"Hooper et al., 2006",journal,"Hooper JW, Golden JW, Ferro AM, King AD",Smallpox DNA vaccine delivered by novel skin electroporation device protects mice against intranasal poxvirus challenge,"2006 Nov 27","","","",Vaccine,"","","","","","","","17240007","",,0,10,0,0,0,,,
165,18,"Belyakov et al., 2003",journal,"Belyakov IM, Earl P, Dzutsev A, Kuznetsov VA, Lemon M, Wyatt LS, Snyder JT, Ahlers JD, Franchini G, Moss B, Berzofsky JA",Shared modes of protection against poxvirus infection by attenuated and conventional smallpox vaccine viruses,"2003 Aug 5","100","16","9458-63",Proceedings of the National Academy of Sciences of the United States of America,"","","","","","","","12869693 ","",,0,10,0,0,0,,,
166,18,"Sugimoto et al., 1994",journal,"Sugimoto M, Yamanouchi K","Characteristics of an attenuated vaccinia virus strain, LC16m0, and its recombinant virus vaccines","1994 Jun","12","8","675-81",Vaccine,"","","","","","","","8091843","",,0,10,0,0,0,,,
167,18,NCBI,website,"",Entrez Gene,"2006","","","","","","","","","","","","",http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?CMD=search&DB=gene,,0,10,0,0,0,,,
168,18,"Morikawa et al., 2005",journal,"Morikawa S, Sakiyama T, Hasegawa H, Saijo M, Maeda A, Kurane I, Maeno G, Kimura J, Hirama C, Yoshida T, Asahi-Ozaki Y, Sata T, Kurata T, Kojima A",An attenuated LC16m8 smallpox vaccine: analysis of full-genome sequence and induction of immune protection,"2005 Sep","79","18","11873-91",Journal of virology,"","","","","","","","16140764","",,0,10,0,0,0,,,
169,12,"Lauriano et al., 2003",journal,"Lauriano CM, Barker JR, Nano FE, Arulanandam BP, Klose KE",Allelic exchange in Francisella tularensis using PCR products,"2003 Dec 12","229","2","195-202",FEMS microbiology letters,"","","","","","","","14680699","",,0,10,0,0,0,,,
170,11,NCBI,website,"",Entrez Gene  ,"","","","","","","","","","","","","",http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?CMD=search&DB=gene,,0,10,0,0,0,,,
171,14,NCBI,website,"", Entrez Gene ,"","","","","","","","","","","","","",http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?CMD=search&DB=gene,,0,10,0,0,0,,,
178,11,"Heesemann et al., 2006",journal,"Heesemann J, Sing A, Trulzsch K",Yersinia's stratagem: targeting innate and adaptive immune defense,"2006 Feb","9","1","55-61",Current opinion in microbiology,"","","","","","","","16413818 ","",,0,10,0,0,0,,,
179,11,"Bashaw et al., 2007",journal,"Bashaw J, Norris S, Weeks S, Trevino S, Adamovicz JJ, Welkos S",Development of in vitro correlate assays of immunity to infection with Yersinia pestis,"2007 May","14","5","605-16",Clinical and vaccine immunology : CVI,"","","","","","","","17376861 ","",,0,10,0,0,0,,,
180,11,"Grosfeld et al., 2003",journal,"Grosfeld H, Cohen S, Bino T, Flashner Y, Ber R, Mamroud E, Kronman C, Shafferman A, Velan B",Effective protective immunity to Yersinia pestis infection conferred by DNA vaccine coding for derivatives of the F1 capsular antigen,"2003 Jan","71","1","374-83",Infection and immunity,"","","","","","","","12496187 ","",,0,10,0,0,0,,,
181,7,"Glomski et al., 2007",journal,"Glomski IJ, Corre JP, Mock M, Goossens PL",Cutting Edge: IFN-gamma-producing CD4 T lymphocytes mediate spore-induced immunity to capsulated Bacillus anthracis,"2007 Mar 1","178","5","2646-50","Journal of immunology (Baltimore, Md. : 1950)","","","","","","","","17312104 ","",,0,10,0,0,0,,,
182,18,"Amanna et al., 2006",journal,"Amanna IJ, Slifka MK, Crotty S",Immunity and immunological memory following smallpox vaccination,"2006 Jun","211","","320-37",Immunological reviews,"","","","","","","","16824139 ","",,0,10,0,0,0,,,
187,8,"Vemulapalli et al., 2004",journal,"Vemulapalli R, Contreras A, Sanakkayala N, Sriranganathan N, Boyle SM, Schurig GG",Enhanced efficacy of recombinant Brucella abortus RB51 vaccines against B. melitensis infection in mice,"2004 Sep 8","102","3-4","237-45",Veterinary microbiology,,,,,,,,"15327798",,,0,10,0,0,0,,,
188,8,"Cheville, 2000",journal,Cheville NF,"Development, testing and commercialization of a new brucellosis vaccine for cattle","2000","916","","147-53",Annals of the New York Academy of Sciences,,,,,,,,"11193615",,,0,10,0,0,0,,,
189,8,"Vemulapalli et al., 2000b",journal,"Vemulapalli R, He Y, Buccolo LS, Boyle SM, Sriranganathan N, Schurig GG",Complementation of Brucella abortus RB51 with a functional wboA gene results in O-antigen synthesis and enhanced vaccine efficacy but no change in rough phenotype and attenuation,"2000 Jul","68","7","3927-32",Infection and immunity,,,,,,,,"10858205",,,0,10,0,0,0,,,
190,8,"Geong et al., 2000",journal,"Geong M, Robertson ID",Response of Bali cattle (Bos javanicus) to vaccination with Brucella abortus strain 19 in West Timor,"2000 Nov 16","47","3","177-86",Preventive veterinary medicine,,,,,,,,"11058778",,,0,10,0,0,0,,,
191,8,"Stevens et al., 1994b",journal,"Stevens MG, Olsen SC, Pugh GW Jr, Palmer MV","Immune and pathologic responses in mice infected with Brucella abortus 19, RB51, or 2308","1994 Aug","62","8","3206-12",Infection and immunity,,,,,,,,"8039890",,,0,10,0,0,0,,,
192,8,"Cloeckaert et al., 2002",journal,"Cloeckaert A, Grayon M, Grepinet O",Identification of Brucella melitensis vaccine strain Rev.1 by PCR-RFLP based on a mutation in the rpsL gene,"2002 Jun 7","20","19-20","2546-50",Vaccine,,,,,,,,"12057611",,,0,10,0,0,0,,,
193,8,"Banai, 2002",journal,Banai M,Control of small ruminant brucellosis by use of Brucella melitensis Rev.1 vaccine: laboratory aspects and field observations,"2002 Dec 20","90","1-4","497-519",Veterinary microbiology,,,,,,,,"12414167",,,0,10,0,0,0,,,
420,8,"Oliveira et al., 1994",journal,"Oliveira SC, Zhu Y, Splitter G",Sequences of the rplJL operon containing the L10 and L7/L12 genes from Brucella abortus,"1994 Mar 11","140","1","137-8",Gene,"","","","","","","","8125331 ","",,0,10,0,0,0,,,
421,30,"Kristoff, 2007",journal,Kristoff J,Malaria stage-specific vaccine candidates,"2007","13","19","1989-99",Current pharmaceutical design,"","","","","","","","17627532","",,0,10,0,0,0,,,
195,8,"Jacques et al., 2007",journal,"Jacques I, Verger JM, Laroucau K, Grayon M, Vizcaino N, Peix A, Cortade F, Carreras F, Guilloteau LA",Immunological responses and protective efficacy against Brucella melitensis induced by bp26 and omp31 B. melitensis Rev.1 deletion mutants in sheep,"2007 Jan 15","25","5","794-805",Vaccine,,,,,,,,"17070627",,,0,10,0,0,0,,,
196,8,"He et al., 2002",journal,"He Y, Vemulapalli R, Schurig GG","Recombinant Ochrobactrum anthropi expressing Brucella abortus Cu,Zn superoxide dismutase protects mice against B. abortus infection only after switching of immune responses to Th1 type","2002 May","70","5","2535-43",Infection and immunity,,,,,,,,"11953393",,,0,10,0,0,0,,,
197,24,"Lee et al., 1999",journal,"Lee LH, Burg E 3rd, Baqar S, Bourgeois AL, Burr DH, Ewing CP, Trust TJ, Guerry P",Evaluation of a truncated recombinant flagellin subunit vaccine against Campylobacter jejuni,"1999 Nov","67","11","5799-805",Infection and immunity,"","","","","","","","10531231","",,0,10,0,0,0,,,
198,24,"Pawelec et al., 2000",journal,"Pawelec DP, Korsak D, Wyszynska AK, Rozynek E, Popowski J, Jagusztyn-Krynicka EK",Genetic diversity of the Campylobacter genes coding immunodominant proteins,"2000 Apr 1","185","1","43-9",FEMS microbiology letters,"","","","","","","","10731605","",,0,10,0,0,0,,,
199,24,"Smibert, 1978",journal,Smibert RM,The genus Campylobacter,"1978","32","","673-709",Annual review of microbiology,"","","","","","","","360978","",,0,10,0,0,0,,,
200,25,Pathport,website,"",Escherichia coli,"","","","","","","","","","","","","",http://pathport.vbi.vt.edu/pathinfo/,,0,10,0,0,0,,,
201,24,"Nelson et al., 2007",journal,"Nelson JM, Chiller TM, Powers JH, Angulo FJ",Fluoroquinolone-resistant Campylobacter species and the withdrawal of fluoroquinolones from use in poultry: a public health success story,"2007 Apr 1","44","7","977-80",Clinical infectious diseases : an official publication of the Infectious Diseases Society of America,"","","","","","","","17342653","",,0,10,0,0,0,,,
202,24,"Abulreesh et al., 2006",journal,"Abulreesh HH, Paget TA, Goulder R",Campylobacter in waterfowl and aquatic environments: incidence and methods of detection,"2006 Dec 1","40","23","7122-31",Environmental science &amp; technology,"","","","","","","","17180958","",,0,10,0,0,0,,,
203,24,"Engberg, 2006",journal,Engberg J,Contributions to the epidemiology of Campylobacter infections. A review of clinical and microbiological studies,"2006 Nov","53","4","361-89",Danish medical bulletin,"","","","","","","","17150145","",,0,10,0,0,0,,,
204,24,"Baqar et al., 1995a",journal,"Baqar S, Bourgeois AL, Schultheiss PJ, Walker RI, Rollins DM, Haberberger RL, Pavlovskis OR",Safety and immunogenicity of a prototype oral whole-cell killed Campylobacter vaccine administered with a mucosal adjuvant in non-human primates,"1995 Jan","13","1","22-8",Vaccine,"","","","","","","","7539199","",,0,10,0,0,0,,,
205,24,"Baqar et al., 1995b",journal,"Baqar S, Applebee LA, Bourgeois AL",Immunogenicity and protective efficacy of a prototype Campylobacter killed whole-cell vaccine in mice,"1995 Sep","63","9","3731-5",Infection and immunity,"","","","","","","","7642317","",,0,10,0,0,0,,,
206,25,"Daley et al., 2007",journal,"Daley A, Randall R, Darsley M, Choudhry N, Thomas N, Sanderson IR, Croft N, Kelly P",Genetically modified enterotoxigenic escherichia coli vaccines induce mucosal immune responses without inflammation,"2007 Jun 12","","","",Gut,"","","","","","","","17566016","",,0,10,0,0,0,,,
207,25,"Melkebeek et al., 2007",journal,"Melkebeek V, Verdonck F, Goddeeris BM, Cox E",Comparison of immune responses in parenteral FaeG DNA primed pigs boosted orally with F4 protein or reimmunized with the DNA vaccine,"2007 Apr 15","116","3-4","199-214",Veterinary immunology and immunopathology,"","","","","","","","17331591","",,0,10,0,0,0,,,
208,25,"van et al., 2007",journal,"van Diemen PM, Dziva F, Abu-Median A, Wallis TS, van den Bosch H, Dougan G, Chanter N, Frankel G, Stevens MP",Subunit vaccines based on intimin and Efa-1 polypeptides induce humoral immunity in cattle but do not protect against intestinal colonisation by enterohaemorrhagic Escherichia coli O157:H7 or O26:H-,"2007 Mar 15","116","1-2","47-58",Veterinary immunology and immunopathology,"","","","","","","","17258324","",,0,10,0,0,0,,,
209,8,"Moriyon et al., 2004",journal,"Moriyon I, Grillo MJ, Monreal D, Gonzalez D, Marin C, Lopez-Goni I, Mainar-Jaime RC, Moreno E, Blasco JM",Rough vaccines in animal brucellosis: structural and genetic basis and present status,"2004 Jan-Feb","35","1","1-38",Veterinary research,,,,,,,,"15099501",,,0,10,0,0,0,,,
210,8,"Blasco et al., 1993",journal,"Blasco JM, Gamazo C, Winter AJ, Jimenez de Bagues MP, Marin C, Barberan M, Moriyon I, Alonso-Urmeneta B, Diaz R",Evaluation of whole cell and subcellular vaccines against Brucella ovis in rams,"1993 Aug","37","3-4","257-70",Veterinary immunology and immunopathology,,,,,,,,"8236802",,,0,10,0,0,0,,,
211,25,"Walker et al., 2007",journal,"Walker RI, Steele D, Aguado T",Analysis of strategies to successfully vaccinate infants in developing countries against enterotoxigenic E. coli (ETEC) disease,"2007 Mar 30","25","14","2545-66",Vaccine,"","","","","","","","17224212","",,0,10,0,0,0,,,
212,25,"Moravec et al., 2007",journal,"Moravec T, Schmidt MA, Herman EM, Woodford-Thomas T",Production of Escherichia coli heat labile toxin (LT) B subunit in soybean seed and analysis of its immunogenicity as an oral vaccine,"2007 Feb 19","25","9","1647-57",Vaccine,"","","","","","","","17188785","",,0,10,0,0,0,,,
213,25,"Durant et al., 2007",journal,"Durant L, Metais A, Soulama-Mouze C, Genevard JM, Nassif X, Escaich S",Identification of candidates for a subunit vaccine against extraintestinal pathogenic Escherichia coli,"2007 Apr","75","4","1916-25",Infection and immunity,"","","","","","","", 17145948 ,"",,0,10,0,0,0,,,
214,25,"Lynne et al., 2006",journal,"Lynne AM, Foley SL, Nolan LK",Immune response to recombinant Escherichia coli Iss protein in poultry,"2006 Jun","50","2","273-6",Avian diseases,"","","","","","","","16863080","",,0,10,0,0,0,,,
215,25,"Zhang et al., 2006",journal,"Zhang J, Shi Z, Kong FK, Jex E, Huang Z, Watt JM, Van Kampen KR, Tang DC",Topical application of Escherichia coli-vectored vaccine as a simple method for eliciting protective immunity,"2006 Jun","74","6","3607-17",Infection and immunity,"","","","","","","","16714593","",,0,10,0,0,0,,,
216,8,"Winter et al., 1996",journal,"Winter AJ, Schurig GG, Boyle SM, Sriranganathan N, Bevins JS, Enright FM, Elzer PH, Kopec JD",Protection of BALB/c mice against homologous and heterologous species of Brucella by rough strain vaccines derived from Brucella melitensis and Brucella suis biovar 4,"1996 May","57","5","677-83",American journal of veterinary research,,,,,,,,"8723881",,,0,10,0,0,0,,,
217,25,"Bozic et al., 2006",journal,"Bozic F, Lackovic G, Kovsca-Janjatovic A, Smolec O, Valpotic I",Levamisole synergizes experimental F4ac+ Escherichia coli oral vaccine in stimulating ileal Peyer's patch T cells in weaned pigs,"2006 Jun","29","3","199-204",Journal of veterinary pharmacology and therapeutics,"","","","","","","","16669864","",,0,10,0,0,0,,,
218,25,"Wen et al., 2006",journal,"Wen SX, Teel LD, Judge NA, O'Brien AD",A plant-based oral vaccine to protect against systemic intoxication by Shiga toxin type 2,"2006 May 2","103","18","7082-7",Proceedings of the National Academy of Sciences of the United States of America,"","","","","","","","16641102","",,0,10,0,0,0,,,
219,8,"Bhattacharjee et al., 2006",journal,"Bhattacharjee AK, Izadjoo MJ, Zollinger WD, Nikolich MP, Hoover DL",Comparison of protective efficacy of subcutaneous versus intranasal immunization of mice with a Brucella melitensis lipopolysaccharide subunit vaccine,"2006 Oct","74","10","5820-5",Infection and immunity,,,,,,,,"16988260",,,0,10,0,0,0,,,
220,8,"Munoz-Montesino et al., 2004",journal,"Munoz-Montesino C, Andrews E, Rivers R, Gonzalez-Smith A, Moraga-Cid G, Folch H, Cespedes S, Onate AA",Intraspleen delivery of a DNA vaccine coding for superoxide dismutase (SOD) of Brucella abortus induces SOD-specific CD4+ and CD8+ T cells,"2004 Apr","72","4","2081-7",Infection and immunity,,,,,,,,"15039330",,,0,10,0,0,0,,,
221,25,Pubmed,website,"",Protein search,"","","","","","","","","","","","","",http://www.ncbi.nlm.nih.gov.proxy.lib.umich.edu/sites/entrez?db=Protein,,0,10,0,0,0,,,
222,8,"Cassataro et al., 2007",journal,"Cassataro J, Pasquevich KA, Estein SM, Laplagne DA, Zwerdling A, de la Barrera S, Bowden R, Fossati CA, Giambartolomei GH, Goldbaum FA",A DNA vaccine coding for the quimera BLSOmp31 induced a better degree of protection against B. ovis and a similar degree of protection against B. melitensis than Rev.1 vaccination,"2007 Jun 12","","","",Vaccine,,,,,,,,"17600596",,,0,10,0,0,0,,,
223,26,"Coffin et al., 1986",journal,"Coffin J, Haase A, Levy JA, Montagnier L, Oroszlan S, Teich N, Temin H, Toyoshima K, Varmus H, Vogt P",What to call the AIDS virus?,"1986 May 1-7","321","6065","10",Nature,"","","","","","","","3010128","",,0,10,0,0,0,,,
224,26,"Palella et al., 1998",journal,"Palella FJ Jr, Delaney KM, Moorman AC, Loveless MO, Fuhrer J, Satten GA, Aschman DJ, Holmberg SD",Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection. HIV Outpatient Study Investigators,"1998 Mar 26","338","13","853-60",The New England journal of medicine,"","","","","","","","9516219","",,0,10,0,0,0,,,
225,26,"Buchbinder et al., 1994",journal,"Buchbinder SP, Katz MH, Hessol NA, O'Malley PM, Holmberg SD",Long-term HIV-1 infection without immunologic progression,"1994 Aug","8","8","1123-8","AIDS (London, England)","","","","","","","","7986410","",,0,10,0,0,0,,,
226,27,"Lednicky, 2003",journal,Lednicky JA,Hantaviruses. a short review,"2003 Jan","127","1","30-5",Archives of pathology &amp; laboratory medicine,,,,,,,,"12521363",,,0,10,0,0,0,,,
227,27,CDC Hantaviruses,website,"",CDC Hantaviruses,"","","","","","","","","","","","","",http://0-www.cdc.gov.mill1.sjlibrary.org/ncidod/diseases/hanta/hps/,,0,10,0,0,0,,,
228,27,"de Carvalho Nicacio et al., 2002",journal,"de Carvalho Nicacio C, Gonzalez Della Valle M, Padula P, Bjorling E, Plyusnin A, Lundkvist A",Cross-protection against challenge with Puumala virus after immunization with nucleocapsid proteins from different hantaviruses,"2002 Jul","76","13","6669-77",Journal of virology,,,,,,,,"12050380",,,0,10,0,0,0,,,
229,27,"Klingstrom et al., 2004",journal,"Klingstrom J, Maljkovic I, Zuber B, Rollman E, Kjerrstrom A, Lundkvist A",Vaccination of C57/BL6 mice with Dobrava hantavirus nucleocapsid protein in Freund's adjuvant induced partial protection against challenge,"2004 Sep 28","22","29-30","4029-34",Vaccine,"","","","","","","","15364453","",,0,10,0,0,0,,,
230,27,"Kruger et al., 2001",journal,"Kruger DH, Ulrich R, Lundkvist A A",Hantavirus infections and their prevention,"2001 Nov","3","13","1129-44",Microbes and infection / Institut Pasteur,"","","","","","","","11709294 ","",,0,10,0,0,0,,,
231,27,"Maes et al., 2006",journal,"Maes P, Keyaerts E, Bonnet V, Clement J, Avsic-Zupanc T, Robert A, Van Ranst M","Truncated recombinant Dobrava hantavirus nucleocapsid proteins induce strong, long-lasting immune responses in mice","2006","49","5","253-60",Intervirology,,,,,,,,"16714853",,,0,10,0,0,0,,,
232,28,"Bausch et al., 2007",journal,"Bausch DG, Geisbert TW",Development of vaccines for Marburg hemorrhagic fever,"2007 Feb","6","1","57-74",Expert review of vaccines,,,,,,,,"17280479",,,0,10,0,0,0,,,
233,29,"Gupta et al., 2007",journal,"Gupta UD, Katoch VM, McMurray DN",Current status of TB vaccines,"2007 May 10","25","19","3742-51",Vaccine,,,,,,,,"17321015",,,0,10,0,0,0,,,
234,29,"Fletcher, 2007",journal,Fletcher HA,Correlates of immune protection from tuberculosis,"2007 May","7","3","319-25",Current molecular medicine,,,,,,,,"17504116",,,0,10,0,0,0,,,
235,25,"Judge et al., 2004",journal,"Judge NA, Mason HS, O'Brien AD",Plant cell-based intimin vaccine given orally to mice primed with intimin reduces time of Escherichia coli O157:H7 shedding in feces,"2004 Jan","72","1","168-75",Infection and immunity,"","","","","","","","14688094 ","",,0,10,0,0,0,,,
236,26,"Chan et al., 1997",journal,"Chan DC, Fass D, Berger JM, Kim PS",Core structure of gp41 from the HIV envelope glycoprotein,"1997 Apr 18","89","2","263-73",Cell,"","","","","","","","9108481","",,0,10,0,0,0,,,
237,26,"Coakley et al., 2005",journal,"Coakley E, Petropoulos CJ, Whitcomb JM",Assessing chemokine co-receptor usage in HIV,"2005 Feb","18","1","9-15",Current opinion in infectious diseases,"","","","","","","","15647694","",,0,10,0,0,0,,,
238,26,"Deng et al., 1996",journal,"Deng H, Liu R, Ellmeier W, Choe S, Unutmaz D, Burkhart M, Di Marzio P, Marmon S, Sutton RE, Hill CM, Davis CB, Peiper SC, Schall TJ, Littman DR, Landau NR",Identification of a major co-receptor for primary isolates of HIV-1,"1996 Jun 20","381","6584","661-6",Nature,"","","","","","","","8649511","",,0,10,0,0,0,,,
239,26,"Knight et al., 1990",journal,"Knight SC, Macatonia SE, Patterson S",HIV I infection of dendritic cells,"1990","6","2-3","163-75",International reviews of immunology,"","","","","","","","2152500","",,0,10,0,0,0,,,
240,30,"Joy et al., 2003",journal,"Joy DA, Feng X, Mu J, Furuya T, Chotivanich K, Krettli AU, Ho M, Wang A, White NJ, Suh E, Beerli P, Su XZ",Early origin and recent expansion of Plasmodium falciparum,"2003 Apr 11","300","5617","318-21","Science (New York, N.Y.)","","","","","","","","12690197","",,0,10,0,0,0,,,
241,30,"Escalante et al., 1998",journal,"Escalante AA, Freeland DE, Collins WE, Lal AA",The evolution of primate malaria parasites based on the gene encoding cytochrome b from the linear mitochondrial genome,"1998 Jul 7","95","14","8124-9",Proceedings of the National Academy of Sciences of the United States of America,"","","","","","","","9653151","",,0,10,0,0,0,,,
242,30,"Kaufman et al., 2005",journal,"Kaufman TS, Ruveda EA",The quest for quinine: those who won the battles and those who won the war,"2005 Jan 28","44","6","854-85",Angewandte Chemie (International ed. in English),"","","","","","","","15669029","",,0,10,0,0,0,,,
243,30,"Meis et al., 1983",journal,"Meis JF, Verhave JP, Jap PH, Sinden RE, Meuwissen JH",Malaria parasites--discovery of the early liver form,"1983 Mar 31-Apr 6","302","5907","424-6",Nature,"","","","","","","","6339945","",,0,10,0,0,0,,,
244,30,"Talman et al., 2004",journal,"Talman AM, Domarle O, McKenzie FE, Ariey F, Robert V",Gametocytogenesis: the puberty of Plasmodium falciparum,"2004 Jul 14","3","","24",Malaria journal,"","","","","","","","15253774","",,0,10,0,0,0,,,
245,30,"Bledsoe, 2005",journal,Bledsoe GH,Malaria primer for clinicians in the United States,"2005 Dec","98","12","1197-204; quiz 1205, 1230",Southern medical journal,"","","","","","","","16440920","",,0,10,0,0,0,,,
246,30,"Sturm et al., 2006",journal,"Sturm A, Amino R, van de Sand C, Regen T, Retzlaff S, Rennenberg A, Krueger A, Pollok JM, Menard R, Heussler VT",Manipulation of host hepatocytes by the malaria parasite for delivery into liver sinusoids,"2006 Sep 1","313","5791","1287-90","Science (New York, N.Y.)","","","","","","","","16888102","",,0,10,0,0,0,,,
247,30,"Breman, 2001",journal,Breman JG,"The ears of the hippopotamus: manifestations, determinants, and estimates of the malaria burden","2001 Jan-Feb","64","1-2 Suppl","1-11",The American journal of tropical medicine and hygiene,"","","","","","","","11425172","",,0,10,0,0,0,,,
248,30,"Greenwood et al., 2005",journal,"Greenwood BM, Bojang K, Whitty CJ, Targett GA",Malaria,"2005 Apr 23-29","365","9469","1487-98",Lancet,"","","","","","","","15850634","",,0,10,0,0,0,,,
249,30,"Hay et al., 2004",journal,"Hay SI, Guerra CA, Tatem AJ, Noor AM, Snow RW","The global distribution and population at risk of malaria: past, present, and future","2004 Jun","4","6","327-36",The Lancet infectious diseases,"","","","","","","","15172341","",,0,10,0,0,0,,,
250,30,"Chen et al., 2000",journal,"Chen Q, Schlichtherle M, Wahlgren M",Molecular aspects of severe malaria,"2000 Jul","13","3","439-50",Clinical microbiology reviews,"","","","","","","","10885986","",,0,10,0,0,0,,,
251,30,"Adams et al., 2002",journal,"Adams S, Brown H, Turner G",Breaking down the blood-brain barrier: signaling a path to cerebral malaria?,"2002 Aug","18","8","360-6",Trends in parasitology,"","","","","","","","12377286","",,0,10,0,0,0,,,
252,31,"Makwana et al., 2007",journal,"Makwana N, Riordan FA",Bacterial meningitis: the impact of vaccination,"2007","21","5","355-66",CNS drugs,"","","","","","","","17447825","",,0,10,0,0,0,,,
253,31,"Marrs et al., 2001",journal,"Marrs CF, Krasan GP, McCrea KW, Clemans DL, Gilsdorf JR",Haemophilus influenzae - human specific bacteria,"2001 Sep 1","6","",E41-60,Frontiers in bioscience : a journal and virtual library,"","","","","","","","11532609","",,0,10,0,0,0,,,
254,31,"Kilian et al, 1991",book,"Kilian, M",Haemophilus,"1991","","", 463-470,"Manual of clinical microbiology, 5th ed",American Society for Microbiology,"Washington, DC","alows, A., Hausler, W.J. Jr., Herrmann, K.L., Isenberg, H.D. & H.J. Shadomy","","","","","","",,0,10,0,0,0,,,
255,31,"Talan et al., 1999",journal,"Talan DA, Moran GJ, Pinner RW","Progress toward eliminating Haemophilus influenzae type b disease among infants and children--United States, 1987-1997","1999 Jul","34","1","109-11",Annals of emergency medicine,"","","","","","","","10382005","",,0,10,0,0,0,,,
256,31,"Reinholdt et al., 1997",journal,"Reinholdt J, Kilian M","Comparative analysis of immunoglobulin A1 protease activity among bacteria representing different genera, species, and strains","1997 Nov","65","11","4452-9",Infection and immunity,"","","","","","","","9353019","",,0,10,0,0,0,,,
257,31,ActHIB 2005,website,Sanofi Pasteur Inc.,Haemophilus b conjugate vaccine ActHIB,"2005","","","","","","","","","","","","",http://www.acthib.com,,0,10,0,0,0,,,
258,31,"Decker et al., 1992",journal,"Decker MD, Edwards KM, Bradley R, Palmer P",Comparative trial in infants of four conjugate Haemophilus influenzae type b vaccines,"1992 Feb","120","2 Pt 1","184-9",The Journal of pediatrics,"","","","","","","","1735812","",,0,10,0,0,0,,,
259,31,"Fritzell et al., 1992",journal,"Fritzell B, Plotkin S",Efficacy and safety of a Haemophilus influenzae type b capsular polysaccharide-tetanus protein conjugate vaccine,"1992 Sep","121","3","355-62",The Journal of pediatrics,"","","","","","","","1517908","",,0,10,0,0,0,,,
260,31,PedvasHIB,website,"",Liquid PedvaxHIB,"","","","","","","","","","","","","",http://www.merck.com/product/usa/pi_circulars/p/pedvax_hib,,0,10,0,0,0,,,
261,31,Marburg 1986,journal,"S. Marburg, D. Jorn, R. L. Tolman, B. Arison, J. McCauley, P. J. Kniskern, A. Hagopian, and P. P. Vella",Bimolecular chemistry of macromolecules: synthesis of bacterial polysaccharide conjugates with Neisseria meningitidis membrane protein,"1986","108","","5282-5287",Journal of the American Chemical Society,"","","","","","","","",http://pubs.acs.org/cgi-bin/archive.cgi/jacsat/1986/108/i17/pdf/ja00277a037.pdf,,0,10,0,0,0,,,
262,31,"Meekison et al., 1989",journal,"Meekison W, Hutcheon M, Guasparini R, Arnott M, Scheifele D, Grace M, Humphreys G, Barreto L",Post-marketing surveillance of adverse events following ProHIBit vaccine--British Columbia,"1989 Jul 15","15","28","143-5",Canada diseases weekly report = Rapport hebdomadaire des maladies au Canada,"","","","","","","", 2791073,"",,0,10,0,0,0,,,
263,26,"Shiver et al., 2002",journal,"Shiver JW, Fu TM, Chen L, Casimiro DR, Davies ME, Evans RK, Zhang ZQ, Simon AJ, Trigona WL, Dubey SA, Huang L, Harris VA, Long RS, Liang X, Handt L, Schleif WA, Zhu L, Freed DC, Persaud NV, Guan L, Punt KS, Tang A, Chen M, Wilson KA, Collins KB, Heidecker GJ, Fernandez VR, Perry HC, Joyce JG, Grimm KM, Cook JC, Keller PM, Kresock DS, Mach H, Troutman RD, Isopi LA, Williams DM, Xu Z, Bohannon KE, Volkin DB, Montefiori DC, Miura A, Krivulka GR, Lifton MA, Kuroda MJ, Schmitz JE, Letvin NL, Caulfield MJ, Bett AJ, Youil R, Kaslow DC, Emini EA",Replication-incompetent adenoviral vaccine vector elicits effective anti-immunodeficiency-virus immunity,"2002 Jan 17","415","6869","331-5",Nature,"","","","","","","","11797011","",,0,10,0,0,0,,,
265,26,"Takehisa et al., 2001",journal,"Takehisa J, Harada Y, Ndembi N, Mboudjeka I, Taniguchi Y, Ngansop C, Kuate S, Zekeng L, Ibuki K, Shimada T, Bikandou B, Yamaguchi-Kabata Y, Miura T, Ikeda M, Ichimura H, Kaptue L, Hayami M",Natural infection of wild-born mandrills (Mandrillus sphinx) with two different types of simian immunodeficiency virus,"2001 Aug 10","17","12","1143-54",AIDS research and human retroviruses,"","","","","","","","11522184","",,0,10,0,0,0,,,
266,31,HibTITER 2007,website,"",HAEMOPHILUS b CONJUGATE VACCINE (Diphtheria CRM197 Protein Conjugate) HibTITER,"2007","","","","","","","","","","","","",http://www.wyeth.com/content/showlabeling.asp?id=105,,0,10,0,0,0,,,
267,31,"Weinberg et al., 1988",journal,"Weinberg GA, Granoff DM",Polysaccharide-protein conjugate vaccines for the prevention of Haemophilus influenzae type b disease,"1988 Oct","113","4","621-31",The Journal of pediatrics,"","","","","","","","3050001 ","",,0,10,0,0,0,,,
268,31,"Rothstein et al., 1991",journal,"Rothstein EP, Madore DV, Long SS",Antibody persistence four years after primary immunization of infants and toddlers with Haemophilus influenzae type b CRM197 conjugate vaccine,"1991 Oct","119","4","655-7",The Journal of pediatrics,"","","","","","","","1919902","",,0,10,0,0,0,,,
269,31,AAPC 1991,journal,American Academy of Pediatrics Committee,American Academy of Pediatrics Committee on Infectious Diseases: Haemophilus influenzae type b conjugate vaccines: recommendations for immunization of infants and children 2 months of age and older: update.,"1991","88","1","169-172",Pediatrics,"","","","","","","","2057256","",,0,10,0,0,0,,,
686,8,"Winter et al., 1988",journal,"Winter AJ, Rowe GE, Duncan JR, Eis MJ, Widom J, Ganem B, Morein B",Effectiveness of natural and synthetic complexes of porin and O polysaccharide as vaccines against Brucella abortus in mice,"1988","56","11","2808-2817",Infection and immunity,"","","","","","","","2844673","","",0,10,0,0,0,,,
682,25,"Pascual et al., 1999",journal,"Pascual DW, Hone DM, Hall S, van Ginkel FW, Yamamoto M, Walters N, Fujihashi K, Powell RJ, Wu S, Vancott JL, Kiyono H, McGhee JR",Expression of recombinant enterotoxigenic Escherichia coli colonization factor antigen I by Salmonella typhimurium elicits a biphasic T helper cell response,"1999","67","12","6249-6256",Infection and immunity,"","","","","","","","10569734 ","","",0,10,0,0,0,,,
311,31,"Tandon et al., 1991",journal,"Tandon MK, Gebski V",A controlled trial of a killed Haemophilus influenzae vaccine for prevention of acute exacerbations of chronic bronchitis,"1991 Aug","21","4","427-32",Australian and New Zealand journal of medicine,"","","","","","","","1953532","",,0,10,0,0,0,,,
279,31,"Lepow et al., 1987",journal,"Lepow ML, Barkin RM, Berkowitz CD, Brunell PA, James D, Meier K, Ward J, Zahradnik JM, Samuelson J, McVerry PH",Safety and immunogenicity of Haemophilus influenzae type b polysaccharide-diphtheria toxoid conjugate vaccine (PRP-D) in infants,"1987 Oct","156","4","591-6",The Journal of infectious diseases,"","","","","","","","3497990 ","",,0,10,0,0,0,,,
310,31,"Lehmann et al., 1991",journal,"Lehmann D, Coakley KJ, Coakley CA, Spooner V, Montgomery JM, Michael A, Riley ID, Smith T, Clancy RL, Cripps AW",Reduction in the incidence of acute bronchitis by an oral Haemophilus influenzae vaccine in patients with chronic bronchitis in the highlands of Papua New Guinea,"1991 Aug","144","2","324-30",The American review of respiratory disease,"","","","","","","","1859055","",,0,10,0,0,0,,,
294,31,"Foxwell et al., 2006",journal,"Foxwell AR, Cripps AW, Dear KB",Haemophilus influenzae oral whole cell vaccination for preventing acute exacerbations of chronic bronchitis,"2006 Oct 18","","4",CD001958,Cochrane database of systematic reviews (Online),"","","","","","","","17054150 ","",,0,10,0,0,0,,,
285,31,ProHIBiT  2007,website,"",Haemophilus b Conjugate Vaccine (Diphtheria Toxoid-Conjugate),"2007","","","","","","","","","","","","",http://www.rxlist.com/cgi/generic/prohibit.htm,,0,10,0,0,0,,,
309,31,"Clancy et al., 1992",journal,"Clancy RL, Cripps AW",Specific protection against acute bronchitis associated with nontypeable Haemophilus influenzae,"1992 Jun","165 Suppl 1","",S194-5,The Journal of infectious diseases,"","","","","","","","1588162","",,0,10,0,0,0,,,
307,31,"Clancy et al., 1985",journal,"Clancy R, Cripps A, Murree-Allen K, Yeung S, Engel M",Oral immunisation with killed Haemophilus influenzae for protection against acute bronchitis in chronic obstructive lung disease,"1985 Dec 21-28","2","8469-70","1395-7",Lancet,"","","","","","","","2867396","",,0,10,0,0,0,,,
308,31,"Clancy et al., 1990",journal,"Clancy RL, Cripps AW, Gebski V",Protection against recurrent acute bronchitis after oral immunization with killed Haemophilus influenzae,"1990 Apr 16","152","8","413-6",The Medical journal of Australia,"","","","","","","","2184330","",,0,10,0,0,0,,,
316,26,"Lu et al., 2000",journal,"Lu Y, Friedman R, Kushner N, Doling A, Thomas L, Touzjian N, Starnbach M, Lieberman J",Genetically modified anthrax lethal toxin safely delivers whole HIV protein antigens into the cytosol to induce T cell immunity,"2000 Jul 5","97","14","8027-32",Proceedings of the National Academy of Sciences of the United States of America,"","","","","","","","10884430","",,0,10,0,0,0,,,
315,26,"McEvers et al., 2005",journal,"McEvers K, Elrefaei M, Norris P, Deeks S, Martin J, Lu Y, Cao H",Modified anthrax fusion proteins deliver HIV antigens through MHC Class I and II pathways,"2005 Jul 14","23","32","4128-35",Vaccine,"","","","","","","","15964481","",,0,10,0,0,0,,,
314,26,"Durier et al., 2006",journal,"Durier C, Launay O, Meiffredy V, Saidi Y, Salmon D, Levy Y, Guillet JG, Pialoux G, Aboulker JP",Clinical safety of HIV lipopeptides used as vaccines in healthy volunteers and HIV-infected adults,"2006 Apr 24","20","7","1039-49","AIDS (London, England)","","","","","","","","16603857","",,0,10,0,0,0,,,
312,26,"Tatalick et al., 2005",journal,"Tatalick LM, Gerard CJ, Takeya R, Price DN, Thorne BA, Wyatt LM, Anklesaria P",Safety characterization of HeLa-based cell substrates used in the manufacture of a recombinant adeno-associated virus-HIV vaccine,"2005 Apr 8","23","20","2628-38",Vaccine,"","","","","","","","15780446","",,0,10,0,0,0,,,
313,26,"Chen et al., 2005",journal,"Chen X, Rock MT, Hammonds J, Tartaglia J, Shintani A, Currier J, Slike B, Crowe JE Jr, Marovich M, Spearman P",Pseudovirion particle production by live poxvirus human immunodeficiency virus vaccine vector enhances humoral and cellular immune responses,"2005 May","79","9","5537-47",Journal of virology,"","","","","","","","15827168","",,0,10,0,0,0,,,
317,26,"Xin et al., 2005",journal,"Xin KQ, Jounai N, Someya K, Honma K, Mizuguchi H, Naganawa S, Kitamura K, Hayakawa T, Saha S, Takeshita F, Okuda K, Honda M, Klinman DM, Okuda K",Prime-boost vaccination with plasmid DNA and a chimeric adenovirus type 5 vector with type 35 fiber induces protective immunity against HIV,"2005 Dec","12","24","1769-77",Gene therapy,"","","","","","","","16079886","",,0,10,0,0,0,,,
318,26,"Kent et al., 2007",journal,"Kent S, De Rose R, Rollman E",Drug evaluation: DNA/MVA prime-boost HIV vaccine,"2007 Feb","8","2","159-67","Current opinion in investigational drugs (London, England : 2000)","","","","","","","","17328232","",,0,10,0,0,0,,,
319,26,"Malm et al., 2005",journal,"Malm M, Rollman E, Ustav M, Hinkula J, Krohn K, Wahren B, Blazevic V","Cross-clade protection induced by human immunodeficiency virus-1 DNA immunogens expressing consensus sequences of multiple genes and epitopes from subtypes A, B, C, and FGH","2005","18","4","678-88",Viral immunology,"","","","","","","","16359234","",,0,10,0,0,0,,,
320,26,"Ayyavoo et al., 2002",journal,"Ayyavoo V, Muthumani K, Kudchodkar S, Zhang D, Ramanathan P, Dayes NS, Kim JJ, Sin JI, Montaner LJ, Weiner DB",HIV-1 viral protein R compromises cellular immune function in vivo,"2002 Jan","14","1","13-22",International immunology,"","","","","","","","11751747","",,0,10,0,0,0,,,
321,26,"Otten et al., 2005",journal,"Otten GR, Schaefer M, Doe B, Liu H, Srivastava I, Megede J, Kazzaz J, Lian Y, Singh M, Ugozzoli M, Montefiori D, Lewis M, Driver DA, Dubensky T, Polo JM, Donnelly J, O'Hagan DT, Barnett S, Ulmer JB",Enhanced potency of plasmid DNA microparticle human immunodeficiency virus vaccines in rhesus macaques by using a priming-boosting regimen with recombinant proteins,"2005 Jul","79","13","8189-200",Journal of virology,"","","","","","","","15956564","",,0,10,0,0,0,,,
322,26,"Santra et al., 2004",journal,"Santra S, Barouch DH, Korioth-Schmitz B, Lord CI, Krivulka GR, Yu F, Beddall MH, Gorgone DA, Lifton MA, Miura A, Philippon V, Manson K, Markham PD, Parrish J, Kuroda MJ, Schmitz JE, Gelman RS, Shiver JW, Montefiori DC, Panicali D, Letvin NL",Recombinant poxvirus boosting of DNA-primed rhesus monkeys augments peak but not memory T lymphocyte responses,"2004 Jul 27","101","30","11088-93",Proceedings of the National Academy of Sciences of the United States of America,"","","","","","","","15258286","",,0,10,0,0,0,,,
323,26,"Liu et al., 2006",journal,"Liu J, Wyatt LS, Amara RR, Moss B, Robinson HL",Studies on in vitro expression and in vivo immunogenicity of a recombinant MVA HIV vaccine,"2006 Apr 12","24","16","3332-9",Vaccine,"","","","","","","","16472543","",,0,10,0,0,0,,,
324,26,"Davis et al., 2002",journal,"Davis NL, West A, Reap E, MacDonald G, Collier M, Dryga S, Maughan M, Connell M, Walker C, McGrath K, Cecil C, Ping LH, Frelinger J, Olmsted R, Keith P, Swanstrom R, Williamson C, Johnson P, Montefiori D, Johnston RE",Alphavirus replicon particles as candidate HIV vaccines,"2002 Apr-May","53","4-5","209-11",IUBMB life,"","","","","","","","12120997","",,0,10,0,0,0,,,
325,31,"Gu et al., 2003",journal,"Gu XX, Rudy SF, Chu C, McCullagh L, Kim HN, Chen J, Li J, Robbins JB, Van Waes C, Battey JF",Phase I study of a lipooligosaccharide-based conjugate vaccine against nontypeable Haemophilus influenzae,"2003 May 16","21","17-18","2107-14",Vaccine,"","","","","","","","12706701","",,0,10,0,0,0,,,
327,29,"Ernst et al., 2007",journal,"Ernst JD, Trevejo-Nunez G, Banaiee N","Genomics and the evolution, pathogenesis, and diagnosis of tuberculosis","2007 Jul","117","7","1738-45",The Journal of clinical investigation,"","","","","","","","17607348","",,0,10,0,0,0,,,
328,31,"Peltola et al., 1977",journal,"Peltola H, Kayhty H, Sivonen A, Makela H","Haemophilus influenzae type b capsular polysaccharide vaccine in children: a double-blind field study of 100,000 vaccinees 3 months to 5 years of age in Finland","1977 Nov","60","5","730-7",Pediatrics,"","","","","","","","335348","",,0,10,0,0,0,,,
329,29,"Vipond et al., 2006",journal,"Vipond J, Clark SO, Hatch GJ, Vipond R, Marie Agger E, Tree JA, Williams A, Marsh PD",Re-formulation of selected DNA vaccine candidates and their evaluation as protein vaccines using a guinea pig aerosol infection model of tuberculosis,"2006 May-Jul","86","3-4","218-24","Tuberculosis (Edinburgh, Scotland)",,,,,,,,"16520093",,,0,10,0,0,0,,,
330,31,"Kayhty et al., 1984",journal,"Kayhty H, Karanko V, Peltola H, Makela PH",Serum antibodies after vaccination with Haemophilus influenzae type b capsular polysaccharide and responses to reimmunization: no evidence of immunologic tolerance or memory,"1984 Nov","74","5","857-65",Pediatrics,"","","","","","","","6387614","",,0,10,0,0,0,,,
331,32,"Weaver et al., 2004",journal,"Weaver SC, Ferro C, Barrera R, Boshell J, Navarro JC",Venezuelan equine encephalitis,"2004","49","","141-74",Annual review of entomology,"","","","","","","","14651460 ","",,0,10,0,0,0,,,
333,32,"Phillpotts, 2006",journal,Phillpotts RJ,"Venezuelan equine encephalitis virus complex-specific monoclonal antibody provides broad protection, in murine models, against airborne challenge with viruses from serogroups I, II and III","2006 Sep","120","1-2","107-12",Virus research,"","","","","","","","16621103 ","",,0,10,0,0,0,,,
334,32,"Phillpotts et al., 2002",journal,"Phillpotts RJ, Jones LD, Howard SC",Monoclonal antibody protects mice against infection and disease when given either before or up to 24 h after airborne challenge with virulent Venezuelan equine encephalitis virus,"2002 Feb 22","20","11-12","1497-504",Vaccine,"","","","","","","","11858855 ","",,0,10,0,0,0,,,
335,32,"Phillpotts et al., 1997",journal,"Phillpotts RJ, Brooks TJ, Cox CS",A simple device for the exposure of animals to infectious microorganisms by the airborne route,"1997 Feb","118","1","71-5",Epidemiology and infection,"","","","","","","","9042037 ","",,0,10,0,0,0,,,
336,32,"Wright et al., 1998",journal,"Wright AJ, Phillpotts RJ",Humane endpoints are an objective measure of morbidity in Venezuelan encephalomyelitis virus infection of mice,"1998","143","6","1155-62",Archives of virology,"","","","","","","","9687872 ","",,0,10,0,0,0,,,
337,32,"Guyton, A.C., 1947",journal,"Guyton, A.C.",Measurement of the respiratory volume of laboratory animals,"1947","150","","10-11",Am. J. Physiol.,"","","","","","","","","",,0,10,0,0,0,,,
338,32,"Walton et al., 1973",journal,"Walton TE, Alvarez O Jr, Buckwalter RM, Johnson KM",Experimental infection of horses with enzootic and epizootic strains of Venezuelan equine encephalomyelitis virus,"1973 Sep","128","3","271-82",The Journal of infectious diseases,"","","","","","","","4728689 ","",,0,10,0,0,0,,,
339,25,"Russo et al., 2007",journal,"Russo TA, Beanan JM, Olson R, Genagon SA, MacDonald U, Cope JJ, Davidson BA, Johnston B, Johnson JR","A killed, genetically engineered derivative of a wild-type extraintestinal pathogenic E. coli strain is a vaccine candidate","2007 May 10","25","19","3859-70",Vaccine,"","","","","","","","17306426","",,0,10,0,0,0,,,
340,25,"Turner et al., 2006",journal,"Turner AK, Beavis JC, Stephens JC, Greenwood J, Gewert C, Thomas N, Deary A, Casula G, Daley A, Kelly P, Randall R, Darsley MJ",Construction and phase I clinical evaluation of the safety and immunogenicity of a candidate enterotoxigenic Escherichia coli vaccine strain expressing colonization factor antigen CFA/I,"2006 Feb","74","2","1062-71",Infection and immunity,"","","","","","","","16428753","",,0,10,0,0,0,,,
343,31,"Green et al., 1991",journal,"Green BA, Farley JE, Quinn-Dey T, Deich RA, Zlotnick GW",The e (P4) outer membrane protein of Haemophilus influenzae: biologic activity of anti-e serum and cloning and sequencing of the structural gene,"1991 Sep","59","9","3191-8",Infection and immunity,"","","","","","","","1715322 ","",,0,10,0,0,0,,,
342,31,"Mason et al., 2004",journal,"Mason KW, Zhu D, Scheuer CA, McMichael JC, Zlotnick GW, Green BA",Reduction of nasal colonization of nontypeable Haemophilus influenzae following intranasal immunization with rLP4/rLP6/UspA2 proteins combined with aqueous formulation of RC529,"2004 Sep 3","22","25-26","3449-56",Vaccine,"","","","","","","","15308371","",,0,10,0,0,0,,,
345,31,"Liu et al., 2004",journal,"Liu DF, Mason KW, Mastri M, Pazirandeh M, Cutter D, Fink DL, St Geme JW 3rd, Zhu D, Green BA",The C-terminal fragment of the internal 110-kilodalton passenger domain of the Hap protein of nontypeable Haemophilus influenzae is a potential vaccine candidate,"2004 Dec","72","12","6961-8",Infection and immunity,"","","","","","","","15557618","",,0,10,0,0,0,,,
346,29,"McShane et al., 2005",journal,"McShane H, Pathan AA, Sander CR, Goonetilleke NP, Fletcher HA, Hill AV",Boosting BCG with MVA85A: the first candidate subunit vaccine for tuberculosis in clinical trials,"2005 Jan-Mar","85","1-2","47-52","Tuberculosis (Edinburgh, Scotland)","","","","","","","","15687027","",,0,10,0,0,0,,,
347,29,"Verreck et al., 2001",journal,"Verreck FA, de Vries RR, Ottenhoff TH",Setting a course for intervening in host-pathogen interactions,"2001 Nov","22","11","588-90",Trends in immunology,"","","","","","","","11698199 ","",,0,10,0,0,0,,,
348,29,"Fonseca et al., 2001",journal,"Fonseca DP, Benaissa-Trouw B, van Engelen M, Kraaijeveld CA, Snippe H, Verheul AF",Induction of cell-mediated immunity against Mycobacterium tuberculosis using DNA vaccines encoding cytotoxic and helper T-cell epitopes of the 38-kilodalton protein,"2001 Aug","69","8","4839-45",Infection and immunity,"","","","","","","","11447158","",,0,10,0,0,0,,,
349,29,"Kamath et al., 1999",journal,"Kamath AT, Feng CG, Macdonald M, Briscoe H, Britton WJ",Differential protective efficacy of DNA vaccines expressing secreted proteins of Mycobacterium tuberculosis,"1999 Apr","67","4","1702-7",Infection and immunity,"","","","","","","","10085007","",,0,10,0,0,0,,,
350,29,"Chandra et al., 2006",journal,"Chandra S, Kaur M, Midha S, Bhatnagar R, Banerjee-Bhatnagar N",Evaluation of the ability of N-terminal fragment of lethal factor of Bacillus anthracis for delivery of Mycobacterium T cell antigen ESAT-6 into cytosol of antigen presenting cells to elicit effective cytotoxic T lymphocyte response,"2006 Dec 22","351","3","702-7",Biochemical and biophysical research communications,"","","","","","","","17084814  ","",,0,10,0,0,0,,,
351,29,"Mollenkopf et al., 2001",journal,"Mollenkopf HJ, Groine-Triebkorn D, Andersen P, Hess J, Kaufmann SH",Protective efficacy against tuberculosis of ESAT-6 secreted by a live Salmonella typhimurium vaccine carrier strain and expressed by naked DNA,"2001 Jul 16","19","28-29","4028-35",Vaccine,"","","","","","","", 11427279,"",,0,10,0,0,0,,,
352,29,"Martin et al., 2006",journal,"Martin C, Williams A, Hernandez-Pando R, Cardona PJ, Gormley E, Bordat Y, Soto CY, Clark SO, Hatch GJ, Aguilar D, Ausina V, Gicquel B",The live Mycobacterium tuberculosis phoP mutant strain is more attenuated than BCG and confers protective immunity against tuberculosis in mice and guinea pigs,"2006 Apr 24","24","17","3408-19",Vaccine,"","","","","","","","16564606 ","",,0,10,0,0,0,,,
353,29,"Perez et al., 2001",journal,"Perez E, Samper S, Bordas Y, Guilhot C, Gicquel B, Martin C",An essential role for phoP in Mycobacterium tuberculosis virulence,"2001 Jul","41","1","179-87",Molecular microbiology,"","","","","","","","11454210","",,0,10,0,0,0,,,
354,29,"Skeiky et al., 2004",journal,"Skeiky YA, Alderson MR, Ovendale PJ, Guderian JA, Brandt L, Dillon DC, Campos-Neto A, Lobet Y, Dalemans W, Orme IM, Reed SG","Differential immune responses and protective efficacy induced by components of a tuberculosis polyprotein vaccine, Mtb72F, delivered as naked DNA or recombinant protein","2004 Jun 15","172","12","7618-28","Journal of immunology (Baltimore, Md. : 1950)","","","","","","","","15187142","",,0,10,0,0,0,,,
355,29,"Hess et al., 1999",journal,"Hess J, Kaufmann SH",Live antigen carriers as tools for improved anti-tuberculosis vaccines,"1999 Feb","23","2","165-73",FEMS immunology and medical microbiology,"","","","","","","", 10076914 ,"",,0,10,0,0,0,,,
356,29,"Agger et al., 2002",journal,"Agger EM, Andersen P",A novel TB vaccine; towards a strategy based on our understanding of BCG failure,"2002 Nov 22","21","1-2","7-14",Vaccine,"","","","","","","","12443657  ","",,0,10,0,0,0,,,
357,29,"Hess et al., 1998",journal,"Hess J, Miko D, Catic A, Lehmensiek V, Russell DG, Kaufmann SH",Mycobacterium bovis Bacille Calmette-Guerin strains secreting listeriolysin of Listeria monocytogenes,"1998 Apr 28","95","9","5299-304",Proceedings of the National Academy of Sciences of the United States of America,"","","","","","","","9560270","",,0,10,0,0,0,,,
358,29,"De et al., 1999",journal,"De Lisle GW, Wilson T, Collins DM, Buddle BM",Vaccination of guinea pigs with nutritionally impaired avirulent mutants of Mycobacterium bovis protects against tuberculosis,"1999 May","67","5","2624-6",Infection and immunity,"","","","","","","","10225931  ","",,0,10,0,0,0,,,
359,32,"Walton et al., 1972",journal,"Walton TE, Alvarez O Jr, Buckwalter RM, Johnson KM",Experimental infection of horses with an attenuated Venezuelan equine encephalomyelitis vaccine (strain TC-83),"1972 May","5","5","750-6",Infection and immunity,"","","","","","","","4637604","",,0,10,0,0,0,,,
360,32,"Phillpotts et al., 1999",journal,"Phillpotts RJ, Wright AJ",TC-83 vaccine protects against airborne or subcutaneous challenge with heterologous mouse-virulent strains of Venezuelan equine encephalitis virus,"1999 Feb 26","17","7-8","982-8",Vaccine,"","","","","","","","10067707","",,0,10,0,0,0,,,
361,32,"Eddy et al., 1972",journal,"Eddy GA, Martin DH, Reeves WC, Johnson KM",Field studies of an attenuated Venezuelan equine encephalomyelitis vaccine (strain TC-83),"1972 Feb","5","2","160-3",Infection and immunity,"","","","","","","","4564397","",,0,10,0,0,0,,,
362,32,"Fine et al., 2007",journal,"Fine DL, Roberts BA, Teehee ML, Terpening SJ, Kelly CL, Raetz JL, Baker DC, Powers AM, Bowen RA","Venezuelan equine encephalitis virus vaccine candidate (V3526) safety, immunogenicity and efficacy in horses","2007 Feb 26","25","10","1868-76",Vaccine,"","","","","","","","17240002","",,0,10,0,0,0,,,
363,32,"Paessler et al., 2006",journal,"Paessler S, Ni H, Petrakova O, Fayzulin RZ, Yun N, Anishchenko M, Weaver SC, Frolov I",Replication and clearance of Venezuelan equine encephalitis virus from the brains of animals vaccinated with chimeric SIN/VEE viruses,"2006 Mar","80","6","2784-96",Journal of virology,"","","","","","","","16501087","",,0,10,0,0,0,,,
364,32,"Phillpotts et al., 2005",journal,"Phillpotts RJ, O'brien L, Appleton RE, Carr S, Bennett A",Intranasal immunisation with defective adenovirus serotype 5 expressing the Venezuelan equine encephalitis virus E2 glycoprotein protects against airborne challenge with virulent virus,"2005 Feb 18","23","13","1615-23",Vaccine,"","","","","","","","15694514","",,0,10,0,0,0,,,
365,32,"Pratt et al., 2003",journal,"Pratt WD, Davis NL, Johnston RE, Smith JF","Genetically engineered, live attenuated vaccines for Venezuelan equine encephalitis: testing in animal models","2003 Sep 8","21","25-26","3854-62",Vaccine,"","","","","","","","12922119","",,0,10,0,0,0,,,
366,32,"Bennett et al., 2000",journal,"Bennett AM, Elvin SJ, Wright AJ, Jones SM, Phillpotts RJ",An immunological profile of Balb/c mice protected from airborne challenge following vaccination with a live attenuated Venezuelan equine encephalitis virus vaccine,"2000 Sep 15","19","2-3","337-47",Vaccine,"","","","","","","","10930689","",,0,10,0,0,0,,,
367,32,"Pushko et al., 2000",journal,"Pushko P, Bray M, Ludwig GV, Parker M, Schmaljohn A, Sanchez A, Jahrling PB, Smith JF",Recombinant RNA replicons derived from attenuated Venezuelan equine encephalitis virus protect guinea pigs and mice from Ebola hemorrhagic fever virus,"2000 Aug 15","19","1","142-53",Vaccine,"","","","","","","","10924796","",,0,10,0,0,0,,,
368,32,"Pratt et al., 1998",journal,"Pratt WD, Gibbs P, Pitt ML, Schmaljohn AL",Use of telemetry to assess vaccine-induced protection against parenteral and aerosol infections of Venezuelan equine encephalitis virus in non-human primates,"1998 May-Jun","16","9-10","1056-64",Vaccine,"","","","","","","","9682359","",,0,10,0,0,0,,,
371,31,"Bolduc et al., 2000",journal,"Bolduc GR, Bouchet V, Jiang RZ, Geisselsoder J, Truong-Bolduc QC, Rice PA, Pelton SI, Goldstein R","Variability of outer membrane protein P1 and its evaluation as a vaccine candidate against experimental otitis media due to nontypeable Haemophilus influenzae: an unambiguous, multifaceted approach","2000 Aug","68","8","4505-17",Infection and immunity,"","","","","","","","10899849","",,0,10,0,0,0,,,
372,32,"Davis et al., 1996",journal,"Davis NL, Brown KW, Johnston RE",A viral vaccine vector that expresses foreign genes in lymph nodes and protects against mucosal challenge,"1996 Jun","70","6","3781-7",Journal of virology,"","","","","","","","8648713","",,0,10,0,0,0,,,
373,32,"Pushko et al., 1997",journal,"Pushko P, Parker M, Ludwig GV, Davis NL, Johnston RE, Smith JF",Replicon-helper systems from attenuated Venezuelan equine encephalitis virus: expression of heterologous genes in vitro and immunization against heterologous pathogens in vivo,"1997 Dec 22","239","2","389-401",Virology,"","","","","","","","9434729","",,0,10,0,0,0,,,
374,32,"Grieder et al., 1995",journal,"Grieder FB, Davis NL, Aronson JF, Charles PC, Sellon DC, Suzuki K, Johnston RE",Specific restrictions in the progression of Venezuelan equine encephalitis virus-induced disease resulting from single amino acid changes in the glycoproteins,"1995 Feb 1","206","2","994-1006",Virology,"","","","","","","","7856110","",,0,10,0,0,0,,,
375,32,"Connolly et al., 1999",journal,"Connolly BM, Steele KE, Davis KJ, Geisbert TW, Kell WM, Jaax NK, Jahrling PB",Pathogenesis of experimental Ebola virus infection in guinea pigs,"1999 Feb","179 Suppl 1","",S203-17,The Journal of infectious diseases,"","","","","","","","9988186","",,0,10,0,0,0,,,
376,32,"Bray et al., 1999",journal,"Bray M, Davis K, Geisbert T, Schmaljohn C, Huggins J",A mouse model for evaluation of prophylaxis and therapy of Ebola hemorrhagic fever,"1999 Feb","179 Suppl 1","",S248-58,The Journal of infectious diseases,"","","","","","","","9988191","",,0,10,0,0,0,,,
377,32,"Hevey et al., 1997",journal,"Hevey M, Negley D, Geisbert J, Jahrling P, Schmaljohn A",Antigenicity and vaccine potential of Marburg virus glycoprotein expressed by baculovirus recombinants,"1997 Dec 8","239","1","206-16",Virology,"","","","","","","","9426460 ","",,0,10,0,0,0,,,
378,32,"Moe et al., 1981",journal,"Moe JB, Lambert RD, Lupton HW",Plaque assay for Ebola virus,"1981 Apr","13","4","791-3",Journal of clinical microbiology,"","","","","","","","7014628","",,0,10,0,0,0,,,
379,32,"Sanchez et al., 1989",journal,"Sanchez A, Kiley MP, Holloway BP, McCormick JB, Auperin DD","The nucleoprotein gene of Ebola virus: cloning, sequencing, and in vitro expression","1989 May","170","1","81-91",Virology,"","","","","","","","2718390","",,0,10,0,0,0,,,
380,32,"Sanchez et al., 1993",journal,"Sanchez A, Kiley MP, Holloway BP, Auperin DD","Sequence analysis of the Ebola virus genome: organization, genetic elements, and comparison with the genome of Marburg virus","1993 Sep","29","3","215-40",Virus research,"","","","","","","","8237108 ","",,0,10,0,0,0,,,
381,32,"Pifat et al., 1988",journal,"Pifat DY, Osterling MC, Smith JF",Antigenic analysis of Punta Toro virus and identification of protective determinants with monoclonal antibodies,"1988 Dec","167","2","442-50",Virology,"","","","","","","","2462308 ","",,0,10,0,0,0,,,
382,32,"Bredenbeek et al., 1993",journal,"Bredenbeek PJ, Frolov I, Rice CM, Schlesinger S",Sindbis virus expression vectors: packaging of RNA replicons by using defective helper RNAs,"1993 Nov","67","11","6439-46",Journal of virology,"","","","","","","","8411346 ","",,0,10,0,0,0,,,
383,32,"Paessler et al., 2003",journal,"Paessler S, Fayzulin RZ, Anishchenko M, Greene IP, Weaver SC, Frolov I",Recombinant sindbis/Venezuelan equine encephalitis virus is highly attenuated and immunogenic,"2003 Sep","77","17","9278-86",Journal of virology,"","","","","","","","12915543 ","",,0,10,0,0,0,,,
670,25,"Ghaem-Maghami et al., 2001",journal,"Ghaem-Maghami M, Simmons CP, Daniell S, Pizza M, Lewis D, Frankel G, Dougan G",Intimin-specific immune responses prevent bacterial colonization by the attaching-effacing pathogen Citrobacter rodentium,"2001","69","9","5597-5605",Infection and immunity,"","","","","","","","11500434 ","","",0,10,0,0,0,,,
385,31,"McMahon et al., 2005",journal,"McMahon M, Murphy TF, Kyd J, Thanavala Y",Role of an immunodominant T cell epitope of the P6 protein of nontypeable Haemophilus influenzae in murine protective immunity,"2005 May 20","23","27","3590-6",Vaccine,"","","","","","","","15855018","",,0,10,0,0,0,,,
386,31,"Hotomi et al., 2005",journal,"Hotomi M, Ikeda Y, Suzumoto M, Yamauchi K, Green BA, Zlotnick G, Billal DS, Shimada J, Fujihara K, Yamanaka N",A recombinant P4 protein of Haemophilus influenzae induces specific immune responses biologically active against nasopharyngeal colonization in mice after intranasal immunization,"2005 Jan 26","23","10","1294-300",Vaccine,"","","","","","","","15652672","",,0,10,0,0,0,,,
387,32,"Davis et al., 1989",journal,"Davis NL, Willis LV, Smith JF, Johnston RE",In vitro synthesis of infectious venezuelan equine encephalitis virus RNA from a cDNA clone: analysis of a viable deletion mutant,"1989 Jul","171","1","189-204",Virology,"","","","","","","","2525837","",,0,10,0,0,0,,,
388,32,"Davis et al., 1991",journal,"Davis NL, Powell N, Greenwald GF, Willis LV, Johnson BJ, Smith JF, Johnston RE",Attenuating mutations in the E2 glycoprotein gene of Venezuelan equine encephalitis virus: construction of single and multiple mutants in a full-length cDNA clone,"1991 Jul","183","1","20-31",Virology,"","","","","","","","2053280 ","",,0,10,0,0,0,,,
389,32,"Hart et al., 1997",journal,"Hart MK, Pratt W, Panelo F, Tammariello R, Dertzbaugh M","Venezuelan equine encephalitis virus vaccines induce mucosal IgA responses and protection from airborne infection in BALB/c, but not C3H/HeN mice","1997 Mar","15","4","363-9",Vaccine,"","","","","","","","9141206 ","",,0,10,0,0,0,,,
671,25,"Dean-Nystrom et al., 2002",journal,"Dean-Nystrom EA, Gansheroff LJ, Mills M, Moon HW, O'Brien AD",Vaccination of pregnant dams with intimin(O157) protects suckling piglets from Escherichia coli O157:H7 infection,"2002","70","5","2414-2418",Infection and immunity,"","","","","","","","11953378","","",0,10,0,0,0,,,
391,29,"Collins et al., 2005",journal,"Collins DM, Skou B, White S, Bassett S, Collins L, For R, Hurr K, Hotter G, de Lisle GW",Generation of attenuated Mycobacterium bovis strains by signature-tagged mutagenesis for discovery of novel vaccine candidates,"2005 Apr","73","4","2379-86",Infection and immunity,"","","","","","","","15784584","",,0,10,0,0,0,,,
392,29,"Vordermeier et al., 2004",journal,"Vordermeier HM, Rhodes SG, Dean G, Goonetilleke N, Huygen K, Hill AV, Hewinson RG, Gilbert SC",Cellular immune responses induced in cattle by heterologous prime-boost vaccination using recombinant viruses and bacille Calmette-Guerin,"2004 Jul","112","3","461-70",Immunology,"","","","","","","","15196215","",,0,10,0,0,0,,,
393,31,"Sabirov et al., 2004",journal,"Sabirov A, Kodama S, Sabirova N, Mogi G, Suzuki M",Intranasal immunization with outer membrane protein P6 and cholera toxin induces specific sinus mucosal immunity and enhances sinus clearance of nontypeable Haemophilus influenzae,"2004 Aug 13","22","23-24","3112-21",Vaccine,"","","","","","","","15297063","",,0,10,0,0,0,,,
394,31,"Bertot et al., 2004",journal,"Bertot GM, Becker PD, Guzman CA, Grinstein S",Intranasal vaccination with recombinant P6 protein and adamantylamide dipeptide as mucosal adjuvant confers efficient protection against otitis media and lung infection by nontypeable Haemophilus influenzae,"2004 Apr 1","189","7","1304-12",The Journal of infectious diseases,"","","","","","","","15031801","",,0,10,0,0,0,,,
396,31,"Kyd et al., 2003",journal,"Kyd JM, Cripps AW, Novotny LA, Bakaletz LO",Efficacy of the 26-kilodalton outer membrane protein and two P5 fimbrin-derived immunogens to induce clearance of nontypeable Haemophilus influenzae from the rat middle ear and lungs as well as from the chinchilla middle ear and nasopharynx,"2003 Aug","71","8","4691-9",Infection and immunity,"","","","","","","","12874350","",,0,10,0,0,0,,,
397,31,"Riedmann et al., 2003",journal,"Riedmann EM, Kyd JM, Smith AM, Gomez-Gallego S, Jalava K, Cripps AW, Lubitz W",Construction of recombinant S-layer proteins (rSbsA) and their expression in bacterial ghosts--a delivery system for the nontypeable Haemophilus influenzae antigen Omp26,"2003 Jul 15","37","2-3","185-92",FEMS immunology and medical microbiology,"","","","","","","","12832124","",,0,10,0,0,0,,,
398,32,BMDP Statistics Software 1992,book,"",BMDP Statistics Software,"1992","","","467",BMDP Statistics Software Release 7,"","","","","","","","","",,0,10,0,0,0,,,
399,31,"Zagursky et al., 2000",journal,"Zagursky RJ, Ooi P, Jones KF, Fiske MJ, Smith RP, Green BA",Identification of a Haemophilus influenzae 5'-nucleotidase protein: cloning of the nucA gene and immunogenicity and characterization of the NucA protein,"2000 May","68","5","2525-34",Infection and immunity,"","","","","","","","10768940","",,0,10,0,0,0,,,
400,31,"Webb et al., 2000",journal,"Webb DC, Cripps AW",A P5 peptide that is homologous to peptide 10 of OprF from Pseudomonas aeruginosa enhances clearance of nontypeable Haemophilus influenzae from acutely infected rat lung in the absence of detectable peptide-specific antibody,"2000 Jan","68","1","377-81",Infection and immunity,"","","","","","","","10603411","",,0,10,0,0,0,,,
401,29,"Kaufmann, 2005",journal,Kaufmann SH,Recent findings in immunology give tuberculosis vaccines a new boost,"2005 Dec","26","12","660-7",Trends in immunology,"","","","","","","","16246622  ","",,0,10,0,0,0,,,
402,31,"Kurono et al., 1999",journal,"Kurono Y, Yamamoto M, Fujihashi K, Kodama S, Suzuki M, Mogi G, McGhee JR, Kiyono H",Nasal immunization induces Haemophilus influenzae-specific Th1 and Th2 responses with mucosal IgA and systemic IgG antibodies for protective immunity,"1999 Jul","180","1","122-32",The Journal of infectious diseases,"","","","","","","","10353870","",,0,10,0,0,0,,,
403,29,"Olsen et al., 2001",journal,"Olsen, A.W., L.A.H. van Pinxteren, P.B Rasmussen, and P. Andersen",Protection of Mice with a Tuberculosis Subunit Vaccine Based on a Fusion Protein of Antigen 85B and ESAT-6,"2001","69","5","2773-2778",Infect. Immun.,"","","","","","","","",http://iai.asm.org/cgi/content/abstract/69/5/2773,,0,10,0,0,0,,,
404,31,"Webb et al., 1999",journal,"Webb DC, Cripps AW",Immunization with recombinant transferrin binding protein B enhances clearance of nontypeable Haemophilus influenzae from the rat lung,"1999 May","67","5","2138-44",Infection and immunity,"","","","","","","","10225866","",,0,10,0,0,0,,,
405,29,"Horwitz et al., 2000",journal,"Horwitz MA, Harth G, Dillon BJ, Maslesa-Galic' S",Recombinant bacillus calmette-guerin (BCG) vaccines expressing the Mycobacterium tuberculosis 30-kDa major secretory protein induce greater protective immunity against tuberculosis than conventional BCG vaccines in a highly susceptible animal model,"2000 Dec 5","97","25","13853-8",Proceedings of the National Academy of Sciences of the United States of America,"","","","","","","","11095745","",,0,10,0,0,0,,,
406,31,"Wu et al., 2005",journal,"Wu T, Chen J, Murphy TF, Green BA, Gu XX",Investigation of non-typeable Haemophilus influenzae outer membrane protein P6 as a new carrier for lipooligosaccharide conjugate vaccines,"2005 Oct 25","23","44","5177-85",Vaccine,"","","","","","","","16039021","",,0,10,0,0,0,,,
407,8,"Al-Mariri et al., 2001",journal,"Al-Mariri A, Tibor A, Mertens P, De Bolle X, Michel P, Godefroid J, Walravens K, Letesson JJ",Protection of BALB/c mice against Brucella abortus 544 challenge by vaccination with bacterioferritin or P39 recombinant proteins with CpG oligodeoxynucleotides as adjuvant,"2001 Aug","69","8","4816-22",Infection and immunity,"","","","","","","","11447155 ","",,0,10,0,0,0,,,
408,8,"Letesson et al., 1997",journal,"Letesson JJ, Tibor A, van Eynde G, Wansard V, Weynants V, Denoel P, Saman E","Humoral immune responses of Brucella-infected cattle, sheep, and goats to eight purified recombinant Brucella proteins in an indirect enzyme-linked immunosorbent assay","1997 Sep","4","5","556-64",Clinical and diagnostic laboratory immunology,,,,,,,,"9302205",,,0,10,0,0,0,,,
410,8,"Corbel, 1997",journal,Corbel MJ,Recent advances in brucellosis,"1997 Feb","46","2","101-3",Journal of medical microbiology,"","","","","","","","9060868 ","",,0,10,0,0,0,,,
411,8,"Roop et al., 2004",journal,"Roop RM 2nd, Bellaire BH, Valderas MW, Cardelli JA",Adaptation of the Brucellae to their intracellular niche,"2004 May","52","3","621-30",Molecular microbiology,"","","","","","","","15101970 ","",,0,10,0,0,0,,,
412,8,"Kohler et al., 2002",journal,"Kohler S, Foulongne V, Ouahrani-Bettache S, Bourg G, Teyssier J, Ramuz M, Liautard JP",The analysis of the intramacrophagic virulome of Brucella suis deciphers the environment encountered by the pathogen inside the macrophage host cell,"2002 Nov 26","99","24","15711-6",Proceedings of the National Academy of Sciences of the United States of America,"","","","","","","","12438693 ","",,0,10,0,0,0,,,
413,8,"Fernandes et al., 1996",journal,"Fernandes DM, Jiang X, Jung JH, Baldwin CL",Comparison of T cell cytokines in resistant and susceptible mice infected with virulent Brucella abortus strain 2308,"1996 Dec 31","16","3-4","193-203",FEMS immunology and medical microbiology,"","","","","","","","9116636 ","",,0,10,0,0,0,,,
414,8,"Montaraz et al., 1986",journal,"Montaraz JA, Winter AJ",Comparison of living and nonliving vaccines for Brucella abortus in BALB/c mice,"1986 Aug","53","2","245-51",Infection and immunity,"","","","","","","","3089933 ","",,0,10,0,0,0,,,
415,8,"Li, 1991",journal,Li HZ,[A pathohistological study on experimental brucellosis in inbred mice],"1991 Jun","20","2","134-6",Zhonghua bing li xue za zhi Chinese journal of pathology,"","","","","","","","1914022 ","",,0,10,0,0,0,,,
416,8,"Velikovsky et al., 2002",journal,"Velikovsky CA, Cassataro J, Giambartolomei GH, Goldbaum FA, Estein S, Bowden RA, Bruno L, Fossati CA, Spitz M",A DNA vaccine encoding lumazine synthase from Brucella abortus induces protective immunity in BALB/c mice,"2002 May","70","5","2507-11",Infection and immunity,"","","","","","","","11953389 ","",,0,10,0,0,0,,,
417,8,"Hemmen et al., 1995",journal,"Hemmen F, Weynants V, Scarcez T, Letesson JJ, Saman E",Cloning and sequence analysis of a newly identified Brucella abortus gene and serological evaluation of the 17-kilodalton antigen that it encodes,"1995 May","2","3","263-7",Clinical and diagnostic laboratory immunology,"","","","","","","","7664168 ","",,0,10,0,0,0,,,
418,8,"Goldbaum et al., 1999",journal,"Goldbaum FA, Velikovsky CA, Baldi PC, Mortl S, Bacher A, Fossati CA",The 18-kDa cytoplasmic protein of Brucella species --an antigen useful for diagnosis--is a lumazine synthase,"1999 Sep","48","9","833-9",Journal of medical microbiology,"","","","","","","","10482294 ","",,0,10,0,0,0,,,
419,8,"Oliveira et al., 1996",journal,"Oliveira SC, Splitter GA",Immunization of mice with recombinant L7/L12 ribosomal protein confers protection against Brucella abortus infection,"1996 Jul","14","10","959-62",Vaccine,"","","","","","","","8873388 ","",,0,10,0,0,0,,,
422,30,"Girard et al., 2007",journal,"Girard MP, Reed ZH, Friede M, Kieny MP",A review of human vaccine research and development: malaria,"2007 Feb 19","25","9","1567-80",Vaccine,"","","","","","","","17045367","",,0,10,0,0,0,,,
423,30,"Komisar, 2007",journal,Komisar JL,Malaria vaccines,"2007 May 1","12","","3928-55",Frontiers in bioscience : a journal and virtual library,"","","","","","","","17485348","",,0,10,0,0,0,,,
424,30,"Kocken et al., 2002",journal,"Kocken CH, Withers-Martinez C, Dubbeld MA, van der Wel A, Hackett F, Valderrama A, Blackman MJ, Thomas AW",High-level expression of the malaria blood-stage vaccine candidate Plasmodium falciparum apical membrane antigen 1 and induction of antibodies that inhibit erythrocyte invasion,"2002 Aug","70","8","4471-6",Infection and immunity,,,,,,,,"12117958",,,0,10,0,0,0,,,
425,30,"Zhou et al., 2006",journal,"Zhou Z, Todd CW, Wohlhueter RM, Price A, Xiao L, Schnake P, Bonner PC, Martin AM, Goldman IF, De La Vega P, Udhayakumar V, Lal AA","Development, characterization and immunogenicity of a multi-stage, multi-valent Plasmodium falciparum vaccine antigen (FALVAC-1A) expressed in Escherichia coli","2006 Jan-Feb","2","1","14-23",Human vaccines,,,,,,,,"17012909",,,0,10,0,0,0,,,
426,30,"Polhemus et al., 2007",journal,"Polhemus ME, Magill AJ, Cummings JF, Kester KE, Ockenhouse CF, Lanar DE, Dutta S, Barbosa A, Soisson L, Diggs CL, Robinson SA, Haynes JD, Stewart VA, Ware LA, Brando C, Krzych U, Bowden RA, Cohen JD, Dubois MC, Ofori-Anyinam O, De-Kock E, Ballou WR, Heppner DG Jr","Phase I dose escalation safety and immunogenicity trial of Plasmodium falciparum apical membrane protein (AMA-1) FMP2.1, adjuvanted with AS02A, in malaria-naive adults at the Walter Reed Army Institute of Research","2007 May 22","25","21","4203-12",Vaccine,,,,,,,,"17442466",,,0,10,0,0,0,,,
427,30,"Lal et al., 1996",journal,"Lal AA, Hughes MA, Oliveira DA, Nelson C, Bloland PB, Oloo AJ, Hawley WE, Hightower AW, Nahlen BL, Udhayakumar V",Identification of T-cell determinants in natural immune responses to the Plasmodium falciparum apical membrane antigen (AMA-1) in an adult population exposed to malaria,"1996 Mar","64","3","1054-9",Infection and immunity,,,,,,,,"8641760",,,0,10,0,0,0,,,
428,8,"Bosseray, 1991",journal,Bosseray N,"Brucella melitensis Rev. 1 living attenuated vaccine: stability of markers, residual virulence and immunogenicity in mice","1991 Oct","19","4","355-63",Biologicals : journal of the International Association of Biological Standardization,,,,,,,,"1797046",,,0,10,0,0,0,,,
429,30,"Kushwaha et al., 2001",journal,"Kushwaha A, Rao PP, Suresh RP, Chauhan VS",Immunogenicity of recombinant fragments of Plasmodium falciparum acidic basic repeat antigen produced in Escherichia coli,"2001 Aug","23","8","435-44",Parasite immunology,,,,,,,,"11489167",,,0,10,0,0,0,,,
430,30,"Kwiatkowski et al., 1997",journal,"Kwiatkowski D, Marsh K",Development of a malaria vaccine,"1997 Dec 6","350","9092","1696-701",Lancet,,,,,,,,"9400530",,,0,10,0,0,0,,,
431,30,"Gilbert et al., 2006",journal,"Gilbert SC, Moorthy VS, Andrews L, Pathan AA, McConkey SJ, Vuola JM, Keating SM, Berthoud T, Webster D, McShane H, Hill AV",Synergistic DNA-MVA prime-boost vaccination regimes for malaria and tuberculosis,"2006 May 22","24","21","4554-61",Vaccine,,,,,,,,"16150517",,,0,10,0,0,0,,,
434,31,"Tristram et al., 2007",journal,"Tristram S, Jacobs MR, Appelbaum PC",Antimicrobial resistance in Haemophilus influenzae,"2007 Apr","20","2","368-89",Clinical microbiology reviews,"","","","","","","","17428889 ","",,0,10,0,0,0,,,
688,8,"Gupta et al., 2007",journal,"Gupta VK, Rout PK, Vihan VS",Induction of immune response in mice with a DNA vaccine encoding outer membrane protein (omp31) of Brucella melitensis 16M,"2007","82","3","305-313",Research in veterinary science,"","","","","","","","17014873","","",0,10,0,0,0,,,
479,30,"Moore et al., 2005",journal,"Moore AC, Gallimore A, Draper SJ, Watkins KR, Gilbert SC, Hill AV",Anti-CD25 antibody enhancement of vaccine-induced immunogenicity: increased durable cellular immunity with reduced immunodominance,"2005 Dec 1","175","11","7264-73","Journal of immunology (Baltimore, Md. : 1950)",,,,,,,,"16301631",,,0,10,0,0,0,,,
480,8,"Yu et al., 2007",journal,"Yu DH, Hu XD, Cai H","A combined DNA vaccine encoding BCSP31, SOD, and L7/L12 confers high protection against Brucella abortus 2308 by inducing specific CTL responses","2007 Jun","26","6","435-43",DNA and cell biology,,,,,,,,"17570767",,,0,10,0,0,0,,,
684,25,"ELBERG and FAUNCE, 1957",journal,"ELBERG SS, FAUNCE K Jr",Immunization against Brucella infection.  VI.  Immunity conferred on goats by a nondependent mutant from a streptomycin-dependent mutant strain of Brucella melitensis,"1957","73","2","211-217",Journal of bacteriology,"","","","","","","","13416171","","",0,10,0,0,0,,,
676,25,"Marcato et al., 2001",journal,"Marcato P, Mulvey G, Read RJ, Vander Helm K, Nation PN, Armstrong GD",Immunoprophylactic potential of cloned Shiga toxin 2 B subunit,"2001","183","3","435-443",The Journal of infectious diseases,"","","","","","","","11133375","","",0,10,0,0,0,,,
677,25,"Berhanu et al., 2008",journal,"Berhanu A, Wilson RL, Kirkwood-Watts DL, King DS, Warren TK, Lund SA, Brown LL, Krupkin AK, Vandermay E, Weimers W, Honeychurch KM, Grosenbach DW, Jones KF, Hruby DE","Vaccination of BALB/c Mice with Escherichia coli-expressed Vaccinia Virus Proteins A27L, B5R, and D8L Protects Mice from Lethal Vaccinia Virus Challenge","2008","","","",Journal of virology,"","","","","","","","18199639","","",0,10,0,0,0,,,
466,0,"Al-Mariri et al., 2001",journal,"Al-Mariri A, Tibor A, Mertens P, De Bolle X, Michel P, Godefroid J, Walravens K, Letesson JJ",Protection of BALB/c mice against Brucella abortus 544 challenge by vaccination with bacterioferritin or P39 recombinant proteins with CpG oligodeoxynucleotides as adjuvant,"2001 Aug","69","8","4816-22",Infection and immunity,"","","","","","","","11447155 ","",,112,10,0,0,0,,,
465,0,"Letesson et al., 1997",journal,"Letesson JJ, Tibor A, van Eynde G, Wansard V, Weynants V, Denoel P, Saman E","Humoral immune responses of Brucella-infected cattle, sheep, and goats to eight purified recombinant Brucella proteins in an indirect enzyme-linked immunosorbent assay","1997 Sep","4","5","556-64",Clinical and diagnostic laboratory immunology,,,,,,,,"9302205",,,112,10,0,0,0,,,
464,0,"Al-Mariri et al., 2001",journal,"Al-Mariri A, Tibor A, Mertens P, De Bolle X, Michel P, Godefroid J, Walravens K, Letesson JJ",Protection of BALB/c mice against Brucella abortus 544 challenge by vaccination with bacterioferritin or P39 recombinant proteins with CpG oligodeoxynucleotides as adjuvant,"2001 Aug","69","8","4816-22",Infection and immunity,"","","","","","","","11447155 ","",,111,10,0,0,0,,,
463,0,"Letesson et al., 1997",journal,"Letesson JJ, Tibor A, van Eynde G, Wansard V, Weynants V, Denoel P, Saman E","Humoral immune responses of Brucella-infected cattle, sheep, and goats to eight purified recombinant Brucella proteins in an indirect enzyme-linked immunosorbent assay","1997 Sep","4","5","556-64",Clinical and diagnostic laboratory immunology,,,,,,,,"9302205",,,111,10,0,0,0,,,
462,0,"Olsen et al., 2001",journal,"Olsen, A.W., L.A.H. van Pinxteren, P.B Rasmussen, and P. Andersen",Protection of Mice with a Tuberculosis Subunit Vaccine Based on a Fusion Protein of Antigen 85B and ESAT-6,"2001","69","5","2773-2778",Infect. Immun.,"","","","","","","","",http://iai.asm.org/cgi/content/abstract/69/5/2773,,109,10,0,0,0,,,
461,0,"Olsen et al., 2001",journal,"Olsen, A.W., L.A.H. van Pinxteren, P.B Rasmussen, and P. Andersen",Protection of Mice with a Tuberculosis Subunit Vaccine Based on a Fusion Protein of Antigen 85B and ESAT-6,"2001","69","5","2773-2778",Infect. Immun.,"","","","","","","","",http://iai.asm.org/cgi/content/abstract/69/5/2773,,108,10,0,0,0,,,
460,0,"Collins et al., 2005",journal,"Collins DM, Skou B, White S, Bassett S, Collins L, For R, Hurr K, Hotter G, de Lisle GW",Generation of attenuated Mycobacterium bovis strains by signature-tagged mutagenesis for discovery of novel vaccine candidates,"2005 Apr","73","4","2379-86",Infection and immunity,"","","","","","","","15784584","",,107,10,0,0,0,,,
459,0,"Skeiky et al., 2004",journal,"Skeiky YA, Alderson MR, Ovendale PJ, Guderian JA, Brandt L, Dillon DC, Campos-Neto A, Lobet Y, Dalemans W, Orme IM, Reed SG","Differential immune responses and protective efficacy induced by components of a tuberculosis polyprotein vaccine, Mtb72F, delivered as naked DNA or recombinant protein","2004 Jun 15","172","12","7618-28","Journal of immunology (Baltimore, Md. : 1950)","","","","","","","","15187142","",,105,10,0,0,0,,,
570,24,"Dolby et al., 1986",journal,"Dolby JM, Newell DG",The protection of infant mice from colonization with Campylobacter jejuni by vaccination of the dams,"1986 Apr","96","2","143-51",The Journal of hygiene,"","","","","","","","3701036 ","",,0,10,0,0,0,,,
685,8,"ELBERG and FAUNCE, 1957",journal,"ELBERG SS, FAUNCE K Jr",Immunization against Brucella infection.  VI.  Immunity conferred on goats by a nondependent mutant from a streptomycin-dependent mutant strain of Brucella melitensis,"1957","73","2","211-217",Journal of bacteriology,"","","","","","","","13416171","","",0,10,0,0,0,,,
674,25,"Bielaszewska et al., 1997",journal,"Bielaszewska M, Clarke I, Karmali MA, Petric M",Localization of intravenously administered verocytotoxins (Shiga-like toxins) 1 and 2 in rabbits immunized with homologous and heterologous toxoids and toxin subunits,"1997","65","7","2509-2516",Infection and immunity,"","","","","","","","9199412","","",0,10,0,0,0,,,
481,30,"Bruna-Romero et al., 2004",journal,"Bruna-Romero O, Rocha CD, Tsuji M, Gazzinelli RT",Enhanced protective immunity against malaria by vaccination with a recombinant adenovirus encoding the circumsporozoite protein of Plasmodium lacking the GPI-anchoring motif,"2004 Sep 9","22","27-28","3575-84",Vaccine,,,,,,,,"15315836",,,0,10,0,0,0,,,
482,30,"Kwon et al., 2005",journal,"Kwon YU, Soucy RL, Snyder DA, Seeberger PH",Assembly of a series of malarial glycosylphosphatidylinositol anchor oligosaccharides,"2005 Apr 8","11","8","2493-504","Chemistry (Weinheim an der Bergstrasse, Germany)",,,,,,,,"15729674",,,0,10,0,0,0,,,
483,30,"Fanning et al., 2003",journal,"Fanning SL, Czesny B, Sedegah M, Carucci DJ, van Gemert GJ, Eling W, Williamson KC","A glycosylphosphatidylinositol anchor signal sequence enhances the immunogenicity of a DNA vaccine encoding Plasmodium falciparum sexual-stage antigen, Pfs230","2003 Jul 4","21","23","3228-35",Vaccine,,,,,,,,"12804852",,,0,10,0,0,0,,,
484,30,"Seeberger et al., 2004",journal,"Seeberger PH, Soucy RL, Kwon YU, Snyder DA, Kanemitsu T","A convergent, versatile route to two synthetic conjugate anti-toxin malaria vaccines","2004 Aug 7","","15","1706-7","Chemical communications (Cambridge, England)","","","","","","","","15278147","",,0,10,0,0,0,,,
485,8,"Cassataro et al., 2007",journal,"Cassataro J, Pasquevich KA, Estein SM, Laplagne DA, Velikovsky CA, de la Barrera S, Bowden R, Fossati CA, Giambartolomei GH, Goldbaum FA",A recombinant subunit vaccine based on the insertion of 27 amino acids from Omp31 to the N-terminus of BLS induced a similar degree of protection against B. ovis than Rev.1 vaccination,"2007 May 30","25","22","4437-46",Vaccine,,,,,,,,"17442465",,,0,10,0,0,0,,,
486,8,"Laplagne et al., 2004",journal,"Laplagne DA, Zylberman V, Ainciart N, Steward MW, Sciutto E, Fossati CA, Goldbaum FA",Engineering of a polymeric bacterial protein as a scaffold for the multiple display of peptides,"2004 Dec 1","57","4","820-8",Proteins,,,,,,,,"15390265",,,0,10,0,0,0,,,
487,8,"Estein et al., 2003",journal,"Estein SM, Cassataro J, Vizcaino N, Zygmunt MS, Cloeckaert A, Bowden RA",The recombinant Omp31 from Brucella melitensis alone or associated with rough lipopolysaccharide induces protection against Brucella ovis infection in BALB/c mice,"2003 Feb","5","2","85-93",Microbes and infection / Institut Pasteur,,,,,,,,"12650766",,,0,10,0,0,0,,,
488,8,"Cassataro et al., 2004",journal,"Cassataro J, Pasquevich K, Bruno L, Wallach JC, Fossati CA, Baldi PC",Antibody reactivity to Omp31 from Brucella melitensis in human and animal infections by smooth and rough Brucellae,"2004 Jan","11","1","111-4",Clinical and diagnostic laboratory immunology,,,,,,,,"14715555",,,0,10,0,0,0,,,
489,8,"Cassataro et al., 2005",journal,"Cassataro J, Velikovsky CA, de la Barrera S, Estein SM, Bruno L, Bowden R, Pasquevich KA, Fossati CA, Giambartolomei GH",A DNA vaccine coding for the Brucella outer membrane protein 31 confers protection against B. melitensis and B. ovis infection by eliciting a specific cytotoxic response,"2005 Oct","73","10","6537-46",Infection and immunity,,,,,,,,"16177328",,,0,10,0,0,0,,,
490,30,"Heppner et al., 2005",journal,"Heppner DG Jr, Kester KE, Ockenhouse CF, Tornieporth N, Ofori O, Lyon JA, Stewart VA, Dubois P, Lanar DE, Krzych U, Moris P, Angov E, Cummings JF, Leach A, Hall BT, Dutta S, Schwenk R, Hillier C, Barbosa A, Ware LA, Nair L, Darko CA, Withers MR, Ogutu B, Polhemus ME, Fukuda M, Pichyangkul S, Gettyacamin M, Diggs C, Soisson L, Milman J, Dubois MC, Garcon N, Tucker K, Wittes J, Plowe CV, Thera MA, Duombo OK, Pau MG, Goudsmit J, Ballou WR, Cohen J","Towards an RTS,S-based, multi-stage, multi-antigen vaccine against falciparum malaria: progress at the Walter Reed Army Institute of Research","2005 Mar 18","23","17-18","2243-50",Vaccine,,,,,,,,"15755604",,,0,10,0,0,0,,,
491,8,"Luo et al., 2006a",journal,"Luo DY, Li P, Xing L, Zhao GY, Shi W, Zhang SL, Wang XL",DNA vaccine encoding L7/L12-P39 of Brucella abortus induces protective immunity in BALB/c mice,"2006 Feb 20","119","4","331-4",Chinese medical journal,,,,,,,,"16537031",,,0,10,0,0,0,,,
615,28,"Riemenschneider et al., 2003",journal,"Riemenschneider J, Garrison A, Geisbert J, Jahrling P, Hevey M, Negley D, Schmaljohn A, Lee J, Hart MK, Vanderzanden L, Custer D, Bray M, Ruff A, Ivins B, Bassett A, Rossi C, Schmaljohn C","Comparison of individual and combination DNA vaccines for B. anthracis, Ebola virus, Marburg virus and Venezuelan equine encephalitis virus","2003","21","25-26","4071-4080",Vaccine,"","","","","","","","12922144 ","",,0,10,0,0,0,,,
494,28,"Warfield et al., 2004",journal,"Warfield KL, Swenson DL, Negley DL, Schmaljohn AL, Aman MJ, Bavari S",Marburg virus-like particles protect guinea pigs from lethal Marburg virus infection,"2004 Sep 3","22","25-26","3495-502",Vaccine,"","","","","","","","15308377 ","",,0,10,0,0,0,,,
495,28,"Wang et al., 2006",journal,"Wang D, Schmaljohn AL, Raja NU, Trubey CM, Juompan LY, Luo M, Deitz SB, Yu H, Woraratanadharm J, Holman DH, Moore KM, Swain BM, Pratt WD, Dong JY",De novo syntheses of Marburg virus antigens from adenovirus vectors induce potent humoral and cellular immune responses,"2006 Apr 5","24","15","2975-86",Vaccine,"","","","","","","","16530297 ","",,0,10,0,0,0,,,
496,27,"Custer et al., 2003",journal,"Custer DM, Thompson E, Schmaljohn CS, Ksiazek TG, Hooper JW",Active and passive vaccination against hantavirus pulmonary syndrome with Andes virus M genome segment-based DNA vaccine,"2003 Sep","77","18","9894-905",Journal of virology,"","","","","","","","12941899 ","",,0,10,0,0,0,,,
497,27,"Ulrich et al., 1998",journal,"Ulrich R, Lundkvist A, Meisel H, Koletzki D, Sjolander KB, Gelderblom HR, Borisova G, Schnitzler P, Darai G, Kruger DH",Chimaeric HBV core particles carrying a defined segment of Puumala hantavirus nucleocapsid protein evoke protective immunity in an animal model,"1998 Jan-Feb","16","2-3","272-80",Vaccine,"","","","","","","","9607042 ","",,0,10,0,0,0,,,
498,24,"Burr et al., 2005",journal,"Burr DH, Rollins D, Lee LH, Pattarini DL, Walz SS, Tian JH, Pace JL, Bourgeois AL, Walker RI",Prevention of disease in ferrets fed an inactivated whole cell Campylobacter jejuni vaccine,"2005 Jul 29","23","34","4315-21",Vaccine,"","","","","","","","16005742 ","",,0,10,0,0,0,,,
499,24,"Wyszynska et al., 2004",journal,"Wyszynska A, Raczko A, Lis M, Jagusztyn-Krynicka EK",Oral immunization of chickens with avirulent Salmonella vaccine strain carrying C. jejuni 72Dz/92 cjaA gene elicits specific humoral immune response associated with protection against challenge with wild-type Campylobacter,"2004 Mar 29","22","11-12","1379-89",Vaccine,"","","","","","","","15063560 ","",,0,10,0,0,0,,,
501,24,"Rice et al., 1997",journal,"Rice BE, Rollins DM, Mallinson ET, Carr L, Joseph SW",Campylobacter jejuni in broiler chickens: colonization and humoral immunity following oral vaccination and experimental infection,"1997 Dec","15","17-18","1922-32",Vaccine,"","","","","","","","9413103 ","",,0,10,0,0,0,,,
502,24,"Khoury et al., 1995",journal,"Khoury CA, Meinersmann RJ",A genetic hybrid of the Campylobacter jejuni flaA gene with LT-B of Escherichia coli and assessment of the efficacy of the hybrid protein as an oral chicken vaccine,"1995 Oct-Dec","39","4","812-20",Avian diseases,"","","","","","","","8719215 ","",,0,10,0,0,0,,,
503,30,"Heal et al., 1999",journal,"Heal KG, Hill HR, Stockley PG, Hollingdale MR, Taylor-Robinson AW",Expression and immunogenicity of a liver stage malaria epitope presented as a foreign peptide on the surface of RNA-free MS2 bacteriophage capsids,"1999 Sep","18","3-4","251-8",Vaccine,,,,,,,,"10506649",,,0,10,0,0,0,,,
504,30,"Hillier et al., 2005",journal,"Hillier CJ, Ware LA, Barbosa A, Angov E, Lyon JA, Heppner DG, Lanar DE","Process development and analysis of liver-stage antigen 1, a preerythrocyte-stage protein-based vaccine for Plasmodium falciparum","2005 Apr","73","4","2109-15",Infection and immunity,,,,,,,,"15784552",,,0,10,0,0,0,,,
505,30,"Moormann et al., 2006",journal,"Moormann AM, John CC, Sumba PO, Tisch D, Embury P, Kazura JW",Stability of interferon-gamma and interleukin-10 responses to Plasmodium falciparum liver stage antigen-1 and thrombospondin-related adhesive protein in residents of a malaria holoendemic area,"2006 Apr","74","4","585-90",The American journal of tropical medicine and hygiene,,,,,,,,"16606988",,,0,10,0,0,0,,,
506,30,"Ong'echa et al., 2003",journal,"Ong'echa JM, Lal AA, Terlouw DJ, Ter Kuile FO, Kariuki SK, Udhayakumar V, Orago AS, Hightower AW, Nahlen BL, Shi YP",Association of interferon-gamma responses to pre-erythrocytic stage vaccine candidate antigens of Plasmodium falciparum in young Kenyan children with improved hemoglobin levels: XV. Asembo Bay Cohort Project,"2003 May","68","5","590-7",The American journal of tropical medicine and hygiene,"","","","","","","","12812352","",,0,10,0,0,0,,,
507,30,"Aidoo et al., 2000",journal,"Aidoo M, Lalvani A, Gilbert SC, Hu JT, Daubersies P, Hurt N, Whittle HC, Druihle P, Hill AV",Cytotoxic T-lymphocyte epitopes for HLA-B53 and other HLA types in the malaria vaccine candidate liver-stage antigen 3,"2000 Jan","68","1","227-32",Infection and immunity,,,,,,,,"10603392",,,0,10,0,0,0,,,
508,30,"Moore et al., 2004",journal,"Moore AC, Hill AV",Progress in DNA-based heterologous prime-boost immunization strategies for malaria,"2004 Jun","199","","126-43",Immunological reviews,,,,,,,,"15233731",,,0,10,0,0,0,,,
509,30,"Garcia et al., 2006",journal,"Garcia JE, Puentes A, Patarroyo ME",Developmental biology of sporozoite-host interactions in Plasmodium falciparum malaria: implications for vaccine design,"2006 Oct","19","4","686-707",Clinical microbiology reviews,,,,,,,,"17041140",,,0,10,0,0,0,,,
510,29,"Hinchey et al., 2007",journal,"Hinchey J, Lee S, Jeon BY, Basaraba RJ, Venkataswamy MM, Chen B, Chan J, Braunstein M, Orme IM, Derrick SC, Morris SL, Jacobs WR, Porcelli SA",Enhanced priming of adaptive immunity by a proapoptotic mutant of Mycobacterium tuberculosis,"2007 Aug 1","117","8","2279-2288",The Journal of clinical investigation,"","","","","","","","17671656","",,0,10,0,0,0,,,
511,30,"BenMohamed et al., 2004",journal,"BenMohamed L, Thomas A, Druilhe P",Long-term multiepitopic cytotoxic-T-lymphocyte responses induced in chimpanzees by combinations of Plasmodium falciparum liver-stage peptides and lipopeptides,"2004 Aug","72","8","4376-84",Infection and immunity,,,,,,,,"15271893",,,0,10,0,0,0,,,
512,32,"Jones et al., 1979",journal,"Jones N, Shenk T",Isolation of adenovirus type 5 host range deletion mutants defective for transformation of rat embryo cells,"1979 Jul","17","3","683-9",Cell,"","","","","","","","476833","",,0,10,0,0,0,,,
513,32,"Bett et al., 1995",journal,"Bett AJ, Krougliak V, Graham FL",DNA sequence of the deletion/insertion in early region 3 of Ad5 dl309,"1995 Nov","39","1","75-82",Virus research,"","","","","","","","8607286","",,0,10,0,0,0,,,
514,32,"Tollefson et al., 2007",journal,"Tollefson AE, Kuppuswamy M, Shashkova EV, Doronin K, Wold WS",Preparation and titration of CsCl-banded adenovirus stocks,"2007","130","","223-35",Methods in molecular medicine,"","","","","","","","17401177","",,0,10,0,0,0,,,
515,30,"Pichyangkul et al., 2004",journal,"Pichyangkul S, Gettayacamin M, Miller RS, Lyon JA, Angov E, Tongtawe P, Ruble DL, Heppner DG Jr, Kester KE, Ballou WR, Diggs CL, Voss G, Cohen JD, Walsh DS",Pre-clinical evaluation of the malaria vaccine candidate P. falciparum MSP1(42) formulated with novel adjuvants or with alum,"2004 Sep 28","22","29-30","3831-40",Vaccine,,,,,,,,"15364429",,,0,10,0,0,0,,,
516,30,"Singh et al., 2003",journal,"Singh S, Kennedy MC, Long CA, Saul AJ, Miller LH, Stowers AW",Biochemical and immunological characterization of bacterially expressed and refolded Plasmodium falciparum 42-kilodalton C-terminal merozoite surface protein 1,"2003 Dec","71","12","6766-74",Infection and immunity,,,,,,,,"14638762",,,0,10,0,0,0,,,
517,30,"Thera et al., 2006",journal,"Thera MA, Doumbo OK, Coulibaly D, Diallo DA, Sagara I, Dicko A, Diemert DJ, Heppner DG, Stewart VA, Angov E, Soisson L, Leach A, Tucker K, Lyke KE, Plowe CV",Safety and allele-specific immunogenicity of a malaria vaccine in malian adults: results of a phase I randomized trial,"2006 Nov 24","1","7",e34,PLoS clinical trials,,,,,,,,"17124530",,,0,10,0,0,0,,,
518,30,"Genton et al., 2003",journal,"Genton B, Al-Yaman F, Betuela I, Anders RF, Saul A, Baea K, Mellombo M, Taraika J, Brown GV, Pye D, Irving DO, Felger I, Beck HP, Smith TA, Alpers MP","Safety and immunogenicity of a three-component blood-stage malaria vaccine (MSP1, MSP2, RESA) against Plasmodium falciparum in Papua New Guinean children","2003 Dec 8","22","1","30-41",Vaccine,,,,,,,,"14604568",,,0,10,0,0,0,,,
519,30,"Langermans et al., 2006",journal,"Langermans JA, Hensmann M, van Gijlswiik M, Zhang D, Pan W, Giersing BK, Locke E, Dubovsk F, Wittes J, Thomas AW",Preclinical evaluation of a chimeric malaria vaccine candidate in Montanide ISA 720: immunogenicity and safety in rhesus macaques,"2006 Sep-Oct","2","5","222-6",Human vaccines,,,,,,,,"17035731",,,0,10,0,0,0,,,
520,30,"Stowers et al., 2002",journal,"Stowers AW, Chen Lh LH, Zhang Y, Kennedy MC, Zou L, Lambert L, Rice TJ, Kaslow DC, Saul A, Long CA, Meade H, Miller LH",A recombinant vaccine expressed in the milk of transgenic mice protects Aotus monkeys from a lethal challenge with Plasmodium falciparum,"2002 Jan 8","99","1","339-44",Proceedings of the National Academy of Sciences of the United States of America,,,,,,,,"11752405",,,0,10,0,0,0,,,
521,30,"Rosa et al., 2004",journal,"Rosa DS, Tzelepis F, Cunha MG, Soares IS, Rodrigues MM",The pan HLA DR-binding epitope improves adjuvant-assisted immunization with a recombinant protein containing a malaria vaccine candidate,"2004 Apr 15","92","3","259-68",Immunology letters,,,,,,,,"15081621",,,0,10,0,0,0,,,
522,30,"Sirima et al., 2007",journal,"Sirima SB, Nebie I, Ouedraogo A, Tiono AB, Konate AT, Gansane A, Derme AI, Diarra A, Ouedraogo A, Soulama I, Cuzzin-Ouattara N, Cousens S, Leroy O","Safety and immunogenicity of the Plasmodium falciparum merozoite surface protein-3 long synthetic peptide (MSP3-LSP) malaria vaccine in healthy, semi-immune adult males in Burkina Faso, West Africa","2007 Mar 30","25","14","2723-32",Vaccine,,,,,,,,"17280744",,,0,10,0,0,0,,,
523,30,"Burgess et al., 2005",journal,"Burgess BR, Schuck P, Garboczi DN","Dissection of merozoite surface protein 3, a representative of a family of Plasmodium falciparum surface proteins, reveals an oligomeric and highly elongated molecule","2005 Nov 4","280","44","37236-45",The Journal of biological chemistry,,,,,,,,"16135515",,,0,10,0,0,0,,,
524,30,"Audran et al., 2005",journal,"Audran R, Cachat M, Lurati F, Soe S, Leroy O, Corradin G, Druilhe P, Spertini F",Phase I malaria vaccine trial with a long synthetic peptide derived from the merozoite surface protein 3 antigen,"2005 Dec","73","12","8017-26",Infection and immunity,,,,,,,,"16299295",,,0,10,0,0,0,,,
525,30,"Pearce et al., 2004",journal,"Pearce JA, Hodder AN, Anders RF",The alanine-rich heptad repeats are intact in the processed form of Plasmodium falciparum MSP3,"2004 Nov-Dec","108","3-4","186-9",Experimental parasitology,"","","","","","","","15582517","",,0,10,0,0,0,,,
526,30,"Healer et al., 1997",journal,"Healer J, McGuinness D, Hopcroft P, Haley S, Carter R, Riley E",Complement-mediated lysis of Plasmodium falciparum gametes by malaria-immune human sera is associated with antibodies to the gamete surface antigen Pfs230,"1997 Aug","65","8","3017-23",Infection and immunity,,,,,,,,"9234748",,,0,10,0,0,0,,,
527,30,"Vincent et al., 1999",journal,"Vincent AA, Fanning S, Caira FC, Williamson KC","Immunogenicity of malaria transmission-blocking vaccine candidate, y230.CA14 following crosslinking in the presence of tetanus toxoid","1999 Nov","21","11","573-81",Parasite immunology,,,,,,,,"10583858",,,0,10,0,0,0,,,
528,30,"Arevalo-Herrera et al., 2005",journal,"Arevalo-Herrera M, Solarte Y, Yasnot MF, Castellanos A, Rincon A, Saul A, Mu J, Long C, Miller L, Herrera S",Induction of transmission-blocking immunity in Aotus monkeys by vaccination with a Plasmodium vivax clinical grade PVS25 recombinant protein,"2005 Nov","73","5 Suppl","32-7",The American journal of tropical medicine and hygiene,,,,,,,,"16291764",,,0,10,0,0,0,,,
529,30,"Eksi et al., 2006",journal,"Eksi S, Czesny B, van Gemert GJ, Sauerwein RW, Eling W, Williamson KC","Malaria transmission-blocking antigen, Pfs230, mediates human red blood cell binding to exflagellating male parasites and oocyst production","2006 Aug","61","4","991-8",Molecular microbiology,,,,,,,,"16879650",,,0,10,0,0,0,,,
530,30,"Carter et al., 1995",journal,"Carter R, Coulson A, Bhatti S, Taylor BJ, Elliott JF","Predicted disulfide-bonded structures for three uniquely related proteins of Plasmodium falciparum, Pfs230, Pfs48/45 and Pf12","1995 May","71","2","203-10",Molecular and biochemical parasitology,"","","","","","","","7477102","",,0,10,0,0,0,,,
531,30,"Genton et al., 2003a",journal,"Genton B, Anders RF, Alpers MP, Reeder JC",The malaria vaccine development program in Papua New Guinea,"2003 Jun","19","6","264-70",Trends in parasitology,"","","","","","","","12798084","",,0,10,0,0,0,,,
543,30,"Castellanos et al., 2007",journal,"Castellanos A, Arevalo-Herrera M, Restrepo N, Gulloso L, Corradin G, Herrera S",Plasmodium vivax thrombospondin related adhesion protein: immunogenicity and protective efficacy in rodents and Aotus monkeys,"2007 Jun","102","3","411-6",Memorias do Instituto Oswaldo Cruz,,,,,,,,"17568948",,,0,10,0,0,0,,,
544,30,"Flanagan et al., 2006",journal,"Flanagan KL, Plebanski M, Odhiambo K, Sheu E, Mwangi T, Gelder C, Hart K, Kortok M, Lowe B, Robson KJ, Marsh K, Hill AV","Cellular reactivity to the p. Falciparum protein trap in adult kenyans: novel epitopes, complex cytokine patterns, and the impact of natural antigenic variation","2006 Mar","74","3","367-75",The American journal of tropical medicine and hygiene,,,,,,,,"16525093",,,0,10,0,0,0,,,
540,29,"Hamasur et al., 2003",journal,"Hamasur B, Haile M, Pawlowski A, Schroder U, Williams A, Hatch G, Hall G, Marsh P, Kallenius G, Svenson SB",Mycobacterium tuberculosis arabinomannan-protein conjugates protect against tuberculosis,"2003 Sep 8","21","25-26","4081-93",Vaccine,"","","","","","","","12922145","",,0,10,0,0,0,,,
541,30,"Flanagan et al., 2003",journal,"Flanagan KL, Mwangi T, Plebanski M, Odhiambo K, Ross A, Sheu E, Kortok M, Lowe B, Marsh K, Hill AV",Ex vivo interferon-gamma immune response to thrombospondin-related adhesive protein in coastal Kenyans: longevity and risk of Plasmodium falciparum infection,"2003 Apr","68","4","421-30",The American journal of tropical medicine and hygiene,,,,,,,,"12875291",,,0,10,0,0,0,,,
534,30,"Stewart et al., 2007",journal,"Stewart VA, McGrath SM, Dubois PM, Pau MG, Mettens P, Shott J, Cobb M, Burge JR, Larson D, Ware LA, Demoitie MA, Weverling GJ, Bayat B, Custers JH, Dubois MC, Cohen J, Goudsmit J, Heppner DG Jr","Priming with an adenovirus 35-circumsporozoite protein (CS) vaccine followed by RTS,S/AS01B boosting significantly improves immunogenicity to Plasmodium falciparum CS compared to that with either malaria vaccine alone","2007 May","75","5","2283-90",Infection and immunity,,,,,,,,"17307942",,,0,10,0,0,0,,,
535,30,"Bojang et al., 2001",journal,"Bojang KA, Milligan PJ, Pinder M, Vigneron L, Alloueche A, Kester KE, Ballou WR, Conway DJ, Reece WH, Gothard P, Yamuah L, Delchambre M, Voss G, Greenwood BM, Hill A, McAdam KP, Tornieporth N, Cohen JD, Doherty T","Efficacy of RTS,S/AS02 malaria vaccine against Plasmodium falciparum infection in semi-immune adult men in The Gambia: a randomised trial","2001 Dec 8","358","9297","1927-34",Lancet,"","","","","","","","11747915","",,0,10,0,0,0,,,
542,30,"Gantt et al., 2000",journal,"Gantt S, Persson C, Rose K, Birkett AJ, Abagyan R, Nussenzweig V",Antibodies against thrombospondin-related anonymous protein do not inhibit Plasmodium sporozoite infectivity in vivo,"2000 Jun","68","6","3667-73",Infection and immunity,,,,,,,,"10816526",,,0,10,0,0,0,,,
537,30,"Stoute et al., 2006",journal,"Stoute JA, Heppner DG Jr, Mason CJ, Siangla J, Opollo MO, Kester KE, Vigneron L, Voss G, Walter MJ, Tornieporth N, Cohen JD, Ballou WR","Phase 1 safety and immunogenicity trial of malaria vaccine RTS,S/AS02A in adults in a hyperendemic region of western Kenya","2006 Jul","75","1","166-70",The American journal of tropical medicine and hygiene,"","","","","","","","16837726","",,0,10,0,0,0,,,
538,30,"Kester et al., 2007",journal,"Kester KE, McKinney DA, Tornieporth N, Ockenhouse CF, Heppner DG Jr, Hall T, Wellde BT, White K, Sun P, Schwenk R, Krzych U, Delchambre M, Voss G, Dubois MC, Gasser RA Jr, Dowler MG, O'Brien M, Wittes J, Wirtz R, Cohen J, Ballou WR","A phase I/IIa safety, immunogenicity, and efficacy bridging randomized study of a two-dose regimen of liquid and lyophilized formulations of the candidate malaria vaccine RTS,S/AS02A in malaria-naive adults","2007 Jul 20","25","29","5359-66",Vaccine,"","","","","","","","17574311","",,0,10,0,0,0,,,
539,30,"Alonso et al., 2004",journal,"Alonso PL, Sacarlal J, Aponte JJ, Leach A, Macete E, Milman J, Mandomando I, Spiessens B, Guinovart C, Espasa M, Bassat Q, Aide P, Ofori-Anyinam O, Navia MM, Corachan S, Ceuppens M, Dubois MC, Demoitie MA, Dubovsky F, Menendez C, Tornieporth N, Ballou WR, Thompson R, Cohen J","Efficacy of the RTS,S/AS02A vaccine against Plasmodium falciparum infection and disease in young African children: randomised controlled trial","2004 Oct 16-22","364","9443","1411-20",Lancet,"","","","","","","","15488216","",,0,10,0,0,0,,,
545,30,"Robson et al., 1998",journal,"Robson KJ, Dolo A, Hackford IR, Doumbo O, Richards MB, Keita MM, Sidibe T, Bosman A, Modiano D, Crisanti A",Natural polymorphism in the thrombospondin-related adhesive protein of Plasmodium falciparum,"1998 Jan","58","1","81-9",The American journal of tropical medicine and hygiene,"","","","","","","","9452297","",,0,10,0,0,0,,,
673,25,"Butterton et al., 1997",journal,"Butterton JR, Ryan ET, Acheson DW, Calderwood SB",Coexpression of the B subunit of Shiga toxin 1 and EaeA from enterohemorrhagic Escherichia coli in Vibrio cholerae vaccine strains,"1997","65","6","2127-2135",Infection and immunity,"","","","","","","","9169742 ","","",0,10,0,0,0,,,
547,29,"Im et al., 2007",journal,"Im EJ, Saubi N, Virgili G, Sander C, Teoh D, Gatell JM, McShane H, Joseph J, Hanke T",Vaccine Platform for Prevention of Tuberculosis and Mother-to-Child Transmission of HIV-1 through Breastfeeding,"2007 Jun 27","","","",Journal of virology,"","","","","","","","17596303","",,0,10,0,0,0,,,
548,29,"SWEDBERG, 1951",journal,SWEDBERG B,Studies in experimental tuberculosis; an investigation of some problems of immunity and resistance,"1951","254","","1-120",Acta medica Scandinavica. Supplementum,"","","","","","","","14837707","",,0,10,0,0,0,,,
549,29,"Khera et al., 2005",journal,"Khera A, Singh R, Shakila H, Rao V, Dhar N, Narayanan PR, Parmasivan CN, Ramanathan VD, Tyagi AK","Elicitation of efficient, protective immune responses by using DNA vaccines against tuberculosis","2005 Dec 1","23","48-49","5655-65",Vaccine,"","","","","","","","16157425 ","",,0,10,0,0,0,,,
550,29,"Ducati et al., 2006",journal,"Ducati RG, Ruffino-Netto A, Basso LA, Santos DS",The resumption of consumption-- a review on tuberculosis,"2006 Nov","101","7","697-714",Memorias do Instituto Oswaldo Cruz,"","","","","","","","17160276","",,0,10,0,0,0,,,
552,24,"Jagusztyn-Krynicka et al., 2004",journal,"Jagusztyn-Krynicka EK, Wyszynska A, Raczko A",New approaches to development of mucosal vaccine against enteric bacterial pathogens; preventing campylobacteriosis,"2004","53 Suppl","","7-15",Polish journal of microbiology / Polskie Towarzystwo Mikrobiologow = The Polish Society of Microbiologists,"","","","","","","","15787191","",,0,10,0,0,0,,,
553,24,"Wallis, 2004",journal,Wallis TS,"Vaccination against salmonella, enterohaemorrhagic E. coli and Campylobacter in food-producing animals","2004","119","","343-50",Developments in biologicals,"","","","","","","","15742645","",,0,10,0,0,0,,,
554,24,"Andrews, 1998",journal,Andrews GP,The enteric Campylobacter: they are everywhere,"1998 Sep-Oct","11","5","305-8",Clinical laboratory science : journal of the American Society for Medical Technology,"","","","","","","","10186956","",,0,10,0,0,0,,,
555,24,"Kopecko, 1997",journal,Kopecko DJ,Regulatory considerations for Campylobacter vaccine development,"1997 Dec","176 Suppl 2","",S189-91,The Journal of infectious diseases,"","","","","","","","9396709","",,0,10,0,0,0,,,
556,24,"Scott, 1997",journal,Scott DA,Vaccines against Campylobacter jejuni,"1997 Dec","176 Suppl 2","",S183-8,The Journal of infectious diseases,"","","","","","","","9396708","",,0,10,0,0,0,,,
557,24,"White et al., 1997",journal,"White PL, Baker AR, James WO",Strategies to control Salmonella and Campylobacter in raw poultry products,"1997 Aug","16","2","525-41",Revue scientifique et technique (International Office of Epizootics),"","","","","","","","9501366","",,0,10,0,0,0,,,
558,24,"Sizemore et al., 2006",journal,"Sizemore DR, Warner B, Lawrence J, Jones A, Killeen KP","Live, attenuated Salmonella typhimurium vectoring Campylobacter antigens","2006 May 1","24","18","3793-803",Vaccine,,,,,,,,"16135393",,,0,10,0,0,0,,,
559,28,"Hevey et al., 1998",journal,"Hevey M, Negley D, Pushko P, Smith J, Schmaljohn A",Marburg virus vaccines based upon alphavirus replicons protect guinea pigs and nonhuman primates,"1998 Nov 10","251","1","28-37",Virology,"","","","","","","","9813200 ","",,0,10,0,0,0,,,
560,28,"Hevey et al., 1997",journal,"Hevey M, Negley D, Geisbert J, Jahrling P, Schmaljohn A",Antigenicity and vaccine potential of Marburg virus glycoprotein expressed by baculovirus recombinants,"1997 Dec 8","239","1","206-16",Virology,"","","","","","","","9426460 ","",,0,10,0,0,0,,,
561,31,"Gu et al., 1996",journal,"Gu XX, Tsai CM, Ueyama T, Barenkamp SJ, Robbins JB, Lim DJ","Synthesis, characterization, and immunologic properties of detoxified lipooligosaccharide from nontypeable Haemophilus influenzae conjugated to proteins","1996 Oct","64","10","4047-53",Infection and immunity,"","","","","","","","8926067 ","",,0,10,0,0,0,,,
564,8,"Onate et al., 2003",journal,"Onate AA, Cespedes S, Cabrera A, Rivers R, Gonzalez A, Munoz C, Folch H, Andrews E","A DNA vaccine encoding Cu,Zn superoxide dismutase of Brucella abortus induces protective immunity in BALB/c mice","2003 Sep","71","9","4857-61",Infection and immunity,,,,,,,,"12933826",,,0,10,0,0,0,,,
565,8,"Gee et al., 2005",journal,"Gee JM, Valderas MW, Kovach ME, Grippe VK, Robertson GT, Ng WL, Richardson JM, Winkler ME, Roop RM 2nd","The Brucella abortus Cu,Zn superoxide dismutase is required for optimal resistance to oxidative killing by murine macrophages and wild-type virulence in experimentally infected mice","2005 May","73","5","2873-80",Infection and immunity,,,,,,,,"15845493",,,0,10,0,0,0,,,
678,25,"Leyten et al., 2005",journal,"Leyten EM, Soonawala D, Schultsz C, Herzog C, Ligthelm RJ, Wijnands S, Visser LG","Analysis of efficacy of CVD 103-HgR live oral cholera vaccine against all-cause travellers' diarrhoea in a randomised, double-blind, placebo-controlled study","2005","23","43","5120-5126",Vaccine,"","","","","","","","15982790","","",0,10,0,0,0,,,
568,24,"Martin et al., 1999",journal,"Martin PR, Mulks MH",Cloning and characterization of a gene encoding an antigenic membrane protein from Actinobacillus pleuropneumoniae with homology to ABC transporters,"1999 Aug 15","25","3","245-54",FEMS immunology and medical microbiology,,,,,,,,"10459579",,,0,10,0,0,0,,,
569,24,"Pawelec et al., 1997",journal,"Pawelec D, Rozynek E, Popowski J, Jagusztyn-Krynicka EK","Cloning and characterization of a Campylobacter jejuni 72Dz/92 gene encoding a 30 kDa immunopositive protein, component of the ABC transport system; expression of the gene in avirulent Salmonella typhimurium","1997 Oct","19","2","137-50",FEMS immunology and medical microbiology,,,,,,,,"9395059",,,0,10,0,0,0,,,
571,24,"Abimiku et al., 1989",journal,"Abimiku AG, Dolby JM, Borriello SP",Comparison of different vaccines and induced immune response against Campylobacter jejuni colonization in the infant mouse,"1989 Apr","102","2","271-80",Epidemiology and infection,"","","","","","","","2703020 ","",,0,10,0,0,0,,,
572,30,"Morais et al., 2006",journal,"Morais CG, Soares IS, Carvalho LH, Fontes CJ, Krettli AU, Braga EM",Antibodies to Plasmodium vivax apical membrane antigen 1: persistence and correlation with malaria transmission intensity,"2006 Oct","75","4","582-7",The American journal of tropical medicine and hygiene,"","","","","","","","17038677","",,0,10,0,0,0,,,
573,0,PFL1385c in GeneDB,website,"",PFL1385c in GeneDB,"","","","","","","","","","","","","",http://www.genedb.org/genedb/Search?organism=malaria&name=PFL1385c&isid=true,,136,10,0,0,0,,,
574,30,PFL1385c in GeneDB,website,"",PFL1385c in GeneDB,"","","","","","","","","","","","","",http://www.genedb.org/genedb/Search?organism=malaria&name=PFL1385c&isid=true,,0,10,0,0,0,,,
575,30,PF13_0201 in GeneDB,website,"",PF13_0201 in GeneDB,"","","","","","","","","","","","","",http://www.genedb.org/genedb/Search?organism=malaria&name=PF13_0201&isid=true,,0,10,0,0,0,,,
576,30,PF11_0344 in GeneDB,website,"",PF11_0344 in GeneDB,"","","","","","","","","","","","","",http://www.genedb.org/genedb/Dispatcher?formType=navBar&organism=malaria&desc=yes&wildcard=yes&name=PF11_0344&ohmr=.&ohmr2=.,,0,10,0,0,0,,,
577,30,"Yuen et al., 2007",journal,"Yuen D, Leung WH, Cheung R, Hashimoto C, Ng SF, Ho W, Hui G","Antigenicity and immunogenicity of the N-terminal 33-kDa processing fragment of the Plasmodium falciparum merozoite surface protein 1, MSP1: implications for vaccine development","2007 Jan 5","25","3","490-9",Vaccine,,,,,,,,"16949181",,,0,10,0,0,0,,,
578,0,"Vemulapalli et al., 2000",journal,"Vemulapalli R, He Y, Cravero S, Sriranganathan N, Boyle SM, Schurig GG",Overexpression of protective antigen as a novel approach to enhance vaccine efficacy of Brucella abortus strain RB51,"2000 Jun","68","6","3286-9",Infection and immunity,,,,,,,,"10816475",,,3,10,0,0,0,,,
579,0,"He et al., 2002",journal,"He Y, Vemulapalli R, Schurig GG","Recombinant Ochrobactrum anthropi expressing Brucella abortus Cu,Zn superoxide dismutase protects mice against B. abortus infection only after switching of immune responses to Th1 type","2002 May","70","5","2535-43",Infection and immunity,,,,,,,,"11953393",,,3,10,0,0,0,,,
580,0,"Onate et al., 2003",journal,"Onate AA, Cespedes S, Cabrera A, Rivers R, Gonzalez A, Munoz C, Folch H, Andrews E","A DNA vaccine encoding Cu,Zn superoxide dismutase of Brucella abortus induces protective immunity in BALB/c mice","2003 Sep","71","9","4857-61",Infection and immunity,,,,,,,,"12933826",,,3,10,0,0,0,,,
581,0,"Gee et al., 2005",journal,"Gee JM, Valderas MW, Kovach ME, Grippe VK, Robertson GT, Ng WL, Richardson JM, Winkler ME, Roop RM 2nd","The Brucella abortus Cu,Zn superoxide dismutase is required for optimal resistance to oxidative killing by murine macrophages and wild-type virulence in experimentally infected mice","2005 May","73","5","2873-80",Infection and immunity,,,,,,,,"15845493",,,3,10,0,0,0,,,
582,24,"Prokhorova et al., 2006",journal,"Prokhorova TA, Nielsen PN, Petersen J, Kofoed T, Crawford JS, Morsczeck C, Boysen A, Schrotz-King P",Novel surface polypeptides of Campylobacter jejuni as traveller's diarrhoea vaccine candidates discovered by proteomics,"2006 Sep 29","24","40-41","6446-55",Vaccine,,,,,,,,"16824653",,,0,10,0,0,0,,,
583,24,"Walker, 2005",journal,Walker RI,Considerations for development of whole cell bacterial vaccines to prevent diarrheal diseases in children in developing countries,"2005 May 16","23","26","3369-85",Vaccine,,,,,,,,"15837361",,,0,10,0,0,0,,,
672,25,"Acheson et al., 1996",journal,"Acheson DW, Levine MM, Kaper JB, Keusch GT",Protective immunity to Shiga-like toxin I following oral immunization with Shiga-like toxin I B-subunit-producing Vibrio cholerae CVD 103-HgR,"1996","64","1","355-357",Infection and immunity,"","","","","","","","8557364","","",0,10,0,0,0,,,
585,24,"Huang et al., 2007",journal,"Huang S, Sahin O, Zhang Q",Infection-induced antibodies against the major outer membrane protein of Campylobacter jejuni mainly recognize conformational epitopes,"2007 Jul","272","2","137-43",FEMS microbiology letters,,,,,,,,"17521366",,,0,10,0,0,0,,,
586,24,"Wilkinson et al., 2003",journal,"Wilkinson J, Rood D, Minior D, Guillard K, Darre M, Silbart LK",Immune response to a mucosally administered aflatoxin B1 vaccine,"2003 Oct","82","10","1565-72",Poultry science,,,,,,,,"14601734",,,0,10,0,0,0,,,
587,26,"Liu et al., 2004",journal,"Liu YZ, Zhou L, Wang Q, Ye SQ, Li HX, Zeng Y",[Immune response induced by HIV DNA vaccine combined with recombinant adeno-associated virus],"2004 Sep","18","3","251-4",Zhonghua shi yan he lin chuang bing du xue za zhi = Zhonghua shiyan he linchuang bingduxue zazhi = Chinese journal of experimental and clinical virology,,,,,,,,"15640860",,,0,10,0,0,0,,,
588,26,"Caley et al., 1999",journal,"Caley IJ, Betts MR, Davis NL, Swanstrom R, Frelinger JA, Johnston RE",Venezuelan equine encephalitis virus vectors expressing HIV-1 proteins: vector design strategies for improved vaccine efficacy,"1999 Aug 6","17","23-24","3124-35",Vaccine,,,,,,,,"10462249",,,0,10,0,0,0,,,
589,29,"Sugawara et al., 2007",journal,"Sugawara I, Li Z, Sun L, Udagawa T, Taniyama T",Recombinant BCG Tokyo (Ag85A) protects cynomolgus monkeys (Macaca fascicularis) infected with H37Rv Mycobacterium tuberculosis,"2007 Aug 24","","","","Tuberculosis (Edinburgh, Scotland)","","","","","","","","17720625 ","",,0,10,0,0,0,,,
590,8,"Makar et al., 1975",journal,"Makar AB, McMartin KE, Palese M, Tephly TR",Formate assay in body fluids: application in methanol poisoning,"1975","13","2","117-126",Biochemical medicine,"","","","","","","","1","",,0,10,0,0,0,,,
592,37,"Waag, 2007",journal,Waag DM,Coxiella burnetii: Host and bacterial responses to infection,"2007","25","42","7288-7295",Vaccine,"","","","","","","","17825460 ","",,0,10,0,0,0,,,
593,37,"Burton et al., 1971",journal,"Burton PR, Kordova N, Paretsky D","Electron microscopic studies of the rickettsia Coxiella burneti: entry, lysosomal response, and fate of rickettsial DNA in L-cells","1971","17","2","143-150",Canadian journal of microbiology,"","","","","","","","4100953","",,0,10,0,0,0,,,
594,37,"Burton et al., 1978",journal,"Burton PR, Stueckemann J, Welsh RM, Paretsky D",Some ultrastructural effects of persistent infections by the rickettsia Coxiella burnetii in mouse L cells and green monkey kidney (Vero) cells,"1978","21","2","556-566",Infection and immunity,"","","","","","","","99368","",,0,10,0,0,0,,,
599,37,"Akporiaye and Baca, 1983",journal,"Akporiaye ET, Baca OG",Superoxide anion production and superoxide dismutase and catalase activities in Coxiella burnetii,"1983","154","1","520-523",Journal of bacteriology,"","","","","","","","6300038 ","",,0,10,0,0,0,,,
596,37,"Tigertt et al., 1961",journal,"Tigertt WD, Beneson AS, Gochenour WS",Airborne Q fever,"1961","25","","285-293",Bacteriological reviews,"","","","","","","","13921201","",,0,10,0,0,0,,,
597,37,"Ohkuma and Poole, 1978",journal,"Ohkuma S, Poole B",Fluorescence probe measurement of the intralysosomal pH in living cells and the perturbation of pH by various agents,"1978","75","7","3327-3331",Proceedings of the National Academy of Sciences of the United States of America,"","","","","","","","28524","",,0,10,0,0,0,,,
598,37,"Hackstadt and Williams, 1981",journal,"Hackstadt T, Williams JC",Biochemical stratagem for obligate parasitism of eukaryotic cells by Coxiella burnetii,"1981","78","5","3240-3244",Proceedings of the National Academy of Sciences of the United States of America,"","","","","","","","6942430","",,0,10,0,0,0,,,
600,37,"Ormsbee, 1969",journal,Ormsbee RA,Rickettsiae (as organisms),"1969","23","","275-292",Annual review of microbiology,"","","","","","","","4899075","",,0,10,0,0,0,,,
602,37,"Mege et al., 1997",journal,"Mege JL, Maurin M, Capo C, Raoult D",Coxiella burnetii: the 'query' fever bacterium. A model of immune subversion by a strictly intracellular microorganism,"1997","19","4","209-217",FEMS microbiology reviews,"","","","","","","","9167255 ","",,0,10,0,0,0,,,
603,37,"Capo et al., 1999",journal,"Capo C, Lindberg FP, Meconi S, Zaffran Y, Tardei G, Brown EJ, Raoult D, Mege JL",Subversion of monocyte functions by coxiella burnetii: impairment of the cross-talk between alphavbeta3 integrin and CR3,"1999","163","11","6078-6085","Journal of immunology (Baltimore, Md. : 1950)","","","","","","","","10570297","",,0,10,0,0,0,,,
606,37,"Langley et al., 2003",journal,"Langley JM, Marrie TJ, Leblanc JC, Almudevar A, Resch L, Raoult D",Coxiella burnetii seropositivity in parturient women is associated with adverse pregnancy outcomes,"2003","189","1","228-232",American journal of obstetrics and gynecology,"","","","","","","","12861167 ","",,0,10,0,0,0,,,
607,37,"Palmer et al., 1983",journal,"Palmer NC, Kierstead M, Key DW, Williams JC, Peacock MG, Vellend H",Placentitis and Abortion in Goats and Sheep in Ontario Caused by Coxiella burnetii,"1983","24","2","60-61",The Canadian veterinary journal. La revue veterinaire canadienne,"","","","","","","","17422227","",,0,10,0,0,0,,,
608,37,"Waldhalm et al., 1978",journal,"Waldhalm DG, Stoenner HG, Simmons RE, Thomas LA",Abortion associated with Coxiella burnetii infection in dairy goats,"1978","173","12","1580-1581",Journal of the American Veterinary Medical Association,"","","","","","","","748297 ","",,0,10,0,0,0,,,
609,37,"Williams and Thompson, 1991",book,"Williams JC, Thompson HA","Methods for isolation, amplification, and purification of Coxiella burnetii","1991","","","73-115",Q Fever: The Biology of Coxiella burnetii,CRC Press,"","","","","","","","",,0,10,0,0,0,,,
610,37,"Stoker and Marmion, 1955",journal,"Stoker MG, Marmion BP",The spread of Q fever from animals to man; the natural history of a rickettsial disease,"1955","13","5","781-806",Bulletin of the World Health Organization,"","","","","","","","13284558 ","",,0,10,0,0,0,,,
611,37,"Zamboni et al., 2004",journal,"Zamboni DS, Campos MA, Torrecilhas AC, Kiss K, Samuel JE, Golenbock DT, Lauw FN, Roy CR, Almeida IC, Gazzinelli RT",Stimulation of toll-like receptor 2 by Coxiella burnetii is required for macrophage production of pro-inflammatory cytokines and resistance to infection,"2004","279","52","54405-54415",The Journal of biological chemistry,"","","","","","","","15485838 ","",,0,10,0,0,0,,,
612,37,"Shannon et al., 2005",journal,"Shannon JG, Howe D, Heinzen RA",Virulent Coxiella burnetii does not activate human dendritic cells: role of lipopolysaccharide as a shielding molecule,"2005","102","24","8722-8727",Proceedings of the National Academy of Sciences of the United States of America,"","","","","","","","15939879 ","",,0,10,0,0,0,,,
613,37,"Brennan et al., 2004",journal,"Brennan RE, Russell K, Zhang G, Samuel JE",Both inducible nitric oxide synthase and NADPH oxidase contribute to the control of virulent phase I Coxiella burnetii infections,"2004","72","11","6666-6675",Infection and immunity,"","","","","","","","15501800","",,0,10,0,0,0,,,
614,37,"Turco et al., 1984",journal,"Turco J, Thompson HA, Winkler HH",Interferon-gamma inhibits growth of Coxiella burnetii in mouse fibroblasts,"1984","45","3","781-783",Infection and immunity,"","","","","","","","6432701 ","",,0,10,0,0,0,,,
616,37,"Ackland et al., 1994",journal,"Ackland JR, Worswick DA, Marmion BP",Vaccine prophylaxis of Q fever. A follow-up study of the efficacy of Q-Vax (CSL) 1985-1990,"1994","160","11","704-708",The Medical journal of Australia,"","","","","","","","8202006 ","",,0,10,0,0,0,,,
631,37,"Robinson and Hasty, 1974",journal,"Robinson DM, Hasty SE",Production of a potent vaccine from the attenuated M-44 strain of Coxiella burneti,"1974","27","4","777-783",Applied microbiology,"","","","","","","","4825980 ","",,0,10,0,0,0,,,
618,37,"Williams and Cantrell, 1982",journal,"Williams JC, Cantrell JL",Biological and immunological properties of Coxiella burnetii vaccines in C57BL/10ScN endotoxin-nonresponder mice,"1982","35","3","1091-1102",Infection and immunity,"","","","","","","","7068212","",,0,10,0,0,0,,,
619,37,"Fries et al., 1993",journal,"Fries LF, Waag DM, Williams JC",Safety and immunogenicity in human volunteers of a chloroform-methanol residue vaccine for Q fever,"1993","61","4","1251-1258",Infection and immunity,"","","","","","","","8454328 ","",,0,10,0,0,0,,,
620,37,"Johnson et al., 1977",journal,"Johnson JW, McLeod CG, Stookey JL, Higbee GA, Pedersen CE Jr",Lesions in guinea pigs infected with Coxiella burnetii strain M-44,"1977","135","6","995-998",The Journal of infectious diseases,"","","","","","","","864292 ","",,0,10,0,0,0,,,
621,37,"Li et al., 2005",journal,"Li Q, Niu D, Wen B, Chen M, Qiu L, Zhang J",Protective immunity against Q fever induced with a recombinant P1 antigen fused with HspB of Coxiella burnetii,"2005","1063","","130-142",Annals of the New York Academy of Sciences,"","","","","","","","16481504 ","",,0,10,0,0,0,,,
622,28,"Mohamadzadeh et al., 2007",journal,"Mohamadzadeh M, Chen L, Schmaljohn AL",How Ebola and Marburg viruses battle the immune system,"2007","7","7","556-567",Nature reviews. Immunology,"","","","","","","","17589545","",,0,10,0,0,0,,,
624,37,"Hackstadt et al., 1985",journal,"Hackstadt T, Peacock MG, Hitchcock PJ, Cole RL",Lipopolysaccharide variation in Coxiella burnetti: intrastrain heterogeneity in structure and antigenicity,"1985","48","2","359-365",Infection and immunity,"","","","","","","","3988339 ","",,0,10,0,0,0,,,
625,37,"Waag et al., 1997",journal,"Waag DM, England MJ, Pitt ML",Comparative efficacy of a Coxiella burnetii chloroform:methanol residue (CMR) vaccine and a licensed cellular vaccine (Q-Vax) in rodents challenged by aerosol,"1997","15","16","1779-1783",Vaccine,"","","","","","","","9364683 ","",,0,10,0,0,0,,,
626,37,"Waag et al., 2002",journal,"Waag DM, England MJ, Tammariello RF, Byrne WR, Gibbs P, Banfield CM, Pitt ML",Comparative efficacy and immunogenicity of Q fever chloroform:methanol residue (CMR) and phase I cellular (Q-Vax) vaccines in cynomolgus monkeys challenged by aerosol,"2002","20","19-20","2623-2634",Vaccine,"","","","","","","","12057622 ","",,0,10,0,0,0,,,
627,37,"Arricau-Bouvery et al., 2005",journal,"Arricau-Bouvery N, Souriau A, Bodier C, Dufour P, Rousset E, Rodolakis A",Effect of vaccination with phase I and phase II Coxiella burnetii vaccines in pregnant goats,"2005","23","35","4392-4402",Vaccine,"","","","","","","","16005747 ","",,0,10,0,0,0,,,
628,28,"Daddario-DiCaprio et al., 2006",journal,"Daddario-DiCaprio KM, Geisbert TW, Geisbert JB, Stroher U, Hensley LE, Grolla A, Fritz EA, Feldmann F, Feldmann H, Jones SM","Cross-protection against Marburg virus strains by using a live, attenuated recombinant vaccine","2006","80","19","9659-9666",Journal of virology,"","","","","","","","16973570","",,0,10,0,0,0,,,
629,28,"Swenson et al., 2005",journal,"Swenson DL, Warfield KL, Negley DL, Schmaljohn A, Aman MJ, Bavari S",Virus-like particles exhibit potential as a pan-filovirus vaccine for both Ebola and Marburg viral infections,"2005","23","23","3033-3042",Vaccine,"","","","","","","","15811650","",,0,10,0,0,0,,,
632,42,"Cheminay and Hensel, 2007",journal,"Cheminay C, Hensel M",Rational design of Salmonella recombinant vaccines,"2007","","","",International journal of medical microbiology : IJMM,"","","","","","","","17888730 ","",,0,10,0,0,0,,,
633,42,"Boyle et al., 2007",journal,"Boyle EC, Bishop JL, Grassl GA, Finlay BB",Salmonella: from pathogenesis to therapeutics,"2007","189","5","1489-1495",Journal of bacteriology,"","","","","","","","17189373","",,0,10,0,0,0,,,
635,42,"Levine et al., 2007",journal,"Levine MM, Ferreccio C, Black RE, Lagos R, San Martin O, Blackwelder WC",Ty21a live oral typhoid vaccine and prevention of paratyphoid fever caused by Salmonella enterica Serovar Paratyphi B,"2007","45 Suppl 1","",S24-28,Clinical infectious diseases : an official publication of the Infectious Diseases Society of America,"","","","","","","","17582564","",,0,10,0,0,0,,,
636,42,"Tacket and Levine, 2007",journal,"Tacket CO, Levine MM","CVD 908, CVD 908-htrA, and CVD 909 live oral typhoid vaccines: a logical progression","2007","45 Suppl 1","",S20-23,Clinical infectious diseases : an official publication of the Infectious Diseases Society of America,"","","","","","","","17582563","",,0,10,0,0,0,,,
637,42,"Wang et al., 2000",journal,"Wang JY, Noriega FR, Galen JE, Barry E, Levine MM",Constitutive expression of the Vi polysaccharide capsular antigen in attenuated Salmonella enterica serovar typhi oral vaccine strain CVD 909,"2000","68","8","4647-4652",Infection and immunity,"","","","","","","","10899868","",,0,10,0,0,0,,,
638,42,"Tacket et al., 2000",journal,"Tacket CO, Sztein MB, Wasserman SS, Losonsky G, Kotloff KL, Wyant TL, Nataro JP, Edelman R, Perry J, Bedford P, Brown D, Chatfield S, Dougan G, Levine MM",Phase 2 clinical trial of attenuated Salmonella enterica serovar typhi oral live vector vaccine CVD 908-htrA in U.S. volunteers,"2000","68","3","1196-1201",Infection and immunity,"","","","","","","","10678926","",,0,10,0,0,0,,,
639,42,"Pasetti et al., 1999",journal,"Pasetti MF, Anderson RJ, Noriega FR, Levine MM, Sztein MB",Attenuated deltaguaBA Salmonella typhi vaccine strain CVD 915 as a live vector utilizing prokaryotic or eukaryotic expression systems to deliver foreign antigens and elicit immune responses,"1999","92","1","76-89","Clinical immunology (Orlando, Fla.)","","","","","","","","10413655","",,0,10,0,0,0,,,
640,42,"Crdenas and Clements, 1992",journal,"Crdenas L, Clements JD",Oral immunization using live attenuated Salmonella spp. as carriers of foreign antigens,"1992","5","3","328-342",Clinical microbiology reviews,"","","","","","","","1498769","",,0,10,0,0,0,,,
643,42,"Methner et al., 1997",journal,"Methner U, Barrow PA, Martin G, Meyer H","Comparative study of the protective effect against Salmonella colonisation in newly hatched SPF chickens using live, attenuated Salmonella vaccine strains, wild-type Salmonella strains or a competitive exclusion product","1997","35","3","223-230",International journal of food microbiology,"","","","","","","","9105931","",,0,10,0,0,0,,,
644,42,"Salvat et al., 1992",journal,"Salvat G, Lalande F, Humbert F, Lahellec C",Use of a competitive exclusion product (Broilact) to prevent Salmonella colonization of newly hatched chicks,"1992","15","3-4","307-311",International journal of food microbiology,"","","","","","","","1419536 ","",,0,10,0,0,0,,,
645,42,"Schneitz and Renney, 2003",journal,"Schneitz C, Renney DJ",Effect of a commerical competitive exclusion product on the colonization of Salmonella infantis in day-old pheasant chicks,"2003","47","4","1448-1451",Avian diseases,"","","","","","","","14708995 ","",,0,10,0,0,0,,,
646,42,Game Bird Health - Broilact,website,"",Game Bird Health - Broilact,"","","","","","","","","","","","","",http://www.gamebirdhealth.co.uk/broilact.htm,,0,10,0,0,0,,,
647,42,"Frech et al., 1998",journal,"Frech G, Weide-Botjes M, Nussbeck E, Rabsch W, Schwarz S",Molecular characterization of Salmonella enterica subsp. enterica serovar Typhimurium DT009 isolates: differentiation of the live vaccine strain Zoosaloral from field isolates,"1998","167","2","263-269",FEMS microbiology letters,"","","","","","","","9809427","",,0,10,0,0,0,,,
648,43,"Niyogi, 2005",journal,Niyogi SK,Shigellosis,"2005","43","2","133-143","Journal of microbiology (Seoul, Korea)","","","","","","","","15880088","",,0,10,0,0,0,,,
649,43,"Klee et al., 1997",journal,"Klee SR, Tzschaschel BD, Flt I, Krnell A, Lindberg AA, Timmis KN, Guzmn CA",Construction and characterization of a live attenuated vaccine candidate against Shigella dysenteriae type 1,"1997","65","6","2112-2118",Infection and immunity,"","","","","","","","9169740","",,0,10,0,0,0,,,
650,43,"Coster et al., 1999",journal,"Coster TS, Hoge CW, VanDeVerg LL, Hartman AB, Oaks EV, Venkatesan MM, Cohen D, Robin G, Fontaine-Thompson A, Sansonetti PJ, Hale TL",Vaccination against shigellosis with attenuated Shigella flexneri 2a strain SC602,"1999","67","7","3437-3443",Infection and immunity,"","","","","","","","10377124","",,0,10,0,0,0,,,
651,43,"Kotloff et al., 2000",journal,"Kotloff KL, Noriega FR, Samandari T, Sztein MB, Losonsky GA, Nataro JP, Picking WD, Barry EM, Levine MM","Shigella flexneri 2a strain CVD 1207, with specific deletions in virG, sen, set, and guaBA, is highly attenuated in humans","2000","68","3","1034-1039",Infection and immunity,"","","","","","","","10678904","",,0,10,0,0,0,,,
652,43,"Noriega et al., 1996",journal,"Noriega FR, Losonsky G, Lauderbaugh C, Liao FM, Wang JY, Levine MM","Engineered deltaguaB-A deltavirG Shigella flexneri 2a strain CVD 1205: construction, safety, immunogenicity, and potential efficacy as a mucosal vaccine","1996","64","8","3055-3061",Infection and immunity,"","","","","","","","8757833","",,0,10,0,0,0,,,
653,43,"Noriega et al., 1994",journal,"Noriega FR, Wang JY, Losonsky G, Maneval DR, Hone DM, Levine MM","Construction and characterization of attenuated delta aroA delta virG Shigella flexneri 2a strain CVD 1203, a prototype live oral vaccine","1994","62","11","5168-5172",Infection and immunity,"","","","","","","","7927802","",,0,10,0,0,0,,,
654,43,"Venkatesan et al., 2002",journal,"Venkatesan MM, Hartman AB, Newland JW, Ivanova VS, Hale TL, McDonough M, Butterton J","Construction, characterization, and animal testing of WRSd1, a Shigella dysenteriae 1 vaccine","2002","70","6","2950-2958",Infection and immunity,"","","","","","","","12010984","",,0,10,0,0,0,,,
655,43,"Kotloff et al., 2002",journal,"Kotloff KL, Taylor DN, Sztein MB, Wasserman SS, Losonsky GA, Nataro JP, Venkatesan M, Hartman A, Picking WD, Katz DE, Campbell JD, Levine MM, Hale TL","Phase I evaluation of delta virG Shigella sonnei live, attenuated, oral vaccine strain WRSS1 in healthy adults","2002","70","4","2016-2021",Infection and immunity,"","","","","","","","11895966","",,0,10,0,0,0,,,
656,43,"Altboum et al., 2001",journal,"Altboum Z, Barry EM, Losonsky G, Galen JE, Levine MM",Attenuated Shigella flexneri 2a Delta guaBA strain CVD 1204 expressing enterotoxigenic Escherichia coli (ETEC) CS2 and CS3 fimbriae as a live mucosal vaccine against Shigella and ETEC infection,"2001","69","5","3150-3158",Infection and immunity,"","","","","","","","11292735","",,0,10,0,0,0,,,
657,43,"Kotloff et al., 1992",journal,"Kotloff KL, Herrington DA, Hale TL, Newland JW, Van De Verg L, Cogan JP, Snoy PJ, Sadoff JC, Formal SB, Levine MM","Safety, immunogenicity, and efficacy in monkeys and humans of invasive Escherichia coli K-12 hybrid vaccine candidates expressing Shigella flexneri 2a somatic antigen","1992","60","6","2218-2224",Infection and immunity,"","","","","","","","1587589","",,0,10,0,0,0,,,
659,43,"Chakrabarti et al., 1999",journal,"Chakrabarti MK, Bhattacharya J, Bhattacharya MK, Nair GB, Bhattacharya SK, Mahalanabis D",Killed oral Shigella vaccine made from Shigella flexneri 2a protects against challenge in the rabbit model of shigellosis,"1999","88","2","161-165","Acta paediatrica (Oslo, Norway : 1992)","","","","","","","","10102148","",,0,10,0,0,0,,,
660,43,"Hartman et al., 1991",journal,"Hartman AB, Powell CJ, Schultz CL, Oaks EV, Eckels KH",Small-animal model to measure efficacy and immunogenicity of Shigella vaccine strains,"1991","59","11","4075-4083",Infection and immunity,"","","","","","","","1937767","",,0,10,0,0,0,,,
661,43,"Orr et al., 1993",journal,"Orr N, Robin G, Cohen D, Arnon R, Lowell GH",Immunogenicity and efficacy of oral or intranasal Shigella flexneri 2a and Shigella sonnei proteosome-lipopolysaccharide vaccines in animal models,"1993","61","6","2390-2395",Infection and immunity,"","","","","","","","8500877","",,0,10,0,0,0,,,
662,43,"Osorio et al., 2007",journal,"Osorio M, Bray MD, Walker RI",Vaccine potential for inactivated shigellae,"2007","25","9","1581-1592",Vaccine,"","","","","","","","17178431","",,0,10,0,0,0,,,
663,43,"Kotloff et al., 2007",journal,"Kotloff KL, Simon JK, Pasetti MF, Sztein MB, Wooden SL, Livio S, Nataro JP, Blackwelder WC, Barry EM, Picking W, Levine MM","Safety and Immunogenicity of CVD 1208S, a Live, Oral DeltaguaBA Deltasen Deltaset Shigella flexneri 2a Vaccine Grown on Animal-Free Media","2007","3","6","",Human vaccines,"","","","","","","","17938573 ","",,0,10,0,0,0,,,
664,43,"Shim et al., 2007",journal,"Shim DH, Chang SY, Park SM, Jang H, Carbis R, Czerkinsky C, Uematsu S, Akira S, Kweon MN",Immunogenicity and protective efficacy offered by a ribosomal-based vaccine from Shigella flexneri 2a,"2007","25","25","4828-4836",Vaccine,"","","","","","","","17507120","",,0,10,0,0,0,,,
665,25,"Potter et al., 2004",journal,"Potter AA, Klashinsky S, Li Y, Frey E, Townsend H, Rogan D, Erickson G, Hinkley S, Klopfenstein T, Moxley RA, Smith DR, Finlay BB",Decreased shedding of Escherichia coli O157:H7 by cattle following vaccination with type III secreted proteins,"2004","22","3-4","362-369",Vaccine,"","","","","","","","14670317","",,0,10,0,0,0,,,
666,8,"Delpino et al., 2007a",journal,"Delpino MV, Estein SM, Fossati CA, Baldi PC",Partial protection against Brucella infection in mice by immunization with nonpathogenic alphaproteobacteria,"2007","14","10","1296-1301",Clinical and vaccine immunology : CVI,"","","","","","","","17715332","",,0,10,0,0,0,,,
668,25,"Mason et al., 1998",journal,"Mason HS, Haq TA, Clements JD, Arntzen CJ",Edible vaccine protects mice against Escherichia coli heat-labile enterotoxin (LT): potatoes expressing a synthetic LT-B gene,"1998","16","13","1336-1343",Vaccine,"","","","","","","","9682399 ","",,0,10,0,0,0,,,
680,25,"Wenners et al., 1992",journal,"Wenners C, Svennerholm AM, Ahrn C, Czerkinsky C",Antibody-secreting cells in human peripheral blood after oral immunization with an inactivated enterotoxigenic Escherichia coli vaccine,"1992","60","7","2605-2611",Infection and immunity,"","","","","","","","1612730","","",0,10,0,0,0,,,
683,8,"Yang et al., 2006",journal,"Yang X, Becker T, Walters N, Pascual DW",Deletion of znuA virulence factor attenuates Brucella abortus and confers protection against wild-type challenge,"2006","74","7","3874-3879",Infection and immunity,"","","","","","","","16790759","","",0,10,0,0,0,,,
687,8,"Delpino et al., 2007b",journal,"Delpino MV, Estein SM, Fossati CA, Baldi PC, Cassataro J",Vaccination with Brucella recombinant DnaK and SurA proteins induces protection against Brucella abortus infection in BALB/c mice,"2007","25","37-38","6721-6729",Vaccine,"","","","","","","","17686554","","",0,10,0,0,0,,,
679,25,"Van et al., 2005",journal,"Van Donkersgoed J, Hancock D, Rogan D, Potter AA",Escherichia coli O157:H7 vaccine field trial in 9 feedlots in Alberta and Saskatchewan,"2005","46","8","724-728",The Canadian veterinary journal. La revue veterinaire canadienne,"","","","","","","","16187717","","",0,10,0,0,0,,,
669,25,"Horne et al., 2002",journal,"Horne C, Vallance BA, Deng W, Finlay BB",Current progress in enteropathogenic and enterohemorrhagic Escherichia coli vaccines,"2002","1","4","483-493",Expert review of vaccines,"","","","","","","","12901587 ","","",0,10,0,0,0,,,
689,8,"Poester et al., 2006",journal,"Poester FP, Gonalves VS, Paixo TA, Santos RL, Olsen SC, Schurig GG, Lage AP",Efficacy of strain RB51 vaccine in heifers against experimental brucellosis,"2006","24","25","5327-5334",Vaccine,"","","","","","","","16713034","","",0,10,0,0,0,,,
690,8,"Guilloteau et al., 2006",journal,"Guilloteau LA, Laroucau K, Olivier M, Grillo MJ, Marin CM, Verger JM, Blasco JM",Residual virulence and immunogenicity of CGV26 and CGV2631 B. melitensis Rev. 1 deletion mutant strains in sheep after subcutaneous or conjunctival vaccination,"2006","24","17","3461-3468",Vaccine,"","","","","","","","16519974","","",0,10,0,0,0,,,
691,8,"Estevan et al., 2006",journal,"Estevan M, Gamazo C, Grill MJ, Del Barrio GG, Blasco JM, Irache JM",Experiments on a sub-unit vaccine encapsulated in microparticles and its efficacy against Brucella melitensis in mice,"2006","24","19","4179-4187",Vaccine,"","","","","","","","16481077","","",0,10,0,0,0,,,
692,8,"Adone et al., 2005",journal,"Adone R, Ciuchini F, Marianelli C, Tarantino M, Pistoia C, Marcon G, Petrucci P, Francia M, Riccardi G, Pasquali P",Protective properties of rifampin-resistant rough mutants of Brucella melitensis,"2005","73","7","4198-4204",Infection and immunity,"","","","","","","","15972510","","",0,10,0,0,0,,,
693,8,"Mallick et al., 2007",journal,"Mallick AI, Singha H, Khan S, Anwar T, Ansari MA, Khalid R, Chaudhuri P, Owais M",Escheriosome-mediated delivery of recombinant ribosomal L7/L12 protein confers protection against murine brucellosis,"2007","25","46","7873-7884",Vaccine,"","","","","","","","17931756","","",0,10,0,0,0,,,
694,8,"Kahl-McDonagh et al., 2007",journal,"Kahl-McDonagh MM, Arenas-Gamboa AM, Ficht TA",Aerosol infection of BALB/c mice with Brucella melitensis and Brucella abortus and protective efficacy against aerosol challenge,"2007","75","10","4923-4932",Infection and immunity,"","","","","","","","17664263","","",0,10,0,0,0,,,
695,8,"Yang et al., 2007",journal,"Yang X, Walters N, Robison A, Trunkle T, Pascual DW",Nasal immunization with recombinant Brucella melitensis bp26 and trigger factor with cholera toxin reduces B. melitensis colonization,"2007","25","12","2261-2268",Vaccine,"","","","","","","","17239499","","",0,10,0,0,0,,,
696,8,"Parent et al., 2007",journal,"Parent MA, Goenka R, Murphy E, Levier K, Carreiro N, Golding B, Ferguson G, Roop RM 2nd, Walker GC, Baldwin CL",Brucella abortus bacA mutant induces greater pro-inflammatory cytokines than the wild-type parent strain,"2007","9","1","55-62",Microbes and infection / Institut Pasteur,"","","","","","","","17196866","","",0,10,0,0,0,,,
697,8,"Luo et al., 2006b",journal,"Luo D, Ni B, Li P, Shi W, Zhang S, Han Y, Mao L, He Y, Wu Y, Wang X",Protective immunity elicited by a divalent DNA vaccine encoding both the L7/L12 and Omp16 genes of Brucella abortus in BALB/c mice,"2006","74","5","2734-2741",Infection and immunity,"","","","","","","","16622210","","",0,10,0,0,0,,,
698,29,"Gartner et al., 2008",journal,"Gartner T, Romano M, Suin V, Kalai M, Korf H, De Baetselier P, Huygen K",Immunogenicity and protective efficacy of a tuberculosis DNA vaccine co-expressing pro-apoptotic caspase-3,"2008","26","11","1458-1470",Vaccine,"","","","","","","","18280621","","",0,10,0,0,0,,,
699,8,"Arenas-Gamboa et al., 2008",journal,"Arenas-Gamboa AM, Ficht TA, Kahl-McDonagh MM, Rice-Ficht AC",Immunization with a Single Dose of a Microencapsulated Brucella melitensis Mutant Enhances Protection Against Wild-type Challenge,"2008","","","",Infection and immunity,"","","","","","","","18362129","","",0,10,0,0,0,,,
700,8,"Kahl-McDonagh and Ficht, 2006",journal,"Kahl-McDonagh MM, Ficht TA",Evaluation of protection afforded by Brucella abortus and Brucella melitensis unmarked deletion mutants exhibiting different rates of clearance in BALB/c mice,"2006","74","7","4048-4057",Infection and immunity,,,,,,,,"16790778",,,0,10,0,0,0,,,
701,18,"Berhanu et al., 2008",journal,"Berhanu A, Wilson RL, Kirkwood-Watts DL, King DS, Warren TK, Lund SA, Brown LL, Krupkin AK, Vandermay E, Weimers W, Honeychurch KM, Grosenbach DW, Jones KF, Hruby DE","Vaccination of BALB/c mice with Escherichia coli-expressed vaccinia virus proteins A27L, B5R, and D8L protects mice from lethal vaccinia virus challenge","2008","82","7","3517-3529",Journal of virology,"","","","","","","","18199639","","",0,10,0,0,0,,,
702,8,"Izadjoo et al., 2004",journal,"Izadjoo MJ, Bhattacharjee AK, Paranavitana CM, Hadfield TL, Hoover DL",Oral vaccination with Brucella melitensis WR201 protects mice against intranasal challenge with virulent Brucella melitensis 16M,"2004","72","7","4031-4039",Infection and immunity,"","","","","","","","15213148","","",0,10,0,0,0,,,
703,8,"Bhattacharjee et al., 2002",journal,"Bhattacharjee AK, Van de Verg L, Izadjoo MJ, Yuan L, Hadfield TL, Zollinger WD, Hoover DL",Protection of mice against brucellosis by intranasal immunization with Brucella melitensis lipopolysaccharide as a noncovalent complex with Neisseria meningitidis group B outer membrane protein,"2002","70","7","3324-3329",Infection and immunity,"","","","","","","","12065469","","",0,10,0,0,0,,,
704,8,"Hoover et al., 1999",journal,"Hoover DL, Crawford RM, Van De Verg LL, Izadjoo MJ, Bhattacharjee AK, Paranavitana CM, Warren RL, Nikolich MP, Hadfield TL",Protection of mice against brucellosis by vaccination with Brucella melitensis WR201(16MDeltapurEK),"1999","67","11","5877-5884",Infection and immunity,"","","","","","","","10531243","","",0,10,0,0,0,,,
705,7,"Bielinska et al., 2007",journal,"Bielinska AU, Janczak KW, Landers JJ, Makidon P, Sower LE, Peterson JW, Baker JR Jr",Mucosal immunization with a novel nanoemulsion-based recombinant anthrax protective antigen vaccine protects against Bacillus anthracis spore challenge,"2007","75","8","4020-4029",Infection and immunity,"","","","","","","","17502384","","",0,10,0,0,0,,,
706,8,"Drazek et al., 1995",journal,"Drazek ES, Houng HS, Crawford RM, Hadfield TL, Hoover DL, Warren RL",Deletion of purE attenuates Brucella melitensis 16M for growth in human monocyte-derived macrophages,"1995","63","9","3297-3301",Infection and immunity,,,,,,,,"7642258",,,0,10,0,0,0,,,
707,26,"Bielinska et al., 2008",journal,"Bielinska AU, Janczak KW, Landers JJ, Markovitz DM, Montefiori DC, Baker JR Jr",Nasal immunization with a recombinant HIV gp120 and nanoemulsion adjuvant produces Th1 polarized responses and neutralizing antibodies to primary HIV type 1 isolates,"2008","24","2","271-281",AIDS research and human retroviruses,"","","","","","","","18260780","","",0,10,0,0,0,,,
708,18,"Bielinska et al., 2008",journal,"Bielinska AU, Chepurnov AA, Landers JJ, Janczak KW, Chepurnova TS, Luker GD, Baker JR Jr","A novel, killed-virus nasal vaccinia virus vaccine","2008","15","2","348-358",Clinical and vaccine immunology : CVI,"","","","","","","","18057181","","",0,10,0,0,0,,,
709,25,"Hancock et al., 2008",journal,"Hancock V, Ferrires L, Klemm P",The ferric yersiniabactin uptake receptor FyuA is required for efficient biofilm formation by urinary tract infectious Escherichia coli in human urine,"2008","154",Pt 1,"167-175","Microbiology (Reading, England)",,,,,,,,"18174135",,,0,10,0,0,0,,,
710,25,"Hagan and Mobley, 2007",journal,"Hagan EC, Mobley HL",Uropathogenic Escherichia coli outer membrane antigens expressed during urinary tract infection,"2007","75","8","3941-3949",Infection and immunity,"","","","","","","","17517861","","",0,10,0,0,0,,,
711,41,"Brook, 2008",journal,Brook I,Current concepts in the management of Clostridium tetani infection,"2008","6","3","327-336",Expert review of anti-infective therapy,"","","","","","","","18588497","","",0,10,0,0,0,,,
712,29,"Stephens et al., 2007",journal,"Stephens DS, Greenwood B, Brandtzaeg P","Epidemic meningitis, meningococcaemia, and Neisseria meningitidis","2007","369","9580","2196-2210",Lancet,"","","","","","","","17604802","","",0,0,0,0,0,,,
713,46,"Stephens et al., 2007",journal,"Stephens DS, Greenwood B, Brandtzaeg P","Epidemic meningitis, meningococcaemia, and Neisseria meningitidis","2007","369","9580","2196-2210",Lancet,"","","","","","","","17604802","","",0,10,0,0,0,,,
714,47,"Ortqvist et al., 2005",journal,"Ortqvist A, Hedlund J, Kalin M","Streptococcus pneumoniae: epidemiology, risk factors, and clinical features","2005","26","6","563-574",Seminars in respiratory and critical care medicine,"","","","","","","","16388428","","",0,10,0,0,0,,,
715,47,Wiki: S. pneumoniae,website,"",Wikipedia: Streptococcus pneumoniae,"","","","","","","","","","","","","",http://en.wikipedia.org/wiki/Streptococcus_pneumoniae,"",0,10,0,0,0,,,
716,47,Merck: PNEUMOVAX 23,website,"",Merck: PNEUMOVAX 23,"","","","","","","","","","","","",Merck: PNEUMOVAX 23,http://www.merckvaccines.com/vaccines/pneu/index.html,"",0,10,0,0,0,,,
717,48,Wiki: Hepatitis A,website,"",Wiki: Hepatitis A virus,"","","","","","","","","","","","","",http://en.wikipedia.org/wiki/Hepatitis_A_virus,"",0,10,0,0,0,,,
718,49,Wiki: Hepatitis B,website,"",Wiki: Hepatitis B virus,"","","","","","","","","","","","","",http://en.wikipedia.org/wiki/Hepatitis_B,"",0,10,0,0,0,,,
719,50,Wiki: Influenza,website,"",Wiki: Influenza,"","","","","","","","","","","","","",http://en.wikipedia.org/wiki/Influenza,"",0,10,0,0,0,,,
720,51,Wiki: Japanese encephalitis,website,"",Wiki: Japanese encephalitis,"","","","","","","","","","","","","",http://en.wikipedia.org/wiki/Japanese_encephalitis,"",0,10,0,0,0,,,
721,45,Wiki: Hepatitis B,website,"",test,"","","","","","","","","","","","","",http://www.wiki.org,"",0,10,0,0,0,,,
722,52,FDA: Attenuvax,website,"",FDA: Attenuvax information,"","","","","","","","","","","","","",http://www.fda.gov/BiologicsBloodVaccines/Vaccines/ApprovedProducts/ucm203032.htm,"",0,10,0,0,0,,,
723,52,"Griffin et al., 2008",journal,"Griffin DE, Pan CH, Moss WJ",Measles vaccines,"2008","13","","1352-1370",Frontiers in bioscience : a journal and virtual library,"","","","","","","","17981635","","",0,10,0,0,0,,,
724,52,"Yanagi et al., 2006",journal,"Yanagi Y, Takeda M, Ohno S","Measles virus: cellular receptors, tropism and pathogenesis","2006","87",Pt 10,"2767-2779",The Journal of general virology,"","","","","","","","16963735","","",0,10,0,0,0,,,
725,53,Merck: Mumpsvax,website,"",Merck: Mumpsvax information,"","","","","","","","","","","","","",http://www.merck.com/product/usa/pi_circulars/m/mumpsvax/mumpsvax_pi.pdf,"",0,10,0,0,0,,,
726,53,"Hviid et al., 2008",journal,"Hviid A, Rubin S, Mhlemann K",Mumps,"2008","371","9616","932-944",Lancet,"","","","","","","","18342688","","",0,10,0,0,0,,,
727,54,FDA: Gardasil,website,"",FDA: Gardasil information,"","","","","","","","","","","","",FDA: Gardasil,http://www.fda.gov/Cber/products/gardasil.htm,"",0,10,0,0,0,,,
728,54,"Panagiotis et al., 2008",journal,"Panagiotis C, Efthimios D, Konstantinos P, George C","Human papilloma virus: diagnostic, treatment and preventive issues","2008","47","1","35-38",Akusherstvo i ginekologiia,"","","","","","","","18642576","","",0,10,0,0,0,,,
729,54,"Huang, 2008",journal,Huang CM,Human papillomavirus and vaccination,"2008","83","6","701-706; quiz 706-706",Mayo Clinic proceedings. Mayo Clinic,"","","","","","","","18533087","","",0,10,0,0,0,,,
730,55,FDA: IPOL,website,"",FDA: IPOL vaccine information,"","","","","","","","","","","","","",http://www.fda.gov/BiologicsBloodVaccines/Vaccines/ApprovedProducts/ucm180053.htm,"",0,10,0,0,0,,,
731,55,FDA: licensed vaccines,website,"",FDA: licensed vaccines,"","","","","","","","","","","","","",http://www.fda.gov/Cber/vaccine/licvacc.htm,"",0,10,0,0,0,,,
732,55,Wiki: Poliovirus,website,"",Wiki: Poliovirus,"","","","","","","","","","","","","",http://en.wikipedia.org/wiki/Poliovirus,"",0,10,0,0,0,,,
733,56,"Manning et al., 2008",journal,"Manning SE, Rupprecht CE, Fishbein D, Hanlon CA, Lumlertdacha B, Guerra M, Meltzer MI, Dhankhar P, Vaidya SA, Jenkins SR, Sun B, Hull HF","Human rabies prevention--United States, 2008: recommendations of the Advisory Committee on Immunization Practices","2008","57",RR-3,"1-28",MMWR. Recommendations and reports : Morbidity and mortality weekly report. Recommendations and reports / Centers for Disease Control,"","","","","","","","18496505","","",0,10,0,0,0,,,
734,56,FDA: Imovax,website,"",FDA: Imovax vaccine information,"","","","","","","","","","","","","",http://www.fda.gov/BiologicsBloodVaccines/Vaccines/ApprovedProducts/ucm180097.htm,"",0,10,0,0,0,,,
735,56,FDA: Rabavert,website,"",FDA: Rabavert vaccine information,"","","","","","","","","","","","","",http://www.fda.gov/BiologicsBloodVaccines/Vaccines/ApprovedProducts/ucm133517.htm,"",0,10,0,0,0,,,
736,56,Wiki: Rabies,website,"",Wiki: Rabies,"","","","","","","","","","","","","",http://en.wikipedia.org/wiki/Rabies,"",0,10,0,0,0,,,
737,57,FDA: ROTARIX,website,"",FDA: ROTARIX vaccine information,"","","","","","","","","","","","","",http://www.fda.gov/BiologicsBloodVaccines/Vaccines/ApprovedProducts/ucm133920.htm,"",0,10,0,0,0,,,
738,57,FDA: RotaTeq,website,"",FDA: RotaTeq vaccine information,"","","","","","","","","","","","","",http://www.fda.gov/BiologicsBloodVaccines/Vaccines/ApprovedProducts/ucm094063.htm,"",0,10,0,0,0,,,
739,57,Wiki: Rotavirus,website,"",Wiki: Rotavirus,"","","","","","","","","","","","","",http://en.wikipedia.org/wiki/Rotavirus,"",0,10,0,0,0,,,
740,58,FDA: Meruvax II,website,"",FDA: Meruvax II vaccine information,"","","","","","","","","","","","","",http://www.fda.gov/BiologicsBloodVaccines/Vaccines/ApprovedProducts/ucm094064.htm,"",0,10,0,0,0,,,
741,58,Wiki: Rebella,website,"",Wiki: Rebella,"","","","","","","","","","","","","",http://en.wikipedia.org/wiki/Rubella,"",0,10,0,0,0,,,
742,59,FDA: YF-Vax,website,"",FDA: YF-Vax vaccine information,"","","","","","","","","","","","","",http://www.fda.gov/BiologicsBloodVaccines/Vaccines/ApprovedProducts/ucm094074.htm,"",0,10,0,0,0,,,
743,59,Wiki: Yellow fever,website,"",Wiki: Yellow fever,"","","","","","","","","","","","","",http://en.wikipedia.org/wiki/Yellow_fever,"",0,10,0,0,0,,,
744,60,FDA: Varivax,website,"",FDA: Varivax vaccine information,"","","","","","","","","","","","","",http://www.fda.gov/BiologicsBloodVaccines/Vaccines/ApprovedProducts/ucm094073.htm,"",0,10,0,0,0,,,
745,60,FDA: Zostavax,website,"",FDA: Zostavax vaccine information,"","","","","","","","","","","","","",http://www.fda.gov/BiologicsBloodVaccines/Vaccines/ApprovedProducts/ucm094075.htm,"",0,10,0,0,0,,,
746,60,Wiki: Varicella zoster,website,"",Wiki: Varicella zoster,"","","","","","","","","","","","","",http://en.wikipedia.org/wiki/Varicella_zoster,"",0,10,0,0,0,,,
747,51,FDA: JE-Vax,website,"",FDA: JE-Vax vaccine information,"","","","","","","","","","","","","",http://www.fda.gov/BiologicsBloodVaccines/Vaccines/ApprovedProducts/ucm094048.htm,"",0,10,0,0,0,,,
748,49,Merck:  Recombivax HB,website,"",Merck: Recombivax HB vaccine information,"","","","","","","","","","","","","",http://www.merck.com/product/usa/pi_circulars/r/recombivax_hb/recombivax_pi.pdf,"",0,10,0,0,0,,,
749,41,FDA: Tetanus Toxoid Adsorbed by Sanofi Pasteur Inc,website,"",FDA: Tetanus Toxoid Adsorbed by Sanofi Pasteur Inc,"","","","","","","","","","","","","",http://www.fda.gov/BiologicsBloodVaccines/Vaccines/ApprovedProducts/ucm094068.htm,"",0,10,0,0,0,,,
750,48,FDA: Havrix,website,"",FDA: Havrix vaccine information,"","","","","","","","","","","","","",http://www.fda.gov/BiologicsBloodVaccines/Vaccines/ApprovedProducts/ucm110016.htm,"",0,10,0,0,0,,,
751,48,FDA: VAQTA,website,"",FDA: VAQTA vaccine information,"","","","","","","","","","","","","",http://www.fda.gov/BiologicsBloodVaccines/Vaccines/ApprovedProducts/ucm110017.htm,"",0,10,0,0,0,,,
752,50,GSK: US Fluarix,website,"",GSK: US Fluarix vaccine information,"","","","","","","","","","","","","",http://us.gsk.com/products/assets/us_fluarix.pdf,"",0,10,0,0,0,,,
753,50,FDA: Flulaval old,website,"",FDA Flulaval information,"","","","","","","","","","","","","",http://www.fda.gov/CbER/label/flulavalLB.pdf,"",0,10,0,0,0,,,
754,50,FDA: Flulaval Approval,website,"",FDA: Flulaval approval information,"","","","","","","","","","","","","",http://www.fda.gov/cber/products/flulaval.htm,"",0,11,0,0,0,,,
755,50,FDA: Afluria,website,CSL Limited,FDA: Afluria influenza virus vaccine information,"","","","","","","","","","","","","",http://www.fda.gov/BiologicsBloodVaccines/Vaccines/ApprovedProducts/ucm094043.htm,"",0,10,0,0,0,,,
756,50,FDA: Fluzone,website,"",FDA: Fluzone influenza vaccine information,"","","","","","","","","","","","","",http://www.fda.gov/BiologicsBloodVaccines/Vaccines/ApprovedProducts/ucm112854.htm,"",0,10,0,0,0,,,
757,50,FDA: Sanofi Pasteur H5N1,website,"",FDA: Sanofi Pasteur H5N1Influenza virus vaccine information,"","","","","","","","","","","","","",http://www.fda.gov/BiologicsBloodVaccines/Vaccines/ApprovedProducts/ucm094044.htm,"",0,10,0,0,0,,,
758,50,FDA: Flumist,website,"",FDA: Flumist Influenza Virus Vaccine,"","","","","","","","","","","","","",http://www.fda.gov/BiologicsBloodVaccines/Vaccines/ApprovedProducts/ucm094047.htm,"",0,10,0,0,0,,,
759,50,FDA: Fluvirin,website,"",FDA: Fluvirin Influenza Virus Vaccine,"","","","","","","","","","","","","",http://www.fda.gov/BiologicsBloodVaccines/Vaccines/ApprovedProducts/ucm112852.htm,"",0,10,0,0,0,,,
760,48,FDA: HAVRIX,website,"",FDA: HAVRIX Influenza Virus Vaccine,"","","","","","","","","","","","","",http://www.fda.gov/cber/label/havrixLB.pdf,"",0,11,0,0,0,,,
761,49,FDA: ENGERIX-B,website,"",FDA: ENGERIX-B I,"","","","","","","","","","","","","",http://www.fda.gov/BiologicsBloodVaccines/Vaccines/ApprovedProducts/ucm110102.htm,"",0,10,0,0,0,,,
762,49,FDA: RECOMBIVAX HB,website,"",FDA: RECOMBIVAX HB,"","","","","","","","","","","","","",http://www.fda.gov/BiologicsBloodVaccines/Vaccines/ApprovedProducts/ucm110098.htm,"",0,10,0,0,0,,,
763,48,FDA: TWINRIX,website,"",FDA: TWINRIX,"","","","","","","","","","","","","",http://www.fda.gov/BiologicsBloodVaccines/Vaccines/ApprovedProducts/ucm094035.htm,"",0,10,0,0,0,,,
764,49,FDA: TWINRIX,website,"",FDA: TWINRIX,"","","","","","","","","","","","","",http://www.fda.gov/BiologicsBloodVaccines/Vaccines/ApprovedProducts/ucm094035.htm,"",0,10,0,0,0,,,
765,7,FDA: Anthrax Vaccine Adsorbed,website,"",FDA: Anthrax Vaccine Adsorbed for Bacillus anthracis,"","","","","","","","","","","","","",http://www.fda.gov/BiologicsBloodVaccines/Vaccines/ApprovedProducts/ucm093863.htm,"",0,10,0,0,0,,,
766,46,FDA: Menomune A/C/Y/W-135,website,"",FDA Menomune A/C/Y/W-135 Neisseria meningitidis vaccine,"","","","","","","","","","","","","",https://www.fda.gov/downloads/BiologicsBloodVaccines/Vaccines/ApprovedProducts/UCM308370.pdf,"",0,10,0,0,0,,,
767,99,FDA: TICE BCG,website,"",FDA TICE BCG information,"","","","","","","","","","","","","",http://www.fda.gov/downloads/BiologicsBloodVaccines/Vaccines/ApprovedProducts/UCM163039.pdf,"",0,10,0,0,0,,,
768,47,FDA: Prevnar,website,"",FDA: Pneumococcal 7-valent Conjugate Vaccine,"","","","","","","","","","","","","",http://www.fda.gov/BiologicsBloodVaccines/Vaccines/ApprovedProducts/ucm094057.htm,"",0,10,0,0,0,,,
769,42,FDA: Vivotif,website,"",FDA: Vivotif Vaccine for Salmonella,"","","","","","","","","","","","","",http://www.fda.gov/BiologicsBloodVaccines/Vaccines/ApprovedProducts/ucm094070.htm,"",0,10,0,0,0,,,
770,18,FDA: Dryvax,website,"",FDA: Dryvax Vaccine for Variola Virus,"","","","","","","","","","","","","",http://www.fda.gov/BiologicsBloodVaccines/Vaccines/ApprovedProducts/ucm094066.htm,"",0,10,0,0,0,,,
771,18,FDA: ACAM2000,website,"",FDA: ACAM2000 Vaccine for Variola Virus,"","","","","","","","","","","","","",http://www.fda.gov/BiologicsBloodVaccines/Vaccines/ApprovedProducts/ucm094065.htm,"",0,10,0,0,0,,,
772,47,FDA: PNEUMOVAX 23,website,"",FDA: PNEUMOVAX 23 Vaccine for Streptococcus pneumoniae,"","","","","","","","","","","","","",http://www.fda.gov/BiologicsBloodVaccines/Vaccines/ApprovedProducts/ucm094055.htm,"",0,10,0,0,0,,,
773,31,FDA: ACTHIB,website,"",FDA: ACTHIB Vaccine for Haemophilus influenzae,"","","","","","","","","","","","","",http://www.fda.gov/BiologicsBloodVaccines/Vaccines/ApprovedProducts/ucm174743.htm,"",0,10,0,0,0,,,
774,62,CDC: Diphtheria,website,"",CDC: Diphtheria general information,"","","","","","","","","","","","","",http://www.cdc.gov/ncidod/dbmd/diseaseinfo/diptheria_t.htm,"",0,10,0,0,0,,,
775,55,Poliovax,website,"",Medicinenet.com: Poliovax,"","","","","","","","","","","","","",http://www.medicinenet.com/poliovirus_vaccine-injection/article.htm,"",0,10,0,0,0,,,
776,56,Rabavert,website,"",Rabavert Package Insert,"","","","","","","","","","","","","",http://www.novartisvaccines.com/downloads/diseases-products/us-pl-rabavert.pdf,"",0,10,0,0,0,,,
777,42,Typhim Vi,website,"",FDA: Typhim Vi Vaccine for Salmonella,"","","","","","","","","","","","","",http://www.fda.gov/cber/label/typhimviLB.pdf,"",0,10,0,0,0,,,
778,62,FDA: Diphtheria and Tetanus Toxoids Adsorbed,website,"",FDA: Diphtheria and Tetanus Toxoids Adsorbed,"","","","","","","","","","","","","",https://www.fda.gov/downloads/BiologicsBloodVaccines/Vaccines/ApprovedProducts/UCM142732.pdf,"",0,10,0,0,0,,,
779,62,FDA: Tripedia,website,"",FDA: Tripedia,"","","","","","","","","","","","","",http://www.fda.gov/BiologicsBloodVaccines/Vaccines/ApprovedProducts/ucm101565.htm,"",0,10,0,0,0,,,
780,62,FDA: INFANRIX,website,"",FDA: INFANRIX,"","","","","","","","","","","","","",http://www.fda.gov/BiologicsBloodVaccines/Vaccines/ApprovedProducts/ucm101568.htm,"",0,10,0,0,0,,,
781,62,FDA: DAPTACEL,website,"",FDA: DAPTACEL Vaccine,"","","","","","","","","","","","","",http://www.fda.gov/BiologicsBloodVaccines/Vaccines/ApprovedProducts/ucm101572.htm,"",0,10,0,0,0,,,
782,62,FDA: Pediarix,website,"",FDA: Pediarix,"","","","","","","","","","","","","",http://www.fda.gov/BiologicsBloodVaccines/Vaccines/ApprovedProducts/ucm146759.htm,"",0,10,0,0,0,,,
783,62,FDA: KINRIX,website,"",FDA: KINRIX Vaccine,"","","","","","","","","","","","","",https://www.fda.gov/downloads/BiologicsBloodVaccines/Vaccines/ApprovedProducts/UCM241453.pdf,"",0,10,0,0,0,,,
784,62,FDA: Pentacel,website,"",FDA: Pentacel Vaccine,"","","","","","","","","","","","","",https://www.fda.gov/downloads/BiologicsBloodVaccines/Vaccines/ApprovedProducts/UCM109810.pdf,"",0,10,0,0,0,,,
785,41,FDA Infanrix,website,"",FDA Infanrix,"","","","","","","","","","","","","",http://www.fda.gov/BiologicsBloodVaccines/Vaccines/ApprovedProducts/ucm101568.htm,"",0,10,0,0,0,,,
786,41,FDA: dttadLB,website,"",FDA: Diphtheria and Tetanus Toxoids Adsorbed USP,"","","","","","","","","","","","","",http://www.fda.gov/BiologicsBloodVaccines/Vaccines/ApprovedProducts/ucm094012.htm,"",0,10,0,0,0,,,
787,41,FDA: DAPTACEL,website,"",FDA: DAPTACEL,"","","","","","","","","","","","","",http://www.fda.gov/BiologicsBloodVaccines/Vaccines/ApprovedProducts/ucm101572.htm,"",0,10,0,0,0,,,
788,41,FDA: Pediarix,website,"",FDA: Pediarix,"","","","","","","","","","","","","",http://www.fda.gov/BiologicsBloodVaccines/Vaccines/ApprovedProducts/ucm146759.htm,"",0,10,0,0,0,,,
789,41,FDA: KINRIX,website,"",FDA: KINRIX,"","","","","","","","","","","","","",https://www.fda.gov/downloads/BiologicsBloodVaccines/Vaccines/ApprovedProducts/UCM241453.pdf,"",0,10,0,0,0,,,
790,41,FDA: Pentacel,website,"",FDA: Pentacel Vaccine,"","","","","","","","","","","","","",https://www.fda.gov/downloads/BiologicsBloodVaccines/Vaccines/ApprovedProducts/UCM109810.pdf,"",0,10,0,0,0,,,
791,52,FDA: MMR-II,website,"",FDA: MMR-II,"","","","","","","","","","","","","",http://www.fda.gov/BiologicsBloodVaccines/Vaccines/ApprovedProducts/ucm094050.htm,"",0,10,0,0,0,,,
792,53,FDA: MMR-II,website,"",FDA: MMR-II,"","","","","","","","","","","","","",http://www.fda.gov/BiologicsBloodVaccines/Vaccines/ApprovedProducts/ucm094050.htm,"",0,10,0,0,0,,,
793,58,FDA: MMR-II,website,"",FDA: MMR-II Vaccine,"","","","","","","","","","","","","",http://www.fda.gov/BiologicsBloodVaccines/Vaccines/ApprovedProducts/ucm094050.htm,"",0,10,0,0,0,,,
794,58,FDA: Proquad,website,"",FDA: Proquad Vaccine,"","","","","","","","","","","","","",http://www.fda.gov/BiologicsBloodVaccines/Vaccines/ApprovedProducts/ucm188806.htm,"",0,10,0,0,0,,,
795,53,FDA: ProQuad,website,"",FDA: ProQuad Vaccine,"","","","","","","","","","","","","",http://www.fda.gov/BiologicsBloodVaccines/Vaccines/ApprovedProducts/ucm094051.htm,"",0,10,0,0,0,,,
796,52,FDA: ProQuad,website,"",FDA: ProQuad Vaccine,"","","","","","","","","","","","","",http://www.fda.gov/BiologicsBloodVaccines/Vaccines/ApprovedProducts/ucm094051.htm,"",0,10,0,0,0,,,
797,60,FDA: ProQuad,website,"",FDA: ProQuad Vaccine,"","","","","","","","","","","","","",http://www.fda.gov/BiologicsBloodVaccines/Vaccines/ApprovedProducts/ucm094051.htm,"",0,10,0,0,0,,,
798,62,FDA: Menactra,website,"",FDA: Menactra Vaccine,"","","","","","","","","","","","","",http://www.fda.gov/BiologicsBloodVaccines/Vaccines/ApprovedProducts/ucm176044.htm,"",0,10,0,0,0,,,
799,46,FDA: Menactra,website,"",FDA: Menactra,"","","","","","","","","","","","","",https://www.fda.gov/downloads/BiologicsBloodVaccines/Vaccines/ApprovedProducts/UCM131170.pdf,"",0,10,0,0,0,,,
800,31,FDA: COMVAX,website,"",FDA: COMVAX information,"","","","","","","","","","","","","",http://www.fda.gov/BiologicsBloodVaccines/Vaccines/ApprovedProducts/ucm174757.htm,"",0,10,0,0,0,,,
801,62,Boostrix,website,"",Boostrix,"","","","","","","","","","","","","",http://www.fda.gov/BiologicsBloodVaccines/Vaccines/ApprovedProducts/ucm172925.htm,"",0,10,0,0,0,,,
802,62,Adacel,website,"",Adacel,"","","","","","","","","","","","","",http://www.fda.gov/BiologicsBloodVaccines/Vaccines/ApprovedProducts/ucm172481.htm,"",0,10,0,0,0,,,
803,62,FDA: TENIVAC,website,"",FDA: TENIVAC vaccine information,"","","","","","","","","","","","","",https://www.fda.gov/downloads/BiologicsBloodVaccines/Vaccines/ApprovedProducts/UCM152826.pdf,"",0,10,0,0,0,,,
804,62,FDA: Decavac,website,"",Decavac,"","","","","","","","","","","","","",http://www.fda.gov/BiologicsBloodVaccines/Vaccines/ApprovedProducts/ucm094067.htm,"",0,10,0,0,0,,,
805,31,Comvax,website,"",Comvax,"","","","","","","","","","","","","",http://www.fda.gov/cber/products/comvax.htm,"",0,10,0,0,0,,,
806,41,FDA: Adacel,website,"",FDA: Adacel,"","","","","","","","","","","","","",http://www.fda.gov/BiologicsBloodVaccines/Vaccines/ApprovedProducts/ucm172481.htm,"",0,10,0,0,0,,,
807,41,FDA: Tripedia,website,"",FDA: Tripedia,"","","","","","","","","","","","","",http://www.fda.gov/BiologicsBloodVaccines/Vaccines/ApprovedProducts/ucm101565.htm,"",0,10,0,0,0,,,
808,41,FDA: Tenivac,website,"",FDA: Tenivac,"","","","","","","","","","","","","",https://www.fda.gov/downloads/BiologicsBloodVaccines/Vaccines/ApprovedProducts/UCM152826.pdf,"",0,10,0,0,0,,,
809,41,FDA Boostrix,website,"",FDA Boostrix,"","","","","","","","","","","","","",http://www.fda.gov/BiologicsBloodVaccines/Vaccines/ApprovedProducts/ucm172925.htm,"",0,10,0,0,0,,,
810,41,FDA Decavac,website,"",FDA Decavac,"","","","","","","","","","","","","",http://www.fda.gov/BiologicsBloodVaccines/Vaccines/ApprovedProducts/ucm094067.htm,"",0,10,0,0,0,,,
811,65,"Ferrari et al., 2000",journal,"Ferrari M, Brack A, Romanelli MG, Mettenleiter TC, Corradi A, Dal Mas N, Losio MN, Silini R, Pinoni C, Pratelli A",A study of the ability of a TK-negative and gI/gE-negative pseudorabies virus (PRV) mutant inoculated by different routes to protect pigs against PRV infection,"2000","47","10","753-762","Journal of veterinary medicine. B, Infectious diseases and veterinary public health","","","","","","","","11204130","","",0,10,0,0,0,,,
812,64,"Wang et al., 2007",journal,"Wang X, Jiang P, Li Y, Jiang W, Dong X",Protection of pigs against post-weaning multisystemic wasting syndrome by a recombinant adenovirus expressing the capsid protein of porcine circovirus type 2,"2007","121","3-4","215-224",Veterinary microbiology,"","","","","","","","17215092","","",0,10,0,0,0,,,
813,64,"Ferrari et al., 2000",journal,"Ferrari M, Brack A, Romanelli MG, Mettenleiter TC, Corradi A, Dal Mas N, Losio MN, Silini R, Pinoni C, Pratelli A",A study of the ability of a TK-negative and gI/gE-negative pseudorabies virus (PRV) mutant inoculated by different routes to protect pigs against PRV infection,"2000","47","10","753-762","Journal of veterinary medicine. B, Infectious diseases and veterinary public health","","","","","","","","11204130","","",0,10,0,0,0,,,
814,66,"van, 2003",journal,van Aarle P,Suitability of an E2 subunit vaccine of classical swine fever in combination with the E(rns)-marker-test for eradication through vaccination,"2003","114","","193-200",Developments in biologicals,"","","","","","","","14677689","","",0,10,0,0,0,,,
815,66,"Moormann et al., 2000",journal,"Moormann RJ, Bouma A, Kramps JA, Terpstra C, De Smit HJ",Development of a classical swine fever subunit marker vaccine and companion diagnostic test,"2000","73","2-3","209-219",Veterinary microbiology,"","","","","","","","10785329","","",0,10,0,0,0,,,
816,67,"van et al., 1996",journal,"van Oirschot JT, Kaashoek MJ, Rijsewijk FA",Advances in the development and evaluation of bovine herpesvirus 1 vaccines,"1996","53","1-2","43-54",Veterinary microbiology,"","","","","","","","9010997","","",0,10,0,0,0,,,
817,50,"Minke et al., 2004",journal,"Minke JM, Audonnet JC, Fischer L","Equine viral vaccines: the past, present and future","2004","35","4","425-443",Veterinary research,"","","","","","","","15236675","","",0,10,0,0,0,,,
818,68,"Monath et al., 2001",journal,"Monath TP, Arroyo J, Miller C, Guirakhoo F",West Nile virus vaccine,"2001","1","1","37-50",Current drug targets. Infectious disorders,"","","","","","","","12455232","","",0,10,0,0,0,,,
819,68,"Davis et al., 2001",journal,"Davis BS, Chang GJ, Cropp B, Roehrig JT, Martin DA, Mitchell CJ, Bowen R, Bunning ML",West Nile virus recombinant DNA vaccine protects mouse and horse from virus challenge and expresses in vitro a noninfectious recombinant antigen that can be used in enzyme-linked immunosorbent assays,"2001","75","9","4040-4047",Journal of virology,"","","","","","","","11287553","","",0,10,0,0,0,,,
820,68,"Minke et al., 2004",journal,"Minke JM, Audonnet JC, Fischer L","Equine viral vaccines: the past, present and future","2004","35","4","425-443",Veterinary research,"","","","","","","","15236675","","",0,10,0,0,0,,,
821,69,"Darteil et al., 1995",journal,"Darteil R, Bublot M, Laplace E, Bouquet JF, Audonnet JC, Rivire M",Herpesvirus of turkey recombinant viruses expressing infectious bursal disease virus (IBDV) VP2 immunogen induce protection against an IBDV virulent challenge in chickens,"1995","211","2","481-490",Virology,"","","","","","","","7645252","","",0,10,0,0,0,,,
829,56,"Mackowiak et al., 1999",journal,"Mackowiak M, Maki J, Motes-Kreimeyer L, Harbin T, Van Kampen K",Vaccination of wildlife against rabies: successful use of a vectored vaccine obtained by recombinant technology,"1999","41","","571-583",Advances in veterinary medicine,"","","","","","","","9890044","","",0,10,0,0,0,,,
828,56,"Brochier et al., 1991",journal,"Brochier B, Kieny MP, Costy F, Coppens P, Bauduin B, Lecocq JP, Languet B, Chappuis G, Desmettre P, Afiademanyo K",Large-scale eradication of rabies using recombinant vaccinia-rabies vaccine,"1991","354","6354","520-522",Nature,"","","","","","","","1758494","","",0,10,0,0,0,,,
827,50,"Bublot et al., 2006",journal,"Bublot M, Pritchard N, Swayne DE, Selleck P, Karaca K, Suarez DL, Audonnet JC, Mickle TR",Development and use of fowlpox vectored vaccines for avian influenza,"2006","1081","","193-201",Annals of the New York Academy of Sciences,"","","","","","","","17135511","","",0,10,0,0,0,,,
824,70,"Meeusen et al., 2007",journal,"Meeusen EN, Walker J, Peters A, Pastoret PP, Jungersen G",Current status of veterinary vaccines,"2007","20","3","489-510",Clinical microbiology reviews,"","","","","","","","17630337","","",0,10,0,0,0,,,
825,50,"Park et al., 2006",journal,"Park MS, Steel J, Garca-Sastre A, Swayne D, Palese P",Engineered viral vaccine constructs with dual specificity: avian influenza and Newcastle disease,"2006","103","21","8203-8208",Proceedings of the National Academy of Sciences of the United States of America,"","","","","","","","16717196","","",0,10,0,0,0,,,
826,50,"Veits et al., 2006",journal,"Veits J, Wiesner D, Fuchs W, Hoffmann B, Granzow H, Starick E, Mundt E, Schirrmeier H, Mebatsion T, Mettenleiter TC, Rmer-Oberdrfer A",Newcastle disease virus expressing H5 hemagglutinin gene protects chickens against Newcastle disease and avian influenza,"2006","103","21","8197-8202",Proceedings of the National Academy of Sciences of the United States of America,"","","","","","","","16717197","","",0,10,0,0,0,,,
830,56,"Rupprecht et al., 2004",journal,"Rupprecht CE, Hanlon CA, Slate D",Oral vaccination of wildlife against rabies: opportunities and challenges in prevention and control,"2004","119","","173-184",Developments in biologicals,"","","","","","","","15742629","","",0,10,0,0,0,,,
831,56,"Stoffregen et al., 2006",journal,"Stoffregen WC, Olsen SC, Bricker BJ",Parenteral vaccination of domestic pigs with Brucella abortus strain RB51,"2006","67","10","1802-1808",American journal of veterinary research,"","","","","","","","17014337","","",0,11,0,0,0,,,
832,73,"Pardo et al., 1999",journal,"Pardo MC, M. Mackowiak","Efficacy of a new canine-origin, modified-live virus vaccine against canine coronavirus.","1999","24","","6-8",Canine Practice,"","","","","","","","","","",0,10,0,0,0,,,
833,76,"Guedes and Gebhart, 2003",journal,"Guedes RM, Gebhart CJ","Onset and duration of fecal shedding, cell-mediated and humoral immune responses in pigs after challenge with a pathogenic isolate or attenuated vaccine strain of Lawsonia intracellularis","2003","91","2-3","135-145",Veterinary microbiology,"","","","","","","","12458163","","",0,10,0,0,0,,,
834,76,"Kroll et al., 2004",journal,"Kroll JJ, Roof MB, McOrist S",Evaluation of protective immunity in pigs following oral administration of an avirulent live vaccine of Lawsonia intracellularis,"2004","65","5","559-565",American journal of veterinary research,"","","","","","","","15141873","","",0,10,0,0,0,,,
835,81,"Jacobs et al., 2000",journal,"Jacobs AA, Goovaerts D, Nuijten PJ, Theelen RP, Hartford OM, Foster TJ",Investigations towards an efficacious and safe strangles vaccine: submucosal vaccination with a live attenuated Streptococcus equi,"2000","147","20","563-567",The Veterinary record,"","","","","","","","11104039","","",0,10,0,0,0,,,
836,82,"Chalmers et al., 1997",journal,"Chalmers WS, Simpson J, Lee SJ, Baxendale W",Use of a live chlamydial vaccine to prevent ovine enzootic abortion,"1997","141","3","63-67",The Veterinary record,"","","","","","","","9257434","","",0,10,0,0,0,,,
837,83,"Morrow et al., 1998",journal,"Morrow CJ, Markham JF, Whithear KG",Production of temperature-sensitive clones of Mycoplasma synoviae for evaluation as live vaccines,"1998","42","4","667-670",Avian diseases,"","","","","","","","9876833","","",0,10,0,0,0,,,
838,84,"Barbour et al., 2000",journal,"Barbour EK, Hamadeh SK, Eidt A",Infection and immunity in broiler chicken breeders vaccinated with a temperature-sensitive mutant of Mycoplasma gallisepticum and impact on performance of offspring,"2000","79","12","1730-1735",Poultry science,"","","","","","","","11194034","","",0,10,0,0,0,,,
839,85,"Jackwood and Saif, 1985",journal,"Jackwood MW, Saif YM",Efficacy of a commercial turkey coryza vaccine (Art-Vax) in turkey poults,"1985","29","4","1130-1139",Avian diseases,"","","","","","","","3833219","","",0,10,0,0,0,,,
840,86,"Van et al., 2001",journal,"Van Overbeke I, Chiers K, Ducatelle R, Haesebrouck F",Effect of endobronchial challenge with Actinobacillus pleuropneumoniae serotype 9 of pigs vaccinated with a vaccine containing Apx toxins and transferrin-binding proteins,"2001","48","1","15-20","Journal of veterinary medicine. B, Infectious diseases and veterinary public health","","","","","","","","11254095","","",0,10,0,0,0,,,
841,86,"Chiers et al., 1998",journal,"Chiers K, van Overbeke I, De Laender P, Ducatelle R, Carel S, Haesebrouck F",Effects of endobronchial challenge with Actinobacillus pleuropneumoniae serotype 9 of pigs vaccinated with inactivated vaccines containing the Apx toxins,"1998","20","2","65-69",The Veterinary quarterly,"","","","","","","","9563163","","",0,10,0,0,0,,,
842,42,"Babu et al., 2004",journal,"Babu U, Dalloul RA, Okamura M, Lillehoj HS, Xie H, Raybourne RB, Gaines D, Heckert RA",Salmonella enteritidis clearance and immune responses in chickens following Salmonella vaccination and challenge,"2004","101","3-4","251-257",Veterinary immunology and immunopathology,"","","","","","","","15350755","","",0,10,0,0,0,,,
843,87,"Shirley et al., 2005",journal,"Shirley MW, Smith AL, Tomley FM",The biology of avian Eimeria with an emphasis on their control by vaccination,"2005","60","","285-330",Advances in parasitology,"","","","","","","","16230106","","",0,10,0,0,0,,,
844,88,"Williams, 2002",journal,Williams RB,Fifty years of anticoccidial vaccines for poultry (1952-2002),"2002","46","4","775-802",Avian diseases,"","","","","","","","12495038","","",0,10,0,0,0,,,
845,89,"Boulter and Hall, 1999",journal,"Boulter N, Hall R",Immunity and vaccine development in the bovine theilerioses,"1999","44","","41-97",Advances in parasitology,"","","","","","","","10563395","","",0,10,0,0,0,,,
846,90,"Shkap and Pipano, 2000",journal,"Shkap V, Pipano E",Culture-derived parasites in vaccination of cattle against tick-borne diseases,"2000","916","","154-171",Annals of the New York Academy of Sciences,"","","","","","","","11193616","","",0,10,0,0,0,,,
847,91,"Buxton and Innes, 1995",journal,"Buxton D, Innes EA",A commercial vaccine for ovine toxoplasmosis,"1995","110 Suppl","",S11-16,Parasitology,"","","","","","","","7784124","","",0,10,0,0,0,,,
848,92,"de and Combrink, 2006",journal,"de Waal DT, Combrink MP",Live vaccines against bovine babesiosis,"2006","138","1-2","88-96",Veterinary parasitology,"","","","","","","","16504404","","",0,10,0,0,0,,,
849,93,"Romero et al., 2004",journal,"Romero JJ, Prez E, Frankena K",Effect of a killed whole Neospora caninum tachyzoite vaccine on the crude abortion rate of Costa Rican dairy cows under field conditions,"2004","123","3-4","149-159",Veterinary parasitology,"","","","","","","","15325041","","",0,10,0,0,0,,,
850,94,"Olson et al., 2000",journal,"Olson ME, Ceri H, Morck DW",Giardia vaccination,"2000","16","5","213-217",Parasitology today (Personal ed.),"","","","","","","","10782082","","",0,10,0,0,0,,,
851,95,"Marsh et al., 2004",journal,"Marsh AE, Lakritz J, Johnson PJ, Miller MA, Chiang YW, Chu HJ",Evaluation of immune responses in horses immunized using a killed Sarcocystis neurona vaccine,"2004","5","1","34-42",Veterinary therapeutics : research in applied veterinary medicine,"","","","","","","","15150728","","",0,10,0,0,0,,,
852,96,"Moreau et al., 1989",journal,"Moreau Y, Vidor E, Bissuel G, Dubreuil N",Vaccination against canine babesiosis: an overview of field observations,"1989","83 Suppl","","95-96",Transactions of the Royal Society of Tropical Medicine and Hygiene,"","","","","","","","2623757","","",0,10,0,0,0,,,
853,97,"Borja-Cabrera et al., 2002",journal,"Borja-Cabrera GP, Correia Pontes NN, da Silva VO, Paraguai de Souza E, Santos WR, Gomes EM, Luz KG, Palatnik M, Palatnik de Sousa CB","Long lasting protection against canine kala-azar using the FML-QuilA saponin vaccine in an endemic area of Brazil (So Gonalo do Amarante, RN)","2002","20","27-28","3277-3284",Vaccine,"","","","","","","","12213397","","",0,10,0,0,0,,,
854,98,"Wallach, 1997",journal,Wallach M,The importance of transmission-blocking immunity in the control of infections by apicomplexan parasites,"1997","27","10","1159-1167",International journal for parasitology,"","","","","","","","9394186","","",0,10,0,0,0,,,
855,8,"Cassataro et al., 2007",journal,"Cassataro J, Velikovsky CA, Bruno L, Estein SM, de la Barrera S, Bowden R, Fossati CA, Giambartolomei GH",Improved immunogenicity of a vaccination regimen combining a DNA vaccine encoding Brucella melitensis outer membrane protein 31 (Omp31) and recombinant Omp31 boosting,"2007","14","7","869-874",Clinical and vaccine immunology : CVI,"","","","","","","","17428946","","",0,10,0,0,0,,,
856,29,"Grode et al., 2005",journal,"Grode L, Seiler P, Baumann S, Hess J, Brinkmann V, Nasser Eddine A, Mann P, Goosmann C, Bandermann S, Smith D, Bancroft GJ, Reyrat JM, van Soolingen D, Raupach B, Kaufmann SH",Increased vaccine efficacy against tuberculosis of recombinant Mycobacterium bovis bacille Calmette-Gurin mutants that secrete listeriolysin,"2005","115","9","2472-2479",The Journal of clinical investigation,"","","","","","","","16110326","","",0,10,0,0,0,,,
857,11,"Alvarez et al., 2006",journal,"Alvarez ML, Pinyerd HL, Crisantes JD, Rigano MM, Pinkhasov J, Walmsley AM, Mason HS, Cardineau GA",Plant-made subunit vaccine against pneumonic and bubonic plague is orally immunogenic in mice,"2006","24","14","2477-2490",Vaccine,"","","","","","","","16442673","","",0,10,0,0,0,,,
858,46,"Pizza et al., 2000",journal,"Pizza M, Scarlato V, Masignani V, Giuliani MM, Aric B, Comanducci M, Jennings GT, Baldi L, Bartolini E, Capecchi B, Galeotti CL, Luzzi E, Manetti R, Marchetti E, Mora M, Nuti S, Ratti G, Santini L, Savino S, Scarselli M, Storni E, Zuo P, Broeker M, Hundt E, Knapp B, Blair E, Mason T, Tettelin H, Hood DW, Jeffries AC, Saunders NJ, Granoff DM, Venter JC, Moxon ER, Grandi G, Rappuoli R",Identification of vaccine candidates against serogroup B meningococcus by whole-genome sequencing,"2000","287","5459","1816-1820","Science (New York, N.Y.)","","","","","","","","10710308","","",0,10,0,0,0,,,
859,46,"Martin et al., 1997",journal,"Martin D, Cadieux N, Hamel J, Brodeur BR",Highly conserved Neisseria meningitidis surface protein confers protection against experimental infection,"1997","185","7","1173-1183",The Journal of experimental medicine,"","","","","","","","9104804","","",0,10,0,0,0,,,
860,46,"Giuliani et al., 2006",journal,"Giuliani MM, Adu-Bobie J, Comanducci M, Aric B, Savino S, Santini L, Brunelli B, Bambini S, Biolchi A, Capecchi B, Cartocci E, Ciucchi L, Di Marcello F, Ferlicca F, Galli B, Luzzi E, Masignani V, Serruto D, Veggi D, Contorni M, Morandi M, Bartalesi A, Cinotti V, Mannucci D, Titta F, Ovidi E, Welsch JA, Granoff D, Rappuoli R, Pizza M",A universal vaccine for serogroup B meningococcus,"2006","103","29","10834-10839",Proceedings of the National Academy of Sciences of the United States of America,"","","","","","","","16825336","","",0,10,0,0,0,,,
861,46,"Pizza et al., 2008",journal,"Pizza M, Donnelly J, Rappuoli R","Factor H-binding protein, a unique meningococcal vaccine antigen","2008","26 Suppl 8","",I46-48,Vaccine,"","","","","","","","19388164","","",0,10,0,0,0,,,
862,25,"Langermann et al., 1997",journal,"Langermann S, Palaszynski S, Barnhart M, Auguste G, Pinkner JS, Burlein J, Barren P, Koenig S, Leath S, Jones CH, Hultgren SJ",Prevention of mucosal Escherichia coli infection by FimH-adhesin-based systemic vaccination,"1997","276","5312","607-611","Science (New York, N.Y.)","","","","","","","","9110982","","",0,10,0,0,0,,,
863,8,"Commander et al., 2007",journal,"Commander NJ, Spencer SA, Wren BW, MacMillan AP",The identification of two protective DNA vaccines from a panel of five plasmid constructs encoding Brucella melitensis 16M genes,"2007","25","1","43-54",Vaccine,"","","","","","","","17049676","","",0,10,0,0,0,,,
864,8,"Pasquevich et al., 2009",journal,"Pasquevich KA, Estein SM, Garca Samartino C, Zwerdling A, Coria LM, Barrionuevo P, Fossati CA, Giambartolomei GH, Cassataro J",Immunization with recombinant Brucella species outer membrane protein Omp16 or Omp19 in adjuvant induces specific CD4+ and CD8+ T cells as well as systemic and oral protection against Brucella abortus infection,"2009","77","1","436-445",Infection and immunity,"","","","","","","","18981242","","",0,10,0,0,0,,,
865,37,"Williams et al., 1990",journal,"Williams JC, Hoover TA, Waag DM, Banerjee-Bhatnagar N, Bolt CR, Scott GH",Antigenic structure of Coxiella burnetii. A comparison of lipopolysaccharide and protein antigens as vaccines against Q fever,"1990","590","","370-380",Annals of the New York Academy of Sciences,"","","","","","","","2378463","","",0,10,0,0,0,,,
866,12,"Bakshi et al., 2008",journal,"Bakshi CS, Malik M, Mahawar M, Kirimanjeswara GS, Hazlett KR, Palmer LE, Furie MB, Singh R, Melendez JA, Sellati TJ, Metzger DW",An improved vaccine for prevention of respiratory tularemia caused by Francisella tularensis SchuS4 strain,"2008","26","41","5276-5288",Vaccine,"","","","","","","","18692537","","",0,10,0,0,0,,,
867,12,"Jia et al., 2009",journal,"Jia Q, Lee BY, Clemens DL, Bowen RA, Horwitz MA",Recombinant attenuated Listeria monocytogenes vaccine expressing Francisella tularensis IglC induces protection in mice against aerosolized Type A F. tularensis,"2009","27","8","1216-1229",Vaccine,"","","","","","","","19126421","","",0,10,0,0,0,,,
868,31,"Kyd and Cripps, 1998",journal,"Kyd JM, Cripps AW","Potential of a novel protein, OMP26, from nontypeable Haemophilus influenzae to enhance pulmonary clearance in a rat model","1998","66","5","2272-2278",Infection and immunity,"","","","","","","","9573117","","",0,10,0,0,0,,,
869,31,"Gu et al., 1997",journal,"Gu XX, Sun J, Jin S, Barenkamp SJ, Lim DJ, Robbins JB, Battey J",Detoxified lipooligosaccharide from nontypeable Haemophilus influenzae conjugated to proteins confers protection against otitis media in chinchillas,"1997","65","11","4488-4493",Infection and immunity,"","","","","","","","9353024","","",0,10,0,0,0,,,
870,43,"Kotloff et al., 2004",journal,"Kotloff KL, Pasetti MF, Barry EM, Nataro JP, Wasserman SS, Sztein MB, Picking WD, Levine MM",Deletion in the Shigella enterotoxin genes further attenuates Shigella flexneri 2a bearing guanine auxotrophy in a phase 1 trial of CVD 1204 and CVD 1208,"2004","190","10","1745-1754",The Journal of infectious diseases,"","","","","","","","15499528","","",0,10,0,0,0,,,
871,43,"Hartman and Venkatesan, 1998",journal,"Hartman AB, Venkatesan MM","Construction of a stable attenuated Shigella sonnei DeltavirG vaccine strain, WRSS1, and protective efficacy and immunogenicity in the guinea pig keratoconjunctivitis model","1998","66","9","4572-4576",Infection and immunity,"","","","","","","","9712824","","",0,10,0,0,0,,,
872,43,"Schneider et al., 1998",journal,"Schneider J, Gilbert SC, Blanchard TJ, Hanke T, Robson KJ, Hannan CM, Becker M, Sinden R, Smith GL, Hill AV",Enhanced immunogenicity for CD8+ T cell induction and complete protective efficacy of malaria DNA vaccination by boosting with modified vaccinia virus Ankara,"1998","4","4","397-402",Nature medicine,"","","","","","","","9546783","","",0,11,0,0,0,,,
873,30,"Schneider et al., 1998",journal,"Schneider J, Gilbert SC, Blanchard TJ, Hanke T, Robson KJ, Hannan CM, Becker M, Sinden R, Smith GL, Hill AV",Enhanced immunogenicity for CD8+ T cell induction and complete protective efficacy of malaria DNA vaccination by boosting with modified vaccinia virus Ankara,"1998","4","4","397-402",Nature medicine,"","","","","","","","9546783","","",0,10,0,0,0,,,
874,30,"Dunachie et al., 2006",journal,"Dunachie SJ, Walther M, Epstein JE, Keating S, Berthoud T, Andrews L, Andersen RF, Bejon P, Goonetilleke N, Poulton I, Webster DP, Butcher G, Watkins K, Sinden RE, Levine GL, Richie TL, Schneider J, Kaslow D, Gilbert SC, Carucci DJ, Hill AV",A DNA prime-modified vaccinia virus ankara boost vaccine encoding thrombospondin-related adhesion protein but not circumsporozoite protein partially protects healthy malaria-naive adults against Plasmodium falciparum sporozoite challenge,"2006","74","10","5933-5942",Infection and immunity,"","","","","","","","16988273","","",0,10,0,0,0,,,
875,46,"Comanducci et al., 2002",journal,"Comanducci M, Bambini S, Brunelli B, Adu-Bobie J, Aric B, Capecchi B, Giuliani MM, Masignani V, Santini L, Savino S, Granoff DM, Caugant DA, Pizza M, Rappuoli R, Mora M","NadA, a novel vaccine candidate of Neisseria meningitidis","2002","195","11","1445-1454",The Journal of experimental medicine,"","","","","","","","12045242","","",0,10,0,0,0,,,
876,8,"Xin, 1986",journal,Xin X,Orally administrable brucellosis vaccine: Brucella suis strain 2 vaccine,"1986","4","4","212-216",Vaccine,"","","","","","","","3541425","","",0,10,0,0,0,,,
877,8,"Tibor et al., 1998",journal,"Tibor A, Jacques I, Guilloteau L, Verger JM, Grayon M, Wansard V, Letesson JJ",Effect of P39 gene deletion in live Brucella vaccine strains on residual virulence and protective activity in mice,"1998","66","11","5561-5564",Infection and immunity,"","","","","","","","9784574","","",0,10,0,0,0,,,
878,7,Spore vaccine,website,"",Anthrax Spore Vaccine,"","","","","","","","","","","","","",http://www.atozvetsupply.com/Anthrax-Vaccine-p/313-csav.htm,"",0,10,0,0,0,,,
879,8,"Martins et al., 2009",journal,"Martins H, Garin-Bastuji B, Lima F, Flor L, Pina Fonseca A, Boinas F","Eradication of bovine brucellosis in the Azores, Portugal-Outcome of a 5-year programme (2002-2007) based on test-and-slaughter and RB51 vaccination","2009","90","1-2","80-89",Preventive veterinary medicine,"","","","","","","","19439382","","",0,10,0,0,0,,,
880,8,"Longo et al., 2009",journal,"Longo M, Mallardo K, Montagnaro S, De Martino L, Gallo S, Fusco G, Galiero G, Guarino A, Pagnini U, Iovane G",Shedding of Brucella abortus rough mutant strain RB51 in milk of water buffalo (Bubalus bubalis),"2009","90","1-2","113-118",Preventive veterinary medicine,"","","","","","","","19362381","","",0,10,0,0,0,,,
881,8,"Nol et al., 2009",journal,"Nol P, Olsen SC, Rhyan JC",Experimental infection of Richardson's ground squirrels (Spermophilus richardsonii) with attenuated and virulent strains of Brucella abortus,"2009","45","1","189-195",Journal of wildlife diseases,"","","","","","","","19204348","","",0,10,0,0,0,,,
882,8,"Arenas-Gamboa et al., 2009",journal,"Arenas-Gamboa AM, Ficht TA, Davis DS, Elzer PH, Wong-Gonzalez A, Rice-Ficht AC",Enhanced immune response of red deer (Cervus elaphus) to live rb51 vaccine strain using composite microspheres,"2009","45","1","165-173",Journal of wildlife diseases,"","","","","","","","19204345","","",0,10,0,0,0,,,
883,8,"Rajasekaran et al., 2008",journal,"Rajasekaran P, Seleem MN, Contreras A, Purwantini E, Schurig GG, Sriranganathan N, Boyle SM",Brucella abortus strain RB51 leucine auxotroph as an environmentally safe vaccine for plasmid maintenance and antigen overexpression,"2008","74","22","7051-7055",Applied and environmental microbiology,"","","","","","","","18836016","","",0,10,0,0,0,,,
884,8,"Jensen and Halling, 2008",journal,"Jensen AE, Halling SM",Effect of polymyxin B and environmental conditions on isolation of Brucella species and the vaccine strain RB51,"2008","","","","Comparative immunology, microbiology and infectious diseases","","","","","","","","18814911","","",0,10,0,0,0,,,
885,8,"Ramamoorthy et al., 2007",journal,"Ramamoorthy S, Sanakkayala N, Vemulapalli R, Duncan RB, Lindsay DS, Schurig GS, Boyle SM, Kasimanickam R, Sriranganathan N",Prevention of lethal experimental infection of C57BL/6 mice by vaccination with Brucella abortus strain RB51 expressing Neospora caninum antigens,"2007","37","13","1521-1529",International journal for parasitology,"","","","","","","","17568587","","",0,10,0,0,0,,,
886,8,"High et al., 2007",journal,"High KP, Prasad R, Marion CR, Schurig GG, Boyle SM, Sriranganathan N",Outcome and immune responses after Brucella abortus infection in young adult and aged mice,"2007","8","5","583-593",Biogerontology,"","","","","","","","17653832","","",0,10,0,0,0,,,
887,8,"Stoffregen et al., 2006",journal,"Stoffregen WC, Olsen SC, Bricker BJ",Parenteral vaccination of domestic pigs with Brucella abortus strain RB51,"2006","67","10","1802-1808",American journal of veterinary research,"","","","","","","","17014337","","",0,10,0,0,0,,,
888,8,"Olsen et al., 2004",journal,"Olsen SC, Rhyan J, Gidlewski T, Goff J, Stoffregen WC",Safety of Brucella abortus strain RB51 in black bears,"2004","40","3","429-433",Journal of wildlife diseases,"","","","","","","","15465709","","",0,10,0,0,0,,,
889,8,"Januszewski et al., 2001",journal,"Januszewski MC, Olsen SC, McLean RG, Clark L, Rhyan JC",Experimental infection of nontarget species of rodents and birds with Brucella abortus strain RB51 vaccine,"2001","37","3","532-537",Journal of wildlife diseases,"","","","","","","","11504226","","",0,10,0,0,0,,,
890,8,"Olsen et al., 2009",journal,"Olsen SC, Boyle SM, Schurig GG, Sriranganathan NN",Immune responses and protection against experimental challenge after vaccination of bison with Brucella abortus strain RB51 or RB51 overexpressing superoxide dismutase and glycosyltransferase genes,"2009","16","4","535-540",Clinical and vaccine immunology : CVI,"","","","","","","","19176693","","",0,10,0,0,0,,,
891,8,"Olsen et al., 2007",journal,"Olsen SC, Waters WR, Stoffregen WS",An aerosolized Brucella spp. challenge model for laboratory animals,"2007","54","8","281-285",Zoonoses and public health,"","","","","","","","17894637","","",0,10,0,0,0,,,
892,8,"Pasquali et al., 2003",journal,"Pasquali P, Rosanna A, Pistoia C, Petrucci P, Ciuchini F",Brucella abortus RB51 induces protection in mice orally infected with the virulent strain B. abortus 2308,"2003","71","5","2326-2330",Infection and immunity,"","","","","","","","12704101","","",0,10,0,0,0,,,
893,8,"Colby et al., 2002",journal,"Colby LA, Schurig GG, Elzer PH",An indirect ELISA to detect the serologic response of elk (Cervus elaphus nelsoni) inoculated with Brucella abortus strain RB51,"2002","38","4","752-759",Journal of wildlife diseases,"","","","","","","","12528442","","",0,10,0,0,0,,,
894,8,"Ko et al., 2002",journal,"Ko J, Gendron-Fitzpatrick A, Ficht TA, Splitter GA",Virulence criteria for Brucella abortus strains as determined by interferon regulatory factor 1-deficient mice,"2002","70","12","7004-7012",Infection and immunity,"","","","","","","","12438380","","",0,10,0,0,0,,,
895,8,"Hamdy et al., 2002",journal,"Hamdy ME, El-Gibaly SM, Montasser AM",Comparison between immune responses and resistance induced in BALB/c mice vaccinated with RB51 and Rev. 1 vaccines and challenged with Brucella melitensis bv. 3,"2002","88","1","85-94",Veterinary microbiology,"","","","","","","","12119140","","",0,10,0,0,0,,,
896,8,"Lee et al., 2001",journal,"Lee IK, Olsen SC, Bolin CA",Effects of exogenous recombinant interleukin-12 on immune responses and protection against Brucella abortus in a murine model,"2001","65","4","223-228",Canadian journal of veterinary research = Revue canadienne de recherche veterinaire,"","","","","","","","11768128","","",0,10,0,0,0,,,
897,8,"Pasquali et al., 2001",journal,"Pasquali P, Adone R, Gasbarre LC, Pistoia C, Ciuchini F",Mouse cytokine profiles associated with Brucella abortus RB51 vaccination or B. abortus 2308 infection,"2001","69","10","6541-6544",Infection and immunity,"","","","","","","","11553603","","",0,10,0,0,0,,,
898,8,"Cook et al., 2001",journal,"Cook WE, Williams ES, Thorne ET, Taylor SK, Anderson S",Safety of Brucella abortus strain RB51 in deer mice,"2001","37","3","621-625",Journal of wildlife diseases,"","","","","","","","11504238","","",0,10,0,0,0,,,
899,8,"Lee et al., 1999",journal,"Lee IK, Olsen SC, Kehrli M, Bolin CA",The adjuvant effect of a single dose of interleukin-12 on murine immune responses to live or killed Brucella abortus strain RB51,"1999","63","4","284-287",Canadian journal of veterinary research = Revue canadienne de recherche veterinaire,"","","","","","","","10534009","","",0,10,0,0,0,,,
900,8,"Stevens et al., 1996",journal,"Stevens MG, Olsen SC, Palmer MV, Pugh GW Jr",Immune responses and resistance to brucellosis in mice vaccinated orally with Brucella abortus RB51,"1996","64","11","4534-4541",Infection and immunity,"","","","","","","","8890203","","",0,10,0,0,0,,,
901,8,"Palmer et al., 1996",journal,"Palmer MV, Cheville NF, Tatum FM",Morphometric and histopathologic analysis of lymphoid depletion in murine spleens following infection with Brucella abortus strains 2308 or RB51 or an htrA deletion mutant,"1996","33","3","282-289",Veterinary pathology,"","","","","","","","8740701","","",0,10,0,0,0,,,
902,8,"Stevens et al., 1995a",journal,"Stevens MG, Olsen SC, Pugh GW Jr",Comparison of spleen cell proliferation in response to Brucella abortus 2308 lipopolysaccharide or proteins in mice vaccinated with strain 19 or RB51,"1995","63","8","3199-3205",Infection and immunity,"","","","","","","","7622248","","",0,10,0,0,0,,,
903,8,"Stevens et al., 1994a",journal,"Stevens MG, Olsen SC, Pugh GW Jr","Lymphocyte proliferation in response to Brucella abortus 2308 or RB51 antigens in mice infected with strain 2308, RB51, or 19","1994","62","10","4659-4663",Infection and immunity,"","","","","","","","7927736","","",0,10,0,0,0,,,
904,8,"Jimnez et al., 1994",journal,"Jimnez de Bags MP, Elzer PH, Jones SM, Blasco JM, Enright FM, Schurig GG, Winter AJ","Vaccination with Brucella abortus rough mutant RB51 protects BALB/c mice against virulent strains of Brucella abortus, Brucella melitensis, and Brucella ovis","1994","62","11","4990-4996",Infection and immunity,"","","","","","","","7927779","","",0,10,0,0,0,,,
905,8,"Stevens et al., 1995b",journal,"Stevens MG, Olsen SC, Pugh GW Jr, Brees D",Comparison of immune responses and resistance to brucellosis in mice vaccinated with Brucella abortus 19 or RB51,"1995","63","1","264-270",Infection and immunity,"","","","","","","","7806364","","",0,10,0,0,0,,,
906,8,"Tobias et al., 1992",journal,"Tobias L, Schurig GG, Cordes DO",Comparative behaviour of Brucella abortus strains 19 and RB51 in the pregnant mouse,"1992","53","2","179-183",Research in veterinary science,"","","","","","","","1439207","","",0,10,0,0,0,,,
907,50,Afluria webpage,website,"",Afluria official web page,"","","","","","","","","","","","","",http://www.afluria.com/,"",0,10,0,0,0,,,
908,50,FDA: FluLaval,website,"",FDA FluLaval information,"2009","","","","","","","","","","","","",http://www.fda.gov/BiologicsBloodVaccines/Vaccines/ApprovedProducts/ucm112845.htm,"",0,10,0,0,0,,,
909,50,FluMist website,website,"",FluMist official website,"","","","","","","","","","","","","",http://www.flumist.com/,"",0,10,0,0,0,,,
910,50,FDA: CSL H1N1 vaccine,website,"",FDA: the H1N1 influenza vaccine from CSL,"","","","","","","","","","","","","",http://www.fda.gov/BiologicsBloodVaccines/Vaccines/ApprovedProducts/ucm181975.htm,"",0,10,0,0,0,,,
911,50,FDA: H1N1 Novartis Vaccine,website,"",FDA H1N1 Influenza Vaccine from Novartis Vaccines and Diagnostics Ltd.,"","","","","","","","","","","","","",http://www.fda.gov/BiologicsBloodVaccines/Vaccines/ApprovedProducts/ucm181973.htm,"",0,10,0,0,0,,,
912,50,FDA: H1N1 Vaccine Sanofi Pasteur,website,"",FDA: H1N1 Influenza virus vaccine from Sanofi Pasteur,"","","","","","","","","","","","","",http://www.fda.gov/BiologicsBloodVaccines/Vaccines/ApprovedProducts/ucm181971.htm,"",0,10,0,0,0,,,
913,50,FDA: MedImmune H1N1 vaccine,website,"",Influenza A (H1N1) 2009 Monovalent Vaccine (MedImmune LLC),"","","","","","","","","","","","","",http://www.fda.gov/BiologicsBloodVaccines/Vaccines/ApprovedProducts/ucm181970.htm,"",0,10,0,0,0,,,
914,50,Solvay Website,website,"",Influvac Manufacter Website,"","","","","","","","","","","","","","http://www.solvay-influenza.com/aboutvaccination/faqs/0,,2659-2-0,00.htm#7","",0,10,0,0,0,,,
915,50,Vaxigrip Package Insert,website,"",Vaxigrip Package Insert,"","","","","","","","","","","","","",https://www.vaccineshoppecanada.com/secure/pdfs/ca/vaxigrip_e.pdf,"",0,10,0,0,0,,,
916,54,FDA: Cevarix,website,"",FDA: Cervarix,"","","","","","","","","","","","","",http://www.fda.gov/BiologicsBloodVaccines/Vaccines/ApprovedProducts/ucm186957.htm,"",0,10,0,0,0,,,
917,51,FDA: Ixiaro,website,"",FDA: Ixiaro,"","","","","","","","","","","","","",http://www.fda.gov/BiologicsBloodVaccines/Vaccines/ApprovedProducts/ucm179132.htm,"",0,10,0,0,0,,,
918,50,GSK: Fluviral S/F,website,"",Fluviral Product Monograph,"","","","","","","","","","","","","",http://www.gsk.ca/english/docs-pdf/Fluviral_2009_PM.pdf,"",0,10,0,0,0,,,
919,48,GSK: Twinrix,website,"",GSK: Twinrix Product information,"","","","","","","","","","","","","",http://www.gsk.ca/english/docs-pdf/Twinrix_PM_20080916_EN.pdf,"",0,10,0,0,0,,,
920,48,EMC: Avaxim,website,"",The electronic Medicines Compendium: Avaxim,"","","","","","","","","","","","","",http://emc.medicines.org.uk/medicine/17385/PIL/AVAXIM/,"",0,10,0,0,0,,,
921,48,SP: Avaxim Pediatrix,website,"",SP: Avaxim Pediatrix,"","","","","","","","","","","","","",https://www.vaccineshoppecanada.com/secure/pdfs/ca/Avaxim_Ped_E.pdf,"",0,10,0,0,0,,,
922,48,EMC: Epaxal,website,"",EMC: Epaxal Product Information,"","","","","","","","","","","","","",http://emc.medicines.org.uk/medicine/12742/SPC/Epaxal/,"",0,10,0,0,0,,,
923,55,SP: IPV,website,"",SP: Inactived Poliomyelitis Vaccine  IPV,"","","","","","","","","","","","","",https://www.vaccineshoppecanada.com/secure/pdfs/ca/ipv_E.pdf,"",0,10,0,0,0,,,
924,60,GSK: Varilrix,website,"",GSK: Varilrix Product Information,"","","","","","","","","","","","","",http://www.gsk.ca/english/docs-pdf/varilrix_PM_20070110.pdf,"",0,10,0,0,0,,,
925,52,GSK: Priorix-Tetra,website,"",GSK: Priorix-Tetra Product Information,"","","","","","","","","","","","","",http://www.gsk.ca/english/docs-pdf/Priorix-Tetra_PM_20090908_EN.pdf,"",0,10,0,0,0,,,
926,52,GSK: Priorix,website,"",GSK: Priorix Product Information,"","","","","","","","","","","","","",http://www.gsk.ca/english/docs-pdf/Priorix_PM_20081103_EN.pdf,"",0,10,0,0,0,,,
927,106,CDC: TBE,website,"",CDC: Tick-borne Encephalitis,"","","","","","","","","","","","","",http://www.cdc.gov/ncidod/dvrd/Spb/mnpages/dispages/TBE.htm,"",0,10,0,0,0,,,
928,42,Burns et al,website,"Burns KE, Kelly-Aehle SM, Lawrence JA",Megan Egg  protection for commercial layers against Salmonella enteritidis infection for consumer protection,"","","","","","","","","","","","","",http://www.fda.gov/ohrms/dockets/dockets/00n0504/00N-0504_emc-001650-02.pdf,"",0,10,0,0,0,,,
929,50,FDA: Fluzone HD,website,"",FDA: Fluzone High-dose,"","","","","","","","","","","","","",http://www.fda.gov/downloads/BiologicsBloodVaccines/Vaccines/ApprovedProducts/UCM195479.pdf,"",0,11,0,0,0,,,
930,50,FDA: Agriflu,website,"",FDA: Agriflu,"","","","","","","","","","","","","",http://www.fda.gov/BiologicsBloodVaccines/Vaccines/ApprovedProducts/ucm192126.htm,"",0,10,0,0,0,,,
931,50,FDA: Fluarix,website,"",FDA: Fluarix,"","","","","","","","","","","","","",http://www.fda.gov/BiologicsBloodVaccines/Vaccines/ApprovedProducts/ucm112850.htm,"",0,10,0,0,0,,,
932,50,"Block et al., 2008",journal,"Block SL, Yogev R, Hayden FG, Ambrose CS, Zeng W, Walker RE",Shedding and immunogenicity of live attenuated influenza vaccine virus in subjects 5-49 years of age,"2008","26","38","4940-4946",Vaccine,"","","","","","","","18662737","","20100209151638.pdf",0,10,0,0,0,,,
933,109,FDA: Pediarix,website,"",FDA: Pediarix,"","","","","","","","","","","","","",http://www.fda.gov/BiologicsBloodVaccines/Vaccines/ApprovedProducts/ucm146759.htm,"",0,10,0,0,0,,,
934,49,FDA: Pediarix,website,"",FDA: Pediarix,"","","","","","","","","","","","","",http://www.fda.gov/BiologicsBloodVaccines/Vaccines/ApprovedProducts/ucm146759.htm,"",0,10,0,0,0,,,
935,55,FDA: Pediarix,website,"",FDA: Pediarix,"","","","","","","","","","","","","",http://www.fda.gov/BiologicsBloodVaccines/Vaccines/ApprovedProducts/ucm146759.htm,"",0,10,0,0,0,,,
936,109,FDA: Pentacel,website,"",FDA: Pentacel,"","","","","","","","","","","","","",http://www.fda.gov/BiologicsBloodVaccines/Vaccines/ApprovedProducts/ucm172502.htm,"",0,10,0,0,0,,,
937,31,FDA: Pentacel,website,"",FDA: Pentacel,"","","","","","","","","","","","","",http://www.fda.gov/BiologicsBloodVaccines/Vaccines/ApprovedProducts/ucm172502.htm,"",0,10,0,0,0,,,
938,55,FDA: Pentacel,website,"",FDA: Pentacel,"","","","","","","","","","","","","",http://www.fda.gov/BiologicsBloodVaccines/Vaccines/ApprovedProducts/ucm172502.htm,"",0,10,0,0,0,,,
939,109,FDA: Boostrix,website,"",FDA: Boostrix,"","","","","","","","","","","","","",http://www.fda.gov/BiologicsBloodVaccines/Vaccines/ApprovedProducts/ucm172925.htm,"",0,10,0,0,0,,,
940,109,FDA: Adacel,website,"",FDA: Adacel,"","","","","","","","","","","","","",http://www.fda.gov/BiologicsBloodVaccines/Vaccines/ApprovedProducts/ucm172481.htm,"",0,10,0,0,0,,,
941,109,FDA: DAPTACEL,website,"",FDA: DAPTACEL,"","","","","","","","","","","","","",http://www.fda.gov/BiologicsBloodVaccines/Vaccines/ApprovedProducts/ucm101572.htm,"",0,10,0,0,0,,,
942,109,FDA: Infanrix,website,"",FDA: Infanrix,"","","","","","","","","","","","","",http://www.fda.gov/BiologicsBloodVaccines/Vaccines/ApprovedProducts/ucm101568.htm,"",0,10,0,0,0,,,
943,109,FDA: Tripedia,website,"",FDA: Tripedia,"","","","","","","","","","","","","",http://www.fda.gov/BiologicsBloodVaccines/Vaccines/ApprovedProducts/ucm101565.htm,"",0,10,0,0,0,,,
944,25,"Alteri et al., 2009",journal,"Alteri CJ, Hagan EC, Sivick KE, Smith SN, Mobley HL",Mucosal immunization with iron receptor antigens protects against urinary tract infection,"2009","5","9",e1000586,PLoS pathogens,"","","","","","","","19806177","","",0,10,0,0,0,,,
945,25,"Thankavel et al., 1997",journal,"Thankavel K, Madison B, Ikeda T, Malaviya R, Shah AH, Arumugam PM, Abraham SN",Localization of a domain in the FimH adhesin of Escherichia coli type 1 fimbriae capable of receptor recognition and use of a domain-specific antibody to confer protection against experimental urinary tract infection,"1997","100","5","1123-1136",The Journal of clinical investigation,"","","","","","","","9276729","","",0,10,0,0,0,,,
946,25,"Durant et al., 2007",journal,"Durant L, Metais A, Soulama-Mouze C, Genevard JM, Nassif X, Escaich S",Identification of candidates for a subunit vaccine against extraintestinal pathogenic Escherichia coli,"2007","75","4","1916-1925",Infection and immunity,"","","","","","","","17145948","","",0,10,0,0,0,,,
947,11,"Galvn et al., 2010",journal,"Galvn EM, Nair MK, Chen H, Del Piero F, Schifferli DM",A BSL-2 model of pneumonic plague and protection studies with F1 and Psa,"2010","","","",Infection and immunity,"","","","","","","","20498260","","",0,10,0,0,0,,,
948,43,"Marteyn et al., 2010",journal,"Marteyn B, West NP, Browning DF, Cole JA, Shaw JG, Palm F, Mounier J, Prvost MC, Sansonetti P, Tang CM",Modulation of Shigella virulence in response to available oxygen in vivo,"2010","465","7296","355-358",Nature,"","","","","","","","20436458","","",0,10,0,0,0,,,
949,25,"Hu et al., 2009",journal,"Hu CX, Xu ZR, Li WF, Niu D, Lu P, Fu LL",Secretory expression of K88 (F4) fimbrial adhesin FaeG by recombinant Lactococcus lactis for oral vaccination and its protective immune response in mice,"2009","31","7","991-997",Biotechnology letters,"","","","","","","","19277476","","",0,10,0,0,0,,,
950,99,"Guinn et al., 2001",journal,"Guinn BA, Bertram EM, DeBenedette MA, Berinstein NL, Watts TH","4-1BBL enhances anti-tumor responses in the presence or absence of CD28 but CD28 is required for protective immunity against parental tumors","2001","210","1","56-65",Cellular immunology,"","","","","","","","11485353","","",0,10,0,0,0,,,
951,99,"Harrop et al., 2006",journal,"Harrop R, Ryan MG, Myers KA, Redchenko I, Kingsman SM, Carroll MW",Active treatment of murine tumors with a highly attenuated vaccinia virus expressing the tumor associated antigen 5T4 (TroVax) is CD4+ T cell dependent and antibody mediated,"2006","55","9","1081-1090","Cancer immunology, immunotherapy : CII","","","","","","","","16311730","","",0,10,0,0,0,,,
952,99,"Campbell et al., 2000",journal,"Campbell I, Moyana T, Carlsen S, Zheng C, Xiang J",Adenoviral transfer of xenogeneic MHC class I gene results in loss of tumorigenicity and inhibition of tumor growth,"2000","7","1","37-44",Cancer gene therapy,"","","","","","","","10678354","","",0,10,0,0,0,,,
953,99,"Hirschowitz et al., 1998",journal,"Hirschowitz EA, Leonard S, Song W, Ferris B, Leopold PL, Lewis JJ, Bowne WB, Wang S, Houghton AN, Crystal RG",Adenovirus-mediated expression of melanoma antigen gp75 as immunotherapy for metastatic melanoma,"1998","5","7","975-983",Gene therapy,"","","","","","","","9813669","","",0,10,0,0,0,,,
954,99,"Cohen et al., 2006",journal,"Cohen AD, Diab A, Perales MA, Wolchok JD, Rizzuto G, Merghoub T, Huggins D, Liu C, Turk MJ, Restifo NP, Sakaguchi S, Houghton AN",Agonist anti-GITR antibody enhances vaccine-induced CD8(+) T-cell responses and tumor immunity,"2006","66","9","4904-4912",Cancer research,"","","","","","","","16651447","","",0,10,0,0,0,,,
955,99,"Benvenuti et al., 2000",journal,"Benvenuti F, Burrone OR, Efremov DG",Anti-idiotypic DNA vaccines for lymphoma immunotherapy require the presence of both variable region genes for tumor protection,"2000","7","7","605-611",Gene therapy,"","","","","","","","10819576","","",0,10,0,0,0,,,
956,99,"Mohanty et al., 2007",journal,"Mohanty K, Saha A, Pal S, Mallick P, Chatterjee SK, Foon KA, Bhattacharya-Chatterjee M",Anti-tumor immunity induced by an anti-idiotype antibody mimicking human Her-2/neu,"2007","104","1","1-11",Breast cancer research and treatment,"","","","","","","","17004107","","",0,10,0,0,0,,,
957,99,"Rinaldi et al., 2008",journal,"Rinaldi M, Fioretti D, Iurescia S, Signori E, Pierimarchi P, Seripa D, Tonon G, Fazio VM",Anti-tumor immunity induced by CDR3-based DNA vaccination in a murine B-cell lymphoma model,"2008","370","2","279-284",Biochemical and biophysical research communications,"","","","","","","","18364239","","",0,10,0,0,0,,,
958,99,"Chen et al., 1997",journal,"Chen K, Braun S, Lyman S, Fan Y, Traycoff CM, Wiebke EA, Gaddy J, Sledge G, Broxmeyer HE, Cornetta K",Antitumor activity and immunotherapeutic properties of Flt3-ligand in a murine breast cancer model,"1997","57","16","3511-3516",Cancer research,"","","","","","","","9270021","","",0,10,0,0,0,,,
959,99,"Zhai et al., 1996",journal,"Zhai Y, Yang JC, Kawakami Y, Spiess P, Wadsworth SC, Cardoza LM, Couture LA, Smith AE, Rosenberg SA",Antigen-specific tumor vaccines. Development and characterization of recombinant adenoviruses encoding MART1 or gp100 for cancer therapy,"1996","156","2","700-710","Journal of immunology (Baltimore, Md. : 1950)","","","","","","","","8543823","","",0,10,0,0,0,,,
960,99,"Duan et al., 2007",journal,"Duan HF, Hu XW, Chen JL, Gao LH, Xi YY, Lu Y, Li JF, Zhao SR, Xu JJ, Chen HP, Chen W, Wu CT",Antitumor activities of TEM8-Fc: an engineered antibody-like molecule targeting tumor endothelial marker 8,"2007","99","20","1551-1555",Journal of the National Cancer Institute,"","","","","","","","17925540","","",0,10,0,0,0,,,
961,99,"Seino et al., 1997",journal,"Seino K, Kayagaki N, Okumura K, Yagita H",Antitumor effect of locally produced CD95 ligand,"1997","3","2","165-170",Nature medicine,"","","","","","","","9018234","","",0,10,0,0,0,,,
962,99,"Reali et al., 2001",journal,"Reali E, Greiner JW, Corti A, Gould HJ, Bottazzoli F, Paganelli G, Schlom J, Siccardi AG",IgEs targeted on tumor cells: therapeutic activity and potential in the design of tumor vaccines,"2001","61","14","5517-5522",Cancer research,"","","","","","","","11454701","","",0,10,0,0,0,,,
963,99,"Nigro et al., 2009",journal,"Nigro EA, Brini AT, Soprana E, Ambrosi A, Dombrowicz D, Siccardi AG, Vangelista L",Antitumor IgE adjuvanticity: key role of Fc epsilon RI,"2009","183","7","4530-4536","Journal of immunology (Baltimore, Md. : 1950)","","","","","","","","19748979","","",0,10,0,0,0,,,
964,99,"Yang et al., 1995",journal,"Yang G, Hellstrm KE, Hellstrm I, Chen L","Antitumor immunity elicited by tumor cells transfected with B7-2, a second ligand for CD28/CTLA-4 costimulatory molecules","1995","154","6","2794-2800","Journal of immunology (Baltimore, Md. : 1950)","","","","","","","","7533183","","",0,10,0,0,0,,,
965,99,"Grossmann et al., 1997",journal,"Grossmann ME, Brown MP, Brenner MK",Antitumor responses induced by transgenic expression of CD40 ligand,"1997","8","16","1935-1943",Human gene therapy,"","","","","","","","9382959","","",0,10,0,0,0,,,
966,43,"Orr et al., 2005",journal,"Orr N, Katz DE, Atsmon J, Radu P, Yavzori M, Halperin T, Sela T, Kayouf R, Klein Z, Ambar R, Cohen D, Wolf MK, Venkatesan MM, Hale TL","Community-based safety, immunogenicity, and transmissibility study of the Shigella sonnei WRSS1 vaccine in Israeli volunteers","2005","73","12","8027-8032",Infection and immunity,"","","","","","","","16299296","","",0,10,0,0,0,,,
967,43,"Turbyfill et al., 2000",journal,"Turbyfill KR, Hartman AB, Oaks EV",Isolation and characterization of a Shigella flexneri invasin complex subunit vaccine,"2000","68","12","6624-6632",Infection and immunity,"","","","","","","","11083774","","",0,10,0,0,0,,,
968,43,"Turbyfill et al., 1995",journal,"Turbyfill KR, Joseph SW, Oaks EV",Recognition of three epitopic regions on invasion plasmid antigen C by immune sera of rhesus monkeys infected with Shigella flexneri 2a,"1995","63","10","3927-3935",Infection and immunity,"","","","","","","","7558301","","",0,10,0,0,0,,,
969,25,"Chen et al., 1994",journal,"Chen L, McGowan P, Ashe S, Johnston JV, Hellstrm I, Hellstrm KE",B7-1/CD80-transduced tumor cells elicit better systemic immunity than wild-type tumor cells admixed with Corynebacterium parvum,"1994","54","20","5420-5423",Cancer research,"","","","","","","","7522958","",,0,0,0,0,0,,,
970,99,"Chen et al., 1994",journal,"Chen L, McGowan P, Ashe S, Johnston JV, Hellstrm I, Hellstrm KE",B7-1/CD80-transduced tumor cells elicit better systemic immunity than wild-type tumor cells admixed with Corynebacterium parvum,"1994","54","20","5420-5423",Cancer research,"","","","","","","","7522958","","",0,10,0,0,0,,,
971,99,"Kim and Sin, 2005",journal,"Kim MS, Sin JI",Both antigen optimization and lysosomal targeting are required for enhanced anti-tumour protective immunity in a human papillomavirus E7-expressing animal tumour model,"2005","116","2","255-266",Immunology,"","","","","","","","16162274","","",0,10,0,0,0,,,
972,99,"Odin et al., 2001",journal,"Odin L, Favrot M, Poujol D, Michot JP, Moingeon P, Tartaglia J, Puisieux I",Canarypox virus expressing wild type p53 for gene therapy in murine tumors mutated in p53,"2001","8","2","87-98",Cancer gene therapy,"","","","","","","","11263530","","",0,10,0,0,0,,,
973,99,"Fenton et al., 1993",journal,"Fenton RG, Taub DD, Kwak LW, Smith MR, Longo DL",Cytotoxic T-cell response and in vivo protection against tumor cells harboring activated ras proto-oncogenes,"1993","85","16","1294-1302",Journal of the National Cancer Institute,"","","","","","","","8340941","","",0,10,0,0,0,,,
974,99,"Vollmer et al., 1999",journal,"Vollmer CM Jr, Eilber FC, Butterfield LH, Ribas A, Dissette VB, Koh A, Montejo LD, Lee MC, Andrews KJ, McBride WH, Glaspy JA, Economou JS",Alpha-fetoprotein-specific genetic immunotherapy for hepatocellular carcinoma,"1999","59","13","3064-3067",Cancer research,"","","","","","","","10397245","","",0,10,0,0,0,,,
975,99,"Saha et al., 2004",journal,"Saha A, Chatterjee SK, Foon KA, Primus FJ, Sreedharan S, Mohanty K, Bhattacharya-Chatterjee M",Dendritic cells pulsed with an anti-idiotype antibody mimicking carcinoembryonic antigen (CEA) can reverse immunological tolerance to CEA and induce antitumor immunity in CEA transgenic mice,"2004","64","14","4995-5003",Cancer research,"","","","","","","","15256474","","",0,10,0,0,0,,,
976,99,"Maruyama et al., 2000",journal,"Maruyama H, Zaloudik J, Li W, Sperlagh M, Koido T, Somasundaram R, Scheck S, Prewett M, Herlyn D",Cancer vaccines: single-epitope anti-idiotype vaccine versus multiple-epitope antigen vaccine,"2000","49","3","123-132","Cancer immunology, immunotherapy : CII","","","","","","","","10881691","","",0,10,0,0,0,,,
977,42,"Kaneshige et al., 2009",journal,"Kaneshige T, Yaguchi K, Ohgitani T",Siderophore receptor IroN is an important protective antigen against Salmonella infection in chickens,"2009","53","4","563-567",Avian diseases,"","","","","","","","20095157","","",0,10,0,0,0,,,
978,42,"Peters et al., 2010",journal,"Peters SE, Paterson GK, Bandularatne ES, Northen HC, Pleasance S, Willers C, Wang J, Foote AK, Constantino-Casas F, Scase TJ, Blacklaws BA, Bryant CE, Mastroeni P, Charles IG, Maskell DJ",Salmonella enterica serovar typhimurium trxA mutants are protective against virulent challenge and induce less inflammation than the live-attenuated vaccine strain SL3261,"2010","78","1","326-336",Infection and immunity,"","","","","","","","19884329","","",0,10,0,0,0,,,
979,42,"Bansal et al., 2010",journal,"Bansal A, Paliwal PK, Sagi SS, Sairam M",Effect of adjuvants on immune response and protective immunity elicited by recombinant Hsp60 (GroEL) of Salmonella typhi against S. typhi infection,"2010","337","1-2","213-221",Molecular and cellular biochemistry,"","","","","","","","19851830","","",0,10,0,0,0,,,
980,42,"Nagarajan et al., 2009",journal,"Nagarajan AG, Balasundaram SV, Janice J, Karnam G, Eswarappa SM, Chakravortty D",SopB of Salmonella enterica serovar Typhimurium is a potential DNA vaccine candidate in conjugation with live attenuated bacteria,"2009","27","21","2804-2811",Vaccine,"","","","","","","","19428891","","",0,10,0,0,0,,,
981,91,"Qu et al., 2008",journal,"Qu D, Wang S, Cai W, Du A",Protective effect of a DNA vaccine delivered in attenuated Salmonella typhimurium against Toxoplasma gondii infection in mice,"2008","26","35","4541-4548",Vaccine,"","","","","","","","18590785","","",0,10,0,0,0,,,
982,42,"Curtiss et al., 1988",journal,"Curtiss R 3rd, Goldschmidt RM, Fletchall NB, Kelly SM",Avirulent Salmonella typhimurium delta cya delta crp oral vaccine strains expressing a streptococcal colonization and virulence antigen,"1988","6","2","155-160",Vaccine,"","","","","","","","3291452","","",0,10,0,0,0,,,
983,42,"Galdiero et al., 1999",journal,"Galdiero M, Marcatili A, Cipollaro de l'Ero G, Nuzzo I, Bentivoglio C, Galdiero M, Romano Carratelli C",Effect of transforming growth factor beta on experimental Salmonella typhimurium infection in mice,"1999","67","3","1432-1438",Infection and immunity,"","","","","","","","10024591","","",0,10,0,0,0,,,
984,42,"Kincy-Cain et al., 1996",journal,"Kincy-Cain T, Clements JD, Bost KL",Endogenous and exogenous interleukin-12 augment the protective immune response in mice orally challenged with Salmonella dublin,"1996","64","4","1437-1440",Infection and immunity,"","","","","","","","8606114","","",0,10,0,0,0,,,
985,42,"Kustanova et al., 2006",journal,"Kustanova GA, Murashev AN, Karpov VL, Margulis BA, Guzhova IV, Prokhorenko IR, Grachev SV, Evgen'ev MB",Exogenous heat shock protein 70 mediates sepsis manifestations and decreases the mortality rate in rats,"2006","11","3","276-286",Cell stress & chaperones,"","","","","","","","17009601","","",0,10,0,0,0,,,
986,42,"Hormaeche et al., 1991",journal,"Hormaeche CE, Joysey HS, Desilva L, Izhar M, Stocker BA",Immunity conferred by Aro- Salmonella live vaccines,"1991","10","2","149-158",Microbial pathogenesis,"","","","","","","","1890952","","",0,10,0,0,0,,,
987,42,"Selke et al., 2007",journal,"Selke M, Meens J, Springer S, Frank R, Gerlach GF",Immunization of pigs to prevent disease in humans: construction and protective efficacy of a Salmonella enterica serovar Typhimurium live negative-marker vaccine,"2007","75","5","2476-2483",Infection and immunity,"","","","","","","","17296750","","",0,10,0,0,0,,,
988,47,"Shi et al., 2010",journal,"Shi H, Wang S, Roland KL, Gunn BM, Curtiss R 3rd",Immunogenicity of a live recombinant Salmonella enterica serovar typhimurium vaccine expressing pspA in neonates and infant mice born from naive and immunized mothers,"2010","17","3","363-371",Clinical and vaccine immunology : CVI,"","","","","","","","20053873","","",0,10,0,0,0,,,
989,11,"Quenee et al., 2010",journal,"Quenee LE, Berube BJ, Segal J, Elli D, Ciletti NA, Anderson D, Schneewind O",Amino acid residues 196-225 of LcrV represent a plague protective epitope,"2010","28","7","1870-1876",Vaccine,"","","","","","","","20005318","","",0,10,0,0,0,,,
990,11,"Wang et al., 2008",journal,"Wang S, Joshi S, Mboudjeka I, Liu F, Ling T, Goguen JD, Lu S",Relative immunogenicity and protection potential of candidate Yersinia Pestis antigens against lethal mucosal plague challenge in Balb/C mice,"2008","26","13","1664-1674",Vaccine,"","","","","","","","18291562","","",0,10,0,0,0,,,
991,11,"Little et al., 2010",journal,"Little SF, Webster WM, Wilhelm H, Fisher D, Norris SL, Powell BS, Enama J, Adamovicz JJ",Quantitative anti-F1 and anti-V IgG ELISAs as serological correlates of protection against plague in female Swiss Webster mice,"2010","28","4","934-939",Vaccine,"","","","","","","","19925906","","",0,10,0,0,0,,,
992,11,"Honko et al., 2006",journal,"Honko AN, Sriranganathan N, Lees CJ, Mizel SB",Flagellin is an effective adjuvant for immunization against lethal respiratory challenge with Yersinia pestis,"2006","74","2","1113-1120",Infection and immunity,"","","","","","","","16428759","","",0,10,0,0,0,,,
993,11,"Li et al., 2009",journal,"Li B, Zhou L, Guo J, Wang X, Ni B, Ke Y, Zhu Z, Guo Z, Yang R",High-throughput identification of new protective antigens from a Yersinia pestis live vaccine by enzyme-linked immunospot assay,"2009","77","10","4356-4361",Infection and immunity,"","","","","","","","19651863","","",0,10,0,0,0,,,
994,11,"Overheim et al., 2005",journal,"Overheim KA, Depaolo RW, Debord KL, Morrin EM, Anderson DM, Green NM, Brubaker RR, Jabri B, Schneewind O",LcrV plague vaccine with altered immunomodulatory properties,"2005","73","8","5152-5159",Infection and immunity,"","","","","","","","16041032","","",0,10,0,0,0,,,
995,11,"Branger et al., 2007",journal,"Branger CG, Fetherston JD, Perry RD, Curtiss R 3rd",Oral vaccination with different antigens from Yersinia pestis KIM delivered by live attenuated Salmonella typhimurium elicits a protective immune response against plague,"2007","603","","387-399",Advances in experimental medicine and biology,"","","","","","","","17966435","","",0,10,0,0,0,,,
996,11,"Benner et al., 1999",journal,"Benner GE, Andrews GP, Byrne WR, Strachan SD, Sample AK, Heath DG, Friedlander AM",Immune response to Yersinia outer proteins and other Yersinia pestis antigens after experimental plague infection in mice,"1999","67","4","1922-1928",Infection and immunity,"","","","","","","","10085037","","",0,10,0,0,0,,,
997,11,"Ivanov et al., 2008",journal,"Ivanov MI, Noel BL, Rampersaud R, Mena P, Benach JL, Bliska JB",Vaccination of mice with a Yop translocon complex elicits antibodies that are protective against infection with F1- Yersinia pestis,"2008","76","11","5181-5190",Infection and immunity,"","","","","","","","18765742","","",0,10,0,0,0,,,
998,11,"Swietnicki et al., 2005",journal,"Swietnicki W, Powell BS, Goodin J","Yersinia pestis Yop secretion protein F: purification, characterization, and protective efficacy against bubonic plague","2005","42","1","166-172",Protein expression and purification,"","","","","","","","15939303","","",0,10,0,0,0,,,
999,111,"Ivanov et al., 2008",journal,"Ivanov MI, Noel BL, Rampersaud R, Mena P, Benach JL, Bliska JB",Vaccination of mice with a Yop translocon complex elicits antibodies that are protective against infection with F1- Yersinia pestis,"2008","76","11","5181-5190",Infection and immunity,"","","","","","","","18765742","","",0,10,0,0,0,,,
1000,31,"Rubin and Rizvi, 1991",journal,"Rubin LG, Rizvi A",Antibody to a 145-kilodalton outer membrane protein has bactericidal activity and protective activity against experimental bacteremia caused by a Brazilian purpuric fever isolate of Haemophilus influenzae biogroup aegyptius. The Brazilian Purpuric Fever Study Group,"1991","59","12","4576-4582",Infection and immunity,"","","","","","","","1937817","","",0,10,0,0,0,,,
1001,31,"Yang et al., 1997",journal,"Yang YP, Munson RS Jr, Grass S, Chong P, Harkness RE, Gisonni L, James O, Kwok Y, Klein MH","Effect of lipid modification on the physicochemical, structural, antigenic and immunoprotective properties of Haemophilus influenzae outer membrane protein P6","1997","15","9","976-987",Vaccine,"","","","","","","","9261944","","",0,10,0,0,0,,,
1002,30,"Etlinger et al., 1991",journal,"Etlinger HM, Caspers P, Matile H, Schoenfeld HJ, Stueber D, Takacs B",Ability of recombinant or native proteins to protect monkeys against heterologous challenge with Plasmodium falciparum,"1991","59","10","3498-3503",Infection and immunity,"","","","","","","","1894356","","",0,10,0,0,0,,,
1003,86,"Chiang et al., 2009",journal,"Chiang CH, Huang WF, Huang LP, Lin SF, Yang WJ",Immunogenicity and protective efficacy of ApxIA and ApxIIA DNA vaccine against Actinobacillus pleuropneumoniae lethal challenge in murine model,"2009","27","34","4565-4570",Vaccine,"","","","","","","","19520199","","",0,10,0,0,0,,,
1004,86,"Li et al., 2008",journal,"Li L, Zhou R, Li T, Kang M, Wan Y, Xu Z, Chen H",Enhanced biofilm formation and reduced virulence of Actinobacillus pleuropneumoniae luxS mutant,"2008","45","3","192-200",Microbial pathogenesis,"","","","","","","","18585450","","",0,10,0,0,0,,,
1005,86,"Lee et al., 2006",journal,"Lee KY, Kim DH, Kang TJ, Kim J, Chung GH, Yoo HS, Arntzen CJ, Yang MS, Jang YS",Induction of protective immune responses against the challenge of Actinobacillus pleuropneumoniae by the oral administration of transgenic tobacco plant expressing ApxIIA toxin from the bacteria,"2006","48","3","381-389",FEMS immunology and medical microbiology,"","","","","","","","17054716","","",0,10,0,0,0,,,
1006,86,"Shin et al., 2007",journal,"Shin SJ, Shin SW, Kang ML, Lee DY, Yang MS, Jang YS, Yoo HS",Enhancement of protective immune responses by oral vaccination with Saccharomyces cerevisiae expressing recombinant Actinobacillus pleuropneumoniae ApxIA or ApxIIA in mice,"2007","8","4","383-392",Journal of veterinary science,"","","","","","","","17993753","","",0,10,0,0,0,,,
1007,86,"Byrd et al., 1992",journal,"Byrd W, Harmon BG, Kadis S",Protective efficacy of conjugate vaccines against experimental challenge with porcine Actinobacillus pleuropneumoniae,"1992","34","3-4","307-324",Veterinary immunology and immunopathology,"","","","","","","","1455686","","",0,10,0,0,0,,,
1008,79,"Lund et al., 2003",journal,"Lund V, Espelid S, Mikkelsen H",Vaccine efficacy in spotted wolffish Anarhichas minor: relationship to molecular variation in A-layer protein of atypical Aeromonas salmonicida,"2003","56","1","31-42",Diseases of aquatic organisms,"","","","","","","","14524499","","",0,10,0,0,0,,,
1009,79,"Sundvold et al., 2010",journal,"Sundvold H, Ruyter B, Ostbye TK, Moen T",Identification of a novel allele of peroxisome proliferator-activated receptor gamma (PPARG) and its association with resistance to Aeromonas salmonicida in Atlantic salmon (Salmo salar),"2010","28","2","394-400",Fish & shellfish immunology,"","","","","","","","20004720","","",0,10,0,0,0,,,
1010,79,"Vaughan et al., 1993",journal,"Vaughan LM, Smith PR, Foster TJ",An aromatic-dependent mutant of the fish pathogen Aeromonas salmonicida is attenuated in fish and is effective as a live vaccine against the salmonid disease furunculosis,"1993","61","5","2172-2181",Infection and immunity,"","","","","","","","8478107","","",0,10,0,0,0,,,
1011,79,"Gudmundsdottir et al., 1997",journal,"BJARNHEIDUR K. GUDMUNDSDTTIR, BERGLJT MAGNADTTIR",Protection of Atlantic salmon (Salmo salarL.) against an experimental infection ofAeromonas salmonicidassp.achromogenes,"1997","7","1","55-69",Fish & shellfish immunology,"","","","","","","","","","",0,10,0,0,0,,,
1012,92,"Brown et al., 1996",journal,"Brown WC, McElwain TF, Ruef BJ, Suarez CE, Shkap V, Chitko-McKown CG, Tuo W, Rice-Ficht AC, Palmer GH",Babesia bovis rhoptry-associated protein 1 is immunodominant for T helper cells of immune cattle and contains T-cell epitopes conserved among geographically distant B. bovis strains,"1996","64","8","3341-3350",Infection and immunity,"","","","","","","","8757873","","",0,10,0,0,0,,,
1013,92,"Norimine et al., 2004",journal,"Norimine J, Mosqueda J, Palmer GH, Lewin HA, Brown WC",Conservation of Babesia bovis small heat shock protein (Hsp20) among strains and definition of T helper cell epitopes recognized by cattle with diverse major histocompatibility complex class II haplotypes,"2004","72","2","1096-1106",Infection and immunity,"","","","","","","","14742557","","",0,10,0,0,0,,,
1014,92,"Brown et al., 1993",journal,"Brown WC, Palmer GH, McElwain TF, Hines SA, Dobbelaere DA",Babesia bovis: characterization of the T helper cell response against the 42-kDa merozoite surface antigen (MSA-1) in cattle,"1993","77","1","97-9110",Experimental parasitology,"","","","","","","","8344411","","",0,10,0,0,0,,,
1015,92,"Wright et al., 1992",journal,"Wright IG, Casu R, Commins MA, Dalrymple BP, Gale KR, Goodger BV, Riddles PW, Waltisbuhl DJ, Abetz I, Berrie DA",The development of a recombinant Babesia vaccine,"1992","44","1-2","3-13",Veterinary parasitology,"","","","","","","","1441189","","",0,10,0,0,0,,,
1016,7,"McConnell et al., 2006",journal,"McConnell MJ, Hanna PC, Imperiale MJ",Cytokine response and survival of mice immunized with an adenovirus expressing Bacillus anthracis protective antigen domain 4,"2006","74","2","1009-1015",Infection and immunity,"","","","","","","","16428747","","",0,10,0,0,0,,,
1017,109,"Novotny et al., 1991",journal,"Novotny P, Chubb AP, Cownley K, Charles IG",Biologic and protective properties of the 69-kDa outer membrane protein of Bordetella pertussis: a novel formulation for an acellular pertussis vaccine,"1991","164","1","114-122",The Journal of infectious diseases,"","","","","","","","2056199","","",0,10,0,0,0,,,
1018,109,"Novotny et al., 1985",journal,"Novotny P, Chubb AP, Cownley K, Montaraz JA, Beesley JE",Bordetella adenylate cyclase: a genus specific protective antigen and virulence factor,"1985","61","","27-41",Developments in biological standardization,"","","","","","","","2872113","","",0,10,0,0,0,,,
1019,109,"Guiso et al., 1989",journal,"Guiso N, Rocancourt M, Szatanik M, Alonso JM",Bordetella adenylate cyclase is a virulence associated factor and an immunoprotective antigen,"1989","7","5","373-380",Microbial pathogenesis,"","","","","","","","2622329","","",0,10,0,0,0,,,
1020,109,"Sato and Sato, 1984",journal,"Sato H, Sato Y","Bordetella pertussis infection in mice: correlation of specific antibodies against two antigens, pertussis toxin, and filamentous hemagglutinin with mouse protectivity in an intracerebral or aerosol challenge system","1984","46","2","415-421",Infection and immunity,"","","","","","","","6542069","","",0,10,0,0,0,,,
1021,109,"Komatsu et al., 2010",journal,"Komatsu E, Yamaguchi F, Abe A, Weiss AA, Watanabe M",Synergic effect of genotype changes in pertussis toxin and pertactin on adaptation to an acellular pertussis vaccine in the murine intranasal challenge model,"2010","17","5","807-812",Clinical and vaccine immunology : CVI,"","","","","","","","20357056","","",0,10,0,0,0,,,
1022,109,"Merkel et al., 1998",journal,"Merkel TJ, Stibitz S, Keith JM, Leef M, Shahin R",Contribution of regulation by the bvg locus to respiratory infection of mice by Bordetella pertussis,"1998","66","9","4367-4373",Infection and immunity,"","","","","","","","9712789","","",0,10,0,0,0,,,
1023,109,"Kinnear et al., 2001",journal,"Kinnear SM, Marques RR, Carbonetti NH",Differential regulation of Bvg-activated virulence factors plays a role in Bordetella pertussis pathogenicity,"2001","69","4","1983-1993",Infection and immunity,"","","","","","","","11254549","","",0,10,0,0,0,,,
1024,109,"Cainelli et al., 2007",journal,"Cainelli Gebara VC, Risolo L, Lopes AP, Ferreira VR, Quintilio W, Lpine F, Silva WD, Raw I",Adjuvant and immunogenic activities of the 73kDa N-terminal alpha-domain of BrkA autotransporter and Cpn60/60kDa chaperonin of Bordetella pertussis,"2007","25","4","621-629",Vaccine,"","","","","","","","17011680","","",0,10,0,0,0,,,
1025,109,"Bruss and Siber, 2002",journal,"Bruss JB, Siber GR",Quantitative priming with inactivated pertussis toxoid vaccine in the aerosol challenge model,"2002","70","8","4600-4608",Infection and immunity,"","","","","","","","12117973","","",0,10,0,0,0,,,
1026,109,"Sukumar et al., 2007",journal,"Sukumar N, Mishra M, Sloan GP, Ogi T, Deora R","Differential Bvg phase-dependent regulation and combinatorial role in pathogenesis of two Bordetella paralogs, BipA and BcfA","2007","189","10","3695-3704",Journal of bacteriology,"","","","","","","","17351043","","",0,10,0,0,0,,,
1027,109,"Chen et al., 1998",journal,"Chen I, Finn TM, Yanqing L, Guoming Q, Rappuoli R, Pizza M",A recombinant live attenuated strain of Vibrio cholerae induces immunity against tetanus toxin and Bordetella pertussis tracheal colonization factor,"1998","66","4","1648-1653",Infection and immunity,"","","","","","","","9529093","","",0,10,0,0,0,,,
1028,67,"Zheng et al., 2005",journal,"Zheng C, Babiuk LA, van Drunen Littel-van den Hurk S",Bovine herpesvirus 1 VP22 enhances the efficacy of a DNA vaccine in cattle,"2005","79","3","1948-1953",Journal of virology,"","","","","","","","15650221","","",0,10,0,0,0,,,
1029,67,"Gogev et al., 2002",journal,"Gogev S, Vanderheijden N, Lemaire M, Schynts F, D'Offay J, Deprez I, Adam M, Eloit M, Thiry E",Induction of protective immunity to bovine herpesvirus type 1 in cattle by intranasal administration of replication-defective human adenovirus type 5 expressing glycoprotein gC or gD,"2002","20","9-10","1451-1465",Vaccine,"","","","","","","","11818166","","",0,10,0,0,0,,,
1030,67,"Kaashoek et al., 1995",journal,"Kaashoek MJ, Moerman A, Madi J, Weerdmeester K, Maris-Veldhuis M, Rijsewijk FA, van Oirschot JT",An inactivated vaccine based on a glycoprotein E-negative strain of bovine herpesvirus 1 induces protective immunity and allows serological differentiation,"1995","13","4","342-346",Vaccine,"","","","","","","","7793128","","",0,10,0,0,0,,,
1031,67,"Gao et al., 1994",journal,"Gao Y, Leary TP, Eskra L, Splitter GA",Truncated bovine herpesvirus-1 glycoprotein I (gpI) initiates a protective local immune response in its natural host,"1994","12","2","145-152",Vaccine,"","","","","","","","8147097","","",0,10,0,0,0,,,
1032,67,"Gupta et al., 2001",journal,"Gupta PK, Saini M, Gupta LK, Rao VD, Bandyopadhyay SK, Butchaiah G, Garg GK, Garg SK",Induction of immune responses in cattle with a DNA vaccine encoding glycoprotein C of bovine herpesvirus-1,"2001","78","4","293-305",Veterinary microbiology,"","","","","","","","11182496","","",0,10,0,0,0,,,
1033,67,"Kaashoek et al., 1998",journal,"Kaashoek MJ, Rijsewijk FA, Ruuls RC, Keil GM, Thiry E, Pastoret PP, Van Oirschot JT","Virulence, immunogenicity and reactivation of bovine herpesvirus 1 mutants with a deletion in the gC, gG, gI, gE, or in both the gI and gE gene","1998","16","8","802-809",Vaccine,"","","","","","","","9627937","","",0,10,0,0,0,,,
1034,67,"Huang et al., 2005",journal,"Huang Y, Babiuk LA, van Drunen Littel-van den Hurk S",Immunization with a bovine herpesvirus 1 glycoprotein B DNA vaccine induces cytotoxic T-lymphocyte responses in mice and cattle,"2005","86",Pt 4,"887-898",The Journal of general virology,"","","","","","","","15784883","","",0,10,0,0,0,,,
1035,67,"Caselli et al., 2005",journal,"Caselli E, Boni M, Di Luca D, Salvatori D, Vita A, Cassai E",A combined bovine herpesvirus 1 gB-gD DNA vaccine induces immune response in mice,"2005","28","2","155-166","Comparative immunology, microbiology and infectious diseases","","","","","","","","15582691","","",0,10,0,0,0,,,
1036,24,"Buckley et al., 2010",journal,"Buckley AM, Wang J, Hudson DL, Grant AJ, Jones MA, Maskell DJ, Stevens MP",Evaluation of live-attenuated Salmonella vaccines expressing Campylobacter antigens for control of C. jejuni in poultry,"2010","28","4","1094-1105",Vaccine,"","","","","","","","19853682","","",0,10,0,0,0,,,
1037,24,"Shoaf-Sweeney et al., 2008",journal,"Shoaf-Sweeney KD, Larson CL, Tang X, Konkel ME",Identification of Campylobacter jejuni proteins recognized by maternal antibodies of chickens,"2008","74","22","6867-6875",Applied and environmental microbiology,"","","","","","","","18805999","",,0,0,0,0,0,,,
1038,24,"Zheng et al., 2007",journal,"Zheng H, Cai FC, Zhong M, Deng B, Li X, Zhang XP",[Experimental study on the chitosan-DNA vaccines against campylobacter jejuni invasion],"2007","41","5","375-379",Zhonghua yu fang yi xue za zhi [Chinese journal of preventive medicine],"","","","","","","","18206008","","",0,10,0,0,0,,,
1039,24,"Baqar et al., 2008",journal,"Baqar S, Applebee LA, Gilliland TC Jr, Lee LH, Porter CK, Guerry P",Immunogenicity and protective efficacy of recombinant Campylobacter jejuni flagellum-secreted proteins in mice,"2008","76","7","3170-3175",Infection and immunity,"","","","","","","","18426878","","",0,10,0,0,0,,,
1040,86,"Prideaux et al., 1999",journal,"Prideaux CT, Lenghaus C, Krywult J, Hodgson AL",Vaccination and protection of pigs against pleuropneumonia with a vaccine strain of Actinobacillus pleuropneumoniae produced by site-specific mutagenesis of the ApxII operon,"1999","67","4","1962-1966",Infection and immunity,"","","","","","","","10085043","","",0,10,0,0,0,,,
1041,86,"Xu et al., 2007",journal,"Xu FZ, Shi AH, Chen XL, Yang B, Wang JL",[Construction and immunogenicity of an attenuated mutant of Actinobacillus pleuropneumoniae by insertional inactivation of apxIC],"2007","47","5","923-927",Wei sheng wu xue bao = Acta microbiologica Sinica,"","","","","","","","18062275","","",0,10,0,0,0,,,
1042,86,"Tonpitak et al., 2002",journal,"Tonpitak W, Baltes N, Hennig-Pauka I, Gerlach GF",Construction of an Actinobacillus pleuropneumoniae serotype 2 prototype live negative-marker vaccine,"2002","70","12","7120-7125",Infection and immunity,"","","","","","","","12438394","","",0,10,0,0,0,,,
1043,86,"Liu et al., 2007",journal,"Liu J, Chen X, Lin L, Tan C, Chen Y, Guo Y, Jin M, Guo A, Bei W, Chen H",Potential use an Actinobacillus pleuropneumoniae double mutant strain DeltaapxIICDeltaapxIVA as live vaccine that allows serological differentiation between vaccinated and infected animals,"2007","25","44","7696-7705",Vaccine,"","","","","","","","17767980","","",0,10,0,0,0,,,
1044,109,"Fennelly et al., 2008",journal,"Fennelly NK, Sisti F, Higgins SC, Ross PJ, van der Heide H, Mooi FR, Boyd A, Mills KH",Bordetella pertussis expresses a functional type III secretion system that subverts protective innate and adaptive immune responses,"2008","76","3","1257-1266",Infection and immunity,"","","","","","","","18195025","","",0,10,0,0,0,,,
1045,24,"Zeng et al., 2009",journal,"Zeng X, Xu F, Lin J","Molecular, antigenic, and functional characteristics of ferric enterobactin receptor CfrA in Campylobacter jejuni","2009","77","12","5437-5448",Infection and immunity,"","","","","","","","19737895","","",0,10,0,0,0,,,
1046,101,"Usui et al., 2003",journal,"Usui T, Konnai S, Tajima S, Watarai S, Aida Y, Ohashi K, Onuma M",Protective effects of vaccination with bovine leukemia virus (BLV) Tax DNA against BLV infection in sheep,"2003","65","11","1201-1205",The Journal of veterinary medical science / the Japanese Society of Veterinary Science,"","","","","","","","14665749","","",0,10,0,0,0,,,
1047,101,"Brillowska et al., 1999",journal,"Brillowska A, Dabrowski S, Ruka J, Kubi P, Buzaa E, Kur J",Protection of cattle against bovine leukemia virus (BLV) infection could be attained by DNA vaccination,"1999","46","4","971-976",Acta biochimica Polonica,"","","","","","","","10824867","","",0,10,0,0,0,,,
1048,74,"Jensen et al., 2009",journal,"Jensen TH, Nielsen L, Aasted B, Blixenkrone-Mller M",Early life DNA vaccination with the H gene of Canine distemper virus induces robust protection against distemper,"2009","27","38","5178-5183",Vaccine,"","","","","","","","19596418","","",0,10,0,0,0,,,
1049,74,"Fischer et al., 2002",journal,"Fischer L, Tronel JP, Pardo-David C, Tanner P, Colombet G, Minke J, Audonnet JC",Vaccination of puppies born to immune dams with a canine adenovirus-based vaccine protects against a canine distemper virus challenge,"2002","20","29-30","3485-3497",Vaccine,"","","","","","","","12297394","","",0,10,0,0,0,,,
1050,72,"Langeveld et al., 2001",journal,"Langeveld JP, Brennan FR, Martnez-Torrecuadrada JL, Jones TD, Boshuizen RS, Vela C, Casal JI, Kamstrup S, Dalsgaard K, Meloen RH, Bendig MM, Hamilton WD",Inactivated recombinant plant virus protects dogs from a lethal challenge with canine parvovirus,"2001","19","27","3661-3670",Vaccine,"","","","","","","","11395200","","",0,10,0,0,0,,,
1051,72,"Jiang et al., 1998",journal,"Jiang W, Baker HJ, Swango LJ, Schorr J, Self MJ, Smith BF",Nucleic acid immunization protects dogs against challenge with virulent canine parvovirus,"1998","16","6","601-607",Vaccine,"","","","","","","","9569471","","",0,10,0,0,0,,,
1052,82,"Stemke-Hale et al., 2005",journal,"Stemke-Hale K, Kaltenboeck B, DeGraves FJ, Sykes KF, Huang J, Bu CH, Johnston SA",Screening the whole genome of a pathogen in vivo for individual protective antigens,"2005","23","23","3016-3025",Vaccine,"","","","","","","","15811648","","",0,10,0,0,0,,,
1053,82,"Hchard et al., 2003",journal,"Hchard C, Grpinet O, Rodolakis A",Evaluation of protection against Chlamydophila abortus challenge after DNA immunization with the major outer-membrane protein-encoding gene in pregnant and non-pregnant mice,"2003","52",Pt 1,"35-40",Journal of medical microbiology,"","","","","","","","12488563","","",0,10,0,0,0,,,
1054,82,"Hchard et al., 2002",journal,"Hchard C, Grpinet O, Rodolakis A",Protection evaluation against Chlamydophila abortus challenge by DNA vaccination with a dnaK-encoding plasmid in pregnant and non-pregnant mice,"2002","33","3","313-326",Veterinary research,"","","","","","","","12056482","","",0,10,0,0,0,,,
1478,29,"Luo et al., 2004",journal,"Luo XD, Zhu DY, Chen Q, Jiang Y, Jiang S, Yang C",[A study of the protective effect of the DNA vaccine encoding tubercle antigen 85B with MPT64 in mice challenged with Mycobacterium tuberculosis],"2004","27","9","611-616",Zhonghua jie he he hu xi za zhi = Zhonghua jiehe he huxi zazhi = Chinese journal of tuberculosis and respiratory diseases,"","","","","","","","15498274","","",0,10,0,0,0,,,
1056,112,"Penttil et al., 2000",journal,"Penttil T, Vuola JM, Puurula V, Anttila M, Sarvas M, Rautonen N, Mkel PH, Puolakkainen M",Immunity to Chlamydia pneumoniae induced by vaccination with DNA vectors expressing a cytoplasmic protein (Hsp60) or outer membrane proteins (MOMP and Omp2),"2000","19","9-10","1256-1265",Vaccine,"","","","","","","","11137265","","",0,10,0,0,0,,,
1057,113,"McNeilly et al., 2007",journal,"McNeilly CL, Beagley KW, Moore RJ, Haring V, Timms P, Hafner LM",Expression library immunization confers partial protection against Chlamydia muridarum genital infection,"2007","25","14","2643-2655",Vaccine,"","","","","","","","17239501","","",0,10,0,0,0,,,
1058,113,"Faludi et al., 2009",journal,"Faludi I, Burian K, Csanadi A, Miczak A, Lu X, Kakkar VV, Gonczol E, Endresz V",Adjuvant modulation of the immune response of mice against the LcrE protein of Chlamydophila pneumoniae,"2009","299","7","520-528",International journal of medical microbiology : IJMM,"","","","","","","","19451031","","",0,10,0,0,0,,,
1059,112,"Faludi et al., 2009",journal,"Faludi I, Burian K, Csanadi A, Miczak A, Lu X, Kakkar VV, Gonczol E, Endresz V",Adjuvant modulation of the immune response of mice against the LcrE protein of Chlamydophila pneumoniae,"2009","299","7","520-528",International journal of medical microbiology : IJMM,"","","","","","","","19451031","","",0,10,0,0,0,,,
1060,112,"Tammiruusu et al., 2007",journal,"Tammiruusu A, Penttil T, Lahesmaa R, Sarvas M, Puolakkainen M, Vuola JM",Intranasal administration of chlamydial outer protein N (CopN) induces protection against pulmonary Chlamydia pneumoniae infection in a mouse model,"2007","25","2","283-290",Vaccine,"","","","","","","","16949182","","",0,10,0,0,0,,,
1061,113,"Skelding et al., 2006",journal,"Skelding KA, Hickey DK, Horvat JC, Bao S, Roberts KG, Finnie JM, Hansbro PM, Beagley KW",Comparison of intranasal and transcutaneous immunization for induction of protective immunity against Chlamydia muridarum respiratory tract infection,"2006","24","3","355-366",Vaccine,"","","","","","","","16153755","","",0,10,0,0,0,,,
1062,113,"Yu et al., 2009",journal,"Yu H, Jiang X, Shen C, Karunakaran KP, Brunham RC",Novel Chlamydia muridarum T cell antigens induce protective immunity against lung and genital tract infection in murine models,"2009","182","3","1602-1608","Journal of immunology (Baltimore, Md. : 1950)","","","","","","","","19155509","","",0,10,0,0,0,,,
1063,112,"Li et al., 2006",journal,"Li D, Borovkov A, Vaglenov A, Wang C, Kim T, Gao D, Sykes KF, Kaltenboeck B",Mouse model of respiratory Chlamydia pneumoniae infection for a genomic screen of subunit vaccine candidates,"2006","24","15","2917-2927",Vaccine,"","","","","","","","16434129","","",0,10,0,0,0,,,
1064,66,"Lin et al., 2009",journal,"Lin GJ, Liu TY, Tseng YY, Chen ZW, You CC, Hsuan SL, Chien MS, Huang C",Yeast-expressed classical swine fever virus glycoprotein E2 induces a protective immune response,"2009","139","3-4","369-374",Veterinary microbiology,"","","","","","","","19625145","","",0,10,0,0,0,,,
1065,66,"Knig et al., 1995",journal,"Knig M, Lengsfeld T, Pauly T, Stark R, Thiel HJ",Classical swine fever virus: independent induction of protective immunity by two structural glycoproteins,"1995","69","10","6479-6486",Journal of virology,"","","","","","","","7666549","","",0,10,0,0,0,,,
1066,66,"Hulst et al., 1993",journal,"Hulst MM, Westra DF, Wensvoort G, Moormann RJ",Glycoprotein E1 of hog cholera virus expressed in insect cells protects swine from hog cholera,"1993","67","9","5435-5442",Journal of virology,"","","","","","","","8350404","","",0,10,0,0,0,,,
1067,14,"Webb et al., 2009",journal,"Webb RP, Smith TJ, Wright P, Brown J, Smith LA","Production of catalytically inactive BoNT/A1 holoprotein and comparison with BoNT/A1 subunit vaccines against toxin subtypes A1, A2, and A3","2009","27","33","4490-4497",Vaccine,"","","","","","","","19450643","","",0,10,0,0,0,,,
1068,14,"Yu et al., 2008",journal,"Yu YZ, Li N, Wang RL, Zhu HQ, Wang S, Yu WY, Sun ZW",Evaluation of a recombinant Hc of Clostridium botulinum neurotoxin serotype F as an effective subunit vaccine,"2008","15","12","1819-1823",Clinical and vaccine immunology : CVI,"","","","","","","","18845829","","",0,10,0,0,0,,,
1069,14,"Clayton et al., 1995",journal,"Clayton MA, Clayton JM, Brown DR, Middlebrook JL",Protective vaccination with a recombinant fragment of Clostridium botulinum neurotoxin serotype A expressed from a synthetic gene in Escherichia coli,"1995","63","7","2738-2742",Infection and immunity,"","","","","","","","7790092","","",0,10,0,0,0,,,
1070,14,"Baldwin et al., 2005",journal,"Baldwin MR, Tepp WH, Pier CL, Bradshaw M, Ho M, Wilson BA, Fritz RB, Johnson EA, Barbieri JT",Characterization of the antibody response to the receptor binding domain of botulinum neurotoxin serotypes A and E,"2005","73","10","6998-7005",Infection and immunity,"","","","","","","","16177380","","",0,10,0,0,0,,,
1071,14,"Yu et al., 2009",journal,"Yu Y, Yu J, Li N, Wang S, Yu W, Sun Z",Individual and bivalent vaccines against botulinum neurotoxin serotypes A and B using DNA-based Semliki Forest virus vectors,"2009","27","44","6148-6153",Vaccine,"","","","","","","","19712769","","",0,10,0,0,0,,,
1072,14,"Zeng et al., 2007",journal,"Zeng M, Xu Q, Elias M, Pichichero ME, Simpson LL, Smith LA",Protective immunity against botulism provided by a single dose vaccination with an adenovirus-vectored vaccine,"2007","25","43","7540-7548",Vaccine,"","","","","","","","17897756","","",0,10,0,0,0,,,
1073,41,"He et al., 2000",journal,"He HJ, He ZY, Shi HJ, Zhu W, Yang GZ, Yuan QS, Wu XF",Cloning and Expression of Tetanus Toxin Fragment C in E.coli,"2000","32","4","322-326",Sheng wu hua xue yu sheng wu wu li xue bao Acta biochimica et biophysica Sinica,"","","","","","","","12075415","","",0,10,0,0,0,,,
1074,13,"Hensley et al., 2010",journal,"Hensley LE, Mulangu S, Asiedu C, Johnson J, Honko AN, Stanley D, Fabozzi G, Nichol ST, Ksiazek TG, Rollin PE, Wahl-Jensen V, Bailey M, Jahrling PB, Roederer M, Koup RA, Sullivan NJ",Demonstration of cross-protective vaccine immunity against an emerging pathogenic Ebolavirus Species,"2010","6","5",e1000904,PLoS pathogens,"","","","","","","","20502688","","",0,10,0,0,0,,,
1075,13,"Bukreyev et al., 2006",journal,"Bukreyev A, Yang L, Zaki SR, Shieh WJ, Rollin PE, Murphy BR, Collins PL, Sanchez A",A single intranasal inoculation with a paramyxovirus-vectored vaccine protects guinea pigs against a lethal-dose Ebola virus challenge,"2006","80","5","2267-2279",Journal of virology,"","","","","","","","16474134","","",0,10,0,0,0,,,
1076,13,"Warfield et al., 2005",journal,"Warfield KL, Olinger G, Deal EM, Swenson DL, Bailey M, Negley DL, Hart MK, Bavari S",Induction of humoral and CD8+ T cell responses are required for protection against lethal Ebola virus infection,"2005","175","2","1184-1191","Journal of immunology (Baltimore, Md. : 1950)","","","","","","","","16002721","","",0,10,0,0,0,,,
1077,98,"Jang et al., 2010",journal,"Jang SI, Lillehoj HS, Lee SH, Lee KW, Park MS, Cha SR, Lillehoj EP, Subramanian BM, Sriraman R, Srinivasan VA",Eimeria maxima recombinant Gam82 gametocyte antigen vaccine protects against coccidiosis and augments humoral and cell-mediated immunity,"2010","28","17","2980-2985",Vaccine,"","","","","","","","20178868","","",0,10,0,0,0,,,
1078,88,"Ding et al., 2005",journal,"Ding X, Lillehoj HS, Dalloul RA, Min W, Sato T, Yasuda A, Lillehoj EP",In ovo vaccination with the Eimeria tenella EtMIC2 gene induces protective immunity against coccidiosis,"2005","23","28","3733-3740",Vaccine,"","","","","","","","15882535","","",0,10,0,0,0,,,
1079,88,"Wang et al., 2009",journal,"Wang Q, Li J, Zhang X, Liu Q, Liu C, Ma G, Cao L, Gong P, Cai Y, Zhang G",Protective immunity of recombinant Mycobacterium bovis BCG expressing rhomboid gene against Eimeria tenella challenge,"2009","160","3-4","198-203",Veterinary parasitology,"","","","","","","","19117681","","",0,10,0,0,0,,,
1080,88,"Song et al., 2009",journal,"Song X, Xu L, Yan R, Huang X, Shah MA, Li X",The optimal immunization procedure of DNA vaccine pcDNA-TA4-IL-2 of Eimeria tenella and its cross-immunity to Eimeria necatrix and Eimeria acervulina,"2009","159","1","30-36",Veterinary parasitology,"","","","","","","","19019543","","",0,10,0,0,0,,,
1081,88,"Xu et al., 2006",journal,"Xu SZ, Chen T, Wang M",Protective immunity enhanced by chimeric DNA prime-protein booster strategy against Eimeria tenella challenge,"2006","50","4","579-585",Avian diseases,"","","","","","","","17274297","","",0,10,0,0,0,,,
1082,88,"Miller et al., 1989",journal,"Miller GA, Bhogal BS, McCandliss R, Strausberg RL, Jessee EJ, Anderson AC, Fuchs CK, Nagle J, Likel MH, Strasser JM",Characterization and vaccine potential of a novel recombinant coccidial antigen,"1989","57","7","2014-2020",Infection and immunity,"","","","","","","","2659532","","",0,10,0,0,0,,,
1083,71,"Poulet et al., 2003",journal,"Poulet H, Brunet S, Boularand C, Guiot AL, Leroy V, Tartaglia J, Minke J, Audonnet JC, Desmettre P",Efficacy of a canarypox virus-vectored vaccine against feline leukaemia,"2003","153","5","141-145",The Veterinary record,"","","","","","","","12934796","","",0,10,0,0,0,,,
1084,12,"Gregory et al., 2010",journal,"Gregory SH, Chen WH, Mott S, Palardy JE, Parejo NA, Heninger S, Anderson CA, Artenstein AW, Opal SM, Cross AS",Detoxified endotoxin vaccine (J5dLPS/OMP) protects mice against lethal respiratory challenge with Francisella tularensis SchuS4,"2010","28","16","2908-2915",Vaccine,"","","","","","","","20170768","","",0,10,0,0,0,,,
1085,12,"Yu et al., 2010",journal,"Yu JJ, Goluguri T, Guentzel MN, Chambers JP, Murthy AK, Klose KE, Forsthuber TG, Arulanandam BP",Francisella tularensis T-cell antigen identification using humanized HLA-DR4 transgenic mice,"2010","17","2","215-222",Clinical and vaccine immunology : CVI,"","","","","","","","20016043","","",0,10,0,0,0,,,
1086,12,"Cong et al., 2009",journal,"Cong Y, Yu JJ, Guentzel MN, Berton MT, Seshu J, Klose KE, Arulanandam BP",Vaccination with a defined Francisella tularensis subsp. novicida pathogenicity island mutant (DeltaiglB) induces protective immunity against homotypic and heterotypic challenge,"2009","27","41","5554-5561",Vaccine,"","","","","","","","19651173","","",0,10,0,0,0,,,
1087,12,"Li et al., 2007",journal,"Li J, Ryder C, Mandal M, Ahmed F, Azadi P, Snyder DS, Pechous RD, Zahrt T, Inzana TJ",Attenuation and protective efficacy of an O-antigen-deficient mutant of Francisella tularensis LVS,"2007","153",Pt 9,"3141-3153","Microbiology (Reading, England)","","","","","","","","17768257","","",0,10,0,0,0,,,
1088,12,"Hartley et al., 2004",journal,"Hartley MG, Green M, Choules G, Rogers D, Rees DG, Newstead S, Sjostedt A, Titball RW",Protection afforded by heat shock protein 60 from Francisella tularensis is due to copurified lipopolysaccharide,"2004","72","7","4109-4113",Infection and immunity,"","","","","","","","15213156","","",0,10,0,0,0,,,
1089,12,"Sjstedt et al., 1992",journal,"Sjstedt A, Sandstrm G, Trnvik A",Humoral and cell-mediated immunity in mice to a 17-kilodalton lipoprotein of Francisella tularensis expressed by Salmonella typhimurium,"1992","60","7","2855-2862",Infection and immunity,"","","","","","","","1612751","","",0,10,0,0,0,,,
1090,12,"Savitt et al., 2009",journal,"Savitt AG, Mena-Taboada P, Monsalve G, Benach JL","Francisella tularensis infection-derived monoclonal antibodies provide detection, protection, and therapy","2009","16","3","414-422",Clinical and vaccine immunology : CVI,"","","","","","","","19176692","","",0,10,0,0,0,,,
1477,29,"Miki et al., 2004",journal,"Miki K, Nagata T, Tanaka T, Kim YH, Uchijima M, Ohara N, Nakamura S, Okada M, Koide Y",Induction of protective cellular immunity against Mycobacterium tuberculosis by recombinant attenuated self-destructing Listeria monocytogenes strains harboring eukaryotic expression plasmids for antigen 85 complex and MPB/MPT51,"2004","72","4","2014-2021",Infection and immunity,"","","","","","","","15039321","","",0,10,0,0,0,,,
1092,94,"Lee et al., 2009",journal,"Lee P, Abdul-Wahid A, Faubert GM",Comparison of the local immune response against Giardia lamblia cyst wall protein 2 induced by recombinant Lactococcus lactis and Streptococcus gordonii,"2009","11","1","20-28",Microbes and infection / Institut Pasteur,"","","","","","","","18992359","","",0,10,0,0,0,,,
1093,94,"Abdul-Wahid and Faubert, 2007",journal,"Abdul-Wahid A, Faubert G",Mucosal delivery of a transmission-blocking DNA vaccine encoding Giardia lamblia CWP2 by Salmonella typhimurium bactofection vehicle,"2007","25","50","8372-8383",Vaccine,"","","","","","","","17996337","","",0,10,0,0,0,,,
1094,31,"Forsgren et al., 2008",journal,"Forsgren A, Riesbeck K, Janson H",Protein D of Haemophilus influenzae: a protective nontypeable H. influenzae antigen and a carrier for pneumococcal conjugate vaccines,"2008","46","5","726-731",Clinical infectious diseases : an official publication of the Infectious Diseases Society of America,"","","","","","","","18230042","","",0,10,0,0,0,,,
1095,31,"Bakaletz et al., 1999",journal,"Bakaletz LO, Kennedy BJ, Novotny LA, Duquesne G, Cohen J, Lobet Y",Protection against development of otitis media induced by nontypeable Haemophilus influenzae by both active and passive immunization in a chinchilla model of virus-bacterium superinfection,"1999","67","6","2746-2762",Infection and immunity,"","","","","","","","10338477","","",0,10,0,0,0,,,
1096,31,"Loosmore et al., 1997",journal,"Loosmore SM, Yang YP, Coleman DC, Shortreed JM, England DM, Klein MH",Outer membrane protein D15 is conserved among Haemophilus influenzae species and may represent a universal protective antigen against invasive disease,"1997","65","9","3701-3707",Infection and immunity,"","","","","","","","9284140","","",0,10,0,0,0,,,
1097,31,"Barenkamp, 1986",journal,Barenkamp SJ,Protection by serum antibodies in experimental nontypable Haemophilus influenzae otitis media,"1986","52","2","572-578",Infection and immunity,"","","","","","","","3486158","","",0,10,0,0,0,,,
1098,31,"Munson et al., 1983",journal,"Munson RS Jr, Shenep JL, Barenkamp SJ, Granoff DM",Purification and comparison of outer membrane protein P2 from Haemophilus influenzae type b isolates,"1983","72","2","677-684",The Journal of clinical investigation,"","","","","","","","6603479","","",0,10,0,0,0,,,
1099,31,"Loosmore et al., 1996",journal,"Loosmore SM, Yang YP, Coleman DC, Shortreed JM, England DM, Harkness RE, Chong PS, Klein MH",Cloning and expression of the Haemophilus influenzae transferrin receptor genes,"1996","19","3","575-586",Molecular microbiology,"","","","","","","","8830248","","",0,10,0,0,0,,,
1100,27,"Yuan et al., 2010",journal,"Yuan ZG, Luo SJ, Xu HJ, Wang XH, Li J, Yuan LG, He LT, Zhang XX",Generation of E3-deleted canine adenovirus type 2 expressing the Gc glycoprotein of Seoul virus by gene insertion of deletion of related terminal region sequences,"2010","","","",The Journal of general virology,"","","","","","","","20181748","","",0,10,0,0,0,,,
1101,27,"Bharadwaj et al., 2002",journal,"Bharadwaj M, Mirowsky K, Ye C, Botten J, Masten B, Yee J, Lyons CR, Hjelle B",Genetic vaccines protect against Sin Nombre hantavirus challenge in the deer mouse (Peromyscus maniculatus),"2002","83",Pt 7,"1745-1751",The Journal of general virology,"","","","","","","","12075094","","",0,10,0,0,0,,,
1102,27,"Chu et al., 1995",journal,"Chu YK, Jennings GB, Schmaljohn CS",A vaccinia virus-vectored Hantaan virus vaccine protects hamsters from challenge with Hantaan and Seoul viruses but not Puumala virus,"1995","69","10","6417-6423",Journal of virology,"","","","","","","","7666542","","",0,10,0,0,0,,,
1103,27,"Yoshimatsu et al., 1993",journal,"Yoshimatsu K, Yoo YC, Yoshida R, Ishihara C, Azuma I, Arikawa J",Protective immunity of Hantaan virus nucleocapsid and envelope protein studied using baculovirus-expressed proteins,"1993","130","3-4","365-376",Archives of virology,"","","","","","","","8517793","","",0,10,0,0,0,,,
1104,27,"Safronetz et al., 2009",journal,"Safronetz D, Hegde NR, Ebihara H, Denton M, Kobinger GP, St Jeor S, Feldmann H, Johnson DC",Adenovirus vectors expressing hantavirus proteins protect hamsters against lethal challenge with andes virus,"2009","83","14","7285-7295",Journal of virology,"","","","","","","","19403663","","",0,10,0,0,0,,,
1105,49,"Payette et al., 2006",journal,"Payette PJ, Ma X, Weeratna RD, McCluskie MJ, Shapiro M, Engle RE, Davis HL, Purcell RH",Testing of CpG-optimized protein and DNA vaccines against the hepatitis B virus in chimpanzees for immunogenicity and protection from challenge,"2006","49","3","144-151",Intervirology,"","","","","","","","16428890","","",0,10,0,0,0,,,
1106,49,"Zhou et al., 2003",journal,"Zhou FJ, Hu ZL, Dai JX, Chen RW, Shi K, Lin Y, Sun SH",Protection of tree shrews by pVAX-PS DNA vaccine against HBV infection,"2003","22","7","475-478",DNA and cell biology,"","","","","","","","12932306","","",0,10,0,0,0,,,
1107,49,"Thermet et al., 2003",journal,"Thermet A, Rollier C, Zoulim F, Trepo C, Cova L",Progress in DNA vaccine for prophylaxis and therapy of hepatitis B,"2003","21","7-8","659-662",Vaccine,"","","","","","","","12531335","","",0,10,0,0,0,,,
1108,49,"Hwang et al., 2002",journal,"Hwang YK, Kim NK, Park JM, Lee K, Han WK, Kim HI, Cheong HS",HLA-A2 1 restricted peptides from the HBx antigen induce specific CTL responses in vitro and in vivo,"2002","20","31-32","3770-3777",Vaccine,"","","","","","","","12399208","","",0,10,0,0,0,,,
1109,100,"Huilan et al., 2010",journal,"Huilan Y, Cui Z, Jianyong F, Lei G, Wei Q","Construction of, and T-helper (Th)1/Th2 immune responses to, a herpes simplex virus type 2 glycoprotein D-cytotoxic T-lymphocyte epitope DNA vaccine","2010","","","",Clinical and experimental dermatology,"","","","","","","","20497188","","",0,10,0,0,0,,,
1110,100,"Kim et al., 2009",journal,"Kim SB, Han YW, Rahman MM, Kim SJ, Yoo DJ, Kang SH, Kim K, Eo SK",Modulation of protective immunity against herpes simplex virus via mucosal genetic co-transfer of DNA vaccine with beta2-adrenergic agonist,"2009","41","11","812-823",Experimental & molecular medicine,"","","","","","","","19641376","","",0,10,0,0,0,,,
1111,100,"Jamali et al., 2009",journal,"Jamali A, Mahdavi M, Hassan ZM, Sabahi F, Farsani MJ, Bamdad T, Soleimanjahi H, Motazakker M, Shahabi S","A novel adjuvant, the general opioid antagonist naloxone, elicits a robust cellular immune response for a DNA vaccine","2009","21","3","217-225",International immunology,"","","","","","","","19174474","","",0,10,0,0,0,,,
1112,100,"Orr et al., 2007",journal,"Orr MT, Orgun NN, Wilson CB, Way SS",Cutting edge: recombinant Listeria monocytogenes expressing a single immune-dominant peptide confers protective immunity to herpes simplex virus-1 infection,"2007","178","8","4731-4735","Journal of immunology (Baltimore, Md. : 1950)","","","","","","","","17404252","","",0,10,0,0,0,,,
1113,100,"Haynes et al., 2006",journal,"Haynes JR, Arrington J, Dong L, Braun RP, Payne LG",Potent protective cellular immune responses generated by a DNA vaccine encoding HSV-2 ICP27 and the E. coli heat labile enterotoxin,"2006","24","23","5016-5026",Vaccine,"","","","","","","","16621198","","",0,10,0,0,0,,,
1114,100,"Goel et al., 2005",journal,"Goel N, Zimmerman DH, Rosenthal KS",Ligand epitope antigen presentation system vaccines against herpes simplex virus,"2005","10","","966-974",Frontiers in bioscience : a journal and virtual library,"","","","","","","","15569635","","",0,10,0,0,0,,,
1115,100,"Grabowska et al., 2000",journal,"Grabowska AM, Jennings R, Laing P, Darsley M, Jameson CL, Swift L, Irving WL",Immunisation with phage displaying peptides representing single epitopes of the glycoprotein G can give rise to partial protective immunity to HSV-2,"2000","269","1","47-53",Virology,"","","","","","","","10725197","","",0,10,0,0,0,,,
1116,100,"Nass et al., 1998",journal,"Nass PH, Elkins KL, Weir JP",Antibody response and protective capacity of plasmid vaccines expressing three different herpes simplex virus glycoproteins,"1998","178","3","611-617",The Journal of infectious diseases,"","","","","","","","9728527","","",0,10,0,0,0,,,
1117,100,"Mester et al., 1999",journal,"Mester JC, Twomey TA, Tepe ET, Bernstein DI",Immunity induced by DNA immunization with herpes simplex virus type 2 glycoproteins B and C,"1999","18","9-10","875-883",Vaccine,"","","","","","","","10580201","","",0,10,0,0,0,,,
1118,54,"Qin et al., 2005",journal,"Qin Y, Wang XH, Cui HL, Cheung YK, Hu MH, Zhu SG, Xie Y",Human papillomavirus type 16 E7 peptide(38-61) linked with an immunoglobulin G fragment provides protective immunity in mice,"2005","96","2","475-483",Gynecologic oncology,"","","","","","","","15661238","","",0,10,0,0,0,,,
1119,54,"Jagu et al., 2009",journal,"Jagu S, Karanam B, Gambhira R, Chivukula SV, Chaganti RJ, Lowy DR, Schiller JT, Roden RB",Concatenated multitype L2 fusion proteins as candidate prophylactic pan-human papillomavirus vaccines,"2009","101","11","782-792",Journal of the National Cancer Institute,"","","","","","","","19470949","","",0,10,0,0,0,,,
1120,54,"Karanam et al., 2009",journal,"Karanam B, Gambhira R, Peng S, Jagu S, Kim DJ, Ketner GW, Stern PL, Adams RJ, Roden RB",Vaccination with HPV16 L2E6E7 fusion protein in GPI-0100 adjuvant elicits protective humoral and cell-mediated immunity,"2009","27","7","1040-1049",Vaccine,"","","","","","","","19095032","","",0,10,0,0,0,,,
1121,54,"Lin et al., 2006",journal,"Lin CT, Tsai YC, He L, Calizo R, Chou HH, Chang TC, Soong YK, Hung CF, Lai CH",A DNA vaccine encoding a codon-optimized human papillomavirus type 16 E6 gene enhances CTL response and anti-tumor activity,"2006","13","4","481-488",Journal of biomedical science,"","","","","","","","16649071","","",0,10,0,0,0,,,
1122,54,"Nieto et al., 2009",journal,"Nieto K, Kern A, Leuchs B, Gissmann L, Mller M, Kleinschmidt JA",Combined prophylactic and therapeutic intranasal vaccination against human papillomavirus type-16 using different adeno-associated virus serotype vectors,"2009","14","8","1125-1137",Antiviral therapy,"","","","","","","","20032542","","",0,10,0,0,0,,,
1123,75,"Einer-Jensen et al., 2009",journal,"Einer-Jensen K, Delgado L, Lorenzen E, Bovo G, Evensen , Lapatra S, Lorenzen N","Dual DNA vaccination of rainbow trout (Oncorhynchus mykiss) against two different rhabdoviruses, VHSV and IHNV, induces specific divalent protection","2009","27","8","1248-1253",Vaccine,"","","","","","","","19118593","","",0,10,0,0,0,,,
1124,50,"Tamura et al., 1996",journal,"Tamura S, Miyata K, Matsuo K, Asanuma H, Takahashi H, Nakajima K, Suzuki Y, Aizawa C, Kurata T",Acceleration of influenza virus clearance by Th1 cells in the nasal site of mice immunized intranasally with adjuvant-combined recombinant nucleoprotein,"1996","156","10","3892-3900","Journal of immunology (Baltimore, Md. : 1950)","","","","","","","","8621928","","",0,10,0,0,0,,,
1125,50,"Lunn et al., 1999",journal,"Lunn DP, Soboll G, Schram BR, Quass J, McGregor MW, Drape RJ, Macklin MD, McCabe DE, Swain WF, Olsen CW",Antibody responses to DNA vaccination of horses using the influenza virus hemagglutinin gene,"1999","17","18","2245-2258",Vaccine,"","","","","","","","10403592","","",0,10,0,0,0,,,
1126,50,"Richt and Garca-Sastre, 2009",journal,"Richt JA, Garca-Sastre A",Attenuated influenza virus vaccines with modified NS1 proteins,"2009","333","","177-195",Current topics in microbiology and immunology,"","","","","","","","19768406","","",0,10,0,0,0,,,
1127,50,"Roberts et al., 1999",journal,"Roberts A, Buonocore L, Price R, Forman J, Rose JK",Attenuated vesicular stomatitis viruses as vaccine vectors,"1999","73","5","3723-3732",Journal of virology,"","","","","","","","10196265","","",0,10,0,0,0,,,
1128,50,"Abe et al., 2003",journal,"Abe T, Takahashi H, Hamazaki H, Miyano-Kurosaki N, Matsuura Y, Takaku H",Baculovirus induces an innate immune response and confers protection from lethal influenza virus infection in mice,"2003","171","3","1133-1139","Journal of immunology (Baltimore, Md. : 1950)","","","","","","","","12874198","","",0,10,0,0,0,,,
1129,50,"Muller et al., 1990",journal,"Muller S, Plau S, Samama JP, Valette M, Briand JP, Van Regenmortel MH",Antigenic properties and protective capacity of a cyclic peptide corresponding to site A of influenza virus haemagglutinin,"1990","8","4","308-314",Vaccine,"","","","","","","","2396470","","",0,10,0,0,0,,,
1130,50,"Cox et al., 2009",journal,"Cox RJ, Major D, Hauge S, Madhun AS, Brokstad KA, Kuhne M, Smith J, Vogel FR, Zambon M, Haaheim LR, Wood J",A cell-based H7N1 split influenza virion vaccine confers protection in mouse and ferret challenge models,"2009","3","3","107-117",Influenza and other respiratory viruses,"","","","","","","","19453487","","",0,10,0,0,0,,,
1131,50,"Andrew et al., 1986",journal,"Andrew ME, Coupar BE, Ada GL, Boyle DB",Cell-mediated immune responses to influenza virus antigens expressed by vaccinia virus recombinants,"1986","1","5","443-452",Microbial pathogenesis,"","","","","","","","3509883","","",0,10,0,0,0,,,
1132,50,"Rota et al., 1987",journal,"Rota PA, Shaw MW, Kendal AP",Comparison of the immune response to variant influenza type B hemagglutinins expressed in vaccinia virus,"1987","161","2","269-275",Virology,"","","","","","","","3318092","","",0,10,0,0,0,,,
1133,50,"Bright et al., 2008",journal,"Bright RA, Carter DM, Crevar CJ, Toapanta FR, Steckbeck JD, Cole KS, Kumar NM, Pushko P, Smith G, Tumpey TM, Ross TM",Cross-clade protective immune responses to influenza viruses with H5N1 HA and NA elicited by an influenza virus-like particle,"2008","3","1",e1501,PloS one,"","","","","","","","18231588","","",0,10,0,0,0,,,
1134,50,"Eliasson et al., 2008",journal,"Eliasson DG, El Bakkouri K, Schn K, Ramne A, Festjens E, Lwenadler B, Fiers W, Saelens X, Lycke N",CTA1-M2e-DD: a novel mucosal adjuvant targeted influenza vaccine,"2008","26","9","1243-1252",Vaccine,"","","","","","","","18243429","","",0,10,0,0,0,,,
1135,50,"Huber et al., 2006",journal,"Huber VC, McKeon RM, Brackin MN, Miller LA, Keating R, Brown SA, Makarova N, Perez DR, Macdonald GH, McCullers JA",Distinct contributions of vaccine-induced immunoglobulin G1 (IgG1) and IgG2a antibodies to protective immunity against influenza,"2006","13","9","981-990",Clinical and vaccine immunology : CVI,"","","","","","","","16960108","","",0,10,0,0,0,,,
1136,50,"Bot et al., 1996",journal,"Bot A, Bot S, Garcia-Sastre A, Bona C",DNA immunization of newborn mice with a plasmid-expressing nucleoprotein of influenza virus,"1996","9","4","207-210",Viral immunology,"","","","","","","","8978016","","",0,10,0,0,0,,,
1137,50,"Kodihalli et al., 1999",journal,"Kodihalli S, Goto H, Kobasa DL, Krauss S, Kawaoka Y, Webster RG",DNA vaccine encoding hemagglutinin provides protective immunity against H5N1 influenza virus infection in mice,"1999","73","3","2094-2098",Journal of virology,"","","","","","","","9971791","","",0,10,0,0,0,,,
1138,50,"Epstein et al., 2002",journal,"Epstein SL, Tumpey TM, Misplon JA, Lo CY, Cooper LA, Subbarao K, Renshaw M, Sambhara S, Katz JM",DNA vaccine expressing conserved influenza virus proteins protective against H5N1 challenge infection in mice,"2002","8","8","796-801",Emerging infectious diseases,"","","","","","","","12141964","","",0,10,0,0,0,,,
1139,50,"Reichert and Mauler, 1975",journal,"Reichert E, Mauler R",Effect of neuraminidase on potency of inactivated influenza virus vaccines in mice,"1975","28","","319-323",Developments in biological standardization,"","","","","","","","1126575","","",0,10,0,0,0,,,
1140,50,"Song et al., 2008",journal,"Song L, Nakaar V, Kavita U, Price A, Huleatt J, Tang J, Jacobs A, Liu G, Huang Y, Desai P, Maksymiuk G, Takahashi V, Umlauf S, Reiserova L, Bell R, Li H, Zhang Y, McDonald WF, Powell TJ, Tussey L",Efficacious recombinant influenza vaccines produced by high yield bacterial expression: a solution to global pandemic and seasonal needs,"2008","3","5",e2257,PloS one,"","","","","","","","18493310","","",0,10,0,0,0,,,
1141,50,"Jiang et al., 2007",journal,"Jiang Y, Yu K, Zhang H, Zhang P, Li C, Tian G, Li Y, Wang X, Ge J, Bu Z, Chen H",Enhanced protective efficacy of H5 subtype avian influenza DNA vaccine with codon optimized HA gene in a pCAGGS plasmid vector,"2007","75","3","234-241",Antiviral research,"","","","","","","","17451817","","",0,10,0,0,0,,,
1142,50,"Tamura et al., 1989",journal,"Tamura SI, Samegai Y, Kurata H, Kikuta K, Nagamine T, Aizawa C, Kurata T",Enhancement of protective antibody responses by cholera toxin B subunit inoculated intranasally with influenza vaccine,"1989","7","3","257-262",Vaccine,"","","","","","","","2781859","","",0,10,0,0,0,,,
1143,50,"Chen et al., 2001",journal,"Chen Z, Kadowaki S, Hagiwara Y, Yoshikawa T, Sata T, Kurata T, Tamura S",Protection against influenza B virus infection by immunization with DNA vaccines,"2001","19","11-12","1446-1455",Vaccine,"","","","","","","","11163667","","",0,10,0,0,0,,,
1144,50,"Prabakaran et al., 2010",journal,"Prabakaran M, Madhan S, Prabhu N, Qiang J, Kwang J",Gastrointestinal delivery of baculovirus displaying influenza virus hemagglutinin protects mice against heterologous H5N1 infection,"2010","84","7","3201-3209",Journal of virology,"","","","","","","","20071572","","",0,10,0,0,0,,,
1145,50,"Donnelly et al., 1997",journal,"Donnelly JJ, Friedman A, Ulmer JB, Liu MA",Further protection against antigenic drift of influenza virus in a ferret model by DNA vaccination,"1997","15","8","865-868",Vaccine,"","","","","","","","9234535","","",0,10,0,0,0,,,
1146,50,"Kao et al., 2010",journal,"Kao RY, Yang D, Lau LS, Tsui WH, Hu L, Dai J, Chan MP, Chan CM, Wang P, Zheng BJ, Sun J, Huang JD, Madar J, Chen G, Chen H, Guan Y, Yuen KY",Identification of influenza A nucleoprotein as an antiviral target,"2010","28","6","600-605",Nature biotechnology,"","","","","","","","20512121","","",0,10,0,0,0,,,
1147,50,"Chen et al., 2009",journal,"Chen Q, Kuang H, Wang H, Fang F, Yang Z, Zhang Z, Zhang X, Chen Z",Comparing the ability of a series of viral protein-expressing plasmid DNAs to protect against H5N1 influenza virus,"2009","38","1","30-38",Virus genes,"","","","","","","","19067149","","",0,10,0,0,0,,,
1148,50,"Luo et al., 2008",journal,"Luo M, Tao P, Li J, Zhou S, Guo D, Pan Z",Immunization with plasmid DNA encoding influenza A virus nucleoprotein fused to a tissue plasminogen activator signal sequence elicits strong immune responses and protection against H5N1 challenge in mice,"2008","154","1-2","121-127",Journal of virological methods,"","","","","","","","18789973","","",0,10,0,0,0,,,
1149,50,"Lalor et al., 2008",journal,"Lalor PA, Webby RJ, Morrow J, Rusalov D, Kaslow DC, Rolland A, Smith LR",Plasmid DNA-based vaccines protect mice and ferrets against lethal challenge with A/Vietnam/1203/04 (H5N1) influenza virus,"2008","197","12","1643-1652",The Journal of infectious diseases,"","","","","","","","18513153","","",0,10,0,0,0,,,
1150,50,"Ge et al., 2010",journal,"Ge J, Tian G, Zeng X, Jiang Y, Chen H, Bua Z",Generation and evaluation of a Newcastle disease virus-based H9 avian influenza live vaccine,"2010","54","1 Suppl","294-296",Avian diseases,"","","","","","","","20521648","","",0,10,0,0,0,,,
1151,50,"Rao et al., 2010",journal,"Rao SS, Kong WP, Wei CJ, Van Hoeven N, Gorres JP, Nason M, Andersen H, Tumpey TM, Nabel GJ","Comparative efficacy of hemagglutinin, nucleoprotein, and matrix 2 protein gene-based vaccination against H5N1 influenza in mouse and ferret","2010","5","3",e9812,PloS one,"","","","","","","","20352112","","",0,10,0,0,0,,,
1152,50,"Watanabe et al., 2009",journal,"Watanabe S, Watanabe T, Kawaoka Y",Influenza A virus lacking M2 protein as a live attenuated vaccine,"2009","83","11","5947-5950",Journal of virology,"","","","","","","","19321619","","",0,10,0,0,0,,,
1153,50,"Bublot et al., 2010",journal,"Bublot M, Manvell RJ, Shell W, Brown IH",High level of protection induced by two fowlpox vector vaccines against a highly pathogenic avian influenza H5N1 challenge in specific-pathogen-free chickens,"2010","54","1 Suppl","257-261",Avian diseases,"","","","","","","","20521642","","",0,10,0,0,0,,,
1154,50,"Oh et al., 2010",journal,"Oh HL, Akerstrom S, Shen S, Bereczky S, Karlberg H, Klingstrm J, Lal SK, Mirazimi A, Tan YJ",An antibody against a novel and conserved epitope in the HA1 subunit neutralizes numerous H5N1 influenza viruses,"2010","","","",Journal of virology,"","","","","","","","20519402","","",0,10,0,0,0,,,
1155,50,"Pushko et al., 2010",journal,"Pushko P, Kort T, Nathan M, Pearce MB, Smith G, Tumpey TM",Recombinant H1N1 virus-like particle vaccine elicits protective immunity in ferrets against the 2009 pandemic H1N1 influenza virus,"2010","","","",Vaccine,"","","","","","","","20470801","","",0,10,0,0,0,,,
1156,50,"Liljebjelke et al., 2010",journal,"Liljebjelke KA, Petkov DI, Kapczynski DR",Mucosal vaccination with a codon-optimized hemagglutinin gene expressed by attenuated Salmonella elicits a protective immune response in chickens against highly pathogenic avian influenza,"2010","28","27","4430-4437",Vaccine,"","","","","","","","20406663","","",0,10,0,0,0,,,
1157,51,"Li et al., 2009",journal,"Li Y, Ye J, Cao S, Xiao S, Zhao Q, Liu X, Jin M, Chen H",Immunization with pseudotype baculovirus expressing envelope protein of Japanese encephalitis virus elicits protective immunity in mice,"2009","11","1","57-65",The journal of gene medicine,"","","","","","","","19006097","","",0,10,0,0,0,,,
1158,51,"Zhao et al., 2003",journal,"Zhao Z, Wakita T, Yasui K",Inoculation of plasmids encoding Japanese encephalitis virus PrM-E proteins with colloidal gold elicits a protective immune response in BALB/c mice,"2003","77","7","4248-4260",Journal of virology,"","","","","","","","12634382","","",0,10,0,0,0,,,
1159,51,"Xu et al., 2004",journal,"Xu G, Xu X, Li Z, He Q, Wu B, Sun S, Chen H",Construction of recombinant pseudorabies virus expressing NS1 protein of Japanese encephalitis (SA14-14-2) virus and its safety and immunogenicity,"2004","22","15-16","1846-1853",Vaccine,"","","","","","","","15121294","","",0,10,0,0,0,,,
1160,51,"Konishi et al., 2003",journal,"Konishi E, Ajiro N, Nukuzuma C, Mason PW, Kurane I",Comparison of protective efficacies of plasmid DNAs encoding Japanese encephalitis virus proteins that induce neutralizing antibody or cytotoxic T lymphocytes in mice,"2003","21","25-26","3675-3683",Vaccine,"","","","","","","","12922097","","",0,10,0,0,0,,,
1161,51,"Yasuda et al., 1990",journal,"Yasuda A, Kimura-Kuroda J, Ogimoto M, Miyamoto M, Sata T, Sato T, Takamura C, Kurata T, Kojima A, Yasui K",Induction of protective immunity in animals vaccinated with recombinant vaccinia viruses that express PreM and E glycoproteins of Japanese encephalitis virus,"1990","64","6","2788-2795",Journal of virology,"","","","","","","","2159544","","",0,10,0,0,0,,,
1162,17,"Rodriguez-Carreno et al., 2005",journal,"Rodriguez-Carreno MP, Nelson MS, Botten J, Smith-Nixon K, Buchmeier MJ, Whitton JL",Evaluating the immunogenicity and protective efficacy of a DNA vaccine encoding Lassa virus nucleoprotein,"2005","335","1","87-98",Virology,"","","","","","","","15823608","",,0,0,0,0,0,,,
1163,17,"Morrison et al., 1989",journal,"Morrison HG, Bauer SP, Lange JV, Esposito JJ, McCormick JB, Auperin DD",Protection of guinea pigs from Lassa fever by vaccinia virus recombinants expressing the nucleoprotein or the envelope glycoproteins of Lassa virus,"1989","171","1","179-188",Virology,"","","","","","","","2741340","","",0,10,0,0,0,,,
1164,97,"Nagill and Kaur, 2010",journal,"Nagill R, Kaur S",Enhanced efficacy and immunogenicity of 78kDa antigen formulated in various adjuvants against murine visceral leishmaniasis,"2010","28","23","4002-4012",Vaccine,"","","","","","","","20093205","","",0,10,0,0,0,,,
1165,97,"Mizbani et al., 2009",journal,"Mizbani A, Taheri T, Zahedifard F, Taslimi Y, Azizi H, Azadmanesh K, Papadopoulou B, Rafati S",Recombinant Leishmania tarentolae expressing the A2 virulence gene as a novel candidate vaccine against visceral leishmaniasis,"2009","28","1","53-62",Vaccine,"","","","","","","","19818721","","",0,10,0,0,0,,,
1166,97,"Bhowmick and Ali, 2009",journal,"Bhowmick S, Ali N",Identification of novel Leishmania donovani antigens that help define correlates of vaccine-mediated protection in visceral leishmaniasis,"2009","4","6",e5820,PloS one,"","","","","","","","19503834","","",0,10,0,0,0,,,
1167,97,"Bhaumik et al., 2009",journal,"Bhaumik S, Basu R, Sen S, Naskar K, Roy S",KMP-11 DNA immunization significantly protects against L. donovani infection but requires exogenous IL-12 as an adjuvant for comparable protection against L. major,"2009","27","9","1306-1316",Vaccine,"","","","","","","","19162111","","",0,10,0,0,0,,,
1168,97,"Bhowmick et al., 2008",journal,"Bhowmick S, Ravindran R, Ali N",gp63 in stable cationic liposomes confers sustained vaccine immunity to susceptible BALB/c mice infected with Leishmania donovani,"2008","76","3","1003-1015",Infection and immunity,"","","","","","","","18195029","","",0,10,0,0,0,,,
1169,97,"Tewary et al., 2006",journal,"Tewary P, Saxena S, Madhubala R",Co-administration of IL-12 DNA with rORFF antigen confers long-term protective immunity against experimental visceral leishmaniaisis,"2006","24","13","2409-2416",Vaccine,"","","","","","","","16413950","","",0,10,0,0,0,,,
1170,97,"Sukumaran and Madhubala, 2004",journal,"Sukumaran B, Madhubala R",Leishmaniasis: current status of vaccine development,"2004","4","6","667-679",Current molecular medicine,"","","","","","","","15357215","","",0,10,0,0,0,,,
1171,97,"Aguilar-Be et al., 2005",journal,"Aguilar-Be I, da Silva Zardo R, Paraguai de Souza E, Borja-Cabrera GP, Rosado-Vallado M, Mut-Martin M, Garca-Miss Mdel R, Palatnik de Sousa CB, Dumonteil E",Cross-protective efficacy of a prophylactic Leishmania donovani DNA vaccine against visceral and cutaneous murine leishmaniasis,"2005","73","2","812-819",Infection and immunity,"","","","","","","","15664920","","",0,10,0,0,0,,,
1172,97,"Stger et al., 2000",journal,"Stger S, Smith DF, Kaye PM",Immunization with a recombinant stage-regulated surface protein from Leishmania donovani induces protection against visceral leishmaniasis,"2000","165","12","7064-7071","Journal of immunology (Baltimore, Md. : 1950)","","","","","","","","11120835","","",0,10,0,0,0,,,
1173,28,"Jones et al., 2005",journal,"Jones SM, Feldmann H, Strher U, Geisbert JB, Fernando L, Grolla A, Klenk HD, Sullivan NJ, Volchkov VE, Fritz EA, Daddario KM, Hensley LE, Jahrling PB, Geisbert TW",Live attenuated recombinant vaccine protects nonhuman primates against Ebola and Marburg viruses,"2005","11","7","786-790",Nature medicine,"","","","","","","","15937495","","",0,10,0,0,0,,,
1174,69,"Lee et al., 2003",journal,"Lee LE, Witter RL, Reddy SM, Wu P, Yanagida N, Yoshida S",Protection and synergism by recombinant fowl pox vaccines expressing multiple genes from Marek's disease virus,"2003","47","3","549-558",Avian diseases,"","","","","","","","14562881","","",0,10,0,0,0,,,
1175,52,"Pan et al., 2010",journal,"Pan CH, Greer CE, Hauer D, Legg HS, Lee EY, Bergen MJ, Lau B, Adams RJ, Polo JM, Griffin DE",A chimeric alphavirus replicon particle vaccine expressing the hemagglutinin and fusion proteins protects juvenile and infant rhesus macaques from measles,"2010","84","8","3798-3807",Journal of virology,"","","","","","","","20130066","","",0,10,0,0,0,,,
1176,52,"Spreng et al., 2000",journal,"Spreng S, Gentschev I, Goebel W, Weidinger G, ter Meulen V, Niewiesk S",Salmonella vaccines secreting measles virus epitopes induce protective immune responses against measles virus encephalitis,"2000","2","14","1687-1692",Microbes and infection / Institut Pasteur,"","","","","","","","11137042","","",0,10,0,0,0,,,
1177,52,"Brinckmann et al., 1991",journal,"Brinckmann UG, Bankamp B, Reich A, ter Meulen V, Liebert UG",Efficacy of individual measles virus structural proteins in the protection of rats from measles encephalitis,"1991","72 ( Pt 10)","","2491-2500",The Journal of general virology,"","","","","","","","1833505","","",0,10,0,0,0,,,
1178,53,"Liang et al., 2008",journal,"Liang Y, Ma S, Yang Z, Liu L, Wang L, Wang J, Jiang L, Shi C, Dong C, Li Q",Immunogenicity and safety of a novel formalin-inactivated and alum-adjuvanted candidate subunit vaccine for mumps,"2008","26","33","4276-4283",Vaccine,"","","","","","","","18597904","","",0,10,0,0,0,,,
1179,29,"Palma et al., 2010",journal,"Palma C, Vendetti S, Cassone A",Role of 4-1BB receptor in the control played by CD8(+) T cells on IFN-gamma production by Mycobacterium tuberculosis antigen-specific CD4(+) T Cells,"2010","5","6",e11019,PloS one,"","","","","","","","20544034","","",0,10,0,0,0,,,
1180,29,"Hall et al., 2009",journal,"Hall LJ, Clare S, Pickard D, Clark SO, Kelly DL, El Ghany MA, Hale C, Dietrich J, Andersen P, Marsh PD, Dougan G",Characterisation of a live Salmonella vaccine stably expressing the Mycobacterium tuberculosis Ag85B-ESAT6 fusion protein,"2009","27","49","6894-6904",Vaccine,"","","","","","","","19755145","","",0,10,0,0,0,,,
1181,29,"Dou et al., 2010",journal,"Dou J, Tang Q, Yu F, Yang H, Zhao F, Xu W, Wang J, Hu W, Hu K, Liou C, Feng He X, Wang Y",Investigation of immunogenic effect of the BCG priming and Ag85A- GM-CSF boosting in Balb/c mice model,"2010","215","2","133-142",Immunobiology,"","","","","","","","19450898","","",0,10,0,0,0,,,
1182,29,"Wu et al., 2008",journal,"Wu Y, Woodworth JS, Shin DS, Morris S, Behar SM",Vaccine-elicited 10-kilodalton culture filtrate protein-specific CD8+ T cells are sufficient to mediate protection against Mycobacterium tuberculosis infection,"2008","76","5","2249-2255",Infection and immunity,"","","","","","","","18332205","","",0,10,0,0,0,,,
1183,29,"Verreck et al., 2009",journal,"Verreck FA, Vervenne RA, Kondova I, van Kralingen KW, Remarque EJ, Braskamp G, van der Werff NM, Kersbergen A, Ottenhoff TH, Heidt PJ, Gilbert SC, Gicquel B, Hill AV, Martin C, McShane H, Thomas AW","MVA.85A boosting of BCG and an attenuated, phoP deficient M. tuberculosis vaccine both show protective efficacy against tuberculosis in rhesus macaques","2009","4","4",e5264,PloS one,"","","","","","","","19367339","","",0,10,0,0,0,,,
1184,29,"Goldstone et al., 2009",journal,"Goldstone RM, Goonesekera SD, Bloom BR, Sampson SL",The transcriptional regulator Rv0485 modulates the expression of a pe and ppe gene pair and is required for Mycobacterium tuberculosis virulence,"2009","77","10","4654-4667",Infection and immunity,"","","","","","","","19651861","","",0,10,0,0,0,,,
1185,84,"Kumar et al., 2003",journal,"Kumar P, Amara RR, Challu VK, Chadda VK, Satchidanandam V",The Apa protein of Mycobacterium tuberculosis stimulates gamma interferon-secreting CD4+ and CD8+ T cells from purified protein derivative-positive individuals and affords protection in a guinea pig model,"2003","71","4","1929-1937",Infection and immunity,"","","","","","","","12654810","",,0,0,0,0,0,,,
1186,29,"Kumar et al., 2003",journal,"Kumar P, Amara RR, Challu VK, Chadda VK, Satchidanandam V",The Apa protein of Mycobacterium tuberculosis stimulates gamma interferon-secreting CD4+ and CD8+ T cells from purified protein derivative-positive individuals and affords protection in a guinea pig model,"2003","71","4","1929-1937",Infection and immunity,"","","","","","","","12654810","","",0,10,0,0,0,,,
1187,91,"Xiang et al., 2009",journal,"Xiang W, Qiong Z, Li-peng L, Kui T, Jian-wu G, Heng-ping S",The location of invasion-related protein MIC3 of Toxoplasma gondii and protective effect of its DNA vaccine in mice,"2009","166","1-2","1-7",Veterinary parasitology,"","","","","","","","19800170","","",0,10,0,0,0,,,
1188,78,"Yang et al., 2009",journal,"Yang H, Chen J, Yang G, Zhang XH, Liu R, Xue X",Protection of Japanese flounder (Paralichthys olivaceus) against Vibrio anguillarum with a DNA vaccine containing the mutated zinc-metalloprotease gene,"2009","27","15","2150-2155",Vaccine,"","","","","","","","19356619","","",0,10,0,0,0,,,
1189,29,"Mustafa, 2009",journal,Mustafa AS,"Th1 cell reactivity and HLA-DR binding prediction for promiscuous recognition of MPT63 (Rv1926c), a major secreted protein of Mycobacterium tuberculosis","2009","69","3","213-222",Scandinavian journal of immunology,"","","","","","","","19281533","","",0,10,0,0,0,,,
1190,68,"Lieberman et al., 2009",journal,"Lieberman MM, Nerurkar VR, Luo H, Cropp B, Carrion R Jr, de la Garza M, Coller BA, Clements D, Ogata S, Wong T, Martyak T, Weeks-Levy C",Immunogenicity and protective efficacy of a recombinant subunit West Nile virus vaccine in rhesus monkeys,"2009","16","9","1332-1337",Clinical and vaccine immunology : CVI,"","","","","","","","19641099","","",0,10,0,0,0,,,
1191,84,"Saito et al., 1993",journal,"Saito S, Fujisawa A, Ohkawa S, Nishimura N, Abe T, Kodama K, Kamogawa K, Aoyama S, Iritani Y, Hayashi Y",Cloning and DNA sequence of a 29 kilodalton polypeptide gene of Mycoplasma gallisepticum as a possible protective antigen,"1993","11","10","1061-1066",Vaccine,"","","","","","","","8212828","","",0,10,0,0,0,,,
1192,32,"Dupuy et al., 2009",journal,"Dupuy LC, Locher CP, Paidhungat M, Richards MJ, Lind CM, Bakken R, Parker MD, Whalen RG, Schmaljohn CS",Directed molecular evolution improves the immunogenicity and protective efficacy of a Venezuelan equine encephalitis virus DNA vaccine,"2009","27","31","4152-4160",Vaccine,"","","","","","","","19406186","","",0,10,0,0,0,,,
1193,46,"Saukkonen et al., 1989",journal,"Saukkonen K, Leinonen M, Abdillahi H, Poolman JT",Comparative evaluation of potential components for group B meningococcal vaccine by passive protection in the infant rat and in vitro bactericidal assay,"1989","7","4","325-328",Vaccine,"","","","","","","","2510417","","",0,10,0,0,0,,,
1194,46,"Carmenate et al., 2004",journal,"Carmenate T, Canan L, Alvarez A, Delgado M, Gonzlez S, Menndez T, Rods L, Guilln G",Effect of conjugation methodology on the immunogenicity and protective efficacy of meningococcal group C polysaccharide-P64k protein conjugates,"2004","40","3","193-199",FEMS immunology and medical microbiology,"","","","","","","","15039094","","",0,10,0,0,0,,,
1195,46,"Lissolo et al., 1995",journal,"Lissolo L, Maitre-Wilmotte G, Dumas P, Mignon M, Danve B, Quentin-Millet MJ",Evaluation of transferrin-binding protein 2 within the transferrin-binding protein complex as a potential antigen for future meningococcal vaccines,"1995","63","3","884-890",Infection and immunity,"","","","","","","","7868259","","",0,10,0,0,0,,,
1196,89,"Morzaria et al., 2000",journal,"Morzaria S, Nene V, Bishop R, Musoke A",Vaccines against Theileria parva,"2000","916","","464-473",Annals of the New York Academy of Sciences,"","","","","","","","11193661","","",0,10,0,0,0,,,
1197,46,"O'dwyer et al., 2004",journal,"O'dwyer CA, Reddin K, Martin D, Taylor SC, Gorringe AR, Hudson MJ, Brodeur BR, Langford PR, Kroll JS",Expression of heterologous antigens in commensal Neisseria spp.: preservation of conformational epitopes with vaccine potential,"2004","72","11","6511-6518",Infection and immunity,"","","","","","","","15501782","","",0,10,0,0,0,,,
1198,46,"Sun et al., 2005",journal,"Sun Y, Li Y, Exley RM, Winterbotham M, Ison C, Smith H, Tang CM",Identification of novel antigens that protect against systemic meningococcal infection,"2005","23","32","4136-4141",Vaccine,"","","","","","","","15964482","","",0,10,0,0,0,,,
1199,90,"Boulter et al., 1998",journal,"Boulter NR, Brown CG, Kirvar E, Glass E, Campbell J, Morzaria S, Nene V, Musoke A, D'Oliveira C, Gubbels MJ, Jongejan F, Hall FR",Different vaccine strategies used to protect against Theileria annulata,"1998","849","","234-246",Annals of the New York Academy of Sciences,"","","","","","","","9668470","","",0,10,0,0,0,,,
1200,90,"d'Oliveira et al., 1997",journal,"d'Oliveira C, Feenstra A, Vos H, Osterhaus AD, Shiels BR, Cornelissen AW, Jongejan F",Induction of protective immunity to Theileria annulata using two major merozoite surface antigens presented by different delivery systems,"1997","15","16","1796-1804",Vaccine,"","","","","","","","9364686","","",0,10,0,0,0,,,
1201,93,"Debache et al., 2010",journal,"Debache K, Guionaud C, Alaeddine F, Hemphill A",Intraperitoneal and intra-nasal vaccination of mice with three distinct recombinant Neospora caninum antigens results in differential effects with regard to protection against experimental challenge with Neospora caninum tachyzoites,"2010","137","2","229-240",Parasitology,"","","","","","","","19835644","","",0,10,0,0,0,,,
1202,47,"Wang et al., 2010",journal,"Wang S, Li Y, Shi H, Scarpellini G, Torres-Escobar A, Roland KL, Curtiss R 3rd",Immune responses to recombinant pneumococcal PsaA antigen delivered by a live attenuated Salmonella vaccine,"2010","78","7","3258-3271",Infection and immunity,"","","","","","","","20479086","","",0,10,0,0,0,,,
1203,47,"Wu et al., 2010",journal,"Wu K, Zhang X, Shi J, Li N, Li D, Luo M, Cao J, Yin N, Wang H, Xu W, He Y, Yin Y",Immunization with a combination of three pneumococcal proteins confers additive and broad protection against Streptococcus pneumoniae Infections in Mice,"2010","78","3","1276-1283",Infection and immunity,"","","","","","","","20038538","","",0,10,0,0,0,,,
1204,93,"Cannas et al., 2003",journal,"Cannas A, Naguleswaran A, Mller N, Eperon S, Gottstein B, Hemphill A",Vaccination of mice against experimental Neospora caninum infection using NcSAG1- and NcSRS2-based recombinant antigens and DNA vaccines,"2003","126",Pt 4,"303-312",Parasitology,"","","","","","","","12741509","","",0,10,0,0,0,,,
1205,47,"Shivshankar et al., 2009",journal,"Shivshankar P, Sanchez C, Rose LF, Orihuela CJ",The Streptococcus pneumoniae adhesin PsrP binds to Keratin 10 on lung cells,"2009","73","4","663-679",Molecular microbiology,"","","","","","","","19627498","","",0,10,0,0,0,,,
1206,93,"Jenkins et al., 2004",journal,"Jenkins MC, Tuo W, Dubey JP",Evaluation of vaccination with Neospora caninum protein for prevention of fetal loss associated with experimentally induced neosporosis in sheep,"2004","65","10","1404-1408",American journal of veterinary research,"","","","","","","","15524328","","",0,10,0,0,0,,,
1207,93,"Ellis et al., 2008",journal,"Ellis J, Miller C, Quinn H, Ryce C, Reichel MP",Evaluation of recombinant proteins of Neospora caninum as vaccine candidates (in a mouse model),"2008","26","47","5989-5996",Vaccine,"","","","","","","","18789996","","",0,10,0,0,0,,,
1208,47,"Gianfaldoni et al., 2009",journal,"Gianfaldoni C, Maccari S, Pancotto L, Rossi G, Hilleringmann M, Pansegrau W, Sinisi A, Moschioni M, Masignani V, Rappuoli R, Del Giudice G, Ruggiero P",Sortase A confers protection against Streptococcus pneumoniae in mice,"2009","77","7","2957-2961",Infection and immunity,"","","","","","","","19433540","","",0,10,0,0,0,,,
1209,93,"Alaeddine et al., 2005",journal,"Alaeddine F, Keller N, Leepin A, Hemphill A",Reduced infection and protection from clinical signs of cerebral neosporosis in C57BL/6 mice vaccinated with recombinant microneme antigen NcMIC1,"2005","91","3","657-665",The Journal of parasitology,"","","","","","","","16108562","","",0,10,0,0,0,,,
1210,47,"Mizrachi et al., 2007",journal,"Mizrachi Nebenzahl Y, Bernstein A, Portnoi M, Shagan M, Rom S, Porgador A, Dagan R","Streptococcus pneumoniae surface-exposed glutamyl tRNA synthetase, a putative adhesin, is able to induce a partially protective immune response in mice","2007","196","6","945-953",The Journal of infectious diseases,"","","","","","","","17703427","","",0,10,0,0,0,,,
1211,93,"Cho et al., 2005",journal,"Cho JH, Chung WS, Song KJ, Na BK, Kang SW, Song CY, Kim TS",Protective efficacy of vaccination with Neospora caninum multiple recombinant antigens against experimental Neospora caninum infection,"2005","43","1","19-25",The Korean journal of parasitology,"","","","","","","","15793355","","",0,10,0,0,0,,,
1212,47,"Ogunniyi et al., 2007",journal,"Ogunniyi AD, Grabowicz M, Briles DE, Cook J, Paton JC",Development of a vaccine against invasive pneumococcal disease based on combinations of virulence proteins of Streptococcus pneumoniae,"2007","75","1","350-357",Infection and immunity,"","","","","","","","17088353","","",0,10,0,0,0,,,
1213,47,"Daniely et al., 2006",journal,"Daniely D, Portnoi M, Shagan M, Porgador A, Givon-Lavi N, Ling E, Dagan R, Mizrachi Nebenzahl Y","Pneumococcal 6-phosphogluconate-dehydrogenase, a putative adhesin, induces protective immune response in mice","2006","144","2","254-263",Clinical and experimental immunology,"","","","","","","","16634799","","",0,10,0,0,0,,,
1214,47,"Brown et al., 2001",journal,"Brown JS, Ogunniyi AD, Woodrow MC, Holden DW, Paton JC",Immunization with components of two iron uptake ABC transporters protects mice against systemic Streptococcus pneumoniae infection,"2001","69","11","6702-6706",Infection and immunity,"","","","","","","","11598041","","",0,10,0,0,0,,,
1215,70,"Lee et al., 2008",journal,"Lee YJ, Sung HW, Choi JG, Lee EK, Yoon H, Kim JH, Song CS",Protection of chickens from Newcastle disease with a recombinant baculovirus subunit vaccine expressing the fusion and hemagglutininneuraminidase proteins,"2008","9","3","301-308",Journal of veterinary science,"","","","","","","","18716451","","",0,10,0,0,0,,,
1216,30,"Horii et al., 2010",journal,"Horii T, Shirai H, Jie L, Ishii KJ, Palacpac NQ, Tougan T, Hato M, Ohta N, Bobogare A, Arakaki N, Matsumoto Y, Namazue J, Ishikawa T, Ueda S, Takahashi M",Evidences of Protection Against Blood-stage Infection of Plasmodium falciparum by the Novel Protein Vaccine SE36,"2010","","","",Parasitology international,"","","","","","","","20493274","","",0,10,0,0,0,,,
1217,81,"Flock et al., 2006",journal,"Flock M, Karlstrm A, Lannergrd J, Guss B, Flock JI",Protective effect of vaccination with recombinant proteins from Streptococcus equi subspecies equi in a strangles model in the mouse,"2006","24","19","4144-4151",Vaccine,"","","","","","","","16580099","","",0,10,0,0,0,,,
1218,30,"Eslava et al., 2010",journal,"Eslava I, Payares G, Pernia BM, Holder AA, Spencer LM",Suppressive and additive effects in protection mediated by combinations of monoclonal antibodies specific for merozoite surface protein 1 of Plasmodium yoelii,"2010","9","","46",Malaria journal,"","","","","","","","20146804","","",0,10,0,0,0,,,
1219,30,"Daly and Long, 1993",journal,"Daly TM, Long CA",A recombinant 15-kilodalton carboxyl-terminal fragment of Plasmodium yoelii yoelii 17XL merozoite surface protein 1 induces a protective immune response in mice,"1993","61","6","2462-2467",Infection and immunity,"","","","","","","","8363656","","",0,10,0,0,0,,,
1220,81,"Flock et al., 2004",journal,"Flock M, Jacobsson K, Frykberg L, Hirst TR, Franklin A, Guss B, Flock JI",Recombinant Streptococcus equi proteins protect mice in challenge experiments and induce immune response in horses,"2004","72","6","3228-3236",Infection and immunity,"","","","","","","","15155624","","",0,10,0,0,0,,,
1221,81,"Meehan et al., 1998",journal,"Meehan M, Nowlan P, Owen P",Affinity purification and characterization of a fibrinogen-binding protein complex which protects mice against lethal challenge with Streptococcus equi subsp. equi,"1998","144 ( Pt 4)","","993-991003","Microbiology (Reading, England)","","","","","","","","9579073","","",0,10,0,0,0,,,
1222,30,"Kumar et al., 1995",journal,"Kumar S, Yadava A, Keister DB, Tian JH, Ohl M, Perdue-Greenfield KA, Miller LH, Kaslow DC",Immunogenicity and in vivo efficacy of recombinant Plasmodium falciparum merozoite surface protein-1 in Aotus monkeys,"1995","1","3","325-332","Molecular medicine (Cambridge, Mass.)","","","","","","","","8529111","","",0,10,0,0,0,,,
1223,30,"Kaba et al., 2009",journal,"Kaba SA, Brando C, Guo Q, Mittelholzer C, Raman S, Tropel D, Aebi U, Burkhard P, Lanar DE",A nonadjuvanted polypeptide nanoparticle vaccine confers long-lasting protection against rodent malaria,"2009","183","11","7268-7277","Journal of immunology (Baltimore, Md. : 1950)","","","","","","","","19915055","","",0,10,0,0,0,,,
1224,30,"Grner et al., 2007",journal,"Grner AC, Mauduit M, Tewari R, Romero JF, Depinay N, Kayibanda M, Lallemand E, Chavatte JM, Crisanti A, Sinnis P, Mazier D, Corradin G, Snounou G, Rnia L",Sterile protection against malaria is independent of immune responses to the circumsporozoite protein,"2007","2","12",e1371,PloS one,"","","","","","","","18159254","","",0,10,0,0,0,,,
1225,30,"Mauduit et al., 2009",journal,"Mauduit M, Grner AC, Tewari R, Depinay N, Kayibanda M, Chavatte JM, Franetich JF, Crisanti A, Mazier D, Snounou G, Rnia L",A role for immune responses against non-CS components in the cross-species protection induced by immunization with irradiated malaria sporozoites,"2009","4","11",e7717,PloS one,"","","","","","","","19890387","","",0,10,0,0,0,,,
1226,30,"Tsai et al., 2009",journal,"Tsai CW, Duggan PF, Jin AJ, Macdonald NJ, Kotova S, Lebowitz J, Hurt DE, Shimp RL Jr, Lambert L, Miller LH, Long CA, Saul A, Narum DL","Characterization of a protective Escherichia coli-expressed Plasmodium falciparum merozoite surface protein 3 indicates a non-linear, multi-domain structure","2009","164","1","45-56",Molecular and biochemical parasitology,"","","","","","","","19073223","","",0,10,0,0,0,,,
1227,30,"Petritus and Burns, 2008",journal,"Petritus PM, Burns JM Jr","Suppression of lethal Plasmodium yoelii malaria following protective immunization requires antibody-, IL-4-, and IFN-gamma-dependent responses induced by vaccination and/or challenge infection","2008","180","1","444-453","Journal of immunology (Baltimore, Md. : 1950)","","","","","","","","18097046","","",0,10,0,0,0,,,
1228,57,"McNeal et al., 2007",journal,"McNeal MM, Basu M, Bean JA, Clements JD, Lycke NY, Ramne A, Lwenadler B, Choi AH, Ward RL",Intrarectal immunization of mice with VP6 and either LT(R192G) or CTA1-DD as adjuvant protects against fecal rotavirus shedding after EDIM challenge,"2007","25","33","6224-6231",Vaccine,"","","","","","","","17629371","","",0,10,0,0,0,,,
1229,30,"Pal-Bhowmick et al., 2007",journal,"Pal-Bhowmick I, Mehta M, Coppens I, Sharma S, Jarori GK",Protective properties and surface localization of Plasmodium falciparum enolase,"2007","75","11","5500-5508",Infection and immunity,"","","","","","","","17785475","","",0,10,0,0,0,,,
1230,30,"Li et al., 2007",journal,"Li SL, Zhang DM, Cao Y, Pan WQ",[Expression and immunogenicity evaluation of ectodomain and subdomains of Plasmodium berghei apical membrane antigen 1],"2007","25","1","1-5",Zhongguo ji sheng chong xue yu ji sheng chong bing za zhi = Chinese journal of parasitology & parasitic diseases,"","","","","","","","17639690","","",0,10,0,0,0,,,
1231,30,"Wan et al., 2007",journal,"Wan Omar A, Roslaini AM, Ngah ZU, Azahari AA, Zahedi M, Baharudin O",A recombinant 19 kDa Plasmodium berghei merozoite surface protein 1 formulated with alum induces protective immune response in mice,"2007","24","1","119-126",Tropical biomedicine,"","","","","","","","17568385","","",0,10,0,0,0,,,
1232,57,"Herrmann et al., 1999",journal,"Herrmann JE, Chen SC, Jones DH, Tinsley-Bown A, Fynan EF, Greenberg HB, Farrar GH",Immune responses and protection obtained by oral immunization with rotavirus VP4 and VP7 DNA vaccines encapsulated in microparticles,"1999","259","1","148-153",Virology,"","","","","","","","10364499","","",0,10,0,0,0,,,
1233,30,"Dobao and Doolan, 2007",journal,"Dobao C, Doolan DL",Identification of minimal CD8+ and CD4+ T cell epitopes in the Plasmodium yoelii hepatocyte erythrocyte protein 17kDa,"2007","44","11","3037-3048",Molecular immunology,"","","","","","","","17303242","","",0,10,0,0,0,,,
1234,30,"Moll et al., 2007",journal,"Moll K, Pettersson F, Vogt AM, Jonsson C, Rasti N, Ahuja S, Spngberg M, Mercereau-Puijalon O, Arnot DE, Wahlgren M, Chen Q",Generation of cross-protective antibodies against Plasmodium falciparum sequestration by immunization with an erythrocyte membrane protein 1-duffy binding-like 1 alpha domain,"2007","75","1","211-219",Infection and immunity,"","","","","","","","17074852","","",0,10,0,0,0,,,
1235,30,"Valderrama-Aguirre et al., 2005",journal,"Valderrama-Aguirre A, Quintero G, Gmez A, Castellanos A, Prez Y, Mndez F, Arvalo-Herrera M, Herrera S","Antigenicity, immunogenicity, and protective efficacy of Plasmodium vivax MSP1 PV200l: a potential malaria vaccine subunit","2005","73","5 Suppl","16-24",The American journal of tropical medicine and hygiene,"","","","","","","","16291762","","",0,10,0,0,0,,,
1236,56,"Kaur et al., 2010",journal,"Kaur M, Saxena A, Rai A, Bhatnagar R",Rabies DNA vaccine encoding lysosome-targeted glycoprotein supplemented with Emulsigen-D confers complete protection in preexposure and postexposure studies in BALB/c mice,"2010","24","1","173-183",The FASEB journal : official publication of the Federation of American Societies for Experimental Biology,"","","","","","","","19741168","","",0,10,0,0,0,,,
1237,56,"Fujii et al., 1994",journal,"Fujii H, Takita-Sonoda Y, Mifune K, Hirai K, Nishizono A, Mannen K",Protective efficacy in mice of post-exposure vaccination with vaccinia virus recombinant expressing either rabies virus glycoprotein or nucleoprotein,"1994","75 ( Pt 6)","","1339-1344",The Journal of general virology,"","","","","","","","8207400","","",0,10,0,0,0,,,
1238,30,"Mohmmed et al., 2005",journal,"Mohmmed A, Kishore S, Patra KP, Dasaradhi PV, Malhotra P, Chauhan VS",Identification of karyopherin beta as an immunogenic antigen of the malaria parasite using immune mice and human sera,"2005","27","5","197-203",Parasite immunology,"","","","","","","","15987343","","",0,10,0,0,0,,,
1239,108,"Crocquet-Valdes et al., 2001",journal,"Crocquet-Valdes PA, Daz-Montero CM, Feng HM, Li H, Barrett AD, Walker DH",Immunization with a portion of rickettsial outer membrane protein A stimulates protective immunity against spotted fever rickettsiosis,"2001","20","5-6","979-988",Vaccine,"","","","","","","","11738766","","",0,10,0,0,0,,,
1240,108,"Daz-Montero et al., 2001",journal,"Daz-Montero CM, Feng HM, Crocquet-Valdes PA, Walker DH",Identification of protective components of two major outer membrane proteins of spotted fever group Rickettsiae,"2001","65","4","371-378",The American journal of tropical medicine and hygiene,"","","","","","","","11693887","","",0,10,0,0,0,,,
1241,30,"Wang et al., 2004",journal,"Wang L, Goschnick MW, Coppel RL",Oral immunization with a combination of Plasmodium yoelii merozoite surface proteins 1 and 4/5 enhances protection against lethal malaria challenge,"2004","72","10","6172-6175",Infection and immunity,"","","","","","","","15385527","","",0,10,0,0,0,,,
1242,30,"Xu et al., 2000",journal,"Xu H, Hodder AN, Yan H, Crewther PE, Anders RF, Good MF",CD4+ T cells acting independently of antibody contribute to protective immunity to Plasmodium chabaudi infection after apical membrane antigen 1 immunization,"2000","165","1","389-396","Journal of immunology (Baltimore, Md. : 1950)","","","","","","","","10861076","","",0,10,0,0,0,,,
1243,65,"Grabowska et al., 2009",journal,"Grabowska AK, Lipiska AD, Rohde J, Szewczyk B, Bienkowska-Szewczyk K, Rziha HJ",New baculovirus recombinants expressing Pseudorabies virus (PRV) glycoproteins protect mice against lethal challenge infection,"2009","27","27","3584-3591",Vaccine,"","","","","","","","19464538","","",0,10,0,0,0,,,
1244,30,"Bonnefoy et al., 1994",journal,"Bonnefoy S, Gysin J, Blisnick T, Guillotte M, Carcy B, Pereira da Silva L, Mercereau-Puijalon O",Immunogenicity and antigenicity of a Plasmodium falciparum protein fraction (90-110 kDa) able to protect squirrel monkeys against asexual blood stages,"1994","12","1","32-40",Vaccine,"","","","","","","","8303938","","",0,10,0,0,0,,,
1245,30,"Pasquetto et al., 1997",journal,"Pasquetto V, Fidock DA, Gras H, Badell E, Eling W, Ballou WR, Belghiti J, Tartar A, Druilhe P",Plasmodium falciparum sporozoite invasion is inhibited by naturally acquired or experimentally induced polyclonal antibodies to the STARP antigen,"1997","27","10","2502-2513",European journal of immunology,"","","","","","","","9368603","","",0,10,0,0,0,,,
1246,65,"Chang et al., 1998",journal,"Chang SW, Bu J, Rompato G, Garmendia AE",A vector DNA vaccine encoding pseudorabies virus immediate early protein demonstrates partial protection in mice against lethal virus challenge,"1998","11","1","27-36",Viral immunology,"","","","","","","","9586695","","",0,10,0,0,0,,,
1247,64,"Shen et al., 2008",journal,"Shen HG, Zhou JY, Huang ZY, Guo JQ, Xing G, He JL, Yan Y, Gong LY",Protective immunity against porcine circovirus 2 by vaccination with ORF2-based DNA and subunit vaccines in mice,"2008","89",Pt 8,"1857-1865",The Journal of general virology,"","","","","","","","18632956","","",0,10,0,0,0,,,
1248,55,"Mahon et al., 1995",journal,"Mahon BP, Katrak K, Nomoto A, Macadam AJ, Minor PD, Mills KH",Poliovirus-specific CD4+ Th1 clones with both cytotoxic and helper activity mediate protective humoral immunity against a lethal poliovirus infection in transgenic mice expressing the human poliovirus receptor,"1995","181","4","1285-1292",The Journal of experimental medicine,"","","","","","","","7699320","","",0,10,0,0,0,,,
1249,106,"Aberle et al., 1999",journal,"Aberle JH, Aberle SW, Allison SL, Stiasny K, Ecker M, Mandl CW, Berger R, Heinz FX",A DNA immunization model study with constructs expressing the tick-borne encephalitis virus envelope protein E in different physical forms,"1999","163","12","6756-6761","Journal of immunology (Baltimore, Md. : 1950)","","","","","","","","10586074","","",0,10,0,0,0,,,
1250,65,"Han et al., 2008",journal,"Han YW, Aleyas AG, George JA, Kim SJ, Kim HK, Yoon HA, Yoo DJ, Kang SH, Kim K, Eo SK",Polarization of protective immunity induced by replication-incompetent adenovirus expressing glycoproteins of pseudorabies virus,"2008","40","6","583-595",Experimental & molecular medicine,"","","","","","","","19116444","","",0,10,0,0,0,,,
1251,60,"Kimura et al., 1998",journal,"Kimura H, Wang Y, Pesnicak L, Cohen JI, Hooks JJ, Straus SE, Williams RK",Recombinant varicella-zoster virus glycoproteins E and I: immunologic responses and clearance of virus in a guinea pig model of chronic uveitis,"1998","178","2","310-317",The Journal of infectious diseases,"","","","","","","","9697709","","",0,10,0,0,0,,,
1252,65,"Vrublevskaia et al., 2007",journal,"Vrublevskaia VV, Musienko VS, Skarga IuIu, Morenkov OS",[Immunological characteristics of Aujeszky's disease virus glycoprotein],"2007","52","3","33-37",Voprosy virusologii,"","","","","","","","17601050","","",0,10,0,0,0,,,
1253,65,"Katayama et al., 1997",journal,"Katayama S, Okada N, Yoshiki K, Okabe T, Shimizu Y",Protective effect of glycoprotein gC-rich antigen against pseudorabies virus,"1997","59","8","657-663",The Journal of veterinary medical science / the Japanese Society of Veterinary Science,"","","","","","","","9300361","","",0,10,0,0,0,,,
1254,65,"Shiau et al., 2001",journal,"Shiau AL, Chu CY, Su WC, Wu CL",Vaccination with the glycoprotein D gene of pseudorabies virus delivered by nonpathogenic Escherichia coli elicits protective immune responses,"2001","19","23-24","3277-3284",Vaccine,"","","","","","","","11312026","","",0,10,0,0,0,,,
1255,65,"Brockmeier and Mengeling, 1996",journal,"Brockmeier SL, Mengeling WL",Comparison of the protective response induced by NYVAC vaccinia recombinants expressing either gp50 or gII and gp50 of pseudorabies virus,"1996","60","4","315-317",Canadian journal of veterinary research = Revue canadienne de recherche veterinaire,"","","","","","","","8904669","","",0,10,0,0,0,,,
1256,65,"Kimman et al., 1994",journal,"Kimman TG, De Wind N, De Bruin T, de Visser Y, Voermans J",Inactivation of glycoprotein gE and thymidine kinase or the US3-encoded protein kinase synergistically decreases in vivo replication of pseudorabies virus and the induction of protective immunity,"1994","205","2","511-518",Virology,"","","","","","","","7975253","","",0,10,0,0,0,,,
1257,65,"Matsuda et al., 1992",journal,"Matsuda Tsuchida A, Katayama S, Okada N, Okabe T, Sasaki N","Protection from pseudorabies virus challenge in mice by a combination of purified gII, gIII and gVI antigens","1992","54","3","447-452",The Journal of veterinary medical science / the Japanese Society of Veterinary Science,"","","","","","","","1322712","","",0,10,0,0,0,,,
1258,65,"Fuchs et al., 1990",journal,"Fuchs W, Rziha HJ, Lukcs N, Braunschweiger I, Visser N, Ltticken D, Schreurs CS, Thiel HJ, Mettenleiter TC",Pseudorabies virus glycoprotein gI: in vitro and in vivo analysis of immunorelevant epitopes,"1990","71 ( Pt 5)","","1141-1151",The Journal of general virology,"","","","","","","","1693164","","",0,10,0,0,0,,,
1259,59,"Pincus et al., 1992",journal,"Pincus S, Mason PW, Konishi E, Fonseca BA, Shope RE, Rice CM, Paoletti E",Recombinant vaccinia virus producing the prM and E proteins of yellow fever virus protects mice from lethal yellow fever encephalitis,"1992","187","1","290-297",Virology,"","","","","","","","1736531","","",0,10,0,0,0,,,
1260,56,"Takita-Sonoda et al., 1993",journal,"Takita-Sonoda Y, Fujii H, Mifune K, Ito Y, Hiraga M, Nishizono A, Mannen K, Minamoto N",Resistance of mice vaccinated with rabies virus internal structural proteins to lethal infection,"1993","132","1-2","51-65",Archives of virology,"","","","","","","","8352659","","",0,10,0,0,0,,,
1261,59,"Desprs et al., 1991",journal,"Desprs P, Dietrich J, Girard M, Bouloy M",Recombinant baculoviruses expressing yellow fever virus E and NS1 proteins elicit protective immunity in mice,"1991","72 ( Pt 11)","","2811-2816",The Journal of general virology,"","","","","","","","1834798","","",0,10,0,0,0,,,
1262,59,"Schlesinger et al., 1986",journal,"Schlesinger JJ, Brandriss MW, Cropp CB, Monath TP",Protection against yellow fever in monkeys by immunization with yellow fever virus nonstructural protein NS1,"1986","60","3","1153-1155",Journal of virology,"","","","","","","","3783816","","",0,10,0,0,0,,,
1263,95,"Ellison and Witonsky, 2009",journal,"Ellison S, Witonsky S",Evidence that antibodies against recombinant SnSAG1 of Sarcocystis neurona merozoites are involved in infection and immunity in equine protozoal myeloencephalitis,"2009","73","3","176-183",Canadian journal of veterinary research = Revue canadienne de recherche veterinaire,"","","","","","","","19794889","","",0,10,0,0,0,,,
1264,57,"Siadat-Pajouh and Cai, 2001",journal,"Siadat-Pajouh M, Cai L","Protective efficacy of rotavirus 2/6-virus-like particles combined with CT-E29H, a detoxified cholera toxin adjuvant","2001","14","1","31-47",Viral immunology,"","","","","","","","11270595","","",0,10,0,0,0,,,
1265,57,"Offit et al., 1986",journal,"Offit PA, Clark HF, Blavat G, Greenberg HB",Reassortant rotaviruses containing structural proteins vp3 and vp7 from different parents induce antibodies protective against each parental serotype,"1986","60","2","491-496",Journal of virology,"","","","","","","","3021983","","",0,10,0,0,0,,,
1266,57,"Redmond et al., 1993",journal,"Redmond MJ, Ijaz MK, Parker MD, Sabara MI, Dent D, Gibbons E, Babiuk LA",Assembly of recombinant rotavirus proteins into virus-like particles and assessment of vaccine potential,"1993","11","2","273-281",Vaccine,"","","","","","","","8382422","","",0,10,0,0,0,,,
1267,57,"Herrmann et al., 1996",journal,"Herrmann JE, Chen SC, Fynan EF, Santoro JC, Greenberg HB, Robinson HL",DNA vaccines against rotavirus infections,"1996","12","","207-215",Archives of virology. Supplementum,"","","","","","","","9015117","","",0,10,0,0,0,,,
1268,57,"Garaicoechea et al., 2008",journal,"Garaicoechea L, Olichon A, Marcoppido G, Wigdorovitz A, Mozgovoj M, Saif L, Surrey T, Parreo V",Llama-derived single-chain antibody fragments directed to rotavirus VP6 protein possess broad neutralizing activity in vitro and confer protection against diarrhea in mice,"2008","82","19","9753-9764",Journal of virology,"","","","","","","","18632867","","",0,10,0,0,0,,,
1269,48,"Karayiannis et al., 1991",journal,"Karayiannis P, O'Rourke S, McGarvey MJ, Luther S, Waters J, Goldin R, Thomas HC",A recombinant vaccinia virus expressing hepatitis A virus structural polypeptides: characterization and demonstration of protective immunogenicity,"1991","72 ( Pt 9)","","2167-2172",The Journal of general virology,"","","","","","","","1654376","","",0,10,0,0,0,,,
1270,8,"Al-Mariri et al., 2002",journal,"Al-Mariri A, Tibor A, Lestrate P, Mertens P, De Bolle X, Letesson JJ",Yersinia enterocolitica as a vehicle for a naked DNA vaccine encoding Brucella abortus bacterioferritin or P39 antigen,"2002","70","4","1915-1923",Infection and immunity,"","","","","","","","11895955","","",0,10,0,0,0,,,
1271,60,"Wu and Forghani, 1997",journal,"Wu L, Forghani B",Characterization of neutralizing domains on varicella-zoster virus glycoprotein E defined by monoclonal antibodies,"1997","142","2","349-362",Archives of virology,"","","","","","","","9125048","","",0,10,0,0,0,,,
1272,60,"Keller et al., 1986",journal,"Keller PM, Lonergan K, Neff BJ, Morton DA, Ellis RW","Purification of individual varicella-zoster virus (VZV) glycoproteins gpI, gpII, and gpIII and their use in ELISA for detection of VZV glycoprotein-specific antibodies","1986","14","2","177-188",Journal of virological methods,"","","","","","","","3021804","","",0,10,0,0,0,,,
1273,47,"Morsczeck et al., 2008",journal,"Morsczeck C, Prokhorova T, Sigh J, Pfeiffer M, Bille-Nielsen M, Petersen J, Boysen A, Kofoed T, Frimodt-Mller N, Nyborg-Nielsen P, Schrotz-King P",Streptococcus pneumoniae: proteomics of surface proteins for vaccine development,"2008","14","1","74-81",Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases,"","","","","","","","18034862","","",0,10,0,0,0,,,
1274,47,"Ogunniyi et al., 2001",journal,"Ogunniyi AD, Woodrow MC, Poolman JT, Paton JC",Protection against Streptococcus pneumoniae elicited by immunization with pneumolysin and CbpA,"2001","69","10","5997-6003",Infection and immunity,"","","","","","","","11553536","","",0,10,0,0,0,,,
1275,114,"Gmez et al., 2008",journal,"Gmez S, Gamazo C, San Roman B, Ferrer M, Sanz ML, Espuelas S, Irache JM",Allergen immunotherapy with nanoparticles containing lipopolysaccharide from Brucella ovis,"2008","70","3","711-717",European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V,"","","","","","","","18582571","","",0,10,0,0,0,,,
1276,114,"Simoes et al., 2008",journal,"Simoes DC, Vassilakopoulos T, Toumpanakis D, Petrochilou K, Roussos C, Papapetropoulos A",Angiopoietin-1 protects against airway inflammation and hyperreactivity in asthma,"2008","177","12","1314-1321",American journal of respiratory and critical care medicine,"","","","","","","","18356565","","",0,10,0,0,0,,,
1277,114,"Focke et al., 2001",journal,"Focke M, Mahler V, Ball T, Sperr WR, Majlesi Y, Valent P, Kraft D, Valenta R","Nonanaphylactic synthetic peptides derived from B cell epitopes of the major grass pollen allergen, Phl p 1, for allergy vaccination","2001","15","11","2042-2044",The FASEB journal : official publication of the Federation of American Societies for Experimental Biology,"","","","","","","","11511525","","",0,10,0,0,0,,,
1278,114,"Eigenmann et al., 2008",journal,"Eigenmann PA, Asigbetse KE, Frossard CP",Avirulant Salmonella typhimurium strains prevent food allergy in mice,"2008","151","3","546-553",Clinical and experimental immunology,"","","","","","","","18190606","","",0,10,0,0,0,,,
1279,114,"Westritschnig et al., 2007",journal,"Westritschnig K, Linhart B, Focke-Tejkl M, Pavkov T, Keller W, Ball T, Mari A, Hartl A, Stcklinger A, Scheiblhofer S, Thalhamer J, Ferreira F, Vieths S, Vogel L, Bhm A, Valent P, Valenta R","A hypoallergenic vaccine obtained by tail-to-head restructuring of timothy grass pollen profilin, Phl p 12, for the treatment of cross-sensitization to profilin","2007","179","11","7624-7634","Journal of immunology (Baltimore, Md. : 1950)","","","","","","","","18025208","","",0,10,0,0,0,,,
1280,114,"Polte et al., 2006",journal,"Polte T, Foell J, Werner C, Hoymann HG, Braun A, Burdach S, Mittler RS, Hansen G",CD137-mediated immunotherapy for allergic asthma,"2006","116","4","1025-1036",The Journal of clinical investigation,"","","","","","","","16528411","","",0,10,0,0,0,,,
1281,114,"Westritschnig et al., 2004",journal,"Westritschnig K, Focke M, Verdino P, Goessler W, Keller W, Twardosz A, Mari A, Horak F, Wiedermann U, Hartl A, Thalhamer J, Sperr WR, Valent P, Valenta R","Generation of an allergy vaccine by disruption of the three-dimensional structure of the cross-reactive calcium-binding allergen, Phl p 7","2004","172","9","5684-5692","Journal of immunology (Baltimore, Md. : 1950)","","","","","","","","15100313","","",0,10,0,0,0,,,
1282,114,"Keane-Myers et al., 1998",journal,"Keane-Myers AM, Gause WC, Finkelman FD, Xhou XD, Wills-Karp M",Development of murine allergic asthma is dependent upon B7-2 costimulation,"1998","160","2","1036-1043","Journal of immunology (Baltimore, Md. : 1950)","","","","","","","","9551945","","",0,10,0,0,0,,,
1283,114,"Maecker et al., 2001",journal,"Maecker HT, Hansen G, Walter DM, DeKruyff RH, Levy S, Umetsu DT","Vaccination with allergen-IL-18 fusion DNA protects against, and reverses established, airway hyperreactivity in a murine asthma model","2001","166","2","959-965","Journal of immunology (Baltimore, Md. : 1950)","","","","","","","","11145673","","",0,10,0,0,0,,,
1284,114,"Wang et al., 2008",journal,"Wang SY, Yang M, Xu XP, Qiu GF, Ma J, Wang SJ, Huang XX, Xu HX",Intranasal delivery of T-bet modulates the profile of helper T cell immune responses in experimental asthma,"2008","18","5","357-365",Journal of investigational allergology & clinical immunology : official organ of the International Association of Asthmology (INTERASMA) and Sociedad Latinoamericana de Alergia e Inmunologia,"","","","","","","","18973099","","",0,10,0,0,0,,,
1285,114,"Chuang et al., 2006",journal,"Chuang YH, Suen JL, Chiang BL",Fas-ligand-expressing adenovirus-transfected dendritic cells decrease allergen-specific T cells and airway inflammation in a murine model of asthma,"2006","84","7","595-603","Journal of molecular medicine (Berlin, Germany)","","","","","","","","16565865","","",0,10,0,0,0,,,
1286,114,"Liu et al., 2009",journal,"Liu X, Li M, Wu Y, Zhou Y, Zeng L, Huang T",Anti-IL-33 antibody treatment inhibits airway inflammation in a murine model of allergic asthma,"2009","386","1","181-185",Biochemical and biophysical research communications,"","","","","","","","19508862","","",0,10,0,0,0,,,
1287,114,"Nagashima et al., 2008",journal,"Nagashima O, Harada N, Usui Y, Yamazaki T, Yagita H, Okumura K, Takahashi K, Akiba H",B7-H3 contributes to the development of pathogenic Th2 cells in a murine model of asthma,"2008","181","6","4062-4071","Journal of immunology (Baltimore, Md. : 1950)","","","","","","","","18768862","","",0,10,0,0,0,,,
1288,114,"Bilsborough et al., 2008",journal,"Bilsborough J, Chadwick E, Mudri S, Ye X, Henderson WR Jr, Waggie K, Hebb L, Shin J, Rixon M, Gross JA, Dillon SR",TACI-Ig prevents the development of airway hyperresponsiveness in a murine model of asthma,"2008","38","12","1959-1968",Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology,"","","","","","","","19037968","","",0,10,0,0,0,,,
1289,114,"Ballantyne et al., 2007",journal,"Ballantyne SJ, Barlow JL, Jolin HE, Nath P, Williams AS, Chung KF, Sturton G, Wong SH, McKenzie AN",Blocking IL-25 prevents airway hyperresponsiveness in allergic asthma,"2007","120","6","1324-1331",The Journal of allergy and clinical immunology,"","","","","","","","17889290","","",0,10,0,0,0,,,
1290,114,"Edwan and Agrawal, 2007",journal,"Edwan JH, Agrawal DK",Flt3-ligand plasmid prevents the development of pathophysiological features of chronic asthma in a mouse model,"2007","37","2","147-159",Immunologic research,"","","","","","","","17695249","","",0,10,0,0,0,,,
1291,99,"Becker et al., 2010",journal,"Becker JT, Olson BM, Johnson LE, Davies JG, Dunphy EJ, McNeel DG",DNA vaccine encoding prostatic acid phosphatase (PAP) elicits long-term T-cell responses in patients with recurrent prostate cancer,"2010","33","6","639-647","Journal of immunotherapy (Hagerstown, Md. : 1997)","","","","","","","","20551832","","",0,10,0,0,0,,,
1292,99,"Koido et al., 2000",journal,"Koido S, Kashiwaba M, Chen D, Gendler S, Kufe D, Gong J",Induction of antitumor immunity by vaccination of dendritic cells transfected with MUC1 RNA,"2000","165","10","5713-5719","Journal of immunology (Baltimore, Md. : 1950)","","","","","","","","11067929","","",0,10,0,0,0,,,
1293,99,"Watson and Gilliam, 2001",journal,"Watson SA, Gilliam AD",G17DT--a new weapon in the therapeutic armoury for gastrointestinal malignancy,"2001","1","2","309-317",Expert opinion on biological therapy,"","","","","","","","11727538","","",0,10,0,0,0,,,
1294,99,"Bernhardt et al., 2006",journal,"Bernhardt SL, Gjertsen MK, Trachsel S, Mller M, Eriksen JA, Meo M, Buanes T, Gaudernack G",Telomerase peptide vaccination of patients with non-resectable pancreatic cancer: A dose escalating phase I/II study,"2006","95","11","1474-1482",British journal of cancer,"","","","","","","","17060934","","",0,10,0,0,0,,,
1295,99,"Bae et al., 2009",journal,"Bae MY, Cho NH, Seong SY",Protective anti-tumour immune responses by murine dendritic cells pulsed with recombinant Tat-carcinoembryonic antigen derived from Escherichia coli,"2009","157","1","128-138",Clinical and experimental immunology,"","","","","","","","19659778","","",0,10,0,0,0,,,
1296,26,"Zhang et al., 2009",journal,"Zhang H, Hong H, Li D, Ma S, Di Y, Stoten A, Haig N, Di Gleria K, Yu Z, Xu XN, McMichael A, Jiang S",Comparing pooled peptides with intact protein for accessing cross-presentation pathways for protective CD8+ and CD4+ T cells,"2009","284","14","9184-9191",The Journal of biological chemistry,"","","","","","","","19193636","","",0,10,0,0,0,,,
1297,99,"Broder et al., 2000",journal,"Broder H, Anderson A, Odesa SK, Kremen TJ, Liau LM",Recombinant adenovirus-transduced dendritic cell immunization in a murine model of central nervous system tumor,"2000","9","6",e6,Neurosurgical focus,"","","","","","","","16817689","","",0,10,0,0,0,,,
1298,99,"Fontana et al., 2009",journal,"Fontana R, Bregni M, Cipponi A, Raccosta L, Rainelli C, Maggioni D, Lunghi F, Ciceri F, Mukenge S, Doglioni C, Colau D, Coulie PG, Bordignon C, Traversari C, Russo V",Peripheral blood lymphocytes genetically modified to express the self/tumor antigen MAGE-A3 induce antitumor immune responses in cancer patients,"2009","113","8","1651-1660",Blood,"","","","","","","","19074732","","",0,10,0,0,0,,,
1299,99,"Russo et al., 2007",journal,"Russo V, Cipponi A, Raccosta L, Rainelli C, Fontana R, Maggioni D, Lunghi F, Mukenge S, Ciceri F, Bregni M, Bordignon C, Traversari C",Lymphocytes genetically modified to express tumor antigens target DCs in vivo and induce antitumor immunity,"2007","117","10","3087-3096",The Journal of clinical investigation,"","","","","","","","17885685","","",0,10,0,0,0,,,
1300,99,"Hodi, 2010",journal,Hodi FS,Overcoming immunological tolerance to melanoma: Targeting CTLA-4,"2010","6 Suppl 1","",S16-23,Asia-Pacific journal of clinical oncology,"","","","","","","","20482528","","",0,10,0,0,0,,,
1301,26,"Brve et al., 2007",journal,"Brve A, Hinkula J, Cafaro A, Eriksson LE, Srivastava IK, Magnani M, Ensoli B, Barnett SW, Wahren B, Rollman E","Candidate HIV-1 gp140DeltaV2, Gag and Tat vaccines protect against experimental HIV-1/MuLV challenge","2007","25","39-40","6882-6890",Vaccine,"","","","","","","","17707956","","",0,10,0,0,0,,,
1302,99,"Lee et al., 2005",journal,"Lee J, Fassnacht M, Nair S, Boczkowski D, Gilboa E","Tumor immunotherapy targeting fibroblast activation protein, a product expressed in tumor-associated fibroblasts","2005","65","23","11156-11163",Cancer research,"","","","","","","","16322266","","",0,10,0,0,0,,,
1303,99,"Ruan et al., 2009",journal,"Ruan Z, Yang Z, Wang Y, Wang H, Chen Y, Shang X, Yang C, Guo S, Han J, Liang H, Wu Y",DNA vaccine against tumor endothelial marker 8 inhibits tumor angiogenesis and growth,"2009","32","5","486-491","Journal of immunotherapy (Hagerstown, Md. : 1997)","","","","","","","","19609240","","",0,10,0,0,0,,,
1304,99,"Morera et al., 2008",journal,"Morera Y, Bequet-Romero M, Ayala M, Lamdn H, Agger EM, Andersen P, Gavilondo JV",Anti-tumoral effect of active immunotherapy in C57BL/6 mice using a recombinant human VEGF protein as antigen and three chemically unrelated adjuvants,"2008","11","4","381-393",Angiogenesis,"","","","","","","","19034678","","",0,10,0,0,0,,,
1305,99,"Oka et al., 2006",journal,"Oka Y, Tsuboi A, Kawakami M, Elisseeva OA, Nakajima H, Udaka K, Kawase I, Oji Y, Sugiyama H",Development of WT1 peptide cancer vaccine against hematopoietic malignancies and solid cancers,"2006","13","20","2345-2352",Current medicinal chemistry,"","","","","","","","16918359","","",0,10,0,0,0,,,
1306,99,"Choi et al., 2007",journal,"Choi Y, Jeon YH, Kang JH, Chung JK, Schmidt M, Kim AC",MIDGE/hNIS vaccination generates antigen-associated CD8+IFN-gamma+ T cells and enhances protective antitumor immunity,"2007","120","9","1942-1950",International journal of cancer. Journal international du cancer,"","","","","","","","17266027","","",0,10,0,0,0,,,
1307,49,"Zhang et al., 2001",journal,"Zhang Z, Torii N, Hu Z, Jacob J, Liang TJ",X-deficient woodchuck hepatitis virus mutants behave like attenuated viruses and induce protective immunity in vivo,"2001","108","10","1523-1531",The Journal of clinical investigation,"","","","","","","","11714744","","",0,10,0,0,0,,,
1308,99,"Ahmad et al., 2010",journal,"Ahmad S, Casey G, Sweeney P, Tangney M, O'Sullivan GC",Optimised electroporation mediated DNA vaccination for treatment of prostate cancer,"2010","8","1","1",Genetic vaccines and therapy,"","","","","","","","20181099","","",0,10,0,0,0,,,
1309,100,"Heineman et al., 1995",journal,"Heineman TC, Connelly BL, Bourne N, Stanberry LR, Cohen J",Immunization with recombinant varicella-zoster virus expressing herpes simplex virus type 2 glycoprotein D reduces the severity of genital herpes in guinea pigs,"1995","69","12","8109-8113",Journal of virology,"","","","","","","","7494331","","",0,10,0,0,0,,,
1310,50,"Song et al., 2009",journal,"Song L, Zhang Y, Yun NE, Poussard AL, Smith JN, Smith JK, Borisevich V, Linde JJ, Zacks MA, Li H, Kavita U, Reiserova L, Liu X, Dumuren K, Balasubramanian B, Weaver B, Parent J, Umlauf S, Liu G, Huleatt J, Tussey L, Paessler S",Superior efficacy of a recombinant flagellin:H5N1 HA globular head vaccine is determined by the placement of the globular head within flagellin,"2009","27","42","5875-5884",Vaccine,"","","","","","","","19654064","","",0,10,0,0,0,,,
1311,50,"Tite et al., 1990",journal,"Tite JP, Hughes-Jenkins C, O'Callaghan D, Dougan G, Russell SM, Gao XM, Liew FY",Anti-viral immunity induced by recombinant nucleoprotein of influenza A virus. II. Protection from influenza infection and mechanism of protection,"1990","71","2","202-207",Immunology,"","","","","","","","2172156","","",0,10,0,0,0,,,
1312,50,"Roy et al., 2007",journal,"Roy S, Kobinger GP, Lin J, Figueredo J, Calcedo R, Kobasa D, Wilson JM",Partial protection against H5N1 influenza in mice with a single dose of a chimpanzee adenovirus vector expressing nucleoprotein,"2007","25","39-40","6845-6851",Vaccine,"","","","","","","","17728024","","",0,10,0,0,0,,,
1313,99,"Lladser et al., 2010",journal,"Lladser A, Ljungberg K, Tufvesson H, Tazzari M, Roos AK, Quest AF, Kiessling R","Intradermal DNA electroporation induces survivin-specific CTLs, suppresses angiogenesis and confers protection against mouse melanoma","2010","59","1","81-92","Cancer immunology, immunotherapy : CII","","","","","","","","19526360","","",0,10,0,0,0,,,
1314,52,"Drillien et al., 1988",journal,"Drillien R, Spehner D, Kirn A, Giraudon P, Buckland R, Wild F, Lecocq JP",Protection of mice from fatal measles encephalitis by vaccination with vaccinia virus recombinants encoding either the hemagglutinin or the fusion protein,"1988","85","4","1252-1256",Proceedings of the National Academy of Sciences of the United States of America,"","","","","","","","3422488","","",0,10,0,0,0,,,
3890,99,"Yano et al., 2016",journal,"Yano S, Takehara K, Tazawa H, Kishimoto H, Urata Y, Kagawa S, Fujiwara T, Hoffman RM",Efficacy of a Cell-Cycle Decoying Killer Adenovirus on 3-D Gelfoam-Histoculture and Tumor-Sphere Models of Chemo-Resistant Stomach Carcinomatosis Visualized by FUCCI Imaging,"2016","11","9",e0162991,PloS one,,,,,,,,"27673332",,,0,10,0,0,0,,,
1316,99,"Seavey et al., 2009",journal,"Seavey MM, Maciag PC, Al-Rawi N, Sewell D, Paterson Y",An anti-vascular endothelial growth factor receptor 2/fetal liver kinase-1 Listeria monocytogenes anti-angiogenesis cancer vaccine for the treatment of primary and metastatic Her-2/neu+ breast tumors in a mouse model,"2009","182","9","5537-5546","Journal of immunology (Baltimore, Md. : 1950)","","","","","","","","19380802","","",0,10,0,0,0,,,
1317,70,"Wu et al., 2000",journal,"Wu YT, Peng DX, Liu XF, Liu WZ, Zhang RK",[A recombinant fowlpox virus expressing the fusion protein of Newcastle disease virus strain F48E8 and its protective efficacy],"2000","16","5","591-594",Sheng wu gong cheng xue bao = Chinese journal of biotechnology,"","","","","","","","11191764","","",0,10,0,0,0,,,
1318,99,"Tan et al., 2007",journal,"Tan GH, Li YN, Huang FY, Wang H, Bai RZ, Jang J",Combination of recombinant xenogeneic endoglin DNA and protein vaccination enhances anti-tumor effects,"2007","36","4","423-440",Immunological investigations,"","","","","","","","17691024","","",0,10,0,0,0,,,
1319,99,"Narayanan et al., 2004",journal,"Narayanan K, Jaramillo A, Benshoff ND, Campbell LG, Fleming TP, Dietz JR, Mohanakumar T",Response of established human breast tumors to vaccination with mammaglobin-A cDNA,"2004","96","18","1388-1396",Journal of the National Cancer Institute,"","","","","","","","15367572","","",0,10,0,0,0,,,
1320,42,"Coynault et al., 1996",journal,"Coynault C, Robbe-Saule V, Norel F",Virulence and vaccine potential of Salmonella typhimurium mutants deficient in the expression of the RpoS (sigma S) regulon,"1996","22","1","149-160",Molecular microbiology,"","","","","","","","8899717","","",0,10,0,0,0,,,
1321,99,"Maraskovsky et al., 2004",journal,"Maraskovsky E, Sjlander S, Drane DP, Schnurr M, Le TT, Mateo L, Luft T, Masterman KA, Tai TY, Chen Q, Green S, Sjlander A, Pearse MJ, Lemonnier FA, Chen W, Cebon J, Suhrbier A",NY-ESO-1 protein formulated in ISCOMATRIX adjuvant is a potent anticancer vaccine inducing both humoral and CD8+ t-cell-mediated immunity and protection against NY-ESO-1+ tumors,"2004","10","8","2879-2890",Clinical cancer research : an official journal of the American Association for Cancer Research,"","","","","","","","15102697","","",0,10,0,0,0,,,
1322,32,"Hunt and Roehrig, 1995",journal,"Hunt AR, Roehrig JT",Localization of a protective epitope on a Venezuelan equine encephalomyelitis (VEE) virus peptide that protects mice from both epizootic and enzootic VEE virus challenge and is immunogenic in horses,"1995","13","3","281-288",Vaccine,"","","","","","","","7543231","","",0,10,0,0,0,,,
1323,42,"Vorob'ev et al., 2009",journal,"Vorob'ev DS, Semenova IB, Kurbatova EA, Sveshnikov PG, Naroditski BS, Logunov DIu, Vaneeva NP",[Assessment of protective effect of heat shock protein-lypopolysaccharide of Salmonella typhimurium recombinant construction in mice],"2009","","3","38-41","Zhurnal mikrobiologii, epidemiologii, i immunobiologii","","","","","","","","19621817","","",0,10,0,0,0,,,
1324,32,"Agapov et al., 1994",journal,"Agapov EV, Razumov IA, Frolov IV, Kolykhalov AA, Netesov SV, Loktev VB",Localization of four antigenic sites involved in Venezuelan equine encephalomyelitis virus protection,"1994","139","1-2","173-181",Archives of virology,"","","","","","","","7529989","","",0,10,0,0,0,,,
1325,42,"Sagi et al., 2006",journal,"Sagi SS, Paliwal P, Bansal A, Mishra C, Khan N, Mustoori SR, Ilavazhagan G, Sawhney RC, Banerjee PK",Studies on immunogenicity and protective efficacy of DnaJ of Salmonella Typhi against lethal infection by Salmonella Typhimurium in mice,"2006","24","49-50","7135-7141",Vaccine,"","","","","","","","16887241","","",0,10,0,0,0,,,
1326,42,"Cao et al., 1992",journal,"Cao Y, Wen Z, Lu D",Construction of a recombinant oral vaccine against Salmonella typhi and Salmonella typhimurium,"1992","60","7","2823-2827",Infection and immunity,"","","","","","","","1612747","","",0,10,0,0,0,,,
1327,42,"Lee et al., 2007",journal,"Lee HY, Cho SA, Lee IS, Park JH, Seok SH, Baek MW, Kim DJ, Lee SH, Hur SJ, Ban SJ, Lee YK, Han YK, Cho YK, Park JH",Evaluation of phoP and rpoS mutants of Salmonella enterica serovar Typhi as attenuated typhoid vaccine candidates: virulence and protective immune responses in intranasally immunized mice,"2007","51","2","310-318",FEMS immunology and medical microbiology,"","","","","","","","17725620","","",0,10,0,0,0,,,
1328,102,"Xu et al., 2009",journal,"Xu G, Wang S, Zhuang L, Hackett A, Gu L, Zhang L, Zhang C, Wang H, Huang Z, Lu S",Intramuscular delivery of a cholera DNA vaccine primes both systemic and mucosal protective antibody responses against cholera,"2009","27","29","3821-3830",Vaccine,"","","","","","","","19443090","","",0,10,0,0,0,,,
1329,102,"Osek et al., 1994",journal,"Osek J, Jonson G, Svennerholm AM, Holmgren J",Role of antibodies against biotype-specific Vibrio cholerae pili in protection against experimental classical and El Tor cholera,"1994","62","7","2901-2907",Infection and immunity,"","","","","","","","7911787","","",0,10,0,0,0,,,
1330,102,"Kirn and Taylor, 2005",journal,"Kirn TJ, Taylor RK",TcpF is a soluble colonization factor and protective antigen secreted by El Tor and classical O1 and O139 Vibrio cholerae serogroups,"2005","73","8","4461-4470",Infection and immunity,"","","","","","","","16040956","","",0,10,0,0,0,,,
1331,115,"Ahmed et al., 2009",journal,"Ahmed SB, Touihri L, Chtourou Y, Dellagi K, Bahloul C",DNA based vaccination with a cocktail of plasmids encoding immunodominant Leishmania (Leishmania) major antigens confers full protection in BALB/c mice,"2009","27","1","99-9106",Vaccine,"","","","","","","","18951941","","",0,10,0,0,0,,,
1332,115,"Rafati et al., 2006",journal,"Rafati S, Ghaemimanesh F, Zahedifard F","Comparison of potential protection induced by three vaccination strategies (DNA/DNA, Protein/Protein and DNA/Protein) against Leishmania major infection using Signal Peptidase type I in BALB/c mice","2006","24","16","3290-3297",Vaccine,"","","","","","","","16481076","","",0,10,0,0,0,,,
1333,115,"Chenik et al., 2006",journal,"Chenik M, Louzir H, Ksontini H, Dilou A, Abdmouleh I, Dellagi K",Vaccination with the divergent portion of the protein histone H2B of Leishmania protects susceptible BALB/c mice against a virulent challenge with Leishmania major,"2006","24","14","2521-2529",Vaccine,"","","","","","","","16417957","","",0,10,0,0,0,,,
1334,108,"Seong et al., 1997",journal,"Seong SY, Huh MS, Jang WJ, Park SG, Kim JG, Woo SG, Choi MS, Kim IS, Chang WH",Induction of homologous immune response to Rickettsia tsutsugamushi Boryong with a partial 56-kilodalton recombinant antigen fused with the maltose-binding protein MBP-Bor56,"1997","65","4","1541-1545",Infection and immunity,"","","","","","","","9119501","","",0,10,0,0,0,,,
1335,115,"Walker et al., 1998",journal,"Walker PS, Scharton-Kersten T, Rowton ED, Hengge U, Bouloc A, Udey MC, Vogel JC",Genetic immunization with glycoprotein 63 cDNA results in a helper T cell type 1 immune response and protection in a murine model of leishmaniasis,"1998","9","13","1899-1907",Human gene therapy,"","","","","","","","9741428","","",0,10,0,0,0,,,
1336,115,"Handman et al., 1995",journal,"Handman E, Symons FM, Baldwin TM, Curtis JM, Scheerlinck JP",Protective vaccination with promastigote surface antigen 2 from Leishmania major is mediated by a TH1 type of immune response,"1995","63","11","4261-4267",Infection and immunity,"","","","","","","","7591056","","",0,10,0,0,0,,,
1337,115,"Solioz et al., 1999",journal,"Solioz N, Blum-Tirouvanziam U, Jacquet R, Rafati S, Corradin G, Maul J, Fasel N",The protective capacities of histone H1 against experimental murine cutaneous leishmaniasis,"1999","18","9-10","850-859",Vaccine,"","","","","","","","10580198","","",0,10,0,0,0,,,
1338,115,"Rafati et al., 2002",journal,"Rafati S, Kariminia A, Seyde-Eslami S, Narimani M, Taheri T, Lebbatard M",Recombinant cysteine proteinases-based vaccines against Leishmania major in BALB/c mice: the partial protection relies on interferon gamma producing CD8(+) T lymphocyte activation,"2002","20","19-20","2439-2447",Vaccine,"","","","","","","","12057598","","",0,10,0,0,0,,,
1339,116,"Goto et al., 2007",journal,"Goto Y, Bogatzki LY, Bertholet S, Coler RN, Reed SG",Protective immunization against visceral leishmaniasis using Leishmania sterol 24-c-methyltransferase formulated in adjuvant,"2007","25","42","7450-7458",Vaccine,"","","","","","","","17804125","","",0,10,0,0,0,,,
1340,116,"Iborra et al., 2003",journal,"Iborra S, Soto M, Carrin J, Nieto A, Fernndez E, Alonso C, Requena JM",The Leishmania infantum acidic ribosomal protein P0 administered as a DNA vaccine confers protective immunity to Leishmania major infection in BALB/c mice,"2003","71","11","6562-6572",Infection and immunity,"","","","","","","","14573678","","",0,10,0,0,0,,,
1341,116,"Gonzalo et al., 2001",journal,"Gonzalo RM, Rodrguez JR, Rodrguez D, Gonzlez-Aseguinolaza G, Larraga V, Esteban M",Protective immune response against cutaneous leishmaniasis by prime/booster immunization regimens with vaccinia virus recombinants expressing Leishmania infantum p36/LACK and IL-12 in combination with purified p36,"2001","3","9","701-711",Microbes and infection / Institut Pasteur,"","","","","","","","11489418","","",0,10,0,0,0,,,
1342,116,"Moreno et al., 2007",journal,"Moreno J, Nieto J, Masina S, Caavate C, Cruz I, Chicharro C, Carrillo E, Napp S, Reymond C, Kaye PM, Smith DF, Fasel N, Alvar J","Immunization with H1, HASPB1 and MML Leishmania proteins in a vaccine trial against experimental canine leishmaniasis","2007","25","29","5290-5300",Vaccine,"","","","","","","","17576026","","",0,10,0,0,0,,,
1343,62,"Holmes, 2000",journal,Holmes RK,Biology and molecular epidemiology of diphtheria toxin and the tox gene,"2000","181 Suppl 1","",S156-167,The Journal of infectious diseases,"","","","","","","","10657208","","",0,10,0,0,0,,,
1344,117,"Campbell et al., 2003",journal,"Campbell K, Diao H, Ji J, Soong L",DNA immunization with the gene encoding P4 nuclease of Leishmania amazonensis protects mice against cutaneous Leishmaniasis,"2003","71","11","6270-6278",Infection and immunity,"","","","","","","","14573646","","",0,10,0,0,0,,,
1345,118,"Duan et al., 2009",journal,"Duan X, Yonemitsu Y, Chou B, Yoshida K, Tanaka S, Hasegawa M, Tetsutani K, Ishida H, Himeno K, Hisaeda H",Efficient protective immunity against Trypanosoma cruzi infection after nasal vaccination with recombinant Sendai virus vector expressing amastigote surface protein-2,"2009","27","44","6154-6159",Vaccine,"","","","","","","","19712768","","",0,10,0,0,0,,,
1346,117,"Campbell et al., 2004",journal,"Campbell K, Popov V, Soong L",Identification and molecular characterization of a gene encoding a protective Leishmania amazonensis Trp-Asp (WD) protein,"2004","72","4","2194-2202",Infection and immunity,"","","","","","","","15039343","","",0,10,0,0,0,,,
1347,117,"Champsi and McMahon-Pratt, 1988",journal,"Champsi J, McMahon-Pratt D",Membrane glycoprotein M-2 protects against Leishmania amazonensis infection,"1988","56","12","3272-3279",Infection and immunity,"","","","","","","","3182080","","",0,10,0,0,0,,,
1348,117,"Dumonteil et al., 2000",journal,"Dumonteil E, Andrade-Narvarez F, Escobedo-Ortegon J, Ramirez-Sierra MJ, Valencia-Pacheco G, Flores-Serrano A, Canto-Lara S, Arjona-Torres A",Comparative study of DNA vaccines encoding various antigens against Leishmania mexicana,"2000","104","","135-141",Developments in biologicals,"","","","","","","","11713811","","",0,10,0,0,0,,,
1349,118,"Schnapp et al., 2002",journal,"Schnapp AR, Eickhoff CS, Sizemore D, Curtiss R 3rd, Hoft DF",Cruzipain induces both mucosal and systemic protection against Trypanosoma cruzi in mice,"2002","70","9","5065-5074",Infection and immunity,"","","","","","","","12183554","","",0,10,0,0,0,,,
1350,118,"Chou et al., 2008",journal,"Chou B, Hisaeda H, Shen J, Duan X, Imai T, Tu L, Murata S, Tanaka K, Himeno K",Critical contribution of immunoproteasomes in the induction of protective immunity against Trypanosoma cruzi in mice vaccinated with a plasmid encoding a CTL epitope fused to green fluorescence protein,"2008","10","3","241-250",Microbes and infection / Institut Pasteur,"","","","","","","","18321749","","",0,10,0,0,0,,,
1351,117,"Fedeli et al., 2010",journal,"Fedeli CE, Ferreira JH, Mussalem JS, Longo-Maugri IM, Gentil LG, dos Santos MR, Katz S, Barbiri CL",Partial protective responses induced by a recombinant cysteine proteinase from Leishmania (Leishmania) amazonensis in a murine model of cutaneous leishmaniasis,"2010","124","2","153-158",Experimental parasitology,"","","","","","","","19735658","","",0,10,0,0,0,,,
1352,118,"Wizel et al., 1998",journal,"Wizel B, Garg N, Tarleton RL",Vaccination with trypomastigote surface antigen 1-encoding plasmid DNA confers protection against lethal Trypanosoma cruzi infection,"1998","66","11","5073-5081",Infection and immunity,"","","","","","","","9784506","","",0,10,0,0,0,,,
1353,75,"Kurath et al., 2006",journal,"Kurath G, Garver KA, Corbeil S, Elliott DG, Anderson ED, LaPatra SE",Protective immunity and lack of histopathological damage two years after DNA vaccination against infectious hematopoietic necrosis virus in trout,"2006","24","3","345-354",Vaccine,"","","","","","","","16154239","","",0,10,0,0,0,,,
1354,118,"Sepulveda et al., 2000",journal,"Sepulveda P, Hontebeyrie M, Liegeard P, Mascilli A, Norris KA",DNA-Based immunization with Trypanosoma cruzi complement regulatory protein elicits complement lytic antibodies and confers protection against Trypanosoma cruzi infection,"2000","68","9","4986-4991",Infection and immunity,"","","","","","","","10948115","","",0,10,0,0,0,,,
1355,118,"Bhatia and Garg, 2008",journal,"Bhatia V, Garg NJ",Previously unrecognized vaccine candidates control Trypanosoma cruzi infection and immunopathology in mice,"2008","15","8","1158-1164",Clinical and vaccine immunology : CVI,"","","","","","","","18550728","","",0,10,0,0,0,,,
1356,118,"Rassi et al., 2010",journal,"Rassi A Jr, Rassi A, Marin-Neto JA",Chagas disease,"2010","375","9723","1388-1402",Lancet,"","","","","","","","20399979","","",0,10,0,0,0,,,
1357,118,"Luhrs et al., 2003",journal,"Luhrs KA, Fouts DL, Manning JE",Immunization with recombinant paraflagellar rod protein induces protective immunity against Trypanosoma cruzi infection,"2003","21","21-22","3058-3069",Vaccine,"","","","","","","","12798650","","",0,10,0,0,0,,,
1358,120,"Verminnen et al., 2010",journal,"Verminnen K, Beeckman DS, Sanders NN, De Smedt S, Vanrompay DC",Vaccination of turkeys against Chlamydophila psittaci through optimised DNA formulation and administration,"2010","28","18","3095-3105",Vaccine,"","","","","","","","20199760","","",0,10,0,0,0,,,
1359,120,"Harkinezhad et al., 2009",journal,"Harkinezhad T, Schautteet K, Vanrompay D",Protection of budgerigars (Melopsittacus undulatus) against Chlamydophila psittaci challenge by DNA vaccination,"2009","40","6","61",Veterinary research,"","","","","","","","19640395","","",0,10,0,0,0,,,
1360,121,"Harland et al., 2007",journal,"Harland DN, Chu K, Haque A, Nelson M, Walker NJ, Sarkar-Tyson M, Atkins TP, Moore B, Brown KA, Bancroft G, Titball RW, Atkins HS","Identification of a LolC homologue in Burkholderia pseudomallei, a novel protective antigen for melioidosis","2007","75","8","4173-4180",Infection and immunity,"","","","","","","","17517877","","",0,10,0,0,0,,,
1361,121,"Chen et al., 2006",journal,"Chen YS, Hsiao YS, Lin HH, Yen CM, Chen SC, Chen YL",Immunogenicity and anti-Burkholderia pseudomallei activity in Balb/c mice immunized with plasmid DNA encoding flagellin,"2006","24","6","750-758",Vaccine,"","","","","","","","16169637","","",0,10,0,0,0,,,
1362,120,"Zhang et al., 2009",journal,"Zhang X, Yuan Z, Duan Q, Zhu H, Yu H, Wang Q",Mucosal immunity in mice induced by orally administered transgenic rice,"2009","27","10","1596-1600",Vaccine,"","","","","","","","19146896","","",0,10,0,0,0,,,
1363,121,"Nelson et al., 2004",journal,"Nelson M, Prior JL, Lever MS, Jones HE, Atkins TP, Titball RW",Evaluation of lipopolysaccharide and capsular polysaccharide as subunit vaccines against experimental melioidosis,"2004","53",Pt 12,"1177-1182",Journal of medical microbiology,"","","","","","","","15585494","","",0,10,0,0,0,,,
1364,122,"Nagata et al., 2005",journal,"Nagata LP, Hu WG, Masri SA, Rayner GA, Schmaltz FL, Das D, Wu J, Long MC, Chan C, Proll D, Jager S, Jebailey L, Suresh MR, Wong JP",Efficacy of DNA vaccination against western equine encephalitis virus infection,"2005","23","17-18","2280-2283",Vaccine,"","","","","","","","15755611","","",0,10,0,0,0,,,
1365,122,"Das et al., 2007",journal,"Das D, Nagata LP, Suresh MR",Immunological evaluation of Escherichia coli expressed E2 protein of Western equine encephalitis virus,"2007","128","1-2","26-33",Virus research,"","","","","","","","17499379","","",0,10,0,0,0,,,
1366,122,"Gauci et al., 2010",journal,"Gauci PJ, Wu JQ, Rayner GA, Barab ND, Nagata LP, Proll DF",Identification of Western equine encephalitis virus structural proteins that confer protection after DNA vaccination,"2010","17","1","176-179",Clinical and vaccine immunology : CVI,"","","","","","","","19923571","","",0,10,0,0,0,,,
1367,123,"Ehigiator et al., 2007",journal,"Ehigiator HN, Romagnoli P, Priest JW, Secor WE, Mead JR",Induction of murine immune responses by DNA encoding a 23-kDa antigen of Cryptosporidium parvum,"2007","101","4","943-950",Parasitology research,"","","","","","","","17487508","","",0,10,0,0,0,,,
1368,123,"Jenkins et al., 1999",journal,"Jenkins MC, O'Brien C, Trout J, Guidry A, Fayer R",Hyperimmune bovine colostrum specific for recombinant Cryptosporidium parvum antigen confers partial protection against cryptosporidiosis in immunosuppressed adult mice,"1999","17","19","2453-2460",Vaccine,"","","","","","","","10392628","","",0,10,0,0,0,,,
1369,124,"Smallshaw et al., 2002",journal,"Smallshaw JE, Firan A, Fulmer JR, Ruback SL, Ghetie V, Vitetta ES",A novel recombinant vaccine which protects mice against ricin intoxication,"2002","20","27-28","3422-3427",Vaccine,"","","","","","","","12213413","","",0,10,0,0,0,,,
1370,125,"McEachern et al., 2008",journal,"McEachern JA, Bingham J, Crameri G, Green DJ, Hancock TJ, Middleton D, Feng YR, Broder CC, Wang LF, Bossart KN",A recombinant subunit vaccine formulation protects against lethal Nipah virus challenge in cats,"2008","26","31","3842-3852",Vaccine,"","","","","","","","18556094","","",0,10,0,0,0,,,
1371,126,"Delenda et al., 1994",journal,"Delenda C, Frenkiel MP, Deubel V",Protective efficacy in mice of a secreted form of recombinant dengue-2 virus envelope protein produced in baculovirus infected insect cells,"1994","139","1-2","197-207",Archives of virology,"","","","","","","","7826210","","",0,10,0,0,0,,,
1372,127,"Guillaume et al., 2006",journal,"Guillaume V, Contamin H, Loth P, Grosjean I, Courbot MC, Deubel V, Buckland R, Wild TF",Antibody prophylaxis and therapy against Nipah virus infection in hamsters,"2006","80","4","1972-1978",Journal of virology,"","","","","","","","16439553","","",0,10,0,0,0,,,
1373,126,"Liu et al., 2006",journal,"Liu WT, Lin WT, Tsai CC, Chuang CC, Liao CL, Lin HC, Hung YW, Huang SS, Liang CC, Hsu HL, Wang HJ, Liu YT",Enhanced immune response by amphotericin B following NS1 protein prime-oral recombinant Salmonella vaccine boost vaccination protects mice from dengue virus challenge,"2006","24","31-32","5852-5861",Vaccine,"","","","","","","","16759760","","",0,10,0,0,0,,,
1374,126,"Wu et al., 2003",journal,"Wu SF, Liao CL, Lin YL, Yeh CT, Chen LK, Huang YF, Chou HY, Huang JL, Shaio MF, Sytwu HK",Evaluation of protective efficacy and immune mechanisms of using a non-structural protein NS1 in DNA vaccine against dengue 2 virus in mice,"2003","21","25-26","3919-3929",Vaccine,"","","","","","","","12922127","","",0,10,0,0,0,,,
1375,127,"Guillaume et al., 2004",journal,"Guillaume V, Contamin H, Loth P, Georges-Courbot MC, Lefeuvre A, Marianneau P, Chua KB, Lam SK, Buckland R, Deubel V, Wild TF",Nipah virus: vaccination and passive protection studies in a hamster model,"2004","78","2","834-840",Journal of virology,"","","","","","","","14694115","","",0,10,0,0,0,,,
1376,126,"Bray and Lai, 1991",journal,"Bray M, Lai CJ",Dengue virus premembrane and membrane proteins elicit a protective immune response,"1991","185","1","505-508",Virology,"","","","","","","","1926792","","",0,10,0,0,0,,,
1377,108,"Carl et al., 1990",journal,"Carl M, Dobson ME, Ching WM, Dasch GA",Characterization of the gene encoding the protective paracrystalline-surface-layer protein of Rickettsia prowazekii: presence of a truncated identical homolog in Rickettsia typhi,"1990","87","21","8237-8241",Proceedings of the National Academy of Sciences of the United States of America,"","","","","","","","2122457","","",0,10,0,0,0,,,
1378,128,"Wallace et al., 2006",journal,"Wallace DB, Ellis CE, Espach A, Smith SJ, Greyling RR, Viljoen GJ",Protective immune responses induced by different recombinant vaccine regimes to Rift Valley fever,"2006","24","49-50","7181-7189",Vaccine,"","","","","","","","16870311","","",0,10,0,0,0,,,
1379,128,"Lagerqvist et al., 2009",journal,"Lagerqvist N, Nslund J, Lundkvist A, Bouloy M, Ahlm C, Bucht G",Characterisation of immune responses and protective efficacy in mice after immunisation with Rift Valley Fever virus cDNA constructs,"2009","6","","6",Virology journal,"","","","","","","","19149901","","",0,10,0,0,0,,,
1380,129,"Du et al., 2008",journal,"Du L, Zhao G, Lin Y, Chan C, He Y, Jiang S, Wu C, Jin DY, Yuen KY, Zhou Y, Zheng BJ",Priming with rAAV encoding RBD of SARS-CoV S protein and boosting with RBD-specific peptides for T cell epitopes elevated humoral and cellular immune responses against SARS-CoV infection,"2008","26","13","1644-1651",Vaccine,"","","","","","","","18289745","","",0,10,0,0,0,,,
1381,130,"Schmidt et al., 1999",journal,"Schmidt A, Schaffelhofer S, Mller K, Rllinghoff M, Beuscher HU",Analysis of the Yersinia enterocolitica 0:8 V antigen for cross protectivity,"1999","26","4","221-233",Microbial pathogenesis,"","","","","","","","10089162","","",0,10,0,0,0,,,
1382,131,"Carrero et al., 2010",journal,"Carrero JC, Contreras-Rojas A, Snchez-Hernndez B, Petrosyan P, Bobes RJ, Ortiz-Ortiz L, Laclette JP",Protection against murine intestinal amoebiasis induced by oral immunization with the 29kDa antigen of Entamoeba histolytica and cholera toxin,"2010","","","",Experimental parasitology,"","","","","","","","20303954","","",0,10,0,0,0,,,
1383,131,"Houpt et al., 2004",journal,"Houpt E, Barroso L, Lockhart L, Wright R, Cramer C, Lyerly D, Petri WA",Prevention of intestinal amebiasis by vaccination with the Entamoeba histolytica Gal/GalNac lectin,"2004","22","5-6","611-617",Vaccine,"","","","","","","","14741152","","",0,10,0,0,0,,,
1384,131,"Zhang and Stanley, 1996",journal,"Zhang T, Stanley SL Jr",Oral immunization with an attenuated vaccine strain of Salmonella typhimurium expressing the serine-rich Entamoeba histolytica protein induces an antiamebic immune response and protects gerbils from amebic liver abscess,"1996","64","5","1526-1531",Infection and immunity,"","","","","","","","8613356","","",0,10,0,0,0,,,
1385,132,"Tarcha et al., 2006a",journal,"Tarcha EJ, Basrur V, Hung CY, Gardner MJ, Cole GT",A recombinant aspartyl protease of Coccidioides posadasii induces protection against pulmonary coccidioidomycosis in mice,"2006","74","1","516-527",Infection and immunity,"","","","","","","","16369008","","",0,10,0,0,0,,,
1386,131,"Petri and Ravdin, 1991",journal,"Petri WA Jr, Ravdin JI",Protection of gerbils from amebic liver abscess by immunization with the galactose-specific adherence lectin of Entamoeba histolytica,"1991","59","1","97-9101",Infection and immunity,"","","","","","","","1987067","","",0,10,0,0,0,,,
1387,132,"Tarcha et al., 2006b",journal,"Tarcha EJ, Basrur V, Hung CY, Gardner MJ, Cole GT",Multivalent recombinant protein vaccine against coccidioidomycosis,"2006","74","10","5802-5813",Infection and immunity,"","","","","","","","16988258","","",0,10,0,0,0,,,
1388,132,"Ivey et al., 2003",journal,"Ivey FD, Magee DM, Woitaske MD, Johnston SA, Cox RA",Identification of a protective antigen of Coccidioides immitis by expression library immunization,"2003","21","27-30","4359-4367",Vaccine,"","","","","","","","14505918","","",0,10,0,0,0,,,
1389,132,"Delgado et al., 2003",journal,"Delgado N, Xue J, Yu JJ, Hung CY, Cole GT","A recombinant beta-1,3-glucanosyltransferase homolog of Coccidioides posadasii protects mice against coccidioidomycosis","2003","71","6","3010-3019",Infection and immunity,"","","","","","","","12761077","","",0,10,0,0,0,,,
1390,132,"Li et al., 2001",journal,"Li K, Yu JJ, Hung CY, Lehmann PF, Cole GT",Recombinant urease and urease DNA of Coccidioides immitis elicit an immunoprotective response against coccidioidomycosis in mice,"2001","69","5","2878-2887",Infection and immunity,"","","","","","","","11292702","","",0,10,0,0,0,,,
1391,132,"Orsborn et al., 2006",journal,"Orsborn KI, Shubitz LF, Peng T, Kellner EM, Orbach MJ, Haynes PA, Galgiani JN",Protein expression profiling of Coccidioides posadasii by two-dimensional differential in-gel electrophoresis and evaluation of a newly recognized peroxisomal matrix protein as a recombinant vaccine candidate,"2006","74","3","1865-1872",Infection and immunity,"","","","","","","","16495561","","",0,10,0,0,0,,,
1392,132,"Awasthi et al., 2005",journal,"Awasthi S, Awasthi V, Magee DM, Coalson JJ",Efficacy of antigen 2/proline-rich antigen cDNA-transfected dendritic cells in immunization of mice against Coccidioides posadasii,"2005","175","6","3900-3906","Journal of immunology (Baltimore, Md. : 1950)","","","","","","","","16148136","","",0,10,0,0,0,,,
1393,133,"Rasooly and Balaban, 2004",journal,"Rasooly R, Balaban N",Trypanosome microtubule-associated protein p15 as a vaccine for the prevention of African sleeping sickness,"2004","22","8","1007-1015",Vaccine,"","","","","","","","15161078","","",0,10,0,0,0,,,
1394,134,"Xu et al., 2007",journal,"Xu C, Li ZS, Du YQ, Gong YF, Yang H, Sun B, Jin J",Construction of recombinant attenuated Salmonella typhimurium DNA vaccine expressing H pylori ureB and IL-2,"2007","13","6","939-944",World journal of gastroenterology : WJG,"","","","","","","","17352028","",,0,0,0,0,0,,,
1395,134,"Smythies et al., 2005",journal,"Smythies LE, Novak MJ, Waites KB, Lindsey JR, Morrow CD, Smith PD",Poliovirus replicons encoding the B subunit of Helicobacter pylori urease protect mice against H. pylori infection,"2005","23","7","901-909",Vaccine,"","","","","","","","15603891","","",0,10,0,0,0,,,
1396,134,"Huang et al., 2005",journal,"Huang W, Bai Y, Wang JD, Wu JB, Li GF, Zhang WM, Zhou DY",[Preparation oral liposome-encapsulated recombinant Helicobacter pylori heat shock protein 60 vaccine for prevention of Hp infection],"2005","25","5","531-534",Di 1 jun yi da xue xue bao = Academic journal of the first medical college of PLA,"","","","","","","","15897126","","",0,10,0,0,0,,,
1397,134,"Satin et al., 2000",journal,"Satin B, Del Giudice G, Della Bianca V, Dusi S, Laudanna C, Tonello F, Kelleher D, Rappuoli R, Montecucco C, Rossi F",The neutrophil-activating protein (HP-NAP) of Helicobacter pylori is a protective antigen and a major virulence factor,"2000","191","9","1467-1476",The Journal of experimental medicine,"","","","","","","","10790422","","",0,10,0,0,0,,,
1398,133,"Silva et al., 2009",journal,"Silva MS, Prazeres DM, Lana A, Atouguia J, Monteiro GA",Trans-sialidase from Trypanosoma brucei as a potential target for DNA vaccine development against African trypanosomiasis,"2009","105","5","1223-1229",Parasitology research,"","","","","","","","19582478","","",0,10,0,0,0,,,
1399,134,"Radcliff et al., 1997",journal,"Radcliff FJ, Hazell SL, Kolesnikow T, Doidge C, Lee A","Catalase, a novel antigen for Helicobacter pylori vaccination","1997","65","11","4668-4674",Infection and immunity,"","","","","","","","9353048","","",0,10,0,0,0,,,
1400,91,"Echeverria et al., 2006",journal,"Echeverria PC, de Miguel N, Costas M, Angel SO",Potent antigen-specific immunity to Toxoplasma gondii in adjuvant-free vaccination system using Rop2-Leishmania infantum Hsp83 fusion protein,"2006","24","19","4102-4110",Vaccine,"","","","","","","","16545504","","",0,10,0,0,0,,,
1401,134,"Manetti et al., 1997",journal,"Manetti R, Massari P, Marchetti M, Magagnoli C, Nuti S, Lupetti P, Ghiara P, Rappuoli R, Telford JL",Detoxification of the Helicobacter pylori cytotoxin,"1997","65","11","4615-4619",Infection and immunity,"","","","","","","","9353041","","",0,10,0,0,0,,,
1402,89,"Musoke et al., 1992",journal,"Musoke A, Morzaria S, Nkonge C, Jones E, Nene V",A recombinant sporozoite surface antigen of Theileria parva induces protection in cattle,"1992","89","2","514-518",Proceedings of the National Academy of Sciences of the United States of America,"","","","","","","","1731322","","",0,10,0,0,0,,,
1403,99,"McNeel et al., 2009",journal,"McNeel DG, Dunphy EJ, Davies JG, Frye TP, Johnson LE, Staab MJ, Horvath DL, Straus J, Alberti D, Marnocha R, Liu G, Eickhoff JC, Wilding G",Safety and immunological efficacy of a DNA vaccine encoding prostatic acid phosphatase in patients with stage D0 prostate cancer,"2009","27","25","4047-4054",Journal of clinical oncology : official journal of the American Society of Clinical Oncology,"","","","","","","","19636017","","",0,10,0,0,0,,,
1404,29,"Palma et al., 2007",journal,"Palma C, Iona E, Giannoni F, Pardini M, Brunori L, Orefici G, Fattorini L, Cassone A",The Ag85B protein of Mycobacterium tuberculosis may turn a protective immune response induced by Ag85B-DNA vaccine into a potent but non-protective Th1 immune response in mice,"2007","9","6","1455-1465",Cellular microbiology,"","","","","","","","17250590","","",0,10,0,0,0,,,
1405,75,"Corbeil et al., 2000",journal,"Corbeil S, LaPatra SE, Anderson ED, Kurath G",Nanogram quantities of a DNA vaccine protect rainbow trout fry against heterologous strains of infectious hematopoietic necrosis virus,"2000","18","25","2817-2824",Vaccine,"","","","","","","","10812224","","",0,10,0,0,0,,,
1406,116,Wiki:  Leishmania infantum,website,"",Leishmania infantum,"","","","","","","","","","","","","",http://en.wikipedia.org/wiki/Leishmania_infantum,"",0,10,0,0,0,,,
1407,129,Wiki: SARS,website,"",Wiki: Sever Acute Respiratory Syndrome,"","","","","","","","","","","","","",http://en.wikipedia.org/wiki/Severe_acute_respiratory_syndrome,"",0,10,0,0,0,,,
1408,120,Wiki:  Chlamydophila psittaci,website,"",Chlamydophila psittaci,"","","","","","","","","","","","","",http://en.wikipedia.org/wiki/Chlamydophila_psittaci,"",0,10,0,0,0,,,
1409,109,Wiki: Bordetella pertussis,website,"",Bordetella pertussis,"","","","","","","","","","","","","",http://en.wikipedia.org/wiki/Bordetella_pertussis,"",0,10,0,0,0,,,
1410,101,Wiki:  Bovine leukemia virus,website,"",Bovine leukemia virus,"","","","","","","","","","","","","",http://en.wikipedia.org/wiki/Bovine_leukemia_virus,"",0,10,0,0,0,,,
1411,134,Wiki:  Helicobacter pylori,website,"",Helicobacter pylori,"","","","","","","","","","","","","",http://en.wikipedia.org/wiki/Helicobacter_pylori,"",0,10,0,0,0,,,
1412,122,Wiki:  Western equine encephalomyelitis virus,website,"",Western equine encephalomyelitis virus,"","","","","","","","","","","","","",http://en.wikipedia.org/wiki/Western_equine_encephalitis_virus,"",0,10,0,0,0,,,
1413,123,Wiki:  Cryptosporidium parvum,website,"",Cryptosporidium parvum,"","","","","","","","","","","","","",http://en.wikipedia.org/wiki/Cryptosporidium_parvum,"",0,10,0,0,0,,,
1414,125,CDC:  Hendra virus,website,"",Hendra Virus Disease and Nipah Virus Encephalitis,"","","","","","","","","","","","","",http://www.cdc.gov/ncidod/dvrd/spb/mnpages/dispages/nipah.htm,"",0,10,0,0,0,,,
1415,127,Wiki:  Nipah virus,website,"",Henipavirus,"","","","","","","","","","","","","",http://en.wikipedia.org/wiki/Henipavirus,"",0,10,0,0,0,,,
1416,128,Wiki:  Rift Valley Fever virus,website,"",Rift Valley Fever,"","","","","","","","","","","","","",http://en.wikipedia.org/wiki/Rift_valley_fever_virus,"",0,10,0,0,0,,,
1417,130,Wiki:  Yersinia enterocolitica,website,"",Yersinia enterocolitica,"","","","","","","","","","","","","",http://en.wikipedia.org/wiki/Yersinia_enterocolitica,"",0,10,0,0,0,,,
1418,131,Wiki:  Entamoeba histolytica,website,"",Entamoeba histolytica,"","","","","","","","","","","","","",http://en.wikipedia.org/wiki/Entamoeba_histolytica,"",0,10,0,0,0,,,
1419,86,ThePigSite Pig Health,website,"",Actinobacillus Pleuropneumonia (App),"","","","","","","","","","","","","",http://www.thepigsite.com/pighealth/article/309/actinobacillus-pleuropneumonia-app,"",0,10,0,0,0,,,
1420,79,Wiki:  Aeromonas salmonicida,website,"",Aeromonas salmonicida,"","","","","","","","","","","","","",http://en.wikipedia.org/wiki/Aeromonas_salmonicida,"",0,10,0,0,0,,,
1421,92,Wiki:  Babesia bovis,website,"",Babesia bovis,"","","","","","","","","","","","",Wiki:  Babesia bovis,http://en.wikipedia.org/wiki/Babesia_bovis,"",0,10,0,0,0,,,
1422,67,Wiki:  Bovine herpesvirus 1,website,"",Bovine herpesvirus 1,"","","","","","","","","","","","","",http://en.wikipedia.org/wiki/Bovine_herpesvirus_1,"",0,10,0,0,0,,,
1423,73,Wiki:  Canine coronavirus,website,"",Canine coronavirus,"","","","","","","","","","","","","",http://en.wikipedia.org/wiki/Canine_coronavirus,"",0,10,0,0,0,,,
1424,74,Wiki:  Canine distemper virus,website,"",Canine distemper virus,"","","","","","","","","","","","","",http://en.wikipedia.org/wiki/Canine_distemper_virus,"",0,10,0,0,0,,,
1425,72,Wiki:  Canine parvovirus,website,"",Canine parvovirus,"","","","","","","","","","","","","",http://en.wikipedia.org/wiki/Canine_parvovirus,"",0,10,0,0,0,,,
1426,113,Wiki:  Chlamydia muridarum,website,"",Chlamydia muridarum,"","","","","","","","","","","","","",http://en.wikipedia.org/wiki/Chlamydia_muridarum,"",0,10,0,0,0,,,
1427,82,Wiki:  Chlamydophila abortus,website,"",Chlamydophila abortus,"","","","","","","","","","","","","",http://en.wikipedia.org/wiki/Chlamydophila_abortus,"",0,10,0,0,0,,,
1428,112,Wiki:  Chlamydophila pneumoniae,website,"",Chlamydophila pneumoniae,"","","","","","","","","","","","","",http://en.wikipedia.org/wiki/Chlamydophila_pneumoniae,"",0,10,0,0,0,,,
1429,66,Wiki:  Classical swine fever,website,"",Classical swine fever,"","","","","","","","","","","","","",http://en.wikipedia.org/wiki/Classical_swine_fever_virus,"",0,10,0,0,0,,,
1430,98,"Smith et al., 2002",journal,"Smith AL, Hesketh P, Archer A, Shirley MW",Antigenic diversity in Eimeria maxima and the influence of host genetics and immunization schedule on cross-protective immunity,"2002","70","5","2472-2479",Infection and immunity,"","","","","","","","11953384","","",0,10,0,0,0,,,
1431,88,Wiki:  Eimeria tenella,website,"",Eimeria tenella,"","","","","","","","","","","","","",http://en.wikipedia.org/wiki/Eimeria_tenella,"",0,10,0,0,0,,,
1432,71,Wiki:  Feline leukemia virus,website,"",Feline leukemia virus,"","","","","","","","","","","","","",http://en.wikipedia.org/wiki/Feline_leukemia_virus,"",0,10,0,0,0,,,
1433,94,Wiki:  Giardia lamblia,website,"",Giardia lamblia,"","","","","","","","","","","","","",http://en.wikipedia.org/wiki/Giardia_duodenalis,"",0,10,0,0,0,,,
1434,100,Wiki:  Herpes simplex virus,website,"",Herpes simplex virus,"","","","","","","","","","","","","",http://en.wikipedia.org/wiki/Herpes_simplex_virus,"",0,10,0,0,0,,,
1435,75,Wiki:  Infectious Hematopoietic Necrosis Virus,website,"",Infectious Hematopoietic Necrosis Virus,"","","","","","","","","","","","","",http://en.wikipedia.org/wiki/Infectious_hematopoietic_necrosis_virus,"",0,10,0,0,0,,,
1436,78,"Tobback et al., 2007",journal,"Tobback E, Decostere A, Hermans K, Haesebrouck F, Chiers K",Yersinia ruckeri infections in salmonid fish,"2007","30","5","257-268",Journal of fish diseases,"","","","","","","","17501736","","",0,10,0,0,0,,,
1437,76,MicrobeWiki:  Lawsonia intracellularis,website,"",Lawsonia intracellularis,"","","","","","","","","","","","","",http://microbewiki.kenyon.edu/index.php/Lawsonia_intracellularis,"",0,10,0,0,0,,,
1438,97,WD:  Leishmania donovani,website,"",Leishmania donovani,"","","","","","","","","","","","","",http://www.wrongdiagnosis.com/medical/leishmania_donovani.htm,"",0,10,0,0,0,,,
1439,69,"Hughes and Rivailler, 2007",journal,"Hughes AL, Rivailler P",Phylogeny and recombination history of gallid herpesvirus 2 (Marek's disease virus) genomes,"2007","130","1-2","28-33",Virus research,"","","","","","","","17566585","","",0,10,0,0,0,,,
1440,68,Wiki: West Nile,website,"",Wiki: West Nile virus,"","","","","","","","","","","","","",http://en.wikipedia.org/wiki/West_Nile_virus,"",0,10,0,0,0,,,
1441,84,Wiki:  Mycoplasma gallisepticum,website,"",Mycoplasma gallisepticum,"","","","","","","","","","","","","",http://en.wikipedia.org/wiki/Mycoplasma_gallisepticum,"",0,10,0,0,0,,,
1442,83,MicrobeWiki:  Mycoplasma synoviae,website,"",Mycoplasma synoviae,"","","","","","","","","","","","","",http://microbewiki.kenyon.edu/index.php/Mycoplasma_synoviae,,0,0,0,0,0,,,
1443,93,Wiki:  Neospora caninum,website,"",Neospora caninum,"","","","","","","","","","","","","",http://en.wikipedia.org/wiki/Neospora_caninum,"",0,10,0,0,0,,,
1444,70,Wiki:  Newcastle disease,website,"",Newcastle disease,"","","","","","","","","","","","","",http://en.wikipedia.org/wiki/Newcastle_disease_virus,"",0,10,0,0,0,,,
1445,64,Wiki:  Porcine circovirus,website,"",Porcine circovirus,"","","","","","","","","","","","","",http://en.wikipedia.org/wiki/Porcine_circovirus,"",0,10,0,0,0,,,
1446,65,Wiki:  Pseudorabies,website,"",Pseudorabies,"","","","","","","","","","","","","",http://en.wikipedia.org/wiki/Pseudorabies,"",0,10,0,0,0,,,
1447,108,Wiki:  Rickettsia,website,"",Rickettsia,"","","","","","","","","","","","","",http://en.wikipedia.org/wiki/Rickettsia,"",0,10,0,0,0,,,
1448,95,USDA Agricultural Research Service:  Sarcocystis neurona,website,"",EPM/Sarcocystis neuorna,"","","","","","","","","","","","","",http://www.ars.usda.gov/Main/docs.htm?docid=11028,"",0,10,0,0,0,,,
1449,81,Wiki:  Strangles,website,"",Strangles,"","","","","","","","","","","","","",http://en.wikipedia.org/wiki/Streptococcus_equi,"",0,10,0,0,0,,,
1450,132,"Kirkland et al., 1998",journal,"Kirkland TN, Thomas PW, Finley F, Cole GT",Immunogenicity of a 48-kilodalton recombinant T-cell-reactive protein of Coccidioides immitis,"1998","66","2","424-431",Infection and immunity,"","","","","","","","9453590","","",0,10,0,0,0,,,
1451,30,"Carvalho et al., 2004",journal,"Carvalho LJ, Oliveira SG, Theisen M, Alves FA, Andrade MC, Zanini GM, Brgido MC, Oeuvray C, Pvoa MM, Muniz JA, Druilhe P, Daniel-Ribeiro CT",Immunization of Saimiri sciureus monkeys with Plasmodium falciparum merozoite surface protein-3 and glutamate-rich protein suggests that protection is related to antibody levels,"2004","59","4","363-372",Scandinavian journal of immunology,"","","","","","","","15049780","","",0,10,0,0,0,,,
1452,80,Vibriosis,website,"",Vibriosis,"","","","","","","","","","","","","",http://www.spaquaculture.com/default.aspx?pageid=528,"",0,10,0,0,0,,,
1453,80,"Kumar et al., 2007",journal,"Kumar SR, Parameswaran V, Ahmed VP, Musthaq SS, Hameed AS",Protective efficiency of DNA vaccination in Asian seabass (Lates calcarifer) against Vibrio anguillarum,"2007","23","2","316-326",Fish & shellfish immunology,"","","","","","","","17337208","","",0,10,0,0,0,,,
1454,68,"Samuel and Diamond, 2006",journal,"Samuel MA, Diamond MS","Pathogenesis of West Nile Virus infection: a balance between virulence, innate and adaptive immunity, and viral evasion","2006","80","19","9349-9360",Journal of virology,"","","","","","","","16973541","","",0,10,0,0,0,,,
1455,102,WHO: Cholera,website,"",WHO: Cholera,"","","","","","","","","","","","","",http://www.who.int/topics/cholera/about/en/index.html,"",0,10,0,0,0,,,
1456,133,Wiki: T. brucei,website,"",Wiki: Trypanosoma brucei,"","","","","","","","","","","","","",http://en.wikipedia.org/wiki/T._brucei,"",0,10,0,0,0,,,
1457,91,Wiki: T. gondii,website,"",Wiki: T. gondii,"","","","","","","","","","","","","",http://en.wikipedia.org/wiki/T._gondii,"",0,10,0,0,0,,,
1458,91,"Bhopale, 2003",journal,Bhopale GM,Pathogenesis of toxoplasmosis,"2003","26","4","213-222","Comparative immunology, microbiology and infectious diseases","","","","","","","","12676122","","",0,10,0,0,0,,,
1459,90,Wiki: T. annulata,website,"",Wiki: T. annulata,"","","","","","","","","","","","","",http://en.wikipedia.org/wiki/Theileria_annulata,"",0,10,0,0,0,,,
1460,90,"Pipano and Shkap, 2000",journal,"Pipano E, Shkap V",Vaccination against tropical theileriosis,"2000","916","","484-500",Annals of the New York Academy of Sciences,"","","","","","","","11193663","","",0,10,0,0,0,,,
1461,47,Textbook of Bacteriology,website,"",Online Textbook of Bacteriology: Streptococcus pneumoniae,"","","","","","","","","","","","","",http://textbookofbacteriology.net/S.pneumoniae.html,"",0,10,0,0,0,,,
1462,81,"Timoney, 2004",journal,Timoney JF,The pathogenic equine streptococci,"2004","35","4","397-409",Veterinary research,"","","","","","","","15236673","","",0,10,0,0,0,,,
1463,108,Textbook of Bacteriology,website,"",Online Textbook of Bacteriology: Rickettsial Diseases,"","","","","","","","","","","","","",http://www.textbookofbacteriology.net/Rickettsia_2.html,"",0,10,0,0,0,,,
1464,65,Merck Vet Manual: Pseudorabies,website,"",Merck Veterinary Manual- Pseudorabies,"","","","","","","","","","","","","",http://www.merckvetmanual.com/mvm/index.jsp?cfile=htm/bc/102200.htm,"",0,10,0,0,0,,,
1465,77,"Hamada et al., 2008",journal,"Hamada N, Takahashi Y, Watanabe K, Kumada H, Oishi Y, Umemoto T",Molecular and antigenic similarities of the fimbrial major components between Porphyromonas gulae and P. gingivalis,"2008","128","1-2","108-117",Veterinary microbiology,"","","","","","","","17977673","","",0,10,0,0,0,,,
1466,77,"Fournier et al., 2001",journal,"Fournier D, Mouton C, Lapierre P, Kato T, Okuda K, Mnard C","Porphyromonas gulae sp. nov., an anaerobic, gram-negative coccobacillus from the gingival sulcus of various animal hosts","2001","51",Pt 3,"1179-1189",International journal of systematic and evolutionary microbiology,"","","","","","","","11411686","",,0,0,0,0,0,,,
1467,93,"Dubey, 2003",journal,Dubey JP,Review of Neospora caninum and neosporosis in animals,"2003","41","1","1-16",The Korean journal of parasitology,"","","","","","","","12666725","","",0,10,0,0,0,,,
1468,84,Merck Vet Manual: M. gallisepticum,website,"",Merck Veterinary Manual- Mycoplasma  gallisepticum  Infection,"","","","","","","","","","","","","",http://www.merckvetmanual.com/mvm/index.jsp?cfile=htm/bc/203402.htm,"",0,10,0,0,0,,,
1469,18,"Golden et al., 2008",journal,"Golden JW, Josleyn MD, Hooper JW",Targeting the vaccinia virus L1 protein to the cell surface enhances production of neutralizing antibodies,"2008","26","27-28","3507-3515",Vaccine,"","","","","","","","18485547","","",0,10,0,0,0,,,
1470,18,"Davies et al., 2005",journal,"Davies DH, McCausland MM, Valdez C, Huynh D, Hernandez JE, Mu Y, Hirst S, Villarreal L, Felgner PL, Crotty S",Vaccinia virus H3L envelope protein is a major target of neutralizing antibodies in humans and elicits protection against lethal challenge in mice,"2005","79","18","11724-11733",Journal of virology,"","","","","","","","16140750","","",0,10,0,0,0,,,
1471,99,"Wagner et al., 2007",journal,"Wagner S, Jasinska J, Breiteneder H, Kundi M, Pehamberger H, Scheiner O, Zielinski CC, Wiedermann U",Delayed tumor onset and reduced tumor growth progression after immunization with a Her-2/neu multi-peptide vaccine and IL-12 in c-neu transgenic mice,"2007","106","1","29-38",Breast cancer research and treatment,"","","","","","","","17203384","","",0,10,0,0,0,,,
1472,114,Wiki:  Allergy,website,"",Allergy,"","","","","","","","","","","","","",http://en.wikipedia.org/wiki/Allergy,"",0,10,0,0,0,,,
1473,96,Pet Education.com:  Babesia canis,website,"",Babesia canis: The Cause of Piroplasmosis,"","","","","","","","","","","","","",http://www.peteducation.com/article.cfm?c=2+2101&aid=720,"",0,10,0,0,0,,,
1474,85,HealthGene Corp:  Bordetella avium,website,"",D417 - Bordetella avium,"","","","","","","","","","","","","",http://www.healthgene.com/avian/d417.asp,"",0,10,0,0,0,,,
1475,99,Wiki:  Cancer,website,"",Cancer,"","","","","","","","","","","","","",http://en.wikipedia.org/wiki/Cancer,"",0,10,0,0,0,,,
1476,87,Wiki:  Eimeria,website,"",Eimeria,"","","","","","","","","","","","","",http://en.wikipedia.org/wiki/Eimeria,"",0,10,0,0,0,,,
1479,29,"Zaks et al., 2006",journal,"Zaks K, Jordan M, Guth A, Sellins K, Kedl R, Izzo A, Bosio C, Dow S",Efficient immunization and cross-priming by vaccine adjuvants containing TLR3 or TLR9 agonists complexed to cationic liposomes,"2006","176","12","7335-7345","Journal of immunology (Baltimore, Md. : 1950)","","","","","","","","16751377","","",0,10,0,0,0,,,
1480,29,"Li et al., 1999",journal,"Li Z, Howard A, Kelley C, Delogu G, Collins F, Morris S",Immunogenicity of DNA vaccines expressing tuberculosis proteins fused to tissue plasminogen activator signal sequences,"1999","67","9","4780-4786",Infection and immunity,"","","","","","","","10456931","","",0,10,0,0,0,,,
1481,29,"Tanghe et al., 1999",journal,"Tanghe A, Lefvre P, Denis O, D'Souza S, Braibant M, Lozes E, Singh M, Montgomery D, Content J, Huygen K",Immunogenicity and protective efficacy of tuberculosis DNA vaccines encoding putative phosphate transport receptors,"1999","162","2","1113-1119","Journal of immunology (Baltimore, Md. : 1950)","","","","","","","","9916741","","",0,10,0,0,0,,,
1482,29,"Parra et al., 2004",journal,"Parra M, Pickett T, Delogu G, Dheenadhayalan V, Debrie AS, Locht C, Brennan MJ",The mycobacterial heparin-binding hemagglutinin is a protective antigen in the mouse aerosol challenge model of tuberculosis,"2004","72","12","6799-6805",Infection and immunity,"","","","","","","","15557600","","",0,10,0,0,0,,,
1483,29,"Skeiky et al., 2005",journal,"Skeiky YA, Alderson MR, Ovendale PJ, Lobet Y, Dalemans W, Orme IM, Reed SG, Campos-Neto A","Protection of mice and guinea pigs against tuberculosis induced by immunization with a single Mycobacterium tuberculosis recombinant antigen, MTB41","2005","23","30","3937-3945",Vaccine,"","","","","","","","15917115","","",0,10,0,0,0,,,
1484,8,"Rosinha et al., 2002b",journal,"Rosinha GM, Myioshi A, Azevedo V, Splitter GA, Oliveira SC","Molecular and immunological characterisation of recombinant Brucella abortus glyceraldehyde-3-phosphate-dehydrogenase, a T- and B-cell reactive protein that induces partial protection when co-administered with an interleukin-12-expressing plasmid in a DNA vaccine formulation","2002","51","8","661-671",Journal of medical microbiology,"","","","","","","","12171297","","",0,10,0,0,0,,,
1485,31,"Loosmore et al., 1998",journal,"Loosmore SM, Yang YP, Oomen R, Shortreed JM, Coleman DC, Klein MH",The Haemophilus influenzae HtrA protein is a protective antigen,"1998","66","3","899-906",Infection and immunity,"","","","","","","","9488373","","",0,10,0,0,0,,,
1486,134,"Ferrero et al., 1995",journal,"Ferrero RL, Thiberge JM, Kansau I, Wuscher N, Huerre M, Labigne A",The GroES homolog of Helicobacter pylori confers protective immunity against mucosal infection in mice,"1995","92","14","6499-6503",Proceedings of the National Academy of Sciences of the United States of America,"","","","","","","","7604021","","",0,10,0,0,0,,,
1487,134,"Dunkley et al., 1999",journal,"Dunkley ML, Harris SJ, McCoy RJ, Musicka MJ, Eyers FM, Beagley LG, Lumley PJ, Beagley KW, Clancy RL",Protection against Helicobacter pylori infection by intestinal immunisation with a 50/52-kDa subunit protein,"1999","24","2","221-225",FEMS immunology and medical microbiology,"","","","","","","","10378424","","",0,10,0,0,0,,,
1488,46,"West et al., 2001",journal,"West D, Reddin K, Matheson M, Heath R, Funnell S, Hudson M, Robinson A, Gorringe A",Recombinant Neisseria meningitidis transferrin binding protein A protects against experimental meningococcal infection,"2001","69","3","1561-1567",Infection and immunity,"","","","","","","","11179327","","",0,10,0,0,0,,,
1489,30,"Daubersies et al., 2000",journal,"Daubersies P, Thomas AW, Millet P, Brahimi K, Langermans JA, Ollomo B, BenMohamed L, Slierendregt B, Eling W, Van Belkum A, Dubreuil G, Meis JF, Gurin-Marchand C, Cayphas S, Cohen J, Gras-Masse H, Druilhe P",Protection against Plasmodium falciparum malaria in chimpanzees by immunization with the conserved pre-erythrocytic liver-stage antigen 3,"2000","6","11","1258-1263",Nature medicine,"","","","","","","","11062538","","",0,10,0,0,0,,,
1490,30,"Sim et al., 2001",journal,"Sim BK, Narum DL, Liang H, Fuhrmann SR, Obaldia N 3rd, Gramzinski R, Aguiar J, Haynes JD, Moch JK, Hoffman SL","Induction of biologically active antibodies in mice, rabbits, and monkeys by Plasmodium falciparum EBA-175 region II DNA vaccine","2001","7","4","247-254","Molecular medicine (Cambridge, Mass.)","","","","","","","","11471569","","",0,10,0,0,0,,,
1491,30,"El et al., 2010",journal,"El Sahly HM, Patel SM, Atmar RL, Lanford TA, Dube T, Thompson D, Lee Sim BK, Long C, Keitel WA",The Safety and Immunogenicity of Recombinant EBA 175-RII NG Malaria Vaccine in Healthy Adults Living in a Non-Endemic Area,"2010","","","",Clinical and vaccine immunology : CVI,"","","","","","","","20702657","","",0,10,0,0,0,,,
1492,47,"Zhang et al., 2001",journal,"Zhang Y, Masi AW, Barniak V, Mountzouros K, Hostetter MK, Green BA","Recombinant PhpA protein, a unique histidine motif-containing protein from Streptococcus pneumoniae, protects mice against intranasal pneumococcal challenge","2001","69","6","3827-3836",Infection and immunity,"","","","","","","","11349048","","",0,10,0,0,0,,,
1493,135,"Probert and LeFebvre, 1994",journal,"Probert WS, LeFebvre RB","Protection of C3H/HeN mice from challenge with Borrelia burgdorferi through active immunization with OspA, OspB, or OspC, but not with OspD or the 83-kilodalton antigen","1994","62","5","1920-1926",Infection and immunity,"","","","","","","","8168958","","",0,10,0,0,0,,,
1494,135,"Hanson et al., 1998",journal,"Hanson MS, Cassatt DR, Guo BP, Patel NK, McCarthy MP, Dorward DW, Hk M",Active and passive immunity against Borrelia burgdorferi decorin binding protein A (DbpA) protects against infection,"1998","66","5","2143-2153",Infection and immunity,"","","","","","","","9573101","","",0,10,0,0,0,,,
1495,135,"Hanson et al., 2000",journal,"Hanson MS, Patel NK, Cassatt DR, Ulbrandt ND",Evidence for vaccine synergy between Borrelia burgdorferi decorin binding protein A and outer surface protein A in the mouse model of lyme borreliosis,"2000","68","11","6457-6460",Infection and immunity,"","","","","","","","11035759","","",0,10,0,0,0,,,
1496,135,Wiki: B. burgdorferi,website,"",Wiki: Borrelia burgdorferi,"","","","","","","","","","","","","",http://en.wikipedia.org/wiki/Borrelia_burgdorferi,"",0,10,0,0,0,,,
1497,136,"Cornell et al., 1999",journal,"Cornell KA, Bouwer HG, Hinrichs DJ, Barry RA",Genetic immunization of mice against Listeria monocytogenes using plasmid DNA encoding listeriolysin O,"1999","163","1","322-329","Journal of immunology (Baltimore, Md. : 1950)","","","","","","","","10384131","","",0,10,0,0,0,,,
1498,137,"Price et al., 2001",journal,"Price BM, Galloway DR, Baker NR, Gilleland LB, Staczek J, Gilleland HE Jr",Protection against Pseudomonas aeruginosa chronic lung infection in mice by genetic immunization against outer membrane protein F (OprF) of P. aeruginosa,"2001","69","5","3510-3515",Infection and immunity,"","","","","","","","11292786","","",0,10,0,0,0,,,
1499,137,"Holder et al., 2001",journal,"Holder IA, Neely AN, Frank DW",PcrV immunization enhances survival of burned Pseudomonas aeruginosa-infected mice,"2001","69","9","5908-5910",Infection and immunity,"","","","","","","","11500471","","",0,10,0,0,0,,,
1500,137,Textbook of Bacteriology,website,"",Pseudomonas,"","","","","","","","","","","","","",http://www.textbookofbacteriology.net/pseudomonas.html,"",0,10,0,0,0,,,
1501,137,"Finke et al., 1990",journal,"Finke M, Duchne M, Eckhardt A, Domdey H, von Specht BU",Protection against experimental Pseudomonas aeruginosa infection by recombinant P. aeruginosa lipoprotein I expressed in Escherichia coli,"1990","58","7","2241-2244",Infection and immunity,"","","","","","","","2114360","","",0,10,0,0,0,,,
1502,138,"Nilsson et al., 1998",journal,"Nilsson IM, Patti JM, Bremell T, Hk M, Tarkowski A",Vaccination with a recombinant fragment of collagen adhesin provides protection against Staphylococcus aureus-mediated septic death,"1998","101","12","2640-2649",The Journal of clinical investigation,"","","","","","","","9637697","","",0,10,0,0,0,,,
1503,138,"Josefsson et al., 2001",journal,"Josefsson E, Hartford O, O'Brien L, Patti JM, Foster T","Protection against experimental Staphylococcus aureus arthritis by vaccination with clumping factor A, a novel virulence determinant","2001","184","12","1572-1580",The Journal of infectious diseases,"","","","","","","","11740733","","",0,10,0,0,0,,,
1504,138,"Senna et al., 2003",journal,"Senna JP, Roth DM, Oliveira JS, Machado DC, Santos DS",Protective immune response against methicillin resistant Staphylococcus aureus in a murine model using a DNA vaccine approach,"2003","21","19-20","2661-2666",Vaccine,"","","","","","","","12744903","","",0,10,0,0,0,,,
1505,138,"Mamo et al., 1994",journal,"Mamo W, Jonsson P, Flock JI, Lindberg M, Mller HP, Wadstrm T, Nelson L",Vaccination against Staphylococcus aureus mastitis: immunological response of mice vaccinated with fibronectin-binding protein (FnBP-A) to challenge with S. aureus,"1994","12","11","988-992",Vaccine,"","","","","","","","7975852","","",0,10,0,0,0,,,
1506,139,"Erdogan et al., 2002",journal,"Erdogan S, Fagan PK, Talay SR, Rohde M, Ferrieri P, Flores AE, Guzmn CA, Walker MJ, Chhatwal GS","Molecular analysis of group B protective surface protein, a new cell surface protective antigen of group B streptococci","2002","70","2","803-811",Infection and immunity,"","","","","","","","11796614","","",0,10,0,0,0,,,
1507,140,"Guzmn et al., 1999",journal,"Guzmn CA, Talay SR, Molinari G, Medina E, Chhatwal GS",Protective immune response against Streptococcus pyogenes in mice after intranasal vaccination with the fibronectin-binding protein SfbI,"1999","179","4","901-906",The Journal of infectious diseases,"","","","","","","","10068585","","",0,10,0,0,0,,,
1508,140,"Kawabata et al., 2001",journal,"Kawabata S, Kunitomo E, Terao Y, Nakagawa I, Kikuchi K, Totsuka K, Hamada S",Systemic and mucosal immunizations with fibronectin-binding protein FBP54 induce protective immune responses against Streptococcus pyogenes challenge in mice,"2001","69","2","924-930",Infection and immunity,"","","","","","","","11159987","","",0,10,0,0,0,,,
1509,140,"Ma et al., 2009",journal,"Ma CQ, Li CH, Wang XR, Zeng RH, Yin XL, Feng HD, Wei L",Similar ability of FbaA with M protein to elicit protective immunity against group A streptococcus challenge in mice,"2009","6","1","73-77",Cellular & molecular immunology,"","","","","","","","19254483","","",0,10,0,0,0,,,
1510,140,"Schulze et al., 2006",journal,"Schulze K, Olive C, Ebensen T, Guzmn CA",Intranasal vaccination with SfbI or M protein-derived peptides conjugated to diphtheria toxoid confers protective immunity against a lethal challenge with Streptococcus pyogenes,"2006","24","35-36","6088-6095",Vaccine,"","","","","","","","16828529","","",0,10,0,0,0,,,
1511,140,"Okamoto et al., 2005",journal,"Okamoto S, Tamura Y, Terao Y, Hamada S, Kawabata S",Systemic immunization with streptococcal immunoglobulin-binding protein Sib 35 induces protective immunity against group: a Streptococcus challenge in mice,"2005","23","40","4852-4859",Vaccine,"","","","","","","","15990202","","",0,10,0,0,0,,,
1512,140,Wiki: S. pyogenes,website,"",Wiki: Streptococcus pyogenes,"","","","","","","","","","","","","",http://en.wikipedia.org/wiki/Streptococcus_pyogenes,"",0,10,0,0,0,,,
1513,141,"Cameron et al., 1998",journal,"Cameron CE, Castro C, Lukehart SA, Van Voorhis WC",Function and protective capacity of Treponema pallidum subsp. pallidum glycerophosphodiester phosphodiesterase,"1998","66","12","5763-5770",Infection and immunity,"","","","","","","","9826352","","",0,10,0,0,0,,,
1514,141,"Wicher et al., 1991",journal,"Wicher K, Schouls LM, Wicher V, Van Embden JD, Nakeeb SS",Immunization of guinea pigs with recombinant TmpB antigen induces protection against challenge infection with Treponema pallidum Nichols,"1991","59","12","4343-4348",Infection and immunity,"","","","","","","","1937794","","",0,10,0,0,0,,,
1515,141,"Cameron et al., 2000",journal,"Cameron CE, Lukehart SA, Castro C, Molini B, Godornes C, Van Voorhis WC","Opsonic potential, protective capacity, and sequence conservation of the Treponema pallidum subspecies pallidum Tp92","2000","181","4","1401-1413",The Journal of infectious diseases,"","","","","","","","10762571","","",0,10,0,0,0,,,
1516,141,Wiki: T. pallidum,website,"",Wiki: T. pallidum,"","","","","","","","","","","","","",http://en.wikipedia.org/wiki/Treponema_pallidum,"",0,10,0,0,0,,,
1517,139,"Brodeur et al., 2000",journal,"Brodeur BR, Boyer M, Charlebois I, Hamel J, Couture F, Rioux CR, Martin D","Identification of group B streptococcal Sip protein, which elicits cross-protective immunity","2000","68","10","5610-5618",Infection and immunity,"","","","","","","","10992461","","",0,10,0,0,0,,,
1518,139,"Larsson et al., 1996",journal,"Larsson C, Stlhammar-Carlemalm M, Lindahl G","Experimental vaccination against group B streptococcus, an encapsulated bacterium, with highly purified preparations of cell surface proteins Rib and alpha","1996","64","9","3518-3523",Infection and immunity,"","","","","","","","8751893","","",0,10,0,0,0,,,
1519,139,"Grenningloh et al., 2008",journal,"Grenningloh R, Darj A, Bauer H, zur Lage S, Chakraborty T, Jacobs T, Weiss S",Liposome-encapsulated antigens induce a protective CTL response against Listeria monocytogenes independent of CD4+ T cell help,"2008","67","6","594-602",Scandinavian journal of immunology,"","","","","","","","18433404","","",0,10,0,0,0,,,
1520,136,"Grenningloh et al., 2008",journal,"Grenningloh R, Darj A, Bauer H, zur Lage S, Chakraborty T, Jacobs T, Weiss S",Liposome-encapsulated antigens induce a protective CTL response against Listeria monocytogenes independent of CD4+ T cell help,"2008","67","6","594-602",Scandinavian journal of immunology,"","","","","","","","18433404","","",0,10,0,0,0,,,
1521,139,Wiki: S. agalactiae,website,"",Wiki: Streptococcus agalactiae,"","","","","","","","","","","","","",http://en.wikipedia.org/wiki/Streptococcus_agalactiae,"",0,10,0,0,0,,,
1522,138,Wiki: S. aureus,website,"",Wiki: Staphylococcus aureus,"","","","","","","","","","","","","",http://en.wikipedia.org/wiki/Staphylococcus_aureus,"",0,10,0,0,0,,,
1523,136,Wiki: L. monocytogenes,website,"",Wiki: Listeria monocytogenes,"","","","","","","","","","","","",Wiki,http://en.wikipedia.org/wiki/Listeria_monocytogenes,"",0,10,0,0,0,,,
1524,136,"Ramaswamy et al., 2007",journal,"Ramaswamy V, Cresence VM, Rejitha JS, Lekshmi MU, Dharsana KS, Prasad SP, Vijila HM",Listeria--review of epidemiology and pathogenesis,"2007","40","1","4-13","Journal of microbiology, immunology, and infection = Wei mian yu gan ran za zhi","","","","","","","","17332901","","",0,10,0,0,0,,,
1525,141,MicrobeWiki: T. pallidum,website,"",MicrobeWiki: Treponema pallidum,"","","","","","","","","","","","","",http://microbewiki.kenyon.edu/index.php/Treponema_pallidum,"",0,10,0,0,0,,,
1526,140,Textbook of Bacteriology,website,"",Streptococcus pyogenes and Streptococcal Disease,"","","","","","","","","","","","","",http://textbookofbacteriology.net/streptococcus,"",0,10,0,0,0,,,
1527,135,"Salyers and Whitt., 2002",book,"Abigail A. Salyers, Dixie D. Whitt",The Spirochetes: Borrelia burgdorferi and Treponema pallidum,"2002","","","187-199",Bacterial Pathogenesis: A Molecular Approach,ASM Press,Washington D.C. USA,"","1-55581-171-x","","","","","","",0,10,0,0,0,,,
1528,141,"Salyers and Whitt., 2002",book,"Abigail A. Salyers, Dixie D. Whitt",The Spirochetes: Borrelia burgdorferi and Treponema pallidum,"2002","","","197-99",Bacterial Pathogenesis: A Molecular Approach,ASM Press,Washington D.C. USA,"","1-55581-171-x","","","","","","",0,10,0,0,0,,,
1529,137,"Salyers and Whitt., 2002",book,"Abigail A. Salyers, Dixie D. Whitt","Pseudomonas aeruginosa and Related Species, a Lesson in Versatility","2002","","","247-62",Bacterial Pathogenesis: A Molecular Approach,ASM Press,Washington D.C. USA,"","1-55581-171-x","","","","","","",0,10,0,0,0,,,
1530,109,"Salyers and Whitt., 2002",book,"Abigail A. Salyers, Dixie D. Whitt",Bordetella pertussis,"2002","","","263-73",Bacterial Pathogenesis: A Molecular Approach,ASM Press,Washington D.C. USA,"","1-55581-171-x","","","","","","",0,10,0,0,0,,,
1531,134,"Salyers and Whitt., 2002",book,"Abigail A. Salyers, Dixie D. Whitt","Helicobacter pylori, A Resourceful Gastric Pathogen","2002","","","339-49",Bacterial Pathogenesis: A Molecular Approach,ASM Press,Washington D.C. USA,"","1-55581-171-x","","","","","","",0,10,0,0,0,,,
1532,29,"Falero-Diaz et al., 2000",journal,"Falero-Diaz G, Challacombe S, Banerjee D, Douce G, Boyd A, Ivanyi J",Intranasal vaccination of mice against infection with Mycobacterium tuberculosis,"2000","18","28","3223-3229",Vaccine,"","","","","","","","10869767","","",0,10,0,0,0,,,
1533,29,"Lowrie et al., 1997",journal,"Lowrie DB, Silva CL, Colston MJ, Ragno S, Tascon RE",Protection against tuberculosis by a plasmid DNA vaccine,"1997","15","8","834-838",Vaccine,"","","","","","","","9234527","","",0,10,0,0,0,,,
1534,29,"Morris et al., 2000",journal,"Morris S, Kelley C, Howard A, Li Z, Collins F",The immunogenicity of single and combination DNA vaccines against tuberculosis,"2000","18","20","2155-2163",Vaccine,"","","","","","","","10715531","","",0,10,0,0,0,,,
1535,29,"Dillon et al., 1999",journal,"Dillon DC, Alderson MR, Day CH, Lewinsohn DM, Coler R, Bement T, Campos-Neto A, Skeiky YA, Orme IM, Roberts A, Steen S, Dalemans W, Badaro R, Reed SG",Molecular characterization and human T-cell responses to a member of a novel Mycobacterium tuberculosis mtb39 gene family,"1999","67","6","2941-2950",Infection and immunity,"","","","","","","","10338503","",,0,0,0,0,0,,,
1536,86,"Haesebrouck et al., 2004",journal,"Haesebrouck F, Pasmans F, Chiers K, Maes D, Ducatelle R, Decostere A",Efficacy of vaccines against bacterial diseases in swine: what can we expect?,"2004","100","3-4","255-268",Veterinary microbiology,"","","","","","","","15145504","","",0,10,0,0,0,,,
1537,79,USGS Fish Disease Leaflets,website,G. L. Bullock and R. C. Cipriano,Furunculosis and Other Diseases Caused by Aeromonas Salmonicida.,"2001","","","","","","","","","","","","",http://www.lsc.usgs.gov/fhb/leaflets/FHB66.pdf,"",0,10,0,0,0,,,
1538,111,Wiki: Y. pseudotuberuclosis,website,"",Wiki: Y. pseudotuberuclosis,"","","","","","","","","","","","","",http://en.wikipedia.org/wiki/Yersinia_pseudotuberculosis,"",0,10,0,0,0,,,
1539,81,MicrobeWiki: S. zooepidemicus,website,"",MicrobeWiki: S. zooepidemicus,"","","","","","","","","","","","","",http://microbewiki.kenyon.edu/index.php/Streptococcus_zooepidemicus,"",0,10,0,0,0,,,
1540,139,MicrobeWiki: S. agalactiae,website,"",MicrobeWiki: S. agalactiae,"","","","","","","","","","","","","",http://microbewiki.kenyon.edu/index.php/Streptococcus_agalactiae,"",0,10,0,0,0,,,
1541,129,"Sims et al., 2008",journal,"Sims AC, Burkett SE, Yount B, Pickles RJ",SARS-CoV replication and pathogenesis in an in vitro model of the human conducting airway epithelium,"2008","133","1","33-44",Virus research,"","","","","","","","17451829","","",0,10,0,0,0,,,
1542,64,"Gillespie et al., 2009",journal,"Gillespie J, Opriessnig T, Meng XJ, Pelzer K, Buechner-Maxwell V",Porcine circovirus type 2 and porcine circovirus-associated disease,"2009","23","6","1151-1163",Journal of veterinary internal medicine / American College of Veterinary Internal Medicine,"","","","","","","","19780932","","",0,10,0,0,0,,,
1543,93,"Buxton et al., 2002",journal,"Buxton D, McAllister MM, Dubey JP",The comparative pathogenesis of neosporosis,"2002","18","12","546-552",Trends in parasitology,"","","","","","","","12482540","","",0,10,0,0,0,,,
1544,46,Textbook of Bacteriology,website,"","Staphylococcus bacteriaPrint this Page Pathogenic Neisseriae: Gonorrhea, Neonatal Ophthalmia and Meningococcal Meningitis","","","","","","","","","","","","","",http://textbookofbacteriology.net/neisseria,"",0,10,0,0,0,,,
1545,52,Wiki: Measles,website,"",Wiki: Measles,"","","","","","","","","","","","","",http://en.wikipedia.org/wiki/Measles,"",0,10,0,0,0,,,
1546,115,"Ameen, 2010",journal,Ameen M,"Cutaneous leishmaniasis: advances in disease pathogenesis, diagnostics and therapeutics","2010","35","7","699-705",Clinical and experimental dermatology,"","","","","","","","20831602","","",0,10,0,0,0,,,
1547,115,"Reithinger et al., 2007",journal,"Reithinger R, Dujardin JC, Louzir H, Pirmez C, Alexander B, Brooker S",Cutaneous leishmaniasis,"2007","7","9","581-596",The Lancet infectious diseases,"","","","","","","","17714672","","",0,10,0,0,0,,,
1548,97,Merck Manual: Leishmaniasis,website,"",Leishmaniasis,"","","","","","","","","","","","","",http://www.merck.com/mmpe/sec14/ch186/ch186f.html,"",0,10,0,0,0,,,
1549,54,Wiki: HPV,website,"",Wiki: Human papillomavirus,"","","","","","","","","","","","","",http://en.wikipedia.org/wiki/Human_papillomavirus,"",0,10,0,0,0,,,
1550,126,"Martina et al., 2009",journal,"Martina BE, Koraka P, Osterhaus AD",Dengue virus pathogenesis: an integrated view,"2009","22","4","564-581",Clinical microbiology reviews,"","","","","","","","19822889","","",0,10,0,0,0,,,
1551,62,MicrobeWiki: C. diphtheriae,website,"",MicrobeWiki: C. diphtheriae,"","","","","","","","","","","","","",http://microbewiki.kenyon.edu/index.php/Corynebacterium_diphtheriae,"",0,10,0,0,0,,,
1552,62,Textbook of Bacteriology,website,"",Diphtheria,"","","","","","","","","","","","","",http://textbookofbacteriology.net/diphtheria,"",0,10,0,0,0,,,
1553,132,"Hung et al., 2007",journal,"Hung CY, Xue J, Cole GT",Virulence mechanisms of coccidioides,"2007","1111","","225-235",Annals of the New York Academy of Sciences,"","","","","","","","17513466","","",0,10,0,0,0,,,
1554,121,Wiki: B. pseudomallei,website,"",Wiki: B. pseudomallei,"","","","","","","","","","","","","",http://en.wikipedia.org/wiki/Burkholderia_pseudomallei,"",0,10,0,0,0,,,
1555,139,"Santi et al., 2009",journal,"Santi I, Maione D, Galeotti CL, Grandi G, Telford JL, Soriani M",BibA induces opsonizing antibodies conferring in vivo protection against group B Streptococcus,"2009","200","4","564-570",The Journal of infectious diseases,"","","","","","","","19586417","","",0,10,0,0,0,,,
1556,50,Sanofi Pasteur: Intanza,website,"",Sanofi Pasteur: Intanza,"","","","","","","","","","","","","",http://www.sanofipasteur.ca/sanofi-pasteur2/sp-media/SP_CA/EN/75/1215/415%20416%20INTANZA%20R0-0510%20En.pdf,"",0,10,0,0,0,,,
1557,55,Health Canada DPD,website,"",Health Canada Drug Product Database,"","","","","","","","","","","","","",www.hc-sc.gc.ca,,0,0,0,0,0,,,
1558,46,FDA: Menveo,website,"",FDA: Menveo,"","","","","","","","","","","","","",http://www.fda.gov/BiologicsBloodVaccines/Vaccines/ApprovedProducts/ucm201342.htm,"",0,10,0,0,0,,,
1559,47,GSK: Synflorix,website,"",GSK: Synflorix,"","","","","","","","","","","","","",http://www.gsk.ca/english/docs-pdf/Synflorix_PM_20090505_EN.pdf,"",0,10,0,0,0,,,
1560,47,FDA: Prevnar 13,website,"",FDA: Prevnar 13,"","","","","","","","","","","","","",http://www.fda.gov/BiologicsBloodVaccines/Vaccines/ApprovedProducts/ucm201667.htm,"",0,10,0,0,0,,,
1561,50,Health Canada DPD,website,"",Health Canada Drug Product Database,"","","","","","","","","","","","","",http://www.hc-sc.gc.ca/dhp-mps/prodpharma/databasdon/index-eng.php,"",0,10,0,0,0,,,
1562,50,Intanza Product Monograph,website,"",Intanza Protduct Monograph,"","","","","","","","","","","","","",http://www.sanofipasteur.com/sanofi-pasteur2/sp-media/SP_CA/EN/75/1215/415%20416%20INTANZA%20R0-0510%20En.pdf,"",0,10,0,0,0,,,
1563,81,"Chanter et al., 1999",journal,"Chanter N, Ward CL, Talbot NC, Flanagan JA, Binns M, Houghton SB, Smith KC, Mumford JA",Recombinant hyaluronate associated protein as a protective immunogen against Streptococcus equi and Streptococcus zooepidemicus challenge in mice,"1999","27","3","133-143",Microbial pathogenesis,"","","","","","","","10455004","","",0,10,0,0,0,,,
1564,142,Avian Reovirus Infections,website,"",Avian Reovirus Infections,"","","","","","","","","","","","","",http://www.thepoultrysite.com/articles/96/avian-reovirus-infections,"",0,10,0,0,0,,,
1565,143,Merck Vet Manual: BRSV,website,"",Merck Veterinary Manual-Bovine Respiratory Syncytial Virus,"","","","","","","","","","","","","",http://www.merckvetmanual.com/mvm/index.jsp?cfile=htm/bc/121211.htm,"",0,10,0,0,0,,,
1566,144,Merck Vet Manual: Parainfluenza-3 Virus,website,"",Merck Veterinary Manual: Parainfluenza-3 Virus,"","","","","","","","","","","","","",http://www.merckvetmanual.com/mvm/index.jsp?cfile=htm/bc/121210.htm,"",0,10,0,0,0,,,
1567,145,Wiki: Infectious Bronchitis Virus,website,"",Wiki: Infectious Bronchitis Virus,"","","","","","","","","","","","","",http://en.wikipedia.org/wiki/Avian_infectious_bronchitis_virus,"",0,10,0,0,0,,,
1568,145,Merck Vet Manual: Infectious Bronchitis,website,"",Merck Veterinary Manual: Infectious Bronchitis,"","","","","","","","","","","","","",http://www.merckvetmanual.com/mvm/index.jsp?cfile=htm/bc/206500.htm,"",0,10,0,0,0,,,
1569,145,Infectious-bronchitis.net,website,"",Information about Infectious Bronchitis in chickens and control of disease,"","","","","","","","","","","","","",http://www.infectious-bronchitis.com,"",0,10,0,0,0,,,
1570,146,Wiki: Infectious Bursal Disease,website,"",Wiki: Infectious Bursal Disease,"","","","","","","","","","","","","",http://en.wikipedia.org/wiki/Infectious_bursal_disease,"",0,10,0,0,0,,,
1571,147,"Fryer and Hedrick, 2003",journal,"Fryer JL, Hedrick RP",Piscirickettsia salmonis: a Gram-negative intracellular bacterial pathogen of fish,"2003","26","5","251-262",Journal of fish diseases,"","","","","","","","12962234","","",0,10,0,0,0,,,
1572,148,"Marvil et al., 1999",journal,"Marvil P, Knowles NJ, Mockett AP, Britton P, Brown TD, Cavanagh D",Avian encephalomyelitis virus is a picornavirus and is most closely related to hepatitis A virus,"1999","80 ( Pt 3)","","653-662",The Journal of general virology,"","","","","","","","10092005","","",0,10,0,0,0,,,
1573,148,"Calneck, B. W., 2003",book,Bruce N. Calneck,Avian Encephalomyelitis,"2003","","","271-281","Diseases of poultry, 11th ed",Iowa State University Press,"Ames, IA","Y. M. Saif, H. J. Barnes, J. R. Glisson, A. M. Fadly, L. R. McDougald, and D. E. Swayne","081380423X","","","","","","",0,10,0,0,0,,,
1574,149,Wiki: Fowl Pox,website,"",Wiki: Fowl Pox,"","","","","","","","","","","","","",http://en.wikipedia.org/wiki/Fowlpox,,0,0,0,0,0,,,
1575,150,Merck Vet Manual: Chicken Anemia Virus Infection,website,"",Merck Vet Manual: Chicken Anemia Virus Infection,"","","","","","","","","","","","","",http://www.merckvetmanual.com/mvm/index.jsp?cfile=htm/bc/200200.htm,"",0,10,0,0,0,,,
1576,151,Wiki: Eastern Equine Encephalitis,website,"",Wiki: Eastern Equine Encephalitis Virus,"","","","","","","","","","","","","",http://en.wikipedia.org/wiki/Eastern_equine_encephalitis_virus,"",0,10,0,0,0,,,
1577,152,"Brooke and Riley, 1999",journal,"Brooke CJ, Riley TV","Erysipelothrix rhusiopathiae: bacteriology, epidemiology and clinical manifestations of an occupational pathogen","1999","48","9","789-799",Journal of medical microbiology,"","","","","","","","10482289","","",0,10,0,0,0,,,
1578,152,"Wang et al., 2010",journal,"Wang Q, Chang BJ, Riley TV",Erysipelothrix rhusiopathiae,"2010","140","3-4","405-417",Veterinary microbiology,"","","","","","","","19733019","","",0,10,0,0,0,,,
1579,153,"Radford et al., 2007",journal,"Radford AD, Coyne KP, Dawson S, Porter CJ, Gaskell RM",Feline calicivirus,"2007","38","2","319-335",Veterinary research,"","","","","","","","17296159","","",0,10,0,0,0,,,
1580,154,Wiki: Feline Immunodeficincy Virus,website,"",Wiki: Feline Immunodeficincy Virus,"","","","","","","","","","","","","",http://en.wikipedia.org/wiki/Feline_immunodeficiency_virus,"",0,10,0,0,0,,,
1581,155,Wiki: Feline Panleukopenia,website,"",Wiki: Feline Panleukopenia,"","","","","","","","","","","","","",http://en.wikipedia.org/wiki/Feline_Panleukopenia,"",0,10,0,0,0,,,
1582,155,"Truyen et al., 2009",journal,"Truyen U, Addie D, Belk S, Boucraut-Baralon C, Egberink H, Frymus T, Gruffydd-Jones T, Hartmann K, Hosie MJ, Lloret A, Lutz H, Marsilio F, Pennisi MG, Radford AD, Thiry E, Horzinek MC",Feline panleukopenia. ABCD guidelines on prevention and management,"2009","11","7","538-546",Journal of feline medicine and surgery,"","","","","","","","19481033","","",0,10,0,0,0,,,
1583,156,"Gaskell et al., 2007",journal,"Gaskell R, Dawson S, Radford A, Thiry E",Feline herpesvirus,"2007","38","2","337-354",Veterinary research,"","","","","","","","17296160","","",0,10,0,0,0,,,
1584,157,"Fuchs et al., 2007",journal,"Fuchs W, Veits J, Helferich D, Granzow H, Teifke JP, Mettenleiter TC",Molecular biology of avian infectious laryngotracheitis virus,"2007","38","2","261-279",Veterinary research,"","","","","","","","17296156","","",0,10,0,0,0,,,
1585,158,"Dumpala et al., 2010",journal,"Dumpala PR, Glsoy N, Lawrence ML, Karsi A",Proteomic analysis of the fish pathogen Flavobacterium columnare,"2010","8","","26",Proteome science,"","","","","","","","20525376","","",0,10,0,0,0,,,
1586,159,Wki: Mink enteritis virus,website,"",Wki: Mink enteritis virus,"","","","","","","","","","","","","",http://en.wikipedia.org/wiki/Mink_enteritis_virus,"",0,10,0,0,0,,,
1587,160,Wiki: Orf disease,website,"",Wiki: Orf Disease,"","","","","","","","","","","","","",http://en.wikipedia.org/wiki/Orf_disease,"",0,10,0,0,0,,,
1588,161,Wiki: P. multocida,website,"",Wiki: Pasteurella multocida,"","","","","","","","","","","","","",http://en.wikipedia.org/wiki/Pasteurella_multocida,"",0,10,0,0,0,,,
1589,161,"Harper et al., 2006",journal,"Harper M, Boyce JD, Adler B",Pasteurella multocida pathogenesis: 125 years after Pasteur,"2006","265","1","1-10",FEMS microbiology letters,"","","","","","","","17107417","","",0,10,0,0,0,,,
1590,162,Wiki: Infectious Salmon anemia virus,website,"",Wiki: Infectious Salmon anemia virus,"","","","","","","","","","","","","",http://en.wikipedia.org/wiki/Infectious_salmon_anemia_virus,"",0,10,0,0,0,,,
1591,162,"Rimstad and Mjaaland, 2002",journal,"Rimstad E, Mjaaland S",Infectious salmon anaemia virus,"2002","110","4","273-282","APMIS : acta pathologica, microbiologica, et immunologica Scandinavica","","","","","","","","12076262","","",0,10,0,0,0,,,
1592,163,"Russo et al., 2009",journal,"Russo R, Shoemaker CA, Panangala VS, Klesius PH",In vitro and in vivo interaction of macrophages from vaccinated and non-vaccinated channel catfish (Ictalurus punctatus) to Edwardsiella ictaluri,"2009","26","3","543-552",Fish & shellfish immunology,"","","","","","","","19233291","","",0,10,0,0,0,,,
1593,163,Microgen,website,"",Microgen:Edwardsiella ictaluri,"","","","","","","","","","","","","",http://microgen.ouhsc.edu/e_ictal/e_ictal_home.htm,"",0,10,0,0,0,,,
1594,165,Wiki: Bluetongue,website,"",Wiki: Bluetongue,"","","","","","","","","","","","","",http://en.wikipedia.org/wiki/Bluetongue,"",0,10,0,0,0,,,
1595,165,"Maclachlan et al., 2009",journal,"Maclachlan NJ, Drew CP, Darpel KE, Worwa G",The pathology and pathogenesis of bluetongue,"2009","141","1","1-16",Journal of comparative pathology,"","","","","","","","19476953","","",0,10,0,0,0,,,
1596,166,"Mattoo et al., 2001",journal,"Mattoo S, Foreman-Wykert AK, Cotter PA, Miller JF",Mechanisms of Bordetella pathogenesis,"2001","6","",E168-186,Frontiers in bioscience : a journal and virtual library,"","","","","","","","11689354","","",0,10,0,0,0,,,
1597,30,"Doolan et al., 1996",journal,"Doolan DL, Sedegah M, Hedstrom RC, Hobart P, Charoenvit Y, Hoffman SL","Circumventing genetic restriction of protection against malaria with multigene DNA immunization: CD8+ cell-, interferon gamma-, and nitric oxide-dependent immunity","1996","183","4","1739-1746",The Journal of experimental medicine,"","","","","","","","8666931","","",0,10,0,0,0,,,
1598,166,"Goodnow, 1980",journal,Goodnow RA,Biology of Bordetella bronchiseptica,"1980","44","4","722-738",Microbiological reviews,"","","","","","","","7010115","","",0,10,0,0,0,,,
1599,167,Merck Vet Manual: Avian Pneumovirus,website,"",Merck Vet Manual: Avian Pneumovirus,"","","","","","","","","","","","","",http://www.merckvetmanual.com/mvm/index.jsp?cfile=htm/bc/206300.htm,"",0,10,0,0,0,,,
1600,164,Wiki: Avain paramyxovirus,website,"",Wiki: Avain paramyxovirus,"","","","","","","","","","","","","",http://en.wikipedia.org/wiki/Avian_paramyxovirus,"",0,10,0,0,0,,,
1601,168,Merck Vet Manual: Avian Polyomavirus,website,"",Merck Vet Manual: Avian Polyomavirus,"","","","","","","","","","","","","",http://www.merckvetmanual.com/mvm/index.jsp?cfile=htm/bc/170221.htm,"",0,10,0,0,0,,,
1602,169,Merck Vet Manual: Bovine Viral Diarrhea,website,"",Merck Vet Manual: Bovine Viral Diarrhea and Mucosal Disease Complex,"","","","","","","","","","","","","",http://www.merckvetmanual.com/mvm/index.jsp?cfile=htm/bc/22103.htm,"",0,10,0,0,0,,,
1603,170,"Buonavoglia and Martella, 2007",journal,"Buonavoglia C, Martella V",Canine respiratory viruses,"2007","38","2","355-373",Veterinary research,"","","","","","","","17296161","","",0,10,0,0,0,,,
1604,171,"Buonavoglia and Martella, 2007",journal,"Buonavoglia C, Martella V",Canine respiratory viruses,"2007","38","2","355-373",Veterinary research,"","","","","","","","17296161","","",0,10,0,0,0,,,
1605,172,Field Manual of Wildlife Diseases,website,"",Field Manual of Wildlife Diseases- Chapter 16 Duck Plague,"","","","","","","","","","","","","",http://www.nwhc.usgs.gov/publications/field_manual/chapter_16.pdf,"",0,10,0,0,0,,,
1606,173,"Patel and Heldens, 2005",journal,"Patel JR, Heldens J","Equine herpesviruses 1 (EHV-1) and 4 (EHV-4)--epidemiology, disease and immunoprophylaxis: a brief review","2005","170","1","14-23","Veterinary journal (London, England : 1997)","","","","","","","","15993786","","",0,10,0,0,0,,,
1607,174,AAEP: Rotaviral Diarrhea,website,"",AAEP: Rotaviral Diarrhea,"","","","","","","","","","","","","",http://www.aaep.org/rotaviral_diarrhea.htm,"",0,10,0,0,0,,,
1608,175,"Addie et al., 2009",journal,"Addie D, Belk S, Boucraut-Baralon C, Egberink H, Frymus T, Gruffydd-Jones T, Hartmann K, Hosie MJ, Lloret A, Lutz H, Marsilio F, Pennisi MG, Radford AD, Thiry E, Truyen U, Horzinek MC",Feline infectious peritonitis. ABCD guidelines on prevention and management,"2009","11","7","594-604",Journal of feline medicine and surgery,"","","","","","","","19481039","","",0,10,0,0,0,,,
1609,176,Merck Vet Manual: Fowlpox,website,"",Merck Veterinary Manual- Fowlpox in Chickens and Turkeys,"","","","","","","","","","","","","",http://www.merckvetmanual.com/mvm/index.jsp?cfile=htm/bc/204801.htm,"",0,10,0,0,0,,,
1610,176,Wiki: Fowlpox,website,"",Wiki: Fowlpox,"","","","","","","","","","","","","",http://en.wikipedia.org/wiki/index.html?curid=6441791,"",0,10,0,0,0,,,
1611,177,Merck Vet Manual: Infectious Canine Hepatitis,website,"",Merck Veterinary Manual- Infectious Canine Hepatitis: Introduction,"","","","","","","","","","","","","",http://www.merckvetmanual.com/mvm/index.jsp?cfile=htm/bc/57200.htm,"",0,10,0,0,0,,,
1612,178,"Oliveira and Pijoan, 2004",journal,"Oliveira S, Pijoan C","Haemophilus parasuis: new trends on diagnosis, epidemiology and control","2004","99","1","1-12",Veterinary microbiology,"","","","","","","","15019107","","",0,10,0,0,0,,,
1613,179,"Sharma, 1991",journal,Sharma JM,Hemorrhagic enteritis of turkeys,"1991","30","1","67-71",Veterinary immunology and immunopathology,"","","","","","","","1664163","","",0,10,0,0,0,,,
1614,180,"Rice et al., 2007",journal,"Rice JA, Carrasco-Medina L, Hodgins DC, Shewen PE",Mannheimia haemolytica and bovine respiratory disease,"2007","8","2","117-128",Animal health research reviews / Conference of Research Workers in Animal Diseases,"","","","","","","","18218156","","",0,10,0,0,0,,,
1615,181,"Katoh et al., 2010",journal,"Katoh H, Ogawa H, Ohya K, Fukushi H",A review of DNA viral infections in psittacine birds,"2010","72","9","1099-1106",The Journal of veterinary medical science / the Japanese Society of Veterinary Science,"","","","","","","","20424393","","",0,10,0,0,0,,,
1616,181,Merck Vet Manual: Pacheco's Disease,website,"",Merck Veterinary Manual: Pacheco's Disease,"","","","","","","","","","","","","",http://www.merckvetmanual.com/mvm/index.jsp?cfile=htm/bc/170223.htm,"",0,10,0,0,0,,,
1617,182,"Vriends et al., 2005",book,Matthew M Vriends; Tommy E Erskine; Diane Jacky; Michele Earle-Bridges,Pox and Pigeon-Related Viruses,"2005","","","74-76",Pigeons,Barron's,"Hauppauge, NY","","","","","","","","",0,10,0,0,0,,,
1618,183,"Cho and Dee, 2006",journal,"Cho JG, Dee SA",Porcine reproductive and respiratory syndrome virus,"2006","66","3","655-662",Theriogenology,"","","","","","","","16730057","","",0,10,0,0,0,,,
1619,183,"Mateu and Diaz, 2008",journal,"Mateu E, Diaz I",The challenge of PRRS immunology,"2008","177","3","345-351","Veterinary journal (London, England : 1997)","","","","","","","","17644436","","",0,10,0,0,0,,,
1620,184,"Li et al., 2010",journal,"Li YJ, Ma GP, Li GW, Qiao XY, Ge JW, Tang LJ, Liu M, Liu LW",Oral vaccination with the porcine rotavirus VP4 outer capsid protein expressed by Lactococcus lactis induces specific antibody production,"2010","2010","","708460",Journal of biomedicine & biotechnology,"","","","","","","","20625406","","",0,10,0,0,0,,,
1621,185,Merck Vet Manual: Riemerella anatipestifer,website,"",Merck Veterinary Manual- Riemerella anatipestifer Infection: Introduction,"","","","","","","","","","","","","",http://www.merckvetmanual.com/mvm/index.jsp?cfile=htm/bc/204000.htm,"",0,10,0,0,0,,,
1622,187,Wiki: Tritrichomonas foetus,website,"",Wiki: Tritrichomonas foetus,"","","","","","","","","","","","","",http://en.wikipedia.org/wiki/Tritrichomonas_foetus,"",0,10,0,0,0,,,
1623,113,"Wang et al., 2009",journal,"Wang J, Chen L, Chen F, Zhang X, Zhang Y, Baseman J, Perdue S, Yeh IT, Shain R, Holland M, Bailey R, Mabey D, Yu P, Zhong G",A chlamydial type III-secreted effector protein (Tarp) is predominantly recognized by antibodies from humans infected with Chlamydia trachomatis and induces protective immunity against upper genital tract pathologies in mice,"2009","27","22","2967-2980",Vaccine,"","","","","","","","19428908","","",0,10,0,0,0,,,
1624,200,Wiki: M. hyopneumoniae,website,"",Wiki: Mycoplasma hyopneumoniae,"","","","","","","","","","","","","",http://en.wikipedia.org/wiki/Mycoplasma_hyopneumoniae,"",0,10,0,0,0,,,
1625,200,"Maes et al., 2008",journal,"Maes D, Segales J, Meyns T, Sibila M, Pieters M, Haesebrouck F",Control of Mycoplasma hyopneumoniae infections in pigs,"2008","126","4","297-309",Veterinary microbiology,"","","","","","","","17964089","",,0,0,0,0,0,,,
1626,199,"Mengeling, 2006",book,"Barbara E. Straw, Jeffery J. Zimmerman, Sylvie D'Allaire, and David J. Taylor",Porcine Parvovirus,"2006","","","373-382","Diseases of Swine, Ninth Edition",Wiley-Blackwell,Oxford,"","081381703X","","","","","",,0,0,0,0,0,,,
1627,192,Wiki: Transmissible gastroenteritis coronavirus,website,"",Wiki: Transmissible gastroenteritis coronavirus,"","","","","","","","","","","","","",http://en.wikipedia.org/wiki/Transmissible_gastroenteritis_coronavirus,,0,0,0,0,0,,,
1628,192,"Laude et al., 1990",journal,"Laude H, Rasschaert D, Delmas B, Godet M, Gelfi J, Charley B",Molecular biology of transmissible gastroenteritis virus,"1990","23","1-4","147-154",Veterinary microbiology,"","","","","","","","2169670","",,0,0,0,0,0,,,
1629,195,Wiki: Leptospirosis,website,"",Wiki: Leptospirosis,"","","","","","","","","","","","","",http://en.wikipedia.org/wiki/Leptospirosis,"",0,10,0,0,0,,,
1630,194,Microbe Wiki: H. somnus,website,"",Microbe Wiki: Haemophilus somnus,"","","","","","","","","","","","","",http://microbewiki.kenyon.edu/index.php/Haemophilus_somnus,"",0,10,0,0,0,,,
1631,191,Wiki: Equine viral arteritis,website,"",Wiki: Equine viral arteritis,"","","","","","","","","","","","","",http://en.wikipedia.org/wiki/Equine_viral_arteritis,,0,0,0,0,0,,,
1632,190,"Ding and Zhang, 2007",journal,"Ding C, Zhang D",Molecular analysis of duck hepatitis virus type 1,"2007","361","1","9-17",Virology,"","","","","","","","17300822","",,0,0,0,0,0,,,
1633,190,Merck Vet Manual: Duck Viral Hepatitis,website,"",Merck Vet Manual: Duck Viral Hepatitis,"","","","","","","","","","","","",http://www.merckvetmanual,http://www.merckvetmanual.com/mvm/index.jsp?cfile=htm/bc/202100.htm,"",0,10,0,0,0,,,
1634,197,Wiki: C. perfringens,website,"",Wiki: C. perfringens,"","","","","","","","","","","","","",http://en.wikipedia.org/wiki/C._perfringens,,0,0,0,0,0,,,
1635,197,"Songer, 2010",journal,Songer JG,Clostridia as agents of zoonotic disease,"2010","140","3-4","399-404",Veterinary microbiology,"","","","","","","","19682805","",,0,0,0,0,0,,,
1636,189,"Tulman et al., 2004",journal,"Tulman ER, Afonso CL, Lu Z, Zsak L, Kutish GF, Rock DL",The genome of canarypox virus,"2004","78","1","353-366",Journal of virology,"","","","","","","","14671117","",,0,0,0,0,0,,,
1637,196,"Thompson, 2002",journal,Thompson SA,Campylobacter surface-layers (S-layers) and immune evasion,"2002","7","1","43-53",Annals of periodontology / the American Academy of Periodontology,"","","","","","","","16013216","",,0,0,0,0,0,,,
1638,193,Wiki: Bovine papillomavirus,website,"",Wiki: Bovine papillomavirus,"","","","","","","","","","","","","",http://en.wikipedia.org/wiki/Bovine_papillomavirus,,0,0,0,0,0,,,
1639,198,"Liu et al., 2006",journal,"Liu L, Hgglund S, Hakhverdyan M, Alenius S, Larsen LE, Belk S",Molecular epidemiology of bovine coronavirus on the basis of comparative analyses of the S gene,"2006","44","3","957-960",Journal of clinical microbiology,"","","","","","","","16517883","",,0,0,0,0,0,,,
1640,24,"Islam et al., 2010",journal,"Islam A, Raghupathy R, Albert MJ","Recombinant PorA, the major outer membrane protein of Campylobacter jejuni, provides heterologous protection in an adult mouse intestinal colonization model","2010","17","11","1666-1671",Clinical and vaccine immunology : CVI,"","","","","","","","20861330","","",0,10,0,0,0,,,
1641,30,"Bergmann-Leitner et al., 2010",journal,"Bergmann-Leitner ES, Mease RM, De La Vega P, Savranskaya T, Polhemus M, Ockenhouse C, Angov E",Immunization with pre-erythrocytic antigen CelTOS from Plasmodium falciparum elicits cross-species protection against heterologous challenge with Plasmodium berghei,"2010","5","8",e12294,PloS one,"","","","","","","","20808868","","",0,10,0,0,0,,,
1642,91,"Liu et al., 2010",journal,"Liu MM, Yuan ZG, Peng GH, Zhou DH, He XH, Yan C, Yin CC, He Y, Lin RQ, Song HQ, Zhu XQ",Toxoplasma gondii microneme protein 8 (MIC8) is a potential vaccine candidate against toxoplasmosis,"2010","106","5","1079-1084",Parasitology research,"","","","","","","","20177910","","",0,10,0,0,0,,,
1643,138,"Buzzola et al., 2006",journal,"Buzzola FR, Barbagelata MS, Caccuri RL, Sordelli DO",Attenuation and persistence of and ability to induce protective immunity to a Staphylococcus aureus aroA mutant in mice,"2006","74","6","3498-3506",Infection and immunity,"","","","","","","","16714581","","",0,10,0,0,0,,,
1644,42,"Pesciaroli et al., 2011",journal,"Pesciaroli M, Aloisio F, Ammendola S, Pistoia C, Petrucci P, Tarantino M, Francia M, Battistoni A, Pasquali P",An attenuated Salmonella enterica serovar Typhimurium strain lacking the ZnuABC transporter induces protection in a mouse intestinal model of Salmonella infection,"2011","","","",Vaccine,"","","","","","","","21219981","","",0,10,0,0,0,,,
1645,42,"Choi et al., 2010",journal,"Choi J, Shin D, Ryu S",Salmonella enterica serovar Typhimurium ruvB mutant can confer protection against salmonellosis in mice,"2010","28","39","6436-6444",Vaccine,"","","","","","","","20670908","","",0,10,0,0,0,,,
1646,42,"Zhang-Barber et al., 1998",journal,"Zhang-Barber L, Turner AK, Dougan G, Barrow PA",Protection of chickens against experimental fowl typhoid using a nuoG mutant of Salmonella serotype Gallinarum,"1998","16","9-10","899-903",Vaccine,"","","","","","","","9682335","","",0,10,0,0,0,,,
1647,42,"Paterson et al., 2009",journal,"Paterson GK, Northen H, Cone DB, Willers C, Peters SE, Maskell DJ",Deletion of tolA in Salmonella Typhimurium generates an attenuated strain with vaccine potential,"2009","155",Pt 1,"220-228","Microbiology (Reading, England)","","","","","","","","19118362","","",0,10,0,0,0,,,
1648,11,"Oyston et al., 2010",journal,"Oyston PC, Mellado-Sanchez G, Pasetti MF, Nataro JP, Titball RW, Atkins HS",A Yersinia pestis guaBA mutant is attenuated in virulence and provides protection against plague in a mouse model of infection,"2010","48","5","191-195",Microbial pathogenesis,"","","","","","","","20096773","","",0,10,0,0,0,,,
1649,42,"Dougan et al., 1987",journal,"Dougan G, Maskell D, Pickard D, Hormaeche C",Isolation of stable aroA mutants of Salmonella typhi Ty2: properties and preliminary characterisation in mice,"1987","207","2-3","402-405",Molecular & general genetics : MGG,"","","","","","","","3039297","","",0,10,0,0,0,,,
1650,81,"Liu et al., 2008",journal,"Liu M, McClure MJ, Zhu H, Xie G, Lei B",The Two-Component Regulatory System VicRK is Important to Virulence of Streptococcus equi Subspecies equi,"2008","2","","89-93",The open microbiology journal,"","","","","","","","19088917","","",0,10,0,0,0,,,
1651,47,"Roche et al., 2007",journal,"Roche AM, King SJ, Weiser JN",Live attenuated Streptococcus pneumoniae strains induce serotype-independent mucosal and systemic protection in mice,"2007","75","5","2469-2475",Infection and immunity,"","","","","","","","17339359","","",0,10,0,0,0,,,
1652,138,"Stranger-Jones et al., 2006",journal,"Stranger-Jones YK, Bae T, Schneewind O",Vaccine assembly from surface proteins of Staphylococcus aureus,"2006","103","45","16942-16947",Proceedings of the National Academy of Sciences of the United States of America,"","","","","","","","17075065","","",0,10,0,0,0,,,
1653,138,"Harro et al., 2010",journal,"Harro C, Betts R, Orenstein W, Kwak EJ, Greenberg HE, Onorato MT, Hartzel J, Lipka J, DiNubile MJ, Kartsonis N",Safety and immunogenicity of a novel Staphylococcus aureus vaccine: results from the first study of the vaccine dose range in humans,"2010","17","12","1868-1874",Clinical and vaccine immunology : CVI,"","","","","","","","20943877","","",0,10,0,0,0,,,
1654,138,"Kuklin et al., 2006",journal,"Kuklin NA, Clark DJ, Secore S, Cook J, Cope LD, McNeely T, Noble L, Brown MJ, Zorman JK, Wang XM, Pancari G, Fan H, Isett K, Burgess B, Bryan J, Brownlow M, George H, Meinz M, Liddell ME, Kelly R, Schultz L, Montgomery D, Onishi J, Losada M, Martin M, Ebert T, Tan CY, Schofield TL, Nagy E, Meineke A, Joyce JG, Kurtz MB, Caulfield MJ, Jansen KU, McClements W, Anderson AS",A novel Staphylococcus aureus vaccine: iron surface determinant B induces rapid antibody responses in rhesus macaques and specific increased survival in a murine S. aureus sepsis model,"2006","74","4","2215-2223",Infection and immunity,"","","","","","","","16552052","","",0,10,0,0,0,,,
1655,30,"Mueller et al., 2005",journal,"Mueller AK, Labaied M, Kappe SH, Matuschewski K",Genetically modified Plasmodium parasites as a protective experimental malaria vaccine,"2005","433","7022","164-167",Nature,"","","","","","","","15580261","","",0,10,0,0,0,,,
1656,11,"Bubeck and Dube, 2007",journal,"Bubeck SS, Dube PH","Yersinia pestis CO92 delta yopH is a potent live, attenuated plague vaccine","2007","14","9","1235-1238",Clinical and vaccine immunology : CVI,"","","","","","","","17652523","","",0,10,0,0,0,,,
1657,11,"Tidhar et al., 2009",journal,"Tidhar A, Flashner Y, Cohen S, Levi Y, Zauberman A, Gur D, Aftalion M, Elhanany E, Zvi A, Shafferman A, Mamroud E",The NlpD lipoprotein is a novel Yersinia pestis virulence factor essential for the development of plague,"2009","4","9",e7023,PloS one,"","","","","","","","19759820","","",0,10,0,0,0,,,
1658,11,"Flashner et al., 2004",journal,"Flashner Y, Mamroud E, Tidhar A, Ber R, Aftalion M, Gur D, Lazar S, Zvi A, Bino T, Ariel N, Velan B, Shafferman A, Cohen S",Generation of Yersinia pestis attenuated strains by signature-tagged mutagenesis in search of novel vaccine candidates,"2004","72","2","908-915",Infection and immunity,"","","","","","","","14742535","","",0,10,0,0,0,,,
1659,78,"Temprano et al., 2005",journal,"Temprano A, Riao J, Yugueros J, Gonzlez P, de Castro L, Villena A, Luengo JM, Naharro G",Potential use of a Yersinia ruckeri O1 auxotrophic aroA mutant as a live attenuated vaccine,"2005","28","7","419-427",Journal of fish diseases,"","","","","","","","16083447","","",0,10,0,0,0,,,
1660,109,"Roberts et al., 1990",journal,"Roberts M, Maskell D, Novotny P, Dougan G",Construction and characterization in vivo of Bordetella pertussis aroA mutants,"1990","58","3","732-739",Infection and immunity,"","","","","","","","2407655","","",0,10,0,0,0,,,
1661,102,"Ravichandran et al., 2006",journal,"Ravichandran M, Ali SA, Rashid NH, Kurunathan S, Yean CY, Ting LC, Bakar AS, Lalitha P, Zainuddin ZF",Construction and evaluation of a O139 Vibrio cholerae vaccine candidate based on a hemA gene mutation,"2006","24","18","3750-3761",Vaccine,"","","","","","","","16102875","","",0,10,0,0,0,,,
1662,130,"Bowe et al., 1989",journal,"Bowe F, O'Gaora P, Maskell D, Cafferkey M, Dougan G","Virulence, persistence, and immunogenicity of Yersinia enterocolitica O:8 aroA mutants","1989","57","10","3234-3236",Infection and immunity,"","","","","","","","2777382","","",0,10,0,0,0,,,
1673,29,"Pinto et al., 2004",journal,"Pinto R, Saunders BM, Camacho LR, Britton WJ, Gicquel B, Triccas JA",Mycobacterium tuberculosis defective in phthiocerol dimycocerosate translocation provides greater protective immunity against tuberculosis than the existing bacille Calmette-Gurin vaccine,"2004","189","1","105-112",The Journal of infectious diseases,"","","","","","","","14702160","","",0,10,0,0,0,,,
1664,91,"Huynh and Carruthers, 2006",journal,"Huynh MH, Carruthers VB",Toxoplasma MIC2 is a major determinant of invasion and virulence,"2006","2","8",e84,PLoS pathogens,"","","","","","","","16933991","","",0,10,0,0,0,,,
1665,166,"Stevenson and Roberts, 2002",journal,"Stevenson A, Roberts M",Use of a rationally attenuated Bordetella bronchiseptica as a live mucosal vaccine and vector for heterologous antigens,"2002","20","17-18","2325-2335",Vaccine,"","","","","","","","12009288","","",0,10,0,0,0,,,
1666,137,"Zaidi et al., 2006",journal,"Zaidi TS, Priebe GP, Pier GB",A live-attenuated Pseudomonas aeruginosa vaccine elicits outer membrane protein-specific active and passive protection against corneal infection,"2006","74","2","975-983",Infection and immunity,"","","","","","","","16428743","","",0,10,0,0,0,,,
1667,84,"Gates et al., 2008",journal,"Gates AE, Frasca S, Nyaoke A, Gorton TS, Silbart LK, Geary SJ",Comparative assessment of a metabolically attenuated Mycoplasma gallisepticum mutant as a live vaccine for the prevention of avian respiratory mycoplasmosis,"2008","26","16","2010-2019",Vaccine,"","","","","","","","18342996","","",0,10,0,0,0,,,
1668,29,"Hernandez et al., 2010",journal,"Hernandez Pando R, Aguilar LD, Smith I, Manganelli R",Immunogenicity and protection induced by a Mycobacterium tuberculosis sigE mutant in a BALB/c mouse model of progressive pulmonary tuberculosis,"2010","78","7","3168-3176",Infection and immunity,"","","","","","","","20457786","","",0,10,0,0,0,,,
1669,29,"Infante et al., 2005",journal,"Infante E, Aguilar LD, Gicquel B, Pando RH",Immunogenicity and protective efficacy of the Mycobacterium tuberculosis fadD26 mutant,"2005","141","1","21-28",Clinical and experimental immunology,"","","","","","","","15958066","","",0,10,0,0,0,,,
1670,0,"Gupta, 1998",journal,Gupta RK,Aluminum compounds as vaccine adjuvants,"1998","32","3","155-172",Advanced drug delivery reviews,"","","","","","","","10837642","","",0,10,3,0,0,,,
1671,0,Vaccine adjuvant website 1,website,"",Vaccine Adjuvants,"","","","","","","","","","","","","",http://www6.ufrgs.br/favet/imunovet/molecular_immunology/adjuvants.html,"",0,10,6,0,0,,,
1672,29,"Smith et al., 2001",journal,"Smith DA, Parish T, Stoker NG, Bancroft GJ",Characterization of auxotrophic mutants of Mycobacterium tuberculosis and their potential as vaccine candidates,"2001","69","2","1142-1150",Infection and immunity,"","","","","","","","11160012","","",0,10,0,0,0,,,
1674,29,"Sambandamurthy et al., 2002",journal,"Sambandamurthy VK, Wang X, Chen B, Russell RG, Derrick S, Collins FM, Morris SL, Jacobs WR Jr",A pantothenate auxotroph of Mycobacterium tuberculosis is highly attenuated and protects mice against tuberculosis,"2002","8","10","1171-1174",Nature medicine,"","","","","","","","12219086","","",0,10,0,0,0,,,
1675,43,"Krnell et al., 1993",journal,"Krnell A, Cam PD, Verma N, Lindberg AA",AroD deletion attenuates Shigella flexneri strain 2457T and makes it a safe and efficacious oral vaccine in monkeys,"1993","11","8","830-836",Vaccine,"","","","","","","","8356844","","",0,10,0,0,0,,,
1676,12,"Santiago et al., 2009",journal,"Santiago AE, Cole LE, Franco A, Vogel SN, Levine MM, Barry EM",Characterization of rationally attenuated Francisella tularensis vaccine strains that harbor deletions in the guaA and guaB genes,"2009","27","18","2426-2436",Vaccine,"","","","","","","","19368784","","",0,10,0,0,0,,,
1677,129,"Lamirande et al., 2008",journal,"Lamirande EW, DeDiego ML, Roberts A, Jackson JP, Alvarez E, Sheahan T, Shieh WJ, Zaki SR, Baric R, Enjuanes L, Subbarao K",A live attenuated severe acute respiratory syndrome coronavirus is immunogenic and efficacious in golden Syrian hamsters,"2008","82","15","7721-7724",Journal of virology,"","","","","","","","18463152","","",0,10,0,0,0,,,
1678,0,"Yau et al., 2006",journal,"Yau KP, Schulze DG, Johnston CT, Hem SL",Aluminum hydroxide adjuvant produced under constant reactant concentration,"2006","95","8","1822-1833",Journal of pharmaceutical sciences,"","","","","","","","16795021","","",0,10,3,0,0,,,
1679,0,"Iyer et al., 2003",journal,"Iyer S, HogenEsch H, Hem SL",Relationship between the degree of antigen adsorption to aluminum hydroxide adjuvant in interstitial fluid and antibody production,"2003","21","11-12","1219-1223",Vaccine,"","","","","","","","12559801","","",0,10,3,0,0,,,
1680,0,"Burrell et al., 2000",journal,"Burrell LS, Johnston CT, Schulze D, Klein J, White JL, Hem SL",Aluminium phosphate adjuvants prepared by precipitation at constant pH. Part I: composition and structure,"2000","19","2-3","275-281",Vaccine,"","","","","","","","10930682","","",0,10,4,0,0,,,
1681,0,"Flarend et al., 1997",journal,"Flarend RE, Hem SL, White JL, Elmore D, Suckow MA, Rudy AC, Dandashli EA",In vivo absorption of aluminium-containing vaccine adjuvants using 26Al,"1997","15","12-13","1314-1318",Vaccine,"","","","","","","","9302736","","",0,10,4,0,0,,,
1682,0,"(O'hagan et al., 2009)",website,"O'hagan, D.",Free Patents Online,"2009","","","","","","","","","","","","",http://www.freepatentsonline.com/y2009/0214592.html,"",0,10,4,0,0,,,
1683,0,"(Kindt T.J. et al., 2007)",book,"Kindt, T.J.,  Goldsby, R.A,  Osborne B.A.,",Antigens and Antibodies,"2007","","","81",Kuby immunology,Freeman and Company,"New York, NY","","1429202114","","","","","","",0,10,5,0,0,,,
1684,0,"Heidary and Cohen, 2005",journal,"Heidary N, Cohen DE",Hypersensitivity reactions to vaccine components,"2005","16","3","115-120","Dermatitis : contact, atopic, occupational, drug : official journal of the American Contact Dermatitis Society, North American Contact Dermatitis Group","","","","","","","","16242081","","",0,10,5,0,0,,,
1685,0,"Ida et al., 1989",journal,"Ida N, Sakurai S, Hosaka T, Hosoi K, Kunitomo T, Shimazu T, Maruyama T, Matsuura Y, Kohase M",Establishment of strongly neutralizing monoclonal antibody to human interleukin-6 and its epitope analysis,"1989","165","2","728-734",Biochemical and biophysical research communications,"","","","","","","","2480783","","",0,10,5,0,0,,,
1686,0,"Billiau and Matthys, 2001",journal,"Billiau A, Matthys P",Modes of action of Freund's adjuvants in experimental models of autoimmune diseases,"2001","70","6","849-860",Journal of leukocyte biology,"","","","","","","","11739546","","",0,10,8,0,0,,,
1687,0,"Qin et al., 1993",journal,"Qin HY, Sadelain MW, Hitchon C, Lauzon J, Singh B",Complete Freund's adjuvant-induced T cells prevent the development and adoptive transfer of diabetes in nonobese diabetic mice,"1993","150","5","2072-2080","Journal of immunology (Baltimore, Md. : 1950)","","","","","","","","8436836","","",0,10,8,0,0,,,
1688,0,"Gregoriadis et al., 1987",journal,"Gregoriadis G, Davis D, Davies A",Liposomes as immunological adjuvants: antigen incorporation studies,"1987","5","2","145-151",Vaccine,"","","","","","","","3604394","","",0,10,8,0,0,,,
1689,0,(Sigma Aldrich),website,"","Freunds Adjuvant, Complete","","","","","","","","","","","","","",http://www.sigmaaldrich.com/catalog/ProductDetail.do?D7=0&N5=SEARCH_CONCAT_PNO%7CBRAND_KEY&N4=F5881%7CSIGMA&N25=0&QS=ON&F=SPEC,"",0,10,8,0,0,,,
1690,0,SIGMA,website,"","FREUNDS ADJUVANT, COMPLETE - Product Info","","","","","","","","","","","","","",http://www.sigmaaldrich.com/etc/medialib/docs/Sigma/Product_Information_Sheet/f5881pis.Par.0001.File.tmp/f5881pis.pdf,"",0,10,8,0,0,,,
1691,0,"Jensen et al., 1998",journal,"Jensen FC, Savary JR, Diveley JP, Chang JC",Adjuvant activity of incomplete Freund's adjuvant,"1998","32","3","173-186",Advanced drug delivery reviews,"","","","","","","","10837643","","",0,10,9,0,0,,,
1692,0,"Gregoriadis et al., 1987",journal,"Gregoriadis G, Davis D, Davies A",Liposomes as immunological adjuvants: antigen incorporation studies,"1987","5","2","145-151",Vaccine,"","","","","","","","3604394","","",0,10,9,0,0,,,
1693,0,"Adam et al., 1972",journal,"Adam A, Ciorbaru R, Petit JF, Lederer E","Isolation and properties of a macromolecular, water-soluble, immuno-adjuvant fraction from the cell wall of Mycobacterium smegmatis","1972","69","4","851-854",Proceedings of the National Academy of Sciences of the United States of America,"","","","","","","","4502937","","",0,10,9,0,0,,,
1694,0,"Qin et al., 1993",journal,"Qin HY, Sadelain MW, Hitchon C, Lauzon J, Singh B",Complete Freund's adjuvant-induced T cells prevent the development and adoptive transfer of diabetes in nonobese diabetic mice,"1993","150","5","2072-2080","Journal of immunology (Baltimore, Md. : 1950)","","","","","","","","8436836","","",0,10,9,0,0,,,
1695,0,"Bomford, 1980",journal,Bomford R,"The comparative selectivity of adjuvants for humoral and cell-mediated immunity. II. Effect on delayed-type hypersensitivity in the mouse and guinea pig, and cell-mediated immunity to tumour antigens in the mouse of Freund's incomplete and complete adjuvants, alhydrogel, Corynebacterium parvum, Bordetella pertussis, muramyl dipeptide and saponin","1980","39","2","435-441",Clinical and experimental immunology,"","","","","","","","6248283","","",0,10,9,0,0,,,
1696,0,"Miller et al., 2005",journal,"Miller LH, Saul A, Mahanty S",Revisiting Freund's incomplete adjuvant for vaccines in the developing world,"2005","21","9","412-414",Trends in parasitology,"","","","","","","","16043410","","",0,10,9,0,0,,,
1697,0,(Sigma Aldrich),website,"","Freunds Adjuvant, Incomplete","","","","","","","","","","","","","",http://www.sigmaaldrich.com/catalog/ProductDetail.do?D7=0&N5=SEARCH_CONCAT_PNO%7CBRAND_KEY&N4=F5506%7CSIGMA&N25=0&QS=ON&F=SPEC,"",0,10,9,0,0,,,
1698,0,"Cox and Coulter, 1997",journal,"Cox JC, Coulter AR",Adjuvants--a classification and review of their modes of action,"1997","15","3","248-256",Vaccine,"","","","","","","","9139482","","",0,10,7,0,0,,,
1699,0,"Sjlander et al., 1998",journal,"Sjlander A, Cox JC, Barr IG",ISCOMs: an adjuvant with multiple functions,"1998","64","6","713-723",Journal of leukocyte biology,"","","","","","","","9850152","","",0,10,7,0,0,,,
1700,0,"Coulter et al., 2003",journal,"Coulter A, Harris R, Davis R, Drane D, Cox J, Ryan D, Sutton P, Rockman S, Pearse M",Intranasal vaccination with ISCOMATRIX adjuvanted influenza vaccine,"2003","21","9-10","946-949",Vaccine,"","","","","","","","12547607","","",0,10,7,0,0,,,
1701,0,"McCluskie et al., 2000",journal,"McCluskie MJ, Weeratna RD, Krieg AM, Davis HL",CpG DNA is an effective oral adjuvant to protein antigens in mice,"2000","19","7-8","950-957",Vaccine,"","","","","","","","11115721","","",0,10,10,0,0,,,
1702,0,"Klinman et al., 1999",journal,"Klinman DM, Barnhart KM, Conover J",CpG motifs as immune adjuvants,"1999","17","1","19-25",Vaccine,"","","","","","","","10078603","","",0,10,10,0,0,,,
1703,0,"McCluskie and Davis, 1999",journal,"McCluskie MJ, Davis HL",CpG DNA as mucosal adjuvant,"1999","18","3-4","231-237",Vaccine,"","","","","","","","10506647","","",0,10,10,0,0,,,
1704,0,"(Hackett et al., 2006)",journal,"Hackett, C.J.,  Harn D.A.",CpG ODN as a Th1 Immune Enhancer for Prophylactic  and Therapeutic Vaccines,"2006","","","90-92",VACCINE ADJUVANTS: Immunological and Clinical Principles,Human Press Inc.,"Totowa, NJ","","","","","","","","",0,10,10,0,0,,,
1705,0,"Hrnquist and Lycke, 1993",journal,"Hrnquist E, Lycke N",Cholera toxin adjuvant greatly promotes antigen priming of T cells,"1993","23","9","2136-2143",European journal of immunology,"","","","","","","","8370397","","",0,10,11,0,0,,,
1706,0,"van et al., 2000",journal,"van Ginkel FW, Jackson RJ, Yuki Y, McGhee JR",Cutting edge: the mucosal adjuvant cholera toxin redirects vaccine proteins into olfactory tissues,"2000","165","9","4778-4782","Journal of immunology (Baltimore, Md. : 1950)","","","","","","","","11045998","","",0,10,11,0,0,,,
1707,0,"Vajdy and Lycke, 1992",journal,"Vajdy M, Lycke NY",Cholera toxin adjuvant promotes long-term immunological memory in the gut mucosa to unrelated immunogens after oral immunization,"1992","75","3","488-492",Immunology,"","","","","","","","1572696","","",0,10,11,0,0,,,
1708,0,"Hagiwara et al., 1999",journal,"Hagiwara Y, Komase K, Chen Z, Matsuo K, Suzuki Y, Aizawa C, Kurata T, Tamura S",Mutants of cholera toxin as an effective and safe adjuvant for nasal influenza vaccine,"1999","17","22","2918-2926",Vaccine,"","","","","","","","10438064","","",0,10,11,0,0,,,
1709,0,"Blanchard et al., 1998",journal,"Blanchard TG, Lycke N, Czinn SJ, Nedrud JG",Recombinant cholera toxin B subunit is not an effective mucosal adjuvant for oral immunization of mice against Helicobacter felis,"1998","94","1","22-27",Immunology,"","","","","","","","9708182","","",0,10,12,0,0,,,
1710,0,"McKenzie and Halsey, 1984",journal,"McKenzie SJ, Halsey JF",Cholera toxin B subunit as a carrier protein to stimulate a mucosal immune response,"1984","133","4","1818-1824","Journal of immunology (Baltimore, Md. : 1950)","","","","","","","","6470484","","",0,10,12,0,0,,,
1711,0,"Tamura et al., 1988",journal,"Tamura S, Samegai Y, Kurata H, Nagamine T, Aizawa C, Kurata T",Protection against influenza virus infection by vaccine inoculated intranasally with cholera toxin B subunit,"1988","6","5","409-413",Vaccine,"","","","","","","","2848377","","",0,10,12,0,0,,,
1712,0,"Hagiwara et al., 1999",journal,"Hagiwara Y, Komase K, Chen Z, Matsuo K, Suzuki Y, Aizawa C, Kurata T, Tamura S",Mutants of cholera toxin as an effective and safe adjuvant for nasal influenza vaccine,"1999","17","22","2918-2926",Vaccine,"","","","","","","","10438064","","",0,10,12,0,0,,,
1713,0,Sigma Aldrich,website,"",Cholera Toxin B subunit,"","","","","","","","","","","","","",http://www.sigmaaldrich.com/catalog/ProductDetail.do?D7=0&N5=SEARCH_CONCAT_PNO%7CBRAND_KEY&N4=C1655%7CSIGMA&N25=0&QS=ON&F=SPEC,"",0,10,12,0,0,,,
1714,0,"Skene and Sutton, 2006",journal,"Skene CD, Sutton P",Saponin-adjuvanted particulate vaccines for clinical use,"2006","40","1","53-59","Methods (San Diego, Calif.)","","","","","","","","16997713","","",0,10,14,0,0,,,
1715,0,"Estrada et al., 2000",journal,"Estrada A, Katselis GS, Laarveld B, Barl B",Isolation and evaluation of immunological adjuvant activities of saponins from Polygala senega L,"2000","23","1","27-43","Comparative immunology, microbiology and infectious diseases","","","","","","","","10660256","","",0,10,14,0,0,,,
1716,0,"Liu et al., 2002",journal,"Liu G, Anderson C, Scaltreto H, Barbon J, Kensil CR",QS-21 structure/function studies: effect of acylation on adjuvant activity,"2002","20","21-22","2808-2815",Vaccine,"","","","","","","","12034108","","",0,10,14,0,0,,,
1717,0,"Coulter et al., 2003",journal,"Coulter A, Harris R, Davis R, Drane D, Cox J, Ryan D, Sutton P, Rockman S, Pearse M",Intranasal vaccination with ISCOMATRIX adjuvanted influenza vaccine,"2003","21","9-10","946-949",Vaccine,"","","","","","","","12547607","","",0,10,14,0,0,,,
1718,0,"Sjlander et al., 1998",journal,"Sjlander A, Cox JC, Barr IG",ISCOMs: an adjuvant with multiple functions,"1998","64","6","713-723",Journal of leukocyte biology,"","","","","","","","9850152","","",0,10,14,0,0,,,
1719,0,"Rom, 1992",book,Rom WN,Page 470,"1992","","","","Environmental and Occupational Medicine, 2nd edition","Little, Brown and Company","Boston, MA","",isbn,"","","","","","",0,10,3,0,0,,,
1720,0,"Rom, 1992",book,Rom WN,"","1992","","","","Environmental and Occupational Medicine, 2nd edition","Little, Brown and Company","Boston, MA","","","","","","","",,0,0,1,0,0,,,
1721,161,"Dagleish et al., 2007",journal,"Dagleish MP, Hodgson JC, Ataei S, Finucane A, Finlayson J, Sales J, Parton R, Coote JG",Safety and protective efficacy of intramuscular vaccination with a live aroA derivative of Pasteurella multocida B:2 against experimental hemorrhagic septicemia in calves,"2007","75","12","5837-5844",Infection and immunity,"","","","","","","","17875632","","",0,10,0,0,0,,,
1722,121,"Srilunchang et al., 2009",journal,"Srilunchang T, Proungvitaya T, Wongratanacheewin S, Strugnell R, Homchampa P",Construction and characterization of an unmarked aroC deletion mutant of Burkholderia pseudomallei strain A2,"2009","40","1","123-130",The Southeast Asian journal of tropical medicine and public health,"","","","","","","","19323044","","",0,10,0,0,0,,,
1723,0,"Nakamura and Mori, 1984",journal,"Nakamura S, Mori KJ",Effects of reticuloendothelial blockade on acute saponin poisoning in mice,"1984","29","3","235-242",Toxicology,"","","","","","","","6695384","","",0,10,14,0,0,,,
1724,0,"Klinguer-Hamour et al., 2002",journal,"Klinguer-Hamour C, Libon C, Plotnicky-Gilquin H, Bussat MC, Revy L, Nguyen T, Bonnefoy JY, Corvaa N, Beck A","DDA adjuvant induces a mixed Th1/Th2 immune response when associated with BBG2Na, a respiratory syncytial virus potential vaccine","2002","20","21-22","2743-2751",Vaccine,"","","","","","","","12034101","","",0,10,15,0,0,,,
1725,0,"Christensen et al., 2007",journal,"Christensen D, Foged C, Rosenkrands I, Nielsen HM, Andersen P, Agger EM",Trehalose preserves DDA/TDB liposomes and their adjuvant effect during freeze-drying,"2007","1768","9","2120-2129",Biochimica et biophysica acta,"","","","","","","","17555704","","",0,10,15,0,0,,,
1726,0,Sigma Aldrich,website,"",Sigma Aldrich,"","","","","","","","","","","","","",http://www.sigmaaldrich.com/etc/medialib/docs/Sigma/Product_Information_Sheet/d2779pis.Par.0001.File.tmp/d2779pis.pdf,"",0,10,15,0,0,,,
1727,0,"Allison, 1999",journal,Allison AC,Squalene and squalane emulsions as adjuvants,"1999","19","1","87-93","Methods (San Diego, Calif.)","","","","","","","","10525443","","",0,10,16,0,0,,,
1728,0,"Bassaganya-Riera et al., 2001",journal,"Bassaganya-Riera J, Hontecillas R, Zimmerman DR, Wannemuehler MJ",Dietary conjugated linoleic acid modulates phenotype and effector functions of porcine CD8(+) lymphocytes,"2001","131","9","2370-2377",The Journal of nutrition,"","","","","","","","11533281","","",0,10,16,0,0,,,
1729,0,"Plant et al., 2003",journal,"Plant A, Williams R, Jackson ME, Williams NA","The B subunit of Escherichia coli heat labile enterotoxin abrogates oral tolerance, promoting predominantly Th2-type immune responses","2003","33","11","3186-3195",European journal of immunology,"","","","","","","","14579287","","",0,10,17,0,0,,,
1730,0,"Nashar et al., 1996",journal,"Nashar TO, Webb HM, Eaglestone S, Williams NA, Hirst TR",Potent immunogenicity of the B subunits of Escherichia coli heat-labile enterotoxin: receptor binding is essential and induces differential modulation of lymphocyte subsets,"1996","93","1","226-230",Proceedings of the National Academy of Sciences of the United States of America,"","","","","","","","8552610","","",0,10,17,0,0,,,
1731,0,"Richards et al., 2001",journal,"Richards CM, Aman AT, Hirst TR, Hill TJ, Williams NA",Protective mucosal immunity to ocular herpes simplex virus type 1 infection in mice by using Escherichia coli heat-labile enterotoxin B subunit as an adjuvant,"2001","75","4","1664-1671",Journal of virology,"","","","","","","","11160664","","",0,10,17,0,0,,,
1732,0,"Rao et al., 1996",journal,"Rao JB, Chamberlain RS, Bronte V, Carroll MW, Irvine KR, Moss B, Rosenberg SA, Restifo NP",IL-12 is an effective adjuvant to recombinant vaccinia virus-based tumor vaccines: enhancement by simultaneous B7-1 expression,"1996","156","9","3357-3365","Journal of immunology (Baltimore, Md. : 1950)","","","","","","","","8617961","","",0,10,18,0,0,,,
1733,0,"Portielje et al., 2003",journal,"Portielje JE, Gratama JW, van Ojik HH, Stoter G, Kruit WH",IL-12: a promising adjuvant for cancer vaccination,"2003","52","3","133-144","Cancer immunology, immunotherapy : CII","","","","","","","","12649742","","",0,10,18,0,0,,,
1734,0,"Ryan et al., 1999",journal,"Ryan EJ, McNeela E, Murphy GA, Stewart H, O'hagan D, Pizza M, Rappuoli R, Mills KH",Mutants of Escherichia coli heat-labile toxin act as effective mucosal adjuvants for nasal delivery of an acellular pertussis vaccine: differential effects of the nontoxic AB complex and enzyme activity on Th1 and Th2 cells,"1999","67","12","6270-6280",Infection and immunity,"","","","","","","","10569737","","",0,10,19,0,0,,,
1735,0,"Marchetti et al., 1998",journal,"Marchetti M, Rossi M, Giannelli V, Giuliani MM, Pizza M, Censini S, Covacci A, Massari P, Pagliaccia C, Manetti R, Telford JL, Douce G, Dougan G, Rappuoli R, Ghiara P",Protection against Helicobacter pylori infection in mice by intragastric vaccination with H. pylori antigens is achieved using a non-toxic mutant of E. coli heat-labile enterotoxin (LT) as adjuvant,"1998","16","1","33-37",Vaccine,"","","","","","","","9607006","","",0,10,19,0,0,,,
1736,0,Sigma Aldrich,website,"",Sigma Aldrich,"","","","","","","","","","","","","",http://www.sigmaaldrich.com/catalog/ProductDetail.do?D7=0&N5=SEARCH_CONCAT_PNO|BRAND_KEY&N4=T2684|SIGMA&N25=0&QS=ON&F=SPEC,"",0,10,20,0,0,,,
1737,0,"Zhou and Afshar, 1995",journal,"Zhou EM, Afshar A",Comparison of Freund's adjuvant and TiterMax in inducing anti-idiotype to idiotypic antibodies against pseudorabies virus antigens,"1995","48","1-2","113-122",Veterinary immunology and immunopathology,"","","","","","","","8533307","","",0,10,20,0,0,,,
1738,0,"Rosa et al., 2004",journal,"Rosa DS, Tzelepis F, Cunha MG, Soares IS, Rodrigues MM",The pan HLA DR-binding epitope improves adjuvant-assisted immunization with a recombinant protein containing a malaria vaccine candidate,"2004","92","3","259-268",Immunology letters,"","","","","","","","15081621","","",0,10,20,0,0,,,
1739,0,"Robuccio et al., 1995",journal,"Robuccio JA, Griffith JW, Chroscinski EA, Cross PJ, Light TE, Lang CM",Comparison of the effects of five adjuvants on the antibody response to influenza virus antigen in guinea pigs,"1995","45","4","420-426",Laboratory animal science,"","","","","","","","7474883","","",0,10,20,0,0,,,
1740,0,Sigma Aldrich,website,"",Sigma Aldrich,"","","","","","","","","","","","","",http://www.sigmaaldrich.com/catalog/ProductDetail.do?D7=0&N5=SEARCH_CONCAT_PNO%7CBRAND_KEY&N4=M6661%7CSIGMA&N25=0&QS=ON&F=SPEC,"",0,10,21,0,0,,,
1741,0,"Deeb et al., 1992",journal,"Deeb BJ, DiGiacomo RF, Kunz LL, Stewart JL",Comparison of Freund's and Ribi adjuvants for inducing antibodies to the synthetic antigen (TG)-AL in rabbits,"1992","152","1","105-113",Journal of immunological methods,"","","","","","","","1640105","","",0,10,21,0,0,,,
1742,0,"Lawrence et al., 1997",journal,"Lawrence GW, Saul A, Giddy AJ, Kemp R, Pye D",Phase I trial in humans of an oil-based adjuvant SEPPIC MONTANIDE ISA 720,"1997","15","2","176-178",Vaccine,"","","","","","","","9066035","","",0,10,22,0,0,,,
1743,0,"Mata et al., 2007",journal,"Mata E, Carcaboso AM, Hernndez RM, Igartua M, Corradin G, Pedraz JL",Adjuvant activity of polymer microparticles and Montanide ISA 720 on immune responses to Plasmodium falciparum MSP2 long synthetic peptides in mice,"2007","25","5","877-885",Vaccine,"","","","","","","","17070628","","",0,10,22,0,0,,,
1744,0,"Perlmann et al., 2002",book,"P. Perlmann, M. Troye-Blomberg","","2002","","","","Malaria Immunology: 2nd Edition, Vol. 80",Reinhardt Druck,"","","3-8055-7376-6","","","","",http://books.google.com/books?id=K7Jq-Lrt_hsC&pg=PA90&dq=malaria+immunology+++montanide+isa&hl=en&ei=cFdzTbXTBoeFtgfHn_C-Bg&sa=X&oi=book_result&ct=result&resnum=1&ved=0CDUQ6AEwAA#v=onepage&q&f=false,"",0,10,22,0,0,,,
1745,0,"Gupta et al., 1993",journal,"Gupta RK, Relyveld EH, Lindblad EB, Bizzini B, Ben-Efraim S, Gupta CK",Adjuvants--a balance between toxicity and adjuvanticity,"1993","11","3","293-306",Vaccine,"","","","","","","","8447157","","",0,10,23,0,0,,,
1746,0,"Mastroeni et al., 1985",journal,"Mastroeni P, Bizzini B, Bonina L, Iannello D, Merendino RA, Delfino D, Berlinghieri MC, Leonardi MS, Arena A, Liberto MC",The restoration of impaired macrophage functions using as immunomodulator the Corynebacterium granulosum-derived P40 fraction,"1985","10","1","27-34",Immunopharmacology,"","","","","","","","2997082","","",0,10,23,0,0,,,
1747,0,"Evans et al., 2003",journal,"Evans JT, Cluff CW, Johnson DA, Lacy MJ, Persing DH, Baldridge JR",Enhancement of antigen-specific immunity via the TLR4 ligands MPL adjuvant and Ribi.529,"2003","2","2","219-229",Expert review of vaccines,"","","","","","","","12899573","","",0,10,24,0,0,,,
1748,0,"Giannini et al., 2006",journal,"Giannini SL, Hanon E, Moris P, Van Mechelen M, Morel S, Dessy F, Fourneau MA, Colau B, Suzich J, Losonksy G, Martin MT, Dubin G, Wettendorff MA",Enhanced humoral and memory B cellular immunity using HPV16/18 L1 VLP vaccine formulated with the MPL/aluminium salt combination (AS04) compared to aluminium salt only,"2006","24","33-34","5937-5949",Vaccine,"","","","","","","","16828940","","",0,10,24,0,0,,,
1749,0,"Mothes et al., 2003",journal,"Mothes N, Heinzkill M, Drachenberg KJ, Sperr WR, Krauth MT, Majlesi Y, Semper H, Valent P, Niederberger V, Kraft D, Valenta R",Allergen-specific immunotherapy with a monophosphoryl lipid A-adjuvanted vaccine: reduced seasonally boosted immunoglobulin E production and inhibition of basophil histamine release by therapy-induced blocking antibodies,"2003","33","9","1198-1208",Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology,"","","","","","","","12956739","","",0,10,24,0,0,,,
1750,0,"McKee et al., 2007",journal,"McKee AS, Munks MW, Marrack P",How do adjuvants work? Important considerations for new generation adjuvants,"2007","27","5","687-690",Immunity,"","","","","","","","18031690","","",0,10,25,0,0,,,
1751,0,"McKee et al., 2007",journal,"McKee AS, Munks MW, Marrack P",How do adjuvants work? Important considerations for new generation adjuvants,"2007","27","5","687-690",Immunity,"","","","","","","","18031690","","",0,10,26,0,0,,,
1752,0,"Jamalan et al., 2011",journal,"Jamalan M, Ardestani SK, Zeinali M, Mosaveri N, Mohammad Taheri M",Effectiveness of Brucella abortus lipopolysaccharide as an adjuvant for tuberculin PPD,"2011","39","1","23-28",Biologicals : journal of the International Association of Biological Standardization,"","","","","","","","20965746","","",0,10,27,0,0,,,
1753,0,"Skidmore et al., 1975",journal,"Skidmore BJ, Chiller JM, Morrison DC, Weigle WO","Immunologic properties of bacterial lipopolysaccharide (LPS): correlation between the mitogenic, adjuvant, and immunogenic activities","1975","114","2 pt 2","770-775","Journal of immunology (Baltimore, Md. : 1950)","","","","","","","","46249","","",0,10,27,0,0,,,
1754,0,"Oppenheim et al., 1980",journal,"Oppenheim JJ, Togawa A, Chedid L, Mizel S",Components of mycobacteria and muramyl dipeptide with adjuvant activity induce lymphocyte activating factor,"1980","50","1","71-81",Cellular immunology,"","","","","","","","6967358","","",0,10,28,0,0,,,
1755,0,"Sugimoto et al., 1978",journal,"Sugimoto M, Germain RN, Chedid L, Benacerraf B","Enhancement of carrier-specific helper T cell function by the synthetic adjuvant, N-acetyl muramyl-L-alanyl-D-isoglutamine (MDP)","1978","120","3","980-982","Journal of immunology (Baltimore, Md. : 1950)","","","","","","","","344799","","",0,10,28,0,0,,,
1756,0,"Gupta and Siber, 1994",journal,"Gupta RK, Siber GR","Comparison of adjuvant activities of aluminium phosphate, calcium phosphate and stearyl tyrosine for tetanus toxoid","1994","22","1","53-63",Biologicals : journal of the International Association of Biological Standardization,"","","","","","","","8068314","","",0,11,29,0,0,,,
1757,0,"He et al., 2000",journal,"He Q, Mitchell AR, Johnson SL, Wagner-Bartak C, Morcol T, Bell SJ",Calcium phosphate nanoparticle adjuvant,"2000","7","6","899-903",Clinical and diagnostic laboratory immunology,"","","","","","","","11063495","","",0,11,29,0,0,,,
1758,0,"Adlam and Scott, 1973",journal,"Adlam C, Scott MT",Lympho-reticular stimulatory properties of Corynebacterium parvum and related bacteria,"1973","6","3","261-274",Journal of medical microbiology,"","","","","","","","4726332","","",0,10,30,0,0,,,
1759,0,"Fisher et al., 1970",journal,"Fisher JC, Grace WR, Mannick JA",The effect of nonspecific immune stimulation with corynebacterium parvum on patterns of tumor growth,"1970","26","6","1379-1382",Cancer,"","","","","","","","5483667","","",0,10,30,0,0,,,
1760,0,"Wu et al., 2008",journal,"Wu Y, Ellis RD, Shaffer D, Fontes E, Malkin EM, Mahanty S, Fay MP, Narum D, Rausch K, Miles AP, Aebig J, Orcutt A, Muratova O, Song G, Lambert L, Zhu D, Miura K, Long C, Saul A, Miller LH, Durbin AP",Phase 1 trial of malaria transmission blocking vaccine candidates Pfs25 and Pvs25 formulated with montanide ISA 51,"2008","3","7",e2636,PloS one,"","","","","","","","18612426","","",0,10,31,0,0,,,
1761,0,"Adlam and Scott, 1973",journal,"Adlam C, Scott MT",Lympho-reticular stimulatory properties of Corynebacterium parvum and related bacteria,"1973","6","3","261-274",Journal of medical microbiology,"","","","","","","","4726332","","",0,10,32,0,0,,,
1762,0,"Athanassiades, 1977",journal,Athanassiades TJ,Adjuvant effect of Bordetella pertussis vaccine to sheep erythrocytes in mice: enhancement of cell-mediated immunity by subcutaneous administration of adjuvant and antigen,"1977","18","2","416-423",Infection and immunity,"","","","","","","","924677","","",0,10,32,0,0,,,
1763,0,"Ravindran et al., 2010",journal,"Ravindran R, Bhowmick S, Das A, Ali N","Comparison of BCG, MPL and cationic liposome adjuvant systems in leishmanial antigen vaccine formulations against murine visceral leishmaniasis","2010","10","","181",BMC microbiology,"","","","","","","","20576102","","",0,10,33,0,0,,,
1764,0,"Bhowmick et al., 2008",journal,"Bhowmick S, Ravindran R, Ali N",gp63 in stable cationic liposomes confers sustained vaccine immunity to susceptible BALB/c mice infected with Leishmania donovani,"2008","76","3","1003-1015",Infection and immunity,"","","","","","","","18195029","","",0,10,33,0,0,,,
1765,0,"Ma et al., 2009",journal,Yifan Ma;  Dongmei Zhou;  Xiaofang Xie;  Bohan Dong;  Yan Zhuang;  Mingbin Zheng,A novel low-toxic liposomal adjuvant: Different liposome compositions regulate monocyte activation and viability,November 2009,"","","","","","","","","","","","",http://ieeexplore.ieee.org/xpl/freeabs_all.jsp?arnumber=5373686,"",0,10,33,0,0,,,
1766,0,"Zdek et al., 1993",journal,"Zdek Z, Masek K, Frankov D, Flegel M","T-cell-dependent immunobiological activity of a desmuramyl analog of muramyl dipeptide, adamantylamide dipeptide (AdDP), and D-isoglutamine","1993","15","5","631-637",International journal of immunopharmacology,"","","","","","","","8375945","","",0,10,34,0,0,,,
1767,0,"Tengerdy and Lacetera, 1991",journal,"Tengerdy RP, Lacetera NG",Vitamin E adjuvant formulations in mice,"1991","9","3","204-206",Vaccine,"","","","","","","","2042393","","",0,10,35,0,0,,,
1768,0,"Gomes et al., 1978",journal,Ivo Gomes ; P. Auge de Mello,Comparison of Oil Adjuvanted Vaccines Prepared with Arlacel A and Montanide 80,"1978","","","43-44","","","","","","","","","",http://bvs1.panaftosa.org.br/local/File/textoc/Bol31-32-p43-44ingGomes.pdf,"",0,10,35,0,0,,,
1769,0,"Van et al., 2005",journal,"Van Donkersgoed J, Hancock D, Rogan D, Potter AA",Escherichia coli O157:H7 vaccine field trial in 9 feedlots in Alberta and Saskatchewan,"2005","46","8","724-728",The Canadian veterinary journal. La revue veterinaire canadienne,"","","","","","","","16187717","","",0,10,36,0,0,,,
1770,0,"Tengerdy and Lacetera, 1991",journal,"Tengerdy RP, Lacetera NG",Vitamin E adjuvant formulations in mice,"1991","9","3","204-206",Vaccine,"","","","","","","","2042393","","",0,11,37,0,0,,,
1771,0,"Gomes et al., 1978",journal,Ivo Gomes ; P. Auge de Mello,Comparison of Oil Adjuvanted Vaccines Prepared with Arlacel A and Montanide 80,"1978","","","",Bltn Centro Panamericano Fiebre Aftosa,"","","","","","","","",http://bvs1.panaftosa.org.br/local/File/textoc/Bol31-32-p43-44ingGomes.pdf,"",0,11,37,0,0,,,
1772,0,MVP Laboratories Inc.,website,MVP Laboratories Inc.,POLYGEN (co-polymer based adjuvant),"","","","","","","","","","","","","",http://www.mvp-technologies.com/adjuvants/Polygen%20Final%20Technical%20Bulletin.pdf,"",0,10,38,0,0,,,
1773,180,"Homchampa et al., 1994",journal,"Homchampa P, Strugnell RA, Adler B",Construction and vaccine potential of an aroA mutant of Pasteurella haemolytica,"1994","42","1","35-44",Veterinary microbiology,"","","","","","","","7839583","","",0,10,0,0,0,,,
1774,136,"Darji et al., 2003",journal,"Darji A, Mohamed W, Domann E, Chakraborty T",Induction of immune responses by attenuated isogenic mutant strains of Listeria monocytogenes,"2003","21 Suppl 2","",S102-109,Vaccine,"","","","","","","","12763691","","",0,10,0,0,0,,,
1775,97,"Selvapandiyan et al., 2009",journal,"Selvapandiyan A, Dey R, Nylen S, Duncan R, Sacks D, Nakhasi HL",Intracellular replication-deficient Leishmania donovani induces long lasting protective immunity against visceral leishmaniasis,"2009","183","3","1813-1820","Journal of immunology (Baltimore, Md. : 1950)","","","","","","","","19592661","","",0,10,0,0,0,,,
1776,0,"Munks et al., 2010",journal,"Munks MW, McKee AS, Macleod MK, Powell RL, Degen JL, Reisdorph NA, Kappler JW, Marrack P",Aluminum adjuvants elicit fibrin-dependent extracellular traps in vivo,"2010","116","24","5191-5199",Blood,"","","","","","","","20876456","","",0,10,6,0,0,,,
1777,0,Vaccine Adjuvant Website1,website,"","","","","","","","","","","","","","","",http://www.niaid.nih.gov/LabsAndResources/labs/aboutlabs/lmiv/productGroups/Pages/asexual.aspx,"",0,10,6,0,0,,,
1778,0,"Vogel and Powell, 1995",journal,"Vogel FR, Powell MF",A compendium of vaccine adjuvants and excipients,"1995","6","","141-228",Pharmaceutical biotechnology,"","","","","","","","7551218","","",0,10,6,0,0,,,
1779,0,TOXNET: SODIUM ALUMINUM PHOSPHATE,website,TOXNET - Toxicology Data Network,SODIUM ALUMINUM PHOSPHATE,"","","","","","","","","","","","","",http://toxnet.nlm.nih.gov/cgi-bin/sis/search/a?dbs+hsdb:@term+@DOCNO+691,"",0,10,4,0,0,,,
1780,0,"Vogel and Powell, 1995",journal,"Vogel FR, Powell MF",A compendium of vaccine adjuvants and excipients,"1995","6","","141-228",Pharmaceutical biotechnology,"","","","","","","","7551218","","",0,10,39,0,0,,,
1781,0,"Vogel and Powell, 1995",journal,"Vogel FR, Powell MF",A compendium of vaccine adjuvants and excipients,"1995","6","","141-228",Pharmaceutical biotechnology,"","","","","","","","7551218","","",0,10,40,0,0,,,
1782,0,"Vogel and Powell, 1995",journal,"Vogel FR, Powell MF",A compendium of vaccine adjuvants and excipients,"1995","6","","141-228",Pharmaceutical biotechnology,"","","","","","","","7551218","","",0,10,41,0,0,,,
1783,106,"Kofler et al., 2002",journal,"Kofler RM, Heinz FX, Mandl CW",Capsid protein C of tick-borne encephalitis virus tolerates large internal deletions and is a favorable target for attenuation of virulence,"2002","76","7","3534-3543",Journal of virology,"","","","","","","","11884577","","",0,10,0,0,0,,,
1784,68,"Schlick et al., 2010",journal,"Schlick P, Kofler RM, Schittl B, Taucher C, Nagy E, Meinke A, Mandl CW",Characterization of West Nile virus live vaccine candidates attenuated by capsid deletion mutations,"2010","28","36","5903-5909",Vaccine,"","","","","","","","20600500","","",0,10,0,0,0,,,
1785,42,"Adriaensen et al., 2007",journal,"Adriaensen C, De Greve H, Tian JQ, De Craeye S, Gubbels E, Eeckhaut V, Van Immerseel F, Ducatelle R, Kumar M, Hernalsteens JP",A live Salmonella enterica serovar Enteritidis vaccine allows serological differentiation between vaccinated and infected animals,"2007","75","5","2461-2468",Infection and immunity,"","","","","","","","17261603","","",0,10,0,0,0,,,
1786,8,"Rosinha et al., 2002a",journal,"Rosinha GM, Freitas DA, Miyoshi A, Azevedo V, Campos E, Cravero SL, Rossetti O, Splitter G, Oliveira SC",Identification and characterization of a Brucella abortus ATP-binding cassette transporter homolog to Rhizobium meliloti ExsA and its role in virulence and protection in mice,"2002","70","9","5036-5044",Infection and immunity,"","","","","","","","12183550","","",0,10,0,0,0,,,
1787,25,"Liu et al., 2009",journal,"Liu J, Sun Y, Feng S, Zhu L, Guo X, Qi C",Towards an attenuated enterohemorrhagic Escherichia coli O157:H7 vaccine characterized by a deleted ler gene and containing apathogenic Shiga toxins,"2009","27","43","5929-5935",Vaccine,"","","","","","","","19682616","","",0,10,0,0,0,,,
1788,25,"Billips et al., 2009",journal,"Billips BK, Yaggie RE, Cashy JP, Schaeffer AJ, Klumpp DJ",A live-attenuated vaccine for the treatment of urinary tract infection by uropathogenic Escherichia coli,"2009","200","2","263-272",The Journal of infectious diseases,"","","","","","","","19522648","","",0,10,0,0,0,,,
1789,42,"Humphreys et al., 1999",journal,"Humphreys S, Stevenson A, Bacon A, Weinhardt AB, Roberts M","The alternative sigma factor, sigmaE, is critically important for the virulence of Salmonella typhimurium","1999","67","4","1560-1568",Infection and immunity,"","","","","","","","10084987","","",0,10,0,0,0,,,
1790,154,"Pistello et al., 2005",journal,"Pistello M, Bonci F, Isola P, Mazzetti P, Merico A, Zaccaro L, Matteucci D, Bendinelli M",Evaluation of feline immunodeficiency virus ORF-A mutants as candidate attenuated vaccine,"2005","332","2","676-690",Virology,"","","","","","","","15680433","","",0,10,0,0,0,,,
1791,12,"Jia et al., 2010",journal,"Jia Q, Lee BY, Bowen R, Dillon BJ, Som SM, Horwitz MA","A Francisella tularensis live vaccine strain (LVS) mutant with a deletion in capB, encoding a putative capsular biosynthesis protein, is significantly more attenuated than LVS yet induces potent protective immunity in mice against F. tularensis challenge","2010","78","10","4341-4355",Infection and immunity,"","","","","","","","20643859","","",0,10,0,0,0,,,
1792,202,"Gonzlez et al., 2011",journal,"Gonzlez LM, Ramiro R, Garca L, Parkhouse RM, McManus DP, Grate T",Genetic variability of the 18kDa/HP6 protective antigen in Taenia saginata and Taenia asiatica: Implications for vaccine development,"2011","176","2","131-134",Molecular and biochemical parasitology,"","","","","","","","21232558","",,0,0,0,0,0,,,
1793,202,"Gauci et al., 2011",journal,"Gauci C, Jenkins D, Lightowlers MW",Strategies for Optimal Expression of Vaccine Antigens from Taeniid Cestode Parasites in Escherichia coli,"2011","","","",Molecular biotechnology,"","","","","","","","21222242","",,0,0,0,0,0,,,
1794,100,"Brittle et al., 2008",journal,"Brittle EE, Wang F, Lubinski JM, Bunte RM, Friedman HM","A replication-competent, neuronal spread-defective, live attenuated herpes simplex virus type 1 vaccine","2008","82","17","8431-8441",Journal of virology,"","","","","","","","18562543","","",0,10,0,0,0,,,
1795,100,"Awasthi et al., 2008",journal,"Awasthi S, Lubinski JM, Eisenberg RJ, Cohen GH, Friedman HM",An HSV-1 gD mutant virus as an entry-impaired live virus vaccine,"2008","26","9","1195-1203",Vaccine,"","","","","","","","18243431","","",0,10,0,0,0,,,
1796,121,"Breitbach et al., 2008",journal,"Breitbach K, Khler J, Steinmetz I",Induction of protective immunity against Burkholderia pseudomallei using attenuated mutants with defects in the intracellular life cycle,"2008","102 Suppl 1","",S89-94,Transactions of the Royal Society of Tropical Medicine and Hygiene,"","","","","","","","19121696","","",0,10,0,0,0,,,
1797,12,"Breitbach et al., 2008",journal,"Breitbach K, Khler J, Steinmetz I",Induction of protective immunity against Burkholderia pseudomallei using attenuated mutants with defects in the intracellular life cycle,"2008","102 Suppl 1","",S89-94,Transactions of the Royal Society of Tropical Medicine and Hygiene,"","","","","","","","19121696","","",0,10,0,0,0,,,
1798,12,"Quarry et al., 2007",journal,"Quarry JE, Isherwood KE, Michell SL, Diaper H, Titball RW, Oyston PC","A Francisella tularensis subspecies novicida purF mutant, but not a purA mutant, induces protective immunity to tularemia in mice","2007","25","11","2011-2018",Vaccine,"","","","","","","","17241711","","",0,10,0,0,0,,,
1799,8,"Crawford et al., 1996",journal,"Crawford RM, Van De Verg L, Yuan L, Hadfield TL, Warren RL, Drazek ES, Houng HH, Hammack C, Sasala K, Polsinelli T, Thompson J, Hoover DL",Deletion of purE attenuates Brucella melitensis infection in mice,"1996","64","6","2188-2192",Infection and immunity,"","","","","","","","8675325","","",0,10,0,0,0,,,
1800,86,"Xu et al., 2006",journal,"Xu F, Chen X, Shi A, Yang B, Wang J, Li Y, Guo X, Blackall PJ, Yang H",Characterization and immunogenicity of an apxIA mutant of Actinobacillus pleuropneumoniae,"2006","118","3-4","230-239",Veterinary microbiology,"","","","","","","","16930871","","",0,10,0,0,0,,,
1801,86,"Ingham et al., 2002",journal,"Ingham A, Zhang Y, Prideaux C",Attenuation of Actinobacillus pleuropneumoniae by inactivation of aroQ,"2002","84","3","263-273",Veterinary microbiology,"","","","","","","","11731178","","",0,10,0,0,0,,,
1802,161,"Tan et al., 2010",journal,"Tan HY, Nagoor NH, Sekaran SD","Cloning, expression and protective capacity of 37 kDa outer membrane protein gene (ompH) of Pasteurella multocida serotype B:2","2010","27","3","430-441",Tropical biomedicine,"","","","","","","","21399583","","",0,10,0,0,0,,,
1803,56,"Morimoto et al., 2005",journal,"Morimoto K, Shoji Y, Inoue S","Characterization of P gene-deficient rabies virus: propagation, pathogenicity and antigenicity","2005","111","1","61-67",Virus research,"","","","","","","","15896403","","",0,10,0,0,0,,,
1804,46,"Li et al., 2004",journal,"Li Y, Sun YH, Ison C, Levine MM, Tang CM",Vaccination with attenuated Neisseria meningitidis strains protects against challenge with live Meningococci,"2004","72","1","345-351",Infection and immunity,"","","","","","","","14688114","","",0,10,0,0,0,,,
1805,109,"Feunou et al., 2008",journal,"Feunou PF, Ismaili J, Debrie AS, Huot L, Hot D, Raze D, Lemoine Y, Locht C",Genetic stability of the live attenuated Bordetella pertussis vaccine candidate BPZE1,"2008","26","45","5722-5727",Vaccine,"","","","","","","","18762220","","",0,10,0,0,0,,,
1806,67,"Kaashoek et al., 1994",journal,"Kaashoek MJ, Moerman A, Madi J, Rijsewijk FA, Quak J, Gielkens AL, van Oirschot JT",A conventionally attenuated glycoprotein E-negative strain of bovine herpesvirus type 1 is an efficacious and safe vaccine,"1994","12","5","439-444",Vaccine,"","","","","","","","8023552","","",0,10,0,0,0,,,
1807,42,"Allam et al., 2011",journal,"Allam US, Krishna MG, Lahiri A, Joy O, Chakravortty D",Salmonella enterica Serovar Typhimurium Lacking hfq Gene Confers Protective Immunity against Murine Typhoid,"2011","6","2",e16667,PloS one,"","","","","","","","21347426","","",0,10,0,0,0,,,
1808,29,"Hondalus et al., 2000",journal,"Hondalus MK, Bardarov S, Russell R, Chan J, Jacobs WR Jr, Bloom BR",Attenuation of and protection induced by a leucine auxotroph of Mycobacterium tuberculosis,"2000","68","5","2888-2898",Infection and immunity,"","","","","","","","10768986","","",0,10,0,0,0,,,
1809,29,"Hinchey et al., 2011",journal,"Hinchey J, Jeon BY, Alley H, Chen B, Goldberg M, Derrick S, Morris S, Jacobs WR Jr, Porcelli SA, Lee S",Lysine auxotrophy combined with deletion of the SecA2 gene results in a safe and highly immunogenic candidate live attenuated vaccine for tuberculosis,"2011","6","1",e15857,PloS one,"","","","","","","","21264335","","",0,10,0,0,0,,,
1810,25,"Kwaga et al., 1994",journal,"Kwaga JK, Allan BJ, van der Hurk JV, Seida H, Potter AA",A carAB mutant of avian pathogenic Escherichia coli serogroup O2 is attenuated and effective as a live oral vaccine against colibacillosis in turkeys,"1994","62","9","3766-3772",Infection and immunity,"","","","","","","","8063392","","",0,10,0,0,0,,,
1811,8,"Trant et al., 2010",journal,"Trant CG, Lacerda TL, Carvalho NB, Azevedo V, Rosinha GM, Salcedo SP, Gorvel JP, Oliveira SC",The Brucella abortus phosphoglycerate kinase mutant is highly attenuated and induces protection superior to that of vaccine strain 19 in immunocompromised and immunocompetent mice,"2010","78","5","2283-2291",Infection and immunity,"","","","","","","","20194591","","",0,10,0,0,0,,,
1812,0,"Vogel and Powell, 1995",journal,"Vogel FR, Powell MF",A compendium of vaccine adjuvants and excipients,"1995","6","","141-228",Pharmaceutical biotechnology,"","","","","","","","7551218","","",0,10,42,0,0,,,
1813,0,"Vogel and Powell, 1995",journal,"Vogel FR, Powell MF",A compendium of vaccine adjuvants and excipients,"1995","6","","141-228",Pharmaceutical biotechnology,"","","","","","","","7551218","","",0,10,43,0,0,,,
1814,0,"Vogel and Powell, 1995",journal,"Vogel FR, Powell MF",A compendium of vaccine adjuvants and excipients,"1995","6","","141-228",Pharmaceutical biotechnology,"","","","","","","","7551218","","",0,10,44,0,0,,,
1815,0,"Jorgensen et al., 2009",book,"Lene Jorgensen, Hanne Mrck Nielsen, S. Moein Moghimi",Chapter 6. The Innate Immune Responses Adjuvants and Delivery Systems,"2009","","",.,"Technologies for Biopharmaceuticals: Peptides, Proteins, Nucleic Acids and Vaccines","John Wiley & Sons, Ltd","Chichester, UK",.,.,"","","","",.,"",0,10,39,0,0,,,
1816,0,"Cooper et al., 1991",journal,"Cooper PD, McComb C, Steele EJ","The adjuvanticity of Algammulin, a new vaccine adjuvant","1991","9","6","408-415",Vaccine,"","","","","","","","1887671","","",0,10,45,0,0,,,
1817,0,"Vogel and Powell, 1995",journal,"Vogel FR, Powell MF",A compendium of vaccine adjuvants and excipients,"1995","6","","141-228",Pharmaceutical biotechnology,"","","","","","","","7551218","","",0,10,45,0,0,,,
1818,0,"Fatunmbi et al., 1992",journal,"Fatunmbi OO, Newman JA, Sivanandan V, Halvorson DA",Enhancement of antibody response of turkeys to trivalent avian influenza vaccine by positively charged liposomal avridine adjuvant,"1992","10","9","623-626",Vaccine,"","","","","","","","1502840","","",0,10,46,0,0,,,
1819,0,"Vogel and Powell, 1995",journal,"Vogel FR, Powell MF",A compendium of vaccine adjuvants and excipients,"1995","6","","141-228",Pharmaceutical biotechnology,"","","","","","","","7551218","","",0,10,46,0,0,,,
1820,0,"Relyveld, 1986",journal,Relyveld EH,Preparation and use of calcium phosphate adsorbed vaccines,"1986","65","","131-136",Developments in biological standardization,"","","","","","","","3549396","","",0,10,47,0,0,,,
1821,0,"Vogel and Powell, 1995",journal,"Vogel FR, Powell MF",A compendium of vaccine adjuvants and excipients,"1995","6","","141-228",Pharmaceutical biotechnology,"","","","","","","","7551218","","",0,10,47,0,0,,,
1822,0,"He et al., 2000",journal,"He Q, Mitchell AR, Johnson SL, Wagner-Bartak C, Morcol T, Bell SJ",Calcium phosphate nanoparticle adjuvant,"2000","7","6","899-903",Clinical and diagnostic laboratory immunology,"","","","","","","","11063495","","",0,10,47,0,0,,,
1823,0,"Vogel and Powell, 1995",journal,"Vogel FR, Powell MF",A compendium of vaccine adjuvants and excipients,"1995","6","","141-228",Pharmaceutical biotechnology,"","","","","","","","7551218","","",0,10,48,0,0,,,
1824,0,Pubchem: Deoxycholic Acid,website,NCBI-PubChem,Deoxycholic Acid - Compound Summary,"","","","","","","","","","","","","",http://pubchem.ncbi.nlm.nih.gov/summary/summary.cgi?cid=23668196&loc=ec_rcs,"",0,10,49,0,0,,,
1825,0,"Vogel and Powell, 1995",journal,"Vogel FR, Powell MF",A compendium of vaccine adjuvants and excipients,"1995","6","","141-228",Pharmaceutical biotechnology,"","","","","","","","7551218","","",0,10,49,0,0,,,
1826,0,"Vogel and Powell, 1995",journal,"Vogel FR, Powell MF",A compendium of vaccine adjuvants and excipients,"1995","6","","141-228",Pharmaceutical biotechnology,"","","","","","","","7551218","","",0,10,50,0,0,,,
1827,0,"Vogel and Powell, 1995",journal,"Vogel FR, Powell MF",A compendium of vaccine adjuvants and excipients,"1995","6","","141-228",Pharmaceutical biotechnology,"","","","","","","","7551218","","",0,10,51,0,0,,,
1828,0,"Stills, 2005",journal,Stills HF Jr,Adjuvants and antibody production: dispelling the myths associated with Freund's complete and other adjuvants,"2005","46","3","280-293","ILAR journal / National Research Council, Institute of Laboratory Animal Resources","","","","","","","","15953835","","",0,10,51,0,0,,,
1829,0,"Vogel and Powell, 1995",journal,"Vogel FR, Powell MF",A compendium of vaccine adjuvants and excipients,"1995","6","","141-228",Pharmaceutical biotechnology,"","","","","","","","7551218","","",0,10,52,0,0,,,
1830,0,"Vogel and Powell, 1995",journal,"Vogel FR, Powell MF",A compendium of vaccine adjuvants and excipients,"1995","6","","141-228",Pharmaceutical biotechnology,"","","","","","","","7551218","","",0,10,53,0,0,,,
1831,0,"Vogel and Powell, 1995",journal,"Vogel FR, Powell MF",A compendium of vaccine adjuvants and excipients,"1995","6","","141-228",Pharmaceutical biotechnology,"","","","","","","","7551218","","",0,10,54,0,0,,,
1832,0,"Vogel and Powell, 1995",journal,"Vogel FR, Powell MF",A compendium of vaccine adjuvants and excipients,"1995","6","","141-228",Pharmaceutical biotechnology,"","","","","","","","7551218","","",0,10,55,0,0,,,
1833,0,"Vogel and Powell, 1995",journal,"Vogel FR, Powell MF",A compendium of vaccine adjuvants and excipients,"1995","6","","141-228",Pharmaceutical biotechnology,"","","","","","","","7551218","","",0,10,56,0,0,,,
1834,0,"Boersma et al., 1992",journal,"Boersma WJ, Bogaerts WJ, Bianchi AT, Claassen E",Adjuvant properties of stable water-in-oil emulsions: evaluation of the experience with Specol,"1992","143","5","503-512",Research in immunology,"","","","","","","","1439130","","",0,10,44,0,0,,,
1835,164,"Beck et al., 2003",journal,"Beck I, Gerlach H, Burkhardt E, Kaleta EF",Investigation of several selected adjuvants regarding their efficacy and side effects for the production of a vaccine for parakeets to prevent a disease caused by a paramyxovirus type 3,"2003","21","9-10","1006-1022",Vaccine,"","","","","","","","12547615","","",0,10,0,0,0,,,
1836,0,"Vogel and Powell, 1995",journal,"Vogel FR, Powell MF",A compendium of vaccine adjuvants and excipients,"1995","6","","141-228",Pharmaceutical biotechnology,"","","","","","","","7551218","","",0,10,58,0,0,,,
1837,0,"Vogel and Powell, 1995",journal,"Vogel FR, Powell MF",A compendium of vaccine adjuvants and excipients,"1995","6","","141-228",Pharmaceutical biotechnology,"","","","","","","","7551218","","",0,10,59,0,0,,,
1838,0,"Vogel and Powell, 1995",journal,"Vogel FR, Powell MF",A compendium of vaccine adjuvants and excipients,"1995","6","","141-228",Pharmaceutical biotechnology,"","","","","","","","7551218","","",0,10,60,0,0,,,
1839,0,"Peschon et al., 1994",journal,"Peschon JJ, Morrissey PJ, Grabstein KH, Ramsdell FJ, Maraskovsky E, Gliniak BC, Park LS, Ziegler SF, Williams DE, Ware CB, Meyer JD, Davison BL",Early lymphocyte expansion is severely impaired in interleukin 7 receptor-deficient mice,"1994","180","5","1955-1960",The Journal of experimental medicine,"","","","","","","","7964471","","",0,10,57,0,0,,,
1840,0,"Colombetti et al., 2009",journal,"Colombetti S, Lvy F, Chapatte L",IL-7 adjuvant treatment enhances long-term tumor-antigen-specific CD8+ T-cell responses after immunization with recombinant lentivector,"2009","113","26","6629-6637",Blood,"","","","","","","","19383968","","",0,10,57,0,0,,,
1841,0,"Pellegrini et al., 2009",journal,"Pellegrini M, Calzascia T, Elford AR, Shahinian A, Lin AE, Dissanayake D, Dhanji S, Nguyen LT, Gronski MA, Morre M, Assouline B, Lahl K, Sparwasser T, Ohashi PS, Mak TW",Adjuvant IL-7 antagonizes multiple cellular and molecular inhibitory networks to enhance immunotherapies,"2009","15","5","528-536",Nature medicine,"","","","","","","","19396174","","",0,10,57,0,0,,,
1842,0,"Vogel and Powell, 1995",journal,"Vogel FR, Powell MF",A compendium of vaccine adjuvants and excipients,"1995","6","","141-228",Pharmaceutical biotechnology,"","","","","","","","7551218","","",0,10,61,0,0,,,
1843,0,Website 1,website,"",Loxoribine,"","","","","","","","","","","","","",http://www.invivogen.com/PDF/Loxoribine_TDS.pdf,"",0,10,61,0,0,,,
1844,0,"Vogel and Powell, 1995",journal,"Vogel FR, Powell MF",A compendium of vaccine adjuvants and excipients,"1995","6","","141-228",Pharmaceutical biotechnology,"","","","","","","","7551218","","",0,10,62,0,0,,,
1845,0,"Ullrich and Fidler, 1992",journal,"Ullrich SE, Fidler IJ",Liposomes containing muramyl tripeptide phosphatidylethanolamine (MTP-PE) are excellent adjuvants for induction of an immune response to protein and tumor antigens,"1992","52","5","489-494",Journal of leukocyte biology,"","","","","","","","1431559","","",0,10,63,0,0,,,
1846,0,"Vogel and Powell, 1995",journal,"Vogel FR, Powell MF",A compendium of vaccine adjuvants and excipients,"1995","6","","141-228",Pharmaceutical biotechnology,"","","","","","","","7551218","","",0,10,63,0,0,,,
1847,0,"Vogel and Powell, 1995",journal,"Vogel FR, Powell MF",A compendium of vaccine adjuvants and excipients,"1995","6","","141-228",Pharmaceutical biotechnology,"","","","","","","","7551218","","",0,10,64,0,0,,,
1848,0,"Vogel and Powell, 1995",journal,"Vogel FR, Powell MF",A compendium of vaccine adjuvants and excipients,"1995","6","","141-228",Pharmaceutical biotechnology,"","","","","","","","7551218","","",0,10,65,0,0,,,
1849,0,"Vogel and Powell, 1995",journal,"Vogel FR, Powell MF",A compendium of vaccine adjuvants and excipients,"1995","6","","141-228",Pharmaceutical biotechnology,"","","","","","","","7551218","","",0,10,66,0,0,,,
1850,0,"Vogel and Powell, 1995",journal,"Vogel FR, Powell MF",A compendium of vaccine adjuvants and excipients,"1995","6","","141-228",Pharmaceutical biotechnology,"","","","","","","","7551218","","",0,10,67,0,0,,,
1851,0,"Vogel and Powell, 1995",journal,"Vogel FR, Powell MF",A compendium of vaccine adjuvants and excipients,"1995","6","","141-228",Pharmaceutical biotechnology,"","","","","","","","7551218","","",0,10,68,0,0,,,
1852,0,"Vogel and Powell, 1995",journal,"Vogel FR, Powell MF",A compendium of vaccine adjuvants and excipients,"1995","6","","141-228",Pharmaceutical biotechnology,"","","","","","","","7551218","","",0,10,69,0,0,,,
1853,0,"Vogel and Powell, 1995",journal,"Vogel FR, Powell MF",A compendium of vaccine adjuvants and excipients,"1995","6","","141-228",Pharmaceutical biotechnology,"","","","","","","","7551218","","",0,10,70,0,0,,,
1854,0,"Vogel and Powell, 1995",journal,"Vogel FR, Powell MF",A compendium of vaccine adjuvants and excipients,"1995","6","","141-228",Pharmaceutical biotechnology,"","","","","","","","7551218","","",0,10,71,0,0,,,
1855,0,"Vogel and Powell, 1995",journal,"Vogel FR, Powell MF",A compendium of vaccine adjuvants and excipients,"1995","6","","141-228",Pharmaceutical biotechnology,"","","","","","","","7551218","","",0,10,72,0,0,,,
1856,7,"Rhie et al., 2005",journal,"Rhie GE, Park YM, Chun JH, Yoo CK, Seong WK, Oh HB",Expression and secretion of the protective antigen of Bacillus anthracis in Bacillus brevis,"2005","45","2","331-339",FEMS immunology and medical microbiology,"","","","","","","","16009541","","",0,10,0,0,0,,,
1857,57,"Choi et al., 2002",journal,"Choi AH, McNeal MM, Flint JA, Basu M, Lycke NY, Clements JD, Bean JA, Davis HL, McCluskie MJ, VanCott JL, Ward RL",The level of protection against rotavirus shedding in mice following immunization with a chimeric VP6 protein is dependent on the route and the coadministered adjuvant,"2002","20","13-14","1733-1740",Vaccine,"","","","","","","","11906760","","",0,10,0,0,0,,,
1858,30,"Saul et al., 1992",journal,"Saul A, Lord R, Jones GL, Spencer L",Protective immunization with invariant peptides of the Plasmodium falciparum antigen MSA2,"1992","148","1","208-211","Journal of immunology (Baltimore, Md. : 1950)","","","","","","","","1727867","","",0,10,0,0,0,,,
1859,42,"Piao et al., 2010",journal,"Piao HH, Tam VT, Na HS, Kim HJ, Ryu PY, Kim SY, Rhee JH, Choy HE, Kim SW, Hong Y",Immunological responses induced by asd and wzy/asd mutant strains of Salmonella enterica serovar Typhimurium in BALB/c mice,"2010","48","4","486-495","Journal of microbiology (Seoul, Korea)","","","","","","","","20799091","","",0,10,0,0,0,,,
1860,42,"Rosu et al., 2007",journal,"Rosu V, Chadfield MS, Santona A, Christensen JP, Thomsen LE, Rubino S, Olsen JE",Effects of crp deletion in Salmonella enterica serotype Gallinarum,"2007","49","","14",Acta veterinaria Scandinavica,"","","","","","","","17488512","","",0,10,0,0,0,,,
1861,42,"Matsuda et al., 2010",journal,"Matsuda K, Chaudhari AA, Kim SW, Lee KM, Lee JH","Physiology, pathogenicity and immunogenicity of lon and/or cpxR deleted mutants of Salmonella Gallinarum as vaccine candidates for fowl typhoid","2010","41","5","59",Veterinary research,"","","","","","","","20487719","","",0,10,0,0,0,,,
1862,67,"van et al., 1997",journal,"van Drunen Littel-van den Hurk S, Tikoo SK, van den Hurk JV, Babiuk LA, Van Donkersgoed J",Protective immunity in cattle following vaccination with conventional and marker bovine herpesvirus-1 (BHV1) vaccines,"1997","15","1","36-44",Vaccine,"","","","","","","","9041664","","",0,10,0,0,0,,,
1863,169,"Beer et al., 2000",journal,"Beer M, Hehnen HR, Wolfmeyer A, Poll G, Kaaden OR, Wolf G",A new inactivated BVDV genotype I and II vaccine. An immunisation and challenge study with BVDV genotype I,"2000","77","1-2","195-208",Veterinary microbiology,"","","","","","","","11042413","","",0,10,0,0,0,,,
1864,206,Wiki: Foot and mouth disease,website,"",Wiki: Foot and mouth disease,"","","","","","","","","","","","","",http://en.wikipedia.org/wiki/Foot-and-mouth_disease,"",0,10,0,0,0,,,
1865,206,"Joyappa et al., 2009",journal,"Joyappa DH, Kumar CA, Banumathi N, Reddy GR, Suryanarayana VV",Calcium phosphate nanoparticle prepared with foot and mouth disease virus P1-3CD gene construct protects mice and guinea pigs against the challenge virus,"2009","139","1-2","58-66",Veterinary microbiology,"","","","","","","","19505774","","",0,10,0,0,0,,,
1866,100,"Morrison and Knipe, 1994",journal,"Morrison LA, Knipe DM",Immunization with replication-defective mutants of herpes simplex virus type 1: sites of immune intervention in pathogenesis of challenge virus infection,"1994","68","2","689-696",Journal of virology,"","","","","","","","8289372","","",0,10,0,0,0,,,
1867,100,"Farrell et al., 1994",journal,"Farrell HE, McLean CS, Harley C, Efstathiou S, Inglis S, Minson AC",Vaccine potential of a herpes simplex virus type 1 mutant with an essential glycoprotein deleted,"1994","68","2","927-932",Journal of virology,"","","","","","","","8289395","","",0,10,0,0,0,,,
1868,183,"Tian et al., 2009",journal,"Tian ZJ, An TQ, Zhou YJ, Peng JM, Hu SP, Wei TC, Jiang YF, Xiao Y, Tong GZ",An attenuated live vaccine based on highly pathogenic porcine reproductive and respiratory syndrome virus (HP-PRRSV) protects piglets against HP-PRRS,"2009","138","1-2","34-40",Veterinary microbiology,"","","","","","","","19339125","","",0,10,0,0,0,,,
1869,0,"Vogel and Powell, 1995",journal,"Vogel FR, Powell MF",A compendium of vaccine adjuvants and excipients,"1995","6","","141-228",Pharmaceutical biotechnology,"","","","","","","","7551218","","",0,10,73,0,0,,,
1870,42,"Germanier and Fer, 1975",journal,"Germanier R, Fer E","Isolation and characterization of Gal E mutant Ty 21a of Salmonella typhi: a candidate strain for a live, oral typhoid vaccine","1975","131","5","553-558",The Journal of infectious diseases,"","","","","","","","1092768","","",0,10,0,0,0,,,
1871,99,"Fernando et al., 1998",journal,"Fernando GJ, Stewart TJ, Tindle RW, Frazer IH",Th2-type CD4+ cells neither enhance nor suppress antitumor CTL activity in a mouse tumor model,"1998","161","5","2421-2427","Journal of immunology (Baltimore, Md. : 1950)","","","","","","","","9725239","","",0,10,0,0,0,,,
1872,0,"Thompson et al., 2005",journal,"Thompson BS, Chilton PM, Ward JR, Evans JT, Mitchell TC","The low-toxicity versions of LPS, MPL adjuvant and RC529, are efficient adjuvants for CD4+ T cells","2005","78","6","1273-1280",Journal of leukocyte biology,"","","","","","","","16204643","","",0,10,74,0,0,,,
1873,206,"Shao et al., 2005",journal,"Shao HJ, Chen L, Su YB",DNA fragment encoding human IL-1beta 163-171 peptide enhances the immune responses elicited in mice by DNA vaccine against foot-and-mouth disease,"2005","29","1","35-46",Veterinary research communications,"","","","","","","","15727290","","",0,10,0,0,0,,,
1874,161,"Muneer et al., 1994",journal,"Muneer R, Akhtar S, Afzal M",Evaluation of three oil-adjuvant vaccines against Pasteurella multocida in buffalo calves,"1994","13","3","837-843",Revue scientifique et technique (International Office of Epizootics),"","","","","","","","7949356","","",0,11,0,0,0,,,
1875,98,"Smith et al., 1994",journal,"Smith NC, Wallach M, Miller CM, Morgenstern R, Braun R, Eckert J",Maternal transmission of immunity to Eimeria maxima: enzyme-linked immunosorbent assay analysis of protective antibodies induced by infection,"1994","62","4","1348-1357",Infection and immunity,"","","","","","","","8132342","","",0,10,0,0,0,,,
1876,0,"Katz et al., 2000",journal,"Katz JM, Lu X, Todd CW, Newman MJ",A nonionic block co-polymer adjuvant (CRL1005) enhances the immunogenicity and protective efficacy of inactivated influenza vaccine in young and aged mice,"2000","18","21","2177-2187",Vaccine,"","","","","","","","10717336","","",0,10,29,0,0,,,
1877,0,"Todd et al., 1997",journal,"Todd CW, Pozzi LA, Guarnaccia JR, Balasubramanian M, Henk WG, Younger LE, Newman MJ",Development of an adjuvant-active nonionic block copolymer for use in oil-free subunit vaccines formulations,"1997","15","5","564-570",Vaccine,"","","","","","","","9160526","","",0,10,29,0,0,,,
1878,0,M-NIMBS Website,website,"",Nanoemulsions,"","","","","","","","","","","","","",http://nano.med.umich.edu/platforms/Nanoemulsions.html,"",0,10,75,0,0,,,
1879,0,Wiki: AS03,website,"",Wiki: AS03,"","","","","","","","","","","","","",http://en.wikipedia.org/wiki/AS03,"",0,10,76,0,0,,,
1880,0,"Lu et al., 2002",journal,"Lu X, Clements JD, Katz JM",Mutant Escherichia coli heat-labile enterotoxin [LT(R192G)] enhances protective humoral and cellular immune responses to orally administered inactivated influenza vaccine,"2002","20","7-8","1019-1029",Vaccine,"","","","","","","","11803061","","",0,10,77,0,0,,,
1881,66,"Fernandez-Sainz et al., 2009",journal,"Fernandez-Sainz I, Holinka LG, Gavrilov BK, Prarat MV, Gladue D, Lu Z, Jia W, Risatti GR, Borca MV",Alteration of the N-linked glycosylation condition in E1 glycoprotein of Classical Swine Fever Virus strain Brescia alters virulence in swine,"2009","386","1","210-216",Virology,"","","","","","","","19203774","","",0,10,0,0,0,,,
1882,66,"Sainz et al., 2008",journal,"Sainz IF, Holinka LG, Lu Z, Risatti GR, Borca MV",Removal of a N-linked glycosylation site of classical swine fever virus strain Brescia Erns glycoprotein affects virulence in swine,"2008","370","1","122-129",Virology,"","","","","","","","17904607","","",0,10,0,0,0,,,
1883,0,"Holmgren et al., 2003",journal,"Holmgren J, Czerkinsky C, Eriksson K, Mharandi A",Mucosal immunisation and adjuvants: a brief overview of recent advances and challenges,"2003","21 Suppl 2","",S89-95,Vaccine,"","","","","","","","12763689","","",0,10,78,0,0,,,
1884,0,"Caulfield et al., 2007",journal,"Caulfield MJ, Shi L, Wang S, Wang B, Tobery TW, Mach H, Ahl PL, Cannon JL, Cook JC, Heinrichs JH, Sitrin RD",Effect of alternative aluminum adjuvants on the absorption and immunogenicity of HPV16 L1 VLPs in mice,"2007","3","4","139-145",Human vaccines,"","","","","","","","17581283","","",0,10,79,0,0,,,
1885,42,"Park et al., 2010",journal,"Park SI, Jeong JH, Choy HE, Rhee JH, Na HS, Lee TH, Her M, Cho KO, Hong Y",Immune response induced by ppGpp-defective Salmonella enterica serovar Gallinarum in chickens,"2010","48","5","674-681","Journal of microbiology (Seoul, Korea)","","","","","","","","21046347","","",0,10,0,0,0,,,
1886,0,"Gupta and Siber, 1994",journal,"Gupta RK, Siber GR","Comparison of adjuvant activities of aluminium phosphate, calcium phosphate and stearyl tyrosine for tetanus toxoid","1994","22","1","53-63",Biologicals : journal of the International Association of Biological Standardization,"","","","","","","","8068314","","",0,10,80,0,0,,,
1887,0,"He et al., 2000",journal,"He Q, Mitchell AR, Johnson SL, Wagner-Bartak C, Morcol T, Bell SJ",Calcium phosphate nanoparticle adjuvant,"2000","7","6","899-903",Clinical and diagnostic laboratory immunology,"","","","","","","","11063495","","",0,10,80,0,0,,,
1888,41,"Gupta and Siber, 1994",journal,"Gupta RK, Siber GR","Comparison of adjuvant activities of aluminium phosphate, calcium phosphate and stearyl tyrosine for tetanus toxoid","1994","22","1","53-63",Biologicals : journal of the International Association of Biological Standardization,"","","","","","","","8068314","","",0,10,0,0,0,,,
1889,26,"Harris et al., 1996",journal,"Harris SJ, Woodrow SA, Gearing AJ, Adams SE, Kingsman AJ, Layton GT",The effects of adjuvants on CTL induction by V3:Ty-virus-like particles (V3-VLPs) in mice,"1996","14","10","971-976",Vaccine,"","","","","","","","8873390","","",0,10,0,0,0,,,
1890,26,"Bomford et al., 1992",journal,"Bomford R, Stapleton M, Winsor S, McKnight A, Andronova T",The control of the antibody isotype response to recombinant human immunodeficiency virus gp120 antigen by adjuvants,"1992","8","10","1765-1771",AIDS research and human retroviruses,"","","","","","","","1457190","","",0,10,0,0,0,,,
1891,50,"Kayamuro et al., 2010",journal,"Kayamuro H, Yoshioka Y, Abe Y, Arita S, Katayama K, Nomura T, Yoshikawa T, Kubota-Koketsu R, Ikuta K, Okamoto S, Mori Y, Kunisawa J, Kiyono H, Itoh N, Nagano K, Kamada H, Tsutsumi Y, Tsunoda S",Interleukin-1 family cytokines as mucosal vaccine adjuvants for induction of protective immunity against influenza virus,"2010","84","24","12703-12712",Journal of virology,"","","","","","","","20881038","","",0,10,0,0,0,,,
1892,99,"Pope et al., 1994",journal,"Pope BL, Sigindere J, Chourmouzis E, MacIntyre P, Goodman MG","7-Allyl-8-oxoguanosine (loxoribine) inhibits the metastasis of B16 melanoma cells and has adjuvant activity in mice immunized with a B16 tumor vaccine","1994","38","2","83-91","Cancer immunology, immunotherapy : CII","","","","","","","","8306370","","",0,10,0,0,0,,,
1893,49,"Jain et al., 2009",journal,"Jain V, Vyas SP, Kohli DV",Well-defined and potent liposomal hepatitis B vaccines adjuvanted with lipophilic MDP derivatives,"2009","5","3","334-344","Nanomedicine : nanotechnology, biology, and medicine","","","","","","","","19523433","","",0,10,0,0,0,,,
1894,208,"Darville and Hiltke, 2010",journal,"Darville T, Hiltke TJ",Pathogenesis of genital tract disease due to Chlamydia trachomatis,"2010","201 Suppl 2","",S114-125,The Journal of infectious diseases,"","","","","","","","20524234","","",0,10,0,0,0,,,
1895,208,"Zhong et al., 1993",journal,"Zhong G, Toth I, Reid R, Brunham RC",Immunogenicity evaluation of a lipidic amino acid-based synthetic peptide vaccine for Chlamydia trachomatis,"1993","151","7","3728-3736","Journal of immunology (Baltimore, Md. : 1950)","","","","","","","","7690812","","",0,10,0,0,0,,,
1896,97,"Henriquez et al., 2010",journal,"Henriquez FL, Campbell SA, Roberts CW, Mullen AB, Burchmore R, Carter KC",Vaccination with recombinant Leishmania donovani gamma-glutamylcysteine synthetase fusion protein protects against L. donovani infection,"2010","96","5","929-936",The Journal of parasitology,"","","","","","","","20950100","","",0,10,0,0,0,,,
1897,26,"Stieneker et al., 1991",journal,"Stieneker F, Kreuter J, Lwer J",High antibody titres in mice with polymethylmethacrylate nanoparticles as adjuvant for HIV vaccines,"1991","5","4","431-435","AIDS (London, England)","","","","","","","","2059385","","",0,10,0,0,0,,,
1898,30,"Bracho et al., 2009",journal,"Bracho G, Zayas C, Wang L, Coppel R, Prez O, Petrovsky N","AFCo1, a meningococcal B-derived cochleate adjuvant, strongly enhances antibody and T-cell immunity against Plasmodium falciparum merozoite surface protein 4 and 5","2009","8","","35",Malaria journal,"","","","","","","","19250541","","",0,10,0,0,0,,,
1899,50,"Deliyannis et al., 1998",journal,"Deliyannis G, Jackson DC, Dyer W, Bates J, Coulter A, Harling-McNabb L, Brown LE",Immunopotentiation of humoral and cellular responses to inactivated influenza vaccines by two different adjuvants with potential for human use,"1998","16","20","2058-2068",Vaccine,"","","","","","","","9796065","","",0,10,0,0,0,,,
1900,99,"Basak et al., 2000",journal,"Basak S, Eck S, Gutzmer R, Smith AJ, Birebent B, Purev E, Staib L, Somasundaram R, Zaloudik J, Li W, Jacob L, Mitchell E, Speicher D, Herlyn D","Colorectal cancer vaccines: antiidiotypic antibody, recombinant protein, and viral vector","2000","910","","237-252",Annals of the New York Academy of Sciences,"","","","","","","","10911917","","",0,10,0,0,0,,,
1901,49,"Wang et al., 2000",journal,"Wang S, Liu X, Fisher K, Smith JG, Chen F, Tobery TW, Ulmer JB, Evans RK, Caulfield MJ",Enhanced type I immune response to a hepatitis B DNA vaccine by formulation with calcium- or aluminum phosphate,"2000","18","13","1227-1235",Vaccine,"","","","","","","","10649624","","",0,10,0,0,0,,,
1902,7,"Ivins et al., 1995",journal,"Ivins B, Fellows P, Pitt L, Estep J, Farchaus J, Friedlander A, Gibbs P",Experimental anthrax vaccines: efficacy of adjuvants combined with protective antigen against an aerosol Bacillus anthracis spore challenge in guinea pigs,"1995","13","18","1779-1784",Vaccine,"","","","","","","","8701593","","",0,10,0,0,0,,,
1903,140,"Kotloff et al., 2004",journal,"Kotloff KL, Corretti M, Palmer K, Campbell JD, Reddish MA, Hu MC, Wasserman SS, Dale JB",Safety and immunogenicity of a recombinant multivalent group a streptococcal vaccine in healthy adults: phase 1 trial,"2004","292","6","709-715",JAMA : the journal of the American Medical Association,"","","","","","","","15304468","","",0,10,0,0,0,,,
1904,91,"Fox and Bzik, 2010",journal,"Fox BA, Bzik DJ",Avirulent uracil auxotrophs based on disruption of orotidine-5'-monophosphate decarboxylase elicit protective immunity to Toxoplasma gondii,"2010","78","9","3744-3752",Infection and immunity,"","","","","","","","20605980","","",0,10,0,0,0,,,
1905,42,"Penha et al., 2010",journal,"Penha Filho RA, de Paiva JB, da Silva MD, de Almeida AM, Berchieri A Jr",Control of Salmonella Enteritidis and Salmonella Gallinarum in birds by using live vaccine candidate containing attenuated Salmonella Gallinarum mutant strain,"2010","28","16","2853-2859",Vaccine,"","","","","","","","20153354","","",0,10,0,0,0,,,
1906,11,"Okan et al., 2010",journal,"Okan NA, Mena P, Benach JL, Bliska JB, Karzai AW",The smpB-ssrA mutant of Yersinia pestis functions as a live attenuated vaccine to protect mice against pulmonary plague infection,"2010","78","3","1284-1293",Infection and immunity,"","","","","","","","20065026","","",0,10,0,0,0,,,
1907,86,"Park et al., 2009",journal,"Park C, Ha Y, Kim S, Chae C, Ryu DY",Construction and characterization of an Actinobacillus pleuropneumoniae serotype 2 mutant lacking the Apx toxin secretion protein genes apxIIIB and apxIIID,"2009","71","10","1317-1323",The Journal of veterinary medical science / the Japanese Society of Veterinary Science,"","","","","","","","19887737","","",0,10,0,0,0,,,
1908,0,"Gupta, 1998",journal,Gupta RK,Aluminum compounds as vaccine adjuvants,"1998","32","3","155-172",Advanced drug delivery reviews,"","","","","","","","10837642","","",0,10,37,0,0,,,
1909,8,"Ugalde et al., 2003",journal,"Ugalde JE, Comerci DJ, Leguizamn MS, Ugalde RA",Evaluation of Brucella abortus phosphoglucomutase (pgm) mutant as a new live rough-phenotype vaccine,"2003","71","11","6264-6269",Infection and immunity,"","","","","","","","14573645","","",0,10,0,0,0,,,
1910,8,"Wang et al., 2011",journal,"Wang Y, Bai Y, Qu Q, Xu J, Chen Y, Zhong Z, Qiu Y, Wang T, Du X, Wang Z, Yu S, Fu S, Yuan J, Zhen Q, Yu Y, Chen Z, Huang L",The 16MvjbR as an ideal live attenuated vaccine candidate for differentiation between Brucella vaccination and infection,"2011","","","",Veterinary microbiology,"","","","","","","","21530111","","",0,10,0,0,0,,,
1911,0,"Adams et al., 2008",journal,"Adams S, O'Neill DW, Nonaka D, Hardin E, Chiriboga L, Siu K, Cruz CM, Angiulli A, Angiulli F, Ritter E, Holman RM, Shapiro RL, Berman RS, Berner N, Shao Y, Manches O, Pan L, Venhaus RR, Hoffman EW, Jungbluth A, Gnjatic S, Old L, Pavlick AC, Bhardwaj N",Immunization of malignant melanoma patients with full-length NY-ESO-1 protein using TLR7 agonist imiquimod as vaccine adjuvant,"2008","181","1","776-784","Journal of immunology (Baltimore, Md. : 1950)","","","","","","","","18566444","","",0,10,82,0,0,,,
1912,0,"Otero et al., 2004",journal,"Otero M, Calarota SA, Felber B, Laddy D, Pavlakis G, Boyer JD, Weiner DB",Resiquimod is a modest adjuvant for HIV-1 gag-based genetic immunization in a mouse model,"2004","22","13-14","1782-1790",Vaccine,"","","","","","","","15068862","","",0,10,83,0,0,,,
1913,0,"Morel et al., 2011",journal,"Morel S, Didierlaurent A, Bourguignon P, Delhaye S, Baras B, Jacob V, Planty C, Elouahabi A, Harvengt P, Carlsen H, Kielland A, Chomez P, Garon N, Van Mechelen M",Adjuvant System AS03 containing -tocopherol modulates innate immune response and leads to improved adaptive immunity,"2011","29","13","2461-2473",Vaccine,"","","","","","","","21256188","","",0,10,76,0,0,,,
1914,0,"Garon et al., 2011",journal,"Garon N, Segal L, Tavares F, Van Mechelen M",The safety evaluation of adjuvants during vaccine development: The AS04 experience,"2011","","","",Vaccine,"","","","","","","","21527299","","",0,10,25,0,0,,,
1915,99,"Adams et al., 2008",journal,"Adams S, O'Neill DW, Nonaka D, Hardin E, Chiriboga L, Siu K, Cruz CM, Angiulli A, Angiulli F, Ritter E, Holman RM, Shapiro RL, Berman RS, Berner N, Shao Y, Manches O, Pan L, Venhaus RR, Hoffman EW, Jungbluth A, Gnjatic S, Old L, Pavlick AC, Bhardwaj N",Immunization of malignant melanoma patients with full-length NY-ESO-1 protein using TLR7 agonist imiquimod as vaccine adjuvant,"2008","181","1","776-784","Journal of immunology (Baltimore, Md. : 1950)","","","","","","","","18566444","","",0,10,0,0,0,,,
1916,26,"Otero et al., 2004",journal,"Otero M, Calarota SA, Felber B, Laddy D, Pavlakis G, Boyer JD, Weiner DB",Resiquimod is a modest adjuvant for HIV-1 gag-based genetic immunization in a mouse model,"2004","22","13-14","1782-1790",Vaccine,"","","","","","","","15068862","","",0,10,0,0,0,,,
1917,42,"Liu et al., 2008",journal,"Liu T, Knig R, Sha J, Agar SL, Tseng CT, Klimpel GR, Chopra AK",Immunological responses against Salmonella enterica serovar Typhimurium Braun lipoprotein and lipid A mutant strains in Swiss-Webster mice: potential use as live-attenuated vaccines,"2008","44","3","224-237",Microbial pathogenesis,"","","","","","","","17997275","","",0,10,0,0,0,,,
1918,0,"Igartua and Pedraz, 2010",journal,"Igartua M, Pedraz JL",Topical resiquimod: a promising adjuvant for vaccine development?,"2010","9","1","23-27",Expert review of vaccines,"","","","","","","","20021302","","",0,10,83,0,0,,,
1919,11,"Feodorova et al., 2007",journal,"Feodorova VA, Pan'kina LN, Savostina EP, Sayapina LV, Motin VL, Dentovskaya SV, Shaikhutdinova RZ, Ivanov SA, Lindner B, Kondakova AN, Bystrova OV, Kocharova NA, Senchenkova SN, Holst O, Pier GB, Knirel YA, Anisimov AP",A Yersinia pestis lpxM-mutant live vaccine induces enhanced immunity against bubonic plague in mice and guinea pigs,"2007","25","44","7620-7628",Vaccine,"","","","","","","","17913308","","",0,10,0,0,0,,,
1920,0,Seppic Website,website,"","","","","","","","","","","","","","","",http://www.seppic.com/animal-health/vaccine-adjuvant/montanide-isa-@/1631/view-979-category.html,"",0,10,81,0,0,,,
1921,50,"Fattal-German et al., 1988",journal,"Fattal-German M, German A, Bizzini B",Potentiating the effectiveness of influenza vaccination by a combined immunostimulation with P40 immunomodulator: an experimental study in mice,"1988","42","1","73-78",Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie,"","","","","","","","3408809","","",0,10,0,0,0,,,
1922,173,"Tsujimura et al., 2006",journal,"Tsujimura K, Yamanaka T, Kondo T, Fukushi H, Matsumura T",Pathogenicity and immunogenicity of equine herpesvirus type 1 mutants defective in either gI or gE gene in murine and hamster models,"2006","68","10","1029-1038",The Journal of veterinary medical science / the Japanese Society of Veterinary Science,"","","","","","","","17085880","","",0,10,0,0,0,,,
1923,136,"Jiang et al., 2007",journal,"Jiang S, Rasmussen RA, Nolan KM, Frankel FR, Lieberman J, McClure HM, Williams KM, Babu US, Raybourne RB, Strobert E, Ruprecht RM",Live attenuated Listeria monocytogenes expressing HIV Gag: immunogenicity in rhesus monkeys,"2007","25","42","7470-7479",Vaccine,"","","","","","","","17854955","","",0,10,0,0,0,,,
1924,136,"Brockstedt et al., 2005",journal,"Brockstedt DG, Bahjat KS, Giedlin MA, Liu W, Leong M, Luckett W, Gao Y, Schnupf P, Kapadia D, Castro G, Lim JY, Sampson-Johannes A, Herskovits AA, Stassinopoulos A, Bouwer HG, Hearst JE, Portnoy DA, Cook DN, Dubensky TW Jr",Killed but metabolically active microbes: a new vaccine paradigm for eliciting effector T-cell responses and protective immunity,"2005","11","8","853-860",Nature medicine,"","","","","","","","16041382","","",0,10,0,0,0,,,
1925,0,"Dubensky and Reed, 2010",journal,"Dubensky TW Jr, Reed SG",Adjuvants for cancer vaccines,"2010","22","3","155-161",Seminars in immunology,"","","","","","","","20488726","","",0,10,37,0,0,,,
1926,0,"Dubensky and Reed, 2010",journal,"Dubensky TW Jr, Reed SG",Adjuvants for cancer vaccines,"2010","22","3","155-161",Seminars in immunology,"","","","","","","","20488726","","",0,10,62,0,0,,,
3889,99,"Berzofsky et al., 2001",journal,"Berzofsky JA, Ahlers JD, Belyakov IM",Strategies for designing and optimizing new generation vaccines,"2001","1","3","209-219",Nature reviews. Immunology,,,,,,,,"11905830",,,0,10,0,0,0,,,
1928,0,"Dubensky and Reed, 2010",journal,"Dubensky TW Jr, Reed SG",Adjuvants for cancer vaccines,"2010","22","3","155-161",Seminars in immunology,"","","","","","","","20488726","","",0,10,24,0,0,,,
1929,0,"Vogel et al., 2009",journal,"Vogel FR, Caillet C, Kusters IC, Haensler J",Emulsion-based adjuvants for influenza vaccines,"2009","8","4","483-492",Expert review of vaccines,"","","","","","","","19348563","","",0,11,62,0,0,,,
1930,0,"Vogel et al., 2009",journal,"Vogel FR, Caillet C, Kusters IC, Haensler J",Emulsion-based adjuvants for influenza vaccines,"2009","8","4","483-492",Expert review of vaccines,"","","","","","","","19348563","","",0,10,84,0,0,,,
1931,0,"Caillet et al., 2010",journal,"Caillet C, Piras F, Bernard MC, de Montfort A, Boudet F, Vogel FR, Hoffenbach A, Moste C, Kusters I",AF03-adjuvanted and non-adjuvanted pandemic influenza A (H1N1) 2009 vaccines induce strong antibody responses in seasonal influenza vaccine-primed and unprimed mice,"2010","28","18","3076-3079",Vaccine,"","","","","","","","20193791","","",0,10,84,0,0,,,
1932,29,"Aguilar et al., 2006",journal,"Aguilar LD, Infante E, Bianco MV, Cataldi A, Bigi F, Pando RH",Immunogenicity and protection induced by Mycobacterium tuberculosis mce-2 and mce-3 mutants in a Balb/c mouse model of progressive pulmonary tuberculosis,"2006","24","13","2333-2342",Vaccine,"","","","","","","","16388878","","",0,10,0,0,0,,,
1933,0,"Honko et al., 2006",journal,"Honko AN, Sriranganathan N, Lees CJ, Mizel SB",Flagellin is an effective adjuvant for immunization against lethal respiratory challenge with Yersinia pestis,"2006","74","2","1113-1120",Infection and immunity,"","","","","","","","16428759","","",0,10,85,0,0,,,
1934,0,"Kumar et al., 2008",journal,"Kumar H, Koyama S, Ishii KJ, Kawai T, Akira S",Cutting edge: cooperation of IPS-1- and TRIF-dependent pathways in poly IC-enhanced antibody production and cytotoxic T cell responses,"2008","180","2","683-687","Journal of immunology (Baltimore, Md. : 1950)","","","","","","","","18178804","","",0,10,86,0,0,,,
1935,0,"Sun et al., 2009",journal,"Sun HX, Xie Y, Ye YP",ISCOMs and ISCOMATRIX,"2009","27","33","4388-4401",Vaccine,"","","","","","","","19450632","","",0,10,87,0,0,,,
3888,99,"Posner et al., 2008",journal,"Posner MC, Niedzwiecki D, Venook AP, Hollis DR, Kindler HL, Martin EW, Schilsky RL, Goldberg RM, Mayer RJ",A phase II prospective multi-institutional trial of adjuvant active specific immunotherapy following curative resection of colorectal cancer hepatic metastases: cancer and leukemia group B study 89903,"2008","15","1","158-164",Annals of surgical oncology,,,,,,,,"18008108",,,0,10,0,0,0,,,
1937,99,"Brockstedt et al., 2005",journal,"Brockstedt DG, Bahjat KS, Giedlin MA, Liu W, Leong M, Luckett W, Gao Y, Schnupf P, Kapadia D, Castro G, Lim JY, Sampson-Johannes A, Herskovits AA, Stassinopoulos A, Bouwer HG, Hearst JE, Portnoy DA, Cook DN, Dubensky TW Jr",Killed but metabolically active microbes: a new vaccine paradigm for eliciting effector T-cell responses and protective immunity,"2005","11","8","853-860",Nature medicine,"","","","","","","","16041382","","",0,10,0,0,0,,,
1938,111,"Najdenski et al., 2009",journal,"Najdenski H, Golkocheva-Markova E, Kussovski V, Vesselinova A, Garbom S, Wolf-Watz H",Attenuation and preserved immunogenic potential of Yersinia pseudotuberculosis mutant strains evidenced in oral pig model,"2009","56","4","157-168",Zoonoses and public health,"","","","","","","","18793276","","",0,10,0,0,0,,,
1939,130,"Dorrell et al., 1998",journal,"Dorrell N, Li SR, Everest PH, Dougan G, Wren BW",Construction and characterisation of a Yersinia enterocolitica O:8 ompR mutant,"1998","165","1","145-151",FEMS microbiology letters,"","","","","","","","9711851","","",0,10,0,0,0,,,
1940,130,"Igwe et al., 1999",journal,"Igwe EI, Rssmann H, Roggenkamp A, Noll A, Autenrieth IB, Heesemann J",Rational live oral carrier vaccine design by mutating virulence-associated genes of Yersinia enterocolitica,"1999","67","10","5500-5507",Infection and immunity,"","","","","","","","10496939","","",0,10,0,0,0,,,
2051,43,"Sansonetti et al., 1991",journal,"Sansonetti PJ, Arondel J, Fontaine A, d'Hauteville H, Bernardini ML",OmpB (osmo-regulation) and icsA (cell-to-cell spread) mutants of Shigella flexneri: vaccine candidates and probes to study the pathogenesis of shigellosis,"1991","9","6","416-422",Vaccine,"","","","","","","","1887672","","",0,10,0,0,0,,,
1941,130,"Li et al., 1996",journal,"Li SR, Dorrell N, Everest PH, Dougan G, Wren BW",Construction and characterization of a Yersinia enterocolitica O:8 high-temperature requirement (htrA) isogenic mutant,"1996","64","6","2088-2094",Infection and immunity,"","","","","","","","8675311","","",0,10,0,0,0,,,
1942,87,"Min et al., 2001",journal,"Min W, Lillehoj HS, Burnside J, Weining KC, Staeheli P, Zhu JJ","Adjuvant effects of IL-1beta, IL-2, IL-8, IL-15, IFN-alpha, IFN-gamma TGF-beta4 and lymphotactin on DNA vaccination against Eimeria acervulina","2001","20","1-2","267-274",Vaccine,"","","","","","","","11567773","","",0,10,0,0,0,,,
1943,49,"Quiroga et al., 1990",journal,"Quiroga JA, Castillo I, Porres JC, Casado S, Sez F, Gracia Martnez M, Gmez M, Inglada L, Snchez-Sicilia L, Mora A",Recombinant gamma-interferon as adjuvant to hepatitis B vaccine in hemodialysis patients,"1990","12","4 Pt 1","661-663","Hepatology (Baltimore, Md.)","","","","","","","","2145212","","",0,10,0,0,0,,,
1944,0,"Pearse and Drane, 2005",journal,"Pearse MJ, Drane D",ISCOMATRIX adjuvant for antigen delivery,"2005","57","3","465-474",Advanced drug delivery reviews,"","","","","","","","15560952","","",0,10,87,0,0,,,
1945,0,Wiki: Poly(I:C),website,"",Wiki: Polyinosinic:polycytidylic acid,"","","","","","","","","","","","","",http://en.wikipedia.org/wiki/Polyinosinic:polycytidylic_acid,"",0,10,86,0,0,,,
1946,8,"Edmonds et al., 2002",journal,"Edmonds MD, Cloeckaert A, Elzer PH",Brucella species lacking the major outer membrane protein Omp25 are attenuated in mice and protect against Brucella melitensis and Brucella ovis,"2002","88","3","205-221",Veterinary microbiology,"","","","","","","","12151196","","",0,10,0,0,0,,,
1947,0,"Sloat and Cui, 2006",journal,"Sloat BR, Cui Z",Nasal immunization with anthrax protective antigen protein adjuvanted with polyriboinosinic-polyribocytidylic acid induced strong mucosal and systemic immunities,"2006","23","6","1217-1226",Pharmaceutical research,"","","","","","","","16718616","","",0,10,86,0,0,,,
1948,0,"Mizel and Bates, 2010",journal,"Mizel SB, Bates JT",Flagellin as an adjuvant: cellular mechanisms and potential,"2010","185","10","5677-5682","Journal of immunology (Baltimore, Md. : 1950)","","","","","","","","21048152","","",0,10,85,0,0,,,
1949,50,"Caillet et al., 2010",journal,"Caillet C, Piras F, Bernard MC, de Montfort A, Boudet F, Vogel FR, Hoffenbach A, Moste C, Kusters I",AF03-adjuvanted and non-adjuvanted pandemic influenza A (H1N1) 2009 vaccines induce strong antibody responses in seasonal influenza vaccine-primed and unprimed mice,"2010","28","18","3076-3079",Vaccine,"","","","","","","","20193791","","",0,10,0,0,0,,,
1950,99,"Nicholaou et al., 2009",journal,"Nicholaou T, Ebert LM, Davis ID, McArthur GA, Jackson H, Dimopoulos N, Tan B, Maraskovsky E, Miloradovic L, Hopkins W, Pan L, Venhaus R, Hoffman EW, Chen W, Cebon J",Regulatory T-cell-mediated attenuation of T-cell responses to the NY-ESO-1 ISCOMATRIX vaccine in patients with advanced malignant melanoma,"2009","15","6","2166-2173",Clinical cancer research : an official journal of the American Association for Cancer Research,"","","","","","","","19276262","","",0,10,0,0,0,,,
1951,7,"Sloat and Cui, 2006",journal,"Sloat BR, Cui Z",Nasal immunization with anthrax protective antigen protein adjuvanted with polyriboinosinic-polyribocytidylic acid induced strong mucosal and systemic immunities,"2006","23","6","1217-1226",Pharmaceutical research,"","","","","","","","16718616","","",0,10,0,0,0,,,
1952,25,"Fan et al., 2011",journal,"Fan HY, Wang L, Luo J, Long BG",Protection against Escherichia coli O157:H7 challenge by immunization of mice with purified Tir proteins,"2011","","","",Molecular biology reports,"","","","","","","","21567195","","",0,10,0,0,0,,,
1953,42,"Curtiss and Kelly, 1987",journal,"Curtiss R 3rd, Kelly SM",Salmonella typhimurium deletion mutants lacking adenylate cyclase and cyclic AMP receptor protein are avirulent and immunogenic,"1987","55","12","3035-3043",Infection and immunity,"","","","","","","","3316029","","",0,10,0,0,0,,,
1954,42,"Dorman et al., 1989",journal,"Dorman CJ, Chatfield S, Higgins CF, Hayward C, Dougan G",Characterization of porin and ompR mutants of a virulent strain of Salmonella typhimurium: ompR mutants are attenuated in vivo,"1989","57","7","2136-2140",Infection and immunity,"","","","","","","","2543631","","",0,10,0,0,0,,,
1955,42,"Matsui et al., 2003",journal,"Matsui H, Suzuki M, Isshiki Y, Kodama C, Eguchi M, Kikuchi Y, Motokawa K, Takaya A, Tomoyasu T, Yamamoto T",Oral immunization with ATP-dependent protease-deficient mutants protects mice against subsequent oral challenge with virulent Salmonella enterica serovar typhimurium,"2003","71","1","30-39",Infection and immunity,"","","","","","","","12496146","","",0,10,0,0,0,,,
1956,12,"Conlan et al., 2010",journal,"Conlan JW, Shen H, Golovliov I, Zingmark C, Oyston PC, Chen W, House RV, Sjstedt A",Differential ability of novel attenuated targeted deletion mutants of Francisella tularensis subspecies tularensis strain SCHU S4 to protect mice against aerosol challenge with virulent bacteria: effects of host background and route of immunization,"2010","28","7","1824-1831",Vaccine,"","","","","","","","20018266","","",0,10,0,0,0,,,
1957,12,"Melillo et al., 2009",journal,"Melillo AA, Mahawar M, Sellati TJ, Malik M, Metzger DW, Melendez JA, Bakshi CS",Identification of Francisella tularensis live vaccine strain CuZn superoxide dismutase as critical for resistance to extracellularly generated reactive oxygen species,"2009","191","20","6447-6456",Journal of bacteriology,"","","","","","","","19684141","","",0,10,0,0,0,,,
1958,12,"Sammons-Jackson et al., 2008",journal,"Sammons-Jackson WL, McClelland K, Manch-Citron JN, Metzger DW, Bakshi CS, Garcia E, Rasley A, Anderson BE",Generation and characterization of an attenuated mutant in a response regulator gene of Francisella tularensis live vaccine strain (LVS),"2008","27","7","387-403",DNA and cell biology,"","","","","","","","18613792","","",0,10,0,0,0,,,
1959,12,"Sebastian et al., 2007",journal,"Sebastian S, Dillon ST, Lynch JG, Blalock LT, Balon E, Lee KT, Comstock LE, Conlan JW, Rubin EJ, Tzianabos AO, Kasper DL",A defined O-antigen polysaccharide mutant of Francisella tularensis live vaccine strain has attenuated virulence while retaining its protective capacity,"2007","75","5","2591-2602",Infection and immunity,"","","","","","","","17296751","","",0,10,0,0,0,,,
1960,12,"Pechous et al., 2006",journal,"Pechous R, Celli J, Penoske R, Hayes SF, Frank DW, Zahrt TC",Construction and characterization of an attenuated purine auxotroph in a Francisella tularensis live vaccine strain,"2006","74","8","4452-4461",Infection and immunity,"","","","","","","","16861631","","",0,10,0,0,0,,,
1961,29,"Sambandamurthy et al., 2006",journal,"Sambandamurthy VK, Derrick SC, Hsu T, Chen B, Larsen MH, Jalapathy KV, Chen M, Kim J, Porcelli SA, Chan J, Morris SL, Jacobs WR Jr",Mycobacterium tuberculosis DeltaRD1 DeltapanCD: a safe and limited replicating mutant strain that protects immunocompetent and immunocompromised mice against experimental tuberculosis,"2006","24","37-39","6309-6320",Vaccine,"","","","","","","","16860907","","",0,10,0,0,0,,,
1962,65,"Weigel et al., 2003",journal,"Weigel RM, Hahn EC, Scherba G",Survival and immunization of raccoons after exposure to pseudorabies (Aujeszky's disease) virus gene-deleted vaccines,"2003","92","1-2","19-24",Veterinary microbiology,"","","","","","","","12488067","","",0,10,0,0,0,,,
1963,42,"Sydenham et al., 2000",journal,"Sydenham M, Douce G, Bowe F, Ahmed S, Chatfield S, Dougan G",Salmonella enterica serovar typhimurium surA mutants are attenuated and effective live oral vaccines,"2000","68","3","1109-1115",Infection and immunity,"","","","","","","","10678914","","",0,10,0,0,0,,,
1964,42,"Chaudhuri et al., 2009",journal,"Chaudhuri RR, Peters SE, Pleasance SJ, Northen H, Willers C, Paterson GK, Cone DB, Allen AG, Owen PJ, Shalom G, Stekel DJ, Charles IG, Maskell DJ",Comprehensive identification of Salmonella enterica serovar typhimurium genes required for infection of BALB/c mice,"2009","5","7",e1000529,PLoS pathogens,"","","","","","","","19649318","","",0,10,0,0,0,,,
1965,166,"McArthur et al., 2003",journal,"McArthur JD, West NP, Cole JN, Jungnitz H, Guzmn CA, Chin J, Lehrbach PR, Djordjevic SP, Walker MJ",An aromatic amino acid auxotrophic mutant of Bordetella bronchiseptica is attenuated and immunogenic in a mouse model of infection,"2003","221","1","7-16",FEMS microbiology letters,"","","","","","","","12694904","","",0,10,0,0,0,,,
1966,102,"Yu et al., 2005",journal,"Yu F, Qi G, Liu Y, Gao S, Kan B",Construction and characterization of a thyA mutant derived from cholera vaccine candidate IEM101,"2005","29","3","191-196",Molecular biotechnology,"","","","","","","","15767696","","",0,10,0,0,0,,,
1967,42,"Kaniga et al., 1998",journal,"Kaniga K, Compton MS, Curtiss R 3rd, Sundaram P",Molecular and functional characterization of Salmonella enterica serovar typhimurium poxA gene: effect on attenuation of virulence and protection,"1998","66","12","5599-5606",Infection and immunity,"","","","","","","","9826331","","",0,10,0,0,0,,,
1968,100,"Halford et al., 2011",journal,"Halford WP, Pschel R, Gershburg E, Wilber A, Gershburg S, Rakowski B",A live-attenuated HSV-2 ICP0 virus elicits 10 to 100 times greater protection against genital herpes than a glycoprotein D subunit vaccine,"2011","6","3",e17748,PloS one,"","","","","","","","21412438","","",0,10,0,0,0,,,
1969,65,"Jns et al., 1997",journal,"Jns A, Gerdts V, Lange E, Kaden V, Mettenleiter TC",Attenuation of dUTPase-deficient pseudorabies virus for the natural host,"1997","56","1-2","47-54",Veterinary microbiology,"","","","","","","","9228681","","",0,10,0,0,0,,,
1970,65,"Dijkstra et al., 1997",journal,"Dijkstra JM, Gerdts V, Klupp BG, Mettenleiter TC",Deletion of glycoprotein gM of pseudorabies virus results in attenuation for the natural host,"1997","78 ( Pt 9)","","2147-2151",The Journal of general virology,"","","","","","","","9292000","","",0,10,0,0,0,,,
1971,30,"Douradinha et al., 2007",journal,"Douradinha B, van Dijk MR, Ataide R, van Gemert GJ, Thompson J, Franetich JF, Mazier D, Luty AJ, Sauerwein R, Janse CJ, Waters AP, Mota MM",Genetically attenuated P36p-deficient Plasmodium berghei sporozoites confer long-lasting and partial cross-species protection,"2007","37","13","1511-1519",International journal for parasitology,"","","","","","","","17604034","","",0,10,0,0,0,,,
1972,30,"Labaied et al., 2007",journal,"Labaied M, Harupa A, Dumpit RF, Coppens I, Mikolajczak SA, Kappe SH",Plasmodium yoelii sporozoites with simultaneous deletion of P52 and P36 are completely attenuated and confer sterile immunity against infection,"2007","75","8","3758-3768",Infection and immunity,"","","","","","","","17517871","","",0,10,0,0,0,,,
1973,30,"Tarun et al., 2007",journal,"Tarun AS, Dumpit RF, Camargo N, Labaied M, Liu P, Takagi A, Wang R, Kappe SH",Protracted sterile protection with Plasmodium yoelii pre-erythrocytic genetically attenuated parasite malaria vaccines is independent of significant liver-stage persistence and is mediated by CD8+ T cells,"2007","196","4","608-616",The Journal of infectious diseases,"","","","","","","","17624848","","",0,10,0,0,0,,,
1974,157,"Helferich et al., 2007",journal,"Helferich D, Veits J, Teifke JP, Mettenleiter TC, Fuchs W",The UL47 gene of avian infectious laryngotracheitis virus is not essential for in vitro replication but is relevant for virulence in chickens,"2007","88",Pt 3,"732-742",The Journal of general virology,"","","","","","","","17325345","","",0,10,0,0,0,,,
1975,157,"Veits et al., 2003",journal,"Veits J, Lschow D, Kindermann K, Werner O, Teifke JP, Mettenleiter TC, Fuchs W","Deletion of the non-essential UL0 gene of infectious laryngotracheitis (ILT) virus leads to attenuation in chickens, and UL0 mutants expressing influenza virus haemagglutinin (H7) protect against ILT and fowl plague","2003","84",Pt 12,"3343-3352",The Journal of general virology,"","","","","","","","14645915","","",0,10,0,0,0,,,
1976,66,"Maurer et al., 2005",journal,"Maurer R, Stettler P, Ruggli N, Hofmann MA, Tratschin JD",Oronasal vaccination with classical swine fever virus (CSFV) replicon particles with either partial or complete deletion of the E2 gene induces partial protection against lethal challenge with highly virulent CSFV,"2005","23","25","3318-3328",Vaccine,"","","","","","","","15837238","","",0,10,0,0,0,,,
1977,56,"Wu et al., 2011",journal,"Wu X, Franka R, Henderson H, Rupprecht CE",Live attenuated rabies virus co-infected with street rabies virus protects animals against rabies,"2011","","","",Vaccine,"","","","","","","","21514343","","",0,10,0,0,0,,,
1978,42,"Roesler et al., 2004",journal,"Roesler U, Marg H, Schrder I, Mauer S, Arnold T, Lehmann J, Truyen U, Hensel A",Oral vaccination of pigs with an invasive gyrA-cpxA-rpoB Salmonella Typhimurium mutant,"2004","23","5","595-603",Vaccine,"","","","","","","","15542179","","",0,10,0,0,0,,,
1979,166,"Nagano et al., 1988",journal,"Nagano H, Nakai T, Horiguchi Y, Kume K",Isolation and characterization of mutant strains of Bordetella bronchiseptica lacking dermonecrotic toxin-producing ability,"1988","26","10","1983-1987",Journal of clinical microbiology,"","","","","","","","3182989","","",0,10,0,0,0,,,
1980,65,"Peeters et al., 1994",journal,"Peeters B, Bouma A, de Bruin T, Moormann R, Gielkens A, Kimman T",Non-transmissible pseudorabies virus gp50 mutants: a new generation of safe live vaccines,"1994","12","4","375-380",Vaccine,"","","","","","","","8178562","","",0,10,0,0,0,,,
1981,156,"Yokoyama et al., 1996",journal,"Yokoyama N, Maeda K, Tohya Y, Kawaguchi Y, Shin YS, Ono M, Ishiguro S, Fujikawa Y, Mikami T",Pathogenicity and vaccine efficacy of a thymidine kinase-deficient mutant of feline herpesvirus type 1 in cats,"1996","141","3-4","481-494",Archives of virology,"","","","","","","","8645090","","",0,10,0,0,0,,,
1982,100,"Field and Wildy, 1978",journal,"Field HJ, Wildy P",The pathogenicity of thymidine kinase-deficient mutants of herpes simplex virus in mice,"1978","81","2","267-277",The Journal of hygiene,"","","","","","","","212476","","",0,10,0,0,0,,,
1983,173,"Slater et al., 1993",journal,"Slater JD, Gibson JS, Field HJ",Pathogenicity of a thymidine kinase-deficient mutant of equine herpesvirus 1 in mice and specific pathogen-free foals,"1993","74 ( Pt 5)","","819-828",The Journal of general virology,"","","","","","","","8388018","","",0,10,0,0,0,,,
1984,67,"Kit et al., 1985",journal,"Kit S, Qavi H, Gaines JD, Billingsley P, McConnell S",Thymidine kinase-negative bovine herpesvirus type 1 mutant is stable and highly attenuated in calves,"1985","86","1-2","63-83",Archives of virology,"","","","","","","","2994602","","",0,10,0,0,0,,,
1985,157,"Han et al., 2002",journal,"Han MG, Kweon CH, Mo IP, Kim SJ",Pathogenicity and vaccine efficacy of a thymidine kinase gene deleted infectious laryngotracheitis virus expressing the green fluorescent protein gene,"2002","147","5","1017-1031",Archives of virology,"","","","","","","","12021870","","",0,10,0,0,0,,,
1986,175,"Haijema et al., 2004",journal,"Haijema BJ, Volders H, Rottier PJ","Live, attenuated coronavirus vaccines through the directed deletion of group-specific genes provide protection against feline infectious peritonitis","2004","78","8","3863-3871",Journal of virology,"","","","","","","","15047802","","",0,10,0,0,0,,,
1987,154,"Lockridge et al., 2000",journal,"Lockridge KM, Chien M, Dean GA, Stefano Cole K, Montelaro RC, Luciw PA, Sparger EE",Protective immunity against feline immunodeficiency virus induced by inoculation with vif-deleted proviral DNA,"2000","273","1","67-79",Virology,"","","","","","","","10891409","","",0,10,0,0,0,,,
1988,8,"Cloeckaert et al., 2004",journal,"Cloeckaert A, Jacques I, Grill MJ, Marn CM, Grayon M, Blasco JM, Verger JM",Development and evaluation as vaccines in mice of Brucella melitensis Rev.1 single and double deletion mutants of the bp26 and omp31 genes coding for antigens of diagnostic significance in ovine brucellosis,"2004","22","21-22","2827-2835",Vaccine,"","","","","","","","15246618","","",0,10,0,0,0,,,
1989,143,"Schmidt et al., 2002",journal,"Schmidt U, Beyer J, Polster U, Gershwin LJ, Buchholz UJ",Mucosal immunization with live recombinant bovine respiratory syncytial virus (BRSV) and recombinant BRSV lacking the envelope glycoprotein G protects against challenge with wild-type BRSV,"2002","76","23","12355-12359",Journal of virology,"","","","","","","","12414977","","",0,10,0,0,0,,,
1990,0,"Vogel and Powell, 1995",journal,"Vogel FR, Powell MF",A compendium of vaccine adjuvants and excipients,"1995","6","","141-228",Pharmaceutical biotechnology,"","","","","","","","7551218","","",0,10,3,0,0,,,
1991,0,"Vogel and Powell, 1995",journal,"Vogel FR, Powell MF",A compendium of vaccine adjuvants and excipients,"1995","6","","141-228",Pharmaceutical biotechnology,"","","","","","","","7551218","","",0,10,7,0,0,,,
1992,0,"Vogel and Powell, 1995",journal,"Vogel FR, Powell MF",A compendium of vaccine adjuvants and excipients,"1995","6","","141-228",Pharmaceutical biotechnology,"","","","","","","","7551218","","",0,10,82,0,0,,,
1993,7,"Gat et al., 2005",journal,"Gat O, Mendelson I, Chitlaru T, Ariel N, Altboum Z, Levy H, Weiss S, Grosfeld H, Cohen S, Shafferman A",The solute-binding component of a putative Mn(II) ABC transporter (MntA) is a novel Bacillus anthracis virulence determinant,"2005","58","2","533-551",Molecular microbiology,"","","","","","","","16194238","","",0,10,0,0,0,,,
1994,0,"Vogel and Powell, 1995",journal,"Vogel FR, Powell MF",A compendium of vaccine adjuvants and excipients,"1995","6","","141-228",Pharmaceutical biotechnology,"","","","","","","","7551218","","",0,10,13,0,0,,,
1995,209,"Lan et al., 2007",journal,"Lan MZ, Peng X, Xiang MY, Xia ZY, Bo W, Jie L, Li XY, Jun ZP","Construction and characterization of a live, attenuated esrB mutant of Edwardsiella tarda and its potential as a vaccine against the haemorrhagic septicaemia in turbot, Scophthamus maximus (L.)","2007","23","3","521-530",Fish & shellfish immunology,"","","","","","","","17478097","","",0,10,0,0,0,,,
1996,210,"Schickli et al., 2008",journal,"Schickli JH, Kaur J, Macphail M, Guzzetta JM, Spaete RR, Tang RS",Deletion of human metapneumovirus M2-2 increases mutation frequency and attenuates growth in hamsters,"2008","5","","69",Virology journal,"","","","","","","","18519001","",,0,0,0,0,0,,,
1997,210,"Biacchesi et al., 2005",journal,"Biacchesi S, Pham QN, Skiadopoulos MH, Murphy BR, Collins PL, Buchholz UJ","Infection of nonhuman primates with recombinant human metapneumovirus lacking the SH, G, or M2-2 protein categorizes each as a nonessential accessory protein and identifies vaccine candidates","2005","79","19","12608-12613",Journal of virology,"","","","","","","","16160190","","",0,10,0,0,0,,,
1998,211,"Hernanz et al., 1998",journal,"Hernanz Moral C, Flao del Castillo E, Lpez Fierro P, Villena Corts A, Anguita Castillo J, Cascn Soriano A, Snchez Salazar M, Razqun Peralta B, Naharro Carrasco G",Molecular characterization of the Aeromonas hydrophila aroA gene and potential use of an auxotrophic aroA mutant as a live attenuated vaccine,"1998","66","5","1813-1821",Infection and immunity,"","","","","","","","9573055","","",0,10,0,0,0,,,
1999,212,"Jin et al., 2003",journal,"Jin H, Cheng X, Traina-Dorge VL, Park HJ, Zhou H, Soike K, Kemble G",Evaluation of recombinant respiratory syncytial virus gene deletion mutants in African green monkeys for their potential as live attenuated vaccine candidates,"2003","21","25-26","3647-3652",Vaccine,"","","","","","","","12922094","","",0,10,0,0,0,,,
2000,200,"Okamba et al., 2010",journal,"Okamba FR, Arella M, Music N, Jia JJ, Gottschalk M, Gagnon CA",Potential use of a recombinant replication-defective adenovirus vector carrying the C-terminal portion of the P97 adhesin protein as a vaccine against Mycoplasma hyopneumoniae in swine,"2010","28","30","4802-4809",Vaccine,"","","","","","","","20472025","","",0,10,0,0,0,,,
2001,213,"Daniel et al., 1992",journal,"Daniel MD, Kirchhoff F, Czajak SC, Sehgal PK, Desrosiers RC",Protective effects of a live attenuated SIV vaccine with a deletion in the nef gene,"1992","258","5090","1938-1941","Science (New York, N.Y.)","","","","","","","","1470917","","",0,10,0,0,0,,,
2002,0,"Vogel and Powell, 1995",journal,"Vogel FR, Powell MF",A compendium of vaccine adjuvants and excipients,"1995","6","","141-228",Pharmaceutical biotechnology,"","","","","","","","7551218","","",0,10,78,0,0,,,
2003,0,"Vogel and Powell, 1995",journal,"Vogel FR, Powell MF",A compendium of vaccine adjuvants and excipients,"1995","6","","141-228",Pharmaceutical biotechnology,"","","","","","","","7551218","","",0,10,31,0,0,,,
2004,0,"Vogel and Powell, 1995",journal,"Vogel FR, Powell MF",A compendium of vaccine adjuvants and excipients,"1995","6","","141-228",Pharmaceutical biotechnology,"","","","","","","","7551218","","",0,10,22,0,0,,,
2005,0,"Vogel and Powell, 1995",journal,"Vogel FR, Powell MF",A compendium of vaccine adjuvants and excipients,"1995","6","","141-228",Pharmaceutical biotechnology,"","","","","","","","7551218","","",0,10,24,0,0,,,
2006,29,"Aagaard et al., 2011",journal,"Aagaard C, Hoang T, Dietrich J, Cardona PJ, Izzo A, Dolganov G, Schoolnik GK, Cassidy JP, Billeskov R, Andersen P",A multistage tuberculosis vaccine that confers efficient protection before and after exposure,"2011","17","2","189-194",Nature medicine,"","","","","","","","21258338","","",0,10,0,0,0,,,
2007,0,AbISCO-100 Website,website,"",AbISCO-100,"","","","","","","","","","","","","",http://www.isconova.com/products/abisco-research-reagent/abisco-100.aspx,"",0,10,89,0,0,,,
2008,0,"Song et al., 2006",journal,"Song R, Liu S, Adams RJ, Leong KW",Enhancing efficacy of HIV gag DNA vaccine by local delivery of GM-CSF in murine and macaque models,"2006","26","6","380-389",Journal of interferon & cytokine research : the official journal of the International Society for Interferon and Cytokine Research,"","","","","","","","16734558","","",0,10,90,0,0,,,
2009,0,"Vogel and Powell, 1995",journal,"Vogel FR, Powell MF",A compendium of vaccine adjuvants and excipients,"1995","6","","141-228",Pharmaceutical biotechnology,"","","","","","","","7551218","","",0,10,93,0,0,,,
2010,0,"Vogel and Powell, 1995",journal,"Vogel FR, Powell MF",A compendium of vaccine adjuvants and excipients,"1995","6","","141-228",Pharmaceutical biotechnology,"","","","","","","","7551218","","",0,10,94,0,0,,,
2011,0,"Vogel and Powell, 1995",journal,"Vogel FR, Powell MF",A compendium of vaccine adjuvants and excipients,"1995","6","","141-228",Pharmaceutical biotechnology,"","","","","","","","7551218","","",0,10,95,0,0,,,
2012,0,"Vogel and Powell, 1995",journal,"Vogel FR, Powell MF",A compendium of vaccine adjuvants and excipients,"1995","6","","141-228",Pharmaceutical biotechnology,"","","","","","","","7551218","","",0,10,96,0,0,,,
2013,0,"Vogel and Powell, 1995",journal,"Vogel FR, Powell MF",A compendium of vaccine adjuvants and excipients,"1995","6","","141-228",Pharmaceutical biotechnology,"","","","","","","","7551218","","",0,10,97,0,0,,,
2014,0,"Vogel and Powell, 1995",journal,"Vogel FR, Powell MF",A compendium of vaccine adjuvants and excipients,"1995","6","","141-228",Pharmaceutical biotechnology,"","","","","","","","7551218","","",0,10,98,0,0,,,
2015,0,"Vogel and Powell, 1995",journal,"Vogel FR, Powell MF",A compendium of vaccine adjuvants and excipients,"1995","6","","141-228",Pharmaceutical biotechnology,"","","","","","","","7551218","","",0,10,99,0,0,,,
2016,114,"Peng et al., 2004",journal,"Peng HJ, Tsai LC, Su SN, Chang ZN, Shen HD, Chao PL, Kuo SW, Tsao IY, Hung MW",Comparison of different adjuvants of protein and DNA vaccination for the prophylaxis of IgE antibody formation,"2004","22","5-6","755-761",Vaccine,"","","","","","","","14741169","","",0,10,0,0,0,,,
2017,0,"Jin et al., 2004",journal,"Jin H, Li Y, Ma Z, Zhang F, Xie Q, Gu D, Wang B",Effect of chemical adjuvants on DNA vaccination,"2004","22","21-22","2925-2935",Vaccine,"","","","","","","","15246629","","",0,10,100,0,0,,,
2018,0,Wiki: Bupivacaine,website,"",Wiki: Bupivacaine,"","","","","","","","","","","","","",http://en.wikipedia.org/wiki/Bupivacaine,"",0,10,100,0,0,,,
2019,113,"Yu et al., 2010",journal,"Yu H, Jiang X, Shen C, Karunakaran KP, Jiang J, Rosin NL, Brunham RC",Chlamydia muridarum T-cell antigens formulated with the adjuvant DDA/TDB induce immunity against infection that correlates with a high frequency of gamma interferon (IFN-gamma)/tumor necrosis factor alpha and IFN-gamma/interleukin-17 double-positive CD4+ T cells,"2010","78","5","2272-2282",Infection and immunity,"","","","","","","","20231405","","",0,10,0,0,0,,,
2020,26,"Song et al., 2006",journal,"Song R, Liu S, Adams RJ, Leong KW",Enhancing efficacy of HIV gag DNA vaccine by local delivery of GM-CSF in murine and macaque models,"2006","26","6","380-389",Journal of interferon & cytokine research : the official journal of the International Society for Interferon and Cytokine Research,"","","","","","","","16734558","","",0,10,0,0,0,,,
2021,166,"Mann et al., 2007",journal,"Mann P, Goebel E, Barbarich J, Pilione M, Kennett M, Harvill E",Use of a genetically defined double mutant strain of Bordetella bronchiseptica lacking adenylate cyclase and type III secretion as a live vaccine,"2007","75","7","3665-3672",Infection and immunity,"","","","","","","","17452472","","",0,10,0,0,0,,,
2022,99,"Soares et al., 2001",journal,"Soares MM, Mehta V, Finn OJ",Three different vaccines based on the 140-amino acid MUC1 peptide with seven tandemly repeated tumor-specific epitopes elicit distinct immune effector mechanisms in wild-type versus MUC1-transgenic mice with different potential for tumor rejection,"2001","166","11","6555-6563","Journal of immunology (Baltimore, Md. : 1950)","","","","","","","","11359807","","",0,10,0,0,0,,,
2023,26,"Locher et al., 2004",journal,"Locher CP, Witt SA, Ashlock BM, Polacino P, Hu SL, Shiboski S, Schmidt AM, Agy MB, Anderson DM, Staprans SI, zur Megede J, Levy JA",Human immunodeficiency virus type 2 DNA vaccine provides partial protection from acute baboon infection,"2004","22","17-18","2261-2272",Vaccine,"","","","","","","","15149785","","",0,10,0,0,0,,,
2024,49,"Morrey et al., 2011",journal,"Morrey JD, Motter NE, Chang S, Fairman J",Breaking B and T cell tolerance using cationic lipid-DNA complexes (CLDC) as a vaccine adjuvant with hepatitis B virus (HBV) surface antigen in transgenic mice expressing HBV,"2011","90","3","227-230",Antiviral research,"","","","","","","","21545812","","",0,10,0,0,0,,,
2025,0,"Chang et al., 2009",journal,"Chang S, Warner J, Liang L, Fairman J",A novel vaccine adjuvant for recombinant flu antigens,"2009","37","3","141-147",Biologicals : journal of the International Association of Biological Standardization,"","","","","","","","19285425","","",0,10,2,0,0,,,
2026,119,"Park et al., 2011",journal,"Park KT, Allen AJ, Bannantine JP, Seo KS, Hamilton MJ, Abdellrazeq GS, Rihan HM, Grimm A, Davis WC",Evaluation of two mutants of Mycobacterium avium subsp. paratuberculosis as candidates for a live attenuated vaccine for Johne's disease,"2011","","","",Vaccine,"","","","","","","","21565243","","",0,10,0,0,0,,,
2027,209,Microbe Wiki: E. tarda,website,"",Microbe Wiki: Edwardsiella tarda,"","","","","","","","","","","","","",http://microbewiki.kenyon.edu/index.php/Edwardsiella_tarda,"",0,10,0,0,0,,,
2028,43,"Barnoy et al., 2010",journal,"Barnoy S, Jeong KI, Helm RF, Suvarnapunya AE, Ranallo RT, Tzipori S, Venkatesan MM","Characterization of WRSs2 and WRSs3, new second-generation virG(icsA)-based Shigella sonnei vaccine candidates with the potential for reduced reactogenicity","2010","28","6","1642-1654",Vaccine,"","","","","","","","19932216","","",0,10,0,0,0,,,
2029,32,"Negrette et al., 2001",journal,"Negrette B, Bonilla E, Valero N, Giraldoth D, Medina-Leendertz S, Aez F",In mice the efficiency of immunization with Venezuelan Equine Encephalomyelitis virus TC-83 is transiently increased by dehydroepiandrosterone,"2001","42","4","235-240",Investigacion clinica,"","","","","","","","11787268","","",0,10,0,0,0,,,
2030,0,"Byrd and Cassels, 2006",journal,"Byrd W, Cassels FJ",The encapsulation of enterotoxigenic Escherichia coli colonization factor CS3 in biodegradable microspheres enhances the murine antibody response following intranasal administration,"2006","152",Pt 3,"779-786","Microbiology (Reading, England)","","","","","","","","16514157","","",0,10,101,0,0,,,
2031,25,"Byrd and Cassels, 2006",journal,"Byrd W, Cassels FJ",The encapsulation of enterotoxigenic Escherichia coli colonization factor CS3 in biodegradable microspheres enhances the murine antibody response following intranasal administration,"2006","152",Pt 3,"779-786","Microbiology (Reading, England)","","","","","","","","16514157","","",0,10,0,0,0,,,
2032,0,"Jiang et al., 2005",journal,"Jiang W, Gupta RK, Deshpande MC, Schwendeman SP",Biodegradable poly(lactic-co-glycolic acid) microparticles for injectable delivery of vaccine antigens,"2005","57","3","391-410",Advanced drug delivery reviews,"","","","","","","","15560948","","",0,10,101,0,0,,,
2033,29,"Kolibab et al., 2010",journal,"Kolibab K, Yang A, Derrick SC, Waldmann TA, Perera LP, Morris SL",Highly persistent and effective prime/boost regimens against tuberculosis that use a multivalent modified vaccine virus Ankara-based tuberculosis vaccine with interleukin-15 as a molecular adjuvant,"2010","17","5","793-801",Clinical and vaccine immunology : CVI,"","","","","","","","20357059","","",0,10,0,0,0,,,
2034,0,"Fewkes and Mackall, 2010",journal,"Fewkes NM, Mackall CL",Novel gamma-chain cytokines as candidate immune modulators in immune therapies for cancer,"2010","16","4","392-398","Cancer journal (Sudbury, Mass.)","","","","","","","","20693852","","",0,10,102,0,0,,,
2035,26,"Ozpolat et al., 1998",journal,"Ozpolat B, Rao XM, Powell MF, Lachman LB",Immunoliposomes containing antibodies to costimulatory molecules as adjuvants for HIV subunit vaccines,"1998","14","5","409-417",AIDS research and human retroviruses,"","","","","","","","9546800","","",0,10,0,0,0,,,
2036,0,"Giuliani et al., 1998",journal,"Giuliani MM, Del Giudice G, Giannelli V, Dougan G, Douce G, Rappuoli R, Pizza M","Mucosal adjuvanticity and immunogenicity of LTR72, a novel mutant of Escherichia coli heat-labile enterotoxin with partial knockout of ADP-ribosyltransferase activity","1998","187","7","1123-1132",The Journal of experimental medicine,"","","","","","","","9529328","","",0,10,103,0,0,,,
2037,47,"Jakobsen et al., 1999",journal,"Jakobsen H, Schulz D, Pizza M, Rappuoli R, Jnsdttir I",Intranasal immunization with pneumococcal polysaccharide conjugate vaccines with nontoxic mutants of Escherichia coli heat-labile enterotoxins as adjuvants protects mice against invasive pneumococcal infections,"1999","67","11","5892-5897",Infection and immunity,"","","","","","","","10531245","","",0,10,0,0,0,,,
2038,97,"Chakravarty et al., 2011",journal,"Chakravarty J, Kumar S, Trivedi S, Rai VK, Singh A, Ashman JA, Laughlin EM, Coler RN, Kahn SJ, Beckmann AM, Cowgill KD, Reed SG, Sundar S, Piazza FM",A clinical trial to evaluate the safety and immunogenicity of the LEISH-F1+MPL-SE vaccine for use in the prevention of visceral leishmaniasis,"2011","29","19","3531-3537",Vaccine,"","","","","","","","21414377","","",0,10,0,0,0,,,
2039,0,"Skeiky et al., 2002",journal,"Skeiky YA, Coler RN, Brannon M, Stromberg E, Greeson K, Crane RT, Webb JR, Campos-Neto A, Reed SG","Protective efficacy of a tandemly linked, multi-subunit recombinant leishmanial vaccine (Leish-111f) formulated in MPL adjuvant","2002","20","27-28","3292-3303",Vaccine,"","","","","","","","12213399","","",0,10,104,0,0,,,
2040,100,"Burke et al., 1994",journal,"Burke RL, Goldbeck C, Ng P, Stanberry L, Ott G, Van Nest G",The influence of adjuvant on the therapeutic efficacy of a recombinant genital herpes vaccine,"1994","170","5","1110-1119",The Journal of infectious diseases,"","","","","","","","7963702","","",0,10,0,0,0,,,
2041,26,"Yoshino et al., 2004",journal,"Yoshino N, L FX, Fujihashi K, Hagiwara Y, Kataoka K, Lu D, Hirst L, Honda M, van Ginkel FW, Takeda Y, Miller CJ, Kiyono H, McGhee JR",A novel adjuvant for mucosal immunity to HIV-1 gp120 in nonhuman primates,"2004","173","11","6850-6857","Journal of immunology (Baltimore, Md. : 1950)","","","","","","","","15557179","","",0,10,0,0,0,,,
2042,118,"Carabarin-Lima A, et al., 2011",journal,"Carabarin-Lima A, Gonzlez-Vzquez MC, Baylon-Pacheco L, Tsutsumi V, Talamas-Rohana P, Rosales-Encina JL",Immunization with the recombinant surface protein rTcSP2 alone or fused to the CHP or ATPase domain of TcHSP70 induces protection against acute Trypanosoma cruzi infection,"2011","1","3","",journal of vaccines and vaccination,"","","","","","","","",http://www.omicsonline.org/2157-7560/2157-7560-1-110.php,"",0,10,0,0,0,,,
2043,0,"Yamamoto et al., 2001",journal,"Yamamoto M, McGhee JR, Hagiwara Y, Otake S, Kiyono H",Genetically manipulated bacterial toxin as a new generation mucosal adjuvant,"2001","53","3","211-217",Scandinavian journal of immunology,"","","","","","","","11251876","","",0,10,105,0,0,,,
2044,30,"Pye et al., 1997",journal,"Pye D, Vandenberg KL, Dyer SL, Irving DO, Goss NH, Woodrow GC, Saul A, Alving CR, Richards RL, Ballou WR, Wu MJ, Skoff K, Anders RF","Selection of an adjuvant for vaccination with the malaria antigen, MSA-2","1997","15","9","1017-1023",Vaccine,"","","","","","","","9261951","","",0,10,0,0,0,,,
2045,50,"el et al., 1989",journal,"el Guink N, Kris RM, Goodman-Snitkoff G, Small PA Jr, Mannino RJ",Intranasal immunization with proteoliposomes protects against influenza,"1989","7","2","147-151",Vaccine,"","","","","","","","2546328","","",0,10,0,0,0,,,
2046,7,"Ivins et al., 1992",journal,"Ivins BE, Welkos SL, Little SF, Crumrine MH, Nelson GO",Immunization against anthrax with Bacillus anthracis protective antigen combined with adjuvants,"1992","60","2","662-668",Infection and immunity,"","","","","","","","1730501","","",0,10,0,0,0,,,
2047,30,"Oliveira-Ferreira et al., 2000",journal,"Oliveira-Ferreira J, Miyahira Y, Layton GT, Savage N, Esteban M, Rodriguez D, Rodriguez JR, Nussenzweig RS, Zavala F",Immunogenicity of Ty-VLP bearing a CD8(+) T cell epitope of the CS protein of P. yoelii: enhanced memory response by boosting with recombinant vaccinia virus,"2000","18","17","1863-1869",Vaccine,"","","","","","","","10699335","","",0,10,0,0,0,,,
2048,0,Euroconferences,website,Moncef SLAOUI,"New trends in vaccine R & D: Adjuvants, delivery systems and antigen formulations","","","","","","","","","","","","","",http://www.pasteur.fr/applications/euroconf/vaccins/vaccins-abs.html,"",0,10,91,0,0,,,
2049,0,"Marciani, 2003",journal,Marciani DJ,Vaccine adjuvants: role and mechanisms of action in vaccine immunogenicity,"2003","8","20","934-943",Drug discovery today,"","","","","","","","14554157","","",0,10,92,0,0,,,
2050,0,Wiki: CD86,website,"",Wiki: CD86,"","","","","","","","","","","","","",http://en.wikipedia.org/wiki/CD86,"",0,10,92,0,0,,,
2052,211,Wiki: Aeromonas Hydrophila,website,"",Aeromonas Hydrophila,"","","","","","","","","","","","","",http://microbewiki.kenyon.edu/index.php/Aeromonas_Hydrophila,"",0,10,0,0,0,,,
2053,97,"Arora et al., 2011",journal,"Arora SK, Masih S, Vasishta RK",Efficacy of Leishmania donovani ribosomal P1 gene as DNA vaccine in experimental visceral leishmaniasis,"2011","","","",Experimental parasitology,"","","","","","","","21640106","","",0,10,0,0,0,,,
2054,11,"Lin et al., 2011",journal,"Lin JS, Szaba FM, Kummer LW, Chromy BA, Smiley ST",Yersinia pestis YopE Contains a Dominant CD8 T Cell Epitope that Confers Protection in a Mouse Model of Pneumonic Plague,"2011","","","","Journal of immunology (Baltimore, Md. : 1950)","","","","","","","","21653834","","",0,10,0,0,0,,,
2055,135,"Sadziene et al., 1996",journal,"Sadziene A, Thompson PA, Barbour AG",A flagella-less mutant of Borrelia burgdorferi as a live attenuated vaccine in the murine model of Lyme disease,"1996","173","5","1184-1193",The Journal of infectious diseases,"","","","","","","","8627071","","",0,10,0,0,0,,,
2056,75,"Thoulouze et al., 2004",journal,"Thoulouze MI, Bouguyon E, Carpentier C, Brmont M",Essential role of the NV protein of Novirhabdovirus for pathogenicity in rainbow trout,"2004","78","8","4098-4107",Journal of virology,"","","","","","","","15047826","","",0,10,0,0,0,,,
2057,212,Wiki: Human respiratory syncytial virus,website,"",Human respiratory syncytial virus,"","","","","","","","","","","","","",http://microbewiki.kenyon.edu/index.php/Human_respiratory_syncytial_virus,"",0,10,0,0,0,,,
2058,210,Wiki: Metapneumovirus,website,"",Metapneumovirus,"","","","","","","","","","","","","",http://en.wikipedia.org/wiki/Metapneumovirus,"",0,10,0,0,0,,,
2059,213,Wiki: Simian immunodeficiency virus,website,"",Simian immunodeficiency virus,"","","","","","","","","","","","","",http://en.wikipedia.org/wiki/Simian_immunodeficiency_virus,"",0,10,0,0,0,,,
2060,32,"Davis et al., 1995",journal,"Davis NL, Brown KW, Greenwald GF, Zajac AJ, Zacny VL, Smith JF, Johnston RE",Attenuated mutants of Venezuelan equine encephalitis virus containing lethal mutations in the PE2 cleavage signal combined with a second-site suppressor mutation in E1,"1995","212","1","102-110",Virology,"","","","","","","","7676619","","",0,10,0,0,0,,,
2061,122,"Turell et al., 2003",journal,"Turell MJ, O'Guinn ML, Parker MD","Limited potential for mosquito transmission of genetically engineered, live-attenuated western equine encephalitis virus vaccine candidates","2003","68","2","218-221",The American journal of tropical medicine and hygiene,"","","","","","","","12641414","","",0,10,0,0,0,,,
2062,26,"Barrett et al., 1989",journal,"Barrett N, Mitterer A, Mundt W, Eibl J, Eibl M, Gallo RC, Moss B, Dorner F",Large-scale production and purification of a vaccinia recombinant-derived HIV-1 gp160 and analysis of its immunogenicity,"1989","5","2","159-171",AIDS research and human retroviruses,"","","","","","","","2713166","","",0,10,0,0,0,,,
2063,215,"Jan et al., 2010",journal,"Jan M, Meng S, Chen NC, Mai J, Wang H, Yang XF",Inflammatory and autoimmune reactions in atherosclerosis and vaccine design informatics,"2010","2010","","459798",Journal of biomedicine & biotechnology,"","","","","","","","20414374","","",0,10,0,0,0,,,
2064,111,"Balada-Llasat et al., 2007",journal,"Balada-Llasat JM, Panilaitis B, Kaplan D, Mecsas J","Oral inoculation with Type III secretion mutants of Yersinia pseudotuberculosis provides protection from oral, intraperitoneal, or intranasal challenge with virulent Yersinia","2007","25","8","1526-1533",Vaccine,"","","","","","","","17194509","","",0,10,0,0,0,,,
2065,42,"Chatfield et al., 1992",journal,"Chatfield SN, Strahan K, Pickard D, Charles IG, Hormaeche CE, Dougan G",Evaluation of Salmonella typhimurium strains harbouring defined mutations in htrA and aroA in the murine salmonellosis model,"1992","12","2","145-151",Microbial pathogenesis,"","","","","","","","1584006","","",0,10,0,0,0,,,
2066,215,"Chyu et al., 2005",journal,"Chyu KY, Zhao X, Reyes OS, Babbidge SM, Dimayuga PC, Yano J, Cercek B, Fredrikson GN, Nilsson J, Shah PK",Immunization using an Apo B-100 related epitope reduces atherosclerosis and plaque inflammation in hypercholesterolemic apo E (-/-) mice,"2005","338","4","1982-1989",Biochemical and biophysical research communications,"","","","","","","","16288717","","",0,10,0,0,0,,,
2067,215,"Fredrikson et al., 2005",journal,"Fredrikson GN, Andersson L, Sderberg I, Dimayuga P, Chyu KY, Shah PK, Nilsson J",Atheroprotective immunization with MDA-modified apo B-100 peptide sequences is associated with activation of Th2 specific antibody expression,"2005","38","2","171-179",Autoimmunity,"","","","","","","","16040338","","",0,10,0,0,0,,,
2068,30,"Butler et al., 2011",journal,"Butler NS, Schmidt NW, Vaughan AM, Aly AS, Kappe SH, Harty JT",Superior antimalarial immunity after vaccination with late liver stage-arresting genetically attenuated parasites,"2011","9","6","451-462",Cell host & microbe,"","","","","","","","21669394","","",0,10,0,0,0,,,
2069,216,"Harrison, 2010",journal,Harrison SC,Virology. Looking inside adenovirus,"2010","329","5995","1026-1027","Science (New York, N.Y.)","","","","","","","","20798308","","",0,10,0,0,0,,,
2070,216,FDA: Adenovirus Vaccine,website,"",FDA: Adenovirus Vaccine,"","","","","","","","","","","","","",http://www.fda.gov/BiologicsBloodVaccines/Vaccines/ApprovedProducts/ucm247508.htm,"",0,10,0,0,0,,,
2071,8,"Arenas-Gamboa et al., 2011",journal,"Arenas-Gamboa AM, Rice-Ficht AC, Kahl-McDonagh MM, Ficht TA",The protective efficacy and safety of 16M{Delta}mucR against intraperitoneal and aerosol challenge in BALB/c mice,"2011","","","",Infection and immunity,"","","","","","","","21708998","","",0,10,0,0,0,,,
2072,0,"Flock et al., 2006",journal,"Flock M, Karlstrm A, Lannergrd J, Guss B, Flock JI",Protective effect of vaccination with recombinant proteins from Streptococcus equi subspecies equi in a strangles model in the mouse,"2006","24","19","4144-4151",Vaccine,"","","","","","","","16580099","","",0,10,106,0,0,,,
2073,0,"Baylor et al., 2002",journal,"Baylor NW, Egan W, Richman P",Aluminum salts in vaccines--US perspective,"2002","20 Suppl 3","",S18-23,Vaccine,"","","","","","","","12184360","","",0,10,37,0,0,,,
2074,49,FDA: COMVAX,website,"",FDA: COMVAX,"","","","","","","","","","","","","",http://www.fda.gov/BiologicsBloodVaccines/Vaccines/ApprovedProducts/ucm174757.htm,"",0,10,0,0,0,,,
2075,11,CDC: Prevention of Plague,website,"Kenneth L. Gage, Ph.D. David T. Dennis, M.D., M.P.H. Theodore F. Tsai, M.D., M.P.H.",Prevention of Plague: Recommendations of the Advisory Committee on Immunization Practices (ACIP),"1996","","","","","","","","","","","","",http://www.cdc.gov/mmwr/preview/mmwrhtml/00044836.htm,"",0,10,0,0,0,,,
2076,41,FDA: Tetanus Toxoid,website,"",FDA: Tetanus Toxoid,"","","","","","","","","","","","","",http://www.fda.gov/BiologicsBloodVaccines/Vaccines/ApprovedProducts/ucm166863.htm,"",0,10,0,0,0,,,
2077,42,"Tennant et al., 2011",journal,"Tennant SM, Wang JY, Galen JE, Simon R, Pasetti MF, Gat O, Levine MM",Engineering and pre-clinical evaluation of attenuated non-typhoidal Salmonella strains serving as live oral vaccines and as reagent strains,"2011","","","",Infection and immunity,"","","","","","","","21807911","","",0,10,0,0,0,,,
2078,121,"Norris et al., 2011",journal,"Norris MH, Propst KL, Kang Y, Dow SW, Schweizer HP, Hoang TT",The Burkholderia pseudomallei {Delta}asd mutant exhibits attenuated intracellular infectivity and imparts protection against acute inhalation melioidosis in mice,"2011","","","",Infection and immunity,"","","","","","","","21807903","","",0,10,0,0,0,,,
2079,209,"Xiao et al., 2011",journal,"Xiao J, Chen T, Wang Q, Liu Q, Wang X, Lv Y, Wu H, Zhang Y",Search for live attenuated vaccine candidate against edwardsiellosis by mutating virulence-related genes of fish pathogen Edwardsiella tarda,"2011","","","",Letters in applied microbiology,"","","","","","","","21777261","","",0,10,0,0,0,,,
2080,116,"Carrion et al., 2011",journal,"Carrion J, Folgueira C, Soto M, Fresno M, Requena JM",Leishmania infantum HSP70-II null mutant as candidate vaccine against leishmaniasis: a preliminary evaluation,"2011","4","1","150",Parasites & vectors,"","","","","","","","21794145","","",0,10,0,0,0,,,
2081,12,"Jayakar et al., 2011",journal,"Jayakar HR, Parvathareddy J, Fitzpatrick EA, Bina XR, Bina JE, Re F, Emery FD, Miller MA",A galU Mutant of Francisella tularensis is Attenuated for Virulence in a Murine Pulmonary Model of Tularemia,"2011","11","1","179",BMC microbiology,"","","","","","","","21819572","","",0,10,0,0,0,,,
2082,42,"Gilbreath et al., 2011",journal,"Gilbreath JJ, Colvocoresses Dodds J, Rick PD, Soloski MJ, Merrell DS, Metcalf ES",Enterobacterial Common Antigen Mutants of Salmonella enterica serovar Typhimurium Establish a Persistent Infection and Provide Protection Against Subsequent Lethal Challenge,"2011","","","",Infection and immunity,"","","","","","","","22025511","","",0,10,0,0,0,,,
2083,163,"Santander et al., 2011",journal,"Santander J, Mitra A, Curtiss R 3rd","Phenotype, virulence and immunogenicity of Edwardsiella ictaluri cyclic adenosine 3',5'-monophosphate receptor protein (Crp) mutants in catfish host","2011","","","",Fish & shellfish immunology,"","","","","","","","22015784","","",0,10,0,0,0,,,
2084,50,Aflunov Product Info,website,"",Aflunov Product Information,"","","","","","","","","","","","","",http://www.ema.europa.eu/docs/en_GB/document_library/EPAR_-_Product_Information/human/002094/WC500101080.pdf,"",0,10,0,0,0,,,
2085,50,Fluad Press Release,website,"",Fluad Press Release from Novartis,"","","","","","","","","","","","","",http://www.novartisvaccines.com/downloads/newsroom/media-releases/20071019_FluadVACCINEpublication.pdf,"",0,10,0,0,0,,,
2086,50,Fluad Product Monograph,website,"",Fluad Product Monograph,"","","","","","","","","","","","","",http://www.novartis.ca/products/en/vaccines-f.shtml,"",0,10,0,0,0,,,
2087,50,Focetria Product Information,website,"",Focetria Summary of Product Characteristics,"","","","","","","","","","","","","",http://www.ema.europa.eu/docs/en_GB/document_library/EPAR_-_Product_Information/human/000710/WC500023749.pdf,"",0,10,0,0,0,,,
2088,0,"Becker et al., 2001",journal,"Becker PD, Corral RS, Guzmn CA, Grinstein S",Adamantylamide dipeptide as effective immunoadjuvant in rabbits and mice,"2001","19","32","4603-4609",Vaccine,"","","","","","","","11535307","","",0,10,34,0,0,,,
2089,0,"Ayyoub et al., 2003",journal,"Ayyoub M, Zippelius A, Pittet MJ, Rimoldi D, Valmori D, Cerottini JC, Romero P, Lejeune F, Linard D, Speiser DE",Activation of human melanoma reactive CD8+ T cells by vaccination with an immunogenic peptide analog derived from Melan-A/melanoma antigen recognized by T cells-1,"2003","9","2","669-677",Clinical cancer research : an official journal of the American Association for Cancer Research,"","","","","","","","12576434","","",0,10,91,0,0,,,
2090,0,"Christensen et al., 2011",journal,"Christensen D, Korsholm KS, Andersen P, Agger EM",Cationic liposomes as vaccine adjuvants,"2011","10","4","513-521",Expert review of vaccines,"","","","","","","","21506648","","",0,10,33,0,0,,,
2091,0,"Bode et al., 2011",journal,"Bode C, Zhao G, Steinhagen F, Kinjo T, Klinman DM",CpG DNA as a vaccine adjuvant,"2011","10","4","499-511",Expert review of vaccines,"","","","","","","","21506647","","",0,10,10,0,0,,,
2095,0,"O'Hagan et al., 2011",journal,"O'Hagan DT, Rappuoli R, De Gregorio E, Tsai T, Del Giudice G",MF59 adjuvant: the best insurance against influenza strain diversity,"2011","10","4","447-462",Expert review of vaccines,"","","","","","","","21506643","",,0,0,89,0,0,,,
2096,8,"Arenas-Gamboa et al., 2009",journal,"Arenas-Gamboa AM, Ficht TA, Kahl-McDonagh MM, Gomez G, Rice-Ficht AC",The Brucella abortus S19 DeltavjbR live vaccine candidate is safer than S19 and confers protection against wild-type challenge in BALB/c mice when delivered in a sustained-release vehicle,"2009","77","2","877-884",Infection and immunity,"","","","","","","","19047401","","",0,10,0,0,0,,,
2097,220,"Sanchez-Vizcaino et al., 2012",journal,"Sanchez-Vizcaino JM, Mur L, Martinez-Lopez B",African Swine Fever: An Epidemiological Update,"2012","","","",Transboundary and emerging diseases,"","","","","","","","22225967","","",0,10,0,0,0,,,
2098,220,"Lewis et al., 2000",journal,"Lewis T, Zsak L, Burrage TG, Lu Z, Kutish GF, Neilan JG, Rock DL","An African swine fever virus ERV1-ALR homologue, 9GL, affects virion maturation and viral growth in macrophages and viral virulence in swine","2000","74","3","1275-1285",Journal of virology,"","","","","","","","10627538","","",0,10,0,0,0,,,
2099,8,"Fu et al., 2012",journal,"Fu S, Xu J, Li X, Xie Y, Qiu Y, Du X, Yu S, Bai Y, Chen Y, Wang T, Wang Z, Yu Y, Peng G, Huang K, Huang L, Wang Y, Chen Z",Immunization of Mice with Recombinant Protein CobB or AsnC Confers Protection against Brucella abortus Infection,"2012","7","2",e29552,PloS one,"","","","","","","","22383953","","",0,10,0,0,0,,,
2100,12,"Rodriguez et al., 2011",journal,"Rodriguez AR, Yu JJ, Murthy AK, Guentzel MN, Klose KE, Forsthuber TG, Chambers JP, Berton MT, Arulanandam BP",Mast cell/IL-4 control of Francisella tularensis replication and host cell death is associated with increased ATP production and phagosomal acidification,"2011","4","2","217-226",Mucosal immunology,"","","","","","","","20861832","","",0,10,0,0,0,,,
2101,29,"Wang et al., 2009",journal,"Wang QL, Pan Q, Ma Y, Wang K, Sun P, Liu S, Zhang XL",An attenuated Salmonella-vectored vaccine elicits protective immunity against Mycobacterium tuberculosis,"2009","27","48","6712-6722",Vaccine,"","","","","","","","19733584","","",0,10,0,0,0,,,
2102,8,"Abtahi et al., 2008",journal,"Abtahi H, Salmanian AH, Rafati S, Nejad GB, Saffari M, Ghazavi A, Mosayebi G",The profile of cytokines and IgG subclasses in BALB/c mice after immunization with Brucella ribosomal gene,"2008","11","21","2472-2477",Pakistan journal of biological sciences: PJBS,"","","","","","","","19205266","","",0,10,0,0,0,,,
2103,12,"Bokhari et al., 2008",journal,"Bokhari SM, Kim KJ, Pinson DM, Slusser J, Yeh HW, Parmely MJ",NK cells and gamma interferon coordinate the formation and function of hepatic granulomas in mice infected with the Francisella tularensis live vaccine strain,"2008","76","4","1379-1389",Infection and immunity,"","","","","","","","18227174","","",0,10,0,0,0,,,
2104,29,"Quintana et al., 2003",journal,"Quintana FJ, Carmi P, Mor F, Cohen IR",DNA fragments of the human 60-kDa heat shock protein (HSP60) vaccinate against adjuvant arthritis: identification of a regulatory HSP60 peptide,"2003","171","7","3533-3541","Journal of immunology (Baltimore, Md. : 1950)","","","","","","","","14500649","",,0,0,0,0,0,,,
2105,29,"Chiong et al., 2011",journal,"Chiong E, Kesavan A, Mahendran R, Chan YH, Sng JH, Lim YK, Kamaraj R, Tan TM, Esuvaranathan K",NRAMP1 and hGPX1 gene polymorphism and response to bacillus Calmette-Gurin therapy for bladder cancer,"2011","59","3","430-437",European urology,"","","","","","","","21163569","","",0,10,0,0,0,,,
2106,29,"Randhawa et al., 2011",journal,"Randhawa AK, Shey MS, Keyser A, Peixoto B, Wells RD, de Kock M, Lerumo L, Hughes J, Hussey G, Hawkridge A, Kaplan G, Hanekom WA, Hawn TR",Association of human TLR1 and TLR6 deficiency with altered immune responses to BCG vaccination in South African infants,"2011","7","8",e1002174,PLoS pathogens,"","","","","","","","21852947","","",0,10,0,0,0,,,
2107,29,"Singh et al., 2011",journal,"Singh VK, Srivastava V, Singh V, Rastogi N, Roy R, Shaw AK, Dwivedi AK, Srivastava R, Srivastava BS",Overexpression of Rv3097c in Mycobacterium bovis BCG abolished the efficacy of BCG vaccine to protect against Mycobacterium tuberculosis infection in mice,"2011","29","29-30","4754-4760",Vaccine,"","","","","","","","21565242","","",0,10,0,0,0,,,
2108,8,"Galindo et al., 2009",journal,"Galindo RC, Muoz PM, de Miguel MJ, Marin CM, Blasco JM, Gortazar C, Kocan KM, de la Fuente J",Characterization of possible correlates of protective response against Brucella ovis infection in rams immunized with the B. melitensis Rev 1 vaccine,"2009","27","23","3039-3044",Vaccine,"","","","","","","","19428917","","",0,10,0,0,0,,,
2109,8,"Paranavitana et al., 2005",journal,"Paranavitana C, Zelazowska E, Izadjoo M, Hoover D",Interferon-gamma associated cytokines and chemokines produced by spleen cells from Brucella-immune mice,"2005","30","2","86-92",Cytokine,"","","","","","","","15804600","","",0,10,0,0,0,,,
2110,29,"Hwang et al., 2005",journal,"Hwang SA, Kruzel ML, Actor JK",Lactoferrin augments BCG vaccine efficacy to generate T helper response and subsequent protection against challenge with virulent Mycobacterium tuberculosis,"2005","5","3","591-599",International immunopharmacology,"","","","","","","","15683854","","",0,10,0,0,0,,,
2111,29,"Thom et al., 2012",journal,"Thom RE, Elmore MJ, Williams A, Andrews SC, Drobniewski F, Marsh PD, Tree JA","The expression of ferritin, lactoferrin, transferrin receptor and solute carrier family 11A1 in the host response to BCG-vaccination and Mycobacterium tuberculosis challenge","2012","30","21","3159-3168",Vaccine,"","","","","","","","22426328","","",0,10,0,0,0,,,
2112,29,"Fontn et al., 2008",journal,"Fontn PA, Aris V, Alvarez ME, Ghanny S, Cheng J, Soteropoulos P, Trevani A, Pine R, Smith I",Mycobacterium tuberculosis sigma factor E regulon modulates the host inflammatory response,"2008","198","6","877-885",The Journal of infectious diseases,"","","","","","","","18657035","","",0,10,0,0,0,,,
2113,29,"Geiman et al., 2004",journal,"Geiman DE, Kaushal D, Ko C, Tyagi S, Manabe YC, Schroeder BG, Fleischmann RD, Morrison NE, Converse PJ, Chen P, Bishai WR",Attenuation of late-stage disease in mice infected by the Mycobacterium tuberculosis mutant lacking the SigF alternate sigma factor and identification of SigF-dependent genes by microarray analysis,"2004","72","3","1733-1745",Infection and immunity,"","","","","","","","14977982","","",0,10,0,0,0,,,
2114,29,"Sun et al., 2004",journal,"Sun R, Converse PJ, Ko C, Tyagi S, Morrison NE, Bishai WR",Mycobacterium tuberculosis ECF sigma factor sigC is required for lethality in mice and for the conditional expression of a defined gene set,"2004","52","1","25-38",Molecular microbiology,"","","","","","","","15049808","","",0,10,0,0,0,,,
2115,26,"Wang et al., 1993",journal,"Wang B, Ugen KE, Srikantan V, Agadjanyan MG, Dang K, Refaeli Y, Sato AI, Boyer J, Williams WV, Weiner DB",Gene inoculation generates immune responses against human immunodeficiency virus type 1,"1993","90","9","4156-4160",Proceedings of the National Academy of Sciences of the United States of America,"","","","","","","","8483929","","",0,10,0,0,0,,,
2116,0,"George, 1976",journal,George RE,Biomedical engineering in West Germany,"1976","11","2","60-61",Biomedical engineering,"","","","","","","","2342","",,0,11,0,1,0,,,
2117,52,"Martinez et al., 1997",journal,"Martinez X, Brandt C, Saddallah F, Tougne C, Barrios C, Wild F, Dougan G, Lambert PH, Siegrist CA",DNA immunization circumvents deficient induction of T helper type 1 and cytotoxic T lymphocyte responses in neonates and during early life,"1997","94","16","8726-8731",Proceedings of the National Academy of Sciences of the United States of America,"","","","","","","","9238045","","",0,10,0,0,0,,,
2118,143,"Schrijver et al., 1997",journal,"Schrijver RS, Langedijk JP, Keil GM, Middel WG, Maris-Veldhuis M, Van Oirschot JT, Rijsewijk FA",Immunization of cattle with a BHV1 vector vaccine or a DNA vaccine both coding for the G protein of BRSV,"1997","15","17-18","1908-1916",Vaccine,"","","","","","","","9413101","","",0,10,0,0,0,,,
2119,99,"Gribben et al., 2005",journal,"Gribben JG, Ryan DP, Boyajian R, Urban RG, Hedley ML, Beach K, Nealon P, Matulonis U, Campos S, Gilligan TD, Richardson PG, Marshall B, Neuberg D, Nadler LM",Unexpected association between induction of immunity to the universal tumor antigen CYP1B1 and response to next therapy,"2005","11","12","4430-4436",Clinical cancer research : an official journal of the American Association for Cancer Research,"","","","","","","","15958627","","",0,10,0,0,0,,,
2120,50,"Olsen et al., 1997",journal,"Olsen CW, McGregor MW, Dybdahl-Sissoko N, Schram BR, Nelson KM, Lunn DP, Macklin MD, Swain WF, Hinshaw VS",Immunogenicity and efficacy of baculovirus-expressed and DNA-based equine influenza virus hemagglutinin vaccines in mice,"1997","15","10","1149-1156",Vaccine,"","","","","","","","9269061","","",0,10,0,0,0,,,
2121,50,"Robinson et al., 1993",journal,"Robinson HL, Hunt LA, Webster RG",Protection against a lethal influenza virus challenge by immunization with a haemagglutinin-expressing plasmid DNA,"1993","11","9","957-960",Vaccine,"","","","","","","","8212843","","",0,10,0,0,0,,,
2122,50,"Fynan et al., 1993",journal,"Fynan EF, Webster RG, Fuller DH, Haynes JR, Santoro JC, Robinson HL","DNA vaccines: protective immunizations by parenteral, mucosal, and gene-gun inoculations","1993","90","24","11478-11482",Proceedings of the National Academy of Sciences of the United States of America,"","","","","","","","8265577","","",0,10,0,0,0,,,
2123,50,"Henke et al., 2006",journal,"Henke A, Rohland N, Zell R, Wutzler P",Co-expression of interleukin-2 by a bicistronic plasmid increases the efficacy of DNA immunization to prevent influenza virus infections,"2006","49","4","249-252",Intervirology,"","","","","","","","16601357","","",0,10,0,0,0,,,
2124,50,"Feltquate et al., 1997",journal,"Feltquate DM, Heaney S, Webster RG, Robinson HL",Different T helper cell types and antibody isotypes generated by saline and gene gun DNA immunization,"1997","158","5","2278-2284","Journal of immunology (Baltimore, Md. : 1950)","","","","","","","","9036975","","",0,10,0,0,0,,,
2125,50,"Pertmer et al., 1995",journal,"Pertmer TM, Eisenbraun MD, McCabe D, Prayaga SK, Fuller DH, Haynes JR",Gene gun-based nucleic acid immunization: elicitation of humoral and cytotoxic T lymphocyte responses following epidermal delivery of nanogram quantities of DNA,"1995","13","15","1427-1430",Vaccine,"","","","","","","","8578820","","",0,10,0,0,0,,,
2126,50,"Raz et al., 1994",journal,"Raz E, Carson DA, Parker SE, Parr TB, Abai AM, Aichinger G, Gromkowski SH, Singh M, Lew D, Yankauckas MA",Intradermal gene immunization: the possible role of DNA uptake in the induction of cellular immunity to viruses,"1994","91","20","9519-9523",Proceedings of the National Academy of Sciences of the United States of America,"","","","","","","","7937799","","",0,10,0,0,0,,,
2127,50,"Tao et al., 2009",journal,"Tao P, Luo M, Pan R, Ling D, Zhou S, Tien P, Pan Z",Enhanced protective immunity against H5N1 influenza virus challenge by vaccination with DNA expressing a chimeric hemagglutinin in combination with an MHC class I-restricted epitope of nucleoprotein in mice,"2009","81","3","253-260",Antiviral research,"","","","","","","","19135483","","",0,10,0,0,0,,,
2128,50,"Berglund et al., 1998",journal,"Berglund P, Smerdou C, Fleeton MN, Tubulekas I, Liljestrm P",Enhancing immune responses using suicidal DNA vaccines,"1998","16","6","562-565",Nature biotechnology,"","","","","","","","9624688","","",0,10,0,0,0,,,
2129,50,"Lena et al., 2002",journal,"Lena P, Villinger F, Giavedoni L, Miller CJ, Rhodes G, Luciw P","Co-immunization of rhesus macaques with plasmid vectors expressing IFN-gamma, GM-CSF, and SIV antigens enhances anti-viral humoral immunity but does not affect viremia after challenge with highly pathogenic virus","2002","20 Suppl 4","",A69-79,Vaccine,"","","","","","","","12477432","","",0,10,0,0,0,,,
2130,50,"Pertmer et al., 2001",journal,"Pertmer TM, Oran AE, Madorin CA, Robinson HL",Th1 genetic adjuvants modulate immune responses in neonates,"2001","19","13-14","1764-1771",Vaccine,"","","","","","","","11166902","","",0,10,0,0,0,,,
2131,50,"Loudon et al., 2010",journal,"Loudon PT, Yager EJ, Lynch DT, Narendran A, Stagnar C, Franchini AM, Fuller JT, White PA, Nyuandi J, Wiley CA, Murphey-Corb M, Fuller DH",GM-CSF increases mucosal and systemic immunogenicity of an H1N1 influenza DNA vaccine administered into the epidermis of non-human primates,"2010","5","6",e11021,PloS one,"","","","","","","","20544035","","",0,10,0,0,0,,,
2132,50,"Smith et al., 2010",journal,"Smith LR, Wloch MK, Ye M, Reyes LR, Boutsaboualoy S, Dunne CE, Chaplin JA, Rusalov D, Rolland AP, Fisher CL, Al-Ibrahim MS, Kabongo ML, Steigbigel R, Belshe RB, Kitt ER, Chu AH, Moss RB",Phase 1 clinical trials of the safety and immunogenicity of adjuvanted plasmid DNA vaccines encoding influenza A virus H5 hemagglutinin,"2010","28","13","2565-2572",Vaccine,"","","","","","","","20117262","","",0,10,0,0,0,,,
2133,50,"Bins et al., 2005",journal,"Bins AD, Jorritsma A, Wolkers MC, Hung CF, Wu TC, Schumacher TN, Haanen JB",A rapid and potent DNA vaccination strategy defined by in vivo monitoring of antigen expression,"2005","11","8","899-904",Nature medicine,"","","","","","","","15965482","","",0,10,0,0,0,,,
2134,50,"Epstein et al., 2005",journal,"Epstein SL, Kong WP, Misplon JA, Lo CY, Tumpey TM, Xu L, Nabel GJ",Protection against multiple influenza A subtypes by vaccination with highly conserved nucleoprotein,"2005","23","46-47","5404-5410",Vaccine,"","","","","","","","16011865","","",0,10,0,0,0,,,
2135,50,"Fu et al., 1999",journal,"Fu TM, Guan L, Friedman A, Schofield TL, Ulmer JB, Liu MA, Donnelly JJ",Dose dependence of CTL precursor frequency induced by a DNA vaccine and correlation with protective immunity against influenza virus challenge,"1999","162","7","4163-4170","Journal of immunology (Baltimore, Md. : 1950)","","","","","","","","10201942","","",0,10,0,0,0,,,
2136,50,"Chen et al., 1999",journal,"Chen Z, Yoshikawa T, Kadowaki S, Hagiwara Y, Matsuo K, Asanuma H, Aizawa C, Kurata T, Tamura S","Protection and antibody responses in different strains of mouse immunized with plasmid DNAs encoding influenza virus haemagglutinin, neuraminidase and nucleoprotein","1999","80 ( Pt 10)","","2559-2564",The Journal of general virology,"","","","","","","","10573147","","",0,10,0,0,0,,,
2137,50,"Rieger, 1975",journal,Rieger HJ,[Commitment of hospital physicians to obligatory treatment of prisoners],"1975","100","15","847-849",Deutsche medizinische Wochenschrift (1946),"","","","","","","","1122836","","",0,10,0,0,0,,,
2138,50,"Jimenez et al., 2007",journal,"Jimenez GS, Planchon R, Wei Q, Rusalov D, Geall A, Enas J, Lalor P, Leamy V, Vahle R, Luke CJ, Rolland A, Kaslow DC, Smith LR",Vaxfectin-formulated influenza DNA vaccines encoding NP and M2 viral proteins protect mice against lethal viral challenge,"2007","3","5","157-164",Human vaccines,"","","","","","","","17637571","","",0,10,0,0,0,,,
2139,50,"Ledgerwood et al., 2011",journal,"Ledgerwood JE, Wei CJ, Hu Z, Gordon IJ, Enama ME, Hendel CS, McTamney PM, Pearce MB, Yassine HM, Boyington JC, Bailer R, Tumpey TM, Koup RA, Mascola JR, Nabel GJ, Graham BS",DNA priming and influenza vaccine immunogenicity: two phase 1 open label randomised clinical trials,"2011","11","12","916-924",The Lancet infectious diseases,"","","","","","","","21975270","","",0,10,0,0,0,,,
2140,50,"Jazayeri et al., 2012",journal,"Jazayeri SD, Ideris A, Zakaria Z, Omar AR",Attenuated Salmonella typhimurium SV4089 as a Potential Carrier of Oral DNA Vaccine in Chickens,"2012","2012","","264986",Journal of biomedicine & biotechnology,"","","","","","","","22701301","","",0,10,0,0,0,,,
2141,91,"Cui et al., 2008",journal,"Cui YL, He SY, Xue MF, Zhang J, Wang HX, Yao Y",Protective effect of a multiantigenic DNA vaccine against Toxoplasma gondii with co-delivery of IL-12 in mice,"2008","30","5","309-313",Parasite immunology,"","","","","","","","18331395","","",0,10,0,0,0,,,
2142,91,"Xue et al., 2008",journal,"Xue M, He S, Zhang J, Cui Y, Yao Y, Wang H",Comparison of cholera toxin A2/B and murine interleukin-12 as adjuvants of Toxoplasma multi-antigenic SAG1-ROP2 DNA vaccine,"2008","119","3","352-357",Experimental parasitology,"","","","","","","","18442818","","",0,10,0,0,0,,,
2143,11,"Yamanaka et al., 2008",journal,"Yamanaka H, Hoyt T, Yang X, Golden S, Bosio CM, Crist K, Becker T, Maddaloni M, Pascual DW",A nasal interleukin-12 DNA vaccine coexpressing Yersinia pestis F1-V fusion protein confers protection against pneumonic plague,"2008","76","10","4564-4573",Infection and immunity,"","","","","","","","18694965","","",0,10,0,0,0,,,
2144,67,"Petrini et al., 2011",journal,"Petrini S, Ramadori G, Corradi A, Borghetti P, Lombardi G, Villa R, Bottarelli E, Guercio A, Amici A, Ferrari M",Evaluation of safety and efficacy of DNA vaccines against bovine herpesvirus-1 (BoHV-1) in calves,"2011","34","1","3-10","Comparative immunology, microbiology and infectious diseases","","","","","","","","19906427","","",0,10,0,0,0,,,
2145,67,"Cox et al., 1993",journal,"Cox GJ, Zamb TJ, Babiuk LA",Bovine herpesvirus 1: immune responses in mice and cattle injected with plasmid DNA,"1993","67","9","5664-5667",Journal of virology,"","","","","","","","8350420","","",0,10,0,0,0,,,
2146,67,"Schrijver et al., 1997",journal,"Schrijver RS, Langedijk JP, Keil GM, Middel WG, Maris-Veldhuis M, Van Oirschot JT, Rijsewijk FA",Immunization of cattle with a BHV1 vector vaccine or a DNA vaccine both coding for the G protein of BRSV,"1997","15","17-18","1908-1916",Vaccine,"","","","","","","","9413101","","",0,10,0,0,0,,,
2147,67,"Deshpande et al., 2002",journal,"Deshpande MS, Ambagala TC, Hegde NR, Hariharan MJ, Navaratnam M, Srikumaran S",Induction of cytotoxic T-lymphocytes specific for bovine herpesvirus-1 by DNA immunization,"2002","20","31-32","3744-3751",Vaccine,"","","","","","","","12399204","","",0,10,0,0,0,,,
2148,67,"Pontarollo et al., 2002",journal,"Pontarollo RA, Babiuk LA, Hecker R, Van Drunen Littel-Van Den Hurk S",Augmentation of cellular immune responses to bovine herpesvirus-1 glycoprotein D by vaccination with CpG-enhanced plasmid vectors,"2002","83",Pt 12,"2973-2981",The Journal of general virology,"","","","","","","","12466473","","",0,10,0,0,0,,,
2149,67,"Castrucci et al., 2004",journal,"Castrucci G, Ferrari M, Marchini C, Salvatori D, Provinciali M, Tosini A, Petrini S, Sardonini Q, Lo Dico M, Frigeri F, Amici A",Immunization against bovine herpesvirus-1 infection. Preliminary tests in calves with a DNA vaccine,"2004","27","3","171-179","Comparative immunology, microbiology and infectious diseases","","","","","","","","15001312","","",0,10,0,0,0,,,
2150,67,"Langellotti et al., 2011",journal,"Langellotti CA, Pappalardo JS, Quattrocchi V, Mongini C, Zamorano P",Induction of specific cytotoxic activity for bovine herpesvirus-1 by DNA immunization with different adjuvants,"2011","90","3","134-142",Antiviral research,"","","","","","","","21443903","","",0,10,0,0,0,,,
2151,67,"Khattar et al., 2010",journal,"Khattar SK, Collins PL, Samal SK",Immunization of cattle with recombinant Newcastle disease virus expressing bovine herpesvirus-1 (BHV-1) glycoprotein D induces mucosal and serum antibody responses and provides partial protection against BHV-1,"2010","28","18","3159-3170",Vaccine,"","","","","","","","20189484","","",0,10,0,0,0,,,
2152,169,"Petrini et al., 2011",journal,"Petrini S, Ramadori G, Corradi A, Borghetti P, Lombardi G, Villa R, Bottarelli E, Guercio A, Amici A, Ferrari M",Evaluation of safety and efficacy of DNA vaccines against bovine herpesvirus-1 (BoHV-1) in calves,"2011","34","1","3-10","Comparative immunology, microbiology and infectious diseases","","","","","","","","19906427","",,0,0,0,0,0,,,
2153,206,"Ward et al., 1997",journal,"Ward G, Rieder E, Mason PW",Plasmid DNA encoding replicating foot-and-mouth disease virus genomes induces antiviral immune responses in swine,"1997","71","10","7442-7447",Journal of virology,"","","","","","","","9311823","","",0,10,0,0,0,,,
2154,206,"Wang et al., 2006",journal,"Wang F, He XW, Jiang L, Ren D, He Y, Li DA, Sun SH",Enhanced immunogenicity of microencapsulated multiepitope DNA vaccine encoding T and B cell epitopes of foot-and-mouth disease virus in mice,"2006","24","12","2017-2026",Vaccine,"","","","","","","","16414158","","",0,10,0,0,0,,,
2155,226,"Coon et al., 1999",journal,"Coon B, An LL, Whitton JL, von Herrath MG",DNA immunization to prevent autoimmune diabetes,"1999","104","2","189-194",The Journal of clinical investigation,"","","","","","","","10411548","",,0,0,0,0,0,,,
2156,75,"Anderson et al., 1996",journal,"Anderson ED, Mourich DV, Fahrenkrug SC, LaPatra S, Shepherd J, Leong JA",Genetic immunization of rainbow trout (Oncorhynchus mykiss) against infectious hematopoietic necrosis virus,"1996","5","2","114-122",Molecular marine biology and biotechnology,"","","","","","","","8680524","","",0,10,0,0,0,,,
2157,226,"Petrini et al., 2011",journal,"Petrini S, Ramadori G, Corradi A, Borghetti P, Lombardi G, Villa R, Bottarelli E, Guercio A, Amici A, Ferrari M",Evaluation of safety and efficacy of DNA vaccines against bovine herpesvirus-1 (BoHV-1) in calves,"2011","34","1","3-10","Comparative immunology, microbiology and infectious diseases","","","","","","","","19906427","",,0,0,0,0,0,,,
2158,227,"Gonzlez et al., 1996",journal,"Gonzlez Armas JC, Morello CS, Cranmer LD, Spector DH",DNA immunization confers protection against murine cytomegalovirus infection,"1996","70","11","7921-7928",Journal of virology,"","","","","","","","8892915","","",0,10,0,0,0,,,
2159,228,"Sarzotti et al., 1997",journal,"Sarzotti M, Dean TA, Remington MP, Ly CD, Furth PA, Robbins DS",Induction of cytotoxic T cell responses in newborn mice by DNA immunization,"1997","15","8","795-797",Vaccine,"","","","","","","","9234516","",,0,0,0,0,0,,,
2160,70,"Sakaguchi et al., 1996",journal,"Sakaguchi M, Nakamura H, Sonoda K, Hamada F, Hirai K",Protection of chickens from Newcastle disease by vaccination with a linear plasmid DNA expressing the F protein of Newcastle disease virus,"1996","14","8","747-752",Vaccine,"","","","","","","","8817820","","",0,10,0,0,0,,,
2161,183,"Pirzadeh and Dea, 1998",journal,"Pirzadeh B, Dea S",Immune response in pigs vaccinated with plasmid DNA encoding ORF5 of porcine reproductive and respiratory syndrome virus,"1998","79 ( Pt 5)","","989-999",The Journal of general virology,"","","","","","","","9603313","","",0,10,0,0,0,,,
2162,56,"Xiang et al., 1994",journal,"Xiang ZQ, Spitalnik S, Tran M, Wunner WH, Cheng J, Ertl HC",Vaccination with a plasmid vector carrying the rabies virus glycoprotein gene induces protective immunity against rabies virus,"1994","199","1","132-140",Virology,"","","","","","","","8116236","","",0,10,0,0,0,,,
2163,226,"Rottembourg et al., 2010",journal,"Rottembourg D, Filippi CM, Bresson D, Ehrhardt K, Estes EA, Oldham JE, von Herrath MG",Essential role for TLR9 in prime but not prime-boost plasmid DNA vaccination to activate dendritic cells and protect from lethal viral infection,"2010","184","12","7100-7107","Journal of immunology (Baltimore, Md. : 1950)","","","","","","","","20483769","",,0,0,0,0,0,,,
2164,54,"Ohlschlger et al., 2011",journal,"Ohlschlger P, Spies E, Alvarez G, Quetting M, Groettrup M",The combination of TLR-9 adjuvantation and electroporation-mediated delivery enhances in vivo antitumor responses after vaccination with HPV-16 E7 encoding DNA,"2011","128","2","473-481",International journal of cancer. Journal international du cancer,"","","","","","","","20309939","","",0,10,0,0,0,,,
2165,54,"Klencke et al., 2002",journal,"Klencke B, Matijevic M, Urban RG, Lathey JL, Hedley ML, Berry M, Thatcher J, Weinberg V, Wilson J, Darragh T, Jay N, Da Costa M, Palefsky JM",Encapsulated plasmid DNA treatment for human papillomavirus 16-associated anal dysplasia: a Phase I study of ZYC101,"2002","8","5","1028-1037",Clinical cancer research : an official journal of the American Association for Cancer Research,"","","","","","","","12006515","","",0,10,0,0,0,,,
2166,54,"Donnelly et al., 1996",journal,"Donnelly JJ, Martinez D, Jansen KU, Ellis RW, Montgomery DL, Liu MA",Protection against papillomavirus with a polynucleotide vaccine,"1996","173","2","314-320",The Journal of infectious diseases,"","","","","","","","8568291","","",0,10,0,0,0,,,
2167,54,"Sin, 2009",journal,Sin JI,Suppression of antitumour protective cytotoxic T lymphocyte responses to a human papillomavirus 16 E7 DNA vaccine by coinjection of interleukin-12 complementary DNA: involvement of nitric oxide in immune suppression,"2009","128","1 Suppl",e707-717,Immunology,"","","","","","","","19740332","","",0,10,0,0,0,,,
2168,54,"Henken et al., 2012",journal,"Henken FE, Oosterhuis K, Ohlschlger P, Bosch L, Hooijberg E, Haanen JB, Steenbergen RD",Preclinical safety evaluation of DNA vaccines encoding modified HPV16 E6 and E7,"2012","30","28","4259-4266",Vaccine,"","","","","","","","22554465","","",0,10,0,0,0,,,
2169,54,"Rocha-Zavaleta et al., 2002",journal,"Rocha-Zavaleta L, Alejandre JE, Garcia-Carranca A",Parenteral and oral immunization with a plasmid DNA expressing the human papillomavirus 16-L1 gene induces systemic and mucosal antibodies and cytotoxic T lymphocyte responses,"2002","66","1","86-95",Journal of medical virology,"","","","","","","","11748663","","",0,10,0,0,0,,,
2170,54,"Cheng et al., 2001",journal,"Cheng WF, Hung CF, Chai CY, Hsu KF, He L, Ling M, Wu TC",Tumor-specific immunity and antiangiogenesis generated by a DNA vaccine encoding calreticulin linked to a tumor antigen,"2001","108","5","669-678",The Journal of clinical investigation,"","","","","","","","11544272","","",0,10,0,0,0,,,
3887,99,"Vardas et al., 2010",journal,"Vardas E, Kaleebu P, Bekker LG, Hoosen A, Chomba E, Johnson PR, Anklesaria P, Birungi J, Barin B, Boaz M, Cox J, Lehrman J, Stevens G, Gilmour J, Tarragona T, Hayes P, Lowenbein S, Kizito E, Fast P, Heald AE, Schmidt C",A phase 2 study to evaluate the safety and immunogenicity of a recombinant HIV type 1 vaccine based on adeno-associated virus,"2010","26","8","933-942",AIDS research and human retroviruses,,,,,,,,"20666584",,,0,10,0,0,0,,,
2173,54,"Brinkman et al., 2007",journal,"Brinkman JA, Xu X, Kast WM",The efficacy of a DNA vaccine containing inserted and replicated regions of the E7 gene for treatment of HPV-16 induced tumors,"2007","25","17","3437-3444",Vaccine,"","","","","","","","17241713","","",0,10,0,0,0,,,
2174,54,"Osen et al., 2001",journal,"Osen W, Peiler T, Ohlschlger P, Caldeira S, Faath S, Michel N, Mller M, Tommasino M, Jochmus I, Gissmann L",A DNA vaccine based on a shuffled E7 oncogene of the human papillomavirus type 16 (HPV 16) induces E7-specific cytotoxic T cells but lacks transforming activity,"2001","19","30","4276-4286",Vaccine,"","","","","","","","11457555","","",0,10,0,0,0,,,
2175,229,"Le et al., 2012",journal,"Le Bayon JC, Lina B, Rosa-Calatrava M, Boivin G",Recent developments with live-attenuated recombinant paramyxovirus vaccines,"2012","","","",Reviews in medical virology,"","","","","","","","22570186","",,0,0,0,0,0,,,
2176,142,"Wan et al., 2012",journal,"Wan J, Wen X, Huang X, Tang Y, Huang Y, Yan Q, Zhao Q, Cao S",Immunogenic analysis of two DNA vaccines of avian reovirus mediated by attenuated Salmonella typhimurium in chickens,"2012","147","3-4","154-160",Veterinary immunology and immunopathology,"","","","","","","","22575372","",,0,0,0,0,0,,,
2177,13,"Sullivan et al., 2006",journal,"Sullivan NJ, Geisbert TW, Geisbert JB, Shedlock DJ, Xu L, Lamoreaux L, Custers JH, Popernack PM, Yang ZY, Pau MG, Roederer M, Koup RA, Goudsmit J, Jahrling PB, Nabel GJ",Immune protection of nonhuman primates against Ebola virus with single low-dose adenovirus vectors encoding modified GPs,"2006","3","6",e177,PLoS medicine,"","","","","","","","16683867","","",0,10,0,0,0,,,
2178,13,"Jones et al., 2005",journal,"Jones SM, Feldmann H, Strher U, Geisbert JB, Fernando L, Grolla A, Klenk HD, Sullivan NJ, Volchkov VE, Fritz EA, Daddario KM, Hensley LE, Jahrling PB, Geisbert TW",Live attenuated recombinant vaccine protects nonhuman primates against Ebola and Marburg viruses,"2005","11","7","786-790",Nature medicine,"","","","","","","","15937495","","",0,10,0,0,0,,,
2179,13,"Pratt et al., 2010",journal,"Pratt WD, Wang D, Nichols DK, Luo M, Woraratanadharm J, Dye JM, Holman DH, Dong JY",Protection of nonhuman primates against two species of Ebola virus infection with a single complex adenovirus vector,"2010","17","4","572-581",Clinical and vaccine immunology : CVI,"","","","","","","","20181765","","",0,10,0,0,0,,,
2180,231,"Temperton et al., 2003",journal,"Temperton NJ, Quenelle DC, Lawson KM, Zuckerman JN, Kern ER, Griffiths PD, Emery VC",Enhancement of humoral immune responses to a human cytomegalovirus DNA vaccine: adjuvant effects of aluminum phosphate and CpG oligodeoxynucleotides,"2003","70","1","86-90",Journal of medical virology,"","","","","","","","12629648","",,0,0,0,0,0,,,
2181,231,"Schleiss, 2009",journal,Schleiss MR,"VCL-CB01, an injectable bivalent plasmid DNA vaccine for potential protection against CMV disease and infection","2009","11","5","572-578",Current opinion in molecular therapeutics,"","","","","","","","19806506","",,0,0,0,0,0,,,
2182,26,"Kaneko et al., 2000",journal,"Kaneko H, Bednarek I, Wierzbicki A, Kiszka I, Dmochowski M, Wasik TJ, Kaneko Y, Kozbor D",Oral DNA vaccination promotes mucosal and systemic immune responses to HIV envelope glycoprotein,"2000","267","1","8-16",Virology,"","","","","","","","10648178","","",0,10,0,0,0,,,
2183,26,"O'Hagan et al., 2001",journal,"O'Hagan D, Singh M, Ugozzoli M, Wild C, Barnett S, Chen M, Schaefer M, Doe B, Otten GR, Ulmer JB",Induction of potent immune responses by cationic microparticles with adsorbed human immunodeficiency virus DNA vaccines,"2001","75","19","9037-9043",Journal of virology,"","","","","","","","11533167","","",0,10,0,0,0,,,
2184,26,"Hawkins et al., 2003",journal,"Hawkins WG, Trcka J, Segal N, Blachere NE, Gold JS, Moroi Y, Bowne WB, Lewis JJ, Wolchok JD, Houghton AN",The role of lipopolysaccharide in T-cell responses following DNA vaccination,"2003","21","13-14","1548-1553",Vaccine,"","","","","","","","12615452","","",0,10,0,0,0,,,
2185,26,"Leclerc et al., 1997",journal,"Leclerc C, Driaud E, Rojas M, Whalen RG",The preferential induction of a Th1 immune response by DNA-based immunization is mediated by the immunostimulatory effect of plasmid DNA,"1997","179","2","97-9106",Cellular immunology,"","","","","","","","9268493","","",0,10,0,0,0,,,
2186,26,"Moore et al., 2002",journal,"Moore AC, Kong WP, Chakrabarti BK, Nabel GJ",Effects of antigen and genetic adjuvants on immune responses to human immunodeficiency virus DNA vaccines in mice,"2002","76","1","243-250",Journal of virology,"","","","","","","","11739689","","",0,10,0,0,0,,,
2187,26,"Cristillo et al., 2011",journal,"Cristillo AD, Ferrari MG, Hudacik L, Lewis B, Galmin L, Bowen B, Thompson D, Petrovsky N, Markham P, Pal R",Induction of mucosal and systemic antibody and T-cell responses following prime-boost immunization with novel adjuvanted human immunodeficiency virus-1-vaccine formulations,"2011","92",Pt 1,"128-140",The Journal of general virology,"","","","","","","","21169215","","",0,10,0,0,0,,,
2188,26,"Ara et al., 2001",journal,"Ara Y, Saito T, Takagi T, Hagiwara E, Miyagi Y, Sugiyama M, Kawamoto S, Ishii N, Yoshida T, Hanashi D, Koshino T, Okada H, Okuda K",Zymosan enhances the immune response to DNA vaccine for human immunodeficiency virus type-1 through the activation of complement system,"2001","103","1","98-9105",Immunology,"","","","","","","","11380697","","",0,10,0,0,0,,,
2189,213,"Lu et al., 1996",journal,"Lu S, Arthos J, Montefiori DC, Yasutomi Y, Manson K, Mustafa F, Johnson E, Santoro JC, Wissink J, Mullins JI, Haynes JR, Letvin NL, Wyand M, Robinson HL",Simian immunodeficiency virus DNA vaccine trial in macaques,"1996","70","6","3978-3991",Journal of virology,"","","","","","","","8648735","","",0,10,0,0,0,,,
2190,26,"Reynolds et al., 2012",journal,"Reynolds MR, Weiler AM, Piaskowski SM, Piatak M Jr, Robertson HT, Allison DB, Bett AJ, Casimiro DR, Shiver JW, Wilson NA, Lifson JD, Koff WC, Watkins DI",A trivalent recombinant Ad5 gag/pol/nef vaccine fails to protect rhesus macaques from infection or control virus replication after a limiting-dose heterologous SIV challenge,"2012","30","30","4465-4475",Vaccine,"","","","","","","","22569124","","",0,10,0,0,0,,,
2191,26,"Duerr et al., 2012",journal,"Duerr A, Huang Y, Buchbinder S, Coombs RW, Sanchez J, Del Rio C, Casapia M, Santiago S, Gilbert P, Corey L, Robertson MN",Extended Follow-up Confirms Early Vaccine-Enhanced Risk of HIV Acquisition and Demonstrates Waning Effect Over Time Among Participants in a Randomized Trial of Recombinant Adenovirus HIV Vaccine (Step Study),"2012","206","2","258-266",The Journal of infectious diseases,"","","","","","","","22561365","","",0,10,0,0,0,,,
2192,26,"Rerks-Ngarm et al., 2009",journal,"Rerks-Ngarm S, Pitisuttithum P, Nitayaphan S, Kaewkungwal J, Chiu J, Paris R, Premsri N, Namwat C, de Souza M, Adams E, Benenson M, Gurunathan S, Tartaglia J, McNeil JG, Francis DP, Stablein D, Birx DL, Chunsuttiwat S, Khamboonruang C, Thongcharoen P, Robb ML, Michael NL, Kunasol P, Kim JH",Vaccination with ALVAC and AIDSVAX to prevent HIV-1 infection in Thailand,"2009","361","23","2209-2220",The New England journal of medicine,"","","","","","","","19843557","","",0,10,0,0,0,,,
2193,26,"Flatz et al., 2012",journal,"Flatz L, Cheng C, Wang L, Foulds KE, Ko SY, Kong WP, Roychoudhuri R, Shi W, Bao S, Todd JP, Asmal M, Shen L, Donaldson M, Schmidt SD, Gall JG, Pinschewer DD, Letvin NL, Rao S, Mascola JR, Roederer M, Nabel GJ",Gene-Based Vaccination with a Mismatched Envelope Protects against Simian Immunodeficiency Virus Infection in Nonhuman Primates,"2012","86","15","7760-7770",Journal of virology,"","","","","","","","22593152","","",0,10,0,0,0,,,
2194,26,"Johnson et al., 2012",journal,"Johnson MJ, Petrovas C, Yamamoto T, Lindsay RW, Lor K, Gall JG, Gostick E, Lefebvre F, Cameron MJ, Price DA, Haddad E, Sekaly RP, Seder RA, Koup RA",Type I IFN induced by adenovirus serotypes 28 and 35 has multiple effects on T cell immunogenicity,"2012","188","12","6109-6118","Journal of immunology (Baltimore, Md. : 1950)","","","","","","","","22586038","","",0,10,0,0,0,,,
2195,26,"Barouch et al., 2012",journal,"Barouch DH, Klasse PJ, Dufour J, Veazey RS, Moore JP",Macaque studies of vaccine and microbicide combinations for preventing HIV-1 sexual transmission,"2012","109","22","8694-8698",Proceedings of the National Academy of Sciences of the United States of America,"","","","","","","","22586094","","",0,10,0,0,0,,,
2196,26,"Aggarwal et al., 2005",journal,"Aggarwal P, Kumar S, Vajpayee M, Seth P",Adjuvant action of murine IL-2/Ig plasmid after intramuscular immunization with Indian HIV-1 subtype C recombinant env.gp 120 construct,"2005","18","4","649-656",Viral immunology,"","","","","","","","16359231","","",0,10,0,0,0,,,
2197,26,"Kim et al., 1998",journal,"Kim JJ, Trivedi NN, Nottingham LK, Morrison L, Tsai A, Hu Y, Mahalingam S, Dang K, Ahn L, Doyle NK, Wilson DM, Chattergoon MA, Chalian AA, Boyer JD, Agadjanyan MG, Weiner DB",Modulation of amplitude and direction of in vivo immune responses by co-administration of cytokine gene expression cassettes with DNA immunogens,"1998","28","3","1089-1103",European journal of immunology,"","","","","","","","9541605","","",0,10,0,0,0,,,
2198,26,"Kim et al., 2000",journal,"Kim JJ, Yang JS, VanCott TC, Lee DJ, Manson KH, Wyand MS, Boyer JD, Ugen KE, Weiner DB",Modulation of antigen-specific humoral responses in rhesus macaques by using cytokine cDNAs as DNA vaccine adjuvants,"2000","74","7","3427-3429",Journal of virology,"","","","","","","","10708463","","",0,10,0,0,0,,,
2199,26,"Kim et al., 2001",journal,"Kim JJ, Yang JS, Manson KH, Weiner DB","Modulation of antigen-specific cellular immune responses to DNA vaccination in rhesus macaques through the use of IL-2, IFN-gamma, or IL-4 gene adjuvants","2001","19","17-19","2496-2505",Vaccine,"","","","","","","","11257383","","",0,10,0,0,0,,,
2200,213,"Barouch et al., 2000",journal,"Barouch DH, Santra S, Schmitz JE, Kuroda MJ, Fu TM, Wagner W, Bilska M, Craiu A, Zheng XX, Krivulka GR, Beaudry K, Lifton MA, Nickerson CE, Trigona WL, Punt K, Freed DC, Guan L, Dubey S, Casimiro D, Simon A, Davies ME, Chastain M, Strom TB, Gelman RS, Montefiori DC, Lewis MG, Emini EA, Shiver JW, Letvin NL",Control of viremia and prevention of clinical AIDS in rhesus monkeys by cytokine-augmented DNA vaccination,"2000","290","5491","486-492","Science (New York, N.Y.)","","","","","","","","11039923","","",0,10,0,0,0,,,
2201,213,"Bertley et al., 2004",journal,"Bertley FM, Kozlowski PA, Wang SW, Chappelle J, Patel J, Sonuyi O, Mazzara G, Montefiori D, Carville A, Mansfield KG, Aldovini A",Control of simian/human immunodeficiency virus viremia and disease progression after IL-2-augmented DNA-modified vaccinia virus Ankara nasal vaccination in nonhuman primates,"2004","172","6","3745-3757","Journal of immunology (Baltimore, Md. : 1950)","","","","","","","","15004179","","",0,10,0,0,0,,,
2202,213,"Barouch et al., 2000",journal,"Barouch DH, Craiu A, Kuroda MJ, Schmitz JE, Zheng XX, Santra S, Frost JD, Krivulka GR, Lifton MA, Crabbs CL, Heidecker G, Perry HC, Davies ME, Xie H, Nickerson CE, Steenbeke TD, Lord CI, Montefiori DC, Strom TB, Shiver JW, Lewis MG, Letvin NL",Augmentation of immune responses to HIV-1 and simian immunodeficiency virus DNA vaccines by IL-2/Ig plasmid administration in rhesus monkeys,"2000","97","8","4192-4197",Proceedings of the National Academy of Sciences of the United States of America,"","","","","","","","10759543","","",0,10,0,0,0,,,
2203,26,"Lena et al., 2002",journal,"Lena P, Villinger F, Giavedoni L, Miller CJ, Rhodes G, Luciw P","Co-immunization of rhesus macaques with plasmid vectors expressing IFN-gamma, GM-CSF, and SIV antigens enhances anti-viral humoral immunity but does not affect viremia after challenge with highly pathogenic virus","2002","20 Suppl 4","",A69-79,Vaccine,"","","","","","","","12477432","","",0,10,0,0,0,,,
2204,26,"Hirao et al., 2008",journal,"Hirao LA, Wu L, Khan AS, Hokey DA, Yan J, Dai A, Betts MR, Draghia-Akli R, Weiner DB",Combined effects of IL-12 and electroporation enhances the potency of DNA vaccination in macaques,"2008","26","25","3112-3120",Vaccine,"","","","","","","","18430495","","",0,10,0,0,0,,,
2205,26,"Robinson et al., 2006",journal,"Robinson HL, Montefiori DC, Villinger F, Robinson JE, Sharma S, Wyatt LS, Earl PL, McClure HM, Moss B, Amara RR",Studies on GM-CSF DNA as an adjuvant for neutralizing Ab elicited by a DNA/MVA immunodeficiency virus vaccine,"2006","352","2","285-294",Virology,"","","","","","","","16740288","","",0,10,0,0,0,,,
2206,26,"Li et al., 2008",journal,"Li W, Li S, Hu Y, Tang B, Cui L, He W",Efficient augmentation of a long-lasting immune responses in HIV-1 gag DNA vaccination by IL-15 plasmid boosting,"2008","26","26","3282-3290",Vaccine,"","","","","","","","18472194","","",0,10,0,0,0,,,
2207,26,"Calarota et al., 2008",journal,"Calarota SA, Dai A, Trocio JN, Weiner DB, Lori F, Lisziewicz J",IL-15 as memory T-cell adjuvant for topical HIV-1 DermaVir vaccine,"2008","26","40","5188-5195",Vaccine,"","","","","","","","18462844","","",0,10,0,0,0,,,
2208,26,"Kutzler et al., 2005",journal,"Kutzler MA, Robinson TM, Chattergoon MA, Choo DK, Choo AY, Choe PY, Ramanathan MP, Parkinson R, Kudchodkar S, Tamura Y, Sidhu M, Roopchand V, Kim JJ, Pavlakis GN, Felber BK, Waldmann TA, Boyer JD, Weiner DB",Coimmunization with an optimized IL-15 plasmid results in enhanced function and longevity of CD8 T cells that are partially independent of CD4 T cell help,"2005","175","1","112-123","Journal of immunology (Baltimore, Md. : 1950)","","","","","","","","15972637","","",0,10,0,0,0,,,
2209,213,"Chong et al., 2007",journal,"Chong SY, Egan MA, Kutzler MA, Megati S, Masood A, Roopchard V, Garcia-Hand D, Montefiori DC, Quiroz J, Rosati M, Schadeck EB, Boyer JD, Pavlakis GN, Weiner DB, Sidhu M, Eldridge JH, Israel ZR",Comparative ability of plasmid IL-12 and IL-15 to enhance cellular and humoral immune responses elicited by a SIVgag plasmid DNA vaccine and alter disease progression following SHIV(89.6P) challenge in rhesus macaques,"2007","25","26","4967-4982",Vaccine,"","","","","","","","17335943","","",0,10,0,0,0,,,
2210,26,"Sizemore et al., 1995",journal,"Sizemore DR, Branstrom AA, Sadoff JC",Attenuated Shigella as a DNA delivery vehicle for DNA-mediated immunization,"1995","270","5234","299-302","Science (New York, N.Y.)","","","","","","","","7569980","","",0,10,0,0,0,,,
2211,26,"Bagley et al., 2003",journal,"Bagley KC, Shata MT, Onyabe DY, DeVico AL, Fouts TR, Lewis GK, Hone DM",Immunogenicity of DNA vaccines that direct the coincident expression of the 120 kDa glycoprotein of human immunodeficiency virus and the catalytic domain of cholera toxin,"2003","21","23","3335-3341",Vaccine,"","","","","","","","12804865","","",0,10,0,0,0,,,
2212,26,"Vecino et al., 2002",journal,"Vecino WH, Morin PM, Agha R, Jacobs WR Jr, Fennelly GJ",Mucosal DNA vaccination with highly attenuated Shigella is superior to attenuated Salmonella and comparable to intramuscular DNA vaccination for T cells against HIV,"2002","82","3","197-204",Immunology letters,"","","","","","","","12036602","","",0,10,0,0,0,,,
2213,26,"Wang et al., 1993",journal,"Wang B, Boyer J, Srikantan V, Coney L, Carrano R, Phan C, Merva M, Dang K, Agadjanan M, Gilbert L",DNA inoculation induces neutralizing immune responses against human immunodeficiency virus type 1 in mice and nonhuman primates,"1993","12","9","799-805",DNA and cell biology,"","","","","","","","8216851","","",0,10,0,0,0,,,
2214,26,"Boyer et al., 1997",journal,"Boyer JD, Ugen KE, Wang B, Agadjanyan M, Gilbert L, Bagarazzi ML, Chattergoon M, Frost P, Javadian A, Williams WV, Refaeli Y, Ciccarelli RB, McCallus D, Coney L, Weiner DB",Protection of chimpanzees from high-dose heterologous HIV-1 challenge by DNA vaccination,"1997","3","5","526-532",Nature medicine,"","","","","","","","9142121","","",0,10,0,0,0,,,
2215,26,"MacGregor et al., 1998",journal,"MacGregor RR, Boyer JD, Ugen KE, Lacy KE, Gluckman SJ, Bagarazzi ML, Chattergoon MA, Baine Y, Higgins TJ, Ciccarelli RB, Coney LR, Ginsberg RS, Weiner DB",First human trial of a DNA-based vaccine for treatment of human immunodeficiency virus type 1 infection: safety and host response,"1998","178","1","92-9100",The Journal of infectious diseases,"","","","","","","","9652427","","",0,10,0,0,0,,,
2216,26,"Calarota et al., 1998",journal,"Calarota S, Bratt G, Nordlund S, Hinkula J, Leandersson AC, Sandstrm E, Wahren B",Cellular cytotoxic response induced by DNA vaccination in HIV-1-infected patients,"1998","351","9112","1320-1325",Lancet,"","","","","","","","9643795","","",0,10,0,0,0,,,
2217,26,"Hanke et al., 2002",journal,"Hanke T, McMichael AJ, Samuel RV, Powell LA, McLoughlin L, Crome SJ, Edlin A",Lack of toxicity and persistence in the mouse associated with administration of candidate DNA- and modified vaccinia virus Ankara (MVA)-based HIV vaccines for Kenya,"2002","21","1-2","108-114",Vaccine,"","","","","","","","12443668","","",0,10,0,0,0,,,
2218,26,"Kang et al., 2003",journal,"Kang KK, Choi SM, Choi JH, Lee DS, Kim CY, Ahn BO, Kim BM, Kim WB","Safety evaluation of GX-12, a new HIV therapeutic vaccine: investigation of integration into the host genome and expression in the reproductive organs","2003","46","5","270-276",Intervirology,"","","","","","","","14555847","","",0,10,0,0,0,,,
2219,26,"Sheets et al., 2006",journal,"Sheets RL, Stein J, Manetz TS, Duffy C, Nason M, Andrews C, Kong WP, Nabel GJ, Gomez PL","Biodistribution of DNA plasmid vaccines against HIV-1, Ebola, Severe Acute Respiratory Syndrome, or West Nile virus is similar, without integration, despite differing plasmid backbones or gene inserts","2006","91","2","610-619",Toxicological sciences : an official journal of the Society of Toxicology,"","","","","","","","16569729","","",0,10,0,0,0,,,
2220,213,"Boyer et al., 2007",journal,"Boyer JD, Robinson TM, Kutzler MA, Vansant G, Hokey DA, Kumar S, Parkinson R, Wu L, Sidhu MK, Pavlakis GN, Felber BK, Brown C, Silvera P, Lewis MG, Monforte J, Waldmann TA, Eldridge J, Weiner DB",Protection against simian/human immunodeficiency virus (SHIV) 89.6P in macaques after coimmunization with SHIV antigen and IL-15 plasmid,"2007","104","47","18648-18653",Proceedings of the National Academy of Sciences of the United States of America,"","","","","","","","18000037","","",0,10,0,0,0,,,
2221,213,"Boyer et al., 2005",journal,"Boyer JD, Robinson TM, Kutzler MA, Parkinson R, Calarota SA, Sidhu MK, Muthumani K, Lewis M, Pavlakis G, Felber B, Weiner D",SIV DNA vaccine co-administered with IL-12 expression plasmid enhances CD8 SIV cellular immune responses in cynomolgus macaques,"2005","34","5-6","262-270",Journal of medical primatology,"","","","","","","","16128921","","",0,10,0,0,0,,,
2222,26,"Wang et al., 2006",journal,"Wang S, Farfan-Arribas DJ, Shen S, Chou TH, Hirsch A, He F, Lu S","Relative contributions of codon usage, promoter efficiency and leader sequence to the antigen expression and immunogenicity of HIV-1 Env DNA vaccine","2006","24","21","4531-4540",Vaccine,"","","","","","","","16140431","","",0,10,0,0,0,,,
2223,26,"Gudmundsdotter et al., 2009",journal,"Gudmundsdotter L, Nilsson C, Brave A, Hejdeman B, Earl P, Moss B, Robb M, Cox J, Michael N, Marovich M, Biberfeld G, Sandstrm E, Wahren B",Recombinant Modified Vaccinia Ankara (MVA) effectively boosts DNA-primed HIV-specific immune responses in humans despite pre-existing vaccinia immunity,"2009","27","33","4468-4474",Vaccine,"","","","","","","","19450644","","",0,10,0,0,0,,,
2224,26,"Harro et al., 2009",journal,"Harro CD, Robertson MN, Lally MA, O'Neill LD, Edupuganti S, Goepfert PA, Mulligan MJ, Priddy FH, Dubey SA, Kierstead LS, Sun X, Casimiro DR, DiNubile MJ, Shiver JW, Leavitt RY, Mehrotra DV",Safety and immunogenicity of adenovirus-vectored near-consensus HIV type 1 clade B gag vaccines in healthy adults,"2009","25","1","103-114",AIDS research and human retroviruses,"","","","","","","","19108693","","",0,10,0,0,0,,,
2225,26,"Casimiro et al., 2003",journal,"Casimiro DR, Chen L, Fu TM, Evans RK, Caulfield MJ, Davies ME, Tang A, Chen M, Huang L, Harris V, Freed DC, Wilson KA, Dubey S, Zhu DM, Nawrocki D, Mach H, Troutman R, Isopi L, Williams D, Hurni W, Xu Z, Smith JG, Wang S, Liu X, Guan L, Long R, Trigona W, Heidecker GJ, Perry HC, Persaud N, Toner TJ, Su Q, Liang X, Youil R, Chastain M, Bett AJ, Volkin DB, Emini EA, Shiver JW","Comparative immunogenicity in rhesus monkeys of DNA plasmid, recombinant vaccinia virus, and replication-defective adenovirus vectors expressing a human immunodeficiency virus type 1 gag gene","2003","77","11","6305-6313",Journal of virology,"","","","","","","","12743287","","",0,10,0,0,0,,,
2226,26,"McElrath et al., 2008",journal,"McElrath MJ, De Rosa SC, Moodie Z, Dubey S, Kierstead L, Janes H, Defawe OD, Carter DK, Hural J, Akondy R, Buchbinder SP, Robertson MN, Mehrotra DV, Self SG, Corey L, Shiver JW, Casimiro DR",HIV-1 vaccine-induced immunity in the test-of-concept Step Study: a case-cohort analysis,"2008","372","9653","1894-1905",Lancet,"","","","","","","","19012957","","",0,10,0,0,0,,,
2227,26,"Dale et al., 2004",journal,"Dale CJ, De Rose R, Stratov I, Chea S, Montefiori DC, Thomson S, Ramshaw IA, Coupar BE, Boyle DB, Law M, Kent SJ",Efficacy of DNA and fowlpox virus priming/boosting vaccines for simian/human immunodeficiency virus,"2004","78","24","13819-13828",Journal of virology,"","","","","","","","15564490","","",0,10,0,0,0,,,
2228,26,"MacGregor et al., 2005",journal,"MacGregor RR, Boyer JD, Ugen KE, Tebas P, Higgins TJ, Baine Y, Ciccarelli RB, Ginsberg RS, Weiner DB","Plasmid vaccination of stable HIV-positive subjects on antiviral treatment results in enhanced CD8 T-cell immunity and increased control of viral ""blips""","2005","23","17-18","2066-2073",Vaccine,"","","","","","","","15755572","","",0,10,0,0,0,,,
2229,26,"Hejdeman et al., 2004",journal,"Hejdeman B, Bostrm AC, Matsuda R, Calarota S, Lenkei R, Fredriksson EL, Sandstrm E, Bratt G, Wahren B",DNA immunization with HIV early genes in HIV type 1-infected patients on highly active antiretroviral therapy,"2004","20","8","860-870",AIDS research and human retroviruses,"","","","","","","","15320990","","",0,10,0,0,0,,,
2230,26,"Mascola et al., 2005",journal,"Mascola JR, Sambor A, Beaudry K, Santra S, Welcher B, Louder MK, Vancott TC, Huang Y, Chakrabarti BK, Kong WP, Yang ZY, Xu L, Montefiori DC, Nabel GJ, Letvin NL",Neutralizing antibodies elicited by immunization of monkeys with DNA plasmids and recombinant adenoviral vectors expressing human immunodeficiency virus type 1 proteins,"2005","79","2","771-779",Journal of virology,"","","","","","","","15613305","","",0,10,0,0,0,,,
2231,26,"Brve et al., 2005",journal,"Brve A, Ljungberg K, Boberg A, Rollman E, Isaguliants M, Lundgren B, Blomberg P, Hinkula J, Wahren B",Multigene/multisubtype HIV-1 vaccine induces potent cellular and humoral immune responses by needle-free intradermal delivery,"2005","12","6","1197-1205",Molecular therapy : the journal of the American Society of Gene Therapy,"","","","","","","","16112909","","",0,10,0,0,0,,,
2232,26,"Peters et al., 2007",journal,"Peters BS, Jaoko W, Vardas E, Panayotakopoulos G, Fast P, Schmidt C, Gilmour J, Bogoshi M, Omosa-Manyonyi G, Dally L, Klavinskis L, Farah B, Tarragona T, Bart PA, Robinson A, Pieterse C, Stevens W, Thomas R, Barin B, McMichael AJ, McIntyre JA, Pantaleo G, Hanke T, Bwayo J",Studies of a prophylactic HIV-1 vaccine candidate based on modified vaccinia virus Ankara (MVA) with and without DNA priming: effects of dosage and route on safety and immunogenicity,"2007","25","11","2120-2127",Vaccine,"","","","","","","","17250931","","",0,10,0,0,0,,,
2233,26,"Weber et al., 2001",journal,"Weber R, Bossart W, Cone R, Luethy R, Moelling K",Phase I clinical trial with HIV-1 gp160 plasmid vaccine in HIV-1-infected asymptomatic subjects,"2001","20","11","800-803",European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology,"","","","","","","","11783696","","",0,10,0,0,0,,,
2234,26,"Qiu et al., 1999",journal,"Qiu JT, Song R, Dettenhofer M, Tian C, August T, Felber BK, Pavlakis GN, Yu XF",Evaluation of novel human immunodeficiency virus type 1 Gag DNA vaccines for protein expression in mammalian cells and induction of immune responses,"1999","73","11","9145-9152",Journal of virology,"","","","","","","","10516021","","",0,10,0,0,0,,,
2235,26,"Lekutis et al., 1997",journal,"Lekutis C, Shiver JW, Liu MA, Letvin NL",HIV-1 env DNA vaccine administered to rhesus monkeys elicits MHC class II-restricted CD4+ T helper cells that secrete IFN-gamma and TNF-alpha,"1997","158","9","4471-4477","Journal of immunology (Baltimore, Md. : 1950)","","","","","","","","9127013","","",0,10,0,0,0,,,
2236,26,"Vinner et al., 1999",journal,"Vinner L, Nielsen HV, Bryder K, Corbet S, Nielsen C, Fomsgaard A",Gene gun DNA vaccination with Rev-independent synthetic HIV-1 gp160 envelope gene using mammalian codons,"1999","17","17","2166-2175",Vaccine,"","","","","","","","10367950","","",0,10,0,0,0,,,
2237,26,"Bower et al., 2004",journal,"Bower JF, Yang X, Sodroski J, Ross TM",Elicitation of neutralizing antibodies with DNA vaccines expressing soluble stabilized human immunodeficiency virus type 1 envelope glycoprotein trimers conjugated to C3d,"2004","78","9","4710-4719",Journal of virology,"","","","","","","","15078953","","",0,10,0,0,0,,,
2238,26,"Denis-Mize et al., 2000",journal,"Denis-Mize KS, Dupuis M, MacKichan ML, Singh M, Doe B, O'Hagan D, Ulmer JB, Donnelly JJ, McDonald DM, Ott G",Plasmid DNA adsorbed onto cationic microparticles mediates target gene expression and antigen presentation by dendritic cells,"2000","7","24","2105-2112",Gene therapy,"","","","","","","","11223992","","",0,10,0,0,0,,,
2239,26,"Caputo et al., 2003",journal,"Caputo A, Gavioli R, Altavilla G, Brocca-Cofano E, Boarini C, Betti M, Castaldello A, Lorenzini F, Micheletti F, Cafaro A, Sparnacci K, Laus M, Tondelli L, Ensoli B",Immunization with low doses of HIV-1 tat DNA delivered by novel cationic block copolymers induces CTL responses against Tat,"2003","21","11-12","1103-1111",Vaccine,"","","","","","","","12559787","","",0,10,0,0,0,,,
2240,26,"Chin'ombe et al., 2009",journal,"Chin'ombe N, Bourn WR, Williamson AL, Shephard EG",Oral vaccination with a recombinant Salmonella vaccine vector provokes systemic HIV-1 subtype C Gag-specific CD4+ Th1 and Th2 cell immune responses in mice,"2009","6","","87",Virology journal,"","","","","","","","19555490","","",0,10,0,0,0,,,
2241,49,"Zhang et al., 2006",journal,"Zhang W, Dong SF, Sun SH, Wang Y, Li GD, Qu D",Coimmunization with IL-15 plasmid enhances the longevity of CD8 T cells induced by DNA encoding hepatitis B virus core antigen,"2006","12","29","4727-4735",World journal of gastroenterology : WJG,"","","","","","","","16937447","","",0,10,0,0,0,,,
2242,49,"Kwissa et al., 2003",journal,"Kwissa M, Krger A, Hauser H, Reimann J, Schirmbeck R",Cytokine-facilitated priming of CD8+ T cell responses by DNA vaccination,"2003","81","2","91-9101","Journal of molecular medicine (Berlin, Germany)","","","","","","","","12601525","","",0,10,0,0,0,,,
2243,49,"Qing et al., 2010",journal,"Qing Y, Chen M, Zhao J, Hu H, Xu H, Ling N, Peng M, Ren H",Construction of an HBV DNA vaccine by fusion of the GM-CSF gene to the HBV-S gene and examination of its immune effects in normal and HBV-transgenic mice,"2010","28","26","4301-4307",Vaccine,"","","","","","","","20430121","","",0,10,0,0,0,,,
2244,49,"He et al., 2005",journal,"He X, Jiang L, Wang F, Xiao Z, Li J, Liu LS, Li D, Ren D, Jin X, Li K, He Y, Shi K, Guo Y, Zhang Y, Sun S",Augmented humoral and cellular immune responses to hepatitis B DNA vaccine adsorbed onto cationic microparticles,"2005","107","2","357-372",Journal of controlled release : official journal of the Controlled Release Society,"","","","","","","","16099068","",,0,0,0,0,0,,,
2245,49,"Kuhrber et al., 1997",journal,"Kuhrber A, Wild J, Pudollek HP, Chisari FV, Reimann J",DNA vaccination with plasmids encoding the intracellular (HBcAg) or secreted (HBeAg) form of the core protein of hepatitis B virus primes T cell responses to two overlapping Kb- and Kd-restricted epitopes,"1997","9","8","1203-1212",International immunology,"","","","","","","","9263018","","",0,10,0,0,0,,,
2246,49,"Triyatni et al., 1998",journal,"Triyatni M, Jilbert AR, Qiao M, Miller DS, Burrell CJ",Protective efficacy of DNA vaccines against duck hepatitis B virus infection,"1998","72","1","84-94",Journal of virology,"","","","","","","","9420203","","",0,10,0,0,0,,,
2247,49,"Zhou et al., 2003",journal,"Zhou X, Zheng L, Liu L, Xiang L, Yuan Z",T helper 2 immunity to hepatitis B surface antigen primed by gene-gun-mediated DNA vaccination can be shifted towards T helper 1 immunity by codelivery of CpG motif-containing oligodeoxynucleotides,"2003","58","3","350-357",Scandinavian journal of immunology,"","","","","","","","12950682","","",0,10,0,0,0,,,
2248,49,"Khatri et al., 2008",journal,"Khatri K, Goyal AK, Gupta PN, Mishra N, Vyas SP",Plasmid DNA loaded chitosan nanoparticles for nasal mucosal immunization against hepatitis B,"2008","354","1-2","235-241",International journal of pharmaceutics,"","","","","","","","18182259","","",0,10,0,0,0,,,
2249,29,"Wang et al., 2010",journal,"Wang D, Xu J, Feng Y, Liu Y, Mchenga SS, Shan F, Sasaki J, Lu C",Liposomal oral DNA vaccine (mycobacterium DNA) elicits immune response,"2010","28","18","3134-3142",Vaccine,"","","","","","","","20197133","","",0,10,0,0,0,,,
2250,49,"Chow et al., 1998",journal,"Chow YH, Chiang BL, Lee YL, Chi WK, Lin WC, Chen YT, Tao MH",Development of Th1 and Th2 populations and the nature of immune responses to hepatitis B virus DNA vaccines can be modulated by codelivery of various cytokine genes,"1998","160","3","1320-1329","Journal of immunology (Baltimore, Md. : 1950)","","","","","","","","9570550","","",0,10,0,0,0,,,
2251,49,"Davis et al., 1993",journal,"Davis HL, Michel ML, Whalen RG",DNA-based immunization induces continuous secretion of hepatitis B surface antigen and high levels of circulating antibody,"1993","2","11","1847-1851",Human molecular genetics,"","","","","","","","8281146","","",0,10,0,0,0,,,
2252,49,"Tacket et al., 1999",journal,"Tacket CO, Roy MJ, Widera G, Swain WF, Broome S, Edelman R",Phase 1 safety and immune response studies of a DNA vaccine encoding hepatitis B surface antigen delivered by a gene delivery device,"1999","17","22","2826-2829",Vaccine,"","","","","","","","10438052","","",0,10,0,0,0,,,
2253,49,"Conry et al., 2002",journal,"Conry RM, Curiel DT, Strong TV, Moore SE, Allen KO, Barlow DL, Shaw DR, LoBuglio AF",Safety and immunogenicity of a DNA vaccine encoding carcinoembryonic antigen and hepatitis B surface antigen in colorectal carcinoma patients,"2002","8","9","2782-2787",Clinical cancer research : an official journal of the American Association for Cancer Research,"","","","","","","","12231517","","",0,10,0,0,0,,,
2254,49,"Zinckgraf and Silbart, 2003",journal,"Zinckgraf JW, Silbart LK","Modulating gene expression using DNA vaccines with different 3'-UTRs influences antibody titer, seroconversion and cytokine profiles","2003","21","15","1640-1649",Vaccine,"","","","","","","","12639485","","",0,10,0,0,0,,,
2255,49,"Xu et al., 2005",journal,"Xu W, Chu Y, Zhang R, Xu H, Wang Y, Xiong S",Endoplasmic reticulum targeting sequence enhances HBV-specific cytotoxic T lymphocytes induced by a CTL epitope-based DNA vaccine,"2005","334","2","255-263",Virology,"","","","","","","","15780875","","",0,10,0,0,0,,,
2256,49,"Davis et al., 1996",journal,"Davis HL, McCluskie MJ, Gerin JL, Purcell RH",DNA vaccine for hepatitis B: evidence for immunogenicity in chimpanzees and comparison with other vaccines,"1996","93","14","7213-7218",Proceedings of the National Academy of Sciences of the United States of America,"","","","","","","","8692971","","",0,10,0,0,0,,,
2257,49,"Chen et al., 2011",journal,"Chen JH, Yu YS, Liu HH, Chen XH, Xi M, Zang GQ, Tang ZH",Ubiquitin conjugation of hepatitis B virus core antigen DNA vaccine leads to enhanced cell-mediated immune response in BALB/c mice,"2011","11","8","620-628",Hepatitis monthly,"","","","","","","","22140385","","",0,10,0,0,0,,,
2258,233,"Lang et al., 2012",journal,"Lang Kuhs KA, Ginsberg AA, Yan J, Wiseman RW, Khan AS, Sardesai NY, O'Connor DH, Weiner DB",Hepatitis C virus NS3/NS4A DNA vaccine induces multiepitope T cell responses in rhesus macaques mimicking human immune responses,"2012","20","3","669-678",Molecular therapy : the journal of the American Society of Gene Therapy,"","","","","","","","21952169","","",0,10,0,0,0,,,
2259,233,"Geissler et al., 1997",journal,"Geissler M, Gesien A, Tokushige K, Wands JR",Enhancement of cellular and humoral immune responses to hepatitis C virus core protein using DNA-based vaccines augmented with cytokine-expressing plasmids,"1997","158","3","1231-1237","Journal of immunology (Baltimore, Md. : 1950)","","","","","","","","9013964","","",0,10,0,0,0,,,
2260,234,"Henke et al., 2004",journal,"Henke A, Chiang CS, Zell R, Stelzner A",Co-expression of interleukin-2 to increase the efficacy of DNA vaccine-mediated protection in coxsackievirus B3-infected mice,"2004","64","2","131-136",Antiviral research,"","","","","","","","15498609","","",0,10,0,0,0,,,
2261,129,"Hu et al., 2007",journal,"Hu H, Lu X, Tao L, Bai B, Zhang Z, Chen Y, Zheng F, Chen J, Chen Z, Wang H",Induction of specific immune responses by severe acute respiratory syndrome coronavirus spike DNA vaccine with or without interleukin-2 immunization using different vaccination routes in mice,"2007","14","7","894-901",Clinical and vaccine immunology : CVI,"","","","","","","","17494640","","",0,10,0,0,0,,,
2262,29,"Cai et al., 2005",journal,"Cai H, Yu DH, Tian X, Zhu YX",Coadministration of interleukin 2 plasmid DNA with combined DNA vaccines significantly enhances the protective efficacy against Mycobacterium tuberculosis,"2005","24","10","605-613",DNA and cell biology,"","","","","","","","16225391","","",0,10,0,0,0,,,
2263,29,"Wang et al., 2004",journal,"Wang J, Thorson L, Stokes RW, Santosuosso M, Huygen K, Zganiacz A, Hitt M, Xing Z","Single mucosal, but not parenteral, immunization with recombinant adenoviral-based vaccine provides potent protection from pulmonary tuberculosis","2004","173","10","6357-6365","Journal of immunology (Baltimore, Md. : 1950)","","","","","","","","15528375","","",0,10,0,0,0,,,
2264,100,"McClements et al., 1996",journal,"McClements WL, Armstrong ME, Keys RD, Liu MA","Immunization with DNA vaccines encoding glycoprotein D or glycoprotein B, alone or in combination, induces protective immunity in animal models of herpes simplex virus-2 disease","1996","93","21","11414-11420",Proceedings of the National Academy of Sciences of the United States of America,"","","","","","","","8876149","","",0,10,0,0,0,,,
2265,100,"Manickan et al., 1997",journal,"Manickan E, Kanangat S, Rouse RJ, Yu Z, Rouse BT",Enhancement of immune response to naked DNA vaccine by immunization with transfected dendritic cells,"1997","61","2","125-132",Journal of leukocyte biology,"","","","","","","","9021916","","",0,10,0,0,0,,,
2266,100,"Toka and Rouse, 2005",journal,"Toka FN, Rouse BT",Mucosal application of plasmid-encoded IL-15 sustains a highly protective anti-Herpes simplex virus immunity,"2005","78","1","178-186",Journal of leukocyte biology,"","","","","","","","15817700","","",0,10,0,0,0,,,
2267,100,"McClements et al., 1997",journal,"McClements WL, Armstrong ME, Keys RD, Liu MA",The prophylactic effect of immunization with DNA encoding herpes simplex virus glycoproteins on HSV-induced disease in guinea pigs,"1997","15","8","857-860",Vaccine,"","","","","","","","9234533","","",0,10,0,0,0,,,
2268,56,"Osorio et al., 1999",journal,"Osorio JE, Tomlinson CC, Frank RS, Haanes EJ, Rushlow K, Haynes JR, Stinchcomb DT",Immunization of dogs and cats with a DNA vaccine against rabies virus,"1999","17","9-10","1109-1116",Vaccine,"","","","","","","","10195621","","",0,10,0,0,0,,,
2269,115,"Bhaumik et al., 2009",journal,"Bhaumik S, Basu R, Sen S, Naskar K, Roy S",KMP-11 DNA immunization significantly protects against L. donovani infection but requires exogenous IL-12 as an adjuvant for comparable protection against L. major,"2009","27","9","1306-1316",Vaccine,"","","","","","","","19162111","","",0,10,0,0,0,,,
2270,118,"Garg and Tarleton, 2002",journal,"Garg N, Tarleton RL",Genetic immunization elicits antigen-specific protective immune responses and decreases disease severity in Trypanosoma cruzi infection,"2002","70","10","5547-5555",Infection and immunity,"","","","","","","","12228281","","",0,10,0,0,0,,,
2271,118,"Arajo et al., 2005",journal,"Arajo AF, de Alencar BC, Vasconcelos JR, Hiyane MI, Marinho CR, Penido ML, Boscardin SB, Hoft DF, Gazzinelli RT, Rodrigues MM",CD8+-T-cell-dependent control of Trypanosoma cruzi infection in a highly susceptible mouse strain after immunization with recombinant proteins based on amastigote surface protein 2,"2005","73","9","6017-6025",Infection and immunity,"","","","","","","","16113322","","",0,10,0,0,0,,,
2272,118,"Chou et al., 2010",journal,"Chou B, Hiromatsu K, Hisaeda H, Duan X, Imai T, Murata S, Tanaka K, Himeno K",Genetic immunization based on the ubiquitin-fusion degradation pathway against Trypanosoma cruzi,"2010","392","3","277-282",Biochemical and biophysical research communications,"","","","","","","","20059980","","",0,10,0,0,0,,,
2273,118,"Eickhoff et al., 2011",journal,"Eickhoff CS, Vasconcelos JR, Sullivan NL, Blazevic A, Bruna-Romero O, Rodrigues MM, Hoft DF",Co-administration of a plasmid DNA encoding IL-15 improves long-term protection of a genetic vaccine against Trypanosoma cruzi,"2011","5","3",e983,PLoS neglected tropical diseases,"","","","","","","","21408124","","",0,10,0,0,0,,,
2274,118,"Limon-Flores et al., 2010",journal,"Limon-Flores AY, Cervera-Cetina R, Tzec-Arjona JL, Ek-Macias L, Snchez-Burgos G, Ramirez-Sierra MJ, Cruz-Chan JV, VanWynsberghe NR, Dumonteil E",Effect of a combination DNA vaccine for the prevention and therapy of Trypanosoma cruzi infection in mice: role of CD4+ and CD8+ T cells,"2010","28","46","7414-7419",Vaccine,"","","","","","","","20850536","","",0,10,0,0,0,,,
2275,118,"Sanchez-Burgos et al., 2007",journal,"Sanchez-Burgos G, Mezquita-Vega RG, Escobedo-Ortegon J, Ramirez-Sierra MJ, Arjona-Torres A, Ouaissi A, Rodrigues MM, Dumonteil E",Comparative evaluation of therapeutic DNA vaccines against Trypanosoma cruzi in mice,"2007","50","3","333-341",FEMS immunology and medical microbiology,"","","","","","","","17521394","","",0,10,0,0,0,,,
2276,65,"Eo et al., 2006",journal,"Eo SK, Yoon HA, Aleyas AG, Park SO, Han YW, Chae JS, Lee JH, Song HJ, Cho JG",Systemic and mucosal immunity induced by oral somatic transgene vaccination against glycoprotein B of pseudorabies virus using live attenuated Salmonella typhimurium,"2006","47","3","451-461",FEMS immunology and medical microbiology,"","","","","","","","16872383","","",0,10,0,0,0,,,
2277,17,"Jiang et al., 2011",journal,"Jiang X, Dalebout TJ, Bredenbeek PJ, Carrion R Jr, Brasky K, Patterson J, Goicochea M, Bryant J, Salvato MS, Lukashevich IS",Yellow fever 17D-vectored vaccines expressing Lassa virus GP1 and GP2 glycoproteins provide protection against fatal disease in guinea pigs,"2011","29","6","1248-1257",Vaccine,"","","","","","","","21145373","",,0,0,0,0,0,,,
2278,13,"Garbutt et al., 2004",journal,"Garbutt M, Liebscher R, Wahl-Jensen V, Jones S, Mller P, Wagner R, Volchkov V, Klenk HD, Feldmann H, Strher U",Properties of replication-competent vesicular stomatitis virus vectors expressing glycoproteins of filoviruses and arenaviruses,"2004","78","10","5458-5465",Journal of virology,"","","","","","","","15113924","","",0,10,0,0,0,,,
2279,13,"Martin et al., 2006",journal,"Martin JE, Sullivan NJ, Enama ME, Gordon IJ, Roederer M, Koup RA, Bailer RT, Chakrabarti BK, Bailey MA, Gomez PL, Andrews CA, Moodie Z, Gu L, Stein JA, Nabel GJ, Graham BS",A DNA vaccine for Ebola virus is safe and immunogenic in a phase I clinical trial,"2006","13","11","1267-1277",Clinical and vaccine immunology : CVI,"","","","","","","","16988008","","",0,10,0,0,0,,,
2280,13,"Riemenschneider et al., 2003",journal,"Riemenschneider J, Garrison A, Geisbert J, Jahrling P, Hevey M, Negley D, Schmaljohn A, Lee J, Hart MK, Vanderzanden L, Custer D, Bray M, Ruff A, Ivins B, Bassett A, Rossi C, Schmaljohn C","Comparison of individual and combination DNA vaccines for B. anthracis, Ebola virus, Marburg virus and Venezuelan equine encephalitis virus","2003","21","25-26","4071-4080",Vaccine,"","","","","","","","12922144","","",0,10,0,0,0,,,
2281,13,"Kobinger et al., 2006",journal,"Kobinger GP, Feldmann H, Zhi Y, Schumer G, Gao G, Feldmann F, Jones S, Wilson JM",Chimpanzee adenovirus vaccine protects against Zaire Ebola virus,"2006","346","2","394-401",Virology,"","","","","","","","16356525","","",0,10,0,0,0,,,
2282,13,"Richardson et al., 2009",journal,"Richardson JS, Yao MK, Tran KN, Croyle MA, Strong JE, Feldmann H, Kobinger GP",Enhanced protection against Ebola virus mediated by an improved adenovirus-based vaccine,"2009","4","4",e5308,PloS one,"","","","","","","","19390586","","",0,10,0,0,0,,,
2283,13,"Swenson et al., 2008",journal,"Swenson DL, Wang D, Luo M, Warfield KL, Woraratanadharm J, Holman DH, Dong JY, Pratt WD",Vaccine to confer to nonhuman primates complete protection against multistrain Ebola and Marburg virus infections,"2008","15","3","460-467",Clinical and vaccine immunology : CVI,"","","","","","","","18216185","","",0,10,0,0,0,,,
2284,13,"Sheets et al., 2006",journal,"Sheets RL, Stein J, Manetz TS, Duffy C, Nason M, Andrews C, Kong WP, Nabel GJ, Gomez PL","Biodistribution of DNA plasmid vaccines against HIV-1, Ebola, Severe Acute Respiratory Syndrome, or West Nile virus is similar, without integration, despite differing plasmid backbones or gene inserts","2006","91","2","610-619",Toxicological sciences : an official journal of the Society of Toxicology,"","","","","","","","16569729","","",0,10,0,0,0,,,
2285,13,"Swenson et al., 2005",journal,"Swenson DL, Warfield KL, Negley DL, Schmaljohn A, Aman MJ, Bavari S",Virus-like particles exhibit potential as a pan-filovirus vaccine for both Ebola and Marburg viral infections,"2005","23","23","3033-3042",Vaccine,"","","","","","","","15811650","","",0,10,0,0,0,,,
2286,7,"Riemenschneider et al., 2003",journal,"Riemenschneider J, Garrison A, Geisbert J, Jahrling P, Hevey M, Negley D, Schmaljohn A, Lee J, Hart MK, Vanderzanden L, Custer D, Bray M, Ruff A, Ivins B, Bassett A, Rossi C, Schmaljohn C","Comparison of individual and combination DNA vaccines for B. anthracis, Ebola virus, Marburg virus and Venezuelan equine encephalitis virus","2003","21","25-26","4071-4080",Vaccine,"","","","","","","","12922144","","",0,10,0,0,0,,,
2287,28,"Swenson et al., 2008",journal,"Swenson DL, Wang D, Luo M, Warfield KL, Woraratanadharm J, Holman DH, Dong JY, Pratt WD",Vaccine to confer to nonhuman primates complete protection against multistrain Ebola and Marburg virus infections,"2008","15","3","460-467",Clinical and vaccine immunology : CVI,"","","","","","","","18216185","","",0,10,0,0,0,,,
2288,28,"Geisbert et al., 2010",journal,"Geisbert TW, Bailey M, Geisbert JB, Asiedu C, Roederer M, Grazia-Pau M, Custers J, Jahrling P, Goudsmit J, Koup R, Sullivan NJ",Vector choice determines immunogenicity and potency of genetic vaccines against Angola Marburg virus in nonhuman primates,"2010","84","19","10386-10394",Journal of virology,"","","","","","","","20660192","","",0,10,0,0,0,,,
2289,8,"Hu et al., 2010",journal,"Hu XD, Chen ST, Li JY, Yu DH, Yi-Zhang, Cai H",An IL-15 adjuvant enhances the efficacy of a combined DNA vaccine against Brucella by increasing the CD8+ cytotoxic T cell response,"2010","28","12","2408-2415",Vaccine,"","","","","","","","20064480","","",0,10,0,0,0,,,
2290,8,"Kurar and Splitter, 1997",journal,"Kurar E, Splitter GA",Nucleic acid vaccination of Brucella abortus ribosomal L7/L12 gene elicits immune response,"1997","15","17-18","1851-1857",Vaccine,"","","","","","","","9413093","","",0,10,0,0,0,,,
2291,8,"Al-Mariri et al., 2001",journal,"Al-Mariri A, Tibor A, Mertens P, De Bolle X, Michel P, Godfroid J, Walravens K, Letesson JJ",Induction of immune response in BALB/c mice with a DNA vaccine encoding bacterioferritin or P39 of Brucella spp,"2001","69","10","6264-6270",Infection and immunity,"","","","","","","","11553569","","",0,10,0,0,0,,,
2292,8,"Leclerq et al., 2002",journal,"Leclerq S, Harms JS, Rosinha GM, Azevedo V, Oliveira SC",Induction of a th1-type of immune response but not protective immunity by intramuscular DNA immunisation with Brucella abortus GroEL heat-shock gene,"2002","51","1","20-26",Journal of medical microbiology,"","","","","","","","11803949","","",0,10,0,0,0,,,
2293,8,"Cassataro et al., 2002",journal,"Cassataro J, Velikovsky CA, Giambartolomei GH, Estein S, Bruno L, Cloeckaert A, Bowden RA, Spitz M, Fossati CA",Immunogenicity of the Brucella melitensis recombinant ribosome recycling factor-homologous protein and its cDNA,"2002","20","11-12","1660-1669",Vaccine,"","","","","","","","11858876","","",0,10,0,0,0,,,
2294,8,"Yu et al., 2007",journal,"Yu DH, Li M, Hu XD, Cai H",A combined DNA vaccine enhances protective immunity against Mycobacterium tuberculosis and Brucella abortus in the presence of an IL-12 expression vector,"2007","25","37-38","6744-6754",Vaccine,"","","","","","","","17681650","","",0,10,0,0,0,,,
2295,99,"Thirdborough et al., 2002",journal,"Thirdborough SM, Radcliffe JN, Friedmann PS, Stevenson FK",Vaccination with DNA encoding a single-chain TCR fusion protein induces anticlonotypic immunity and protects against T-cell lymphoma,"2002","62","6","1757-1760",Cancer research,"","","","","","","","11912151","","",0,10,0,0,0,,,
2296,99,"Williams et al., 2008",journal,"Williams BB, Wall M, Miao RY, Williams B, Bertoncello I, Kershaw MH, Mantamadiotis T, Haber M, Norris MD, Gautam A, Darcy PK, Ramsay RG",Induction of T cell-mediated immunity using a c-Myb DNA vaccine in a mouse model of colon cancer,"2008","57","11","1635-1645","Cancer immunology, immunotherapy : CII","","","","","","","","18386000","","",0,10,0,0,0,,,
2297,99,"Mincheff et al., 2000",journal,"Mincheff M, Tchakarov S, Zoubak S, Loukinov D, Botev C, Altankova I, Georgiev G, Petrov S, Meryman HT",Naked DNA and adenoviral immunizations for immunotherapy of prostate cancer: a phase I/II clinical trial,"2000","38","2","208-217",European urology,"","","","","","","","10895014","","",0,10,0,0,0,,,
2298,99,"Drake, 2011",journal,Drake CG,Update on prostate cancer vaccines,"2011","17","5","294-299","Cancer journal (Sudbury, Mass.)","","","","","","","","21952278","","",0,10,0,0,0,,,
2299,30,"Le et al., 2000",journal,"Le TP, Coonan KM, Hedstrom RC, Charoenvit Y, Sedegah M, Epstein JE, Kumar S, Wang R, Doolan DL, Maguire JD, Parker SE, Hobart P, Norman J, Hoffman SL","Safety, tolerability and humoral immune responses after intramuscular administration of a malaria DNA vaccine to healthy adult volunteers","2000","18","18","1893-1901",Vaccine,"","","","","","","","10699338","","",0,10,0,0,0,,,
2300,30,"Wang et al., 2005",journal,"Wang R, Richie TL, Baraceros MF, Rahardjo N, Gay T, Banania JG, Charoenvit Y, Epstein JE, Luke T, Freilich DA, Norman J, Hoffman SL",Boosting of DNA vaccine-elicited gamma interferon responses in humans by exposure to malaria parasites,"2005","73","5","2863-2872",Infection and immunity,"","","","","","","","15845492","","",0,10,0,0,0,,,
2301,30,"McConkey et al., 2003",journal,"McConkey SJ, Reece WH, Moorthy VS, Webster D, Dunachie S, Butcher G, Vuola JM, Blanchard TJ, Gothard P, Watkins K, Hannan CM, Everaere S, Brown K, Kester KE, Cummings J, Williams J, Heppner DG, Pathan A, Flanagan K, Arulanantham N, Roberts MT, Roy M, Smith GL, Schneider J, Peto T, Sinden RE, Gilbert SC, Hill AV",Enhanced T-cell immunogenicity of plasmid DNA vaccines boosted by recombinant modified vaccinia virus Ankara in humans,"2003","9","6","729-735",Nature medicine,"","","","","","","","12766765","","",0,10,0,0,0,,,
2302,30,"Webster et al., 2005",journal,"Webster DP, Dunachie S, Vuola JM, Berthoud T, Keating S, Laidlaw SM, McConkey SJ, Poulton I, Andrews L, Andersen RF, Bejon P, Butcher G, Sinden R, Skinner MA, Gilbert SC, Hill AV",Enhanced T cell-mediated protection against malaria in human challenges by using the recombinant poxviruses FP9 and modified vaccinia virus Ankara,"2005","102","13","4836-4841",Proceedings of the National Academy of Sciences of the United States of America,"","","","","","","","15781866","","",0,10,0,0,0,,,
2303,30,"Parker et al., 2001",journal,"Parker SE, Monteith D, Horton H, Hof R, Hernandez P, Vilalta A, Hartikka J, Hobart P, Bentley CE, Chang A, Hedstrom R, Rogers WO, Kumar S, Hoffman SL, Norman JA",Safety of a GM-CSF adjuvant-plasmid DNA malaria vaccine,"2001","8","13","1011-1023",Gene therapy,"","","","","","","","11438836","","",0,10,0,0,0,,,
2304,235,"Ramshaw et al., 1997",journal,"Ramshaw IA, Fordham SA, Bernard CC, Maguire D, Cowden WB, Willenborg DO",DNA vaccines for the treatment of autoimmune disease,"1997","75","4","409-413",Immunology and cell biology,"","","","","","","","9315486","","",0,10,0,0,0,,,
2305,235,"Weissert et al., 2000",journal,"Weissert R, Lobell A, de Graaf KL, Eltayeb SY, Andersson R, Olsson T, Wigzell H",Protective DNA vaccination against organ-specific autoimmunity is highly specific and discriminates between single amino acid substitutions in the peptide autoantigen,"2000","97","4","1689-1694",Proceedings of the National Academy of Sciences of the United States of America,"","","","","","","","10677519","","",0,10,0,0,0,,,
2306,235,"Ruiz et al., 1999",journal,"Ruiz PJ, Garren H, Ruiz IU, Hirschberg DL, Nguyen LV, Karpuj MV, Cooper MT, Mitchell DJ, Fathman CG, Steinman L",Suppressive immunization with DNA encoding a self-peptide prevents autoimmune disease: modulation of T cell costimulation,"1999","162","6","3336-3341","Journal of immunology (Baltimore, Md. : 1950)","","","","","","","","10092787","","",0,10,0,0,0,,,
2307,235,"Tsunoda et al., 1998",journal,"Tsunoda I, Kuang LQ, Tolley ND, Whitton JL, Fujinami RS",Enhancement of experimental allergic encephalomyelitis (EAE) by DNA immunization with myelin proteolipid protein (PLP) plasmid DNA,"1998","57","8","758-767",Journal of neuropathology and experimental neurology,"","","","","","","","9720491","","",0,10,0,0,0,,,
2308,235,"Bourquin et al., 2000",journal,"Bourquin C, Iglesias A, Berger T, Wekerle H, Linington C",Myelin oligodendrocyte glycoprotein-DNA vaccination induces antibody-mediated autoaggression in experimental autoimmune encephalomyelitis,"2000","30","12","3663-3671",European journal of immunology,"","","","","","","","11169409","","",0,10,0,0,0,,,
2309,235,"Lobell et al., 2003",journal,"Lobell A, Weissert R, Eltayeb S, de Graaf KL, Wefer J, Storch MK, Lassmann H, Wigzell H, Olsson T",Suppressive DNA vaccination in myelin oligodendrocyte glycoprotein peptide-induced experimental autoimmune encephalomyelitis involves a T1-biased immune response,"2003","170","4","1806-1813","Journal of immunology (Baltimore, Md. : 1950)","","","","","","","","12574345","","",0,10,0,0,0,,,
2310,235,"Selmaj et al., 2000",journal,"Selmaj K, Kowal C, Walczak A, Nowicka J, Raine CS",Naked DNA vaccination differentially modulates autoimmune responses in experimental autoimmune encephalomyelitis,"2000","111","1-2","34-44",Journal of neuroimmunology,"","","","","","","","11063819","","",0,10,0,0,0,,,
2311,235,"Walczak et al., 2004",journal,"Walczak A, Szymanska B, Selmaj K",Differential prevention of experimental autoimmune encephalomyelitis with antigen-specific DNA vaccination,"2004","106","3","241-245",Clinical neurology and neurosurgery,"","","","","","","","15177776","","",0,10,0,0,0,,,
2312,235,"Lobell et al., 1999",journal,"Lobell A, Weissert R, Eltayeb S, Svanholm C, Olsson T, Wigzell H",Presence of CpG DNA and the local cytokine milieu determine the efficacy of suppressive DNA vaccination in experimental autoimmune encephalomyelitis,"1999","163","9","4754-4762","Journal of immunology (Baltimore, Md. : 1950)","","","","","","","","10528174","","",0,10,0,0,0,,,
2313,235,"Waisman et al., 1996",journal,"Waisman A, Ruiz PJ, Hirschberg DL, Gelman A, Oksenberg JR, Brocke S, Mor F, Cohen IR, Steinman L",Suppressive vaccination with DNA encoding a variable region gene of the T-cell receptor prevents autoimmune encephalomyelitis and activates Th2 immunity,"1996","2","8","899-905",Nature medicine,"","","","","","","","8705860","","",0,10,0,0,0,,,
2314,236,"Silver et al., 2007",journal,"Silver PB, Agarwal RK, Su SB, Suffia I, Grajewski RS, Luger D, Chan CC, Mahdi RM, Nickerson JM, Caspi RR",Hydrodynamic vaccination with DNA encoding an immunologically privileged retinal antigen protects from autoimmunity through induction of regulatory T cells,"2007","179","8","5146-5158","Journal of immunology (Baltimore, Md. : 1950)","","","","","","","","17911600","","",0,10,0,0,0,,,
2315,240,"Ferrera et al., 2007",journal,"Ferrera F, Hahn BH, Rizzi M, Anderson M, Fitzgerald J, Millo E, Indiveri F, Shi FD, Filaci G, La Cava A",Protection against renal disease in (NZB x NZW)F(1) lupus-prone mice after somatic B cell gene vaccination with anti-DNA immunoglobulin consensus peptide,"2007","56","6","1945-1953",Arthritis and rheumatism,"","","","","","","","17530718","",,0,0,0,0,0,,,
2316,237,"Filippova et al., 2001",journal,"Filippova M, Liu J, Escher A",Effects of plasmid DNA injection on cyclophosphamide-accelerated diabetes in NOD mice,"2001","20","3","175-181",DNA and cell biology,"","","","","","","","11313020","","",0,10,0,0,0,,,
2317,237,"Balasa et al., 2001",journal,"Balasa B, Boehm BO, Fortnagel A, Karges W, Van Gunst K, Jung N, Camacho SA, Webb SR, Sarvetnick N",Vaccination with glutamic acid decarboxylase plasmid DNA protects mice from spontaneous autoimmune diabetes and B7/CD28 costimulation circumvents that protection,"2001","99","2","241-252","Clinical immunology (Orlando, Fla.)","","","","","","","","11318596","","",0,10,0,0,0,,,
2318,237,"Urbanek-Ruiz et al., 2001",journal,"Urbanek-Ruiz I, Ruiz PJ, Paragas V, Garren H, Steinman L, Fathman CG",Immunization with DNA encoding an immunodominant peptide of insulin prevents diabetes in NOD mice,"2001","100","2","164-171","Clinical immunology (Orlando, Fla.)","","","","","","","","11465945","","",0,10,0,0,0,,,
2319,237,"Solvason et al., 2008",journal,"Solvason N, Lou YP, Peters W, Evans E, Martinez J, Ramirez U, Ocampo A, Yun R, Ahmad S, Liu E, Yu L, Eisenbarth G, Leviten M, Steinman L, Garren H",Improved efficacy of a tolerizing DNA vaccine for reversal of hyperglycemia through enhancement of gene expression and localization to intracellular sites,"2008","181","12","8298-8307","Journal of immunology (Baltimore, Md. : 1950)","","","","","","","","19050246","","",0,10,0,0,0,,,
2320,237,"Li et al., 2004",journal,"Li AF, Hough J, Henderson D, Escher A",Co-delivery of pro-apoptotic BAX with a DNA vaccine recruits dendritic cells and promotes efficacy of autoimmune diabetes prevention in mice,"2004","22","13-14","1751-1763",Vaccine,"","","","","","","","15068859","","",0,10,0,0,0,,,
2321,237,"Tisch et al., 2001",journal,"Tisch R, Wang B, Weaver DJ, Liu B, Bui T, Arthos J, Serreze DV",Antigen-specific mediated suppression of beta cell autoimmunity by plasmid DNA vaccination,"2001","166","3","2122-2132","Journal of immunology (Baltimore, Md. : 1950)","","","","","","","","11160264","","",0,10,0,0,0,,,
2322,237,"Bot et al., 2001",journal,"Bot A, Smith D, Bot S, Hughes A, Wolfe T, Wang L, Woods C, von Herrath M",Plasmid vaccination with insulin B chain prevents autoimmune diabetes in nonobese diabetic mice,"2001","167","5","2950-2955","Journal of immunology (Baltimore, Md. : 1950)","","","","","","","","11509644","","",0,10,0,0,0,,,
2323,237,"Wolfe et al., 2002",journal,"Wolfe T, Bot A, Hughes A, Mhrle U, Rodrigo E, Jaume JC, Baekkeskov S, von Herrath M",Endogenous expression levels of autoantigens influence success or failure of DNA immunizations to prevent type 1 diabetes: addition of IL-4 increases safety,"2002","32","1","113-121",European journal of immunology,"","","","","","","","11754351","","",0,10,0,0,0,,,
2324,238,"Quintana et al., 2002",journal,"Quintana FJ, Carmi P, Mor F, Cohen IR",Inhibition of adjuvant arthritis by a DNA vaccine encoding human heat shock protein 60,"2002","169","6","3422-3428","Journal of immunology (Baltimore, Md. : 1950)","","","","","","","","12218165","","",0,10,0,0,0,,,
2325,238,"Ragno et al., 1997",journal,"Ragno S, Colston MJ, Lowrie DB, Winrow VR, Blake DR, Tascon R",Protection of rats from adjuvant arthritis by immunization with naked DNA encoding for mycobacterial heat shock protein 65,"1997","40","2","277-283",Arthritis and rheumatism,"","","","","","","","9041939","","",0,10,0,0,0,,,
2326,238,"Santos-Junior et al., 2005",journal,"Santos-Junior RR, Sartori A, De Franco M, Filho OG, Coelho-Castelo AA, Bonato VL, Cabrera WH, Ibaez OM, Silva CL",Immunomodulation and protection induced by DNA-hsp65 vaccination in an animal model of arthritis,"2005","16","11","1338-1345",Human gene therapy,"","","","","","","","16259568","","",0,10,0,0,0,,,
2327,238,"Ho et al., 2006",journal,"Ho PP, Higgins JP, Kidd BA, Tomooka B, Digennaro C, Lee LY, de Vegvar HE, Steinman L, Robinson WH",Tolerizing DNA vaccines for autoimmune arthritis,"2006","39","8","675-682",Autoimmunity,"","","","","","","","17178564","","",0,10,0,0,0,,,
2328,238,"Song et al., 2009",journal,"Song X, Liang F, Liu N, Luo Y, Xue H, Yuan F, Tan L, Sun Y, Xi C, Xi Y",Construction and characterization of a novel DNA vaccine that is potent antigen-specific tolerizing therapy for experimental arthritis by increasing CD4+CD25+Treg cells and inducing Th1 to Th2 shift in both cells and cytokines,"2009","27","5","690-700",Vaccine,"","","","","","","","19095031","","",0,10,0,0,0,,,
2329,100,"Hariharan et al., 1998",journal,"Hariharan MJ, Driver DA, Townsend K, Brumm D, Polo JM, Belli BA, Catton DJ, Hsu D, Mittelstaedt D, McCormack JE, Karavodin L, Dubensky TW Jr, Chang SM, Banks TA",DNA immunization against herpes simplex virus: enhanced efficacy using a Sindbis virus-based vector,"1998","72","2","950-958",Journal of virology,"","","","","","","","9444987","","",0,10,0,0,0,,,
2330,135,"Weiss et al., 1999",journal,"Weiss R, Drnberger J, Mostbck S, Scheiblhofer S, Hartl A, Breitenbach M, Strasser P, Dorner F, Livey I, Crowe B, Thalhamer J",Improvement of the immune response against plasmid DNA encoding OspC of Borrelia by an ER-targeting leader sequence,"1999","18","9-10","815-824",Vaccine,"","","","","","","","10580194","",,0,0,0,0,0,,,
2331,129,"Sheets et al., 2006",journal,"Sheets RL, Stein J, Manetz TS, Duffy C, Nason M, Andrews C, Kong WP, Nabel GJ, Gomez PL","Biodistribution of DNA plasmid vaccines against HIV-1, Ebola, Severe Acute Respiratory Syndrome, or West Nile virus is similar, without integration, despite differing plasmid backbones or gene inserts","2006","91","2","610-619",Toxicological sciences : an official journal of the Society of Toxicology,"","","","","","","","16569729","","",0,10,0,0,0,,,
2332,51,"Sheets et al., 2006",journal,"Sheets RL, Stein J, Manetz TS, Duffy C, Nason M, Andrews C, Kong WP, Nabel GJ, Gomez PL","Biodistribution of DNA plasmid vaccines against HIV-1, Ebola, Severe Acute Respiratory Syndrome, or West Nile virus is similar, without integration, despite differing plasmid backbones or gene inserts","2006","91","2","610-619",Toxicological sciences : an official journal of the Society of Toxicology,"","","","","","","","16569729","","",0,10,0,0,0,,,
2333,41,"Anderson et al., 1997",journal,"Anderson R, Gao XM, Papakonstantinopoulou A, Fairweather N, Roberts M, Dougan G",Immunization of mice with DNA encoding fragment C of tetanus toxin,"1997","15","8","827-829",Vaccine,"","","","","","","","9234525","","",0,10,0,0,0,,,
2334,57,"McClenahan et al., 2011",journal,"McClenahan SD, Krause PR, Uhlenhaut C",Molecular and infectivity studies of porcine circovirus in vaccines,"2011","29","29-30","4745-4753",Vaccine,"","","","","","","","21569811","","",0,10,0,0,0,,,
2335,7,"Chitlaru et al., 2007",journal,"Chitlaru T, Gat O, Grosfeld H, Inbar I, Gozlan Y, Shafferman A",Identification of in vivo-expressed immunogenic proteins by serological proteome analysis of the Bacillus anthracis secretome,"2007","75","6","2841-2852",Infection and immunity,"","","","","","","","17353282","","",0,10,0,0,0,,,
2336,87,"Lillehoj et al., 2005",journal,"Lillehoj HS, Ding X, Quiroz MA, Bevensee E, Lillehoj EP","Resistance to intestinal coccidiosis following DNA immunization with the cloned 3-1E Eimeria gene plus IL-2, IL-15, and IFN-gamma","2005","49","1","112-117",Avian diseases,"","","","","","","","15839423","","",0,10,0,0,0,,,
2337,239,"Yasuike et al., 2007",journal,"Yasuike M, Kondo H, Hirono I, Aoki T","Difference in Japanese flounder, Paralichthys olivaceus gene expression profile following hirame rhabdovirus (HIRRV) G and N protein DNA vaccination","2007","23","3","531-541",Fish & shellfish immunology,"","","","","","","","17449275","","",0,10,0,0,0,,,
2338,75,"Corbeil et al., 1999",journal,"Corbeil S, Lapatra SE, Anderson ED, Jones J, Vincent B, Hsu YL, Kurath G","Evaluation of the protective immunogenicity of the N, P, M, NV and G proteins of infectious hematopoietic necrosis virus in rainbow trout oncorhynchus mykiss using DNA vaccines","1999","39","1","29-36",Diseases of aquatic organisms,"","","","","","","","11407402","","",0,10,0,0,0,,,
2339,99,"Buchan et al., 2005",journal,"Buchan S, Grnevik E, Mathiesen I, King CA, Stevenson FK, Rice J","Electroporation as a ""prime/boost"" strategy for naked DNA vaccination against a tumor antigen","2005","174","10","6292-6298","Journal of immunology (Baltimore, Md. : 1950)","","","","","","","","15879128","","",0,10,0,0,0,,,
2340,99,"Lindencrona et al., 2004",journal,"Lindencrona JA, Preiss S, Kammertoens T, Schler T, Piechocki M, Wei WZ, Seliger B, Blankenstein T, Kiessling R",CD4+ T cell-mediated HER-2/neu-specific tumor rejection in the absence of B cells,"2004","109","2","259-264",International journal of cancer. Journal international du cancer,"","","","","","","","14750178","","",0,10,0,0,0,,,
2341,99,"Timmerman et al., 2002",journal,"Timmerman JM, Singh G, Hermanson G, Hobart P, Czerwinski DK, Taidi B, Rajapaksa R, Caspar CB, Van Beckhoven A, Levy R",Immunogenicity of a plasmid DNA vaccine encoding chimeric idiotype in patients with B-cell lymphoma,"2002","62","20","5845-5852",Cancer research,"","","","","","","","12384547","","",0,10,0,0,0,,,
2342,99,"Conry et al., 2002",journal,"Conry RM, Curiel DT, Strong TV, Moore SE, Allen KO, Barlow DL, Shaw DR, LoBuglio AF",Safety and immunogenicity of a DNA vaccine encoding carcinoembryonic antigen and hepatitis B surface antigen in colorectal carcinoma patients,"2002","8","9","2782-2787",Clinical cancer research : an official journal of the American Association for Cancer Research,"","","","","","","","12231517","","",0,10,0,0,0,,,
2343,99,"Leitner et al., 2003",journal,"Leitner WW, Hwang LN, deVeer MJ, Zhou A, Silverman RH, Williams BR, Dubensky TW, Ying H, Restifo NP",Alphavirus-based DNA vaccine breaks immunological tolerance by activating innate antiviral pathways,"2003","9","1","33-39",Nature medicine,"","","","","","","","12496961","","",0,10,0,0,0,,,
2344,99,"Pavlenko et al., 2004",journal,"Pavlenko M, Roos AK, Lundqvist A, Palmborg A, Miller AM, Ozenci V, Bergman B, Egevad L, Hellstrm M, Kiessling R, Masucci G, Wersll P, Nilsson S, Pisa P",A phase I trial of DNA vaccination with a plasmid expressing prostate-specific antigen in patients with hormone-refractory prostate cancer,"2004","91","4","688-694",British journal of cancer,"","","","","","","","15280930","","",0,10,0,0,0,,,
2346,99,"Rice et al., 2004",journal,"Rice J, Buchan S, Dewchand H, Simpson E, Stevenson FK",DNA fusion vaccines induce targeted epitope-specific CTLs against minor histocompatibility antigens from a normal or tolerized repertoire,"2004","173","7","4492-4499","Journal of immunology (Baltimore, Md. : 1950)","","","","","","","","15383580","","",0,10,0,0,0,,,
2347,99,"Stevenson et al., 2004",journal,"Stevenson FK, Ottensmeier CH, Johnson P, Zhu D, Buchan SL, McCann KJ, Roddick JS, King AT, McNicholl F, Savelyeva N, Rice J",DNA vaccines to attack cancer,"2004","101 Suppl 2","","14646-14652",Proceedings of the National Academy of Sciences of the United States of America,"","","","","","","","15292504","","",0,10,0,0,0,,,
2348,99,"Liao et al., 2006",journal,"Liao JC, Gregor P, Wolchok JD, Orlandi F, Craft D, Leung C, Houghton AN, Bergman PJ",Vaccination with human tyrosinase DNA induces antibody responses in dogs with advanced melanoma,"2006","6","","8",Cancer immunity,"","","","","","","","16626110","","",0,10,0,0,0,,,
2349,99,"Bergman et al., 2003",journal,"Bergman PJ, McKnight J, Novosad A, Charney S, Farrelly J, Craft D, Wulderk M, Jeffers Y, Sadelain M, Hohenhaus AE, Segal N, Gregor P, Engelhorn M, Riviere I, Houghton AN, Wolchok JD",Long-term survival of dogs with advanced malignant melanoma after DNA vaccination with xenogeneic human tyrosinase: a phase I trial,"2003","9","4","1284-1290",Clinical cancer research : an official journal of the American Association for Cancer Research,"","","","","","","","12684396","","",0,10,0,0,0,,,
2350,99,"Chudley et al., 2012",journal,"Chudley L, McCann K, Mander A, Tjelle T, Campos-Perez J, Godeseth R, Creak A, Dobbyn J, Johnson B, Bass P, Heath C, Kerr P, Mathiesen I, Dearnaley D, Stevenson F, Ottensmeier C",DNA fusion-gene vaccination in patients with prostate cancer induces high-frequency CD8(+) T-cell responses and increases PSA doubling time,"2012","","","","Cancer immunology, immunotherapy : CII","","","","","","","","22729556","","",0,10,0,0,0,,,
2351,99,"Zhang et al., 2012",journal,"Zhang H, Wang Y, Liu C, Zhang L, Xia Q, Zhang Y, Wu J, Jiang C, Chen Y, Wu Y, Zha X, Yu X, Kong W",DNA and adenovirus tumor vaccine expressing truncated survivin generates specific immune responses and anti-tumor effects in a murine melanoma model,"2012","","","","Cancer immunology, immunotherapy : CII","","","","","","","","22706381","","",0,10,0,0,0,,,
2352,99,"Eschenburg et al., 2010",journal,"Eschenburg G, Stermann A, Preissner R, Meyer HA, Lode HN",DNA vaccination: using the patient's immune system to overcome cancer,"2010","2010","","169484",Clinical & developmental immunology,"","","","","","","","21197271","","",0,10,0,0,0,,,
2353,99,"Weber et al., 2008",journal,"Weber J, Boswell W, Smith J, Hersh E, Snively J, Diaz M, Miles S, Liu X, Obrocea M, Qiu Z, Bot A",Phase 1 trial of intranodal injection of a Melan-A/MART-1 DNA plasmid vaccine in patients with stage IV melanoma,"2008","31","2","215-223","Journal of immunotherapy (Hagerstown, Md. : 1997)","","","","","","","","18481391","","",0,10,0,0,0,,,
2354,99,"Meyer et al., 2005",journal,"Meyer RG, Britten CM, Siepmann U, Petzold B, Sagban TA, Lehr HA, Weigle B, Schmitz M, Mateo L, Schmidt B, Bernhard H, Jakob T, Hein R, Schuler G, Schuler-Thurner B, Wagner SN, Drexler I, Sutter G, Arndtz N, Chaplin P, Metz J, Enk A, Huber C, Wlfel T",A phase I vaccination study with tyrosinase in patients with stage II melanoma using recombinant modified vaccinia virus Ankara (MVA-hTyr),"2005","54","5","453-467","Cancer immunology, immunotherapy : CII","","","","","","","","15627214","","",0,10,0,0,0,,,
2355,99,"Fang et al., 2009",journal,"Fang J, Lu Y, Ouyang K, Wu G, Zhang H, Liu Y, Chen Y, Lin M, Wang H, Jin L, Cao R, Roque RS, Zong L, Liu J, Li T",Specific antibodies elicited by a novel DNA vaccine targeting gastrin-releasing peptide inhibit murine melanoma growth in vivo,"2009","16","7","1033-1039",Clinical and vaccine immunology : CVI,"","","","","","","","19458203","","",0,10,0,0,0,,,
2356,99,"Sun et al., 2002",journal,"Sun X, Hodge LM, Jones HP, Tabor L, Simecka JW",Co-expression of granulocyte-macrophage colony-stimulating factor with antigen enhances humoral and tumor immunity after DNA vaccination,"2002","20","9-10","1466-1474",Vaccine,"","","","","","","","11818167","","",0,10,0,0,0,,,
2357,99,"Leslie et al., 2007",journal,"Leslie MC, Zhao YJ, Lachman LB, Hwu P, Wu GJ, Bar-Eli M","Immunization against MUC18/MCAM, a novel antigen that drives melanoma invasion and metastasis","2007","14","4","316-323",Gene therapy,"","","","","","","","17024104","","",0,10,0,0,0,,,
2358,99,"Wang et al., 2008",journal,"Wang YJ, Hou Y, Huang H, Liu GR, White AP, Liu SL",Two oral HBx vaccines delivered by live attenuated Salmonella: both eliciting effective anti-tumor immunity,"2008","263","1","67-76",Cancer letters,"","","","","","","","18226855","","",0,10,0,0,0,,,
2359,99,"Kamata et al., 2002",journal,"Kamata M, Denda-Nagai K, Kubota N, Aida S, Takeda K, Irimura T",Vaccination of mice with MUC1 cDNA suppresses the development of lung metastases,"2002","19","8","689-696",Clinical & experimental metastasis,"","","","","","","","12553374","","",0,10,0,0,0,,,
2360,99,"Rakhmilevich et al., 2001",journal,"Rakhmilevich AL, Imboden M, Hao Z, Macklin MD, Roberts T, Wright KM, Albertini MR, Yang NS, Sondel PM",Effective particle-mediated vaccination against mouse melanoma by coadministration of plasmid DNA encoding Gp100 and granulocyte-macrophage colony-stimulating factor,"2001","7","4","952-961",Clinical cancer research : an official journal of the American Association for Cancer Research,"","","","","","","","11309346","","",0,10,0,0,0,,,
2361,99,"Cochlovius et al., 2002",journal,"Cochlovius B, Stassar MJ, Schreurs MW, Benner A, Adema GJ",Oral DNA vaccination: antigen uptake and presentation by dendritic cells elicits protective immunity,"2002","80","2","89-96",Immunology letters,"","","","","","","","11750039","","",0,10,0,0,0,,,
2362,99,"Wagner et al., 2000",journal,"Wagner SN, Wagner C, Lhrs P, Weimann TK, Kutil R, Goos M, Stingl G, Schneeberger A",Intracutaneous genetic immunization with autologous melanoma-associated antigen Pmel17/gp100 induces T cell-mediated tumor protection in vivo,"2000","115","6","1082-1087",The Journal of investigative dermatology,"","","","","","","","11121145","","",0,10,0,0,0,,,
2363,99,"Weber et al., 1998",journal,"Weber LW, Bowne WB, Wolchok JD, Srinivasan R, Qin J, Moroi Y, Clynes R, Song P, Lewis JJ, Houghton AN",Tumor immunity and autoimmunity induced by immunization with homologous DNA,"1998","102","6","1258-1264",The Journal of clinical investigation,"","","","","","","","9739060","","",0,10,0,0,0,,,
2364,99,"Overwijk et al., 1999",journal,"Overwijk WW, Lee DS, Surman DR, Irvine KR, Touloukian CE, Chan CC, Carroll MW, Moss B, Rosenberg SA, Restifo NP","Vaccination with a recombinant vaccinia virus encoding a ""self"" antigen induces autoimmune vitiligo and tumor cell destruction in mice: requirement for CD4(+) T lymphocytes","1999","96","6","2982-2987",Proceedings of the National Academy of Sciences of the United States of America,"","","","","","","","10077623","","",0,10,0,0,0,,,
2365,99,"Hawkins et al., 2002",journal,"Hawkins WG, Gold JS, Blachere NE, Bowne WB, Hoos A, Lewis JJ, Houghton AN",Xenogeneic DNA immunization in melanoma models for minimal residual disease,"2002","102","2","137-143",The Journal of surgical research,"","","","","","","","11796010","","",0,10,0,0,0,,,
2366,99,"Zhang et al., 2005",journal,"Zhang M, Obata C, Hisaeda H, Ishii K, Murata S, Chiba T, Tanaka K, Li Y, Furue M, Chou B, Imai T, Duan X, Himeno K",A novel DNA vaccine based on ubiquitin-proteasome pathway targeting 'self'-antigens expressed in melanoma/melanocyte,"2005","12","13","1049-1057",Gene therapy,"","","","","","","","15800663","","",0,10,0,0,0,,,
2367,99,"Carpentier et al., 1998",journal,"Carpentier AF, Rosenfeld MR, Delattre JY, Whalen RG, Posner JB, Dalmau J",DNA vaccination with HuD inhibits growth of a neuroblastoma in mice,"1998","4","11","2819-2824",Clinical cancer research : an official journal of the American Association for Cancer Research,"","","","","","","","9829748","","",0,10,0,0,0,,,
2368,99,"Lode et al., 2000",journal,"Lode HN, Pertl U, Xiang R, Gaedicke G, Reisfeld RA",Tyrosine hydroxylase-based DNA-vaccination is effective against murine neuroblastoma,"2000","35","6","641-646",Medical and pediatric oncology,"","","","","","","","11107137","","",0,10,0,0,0,,,
2369,99,"Huebener et al., 2008",journal,"Huebener N, Fest S, Strandsby A, Michalsky E, Preissner R, Zeng Y, Gaedicke G, Lode HN",A rationally designed tyrosine hydroxylase DNA vaccine induces specific antineuroblastoma immunity,"2008","7","7","2241-2251",Molecular cancer therapeutics,"","","","","","","","18645033","","",0,10,0,0,0,,,
2370,99,"Pertl et al., 2003",journal,"Pertl U, Wodrich H, Ruehlmann JM, Gillies SD, Lode HN, Reisfeld RA",Immunotherapy with a posttranscriptionally modified DNA vaccine induces complete protection against metastatic neuroblastoma,"2003","101","2","649-654",Blood,"","","","","","","","12393580","","",0,10,0,0,0,,,
2371,99,"Mincheff et al., 2006",journal,"Mincheff M, Zoubak S, Makogonenko Y",Immune responses against PSMA after gene-based vaccination for immunotherapy-A: results from immunizations in animals,"2006","13","4","436-444",Cancer gene therapy,"","","","","","","","16276349","","",0,10,0,0,0,,,
2372,99,"Roos et al., 2005",journal,"Roos AK, Pavlenko M, Charo J, Egevad L, Pisa P",Induction of PSA-specific CTLs and anti-tumor immunity by a genetic prostate cancer vaccine,"2005","62","3","217-223",The Prostate,"","","","","","","","15389792","","",0,10,0,0,0,,,
2373,99,"Qin et al., 2005",journal,"Qin H, Zhou C, Wang D, Ma W, Liang X, Lin C, Zhang Y, Zhang S",Specific antitumor immune response induced by a novel DNA vaccine composed of multiple CTL and T helper cell epitopes of prostate cancer associated antigens,"2005","99","1","85-93",Immunology letters,"","","","","","","","15894116","","",0,10,0,0,0,,,
2374,99,"Johnson et al., 2006",journal,"Johnson LE, Frye TP, Arnot AR, Marquette C, Couture LA, Gendron-Fitzpatrick A, McNeel DG",Safety and immunological efficacy of a prostate cancer plasmid DNA vaccine encoding prostatic acid phosphatase (PAP),"2006","24","3","293-303",Vaccine,"","","","","","","","16115700","","",0,10,0,0,0,,,
2375,99,"Zhang et al., 2007",journal,"Zhang X, Yu C, Zhao J, Fu L, Yi S, Liu S, Yu T, Chen W",Vaccination with a DNA vaccine based on human PSCA and HSP70 adjuvant enhances the antigen-specific CD8+ T-cell response and inhibits the PSCA+ tumors growth in mice,"2007","9","8","715-726",The journal of gene medicine,"","","","","","","","17595048","","",0,10,0,0,0,,,
2376,99,"Garcia-Hernandez et al., 2008",journal,"Garcia-Hernandez Mde L, Gray A, Hubby B, Klinger OJ, Kast WM",Prostate stem cell antigen vaccination induces a long-term protective immune response against prostate cancer in the absence of autoimmunity,"2008","68","3","861-869",Cancer research,"","","","","","","","18245488","","",0,10,0,0,0,,,
2377,99,"Ahmad et al., 2009",journal,"Ahmad S, Casey G, Sweeney P, Tangney M, O'Sullivan GC",Prostate stem cell antigen DNA vaccination breaks tolerance to self-antigen and inhibits prostate cancer growth,"2009","17","6","1101-1108",Molecular therapy : the journal of the American Society of Gene Therapy,"","","","","","","","19337234","","",0,10,0,0,0,,,
2378,99,"Kim et al., 2001",journal,"Kim JJ, Yang JS, Nottingham LK, Tang W, Dang K, Manson KH, Wyand MS, Wilson DM, Weiner DB",Induction of immune responses and safety profiles in rhesus macaques immunized with a DNA vaccine expressing human prostate specific antigen,"2001","20","33","4497-4506",Oncogene,"","","","","","","","11494145","","",0,10,0,0,0,,,
2379,99,"Kim et al., 2001",journal,"Kim JJ, Yang JS, Dang K, Manson KH, Weiner DB",Engineering enhancement of immune responses to DNA-based vaccines in a prostate cancer model in rhesus macaques through the use of cytokine gene adjuvants,"2001","7","3 Suppl","882s-889s",Clinical cancer research : an official journal of the American Association for Cancer Research,"","","","","","","","11300487","","",0,10,0,0,0,,,
2380,56,"Lodmell et al., 2000",journal,"Lodmell DL, Ray NB, Ulrich JT, Ewalt LC",DNA vaccination of mice against rabies virus: effects of the route of vaccination and the adjuvant monophosphoryl lipid A (MPL),"2000","18","11-12","1059-1066",Vaccine,"","","","","","","","10590326","","",0,10,0,0,0,,,
2381,99,"Tanaka et al., 2012",journal,"Tanaka K, Ishikawa S, Matsui Y, Kawanishi T, Tamesada M, Harashima N, Harada M",Combining a peptide vaccine with oral ingestion of Lentinula edodes mycelia extract enhances anti-tumor activity in B16 melanoma-bearing mice,"2012","","","","Cancer immunology, immunotherapy : CII","","","","","","","","22588648","","",0,10,0,0,0,,,
2382,99,"Sawada et al., 2012",journal,"Sawada Y, Yoshikawa T, Nobuoka D, Shirakawa H, Kuronuma T, Motomura Y, Mizuno S, Ishii H, Nakachi K, Konishi M, Nakagohri T, Takahashi S, Gotohda N, Takayama T, Yamao K, Uesaka K, Furuse J, Kinoshita T, Nakatsura T",Phase I Trial of a Glypican-3-Derived Peptide Vaccine for Advanced Hepatocellular Carcinoma: Immunologic Evidence and Potential for Improving Overall Survival,"2012","18","13","3686-3696",Clinical cancer research : an official journal of the American Association for Cancer Research,"","","","","","","","22577059","","",0,10,0,0,0,,,
2383,66,"Hammond et al., 2001",journal,"Hammond JM, Jansen ES, Morrissy CJ, Goff WV, Meehan GC, Williamson MM, Lenghaus C, Sproat KW, Andrew ME, Coupar BE, Johnson MA",A prime-boost vaccination strategy using naked DNA followed by recombinant porcine adenovirus protects pigs from classical swine fever,"2001","80","2","101-119",Veterinary microbiology,"","","","","","","","11295331","","",0,10,0,0,0,,,
2384,49,"Schirmbeck et al., 1995",journal,"Schirmbeck R, Bhm W, Ando K, Chisari FV, Reimann J",Nucleic acid vaccination primes hepatitis B virus surface antigen-specific cytotoxic T lymphocytes in nonresponder mice,"1995","69","10","5929-5934",Journal of virology,"","","","","","","","7666497","","",0,10,0,0,0,,,
2385,232,"He et al., 1997",journal,"He J, Hoffman SL, Hayes CG",DNA inoculation with a plasmid vector carrying the hepatitis E virus structural protein gene induces immune response in mice,"1997","15","4","357-362",Vaccine,"","","","","","","","9141205","","",0,10,0,0,0,,,
2386,99,"Garcia-Hernandez et al., 2007",journal,"Garcia-Hernandez Mde L, Gray A, Hubby B, Kast WM",In vivo effects of vaccination with six-transmembrane epithelial antigen of the prostate: a candidate antigen for treating prostate cancer,"2007","67","3","1344-1351",Cancer research,"","","","","","","","17283172","","",0,10,0,0,0,,,
2387,91,"Cong et al., 2008",journal,"Cong H, Gu QM, Yin HE, Wang JW, Zhao QL, Zhou HY, Li Y, Zhang JQ",Multi-epitope DNA vaccine linked to the A2/B subunit of cholera toxin protect mice against Toxoplasma gondii,"2008","26","31","3913-3921",Vaccine,"","","","","","","","18555564","","",0,10,0,0,0,,,
2388,91,"Ismael et al., 2009",journal,"Ismael AB, Hedhli D, Crde O, Lebrun M, Dimier-Poisson I, Mvlec MN","Further analysis of protection induced by the MIC3 DNA vaccine against T. gondii: CD4 and CD8 T cells are the major effectors of the MIC3 DNA vaccine-induced protection, both Lectin-like and EGF-like domains of MIC3 conferred protection","2009","27","22","2959-2966",Vaccine,"","","","","","","","19428907","","",0,10,0,0,0,,,
2389,91,"Scorza et al., 2003",journal,"Scorza T, D'Souza S, Laloup M, Dewit J, De Braekeleer J, Verschueren H, Vercammen M, Huygen K, Jongert E",A GRA1 DNA vaccine primes cytolytic CD8(+) T cells to control acute Toxoplasma gondii infection,"2003","71","1","309-316",Infection and immunity,"","","","","","","","12496180","","",0,10,0,0,0,,,
2390,91,"Kikumura et al., 2010",journal,"Kikumura A, Fang H, Mun HS, Uemura N, Makino M, Sayama Y, Norose K, Aosai F",Protective immunity against lethal anaphylactic reaction in Toxoplasma gondii-infected mice by DNA vaccination with T. gondii-derived heat shock protein 70 gene,"2010","59","2","105-111",Parasitology international,"","","","","","","","20346412","","",0,10,0,0,0,,,
2391,242,"Zhou et al., 2000",journal,"Zhou S, Liu S, Song G, Xu Y, Sun W",Protective immunity induced by the full-length cDNA encoding paramyosin of Chinese Schistosoma japonicum,"2000","18","27","3196-3204",Vaccine,"","","","","","","","10856799","","",0,10,0,0,0,,,
2392,242,"Wei et al., 2009",journal,"Wei F, Liu Q, Zhai Y, Fu Z, Liu W, Shang L, Men J, Gao S, Lian H, Jin H, Chen C, Lin J, Shi Y, Xia Z, Zhu XQ",IL-18 enhances protective effect in mice immunized with a Schistosoma japonicum FABP DNA vaccine,"2009","111","3","284-288",Acta tropica,"","","","","","","","19467215","","",0,10,0,0,0,,,
2393,242,"Da'dara et al., 2008",journal,"Da'dara AA, Li YS, Xiong T, Zhou J, Williams GM, McManus DP, Feng Z, Yu XL, Gray DJ, Harn DA",DNA-based vaccines protect against zoonotic schistosomiasis in water buffalo,"2008","26","29-30","3617-3625",Vaccine,"","","","","","","","18524429","","",0,10,0,0,0,,,
2394,242,"Gan et al., 2004",journal,"Gan Y, Shi YE, Bu LY, Zhu XH, Ning CX, Zhu HG",Immune responses against Schistosoma japonicum after vaccinating mice with a multivalent DNA vaccine encoding integrated membrane protein Sj23 and cytokine interleukin-12,"2004","117","12","1842-1846",Chinese medical journal,"","","","","","","","15603716","","",0,10,0,0,0,,,
2395,225,"Da'dara et al., 2001",journal,"Da'dara AA, Skelly PJ, Wang MM, Harn DA","Immunization with plasmid DNA encoding the integral membrane protein, Sm23, elicits a protective immune response against schistosome infection in mice","2001","20","3-4","359-369",Vaccine,"","","","","","","","11672898","","",0,10,0,0,0,,,
2396,225,"Shalaby et al., 2003",journal,"Shalaby KA, Yin L, Thakur A, Christen L, Niles EG, LoVerde PT","Protection against Schistosoma mansoni utilizing DNA vaccination with genes encoding Cu/Zn cytosolic superoxide dismutase, signal peptide-containing superoxide dismutase and glutathione peroxidase enzymes","2003","22","1","130-136",Vaccine,"","","","","","","","14604580","","",0,10,0,0,0,,,
2397,225,"Siddiqui et al., 2003",journal,"Siddiqui AA, Phillips T, Charest H, Podesta RB, Quinlin ML, Pinkston JR, Lloyd JD, Pompa J, Villalovos RM, Paz M",Enhancement of Sm-p80 (large subunit of calpain) induced protective immunity against Schistosoma mansoni through co-delivery of interleukin-2 and interleukin-12 in a DNA vaccine formulation,"2003","21","21-22","2882-2889",Vaccine,"","","","","","","","12798631","","",0,10,0,0,0,,,
2398,67,"Babiuk et al., 1987",journal,"Babiuk LA, L'Italien J, van Drunen Littel-van den Hurk S, Zamb T, Lawman JP, Hughes G, Gifford GA",Protection of cattle from bovine herpesvirus type I (BHV-1) infection by immunization with individual viral glycoproteins,"1987","159","1","57-66",Virology,"","","","","","","","3037783","","",0,10,0,0,0,,,
2399,54,"Chu et al., 2011",website,"Christina Chu, Robert Parker, John Sunyecz, Javier Morales",Phase I of Human Papillomavirus (HPV) DNA Plasmid (VGX-3100) + Electroporation for CIN 2 or 3,"2011","","","","","","","","","","","","",http://www.clinicaltrials.gov/ct2/show/NCT00685412?term=vgx&rank=1,"",0,10,0,0,0,,,
2400,230,"Heppel et al., 1997",journal,"JOL HEPPELL, NIELS LORENZEN, NEIL K. ARMSTRONG, TONG WU, ELLEN LORENZEN, KATJA EINER-JENSEN, JOACHIM SCHORR, HEATHER L. DAVIS","Development of DNA vaccines for fish: vector design, intramuscular injection and antigen expression using viral haemorrhagic septicaemia virus genes as model","1997","8","4","271-286",Fish & Shellfish Immunology,"","","","","","","","","","",0,10,0,0,0,,,
2401,99,"Manley et al., 2011",journal,"Manley CA, Leibman NF, Wolchok JD, Rivire IC, Bartido S, Craft DM, Bergman PJ",Xenogeneic murine tyrosinase DNA vaccine for malignant melanoma of the digit of dogs,"2011","25","1","94-99",Journal of veterinary internal medicine / American College of Veterinary Internal Medicine,"","","","","","","","21143299","","",0,10,0,0,0,,,
2402,126,"Ramanathan et al., 2009",journal,"Ramanathan MP, Kuo YC, Selling BH, Li Q, Sardesai NY, Kim JJ, Weiner DB",Development of a novel DNA SynCon tetravalent dengue vaccine that elicits immune responses against four serotypes,"2009","27","46","6444-6453",Vaccine,"","","","","","","","19580892","","",0,10,0,0,0,,,
2403,126,"Raviprakash et al., 2006",journal,"Raviprakash K, Apt D, Brinkman A, Skinner C, Yang S, Dawes G, Ewing D, Wu SJ, Bass S, Punnonen J, Porter K",A chimeric tetravalent dengue DNA vaccine elicits neutralizing antibody to all four virus serotypes in rhesus macaques,"2006","353","1","166-173",Virology,"","","","","","","","16814355","","",0,10,0,0,0,,,
2404,126,"Konishi et al., 2006",journal,"Konishi E, Kosugi S, Imoto J",Dengue tetravalent DNA vaccine inducing neutralizing antibody and anamnestic responses to four serotypes in mice,"2006","24","12","2200-2207",Vaccine,"","","","","","","","16316713","","",0,10,0,0,0,,,
2405,126,"Konishi et al., 2003",journal,"Konishi E, Terazawa A, Fujii A",Evidence for antigen production in muscles by dengue and Japanese encephalitis DNA vaccines and a relation to their immunogenicity in mice,"2003","21","25-26","3713-3720",Vaccine,"","","","","","","","12922102","","",0,10,0,0,0,,,
2406,126,"Konishi et al., 2000",journal,"Konishi E, Yamaoka M, Kurane I, Mason PW",A DNA vaccine expressing dengue type 2 virus premembrane and envelope genes induces neutralizing antibody and memory B cells in mice,"2000","18","11-12","1133-1139",Vaccine,"","","","","","","","10590335","","",0,10,0,0,0,,,
2407,126,"Raviprakash et al., 2000",journal,"Raviprakash K, Porter KR, Kochel TJ, Ewing D, Simmons M, Phillips I, Murphy GS, Weiss WR, Hayes CG",Dengue virus type 1 DNA vaccine induces protective immune responses in rhesus macaques,"2000","81",Pt 7,"1659-1667",The Journal of general virology,"","","","","","","","10859370","","",0,10,0,0,0,,,
2408,126,"Azevedo et al., 2011",journal,"Azevedo AS, Yamamura AM, Freire MS, Trindade GF, Bonaldo M, Galler R, Alves AM",DNA vaccines against dengue virus type 2 based on truncate envelope protein or its domain III,"2011","6","7",e20528,PloS one,"","","","","","","","21779317","","",0,10,0,0,0,,,
2409,126,"Costa et al., 2006",journal,"Costa SM, Paes MV, Barreto DF, Pinho AT, Barth OM, Queiroz JL, Arma GR, Freire MS, Alves AM",Protection against dengue type 2 virus induced in mice immunized with a DNA plasmid encoding the non-structural 1 (NS1) gene fused to the tissue plasminogen activator signal sequence,"2006","24","2","195-205",Vaccine,"","","","","","","","16122850","","",0,10,0,0,0,,,
2410,126,"Raviprakash et al., 2001",journal,"Raviprakash K, Marques E, Ewing D, Lu Y, Phillips I, Porter KR, Kochel TJ, August TJ, Hayes CG, Murphy GS",Synergistic neutralizing antibody response to a dengue virus type 2 DNA vaccine by incorporation of lysosome-associated membrane protein sequences and use of plasmid expressing GM-CSF,"2001","290","1","74-82",Virology,"","","","","","","","11883007","","",0,10,0,0,0,,,
2411,126,"Porter et al., 1998",journal,"Porter KR, Kochel TJ, Wu SJ, Raviprakash K, Phillips I, Hayes CG",Protective efficacy of a dengue 2 DNA vaccine in mice and the effect of CpG immuno-stimulatory motifs on antibody responses,"1998","143","5","997-991003",Archives of virology,"","","","","","","","9645204","","",0,10,0,0,0,,,
2412,54,"Kim et al., 2008",journal,"Kim D, Gambhira R, Karanam B, Monie A, Hung CF, Roden R, Wu TC",Generation and characterization of a preventive and therapeutic HPV DNA vaccine,"2008","26","3","351-360",Vaccine,"","","","","","","","18096279","","",0,10,0,0,0,,,
2413,99,"Kaplan et al., 2006",journal,"Kaplan CD, Krger JA, Zhou H, Luo Y, Xiang R, Reisfeld RA","A novel DNA vaccine encoding PDGFRbeta suppresses growth and dissemination of murine colon, lung and breast carcinoma","2006","24","47-48","6994-7002",Vaccine,"","","","","","","","17050049","","",0,10,0,0,0,,,
2414,99,"Xiang et al., 2008",journal,"Xiang R, Luo Y, Niethammer AG, Reisfeld RA",Oral DNA vaccines target the tumor vasculature and microenvironment and suppress tumor growth and metastasis,"2008","222","","117-128",Immunological reviews,"","","","","","","","18363997","","",0,10,0,0,0,,,
2415,7,"Midha and Bhatnagar, 2009",journal,"Midha S, Bhatnagar R",Anthrax protective antigen administered by DNA vaccination to distinct subcellular locations potentiates humoral and cellular immune responses,"2009","39","1","159-177",European journal of immunology,"","","","","","","","19130551","","",0,10,0,0,0,,,
2416,7,"Tucker et al., 2003",journal,"Tucker SN, Lin K, Stevens S, Scollay R, Bennett MJ, Olson DC",Systemic and mucosal antibody responses following retroductal gene transfer to the salivary gland,"2003","8","3","392-399",Molecular therapy : the journal of the American Society of Gene Therapy,"","","","","","","","12946312","","",0,10,0,0,0,,,
2417,7,"Luxembourg et al., 2008",journal,"Luxembourg A, Hannaman D, Nolan E, Ellefsen B, Nakamura G, Chau L, Tellez O, Little S, Bernard R",Potentiation of an anthrax DNA vaccine with electroporation,"2008","26","40","5216-5222",Vaccine,"","","","","","","","18462850","","",0,10,0,0,0,,,
2418,7,"Ribeiro et al., 2007",journal,"Ribeiro S, Rijpkema SG, Durrani Z, Florence AT",PLGA-dendron nanoparticles enhance immunogenicity but not lethal antibody production of a DNA vaccine against anthrax in mice,"2007","331","2","228-232",International journal of pharmaceutics,"","","","","","","","17258876","","",0,10,0,0,0,,,
2419,7,"Vilalta et al., 2005",journal,"Vilalta A, Mahajan RK, Hartikka J, Leamy V, Martin T, Rusalov D, Bozoukova V, Lalor P, Hall K, Kaslow DC, Rolland A",II. Cationic lipid-formulated plasmid DNA-based Bacillus anthracis vaccine: evaluation of plasmid DNA persistence and integration potential,"2005","16","10","1151-1156",Human gene therapy,"","","","","","","","16218776","","",0,10,0,0,0,,,
2420,243,"Galmiche et al., 1999",journal,"Galmiche MC, Goenaga J, Wittek R, Rindisbacher L",Neutralizing and protective antibodies directed against vaccinia virus envelope antigens,"1999","254","1","71-80",Virology,"","","","","","","","9927575","","",0,10,0,0,0,,,
2421,243,"Hooper et al., 2000",journal,"Hooper JW, Custer DM, Schmaljohn CS, Schmaljohn AL",DNA vaccination with vaccinia virus L1R and A33R genes protects mice against a lethal poxvirus challenge,"2000","266","2","329-339",Virology,"","","","","","","","10639319","","",0,10,0,0,0,,,
2422,243,"Hooper et al., 2007",journal,"Hooper JW, Golden JW, Ferro AM, King AD",Smallpox DNA vaccine delivered by novel skin electroporation device protects mice against intranasal poxvirus challenge,"2007","25","10","1814-1823",Vaccine,"","","","","","","","17240007","","",0,10,0,0,0,,,
2423,243,"Sakhatskyy et al., 2006",journal,"Sakhatskyy P, Wang S, Chou TH, Lu S",Immunogenicity and protection efficacy of monovalent and polyvalent poxvirus vaccines that include the D8 antigen,"2006","355","2","164-174",Virology,"","","","","","","","16919703","","",0,10,0,0,0,,,
2424,243,"Otero et al., 2006",journal,"Otero M, Calarota SA, Dai A, De Groot AS, Boyer JD, Weiner DB",Efficacy of novel plasmid DNA encoding vaccinia antigens in improving current smallpox vaccination strategy,"2006","24","21","4461-4470",Vaccine,"","","","","","","","16137803","","",0,10,0,0,0,,,
2425,32,"Bennett et al., 1999",journal,"Bennett AM, Phillpotts RJ, Perkins SD, Jacobs SC, Williamson ED",Gene gun mediated vaccination is superior to manual delivery for immunisation with DNA vaccines expressing protective antigens from Yersinia pestis or Venezuelan Equine Encephalitis virus,"1999","18","7-8","588-596",Vaccine,"","","","","","","","10547416","","",0,10,0,0,0,,,
2426,32,"Riemenschneider et al., 2003",journal,"Riemenschneider J, Garrison A, Geisbert J, Jahrling P, Hevey M, Negley D, Schmaljohn A, Lee J, Hart MK, Vanderzanden L, Custer D, Bray M, Ruff A, Ivins B, Bassett A, Rossi C, Schmaljohn C","Comparison of individual and combination DNA vaccines for B. anthracis, Ebola virus, Marburg virus and Venezuelan equine encephalitis virus","2003","21","25-26","4071-4080",Vaccine,"","","","","","","","12922144","","",0,10,0,0,0,,,
2427,32,"Perkins et al., 2006",journal,"Perkins SD, O'Brien LM, Phillpotts RJ",Boosting with an adenovirus-based vaccine improves protective efficacy against Venezuelan equine encephalitis virus following DNA vaccination,"2006","24","17","3440-3445",Vaccine,"","","","","","","","16527377","","",0,10,0,0,0,,,
2428,244,"Zanin et al., 2007",journal,"Zanin MP, Webster DE, Wesselingh SL","A DNA prime, orally delivered protein boost vaccination strategy against viral encephalitis","2007","13","3","284-289",Journal of neurovirology,"","","","","","","","17613719","",,0,0,0,0,0,,,
2429,71,"Hanlon et al., 2001",journal,"Hanlon L, Argyle D, Bain D, Nicolson L, Dunham S, Golder MC, McDonald M, McGillivray C, Jarrett O, Neil JC, Onions DE",Feline leukemia virus DNA vaccine efficacy is enhanced by coadministration with interleukin-12 (IL-12) and IL-18 expression vectors,"2001","75","18","8424-8433",Journal of virology,"","","","","","","","11507187","","",0,10,0,0,0,,,
2430,31,FDA: MenHibrix,website,"",FDA: MenHibrix Package insert,"","","","","","","","","","","","","",http://www.fda.gov/BiologicsBloodVaccines/Vaccines/ApprovedProducts/ucm308566.htm,"",0,10,0,0,0,,,
2431,46,FDA: MenHibrix,website,"",FDA: MenHibrix Package insert,"","","","","","","","","","","","","",http://www.fda.gov/BiologicsBloodVaccines/Vaccines/ApprovedProducts/ucm308566.htm,"",0,10,0,0,0,,,
2432,245,"Mikalsen et al., 2004",journal,"Mikalsen AB, Torgersen J, Alestrm P, Hellemann AL, Koppang EO, Rimstad E",Protection of atlantic salmon Salmo salar against infectious pancreatic necrosis after DNA vaccination,"2004","60","1","11-20",Diseases of aquatic organisms,"","","","","","","","15352520","","",0,10,0,0,0,,,
2433,230,"Lorenzen et al., 2002",journal,"Lorenzen N, Lorenzen E, Einer-Jensen K, LaPatra SE",Immunity induced shortly after DNA vaccination of rainbow trout against rhabdoviruses protects against heterologous virus but not against bacterial pathogens,"2002","26","2","173-179",Developmental and comparative immunology,"","","","","","","","11696382","","",0,10,0,0,0,,,
2434,75,"Lorenzen et al., 2002",journal,"Lorenzen N, Lorenzen E, Einer-Jensen K, LaPatra SE",Immunity induced shortly after DNA vaccination of rainbow trout against rhabdoviruses protects against heterologous virus but not against bacterial pathogens,"2002","26","2","173-179",Developmental and comparative immunology,"","","","","","","","11696382","","",0,10,0,0,0,,,
2435,246,"Pasnik and Smith, 2005",journal,"Pasnik DJ, Smith SA",Immunogenic and protective effects of a DNA vaccine for Mycobacterium marinum in fish,"2005","103","3-4","195-206",Veterinary immunology and immunopathology,"","","","","","","","15621306","","",0,10,0,0,0,,,
2436,50,"Laddy et al., 2008",journal,"Laddy DJ, Yan J, Kutzler M, Kobasa D, Kobinger GP, Khan AS, Greenhouse J, Sardesai NY, Draghia-Akli R, Weiner DB",Heterosubtypic protection against pathogenic human and avian influenza viruses via in vivo electroporation of synthetic consensus DNA antigens,"2008","3","6",e2517,PloS one,"","","","","","","","18575608","","",0,10,0,0,0,,,
2437,50,"Kodihalli et al., 2000",journal,"Kodihalli S, Kobasa DL, Webster RG",Strategies for inducing protection against avian influenza A virus subtypes with DNA vaccines,"2000","18","23","2592-2599",Vaccine,"","","","","","","","10775793","","",0,10,0,0,0,,,
2438,50,"Le et al., 2007",journal,"Le Gall-Recul G, Cherbonnel M, Pelotte N, Blanchard P, Morin Y, Jestin V",Importance of a prime-boost DNA/protein vaccination to protect chickens against low-pathogenic H7 avian influenza infection,"2007","51","1 Suppl","490-494",Avian diseases,"","","","","","","","17494616","","",0,10,0,0,0,,,
2439,183,"Hou et al., 2008",journal,"Hou YH, Chen J, Tong GZ, Tian ZJ, Zhou YJ, Li GX, Li X, Peng JM, An TQ, Yang HC",A recombinant plasmid co-expressing swine ubiquitin and the GP5 encoding-gene of porcine reproductive and respiratory syndrome virus induces protective immunity in piglets,"2008","26","11","1438-1449",Vaccine,"","","","","","","","18262692","","",0,10,0,0,0,,,
2440,183,"Xue et al., 2004",journal,"Xue Q, Zhao YG, Zhou YJ, Qiu HJ, Wang YF, Wu DL, Tian ZJ, Tong GZ","Immune responses of swine following DNA immunization with plasmids encoding porcine reproductive and respiratory syndrome virus ORFs 5 and 7, and porcine IL-2 and IFNgamma","2004","102","3","291-298",Veterinary immunology and immunopathology,"","","","","","","","15507312","","",0,10,0,0,0,,,
2441,183,"Jiang et al., 2006",journal,"Jiang Y, Xiao S, Fang L, Yu X, Song Y, Niu C, Chen H",DNA vaccines co-expressing GP5 and M proteins of porcine reproductive and respiratory syndrome virus (PRRSV) display enhanced immunogenicity,"2006","24","15","2869-2879",Vaccine,"","","","","","","","16446016","","",0,10,0,0,0,,,
2442,26,"Parker, 2007",website,Scott Parker,"Safety and Effectiveness of PENNVAX-B Vaccine Alone, With Il-12, or IL-15 in Healthy Adults","2007","","","","","","","","","","","","",http://clinicaltrials.gov/ct2/show/NCT00528489,"",0,10,0,0,0,,,
2443,26,"Hammer et al., 2009",website,"Scott Hammer, Magdalena Sobieszczyk, Michael Yin","Safety and Effectiveness of HIV-1 DNA Plasmid Vaccine and HIV-1 Recombinant Adenoviral Vector Vaccine in HIV-Uninfected, Circumcised Men and Male-to-Female (MTF) Transgender Persons Who Have Sex With Men","2009","","","","","","","","","","","","",http://www.clinicaltrials.gov/ct2/show/NCT00865566?term=Ad5+DNA&rank=3,"",0,10,0,0,0,,,
2444,0,Stanford 1997,website,"",VectorDB,"1997","","","","","","","","","","","","",http://genome-www.stanford.edu/vectordb/vector_descrip/PBACPAK9.html,"",0,10,0,4,0,,,
2445,0,"Pontarollo et al., 2002",journal,"Pontarollo RA, Babiuk LA, Hecker R, Van Drunen Littel-Van Den Hurk S",Augmentation of cellular immune responses to bovine herpesvirus-1 glycoprotein D by vaccination with CpG-enhanced plasmid vectors,"2002","83",Pt 12,"2973-2981",The Journal of general virology,"","","","","","","","12466473","","",0,10,0,8,0,,,
2446,0,"Nordstrm et al., 2005",journal,"Nordstrm EK, Forsell MN, Barnfield C, Bonin E, Hanke T, Sundstrm M, Karlsson GB, Liljestrm P",Enhanced immunogenicity using an alphavirus replicon DNA vaccine against human immunodeficiency virus type 1,"2005","86",Pt 2,"349-354",The Journal of general virology,"","","","","","","","15659754","","",0,10,0,9,0,,,
2447,0,Invitrogen 2010,website,Invitrogen,pBudCE4.1,"2010","","","","","","","","","","","","",http://tools.invitrogen.com/content/sfs/manuals/pbudce4_1man.pdf,"",0,10,0,10,0,,,
2448,0,"Niwa et al., 1991",journal,"Niwa H, Yamamura K, Miyazaki J",Efficient selection for high-expression transfectants with a novel eukaryotic vector,"1991","108","2","193-199",Gene,"","","","","","","","1660837","","",0,10,0,12,0,,,
2449,0,"Davis et al., 2001",journal,"Davis BS, Chang GJ, Cropp B, Roehrig JT, Martin DA, Mitchell CJ, Bowen R, Bunning ML",West Nile virus recombinant DNA vaccine protects mouse and horse from virus challenge and expresses in vitro a noninfectious recombinant antigen that can be used in enzyme-linked immunosorbent assays,"2001","75","9","4040-4047",Journal of virology,"","","","","","","","11287553","","",0,10,0,13,0,,,
2450,0,BVTech 2005,website,BVTech Plasmid,Plasmid map of pcDNA3.1(+),"2005","","","","","","","","","","","","",http://www.biovisualtech.com/bvplasmid/pcDNA3.1%28+%29.htm,"",0,10,0,17,0,,,
2451,0,Invitrogen 2010,website,Invitrogen,pCEP4,"2010","","","","","","","","","","","","",http://tools.invitrogen.com/content/sfs/manuals/pcep4_man.pdf,"",0,10,0,19,0,,,
2452,0,NCBI,website,"","Cloning vector pCI, mammalian expression vector, complete sequence","","","","","","","","","","","","","",http://www.ncbi.nlm.nih.gov/nuccore/5870896,"",0,10,0,21,0,,,
2453,0,Promega 2009,website,Promega,pCI-neo Mammalian Expression Vector,"2009","","","","","","","","","","","","",http://www.promega.com/~/media/files/resources/protocols/technical%20bulletins/0/pci%20neo%20mammalian%20expression%20vector%20protocol.pdf?la=en,"",0,10,0,22,0,,,
2454,0,"Balasa et al., 2001",journal,"Balasa B, Boehm BO, Fortnagel A, Karges W, Van Gunst K, Jung N, Camacho SA, Webb SR, Sarvetnick N",Vaccination with glutamic acid decarboxylase plasmid DNA protects mice from spontaneous autoimmune diabetes and B7/CD28 costimulation circumvents that protection,"2001","99","2","241-252","Clinical immunology (Orlando, Fla.)","","","","","","","","11318596","","",0,10,0,23,0,,,
2455,0,"Balasa et al., 2001",journal,"Balasa B, Boehm BO, Fortnagel A, Karges W, Van Gunst K, Jung N, Camacho SA, Webb SR, Sarvetnick N",Vaccination with glutamic acid decarboxylase plasmid DNA protects mice from spontaneous autoimmune diabetes and B7/CD28 costimulation circumvents that protection,"2001","99","2","241-252","Clinical immunology (Orlando, Fla.)","","","","","","","","11318596","","",0,10,0,24,0,,,
2456,0,Vector Database,website,"",Vector Database,"","","","","","","","","","","","","",http://www.addgene.org/vector-database/2241/,"",0,10,0,25,0,,,
2457,0,Vector Database,website,"",Plasmid: pCMV-TnT,"","","","","","","","","","","","","",http://www.addgene.org/vector-database/2234/,"",0,10,0,28,0,,,
2458,0,"Encke et al., 1998",journal,"Encke J, zu Putlitz J, Geissler M, Wands JR",Genetic immunization generates cellular and humoral immune responses against the nonstructural proteins of the hepatitis C virus in a murine model,"1998","161","9","4917-4923","Journal of immunology (Baltimore, Md. : 1950)","","","","","","","","9794426","","",0,10,0,3,0,,,
2459,0,pBacPAK9 sequence,website,"",pBacPAK9 DNA sequence information,"","","","","","","","","","","","","",http://genome-www.stanford.edu/vectordb/vector_descrip/COMPLETE/PBACPAK9.SEQ.html,"",0,10,0,4,0,,,
2460,0,pBudCE4.1 sequence,website,"","","","","","","","","","","","","","","",http://www.synthesisgene.com/vector/pbudce4.1.pdf,"",0,10,0,10,0,,,
2461,0,Pcaggs sequence,website,"","","","","","","","","","","","","","","",http://www.addgene.org/11160/sequences/,"",0,10,0,11,0,,,
2462,0,pCAGGST7 sequence,website,"","","","","","","","","","","","","","","",http://www.ncbi.nlm.nih.gov/pubmed/1660837,"",0,10,0,12,0,,,
2463,0,pcDNA I/Amp sequence,website,"","","","","","","","","","","","","","","",http://www.dmlim.net/vectors/pCDNA1-neo/pcDNA1-neo_map.pdf,"",0,10,0,15,0,,,
2464,0,pcDNA3 sequence,website,"","","","","","","","","","","","","","","",http://www.molecularinfo.com/MTM/K/K2/K2-1/pcdna3.pdf,"",0,10,0,16,0,,,
2465,0,pcDNA3.1 sequence,website,"","","","","","","","","","","","","","","",http://www.biovisualtech.com/bvplasmid/pcDNA3.1%28+%29_seq.htm,"",0,10,0,17,0,,,
2466,0,pcDNA3.1V5HisTOPO/TA sequence,website,"","","","","","","","","","","","","","","",http://www.biovisualtech.com/bvplasmid/pcDNA3.1D_V5-His-TOPO.htm,"",0,10,0,18,0,,,
2467,0,pCEP4 sequence,website,"","","","","","","","","","","","","","","",http://www.invitrogen.com/site/us/en/home/support/Research-Tools/Image-Gallery/Image-Detail.2847.html,"",0,10,0,19,0,,,
2468,0,pCl-neo sequence,website,"","","","","","","","","","","","","","","",http://www.ncbi.nlm.nih.gov/nuccore/8677398,"",0,10,0,22,0,,,
2469,0,pCMV sequence,website,"","","","","","","","","","","","","","","",http://ac.els-cdn.com/S1521661601950120/1-s2.0-S1521661601950120-main.pdf?_tid=90d69c1c494370be47c2e23240d038e1&acdnat=1343059263_f45a8f04f6c6947316c675f0c193d908,"",0,10,0,23,0,,,
2470,0,pCMV-1 sequence,website,"","","","","","","","","","","","","","","",http://ac.els-cdn.com/S1521661601950120/1-s2.0-S1521661601950120-main.pdf?_tid=90d69c1c494370be47c2e23240d038e1&acdnat=1343059263_f45a8f04f6c6947316c675f0c193d908,"",0,10,0,24,0,,,
2471,0,pCMV4 sequence,website,"","","","","","","","","","","","","","","",http://www.addgene.org/browse/sequence_vdb/2241/,"",0,10,0,25,0,,,
2472,0,pCMV-int sequence,website,"","","","","","","","","","","","","","","",http://www.addgene.org/browse/sequence_vdb/2234/,"",0,10,0,28,0,,,
2473,0,pCR3.1 sequence,website,"","","","","","","","","","","","","","","",http://www.addgene.org/15994/sequences/,"",0,10,0,33,0,,,
2474,0,pCR4-TOPO sequence,website,"","","","","","","","","","","","","","","",http://addgene.org/browse/sequence_vdb/2287/,"",0,10,0,34,0,,,
2475,0,"Swanson et al., 2004",journal,"Swanson CM, Puffer BA, Ahmad KM, Doms RW, Malim MH",Retroviral mRNA nuclear export elements regulate protein function and virion assembly,"2004","23","13","2632-2640",The EMBO journal,"","","","","","","","15201866","","",0,10,0,35,0,,,
2476,0,"Xu et al., 2005",journal,"Xu W, Chu Y, Zhang R, Xu H, Wang Y, Xiong S",Endoplasmic reticulum targeting sequence enhances HBV-specific cytotoxic T lymphocytes induced by a CTL epitope-based DNA vaccine,"2005","334","2","255-263",Virology,"","","","","","","","15780875","","",0,10,0,37,0,,,
2477,0,pET21a sequence,website,"","","","","","","","","","","","","","","",http://www.addgene.org/browse/sequence_vdb/2549/,"",0,10,0,38,0,,,
2478,0,pET-28a sequence,website,"","","","","","","","","","","","","","","",http://www.addgene.org/20378/sequences/,"",0,10,0,39,0,,,
2479,0,pGA sequence,website,"","","","","","","","","","","","","","","",http://sil.biochem.uiowa.edu/vectors/pGEX/pGEX-3X_seq.html,"",0,10,0,40,0,,,
2480,0,pGEX-3X sequence,website,"","","","","","","","","","","","","","","",http://genome-www.stanford.edu/vectordb/vector_descrip/COMPLETE/PGEX3X.SEQ.html,"",0,10,0,41,0,,,
2481,0,pIRES sequence,website,"","","","","","","","","","","","","","","",http://addgene.org/browse/sequence_vdb/3171/,"",0,10,0,42,0,,,
2482,0,pIRES2 DsRed2,website,"","","","","","","","","","","","","","","",http://addgene.org/browse/sequence_vdb/3177/,"",0,10,0,43,0,,,
2483,0,"Wang et al., 2004",journal,"Wang J, Thorson L, Stokes RW, Santosuosso M, Huygen K, Zganiacz A, Hitt M, Xing Z","Single mucosal, but not parenteral, immunization with recombinant adenoviral-based vaccine provides potent protection from pulmonary tuberculosis","2004","173","10","6357-6365","Journal of immunology (Baltimore, Md. : 1950)","","","","","","","","15528375","","",0,10,0,45,0,,,
2484,0,pMAMneoBlue sequence,website,"","","","","","","","","","","","","","","",http://www.ncbi.nlm.nih.gov/nuccore/413796,"",0,10,0,50,0,,,
2485,0,"Pontarollo et al., 2002",journal,"Pontarollo RA, Babiuk LA, Hecker R, Van Drunen Littel-Van Den Hurk S",Augmentation of cellular immune responses to bovine herpesvirus-1 glycoprotein D by vaccination with CpG-enhanced plasmid vectors,"2002","83",Pt 12,"2973-2981",The Journal of general virology,"","","","","","","","12466473","","",0,10,0,51,0,,,
2486,166,"Scheiblhofer et al., 2003",journal,"Scheiblhofer S, Weiss R, Drnberger H, Mostbck S, Breitenbach M, Livey I, Thalhamer J",A DNA vaccine encoding the outer surface protein C from Borrelia burgdorferi is able to induce protective immune responses,"2003","5","11","939-946",Microbes and infection / Institut Pasteur,"","","","","","","","12941385","","",0,10,0,0,0,,,
2487,0,pNL3-gal sequence,website,"","","","","","","","","","","","","","","",http://mic.sgmjournals.org/content/156/9/2807.full,,0,0,0,55,0,,,
2488,0,"Botteaux et al., 2010",journal,"Botteaux A, Kayath CA, Page AL, Jouihri N, Sani M, Boekema E, Biskri L, Parsot C, Allaoui A",The 33 carboxyl-terminal residues of Spa40 orchestrate the multi-step assembly process of the type III secretion needle complex in Shigella flexneri,"2010","156",Pt 9,"2807-2817","Microbiology (Reading, England)","","","","","","","","20507885","","",0,10,0,55,0,,,
2489,0,"Sun et al., 2002",journal,"Sun X, Hodge LM, Jones HP, Tabor L, Simecka JW",Co-expression of granulocyte-macrophage colony-stimulating factor with antigen enhances humoral and tumor immunity after DNA vaccination,"2002","20","9-10","1466-1474",Vaccine,"","","","","","","","11818167","","",0,10,0,56,0,,,
2490,0,pRc/CMV sequence,website,"","","","","","","","","","","","","","","",http://tools.invitrogen.com/content/sfs/vectors/prccmv_seq.txt,"",0,10,0,57,0,,,
2491,0,pRc/CMV map,website,"","","","","","","","","","","","","","","",http://tools.invitrogen.com/content/sfs/vectors/prccmv_map.pdf,"",0,10,0,57,0,,,
2492,0,pRc/CMV2 sequence,website,"","","","","","","","","","","","","","","",http://tools.invitrogen.com/content/sfs/vectors/prccmv2cat_seq.txt,"",0,10,0,58,0,,,
2493,0,pRc/CMV2 map,website,"","","","","","","","","","","","","","","",http://tools.invitrogen.com/content/sfs/vectors/prccmv2cat.pdf,"",0,10,0,58,0,,,
2494,0,"Schirmbeck et al., 1995",journal,"Schirmbeck R, Bhm W, Ando K, Chisari FV, Reimann J",Nucleic acid vaccination primes hepatitis B virus surface antigen-specific cytotoxic T lymphocytes in nonresponder mice,"1995","69","10","5929-5934",Journal of virology,"","","","","","","","7666497","","",0,10,0,59,0,,,
2495,0,pRSV sequence,website,"","","","","","","","","","","","","","","",http://tools.invitrogen.com/content/sfs/manuals/prcrsv_man.pdf,"",0,10,0,60,0,,,
2496,0,pSG2 sequence,website,"","","","","","","","","","","","","","","",http://204.9.46.202:8080/NoegenAppExt/DrawMapBySKU?drawMap=drawMap&SKU=RC204743&VECTOR=pCMV6Entry,"",0,10,0,63,0,,,
2497,0,pSG5 sequence,website,"","","","","","","","","","","","","","","",http://www.addgene.org/9053/sequences/,"",0,10,0,64,0,,,
2498,0,pSG5 map,website,"","","","","","","","","","","","","","","",http://www.addgene.org/static/data/52/88/2d0c7478-af61-11e0-90fe-003048dd6500.jpeg,"",0,10,0,64,0,,,
2499,0,Psin sequence,website,"","","","","","","","","","","","","","","",http://ac.els-cdn.com/S0264410X02003754/1-s2.0-S0264410X02003754-main.pdf?_tid=405220a70befb06a05f3780e67d84a08&acdnat=1343049276_64386c5dd8981d9ef741310fdd659dcd,"",0,10,0,65,0,,,
2500,0,pTARGET sequence,website,"","","","","","","","","","","","","","","",http://addgene.org/browse/sequence_vdb/4347/,"",0,10,0,66,0,,,
2501,0,pTH map,website,"","","","","","","","","","","","","","","",http://204.9.46.202:8080/NoegenAppExt/DrawMapBySKU?drawMap=drawMap&SKU=RC219848&VECTOR=pCMV6Entry,"",0,10,0,67,0,,,
2502,0,pTR600 map,website,"","","","","","","","","","","","","","","",http://jvi.asm.org/content/78/9/4710.full,"",0,10,0,69,0,,,
2503,0,pUC18 map,website,"","","","","","","","","","","","","","","",http://dwb4.unl.edu/Chem/CHEM869N/CHEM869NLinks/www.fermentas.com/TechInfo/NucleicAcids/MappUC1819.htm,"",0,10,0,71,0,,,
2504,0,pUC19 map,website,"","","","","","","","","","","","","","","",http://dwb4.unl.edu/Chem/CHEM869N/CHEM869NLinks/www.fermentas.com/TechInfo/NucleicAcids/MappUC1819.htm,"",0,10,0,72,0,,,
2505,0,"Calarota et al., 2008",journal,"Calarota SA, Dai A, Trocio JN, Weiner DB, Lori F, Lisziewicz J",IL-15 as memory T-cell adjuvant for topical HIV-1 DermaVir vaccine,"2008","26","40","5188-5195",Vaccine,"","","","","","","","18462844","","",0,10,0,1,0,,,
2506,0,pVAX1 sequence,website,"","","","","","","","","","","","","","","",http://tools.invitrogen.com/content/sfs/vectors/pvax1_seq.txt,"",0,10,0,74,0,,,
2507,0,pVAX1 map,website,"","","","","","","","","","","","","","","",http://tools.invitrogen.com/content/sfs/vectors/pvax1.pdf,"",0,10,0,74,0,,,
2508,0,pVCL(pCXN2-mVIN) sequence,website,"","","","","","","","","","","","","","","",http://www.addgene.org/11776/sequences/,"",0,10,0,75,0,,,
2509,0,pVCL(pCXN2-mVIN) map,website,"","","","","","","","","","","","","","","",http://www.addgene.org/static/data/22/47/6caed602-af61-11e0-90fe-003048dd6500.gif,"",0,10,0,75,0,,,
2510,50,"Nakaya et al., 2011",journal,"Nakaya HI, Wrammert J, Lee EK, Racioppi L, Marie-Kunze S, Haining WN, Means AR, Kasturi SP, Khan N, Li GM, McCausland M, Kanchan V, Kokko KE, Li S, Elbein R, Mehta AK, Aderem A, Subbarao K, Ahmed R, Pulendran B",Systems biology of vaccination for seasonal influenza in humans,"2011","12","8","786-795",Nature immunology,"","","","","","","","21743478","","",0,10,0,0,0,,,
2511,49,FDA COMVAX,website,"",FDA COMVAX package insert information,"","","","","","","","","","","","","",http://www.fda.gov/downloads/BiologicsBloodVaccines/Vaccines/ApprovedProducts/UCM109869.pdf,"",0,10,0,0,0,,,
2512,226,"Hassett et al., 2000",journal,"Hassett DE, Slifka MK, Zhang J, Whitton JL",Direct ex vivo kinetic and phenotypic analyses of CD8(+) T-cell responses induced by DNA immunization,"2000","74","18","8286-8291",Journal of virology,"","","","","","","","10954526","",,0,0,0,0,0,,,
2513,118,"Vasconcelos et al., 2004",journal,"Vasconcelos JR, Hiyane MI, Marinho CR, Claser C, Machado AM, Gazzinelli RT, Brua-Romero O, Alvarez JM, Boscardin SB, Rodrigues MM",Protective immunity against trypanosoma cruzi infection in a highly susceptible mouse strain after vaccination with genes encoding the amastigote surface protein-2 and trans-sialidase,"2004","15","9","878-886",Human gene therapy,"","","","","","","","15353042","","",0,10,0,0,0,,,
2514,251,"Mavromatis et al., 2006",journal,"Mavromatis K, Doyle CK, Lykidis A, Ivanova N, Francino MP, Chain P, Shin M, Malfatti S, Larimer F, Copeland A, Detter JC, Land M, Richardson PM, Yu XJ, Walker DH, McBride JW, Kyrpides NC",The genome of the obligately intracellular bacterium Ehrlichia canis reveals themes of complex membrane structure and immune evasion strategies,"2006","188","11","4015-4023",Journal of bacteriology,"","","","","","","","16707693","",,0,0,0,0,0,,,
2515,251,"Aguiar et al., 2013",journal,"Aguiar DM, Zhang X, Melo AL, Pacheco TA, Meneses AM, Zanutto MS, Horta MC, Santarm VA, Camargo LM, McBride JW, Labruna MB",Genetic diversity of Ehrlichia canis in Brazil,"2013","","","",Veterinary microbiology,"","","","","","","","23490559","",,0,0,0,0,0,,,
2516,251,"Rudoler et al., 2012",journal,"Rudoler N, Baneth G, Eyal O, van Straten M, Harrus S",Evaluation of an attenuated strain of Ehrlichia canis as a vaccine for canine monocytic ehrlichiosis,"2012","31","1","226-233",Vaccine,"","","","","","","","23072894","",,0,0,0,0,0,,,
2517,251,"Thomas et al., 2011",journal,"Thomas S, Thirumalapura NR, Crocquet-Valdes PA, Luxon BA, Walker DH",Structure-based vaccines provide protection in a mouse model of ehrlichiosis,"2011","6","11",e27981,PloS one,"","","","","","","","22114733","",,0,0,0,0,0,,,
2518,251,"Santos et al., 2012",journal,"Santos EV, Silva G, Cardozo GP, Bitencourt TA, Frana SC, Fachin AL, Marins M",In silico characterization of three two-component systems of Ehrlichia canis and evaluation of a natural plant-derived inhibitor,"2012","11","4","3576-3584",Genetics and molecular research : GMR,"","","","","","","","23096683","",,0,0,0,0,0,,,
2519,252,"Crocquet-Valdes et al., 2011",journal,"Crocquet-Valdes PA, Thirumalapura NR, Ismail N, Yu X, Saito TB, Stevenson HL, Pietzsch CA, Thomas S, Walker DH",Immunization with Ehrlichia P28 outer membrane proteins confers protection in a mouse model of ehrlichiosis,"2011","18","12","2018-2025",Clinical and vaccine immunology : CVI,"","","","","","","","22030371","",,0,0,0,0,0,,,
2520,252,"Thomas et al., 2011",journal,"Thomas S, Thirumalapura NR, Crocquet-Valdes PA, Luxon BA, Walker DH",Structure-based vaccines provide protection in a mouse model of ehrlichiosis,"2011","6","11",e27981,PloS one,"","","","","","","","22114733","",,0,0,0,0,0,,,
2521,252,"Dunning et al., 2006",journal,"Dunning Hotopp JC, Lin M, Madupu R, Crabtree J, Angiuoli SV, Eisen JA, Seshadri R, Ren Q, Wu M, Utterback TR, Smith S, Lewis M, Khouri H, Zhang C, Niu H, Lin Q, Ohashi N, Zhi N, Nelson W, Brinkac LM, Dodson RJ, Rosovitz MJ, Sundaram J, Daugherty SC, Davidsen T, Durkin AS, Gwinn M, Haft DH, Selengut JD, Sullivan SA, Zafar N, Zhou L, Benahmed F, Forberger H, Halpin R, Mulligan S, Robinson J, White O, Rikihisa Y, Tettelin H",Comparative genomics of emerging human ehrlichiosis agents,"2006","2","2",e21,PLoS genetics,"","","","","","","","16482227","",,0,0,0,0,0,,,
2522,220,"Argilaguet et al., 2011",journal,"Argilaguet JM, Prez-Martn E, Gallardo C, Salguero FJ, Borrego B, Lacasta A, Accensi F, Daz I, Nofraras M, Pujols J, Blanco E, Prez-Filgueira M, Escribano JM, Rodrguez F",Enhancing DNA immunization by targeting ASFV antigens to SLA-II bearing cells,"2011","29","33","5379-5385",Vaccine,"","","","","","","","21679736","","",0,10,0,0,0,,,
2523,135,"Luke et al., 1997",journal,"Luke CJ, Carner K, Liang X, Barbour AG",An OspA-based DNA vaccine protects mice against infection with Borrelia burgdorferi,"1997","175","1","91-97",The Journal of infectious diseases,"","","","","","","","8985201","",,0,0,0,0,0,,,
2524,135,"Scheiblhofer et al., 2003",journal,"Scheiblhofer S, Weiss R, Drnberger H, Mostbck S, Breitenbach M, Livey I, Thalhamer J",A DNA vaccine encoding the outer surface protein C from Borrelia burgdorferi is able to induce protective immune responses,"2003","5","11","939-946",Microbes and infection / Institut Pasteur,"","","","","","","","12941385","",,0,0,0,0,0,,,
2525,66,"Tarradas et al., 2011",journal,"Tarradas J, lvarez B, Fraile L, Rosell R, Muoz M, Galindo-Cardiel I, Domingo M, Dominguez J, Ezquerra A, Sobrino F, Ganges L",Immunomodulatory effect of swine CCL20 chemokine in DNA vaccination against CSFV,"2011","142","3-4","243-251",Veterinary immunology and immunopathology,"","","","","","","","21684019","","",0,10,0,0,0,,,
2526,178,"Fu et al., 2012",journal,"Fu S, Zhang M, Ou J, Liu H, Tan C, Liu J, Chen H, Bei W",Construction and immune effect of Haemophilus parasuis DNA vaccine encoding glyceraldehyde-3-phosphate dehydrogenase (GAPDH) in mice,"2012","30","48","6839-6844",Vaccine,"","","","","","","","23000128","","",0,10,0,0,0,,,
2527,47,"Vadesilho et al., 2012",journal,"Vadesilho CF, Ferreira DM, Moreno AT, Chavez-Olortegui C, Machado de Avila RA, Oliveira ML, Ho PL, Miyaji EN",Characterization of the antibody response elicited by immunization with pneumococcal surface protein A (PspA) as recombinant protein or DNA vaccine and analysis of protection against an intranasal lethal challenge with Streptococcus pneumoniae,"2012","53","5-6","243-249",Microbial pathogenesis,"","","","","","","","22981893","","",0,10,0,0,0,,,
2528,47,"Ferreira et al., 2006",journal,"Ferreira DM, Miyaji EN, Oliveira ML, Darrieux M, Aras AP, Ho PL, Leite LC",DNA vaccines expressing pneumococcal surface protein A (PspA) elicit protection levels comparable to recombinant protein,"2006","55",Pt 4,"375-378",Journal of medical microbiology,"","","","","","","","16533983","","",0,10,0,0,0,,,
2529,47,"Miyaji et al., 2001",journal,"Miyaji EN, Dias WO, Gamberini M, Gebara VC, Schenkman RP, Wild J, Riedl P, Reimann J, Schirmbeck R, Leite LC",PsaA (pneumococcal surface adhesin A) and PspA (pneumococcal surface protein A) DNA vaccines induce humoral and cellular immune responses against Streptococcus pneumoniae,"2001","20","5-6","805-812",Vaccine,"","","","","","","","11738744","","",0,10,0,0,0,,,
2530,99,"Syrengelas et al., 1996",journal,"Syrengelas AD, Chen TT, Levy R",DNA immunization induces protective immunity against B-cell lymphoma,"1996","2","9","1038-1041",Nature medicine,"","","","","","","","8782465","","",0,10,0,0,0,,,
2531,100,"Hu et al., 2011",journal,"Hu K, Dou J, Yu F, He X, Yuan X, Wang Y, Liu C, Gu N",An ocular mucosal administration of nanoparticles containing DNA vaccine pRSC-gD-IL-21 confers protection against mucosal challenge with herpes simplex virus type 1 in mice,"2011","29","7","1455-1462",Vaccine,"","","","","","","","21185849","","",0,10,0,0,0,,,
2532,100,"Osorio et al., 2004",journal,"Osorio Y, Cohen J, Ghiasi H",Improved protection from primary ocular HSV-1 infection and establishment of latency using multigenic DNA vaccines,"2004","45","2","506-514",Investigative ophthalmology & visual science,"","","","","","","","14744892","","",0,10,0,0,0,,,
2533,100,"Veselenak et al., 2012",journal,"Veselenak RL, Shlapobersky M, Pyles RB, Wei Q, Sullivan SM, Bourne N",A Vaxfectin()-adjuvanted HSV-2 plasmid DNA vaccine is effective for prophylactic and therapeutic use in the guinea pig model of genital herpes,"2012","30","49","7046-7051",Vaccine,"","","","","","","","23041125","","",0,10,0,0,0,,,
2534,100,"Shlapobersky et al., 2012",journal,"Shlapobersky M, Marshak JO, Dong L, Huang ML, Wei Q, Chu A, Rolland A, Sullivan S, Koelle DM",Vaxfectin-adjuvanted plasmid DNA vaccine improves protection and immunogenicity in a murine model of genital herpes infection,"2012","93",Pt 6,"1305-1315",The Journal of general virology,"","","","","","","","22398318","","",0,10,0,0,0,,,
2535,100,"Tirabassi et al., 2011",journal,"Tirabassi RS, Ace CI, Levchenko T, Torchilin VP, Selin LK, Nie S, Guberski DL, Yang K",A mucosal vaccination approach for herpes simplex virus type 2,"2011","29","5","1090-1098",Vaccine,"","","","","","","","21134447","","",0,10,0,0,0,,,
2536,100,"Sin et al., 2001",journal,"Sin JI, Kim JJ, Zhang D, Weiner DB",Modulation of cellular responses by plasmid CD40L: CD40L plasmid vectors enhance antigen-specific helper T cell type 1 CD4+ T cell-mediated protective immunity against herpes simplex virus type 2 in vivo,"2001","12","9","1091-1102",Human gene therapy,"","","","","","","","11399230","","",0,10,0,0,0,,,
2537,0,pRK7 Sequence,website,"","","","","","","","","","","","","","","",http://www.addgene.org/10883/sequences/,"",0,10,0,76,0,,,
2538,0,Addgene plasmid 10883,website,"","","","","","","","","","","","","","","",http://www.addgene.org/10883/,"",0,10,0,76,0,,,
2539,0,Invivogen - pVIVO2,website,"","","","","","","","","","","","","","","",http://www.invivogen.com/PDF/pVIVO2-mcs_TDS.pdf,"",0,10,0,77,0,,,
2540,0,"Mascola et al., 2005",journal,"Mascola JR, Sambor A, Beaudry K, Santra S, Welcher B, Louder MK, Vancott TC, Huang Y, Chakrabarti BK, Kong WP, Yang ZY, Xu L, Montefiori DC, Nabel GJ, Letvin NL",Neutralizing antibodies elicited by immunization of monkeys with DNA plasmids and recombinant adenoviral vectors expressing human immunodeficiency virus type 1 proteins,"2005","79","2","771-779",Journal of virology,"","","","","","","","15613305","","",0,10,0,78,0,,,
2541,0,"Raviprakash et al., 2000",journal,"Raviprakash K, Porter KR, Kochel TJ, Ewing D, Simmons M, Phillips I, Murphy GS, Weiss WR, Hayes CG",Dengue virus type 1 DNA vaccine induces protective immune responses in rhesus macaques,"2000","81",Pt 7,"1659-1667",The Journal of general virology,"","","","","","","","10859370","","",0,10,0,78,0,,,
2542,0,"Sheets et al., 2006",journal,"Sheets RL, Stein J, Manetz TS, Duffy C, Nason M, Andrews C, Kong WP, Nabel GJ, Gomez PL","Biodistribution of DNA plasmid vaccines against HIV-1, Ebola, Severe Acute Respiratory Syndrome, or West Nile virus is similar, without integration, despite differing plasmid backbones or gene inserts","2006","91","2","610-619",Toxicological sciences : an official journal of the Society of Toxicology,"","","","","","","","16569729","","",0,10,0,79,0,,,
2543,0,"Aravindaram et al., 2009",journal,"Aravindaram K, Yu HH, Lan CW, Wang PH, Chen YH, Chen HM, Yagita H, Yang NS",Transgenic expression of human gp100 and RANTES at specific time points for suppression of melanoma,"2009","16","11","1329-1339",Gene therapy,"","","","","","","","19626052","","",0,10,0,80,0,,,
2544,0,"Schmaljohn et al., 1997",journal,"Schmaljohn C, Vanderzanden L, Bray M, Custer D, Meyer B, Li D, Rossi C, Fuller D, Fuller J, Haynes J, Huggins J",Naked DNA vaccines expressing the prM and E genes of Russian spring summer encephalitis virus and Central European encephalitis virus protect mice from homologous and heterologous challenge,"1997","71","12","9563-9569",Journal of virology,"","","","","","","","9371620","","",0,10,0,81,0,,,
2545,0,"Ward et al., 1997",journal,"Ward G, Rieder E, Mason PW",Plasmid DNA encoding replicating foot-and-mouth disease virus genomes induces antiviral immune responses in swine,"1997","71","10","7442-7447",Journal of virology,"","","","","","","","9311823","","",0,10,0,82,0,,,
2546,0,Addgene - pcDNA1.1/Amp,website,"","","","","","","","","","","","","","","",http://www.addgene.org/vector-database/2091/,"",0,10,0,83,0,,,
2547,0,"Lobell et al., 1999",journal,"Lobell A, Weissert R, Eltayeb S, Svanholm C, Olsson T, Wigzell H",Presence of CpG DNA and the local cytokine milieu determine the efficacy of suppressive DNA vaccination in experimental autoimmune encephalomyelitis,"1999","163","9","4754-4762","Journal of immunology (Baltimore, Md. : 1950)","","","","","","","","10528174","","",0,10,0,84,0,,,
2548,0,"Chen et al., 1998",journal,"Chen Z, Sahashi Y, Matsuo K, Asanuma H, Takahashi H, Iwasaki T, Suzuki Y, Aizawa C, Kurata T, Tamura S",Comparison of the ability of viral protein-expressing plasmid DNAs to protect against influenza,"1998","16","16","1544-1549",Vaccine,"","","","","","","","9711802","","",0,10,0,85,0,,,
2549,0,"Kobasa et al., 1997",journal,"Kobasa D, Rodgers ME, Wells K, Kawaoka Y","Neuraminidase hemadsorption activity, conserved in avian influenza A viruses, does not influence viral replication in ducks","1997","71","9","6706-6713",Journal of virology,"","","","","","","","9261394","","",0,10,0,86,0,,,
2550,0,"Lunn et al., 1999",journal,"Lunn DP, Soboll G, Schram BR, Quass J, McGregor MW, Drape RJ, Macklin MD, McCabe DE, Swain WF, Olsen CW",Antibody responses to DNA vaccination of horses using the influenza virus hemagglutinin gene,"1999","17","18","2245-2258",Vaccine,"","","","","","","","10403592","","",0,10,0,87,0,,,
2551,0,"Hoffmann et al., 2000",journal,"Hoffmann E, Neumann G, Hobom G, Webster RG, Kawaoka Y","""Ambisense"" approach for the generation of influenza A virus: vRNA and mRNA synthesis from one template","2000","267","2","310-317",Virology,"","","","","","","","10662626","","",0,10,0,88,0,,,
2552,0,"Geisbert et al., 2010",journal,"Geisbert TW, Bailey M, Geisbert JB, Asiedu C, Roederer M, Grazia-Pau M, Custers J, Jahrling P, Goudsmit J, Koup R, Sullivan NJ",Vector choice determines immunogenicity and potency of genetic vaccines against Angola Marburg virus in nonhuman primates,"2010","84","19","10386-10394",Journal of virology,"","","","","","","","20660192","","",0,10,0,89,0,,,
2553,0,"Ledgerwood et al., 2011",journal,"Ledgerwood JE, Wei CJ, Hu Z, Gordon IJ, Enama ME, Hendel CS, McTamney PM, Pearce MB, Yassine HM, Boyington JC, Bailer R, Tumpey TM, Koup RA, Mascola JR, Nabel GJ, Graham BS",DNA priming and influenza vaccine immunogenicity: two phase 1 open label randomised clinical trials,"2011","11","12","916-924",The Lancet infectious diseases,"","","","","","","","21975270","","",0,10,0,90,0,,,
2554,0,"Loudon et al., 2010",journal,"Loudon PT, Yager EJ, Lynch DT, Narendran A, Stagnar C, Franchini AM, Fuller JT, White PA, Nyuandi J, Wiley CA, Murphey-Corb M, Fuller DH",GM-CSF increases mucosal and systemic immunogenicity of an H1N1 influenza DNA vaccine administered into the epidermis of non-human primates,"2010","5","6",e11021,PloS one,"","","","","","","","20544035","","",0,10,0,91,0,,,
2555,0,"Robinson et al., 1993",journal,"Robinson HL, Hunt LA, Webster RG",Protection against a lethal influenza virus challenge by immunization with a haemagglutinin-expressing plasmid DNA,"1993","11","9","957-960",Vaccine,"","","","","","","","8212843","","",0,10,0,92,0,,,
2556,0,"Jimenez et al., 2007",journal,"Jimenez GS, Planchon R, Wei Q, Rusalov D, Geall A, Enas J, Lalor P, Leamy V, Vahle R, Luke CJ, Rolland A, Kaslow DC, Smith LR",Vaxfectin-formulated influenza DNA vaccines encoding NP and M2 viral proteins protect mice against lethal viral challenge,"2007","3","5","157-164",Human vaccines,"","","","","","","","17637571","","",0,10,0,93,0,,,
2557,0,"Timmerman et al., 2002",journal,"Timmerman JM, Singh G, Hermanson G, Hobart P, Czerwinski DK, Taidi B, Rajapaksa R, Caspar CB, Van Beckhoven A, Levy R",Immunogenicity of a plasmid DNA vaccine encoding chimeric idiotype in patients with B-cell lymphoma,"2002","62","20","5845-5852",Cancer research,"","","","","","","","12384547","","",0,10,0,94,0,,,
2558,0,"Leitner et al., 2003",journal,"Leitner WW, Hwang LN, deVeer MJ, Zhou A, Silverman RH, Williams BR, Dubensky TW, Ying H, Restifo NP",Alphavirus-based DNA vaccine breaks immunological tolerance by activating innate antiviral pathways,"2003","9","1","33-39",Nature medicine,"","","","","","","","12496961","","",0,10,0,95,0,,,
2559,0,"Leitner et al., 2000",journal,"Leitner WW, Ying H, Driver DA, Dubensky TW, Restifo NP",Enhancement of tumor-specific immune response with plasmid DNA replicon vectors,"2000","60","1","51-55",Cancer research,"","","","","","","","10646851","","",0,10,0,96,0,,,
2560,0,"Yang et al., 1995",journal,"Yang G, Hellstrm KE, Hellstrm I, Chen L","Antitumor immunity elicited by tumor cells transfected with B7-2, a second ligand for CD28/CTLA-4 costimulatory molecules","1995","154","6","2794-2800","Journal of immunology (Baltimore, Md. : 1950)","","","","","","","","7533183","","",0,10,0,97,0,,,
2561,0,"Weber et al., 1998",journal,"Weber LW, Bowne WB, Wolchok JD, Srinivasan R, Qin J, Moroi Y, Clynes R, Song P, Lewis JJ, Houghton AN",Tumor immunity and autoimmunity induced by immunization with homologous DNA,"1998","102","6","1258-1264",The Journal of clinical investigation,"","","","","","","","9739060","","",0,10,0,98,0,,,
2562,0,"Sun et al., 2002",journal,"Sun X, Hodge LM, Jones HP, Tabor L, Simecka JW",Co-expression of granulocyte-macrophage colony-stimulating factor with antigen enhances humoral and tumor immunity after DNA vaccination,"2002","20","9-10","1466-1474",Vaccine,"","","","","","","","11818167","","",0,10,0,99,0,,,
2563,0,"Sun et al., 2002",journal,"Sun X, Hodge LM, Jones HP, Tabor L, Simecka JW",Co-expression of granulocyte-macrophage colony-stimulating factor with antigen enhances humoral and tumor immunity after DNA vaccination,"2002","20","9-10","1466-1474",Vaccine,"","","","","","","","11818167","","",0,10,0,100,0,,,
2564,0,"Leslie et al., 2007",journal,"Leslie MC, Zhao YJ, Lachman LB, Hwu P, Wu GJ, Bar-Eli M","Immunization against MUC18/MCAM, a novel antigen that drives melanoma invasion and metastasis","2007","14","4","316-323",Gene therapy,"","","","","","","","17024104","","",0,10,0,101,0,,,
3885,99,"Senzer et al., 2012",journal,"Senzer N, Barve M, Kuhn J, Melnyk A, Beitsch P, Lazar M, Lifshitz S, Magee M, Oh J, Mill SW, Bedell C, Higgs C, Kumar P, Yu Y, Norvell F, Phalon C, Taquet N, Rao DD, Wang Z, Jay CM, Pappen BO, Wallraven G, Brunicardi FC, Shanahan DM, Maples PB, Nemunaitis J","Phase I trial of ""bi-shRNAi(furin)/GMCSF DNA/autologous tumor cell"" vaccine (FANG) in advanced cancer","2012","20","3","679-686",Molecular therapy : the journal of the American Society of Gene Therapy,,,,,,,,"22186789",,,0,10,0,0,0,,,
2566,0,Addgene - pCMV/myc/ER,website,"","","","","","","","","","","","","","","",http://www.addgene.org/vector-database/2236/,"",0,10,0,103,0,,,
2567,0,"Midha and Bhatnagar, 2009",journal,"Midha S, Bhatnagar R",Anthrax protective antigen administered by DNA vaccination to distinct subcellular locations potentiates humoral and cellular immune responses,"2009","39","1","159-177",European journal of immunology,"","","","","","","","19130551","","",0,10,0,104,0,,,
2568,0,"Midha and Bhatnagar, 2009",journal,"Midha S, Bhatnagar R",Anthrax protective antigen administered by DNA vaccination to distinct subcellular locations potentiates humoral and cellular immune responses,"2009","39","1","159-177",European journal of immunology,"","","","","","","","19130551","","",0,10,0,105,0,,,
2569,0,"Midha and Bhatnagar, 2009",journal,"Midha S, Bhatnagar R",Anthrax protective antigen administered by DNA vaccination to distinct subcellular locations potentiates humoral and cellular immune responses,"2009","39","1","159-177",European journal of immunology,"","","","","","","","19130551","","",0,10,0,106,0,,,
2570,0,Invitrogen - pSecTag2 B,website,"","","","","","","","","","","","","","","",http://tools.invitrogen.com/content/sfs/manuals/psectag2_man.pdf,"",0,10,0,107,0,,,
2571,0,pSecTag2 B Sequence,website,"","","","","","","","","","","","","","","",http://tools.invitrogen.com/content/sfs/vectors/psectag2b_seq.txt,"",0,10,0,107,0,,,
2572,0,pSecTag2 A Sequence,website,"","","","","","","","","","","","","","","",http://tools.invitrogen.com/content/sfs/vectors/psectag2a_seq.txt,"",0,10,0,108,0,,,
2573,0,Invitrogen - pSecTag2 A,website,"","","","","","","","","","","","","","","",http://tools.invitrogen.com/content/sfs/manuals/psectag2_man.pdf,"",0,10,0,108,0,,,
2574,0,"Luke et al., 1997",journal,"Luke CJ, Carner K, Liang X, Barbour AG",An OspA-based DNA vaccine protects mice against infection with Borrelia burgdorferi,"1997","175","1","91-97",The Journal of infectious diseases,"","","","","","","","8985201","","",0,10,0,109,0,,,
2575,0,"Scheiblhofer et al., 2003",journal,"Scheiblhofer S, Weiss R, Drnberger H, Mostbck S, Breitenbach M, Livey I, Thalhamer J",A DNA vaccine encoding the outer surface protein C from Borrelia burgdorferi is able to induce protective immune responses,"2003","5","11","939-946",Microbes and infection / Institut Pasteur,"","","","","","","","12941385","","",0,10,0,110,0,,,
2576,0,"Weiss et al., 1999",journal,"Weiss R, Drnberger J, Mostbck S, Scheiblhofer S, Hartl A, Breitenbach M, Strasser P, Dorner F, Livey I, Crowe B, Thalhamer J",Improvement of the immune response against plasmid DNA encoding OspC of Borrelia by an ER-targeting leader sequence,"1999","18","9-10","815-824",Vaccine,"","","","","","","","10580194","","",0,10,0,110,0,,,
2577,0,Addgene - pDONR221,website,"","","","","","","","","","","","","","","",http://www.addgene.org/vector-database/2394/,"",0,10,0,111,0,,,
2578,0,Invitrogen - pDONR221,website,"","","","","","","","","","","","","","","",http://tools.invitrogen.com/content/sfs/manuals/gateway_pdonr_vectors.pdf,"",0,10,0,111,0,,,
2579,0,pDONR221 Sequence,website,"","","","","","","","","","","","","","","",http://tools.invitrogen.com/content/sfs/vectors/pdonr221_seq.txt,"",0,10,0,111,0,,,
2580,0,"Sekiya et al., 2001",journal,"Sekiya K, Ohishi M, Ogino T, Tamano K, Sasakawa C, Abe A",Supermolecular structure of the enteropathogenic Escherichia coli type III secretion system and its direct interaction with the EspA-sheath-like structure,"2001","98","20","11638-11643",Proceedings of the National Academy of Sciences of the United States of America,"","","","","","","","11562461","","",0,10,0,112,0,,,
2581,0,"Pontarollo et al., 2002",journal,"Pontarollo RA, Babiuk LA, Hecker R, Van Drunen Littel-Van Den Hurk S",Augmentation of cellular immune responses to bovine herpesvirus-1 glycoprotein D by vaccination with CpG-enhanced plasmid vectors,"2002","83",Pt 12,"2973-2981",The Journal of general virology,"","","","","","","","12466473","","",0,10,0,113,0,,,
2582,0,"Sykes and Johnston, 1999",journal,"Sykes KF, Johnston SA",Genetic live vaccines mimic the antigenicity but not pathogenicity of live viruses,"1999","18","7","521-531",DNA and cell biology,"","","","","","","","10433551","","",0,10,0,114,0,,,
2583,0,"McNeilly et al., 2007",journal,"McNeilly CL, Beagley KW, Moore RJ, Haring V, Timms P, Hafner LM",Expression library immunization confers partial protection against Chlamydia muridarum genital infection,"2007","25","14","2643-2655",Vaccine,"","","","","","","","17239501","","",0,10,0,115,0,,,
2584,0,"Moore et al., 2001",journal,"Moore RJ, Lenghaus C, Sheedy SA, Doran TJ",Improved vectors for expression library immunization--application to Mycoplasma hyopneumoniae infection in pigs,"2001","20","1-2","115-120",Vaccine,"","","","","","","","11567754","","",0,10,0,115,0,,,
2585,0,"Jenkins et al., 1999",journal,"Jenkins MC, O'Brien C, Trout J, Guidry A, Fayer R",Hyperimmune bovine colostrum specific for recombinant Cryptosporidium parvum antigen confers partial protection against cryptosporidiosis in immunosuppressed adult mice,"1999","17","19","2453-2460",Vaccine,"","","","","","","","10392628","","",0,10,0,116,0,,,
2586,0,pUMVC4b sequence,website,"","","","","","","","","","","","","","","",https://system.netsuite.com/c.606687/pUMVC4a.txt,"",0,10,0,117,0,,,
2587,0,Aldevron - pUMVC4b,website,"","","","","","","","","","","","","","","",http://www.aldevron.com/products/dnas/umvc_expression/,"",0,10,0,117,0,,,
2588,0,Addgene - pcDNA1,website,"","","","","","","","","","","","","","","",https://www.addgene.org/vector-database/2089/,"",0,10,0,118,0,,,
2589,0,Addgene - pCAT,website,"","","","","","","","","","","","","","","",http://www.addgene.org/vector-database/2051/,"",0,10,0,119,0,,,
2590,0,"Jiang et al., 1998",journal,"Jiang W, Baker HJ, Swango LJ, Schorr J, Self MJ, Smith BF",Nucleic acid immunization protects dogs against challenge with virulent canine parvovirus,"1998","16","6","601-607",Vaccine,"","","","","","","","9569471","","",0,10,0,120,0,,,
2591,0,"Raviprakash et al., 2001",journal,"Raviprakash K, Marques E, Ewing D, Lu Y, Phillips I, Porter KR, Kochel TJ, August TJ, Hayes CG, Murphy GS",Synergistic neutralizing antibody response to a dengue virus type 2 DNA vaccine by incorporation of lysosome-associated membrane protein sequences and use of plasmid expressing GM-CSF,"2001","290","1","74-82",Virology,"","","","","","","","11883007","","",0,10,0,121,0,,,
2592,216,"Tompkins et al., 2007",journal,"Tompkins SM, Zhao ZS, Lo CY, Misplon JA, Liu T, Ye Z, Hogan RJ, Wu Z, Benton KA, Tumpey TM, Epstein SL","Matrix protein 2 vaccination and protection against influenza viruses, including subtype H5N1","2007","13","3","426-435",Emerging infectious diseases,"","","","","","","","17552096","","",0,10,0,0,0,,,
2593,66,"Wan et al., 2010",journal,"Wan C, Yi L, Yang Z, Yang J, Shao H, Zhang C, Pan Z",The Toll-like receptor adaptor molecule TRIF enhances DNA vaccination against classical swine fever,"2010","137","1-2","47-53",Veterinary immunology and immunopathology,"","","","","","","","20466439","","",0,10,0,0,0,,,
2594,238,"Xue et al., 2011",journal,"Xue H, Liang F, Liu N, Song X, Yuan F, Luo Y, Zhao X, Long J, Sun Y, Xi Y",Potent antirheumatic activity of a new DNA vaccine targeted to B7-2/CD28 costimulatory signaling pathway in autoimmune arthritis,"2011","22","1","65-76",Human gene therapy,"","","","","","","","20695769","",,0,0,0,0,0,,,
2595,0,"Costa et al., 2006",journal,"Costa SM, Paes MV, Barreto DF, Pinho AT, Barth OM, Queiroz JL, Arma GR, Freire MS, Alves AM",Protection against dengue type 2 virus induced in mice immunized with a DNA plasmid encoding the non-structural 1 (NS1) gene fused to the tissue plasminogen activator signal sequence,"2006","24","2","195-205",Vaccine,"","","","","","","","16122850","","",0,10,0,122,0,,,
2596,0,"Apt et al., 2006",journal,"Apt D, Raviprakash K, Brinkman A, Semyonov A, Yang S, Skinner C, Diehl L, Lyons R, Porter K, Punnonen J",Tetravalent neutralizing antibody response against four dengue serotypes by a single chimeric dengue envelope antigen,"2006","24","3","335-344",Vaccine,"","","","","","","","16125280","","",0,10,0,123,0,,,
2597,0,Addgene - pET11d,website,"","","","","","","","","","","","","","","",http://www.addgene.org/vector-database/2628/,"",0,10,0,124,0,,,
2598,0,"Vipond et al., 2006",journal,"Vipond J, Clark SO, Hatch GJ, Vipond R, Marie Agger E, Tree JA, Williams A, Marsh PD",Re-formulation of selected DNA vaccine candidates and their evaluation as protein vaccines using a guinea pig aerosol infection model of tuberculosis,"2006","86","3-4","218-224","Tuberculosis (Edinburgh, Scotland)","","","","","","","","16520093","","",0,10,0,124,0,,,
2599,0,"Kumar et al., 2003",journal,"Kumar P, Amara RR, Challu VK, Chadda VK, Satchidanandam V",The Apa protein of Mycobacterium tuberculosis stimulates gamma interferon-secreting CD4+ and CD8+ T cells from purified protein derivative-positive individuals and affords protection in a guinea pig model,"2003","71","4","1929-1937",Infection and immunity,"","","","","","","","12654810","","",0,10,0,125,0,,,
2600,0,Aldevron - pUMVC3,website,"","","","","","","","","","","","","","","",http://www.aldevron.com/products/dnas/umvc_expression/,"",0,10,0,125,0,,,
2601,0,"Papa et al., 1998",journal,"Papa S, Rinaldi M, Mangia A, Parrella P, Signori E, Lombardi L, Fazio VM",Development of a multigenic plasmid vector for HCV DNA immunization,"1998","149","5","315-319",Research in virology,"","","","","","","","9879611","","",0,10,0,126,0,,,
2602,0,"Khera et al., 2005",journal,"Khera A, Singh R, Shakila H, Rao V, Dhar N, Narayanan PR, Parmasivan CN, Ramanathan VD, Tyagi AK","Elicitation of efficient, protective immune responses by using DNA vaccines against tuberculosis","2005","23","48-49","5655-5665",Vaccine,"","","","","","","","16157425","","",0,10,0,127,0,,,
2603,0,"Bharadwaj et al., 1999",journal,"Bharadwaj M, Lyons CR, Wortman IA, Hjelle B",Intramuscular inoculation of Sin Nombre hantavirus cDNAs induces cellular and humoral immune responses in BALB/c mice,"1999","17","22","2836-2843",Vaccine,"","","","","","","","10438054","","",0,10,0,128,0,,,
2604,0,"Malm et al., 2005",journal,"Malm M, Rollman E, Ustav M, Hinkula J, Krohn K, Wahren B, Blazevic V","Cross-clade protection induced by human immunodeficiency virus-1 DNA immunogens expressing consensus sequences of multiple genes and epitopes from subtypes A, B, C, and FGH","2005","18","4","678-688",Viral immunology,"","","","","","","","16359234","","",0,10,0,129,0,,,
2605,0,"Dale et al., 2004",journal,"Dale CJ, De Rose R, Stratov I, Chea S, Montefiori DC, Thomson S, Ramshaw IA, Coupar BE, Boyle DB, Law M, Kent SJ",Efficacy of DNA and fowlpox virus priming/boosting vaccines for simian/human immunodeficiency virus,"2004","78","24","13819-13828",Journal of virology,"","","","","","","","15564490","","",0,10,0,130,0,,,
2606,0,"Boyer et al., 1997",journal,"Boyer JD, Ugen KE, Wang B, Agadjanyan M, Gilbert L, Bagarazzi ML, Chattergoon M, Frost P, Javadian A, Williams WV, Refaeli Y, Ciccarelli RB, McCallus D, Coney L, Weiner DB",Protection of chimpanzees from high-dose heterologous HIV-1 challenge by DNA vaccination,"1997","3","5","526-532",Nature medicine,"","","","","","","","9142121","","",0,10,0,131,0,,,
2607,0,"Lekutis et al., 1997",journal,"Lekutis C, Shiver JW, Liu MA, Letvin NL",HIV-1 env DNA vaccine administered to rhesus monkeys elicits MHC class II-restricted CD4+ T helper cells that secrete IFN-gamma and TNF-alpha,"1997","158","9","4471-4477","Journal of immunology (Baltimore, Md. : 1950)","","","","","","","","9127013","","",0,10,0,132,0,,,
2608,0,"Locher et al., 2004",journal,"Locher CP, Witt SA, Ashlock BM, Polacino P, Hu SL, Shiboski S, Schmidt AM, Agy MB, Anderson DM, Staprans SI, zur Megede J, Levy JA",Human immunodeficiency virus type 2 DNA vaccine provides partial protection from acute baboon infection,"2004","22","17-18","2261-2272",Vaccine,"","","","","","","","15149785","","",0,10,0,133,0,,,
2609,0,Bioresearch Online - pRc/CMV-HBs(S),website,"","","","","","","","","","","","","","","",http://www.bioresearchonline.com/doc/pRcCMV-HBsS-0001,"",0,10,0,134,0,,,
2610,0,"Lillehoj et al., 2005",journal,"Lillehoj HS, Ding X, Quiroz MA, Bevensee E, Lillehoj EP","Resistance to intestinal coccidiosis following DNA immunization with the cloned 3-1E Eimeria gene plus IL-2, IL-15, and IFN-gamma","2005","49","1","112-117",Avian diseases,"","","","","","","","15839423","","",0,10,0,135,0,,,
2611,0,"Du et al., 2007",journal,"Du X, Zheng G, Jin H, Kang Y, Wang J, Xiao C, Zhang S, Zhao L, Chen A, Wang B",The adjuvant effects of co-stimulatory molecules on cellular and memory responses to HBsAg DNA vaccination,"2007","9","2","136-146",The journal of gene medicine,"","","","","","","","17310492","","",0,10,0,136,0,,,
2612,0,"Sullivan et al., 2000",journal,"Sullivan NJ, Sanchez A, Rollin PE, Yang ZY, Nabel GJ",Development of a preventive vaccine for Ebola virus infection in primates,"2000","408","6812","605-609",Nature,"","","","","","","","11117750","","",0,10,0,137,0,,,
2613,0,"Hanlon et al., 2001",journal,"Hanlon L, Argyle D, Bain D, Nicolson L, Dunham S, Golder MC, McDonald M, McGillivray C, Jarrett O, Neil JC, Onions DE",Feline leukemia virus DNA vaccine efficacy is enhanced by coadministration with interleukin-12 (IL-12) and IL-18 expression vectors,"2001","75","18","8424-8433",Journal of virology,"","","","","","","","11507187","","",0,10,0,138,0,,,
2614,0,"Brinkman et al., 2007",journal,"Brinkman JA, Xu X, Kast WM",The efficacy of a DNA vaccine containing inserted and replicated regions of the E7 gene for treatment of HPV-16 induced tumors,"2007","25","17","3437-3444",Vaccine,"","","","","","","","17241713","","",0,10,0,139,0,,,
2615,0,Addgene - pEGFP-N1,website,"","","","","","","","","","","","","","","",http://www.addgene.org/vector-database/2491/,"",0,10,0,140,0,,,
2616,0,Addgene - pcDL-SRa296,website,"","","","","","","","","","","","","","","",http://www.addgene.org/vector-database/2084/,"",0,10,0,141,0,,,
2617,0,"Takebe et al., 1988",journal,"Takebe Y, Seiki M, Fujisawa J, Hoy P, Yokota K, Arai K, Yoshida M, Arai N",SR alpha promoter: an efficient and versatile mammalian cDNA expression system composed of the simian virus 40 early promoter and the R-U5 segment of human T-cell leukemia virus type 1 long terminal repeat,"1988","8","1","466-472",Molecular and cellular biology,"","","","","","","","2827008","","",0,10,0,141,0,,,
2618,0,"Xu et al., 2004",journal,"Xu G, Xu X, Li Z, He Q, Wu B, Sun S, Chen H",Construction of recombinant pseudorabies virus expressing NS1 protein of Japanese encephalitis (SA14-14-2) virus and its safety and immunogenicity,"2004","22","15-16","1846-1853",Vaccine,"","","","","","","","15121294","","",0,10,0,142,0,,,
2619,0,"Konishi et al., 2003",journal,"Konishi E, Ajiro N, Nukuzuma C, Mason PW, Kurane I",Comparison of protective efficacies of plasmid DNAs encoding Japanese encephalitis virus proteins that induce neutralizing antibody or cytotoxic T lymphocytes in mice,"2003","21","25-26","3675-3683",Vaccine,"","","","","","","","12922097","","",0,10,0,143,0,,,
2620,0,Addgene - pcDNA3.1/Hygro(-),website,"","","","","","","","","","","","","","","",http://www.addgene.org/vector-database/2105/,"",0,10,0,144,0,,,
2621,0,"Ahmed et al., 2009",journal,"Ahmed SB, Touihri L, Chtourou Y, Dellagi K, Bahloul C",DNA based vaccination with a cocktail of plasmids encoding immunodominant Leishmania (Leishmania) major antigens confers full protection in BALB/c mice,"2009","27","1","99-9106",Vaccine,"","","","","","","","18951941","","",0,10,0,145,0,,,
2622,0,"Riemenschneider et al., 2003",journal,"Riemenschneider J, Garrison A, Geisbert J, Jahrling P, Hevey M, Negley D, Schmaljohn A, Lee J, Hart MK, Vanderzanden L, Custer D, Bray M, Ruff A, Ivins B, Bassett A, Rossi C, Schmaljohn C","Comparison of individual and combination DNA vaccines for B. anthracis, Ebola virus, Marburg virus and Venezuelan equine encephalitis virus","2003","21","25-26","4071-4080",Vaccine,"","","","","","","","12922144","","",0,10,0,146,0,,,
2623,0,"Price et al., 2001",journal,"Price BM, Galloway DR, Baker NR, Gilleland LB, Staczek J, Gilleland HE Jr",Protection against Pseudomonas aeruginosa chronic lung infection in mice by genetic immunization against outer membrane protein F (OprF) of P. aeruginosa,"2001","69","5","3510-3515",Infection and immunity,"","","","","","","","11292786","","",0,10,0,147,0,,,
2624,0,"Doolan et al., 1996",journal,"Doolan DL, Sedegah M, Hedstrom RC, Hobart P, Charoenvit Y, Hoffman SL","Circumventing genetic restriction of protection against malaria with multigene DNA immunization: CD8+ cell-, interferon gamma-, and nitric oxide-dependent immunity","1996","183","4","1739-1746",The Journal of experimental medicine,"","","","","","","","8666931","","",0,10,0,148,0,,,
2625,0,Addgene - pcDNA3.1/V5-His-TOPO,website,"","","","","","","","","","","","","","","",http://www.addgene.org/vector-database/5587/,"",0,10,0,149,0,,,
2626,0,Metalife - pIRES1neo,website,"","","","","","","","","","","","","","","",http://www.metalife.com/Genbank/1899169,"",0,10,0,150,0,,,
2627,0,Addgene - pRc/RSV,website,"","","","","","","","","","","","","","","",http://www.addgene.org/vector-database/3908/,"",0,10,0,151,0,,,
2628,0,"Nagarajan et al., 2009",journal,"Nagarajan AG, Balasundaram SV, Janice J, Karnam G, Eswarappa SM, Chakravortty D",SopB of Salmonella enterica serovar Typhimurium is a potential DNA vaccine candidate in conjugation with live attenuated bacteria,"2009","27","21","2804-2811",Vaccine,"","","","","","","","19428891","","",0,10,0,152,0,,,
2629,0,"Boyer et al., 2007",journal,"Boyer JD, Robinson TM, Kutzler MA, Vansant G, Hokey DA, Kumar S, Parkinson R, Wu L, Sidhu MK, Pavlakis GN, Felber BK, Brown C, Silvera P, Lewis MG, Monforte J, Waldmann TA, Eldridge J, Weiner DB",Protection against simian/human immunodeficiency virus (SHIV) 89.6P in macaques after coimmunization with SHIV antigen and IL-15 plasmid,"2007","104","47","18648-18653",Proceedings of the National Academy of Sciences of the United States of America,"","","","","","","","18000037","","",0,10,0,153,0,,,
2630,0,"Bertley et al., 2004",journal,"Bertley FM, Kozlowski PA, Wang SW, Chappelle J, Patel J, Sonuyi O, Mazzara G, Montefiori D, Carville A, Mansfield KG, Aldovini A",Control of simian/human immunodeficiency virus viremia and disease progression after IL-2-augmented DNA-modified vaccinia virus Ankara nasal vaccination in nonhuman primates,"2004","172","6","3745-3757","Journal of immunology (Baltimore, Md. : 1950)","","","","","","","","15004179","","",0,10,0,154,0,,,
2631,0,"Sepulveda et al., 2000",journal,"Sepulveda P, Hontebeyrie M, Liegeard P, Mascilli A, Norris KA",DNA-Based immunization with Trypanosoma cruzi complement regulatory protein elicits complement lytic antibodies and confers protection against Trypanosoma cruzi infection,"2000","68","9","4986-4991",Infection and immunity,"","","","","","","","10948115","","",0,10,0,155,0,,,
2632,0,Clontech - pGFP,website,"","","","","","","","","","","","","","","",http://www.clontech.com/xxclt_ibcGetAttachment.jsp?cItemId=17740,"",0,10,0,156,0,,,
2633,0,Addgene - pCMV-beta,website,"","","","","","","","","","","","","","","",http://www.addgene.org/vector-database/2245/,"",0,10,0,157,0,,,
2634,0,"Sakhatskyy et al., 2006",journal,"Sakhatskyy P, Wang S, Chou TH, Lu S",Immunogenicity and protection efficacy of monovalent and polyvalent poxvirus vaccines that include the D8 antigen,"2006","355","2","164-174",Virology,"","","","","","","","16919703","","",0,10,0,158,0,,,
2635,0,NIH AIDS Reagent Program,website,"","","","","","","","","","","","","","","",https://www.aidsreagent.org/reagentdetail.cfm?t=cloning_vectors&id=76,"",0,10,0,159,0,,,
2636,0,"Yamanaka et al., 2008",journal,"Yamanaka H, Hoyt T, Yang X, Golden S, Bosio CM, Crist K, Becker T, Maddaloni M, Pascual DW",A nasal interleukin-12 DNA vaccine coexpressing Yersinia pestis F1-V fusion protein confers protection against pneumonic plague,"2008","76","10","4564-4573",Infection and immunity,"","","","","","","","18694965","","",0,10,0,160,0,,,
2637,0,"Tirabassi et al., 2011",journal,"Tirabassi RS, Ace CI, Levchenko T, Torchilin VP, Selin LK, Nie S, Guberski DL, Yang K",A mucosal vaccination approach for herpes simplex virus type 2,"2011","29","5","1090-1098",Vaccine,"","","","","","","","21134447","","",0,10,0,161,0,,,
2638,0,"Horton et al., 1999",journal,"Horton HM, Anderson D, Hernandez P, Barnhart KM, Norman JA, Parker SE",A gene therapy for cancer using intramuscular injection of plasmid DNA encoding interferon alpha,"1999","96","4","1553-1558",Proceedings of the National Academy of Sciences of the United States of America,"","","","","","","","9990062","","",0,10,0,162,0,,,
2639,0,"Hu et al., 2011",journal,"Hu K, Dou J, Yu F, He X, Yuan X, Wang Y, Liu C, Gu N",An ocular mucosal administration of nanoparticles containing DNA vaccine pRSC-gD-IL-21 confers protection against mucosal challenge with herpes simplex virus type 1 in mice,"2011","29","7","1455-1462",Vaccine,"","","","","","","","21185849","","",0,10,0,163,0,,,
2640,167,"Kapczynski and Sellers, 2003",journal,"Kapczynski DR, Sellers HS",Immunization of turkeys with a DNA vaccine expressing either the F or N gene of avian metapneumovirus,"2003","47","4","1376-1383",Avian diseases,"","","","","","","","14708985","",,0,0,0,0,0,,,
2641,142,"Wan et al., 2011",journal,"Wan J, Wang C, Wen X, Huang X, Ling S, Huang Y, Cao S",Immunogenicity of a DNA vaccine of Avian Reovirus orally delivered by attenuated Salmonella typhimurium,"2011","91","3","382-383",Research in veterinary science,"","","","","","","","20947110","",,0,0,0,0,0,,,
2642,227,"Wang et al., 2013",journal,"Wang H, Yao Y, Huang C, Chen Q, Chen J, Chen Z",Immunization with cytomegalovirus envelope glycoprotein M and glycoprotein N DNA vaccines can provide mice with complete protection against a lethal murine cytomegalovirus challenge,"2013","","","",Virologica Sinica,"","","","","","","","23715998","","",0,10,0,0,0,,,
2643,98,"Xu et al., 2013",journal,"Xu J, Zhang Y, Tao J",Efficacy of a DNA Vaccine Carrying Eimeria maxima Gam56 Antigen Gene against Coccidiosis in Chickens,"2013","51","2","147-154",The Korean journal of parasitology,"","","","","","","","23710081","",,0,0,0,0,0,,,
2644,0,Addgene - pcDNA3.1/Zeo(+),website,"","","","","","","","","","","","","","","",http://www.addgene.org/vector-database/2110/,"",0,10,0,164,0,,,
2645,91,"Yuan et al., 2013",journal,"Yuan ZG, Ren D, Zhou DH, Zhang XX, Petersen E, Li XZ, Zhou Y, Yang GL, Zhu XQ",Evaluation of protective effect of pVAX-TgMIC13 plasmid against acute and chronic Toxoplasma gondii infection in a murine model,"2013","","","",Vaccine,"","","","","","","","23707448","","",0,10,0,0,0,,,
2646,255,"Fiedler et al., 2013",journal,"Fiedler M, Kosinska A, Schumann A, Brovko O, Walker A, Lu M, Johrden L, Mayer A, Wildner O, Roggendorf M",Prime/Boost Immunization with DNA and Adenoviral Vectors Protects from Hepatitis D Virus (HDV) Infection after Simultaneous Infection with HDV and Woodchuck Hepatitis Virus,"2013","","","",Journal of virology,"","","","","","","","23637419","","",0,10,0,0,0,,,
2647,115,"Hezarjaribi et al., 2013",journal,"Hezarjaribi HZ, Ghaffarifar F, Dalimi A, Sharifi Z, Jorjani O",Effect of IL-22 on DNA vaccine encoding LACK gene of Leishmania major in BALB/c mice,"2013","134","3","341-348",Experimental parasitology,"","","","","","","","23541883","","",0,10,0,0,0,,,
2648,255,A.D.A.M. Medical Encyclopedia,website,"",Delta agent (Hepatitis D),"2012","","","","","","","","","","","","",http://www.ncbi.nlm.nih.gov/pubmedhealth/PMH0001264/,"",0,10,0,0,0,,,
2649,91,"Parthasarathy et al., 2013",journal,"Parthasarathy S, Fong MY, Ramaswamy K, Lau YL",Protective Immune Response in BALB/c Mice Induced by DNA Vaccine of the ROP8 gene of Toxoplasma gondii,"2013","88","5","883-887",The American journal of tropical medicine and hygiene,"","","","","","","","23509124","","",0,10,0,0,0,,,
2650,118,"Quijano-Hernndez et al., 2013",journal,"Quijano-Hernndez IA, Castro-Barcena A, Vzquez-Chagoyn JC, Bolio-Gonzlez ME, Ortega-Lpez J, Dumonteil E",Preventive and therapeutic DNA vaccination partially protect dogs against an infectious challenge with Trypanosoma cruzi,"2013","31","18","2246-2252",Vaccine,"","","","","","","","23499599","","",0,10,0,0,0,,,
2651,146,"Gao et al., 2013",journal,"Gao H, Li K, Gao L, Qi X, Gao Y, Qin L, Wang Y, Wang X",DNA prime-protein boost vaccination enhances protective immunity against infectious bursal disease virus in chickens,"2013","164","1-2","9-17",Veterinary microbiology,"","","","","","","","23419823","","",0,10,0,0,0,,,
2652,146,"Li et al., 2013",journal,"Li K, Gao H, Gao L, Qi X, Gao Y, Qin L, Wang Y, Wang X",Adjuvant effects of interleukin-18 in DNA vaccination against infectious bursal disease virus in chickens,"2013","31","14","1799-1805",Vaccine,"","","","","","","","23395585","","",0,10,0,0,0,,,
2653,145,"Yan et al., 2013",journal,"Yan F, Zhao Y, Hu Y, Qiu J, Lei W, Ji W, Li X, Wu Q, Shi X, Li Z",Protection of chickens against infectious bronchitis virus with a multivalent DNA vaccine and boosting with an inactivated vaccine,"2013","14","1","53-60",Journal of veterinary science,"","","","","","","","23388447","","",0,10,0,0,0,,,
2654,161,"Gong et al., 2013",journal,"Gong Q, Qu N, Niu M, Qin C, Cheng M, Sun X, Zhang A",Immune responses and protective efficacy of a novel DNA vaccine encoding outer membrane protein of avian Pasteurella multocida,"2013","152","3-4","317-324",Veterinary immunology and immunopathology,"","","","","","","","23340446","","",0,10,0,0,0,,,
2655,256,"Liang et al., 2008",journal,"Liang R, van den Hurk JV, Landi A, Lawman Z, Deregt D, Townsend H, Babiuk LA, van Drunen Littel-van den Hurk S",DNA prime protein boost strategies protect cattle from bovine viral diarrhea virus type 2 challenge,"2008","89",Pt 2,"453-466",The Journal of general virology,"","","","","","","","18198376","","",0,10,0,0,0,,,
2656,256,"van et al., 2013",journal,"van Drunen Littel-van den Hurk S, Lawman Z, Snider M, Wilson D, van den Hurk JV, Ellefsen B, Hannaman D",Two doses of bovine viral diarrhea virus DNA vaccine delivered by electroporation induce long-term protective immune responses,"2013","20","2","166-173",Clinical and vaccine immunology : CVI,"","","","","","","","23220999","","",0,10,0,0,0,,,
2657,256,Merck Vet Manual: Bovine Viral Diarrhea,website,"",Merck Vet Manual: Bovine Viral Diarrhea and Mucosal Disease Complex,"","","","","","","","","","","","","",http://www.merckmanuals.com/vet/digestive_system/intestinal_diseases_in_ruminants/intestinal_diseases_in_cattle.html#v3263133?qt=&sc=&alt=,"",0,10,0,0,0,,,
2658,152,"Chen et al., 2009",journal,"Chen KX, Li YJ, Zhang FC, Cao WY, Li JW",[Enhancement of antibodies to protective domain of surface protective antigen A of Erysipelothrix rhusiopathiae by DNA immunization with plasmids expressing spaA-chimeras],"2009","25","11","984-986",Xi bao yu fen zi mian yi xue za zhi = Chinese journal of cellular and molecular immunology,"","","","","","","","19900362","","",0,10,0,0,0,,,
2659,119,"Martin et al., 2003",journal,"Martin E, Kamath AT, Briscoe H, Britton WJ",The combination of plasmid interleukin-12 with a single DNA vaccine is more effective than Mycobacterium bovis (bacille Calmette-Gurin) in protecting against systemic Mycobacterim avium infection,"2003","109","2","308-314",Immunology,"","","","","","","","12757627","","",0,10,0,0,0,,,
2660,138,"Gaudreau et al., 2007",journal,"Gaudreau MC, Lacasse P, Talbot BG",Protective immune responses to a multi-gene DNA vaccine against Staphylococcus aureus,"2007","25","5","814-824",Vaccine,"","","","","","","","17027124","","",0,10,0,0,0,,,
2661,138,"Castagliuolo et al., 2006",journal,"Castagliuolo I, Piccinini R, Beggiao E, Pal G, Mengoli C, Ditadi F, Vicenzoni G, Zecconi A",Mucosal genetic immunization against four adhesins protects against Staphylococcus aureus-induced mastitis in mice,"2006","24","20","4393-4402",Vaccine,"","","","","","","","16580097","","",0,10,0,0,0,,,
2662,7,"Livingston et al., 2010",journal,"Livingston BD, Little SF, Luxembourg A, Ellefsen B, Hannaman D",Comparative performance of a licensed anthrax vaccine versus electroporation based delivery of a PA encoding DNA vaccine in rhesus macaques,"2010","28","4","1056-1061",Vaccine,"","","","","","","","19896452","","",0,10,0,0,0,,,
2663,109,"Kamachi et al., 2003",journal,"Kamachi K, Konda T, Arakawa Y",DNA vaccine encoding pertussis toxin S1 subunit induces protection against Bordetella pertussis in mice,"2003","21","31","4609-4615",Vaccine,"","","","","","","","14575775","","",0,10,0,0,0,,,
2664,8,"Sislema-Egas et al., 2012",journal,"Sislema-Egas F, Cspedes S, Fernndez P, Retamal-Daz A, Sez D, Oate A",Evaluation of protective effect of DNA vaccines encoding the BAB1_0263 and BAB1_0278 open reading frames of Brucella abortus in BALB/c mice,"2012","30","50","7286-7291",Vaccine,"","","","","","","","23026687","","",0,10,0,0,0,,,
2665,0,"Sislema-Egas et al., 2012",journal,"Sislema-Egas F, Cspedes S, Fernndez P, Retamal-Daz A, Sez D, Oate A",Evaluation of protective effect of DNA vaccines encoding the BAB1_0263 and BAB1_0278 open reading frames of Brucella abortus in BALB/c mice,"2012","30","50","7286-7291",Vaccine,"","","","","","","","23026687","","",0,10,0,165,0,,,
2666,166,"Register et al., 2007",journal,"Register KB, Sacco RE, Brockmeier SL",Immune response in mice and swine to DNA vaccines derived from the Pasteurella multocida toxin gene,"2007","25","32","6118-6128",Vaccine,"","","","","","","","17590484","",,0,0,0,0,0,,,
2667,126,"Lima et al., 2011",journal,"Lima DM, de Paula SO, Frana RF, Palma PV, Morais FR, Gomes-Ruiz AC, de Aquino MT, da Fonseca BA",A DNA vaccine candidate encoding the structural prM/E proteins elicits a strong immune response and protects mice against dengue-4 virus infection,"2011","29","4","831-838",Vaccine,"","","","","","","","21115054","","",0,10,0,0,0,,,
2668,126,"Chen et al., 2007",journal,"Chen L, Ewing D, Subramanian H, Block K, Rayner J, Alterson KD, Sedegah M, Hayes C, Porter K, Raviprakash K",A heterologous DNA prime-Venezuelan equine encephalitis virus replicon particle boost dengue vaccine regimen affords complete protection from virus challenge in cynomolgus macaques,"2007","81","21","11634-11639",Journal of virology,"","","","","","","","17715224","","",0,10,0,0,0,,,
2669,88,"Du and Wang, 2005",journal,"Du A, Wang S",Efficacy of a DNA vaccine delivered in attenuated Salmonella typhimurium against Eimeria tenella infection in chickens,"2005","35","7","777-785",International journal for parasitology,"","","","","","","","15890351","",,0,0,0,0,0,,,
2670,0,"Dale et al., 2004",journal,"Dale CJ, De Rose R, Stratov I, Chea S, Montefiori DC, Thomson S, Ramshaw IA, Coupar BE, Boyle DB, Law M, Kent SJ",Efficacy of DNA and fowlpox virus priming/boosting vaccines for simian/human immunodeficiency virus,"2004","78","24","13819-13828",Journal of virology,"","","","","","","","15564490","","",0,10,0,20,0,,,
2671,154,"Hosie et al., 1998",journal,"Hosie MJ, Flynn JN, Rigby MA, Cannon C, Dunsford T, Mackay NA, Argyle D, Willett BJ, Miyazawa T, Onions DE, Jarrett O, Neil JC",DNA vaccination affords significant protection against feline immunodeficiency virus infection without inducing detectable antiviral antibodies,"1998","72","9","7310-7319",Journal of virology,"","","","","","","","9696827","",,0,0,0,0,0,,,
2672,206,"Dar et al., 2012",journal,"Dar PA, Ganesh K, Nagarajan G, Sarika S, Reddy GR, Suryanarayana VV",Sindbis virus replicase-based DNA vaccine construct encoding FMDV-specific multivalent epitope gene: studies on its immune responses in guinea pigs,"2012","76","4","345-353",Scandinavian journal of immunology,"","","","","","","","22702835","",,0,0,0,0,0,,,
2673,206,"Reddy et al., 2012",journal,"Reddy KS, Rashmi BR, Dechamma HJ, Gopalakrishna S, Banumathi N, Suryanarayana VV, Reddy GR","Cationic microparticle [poly(D,L-lactide-co-glycolide)]-coated DNA vaccination induces a long-term immune response against foot and mouth disease in guinea pigs","2012","14","5","348-352",The journal of gene medicine,"","","","","","","","22438260","",,0,0,0,0,0,,,
2674,206,"Fowler et al., 2012",journal,"Fowler V, Robinson L, Bankowski B, Cox S, Parida S, Lawlor C, Gibson D, O'Brien F, Ellefsen B, Hannaman D, Takamatsu HH, Barnett PV",A DNA vaccination regime including protein boost and electroporation protects cattle against foot-and-mouth disease,"2012","94","1","25-34",Antiviral research,"","","","","","","","22330893","",,0,0,0,0,0,,,
2675,208,"Schautteet et al., 2011",journal,"Schautteet K, Stuyven E, Beeckman DS, Van Acker S, Carlon M, Chiers K, Cox E, Vanrompay D",Protection of pigs against Chlamydia trachomatis challenge by administration of a MOMP-based DNA vaccine in the vaginal mucosa,"2011","29","7","1399-1407",Vaccine,"","","","","","","","21195805","","",0,10,0,0,0,,,
2676,112,"Svanholm et al., 2000",journal,"Svanholm C, Bandholtz L, Castaos-Velez E, Wigzell H, Rottenberg ME",Protective DNA immunization against Chlamydia pneumoniae,"2000","51","4","345-353",Scandinavian journal of immunology,"","","","","","","","10736106","","",0,10,0,0,0,,,
2677,209,"Jiao et al., 2009",journal,"Jiao XD, Zhang M, Hu YH, Sun L",Construction and evaluation of DNA vaccines encoding Edwardsiella tarda antigens,"2009","27","38","5195-5202",Vaccine,"","","","","","","","19596416","","",0,10,0,0,0,,,
2678,209,"Sun et al., 2011",journal,"Sun Y, Liu CS, Sun L",Construction and analysis of the immune effect of an Edwardsiella tarda DNA vaccine encoding a D15-like surface antigen,"2011","30","1","273-279",Fish & shellfish immunology,"","","","","","","","21059395","","",0,10,0,0,0,,,
2679,0,"Sun et al., 2011",journal,"Sun Y, Liu CS, Sun L",Construction and analysis of the immune effect of an Edwardsiella tarda DNA vaccine encoding a D15-like surface antigen,"2011","30","1","273-279",Fish & shellfish immunology,"","","","","","","","21059395","","",0,10,0,166,0,,,
2680,0,"Jiao et al., 2009",journal,"Jiao XD, Zhang M, Hu YH, Sun L",Construction and evaluation of DNA vaccines encoding Edwardsiella tarda antigens,"2009","27","38","5195-5202",Vaccine,"","","","","","","","19596416","","",0,10,0,166,0,,,
2681,134,"Chen et al., 2012",journal,"Chen J, Lin L, Li N, She F",Enhancement of Helicobacter pylori outer inflammatory protein DNA vaccine efficacy by co-delivery of interleukin-2 and B subunit heat-labile toxin gene encoded plasmids,"2012","56","2","85-92",Microbiology and immunology,"","","","","","","","22150716","","",0,10,0,0,0,,,
2682,134,"Todoroki et al., 2000",journal,"Todoroki I, Joh T, Watanabe K, Miyashita M, Seno K, Nomura T, Ohara H, Yokoyama Y, Tochikubo K, Itoh M",Suppressive effects of DNA vaccines encoding heat shock protein on Helicobacter pylori-induced gastritis in mice,"2000","277","1","159-163",Biochemical and biophysical research communications,"","","","","","","","11027657","","",0,10,0,0,0,,,
2683,195,"Maneewatch et al., 2007",journal,"Maneewatch S, Tapchaisri P, Sakolvaree Y, Klaysing B, Tongtawe P, Chaisri U, Songserm T, Wongratanacheewin S, Srimanote P, Chongsa-nguanz M, Chaicumpa W",OmpL1 DNA vaccine cross-protects against heterologous Leptospira spp. challenge,"2007","25","1","75-82",Asian Pacific journal of allergy and immunology / launched by the Allergy and Immunology Society of Thailand,"","","","","","","","17891923","","",0,10,0,0,0,,,
2684,195,"Forster et al., 2013",journal,"Forster KM, Hartwig DD, Seixas FK, Bacelo KL, Amaral M, Hartleben CP, Dellagostin OA",A Conserved Region of Leptospiral Immunoglobulin-Like A and B Proteins as a DNA Vaccine Elicits a Prophylactic Immune Response against Leptospirosis,"2013","20","5","725-731",Clinical and vaccine immunology : CVI,"","","","","","","","23486420","","",0,10,0,0,0,,,
2685,0,"Shiver et al., 2002",journal,"Shiver JW, Fu TM, Chen L, Casimiro DR, Davies ME, Evans RK, Zhang ZQ, Simon AJ, Trigona WL, Dubey SA, Huang L, Harris VA, Long RS, Liang X, Handt L, Schleif WA, Zhu L, Freed DC, Persaud NV, Guan L, Punt KS, Tang A, Chen M, Wilson KA, Collins KB, Heidecker GJ, Fernandez VR, Perry HC, Joyce JG, Grimm KM, Cook JC, Keller PM, Kresock DS, Mach H, Troutman RD, Isopi LA, Williams DM, Xu Z, Bohannon KE, Volkin DB, Montefiori DC, Miura A, Krivulka GR, Lifton MA, Kuroda MJ, Schmitz JE, Letvin NL, Caulfield MJ, Bett AJ, Youil R, Kaslow DC, Emini EA",Replication-incompetent adenoviral vaccine vector elicits effective anti-immunodeficiency-virus immunity,"2002","415","6869","331-335",Nature,"","","","","","","","11797011","","",0,10,0,167,0,,,
2686,0,"Santra et al., 2004",journal,"Santra S, Barouch DH, Korioth-Schmitz B, Lord CI, Krivulka GR, Yu F, Beddall MH, Gorgone DA, Lifton MA, Miura A, Philippon V, Manson K, Markham PD, Parrish J, Kuroda MJ, Schmitz JE, Gelman RS, Shiver JW, Montefiori DC, Panicali D, Letvin NL",Recombinant poxvirus boosting of DNA-primed rhesus monkeys augments peak but not memory T lymphocyte responses,"2004","101","30","11088-11093",Proceedings of the National Academy of Sciences of the United States of America,"","","","","","","","15258286","","",0,10,0,167,0,,,
2687,0,"Yu et al., 2009",journal,"Yu Y, Yu J, Li N, Wang S, Yu W, Sun Z",Individual and bivalent vaccines against botulinum neurotoxin serotypes A and B using DNA-based Semliki Forest virus vectors,"2009","27","44","6148-6153",Vaccine,"","","","","","","","19712769","","",0,10,0,168,0,,,
2688,0,"Yu et al., 2007",journal,"Yu YZ, Zhang SM, Sun ZW, Wang S, Yu WY",Enhanced immune responses using plasmid DNA replicon vaccine encoding the Hc domain of Clostridium botulinum neurotoxin serotype A,"2007","25","52","8843-8850",Vaccine,"","","","","","","","18022294","","",0,10,0,168,0,,,
2689,244,Wikipedia - Sindbis virus,website,"",Sindbis virus,"","","","","","","","","","","","","",http://en.wikipedia.org/wiki/Sindbis_virus,"",0,10,0,0,0,,,
2690,213,"Flatz et al., 2012",journal,"Flatz L, Cheng C, Wang L, Foulds KE, Ko SY, Kong WP, Roychoudhuri R, Shi W, Bao S, Todd JP, Asmal M, Shen L, Donaldson M, Schmidt SD, Gall JG, Pinschewer DD, Letvin NL, Rao S, Mascola JR, Roederer M, Nabel GJ",Gene-based vaccination with a mismatched envelope protects against simian immunodeficiency virus infection in nonhuman primates,"2012","86","15","7760-7770",Journal of virology,"","","","","","","","22593152","","",0,10,0,0,0,,,
2691,157,"Chen et al., 2011",journal,"Chen HY, Zhang HY, Li XS, Cui BA, Wang SJ, Geng JW, Li K",Interleukin-18-mediated enhancement of the protective effect of an infectious laryngotracheitis virus glycoprotein B plasmid DNA vaccine in chickens,"2011","60",Pt 1,"110-116",Journal of medical microbiology,"","","","","","","","20829398","","",0,10,0,0,0,,,
2692,237,CDC - Basics about Diabetes,website,"",Basics about Diabetes,"2012","","","","","","","","","","","","",http://www.cdc.gov/diabetes/consumer/learn.htm,"",0,10,0,0,0,,,
2693,239,"Seo et al., 2006",journal,"Seo JY, Kim KH, Kim SG, Oh MJ, Nam SW, Kim YT, Choi TJ",Protection of flounder against hirame rhabdovirus (HIRRV) with a DNA vaccine containing the glycoprotein gene,"2006","24","7","1009-1015",Vaccine,"","","","","","","","16176849","","",0,10,0,0,0,,,
2694,50,"Tompkins et al., 2007",journal,"Tompkins SM, Zhao ZS, Lo CY, Misplon JA, Liu T, Ye Z, Hogan RJ, Wu Z, Benton KA, Tumpey TM, Epstein SL","Matrix protein 2 vaccination and protection against influenza viruses, including subtype H5N1","2007","13","3","426-435",Emerging infectious diseases,"","","","","","","","17552096","","",0,10,0,0,0,,,
2695,231,"Wang et al., 2013",journal,"Wang H, Yao Y, Huang C, Chen Q, Chen J, Chen Z",Immunization with cytomegalovirus envelope glycoprotein M and glycoprotein N DNA vaccines can provide mice with complete protection against a lethal murine cytomegalovirus challenge,"2013","28","3","174-182",Virologica Sinica,"","","","","","","","23715998","",,0,0,0,0,0,,,
2696,210,"Kapczynski and Sellers, 2003",journal,"Kapczynski DR, Sellers HS",Immunization of turkeys with a DNA vaccine expressing either the F or N gene of avian metapneumovirus,"2003","47","4","1376-1383",Avian diseases,"","","","","","","","14708985","",,0,0,0,0,0,,,
2697,0,"Jadav et al., 2011",journal,"Jadav SK, Reddy KS, Rashmi BR, Dechamma HJ, Ganesh K, Suryanarayana VV, Reddy GR",Improved immune response by ID-pVAC: a secretory DNA vaccine construct delivered by PLG micro particles against foot and mouth disease in guinea pigs,"2011","91","1","86-89",Research in veterinary science,"","","","","","","","20884037","","",0,10,0,169,0,,,
2698,0,"Nagarajan et al., 2011",journal,"Nagarajan G, Ravikumar P, Ashok Kumar C, Reddy GR, Dechamma HJ, Suryanarayana VV",Self Replicating Gene Vaccine Carrying P1-2A Gene of FMDV Serotype O and its Effects on the Immune Responses of Cattle,"2011","22","1","50-58",Indian journal of virology : an official organ of Indian Virological Society,"","","","","","","","23637502","","",0,10,0,170,0,,,
2699,0,"Dar et al., 2012",journal,"Dar PA, Ganesh K, Nagarajan G, Sarika S, Reddy GR, Suryanarayana VV",Sindbis virus replicase-based DNA vaccine construct encoding FMDV-specific multivalent epitope gene: studies on its immune responses in guinea pigs,"2012","76","4","345-353",Scandinavian journal of immunology,"","","","","","","","22702835","","",0,10,0,170,0,,,
2700,46,"Prinz et al., 2003",journal,"Prinz DM, Smithson SL, Kieber-Emmons T, Westerink MA",Induction of a protective capsular polysaccharide antibody response to a multiepitope DNA vaccine encoding a peptide mimic of meningococcal serogroup C capsular polysaccharide,"2003","110","2","242-249",Immunology,"","","","","","","","14511238","","",0,10,0,0,0,,,
2701,137,"Saha et al., 2006",journal,"Saha S, Takeshita F, Sasaki S, Matsuda T, Tanaka T, Tozuka M, Takase K, Matsumoto T, Okuda K, Ishii N, Yamaguchi K, Klinman DM, Xin KQ, Okuda K",Multivalent DNA vaccine protects mice against pulmonary infection caused by Pseudomonas aeruginosa,"2006","24","37-39","6240-6249",Vaccine,"","","","","","","","16806598","","",0,10,0,0,0,,,
2702,143,"Taylor et al., 2005",journal,"Taylor G, Bruce C, Barbet AF, Wyld SG, Thomas LH",DNA vaccination against respiratory syncytial virus in young calves,"2005","23","10","1242-1250",Vaccine,"","","","","","","","15652666","","",0,10,0,0,0,,,
2703,190,"Fu et al., 2012",journal,"Fu Y, Chen Z, Li C, Liu G",Protective immune responses in ducklings induced by a suicidal DNA vaccine of the VP1 gene of duck hepatitis virus type 1,"2012","160","3-4","314-318",Veterinary microbiology,"","","","","","","","22819169","","",0,10,0,0,0,,,
2704,27,"Hooper et al., 2001",journal,"Hooper JW, Custer DM, Thompson E, Schmaljohn CS",DNA vaccination with the Hantaan virus M gene protects Hamsters against three of four HFRS hantaviruses and elicits a high-titer neutralizing antibody response in Rhesus monkeys,"2001","75","18","8469-8477",Journal of virology,"","","","","","","","11507192","","",0,10,0,0,0,,,
2705,257,"Yuan et al., 2013",journal,"Yuan D, Qu L, Liu J, Guo D, Jiang Q, Lin H, Si C",DNA vaccination with a gene encoding VP60 elicited protective immunity against rabbit hemorrhagic disease virus,"2013","164","1-2","1-8",Veterinary microbiology,"","","","","","","","23419819","","",0,10,0,0,0,,,
2706,257,Wiki: Rabbit haemorrhagic disease,website,"",Rabbit haemorrhagic disease,"","","","","","","","","","","","","",https://en.wikipedia.org/wiki/Rabbit_haemorrhagic_disease,"",0,10,0,0,0,,,
2707,0,"Taylor et al., 2005",journal,"Taylor G, Bruce C, Barbet AF, Wyld SG, Thomas LH",DNA vaccination against respiratory syncytial virus in young calves,"2005","23","10","1242-1250",Vaccine,"","","","","","","","15652666","","",0,10,0,172,0,,,
2708,0,"Fu et al., 2012",journal,"Fu Y, Chen Z, Li C, Liu G",Protective immune responses in ducklings induced by a suicidal DNA vaccine of the VP1 gene of duck hepatitis virus type 1,"2012","160","3-4","314-318",Veterinary microbiology,"","","","","","","","22819169","","",0,10,0,173,0,,,
2709,0,"Takeshita et al., 2007",journal,"Takeshita F, Takase K, Tozuka M, Saha S, Okuda K, Ishii N, Sasaki S",Muscle creatine kinase/SV40 hybrid promoter for muscle-targeted long-term transgene expression,"2007","19","2","309-315",International journal of molecular medicine,"","","","","","","","17203206","","",0,10,0,171,0,,,
2710,100,"Fan and Yang, 2010",journal,"Fan J, Yang H",Construction and immune response of HSV-2gD-Hsp70 DNA vaccine,"2010","57","1","64-66",Journal of dermatological science,"","","","","","","","19942410","","",0,10,0,0,0,,,
2711,212,"Wu et al., 2009",journal,"Wu H, Dennis VA, Pillai SR, Singh SR",RSV fusion (F) protein DNA vaccine provides partial protection against viral infection,"2009","145","1","39-47",Virus research,"","","","","","","","19540885","","",0,10,0,0,0,,,
2712,0,"Wu et al., 2009",journal,"Wu H, Dennis VA, Pillai SR, Singh SR",RSV fusion (F) protein DNA vaccine provides partial protection against viral infection,"2009","145","1","39-47",Virus research,"","","","","","","","19540885","","",0,10,0,174,0,,,
2713,0,Genlantis - phCMV1,website,"","","","","","","","","","","","","","","",http://www.genlantis.com/faq-phcmv.html,"",0,10,0,174,0,,,
2714,212,"Miller et al., 2002",journal,"Miller M, Cho JY, Baek KJ, Castaneda D, Nayar J, Rodriguez M, Roman M, Raz E, Broide DH",Plasmid DNA encoding the respiratory syncytial virus G protein protects against RSV-induced airway hyperresponsiveness,"2002","20","23-24","3023-3033",Vaccine,"","","","","","","","12126916","","",0,10,0,0,0,,,
2715,145,"Guo et al., 2010",journal,"Guo Z, Wang H, Yang T, Wang X, Lu D, Li Y, Zhang Y",Priming with a DNA vaccine and boosting with an inactivated vaccine enhance the immune response against infectious bronchitis virus,"2010","167","1","84-89",Journal of virological methods,"","","","","","","","20307574","","",0,10,0,0,0,,,
2716,145,"Tan et al., 2009",journal,"Tan B, Wang H, Shang L, Yang T",Coadministration of chicken GM-CSF with a DNA vaccine expressing infectious bronchitis virus (IBV) S1 glycoprotein enhances the specific immune response and protects against IBV infection,"2009","154","7","1117-1124",Archives of virology,"","","","","","","","19543689","","",0,10,0,0,0,,,
2717,145,"Yang et al., 2009",journal,"Yang T, Wang HN, Wang X, Tang JN, Gao R, Li J, Guo ZC, Li YL",Multivalent DNA vaccine enhanced protection efficacy against infectious bronchitis virus in chickens,"2009","71","12","1585-1590",The Journal of veterinary medical science / the Japanese Society of Veterinary Science,"","","","","","","","20046025","","",0,10,0,0,0,,,
2718,146,"Kumar et al., 2009",journal,"Kumar S, Ahi YS, Salunkhe SS, Koul M, Tiwari AK, Gupta PK, Rai A",Effective protection by high efficiency bicistronic DNA vaccine against infectious bursal disease virus expressing VP2 protein and chicken IL-2,"2009","27","6","864-869",Vaccine,"","","","","","","","19111591","","",0,10,0,0,0,,,
2719,51,"Kulkarni et al., 2012",journal,"Kulkarni R, Sapkal G, Gore M",Evaluation of Japanese encephalitis virus polytope DNA vaccine candidate in BALB/c mice,"2012","170","1-2","118-125",Virus research,"","","","","","","","23007095","","",0,10,0,0,0,,,
2720,51,"Wu et al., 2006",journal,"Wu CJ, Li TL, Huang HW, Tao MH, Chan YL",Development of an effective Japanese encephalitis virus-specific DNA vaccine,"2006","8","11","2578-2586",Microbes and infection / Institut Pasteur,"","","","","","","","16949850","","",0,10,0,0,0,,,
2721,0,Invitrogen - pSecTag2 C,website,"","","","","","","","","","","","","","","",http://tools.invitrogen.com/content/sfs/manuals/psectag2_man.pdf,"",0,10,0,175,0,,,
2722,0,"Wu et al., 2006",journal,"Wu CJ, Li TL, Huang HW, Tao MH, Chan YL",Development of an effective Japanese encephalitis virus-specific DNA vaccine,"2006","8","11","2578-2586",Microbes and infection / Institut Pasteur,"","","","","","","","16949850","","",0,10,0,176,0,,,
2723,0,"Kulkarni et al., 2012",journal,"Kulkarni R, Sapkal G, Mahishi L, Shil P, Gore MM",Design and characterization of polytope construct with multiple B and TH epitopes of Japanese encephalitis virus,"2012","166","1-2","77-86",Virus research,"","","","","","","","22445688","","",0,10,0,177,0,,,
2724,99,"Reid et al., 2004",journal,"Reid Y, Storts D, Riss T, Minor L",Authentication of Human Cell Lines by STR DNA Profiling Analysis,"2004","","","","","","","","","","","","23805434","","",0,10,0,0,0,,,
2725,0,"Dupuy et al., 2009",journal,"Dupuy LC, Locher CP, Paidhungat M, Richards MJ, Lind CM, Bakken R, Parker MD, Whalen RG, Schmaljohn CS",Directed molecular evolution improves the immunogenicity and protective efficacy of a Venezuelan equine encephalitis virus DNA vaccine,"2009","27","31","4152-4160",Vaccine,"","","","","","","","19406186","","",0,10,0,178,0,,,
2726,0,"Kaur et al., 2009",journal,"Kaur M, Rai A, Bhatnagar R",Rabies DNA vaccine: no impact of MHC class I and class II targeting sequences on immune response and protection against lethal challenge,"2009","27","15","2128-2137",Vaccine,"","","","","","","","19356616","","",0,10,0,179,0,,,
2727,258,"Drechsler et al., 2013",journal,"Drechsler Y, Tkalcic S, Saggese MD, Shivaprasad HL, Ajithdoss DK, Collisson EW",A DNA vaccine expressing ENV and GAG offers partial protection against reticuloendotheliosis virus in the prairie chicken (Tympanicus cupido),"2013","44","2","251-261",Journal of zoo and wildlife medicine : official publication of the American Association of Zoo Veterinarians,"","","","","","","","23805542","",,0,0,0,0,0,,,
2728,235,Wiki: Experimental autoimmune encephalomyelitis,website,"",Experimental autoimmune encephalomyelitis,"","","","","","","","","","","","","",http://en.wikipedia.org/wiki/Experimental_autoimmune_encephalomyelitis,"",0,10,0,0,0,,,
2729,236,"Commodaro et al., 2010",journal,"Commodaro AG, Peron JP, Lopes CT, Arslanian C, Belfort R Jr, Rizzo LV, Bueno V",Evaluation of experimental autoimmune uveitis in mice treated with FTY720,"2010","51","5","2568-2574",Investigative ophthalmology & visual science,"","","","","","","","20019358","","",0,10,0,0,0,,,
2730,0,NIH AIDS Reagent Program - pBC12/CMV,website,"","","","","","","","","","","","","","","",https://www.aidsreagent.org/reagentdetail.cfm?t=expression_vectors&id=159,"",0,10,0,5,0,,,
2731,0,Clontech - pBI/tTA,website,"","","","","","","","","","","","","","","",http://www.clontech.com/xxclt_ibcGetAttachment.jsp?cItemId=17933,"",0,10,0,7,0,,,
2732,0,Addgene- pCAGGS,website,"","","","","","","","","","","","","","","",http://www.addgene.org/vector-database/2042/,"",0,10,0,11,0,,,
2733,0,Invitrogen - pcDNA1/Amp,website,"","","","","","","","","","","","","","","",http://tools.invitrogen.com/content/sfs/productnotes/F_071215_MammalianExpressionVectors.pdf,"",0,10,0,15,0,,,
2734,0,Invitrogen - pcDNA3,website,"","","","","","","","","","","","","","","",http://tools.invitrogen.com/content/sfs/productnotes/F_051025_MammalianExpressionVectors-TS-TL-MKT-HL.pdf,"",0,10,0,16,0,,,
2735,0,Invitrogen - pcDNA3.1,website,"","","","","","","","","","","","","","","",http://tools.invitrogen.com/content/sfs/productnotes/F_051025_MammalianExpressionVectors-TS-TL-MKT-HL.pdf,"",0,10,0,17,0,,,
2736,0,Invitrogen - pcDNA3.1V5HisTOPO/TA,website,"","","","","","","","","","","","","","","",http://products.invitrogen.com/ivgn/product/K480001,"",0,10,0,18,0,,,
2737,0,Promega - pCI,website,"","","","","","","","","","","","","","","",http://www.promega.com/products/vectors/mammalian-expression-vectors/pci-mammalian-expression-vector/,"",0,10,0,21,0,,,
2738,0,Clontech - pCMV-LacZ,website,"","","","","","","","","","","","","","","",http://www.google.com/url?sa=t&rct=j&q=pcmv-lacz%20plasmid&source=web&cd=1&ved=0CCoQFjAA&url=http%3A%2F%2Fwww.clontech.com%2Fxxclt_ibcGetAttachment.jsp%3FcItemId%3D17704&ei=CA_cUfeKKsT9ygGy34GQCA&usg=AFQjCNEZFIuddGoULjHW6HXainbDLMbt8Q,"",0,10,0,29,0,,,
2739,0,"Bhaumik et al., 2009",journal,"Bhaumik S, Basu R, Sen S, Naskar K, Roy S",KMP-11 DNA immunization significantly protects against L. donovani infection but requires exogenous IL-12 as an adjuvant for comparable protection against L. major,"2009","27","9","1306-1316",Vaccine,"","","","","","","","19162111","","",0,10,0,30,0,,,
2740,0,"Garg and Tarleton, 2002",journal,"Garg N, Tarleton RL",Genetic immunization elicits antigen-specific protective immune responses and decreases disease severity in Trypanosoma cruzi infection,"2002","70","10","5547-5555",Infection and immunity,"","","","","","","","12228281","","",0,10,0,26,0,,,
2741,0,"Hawkins et al., 2002",journal,"Hawkins WG, Gold JS, Blachere NE, Bowne WB, Hoos A, Lewis JJ, Houghton AN",Xenogeneic DNA immunization in melanoma models for minimal residual disease,"2002","102","2","137-143",The Journal of surgical research,"","","","","","","","11796010","","",0,10,0,32,0,,,
2742,0,"Manley et al., 2011",journal,"Manley CA, Leibman NF, Wolchok JD, Rivire IC, Bartido S, Craft DM, Bergman PJ",Xenogeneic murine tyrosinase DNA vaccine for malignant melanoma of the digit of dogs,"2011","25","1","94-99",Journal of veterinary internal medicine / American College of Veterinary Internal Medicine,"","","","","","","","21143299","","",0,10,0,44,0,,,
2743,0,"Cai et al., 2005",journal,"Cai H, Yu DH, Tian X, Zhu YX",Coadministration of interleukin 2 plasmid DNA with combined DNA vaccines significantly enhances the protective efficacy against Mycobacterium tuberculosis,"2005","24","10","605-613",DNA and cell biology,"","","","","","","","16225391","","",0,10,0,46,0,,,
2744,0,"Kikumura et al., 2010",journal,"Kikumura A, Fang H, Mun HS, Uemura N, Makino M, Sayama Y, Norose K, Aosai F",Protective immunity against lethal anaphylactic reaction in Toxoplasma gondii-infected mice by DNA vaccination with T. gondii-derived heat shock protein 70 gene,"2010","59","2","105-111",Parasitology international,"","","","","","","","20346412","","",0,10,0,2,0,,,
2745,0,"Miller et al., 2002",journal,"Miller M, Cho JY, Baek KJ, Castaneda D, Nayar J, Rodriguez M, Roman M, Raz E, Broide DH",Plasmid DNA encoding the respiratory syncytial virus G protein protects against RSV-induced airway hyperresponsiveness,"2002","20","23-24","3023-3033",Vaccine,"","","","","","","","12126916","","",0,10,0,52,0,,,
2746,0,"Li et al., 2004",journal,"Li AF, Hough J, Henderson D, Escher A",Co-delivery of pro-apoptotic BAX with a DNA vaccine recruits dendritic cells and promotes efficacy of autoimmune diabetes prevention in mice,"2004","22","13-14","1751-1763",Vaccine,"","","","","","","","15068859","","",0,10,0,53,0,,,
2747,0,Addgene - pSC65,website,"","","","","","","","","","","","","","","",http://www.addgene.org/30327/,"",0,10,0,62,0,,,
2748,0,"Fu et al., 1999",journal,"Fu TM, Guan L, Friedman A, Schofield TL, Ulmer JB, Liu MA, Donnelly JJ",Dose dependence of CTL precursor frequency induced by a DNA vaccine and correlation with protective immunity against influenza virus challenge,"1999","162","7","4163-4170","Journal of immunology (Baltimore, Md. : 1950)","","","","","","","","10201942","","",0,10,0,73,0,,,
2749,0,Clontech - pIRES,website,"","","","","","","","","","","","","","","",http://www.clontech.com/xxclt_ibcGetAttachment.jsp?cItemId=17708,"",0,10,0,42,0,,,
2750,0,pTVG4 map,website,"","","","","","","","","","","","","","","",http://www.google.com/patents/US20040142890,"",0,10,0,70,0,,,
2751,0,"Johnson et al., 2006",journal,"Johnson LE, Frye TP, Arnot AR, Marquette C, Couture LA, Gendron-Fitzpatrick A, McNeel DG",Safety and immunological efficacy of a prostate cancer plasmid DNA vaccine encoding prostatic acid phosphatase (PAP),"2006","24","3","293-303",Vaccine,"","","","","","","","16115700","","",0,10,0,70,0,,,
2752,0,pUMVC3 map,website,"","","","","","","","","","","","","","","",http://www.violinet.org/dnavaxdb/docs/pUMVC3.pdf,"",0,10,0,100,0,,,
2753,0,pUMVC3 sequence,website,"","","","","","","","","","","","","","","",http://www.violinet.org/dnavaxdb/docs/pUMVC3_nt_seq.pdf,"",0,10,0,100,0,,,
2754,0,pTVG4 sequence,website,"","","","","","","","","","","","","","","","","",0,11,0,70,0,,,
2755,0,pTVG4 sequence,website,"","","","","","","","","","","","","","","",http://www.violinet.org/dnavaxdb/docs/pTVG4_nt_seq.pdf,"",0,10,0,70,0,,,
2756,238,Mayo Clinic - Arthritis,website,"",Arthritis,"","","","","","","","","","","","","",http://www.mayoclinic.com/health/arthritis/DS01122,"",0,10,0,0,0,,,
2757,233,CDC - Hepatitis C,website,"",Hepatitis C Information for Health Professionals,"","","","","","","","","","","","","",http://www.cdc.gov/hepatitis/hcv/,"",0,10,0,0,0,,,
2758,232,CDC - Hepatitis E,website,"",Hepatitis E Information for Health Professionals,"","","","","","","","","","","","","",http://www.cdc.gov/hepatitis/HEV/,"",0,10,0,0,0,,,
2759,239,"Borzym et al., 2012",website,"Ewa Borzym, Marek Matras, Joanna Maj, Agnieszka Sandomierska, Niels Jrgen Olesen, Mette Eliassen, Marine Baud, Chiraz Talbi, Laurent Bigarr",First detection of Hirame rhabdovirus (HIRRV) in Europe,"2012","","","","","","","","","","","","",http://orbit.dtu.dk/fedora/objects/orbit:112698/datastreams/file_9708708/content,"",0,10,0,0,0,,,
2760,234,MedicineNet - Coxsackievirus,website,"",Coxsackie Virus,"","","","","","","","","","","","","",http://www.medicinenet.com/coxsackie_virus/article.htm,"",0,10,0,0,0,,,
2761,231,Mayo Clinic - CMV,website,"",Cytomegalovirus (CMV) infection,"","","","","","","","","","","","","",http://www.mayoclinic.com/health/cmv/DS00938,"",0,10,0,0,0,,,
2762,245,Merck - Infectious Pancreatic Necrosis Virus,website,"",Infectious Pancreatic Necrosis,"","","","","","","","","","","","","",http://aqua.merck-animal-health.com/diseases/infectious-pancreatic-necrosis/productadditional_127_113313.aspx,"",0,10,0,0,0,,,
2763,226,CDC - LCMV,website,"",Lymphocytic Choriomeningitis,"","","","","","","","","","","","","",http://www.cdc.gov/ncidod/dvrd/spb/mnpages/dispages/lcmv/qa.htm,"",0,10,0,0,0,,,
2764,227,"Krmpotic et al., 2003",journal,"Krmpotic A, Bubic I, Polic B, Lucin P, Jonjic S",Pathogenesis of murine cytomegalovirus infection,"2003","5","13","1263-1277",Microbes and infection / Institut Pasteur,"","","","","","","","14623023","","",0,10,0,0,0,,,
2765,228,MicrobeWiki - Murine Leukemia Virus,website,"",Murine Leukemia Virus (MuLV),"","","","","","","","","","","","","",http://microbewiki.kenyon.edu/index.php/Murine_Leukemia_Virus_(MuLV),"",0,10,0,0,0,,,
2766,119,WebMD - Mycobacterium avium complex,website,"","HIV, AIDS, and Mycobacterium Avium Complex","","","","","","","","","","","","","",http://www.webmd.com/hiv-aids/guide/aids-hiv-opportunistic-infections-mycobacterium-avium-complex,"",0,10,0,0,0,,,
2767,246,Medscape - Mycobacterium marinum,website,"",Mycobacterium Marinum,"","","","","","","","","","","","","",http://emedicine.medscape.com/article/223363-overview,"",0,10,0,0,0,,,
2768,229,CDC - Human Parainfluenza Viruses,website,"",Human Parainfluenza Viruses,"","","","","","","","","","","","","",http://www.cdc.gov/parainfluenza/about/overview.html,"",0,10,0,0,0,,,
2769,124,Mayo Clinic - Ricin poisoning,website,"",Ricin poisoning,"","","","","","","","","","","","","",http://www.mayoclinic.com/health/ricin/AN02211,"",0,10,0,0,0,,,
2770,242,"Balen et al., 2007",journal,"Balen J, Zhao ZY, Williams GM, McManus DP, Raso G, Utzinger J, Zhou J, Li YS","Prevalence, intensity and associated morbidity of Schistosoma japonicum infection in the Dongting Lake region, China","2007","85","7","519-526",Bulletin of the World Health Organization,"","","","","","","","17768500","","",0,10,0,0,0,,,
2771,225,CDC - Schistosomiasis,website,"",Parasites - Schistosomiasis,"","","","","","","","","","","","","",http://www.cdc.gov/parasites/schistosomiasis/gen_info/faqs.html,"",0,10,0,0,0,,,
2772,243,Stanford - Vaccinia Virus,website,"",Vaccinia Virus,"","","","","","","","","","","","","",http://www.stanford.edu/group/virus/pox/2000/vaccinia_virus.html,"",0,10,0,0,0,,,
2773,230,WISC - VHSV,website,"",Viral Hemorrhagic Septicemia Virus,"","","","","","","","","","","","","",http://www.invasivespecies.wa.gov/priorities/viral_hemorrhagic.shtml,"",0,10,0,0,0,,,
2774,30,"Hoffman et al., 1994",journal,"Hoffman SL, Sedegah M, Hedstrom RC",Protection against malaria by immunization with a Plasmodium yoelii circumsporozoite protein nucleic acid vaccine,"1994","12","16","1529-1533",Vaccine,"","","","","","","","7879419","","",0,10,0,0,0,,,
2775,30,"Hoffman et al., 1997",journal,"Hoffman SL, Doolan DL, Sedegah M, Aguiar JC, Wang R, Malik A, Gramzinski RA, Weiss WR, Hobart P, Norman JA, Margalith M, Hedstrom RC",Strategy for development of a pre-erythrocytic Plasmodium falciparum DNA vaccine for human use,"1997","15","8","842-845",Vaccine,"","","","","","","","9234529","","",0,10,0,0,0,,,
2776,30,"Yoshida et al., 2000",journal,"Yoshida S, Kashiwamura SI, Hosoya Y, Luo E, Matsuoka H, Ishii A, Fujimura A, Kobayashi E",Direct immunization of malaria DNA vaccine into the liver by gene gun protects against lethal challenge of Plasmodium berghei sporozoite,"2000","271","1","107-115",Biochemical and biophysical research communications,"","","","","","","","10777689","","",0,10,0,0,0,,,
2777,30,"Sanchez et al., 2001",journal,"Sanchez GI, Sedegah M, Rogers WO, Jones TR, Sacci J, Witney A, Carucci DJ, Kumar N, Hoffman SL",Immunogenicity and protective efficacy of a Plasmodium yoelii Hsp60 DNA vaccine in BALB/c mice,"2001","69","6","3897-3905",Infection and immunity,"","","","","","","","11349057","","",0,10,0,0,0,,,
2778,30,"Sakai et al., 2003",journal,"Sakai T, Hisaeda H, Nakano Y, Zhang M, Takashima M, Ishii K, Maekawa Y, Matsumoto S, Nitta Y, Miyazaki Ji, Yamamoto S, Himeno K",Gene gun-based co-immunization of merozoite surface protein-1 cDNA with IL-12 expression plasmid confers protection against lethal Plasmodium yoelii in A/J mice,"2003","21","13-14","1432-1444",Vaccine,"","","","","","","","12615440","","",0,10,0,0,0,,,
2779,30,"Bergmann-Leitner et al., 2007",journal,"Bergmann-Leitner ES, Duncan EH, Leitner WW, Neutzner A, Savranskaya T, Angov E, Tsokos GC",C3d-defined complement receptor-binding peptide p28 conjugated to circumsporozoite protein provides protection against Plasmodium berghei,"2007","25","45","7732-7736",Vaccine,"","","","","","","","17931754","","",0,10,0,0,0,,,
2780,30,"Rogers et al., 2001",journal,"Rogers WO, Baird JK, Kumar A, Tine JA, Weiss W, Aguiar JC, Gowda K, Gwadz R, Kumar S, Gold M, Hoffman SL",Multistage multiantigen heterologous prime boost vaccine for Plasmodium knowlesi malaria provides partial protection in rhesus macaques,"2001","69","9","5565-5572",Infection and immunity,"","","","","","","","11500430","","",0,10,0,0,0,,,
2781,0,Davidson College - pBLUESCRIPT,website,"",Plasmids and Phages Combine For pBluescript,"","","","","","","","","","","","","",http://www.bio.davidson.edu/Courses/Molbio/MolStudents/spring2003/Keogh/plasmids.html,"",0,10,0,180,0,,,
2782,0,"Hoffman et al., 1997",journal,"Hoffman SL, Doolan DL, Sedegah M, Aguiar JC, Wang R, Malik A, Gramzinski RA, Weiss WR, Hobart P, Norman JA, Margalith M, Hedstrom RC",Strategy for development of a pre-erythrocytic Plasmodium falciparum DNA vaccine for human use,"1997","15","8","842-845",Vaccine,"","","","","","","","9234529","","",0,10,0,181,0,,,
2783,0,NIH AIDS Reagent Program - pBC12/CMV/IL-2,website,"","","","","","","","","","","","","","","",https://www.aidsreagent.org/reagentdetail.cfm?t=expression_vectors&id=159,"",0,10,0,182,0,,,
2784,26,"Pal et al., 2006",journal,"Pal R, Kalyanaraman VS, Nair BC, Whitney S, Keen T, Hocker L, Hudacik L, Rose N, Mboudjeka I, Shen S, Wu-Chou TH, Montefiori D, Mascola J, Markham P, Lu S",Immunization of rhesus macaques with a polyvalent DNA prime/protein boost human immunodeficiency virus type 1 vaccine elicits protective antibody response against simian human immunodeficiency virus of R5 phenotype,"2006","348","2","341-353",Virology,"","","","","","","","16460776","","",0,10,0,0,0,,,
2785,0,"Pal et al., 2006",journal,"Pal R, Kalyanaraman VS, Nair BC, Whitney S, Keen T, Hocker L, Hudacik L, Rose N, Mboudjeka I, Shen S, Wu-Chou TH, Montefiori D, Mascola J, Markham P, Lu S",Immunization of rhesus macaques with a polyvalent DNA prime/protein boost human immunodeficiency virus type 1 vaccine elicits protective antibody response against simian human immunodeficiency virus of R5 phenotype,"2006","348","2","341-353",Virology,"","","","","","","","16460776","","",0,10,0,158,0,,,
2786,26,"Pal et al., 2005",journal,"Pal R, Wang S, Kalyanaraman VS, Nair BC, Whitney S, Keen T, Hocker L, Hudacik L, Rose N, Cristillo A, Mboudjeka I, Shen S, Wu-Chou TH, Montefiori D, Mascola J, Lu S, Markham P",Polyvalent DNA prime and envelope protein boost HIV-1 vaccine elicits humoral and cellular responses and controls plasma viremia in rhesus macaques following rectal challenge with an R5 SHIV isolate,"2005","34","5-6","226-236",Journal of medical primatology,"","","","","","","","16128917","","",0,10,0,0,0,,,
2787,100,"GlaxoSmithKline, 2013",website,GlaxoSmithKline,Study to Evaluate GSK Biologicals' Herpes Zoster Vaccine GSK1437173A in Adults Aged >= 50 Years,"","","","","","","","","","","","","",http://clinicaltrials.gov/ct2/show/study/NCT01165177,"",0,10,0,0,0,,,
2788,100,"Chlibek et al., 2013",journal,"Chlibek R, Bayas JM, Collins H, de la Pinta ML, Ledent E, Mols JF, Heineman TC",Safety and Immunogenicity of an AS01-adjuvanted Varicella-zoster Virus Subunit Candidate Vaccine Against Herpes Zoster in Adults >=50 Years of Age,"2013","","","",The Journal of infectious diseases,"","","","","","","","23904292","","",0,10,0,0,0,,,
2789,50,"EMA Pandemrix, 2013",website,"",European Medicines Agency (EMA) Pandemrix,"","","","","","","","","","","","","",http://www.ema.europa.eu/ema/index.jsp?curl=pages/medicines/human/medicines/000832/human_med_000965.jsp&mid=WC0b01ac058001d124,"",0,10,0,0,0,,,
2790,50,"EMA Pandemrix Suppl, 2013",website,"",EMA Pandemrix Summary of Product Characteristics,"","","","","","","","","","","","","",http://www.ema.europa.eu/docs/en_GB/document_library/EPAR_-_Product_Information/human/000832/WC500038121.pdf,"",0,10,0,0,0,,,
2791,100,"Awasthi et al., 2011",journal,"Awasthi S, Lubinski JM, Shaw CE, Barrett SM, Cai M, Wang F, Betts M, Kingsley S, Distefano DJ, Balliet JW, Flynn JA, Casimiro DR, Bryan JT, Friedman HM",Immunization with a vaccine combining herpes simplex virus 2 (HSV-2) glycoprotein C (gC) and gD subunits improves the protection of dorsal root ganglia in mice and reduces the frequency of recurrent vaginal shedding of HSV-2 DNA in guinea pigs compared to immunization with gD alone,"2011","85","20","10472-10486",Journal of virology,"","","","","","","","21813597","","",0,10,0,0,0,,,
2792,231,"Hwang et al., 1999",journal,"Hwang ES, Kwon KB, Park JW, Kim DJ, Park CG, Cha CY",Induction of neutralizing antibody against human cytomegalovirus (HCMV) with DNA-mediated immunization of HCMV glycoprotein B in mice,"1999","43","3","307-310",Microbiology and immunology,"","","","","","","","10338203","","",0,10,0,0,0,,,
2793,261,"Wilgenhof et al., 2011",journal,"Wilgenhof S, Van Nuffel AM, Corthals J, Heirman C, Tuyaerts S, Benteyn D, De Coninck A, Van Riet I, Verfaillie G, Vandeloo J, Bonehill A, Thielemans K, Neyns B",Therapeutic vaccination with an autologous mRNA electroporated dendritic cell vaccine in patients with advanced melanoma,"2011","34","5","448-456","Journal of immunotherapy (Hagerstown, Md. : 1997)","","","","","","","","21577140","",,0,0,0,0,0,,,
2794,26,"Ami et al., 2005",journal,"Ami Y, Izumi Y, Matsuo K, Someya K, Kanekiyo M, Horibata S, Yoshino N, Sakai K, Shinohara K, Matsumoto S, Yamada T, Yamazaki S, Yamamoto N, Honda M",Priming-boosting vaccination with recombinant Mycobacterium bovis bacillus Calmette-Gurin and a nonreplicating vaccinia virus recombinant leads to long-lasting and effective immunity,"2005","79","20","12871-12879",Journal of virology,"","","","","","","","16188989","","",0,10,0,0,0,,,
2795,47,"Langermann et al., 1994",journal,"Langermann S, Palaszynski SR, Burlein JE, Koenig S, Hanson MS, Briles DE, Stover CK",Protective humoral response against pneumococcal infection in mice elicited by recombinant bacille Calmette-Gurin vaccines expressing pneumococcal surface protein A,"1994","180","6","2277-2286",The Journal of experimental medicine,"","","","","","","","7964500","","",0,10,0,0,0,,,
2796,91,"Yu et al., 2013",journal,"Yu Q, Huang X, Gong P, Zhang Q, Li J, Zhang G, Yang J, Li H, Wang N, Zhang X",Protective immunity induced by a recombinant BCG vaccine encoding the cyclophilin gene of Toxoplasma gondii,"2013","","","",Vaccine,"","","","","","","","24176493","","",0,10,0,0,0,,,
2797,29,"Singhal et al., 2011",journal,"Singhal A, Mathys V, Kiass M, Creusy C, Delaire B, Aliouat el M, Dartois V, Kaplan G, Bifani P",BCG induces protection against Mycobacterium tuberculosis infection in the Wistar rat model,"2011","6","12",e28082,PloS one,"","","","","","","","22162757","","",0,10,0,0,0,,,
2812,0,"Kanekiyo et al., 2005",journal,"Kanekiyo M, Matsuo K, Hamatake M, Hamano T, Ohsu T, Matsumoto S, Yamada T, Yamazaki S, Hasegawa A, Yamamoto N, Honda M",Mycobacterial codon optimization enhances antigen expression and virus-specific immune responses in recombinant Mycobacterium bovis bacille Calmette-Gurin expressing human immunodeficiency virus type 1 Gag,"2005","79","14","8716-8723",Journal of virology,"","","","","","","","15994765","","",0,10,0,0,12,,,
2800,29,"Oksanen et al., 2013",journal,"Oksanen KE, Halfpenny NJ, Sherwood E, Harjula SK, Hammarn MM, Ahava MJ, Pajula ET, Lahtinen MJ, Parikka M, Rmet M",An adult zebrafish model for preclinical tuberculosis vaccine development,"2013","31","45","5202-5209",Vaccine,"","","","","","","","24055305","","",0,10,0,0,0,,,
2801,29,"Khatri et al., 2014",journal,"Khatri B, Whelan A, Clifford D, Petrera A, Sander P, Vordermeier HM",BCG zmp1 vaccine induces enhanced antigen specific immune responses in cattle,"2014","","","",Vaccine,"","","","","","","","24394444","","",0,10,0,0,0,,,
2802,148,AE-Poxine,website,Zoetis,AE-Poxine vaccine website,"","","","","","","","","","","","","",https://online.zoetis.com/US/EN/Products/Pages/AE_Poxine.aspx,"",0,10,0,0,0,,,
2813,0,"Gheorghiu et al., 1996",journal,"Gheorghiu M, Lagranderie M, Balazuc AM",Stabilisation of BCG vaccines,"1996","87","","251-261",Developments in biological standardization,"","","","","","","","8854025","","",0,10,0,0,12,,,
2811,0,"Tomczyk and Orzechowska, 2013",journal,"Tomczyk T, Orzechowska B",[Vesicular stomatitis virus (VSV) as a vaccine vector for immunization against viral infections],"2013","67","","1345-1358",Postepy higieny i medycyny doswiadczalnej (Online),"","","","","","","","24379275","",,0,10,0,0,11,,,
2810,0,"Garbutt et al., 2004",journal,"Garbutt M, Liebscher R, Wahl-Jensen V, Jones S, Moller P, Wagner R, Volchkov V, Klenk HD, Feldmann H, Stroher U",Properties of replication-competent vesicular stomatitis virus vectors expressing glycoproteins of filoviruses and arenaviruses,"2004","78","10","5458-5465",Journal of virology,"","","","","","","","15113924","","",0,10,0,0,11,,,
2806,0,"Robert, 1975",journal,Robert M,[Oxygen affinity of haemoglobin (author's transl)],"1975","11","1","79-7170",Bulletin de physio-pathologie respiratoire,"","","","","","","","111","",,0,0,109,0,0,,,
2814,0,"Kumar et al., 1999",journal,"Kumar M, Behera AK, Matsuse H, Lockey RF, Mohapatra SS",A recombinant BCG vaccine generates a Th1-like response and inhibits IgE synthesis in BALB/c mice,"1999","97","3","515-521",Immunology,"","","","","","","","10447775","","",0,10,0,0,12,,,
2815,0,"Vemulapalli et al., 2007",journal,"Vemulapalli R, Sanakkayala N, Gulani J, Schurig GG, Boyle SM, Lindsay DS, Sriranganathan N",Reduced cerebral infection of Neospora caninum in BALB/c mice vaccinated with recombinant Brucella abortus RB51 strains expressing N. caninum SRS2 and GRA7 proteins,"2007","148","3-4","219-230",Veterinary parasitology,"","","","","","","","17651896","","",0,10,0,0,13,,,
2829,93,"Vemulapalli et al., 2007",journal,"Vemulapalli R, Sanakkayala N, Gulani J, Schurig GG, Boyle SM, Lindsay DS, Sriranganathan N",Reduced cerebral infection of Neospora caninum in BALB/c mice vaccinated with recombinant Brucella abortus RB51 strains expressing N. caninum SRS2 and GRA7 proteins,"2007","148","3-4","219-230",Veterinary parasitology,"","","","","","","","17651896","","",0,10,0,0,0,,,
2816,29,"Buddle et al., 1995",journal,"Buddle BM, Keen D, Thomson A, Jowett G, McCarthy AR, Heslop J, De Lisle GW, Stanford JL, Aldwell FE","Protection of cattle from bovine tuberculosis by vaccination with BCG by the respiratory or subcutaneous route, but not by vaccination with killed Mycobacterium vaccae","1995","59","1","10-16",Research in veterinary science,"","","","","","","","8525078","","",0,10,0,0,0,,,
2817,29,"Langermans et al., 2001",journal,"Langermans JA, Andersen P, van Soolingen D, Vervenne RA, Frost PA, van der Laan T, van Pinxteren LA, van den Hombergh J, Kroon S, Peekel I, Florquin S, Thomas AW",Divergent effect of bacillus Calmette-Gurin (BCG) vaccination on Mycobacterium tuberculosis infection in highly related macaque species: implications for primate models in tuberculosis vaccine research,"2001","98","20","11497-11502",Proceedings of the National Academy of Sciences of the United States of America,"","","","","","","","11562492","","",0,10,0,0,0,,,
2818,29,"Tsenova et al., 2006",journal,"Tsenova L, Harbacheuski R, Moreira AL, Ellison E, Dalemans W, Alderson MR, Mathema B, Reed SG, Skeiky YA, Kaplan G",Evaluation of the Mtb72F polyprotein vaccine in a rabbit model of tuberculous meningitis,"2006","74","4","2392-2401",Infection and immunity,"","","","","","","","16552069","","",0,10,0,0,0,,,
2819,59,"Pulendran, 2009",journal,Pulendran B,Learning immunology from the yellow fever vaccine: innate immunity to systems vaccinology,"2009","9","10","741-747",Nature reviews. Immunology,"","","","","","","","19763148","","",0,10,0,0,0,,,
2820,59,"Querec et al., 2009",journal,"Querec TD, Akondy RS, Lee EK, Cao W, Nakaya HI, Teuwen D, Pirani A, Gernert K, Deng J, Marzolf B, Kennedy K, Wu H, Bennouna S, Oluoch H, Miller J, Vencio RZ, Mulligan M, Aderem A, Ahmed R, Pulendran B",Systems biology approach predicts immunogenicity of the yellow fever vaccine in humans,"2009","10","1","116-125",Nature immunology,"","","","","","","","19029902","","",0,10,0,0,0,,,
2821,0,"Di et al., 2013",journal,"Di Pilato M, Mejas-Prez E, Gmez CE, Perdiguero B, Sorzano CO, Esteban M",New vaccinia virus promoter as a potential candidate for future vaccines,"2013","94",Pt 12,"2771-2776",The Journal of general virology,"","","","","","","","24077296","","",0,10,0,0,14,,,
2822,0,"Bose and Sarma, 1975",journal,"Bose KS, Sarma RH",Delineation of the intimate details of the backbone conformation of pyridine nucleotide coenzymes in aqueous solution,"1975","66","4","1173-1179",Biochemical and biophysical research communications,"","","","","","","","2","",,0,10,0,0,0,,1,
2823,0,"Corrocher et al., 1975",journal,"Corrocher R, Tedesco F, Rabusin P, De Sandre G",Effect of human erythrocyte stromata on complement activation,"1975","29","2","235-241",British journal of haematology,"","","","","","","","33","","",0,10,0,0,0,,2,
2824,0,"Wiesmann et al., 1975",journal,"Wiesmann UN, DiDonato S, Herschkowitz NN",Effect of chloroquine on cultured fibroblasts: release of lysosomal hydrolases and inhibition of their uptake,"1975","66","4","1338-1343",Biochemical and biophysical research communications,"","","","","","","","4","",,0,0,0,0,0,,3,
2830,0,"Jia et al., 2012",journal,"Jia Y, Yin Y, Duan F, Fu H, Hu M, Gao Y, Pan Z, Jiao X",Prophylactic and therapeutic efficacy of an attenuated Listeria monocytogenes-based vaccine delivering HPV16 E7 in a mouse model,"2012","30","6","1335-1342",International journal of molecular medicine,"","","","","","","","23027427","","",0,10,0,0,16,,,
2827,0,"He et al., 2001",journal,"He Y, Vemulapalli R, Zeytun A, Schurig GG",Induction of specific cytotoxic lymphocytes in mice vaccinated with Brucella abortus RB51,"2001","69","9","5502-5508",Infection and immunity,"","","","","","","","11500423","","",0,10,0,0,13,,,
2828,0,"Schurig et al., 1991",journal,"Schurig GG, Roop RM 2nd, Bagchi T, Boyle S, Buhrman D, Sriranganathan N",Biological properties of RB51; a stable rough strain of Brucella abortus,"1991","28","2","171-188",Veterinary microbiology,"","","","","","","","1908158","","",0,10,0,0,13,,,
3332,13,"Wilson and Hart, 2001",journal,"Wilson JA, Hart MK",Protection from Ebola virus mediated by cytotoxic T lymphocytes specific for the viral nucleoprotein,"2001","75","6","2660-2664",Journal of virology,"","","","","","","","11222689","","",0,10,0,0,0,,,
2832,0,"Hernndez-Luna et al., 2013",journal,"Hernndez-Luna MA, Luria-Prez R, Huerta-Ypez S","[Therapeutic intervention alternatives in cancer, using attenuated live bacterial vectors: Salmonella enterica as a carrier of heterologous molecules]","2013","65","1","65-73",Revista de investigacion clinica; organo del Hospital de Enfermedades de la Nutricion,"","","","","","","","23745445","","",0,10,0,0,17,,,
2833,0,"Pompa-Mera et al., 2011",journal,"Pompa-Mera EN, Ypez-Mulia L, Ocaa-Mondragn A, Garca-Zepeda EA, Ortega-Pierres G, Gonzlez-Bonilla CR",Trichinella spiralis: intranasal immunization with attenuated Salmonella enterica carrying a gp43 antigen-derived 30mer epitope elicits protection in BALB/c mice,"2011","129","4","393-401",Experimental parasitology,"","","","","","","","21907709","","",0,10,0,0,17,,,
2834,0,"Safronetz et al., 2009",journal,"Safronetz D, Hegde NR, Ebihara H, Denton M, Kobinger GP, St Jeor S, Feldmann H, Johnson DC",Adenovirus vectors expressing hantavirus proteins protect hamsters against lethal challenge with andes virus,"2009","83","14","7285-7295",Journal of virology,"","","","","","","","19403663","","",0,10,0,0,15,,,
2835,0,"Wennier et al., 2013",journal,"Wennier ST, Brinkmann K, Steinhuer C, Maylnder N, Mnich C, Wielert U, Dirmeier U, Hausmann J, Chaplin P, Steigerwald R",A novel naturally occurring tandem promoter in modified vaccinia virus ankara drives very early gene expression and potent immune responses,"2013","8","8",e73511,PloS one,"","","","","","","","23951355","","",0,10,0,0,18,,,
2836,59,"Akondy et al., 2009",journal,"Akondy RS, Monson ND, Miller JD, Edupuganti S, Teuwen D, Wu H, Quyyumi F, Garg S, Altman JD, Del Rio C, Keyserling HL, Ploss A, Rice CM, Orenstein WA, Mulligan MJ, Ahmed R",The yellow fever virus vaccine induces a broad and polyfunctional human memory CD8+ T cell response,"2009","183","12","7919-7930","Journal of immunology (Baltimore, Md. : 1950)","","","","","","","","19933869","","",0,10,0,0,0,,,
2837,0,"Lu et al., 2012",journal,"Lu HY, Chen YH, Liu HJ",Baculovirus as a vaccine vector,"2012","3","5","271-274",Bioengineered,"","","","","","","","22705893","","",0,10,0,0,19,,,
2838,0,"Withers and Beemon, 2011",journal,"Withers JB, Beemon KL",The structure and function of the rous sarcoma virus RNA stability element,"2011","112","11","3085-3092",Journal of cellular biochemistry,"","","","","","","","21769913","","",0,10,0,0,20,,,
2839,0,"Wirth et al., 2013",journal,"Wirth T, Parker N, Yl-Herttuala S",History of gene therapy,"2013","525","2","162-169",Gene,"","","","","","","","23618815","","",0,10,0,0,20,,,
2840,0,"Schwartz et al., 1983",journal,"Schwartz DE, Tizard R, Gilbert W",Nucleotide sequence of Rous sarcoma virus,"1983","32","3","853-869",Cell,"","","","","","","","6299578","","",0,10,0,0,20,,,
2841,0,"Afonso et al., 2000",journal,"Afonso CL, Tulman ER, Lu Z, Zsak L, Kutish GF, Rock DL",The genome of fowlpox virus,"2000","74","8","3815-3831",Journal of virology,"","","","","","","","10729156","","",0,10,0,0,21,,,
2842,0,"Liechtenstein et al., 2013",journal,"Liechtenstein T, Perez-Janices N, Escors D",Lentiviral vectors for cancer immunotherapy and clinical applications,"2013","5","3","815-837",Cancers,"","","","","","","","24078865","","",0,10,0,0,22,,,
2843,0,"Liechtenstein et al., 2013",journal,"Liechtenstein T, Perez-Janices N, Escors D",Lentiviral vectors for cancer immunotherapy and clinical applications,"2013","5","3","815-837",Cancers,"","","","","","","","24078865","","",0,10,0,0,23,,,
2844,0,"Nikolic et al., 2012",journal,"Nikolic EI, King LM, Vidakovic M, Irigoyen N, Brierley I",Modulation of ribosomal frameshifting frequency and its effect on the replication of Rous sarcoma virus,"2012","86","21","11581-11594",Journal of virology,"","","","","","","","22896611","","",0,10,0,0,23,,,
2845,0,"Madhan et al., 2010",journal,"Madhan S, Prabakaran M, Kwang J",Baculovirus as vaccine vectors,"2010","10","3","201-213",Current gene therapy,"","","","","","","","20394572","",,0,10,0,0,19,,,
2846,0,"Smith and Bryant, 1975",journal,"Smith RJ, Bryant RG",Metal substitutions incarbonic anhydrase: a halide ion probe study,"1975","66","4","1281-1286",Biochemical and biophysical research communications,"","","","","","","","3","",,0,11,0,0,19,,,
3088,50,"Soejoedono et al., 2012",journal,"Soejoedono RD, Murtini S, Palya V, Felfldi B, Mat T, Gardin Y",Efficacy of a recombinant HVT-H5 vaccine against challenge with two genetically divergent Indonesian HPAI H5N1 strains,"2012","56","4 Suppl","923-927",Avian diseases,"","","","","","","","23402113","","",0,10,0,0,0,,,
3087,70,"Esaki et al., 2013",journal,"Esaki M, Godoy A, Rosenberger JK, Rosenberger SC, Gardin Y, Yasuda A, Dorsey KM",Protection and antibody response caused by turkey herpesvirus vector Newcastle disease vaccine,"2013","57","4","750-755",Avian diseases,"","","","","","","","24597117","","",0,10,0,0,0,,,
2849,0,"Makar et al., 1975",journal,"Makar AB, McMartin KE, Palese M, Tephly TR",Formate assay in body fluids: application in methanol poisoning,"1975","13","2","117-126",Biochemical medicine,"","","","","","","","1","",,0,0,0,0,19,,,
3086,272,"Esaki et al., 2013",journal,"Esaki M, Noland L, Eddins T, Godoy A, Saeki S, Saitoh S, Yasuda A, Dorsey KM",Safety and efficacy of a turkey herpesvirus vector laryngotracheitis vaccine for chickens,"2013","57","2","192-198",Avian diseases,"","","","","","","","24689173","",,0,0,0,0,0,,,
3085,13,"O'Brien et al., 2014",journal,"O'Brien LM, Stokes MG, Lonsdale SG, Maslowski DR, Smither SJ, Lever MS, Laws TR, Perkins SD",Vaccination with recombinant adenoviruses expressing Ebola virus glycoprotein elicits protection in the interferon alpha/beta receptor knock-out mouse,"2014","452-453","","324-333",Virology,"","","","","","","","24461913","","",0,10,0,0,0,,,
3084,56,"Xiang et al., 2014",journal,"Xiang ZQ, Greenberg L, Ertl HC, Rupprecht CE",Protection of non-human primates against rabies with an adenovirus recombinant vaccine,"2014","450-451","","243-249",Virology,"","","","","","","","24503087","","",0,10,0,0,0,,,
3083,271,"Kim et al., 2014",journal,"Kim E, Okada K, Beeler JA, Crim RL, Piedra PA, Gilbert BE, Gambotto A","Development of an adenovirus-based respiratory syncytial virus vaccine: preclinical evaluation of efficacy, immunogenicity, and enhanced disease in a cotton rat model","2014","88","9","5100-5108",Journal of virology,"","","","","","","","24574396","",,0,0,0,0,0,,,
3082,26,"Breton et al., 2007",journal,"Breton M, Zhao C, Ouellette M, Tremblay MJ, Papadopoulou B",A recombinant non-pathogenic Leishmania vaccine expressing human immunodeficiency virus 1 (HIV-1) Gag elicits cell-mediated immunity in mice and decreases HIV-1 replication in human tonsillar tissue following exposure to HIV-1 infection,"2007","88",Pt 1,"217-225",The Journal of general virology,"","","","","","","","17170454","","",0,10,0,0,0,,,
3081,116,"Saljoughian et al., 2013",journal,"Saljoughian N, Taheri T, Zahedifard F, Taslimi Y, Doustdari F, Bolhassani A, Doroud D, Azizi H, Heidari K, Vasei M, Namvar Asl N, Papadopoulou B, Rafati S",Development of novel prime-boost strategies based on a tri-gene fusion recombinant L. tarentolae vaccine against experimental murine visceral leishmaniasis,"2013","7","4",e2174,PLoS neglected tropical diseases,"","","","","","","","23638195","","",0,10,0,0,0,,,
3080,115,"Zahedifard et al., 2014",journal,"Zahedifard F, Gholami E, Taheri T, Taslimi Y, Doustdari F, Seyed N, Torkashvand F, Meneses C, Papadopoulou B, Kamhawi S, Valenzuela JG, Rafati S",Enhanced protective efficacy of nonpathogenic recombinant leishmania tarentolae expressing cysteine proteinases combined with a sand fly salivary antigen,"2014","8","3",e2751,PLoS neglected tropical diseases,"","","","","","","","24675711","","",0,10,0,0,0,,,
3079,270,"Coutant et al., 2012",journal,"Coutant F, Sanchez David RY, Flix T, Boulay A, Caleechurn L, Souque P, Thouvenot C, Bourgouin C, Beignon AS, Charneau P",A nonintegrative lentiviral vector-based vaccine provides long-term sterile protection against malaria,"2012","7","11",e48644,PloS one,"","","","","","","","23133649","","",0,10,0,0,0,,,
3078,0,"Coutant et al., 2012",journal,"Coutant F, Sanchez David RY, Flix T, Boulay A, Caleechurn L, Souque P, Thouvenot C, Bourgouin C, Beignon AS, Charneau P",A nonintegrative lentiviral vector-based vaccine provides long-term sterile protection against malaria,"2012","7","11",e48644,PloS one,"","","","","","","","23133649","","",0,10,0,0,22,,,
3077,269,"Kim et al., 2013",journal,"Kim JH, Sohn HJ, Lee J, Yang HJ, Chwae YJ, Kim K, Park S, Shin HJ",Vaccination with lentiviral vector expressing the nfa1 gene confers a protective immune response to mice infected with Naegleria fowleri,"2013","20","7","1055-1060",Clinical and vaccine immunology : CVI,"","","","","","","","23677321","",,0,0,0,0,0,,,
3076,0,"Kim et al., 2013",journal,"Kim JH, Sohn HJ, Lee J, Yang HJ, Chwae YJ, Kim K, Park S, Shin HJ",Vaccination with lentiviral vector expressing the nfa1 gene confers a protective immune response to mice infected with Naegleria fowleri,"2013","20","7","1055-1060",Clinical and vaccine immunology : CVI,"","","","","","","","23677321","","",0,10,0,0,22,,,
3075,0,"Xu et al., 2014",journal,"Xu Y, Yang E, Wang J, Li R, Li G, Liu G, Song N, Huang Q, Kong C, Wang H",Prime-boost BCG vaccination with lentivirus-vectored and DNA-based vaccines expressing antigens Ag85B and Rv3425 improves protective efficacy against M. tuberculosis in mice,"2014","","","",Immunology,"","","","","","","","24773322","","",0,10,0,0,22,,,
3074,29,"Xu et al., 2014",journal,"Xu Y, Yang E, Wang J, Li R, Li G, Liu G, Song N, Huang Q, Kong C, Wang H",Prime-boost BCG vaccination with lentivirus-vectored and DNA-based vaccines expressing antigens Ag85B and Rv3425 improves protective efficacy against M. tuberculosis in mice,"2014","","","",Immunology,"","","","","","","","24773322","","",0,10,0,0,0,,,
3073,146,"Tsukamoto et al., 2000",journal,"Tsukamoto K, Sato T, Saito S, Tanimura N, Hamazaki N, Mase M, Yamaguchi S",Dual-viral vector approach induced strong and long-lasting protective immunity against very virulent infectious bursal disease virus,"2000","269","2","257-267",Virology,"","","","","","","","10753704","","",0,10,0,0,0,,,
2870,0,"Koivula and Koivusalo, 1975",journal,"Koivula T, Koivusalo M",Partial purification and properties of a phenobarbital-induced aldehyde dehydrogenase of rat liver,"1975","410","1","1-11",Biochimica et biophysica acta,"","","","","","","","66","",,0,10,108,0,0,,,
3072,268,"Vagnozzi et al., 2012",journal,"Vagnozzi A, Zavala G, Riblet SM, Mundt A, Garca M",Protection induced by commercially available live-attenuated and recombinant viral vector vaccines against infectious laryngotracheitis virus in broiler chickens,"2012","41","1","21-31",Avian pathology : journal of the W.V.P.A,"","","","","","","","22845318","","",0,10,0,0,0,,,
3071,50,"Liu et al., 2013",journal,"Liu J, Chen P, Jiang Y, Deng G, Shi J, Wu L, Lin Y, Bu Z, Chen H",Recombinant duck enteritis virus works as a single-dose vaccine in broilers providing rapid protection against H5N1 influenza infection,"2013","97","3","329-333",Antiviral research,"","","","","","","","23267833","","",0,10,0,0,0,,,
3070,50,"Butter et al., 2013",journal,"Butter C, Staines K, van Hateren A, Davison TF, Kaufman J",The peptide motif of the single dominantly expressed class I molecule of the chicken MHC can explain the response to a molecular defined vaccine of infectious bursal disease virus (IBDV),"2013","65","8","609-618",Immunogenetics,"","","","","","","","23644721","","",0,10,0,0,0,,,
3069,0,"Niqueux et al., 2013",journal,"Niqueux E, Guionie O, Amelot M, Jestin V",Prime-boost vaccination with recombinant H5-fowlpox and Newcastle disease virus vectors affords lasting protection in SPF Muscovy ducks against highly pathogenic H5N1 influenza virus,"2013","31","38","4121-4128",Vaccine,"","","","","","","","23845804","","",0,10,0,0,44,,,
2876,0,"Mu et al., 2011",journal,"Mu W, Guan L, Yan Y, Liu Q, Zhang Y",A novel in vivo inducible expression system in Edwardsiella tarda for potential application in bacterial polyvalence vaccine,"2011","31","6","1097-1105",Fish & shellfish immunology,"","","","","","","","21964456","","",0,10,0,0,25,,,
2877,0,"Yan et al., 2013",journal,"Yan Y, Mu W, Zhang L, Guan L, Liu Q, Zhang Y",Asd-based balanced-lethal system in attenuated Edwardsiella tarda to express a heterologous antigen for a multivalent bacterial vaccine,"2013","34","5","1188-1194",Fish & shellfish immunology,"","","","","","","","23454428","","",0,10,0,0,25,,,
2878,0,"Wang et al., 2013",journal,"Wang L, Liu W, Yang M, Peng D, Chen L",Development of a Streptococcus gordonii vaccine strain expressing Schistosoma japonicum Sj-F1 and evaluation of using this strain for intranasal immunization in mice,"2013","112","4","1701-1708",Parasitology research,"","","","","","","","23403993","","",0,10,0,0,26,,,
2879,99,"Wilgenhof et al., 2011",journal,"Wilgenhof S, Van Nuffel AM, Corthals J, Heirman C, Tuyaerts S, Benteyn D, De Coninck A, Van Riet I, Verfaillie G, Vandeloo J, Bonehill A, Thielemans K, Neyns B",Therapeutic vaccination with an autologous mRNA electroporated dendritic cell vaccine in patients with advanced melanoma,"2011","34","5","448-456","Journal of immunotherapy (Hagerstown, Md. : 1997)","","","","","","","","21577140","","",0,10,0,0,0,,,
2880,99,"Baldueva et al., 2012",journal,"Baldueva IA, Novik AV, Moiseenko VM, Nekhaeva TL, Danilova AB, Danilov AO, Protsenko SA, Petrova TIu, Uleskaia GI, Shchekina LA, Semenova AI, Mikhalichenko TD, Teletaeva GM, Zhabina AS, Volkov NV, Komarov IuI",[Phase II clinical trial of autologous dendritic cell vaccine with immunologic adjuvant in cutaneous melanoma patients],"2012","58","2","212-221",Voprosy onkologii,"","","","","","","","22774527","","",0,10,0,0,0,,,
2881,99,"Jha et al., 2012",journal,"Jha G, Miller JS, Curtsinger JM, Zhang Y, Mescher MF, Dudek AZ",Randomized Phase II Study of IL-2 With or Without an Allogeneic Large Multivalent Immunogen Vaccine for the Treatment of Stage IV Melanoma,"2012","","","",American journal of clinical oncology,"","","","","","","","23241505","","",0,10,0,0,0,,,
2882,264,"Pompa-Mera et al., 2011",journal,"Pompa-Mera EN, Ypez-Mulia L, Ocaa-Mondragn A, Garca-Zepeda EA, Ortega-Pierres G, Gonzlez-Bonilla CR",Trichinella spiralis: intranasal immunization with attenuated Salmonella enterica carrying a gp43 antigen-derived 30mer epitope elicits protection in BALB/c mice,"2011","129","4","393-401",Experimental parasitology,"","","","","","","","21907709","","",0,10,0,0,0,,,
2883,211,"Mu et al., 2011",journal,"Mu W, Guan L, Yan Y, Liu Q, Zhang Y",A novel in vivo inducible expression system in Edwardsiella tarda for potential application in bacterial polyvalence vaccine,"2011","31","6","1097-1105",Fish & shellfish immunology,"","","","","","","","21964456","","",0,10,0,0,0,,,
2884,0,"Mayer et al., 2009",journal,"Mayer ML, Phillips CM, Townsend RA, Halperin SA, Lee SF",Differential activation of dendritic cells by Toll-like receptor agonists isolated from the Gram-positive vaccine vector Streptococcus gordonii,"2009","69","4","351-356",Scandinavian journal of immunology,"","","","","","","","19284500","","",0,10,0,0,26,,,
2885,0,"Mayer et al., 2009",journal,"Mayer ML, Phillips CM, Stadnyk AW, Halperin SA, Lee SF",Synergistic BM-DC activation and immune induction by the oral vaccine vector Streptococcus gordonii and exogenous tumor necrosis factor,"2009","46","8-9","1883-1891",Molecular immunology,"","","","","","","","19278729","","",0,10,0,0,26,,,
2886,242,"Wang et al., 2013",journal,"Wang L, Liu W, Yang M, Peng D, Chen L",Development of a Streptococcus gordonii vaccine strain expressing Schistosoma japonicum Sj-F1 and evaluation of using this strain for intranasal immunization in mice,"2013","112","4","1701-1708",Parasitology research,"","","","","","","","23403993","",,0,0,0,0,0,,,
2887,0,"Shin et al., 2013",journal,"Shin MK, Kang ML, Jung MH, Cha SB, Lee WJ, Kim JM, Kim DH, Yoo HS",Induction of protective immune responses against challenge of Actinobacillus pleuropneumoniae by oral administration with Saccharomyces cerevisiae expressing Apx toxins in pigs,"2013","151","1-2","132-139",Veterinary immunology and immunopathology,"","","","","","","","23206402","","",0,10,0,0,27,,,
2888,0,"Prideaux et al., 1998",journal,"Prideaux CT, Pierce L, Krywult J, Hodgson AL",Protection of mice against challenge with homologous and heterologous serovars of Actinobacillus pleuropneumoniae after live vaccination,"1998","37","5","324-332",Current microbiology,"","","","","","","","9767712","","",0,10,0,0,27,,,
2889,86,"Prideaux et al., 1998",journal,"Prideaux CT, Pierce L, Krywult J, Hodgson AL",Protection of mice against challenge with homologous and heterologous serovars of Actinobacillus pleuropneumoniae after live vaccination,"1998","37","5","324-332",Current microbiology,"","","","","","","","9767712","","",0,10,0,0,0,,,
2890,0,"Mielcarek et al., 2006",journal,"Mielcarek N, Debrie AS, Raze D, Quatannens J, Engle J, Goldman WE, Locht C",Attenuated Bordetella pertussis: new live vaccines for intranasal immunisation,"2006","24 Suppl 2","",S2-54-5,Vaccine,"","","","","","","","16823926","","",0,10,0,0,28,,,
2891,109,"Mielcarek et al., 2006",journal,"Mielcarek N, Debrie AS, Raze D, Quatannens J, Engle J, Goldman WE, Locht C",Attenuated Bordetella pertussis: new live vaccines for intranasal immunisation,"2006","24 Suppl 2","",S2-54-5,Vaccine,"","","","","","","","16823926","","",0,10,0,0,0,,,
2892,59,"Gaucher et al., 2008",journal,"Gaucher D, Therrien R, Kettaf N, Angermann BR, Boucher G, Filali-Mouhim A, Moser JM, Mehta RS, Drake DR 3rd, Castro E, Akondy R, Rinfret A, Yassine-Diab B, Said EA, Chouikh Y, Cameron MJ, Clum R, Kelvin D, Somogyi R, Greller LD, Balderas RS, Wilkinson P, Pantaleo G, Tartaglia J, Haddad EK, Skaly RP",Yellow fever vaccine induces integrated multilineage and polyfunctional immune responses,"2008","205","13","3119-3131",The Journal of experimental medicine,"","","","","","","","19047440","","",0,10,0,0,0,,,
3331,0,"Anaplasma marginale strain Zulia major surface protein 4 gene, complete cds GenBank: AY737009.1",thesis,"Franco,J.A., Villalba,M.V. and Giardina,S.",Immune response of Balb/c mice immunized with a plasmid expressing p31 gene from Anaplasma marginale 1.,"2004","","","","","","","","",Simn Bolvar,"Caracas, Venezula",PhD,"",http://www.ncbi.nlm.nih.gov/nuccore/57908861,,0,0,0,0,0,,7,
2894,59,"Miller et al., 2008",journal,"Miller JD, van der Most RG, Akondy RS, Glidewell JT, Albott S, Masopust D, Murali-Krishna K, Mahar PL, Edupuganti S, Lalor S, Germon S, Del Rio C, Mulligan MJ, Staprans SI, Altman JD, Feinberg MB, Ahmed R",Human effector and memory CD8+ T cell responses to smallpox and yellow fever vaccines,"2008","28","5","710-722",Immunity,"","","","","","","","18468462","","",0,10,0,0,0,,,
2895,99,"Schwartzentruber et al., 2011",journal,"Schwartzentruber DJ, Lawson DH, Richards JM, Conry RM, Miller DM, Treisman J, Gailani F, Riley L, Conlon K, Pockaj B, Kendra KL, White RL, Gonzalez R, Kuzel TM, Curti B, Leming PD, Whitman ED, Balkissoon J, Reintgen DS, Kaufman H, Marincola FM, Merino MJ, Rosenberg SA, Choyke P, Vena D, Hwu P",gp100 peptide vaccine and interleukin-2 in patients with advanced melanoma,"2011","364","22","2119-2127",The New England journal of medicine,"","","","","","","","21631324","","",0,10,0,0,0,,,
2896,99,"Wolchok et al., 2010",journal,"Wolchok JD, Weber JS, Hamid O, Lebb C, Maio M, Schadendorf D, de Pril V, Heller K, Chen TT, Ibrahim R, Hoos A, O'Day SJ",Ipilimumab efficacy and safety in patients with advanced melanoma: a retrospective analysis of HLA subtype from four trials,"2010","10","","9",Cancer immunity,"","","","","","","","20957980","","",0,10,0,0,0,,,
3884,99,"Butterfield et al., 2008",journal,"Butterfield LH, Comin-Anduix B, Vujanovic L, Lee Y, Dissette VB, Yang JQ, Vu HT, Seja E, Oseguera DK, Potter DM, Glaspy JA, Economou JS, Ribas A",Adenovirus MART-1-engineered autologous dendritic cell vaccine for metastatic melanoma,"2008","31","3","294-309","Journal of immunotherapy (Hagerstown, Md. : 1997)",,,,,,,,"18317358",,,0,10,0,0,0,,,
2898,99,"Stebbing et al., 2012",journal,"Stebbing J, Dalgleish A, Gifford-Moore A, Martin A, Gleeson C, Wilson G, Brunet LR, Grange J, Mudan S",An intra-patient placebo-controlled phase I trial to evaluate the safety and tolerability of intradermal IMM-101 in melanoma,"2012","23","5","1314-1319",Annals of oncology : official journal of the European Society for Medical Oncology / ESMO,"","","","","","","","21930686","","",0,10,0,0,0,,,
2899,265,"Filipazzi et al., 2012",journal,"Filipazzi P, Pilla L, Mariani L, Patuzzo R, Castelli C, Camisaschi C, Maurichi A, Cova A, Rigamonti G, Giardino F, Di Florio A, Asioli M, Frati P, Sovena G, Squarcina P, Maio M, Danielli R, Chiarion-Sileni V, Villa A, Lombardo C, Tragni G, Santinami M, Parmiani G, Rivoltini L",Limited induction of tumor cross-reactive T cells without a measurable clinical benefit in early melanoma patients vaccinated with human leukocyte antigen class I-modified peptides,"2012","18","23","6485-6496",Clinical cancer research : an official journal of the American Association for Cancer Research,"","","","","","","","23032742","",,0,0,0,0,0,,,
2900,99,"Slingluff et al., 2011",journal,"Slingluff CL Jr, Petroni GR, Chianese-Bullock KA, Smolkin ME, Ross MI, Haas NB, von Mehren M, Grosh WW",Randomized multicenter trial of the effects of melanoma-associated helper peptides and cyclophosphamide on the immunogenicity of a multipeptide melanoma vaccine,"2011","29","21","2924-2932",Journal of clinical oncology : official journal of the American Society of Clinical Oncology,"","","","","","","","21690475","","",0,10,0,0,0,,,
2901,99,"Speiser et al., 2010",journal,"Speiser DE, Schwarz K, Baumgaertner P, Manolova V, Devevre E, Sterry W, Walden P, Zippelius A, Conzett KB, Senti G, Voelter V, Cerottini JP, Guggisberg D, Willers J, Geldhof C, Romero P, Kndig T, Knuth A, Dummer R, Trefzer U, Bachmann MF",Memory and effector CD8 T-cell responses after nanoparticle vaccination of melanoma patients,"2010","33","8","848-858","Journal of immunotherapy (Hagerstown, Md. : 1997)","","","","","","","","20842051","","",0,10,0,0,0,,,
2902,99,"Filipazzi et al., 2012",journal,"Filipazzi P, Pilla L, Mariani L, Patuzzo R, Castelli C, Camisaschi C, Maurichi A, Cova A, Rigamonti G, Giardino F, Di Florio A, Asioli M, Frati P, Sovena G, Squarcina P, Maio M, Danielli R, Chiarion-Sileni V, Villa A, Lombardo C, Tragni G, Santinami M, Parmiani G, Rivoltini L",Limited induction of tumor cross-reactive T cells without a measurable clinical benefit in early melanoma patients vaccinated with human leukocyte antigen class I-modified peptides,"2012","18","23","6485-6496",Clinical cancer research : an official journal of the American Association for Cancer Research,"","","","","","","","23032742","","",0,10,0,0,0,,,
2903,99,"Trepiakas et al., 2010",journal,"Trepiakas R, Berntsen A, Hadrup SR, Bjrn J, Geertsen PF, Straten PT, Andersen MH, Pedersen AE, Soleimani A, Lorentzen T, Johansen JS, Svane IM",Vaccination with autologous dendritic cells pulsed with multiple tumor antigens for treatment of patients with malignant melanoma: results from a phase I/II trial,"2010","12","6","721-734",Cytotherapy,"","","","","","","","20429791","","",0,10,0,0,0,,,
2904,99,"Eton et al., 2010",journal,"Eton O, Ross MI, East MJ, Mansfield PF, Papadopoulos N, Ellerhorst JA, Bedikian AY, Lee JE",Autologous tumor-derived heat-shock protein peptide complex-96 (HSPPC-96) in patients with metastatic melanoma,"2010","8","","9",Journal of translational medicine,"","","","","","","","20109236","","",0,10,0,0,0,,,
2905,99,"Xie et al., 2013",journal,"Xie Y, Wang L, Freywald A, Qureshi M, Chen Y, Xiang J",A novel T cell-based vaccine capable of stimulating long-term functional CTL memory against B16 melanoma via CD40L signaling,"2013","10","1","72-77",Cellular & molecular immunology,"","","","","","","","23042534","","",0,10,0,0,0,,,
2906,99,"Faries et al., 2009",journal,"Faries MB, Hsueh EC, Ye X, Hoban M, Morton DL",Effect of granulocyte/macrophage colony-stimulating factor on vaccination with an allogeneic whole-cell melanoma vaccine,"2009","15","22","7029-7035",Clinical cancer research : an official journal of the American Association for Cancer Research,"","","","","","","","19903777","","",0,10,0,0,0,,,
2907,99,"Lienard et al., 2009",journal,"Lienard D, Avril MF, Le Gal FA, Baumgaertner P, Vermeulen W, Blom A, Geldhof C, Rimoldi D, Pagliusi S, Romero P, Dietrich PY, Corvaia N, Speiser DE",Vaccination of melanoma patients with Melan-A/Mart-1 peptide and Klebsiella outer membrane protein p40 as an adjuvant,"2009","32","8","875-883","Journal of immunotherapy (Hagerstown, Md. : 1997)","","","","","","","","19752746","","",0,10,0,0,0,,,
2908,99,"Wang et al., 2013",journal,"Wang J, Wang X, Chen Y, Wan M, Xiang Z, Wu X, Wei H, Wang L, Zhang P, Wang L, Yu Y",Immunization with a HSP65-HER2 fusion peptide selectively eliminates HER2(+) B16 melanoma cells in a xenograft tumor mouse model,"2013","34","1","193-201",Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine,"","","","","","","","23055194","","",0,10,0,0,0,,,
2909,99,"Finocchiaro and Glikin, 2012",journal,"Finocchiaro LM, Glikin GC",Cytokine-enhanced vaccine and suicide gene therapy as surgery adjuvant treatments for spontaneous canine melanoma: 9 years of follow-up,"2012","19","12","852-861",Cancer gene therapy,"","","","","","","","23059870","","",0,10,0,0,0,,,
2910,99,"Slingluff et al., 2008",journal,"Slingluff CL Jr, Petroni GR, Olson W, Czarkowski A, Grosh WW, Smolkin M, Chianese-Bullock KA, Neese PY, Deacon DH, Nail C, Merrill P, Fink R, Patterson JW, Rehm PK",Helper T-cell responses and clinical activity of a melanoma vaccine with multiple peptides from MAGE and melanocytic differentiation antigens,"2008","26","30","4973-4980",Journal of clinical oncology : official journal of the American Society of Clinical Oncology,"","","","","","","","18809608","","",0,10,0,0,0,,,
2911,99,"Fourcade et al., 2008",journal,"Fourcade J, Kudela P, Andrade Filho PA, Janjic B, Land SR, Sander C, Krieg A, Donnenberg A, Shen H, Kirkwood JM, Zarour HM",Immunization with analog peptide in combination with CpG and montanide expands tumor antigen-specific CD8+ T cells in melanoma patients,"2008","31","8","781-791","Journal of immunotherapy (Hagerstown, Md. : 1997)","","","","","","","","18779741","","",0,10,0,0,0,,,
2912,99,"Chen et al., 2012",journal,"Chen J, Zhang L, Wen W, Hao J, Zeng P, Qian X, Zhang Y, Yin Y",Induction of HCA587-specific antitumor immunity with HCA587 protein formulated with CpG and ISCOM in mice,"2012","7","10",e47219,PloS one,"","","","","","","","23071764","","",0,10,0,0,0,,,
2913,99,"Hersey et al., 2005",journal,"Hersey P, Menzies SW, Coventry B, Nguyen T, Farrelly M, Collins S, Hirst D, Johnson H",Phase I/II study of immunotherapy with T-cell peptide epitopes in patients with stage IV melanoma,"2005","54","3","208-218","Cancer immunology, immunotherapy : CII","","","","","","","","15449035","","",0,10,0,0,0,,,
2914,99,"Smith et al., 2005",journal,"Smith CL, Dunbar PR, Mirza F, Palmowski MJ, Shepherd D, Gilbert SC, Coulie P, Schneider J, Hoffman E, Hawkins R, Harris AL, Cerundolo V",Recombinant modified vaccinia Ankara primes functionally activated CTL specific for a melanoma tumor antigen epitope in melanoma patients with a high risk of disease recurrence,"2005","113","2","259-266",International journal of cancer. Journal international du cancer,"","","","","","","","15386406","","",0,10,0,0,0,,,
2915,99,"Agarwala et al., 2004",journal,"Agarwala SS, Neuberg D, Park Y, Kirkwood JM",Mature results of a phase III randomized trial of bacillus Calmette-Guerin (BCG) versus observation and BCG plus dacarbazine versus BCG in the adjuvant therapy of American Joint Committee on Cancer Stage I-III melanoma (E1673): a trial of the Eastern Oncology Group,"2004","100","8","1692-1698",Cancer,"","","","","","","","15073858","","",0,10,0,0,0,,,
2916,99,"Sondak and Sosman, 2003",journal,"Sondak VK, Sosman JA",Results of clinical trials with an allogenic melanoma tumor cell lysate vaccine: Melacine,"2003","13","6","409-415",Seminars in cancer biology,"","","","","","","","15001159","","",0,10,0,0,0,,,
2917,99,"Hsueh and Morton, 2003",journal,"Hsueh EC, Morton DL",Antigen-based immunotherapy of melanoma: Canvaxin therapeutic polyvalent cancer vaccine,"2003","13","6","401-407",Seminars in cancer biology,"","","","","","","","15001158","","",0,10,0,0,0,,,
3883,99,"Frankowski et al., 2004",journal,"Frankowski DJ, Raez J, Manners I, Winnik MA, Khan SA, Spontak RJ",Formation of dispersed nanostructures from poly(ferrocenyldimethylsilane-b-dimethylsiloxane) nanotubes upon exposure to supercritical carbon dioxide,"2004","20","21","9304-9314",Langmuir : the ACS journal of surfaces and colloids,,,,,,,,"15461522",,,0,10,0,0,0,,,
2919,99,"Slingluff et al., 2003",journal,"Slingluff CL Jr, Petroni GR, Yamshchikov GV, Barnd DL, Eastham S, Galavotti H, Patterson JW, Deacon DH, Hibbitts S, Teates D, Neese PY, Grosh WW, Chianese-Bullock KA, Woodson EM, Wiernasz CJ, Merrill P, Gibson J, Ross M, Engelhard VH",Clinical and immunologic results of a randomized phase II trial of vaccination using four melanoma peptides either administered in granulocyte-macrophage colony-stimulating factor in adjuvant or pulsed on dendritic cells,"2003","21","21","4016-4026",Journal of clinical oncology : official journal of the American Society of Clinical Oncology,"","","","","","","","14581425","","",0,10,0,0,0,,,
2920,99,"Irie et al., 2004",journal,"Irie RF, Ollila DW, O'Day S, Morton DL",Phase I pilot clinical trial of human IgM monoclonal antibody to ganglioside GM3 in patients with metastatic melanoma,"2004","53","2","110-117","Cancer immunology, immunotherapy : CII","","","","","","","","14564483","","",0,10,0,0,0,,,
2921,99,"Nicholson et al., 2003",journal,"Nicholson S, Guile K, John J, Clarke IA, Diffley J, Donnellan P, Michael A, Szlosarek P, Dalgleish AG",A randomized phase II trial of SRL172 (Mycobacterium vaccae) +/- low-dose interleukin-2 in the treatment of metastatic malignant melanoma,"2003","13","4","389-393",Melanoma research,"","","","","","","","12883365","","",0,10,0,0,0,,,
2922,99,"Pullarkat et al., 2003",journal,"Pullarkat V, Lee PP, Scotland R, Rubio V, Groshen S, Gee C, Lau R, Snively J, Sian S, Woulfe SL, Wolfe RA, Weber JS",A phase I trial of SD-9427 (progenipoietin) with a multipeptide vaccine for resected metastatic melanoma,"2003","9","4","1301-1312",Clinical cancer research : an official journal of the American Association for Cancer Research,"","","","","","","","12684398","","",0,10,0,0,0,,,
2923,99,"Bettinotti et al., 2003",journal,"Bettinotti MP, Panelli MC, Ruppe E, Mocellin S, Phan GQ, White DE, Marincola FM",Clinical and immunological evaluation of patients with metastatic melanoma undergoing immunization with the HLA-Cw*0702-associated epitope MAGE-A12:170-178,"2003","105","2","210-216",International journal of cancer. Journal international du cancer,"","","","","","","","12673681","","",0,10,0,0,0,,,
2924,99,"Tarhini et al., 2012",journal,"Tarhini AA, Butterfield LH, Shuai Y, Gooding WE, Kalinski P, Kirkwood JM",Differing patterns of circulating regulatory T cells and myeloid-derived suppressor cells in metastatic melanoma patients receiving anti-CTLA4 antibody and interferon- or TLR-9 agonist and GM-CSF with peptide vaccination,"2012","35","9","702-710","Journal of immunotherapy (Hagerstown, Md. : 1997)","","","","","","","","23090079","","",0,10,0,0,0,,,
2925,99,"Hsueh et al., 2002",journal,"Hsueh EC, Essner R, Foshag LJ, Ollila DW, Gammon G, O'Day SJ, Boasberg PD, Stern SL, Ye X, Morton DL",Prolonged survival after complete resection of disseminated melanoma and active immunotherapy with a therapeutic cancer vaccine,"2002","20","23","4549-4554",Journal of clinical oncology : official journal of the American Society of Clinical Oncology,"","","","","","","","12454111","","",0,10,0,0,0,,,
2926,99,"Hersey et al., 2002",journal,"Hersey P, Coates AS, McCarthy WH, Thompson JF, Sillar RW, McLeod R, Gill PG, Coventry BJ, McMullen A, Dillon H, Simes RJ",Adjuvant immunotherapy of patients with high-risk melanoma using vaccinia viral lysates of melanoma: results of a randomized trial,"2002","20","20","4181-4190",Journal of clinical oncology : official journal of the American Society of Clinical Oncology,"","","","","","","","12377961","","",0,10,0,0,0,,,
2927,99,"Rosenberg et al., 1998",journal,"Rosenberg SA, Yang JC, Schwartzentruber DJ, Hwu P, Marincola FM, Topalian SL, Restifo NP, Dudley ME, Schwarz SL, Spiess PJ, Wunderlich JR, Parkhurst MR, Kawakami Y, Seipp CA, Einhorn JH, White DE",Immunologic and therapeutic evaluation of a synthetic peptide vaccine for the treatment of patients with metastatic melanoma,"1998","4","3","321-327",Nature medicine,"","","","","","","","9500606","","",0,10,0,0,0,,,
2928,99,"Berd et al., 1997",journal,"Berd D, Maguire HC Jr, Schuchter LM, Hamilton R, Hauck WW, Sato T, Mastrangelo MJ",Autologous hapten-modified melanoma vaccine as postsurgical adjuvant treatment after resection of nodal metastases,"1997","15","6","2359-2370",Journal of clinical oncology : official journal of the American Society of Clinical Oncology,"","","","","","","","9196151","","",0,10,0,0,0,,,
2929,99,"Mattarollo et al., 2013",journal,"Mattarollo SR, Steegh K, Li M, Duret H, Foong Ngiow S, Smyth MJ",Transient Foxp3(+) regulatory T-cell depletion enhances therapeutic anticancer vaccination targeting the immune-stimulatory properties of NKT cells,"2013","91","1","105-114",Immunology and cell biology,"","","","","","","","23090488","","",0,10,0,0,0,,,
2930,99,"Elias et al., 1997",journal,"Elias EG, Suter CM, Fabian DS",Adjuvant immunotherapy in melanoma with irradiated autologous tumor cells and low dose cyclophosphamide,"1997","64","1","17-22",Journal of surgical oncology,"","","","","","","","9040795","","",0,10,0,0,0,,,
2931,99,"Jones et al., 1996",journal,"Jones RC, Kelley M, Gupta RK, Nizze JA, Yee R, Leopoldo Z, Qi K, Stern S, Morton DL",Immune response to polyvalent melanoma cell vaccine in AJCC stage III melanoma: an immunologic survival model,"1996","3","5","437-445",Annals of surgical oncology,"","","","","","","","8876885","","",0,10,0,0,0,,,
2932,99,"Henz et al., 1996",journal,"Henz BM, Macher E, Brcker EB, Suciu S, Steerenberg PA, Jung E, Rmke P",Prognostic value of tuberculin and BCG immunoreactivity in stage I high-risk malignant melanoma (EORTC protocol 18781),"1996","193","2","105-109","Dermatology (Basel, Switzerland)","","","","","","","","8884144","","",0,10,0,0,0,,,
2933,99,"Mittelman et al., 1995",journal,"Mittelman A, Chen GZ, Wong GY, Liu C, Hirai S, Ferrone S",Human high molecular weight-melanoma associated antigen mimicry by mouse anti-idiotypic monoclonal antibody MK2-23: modulation of the immunogenicity in patients with malignant melanoma,"1995","1","7","705-713",Clinical cancer research : an official journal of the American Association for Cancer Research,"","","","","","","","9816036","","",0,10,0,0,0,,,
2934,99,"Morton et al., 1992",journal,"Morton DL, Foshag LJ, Hoon DS, Nizze JA, Famatiga E, Wanek LA, Chang C, Davtyan DG, Gupta RK, Elashoff R",Prolongation of survival in metastatic melanoma after active specific immunotherapy with a new polyvalent melanoma vaccine,"1992","216","4","463-482",Annals of surgery,"","","","","","","","1417196","","",0,10,0,0,0,,,
2935,99,"Steitz and Tting, 2013",journal,"Steitz J, Tting T",Biolistic DNA vaccination against melanoma,"2013","940","","317-337","Methods in molecular biology (Clifton, N.J.)","","","","","","","","23104352","","",0,10,0,0,0,,,
2936,99,"Baghdadi et al., 2013",journal,"Baghdadi M, Nagao H, Yoshiyama H, Akiba H, Yagita H, Dosaka-Akita H, Jinushi M",Combined blockade of TIM-3 and TIM-4 augments cancer vaccine efficacy against established melanomas,"2013","62","4","629-637","Cancer immunology, immunotherapy : CII","","","","","","","","23143694","","",0,10,0,0,0,,,
2937,99,"Hersey, 1992",journal,Hersey P,Active immunotherapy with viral lysates of micrometastases following surgical removal of high risk melanoma,"1992","16","2","251-260",World journal of surgery,"","","","","","","","1561807","","",0,10,0,0,0,,,
2938,99,"Quirt et al., 1991",journal,"Quirt IC, Shelley WE, Pater JL, Bodurtha AJ, McCulloch PB, McPherson TA, Paterson AH, Prentice R, Silver HK, Willan AR",Improved survival in patients with poor-prognosis malignant melanoma treated with adjuvant levamisole: a phase III study by the National Cancer Institute of Canada Clinical Trials Group,"1991","9","5","729-735",Journal of clinical oncology : official journal of the American Society of Clinical Oncology,"","","","","","","","2016615","","",0,10,0,0,0,,,
2939,99,"Castel et al., 1991",journal,"Castel T, Estap J, Violas N, Mascar JM, Castro J, Vilalta A, Gratacs R, Daniels M, Palou J, Grau JJ",Adjuvant treatment in stage I and II malignant melanoma: a randomized trial between chemoimmunotherapy and immunotherapy,"1991","183","1","25-30",Dermatologica,"","","","","","","","1769411","","",0,10,0,0,0,,,
2940,99,"Lipton et al., 1991",journal,"Lipton A, Harvey HA, Balch CM, Antle CE, Heckard R, Bartolucci AA",Corynebacterium parvum versus bacille Calmette-Gurin adjuvant immunotherapy of stage II malignant melanoma,"1991","9","7","1151-1156",Journal of clinical oncology : official journal of the American Society of Clinical Oncology,"","","","","","","","2045856","","",0,10,0,0,0,,,
2941,99,"Wallack et al., 1986",journal,"Wallack MK, McNally K, Michaelides M, Bash J, Bartolucci A, Siegler H, Balch C, Wanebo H",A phase I/II SECSG (Southeastern Cancer Study Group) pilot study of surgical adjuvant immunotherapy with vaccinia melanoma oncolysates (VMO),"1986","52","3","148-151",The American surgeon,"","","","","","","","3513682","","",0,10,0,0,0,,,
2942,99,"Campisano et al., 2013",journal,"Campisano S, Mac Keon S, Gazzaniga S, Ruiz MS, Traian MD, Mordoh J, Wainstok R",Anti-melanoma vaccinal capacity of CD11c-positive and -negative cell populations present in GM-CSF cultures derived from murine bone marrow precursors,"2013","31","2","354-361",Vaccine,"","","","","","","","23146677","","",0,10,0,0,0,,,
2943,99,"Cassel et al., 1983",journal,"Cassel WA, Murray DR, Phillips HS",A phase II study on the postsurgical management of Stage II malignant melanoma with a Newcastle disease virus oncolysate,"1983","52","5","856-860",Cancer,"","","","","","","","6871827","","",0,10,0,0,0,,,
2944,99,"Lipton et al., 1983",journal,"Lipton A, Harvey HA, Lawrence B, Gottlieb R, Kukrika M, Dixon R, Graham W, Miller S, Heckard R, Schelzel D, White DS",Corynebacterium parvum versus BCG adjuvant immunotherapy in human malignant melanoma,"1983","51","1","57-60",Cancer,"","","","","","","","6821809","","",0,10,0,0,0,,,
2945,99,"Cochran et al., 1981",journal,"Cochran AJ, Buyse ME, Lejeune FJ, Macher E, Revuz J, Rmke P","Adjuvant reactivity predicts survival in patients with ""high-risk"" primary malignant melanoma treated with systemic BCG. EORTC Malignant Melanoma Cooperative Group Writing Committee","1981","28","5","543-550",International journal of cancer. Journal international du cancer,"","","","","","","","7309294","","",0,10,0,0,0,,,
2946,99,"Varella et al., 1981",journal,"Varella AD, Bandiera DC, de Amorim AR Sr, Calvis LA, Santos IO, Escaleira N, Gentil F",Treatment of disseminated malignant melanoma with high-dose oral BCG,"1981","48","6","1353-1362",Cancer,"","","","","","","","7023654","","",0,10,0,0,0,,,
2947,99,"Storm et al., 1979",journal,"Storm FK, Sparks FC, Morton DL",Treatment for melanoma of the lower extremity with intralesional injection of bacille Calmette Gurin and hyperthermic perfusion,"1979","149","1","17-21","Surgery, gynecology & obstetrics","","","","","","","","451822","","",0,10,0,0,0,,,
2948,99,"MacGregor et al., 1977",journal,"MacGregor AB, Falk RE, Landi S, Ambus U, Samuel ES, Langer B",Adjuvant immunostimulation in malignant melanoma with oral Bacille Calmette-Gurin,"1977","20","1","25-30",Canadian journal of surgery. Journal canadien de chirurgie,"","","","","","","","832200","","",0,10,0,0,0,,,
2949,99,"Bilgi et al., 1979",journal,"Bilgi C, Brown NE, McPherson TA, Lentle B",Pulmonary manifestations in patients with malignant melanoma during BCG immunotherapy. A preliminary report,"1979","75","6","685-687",Chest,"","","","","","","","436519","","",0,10,0,0,0,,,
2950,99,"Kolari et al., 1979",journal,"Kolari K, Malenica B, Roth A",A preliminary report of a pilot trial in adjuvant chemotherapy of primary melanoma,"1979","65","2","229-236",Tumori,"","","","","","","","462575","","",0,10,0,0,0,,,
2951,99,"Wtzig and Knopf, 1979",journal,"Wtzig V, Knopf B",[Clinical administration of BCG-immunotherapy in malignant melanoma (author's transl)],"1979","49","2","140-145",Archiv fur Geschwulstforschung,"","","","","","","","475550","","",0,10,0,0,0,,,
2952,99,"Krown et al., 1978",journal,"Krown SE, Hilal EY, Pinsky CM, Hirshaut Y, Wanebo HJ, Hansen JA, Huvos AG, Oettgen HF",Intralesional injection of the methanol extraction residue of Bacillus Calmette-Guerin (MER) into cutaneous metastases of malignant melanoma,"1978","42","6","2648-2660",Cancer,"","","","","","","","728866","","",0,10,0,0,0,,,
2953,99,"Cohen et al., 1978",journal,"Cohen MH, Jessup JM, Felix EL, Weese JL, Herberman RB",Intralesional treatment of recurrent metastatic cutaneous malignant melanoma: a randomized prospective study of intralesional Bacillus Calmette-Guerin versus intralesional dinitrochlorobenzene,"1978","41","6","2456-2463",Cancer,"","","","","","","","657108","","",0,10,0,0,0,,,
2954,99,"Thatcher and Crowther, 1977",journal,"Thatcher N, Crowther D",Effects of BCG and Corynebacterium parvum on immune reactivity in melanoma patients,"1977","38","","449-453",Developments in biological standardization,"","","","","","","","608536","","",0,10,0,0,0,,,
2955,99,"Lieberman et al., 1975",journal,"Lieberman R, Wybran J, Epstein W",The immunologic and histopathologic changes of BCG-mediated tumor regression in patients with malignant melanoma,"1975","35","3","756-777",Cancer,"","","","","","","","234295","","",0,10,0,0,0,,,
2956,99,"Currie and McElwain, 1975",journal,"Currie GA, McElwain TJ",Active immunotherapy as an adjunct to chemotherapy in the treatment of disseminated malignant melanoma: a pilot study,"1975","31","2","143-156",British journal of cancer,"","","","","","","","1164466","","",0,10,0,0,0,,,
2957,99,"Russo et al., 2013",journal,"Russo V, Pilla L, Lunghi F, Crocchiolo R, Greco R, Ciceri F, Maggioni D, Fontana R, Mukenge S, Rivoltini L, Rigamonti G, Mercuri SR, Nicoletti R, Maschio AD, Gianolli L, Fazio F, Marchian A, Florio AD, Maio M, Salomoni M, Gallo-Stampino C, Fiacco MD, Lambiase A, Coulie PG, Patuzzo R, Parmiani G, Traversari C, Bordignon C, Santinami M, Bregni M",Clinical and immunologic responses in melanoma patients vaccinated with MAGE-A3-genetically modified lymphocytes,"2013","132","11","2557-2566",International journal of cancer. Journal international du cancer,"","","","","","","","23151995","","",0,10,0,0,0,,,
2958,99,"Clunie et al., 1980",journal,"Clunie GJ, Gough IR, Dury M, Furnival CM, Bolton PM",A trial of imidazole carboxamide and corynebacterium parvum in disseminated melanoma: clinical and immunologic results,"1980","46","3","475-479",Cancer,"","","","","","","","6994866","","",0,10,0,0,0,,,
2959,99,"Byrne et al., 1983",journal,"Byrne MJ, Van Hazel G, Reynolds PM, Lemish WM, Holman CD",Adjuvant immunotherapy with BCG in stage II malignant melanoma,"1983","23","2","114-116",Journal of surgical oncology,"","","","","","","","6343725","","",0,10,0,0,0,,,
2960,99,"O'Connor et al., 1978",journal,"O'Connor TP, Labandter HP, Hiles RW, Bodenham DC",A clinical trial of BCG immunotherapy as an adjunct to surgery in the treatment of primary malignant melanoma,"1978","31","4","317-322",British journal of plastic surgery,"","","","","","","","361132","","",0,10,0,0,0,,,
2961,99,"El-Domeiri et al., 1978",journal,"El-Domeiri AA, Das Gupta TK, Trippon M, Simo C, Sabet TY, Crispen R",Adjuvant chemotherapy and immunotherapy in high risk patients with melanoma,"1978","146","2","230-232","Surgery, gynecology & obstetrics","","","","","","","","622668","","",0,10,0,0,0,,,
2962,99,"Hunter-Craig et al., 1970",journal,"Hunter-Craig I, Newton KA, Westbury G, Lacey BW",Use of vaccinia virus in the treatment of metastatic malignant melanoma,"1970","2","5708","512-515",British medical journal,"","","","","","","","4913781","","",0,10,0,0,0,,,
2963,99,"Culos and Cuellar, 2013",journal,"Culos KA, Cuellar S",Novel targets in the treatment of advanced melanoma: new first-line treatment options,"2013","47","4","519-526",The Annals of pharmacotherapy,"","","","","","","","23548648","","",0,10,0,0,0,,,
2964,99,"Wu et al., 2013",journal,"Wu H, Han Y, Qin Y, Cao C, Xia Y, Liu C, Wang Y",Whole-cell vaccine coated with recombinant calreticulin enhances activation of dendritic cells and induces tumour-specific immune responses,"2013","29","2","529-534",Oncology reports,"","","","","","","","23166014","","",0,10,0,0,0,,,
2965,99,"Miguel et al., 2012",journal,"Miguel A, Herrero MJ, Sendra L, Botella R, Algs R, Snchez M, Alio SF",Comparative antitumor effect of preventive versus therapeutic vaccines employing B16 melanoma cells genetically modified to express GM-CSF and B7.2 in a murine model,"2012","4","11","1058-1081",Toxins,"","","","","","","","23202306","","",0,10,0,0,0,,,
2966,99,"Ly et al., 2013",journal,"Ly LV, Sluijter M, van der Burg SH, Jager MJ, van Hall T",Effective cooperation of monoclonal antibody and peptide vaccine for the treatment of mouse melanoma,"2013","190","1","489-496","Journal of immunology (Baltimore, Md. : 1950)","","","","","","","","23203930","","",0,10,0,0,0,,,
2967,99,"Mordoh et al., 2013",journal,"Mordoh J, Tapia IJ, Barrio MM",A word of caution: do not wake sleeping dogs; micrometastases of melanoma suddenly grew after progesterone treatment,"2013","13","","132",BMC cancer,"","","","","","","","23510193","","",0,10,0,0,0,,,
2968,99,"Baird et al., 2013",journal,"Baird JR, Byrne KT, Lizotte PH, Toraya-Brown S, Scarlett UK, Alexander MP, Sheen MR, Fox BA, Bzik DJ, Bosenberg M, Mullins DW, Turk MJ, Fiering S",Immune-mediated regression of established B16F10 melanoma by intratumoral injection of attenuated Toxoplasma gondii protects against rechallenge,"2013","190","1","469-478","Journal of immunology (Baltimore, Md. : 1950)","","","","","","","","23225891","","",0,10,0,0,0,,,
2969,99,"Durn-Aniotz et al., 2013",journal,"Durn-Aniotz C, Segal G, Salazar L, Pereda C, Falcn C, Tempio F, Aguilera R, Gonzlez R, Prez C, Tittarelli A, Cataln D, Nervi B, Larrondo M, Salazar-Onfray F, Lpez MN",The immunological response and post-treatment survival of DC-vaccinated melanoma patients are associated with increased Th1/Th17 and reduced Th3 cytokine responses,"2013","62","4","761-772","Cancer immunology, immunotherapy : CII","","","","","","","","23242374","","",0,10,0,0,0,,,
2970,99,"Robert et al., 2013",journal,"Robert C, Schadendorf D, Messina M, Hodi FS, O'Day S",Efficacy and safety of retreatment with ipilimumab in patients with pretreated advanced melanoma who progressed after initially achieving disease control,"2013","19","8","2232-2239",Clinical cancer research : an official journal of the American Association for Cancer Research,"","","","","","","","23444228","","",0,10,0,0,0,,,
2971,99,"Tanaka et al., 2011",journal,"Tanaka A, Jensen JD, Prado R, Riemann H, Shellman YG, Norris DA, Chin L, Yee C, Fujita M",Whole recombinant yeast vaccine induces antitumor immunity and improves survival in a genetically engineered mouse model of melanoma,"2011","18","8","827-834",Gene therapy,"","","","","","","","21390072","","",0,10,0,0,0,,,
2972,99,"Aarntzen et al., 2012",journal,"Aarntzen EH, Schreibelt G, Bol K, Lesterhuis WJ, Croockewit AJ, de Wilt JH, van Rossum MM, Blokx WA, Jacobs JF, Duiveman-de Boer T, Schuurhuis DH, Mus R, Thielemans K, de Vries IJ, Figdor CG, Punt CJ, Adema GJ",Vaccination with mRNA-electroporated dendritic cells induces robust tumor antigen-specific CD4+ and CD8+ T cells responses in stage III and IV melanoma patients,"2012","18","19","5460-5470",Clinical cancer research : an official journal of the American Association for Cancer Research,"","","","","","","","22896657","","",0,10,0,0,0,,,
3089,50,"Rauw et al., 2012",journal,"Rauw F, Palya V, Gardin Y, Tatar-Kis T, Dorsey KM, Lambrecht B, van den Berg T",Efficacy of rHVT-AI vector vaccine in broilers with passive immunity against challenge with two antigenically divergent Egyptian clade 2.2.1 HPAI H5N1 strains,"2012","56","4 Suppl","913-922",Avian diseases,"","","","","","","","23402112","","",0,10,0,0,0,,,
2974,0,"Liechtenstein et al., 2013",journal,"Liechtenstein T, Perez-Janices N, Escors D",Lentiviral vectors for cancer immunotherapy and clinical applications,"2013","5","3","815-837",Cancers,"","","","","","","","24078865","","",0,10,0,0,31,,,
2975,0,"Swenson et al., 2008",journal,"Swenson DL, Wang D, Luo M, Warfield KL, Woraratanadharm J, Holman DH, Dong JY, Pratt WD",Vaccine to confer to nonhuman primates complete protection against multistrain Ebola and Marburg virus infections,"2008","15","3","460-467",Clinical and vaccine immunology : CVI,"","","","","","","","18216185","","",0,10,0,0,33,,,
2976,0,"Bangari and Mittal, 2006",journal,"Bangari DS, Mittal SK",Development of nonhuman adenoviruses as vaccine vectors,"2006","24","7","849-862",Vaccine,"","","","","","","","16297508","","",0,10,0,0,35,,,
2977,0,"Swenson et al., 2008",journal,"Swenson DL, Wang D, Luo M, Warfield KL, Woraratanadharm J, Holman DH, Dong JY, Pratt WD",Vaccine to confer to nonhuman primates complete protection against multistrain Ebola and Marburg virus infections,"2008","15","3","460-467",Clinical and vaccine immunology : CVI,"","","","","","","","18216185","","",0,10,0,0,36,,,
2978,0,"Wang et al., 2006",journal,"Wang D, Hevey M, Juompan LY, Trubey CM, Raja NU, Deitz SB, Woraratanadharm J, Luo M, Yu H, Swain BM, Moore KM, Dong JY",Complex adenovirus-vectored vaccine protects guinea pigs from three strains of Marburg virus challenges,"2006","353","2","324-332",Virology,"","","","","","","","16820184","",,0,0,0,0,36,,,
2979,0,"Perdiguero et al., 2013",journal,"Perdiguero B, Gmez CE, Di Pilato M, Sorzano CO, Delaloye J, Roger T, Calandra T, Pantaleo G, Esteban M","Deletion of the vaccinia virus gene A46R, encoding for an inhibitor of TLR signalling, is an effective approach to enhance the immunogenicity in mice of the HIV/AIDS vaccine candidate NYVAC-C","2013","8","9",e74831,PloS one,"","","","","","","","24069354","","",0,10,0,0,37,,,
2980,0,"Wennier et al., 2013",journal,"Wennier ST, Brinkmann K, Steinhuer C, Maylnder N, Mnich C, Wielert U, Dirmeier U, Hausmann J, Chaplin P, Steigerwald R",A novel naturally occurring tandem promoter in modified vaccinia virus ankara drives very early gene expression and potent immune responses,"2013","8","8",e73511,PloS one,"","","","","","","","23951355","","",0,10,0,0,32,,,
2981,0,"Di et al., 2013",journal,"Di Pilato M, Mejas-Prez E, Gmez CE, Perdiguero B, Sorzano CO, Esteban M",New vaccinia virus promoter as a potential candidate for future vaccines,"2013","94",Pt 12,"2771-2776",The Journal of general virology,"","","","","","","","24077296","","",0,10,0,0,32,,,
2982,0,"Lu et al., 2012",journal,"Lu HY, Chen YH, Liu HJ",Baculovirus as a vaccine vector,"2012","3","5","271-274",Bioengineered,"","","","","","","","22705893","","",0,10,0,0,38,,,
2983,0,"Lu et al., 2012",journal,"Lu HY, Chen YH, Liu HJ",Baculovirus as a vaccine vector,"2012","3","5","271-274",Bioengineered,"","","","","","","","22705893","","",0,10,0,0,39,,,
2984,0,"Lee et al., 2009",journal,"Lee P, Abdul-Wahid A, Faubert GM",Comparison of the local immune response against Giardia lamblia cyst wall protein 2 induced by recombinant Lactococcus lactis and Streptococcus gordonii,"2009","11","1","20-28",Microbes and infection / Institut Pasteur,"","","","","","","","18992359","","",0,10,0,0,26,,,
2986,266,"Lee et al., 2009",journal,"Lee P, Abdul-Wahid A, Faubert GM",Comparison of the local immune response against Giardia lamblia cyst wall protein 2 induced by recombinant Lactococcus lactis and Streptococcus gordonii,"2009","11","1","20-28",Microbes and infection / Institut Pasteur,"","","","","","","","18992359","",,0,0,0,0,0,,,
2987,25,"Fujii et al., 2012",journal,"Fujii J, Naito M, Yutsudo T, Matsumoto S, Heatherly DP, Yamada T, Kobayashi H, Yoshida S, Obrig T",Protection by a recombinant Mycobacterium bovis Bacillus Calmette-Guerin vaccine expressing Shiga toxin 2 B subunit against Shiga toxin-producing Escherichia coli in mice,"2012","19","12","1932-1937",Clinical and vaccine immunology : CVI,"","","","","","","","23035176","","",0,10,0,0,0,,,
2988,99,"Gomez et al., 2013",journal,"Gomez B, He L, Tsai YC, Wu TC, Viscidi RP, Hung CF",Creation of a Merkel cell polyomavirus small T antigen-expressing murine tumor model and a DNA vaccine targeting small T antigen,"2013","3","1","29",Cell & bioscience,"","","","","","","","23856459","","",0,10,0,0,0,,,
2989,99,"Abkin et al., 2013",journal,"Abkin SV, Pankratova KM, Komarova EY, Guzhova IV, Margulis BA",Hsp70 chaperone-based gel composition as a novel immunotherapeutic anti-tumor tool,"2013","18","3","391-396",Cell stress & chaperones,"","","","","","","","23233202","","",0,10,0,0,0,,,
2990,99,"Kruit et al., 2013",journal,"Kruit WH, Suciu S, Dreno B, Mortier L, Robert C, Chiarion-Sileni V, Maio M, Testori A, Dorval T, Grob JJ, Becker JC, Spatz A, Eggermont AM, Louahed J, Lehmann FF, Brichard VG, Keilholz U",Selection of immunostimulant AS15 for active immunization with MAGE-A3 protein: results of a randomized phase II study of the European Organisation for Research and Treatment of Cancer Melanoma Group in Metastatic Melanoma,"2013","31","19","2413-2420",Journal of clinical oncology : official journal of the American Society of Clinical Oncology,"","","","","","","","23715572","","",0,10,0,0,0,,,
2991,99,"Liu et al., 2013",journal,"Liu H, Geng S, Feng C, Xie X, Wu B, Chen X, Zou Q, Wang S, Cui J, Xing R, Li W, Lu Y, Wang B",A DNA vaccine targeting p42.3 induces protective antitumor immunity via eliciting cytotoxic CD8+T lymphocytes in a murine melanoma model,"2013","9","10","2196-2202",Human vaccines & immunotherapeutics,"","","","","","","","24051432","","",0,10,0,0,0,,,
2992,99,"Miguel et al., 2013",journal,"Miguel A, Herrero MJ, Sendra L, Botella R, Algs R, Snchez M, Alio SF","Comparative antitumor effect among GM-CSF, IL-12 and GM-CSF+IL-12 genetically modified tumor cell vaccines","2013","20","10","576-581",Cancer gene therapy,"","","","","","","","23969885","","",0,10,0,0,0,,,
2993,99,"Carreno et al., 2013",journal,"Carreno BM, Becker-Hapak M, Huang A, Chan M, Alyasiry A, Lie WR, Aft RL, Cornelius LA, Trinkaus KM, Linette GP",IL-12p70-producing patient DC vaccine elicits Tc1-polarized immunity,"2013","123","8","3383-3394",The Journal of clinical investigation,"","","","","","","","23867552","","",0,10,0,0,0,,,
2994,99,"Woods and Cebon, 2013",journal,"Woods K, Cebon J",Tumor-specific T-cell help is associated with improved survival in melanoma,"2013","19","15","4021-4023",Clinical cancer research : an official journal of the American Association for Cancer Research,"","","","","","","","23864163","","",0,10,0,0,0,,,
2995,99,"Suriano et al., 2013",journal,"Suriano R, Rajoria S, L George A, Geliebter J, Wallack M, Tiwari RK",Ex vivo derived primary melanoma cells: implications for immunotherapeutic vaccines,"2013","4","5","371-382",Journal of Cancer,"","","","","","","","23833682","","",0,10,0,0,0,,,
2996,99,"Xu et al., 2013",journal,"Xu G, Smith T, Grey F, Hill AB",Cytomegalovirus-based cancer vaccines expressing TRP2 induce rejection of melanoma in mice,"2013","437","2","287-291",Biochemical and biophysical research communications,"","","","","","","","23811402","","",0,10,0,0,0,,,
2997,99,"Tan et al., 2013",journal,"Tan C, Reddy V, Dannull J, Ding E, Nair SK, Tyler DS, Pruitt SK, Lee WT",Impact of anti-CD25 monoclonal antibody on dendritic cell-tumor fusion vaccine efficacy in a murine melanoma model,"2013","11","","148",Journal of translational medicine,"","","","","","","","23768240","","",0,10,0,0,0,,,
2998,99,"He et al., 2013",journal,"He X, Wang J, Zhao F, Chen D, Chen J, Zhang H, Yang C, Liu Y, Dou J",ESAT-6-gpi DNA vaccine augmented the specific antitumour efficacy induced by the tumour vaccine B16F10-ESAT-6-gpi/IL-21 in a mouse model,"2013","78","1","69-78",Scandinavian journal of immunology,"","","","","","","","23679337","","",0,10,0,0,0,,,
2999,99,"Kalli et al., 2013",journal,"Kalli F, Machiorlatti R, Battaglia F, Parodi A, Conteduca G, Ferrera F, Proietti M, Tardito S, Sanguineti M, Millo E, Fenoglio D, De Palma R, Inghirami G, Filaci G",Comparative analysis of cancer vaccine settings for the selection of an effective protocol in mice,"2013","11","","120",Journal of translational medicine,"","","","","","","","23663506","","",0,10,0,0,0,,,
3000,99,"Salerno et al., 2013",journal,"Salerno EP, Shea SM, Olson WC, Petroni GR, Smolkin ME, McSkimming C, Chianese-Bullock KA, Slingluff CL Jr","Activation, dysfunction and retention of T cells in vaccine sites after injection of incomplete Freund's adjuvant, with or without peptide","2013","62","7","1149-1159","Cancer immunology, immunotherapy : CII","","","","","","","","23657629","","",0,10,0,0,0,,,
3001,99,"Slingluff et al., 2013",journal,"Slingluff CL Jr, Lee S, Zhao F, Chianese-Bullock KA, Olson WC, Butterfield LH, Whiteside TL, Leming PD, Kirkwood JM",A randomized phase II trial of multiepitope vaccination with melanoma peptides for cytotoxic T cells and helper T cells for patients with metastatic melanoma (E1602),"2013","19","15","4228-4238",Clinical cancer research : an official journal of the American Association for Cancer Research,"","","","","","","","23653149","","",0,10,0,0,0,,,
3002,99,"Wang et al., 2013",journal,"Wang Z, You H, Song S",[Inhibiting effect of IL-10 in tumor microenvironment on anti-tumor activity of SOCS1-silenced DC vaccine],"2013","29","4","379-383",Xi bao yu fen zi mian yi xue za zhi = Chinese journal of cellular and molecular immunology,"","","","","","","","23643168","","",0,10,0,0,0,,,
3003,99,"Vence et al., 2013",journal,"Vence LM, Wang C, Pappu H, Anson RE, Patel TA, Miller P, Bassett R, Lizee G, Overwijk WW, Komanduri K, Benjamin C, Alvarado G, Patel SP, Kim K, Papadopoulos NE, Bedikian AY, Homsi J, Hwu WJ, Boyd R, Radvanyi L, Hwu P",Chemical castration of melanoma patients does not increase the frequency of tumor-specific CD4 and CD8 T cells after peptide vaccination,"2013","36","4","276-286","Journal of immunotherapy (Hagerstown, Md. : 1997)","","","","","","","","23603862","","",0,10,0,0,0,,,
3004,99,"Hanwell et al., 2013",journal,"Hanwell DG, McNeil B, Visan L, Rodrigues L, Dunn P, Shewen PE, Macallum GE, Turner PV, Vogel TU","Murine responses to recombinant MVA versus ALVAC vaccines against tumor-associated antigens, gp100 and 5T4","2013","36","4","238-247","Journal of immunotherapy (Hagerstown, Md. : 1997)","","","","","","","","23603858","","",0,10,0,0,0,,,
3005,99,"Ricupito et al., 2013",journal,"Ricupito A, Grioni M, Calcinotto A, Hess Michelini R, Longhi R, Mondino A, Bellone M",Booster vaccinations against cancer are critical in prophylactic but detrimental in therapeutic settings,"2013","73","12","3545-3554",Cancer research,"","","","","","","","23539449","","",0,10,0,0,0,,,
3006,99,"Benteyn et al., 2013",journal,"Benteyn D, Van Nuffel AM, Wilgenhof S, Corthals J, Heirman C, Neyns B, Thielemans K, Bonehill A",Characterization of CD8+ T-cell responses in the peripheral blood and skin injection sites of melanoma patients treated with mRNA electroporated autologous dendritic cells (TriMixDC-MEL),"2013","2013","","976383",BioMed research international,"","","","","","","","23509826","","",0,10,0,0,0,,,
3007,99,"Wolfraim et al., 2013",journal,"Wolfraim LA, Takahara M, Viley AM, Shivakumar R, Nieda M, Maekawa R, Liu LN, Peshwa MV",Clinical scale electroloading of mature dendritic cells with melanoma whole tumor cell lysate is superior to conventional lysate co-incubation in triggering robust in vitro expansion of functional antigen-specific CTL,"2013","15","3","488-497",International immunopharmacology,"","","","","","","","23474736","","",0,10,0,0,0,,,
3008,99,"Xu et al., 2013",journal,"Xu M, Xing Y, Zhou L, Yang X, Yao W, Xiao W, Ge C, Ma Y, Yang J, Wu J, Cao R, Li T, Liu J",Improved efficacy of therapeutic vaccination with viable human umbilical vein endothelial cells against murine melanoma by introduction of OK432 as adjuvant,"2013","34","3","1399-1408",Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine,"","","","","","","","23456765","","",0,10,0,0,0,,,
3009,99,"Hailemichael et al., 2013",journal,"Hailemichael Y, Dai Z, Jaffarzad N, Ye Y, Medina MA, Huang XF, Dorta-Estremera SM, Greeley NR, Nitti G, Peng W, Liu C, Lou Y, Wang Z, Ma W, Rabinovich B, Sowell RT, Schluns KS, Davis RE, Hwu P, Overwijk WW","Persistent antigen at vaccination sites induces tumor-specific CD8 T cell sequestration, dysfunction and deletion","2013","19","4","465-472",Nature medicine,"","","","","","","","23455713","","",0,10,0,0,0,,,
3010,99,"Komatsu et al., 2013",journal,"Komatsu N, Jackson HM, Chan KF, Oveissi S, Cebon J, Itoh K, Chen W",Fine-mapping naturally occurring NY-ESO-1 antibody epitopes in melanoma patients' sera using short overlapping peptides and full-length recombinant protein,"2013","54","3-4","465-471",Molecular immunology,"","","","","","","","23454162","","",0,10,0,0,0,,,
3011,99,"Aarntzen et al., 2013",journal,"Aarntzen EH, Srinivas M, Bonetto F, Cruz LJ, Verdijk P, Schreibelt G, van de Rakt M, Lesterhuis WJ, van Riel M, Punt CJ, Adema GJ, Heerschap A, Figdor CG, Oyen WJ, de Vries IJ",Targeting of 111In-labeled dendritic cell human vaccines improved by reducing number of cells,"2013","19","6","1525-1533",Clinical cancer research : an official journal of the American Association for Cancer Research,"","","","","","","","23382117","","",0,10,0,0,0,,,
3012,99,"Yu et al., 2013",journal,"Yu X, Guo C, Yi H, Qian J, Fisher PB, Subjeck JR, Wang XY",A multifunctional chimeric chaperone serves as a novel immune modulator inducing therapeutic antitumor immunity,"2013","73","7","2093-2103",Cancer research,"","","","","","","","23333935","","",0,10,0,0,0,,,
3013,29,"Skerry et al., 2013",journal,"Skerry C, Pokkali S, Pinn M, Be NA, Harper J, Karakousis PC, Jain SK",Vaccination with recombinant Mycobacterium tuberculosis PknD attenuates bacterial dissemination to the brain in guinea pigs,"2013","8","6",e66310,PloS one,"","","","","","","","23776655","","",0,10,0,0,0,,,
3014,29,"Mukai et al., 2014",journal,"Mukai T, Tsukamoto Y, Maeda Y, Tamura T, Makino M",Efficient activation of human T cells of both CD4 and CD8 subsets by urease-deficient recombinant Mycobacterium bovis BCG that produced a heat shock protein 70-M. tuberculosis-derived major membrane protein II fusion protein,"2014","21","1","1-11",Clinical and vaccine immunology : CVI,"","","","","","","","24152387","","",0,10,0,0,0,,,
3015,0,"Xu et al., 2013",journal,"Xu J, Yang D, Huang D, Xu J, Liu S, Lin H, Zhu H, Liu B, Lu C",Protection of guinea pigs by vaccination with a recombinant swinepox virus co-expressing HA1 genes of swine H1N1 and H3N2 influenza viruses,"2013","158","3","629-637",Archives of virology,"","","","","","","","23135159","","",0,10,0,0,41,,,
3016,0,"Lin et al., 2011",journal,"Lin HX, Huang DY, Wang Y, Lu CP, Fan HJ",A novel vaccine against Streptococcus equi ssp. zooepidemicus infections: the recombinant swinepox virus expressing M-like protein,"2011","29","40","7027-7034",Vaccine,"","","","","","","","21807055","","",0,10,0,0,41,,,
3017,267,"Lin et al., 2011",journal,"Lin HX, Huang DY, Wang Y, Lu CP, Fan HJ",A novel vaccine against Streptococcus equi ssp. zooepidemicus infections: the recombinant swinepox virus expressing M-like protein,"2011","29","40","7027-7034",Vaccine,"","","","","","","","21807055","",,0,0,0,0,0,,,
3018,267,"Xu et al., 2013",journal,"Xu J, Yang D, Huang D, Xu J, Liu S, Lin H, Zhu H, Liu B, Lu C",Protection of guinea pigs by vaccination with a recombinant swinepox virus co-expressing HA1 genes of swine H1N1 and H3N2 influenza viruses,"2013","158","3","629-637",Archives of virology,"","","","","","","","23135159","",,0,0,0,0,0,,,
3019,216,"Baden et al., 2014",journal,"Baden LR, Walsh SR, Seaman MS, Johnson JA, Tucker RP, Kleinjan JA, Gothing JA, Engelson BA, Carey BR, Oza A, Bajimaya S, Peter L, Bleckwehl C, Abbink P, Pau MG, Weijtens M, Kunchai M, Swann EM, Wolff M, Dolin R, Barouch DH",First-in-Human Evaluation of a Hexon Chimeric Adenovirus Vector Expressing HIV-1 Env (IPCAVD 002),"2014","","","",The Journal of infectious diseases,"","","","","","","","24719474","","",0,10,0,0,0,,,
3020,216,"Kim et al., 2014",journal,"Kim E, Okada K, Beeler JA, Crim RL, Piedra PA, Gilbert BE, Gambotto A","Development of an adenovirus-based respiratory syncytial virus vaccine: preclinical evaluation of efficacy, immunogenicity, and enhanced disease in a cotton rat model","2014","88","9","5100-5108",Journal of virology,"","","","","","","","24574396","","",0,10,0,0,0,,,
3021,0,"Kim et al., 2014",journal,"Kim E, Okada K, Beeler JA, Crim RL, Piedra PA, Gilbert BE, Gambotto A","Development of an adenovirus-based respiratory syncytial virus vaccine: preclinical evaluation of efficacy, immunogenicity, and enhanced disease in a cotton rat model","2014","88","9","5100-5108",Journal of virology,"","","","","","","","24574396","","",0,10,0,0,33,,,
3022,0,"Xiang et al., 2014",journal,"Xiang ZQ, Greenberg L, Ertl HC, Rupprecht CE",Protection of non-human primates against rabies with an adenovirus recombinant vaccine,"2014","450-451","","243-249",Virology,"","","","","","","","24503087","","",0,10,0,0,33,,,
3023,0,"Brown et al., 2014",journal,"Brown LJ, Rosatte RC, Fehlner-Gardiner C, Bachmann P, Ellison JA, Jackson FR, Taylor JS, Davies C, Donovan D","Oral vaccination and protection of red foxes (Vulpes vulpes) against rabies using ONRAB, an adenovirus-rabies recombinant vaccine","2014","32","8","984-989",Vaccine,"","","","","","","","24374501","","",0,10,0,0,33,,,
3024,0,"Zhou and Blissard, 2008",journal,"Zhou J, Blissard GW",Display of heterologous proteins on gp64null baculovirus virions and enhanced budding mediated by a vesicular stomatitis virus G-stem construct,"2008","82","3","1368-1377",Journal of virology,"","","","","","","","17989172","","",0,10,0,0,39,,,
3025,0,"Harari et al., 2012",journal,"Harari A, Rozot V, Cavassini M, Bellutti Enders F, Vigano S, Tapia G, Castro E, Burnet S, Lange J, Moog C, Garin D, Costagliola D, Autran B, Pantaleo G, Bart PA","NYVAC immunization induces polyfunctional HIV-specific T-cell responses in chronically-infected, ART-treated HIV patients","2012","42","11","3038-3048",European journal of immunology,"","","","","","","","22930439","","",0,10,0,0,37,,,
3026,0,"Holman et al., 2009",journal,"Holman DH, Penn-Nicholson A, Wang D, Woraratanadharm J, Harr MK, Luo M, Maher EM, Holbrook MR, Dong JY",A complex adenovirus-vectored vaccine against Rift Valley fever virus protects mice against lethal infection in the presence of preexisting vector immunity,"2009","16","11","1624-1632",Clinical and vaccine immunology : CVI,"","","","","","","","19776190","","",0,10,0,0,36,,,
3027,0,"Raviprakash et al., 2008",journal,"Raviprakash K, Wang D, Ewing D, Holman DH, Block K, Woraratanadharm J, Chen L, Hayes C, Dong JY, Porter K",A tetravalent dengue vaccine based on a complex adenovirus vector provides significant protection in rhesus monkeys against all four serotypes of dengue virus,"2008","82","14","6927-6934",Journal of virology,"","","","","","","","18480438","","",0,10,0,0,36,,,
3028,0,"Schepp-Berglind et al., 2007",journal,"Schepp-Berglind J, Luo M, Wang D, Wicker JA, Raja NU, Hoel BD, Holman DH, Barrett AD, Dong JY","Complex adenovirus-mediated expression of West Nile virus C, PreM, E, and NS1 proteins induces both humoral and cellular immune responses","2007","14","9","1117-1126",Clinical and vaccine immunology : CVI,"","","","","","","","17634508","","",0,10,0,0,36,,,
3029,0,"Wang et al., 2006",journal,"Wang D, Raja NU, Trubey CM, Juompan LY, Luo M, Woraratanadharm J, Deitz SB, Yu H, Swain BM, Moore KM, Pratt WD, Hart MK, Dong JY",Development of a cAdVax-based bivalent ebola virus vaccine that induces immune responses against both the Sudan and Zaire species of Ebola virus,"2006","80","6","2738-2746",Journal of virology,"","","","","","","","16501083","","",0,10,0,0,36,,,
3030,0,"Buttigieg et al., 2014",journal,"Buttigieg KR, Dowall SD, Findlay-Wilson S, Miloszewska A, Rayner E, Hewson R, Carroll MW",A novel vaccine against Crimean-Congo Haemorrhagic Fever protects 100% of animals against lethal challenge in a mouse model,"2014","9","3",e91516,PloS one,"","","","","","","","24621656","","",0,10,0,0,32,,,
3031,0,"Walther-Jallow et al., 2001",journal,"Walther-Jallow L, Nilsson C, Sderlund J, ten Haaft P, Mkitalo B, Biberfeld P, Bttiger P, Heeney J, Biberfeld G, Thorstensson R",Cross-protection against mucosal simian immunodeficiency virus (SIVsm) challenge in human immunodeficiency virus type 2-vaccinated cynomolgus monkeys,"2001","82",Pt 7,"1601-1612",The Journal of general virology,"","","","","","","","11413371","","",0,10,0,0,14,,,
3032,0,"Boone et al., 2007",journal,"Boone JD, Balasuriya UB, Karaca K, Audonnet JC, Yao J, He L, Nordgren R, Monaco F, Savini G, Gardner IA, Maclachlan NJ",Recombinant canarypox virus vaccine co-expressing genes encoding the VP2 and VP5 outer capsid proteins of bluetongue virus induces high level protection in sheep,"2007","25","4","672-678",Vaccine,"","","","","","","","17059856","","",0,10,0,0,14,,,
3033,0,"Guthrie et al., 2009",journal,"Guthrie AJ, Quan M, Lourens CW, Audonnet JC, Minke JM, Yao J, He L, Nordgren R, Gardner IA, Maclachlan NJ",Protective immunization of horses with a recombinant canarypox virus vectored vaccine co-expressing genes encoding the outer capsid proteins of African horse sickness virus,"2009","27","33","4434-4438",Vaccine,"","","","","","","","19490959","","",0,10,0,0,14,,,
3034,0,"de et al., 2004",journal,"de Bruyn G, Rossini AJ, Chiu YL, Holman D, Elizaga ML, Frey SE, Burke D, Evans TG, Corey L, Keefer MC",Safety profile of recombinant canarypox HIV vaccines,"2004","22","5-6","704-713",Vaccine,"","","","","","","","14741163","","",0,10,0,0,14,,,
3035,0,"Wu et al., 2014",journal,"Wu F, Fan X, Yue Y, Xiong S, Dong C",A vesicular stomatitis virus-based mucosal vaccine promotes dendritic cell maturation and elicits preferable immune response against coxsackievirus B3 induced viral myocarditis,"2014","","","",Vaccine,"","","","","","","","24874923","","",0,10,0,0,11,,,
3036,0,"Halbherr et al., 2013",journal,"Halbherr SJ, Brostoff T, Tippenhauer M, Locher S, Berger Rentsch M, Zimmer G",Vaccination with recombinant RNA replicon particles protects chickens from H5N1 highly pathogenic avian influenza virus,"2013","8","6",e66059,PloS one,"","","","","","","","23762463","","",0,10,0,0,11,,,
3037,0,"Cobleigh et al., 2013",journal,"Cobleigh MA, Wei X, Robek MD",A vesicular stomatitis virus-based therapeutic vaccine generates a functional CD8 T cell response to hepatitis B virus in transgenic mice,"2013","87","5","2969-2973",Journal of virology,"","","","","","","","23269785","","",0,10,0,0,11,,,
3038,0,"Johnson et al., 2013",journal,"Johnson JE, McNeil LK, Megati S, Witko SE, Roopchand VS, Obregon JH, Illenberger DM, Kotash CS, Nowak RM, Braunstein E, Yurgelonis I, Jansen KU, Kalyan NK, Sidhu MK","Non-propagating, recombinant vesicular stomatitis virus vectors encoding respiratory syncytial virus proteins generate potent humoral and cellular immunity against RSV and are protective in mice","2013","150","1-2","134-144",Immunology letters,"","","","","","","","23261719","","",0,10,0,0,11,,,
3039,0,"Falzarano et al., 2011",journal,"Falzarano D, Feldmann F, Grolla A, Leung A, Ebihara H, Strong JE, Marzi A, Takada A, Jones S, Gren J, Geisbert J, Jones SM, Geisbert TW, Feldmann H",Single immunization with a monovalent vesicular stomatitis virus-based vaccine protects nonhuman primates against heterologous challenge with Bundibugyo ebolavirus,"2011","204 Suppl 3","",S1082-1089,The Journal of infectious diseases,"","","","","","","","21987745","","",0,10,0,0,11,,,
3040,0,"Brown et al., 2011",journal,"Brown KS, Safronetz D, Marzi A, Ebihara H, Feldmann H",Vesicular stomatitis virus-based vaccine protects hamsters against lethal challenge with Andes virus,"2011","85","23","12781-12791",Journal of virology,"","","","","","","","21917979","","",0,10,0,0,11,,,
3041,0,"Gautam et al., 2011",journal,"Gautam R, Iyer A, Hunter M, Das A, Williams T, Dufour J, Apetrei C, Kousoulas KG, Marx PA",Vesicular stomatitis virus-simian retrovirus type 2 vaccine protects macaques from detectable infection and B-cell destruction,"2011","85","12","5889-5896",Journal of virology,"","","","","","","","21490096","","",0,10,0,0,11,,,
3042,0,"Schell et al., 2011",journal,"Schell JB, Rose NF, Bahl K, Diller K, Buonocore L, Hunter M, Marx PA, Gambhira R, Tang H, Montefiori DC, Johnson WE, Rose JK",Significant protection against high-dose simian immunodeficiency virus challenge conferred by a new prime-boost vaccine regimen,"2011","85","12","5764-5772",Journal of virology,"","","","","","","","21490100","","",0,10,0,0,11,,,
3043,0,"Marthas et al., 2011",journal,"Marthas ML, Van Rompay KK, Abbott Z, Earl P, Buonocore-Buzzelli L, Moss B, Rose NF, Rose JK, Kozlowski PA, Abel K",Partial efficacy of a VSV-SIV/MVA-SIV vaccine regimen against oral SIV challenge in infant macaques,"2011","29","17","3124-3137",Vaccine,"","","","","","","","21377510","","",0,10,0,0,11,,,
3044,0,"Schwartz et al., 2011",journal,"Schwartz JA, Buonocore L, Suguitan A Jr, Hunter M, Marx PA, Subbarao K, Rose JK",Vesicular stomatitis virus-based H5N1 avian influenza vaccines induce potent cross-clade neutralizing antibodies in rhesus macaques,"2011","85","9","4602-4605",Journal of virology,"","","","","","","","21325423","","",0,10,0,0,11,,,
3045,0,"Medaglini et al., 2001",journal,"Medaglini D, Ciabattini A, Spinosa MR, Maggi T, Marcotte H, Oggioni MR, Pozzi G",Immunization with recombinant Streptococcus gordonii expressing tetanus toxin fragment C confers protection from lethal challenge in mice,"2001","19","15-16","1931-1939",Vaccine,"","","","","","","","11228363","","",0,10,0,0,26,,,
3046,0,"Oggioni et al., 1999",journal,"Oggioni MR, Medaglini D, Romano L, Peruzzi F, Maggi T, Lozzi L, Bracci L, Zazzi M, Manca F, Valensin PE, Pozzi G",Antigenicity and immunogenicity of the V3 domain of HIV type 1 glycoprotein 120 expressed on the surface of Streptococcus gordonii,"1999","15","5","451-459",AIDS research and human retroviruses,"","","","","","","","10195755","","",0,10,0,0,26,,,
3047,0,"Pozzi et al., 1994",journal,"Pozzi G, Oggioni MR, Manganelli R, Medaglini D, Fischetti VA, Fenoglio D, Valle MT, Kunkl A, Manca F",Human T-helper cell recognition of an immunodominant epitope of HIV-1 gp120 expressed on the surface of Streptococcus gordonii,"1994","12","12","1071-1077",Vaccine,"","","","","","","","7998415","","",0,10,0,0,26,,,
3048,0,"Schroeder et al., 2011",journal,"Schroeder J, Brown N, Kaye P, Aebischer T",Single dose novel Salmonella vaccine enhances resistance against visceralizing L. major and L. donovani infection in susceptible BALB/c mice,"2011","5","12",e1406,PLoS neglected tropical diseases,"","","","","","","","22216363","","",0,10,0,0,17,,,
3049,0,"Breau et al., 2012",journal,"Breau C, Cameron DW, Desjardins M, Lee BC",Oral immunization using HgbA in a recombinant chancroid vaccine delivered by attenuated Salmonella typhimurium SL3261 in the temperature-dependent rabbit model,"2012","375","1-2","232-242",Journal of immunological methods,"","","","","","","","22100216","","",0,10,0,0,17,,,
3050,0,"Qi et al., 2006",journal,"Qi H, Li YH, Zheng SB",[Oral gene therapy via live attenuated Salmonella leads to tumor regression and survival prolongation in mice],"2006","26","12","1738-1741",Nan fang yi ke da xue xue bao = Journal of Southern Medical University,"","","","","","","","17259109","","",0,10,0,0,17,,,
3051,0,"Pogonka et al., 2003",journal,"Pogonka T, Klotz C, Kovcs F, Lucius R",A single dose of recombinant Salmonella typhimurium induces specific humoral immune responses against heterologous Eimeria tenella antigens in chicken,"2003","33","1","81-88",International journal for parasitology,"","","","","","","","12547349","","",0,10,0,0,17,,,
3052,0,"Gmez-Duarte et al., 1998",journal,"Gmez-Duarte OG, Lucas B, Yan ZX, Panthel K, Haas R, Meyer TF",Protection of mice against gastric colonization by Helicobacter pylori by single oral dose immunization with attenuated Salmonella typhimurium producing urease subunits A and B,"1998","16","5","460-471",Vaccine,"","","","","","","","9491500","","",0,10,0,0,17,,,
3053,0,"Tite et al., 1990",journal,"Tite JP, Gao XM, Hughes-Jenkins CM, Lipscombe M, O'Callaghan D, Dougan G, Liew FY",Anti-viral immunity induced by recombinant nucleoprotein of influenza A virus. III. Delivery of recombinant nucleoprotein to the immune system using attenuated Salmonella typhimurium as a live carrier,"1990","70","4","540-546",Immunology,"","","","","","","","2168340","","",0,10,0,0,17,,,
3054,0,"Manservigi et al., 1990",journal,"Manservigi R, Grossi MP, Gualandri R, Balboni PG, Marchini A, Rotola A, Rimessi P, Di Luca D, Cassai E, Barbanti-Brodano G",Protection from herpes simplex virus type 1 lethal and latent infections by secreted recombinant glycoprotein B constitutively expressed in human cells with a BK virus episomal vector,"1990","64","1","431-436",Journal of virology,"","","","","","","","2152829","",,0,0,0,0,20,,,
3055,0,"Hunt et al., 1988",journal,"Hunt LA, Brown DW, Robinson HL, Naeve CW, Webster RG",Retrovirus-expressed hemagglutinin protects against lethal influenza virus infections,"1988","62","8","3014-3019",Journal of virology,"","","","","","","","2839718","","",0,10,0,0,23,,,
3056,0,"Lin et al., 2014",journal,"Lin L, Wei J, Chen Y, Huang A, Li KK, Zhang W",Induction of antigen-specific immune responses by dendritic cells transduced with a recombinant lentiviral vector encoding MAGE-A3 gene,"2014","140","2","281-289",Journal of cancer research and clinical oncology,"","","","","","","","24322180","","",0,10,0,0,22,,,
3057,0,"Wu et al., 2014",journal,"Wu Q, Yu F, Xu J, Li Y, Chen H, Xiao S, Fu ZF, Fang L",Rabies-virus-glycoprotein-pseudotyped recombinant baculovirus vaccine confers complete protection against lethal rabies virus challenge in a mouse model,"2014","171","1-2","93-9101",Veterinary microbiology,"","","","","","","","24793501","",,0,0,0,0,19,,,
3058,0,"Liu et al., 2014",journal,"Liu Q, Huang W, Zhang H, Wang Y, Zhao J, Song A, Xie H, Zhao C, Gao D, Wang Y","Neutralizing antibodies against AAV2, AAV5and AAV8 in healthy and HIV-1-infected subjects in China: implications for gene therapy using AAV vectors","2014","","","",Gene therapy,"","","","","","","","24849042","","",0,10,0,0,24,,,
3059,0,"Weber et al., 2014",journal,"Weber ND, Stone D, Sedlak RH, De Silva Feelixge HS, Roychoudhury P, Schiffer JT, Aubert M, Jerome KR",AAV-Mediated Delivery of Zinc Finger Nucleases Targeting Hepatitis B Virus Inhibits Active Replication,"2014","9","5",e97579,PloS one,"","","","","","","","24827459","","",0,10,0,0,24,,,
3060,0,"Tian et al., 2014",journal,"Tian F, Wang L, Arias A, Yang M, Sharifi BG, Shah PK",Comparative Antiatherogenic Effects of Intravenous AAV8- and AAV2-Mediated ApoA-IMilano Gene Transfer in Hypercholesterolemic Mice,"2014","","","",Journal of cardiovascular pharmacology and therapeutics,"","","","","","","","24742767","","",0,10,0,0,24,,,
3061,0,"Cwerman-Thibault et al., 2014",journal,"Cwerman-Thibault H, Augustin S, Ellouze S, Sahel JA, Corral-Debrinski M",Gene therapy for mitochondrial diseases: Leber Hereditary Optic Neuropathy as the first candidate for a clinical trial,"2014","337","3","193-206",Comptes rendus biologies,"","","","","","","","24702846","","",0,10,0,0,24,,,
3062,0,"Joyeux et al., 2014",journal,"Joyeux L, Danzer E, Limberis MP, Zoltick PW, Radu A, Flake AW, Davey MG",In Utero Lung Gene Transfer Using Adeno-Associated Viral and Lentiviral Vectors in Mice,"2014","","","",Human gene therapy methods,"","","","","","","","24660751","","",0,10,0,0,24,,,
3063,0,"Dyka et al., 2014",journal,"Dyka FM, Boye SL, Chiodo VA, Hauswirth WW, Boye SE","Dual adeno-associated virus vectors result in efficient in vitro and in vivo expression of an oversized gene, MYO7A","2014","25","2","166-177",Human gene therapy methods,"","","","","","","","24568220","","",0,10,0,0,24,,,
3064,0,"Lin et al., 2012",journal,"Lin HX, Ma Z, Fan HJ, Lu CP",Construction and immunogenicity of recombinant swinepox virus expressing capsid protein of PCV2,"2012","30","44","6307-6313",Vaccine,"","","","","","","","22884664","","",0,10,0,0,41,,,
3065,0,"Huang et al., 2012",journal,"Huang D, Zhu H, Lin H, Xu J, Lu C",First insights into the protective effects of a recombinant swinepox virus expressing truncated MRP of Streptococcus suis type 2 in mice,"2012","125","3-4","144-152",Berliner und Munchener tierarztliche Wochenschrift,"","","","","","","","22515033","","",0,10,0,0,41,,,
3066,50,"Niqueux et al., 2013",journal,"Niqueux E, Guionie O, Amelot M, Jestin V",Prime-boost vaccination with recombinant H5-fowlpox and Newcastle disease virus vectors affords lasting protection in SPF Muscovy ducks against highly pathogenic H5N1 influenza virus,"2013","31","38","4121-4128",Vaccine,"","","","","","","","23845804","","",0,10,0,0,0,,,
3067,0,"Liu et al., 2013",journal,"Liu J, Chen P, Jiang Y, Deng G, Shi J, Wu L, Lin Y, Bu Z, Chen H",Recombinant duck enteritis virus works as a single-dose vaccine in broilers providing rapid protection against H5N1 influenza infection,"2013","97","3","329-333",Antiviral research,"","","","","","","","23267833","","",0,10,0,0,42,,,
3068,0,"Vagnozzi et al., 2012",journal,"Vagnozzi A, Zavala G, Riblet SM, Mundt A, Garca M",Protection induced by commercially available live-attenuated and recombinant viral vector vaccines against infectious laryngotracheitis virus in broiler chickens,"2012","41","1","21-31",Avian pathology : journal of the W.V.P.A,"","","","","","","","22845318","","",0,10,0,0,43,,,
3090,64,"Lin et al., 2012",journal,"Lin HX, Ma Z, Fan HJ, Lu CP",Construction and immunogenicity of recombinant swinepox virus expressing capsid protein of PCV2,"2012","30","44","6307-6313",Vaccine,"","","","","","","","22884664","","",0,10,0,0,0,,,
3091,64,"Xu et al., 2013",journal,"Xu J, Yang D, Huang D, Xu J, Liu S, Lin H, Zhu H, Liu B, Lu C",Protection of guinea pigs by vaccination with a recombinant swinepox virus co-expressing HA1 genes of swine H1N1 and H3N2 influenza viruses,"2013","158","3","629-637",Archives of virology,"","","","","","","","23135159","","",0,10,0,0,0,,,
3092,273,"Huang et al., 2012",journal,"Huang D, Zhu H, Lin H, Xu J, Lu C",First insights into the protective effects of a recombinant swinepox virus expressing truncated MRP of Streptococcus suis type 2 in mice,"2012","125","3-4","144-152",Berliner und Munchener tierarztliche Wochenschrift,"","","","","","","","22515033","","",0,10,0,0,0,,,
3093,50,"Xu et al., 2012",journal,"Xu J, Huang D, Liu S, Lin H, Zhu H, Liu B, Lu C",Immune responses and protective efficacy of a recombinant swinepox virus expressing HA1 against swine H1N1 influenza virus in mice and pigs,"2012","30","20","3119-3125",Vaccine,"","","","","","","","22391400","","",0,10,0,0,0,,,
3094,68,"Angenvoort et al., 2014",journal,"Angenvoort J, Fischer D, Fast C, Ziegler U, Eiden M, de la Fuente JG, Lierz M, Groschup MH",Limited efficacy of West Nile virus vaccines in large falcons (Falco spp.),"2014","45","","41",Veterinary research,"","","","","","","","24708385","","",0,10,0,0,0,,,
3095,26,"Pegu et al., 2013",journal,"Pegu P, Vaccari M, Gordon S, Keele BF, Doster M, Guan Y, Ferrari G, Pal R, Ferrari MG, Whitney S, Hudacik L, Billings E, Rao M, Montefiori D, Tomaras G, Alam SM, Fenizia C, Lifson JD, Stablein D, Tartaglia J, Michael N, Kim J, Venzon D, Franchini G",Antibodies with high avidity to the gp120 envelope protein in protection from simian immunodeficiency virus SIV(mac251) acquisition in an immunization regimen that mimics the RV-144 Thai trial,"2013","87","3","1708-1719",Journal of virology,"","","","","","","","23175374","","",0,10,0,0,0,,,
3096,56,"Jas et al., 2012",journal,"Jas D, Coupier C, Toulemonde CE, Guigal PM, Poulet H",Three-year duration of immunity in cats vaccinated with a canarypox-vectored recombinant rabies virus vaccine,"2012","30","49","6991-6996",Vaccine,"","","","","","","","23059358","","",0,10,0,0,0,,,
3097,0,"Ma et al., 2014",journal,"Ma J, Xu J, Guan L, Hu T, Liu Q, Xiao J, Zhang Y",Cell-penetrating peptides mediated protein cross-membrane delivery and its use in bacterial vector vaccine,"2014","39","1","8-16",Fish & shellfish immunology,"","","","","","","","24746937","","",0,10,0,0,45,,,
3098,209,"Ma et al., 2014",journal,"Ma J, Xu J, Guan L, Hu T, Liu Q, Xiao J, Zhang Y",Cell-penetrating peptides mediated protein cross-membrane delivery and its use in bacterial vector vaccine,"2014","39","1","8-16",Fish & shellfish immunology,"","","","","","","","24746937","","",0,10,0,0,0,,,
3099,128,"Holman et al., 2009",journal,"Holman DH, Penn-Nicholson A, Wang D, Woraratanadharm J, Harr MK, Luo M, Maher EM, Holbrook MR, Dong JY",A complex adenovirus-vectored vaccine against Rift Valley fever virus protects mice against lethal infection in the presence of preexisting vector immunity,"2009","16","11","1624-1632",Clinical and vaccine immunology : CVI,"","","","","","","","19776190","","",0,10,0,0,0,,,
3100,126,"Raviprakash et al., 2008",journal,"Raviprakash K, Wang D, Ewing D, Holman DH, Block K, Woraratanadharm J, Chen L, Hayes C, Dong JY, Porter K",A tetravalent dengue vaccine based on a complex adenovirus vector provides significant protection in rhesus monkeys against all four serotypes of dengue virus,"2008","82","14","6927-6934",Journal of virology,"","","","","","","","18480438","","",0,10,0,0,0,,,
3101,13,"Wang et al., 2006",journal,"Wang D, Raja NU, Trubey CM, Juompan LY, Luo M, Woraratanadharm J, Deitz SB, Yu H, Swain BM, Moore KM, Pratt WD, Hart MK, Dong JY",Development of a cAdVax-based bivalent ebola virus vaccine that induces immune responses against both the Sudan and Zaire species of Ebola virus,"2006","80","6","2738-2746",Journal of virology,"","","","","","","","16501083","","",0,10,0,0,0,,,
3102,93,"Ramamoorthy et al., 2007",journal,"Ramamoorthy S, Sanakkayala N, Vemulapalli R, Jain N, Lindsay DS, Schurig GS, Boyle SM, Sriranganathan N",Prevention of vertical transmission of Neospora caninum in C57BL/6 mice vaccinated with Brucella abortus strain RB51 expressing N. caninum protective antigens,"2007","37","13","1531-1538",International journal for parasitology,"","","","","","","","17575983","","",0,10,0,0,0,,,
3103,50,"Li et al., 2011",journal,"Li R, Lim A, Ow ST, Phoon MC, Locht C, Chow VT, Alonso S",Development of live attenuated Bordetella pertussis strains expressing the universal influenza vaccine candidate M2e,"2011","29","33","5502-5511",Vaccine,"","","","","","","","21624415","","",0,10,0,0,0,,,
3104,50,"Mielcarek et al., 2006",journal,"Mielcarek N, Debrie AS, Raze D, Quatannens J, Engle J, Goldman WE, Locht C",Attenuated Bordetella pertussis: new live vaccines for intranasal immunisation,"2006","24 Suppl 2","",S2-54-5,Vaccine,"","","","","","","","16823926","","",0,10,0,0,0,,,
3105,0,"Chen et al., 1998",journal,"Chen I, Finn TM, Yanqing L, Guoming Q, Rappuoli R, Pizza M",A recombinant live attenuated strain of Vibrio cholerae induces immunity against tetanus toxin and Bordetella pertussis tracheal colonization factor,"1998","66","4","1648-1653",Infection and immunity,"","","","","","","","9529093","","",0,10,0,0,46,,,
3106,56,"Wu et al., 2014",journal,"Wu Q, Yu F, Xu J, Li Y, Chen H, Xiao S, Fu ZF, Fang L",Rabies-virus-glycoprotein-pseudotyped recombinant baculovirus vaccine confers complete protection against lethal rabies virus challenge in a mouse model,"2014","171","1-2","93-9101",Veterinary microbiology,"","","","","","","","24793501","","",0,10,0,0,0,,,
3107,146,"Zhang et al., 2014",journal,"Zhang J, Chen XW, Tong TZ, Ye Y, Liao M, Fan HY",BacMam virus-based surface display of the infectious bronchitis virus (IBV) S1 glycoprotein confers strong protection against virulent IBV challenge in chickens,"2014","32","6","664-670",Vaccine,"","","","","","","","24342247","","",0,10,0,0,0,,,
3108,50,"Choi et al., 2013",journal,"Choi JY, Gwon YD, Kim JK, Cho YD, Heo YK, Cho HS, Choi TJ, Poo HR, Oh YK, Kim YB","Protective efficacy of a human endogenous retrovirus envelope-coated, nonreplicable, baculovirus-based hemagglutin vaccine against pandemic influenza H1N1 2009","2013","8","11",e80762,PloS one,"","","","","","","","24260476","","",0,10,0,0,0,,,
3109,270,"Iyori et al., 2013",journal,"Iyori M, Nakaya H, Inagaki K, Pichyangkul S, Yamamoto DS, Kawasaki M, Kwak K, Mizukoshi M, Goto Y, Matsuoka H, Matsumoto M, Yoshida S",Protective efficacy of baculovirus dual expression system vaccine expressing Plasmodium falciparum circumsporozoite protein,"2013","8","8",e70819,PloS one,"","","","","","","","23951015","","",0,10,0,0,0,,,
3110,50,"Tretyakova et al., 2013",journal,"Tretyakova I, Pearce MB, Florese R, Tumpey TM, Pushko P","Intranasal vaccination with H5, H7 and H9 hemagglutinins co-localized in a virus-like particle protects ferrets from multiple avian influenza viruses","2013","442","1","67-73",Virology,"","","","","","","","23618102","","",0,10,0,0,0,,,
3111,220,"Argilaguet et al., 2013",journal,"Argilaguet JM, Prez-Martn E, Lpez S, Goethe M, Escribano JM, Giesow K, Keil GM, Rodrguez F",BacMam immunization partially protects pigs against sublethal challenge with African swine fever virus,"2013","98","1","61-65",Antiviral research,"","","","","","","","23428670","","",0,10,0,0,0,,,
3112,29,"Wang et al., 2012",journal,"Wang C, Fu R, Chen Z, Tan K, Chen L, Teng X, Lu J, Shi C, Fan X",Immunogenicity and protective efficacy of a novel recombinant BCG strain overexpressing antigens Ag85A and Ag85B,"2012","2012","","563838",Clinical & developmental immunology,"","","","","","","","22570667","","",0,10,0,0,0,,,
3113,274,"Nascimento et al., 2008",journal,"Nascimento IP, Dias WO, Quintilio W, Christ AP, Moraes JF, Vancetto MD, Ribeiro-Dos-Santos G, Raw I, Leite LC",Neonatal immunization with a single dose of recombinant BCG expressing subunit S1 from pertussis toxin induces complete protection against Bordetella pertussis intracerebral challenge,"2008","10","2","198-202",Microbes and infection / Institut Pasteur,"","","","","","","","18248757","",,0,0,0,0,0,,,
3114,275,"Abi et al., 2014",journal,"Abi Abdallah DS, Pavinski Bitar A, Oliveira F, Meneses C, Park JJ, Mendez S, Kamhawi S, Valenzuela JG, Marquis H",A Listeria-based vaccine that secretes the sand fly salivary protein LJM11 confers long-term protection against vector-transmitted Leishmania major,"2014","","","",Infection and immunity,"","","","","","","","24733091","",,0,0,0,0,0,,,
3115,0,"Wood and Paterson, 2014",journal,"Wood LM, Paterson Y",Attenuated Listeria monocytogenes: a powerful and versatile vector for the future of tumor immunotherapy,"2014","4","","51",Frontiers in cellular and infection microbiology,"","","","","","","","24860789","","",0,10,0,0,47,,,
3116,276,"Matsumoto et al., 1998",journal,"Matsumoto S, Yukitake H, Kanbara H, Yamada T",Recombinant Mycobacterium bovis bacillus Calmette-Gurin secreting merozoite surface protein 1 (MSP1) induces protection against rodent malaria parasite infection depending on MSP1-stimulated interferon gamma and parasite-specific antibodies,"1998","188","5","845-854",The Journal of experimental medicine,"","","","","","","","9730886","",,0,0,0,0,0,,,
3117,50,"Liu et al., 2011",journal,"Liu J, Chen P, Jiang Y, Wu L, Zeng X, Tian G, Ge J, Kawaoka Y, Bu Z, Chen H",A duck enteritis virus-vectored bivalent live vaccine provides fast and complete protection against H5N1 avian influenza virus infection in ducks,"2011","85","21","10989-10998",Journal of virology,"","","","","","","","21865383","","",0,10,0,0,0,,,
3118,50,"Halbherr et al., 2013",journal,"Halbherr SJ, Brostoff T, Tippenhauer M, Locher S, Berger Rentsch M, Zimmer G",Vaccination with recombinant RNA replicon particles protects chickens from H5N1 highly pathogenic avian influenza virus,"2013","8","6",e66059,PloS one,"","","","","","","","23762463","","",0,10,0,0,0,,,
3119,271,"Eyles et al., 2013",journal,"Eyles JE, Johnson JE, Megati S, Roopchand V, Cockle PJ, Weeratna R, Makinen S, Brown TP, Lang S, Witko SE, Kotash CS, Li J, West K, Maldonado O, Falconer DJ, Lees C, Smith GJ, White P, Wright P, Loudon PT, Merson JR, Jansen KU, Sidhu MK",Nonreplicating vaccines can protect african green monkeys from the memphis 37 strain of respiratory syncytial virus,"2013","208","2","319-329",The Journal of infectious diseases,"","","","","","","","23596321","",,0,0,0,0,0,,,
3120,271,"Johnson et al., 2013",journal,"Johnson JE, McNeil LK, Megati S, Witko SE, Roopchand VS, Obregon JH, Illenberger DM, Kotash CS, Nowak RM, Braunstein E, Yurgelonis I, Jansen KU, Kalyan NK, Sidhu MK","Non-propagating, recombinant vesicular stomatitis virus vectors encoding respiratory syncytial virus proteins generate potent humoral and cellular immunity against RSV and are protective in mice","2013","150","1-2","134-144",Immunology letters,"","","","","","","","23261719","",,0,0,0,0,0,,,
3121,13,"Falzarano et al., 2011",journal,"Falzarano D, Feldmann F, Grolla A, Leung A, Ebihara H, Strong JE, Marzi A, Takada A, Jones S, Gren J, Geisbert J, Jones SM, Geisbert TW, Feldmann H",Single immunization with a monovalent vesicular stomatitis virus-based vaccine protects nonhuman primates against heterologous challenge with Bundibugyo ebolavirus,"2011","204 Suppl 3","",S1082-1089,The Journal of infectious diseases,"","","","","","","","21987745","","",0,10,0,0,0,,,
3122,13,"Marzi et al., 2011",journal,"Marzi A, Ebihara H, Callison J, Groseth A, Williams KJ, Geisbert TW, Feldmann H",Vesicular stomatitis virus-based Ebola vaccines with improved cross-protective efficacy,"2011","204 Suppl 3","",S1066-1074,The Journal of infectious diseases,"","","","","","","","21987743","","",0,10,0,0,0,,,
3123,27,"Brown et al., 2011",journal,"Brown KS, Safronetz D, Marzi A, Ebihara H, Feldmann H",Vesicular stomatitis virus-based vaccine protects hamsters against lethal challenge with Andes virus,"2011","85","23","12781-12791",Journal of virology,"","","","","","","","21917979","","",0,10,0,0,0,,,
3124,128,"Busquets et al., 2014",journal,"Busquets N, Lorenzo G, Lpez-Gil E, Rivas R, Solanes D, Galindo-Cardiel I, Xavier Abad F, Rodrguez F, Bensaid A, Warimwe G, Gilbert SC, Domingo M, Brun A",Efficacy assessment of an MVA vectored Rift Valley Fever vaccine in lambs,"2014","","","",Antiviral research,"","","","","","","","24933081","","",0,10,0,0,0,,,
3125,213,"Kwa et al., 2014",journal,"Kwa S, Lai L, Gangadhara S, Siddiqui M, Pillai VB, Labranche C, Yu T, Moss B, Montefiori DC, Robinson HL, Kozlowski PA, Amara RR","CD40L-adjuvanted DNA/MVA SIV239 vaccine enhances SIV-specific humoral and cellular immunity, and improves protection against a heterologous SIVE660 mucosal challenge","2014","","","",Journal of virology,"","","","","","","","24920805","","",0,10,0,0,0,,,
3126,277,"Buttigieg et al., 2014",journal,"Buttigieg KR, Dowall SD, Findlay-Wilson S, Miloszewska A, Rayner E, Hewson R, Carroll MW",A novel vaccine against Crimean-Congo Haemorrhagic Fever protects 100% of animals against lethal challenge in a mouse model,"2014","9","3",e91516,PloS one,"","","","","","","","24621656","","",0,10,0,0,0,,,
3127,278,"Garca-Arriaza et al., 2014",journal,"Garca-Arriaza J, Cepeda V, Hallengrd D, Sorzano C, Kmmerer BM, Liljestrm P, Esteban M","A novel poxvirus-based vaccine, MVA-CHIKV, is highly immunogenic and protects mice against chikungunya infection","2014","88","6","3527-3547",Journal of virology,"","","","","","","","24403588","","",0,10,0,0,0,,,
3128,270,"Bauza et al., 2014",journal,"Bauza K, Malinauskas T, Pfander C, Anar B, Jones EY, Billker O, Hill AV, Reyes-Sandoval A",Efficacy of a Plasmodium vivax malaria vaccine using ChAd63 and modified vaccinia Ankara expressing thrombospondin-related anonymous protein as assessed with transgenic Plasmodium berghei parasites,"2014","82","3","1277-1286",Infection and immunity,"","","","","","","","24379295","","",0,10,0,0,0,,,
3129,50,"Xiao et al., 2013",journal,"Xiao H, Liu L, Zhu Q, Tan Z, Yu W, Tang X, Zhan D, Du Y, Wang H, Liu D, Li Z, Yuen KY, Ho DD, Gao GF, Chen Z",A replicating modified vaccinia tiantan strain expressing an avian-derived influenza H5N1 hemagglutinin induce broadly neutralizing antibodies and cross-clade protective immunity in mice,"2013","8","12",e83274,PloS one,"","","","","","","","24358269","","",0,10,0,0,0,,,
3130,279,"Medaglini et al., 2001",journal,"Medaglini D, Ciabattini A, Spinosa MR, Maggi T, Marcotte H, Oggioni MR, Pozzi G",Immunization with recombinant Streptococcus gordonii expressing tetanus toxin fragment C confers protection from lethal challenge in mice,"2001","19","15-16","1931-1939",Vaccine,"","","","","","","","11228363","","",0,10,0,0,0,,,
3131,109,"Lee et al., 1999",journal,"Lee SF, March RJ, Halperin SA, Faulkner G, Gao L",Surface expression of a protective recombinant pertussis toxin S1 subunit fragment in Streptococcus gordonii,"1999","67","3","1511-1516",Infection and immunity,"","","","","","","","10024603","","",0,10,0,0,0,,,
3132,115,"Schroeder et al., 2011",journal,"Schroeder J, Brown N, Kaye P, Aebischer T",Single dose novel Salmonella vaccine enhances resistance against visceralizing L. major and L. donovani infection in susceptible BALB/c mice,"2011","5","12",e1406,PLoS neglected tropical diseases,"","","","","","","","22216363","","",0,10,0,0,0,,,
3133,97,"Schroeder et al., 2011",journal,"Schroeder J, Brown N, Kaye P, Aebischer T",Single dose novel Salmonella vaccine enhances resistance against visceralizing L. major and L. donovani infection in susceptible BALB/c mice,"2011","5","12",e1406,PLoS neglected tropical diseases,"","","","","","","","22216363","","",0,10,0,0,0,,,
3134,99,"Qi et al., 2006",journal,"Qi H, Li YH, Zheng SB",[Oral gene therapy via live attenuated Salmonella leads to tumor regression and survival prolongation in mice],"2006","26","12","1738-1741",Nan fang yi ke da xue xue bao = Journal of Southern Medical University,"","","","","","","","17259109","","",0,10,0,0,0,,,
3135,137,"DiGiandomenico et al., 2004",journal,"DiGiandomenico A, Rao J, Goldberg JB",Oral vaccination of BALB/c mice with Salmonella enterica serovar Typhimurium expressing Pseudomonas aeruginosa O antigen promotes increased survival in an acute fatal pneumonia model,"2004","72","12","7012-7021",Infection and immunity,"","","","","","","","15557624","",,0,0,0,0,0,,,
3136,134,"Gmez-Duarte et al., 1998",journal,"Gmez-Duarte OG, Lucas B, Yan ZX, Panthel K, Haas R, Meyer TF",Protection of mice against gastric colonization by Helicobacter pylori by single oral dose immunization with attenuated Salmonella typhimurium producing urease subunits A and B,"1998","16","5","460-471",Vaccine,"","","","","","","","9491500","","",0,10,0,0,0,,,
3137,140,"Poirier et al., 1988",journal,"Poirier TP, Kehoe MA, Beachey EH",Protective immunity evoked by oral administration of attenuated aroA Salmonella typhimurium expressing cloned streptococcal M protein,"1988","168","1","25-32",The Journal of experimental medicine,"","","","","","","","3294331","","",0,10,0,0,0,,,
3138,50,"Hunt et al., 1988",journal,"Hunt LA, Brown DW, Robinson HL, Naeve CW, Webster RG",Retrovirus-expressed hemagglutinin protects against lethal influenza virus infections,"1988","62","8","3014-3019",Journal of virology,"","","","","","","","2839718","","",0,10,0,0,0,,,
3139,129,"Zheng et al., 2008",journal,"Zheng BJ, Du LY, Zhao GY, Lin YP, Sui HY, Chan C, Ma S, Guan Y, Yuen KY",Studies of SARS virus vaccines,"2008","14 Suppl 4","","39-43",Hong Kong medical journal = Xianggang yi xue za zhi / Hong Kong Academy of Medicine,"","","","","","","","18708674","","",0,10,0,0,0,,,
3140,129,"Du et al., 2008",journal,"Du L, Zhao G, Lin Y, Sui H, Chan C, Ma S, He Y, Jiang S, Wu C, Yuen KY, Jin DY, Zhou Y, Zheng BJ",Intranasal vaccination of recombinant adeno-associated virus encoding receptor-binding domain of severe acute respiratory syndrome coronavirus (SARS-CoV) spike protein induces strong mucosal immune responses and provides long-term protection against SARS-CoV infection,"2008","180","2","948-956","Journal of immunology (Baltimore, Md. : 1950)","","","","","","","","18178835","","",0,10,0,0,0,,,
3141,268,"Kanabagatte et al., 2014",journal,"Kanabagatte Basavarajappa M, Kumar S, Khattar SK, Gebreluul GT, Paldurai A, Samal SK",A recombinant Newcastle disease virus (NDV) expressing infectious laryngotracheitis virus (ILTV) surface glycoprotein D protects against highly virulent ILTV and NDV challenges in chickens,"2014","32","28","3555-3563",Vaccine,"","","","","","","","24793943","","",0,10,0,0,0,,,
3142,50,"Ferreira et al., 2014",journal,"Ferreira HL, Rauw F, Pirlot JF, Reynard F, van den Berg T, Bublot M, Lambrecht B",Comparison of single 1-day-old chick vaccination using a Newcastle disease virus vector with a prime/boost vaccination scheme against a highly pathogenic avian influenza H5N1 challenge,"2014","43","1","68-77",Avian pathology : journal of the W.V.P.A,"","","","","","","","24320551","","",0,10,0,0,0,,,
3143,50,"Ferreira et al., 2012",journal,"Ferreira HL, Pirlot JF, Reynard F, van den Berg T, Bublot M, Lambrecht B",Immune responses and protection against H5N1 highly pathogenic avian influenza virus induced by the Newcastle disease virus H5 vaccine in ducks,"2012","56","4 Suppl","940-948",Avian diseases,"","","","","","","","23402116","","",0,10,0,0,0,,,
3144,50,"Schrer et al., 2011",journal,"Schrer D, Veits J, Keil G, Rmer-Oberdrfer A, Weber S, Mettenleiter TC",Efficacy of Newcastle disease virus recombinant expressing avian influenza virus H6 hemagglutinin against Newcastle disease and low pathogenic avian influenza in chickens and turkeys,"2011","55","2","201-211",Avian diseases,"","","","","","","","21793434","","",0,10,0,0,0,,,
3145,0,"Pol et al., 2014",journal,"Pol JG, Zhang L, Bridle BW, Stephenson KB, Ressguier J, Hanson S, Chen L, Kazdhan N, Bramson JL, Stojdl DF, Wan Y, Lichty BD",Maraba virus as a potent oncolytic vaccine vector,"2014","22","2","420-429",Molecular therapy : the journal of the American Society of Gene Therapy,"","","","","","","","24322333","","",0,10,0,0,49,,,
3146,0,"Xu et al., 2013",journal,"Xu G, Smith T, Grey F, Hill AB",Cytomegalovirus-based cancer vaccines expressing TRP2 induce rejection of melanoma in mice,"2013","437","2","287-291",Biochemical and biophysical research communications,"","","","","","","","23811402","","",0,10,0,0,50,,,
3147,280,"Ami et al., 2005",journal,"Ami Y, Izumi Y, Matsuo K, Someya K, Kanekiyo M, Horibata S, Yoshino N, Sakai K, Shinohara K, Matsumoto S, Yamada T, Yamazaki S, Yamamoto N, Honda M",Priming-boosting vaccination with recombinant Mycobacterium bovis bacillus Calmette-Gurin and a nonreplicating vaccinia virus recombinant leads to long-lasting and effective immunity,"2005","79","20","12871-12879",Journal of virology,"","","","","","","","16188989","",,0,0,0,0,0,,,
3148,0,"Donofrio et al., 2013",journal,"Donofrio G, Franceschi V, Lovero A, Capocefalo A, Camero M, Losurdo M, Cavirani S, Marinaro M, Grandolfo E, Buonavoglia C, Tempesta M",Clinical protection of goats against CpHV-1 induced genital disease with a BoHV-4-based vector expressing CpHV-1 gD,"2013","8","1",e52758,PloS one,"","","","","","","","23300989","","",0,10,0,0,51,,,
3149,0,"Capocefalo et al., 2013",journal,"Capocefalo A, Mangia C, Franceschi V, Jacca S, van Santen VL, Donofrio G",Efficient heterologous antigen gene delivery and expression by a replication-attenuated BoHV-4-based vaccine vector,"2013","31","37","3906-3914",Vaccine,"","","","","","","","23830977","","",0,10,0,0,51,,,
3150,0,"Franceschi et al., 2014",journal,"Franceschi V, Stellari FF, Mangia C, Jacca S, Lavrentiadou S, Cavirani S, Heikenwalder M, Donofrio G",In vivo image analysis of BoHV-4-based vector in mice,"2014","9","4",e95779,PloS one,"","","","","","","","24752229","","",0,10,0,0,51,,,
3151,0,"Franceschi et al., 2011",journal,"Franceschi V, Capocefalo A, Calvo-Pinilla E, Redaelli M, Mucignat-Caretta C, Mertens P, Ortego J, Donofrio G",Immunization of knock-out / interferon receptor mice against lethal bluetongue infection with a BoHV-4-based vector expressing BTV-8 VP2 antigen,"2011","29","16","3074-3082",Vaccine,"","","","","","","","21320537","","",0,10,0,0,51,,,
3152,0,"Escriou et al., 2014",journal,"Escriou N, Callendret B, Lorin V, Combredet C, Marianneau P, Fvrier M, Tangy F",Protection from SARS coronavirus conferred by live measles vaccine expressing the spike glycoprotein,"2014","452-453","","32-41",Virology,"","","","","","","","24606680","","",0,10,0,0,52,,,
3153,0,"Brandler and Tangy, 2013",journal,"Brandler S, Tangy F",Vaccines in development against West Nile virus,"2013","5","10","2384-2409",Viruses,"","","","","","","","24084235","","",0,10,0,0,52,,,
3154,0,"Grossardt et al., 2013",journal,"Grossardt C, Engeland CE, Bossow S, Halama N, Zaoui K, Leber MF, Springfeld C, Jaeger D, von Kalle C, Ungerechts G",Granulocyte-macrophage colony-stimulating factor-armed oncolytic measles virus is an effective therapeutic cancer vaccine,"2013","24","7","644-654",Human gene therapy,"","","","","","","","23642239","","",0,10,0,0,52,,,
3155,0,"Lange et al., 2013",journal,"Lange S, Lampe J, Bossow S, Zimmermann M, Neubert W, Bitzer M, Lauer UM",A novel armed oncolytic measles vaccine virus for the treatment of cholangiocarcinoma,"2013","24","5","554-564",Human gene therapy,"","","","","","","","23550539","","",0,10,0,0,52,,,
3156,0,"Yoneda et al., 2013",journal,"Yoneda M, Georges-Courbot MC, Ikeda F, Ishii M, Nagata N, Jacquot F, Raoul H, Sato H, Kai C",Recombinant measles virus vaccine expressing the Nipah virus glycoprotein protects against lethal Nipah virus challenge,"2013","8","3",e58414,PloS one,"","","","","","","","23516477","","",0,10,0,0,52,,,
3157,0,"O'Hara et al., 2012",journal,"O'Hara GA, Duncan CJ, Ewer KJ, Collins KA, Elias SC, Halstead FD, Goodman AL, Edwards NJ, Reyes-Sandoval A, Bird P, Rowland R, Sheehy SH, Poulton ID, Hutchings C, Todryk S, Andrews L, Folgori A, Berrie E, Moyle S, Nicosia A, Colloca S, Cortese R, Siani L, Lawrie AM, Gilbert SC, Hill AV",Clinical assessment of a recombinant simian adenovirus ChAd63: a potent new vaccine vector,"2012","205","5","772-781",The Journal of infectious diseases,"","","","","","","","22275401","","",0,10,0,0,53,,,
3158,0,"Sheehy et al., 2012",journal,"Sheehy SH, Duncan CJ, Elias SC, Biswas S, Collins KA, O'Hara GA, Halstead FD, Ewer KJ, Mahungu T, Spencer AJ, Miura K, Poulton ID, Dicks MD, Edwards NJ, Berrie E, Moyle S, Colloca S, Cortese R, Gantlett K, Long CA, Lawrie AM, Gilbert SC, Doherty T, Nicosia A, Hill AV, Draper SJ",Phase Ia clinical evaluation of the safety and immunogenicity of the Plasmodium falciparum blood-stage antigen AMA1 in ChAd63 and MVA vaccine vectors,"2012","7","2",e31208,PloS one,"","","","","","","","22363582","","",0,10,0,0,53,,,
3159,0,"Ogwang et al., 2013",journal,"Ogwang C, Afolabi M, Kimani D, Jagne YJ, Sheehy SH, Bliss CM, Duncan CJ, Collins KA, Garcia Knight MA, Kimani E, Anagnostou NA, Berrie E, Moyle S, Gilbert SC, Spencer AJ, Soipei P, Mueller J, Okebe J, Colloca S, Cortese R, Viebig NK, Roberts R, Gantlett K, Lawrie AM, Nicosia A, Imoukhuede EB, Bejon P, Urban BC, Flanagan KL, Ewer KJ, Chilengi R, Hill AV, Bojang K","Safety and immunogenicity of heterologous prime-boost immunisation with Plasmodium falciparum malaria candidate vaccines, ChAd63 ME-TRAP and MVA ME-TRAP, in healthy Gambian and Kenyan adults","2013","8","3",e57726,PloS one,"","","","","","","","23526949","","",0,10,0,0,53,,,
3160,0,"Mohamadzadeh et al., 2010",journal,"Mohamadzadeh M, Durmaz E, Zadeh M, Pakanati KC, Gramarossa M, Cohran V, Klaenhammer TR",Targeted expression of anthrax protective antigen by Lactobacillus gasseri as an anthrax vaccine,"2010","5","8","1289-1296",Future microbiology,"","","","","","","","20722604","","",0,10,0,0,54,,,
3161,0,"Duong et al., 2011",journal,"Duong T, Miller MJ, Barrangou R, Azcarate-Peril MA, Klaenhammer TR",Construction of vectors for inducible and constitutive gene expression in Lactobacillus,"2011","4","3","357-367",Microbial biotechnology,"","","","","","","","21375708","","",0,10,0,0,54,,,
3162,0,"Stoeker et al., 2011",journal,"Stoeker L, Nordone S, Gunderson S, Zhang L, Kajikawa A, LaVoy A, Miller M, Klaenhammer TR, Dean GA",Assessment of Lactobacillus gasseri as a candidate oral vaccine vector,"2011","18","11","1834-1844",Clinical and vaccine immunology : CVI,"","","","","","","","21900526","","",0,10,0,0,54,,,
3163,0,"Top et al., 2012",journal,"Top S, Foucras G, Deplanche M, Rives G, Calvalido J, Comtet L, Bertagnoli S, Meyer G",Myxomavirus as a vector for the immunisation of sheep: protection study against challenge with bluetongue virus,"2012","30","9","1609-1616",Vaccine,"","","","","","","","22244980","","",0,10,0,0,55,,,
3164,0,"Top et al., 2011",journal,"Top S, Foulon E, Pignolet B, Deplanche M, Caubet C, Tasca C, Bertagnoli S, Meyer G, Foucras G",Infection of nonhost species dendritic cells in vitro with an attenuated myxoma virus induces gene expression that predicts its efficacy as a vaccine vector,"2011","85","24","12982-12994",Journal of virology,"","","","","","","","21835800","","",0,10,0,0,55,,,
3165,0,"Pignolet et al., 2008",journal,"Pignolet B, Boullier S, Gelfi J, Bozzetti M, Russo P, Foulon E, Meyer G, Delverdier M, Foucras G, Bertagnoli S",Safety and immunogenicity of myxoma virus as a new viral vector for small ruminants,"2008","89",Pt 6,"1371-1379",The Journal of general virology,"","","","","","","","18474552","","",0,10,0,0,55,,,
3166,0,"Gu et al., 2004",journal,"Gu W, Holland M, Janssens P, Seamark R, Kerr P",Immune response in rabbit ovaries following infection of a recombinant myxoma virus expressing rabbit zona pellucida protein B,"2004","318","2","516-523",Virology,"","","","","","","","14972520","","",0,10,0,0,55,,,
3167,0,"Gu et al., 2003",journal,"Gu W, Holland M, Janssens P, Kerr P",Antibody response in the female rabbit reproductive tract to influenza haemagglutinin encoded by a recombinant myxoma virus,"2003","313","1","286-295",Virology,"","","","","","","","12951040","","",0,10,0,0,55,,,
3168,0,"McCabe et al., 2002",journal,"McCabe VJ, Tarpey I, Spibey N",Vaccination of cats with an attenuated recombinant myxoma virus expressing feline calicivirus capsid protein,"2002","20","19-20","2454-2462",Vaccine,"","","","","","","","12057600","","",0,10,0,0,55,,,
3169,0,"Brcena et al., 2000",journal,"Brcena J, Morales M, Vzquez B, Boga JA, Parra F, Lucientes J, Pags-Mant A, Snchez-Vizcano JM, Blasco R, Torres JM",Horizontal transmissible protection against myxomatosis and rabbit hemorrhagic disease by using a recombinant myxoma virus,"2000","74","3","1114-1123",Journal of virology,"","","","","","","","10627521","","",0,10,0,0,55,,,
3170,0,"Kerr and Jackson, 1995",journal,"Kerr PJ, Jackson RJ",Myxoma virus as a vaccine vector for rabbits: antibody levels to influenza virus haemagglutinin presented by a recombinant myxoma virus,"1995","13","17","1722-1726",Vaccine,"","","","","","","","8719525","","",0,10,0,0,55,,,
3171,0,"Patel et al., 2010",journal,"Patel A, Tikoo S, Kobinger G",A porcine adenovirus with low human seroprevalence is a promising alternative vaccine vector to human adenovirus 5 in an H5N1 virus disease model,"2010","5","12",e15301,PloS one,"","","","","","","","21179494","","",0,10,0,0,56,,,
3172,0,"Zhou et al., 2007",journal,"Zhou Y, Ficzycz A, Tikoo SK",Porcine adenovirus type 3 E1B large protein downregulates the induction of IL-8,"2007","4","","60",Virology journal,"","","","","","","","17565687","","",0,10,0,0,56,,,
3173,0,"Nagy and Tuboly, 2000",journal,"Nagy M, Tuboly T",Porcine adenoviruses: an update on genome analysis and vector development,"2000","48","4","491-499",Acta veterinaria Hungarica,"","","","","","","","11402666","","",0,10,0,0,56,,,
3174,0,"Zakhartchouk et al., 2003",journal,"Zakhartchouk A, Zhou Y, Tikoo SK",A recombinant E1-deleted porcine adenovirus-3 as an expression vector,"2003","313","2","377-386",Virology,"","","","","","","","12954206","","",0,10,0,0,56,,,
3175,0,"Reddy et al., 1999",journal,"Reddy PS, Idamakanti N, Hyun BH, Tikoo SK, Babiuk LA",Development of porcine adenovirus-3 as an expression vector,"1999","80 ( Pt 3)","","563-570",The Journal of general virology,"","","","","","","","10091994","","",0,10,0,0,56,,,
3176,0,"Kumar et al., 2011",journal,"Kumar S, Nayak B, Collins PL, Samal SK",Evaluation of the Newcastle disease virus F and HN proteins in protective immunity by using a recombinant avian paramyxovirus type 3 vector in chickens,"2011","85","13","6521-6534",Journal of virology,"","","","","","","","21525340","","",0,10,0,0,57,,,
3177,0,"Kim and Nam, 2011",journal,"Kim DS, Nam JH",Application of attenuated coxsackievirus B3 as a viral vector system for vaccines and gene therapy,"2011","7","4","410-416",Human vaccines,"","","","","","","","21389776","","",0,10,0,0,58,,,
3178,0,"Gu et al., 2010",journal,"Gu R, Shampang A, Nashar T, Patil M, Fuller DH, Ramsingh AI",Oral immunization with a live coxsackievirus/HIV recombinant induces gag p24-specific T cell responses,"2010","5","9","",PloS one,"","","","","","","","20824074","","",0,10,0,0,58,,,
3179,0,"Kim and Nam, 2010",journal,"Kim DS, Nam JH",Characterization of attenuated coxsackievirus B3 strains and prospects of their application as live-attenuated vaccines,"2010","10","2","179-190",Expert opinion on biological therapy,"","","","","","","","20088713","","",0,10,0,0,58,,,
3180,0,"Kim et al., 2010",journal,"Kim DS, Cho YJ, Kim BG, Lee SH, Nam JH",Systematic analysis of attenuated Coxsackievirus expressing a foreign gene as a viral vaccine vector,"2010","28","5","1234-1240",Vaccine,"","","","","","","","19941986","","",0,10,0,0,58,,,
3181,0,"Henke et al., 2008",journal,"Henke A, Jarasch N, Wutzler P",Coxsackievirus B3 vaccines: use as an expression vector for prevention of myocarditis,"2008","7","10","1557-1567",Expert review of vaccines,"","","","","","","","19053211","","",0,10,0,0,58,,,
3182,0,"Slifka et al., 2001",journal,"Slifka MK, Pagarigan R, Mena I, Feuer R, Whitton JL",Using recombinant coxsackievirus B3 to evaluate the induction and protective efficacy of CD8+ T cells during picornavirus infection,"2001","75","5","2377-2387",Journal of virology,"","","","","","","","11160741","","",0,10,0,0,58,,,
3183,0,"Halim et al., 2000",journal,"Halim SS, Ostrowski SE, Lee WT, Ramsingh AI",Immunogenicity of a foreign peptide expressed within a capsid protein of an attenuated coxsackievirus,"2000","19","7-8","958-965",Vaccine,"","","","","","","","11115722","","",0,10,0,0,58,,,
3184,0,"Liu et al., 2009",journal,"Liu X, Broberg E, Watanabe D, Dudek T, Deluca N, Knipe DM",Genetic engineering of a modified herpes simplex virus 1 vaccine vector,"2009","27","21","2760-2767",Vaccine,"","","","","","","","19428888","","",0,10,0,0,59,,,
3185,0,"Watanabe et al., 2007",journal,"Watanabe D, Brockman MA, Ndung'u T, Mathews L, Lucas WT, Murphy CG, Felber BK, Pavlakis GN, Deluca NA, Knipe DM",Properties of a herpes simplex virus multiple immediate-early gene-deleted recombinant as a vaccine vector,"2007","357","2","186-198",Virology,"","","","","","","","16996101","","",0,10,0,0,59,,,
3186,0,"Laimbacher et al., 2012",journal,"Laimbacher AS, Esteban LE, Castello AA, Abdusetir Cerfoglio JC, Argelles MH, Glikmann G, D'Antuono A, Mattion N, Berois M, Arbiza J, Hilbe M, Schraner EM, Seyffert M, Dresch C, Epstein AL, Ackermann M, Fraefel C",HSV-1 amplicon vectors launch the production of heterologous rotavirus-like particles and induce rotavirus-specific immune responses in mice,"2012","20","9","1810-1820",Molecular therapy : the journal of the American Society of Gene Therapy,"","","","","","","","22713696","","",0,10,0,0,59,,,
3187,0,"Manservigi et al., 2010",journal,"Manservigi R, Argnani R, Marconi P",HSV Recombinant Vectors for Gene Therapy,"2010","4","","123-156",The open virology journal,"","","","","","","","20835362","","",0,10,0,0,59,,,
3188,0,"Li et al., 2007",journal,"Li C, Han W, Zhang Y, Wang J",A Sabin 1 poliovirus-based vaccine vector transfects Vero cells with high efficiency,"2007","54","3","169-179",Cytotechnology,"","","","","","","","19003009","","",0,10,0,0,60,,,
3189,0,"Zhang et al., 2007",journal,"Zhang YD, Lu XL, Li NF",The prospective preventative HIV vaccine based on modified poliovirus,"2007","68","6","1258-1261",Medical hypotheses,"","","","","","","","17196342","","",0,10,0,0,60,,,
3190,0,"van et al., 2002",journal,"van Kuppeveld FJ, de Jong A, Dijkman HB, Andino R, Melchers WJ",Studies towards the potential of poliovirus as a vector for the expression of HPV 16 virus-like-particles,"2002","34","3","201-208",FEMS immunology and medical microbiology,"","","","","","","","12423772","","",0,10,0,0,60,,,
3191,0,"Klingbeil et al., 2014",journal,"Klingbeil K, Lange E, Teifke JP, Mettenleiter TC, Fuchs W",Immunization of pigs with an attenuated pseudorabies virus recombinant expressing the haemagglutinin of pandemic swine origin H1N1 influenza A virus,"2014","95",Pt 4,"948-959",The Journal of general virology,"","","","","","","","24431235","","",0,10,0,0,62,,,
3192,0,"Liu et al., 2009",journal,"Liu X, Broberg E, Watanabe D, Dudek T, Deluca N, Knipe DM",Genetic engineering of a modified herpes simplex virus 1 vaccine vector,"2009","27","21","2760-2767",Vaccine,"","","","","","","","19428888","","",0,10,0,0,63,,,
3193,0,"Shiraki and Suzuki, 2006",journal,"Shiraki K, Suzuki M",[Oka varicella vaccine as a novel vaccine vector],"2006","64 Suppl 3","","340-344",Nihon rinsho. Japanese journal of clinical medicine,"","","","","","","","16615495","","",0,10,0,0,64,,,
3194,0,"Somboonthum et al., 2007",journal,"Somboonthum P, Yoshii H, Okamoto S, Koike M, Gomi Y, Uchiyama Y, Takahashi M, Yamanishi K, Mori Y",Generation of a recombinant Oka varicella vaccine expressing mumps virus hemagglutinin-neuraminidase protein as a polyvalent live vaccine,"2007","25","52","8741-8755",Vaccine,"","","","","","","","18053621","","",0,10,0,0,64,,,
3195,0,"Kamiyama et al., 2000",journal,"Kamiyama T, Sato H, Takahara T, Kageyama S, Shiraki K",Novel immunogenicity of Oka varicella vaccine vector expressing hepatitis B surface antigen,"2000","181","3","1158-1161",The Journal of infectious diseases,"","","","","","","","10720546","","",0,10,0,0,64,,,
3196,0,"L et al., 2011",journal,"L L, Zeng HQ, Wang PL, Shen W, Xiang TX, Mei ZC",Oral immunization with recombinant Mycobacterium smegmatis expressing the outer membrane protein 26-kilodalton antigen confers prophylactic protection against Helicobacter pylori infection,"2011","18","11","1957-1961",Clinical and vaccine immunology : CVI,"","","","","","","","21900527","","",0,10,0,0,65,,,
3197,0,"Guo et al., 2012",journal,"Guo XQ, Wei YM, Yu B",Recombinant Mycobacterium smegmatis expressing Hsp65-hIL-2 fusion protein and its influence on lymphocyte function in mice,"2012","5","5","347-351",Asian Pacific journal of tropical medicine,"","","","","","","","22546648","","",0,10,0,0,65,,,
3198,0,"Xiaowu et al., 2006",journal,"Xiaowu P, Fu WC, Guo YH, Zhang LS, Xie TP, Xinbin G",[Construction of recombinant yellow fever virus 17D containing 2A fragment as a vaccine vector],"2006","22","3","492-498",Sheng wu gong cheng xue bao = Chinese journal of biotechnology,"","","","","","","","16755933","","",0,10,0,0,66,,,
3199,0,"Kingstad-Bakke et al., 2012",journal,"Kingstad-Bakke B, Brewoo JN, Mai le Q, Kawaoka Y, Osorio JE",Effects of route and coadministration of recombinant raccoon poxviruses on immune responses and protection against highly pathogenic avian influenza in mice,"2012","30","45","6402-6408",Vaccine,"","","","","","","","22921740","","",0,10,0,0,67,,,
3200,70,"Kumar et al., 2011",journal,"Kumar S, Nayak B, Collins PL, Samal SK",Evaluation of the Newcastle disease virus F and HN proteins in protective immunity by using a recombinant avian paramyxovirus type 3 vector in chickens,"2011","85","13","6521-6534",Journal of virology,"","","","","","","","21525340","","",0,10,0,0,0,,,
3201,281,"Donofrio et al., 2013",journal,"Donofrio G, Franceschi V, Lovero A, Capocefalo A, Camero M, Losurdo M, Cavirani S, Marinaro M, Grandolfo E, Buonavoglia C, Tempesta M",Clinical protection of goats against CpHV-1 induced genital disease with a BoHV-4-based vector expressing CpHV-1 gD,"2013","8","1",e52758,PloS one,"","","","","","","","23300989","","",0,10,0,0,0,,,
3202,165,"Franceschi et al., 2011",journal,"Franceschi V, Capocefalo A, Calvo-Pinilla E, Redaelli M, Mucignat-Caretta C, Mertens P, Ortego J, Donofrio G",Immunization of knock-out / interferon receptor mice against lethal bluetongue infection with a BoHV-4-based vector expressing BTV-8 VP2 antigen,"2011","29","16","3074-3082",Vaccine,"","","","","","","","21320537","","",0,10,0,0,0,,,
3203,99,"Gu et al., 2010",journal,"Gu R, Shampang A, Nashar T, Patil M, Fuller DH, Ramsingh AI",Oral immunization with a live coxsackievirus/HIV recombinant induces gag p24-specific T cell responses,"2010","5","9","",PloS one,"","","","","","","","20824074","","",0,10,0,0,0,,,
3204,282,"Henke et al., 2008",journal,"Henke A, Jarasch N, Wutzler P",Coxsackievirus B3 vaccines: use as an expression vector for prevention of myocarditis,"2008","7","10","1557-1567",Expert review of vaccines,"","","","","","","","19053211","",,0,0,0,0,0,,,
3205,57,"Laimbacher et al., 2012",journal,"Laimbacher AS, Esteban LE, Castello AA, Abdusetir Cerfoglio JC, Argelles MH, Glikmann G, D'Antuono A, Mattion N, Berois M, Arbiza J, Hilbe M, Schraner EM, Seyffert M, Dresch C, Epstein AL, Ackermann M, Fraefel C",HSV-1 amplicon vectors launch the production of heterologous rotavirus-like particles and induce rotavirus-specific immune responses in mice,"2012","20","9","1810-1820",Molecular therapy : the journal of the American Society of Gene Therapy,"","","","","","","","22713696","","",0,10,0,0,0,,,
3206,134,"L et al., 2011",journal,"L L, Zeng HQ, Wang PL, Shen W, Xiang TX, Mei ZC",Oral immunization with recombinant Mycobacterium smegmatis expressing the outer membrane protein 26-kilodalton antigen confers prophylactic protection against Helicobacter pylori infection,"2011","18","11","1957-1961",Clinical and vaccine immunology : CVI,"","","","","","","","21900527","","",0,10,0,0,0,,,
3207,29,"Sweeney et al., 2011",journal,"Sweeney KA, Dao DN, Goldberg MF, Hsu T, Venkataswamy MM, Henao-Tamayo M, Ordway D, Sellers RS, Jain P, Chen B, Chen M, Kim J, Lukose R, Chan J, Orme IM, Porcelli SA, Jacobs WR Jr",A recombinant Mycobacterium smegmatis induces potent bactericidal immunity against Mycobacterium tuberculosis,"2011","17","10","1261-1268",Nature medicine,"","","","","","","","21892180","","",0,10,0,0,0,,,
3208,270,"Elias et al., 2014",journal,"Elias SC, Choudhary P, de Cassan SC, Biswas S, Collins KA, Halstead FD, Bliss CM, Ewer KJ, Hodgson SH, Duncan CJ, Hill AV, Draper SJ",Analysis of human B-cell responses following ChAd63-MVA MSP1 and AMA1 immunization and controlled malaria infection,"2014","141","4","628-644",Immunology,"","","","","","","","24303947","","",0,10,0,0,0,,,
3209,26,"Franco et al., 2010",journal,"Franco D, Li W, Qing F, Stoyanov CT, Moran T, Rice CM, Ho DD",Evaluation of yellow fever virus 17D strain as a new vector for HIV-1 vaccine development,"2010","28","35","5676-5685",Vaccine,"","","","","","","","20600494","","",0,10,0,0,0,,,
3210,0,"Franco et al., 2010",journal,"Franco D, Li W, Qing F, Stoyanov CT, Moran T, Rice CM, Ho DD",Evaluation of yellow fever virus 17D strain as a new vector for HIV-1 vaccine development,"2010","28","35","5676-5685",Vaccine,"","","","","","","","20600494","","",0,10,0,0,66,,,
3211,0,"Bonaldo et al., 2000",journal,"Bonaldo MC, Caufour PS, Freire MS, Galler R",The yellow fever 17D vaccine virus as a vector for the expression of foreign proteins: development of new live flavivirus vaccines,"2000","95 Suppl 1","","215-223",Memorias do Instituto Oswaldo Cruz,"","","","","","","","11142718","","",0,10,0,0,66,,,
3212,0,"Galler et al., 1997",journal,"Galler R, Freire MS, Jabor AV, Mann GF",The yellow fever 17D vaccine virus: molecular basis of viral attenuation and its use as an expression vector,"1997","30","2","157-168",Brazilian journal of medical and biological research = Revista brasileira de pesquisas medicas e biologicas / Sociedade Brasileira de Biofisica ... [et al.],"","","","","","","","9239300","","",0,10,0,0,66,,,
3213,50,"Kingstad-Bakke et al., 2012",journal,"Kingstad-Bakke B, Brewoo JN, Mai le Q, Kawaoka Y, Osorio JE",Effects of route and coadministration of recombinant raccoon poxviruses on immune responses and protection against highly pathogenic avian influenza in mice,"2012","30","45","6402-6408",Vaccine,"","","","","","","","22921740","","",0,10,0,0,0,,,
3214,11,"Rocke et al., 2010",journal,"Rocke TE, Pussini N, Smith SR, Williamson J, Powell B, Osorio JE",Consumption of baits containing raccoon pox-based plague vaccines protects black-tailed prairie dogs (Cynomys ludovicianus),"2010","10","1","53-58","Vector borne and zoonotic diseases (Larchmont, N.Y.)","","","","","","","","20158332","",,0,0,0,0,0,,,
3215,56,"Osorio et al., 2003",journal,"Osorio JE, Frank RS, Moss K, Taraska T, Powell T, Stinchcomb DT",Raccoon poxvirus as a mucosal vaccine vector for domestic cats,"2003","11","8-10","463-470",Journal of drug targeting,"","","","","","","","15203914","","",0,10,0,0,0,,,
3216,11,"Osorio et al., 2003",journal,"Osorio JE, Powell TD, Frank RS, Moss K, Haanes EJ, Smith SR, Rocke TE, Stinchcomb DT",Recombinant raccoon pox vaccine protects mice against lethal plague,"2003","21","11-12","1232-1238",Vaccine,"","","","","","","","12559803","",,0,0,0,0,0,,,
3217,0,"Osorio et al., 2003",journal,"Osorio JE, Powell TD, Frank RS, Moss K, Haanes EJ, Smith SR, Rocke TE, Stinchcomb DT",Recombinant raccoon pox vaccine protects mice against lethal plague,"2003","21","11-12","1232-1238",Vaccine,"","","","","","","","12559803","","",0,10,0,0,67,,,
3218,0,"Rocke et al., 2010",journal,"Rocke TE, Pussini N, Smith SR, Williamson J, Powell B, Osorio JE",Consumption of baits containing raccoon pox-based plague vaccines protects black-tailed prairie dogs (Cynomys ludovicianus),"2010","10","1","53-58","Vector borne and zoonotic diseases (Larchmont, N.Y.)","","","","","","","","20158332","","",0,10,0,0,67,,,
3219,50,"Patel et al., 2010",journal,"Patel A, Tikoo S, Kobinger G",A porcine adenovirus with low human seroprevalence is a promising alternative vaccine vector to human adenovirus 5 in an H5N1 virus disease model,"2010","5","12",e15301,PloS one,"","","","","","","","21179494","","",0,10,0,0,0,,,
3220,50,"Klingbeil et al., 2014",journal,"Klingbeil K, Lange E, Teifke JP, Mettenleiter TC, Fuchs W",Immunization of pigs with an attenuated pseudorabies virus recombinant expressing the haemagglutinin of pandemic swine origin H1N1 influenza A virus,"2014","95",Pt 4,"948-959",The Journal of general virology,"","","","","","","","24431235","","",0,10,0,0,0,,,
3221,64,"Chao et al., 2014",journal,"Chao A, Fu P, Guo X, Gao X, Cui B, Chen H",[Immune efficacy in mice by recombinant pseudorabies virus PGO expressing ORF2 gene of porcine circovirus type 2],"2014","54","2","211-217",Wei sheng wu xue bao = Acta microbiologica Sinica,"","","","","","","","24818470","","",0,10,0,0,0,,,
3222,66,"Sun et al., 2013",journal,"Sun Y, Tian DY, Li S, Meng QL, Zhao BB, Li Y, Li D, Ling LJ, Liao YJ, Qiu HJ",Comprehensive evaluation of the adenovirus/alphavirus-replicon chimeric vector-based vaccine rAdV-SFV-E2 against classical swine fever,"2013","31","3","538-544",Vaccine,"","","","","","","","23153441","","",0,10,0,0,0,,,
3223,43,"Dharmasena et al., 2013",journal,"Dharmasena MN, Hanisch BW, Wai TT, Kopecko DJ",Stable expression of Shigella sonnei form I O-polysaccharide genes recombineered into the chromosome of live Salmonella oral vaccine vector Ty21a,"2013","303","3","105-113",International journal of medical microbiology : IJMM,"","","","","","","","23474241","",,0,0,0,0,0,,,
3224,7,"Osorio et al., 2009",journal,"Osorio M, Wu Y, Singh S, Merkel TJ, Bhattacharyya S, Blake MS, Kopecko DJ",Anthrax protective antigen delivered by Salmonella enterica serovar Typhi Ty21a protects mice from a lethal anthrax spore challenge,"2009","77","4","1475-1482",Infection and immunity,"","","","","","","","19179420","","",0,10,0,0,0,,,
3225,43,"Xu et al., 2007",journal,"Xu de Q, Cisar JO, Osorio M, Wai TT, Kopecko DJ",Core-linked LPS expression of Shigella dysenteriae serotype 1 O-antigen in live Salmonella Typhi vaccine vector Ty21a: preclinical evidence of immunogenicity and protection,"2007","25","33","6167-6175",Vaccine,"","","","","","","","17629369","",,0,0,0,0,0,,,
3226,213,"Crotty et al., 2001",journal,"Crotty S, Miller CJ, Lohman BL, Neagu MR, Compton L, Lu D, L FX, Fritts L, Lifson JD, Andino R",Protection against simian immunodeficiency virus vaginal challenge by using Sabin poliovirus vectors,"2001","75","16","7435-7452",Journal of virology,"","","","","","","","11462016","","",0,10,0,0,0,,,
3227,99,"Mandl et al., 1998",journal,"Mandl S, Sigal LJ, Rock KL, Andino R",Poliovirus vaccine vectors elicit antigen-specific cytotoxic T cells and protect mice against lethal challenge with malignant melanoma cells expressing a model antigen,"1998","95","14","8216-8221",Proceedings of the National Academy of Sciences of the United States of America,"","","","","","","","9653167","","",0,10,0,0,0,,,
3228,165,"Top et al., 2012",journal,"Top S, Foucras G, Deplanche M, Rives G, Calvalido J, Comtet L, Bertagnoli S, Meyer G",Myxomavirus as a vector for the immunisation of sheep: protection study against challenge with bluetongue virus,"2012","30","9","1609-1616",Vaccine,"","","","","","","","22244980","","",0,10,0,0,0,,,
3229,153,"McCabe et al., 2002",journal,"McCabe VJ, Tarpey I, Spibey N",Vaccination of cats with an attenuated recombinant myxoma virus expressing feline calicivirus capsid protein,"2002","20","19-20","2454-2462",Vaccine,"","","","","","","","12057600","","",0,10,0,0,0,,,
3230,99,"Pol et al., 2014",journal,"Pol JG, Zhang L, Bridle BW, Stephenson KB, Ressguier J, Hanson S, Chen L, Kazdhan N, Bramson JL, Stojdl DF, Wan Y, Lichty BD",Maraba virus as a potent oncolytic vaccine vector,"2014","22","2","420-429",Molecular therapy : the journal of the American Society of Gene Therapy,"","","","","","","","24322333","","",0,10,0,0,0,,,
3231,0,"Barouch and Nabel, 2005",journal,"Barouch DH, Nabel GJ",Adenovirus vector-based vaccines for human immunodeficiency virus type 1,"2005","16","2","149-156",Human gene therapy,"","","","","","","","15761255","","",0,10,0,0,35,,,
3232,0,"Tartaglia et al., 1992",journal,"Tartaglia J, Perkus ME, Taylor J, Norton EK, Audonnet JC, Cox WI, Davis SW, van der Hoeven J, Meignier B, Riviere M",NYVAC: a highly attenuated strain of vaccinia virus,"1992","188","1","217-232",Virology,"","","","","","","","1566575","","",0,10,0,0,37,,,
3233,0,"Shiraki et al., 1992",journal,"Shiraki K, Ochiai H, Matsui S, Aiba N, Yoshida Y, Okuno T, Yamanishi K, Takahashi M",Processing of hepatitis B virus surface antigen expressed by recombinant Oka varicella vaccine virus,"1992","73 ( Pt 6)","","1401-1407",The Journal of general virology,"","","","","","","","1318942","",,0,0,0,0,64,,,
3234,0,"Heineman et al., 1995",journal,"Heineman TC, Connelly BL, Bourne N, Stanberry LR, Cohen J",Immunization with recombinant varicella-zoster virus expressing herpes simplex virus type 2 glycoprotein D reduces the severity of genital herpes in guinea pigs,"1995","69","12","8109-8113",Journal of virology,"","","","","","","","7494331","",,0,0,0,0,64,,,
3235,53,"Somboonthum et al., 2007",journal,"Somboonthum P, Yoshii H, Okamoto S, Koike M, Gomi Y, Uchiyama Y, Takahashi M, Yamanishi K, Mori Y",Generation of a recombinant Oka varicella vaccine expressing mumps virus hemagglutinin-neuraminidase protein as a polyvalent live vaccine,"2007","25","52","8741-8755",Vaccine,"","","","","","","","18053621","",,0,0,0,0,0,,,
3236,129,"Escriou et al., 2014",journal,"Escriou N, Callendret B, Lorin V, Combredet C, Marianneau P, Fvrier M, Tangy F",Protection from SARS coronavirus conferred by live measles vaccine expressing the spike glycoprotein,"2014","452-453","","32-41",Virology,"","","","","","","","24606680","","",0,10,0,0,0,,,
3237,68,"Brandler and Tangy, 2013",journal,"Brandler S, Tangy F",Vaccines in development against West Nile virus,"2013","5","10","2384-2409",Viruses,"","","","","","","","24084235","","",0,10,0,0,0,,,
3238,99,"Lange et al., 2013",journal,"Lange S, Lampe J, Bossow S, Zimmermann M, Neubert W, Bitzer M, Lauer UM",A novel armed oncolytic measles vaccine virus for the treatment of cholangiocarcinoma,"2013","24","5","554-564",Human gene therapy,"","","","","","","","23550539","","",0,10,0,0,0,,,
3239,127,"Yoneda et al., 2013",journal,"Yoneda M, Georges-Courbot MC, Ikeda F, Ishii M, Nagata N, Jacquot F, Raoul H, Sato H, Kai C",Recombinant measles virus vaccine expressing the Nipah virus glycoprotein protects against lethal Nipah virus challenge,"2013","8","3",e58414,PloS one,"","","","","","","","23516477","","",0,10,0,0,0,,,
3240,7,"Mohamadzadeh et al., 2010",journal,"Mohamadzadeh M, Durmaz E, Zadeh M, Pakanati KC, Gramarossa M, Cohran V, Klaenhammer TR",Targeted expression of anthrax protective antigen by Lactobacillus gasseri as an anthrax vaccine,"2010","5","8","1289-1296",Future microbiology,"","","","","","","","20722604","","",0,10,0,0,0,,,
3241,13,"Tsuda et al., 2011",journal,"Tsuda Y, Caposio P, Parkins CJ, Botto S, Messaoudi I, Cicin-Sain L, Feldmann H, Jarvis MA",A replicating cytomegalovirus-based vaccine encoding a single Ebola virus nucleoprotein CTL epitope confers protection against Ebola virus,"2011","5","8",e1275,PLoS neglected tropical diseases,"","","","","","","","21858240","","",0,10,0,0,0,,,
3242,279,"Tierney et al., 2012",journal,"Tierney R, Nakai T, Parkins CJ, Caposio P, Fairweather NF, Sesardic D, Jarvis MA",A single-dose cytomegalovirus-based vaccine encoding tetanus toxin fragment C induces sustained levels of protective tetanus toxin antibodies in mice,"2012","30","20","3047-3052",Vaccine,"","","","","","","","22414558","","",0,10,0,0,0,,,
3243,26,"Gu et al., 2010",journal,"Gu R, Shampang A, Nashar T, Patil M, Fuller DH, Ramsingh AI",Oral immunization with a live coxsackievirus/HIV recombinant induces gag p24-specific T cell responses,"2010","5","9","",PloS one,"","","","","","","","20824074","","",0,10,0,0,0,,,
3244,208,"Eko et al., 2011",journal,"Eko FO, Okenu DN, Singh UP, He Q, Black C, Igietseme JU",Evaluation of a broadly protective Chlamydia-cholera combination vaccine candidate,"2011","29","21","3802-3810",Vaccine,"","","","","","","","21421002","","",0,10,0,0,0,,,
3245,25,"Keller et al., 2010",journal,"Keller R, Hilton TD, Rios H, Boedeker EC, Kaper JB",Development of a live oral attaching and effacing Escherichia coli vaccine candidate using Vibrio cholerae CVD 103-HgR as antigen vector,"2010","48","1","1-8",Microbial pathogenesis,"","","","","","","","19878715","","",0,10,0,0,0,,,
3246,208,"Macmillan et al., 2007",journal,"Macmillan L, Ifere GO, He Q, Igietseme JU, Kellar KL, Okenu DM, Eko FO",A recombinant multivalent combination vaccine protects against Chlamydia and genital herpes,"2007","49","1","46-55",FEMS immunology and medical microbiology,"","","","","","","","17094789","","",0,10,0,0,0,,,
3247,100,"Manservigi et al., 1990",journal,"Manservigi R, Grossi MP, Gualandri R, Balboni PG, Marchini A, Rotola A, Rimessi P, Di Luca D, Cassai E, Barbanti-Brodano G",Protection from herpes simplex virus type 1 lethal and latent infections by secreted recombinant glycoprotein B constitutively expressed in human cells with a BK virus episomal vector,"1990","64","1","431-436",Journal of virology,"","","","","","","","2152829","",,0,0,0,0,0,,,
3248,283,"Guthrie et al., 2009",journal,"Guthrie AJ, Quan M, Lourens CW, Audonnet JC, Minke JM, Yao J, He L, Nordgren R, Gardner IA, Maclachlan NJ",Protective immunization of horses with a recombinant canarypox virus vectored vaccine co-expressing genes encoding the outer capsid proteins of African horse sickness virus,"2009","27","33","4434-4438",Vaccine,"","","","","","","","19490959","","",0,10,0,0,0,,,
3249,26,"Walther-Jallow et al., 2001",journal,"Walther-Jallow L, Nilsson C, Sderlund J, ten Haaft P, Mkitalo B, Biberfeld P, Bttiger P, Heeney J, Biberfeld G, Thorstensson R",Cross-protection against mucosal simian immunodeficiency virus (SIVsm) challenge in human immunodeficiency virus type 2-vaccinated cynomolgus monkeys,"2001","82",Pt 7,"1601-1612",The Journal of general virology,"","","","","","","","11413371","","",0,10,0,0,0,,,
3250,50,"Bublot et al., 2010",journal,"Bublot M, Richard-Mazet A, Chanavat-Bizzini S, Le Gros FX, Duboeuf M, Stoll A, Palfi V, Niqueux E, Guionie O, Dren N",Immunogenicity of poxvirus vector avian influenza vaccines in Muscovy and Pekin ducks,"2010","54","1 Suppl","232-238",Avian diseases,"","","","","","","","20521637","","",0,10,0,0,0,,,
3251,68,"Seino et al., 2007",journal,"Seino KK, Long MT, Gibbs EP, Bowen RA, Beachboard SE, Humphrey PP, Dixon MA, Bourgeois MA",Comparative efficacies of three commercially available vaccines against West Nile Virus (WNV) in a short-duration challenge trial involving an equine WNV encephalitis model,"2007","14","11","1465-1471",Clinical and vaccine immunology : CVI,"","","","","","","","17687109","","",0,10,0,0,0,,,
3252,165,"Boone et al., 2007",journal,"Boone JD, Balasuriya UB, Karaca K, Audonnet JC, Yao J, He L, Nordgren R, Monaco F, Savini G, Gardner IA, Maclachlan NJ",Recombinant canarypox virus vaccine co-expressing genes encoding the VP2 and VP5 outer capsid proteins of bluetongue virus induces high level protection in sheep,"2007","25","4","672-678",Vaccine,"","","","","","","","17059856","","",0,10,0,0,0,,,
3253,127,"Weingartl et al., 2006",journal,"Weingartl HM, Berhane Y, Caswell JL, Loosmore S, Audonnet JC, Roth JA, Czub M",Recombinant nipah virus vaccines protect pigs against challenge,"2006","80","16","7929-7938",Journal of virology,"","","","","","","","16873250","","",0,10,0,0,0,,,
3254,50,"Paillot et al., 2006",journal,"Paillot R, Kydd JH, Sindle T, Hannant D, Edlund Toulemonde C, Audonnet JC, Minke JM, Daly JM",Antibody and IFN-gamma responses induced by a recombinant canarypox vaccine and challenge infection with equine influenza virus,"2006","112","3-4","225-233",Veterinary immunology and immunopathology,"","","","","","","","16621023","","",0,10,0,0,0,,,
3255,68,"Karaca et al., 2005",journal,"Karaca K, Bowen R, Austgen LE, Teehee M, Siger L, Grosenbaugh D, Loosemore L, Audonnet JC, Nordgren R, Minke JM",Recombinant canarypox vectored West Nile virus (WNV) vaccine protects dogs and cats against a mosquito WNV challenge,"2005","23","29","3808-3813",Vaccine,"","","","","","","","15893618","","",0,10,0,0,0,,,
3256,257,"Fischer et al., 1997",journal,"Fischer L, Le Gros FX, Mason PW, Paoletti E",A recombinant canarypox virus protects rabbits against a lethal rabbit hemorrhagic disease virus (RHDV) challenge,"1997","15","1","90-96",Vaccine,"","","","","","","","9041672","","",0,10,0,0,0,,,
3257,99,"Roth et al., 1996",journal,"Roth J, Dittmer D, Rea D, Tartaglia J, Paoletti E, Levine AJ",p53 as a target for cancer vaccines: recombinant canarypox virus vectors expressing p53 protect mice against lethal tumor cell challenge,"1996","93","10","4781-4786",Proceedings of the National Academy of Sciences of the United States of America,"","","","","","","","8643480","","",0,10,0,0,0,,,
3258,71,"Tartaglia et al., 1993",journal,"Tartaglia J, Jarrett O, Neil JC, Desmettre P, Paoletti E","Protection of cats against feline leukemia virus by vaccination with a canarypox virus recombinant, ALVAC-FL","1993","67","4","2370-2375",Journal of virology,"","","","","","","","8383248","","",0,10,0,0,0,,,
3259,52,"Taylor et al., 1992",journal,"Taylor J, Weinberg R, Tartaglia J, Richardson C, Alkhatib G, Briedis D, Appel M, Norton E, Paoletti E",Nonreplicating viral vectors as potential vaccines: recombinant canarypox virus expressing measles virus fusion (F) and hemagglutinin (HA) glycoproteins,"1992","187","1","321-328",Virology,"","","","","","","","1736535","",,0,0,0,0,0,,,
3260,146,"Butter et al., 2013",journal,"Butter C, Staines K, van Hateren A, Davison TF, Kaufman J",The peptide motif of the single dominantly expressed class I molecule of the chicken MHC can explain the response to a molecular defined vaccine of infectious bursal disease virus (IBDV),"2013","65","8","609-618",Immunogenetics,"","","","","","","","23644721","","",0,10,0,0,0,,,
3261,50,"Qian et al., 2012",journal,"Qian C, Chen S, Ding P, Chai M, Xu C, Gan J, Peng D, Liu X",The immune response of a recombinant fowlpox virus coexpressing the HA gene of the H5N1 highly pathogenic avian influenza virus and chicken interleukin 6 gene in ducks,"2012","30","44","6279-6286",Vaccine,"","","","","","","","22902682","","",0,10,0,0,0,,,
3262,268,"Johnson et al., 2010",journal,"Johnson DI, Vagnozzi A, Dorea F, Riblet SM, Mundt A, Zavala G, Garca M",Protection against infectious laryngotracheitis by in ovo vaccination with commercially available viral vector recombinant vaccines,"2010","54","4","1251-1259",Avian diseases,"","","","","","","","21313847","","",0,10,0,0,0,,,
3263,50,"Yun et al., 2009",journal,"Yun SL, Zhang W, Liu WJ, Zhang XR, Chen SJ, Wu YT, Peng DX, Liu XF",[Construction of recombinant fowlpox virus coexpressing HA gene from H5N1 avian influenza virus and chicken interleukin-2 gene and assessment of its protective efficacy],"2009","25","6","430-436","Bing du xue bao = Chinese journal of virology / [bian ji, Bing du xue bao bian ji wei yuan hui]","","","","","","","","20077933","","",0,10,0,0,0,,,
3264,50,"Kyriakis et al., 2009",journal,"Kyriakis CS, De Vleeschauwer A, Barb F, Bublot M, Van Reeth K","Safety, immunogenicity and efficacy of poxvirus-based vector vaccines expressing the haemagglutinin gene of a highly pathogenic H5N1 avian influenza virus in pigs","2009","27","16","2258-2264",Vaccine,"","","","","","","","19428840","","",0,10,0,0,0,,,
3265,66,"Wang et al., 2008",journal,"Wang YH, Li PH, Zhang MT, Zhang YM",[Construction of recombinant fowlpox virus expressing E0 gene of classical swine fever virus shimen strain and the animal immunity experiment],"2008","24","1","59-63","Bing du xue bao = Chinese journal of virology / [bian ji, Bing du xue bao bian ji wei yuan hui]","","","","","","","","18320824","","",0,10,0,0,0,,,
3266,270,"Hutchings et al., 2007",journal,"Hutchings CL, Birkett AJ, Moore AC, Hill AV",Combination of protein and viral vaccines induces potent cellular and humoral immune responses and enhanced protection from murine malaria challenge,"2007","75","12","5819-5826",Infection and immunity,"","","","","","","","17908809","","",0,10,0,0,0,,,
3267,284,"Cardona et al., 1999",journal,"Cardona CJ, Reed WM, Witter RL, Silva RF",Protection of turkeys from hemorrhagic enteritis with a recombinant fowl poxvirus expressing the native hexon of hemorrhagic enteritis virus,"1999","43","2","234-244",Avian diseases,"","","","","","","","10396636","",,0,0,0,0,0,,,
3268,146,"Heine and Boyle, 1993",journal,"Heine HG, Boyle DB",Infectious bursal disease virus structural protein VP2 expressed by a fowlpox virus recombinant confers protection against disease in chickens,"1993","131","3-4","277-292",Archives of virology,"","","","","","","","8394069","","",0,10,0,0,0,,,
3269,70,"Boursnell et al., 1990",journal,"Boursnell ME, Green PF, Samson AC, Campbell JI, Deuter A, Peters RW, Millar NS, Emmerson PT, Binns MM",A recombinant fowlpox virus expressing the hemagglutinin-neuraminidase gene of Newcastle disease virus (NDV) protects chickens against challenge by NDV,"1990","178","1","297-300",Virology,"","","","","","","","2167557","","",0,10,0,0,0,,,
3270,285,"Jones et al., 1997",journal,"Jones L, Tenorio E, Gorham J, Yilma T",Protective vaccination of ferrets against canine distemper with recombinant pox virus vaccines expressing the H or F genes of rinderpest virus,"1997","58","6","590-593",American journal of veterinary research,"","","","","","","","9185963","","",0,10,0,0,0,,,
3271,145,"Zhang et al., 2014",journal,"Zhang J, Chen XW, Tong TZ, Ye Y, Liao M, Fan HY",BacMam virus-based surface display of the infectious bronchitis virus (IBV) S1 glycoprotein confers strong protection against virulent IBV challenge in chickens,"2014","32","6","664-670",Vaccine,"","","","","","","","24342247","","",0,10,0,0,0,,,
3272,64,"Ye et al., 2013",journal,"Ye Y, Cheng X, Zhang J, Tong T, Lin W, Liao M, Fan H",Induction of robust immunity response in mice by dual-expression-system-based recombinant baculovirus expressing the capsid protein of porcine circovirus type 2,"2013","10","","316",Virology journal,"","","","","","","","24161107","","",0,10,0,0,0,,,
3273,50,"Xu et al., 2013",journal,"Xu J, Yang D, Huang D, Xu J, Liu S, Lin H, Zhu H, Liu B, Lu C",Protection of guinea pigs by vaccination with a recombinant swinepox virus co-expressing HA1 genes of swine H1N1 and H3N2 influenza viruses,"2013","158","3","629-637",Archives of virology,"","","","","","","","23135159","","",0,10,0,0,0,,,
3274,268,"Esaki et al., 2013",journal,"Esaki M, Noland L, Eddins T, Godoy A, Saeki S, Saitoh S, Yasuda A, Dorsey KM",Safety and efficacy of a turkey herpesvirus vector laryngotracheitis vaccine for chickens,"2013","57","2","192-198",Avian diseases,"","","","","","","","24689173","","",0,10,0,0,0,,,
3275,283,"Castillo-Olivares et al., 2011",journal,"Castillo-Olivares J, Calvo-Pinilla E, Casanova I, Bachanek-Bankowska K, Chiam R, Maan S, Nieto JM, Ortego J, Mertens PP",A modified vaccinia Ankara virus (MVA) vaccine expressing African horse sickness virus (AHSV) VP2 protects against AHSV challenge in an IFNAR -/- mouse model,"2011","6","1",e16503,PloS one,"","","","","","","","21298069","","",0,10,0,0,0,,,
3276,26,"Sun et al., 2013",journal,"Sun C, Chen Z, Tang X, Zhang Y, Feng L, Du Y, Xiao L, Liu L, Zhu W, Chen L, Zhang L",Mucosal priming with a replicating-vaccinia virus-based vaccine elicits protective immunity to simian immunodeficiency virus challenge in rhesus monkeys,"2013","87","10","5669-5677",Journal of virology,"","","","","","","","23487457","","",0,10,0,0,0,,,
3277,99,"Zhi et al., 2002",journal,"Zhi H, Han L, Ren J, Tian H, Luo W, Liang Y, Ruan L",[Construction of recombinant vaccinia virus co-expressing mutant E6 plus E7 proteins and detection of its immunogenicity and antitumor response],"2002","16","4","341-344",Zhonghua shi yan he lin chuang bing du xue za zhi = Zhonghua shiyan he linchuang bingduxue zazhi = Chinese journal of experimental and clinical virology,"","","","","","","","12665900","","",0,10,0,0,0,,,
3278,56,"Aspden et al., 2003",journal,"Aspden K, Passmore JA, Tiedt F, Williamson AL","Evaluation of lumpy skin disease virus, a capripoxvirus, as a replication-deficient vaccine vector","2003","84",Pt 8,"1985-1996",The Journal of general virology,"","","","","","","","12867628","","",0,10,0,0,0,,,
3279,285,"Ngichabe et al., 2002",journal,"Ngichabe CK, Wamwayi HM, Ndungu EK, Mirangi PK, Bostock CJ, Black DN, Barrett T",Long term immunity in African cattle vaccinated with a recombinant capripox-rinderpest virus vaccine,"2002","128","2","343-349",Epidemiology and infection,"","","","","","","","12002554","","",0,10,0,0,0,,,
3280,50,"Rohde et al., 2013",journal,"Rohde J, Amann R, Rziha HJ",New Orf virus (Parapoxvirus) recombinant expressing H5 hemagglutinin protects mice against H5N1 and H1N1 influenza A virus,"2013","8","12",e83802,PloS one,"","","","","","","","24376753","","",0,10,0,0,0,,,
3281,56,"Amann et al., 2013",journal,"Amann R, Rohde J, Wulle U, Conlee D, Raue R, Martinon O, Rziha HJ",A new rabies vaccine based on a recombinant ORF virus (parapoxvirus) expressing the rabies virus glycoprotein,"2013","87","3","1618-1630",Journal of virology,"","","","","","","","23175365","","",0,10,0,0,0,,,
3282,257,"Rohde et al., 2011",journal,"Rohde J, Schirrmeier H, Granzow H, Rziha HJ","A new recombinant Orf virus (ORFV, Parapoxvirus) protects rabbits against lethal infection with rabbit hemorrhagic disease virus (RHDV)","2011","29","49","9256-9264",Vaccine,"","","","","","","","22001119","","",0,10,0,0,0,,,
3283,66,"Voigt et al., 2007",journal,"Voigt H, Merant C, Wienhold D, Braun A, Hutet E, Le Potier MF, Saalmller A, Pfaff E, Bttner M",Efficient priming against classical swine fever with a safe glycoprotein E2 expressing Orf virus recombinant (ORFV VrV-E2),"2007","25","31","5915-5926",Vaccine,"","","","","","","","17600594","","",0,10,0,0,0,,,
3284,286,"Henkel et al., 2005",journal,"Henkel M, Planz O, Fischer T, Stitz L, Rziha HJ",Prevention of virus persistence and protection against immunopathology after Borna disease virus infection of the brain by a novel Orf virus recombinant,"2005","79","1","314-325",Journal of virology,"","","","","","","","15596826","","",0,10,0,0,0,,,
3285,65,"Fischer et al., 2003",journal,"Fischer T, Planz O, Stitz L, Rziha HJ",Novel recombinant parapoxvirus vectors induce protective humoral and cellular immunity against lethal herpesvirus challenge infection in mice,"2003","77","17","9312-9323",Journal of virology,"","","","","","","","12915547","","",0,10,0,0,0,,,
3286,173,"Paillot et al., 2006",journal,"Paillot R, Ellis SA, Daly JM, Audonnet JC, Minke JM, Davis-Poynter N, Hannant D, Kydd JH","Characterisation of CTL and IFN-gamma synthesis in ponies following vaccination with a NYVAC-based construct coding for EHV-1 immediate early gene, followed by challenge infection","2006","24","10","1490-1500",Vaccine,"","","","","","","","16269205","",,0,0,0,0,0,,,
3287,74,"Welter et al., 2000",journal,"Welter J, Taylor J, Tartaglia J, Paoletti E, Stephensen CB","Vaccination against canine distemper virus infection in infant ferrets with and without maternal antibody protection, using recombinant attenuated poxvirus vaccines","2000","74","14","6358-6367",Journal of virology,"","","","","","","","10864646","","",0,10,0,0,0,,,
3288,26,"Patterson et al., 2000",journal,"Patterson LJ, Peng B, Abimiku AG, Aldrich K, Murty L, Markham PD, Kalyanaraman VS, Alvord WG, Tartaglia J, Franchini G, Robert-Guroff M",Cross-protection in NYVAC-HIV-1-immunized/HIV-2-challenged but not in NYVAC-HIV-2-immunized/SHIV-challenged rhesus macaques,"2000","14","16","2445-2455","AIDS (London, England)","","","","","","","","11101054","","",0,10,0,0,0,,,
3289,51,"Raengsakulrach et al., 1999",journal,"Raengsakulrach B, Nisalak A, Gettayacamin M, Thirawuth V, Young GD, Myint KS, Ferguson LM, Hoke CH Jr, Innis BL, Vaughn DW","Safety, immunogenicity, and protective efficacy of NYVAC-JEV and ALVAC-JEV recombinant Japanese encephalitis vaccines in rhesus monkeys","1999","60","3","343-349",The American journal of tropical medicine and hygiene,"","","","","","","","10466959","","",0,10,0,0,0,,,
3290,287,"Ockenhouse et al., 1998",journal,"Ockenhouse CF, Sun PF, Lanar DE, Wellde BT, Hall BT, Kester K, Stoute JA, Magill A, Krzych U, Farley L, Wirtz RA, Sadoff JC, Kaslow DC, Kumar S, Church LW, Crutcher JM, Wizel B, Hoffman S, Lalvani A, Hill AV, Tine JA, Guito KP, de Taisne C, Anders R, Ballou WR","Phase I/IIa safety, immunogenicity, and efficacy trial of NYVAC-Pf7, a pox-vectored, multiantigen, multistage vaccine candidate for Plasmodium falciparum malaria","1998","177","6","1664-1673",The Journal of infectious diseases,"","","","","","","","9607847","","",0,10,0,0,0,,,
3291,26,"Benson et al., 1998",journal,"Benson J, Chougnet C, Robert-Guroff M, Montefiori D, Markham P, Shearer G, Gallo RC, Cranage M, Paoletti E, Limbach K, Venzon D, Tartaglia J, Franchini G",Recombinant vaccine-induced protection against the highly pathogenic simian immunodeficiency virus SIV(mac251): dependence on route of challenge exposure,"1998","72","5","4170-4182",Journal of virology,"","","","","","","","9557706","","",0,10,0,0,0,,,
3292,270,"Lanar et al., 1996",journal,"Lanar DE, Tine JA, de Taisne C, Seguin MC, Cox WI, Winslow JP, Ware LA, Kauffman EB, Gordon D, Ballou WR, Paoletti E, Sadoff JC",Attenuated vaccinia virus-circumsporozoite protein recombinants confer protection against rodent malaria,"1996","64","5","1666-1671",Infection and immunity,"","","","","","","","8613376","","",0,10,0,0,0,,,
3293,51,"Konishi et al., 1992",journal,"Konishi E, Pincus S, Paoletti E, Laegreid WW, Shope RE, Mason PW","A highly attenuated host range-restricted vaccinia virus strain, NYVAC, encoding the prM, E, and NS1 genes of Japanese encephalitis virus prevents JEV viremia in swine","1992","190","1","454-458",Virology,"","","","","","","","1326813","","",0,10,0,0,0,,,
3294,270,"Reyes-Sandoval et al., 2008",journal,"Reyes-Sandoval A, Sridhar S, Berthoud T, Moore AC, Harty JT, Gilbert SC, Gao G, Ertl HC, Wilson JC, Hill AV",Single-dose immunogenicity and protective efficacy of simian adenoviral vectors against Plasmodium berghei,"2008","38","3","732-741",European journal of immunology,"","","","","","","","18266272","","",0,10,0,0,0,,,
3295,219,"Dean et al., 2014",journal,"Dean G, Clifford D, Gilbert S, McShane H, Hewinson RG, Vordermeier HM, Villarreal-Ramos B",Effect of dose and route of immunisation on the immune response induced in cattle by heterologous Bacille Calmette-Guerin priming and recombinant adenoviral vector boosting,"2014","158","3-4","208-213",Veterinary immunology and immunopathology,"","","","","","","","24581917","",,0,0,0,0,0,,,
3296,271,"Fu et al., 2014",journal,"Fu YH, Jiao YY, He JS, Giang GY, Zhang W, Yan YF, Ma Y, Hua Y, Zhang Y, Peng XL, Shi CX, Hong T",Sublingual administration of a helper-dependent adenoviral vector expressing the codon-optimized soluble fusion glycoprotein of human respiratory syncytial virus elicits protective immunity in mice,"2014","105","","72-79",Antiviral research,"","","","","","","","24560779","",,0,0,0,0,0,,,
3297,242,"Dai et al., 2014",journal,"Dai Y, Wang X, Zhao S, Tang J, Zhang L, Dai J, Zeng M, Lu S, Zhu Y, Su C",Construction and evaluation of replication-defective recombinant optimized triosephosphate isomerase adenoviral vaccination in Schistosoma japonicum challenged mice,"2014","32","7","771-778",Vaccine,"","","","","","","","24397904","",,0,0,0,0,0,,,
3298,0,"Liang et al., 2014",journal,"Liang B, Munir S, Amaro-Carambot E, Surman S, Mackow N, Yang L, Buchholz UJ, Collins PL, Schaap-Nutt A","Chimeric bovine/human parainfluenza virus type 3 expressing respiratory syncytial virus (RSV) F glycoprotein: effect of insert position on expression, replication, immunogenicity, stability, and protection against RSV infection","2014","88","8","4237-4250",Journal of virology,"","","","","","","","24478424","","",0,10,0,0,71,,,
3299,0,"Le et al., 2013",journal,"Le Bayon JC, Lina B, Rosa-Calatrava M, Boivin G",Recent developments with live-attenuated recombinant paramyxovirus vaccines,"2013","23","1","15-34",Reviews in medical virology,"","","","","","","","22570186","","",0,10,0,0,71,,,
3300,271,"Liang et al., 2014",journal,"Liang B, Munir S, Amaro-Carambot E, Surman S, Mackow N, Yang L, Buchholz UJ, Collins PL, Schaap-Nutt A","Chimeric bovine/human parainfluenza virus type 3 expressing respiratory syncytial virus (RSV) F glycoprotein: effect of insert position on expression, replication, immunogenicity, stability, and protection against RSV infection","2014","88","8","4237-4250",Journal of virology,"","","","","","","","24478424","",,0,0,0,0,0,,,
3301,50,"Tompkins et al., 2007",journal,"Tompkins SM, Lin Y, Leser GP, Kramer KA, Haas DL, Howerth EW, Xu J, Kennett MJ, Durbin RK, Durbin JE, Tripp R, Lamb RA, He B",Recombinant parainfluenza virus 5 (PIV5) expressing the influenza A virus hemagglutinin provides immunity in mice to influenza A virus challenge,"2007","362","1","139-150",Virology,"","","","","","","","17254623","","",0,10,0,0,0,,,
3302,271,"Tang et al., 2003",journal,"Tang RS, Schickli JH, MacPhail M, Fernandes F, Bicha L, Spaete J, Fouchier RA, Osterhaus AD, Spaete R, Haller AA",Effects of human metapneumovirus and respiratory syncytial virus antigen insertion in two 3' proximal genome positions of bovine/human parainfluenza virus type 3 on virus replication and immunogenicity,"2003","77","20","10819-10828",Journal of virology,"","","","","","","","14512532","",,0,0,0,0,0,,,
3303,271,"Haller et al., 2003",journal,"Haller AA, Mitiku M, MacPhail M",Bovine parainfluenza virus type 3 (PIV3) expressing the respiratory syncytial virus (RSV) attachment and fusion proteins protects hamsters from challenge with human PIV3 and RSV,"2003","84",Pt 8,"2153-2162",The Journal of general virology,"","","","","","","","12867647","",,0,0,0,0,0,,,
3304,271,"Schmidt et al., 2001",journal,"Schmidt AC, McAuliffe JM, Murphy BR, Collins PL",Recombinant bovine/human parainfluenza virus type 3 (B/HPIV3) expressing the respiratory syncytial virus (RSV) G and F proteins can be used to achieve simultaneous mucosal immunization against RSV and HPIV3,"2001","75","10","4594-4603",Journal of virology,"","","","","","","","11312329","",,0,0,0,0,0,,,
3305,288,"Lee et al., 2001",journal,"Lee JS, Pushko P, Parker MD, Dertzbaugh MT, Smith LA, Smith JF",Candidate vaccine against botulinum neurotoxin serotype A derived from a Venezuelan equine encephalitis virus vector system,"2001","69","9","5709-5715",Infection and immunity,"","","","","","","","11500447","",,0,0,0,0,0,,,
3306,50,"Davis et al., 1996",journal,"Davis NL, Brown KW, Johnston RE",A viral vaccine vector that expresses foreign genes in lymph nodes and protects against mucosal challenge,"1996","70","6","3781-3787",Journal of virology,"","","","","","","","8648713","","",0,10,0,0,0,,,
3307,86,"Shin et al., 2013",journal,"Shin MK, Kang ML, Jung MH, Cha SB, Lee WJ, Kim JM, Kim DH, Yoo HS",Induction of protective immune responses against challenge of Actinobacillus pleuropneumoniae by oral administration with Saccharomyces cerevisiae expressing Apx toxins in pigs,"2013","151","1-2","132-139",Veterinary immunology and immunopathology,"","","","","","","","23206402","","",0,10,0,0,0,,,
3308,86,"Kim et al., 2010",journal,"Kim JM, Jung DI, Eom YJ, Park SM, Yoo HS, Jang YS, Yang MS, Kim DH",Surface-displayed expression of a neutralizing epitope of ApxIIA exotoxin in Saccharomyces cerevisiae and oral administration of it for protective immune responses against challenge by Actinobacillus pleuropneumoniae,"2010","74","7","1362-1367","Bioscience, biotechnology, and biochemistry","","","","","","","","20622458","","",0,10,0,0,0,,,
3309,289,"Hodgson et al., 1994",journal,"Hodgson AL, Tachedjian M, Corner LA, Radford AJ",Protection of sheep against caseous lymphadenitis by use of a single oral dose of live recombinant Corynebacterium pseudotuberculosis,"1994","62","12","5275-5280",Infection and immunity,"","","","","","","","7960105","",,0,0,0,0,0,,,
3310,50,"Mayrhofer et al., 2009",journal,"Mayrhofer J, Coulibaly S, Hessel A, Holzer GW, Schwendinger M, Brhl P, Gerencer M, Crowe BA, Shuo S, Hong W, Tan YJ, Dietrich B, Sabarth N, Savidis-Dacho H, Kistner O, Barrett PN, Falkner FG",Nonreplicating vaccinia virus vectors expressing the H5 influenza virus hemagglutinin produced in modified Vero cells induce robust protection,"2009","83","10","5192-5203",Journal of virology,"","","","","","","","19279103","","",0,10,0,0,0,,,
3311,241,"Caufour et al., 2014",journal,"Caufour P, Rufael T, Lamien CE, Lancelot R, Kidane M, Awel D, Sertse T, Kwiatek O, Libeau G, Sahle M, Diallo A, Albina E",Protective efficacy of a single immunization with capripoxvirus-vectored recombinant peste des petits ruminants vaccines in presence of pre-existing immunity,"2014","32","30","3772-3779",Vaccine,"","","","","","","","24837763","",,0,0,0,0,0,,,
3312,165,"Perrin et al., 2007",journal,"Perrin A, Albina E, Brard E, Sailleau C, Prom S, Grillet C, Kwiatek O, Russo P, Thiry R, Zientara S, Ctre-Sossah C",Recombinant capripoxviruses expressing proteins of bluetongue virus: evaluation of immune responses and protection in small ruminants,"2007","25","37-38","6774-6783",Vaccine,"","","","","","","","17669563","","",0,10,0,0,0,,,
3313,241,"Chen et al., 2010",journal,"Chen W, Hu S, Qu L, Hu Q, Zhang Q, Zhi H, Huang K, Bu Z",A goat poxvirus-vectored peste-des-petits-ruminants vaccine induces long-lasting neutralization antibody to high levels in goats and sheep,"2010","28","30","4742-4750",Vaccine,"","","","","","","","20471441","",,0,0,0,0,0,,,
3314,213,"Ami et al., 2005",journal,"Ami Y, Izumi Y, Matsuo K, Someya K, Kanekiyo M, Horibata S, Yoshino N, Sakai K, Shinohara K, Matsumoto S, Yamada T, Yamazaki S, Yamamoto N, Honda M",Priming-boosting vaccination with recombinant Mycobacterium bovis bacillus Calmette-Gurin and a nonreplicating vaccinia virus recombinant leads to long-lasting and effective immunity,"2005","79","20","12871-12879",Journal of virology,"","","","","","","","16188989","","",0,10,0,0,0,,,
3315,109,"Nascimento et al., 2008",journal,"Nascimento IP, Dias WO, Quintilio W, Christ AP, Moraes JF, Vancetto MD, Ribeiro-Dos-Santos G, Raw I, Leite LC",Neonatal immunization with a single dose of recombinant BCG expressing subunit S1 from pertussis toxin induces complete protection against Bordetella pertussis intracerebral challenge,"2008","10","2","198-202",Microbes and infection / Institut Pasteur,"","","","","","","","18248757","","",0,10,0,0,0,,,
3316,30,"Matsumoto et al., 1998",journal,"Matsumoto S, Yukitake H, Kanbara H, Yamada T",Recombinant Mycobacterium bovis bacillus Calmette-Gurin secreting merozoite surface protein 1 (MSP1) induces protection against rodent malaria parasite infection depending on MSP1-stimulated interferon gamma and parasite-specific antibodies,"1998","188","5","845-854",The Journal of experimental medicine,"","","","","","","","9730886","","",0,10,0,0,0,,,
3317,26,"Kwa et al., 2014",journal,"Kwa S, Lai L, Gangadhara S, Siddiqui M, Pillai VB, Labranche C, Yu T, Moss B, Montefiori DC, Robinson HL, Kozlowski PA, Amara RR","CD40L-adjuvanted DNA/MVA SIV239 vaccine enhances SIV-specific humoral and cellular immunity, and improves protection against a heterologous SIVE660 mucosal challenge","2014","","","",Journal of virology,"","","","","","","","24920805","","",0,10,0,0,0,,,
3318,125,"Brown et al., 2011",journal,"Brown KS, Safronetz D, Marzi A, Ebihara H, Feldmann H",Vesicular stomatitis virus-based vaccine protects hamsters against lethal challenge with Andes virus,"2011","85","23","12781-12791",Journal of virology,"","","","","","","","21917979","",,0,0,0,0,0,,,
3319,68,"Franco et al., 2010",journal,"Franco D, Li W, Qing F, Stoyanov CT, Moran T, Rice CM, Ho DD",Evaluation of yellow fever virus 17D strain as a new vector for HIV-1 vaccine development,"2010","28","35","5676-5685",Vaccine,"","","","","","","","20600494","","",0,10,0,0,0,,,
3320,208,"Chen et al., 1998",journal,"Chen I, Finn TM, Yanqing L, Guoming Q, Rappuoli R, Pizza M",A recombinant live attenuated strain of Vibrio cholerae induces immunity against tetanus toxin and Bordetella pertussis tracheal colonization factor,"1998","66","4","1648-1653",Infection and immunity,"","","","","","","","9529093","","",0,10,0,0,0,,,
3321,30,"Ockenhouse et al., 1998",journal,"Ockenhouse CF, Sun PF, Lanar DE, Wellde BT, Hall BT, Kester K, Stoute JA, Magill A, Krzych U, Farley L, Wirtz RA, Sadoff JC, Kaslow DC, Kumar S, Church LW, Crutcher JM, Wizel B, Hoffman S, Lalvani A, Hill AV, Tine JA, Guito KP, de Taisne C, Anders R, Ballou WR","Phase I/IIa safety, immunogenicity, and efficacy trial of NYVAC-Pf7, a pox-vectored, multiantigen, multistage vaccine candidate for Plasmodium falciparum malaria","1998","177","6","1664-1673",The Journal of infectious diseases,"","","","","","","","9607847","","",0,10,0,0,0,,,
3322,14,"Lee et al., 2001",journal,"Lee JS, Pushko P, Parker MD, Dertzbaugh MT, Smith LA, Smith JF",Candidate vaccine against botulinum neurotoxin serotype A derived from a Venezuelan equine encephalitis virus vector system,"2001","69","9","5709-5715",Infection and immunity,"","","","","","","","11500447","",,0,0,0,0,0,,,
3323,221,"Hodgson et al., 1994",journal,"Hodgson AL, Tachedjian M, Corner LA, Radford AJ",Protection of sheep against caseous lymphadenitis by use of a single oral dose of live recombinant Corynebacterium pseudotuberculosis,"1994","62","12","5275-5280",Infection and immunity,"","","","","","","","7960105","","",0,10,0,0,0,,,
3324,30,"Bauza et al., 2014",journal,"Bauza K, Malinauskas T, Pfander C, Anar B, Jones EY, Billker O, Hill AV, Reyes-Sandoval A",Efficacy of a Plasmodium vivax malaria vaccine using ChAd63 and modified vaccinia Ankara expressing thrombospondin-related anonymous protein as assessed with transgenic Plasmodium berghei parasites,"2014","82","3","1277-1286",Infection and immunity,"","","","","","","","24379295","","",0,10,0,0,0,,,
3325,30,"Coutant et al., 2012",journal,"Coutant F, Sanchez David RY, Flix T, Boulay A, Caleechurn L, Souque P, Thouvenot C, Bourgouin C, Beignon AS, Charneau P",A nonintegrative lentiviral vector-based vaccine provides long-term sterile protection against malaria,"2012","7","11",e48644,PloS one,"","","","","","","","23133649","","",0,10,0,0,0,,,
3326,30,"Reyes-Sandoval et al., 2008",journal,"Reyes-Sandoval A, Sridhar S, Berthoud T, Moore AC, Harty JT, Gilbert SC, Gao G, Ertl HC, Wilson JC, Hill AV",Single-dose immunogenicity and protective efficacy of simian adenoviral vectors against Plasmodium berghei,"2008","38","3","732-741",European journal of immunology,"","","","","","","","18266272","","",0,10,0,0,0,,,
3327,30,"Lanar et al., 1996",journal,"Lanar DE, Tine JA, de Taisne C, Seguin MC, Cox WI, Winslow JP, Ware LA, Kauffman EB, Gordon D, Ballou WR, Paoletti E, Sadoff JC",Attenuated vaccinia virus-circumsporozoite protein recombinants confer protection against rodent malaria,"1996","64","5","1666-1671",Infection and immunity,"","","","","","","","8613376","","",0,10,0,0,0,,,
3328,30,"Iyori et al., 2013",journal,"Iyori M, Nakaya H, Inagaki K, Pichyangkul S, Yamamoto DS, Kawasaki M, Kwak K, Mizukoshi M, Goto Y, Matsuoka H, Matsumoto M, Yoshida S",Protective efficacy of baculovirus dual expression system vaccine expressing Plasmodium falciparum circumsporozoite protein,"2013","8","8",e70819,PloS one,"","","","","","","","23951015","","",0,10,0,0,0,,,
3329,212,"Fu et al., 2014",journal,"Fu YH, Jiao YY, He JS, Giang GY, Zhang W, Yan YF, Ma Y, Hua Y, Zhang Y, Peng XL, Shi CX, Hong T",Sublingual administration of a helper-dependent adenoviral vector expressing the codon-optimized soluble fusion glycoprotein of human respiratory syncytial virus elicits protective immunity in mice,"2014","105","","72-79",Antiviral research,"","","","","","","","24560779","","",0,10,0,0,0,,,
3338,0,"Saljoughian et al., 2013",journal,"Saljoughian N, Taheri T, Zahedifard F, Taslimi Y, Doustdari F, Bolhassani A, Doroud D, Azizi H, Heidari K, Vasei M, Namvar Asl N, Papadopoulou B, Rafati S",Development of novel prime-boost strategies based on a tri-gene fusion recombinant L. tarentolae vaccine against experimental murine visceral leishmaniasis,"2013","7","4",e2174,PLoS neglected tropical diseases,"","","","","","","","23638195","","",0,10,0,0,29,,,
3886,99,"Pruitt et al., 2011",journal,"Pruitt SK, Boczkowski D, de Rosa N, Haley NR, Morse MA, Tyler DS, Dannull J, Nair S",Enhancement of anti-tumor immunity through local modulation of CTLA-4 and GITR by dendritic cells,"2011","41","12","3553-3563",European journal of immunology,,,,,,,,"22028176",,,0,10,0,0,0,,,
3330,54,"Jia et al., 2012",journal,"Jia Y, Yin Y, Duan F, Fu H, Hu M, Gao Y, Pan Z, Jiao X",Prophylactic and therapeutic efficacy of an attenuated Listeria monocytogenes-based vaccine delivering HPV16 E7 in a mouse model,"2012","30","6","1335-1342",International journal of molecular medicine,"","","","","","","","23027427","","",0,10,0,0,0,,,
3333,0,"Wilson and Hart, 2001",journal,"Wilson JA, Hart MK",Protection from Ebola virus mediated by cytotoxic T lymphocytes specific for the viral nucleoprotein,"2001","75","6","2660-2664",Journal of virology,"","","","","","","","11222689","","",0,10,0,0,75,,,
3334,0,"Poulet et al., 2007",journal,"Poulet H, Minke J, Pardo MC, Juillard V, Nordgren B, Audonnet JC",Development and registration of recombinant veterinary vaccines. The example of the canarypox vector platform,"2007","25","30","5606-5612",Vaccine,"","","","","","","","17227690","","",0,10,0,0,77,,,
3335,0,"Kim and Gulley, 2012",journal,"Kim JW, Gulley JL",Poxviral vectors for cancer immunotherapy,"2012","12","4","463-478",Expert opinion on biological therapy,"","","","","","","","22413824","","",0,10,0,0,18,,,
3336,0,"Wennier et al., 2013",journal,"Wennier ST, Brinkmann K, Steinhuer C, Maylnder N, Mnich C, Wielert U, Dirmeier U, Hausmann J, Chaplin P, Steigerwald R",A novel naturally occurring tandem promoter in modified vaccinia virus ankara drives very early gene expression and potent immune responses,"2013","8","8",e73511,PloS one,"","","","","","","","23951355","","",0,10,0,0,78,,,
3337,0,"Mayr and Munz, 1964",journal,"Mayr A, Munz E",[Changes in the vaccinia virus through continuing passages in chick embryo fibroblast cultures],"1964","195","1","24-35","Zentralblatt fur Bakteriologie, Parasitenkunde, Infektionskrankheiten und Hygiene. 1. Abt. Medizinisch-hygienische Bakteriologie, Virusforschung und Parasitologie. Originale","","","","","","","","5890664","","",0,10,0,0,78,,,
3339,0,"Shin et al., 2013",journal,"Shin MK, Kang ML, Jung MH, Cha SB, Lee WJ, Kim JM, Kim DH, Yoo HS",Induction of protective immune responses against challenge of Actinobacillus pleuropneumoniae by oral administration with Saccharomyces cerevisiae expressing Apx toxins in pigs,"2013","151","1-2","132-139",Veterinary immunology and immunopathology,"","","","","","","","23206402","","",0,10,0,0,76,,,
3340,41,"Medaglini et al., 2001",journal,"Medaglini D, Ciabattini A, Spinosa MR, Maggi T, Marcotte H, Oggioni MR, Pozzi G",Immunization with recombinant Streptococcus gordonii expressing tetanus toxin fragment C confers protection from lethal challenge in mice,"2001","19","15-16","1931-1939",Vaccine,"","","","","","","","11228363","","",0,10,0,0,0,,,
3341,59,"Li et al., 2014",journal,"Li S, Rouphael N, Duraisingham S, Romero-Steiner S, Presnell S, Davis C, Schmidt DS, Johnson SE, Milton A, Rajam G, Kasturi S, Carlone GM, Quinn C, Chaussabel D, Palucka AK, Mulligan MJ, Ahmed R, Stephens DS, Nakaya HI, Pulendran B",Molecular signatures of antibody responses derived from a systems biology study of five human vaccines,"2014","15","2","195-204",Nature immunology,"","","","","","","","24336226","","",0,11,0,0,0,,,
3342,46,"Li et al., 2014",journal,"Li S, Rouphael N, Duraisingham S, Romero-Steiner S, Presnell S, Davis C, Schmidt DS, Johnson SE, Milton A, Rajam G, Kasturi S, Carlone GM, Quinn C, Chaussabel D, Palucka AK, Mulligan MJ, Ahmed R, Stephens DS, Nakaya HI, Pulendran B",Molecular signatures of antibody responses derived from a systems biology study of five human vaccines,"2014","15","2","195-204",Nature immunology,"","","","","","","","24336226","","",0,10,0,0,0,,,
3343,290,"Teixeira et al., 2006",journal,"Teixeira FM, Teixeira HC, Ferreira AP, Rodrigues MF, Azevedo V, Macedo GC, Oliveira SC",DNA vaccine using Mycobacterium bovis Ag85B antigen induces partial protection against experimental infection in BALB/c mice,"2006","13","8","930-935",Clinical and vaccine immunology : CVI,"","","","","","","","16893994","","",0,10,0,0,0,,,
3344,290,"Buddle et al., 2013",journal,"Buddle BM, Hewinson RG, Vordermeier HM, Wedlock DN","Subcutaneous administration of a 10-fold-lower dose of a commercial human tuberculosis vaccine, Mycobacterium bovis bacillus Calmette-Guerin Danish, induced levels of protection against bovine tuberculosis and responses in the tuberculin intradermal test similar to those induced by a standard cattle dose","2013","20","10","1559-1562",Clinical and vaccine immunology : CVI,"","","","","","","","23925885","","",0,10,0,0,0,,,
3345,59,"Scherer et al., 2007",journal,"Scherer CA, Magness CL, Steiger KV, Poitinger ND, Caputo CM, Miner DG, Winokur PL, Klinzman D, McKee J, Pilar C, Ward PA, Gillham MH, Haulman NJ, Stapleton JT, Iadonato SP","Distinct gene expression profiles in peripheral blood mononuclear cells from patients infected with vaccinia virus, yellow fever 17D virus, or upper respiratory infections","2007","25","35","6458-6473",Vaccine,"","","","","","","","17651872","",,0,0,0,0,0,,,
3346,243,"Scherer et al., 2007",journal,"Scherer CA, Magness CL, Steiger KV, Poitinger ND, Caputo CM, Miner DG, Winokur PL, Klinzman D, McKee J, Pilar C, Ward PA, Gillham MH, Haulman NJ, Stapleton JT, Iadonato SP","Distinct gene expression profiles in peripheral blood mononuclear cells from patients infected with vaccinia virus, yellow fever 17D virus, or upper respiratory infections","2007","25","35","6458-6473",Vaccine,"","","","","","","","17651872","","",0,10,0,0,0,,,
3347,118,"Rudd et al., 2007",journal,"Rudd BD, Schaller MA, Smit JJ, Kunkel SL, Neupane R, Kelley L, Berlin AA, Lukacs NW",MyD88-mediated instructive signals in dendritic cells regulate pulmonary immune responses during respiratory virus infection,"2007","178","9","5820-5827","Journal of immunology (Baltimore, Md. : 1950)","","","","","","","","17442966","","",0,10,0,0,0,,,
3348,50,"Bucasas et al., 2011",journal,"Bucasas KL, Franco LM, Shaw CA, Bray MS, Wells JM, Nio D, Arden N, Quarles JM, Couch RB, Belmont JW",Early patterns of gene expression correlate with the humoral immune response to influenza vaccination in humans,"2011","203","7","921-929",The Journal of infectious diseases,"","","","","","","","21357945","","",0,10,0,0,0,,,
3349,264,"Liu et al., 2015",journal,"Liu P, Cui J, Liu RD, Wang M, Jiang P, Liu LN, Long SR, Li LG, Zhang SB, Zhang XZ, Wang ZQ",Protective immunity against Trichinella spiralis infection induced by TsNd vaccine in mice,"2015","8","1","185",Parasites & vectors,"","","","","","","","25889976","",,0,0,0,0,0,,,
3350,50,"Hoek et al., 2015",journal,"Hoek KL, Samir P, Howard LM, Niu X, Prasad N, Galassie A, Liu Q, Allos TM, Floyd KA, Guo Y, Shyr Y, Levy SE, Joyce S, Edwards KM, Link AJ",A cell-based systems biology assessment of human blood to monitor immune responses after influenza vaccination,"2015","10","2",e0118528,PloS one,"","","","","","","","25706537","","",0,10,0,0,0,,,
3351,50,"Mizukami et al., 2014",journal,"Mizukami T, Momose H, Kuramitsu M, Takizawa K, Araki K, Furuhata K, Ishii KJ, Hamaguchi I, Yamaguchi K",System vaccinology for the evaluation of influenza vaccine safety by multiplex gene detection of novel biomarkers in a preclinical study and batch release test,"2014","9","7",e101835,PloS one,"","","","","","","","25010690","","",0,10,0,0,0,,,
3352,211,"Liu et al., 2015",journal,"Liu L, Gong YX, Zhu B, Liu GL, Wang GX, Ling F",Effect of a new recombinant Aeromonas hydrophila vaccine on the grass carp intestinal microbiota and correlations with immunological responses,"2015","","","",Fish & shellfish immunology,"","","","","","","","25862971","","",0,10,0,0,0,,,
3353,50,"Zou et al., 2015",journal,"Zou Z, Hu Y, Liu Z, Zhong W, Cao H, Chen H, Jin M",Efficient strategy for constructing duck enteritis virus-based live attenuated vaccine against homologous and heterologous H5N1 avian influenza virus and duck enteritis virus infection,"2015","46","1","42",Veterinary research,"","","","","","","","25889564","","",0,10,0,0,0,,,
3354,285,"Verardi et al., 2002",journal,"Verardi PH, Aziz FH, Ahmad S, Jones LA, Beyene B, Ngotho RN, Wamwayi HM, Yesus MG, Egziabher BG, Yilma TD",Long-term sterilizing immunity to rinderpest in cattle vaccinated with a recombinant vaccinia virus expressing high levels of the fusion and hemagglutinin glycoproteins,"2002","76","2","484-491",Journal of virology,"","","","","","","","11752138","","",0,10,0,0,0,,,
3355,50,"Momose et al., 2015",journal,"Momose H, Mizukami T, Kuramitsu M, Takizawa K, Masumi A, Araki K, Furuhata K, Yamaguchi K, Hamaguchi I",Establishment of a new quality control and vaccine safety test for influenza vaccines and adjuvants using gene expression profiling,"2015","10","4",e0124392,PloS one,"","","","","","","","25909814","","",0,10,0,0,0,,,
3356,29,"He et al., 2002",journal,"He Y, Vemulapalli R, Schurig GG","Recombinant Ochrobactrum anthropi expressing Brucella abortus Cu,Zn superoxide dismutase protects mice against B. abortus infection only after switching of immune responses to Th1 type","2002","70","5","2535-2543",Infection and immunity,"","","","","","","","11953393","",,0,0,0,0,0,,,
3357,247,"Badmasti et al., 2015",journal,"Badmasti F, Ajdary S, Bouzari S, Fooladi AA, Shahcheraghi F, Siadat SD",Immunological evaluation of OMV(PagL)+Bap(1-487aa) and AbOmpA(8-346aa)+Bap(1-487aa) as vaccine candidates against Acinetobacter baumannii sepsis infection,"2015","67","2 Pt B","552-558",Molecular immunology,"","","","","","","","26277277","",,0,0,0,0,0,,,
3358,247,"Bentancor et al., 2012",journal,"Bentancor LV, Routray A, Bozkurt-Guzel C, Camacho-Peiro A, Pier GB, Maira-Litrn T",Evaluation of the trimeric autotransporter Ata as a vaccine candidate against Acinetobacter baumannii infections,"2012","80","10","3381-3388",Infection and immunity,"","","","","","","","22825448","",,0,0,0,0,0,,,
3359,247,"Fattahian et al., 2011",journal,"Fattahian Y, Rasooli I, Mousavi Gargari SL, Rahbar MR, Darvish Alipour Astaneh S, Amani J",Protection against Acinetobacter baumannii infection via its functional deprivation of biofilm associated protein (Bap),"2011","51","6","402-406",Microbial pathogenesis,"","","","","","","","21946278","",,0,0,0,0,0,,,
3360,247,"Huang et al., 2015",journal,"Huang W, Wang S, Yao Y, Xia Y, Yang X, Long Q, Sun W, Liu C, Li Y, Ma Y",OmpW is a potential target for eliciting protective immunity against Acinetobacter baumannii infections,"2015","33","36","4479-4485",Vaccine,"","","","","","","","26207591","",,0,0,0,0,0,,,
3361,247,"Islam et al., 2011",journal,"Islam AH, Singh KK, Ismail A",Demonstration of an outer membrane protein that is antigenically specific for Acinetobacter baumannii,"2011","69","1","38-44",Diagnostic microbiology and infectious disease,"","","","","","","","21146712","",,0,0,0,0,0,,,
3362,247,"Hosseingholi et al., 2014",journal,"Hosseingholi EZ, Rasooli I, Gargari SL",In silico analysis of Acinetobacter baumannii phospholipase D as a subunit vaccine candidate,"2014","62","4","455-478",Acta biotheoretica,"","","","","","","","24957752","",,0,0,0,0,0,,,
3363,247,"Garg et al., 2016",journal,"Garg N, Singh R, Shukla G, Capalash N, Sharma P","Immunoprotective potential of in silico predicted Acinetobacter baumannii outer membrane nuclease, NucAb","2016","306","1","1-9",International journal of medical microbiology : IJMM,"","","","","","","","26614015","",,0,0,0,0,0,,,
3364,134,"Talebi, 2016",journal,Talebi Bezmin Abadi A,Vaccine against Helicobacter pylori: Inevitable approach,"2016","22","11","3150-3157",World journal of gastroenterology,"","","","","","","","27003991",http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4789989/,,0,0,0,0,0,,,
3365,295,"1998",website,"",Determination of Amino Acid Composition,"","","","","","","","","","","","","",http://www.creative-proteomics.com/services/determination-of-amino-acid-composition.htm,,0,0,0,0,0,,,
3367,99,"NCT01972737, ClinicalTrials.gov",website,"",Phase I Study of Ad5-hGCC (Human Guanylyl Cyclase C)-PADRE in Stage I/II Colon Cancer,"","","","","","","","","","","","","",https://clinicaltrials.gov/show/NCT01972737,"",0,10,0,0,0,,,
3881,99,"Stern and Wiley, 1994",journal,"Stern LJ, Wiley DC",Antigenic peptide binding by class I and class II histocompatibility proteins,"1994","","94","1-10",Behring Institute Mitteilungen,,,,,,,,"7998902",,,0,10,0,0,0,,,
3882,99,"Atencio et al., 2006",journal,"Atencio IA, Grace M, Bordens R, Fritz M, Horowitz JA, Hutchins B, Indelicato S, Jacobs S, Kolz K, Maneval D, Musco ML, Shinoda J, Venook A, Wen S, Warren R",Biological activities of a recombinant adenovirus p53 (SCH 58500) administered by hepatic arterial infusion in a Phase 1 colorectal cancer trial,"2006","13","2","169-181",Cancer gene therapy,,,,,,,,"16082381",,,0,10,0,0,0,,,
3369,99,NCT00874588,website,,,,,,,,,,,,,,,,https://clinicaltrials.gov/ct2/show/NCT00874588?term=HLA-A*2402-Restricted+VEGFR1+Peptide+Vaccine&rank=2,,0,10,0,0,0,,,
3370,99,NCT02479230,website,,,,,,,,,,,,,,,,https://clinicaltrials.gov/ct2/show/NCT02479230,,0,10,0,0,0,,,
3371,99,NCT00028496,website,,,,,,,,,,,,,,,,https://clinicaltrials.gov/ct2/show/NCT00028496?term=Recombinant+Fowlpox-CEA%286D%29%2FTRICOM+Vaccine&rank=1,,0,10,0,0,0,,,
3372,99,NCT00019110,website,,,,,,,,,,,,,,,,https://clinicaltrials.gov/ct2/show/NCT00019110,,0,10,0,0,0,,,
3373,99,NCT00726739,website,,,,,,,,,,,,,,,,https://clinicaltrials.gov/ct2/show/NCT00726739,,0,10,0,0,0,,,
3374,99,NCT00071942,website,,,,,,,,,,,,,,,,https://clinicaltrials.gov/show/NCT00071942/,,0,10,0,0,0,,,
3375,99,NCT01045460,website,,,,,,,,,,,,,,,,https://clinicaltrials.gov/ct2/show/NCT01045460,,0,10,0,0,0,,,
3376,99,NCT02223312,website,,,,,,,,,,,,,,,,https://clinicaltrials.gov/ct2/show/NCT02223312,,0,10,0,0,0,,,
3377,99,NCT00074295,website,,,,,,,,,,,,,,,,https://clinicaltrials.gov/ct2/show/NCT00074295,,0,10,0,0,0,,,
3378,99,NCT02654587,website,,,,,,,,,,,,,,,,https://clinicaltrials.gov/ct2/show/NCT02654587,,0,10,0,0,0,,,
3379,99,NCT02316457,website,,,,,,,,,,,,,,,,https://clinicaltrials.gov/ct2/show/NCT02316457,,0,10,0,0,0,,,
3380,99,NCT00509496,website,,,,,,,,,,,,,,,,https://clinicaltrials.gov/ct2/show/NCT00509496,,0,10,0,0,0,,,
3381,99,NCT02323230,website,,,,,,,,,,,,,,,,https://clinicaltrials.gov/show/NCT02323230/,,0,10,0,0,0,,,
3382,99,NCT00716495,website,,,,,,,,,,,,,,,,https://clinicaltrials.gov/ct2/show/NCT00716495,,0,10,0,0,0,,,
3383,99,NCT00307229,website,,,,,,,,,,,,,,,,https://clinicaltrials.gov/ct2/show/NCT00307229,,0,10,0,0,0,,,
3384,99,NCT00629057,website,,,,,,,,,,,,,,,,https://clinicaltrials.gov/show/NCT00629057/,,0,10,0,0,0,,,
3385,99,NCT01400672,website,,,,,,,,,,,,,,,,https://clinicaltrials.gov/ct2/show/NCT01400672,,0,10,0,0,0,,,
3386,99,NCT00108875,website,,,,,,,,,,,,,,,,https://clinicaltrials.gov/ct2/show/NCT00108875?term=Survivin+Peptide+Vaccine&rank=2,,0,10,0,0,0,,,
3387,99,NCT00613509,website,,,,,,,,,,,,,,,,https://clinicaltrials.gov/ct2/show/NCT00613509?term=ALVAC%282%29+Melanoma+Multi-antigen+Vaccine&rank=1,,0,10,0,0,0,,,
3388,99,NCT00972309,website,,,,,,,,,,,,,,,,https://clinicaltrials.gov/show/NCT00972309/,,0,10,0,0,0,,,
3389,99,NCT01828762,website,,,,,,,,,,,,,,,,https://clinicaltrials.gov/ct2/show/NCT01828762,,0,10,0,0,0,,,
3390,99,NCT00937183,website,,,,,,,,,,,,,,,,https://clinicaltrials.gov/ct2/show/NCT00937183,,0,10,0,0,0,,,
3391,99,NCT01048151,website,,,,,,,,,,,,,,,,https://clinicaltrials.gov/ct2/show/NCT01048151?term=Golnerminogene+Pradenovec&rank=1,,0,10,0,0,0,,,
3392,99,NCT01398124,website,,,,,,,,,,,,,,,,https://clinicaltrials.gov/ct2/show/NCT01398124,,0,10,0,0,0,,,
3393,99,NCT00109655,website,,,,,,,,,,,,,,,,https://clinicaltrials.gov/ct2/show/NCT00109655?term=CG0070&rank=1,,0,10,0,0,0,,,
3394,99,NCT01008813,website,,,,,,,,,,,,,,,,https://clinicaltrials.gov/ct2/show/NCT01008813,,0,10,0,0,0,,,
3395,99,NCT01972737,website,,,,,,,,,,,,,,,,https://clinicaltrials.gov/show/NCT01972737,,0,10,0,0,0,,,
3396,99,NCT01016548,website,,,,,,,,,,,,,,,,https://clinicaltrials.gov/show/NCT01016548,,0,10,0,0,0,,,
3397,99,NCT02061423,website,,,,,,,,,,,,,,,,https://clinicaltrials.gov/ct2/show/NCT02061423,,0,10,0,0,0,,,
3398,99,NCT00849290,website,,,,,,,,,,,,,,,,https://clinicaltrials.gov/ct2/show/NCT00849290,,0,10,0,0,0,,,
3399,99,NCT00411749,website,,,,,,,,,,,,,,,,https://clinicaltrials.gov/ct2/show/NCT00411749?term=V501&rank=1,,0,10,0,0,0,,,
3400,99,NCT00003761,website,,,,,,,,,,,,,,,,https://clinicaltrials.gov/ct2/show/NCT00003761?term=Recombinant+Vaccinia+DF3%2FMUC1+Vaccine&rank=1,,0,10,0,0,0,,,
3401,99,NCT00030823,website,,,,,,,,,,,,,,,,https://clinicaltrials.gov/ct2/show/NCT00030823?term=Globo-H-GM2-Lewis-y-MUC1-32%28aa%29-sTn%28c%29-TF%28c%29-Tn%28c%29-KLH+Conjugate+Vaccine&rank=1,,0,10,0,0,0,,,
3402,99,NCT00100971,website,,,,,,,,,,,,,,,,https://clinicaltrials.gov/ct2/show/NCT00100971,,0,10,0,0,0,,,
3403,99,NCT01744171,website,,,,,,,,,,,,,,,,https://clinicaltrials.gov/ct2/show/NCT01744171,,0,10,0,0,0,,,
3404,99,NCT00006352,website,,,,,,,,,,,,,,,,https://clinicaltrials.gov/ct2/show/NCT00006352,,0,10,0,0,0,,,
3405,99,NCT01556789,website,,,,,,,,,,,,,,,,https://clinicaltrials.gov/ct2/show/NCT01556789?term=ONT-10&rank=1,,0,10,0,0,0,,,
3406,99,NCT00278200,website,,,,,,,,,,,,,,,,https://clinicaltrials.gov/ct2/show/NCT00278200,,0,10,0,0,0,,,
3407,99,NCT00612001,website,,,,,,,,,,,,,,,,https://clinicaltrials.gov/ct2/show/NCT00612001,,0,10,0,0,0,,,
3408,99,NCT00121173,website,,,,,,,,,,,,,,,,https://clinicaltrials.gov/show/NCT00121173,,0,10,0,0,0,,,
3409,99,NCT00006216,website,,,,,,,,,,,,,,,,https://clinicaltrials.gov/ct2/show/NCT00006216,,0,10,0,0,0,,,
3410,99,NCT00831467,website,,,,,,,,,,,,,,,,https://clinicaltrials.gov/show/NCT00831467/,,0,10,0,0,0,,,
3411,99,NCT00831753,website,,,,,,,,,,,,,,,,https://clinicaltrials.gov/ct2/show/NCT00831753,,0,10,0,0,0,,,
3412,99,NCT01322802,website,,,,,,,,,,,,,,,,https://clinicaltrials.gov/show/NCT01322802,,0,10,0,0,0,,,
3413,99,NCT02528682,website,,,,,,,,,,,,,,,,https://clinicaltrials.gov/ct2/show/NCT02528682,,0,10,0,0,0,,,
3414,99,NCT02334865,website,,,,,,,,,,,,,,,,https://clinicaltrials.gov/show/NCT02334865/,,0,10,0,0,0,,,
3415,99,NCT01066390,website,,,,,,,,,,,,,,,,https://clinicaltrials.gov/ct2/show/NCT01066390,,0,10,0,0,0,,,
3416,99,NCT00004032,website,,,,,,,,,,,,,,,,https://clinicaltrials.gov/ct2/show/NCT00004032,,0,10,0,0,0,,,
3417,99,NCT00616291,website,,,,,,,,,,,,,,,,https://clinicaltrials.gov/ct2/show/NCT00616291?term=NY-ESO-1%2FLAGE-1+Peptide+Vaccine&rank=1,,0,10,0,0,0,,,
3418,99,NCT01280552,website,,,,,,,,,,,,,,,,https://clinicaltrials.gov/ct2/show/NCT01280552,,0,10,0,0,0,,,
3419,99,NCT00107159,website,,,,,,,,,,,,,,,,https://clinicaltrials.gov/ct2/show/NCT00107159,,0,10,0,0,0,,,
3420,99,NCT01242618,website,,,,,,,,,,,,,,,,https://clinicaltrials.gov/show/NCT01242618/,,0,10,0,0,0,,,
3421,99,NCT01334060,website,,,,,,,,,,,,,,,,https://clinicaltrials.gov/show/NCT01334060,,0,10,0,0,0,,,
3422,99,NCT00091104,website,,,,,,,,,,,,,,,,https://clinicaltrials.gov/ct2/show/NCT00091104,,0,10,0,0,0,,,
3423,99,NCT01498328,website,,,,,,,,,,,,,,,,https://clinicaltrials.gov/ct2/show/NCT01498328,,0,10,0,0,0,,,
3424,99,NCT00116363,website,,,,,,,,,,,,,,,,https://clinicaltrials.gov/ct2/show/NCT00116363,,0,10,0,0,0,,,
3425,99,NCT00674791,website,,,,,,,,,,,,,,,,https://clinicaltrials.gov/ct2/show/NCT00674791?term=IMT-1012+Immunotherapeutic+Vaccine&rank=1,,0,10,0,0,0,,,
3426,99,NCT00798629,website,,,,,,,,,,,,,,,,https://clinicaltrials.gov/ct2/show/NCT00798629?term=gp100+Adenovirus+Vaccine&rank=1,,0,10,0,0,0,,,
3427,99,NCT00101309,website,,,,,,,,,,,,,,,,https://clinicaltrials.gov/ct2/show/NCT00101309,,0,10,0,0,0,,,
3428,99,NCT00423254,website,,,,,,,,,,,,,,,,https://clinicaltrials.gov/show/NCT00423254/,,0,10,0,0,0,,,
3429,99,NCT00145158,website,,,,,,,,,,,,,,,,https://clinicaltrials.gov/ct2/show/NCT00145158?term=Peptides%2FMontanide+ISA-51&rank=1,,0,10,0,0,0,,,
3430,99,NCT00264732,website,,,,,,,,,,,,,,,,https://clinicaltrials.gov/show/NCT00264732,,0,10,0,0,0,,,
3431,99,NCT02390063,website,,,,,,,,,,,,,,,,https://clinicaltrials.gov/ct2/show/NCT02390063,,0,10,0,0,0,,,
3432,99,NCT02122861,website,,,,,,,,,,,,,,,,https://clinicaltrials.gov/ct2/show/NCT02122861?term=Dendritic+Cell-targeting+Lentiviral+Vector+ID-LV305&rank=1,,0,10,0,0,0,,,
3433,99,NCT01536054,website,,,,,,,,,,,,,,,,https://clinicaltrials.gov/ct2/show/NCT01536054?term=ALVAC%282%29-NY-ESO-1+%28M%29%2FTRICOM+Vaccine&rank=1,,0,10,0,0,0,,,
3434,99,NCT01624701,website,,,,,,,,,,,,,,,,https://clinicaltrials.gov/show/NCT01624701/,,0,10,0,0,0,,,
3435,99,NCT02204085,website,,,,,,,,,,,,,,,,https://clinicaltrials.gov/ct2/show/NCT02204085?term=GO-203-2C&rank=1,,0,10,0,0,0,,,
3436,99,NCT00015977,website,,,,,,,,,,,,,,,,https://clinicaltrials.gov/ct2/show/NCT00015977,,0,10,0,0,0,,,
3437,99,NCT00943722,website,,,,,,,,,,,,,,,,https://clinicaltrials.gov/ct2/show/NCT00943722,,0,10,0,0,0,,,
3438,99,NCT00398073,website,,,,,,,,,,,,,,,,https://clinicaltrials.gov/show/NCT00398073,,0,10,0,0,0,,,
3439,99,NCT01488188,website,,,,,,,,,,,,,,,,https://clinicaltrials.gov/ct2/show/NCT01488188,,0,10,0,0,0,,,
3440,99,NCT00298298,website,,,,,,,,,,,,,,,,https://clinicaltrials.gov/ct2/show/NCT00298298,,0,10,0,0,0,,,
3441,99,NCT02848911,website,,,,,,,,,,,,,,,,https://clinicaltrials.gov/show/NCT02848911/,,0,10,0,0,0,,,
3442,99,NCT00092534,website,,,,,,,,,,,,,,,,https://clinicaltrials.gov/ct2/show/NCT00092534,,0,10,0,0,0,,,
3443,99,NCT01690377,website,,,,,,,,,,,,,,,,https://clinicaltrials.gov/ct2/show/NCT01690377,,0,10,0,0,0,,,
3444,99,NCT00003556,website,,,,,,,,,,,,,,,,https://clinicaltrials.gov/ct2/show/NCT00003556?term=Canarypox-hIL-12+Melanoma+Vaccine&rank=1,,0,10,0,0,0,,,
3445,99,NCT00146835,website,,,,,,,,,,,,,,,,https://clinicaltrials.gov/ct2/show/NCT00146835,,0,10,0,0,0,,,
3446,99,NCT00616135,website,,,,,,,,,,,,,,,,https://clinicaltrials.gov/show/NCT00616135/,,0,10,0,0,0,,,
3447,99,NCT00784524,website,,,,,,,,,,,,,,,,https://clinicaltrials.gov/ct2/show/NCT00784524,,0,10,0,0,0,,,
3448,99,NCT00681421,website,,,,,,,,,,,,,,,,https://clinicaltrials.gov/ct2/show/NCT00681421,,0,10,0,0,0,,,
3449,99,NCT01961115,website,,,,,,,,,,,,,,,,https://clinicaltrials.gov/ct2/show/NCT01961115?term=MELITAC+12.1+Peptide+Vaccine&rank=1,,0,10,0,0,0,,,
3450,99,NCT00306566,website,,,,,,,,,,,,,,,,https://clinicaltrials.gov/ct2/show/NCT00306566?term=Melan-A+VLP+Vaccine&rank=1,,0,10,0,0,0,,,
3451,99,NCT02460367,website,,,,,,,,,,,,,,,,https://clinicaltrials.gov/ct2/show/NCT02460367,,0,10,0,0,0,,,
3452,99,NCT00003895,website,,,,,,,,,,,,,,,,https://clinicaltrials.gov/ct2/show/NCT00003895,,0,10,0,0,0,,,
3453,99,NCT00399529,website,,,,,,,,,,,,,,,,https://clinicaltrials.gov/ct2/show/NCT00399529,,0,10,0,0,0,,,
3454,99,NCT02423928,website,,,,,,,,,,,,,,,,https://clinicaltrials.gov/ct2/show/NCT02423928,,0,10,0,0,0,,,
3455,99,NCT00006106,website,,,,,,,,,,,,,,,,https://clinicaltrials.gov/ct2/show/NCT00006106?term=ONYX-015&rank=1,,0,10,0,0,0,,,
3456,99,NCT02264236,website,,,,,,,,,,,,,,,,https://clinicaltrials.gov/ct2/show/NCT02264236?term=Mimotope-P10s-PADRE+Peptide+Vaccine&rank=1,,0,10,0,0,0,,,
3457,99,NCT02648282,website,,,,,,,,,,,,,,,,https://clinicaltrials.gov/ct2/show/NCT02648282,,0,10,0,0,0,,,
3458,99,NCT00935597,website,,,,,,,,,,,,,,,,https://clinicaltrials.gov/ct2/show/NCT00935597,,0,10,0,0,0,,,
3459,99,NCT01307618,website,,,,,,,,,,,,,,,,https://clinicaltrials.gov/ct2/show/NCT01307618?term=NA17.A2&rank=2,,0,10,0,0,0,,,
3460,99,NCT00978107,website,,,,,,,,,,,,,,,,https://clinicaltrials.gov/show/NCT00978107/,,0,10,0,0,0,,,
3461,99,NCT01241682,website,,,,,,,,,,,,,,,,https://clinicaltrials.gov/ct2/show/NCT01241682,,0,10,0,0,0,,,
3462,99,NCT01836432,website,,,,,,,,,,,,,,,,https://clinicaltrials.gov/ct2/show/NCT01836432,,0,10,0,0,0,,,
3463,99,NCT00859729,website,,,,,,,,,,,,,,,,https://clinicaltrials.gov/show/NCT00859729,,0,10,0,0,0,,,
3464,99,NCT01660529,website,,,,,,,,,,,,,,,,https://clinicaltrials.gov/ct2/show/NCT01660529?term=hTERT%2FSurvivin%2FCMV+Multipeptide+Vaccine&rank=1,,0,10,0,0,0,,,
3465,99,NCT02170389,website,,,,,,,,,,,,,,,,https://clinicaltrials.gov/ct2/show/NCT02170389,,0,10,0,0,0,,,
3466,99,NCT00574977,website,,,,,,,,,,,,,,,,https://clinicaltrials.gov/show/NCT00574977,,0,10,0,0,0,,,
3467,99,NCT01854099,website,,,,,,,,,,,,,,,,https://clinicaltrials.gov/show/NCT01854099/,,0,10,0,0,0,,,
3468,99,NCT00136903,website,,,,,,,,,,,,,,,,https://clinicaltrials.gov/show/NCT00136903,,0,10,0,0,0,,,
3469,99,NCT00019006,website,,,,,,,,,,,,,,,,https://clinicaltrials.gov/show/NCT00019006/,,0,10,0,0,0,,,
3470,99,NCT02773849,website,,,,,,,,,,,,,,,,https://clinicaltrials.gov/ct2/show/NCT02773849?term=Instiladrin&rank=1,,0,10,0,0,0,,,
3471,99,NCT01405521,website,,,,,,,,,,,,,,,,https://clinicaltrials.gov/ct2/show/NCT01405521?term=Ty21a&rank=2,,0,10,0,0,0,,,
3472,99,NCT00304096,website,,,,,,,,,,,,,,,,https://clinicaltrials.gov/show/NCT00304096/,,0,10,0,0,0,,,
3473,99,NCT00505063,website,,,,,,,,,,,,,,,,https://clinicaltrials.gov/show/NCT00505063,,0,10,0,0,0,,,
3474,99,NCT02411019,website,,,,,,,,,,,,,,,,https://clinicaltrials.gov/show/NCT02411019,,0,10,0,0,0,,,
3475,99,NCT00616720,website,,,,,,,,,,,,,,,,https://clinicaltrials.gov/ct2/show/NCT00616720,,0,10,0,0,0,,,
3476,99,NCT00257465,website,,,,,,,,,,,,,,,,https://clinicaltrials.gov/ct2/show/NCT00257465,,0,10,0,0,0,,,
3477,99,NCT00654030,website,,,,,,,,,,,,,,,,https://clinicaltrials.gov/ct2/show/NCT00654030,,0,10,0,0,0,,,
3478,99,NCT00470379,website,,,,,,,,,,,,,,,,https://clinicaltrials.gov/ct2/show/NCT00470379?term=NY-ESO-1b+Peptide+Vaccine&rank=1,,0,10,0,0,0,,,
3479,99,NCT00203892,website,,,,,,,,,,,,,,,,https://clinicaltrials.gov/ct2/show/NCT00203892,,0,10,0,0,0,,,
3480,99,NCT00116467,website,,,,,,,,,,,,,,,,https://clinicaltrials.gov/ct2/show/NCT00116467,,0,10,0,0,0,,,
3481,99,NCT00057915,website,,,,,,,,,,,,,,,,https://clinicaltrials.gov/ct2/show/NCT00057915,,0,10,0,0,0,,,
3482,99,NCT00836199,website,,,,,,,,,,,,,,,,https://clinicaltrials.gov/ct2/show/NCT00836199?term=NicVax&rank=1,,0,10,0,0,0,,,
3483,99,NCT00078494,website,,,,,,,,,,,,,,,,https://clinicaltrials.gov/ct2/show/NCT00078494?term=LMP-2%3A340-349+Peptide+Vaccine&rank=1,,0,10,0,0,0,,,
3484,99,NCT00589186,website,,,,,,,,,,,,,,,,https://clinicaltrials.gov/ct2/show/NCT00589186,,0,10,0,0,0,,,
3485,99,NCT00109811,website,,,,,,,,,,,,,,,,https://clinicaltrials.gov/show/NCT00109811/,,0,10,0,0,0,,,
3486,99,NCT00003167,website,,,,,,,,,,,,,,,,https://clinicaltrials.gov/ct2/show/NCT00003167,,0,10,0,0,0,,,
3487,99,NCT01022346,website,,,,,,,,,,,,,,,,https://clinicaltrials.gov/show/NCT01022346/,,0,10,0,0,0,,,
3488,99,NCT00312286,website,,,,,,,,,,,,,,,,https://clinicaltrials.gov/ct2/show/NCT00312286,,0,10,0,0,0,,,
3489,99,NCT00900809,website,,,,,,,,,,,,,,,,https://clinicaltrials.gov/show/NCT00900809/,,0,10,0,0,0,,,
3490,99,NCT00458679,website,,,,,,,,,,,,,,,,https://clinicaltrials.gov/ct2/show/NCT00458679,,0,10,0,0,0,,,
3491,99,NCT00006066,website,,,,,,,,,,,,,,,,https://clinicaltrials.gov/ct2/show/NCT00006066,,0,10,0,0,0,,,
3492,99,NCT00505713,website,,,,,,,,,,,,,,,,https://clinicaltrials.gov/show/NCT00505713,,0,10,0,0,0,,,
3493,99,NCT00033228,website,,,,,,,,,,,,,,,,https://clinicaltrials.gov/show/NCT00033228,,0,10,0,0,0,,,
3494,99,NCT00039325,website,,,,,,,,,,,,,,,,https://clinicaltrials.gov/ct2/show/NCT00039325,,0,10,0,0,0,,,
3495,99,NCT02033616,website,,,,,,,,,,,,,,,,https://clinicaltrials.gov/ct2/show/NCT02033616,,0,10,0,0,0,,,
3496,99,NCT02140996,website,,,,,,,,,,,,,,,,https://clinicaltrials.gov/ct2/show/NCT02140996,,0,10,0,0,0,,,
3497,99,NCT00069940,website,,,,,,,,,,,,,,,,https://clinicaltrials.gov/show/NCT00069940/,,0,10,0,0,0,,,
3498,99,NCT02587520,website,,,,,,,,,,,,,,,,https://clinicaltrials.gov/ct2/show/NCT02587520?term=Bordetella+pertussis+Vaccine+Adsorbed&rank=1,,0,10,0,0,0,,,
3499,99,NCT00003877,website,,,,,,,,,,,,,,,,https://clinicaltrials.gov/show/NCT00003877/,,0,10,0,0,0,,,
3500,99,NCT00019383,website,,,,,,,,,,,,,,,,https://clinicaltrials.gov/show/NCT00019383/,,0,10,0,0,0,,,
3501,99,NCT01800071,website,,,,,,,,,,,,,,,,https://clinicaltrials.gov/show/NCT01800071/,,0,10,0,0,0,,,
3502,99,NCT00005629,website,,,,,,,,,,,,,,,,https://clinicaltrials.gov/ct2/show/NCT00005629,,0,10,0,0,0,,,
3503,99,NCT01621542,website,,,,,,,,,,,,,,,,https://clinicaltrials.gov/show/NCT01621542/,,0,10,0,0,0,,,
3504,99,NCT00685412,website,,,,,,,,,,,,,,,,https://clinicaltrials.gov/show/NCT00685412,,0,10,0,0,0,,,
3505,99,NCT00480025,website,,,,,,,,,,,,,,,,https://clinicaltrials.gov/ct2/show/NCT00480025?term=GSK1572932A&rank=1,,0,10,0,0,0,,,
3506,99,NCT01213472,website,,,,,,,,,,,,,,,,https://clinicaltrials.gov/ct2/show/NCT01213472,,0,10,0,0,0,,,
3507,99,NCT00694551,website,,,,,,,,,,,,,,,,https://clinicaltrials.gov/show/NCT00694551/,,0,10,0,0,0,,,
3508,99,NCT00005039,website,,,,,,,,,,,,,,,,https://clinicaltrials.gov/show/NCT00005039/,,0,10,0,0,0,,,
3509,99,NCT00988559,website,,,,,,,,,,,,,,,,https://clinicaltrials.gov/show/NCT00988559,,0,10,0,0,0,,,
3510,99,NCT02587520,website,,,,,,,,,,,,,,,,https://clinicaltrials.gov/ct2/show/NCT02587520?term=Diphtheria+Toxoid+Tetanus+Toxoid+Vaccine+Adsorbed&rank=1,,0,10,0,0,0,,,
3511,99,NCT02499835,website,,,,,,,,,,,,,,,,https://clinicaltrials.gov/show/NCT02499835,,0,10,0,0,0,,,
3512,99,NCT00091273,website,,,,,,,,,,,,,,,,https://clinicaltrials.gov/ct2/show/NCT00091273,,0,10,0,0,0,,,
3513,99,NCT00698711,website,,,,,,,,,,,,,,,,https://clinicaltrials.gov/ct2/show/NCT00698711?term=MUC-2-KLH+Vaccine&rank=1,,0,10,0,0,0,,,
3514,99,NCT00081848,website,,,,,,,,,,,,,,,,https://clinicaltrials.gov/show/NCT00081848/,,0,10,0,0,0,,,
3515,99,NCT02063724,website,,,,,,,,,,,,,,,,https://clinicaltrials.gov/ct2/show/NCT02063724,,0,10,0,0,0,,,
3516,99,NCT01711970,website,,,,,,,,,,,,,,,,https://clinicaltrials.gov/ct2/show/NCT01711970,,0,10,0,0,0,,,
3517,99,NCT01220128,website,,,,,,,,,,,,,,,,https://clinicaltrials.gov/show/NCT01220128/,,0,10,0,0,0,,,
3518,99,NCT02035358,website,,,,,,,,,,,,,,,,https://clinicaltrials.gov/ct2/show/NCT02035358,,0,10,0,0,0,,,
3519,99,NCT02935790,website,,,,,,,,,,,,,,,,https://clinicaltrials.gov/show/NCT02935790/,,0,10,0,0,0,,,
3520,99,NCT00927381,website,,,,,,,,,,,,,,,,https://clinicaltrials.gov/ct2/show/NCT00927381,,0,10,0,0,0,,,
3521,99,NCT02237638,website,,,,,,,,,,,,,,,,https://clinicaltrials.gov/ct2/show/NCT02237638?term=hVEGF26-104%2FRFASE&rank=1,,0,10,0,0,0,,,
3522,99,NCT01639612,website,,,,,,,,,,,,,,,,https://clinicaltrials.gov/show/NCT01639612/,,0,10,0,0,0,,,
3523,99,NCT01088789,website,,,,,,,,,,,,,,,,https://clinicaltrials.gov/ct2/show/NCT01088789,,0,10,0,0,0,,,
3524,99,NCT00054535,website,,,,,,,,,,,,,,,,https://clinicaltrials.gov/ct2/show/NCT00054535?term=Recombinant+Fowlpox-Tyrosinase+Vaccine&rank=1,,0,10,0,0,0,,,
3525,99,NCT00007826,website,,,,,,,,,,,,,,,,https://clinicaltrials.gov/ct2/show/NCT00007826,,0,10,0,0,0,,,
3526,99,NCT00404339,website,,,,,,,,,,,,,,,,https://clinicaltrials.gov/ct2/show/NCT00404339,,0,10,0,0,0,,,
3527,99,NCT00944580,website,,,,,,,,,,,,,,,,https://clinicaltrials.gov/ct2/show/NCT00944580?term=MAGE-A1%2FMAGE-A3%2FNY-ESO-1+Peptides+Vaccine&rank=2,,0,10,0,0,0,,,
3528,99,NCT00004211,website,,,,,,,,,,,,,,,,https://clinicaltrials.gov/ct2/show/NCT00004211,,0,10,0,0,0,,,
3529,99,NCT00004184,website,,,,,,,,,,,,,,,,https://clinicaltrials.gov/ct2/show/NCT00004184,,0,10,0,0,0,,,
3530,99,NCT00329368,website,,,,,,,,,,,,,,,,https://clinicaltrials.gov/ct2/show/NCT00329368?term=KLH-FITC&rank=1,,0,10,0,0,0,,,
3531,99,NCT02555397,website,,,,,,,,,,,,,,,,https://clinicaltrials.gov/ct2/show/NCT02555397,,0,10,0,0,0,,,
3532,99,NCT00019734,website,,,,,,,,,,,,,,,,https://clinicaltrials.gov/show/NCT00019734/,,0,10,0,0,0,,,
3533,99,NCT01219348,website,,,,,,,,,,,,,,,,https://clinicaltrials.gov/ct2/show/NCT01219348?term=IDO+Peptide+Vaccine&rank=1,,0,10,0,0,0,,,
3534,99,NCT02079324,website,,,,,,,,,,,,,,,,https://clinicaltrials.gov/show/NCT02079324/,,0,10,0,0,0,,,
3535,99,NCT01697527,website,,,,,,,,,,,,,,,,https://clinicaltrials.gov/ct2/show/NCT01697527,,0,10,0,0,0,,,
3536,99,NCT00660101,website,,,,,,,,,,,,,,,,https://clinicaltrials.gov/ct2/show/NCT00660101,,0,10,0,0,0,,,
3537,99,NCT00062907,website,,,,,,,,,,,,,,,,https://clinicaltrials.gov/ct2/show/NCT00062907?term=Recombinant+Adenovirus+L523S+Vaccine&rank=1,,0,10,0,0,0,,,
3538,99,NCT01176462,website,,,,,,,,,,,,,,,,https://clinicaltrials.gov/ct2/show/NCT01176462,,0,10,0,0,0,,,
3539,99,NCT01967758,website,,,,,,,,,,,,,,,,https://clinicaltrials.gov/ct2/show/NCT01967758,,0,10,0,0,0,,,
3540,99,NCT02293707,website,,,,,,,,,,,,,,,,https://clinicaltrials.gov/ct2/show/NCT02293707?term=GX+301&rank=1,,0,10,0,0,0,,,
3541,99,NCT01766739,website,,,,,,,,,,,,,,,,https://clinicaltrials.gov/show/NCT01766739/,,0,10,0,0,0,,,
3542,99,NCT00005057,website,,,,,,,,,,,,,,,,https://clinicaltrials.gov/ct2/show/NCT00005057,,0,10,0,0,0,,,
3543,99,NCT00203866,website,,,,,,,,,,,,,,,,https://clinicaltrials.gov/ct2/show/NCT00203866,,0,10,0,0,0,,,
3544,99,NCT00002817,website,,,,,,,,,,,,,,,,https://clinicaltrials.gov/show/NCT00002817/,,0,10,0,0,0,,,
3545,99,NCT00019890,website,,,,,,,,,,,,,,,,https://clinicaltrials.gov/ct2/show/NCT00019890,,0,10,0,0,0,,,
3546,99,NCT00534209,website,,,,,,,,,,,,,,,,https://clinicaltrials.gov/ct2/show/NCT00534209,,0,10,0,0,0,,,
3547,99,NCT00089778,website,,,,,,,,,,,,,,,,https://clinicaltrials.gov/ct2/show/NCT00089778,,0,10,0,0,0,,,
3548,99,NCT00793208,website,,,,,,,,,,,,,,,,https://clinicaltrials.gov/ct2/show/NCT00793208,,0,10,0,0,0,,,
3549,99,NCT00423254,website,,,,,,,,,,,,,,,,https://clinicaltrials.gov/show/NCT00423254,,0,10,0,0,0,,,
3550,99,NCT00677859,website,,,,,,,,,,,,,,,,https://clinicaltrials.gov/show/NCT00677859/,,0,10,0,0,0,,,
3551,99,NCT00112957,website,,,,,,,,,,,,,,,,https://clinicaltrials.gov/show/NCT00112957/,,0,10,0,0,0,,,
3552,99,NCT01525017,website,,,,,,,,,,,,,,,,https://clinicaltrials.gov/ct2/show/NCT01525017,,0,10,0,0,0,,,
3553,99,NCT00722839,website,,,,,,,,,,,,,,,,https://clinicaltrials.gov/ct2/show/NCT00722839?term=PADRE-CMV+Fusion+Peptide+Vaccine&rank=1,,0,10,0,0,0,,,
3554,99,NCT00257738,website,,,,,,,,,,,,,,,,https://clinicaltrials.gov/ct2/show/NCT00257738?term=MAGE-A3+Peptide+Vaccine&rank=1,,0,10,0,0,0,,,
3555,99,NCT00482027,website,,,,,,,,,,,,,,,,https://clinicaltrials.gov/ct2/show/NCT00482027,,0,10,0,0,0,,,
3556,99,NCT02015416,website,,,,,,,,,,,,,,,,https://clinicaltrials.gov/ct2/show/NCT02015416,,0,10,0,0,0,,,
3557,99,show,website,,,,,,,,,,,,,,,,https://clinicaltrials.gov/show/,,0,10,0,0,0,,,
3558,99,NCT00389610,website,,,,,,,,,,,,,,,,https://clinicaltrials.gov/ct2/show/NCT00389610,,0,10,0,0,0,,,
3559,99,NCT01146262,website,,,,,,,,,,,,,,,,https://clinicaltrials.gov/ct2/show/NCT01146262,,0,10,0,0,0,,,
3560,99,NCT01559597,website,,,,,,,,,,,,,,,,https://clinicaltrials.gov/ct2/show/NCT01559597?term=Tetanus+Toxoid+Vaccine&rank=3,,0,10,0,0,0,,,
3561,99,NCT00066404,website,,,,,,,,,,,,,,,,https://clinicaltrials.gov/ct2/show/NCT00066404?term=Recombinant+Adenovirus-hIFN-beta&rank=1,,0,10,0,0,0,,,
3562,99,NCT01966289,website,,,,,,,,,,,,,,,,https://clinicaltrials.gov/ct2/show/NCT01966289,,0,10,0,0,0,,,
3563,99,NCT01863108,website,,,,,,,,,,,,,,,,https://clinicaltrials.gov/ct2/show/NCT01863108,,0,10,0,0,0,,,
3564,99,NCT02601040,website,,,,,,,,,,,,,,,,https://clinicaltrials.gov/show/NCT02601040,,0,10,0,0,0,,,
3565,99,NCT00703222,website,,,,,,,,,,,,,,,,https://clinicaltrials.gov/ct2/show/NCT00703222,,0,10,0,0,0,,,
3566,99,NCT00313508,website,,,,,,,,,,,,,,,,https://clinicaltrials.gov/ct2/show/NCT00313508,,0,10,0,0,0,,,
3567,99,NCT00003556,website,,,,,,,,,,,,,,,,https://clinicaltrials.gov/ct2/show/NCT00003556?term=ALVAC-hB7.1&rank=1,,0,10,0,0,0,,,
3568,99,NCT00078520,website,,,,,,,,,,,,,,,,https://clinicaltrials.gov/ct2/show/NCT00078520,,0,10,0,0,0,,,
3569,99,NCT02411786,website,,,,,,,,,,,,,,,,https://clinicaltrials.gov/show/NCT02411786,,0,10,0,0,0,,,
3570,99,NCT00096629,website,,,,,,,,,,,,,,,,https://clinicaltrials.gov/show/NCT00096629,,0,10,0,0,0,,,
3571,99,NCT00791570,website,,,,,,,,,,,,,,,,https://clinicaltrials.gov/ct2/show/NCT00791570?,,0,10,0,0,0,,,
3572,99,NCT02410733,website,,,,,,,,,,,,,,,,https://clinicaltrials.gov/ct2/show/NCT02410733,,0,10,0,0,0,,,
3573,99,NCT00140738,website,,,,,,,,,,,,,,,,https://clinicaltrials.gov/show/NCT00140738/,,0,10,0,0,0,,,
3574,99,NCT00023647,website,,,,,,,,,,,,,,,,https://clinicaltrials.gov/show/NCT00023647,,0,10,0,0,0,,,
3575,99,NCT02157051,website,,,,,,,,,,,,,,,,https://clinicaltrials.gov/show/NCT02157051,,0,10,0,0,0,,,
3576,99,NCT01094548,website,,,,,,,,,,,,,,,,https://clinicaltrials.gov/ct2/show/NCT01094548,,0,10,0,0,0,,,
3577,99,NCT01176461,website,,,,,,,,,,,,,,,,https://clinicaltrials.gov/ct2/show/NCT01176461,,0,10,0,0,0,,,
3578,99,NCT02427581,website,,,,,,,,,,,,,,,,https://clinicaltrials.gov/ct2/show/NCT02427581,,0,10,0,0,0,,,
3579,99,NCT00381875,website,,,,,,,,,,,,,,,,https://clinicaltrials.gov/ct2/show/NCT00381875,,0,10,0,0,0,,,
3580,99,NCT00521261,website,,,,,,,,,,,,,,,,https://clinicaltrials.gov/show/NCT00521261/,,0,10,0,0,0,,,
3581,99,NCT02111941,website,,,,,,,,,,,,,,,,https://clinicaltrials.gov/ct2/show/NCT02111941,,0,10,0,0,0,,,
3582,99,NCT02028442,website,,,,,,,,,,,,,,,,https://clinicaltrials.gov/ct2/show/NCT02028442,,0,10,0,0,0,,,
3583,99,NCT00493545,website,,,,,,,,,,,,,,,,https://clinicaltrials.gov/show/NCT00493545/,,0,10,0,0,0,,,
3584,99,NCT00669136,website,,,,,,,,,,,,,,,,https://clinicaltrials.gov/ct2/show/NCT00669136,,0,10,0,0,0,,,
3585,99,NCT01453361,website,,,,,,,,,,,,,,,,https://clinicaltrials.gov/show/NCT01453361,,0,10,0,0,0,,,
3586,99,NCT00807781,website,,,,,,,,,,,,,,,,https://clinicaltrials.gov/show/NCT00807781,,0,10,0,0,0,,,
3587,99,NCT00003871,website,,,,,,,,,,,,,,,,https://clinicaltrials.gov/ct2/show/NCT00003871?term=FOWLVAC&rank=1,,0,10,0,0,0,,,
3588,99,NCT00273910,website,,,,,,,,,,,,,,,,https://clinicaltrials.gov/ct2/show/NCT00273910,,0,10,0,0,0,,,
3589,99,NCT00393029,website,,,,,,,,,,,,,,,,https://clinicaltrials.gov/ct2/show/NCT00393029,,0,10,0,0,0,,,
3590,99,NCT00676507,website,,,,,,,,,,,,,,,,https://clinicaltrials.gov/ct2/show/NCT00676507,,0,10,0,0,0,,,
3591,99,NCT01147965,website,,,,,,,,,,,,,,,,https://clinicaltrials.gov/ct2/show/NCT01147965,,0,10,0,0,0,,,
3592,99,NCT02045836,website,,,,,,,,,,,,,,,,https://clinicaltrials.gov/ct2/show/NCT02045836,,0,10,0,0,0,,,
3593,99,NCT01994369,website,,,,,,,,,,,,,,,,https://clinicaltrials.gov/ct2/show/NCT01994369?term=EC17&rank=2,,0,10,0,0,0,,,
3594,99,NCT00471133,website,,,,,,,,,,,,,,,,https://clinicaltrials.gov/show/NCT00471133,,0,10,0,0,0,,,
3595,99,NCT00633724,website,,,,,,,,,,,,,,,,https://clinicaltrials.gov/ct2/show/NCT00633724?term=HLA-A*2402-Restricted+VEGFR1+VEGFR2&rank=3,,0,10,0,0,0,,,
3596,99,NCT00868595,website,,,,,,,,,,,,,,,,https://clinicaltrials.gov/ct2/show/NCT00868595,,0,10,0,0,0,,,
3597,99,NCT00002787,website,,,,,,,,,,,,,,,,https://clinicaltrials.gov/ct2/show/NCT00002787?term=Autologous+Immunoglobulin+Idiotype-Keyhole+Limpet+Hemocyanin+Conjugate+Vaccine&rank=1,,0,10,0,0,0,,,
3598,99,NCT01823978,website,,,,,,,,,,,,,,,,https://clinicaltrials.gov/ct2/show/NCT01823978,,0,10,0,0,0,,,
3599,99,NCT00006470,website,,,,,,,,,,,,,,,,https://clinicaltrials.gov/ct2/show/NCT00006470,,0,10,0,0,0,,,
3600,99,NCT01995708,website,,,,,,,,,,,,,,,,https://clinicaltrials.gov/ct2/show/NCT01995708,,0,10,0,0,0,,,
3601,99,NCT00003023,website,,,,,,,,,,,,,,,,https://clinicaltrials.gov/ct2/show/NCT00003023,,0,10,0,0,0,,,
3602,99,NCT00978913,website,,,,,,,,,,,,,,,,https://clinicaltrials.gov/ct2/show/NCT00978913,,0,10,0,0,0,,,
3603,99,NCT00551187,website,,,,,,,,,,,,,,,,https://clinicaltrials.gov/ct2/show/NCT00551187,,0,10,0,0,0,,,
3604,99,NCT01082198,website,,,,,,,,,,,,,,,,https://clinicaltrials.gov/ct2/show/NCT01082198,,0,10,0,0,0,,,
3605,99,NCT02241369,website,,,,,,,,,,,,,,,,https://clinicaltrials.gov/show/NCT02241369,,0,10,0,0,0,,,
3606,99,NCT00003184,website,,,,,,,,,,,,,,,,https://clinicaltrials.gov/ct2/show/NCT00003184,,0,10,0,0,0,,,
3607,99,NCT02078648,website,,,,,,,,,,,,,,,,https://clinicaltrials.gov/ct2/show/NCT02078648,,0,10,0,0,0,,,
3608,99,NCT00323557,website,,,,,,,,,,,,,,,,https://clinicaltrials.gov/ct2/show/NCT00323557?term=Streptococcus+pneumoniae+Vaccine&rank=1,,0,10,0,0,0,,,
3609,99,NCT01795313,website,,,,,,,,,,,,,,,,https://clinicaltrials.gov/ct2/show/NCT01795313?term=HLA-A2-Restricted+Synthetic+Glioma+Antigen+Peptides+Vaccine&rank=1,,0,10,0,0,0,,,
3610,99,NCT00405327,website,,,,,,,,,,,,,,,,https://clinicaltrials.gov/ct2/show/NCT00405327,,0,10,0,0,0,,,
3611,99,NCT01437280,website,,,,,,,,,,,,,,,,https://clinicaltrials.gov/ct2/show/NCT01437280?term=CGTG-102&rank=1,,0,10,0,0,0,,,
3612,99,NCT00062907,website,,,,,,,,,,,,,,,,https://clinicaltrials.gov/show/NCT00062907,,0,10,0,0,0,,,
3613,99,NCT00031564,website,,,,,,,,,,,,,,,,https://clinicaltrials.gov/ct2/show/NCT00031564,,0,10,0,0,0,,,
3614,99,NCT00197860,website,,,,,,,,,,,,,,,,https://clinicaltrials.gov/ct2/show/NCT00197860,,0,10,0,0,0,,,
3615,99,NCT01334047,website,,,,,,,,,,,,,,,,https://clinicaltrials.gov/ct2/show/NCT01334047,,0,10,0,0,0,,,
3616,99,NCT00844506,website,,,,,,,,,,,,,,,,https://clinicaltrials.gov/ct2/show/NCT00844506?term=P53-Synthetic+Long+Peptides+Vaccine&rank=1,,0,10,0,0,0,,,
3617,99,NCT01253837,website,,,,,,,,,,,,,,,,https://clinicaltrials.gov/ct2/show/NCT01253837,,0,10,0,0,0,,,
3618,99,NCT00753415,website,,,,,,,,,,,,,,,,https://clinicaltrials.gov/ct2/show/NCT00753415?term=V934%2FV935&rank=1,,0,10,0,0,0,,,
3619,99,NCT01784913,website,,,,,,,,,,,,,,,,https://clinicaltrials.gov/show/NCT01784913/,,0,10,0,0,0,,,
3620,99,NCT00612222,website,,,,,,,,,,,,,,,,https://clinicaltrials.gov/ct2/show/NCT00612222?term=ALVAC-MART-1+Vaccine&rank=1,,0,10,0,0,0,,,
3621,99,NCT02103426,website,,,,,,,,,,,,,,,,https://clinicaltrials.gov/show/NCT02103426,,0,10,0,0,0,,,
3622,99,NCT01047345,website,,,,,,,,,,,,,,,,https://clinicaltrials.gov/ct2/show/NCT01047345,,0,10,0,0,0,,,
3623,99,NCT00199849,website,,,,,,,,,,,,,,,,https://clinicaltrials.gov/show/NCT00199849,,0,10,0,0,0,,,
3624,99,NCT00019916,website,,,,,,,,,,,,,,,,https://clinicaltrials.gov/ct2/show/NCT00019916?term=p53+Peptide+Vaccine&rank=1,,0,10,0,0,0,,,
3625,99,NCT00436254,website,,,,,,,,,,,,,,,,https://clinicaltrials.gov/show/NCT00436254,,0,10,0,0,0,,,
3626,99,NCT00722839,website,,,,,,,,,,,,,,,,https://clinicaltrials.gov/show/NCT00722839/,,0,10,0,0,0,,,
3627,99,NCT00886613,website,,,,,,,,,,,,,,,,https://clinicaltrials.gov/show/NCT00886613,,0,10,0,0,0,,,
3628,99,NCT00477906,website,,,,,,,,,,,,,,,,https://clinicaltrials.gov/ct2/show/NCT00477906,,0,10,0,0,0,,,
3629,99,NCT02040637,website,,,,,,,,,,,,,,,,https://clinicaltrials.gov/ct2/show/NCT02040637,,0,10,0,0,0,,,
3630,99,NCT02040636,website,,,,,,,,,,,,,,,,https://clinicaltrials.gov/ct2/show/NCT02040636,,0,10,0,0,0,,,
3631,99,NCT01353222,website,,,,,,,,,,,,,,,,https://clinicaltrials.gov/ct2/show/NCT01353222,,0,10,0,0,0,,,
3632,99,NCT00002767,website,,,,,,,,,,,,,,,,https://clinicaltrials.gov/ct2/show/NCT00002767,,0,10,0,0,0,,,
3633,99,NCT01767467,website,,,,,,,,,,,,,,,,https://clinicaltrials.gov/ct2/show/NCT01767467,,0,10,0,0,0,,,
3634,99,NCT00895466,website,,,,,,,,,,,,,,,,https://clinicaltrials.gov/ct2/show/NCT00895466,,0,10,0,0,0,,,
3635,99,NCT01265368,website,,,,,,,,,,,,,,,,https://clinicaltrials.gov/ct2/show/NCT01265368,,0,10,0,0,0,,,
3636,99,NCT00003871,website,,,,,,,,,,,,,,,,https://clinicaltrials.gov/ct2/show/NCT00003871?term=Fowlpox+Vaccine&rank=1,,0,10,0,0,0,,,
3637,99,NCT00523159,website,,,,,,,,,,,,,,,,https://clinicaltrials.gov/show/NCT00523159/,,0,10,0,0,0,,,
3638,99,NCT00016146,website,,,,,,,,,,,,,,,,https://clinicaltrials.gov/ct2/show/NCT00016146?term=MUC-2-Globo+H-KLH+Conjugate+Vaccine&rank=2,,0,10,0,0,0,,,
3639,99,NCT02529930,website,,,,,,,,,,,,,,,,https://clinicaltrials.gov/show/NCT02529930,,0,10,0,0,0,,,
3640,99,NCT01064375,website,,,,,,,,,,,,,,,,https://clinicaltrials.gov/show/NCT01064375,,0,10,0,0,0,,,
3641,99,NCT02822079,website,,,,,,,,,,,,,,,,https://clinicaltrials.gov/show/NCT02822079,,0,10,0,0,0,,,
3642,99,NCT02293850,website,,,,,,,,,,,,,,,,https://clinicaltrials.gov/ct2/show/NCT02293850?term=OBP-301&rank=1,,0,10,0,0,0,,,
3643,99,NCT01748747,website,,,,,,,,,,,,,,,,https://clinicaltrials.gov/ct2/show/NCT01748747,,0,10,0,0,0,,,
3644,99,NCT01598454,website,,,,,,,,,,,,,,,,https://clinicaltrials.gov/ct2/show/NCT01598454,,0,10,0,0,0,,,
3645,99,NCT01171729,website,,,,,,,,,,,,,,,,https://clinicaltrials.gov/ct2/show/NCT01171729,,0,10,0,0,0,,,
3646,99,NCT00524277,website,,,,,,,,,,,,,,,,https://clinicaltrials.gov/ct2/show/NCT00524277,,0,10,0,0,0,,,
3647,99,NCT00005039,website,,,,,,,,,,,,,,,,https://clinicaltrials.gov/ct2/show/NCT00005039?term=Recombinant+Fowlpox-Prostate+Specific+Antigen+Vaccine&rank=1,,0,10,0,0,0,,,
3648,99,NCT00379977,website,,,,,,,,,,,,,,,,https://clinicaltrials.gov/ct2/show/NCT00379977?term=Haemophilus+Influenzae+B+Vaccine&rank=4,,0,10,0,0,0,,,
3649,99,NCT02503150,website,,,,,,,,,,,,,,,,https://clinicaltrials.gov/ct2/show/NCT02503150,,0,10,0,0,0,,,
3650,99,NCT01961882,website,,,,,,,,,,,,,,,,https://clinicaltrials.gov/show/NCT01961882/,,0,10,0,0,0,,,
3651,99,NCT00509288,website,,,,,,,,,,,,,,,,https://clinicaltrials.gov/ct2/show/NCT00509288,,0,10,0,0,0,,,
3652,99,NCT00433914,website,,,,,,,,,,,,,,,,https://clinicaltrials.gov/ct2/show/NCT00433914,,0,10,0,0,0,,,
3653,99,NCT01606241,website,,,,,,,,,,,,,,,,https://clinicaltrials.gov/ct2/show/NCT01606241?term=FR+Alpha+Peptide+Vaccine&rank=1,,0,10,0,0,0,,,
3654,99,NCT00285259,website,,,,,,,,,,,,,,,,https://clinicaltrials.gov/show/NCT00285259,,0,10,0,0,0,,,
3655,99,NCT02718443,website,,,,,,,,,,,,,,,,https://clinicaltrials.gov/show/NCT02718443,,0,10,0,0,0,,,
3656,99,NCT02506933,website,,,,,,,,,,,,,,,,https://clinicaltrials.gov/ct2/show/NCT02506933?term=CMV-MVA+Triplex+Vaccine&rank=1,,0,10,0,0,0,,,
3657,99,NCT02149225,website,,,,,,,,,,,,,,,,https://clinicaltrials.gov/show/NCT02149225/,,0,10,0,0,0,,,
3658,99,NCT00006041,website,,,,,,,,,,,,,,,,https://clinicaltrials.gov/ct2/show/NCT00006041?term=MUC1-KLH+Conjugate+Vaccine&rank=1,,0,10,0,0,0,,,
3659,99,NCT00890110,website,,,,,,,,,,,,,,,,https://clinicaltrials.gov/ct2/show/NCT00890110,,0,10,0,0,0,,,
3660,99,NCT00001564,website,,,,,,,,,,,,,,,,https://clinicaltrials.gov/ct2/show/NCT00001564,,0,10,0,0,0,,,
3661,99,NCT00001565,website,,,,,,,,,,,,,,,,https://clinicaltrials.gov/ct2/show/NCT00001565,,0,10,0,0,0,,,
3662,99,NCT00217373,website,,,,,,,,,,,,,,,,https://clinicaltrials.gov/show/NCT00217373/,,0,10,0,0,0,,,
3663,99,NCT00001561,website,,,,,,,,,,,,,,,,https://clinicaltrials.gov/ct2/show/NCT00001561,,0,10,0,0,0,,,
3664,99,NCT02568566,website,,,,,,,,,,,,,,,,https://clinicaltrials.gov/ct2/show/NCT02568566?term=Recombinant+Human+Papillomavirus+Nonavalent+Vaccine&rank=1,,0,10,0,0,0,,,
3665,99,NCT00004604,website,,,,,,,,,,,,,,,,https://clinicaltrials.gov/ct2/show/NCT00004604,,0,10,0,0,0,,,
3666,99,NCT02826434,website,,,,,,,,,,,,,,,,https://clinicaltrials.gov/show/NCT02826434/,,0,10,0,0,0,,,
3667,99,NCT00624182,website,,,,,,,,,,,,,,,,https://clinicaltrials.gov/show/NCT00624182/,,0,10,0,0,0,,,
3668,99,NCT00108732,website,,,,,,,,,,,,,,,,https://clinicaltrials.gov/ct2/show/NCT00108732?term=Fowlpox-PSA-TRICOM+Vaccine&rank=1,,0,10,0,0,0,,,
3669,99,NCT01308294,website,,,,,,,,,,,,,,,,https://clinicaltrials.gov/ct2/show/NCT01308294?term=Melan-A%2FMAGE-3.DP4+Peptide+Vaccine&rank=1,,0,10,0,0,0,,,
3670,99,NCT02693236,website,,,,,,,,,,,,,,,,https://clinicaltrials.gov/show/NCT02693236/,,0,10,0,0,0,,,
3671,99,NCT00020475,website,,,,,,,,,,,,,,,,https://clinicaltrials.gov/ct2/show/NCT00020475?term=MART-1%3A26-35+%2827L%29&rank=1,,0,10,0,0,0,,,
3672,99,NCT00145145,website,,,,,,,,,,,,,,,,https://clinicaltrials.gov/ct2/show/NCT00145145?term=MAGE-3.A1&rank=1,,0,10,0,0,0,,,
3673,99,NCT01380600,website,,,,,,,,,,,,,,,,https://clinicaltrials.gov/show/NCT01380600,,0,10,0,0,0,,,
3674,99,NCT00002916,website,,,,,,,,,,,,,,,,https://clinicaltrials.gov/ct2/show/NCT00002916,,0,10,0,0,0,,,
3675,99,NCT02772562,website,,,,,,,,,,,,,,,,https://clinicaltrials.gov/show/NCT02772562/,,0,10,0,0,0,,,
3676,99,NCT00458653,website,,,,,,,,,,,,,,,,https://clinicaltrials.gov/ct2/show/NCT00458653,,0,10,0,0,0,,,
3677,99,NCT00727441,website,,,,,,,,,,,,,,,,https://clinicaltrials.gov/ct2/show/NCT00727441,,0,10,0,0,0,,,
3678,99,NCT02615574,website,,,,,,,,,,,,,,,,https://clinicaltrials.gov/show/NCT02615574/,,0,10,0,0,0,,,
3679,99,NCT00072137,website,,,,,,,,,,,,,,,,https://clinicaltrials.gov/ct2/show/NCT00072137?term=Recombinant+Fowlpox+GM-CSF+Vaccine+Adjuvant&rank=1,,0,10,0,0,0,,,
3680,99,NCT00001386,website,,,,,,,,,,,,,,,,https://clinicaltrials.gov/ct2/show/NCT00001386,,0,10,0,0,0,,,
3681,99,NCT02010203,website,,,,,,,,,,,,,,,,https://clinicaltrials.gov/ct2/show/NCT02010203,,0,10,0,0,0,,,
3682,99,NCT00058747,website,,,,,,,,,,,,,,,,https://clinicaltrials.gov/ct2/show/NCT00058747,,0,10,0,0,0,,,
3683,99,NCT02514213,website,,,,,,,,,,,,,,,,https://clinicaltrials.gov/show/NCT02514213,,0,10,0,0,0,,,
3684,99,NCT02454634,website,,,,,,,,,,,,,,,,https://clinicaltrials.gov/ct2/show/NCT02454634?term=IDH1R132H-specific+Peptide+Vaccine&rank=1,,0,10,0,0,0,,,
3685,99,NCT00418574,website,,,,,,,,,,,,,,,,https://clinicaltrials.gov/ct2/show/NCT00418574,,0,10,0,0,0,,,
3686,99,NCT02636582,website,,,,,,,,,,,,,,,,https://clinicaltrials.gov/ct2/show/NCT02636582?term=Nelipepimut-S+Plus+GM-CSF+Vaccine&rank=1,,0,10,0,0,0,,,
3687,99,NCT00072085,website,,,,,,,,,,,,,,,,https://clinicaltrials.gov/ct2/show/NCT00072085,,0,10,0,0,0,,,
3688,99,NCT01666782,website,,,,,,,,,,,,,,,,https://clinicaltrials.gov/ct2/show/NCT01666782,,0,10,0,0,0,,,
3689,99,NCT01666783,website,,,,,,,,,,,,,,,,https://clinicaltrials.gov/ct2/show/NCT01666783,,0,10,0,0,0,,,
3690,99,NCT00110526,website,,,,,,,,,,,,,,,,https://clinicaltrials.gov/ct2/show/NCT00110526,,0,10,0,0,0,,,
3691,99,NCT02310464,website,,,,,,,,,,,,,,,,https://clinicaltrials.gov/ct2/show/NCT02310464?term=Globo+H-DT+Vaccine+OBI-833&rank=1,,0,10,0,0,0,,,
3692,99,NCT00087373,website,,,,,,,,,,,,,,,,https://clinicaltrials.gov/ct2/show/NCT00087373?term=Recombinant+Fowlpox-TRICOM+Vaccine&rank=1,,0,10,0,0,0,,,
3693,99,NCT02179515,website,,,,,,,,,,,,,,,,https://clinicaltrials.gov/show/NCT02179515/,,0,10,0,0,0,,,
3694,99,NCT00798629,website,,,,,,,,,,,,,,,,https://clinicaltrials.gov/ct2/show/NCT00798629,,0,10,0,0,0,,,
3695,99,NCT00002960,website,,,,,,,,,,,,,,,,https://clinicaltrials.gov/ct2/show/NCT00002960?term=Recombinant+Adenovirus+p53+SCH+58500&rank=1,,0,10,0,0,0,,,
3696,99,NCT02107404,website,,,,,,,,,,,,,,,,https://clinicaltrials.gov/ct2/show/NCT02107404,,0,10,0,0,0,,,
3697,99,NCT00891137,website,,,,,,,,,,,,,,,,https://clinicaltrials.gov/show/NCT00891137/,,0,10,0,0,0,,,
3698,99,NCT01250470,website,,,,,,,,,,,,,,,,https://clinicaltrials.gov/ct2/show/NCT01250470?term=Montanide+ISA-51%2FSurvivin+Peptide+Vaccine&rank=1,,0,10,0,0,0,,,
3699,99,NCT00001705,website,,,,,,,,,,,,,,,,https://clinicaltrials.gov/ct2/show/NCT00001705,,0,10,0,0,0,,,
3700,99,NCT00022438,website,,,,,,,,,,,,,,,,https://clinicaltrials.gov/show/NCT00022438/,,0,10,0,0,0,,,
3701,99,NCT00039325,website,,,,,,,,,,,,,,,,https://clinicaltrials.gov/ct2/show/NCT00039325?term=MART-1+Adenovirus+Vaccine&rank=1,,0,10,0,0,0,,,
3702,99,NCT00001564,website,,,,,,,,,,,,,,,,https://clinicaltrials.gov/show/NCT00001564/,,0,10,0,0,0,,,
3703,99,NCT00626015,website,,,,,,,,,,,,,,,,https://clinicaltrials.gov/ct2/show/NCT00626015?term=PEP-3-KLH&rank=1,,0,10,0,0,0,,,
3704,99,NCT00004918,website,,,,,,,,,,,,,,,,https://clinicaltrials.gov/show/NCT00004918/,,0,10,0,0,0,,,
3705,99,NCT02625857,website,,,,,,,,,,,,,,,,https://clinicaltrials.gov/ct2/show/NCT02625857,,0,10,0,0,0,,,
3706,99,NCT00580060,website,,,,,,,,,,,,,,,,https://clinicaltrials.gov/show/NCT00580060,,0,10,0,0,0,,,
3707,99,NCT00923195,website,,,,,,,,,,,,,,,,https://clinicaltrials.gov/ct2/show/NCT00923195,,0,10,0,0,0,,,
3708,99,NCT00880464,website,,,,,,,,,,,,,,,,https://clinicaltrials.gov/ct2/show/NCT00880464,,0,10,0,0,0,,,
3709,99,NCT02550678,website,,,,,,,,,,,,,,,,https://clinicaltrials.gov/ct2/show/NCT02550678?term=Interferon-gamma-expressing+Adenovirus+Vaccine+ASN-002&rank=1,,0,10,0,0,0,,,
3710,99,NCT02327468,website,,,,,,,,,,,,,,,,https://clinicaltrials.gov/show/NCT02327468,,0,10,0,0,0,,,
3711,99,NCT00001703,website,,,,,,,,,,,,,,,,https://clinicaltrials.gov/show/NCT00001703/,,0,10,0,0,0,,,
3712,99,NCT02285816,website,,,,,,,,,,,,,,,,https://clinicaltrials.gov/ct2/show/NCT02285816?term=AdMA3&rank=1,,0,10,0,0,0,,,
3713,99,NCT00725283,website,,,,,,,,,,,,,,,,https://clinicaltrials.gov/show/NCT00725283/,,0,10,0,0,0,,,
3714,99,NCT01095848,website,,,,,,,,,,,,,,,,https://clinicaltrials.gov/ct2/show/NCT01095848,,0,10,0,0,0,,,
3715,99,NCT00006243,website,,,,,,,,,,,,,,,,https://clinicaltrials.gov/ct2/show/NCT00006243?term=MART-1%3A27-35+Peptide&rank=1,,0,10,0,0,0,,,
3716,99,NCT00128661,website,,,,,,,,,,,,,,,,https://clinicaltrials.gov/ct2/show/NCT00128661,,0,10,0,0,0,,,
3717,99,NCT02017678,website,,,,,,,,,,,,,,,,https://clinicaltrials.gov/show/NCT02017678/,,0,10,0,0,0,,,
3718,99,NCT00897923,website,,,,,,,,,,,,,,,,https://clinicaltrials.gov/show/NCT00897923/,,0,10,0,0,0,,,
3719,99,NCT01842139,website,,,,,,,,,,,,,,,,https://clinicaltrials.gov/show/NCT01842139/,,0,10,0,0,0,,,
3720,99,NCT01526473,website,,,,,,,,,,,,,,,,https://clinicaltrials.gov/ct2/show/NCT01526473?term=AVX901&rank=1,,0,10,0,0,0,,,
3721,99,NCT02649439,website,,,,,,,,,,,,,,,,https://clinicaltrials.gov/show/NCT02649439/,,0,10,0,0,0,,,
3722,99,NCT02065973,website,,,,,,,,,,,,,,,,https://clinicaltrials.gov/ct2/show/NCT02065973?term=PDS0101&rank=1,,0,10,0,0,0,,,
3723,99,NCT02126579,website,,,,,,,,,,,,,,,,https://clinicaltrials.gov/ct2/show/NCT02126579?term=LPV7&rank=1,,0,10,0,0,0,,,
3724,99,NCT02439450,website,,,,,,,,,,,,,,,,https://clinicaltrials.gov/ct2/show/NCT02439450,,0,10,0,0,0,,,
3725,99,NCT00001512,website,,,,,,,,,,,,,,,,https://clinicaltrials.gov/ct2/show/NCT00001512,,0,10,0,0,0,,,
3726,99,NCT00499577,website,,,,,,,,,,,,,,,,https://clinicaltrials.gov/ct2/show/NCT00499577?term=hTERT+I540%2FR572Y%2FD988Y+Multipeptide+Vaccine&rank=1,,0,10,0,0,0,,,
3727,99,NCT00227474,website,,,,,,,,,,,,,,,,https://clinicaltrials.gov/show/NCT00227474/,,0,10,0,0,0,,,
3728,99,NCT00112957,website,,,,,,,,,,,,,,,,https://clinicaltrials.gov/ct2/show/NCT00112957?term=rF-NY-ESO-1&rank=1,,0,10,0,0,0,,,
3729,99,NCT01827137,website,,,,,,,,,,,,,,,,https://clinicaltrials.gov/show/NCT01827137/,,0,10,0,0,0,,,
3730,99,NCT01216436,website,,,,,,,,,,,,,,,,https://clinicaltrials.gov/ct2/show/NCT01216436,,0,10,0,0,0,,,
3731,99,NCT00085462,website,,,,,,,,,,,,,,,,https://clinicaltrials.gov/ct2/show/NCT00085462?term=gp100-Fowlpox+Vaccine&rank=1,,0,10,0,0,0,,,
3732,99,NCT00639925,website,,,,,,,,,,,,,,,,https://clinicaltrials.gov/show/NCT00639925/,,0,10,0,0,0,,,
3733,99,NCT01058850,website,,,,,,,,,,,,,,,,https://clinicaltrials.gov/ct2/show/NCT01058850?,,0,10,0,0,0,,,
3734,99,NCT00080353,website,,,,,,,,,,,,,,,,https://clinicaltrials.gov/ct2/show/NCT00080353?term=Recombinant+Fowlpox-gp100p209&rank=1,,0,10,0,0,0,,,
3735,99,NCT02107950,website,,,,,,,,,,,,,,,,https://clinicaltrials.gov/ct2/show/NCT02107950,,0,10,0,0,0,,,
3736,99,NCT00003638,website,,,,,,,,,,,,,,,,https://clinicaltrials.gov/ct2/show/NCT00003638,,0,10,0,0,0,,,
3737,99,NCT00033748,website,,,,,,,,,,,,,,,,https://clinicaltrials.gov/ct2/show/NCT00033748,,0,10,0,0,0,,,
3738,99,NCT02049489,website,,,,,,,,,,,,,,,,https://clinicaltrials.gov/ct2/show/NCT02049489,,0,10,0,0,0,,,
3739,99,NCT00499577,website,,,,,,,,,,,,,,,,https://clinicaltrials.gov/show/NCT00499577/,,0,10,0,0,0,,,
3740,99,NCT02193347,website,,,,,,,,,,,,,,,,https://clinicaltrials.gov/ct2/show/NCT02193347?term=PEPIDH1M+Vaccine&rank=1,,0,10,0,0,0,,,
3741,99,NCT00008099,website,,,,,,,,,,,,,,,,https://clinicaltrials.gov/ct2/show/NCT00008099?term=MUC1+Antigen%2FSB+AS-2&rank=1,,0,10,0,0,0,,,
3742,99,NCT00030693,website,,,,,,,,,,,,,,,,https://clinicaltrials.gov/ct2/show/NCT00030693?term=Recombinant+Fowlpox-B7.1+Vaccine&rank=1,,0,10,0,0,0,,,
3743,99,NCT00669734,website,,,,,,,,,,,,,,,,https://clinicaltrials.gov/ct2/show/NCT00669734?term=Falimarev&rank=2,,0,10,0,0,0,,,
3744,99,NCT02795988,website,,,,,,,,,,,,,,,,https://clinicaltrials.gov/ct2/show/NCT02795988,,0,10,0,0,0,,,
3745,99,NCT00514072,website,,,,,,,,,,,,,,,,https://clinicaltrials.gov/ct2/show/NCT00514072,,0,10,0,0,0,,,
3746,99,NCT00004156,website,,,,,,,,,,,,,,,,https://clinicaltrials.gov/ct2/show/NCT00004156?term=MUC1-KLH+Vaccine%2FQS21&rank=1,,0,10,0,0,0,,,
3747,99,NCT00457249,website,,,,,,,,,,,,,,,,https://clinicaltrials.gov/ct2/show/NCT00457249?term=DECAVAC&rank=1,,0,10,0,0,0,,,
3748,99,NCT02501278,website,,,,,,,,,,,,,,,,https://clinicaltrials.gov/show/NCT02501278,,0,10,0,0,0,,,
3749,99,NCT00103142,website,,,,,,,,,,,,,,,,https://clinicaltrials.gov/show/NCT00103142/,,0,10,0,0,0,,,
3750,99,NCT00098917,website,,,,,,,,,,,,,,,,https://clinicaltrials.gov/ct2/show/NCT00098917,,0,10,0,0,0,,,
3751,99,NCT02159950,website,,,,,,,,,,,,,,,,https://clinicaltrials.gov/ct2/show/NCT02159950,,0,10,0,0,0,,,
3752,99,NCT00049218,website,,,,,,,,,,,,,,,,https://clinicaltrials.gov/ct2/show/NCT00049218,,0,10,0,0,0,,,
3753,99,NCT00516685,website,,,,,,,,,,,,,,,,https://clinicaltrials.gov/show/NCT00516685/,,0,10,0,0,0,,,
3754,99,NCT00040170,website,,,,,,,,,,,,,,,,https://clinicaltrials.gov/show/NCT00040170/,,0,10,0,0,0,,,
3755,99,NCT01957956,website,,,,,,,,,,,,,,,,https://clinicaltrials.gov/ct2/show/NCT01957956,,0,10,0,0,0,,,
3756,99,NCT02203357,website,,,,,,,,,,,,,,,,https://clinicaltrials.gov/ct2/show/NCT02203357?term=Hepatitis+B+Vaccine&rank=1,,0,10,0,0,0,,,
3757,99,NCT01143545,website,,,,,,,,,,,,,,,,https://clinicaltrials.gov/ct2/show/NCT01143545,,0,10,0,0,0,,,
3758,99,NCT00450619,website,,,,,,,,,,,,,,,,https://clinicaltrials.gov/ct2/show/NCT00450619?term=TRICOM+Vaccine&rank=1,,0,10,0,0,0,,,
3759,99,NCT00116597,website,,,,,,,,,,,,,,,,https://clinicaltrials.gov/show/NCT00116597/,,0,10,0,0,0,,,
3760,99,NCT00093548,website,,,,,,,,,,,,,,,,https://clinicaltrials.gov/show/NCT00093548,,0,10,0,0,0,,,
3761,99,NCT02128126,website,,,,,,,,,,,,,,,,https://clinicaltrials.gov/show/NCT02128126/,,0,10,0,0,0,,,
3762,99,NCT00510133,website,,,,,,,,,,,,,,,,https://clinicaltrials.gov/ct2/show/NCT00510133,,0,10,0,0,0,,,
3763,99,NCT00071981,website,,,,,,,,,,,,,,,,https://clinicaltrials.gov/ct2/show/NCT00071981,,0,10,0,0,0,,,
3764,99,NCT01853878,website,,,,,,,,,,,,,,,,https://clinicaltrials.gov/ct2/show/NCT01853878,,0,10,0,0,0,,,
3765,99,NCT01270503,website,,,,,,,,,,,,,,,,https://clinicaltrials.gov/ct2/show/NCT01270503?term=Menactra&rank=1,,0,10,0,0,0,,,
3879,99,"Niethammer et al., 2002",journal,"Niethammer AG, Xiang R, Becker JC, Wodrich H, Pertl U, Karsten G, Eliceiri BP, Reisfeld RA",A DNA vaccine against VEGF receptor 2 prevents effective angiogenesis and inhibits tumor growth,"2002","8","12","1369-1375",Nature medicine,,,,,,,,"12415261",,,0,10,0,0,0,,,
3880,99,"FUTURE II Study Group., 2007",journal,"",Quadrivalent vaccine against human papillomavirus to prevent high-grade cervical lesions,"2007","356","19","1915-1927",The New England journal of medicine,,,,,,,,"17494925",,,0,10,0,0,0,,,
3878,99,"Kawakami et al., 1994",journal,"Kawakami Y, Eliyahu S, Delgado CH, Robbins PF, Rivoltini L, Topalian SL, Miki T, Rosenberg SA",Cloning of the gene coding for a shared human melanoma antigen recognized by autologous T cells infiltrating into tumor,"1994","91","9","3515-3519",Proceedings of the National Academy of Sciences of the United States of America,,,,,,,,"8170938",,,0,10,0,0,0,,,
3876,99,"Steuerwald et al., 2016",journal,"Steuerwald MT, Gabbard SR, Beauchamp GA, Riddle MK, Otten EJ",Administration of CroFab Antivenom by a Helicopter Emergency Medical Service Team,"2016","35","6","371-373",Air medical journal,,,,,,,,"27894563",,,0,10,0,0,0,,,
3877,99,"Fishman et al., 2008",journal,"Fishman M, Hunter TB, Soliman H, Thompson P, Dunn M, Smilee R, Farmelo MJ, Noyes DR, Mahany JJ, Lee JH, Cantor A, Messina J, Seigne J, Pow-Sang J, Janssen W, Antonia SJ","Phase II trial of B7-1 (CD-86) transduced, cultured autologous tumor cell vaccine plus subcutaneous interleukin-2 for treatment of stage IV renal cell carcinoma","2008","31","1","72-80","Journal of immunotherapy (Hagerstown, Md. : 1997)",,,,,,,,"18157014",,,0,10,0,0,0,,,
3875,99,"Kim et al., 2000",journal,"Kim SK, Ragupathi G, Cappello S, Kagan E, Livingston PO",Effect of immunological adjuvant combinations on the antibody and T-cell response to vaccination with MUC1-KLH and GD3-KLH conjugates,"2000","19","4-5","530-537",Vaccine,,,,,,,,"11027818",,,0,10,0,0,0,,,
3874,99,"Reuschenbach et al., 2016",journal,"Reuschenbach M, Pauligk C, Karbach J, Rafiyan MR, Kloor M, Prigge ES, Sauer M, Al-Batran SE, Kaufmann AM, Schneider A, Jger E, von Knebel Doeberitz M",A phase 1/2a study to test the safety and immunogenicity of a p16(INK4a) peptide vaccine in patients with advanced human papillomavirus-associated cancers,"2016","122","9","1425-1433",Cancer,,,,,,,,"26949913",,,0,10,0,0,0,,,
3873,99,"Giaccone et al., 2005",journal,"Giaccone G, Debruyne C, Felip E, Chapman PB, Grant SC, Millward M, Thiberville L, D'addario G, Coens C, Rome LS, Zatloukal P, Masso O, Legrand C",Phase III study of adjuvant vaccination with Bec2/bacille Calmette-Guerin in responding patients with limited-disease small-cell lung cancer (European Organisation for Research and Treatment of Cancer 08971-08971B; Silva Study),"2005","23","28","6854-6864",Journal of clinical oncology : official journal of the American Society of Clinical Oncology,,,,,,,,"16192577",,,0,10,0,0,0,,,
3872,99,"Hong et al., 1993",journal,"Hong WK, Lippman SM, Wolf GT",Recent advances in head and neck cancer--larynx preservation and cancer chemoprevention: the Seventeenth Annual Richard and Hinda Rosenthal Foundation Award Lecture,"1993","53","21","5113-5120",Cancer research,,,,,,,,"8221647",,,0,10,0,0,0,,,
3870,99,"Tashani et al., 2016",journal,"Tashani M, Alfelali M, Barasheed O, Alqahtani AS, Heron L, Wong M, Rashid H, Booy R","Effect of Tdap when administered before, with or after the 13-valent pneumococcal conjugate vaccine (coadministered with the quadrivalent meningococcal conjugate vaccine) in adults: A randomised controlled trial","2016","34","48","5929-5937",Vaccine,,,,,,,,"27780630",,,0,10,0,0,0,,,
3871,99,"Shapiro et al., 1993",journal,"Shapiro DN, Sublett JE, Li B, Downing JR, Naeve CW",Fusion of PAX3 to a member of the forkhead family of transcription factors in human alveolar rhabdomyosarcoma,"1993","53","21","5108-5112",Cancer research,,,,,,,,"8221646",,,0,10,0,0,0,,,
3869,99,"Freytag et al., 2015",journal,"Freytag SO, Zhang Y, Siddiqui F",Preclinical toxicology of oncolytic adenovirus-mediated cytotoxic and interleukin-12 gene therapy for prostate cancer,"2015","2","","",Molecular therapy oncolytics,,,,,,,,"26767191",,,0,10,0,0,0,,,
3867,99,"Braun et al., 2012",journal,"Braun M, Jandus C, Maurer P, Hammann-Haenni A, Schwarz K, Bachmann MF, Speiser DE, Romero P",Virus-like particles induce robust human T-helper cell responses,"2012","42","2","330-340",European journal of immunology,,,,,,,,"22057679",,,0,10,0,0,0,,,
3868,99,"Berd et al., 2001",journal,"Berd D, Sato T, Cohn H, Maguire HC Jr, Mastrangelo MJ","Treatment of metastatic melanoma with autologous, hapten-modified melanoma vaccine: regression of pulmonary metastases","2001","94","4","531-539",International journal of cancer,,,,,,,,"11745440",,,0,10,0,0,0,,,
3865,99,"Dharmasena et al., 2016",journal,"Dharmasena MN, Feuille CM, Starke CE, Bhagwat AA, Stibitz S, Kopecko DJ",Development of an Acid-Resistant Salmonella Typhi Ty21a Attenuated Vector For Improved Oral Vaccine Delivery,"2016","11","9",e0163511,PloS one,,,,,,,,"27673328",,,0,10,0,0,0,,,
3866,99,"Tagawa et al., 2003",journal,"Tagawa ST, Lee P, Snively J, Boswell W, Ounpraseuth S, Lee S, Hickingbottom B, Smith J, Johnson D, Weber JS",Phase I study of intranodal delivery of a plasmid DNA vaccine for patients with Stage IV melanoma,"2003","98","1","144-154",Cancer,,,,,,,,"12833467",,,0,10,0,0,0,,,
3864,99,"Sirisinha and Eisen, 1971",journal,"Sirisinha S, Eisen HN",Autoimmune-like antibodies to the ligand-binding sites of myeloma proteins,"1971","68","12","3130-3135",Proceedings of the National Academy of Sciences of the United States of America,,,,,,,,"4108872",,,0,10,0,0,0,,,
3863,99,"Kelsen et al., 2007",journal,"Kelsen DP, Winter KA, Gunderson LL, Mortimer J, Estes NC, Haller DG, Ajani JA, Kocha W, Minsky BD, Roth JA, Willett CG",Long-term results of RTOG trial 8911 (USA Intergroup 113): a random assignment trial comparison of chemotherapy followed by surgery compared with surgery alone for esophageal cancer,"2007","25","24","3719-3725",Journal of clinical oncology : official journal of the American Society of Clinical Oncology,,,,,,,,"17704421",,,0,10,0,0,0,,,
3862,99,"Berzofsky et al., 1991",journal,"Berzofsky JA, Pendleton CD, Clerici M, Ahlers J, Lucey DR, Putney SD, Shearer GM",Construction of peptides encompassing multideterminant clusters of human immunodeficiency virus envelope to induce in vitro T cell responses in mice and humans of multiple MHC types,"1991","88","3","876-884",The Journal of clinical investigation,,,,,,,,"1715888",,,0,10,0,0,0,,,
3860,99,"Drugs R D, 2007",journal,"","INGN 201: Ad-p53, Ad5CMV-p53, adenoviral p53, p53 gene therapy--introgen, RPR/INGN 201","2007","8","3","176-187",Drugs in R&amp;D,,,,,,,,"17472413",,,0,10,0,0,0,,,
3861,99,"Miyauchi et al., 2011",journal,"Miyauchi M, Murata M, Shibuya K, Koga-Yamakawa E, Uenishi Y, Kusunose N, Sunagawa M, Yano I, Kashiwazaki Y",Arabino-mycolates derived from cell-wall skeleton of Mycobacterium bovis BCG as a prominent structure for recognition by host immunity,"2011","5","3","130-135",Drug discoveries &amp; therapeutics,,,,,,,,"22466242",,,0,10,0,0,0,,,
3859,99,"Nemunaitis et al., 2009",journal,"Nemunaitis J, Nemunaitis M, Senzer N, Snitz P, Bedell C, Kumar P, Pappen B, Maples PB, Shawler D, Fakhrai H","Phase II trial of Belagenpumatucel-L, a TGF-beta2 antisense gene modified allogeneic tumor vaccine in advanced non small cell lung cancer (NSCLC) patients","2009","16","8","620-624",Cancer gene therapy,,,,,,,,"19287371",,,0,10,0,0,0,,,
3857,99,"Sun et al., 2015",journal,"Sun P, Dong L, MacDonald AI, Akbari S, Edward M, Hodgins MB, Johnstone SR, Graham SV",HPV16 E6 Controls the Gap Junction Protein Cx43 in Cervical Tumour Cells,"2015","7","10","5243-5256",Viruses,,,,,,,,"26445057",,,0,10,0,0,0,,,
3858,99,"Tomillero and Moral, 2009",journal,"Tomillero A, Moral MA",Gateways to clinical trials,"2009","31","10","661-700",Methods and findings in experimental and clinical pharmacology,,,,,,,,"20140276",,,0,10,0,0,0,,,
3856,99,"Hoogsteder et al., 2014",journal,"Hoogsteder PH, Kotz D, van Spiegel PI, Viechtbauer W, van Schayck OC",Efficacy of the nicotine vaccine 3'-AmNic-rEPA (NicVAX) co-administered with varenicline and counselling for smoking cessation: a randomized placebo-controlled trial,"2014","109","8","1252-1259","Addiction (Abingdon, England)",,,,,,,,"24894625",,,0,10,0,0,0,,,
3855,99,"Gathuru et al., 2005",journal,"Gathuru JK, Koide F, Ragupathi G, Adams JL, Kerns RT, Coleman TP, Livingston PO",Identification of DHBcAg as a potent carrier protein comparable to KLH for augmenting MUC1 antigenicity,"2005","23","39","4727-4733",Vaccine,,,,,,,,"15978705",,,0,10,0,0,0,,,
3854,99,"Morse et al., 2013",journal,"Morse MA, Chaudhry A, Gabitzsch ES, Hobeika AC, Osada T, Clay TM, Amalfitano A, Burnett BK, Devi GR, Hsu DS, Xu Y, Balcaitis S, Dua R, Nguyen S, Balint JP Jr, Jones FR, Lyerly HK",Novel adenoviral vector induces T-cell responses despite anti-adenoviral neutralizing antibodies in colorectal cancer patients,"2013","62","8","1293-1301","Cancer immunology, immunotherapy : CII",,,,,,,,"23624851",,,0,10,0,0,0,,,
3853,99,"Date et al., 1996",journal,"Date Y, Kimura A, Kato H, Sasazuki T",DNA typing of the HLA-A gene: population study and identification of four new alleles in Japanese,"1996","47","2","93-101",Tissue antigens,,,,,,,,"8851721",,,0,10,0,0,0,,,
3852,99,"Wada et al., 2005",journal,"Wada S, Tsunoda T, Baba T, Primus FJ, Kuwano H, Shibuya M, Tahara H",Rationale for antiangiogenic cancer therapy with vaccination using epitope peptides derived from human vascular endothelial growth factor receptor 2,"2005","65","11","4939-4946",Cancer research,,,,,,,,"15930316",,,0,10,0,0,0,,,
3851,99,"Nelson et al., 2016",journal,"Nelson HH, Pawlita M, Michaud DS, McClean M, Langevin SM, Eliot MN, Kelsey KT",Immune Response to HPV16 E6 and E7 Proteins and Patient Outcomes in Head and Neck Cancer,"2016","","","",JAMA oncology,,,,,,,,"27930753",,,0,10,0,0,0,,,
3850,99,"Garland et al., 2015",journal,"Garland SM, Cheung TH, McNeill S, Petersen LK, Romaguera J, Vazquez-Narvaez J, Bautista O, Shields C, Vuocolo S, Luxembourg A",Safety and immunogenicity of a 9-valent HPV vaccine in females 12-26 years of age who previously received the quadrivalent HPV vaccine,"2015","33","48","6855-6864",Vaccine,,,,,,,,"26411885",,,0,10,0,0,0,,,
3849,99,"Kouiavskaia et al., 2009",journal,"Kouiavskaia DV, Berard CA, Datena E, Hussain A, Dawson N, Klyushnenkova EN, Alexander RB",Vaccination with agonist peptide PSA: 154-163 (155L) derived from prostate specific antigen induced CD8 T-cell response to the native peptide PSA: 154-163 but failed to induce the reactivity against tumor targets expressing PSA: a phase 2 study in patients with recurrent prostate cancer,"2009","32","6","655-666","Journal of immunotherapy (Hagerstown, Md. : 1997)",,,,,,,,"19483644",,,0,10,0,0,0,,,
3848,99,"Hodge et al., 2008",journal,"Hodge JW, Guha C, Neefjes J, Gulley JL",Synergizing radiation therapy and immunotherapy for curing incurable cancers. Opportunities and challenges,"2008","22","9","1064-1070","Oncology (Williston Park, N.Y.)",,,,,,,,"18777956",,,0,10,0,0,0,,,
3847,99,"Fotin-Mleczek et al., 2011",journal,"Fotin-Mleczek M, Duchardt KM, Lorenz C, Pfeiffer R, Ojki-Zrna S, Probst J, Kallen KJ",Messenger RNA-based vaccines with dual activity induce balanced TLR-7 dependent adaptive immune responses and provide antitumor activity,"2011","34","1","1-15","Journal of immunotherapy (Hagerstown, Md. : 1997)",,,,,,,,"21150709",,,0,10,0,0,0,,,
3846,99,"Lazarus et al., 2005",journal,"Lazarus HM, Koc ON, Devine SM, Curtin P, Maziarz RT, Holland HK, Shpall EJ, McCarthy P, Atkinson K, Cooper BW, Gerson SL, Laughlin MJ, Loberiza FR Jr, Moseley AB, Bacigalupo A",Cotransplantation of HLA-identical sibling culture-expanded mesenchymal stem cells and hematopoietic stem cells in hematologic malignancy patients,"2005","11","5","389-398",Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation,,,,,,,,"15846293",,,0,10,0,0,0,,,
3845,99,"Gao et al., 2016",journal,"Gao S, Zeng L, Zhang X, Wu Y, Cui J, Song Z, Sun X, Wang H, Yin Y, Xu W",Attenuated Streptococcus pneumoniae vaccine candidate SPY1 promotes dendritic cell activation and drives a Th1/Th17 response,"2016","179","","47-55",Immunology letters,,,,,,,,"27609353",,,0,10,0,0,0,,,
3844,99,"Chen et al., 2015",journal,"Chen JL, Dawoodji A, Tarlton A, Gnjatic S, Tajar A, Karydis I, Browning J, Pratap S, Verfaille C, Venhaus RR, Pan L, Altman DG, Cebon JS, Old LL, Nathan P, Ottensmeier C, Middleton M, Cerundolo V",NY-ESO-1 specific antibody and cellular responses in melanoma patients primed with NY-ESO-1 protein in ISCOMATRIX and boosted with recombinant NY-ESO-1 fowlpox virus,"2015","136","6",E590-601,International journal of cancer,,,,,,,,"25081390",,,0,10,0,0,0,,,
3843,99,"Pollack et al., 2016",journal,"Pollack IF, Jakacki RI, Butterfield LH, Hamilton RL, Panigrahy A, Normolle DP, Connelly AK, Dibridge S, Mason G, Whiteside TL, Okada H",Antigen-specific immunoreactivity and clinical outcome following vaccination with glioma-associated antigen peptides in children with recurrent high-grade gliomas: results of a pilot study,"2016","130","3","517-527",Journal of neuro-oncology,,,,,,,,"27624914",,,0,10,0,0,0,,,
3842,99,"Kawakami et al., 1994",journal,"Kawakami Y, Eliyahu S, Delgado CH, Robbins PF, Sakaguchi K, Appella E, Yannelli JR, Adema GJ, Miki T, Rosenberg SA",Identification of a human melanoma antigen recognized by tumor-infiltrating lymphocytes associated with in vivo tumor rejection,"1994","91","14","6458-6462",Proceedings of the National Academy of Sciences of the United States of America,,,,,,,,"8022805",,,0,10,0,0,0,,,
3841,99,"Lawatscheck et al., 2007",journal,"Lawatscheck R, Aleksaite E, Schenk JA, Micheel B, Jandrig B, Holland G, Sasnauskas K, Gedvilaite A, Ulrich RG",Chimeric polyomavirus-derived virus-like particles: the immunogenicity of an inserted peptide applied without adjuvant to mice depends on its insertion site and its flanking linker sequence,"2007","20","3","453-460",Viral immunology,,,,,,,,"17931115",,,0,10,0,0,0,,,
3840,99,"Ferguson et al., 2016",journal,"Ferguson PJ, Sykelyk A, Figueredo R, Koropatnick J",Synergistic cytotoxicity against human tumor cell lines by oncolytic adenovirus dl1520 (ONYX-015) and melphalan,"2016","102","1","31-39",Tumori,,,,,,,,"26429639",,,0,10,0,0,0,,,
3839,99,"Prins et al., 2013",journal,"Prins RM, Wang X, Soto H, Young E, Lisiero DN, Fong B, Everson R, Yong WH, Lai A, Li G, Cloughesy TF, Liau LM",Comparison of glioma-associated antigen peptide-loaded versus autologous tumor lysate-loaded dendritic cell vaccination in malignant glioma patients,"2013","36","2","152-157","Journal of immunotherapy (Hagerstown, Md. : 1997)",,,,,,,,"23377664",,,0,10,0,0,0,,,
3838,99,"Erbs et al., 2008",journal,"Erbs P, Findeli A, Kintz J, Cordier P, Hoffmann C, Geist M, Balloul JM",Modified vaccinia virus Ankara as a vector for suicide gene therapy,"2008","15","1","18-28",Cancer gene therapy,,,,,,,,"17992203",,,0,10,0,0,0,,,
3837,99,"McNeil et al., 2007",journal,"McNeil SA, Noya F, Dionne M, Predy G, Meekison W, Ojah C, Ferro S, Mills EL, Langley JM, Halperin SA",Comparison of the safety and immunogenicity of concomitant and sequential administration of an adult formulation tetanus and diphtheria toxoids adsorbed combined with acellular pertussis (Tdap) vaccine and trivalent inactivated influenza vaccine in adults,"2007","25","17","3464-3474",Vaccine,,,,,,,,"17270320",,,0,10,0,0,0,,,
3836,99,"Kawakami et al., 1994",journal,"Kawakami Y, Eliyahu S, Sakaguchi K, Robbins PF, Rivoltini L, Yannelli JR, Appella E, Rosenberg SA",Identification of the immunodominant peptides of the MART-1 human melanoma antigen recognized by the majority of HLA-A2-restricted tumor infiltrating lymphocytes,"1994","180","1","347-352",The Journal of experimental medicine,,,,,,,,"7516411",,,0,10,0,0,0,,,
3835,99,"Nemunaitis et al., 2006",journal,"Nemunaitis J, Dillman RO, Schwarzenberger PO, Senzer N, Cunningham C, Cutler J, Tong A, Kumar P, Pappen B, Hamilton C, DeVol E, Maples PB, Liu L, Chamberlin T, Shawler DL, Fakhrai H","Phase II study of belagenpumatucel-L, a transforming growth factor beta-2 antisense gene-modified allogeneic tumor cell vaccine in non-small-cell lung cancer","2006","24","29","4721-4730",Journal of clinical oncology : official journal of the American Society of Clinical Oncology,,,,,,,,"16966690",,,0,10,0,0,0,,,
3834,99,"Schneble et al., 2014",journal,"Schneble EJ, Berry JS, Trappey FA, Clifton GT, Ponniah S, Mittendorf E, Peoples GE",The HER2 peptide nelipepimut-S (E75) vaccine (NeuVax) in breast cancer patients at risk for recurrence: correlation of immunologic data with clinical response,"2014","6","5","519-531",Immunotherapy,,,,,,,,"24896623",,,0,10,0,0,0,,,
3833,99,"Baxter et al., 2016",journal,"Baxter R, Hansen J, Timbol J, Pool V, Greenberg DP, Johnson DR, Decker MD","Post-licensure safety surveillance study of routine use of tetanus toxoid, reduced diphtheria toxoid and 5-component acellular pertussis vaccine","2016","12","11","2742-2748",Human vaccines &amp; immunotherapeutics,,,,,,,,"27388557",,,0,10,0,0,0,,,
3831,99,"Germain and Margulies, 1993",journal,"Germain RN, Margulies DH",The biochemistry and cell biology of antigen processing and presentation,"1993","11","","403-450",Annual review of immunology,,,,,,,,"8476568",,,0,10,0,0,0,,,
3832,99,"Ribas et al., 2010",journal,"Ribas A, Camacho LH, Lee SM, Hersh EM, Brown CK, Richards JM, Rodriguez MJ, Prieto VG, Glaspy JA, Oseguera DK, Hernandez J, Villanueva A, Chmielowski B, Mitsky P, Bercovici N, Wasserman E, Landais D, Ross MI",Multicenter phase II study of matured dendritic cells pulsed with melanoma cell line lysates in patients with advanced melanoma,"2010","8","","89",Journal of translational medicine,,,,,,,,"20875102",,,0,10,0,0,0,,,
3830,99,"Ko et al., 2009",journal,"Ko JS, Zea AH, Rini BI, Ireland JL, Elson P, Cohen P, Golshayan A, Rayman PA, Wood L, Garcia J, Dreicer R, Bukowski R, Finke JH",Sunitinib mediates reversal of myeloid-derived suppressor cell accumulation in renal cell carcinoma patients,"2009","15","6","2148-2157",Clinical cancer research : an official journal of the American Association for Cancer Research,,,,,,,,"19276286",,,0,10,0,0,0,,,
3829,99,"Zandberg et al., 2015",journal,"Zandberg DP, Rollins S, Goloubeva O, Morales RE, Tan M, Taylor R, Wolf JS, Schumaker LM, Cullen KJ, Zimrin A, Ord R, Lubek JE, Suntharalingam M, Papadimitriou JC, Mann D, Strome SE, Edelman MJ",A phase I dose escalation trial of MAGE-A3- and HPV16-specific peptide immunomodulatory vaccines in patients with recurrent/metastatic (RM) squamous cell carcinoma of the head and neck (SCCHN),"2015","64","3","367-379","Cancer immunology, immunotherapy : CII",,,,,,,,"25537079",,,0,10,0,0,0,,,
3828,99,"Morse et al., 2013",journal,"Morse MA, Niedzwiecki D, Marshall JL, Garrett C, Chang DZ, Aklilu M, Crocenzi TS, Cole DJ, Dessureault S, Hobeika AC, Osada T, Onaitis M, Clary BM, Hsu D, Devi GR, Bulusu A, Annechiarico RP, Chadaram V, Clay TM, Lyerly HK",A randomized phase II study of immunization with dendritic cells modified with poxvectors encoding CEA and MUC1 compared with the same poxvectors plus GM-CSF for resected metastatic colorectal cancer,"2013","258","6","879-886",Annals of surgery,,,,,,,,"23657083",,,0,10,0,0,0,,,
3827,99,"Aspord et al., 2010",journal,"Aspord C, Charles J, Leccia MT, Laurin D, Richard MJ, Chaperot L, Plumas J",A novel cancer vaccine strategy based on HLA-A*0201 matched allogeneic plasmacytoid dendritic cells,"2010","5","5",e10458,PloS one,,,,,,,,"20454561",,,0,10,0,0,0,,,
3826,99,"Bramante et al., 2014",journal,"Bramante S, Koski A, Kipar A, Diaconu I, Liikanen I, Hemminki O, Vassilev L, Parviainen S, Cerullo V, Pesonen SK, Oksanen M, Heiskanen R, Rouvinen-Lagerstrm N, Merisalo-Soikkeli M, Hakonen T, Joensuu T, Kanerva A, Pesonen S, Hemminki A",Serotype chimeric oncolytic adenovirus coding for GM-CSF for treatment of sarcoma in rodents and humans,"2014","135","3","720-730",International journal of cancer,,,,,,,,"24374597",,,0,10,0,0,0,,,
3891,99,"Stahl et al., 1992",journal,"Stahl M, Wilke HJ, Seeber S, Schmoll HJ",Cytokines and cytotoxic agents in renal cell carcinoma: a review,"1992","19","2 Suppl 4","70-79",Seminars in oncology,,,,,,,,"1553577",,,0,10,0,0,0,,,
3892,99,"Siurala et al., 2015",journal,"Siurala M, Bramante S, Vassilev L, Hirvinen M, Parviainen S, Thtinen S, Guse K, Cerullo V, Kanerva A, Kipar A, Vh-Koskela M, Hemminki A",Oncolytic adenovirus and doxorubicin-based chemotherapy results in synergistic antitumor activity against soft-tissue sarcoma,"2015","136","4","945-954",International journal of cancer,,,,,,,,"24975392",,,0,10,0,0,0,,,
3893,99,"Burke et al., 2012",journal,"Burke JM, Lamm DL, Meng MV, Nemunaitis JJ, Stephenson JJ, Arseneau JC, Aimi J, Lerner S, Yeung AW, Kazarian T, Maslyar DJ, McKiernan JM","A first in human phase 1 study of CG0070, a GM-CSF expressing oncolytic adenovirus, for the treatment of nonmuscle invasive bladder cancer","2012","188","6","2391-2397",The Journal of urology,,,,,,,,"23088985",,,0,10,0,0,0,,,
3894,99,"Zhai et al., 2011",journal,"Zhai SQ, Guo W, Hu YY, Yu N, Chen Q, Wang JZ, Fan M, Yang WY",Protective effects of brain-derived neurotrophic factor on the noise-damaged cochlear spiral ganglion,"2011","125","5","449-454",The Journal of laryngology and otology,,,,,,,,"21078216",,,0,10,0,0,0,,,
3895,99,"Akagi et al., 1997",journal,"Akagi J, Hodge JW, McLaughlin JP, Gritz L, Mazzara G, Kufe D, Schlom J, Kantor JA",Therapeutic antitumor response after immunization with an admixture of recombinant vaccinia viruses expressing a modified MUC1 gene and the murine T-cell costimulatory molecule B7,"1997","20","1","38-47","Journal of immunotherapy (Hagerstown, Md. : 1997)",,,,,,,,"9101412",,,0,10,0,0,0,,,
3896,99,"La et al., 2012",journal,"La Rosa C, Longmate J, Lacey SF, Kaltcheva T, Sharan R, Marsano D, Kwon P, Drake J, Williams B, Denison S, Broyer S, Couture L, Nakamura R, Dadwal S, Kelsey MI, Krieg AM, Diamond DJ, Zaia JA",Clinical evaluation of safety and immunogenicity of PADRE-cytomegalovirus (CMV) and tetanus-CMV fusion peptide vaccines with or without PF03512676 adjuvant,"2012","205","8","1294-1304",The Journal of infectious diseases,,,,,,,,"22402037",,,0,10,0,0,0,,,
3897,99,"Huang et al., 2012",journal,"Huang J, Jochems C, Talaie T, Anderson A, Jales A, Tsang KY, Madan RA, Gulley JL, Schlom J",Elevated serum soluble CD40 ligand in cancer patients may play an immunosuppressive role,"2012","120","15","3030-3038",Blood,,,,,,,,"22932804",,,0,10,0,0,0,,,
3898,99,"Crum et al., 2004",journal,"Crum CP, Beach KJ, Hedley ML, Yuan L, Lee KR, Wright TC, Urban RG",Dynamics of human papillomavirus infection between biopsy and excision of cervical intraepithelial neoplasia: results from the ZYC101a protocol,"2004","189","8","1348-1354",The Journal of infectious diseases,,,,,,,,"15073670",,,0,10,0,0,0,,,
3899,99,"Lu et al., 2009",journal,"Lu Y, Klein PJ, Westrick E, Xu LC, Santhapuram HK, Bloomfield A, Howard SJ, Vlahov IR, Ellis PR, Low PS, Leamon CP",Strategy to prevent drug-related hypersensitivity in folate-targeted hapten immunotherapy of cancer,"2009","11","3","628-638",The AAPS journal,,,,,,,,"19728104",,,0,10,0,0,0,,,
3900,99,"Miyauchi et al., 2012",journal,"Miyauchi M, Murata M, Fukushima A, Sato T, Nakagawa M, Fujii T, Koseki N, Chiba N, Kashiwazaki Y",Optimization of cell-wall skeleton derived from Mycobacterium bovis BCG Tokyo 172 (SMP-105) emulsion in delayed-type hypersensitivity and antitumor models,"2012","6","4","218-225",Drug discoveries &amp; therapeutics,,,,,,,,"23006993",,,0,10,0,0,0,,,
3901,99,"Fernando et al., 2010",journal,"Fernando RI, Litzinger M, Trono P, Hamilton DH, Schlom J, Palena C",The T-box transcription factor Brachyury promotes epithelial-mesenchymal transition in human tumor cells,"2010","120","2","533-544",The Journal of clinical investigation,,,,,,,,"20071775",,,0,10,0,0,0,,,
3902,99,"Ahlers et al., 1993",journal,"Ahlers JD, Pendleton CD, Dunlop N, Minassian A, Nara PL, Berzofsky JA",Construction of an HIV-1 peptide vaccine containing a multideterminant helper peptide linked to a V3 loop peptide 18 inducing strong neutralizing antibody responses in mice of multiple MHC haplotypes after two immunizations,"1993","150","12","5647-5665","Journal of immunology (Baltimore, Md. : 1950)",,,,,,,,"8515081",,,0,10,0,0,0,,,
3903,99,"Butterfield et al., 2014",journal,"Butterfield LH, Economou JS, Gamblin TC, Geller DA",Alpha fetoprotein DNA prime and adenovirus boost immunization of two hepatocellular cancer patients,"2014","12","","86",Journal of translational medicine,,,,,,,,"24708667",,,0,10,0,0,0,,,
3904,99,"Illiano et al., 2016",journal,"Illiano E, Bissa M, Paolini F, Zanotto C, De Giuli Morghen C, Franconi R, Radaelli A, Venuti A",Prime-boost therapeutic vaccination in mice with DNA/DNA or DNA/Fowlpox virus recombinants expressing the Human Papilloma Virus type 16 E6 and E7 mutated proteins fused to the coat protein of Potato virus X,"2016","225","","82-90",Virus research,,,,,,,,"27664839",,,0,10,0,0,0,,,
3905,99,"Berd et al., 2004",journal,"Berd D, Sato T, Maguire HC Jr, Kairys J, Mastrangelo MJ","Immunopharmacologic analysis of an autologous, hapten-modified human melanoma vaccine","2004","22","3","403-415",Journal of clinical oncology : official journal of the American Society of Clinical Oncology,,,,,,,,"14691123",,,0,10,0,0,0,,,
3906,99,"Freytag et al., 2013",journal,"Freytag SO, Barton KN, Zhang Y",Efficacy of oncolytic adenovirus expressing suicide genes and interleukin-12 in preclinical model of prostate cancer,"2013","20","12","1131-1139",Gene therapy,,,,,,,,"23842593",,,0,10,0,0,0,,,
3907,99,"Suzuki et al., 2017",journal,"Suzuki N, Hazama S, Iguchi H, Uesugi K, Tanaka H, Hirakawa K, Aruga A, Hatori T, Ishizaki H, Umeda Y, Fujiwara T, Ikemoto T, Shimada M, Yoshimatsu K, Shimizu R, Hayashi H, Sakata K, Takenouchi H, Matsui H, Shindo Y, Iida M, Koki Y, Arima H, Furukawa H, Ueno T, Yoshino S, Nakamura Y, Oka M, Nagano H",Phase II clinical trial of peptide cocktail therapy for patients with advanced pancreatic cancer: VENUS-PC study,"2017","108","1","73-80",Cancer science,,,,,,,,"27783849",,,0,10,0,0,0,,,
3908,99,"Abate-Daga et al., 2013",journal,"Abate-Daga D, Hanada K, Davis JL, Yang JC, Rosenberg SA, Morgan RA",Expression profiling of TCR-engineered T cells demonstrates overexpression of multiple inhibitory receptors in persisting lymphocytes,"2013","122","8","1399-1410",Blood,,,,,,,,"23861247",,,0,10,0,0,0,,,
3909,99,"Cacciavillano et al., 2015",journal,"Cacciavillano W, Sampor C, Venier C, Gabri MR, de Dvila MT, Galluzzo ML, Guthmann MD, Fainboim L, Alonso DF, Chantada GL",A Phase I Study of the Anti-Idiotype Vaccine Racotumomab in Neuroblastoma and Other Pediatric Refractory Malignancies,"2015","62","12","2120-2124",Pediatric blood &amp; cancer,,,,,,,,"26154941",,,0,10,0,0,0,,,
3910,99,"Insaidoo et al., 2011",journal,"Insaidoo FK, Borbulevych OY, Hossain M, Santhanagopolan SM, Baxter TK, Baker BM",Loss of T cell antigen recognition arising from changes in peptide and major histocompatibility complex protein flexibility: implications for vaccine design,"2011","286","46","40163-40173",The Journal of biological chemistry,,,,,,,,"21937447",,,0,10,0,0,0,,,
3911,99,"Van et al., 2015",journal,"Van Damme P, Olsson SE, Block S, Castellsague X, Gray GE, Herrera T, Huang LM, Kim DS, Pitisuttithum P, Chen J, Christiano S, Maansson R, Moeller E, Sun X, Vuocolo S, Luxembourg A",Immunogenicity and Safety of a 9-Valent HPV Vaccine,"2015","136","1",e28-39,Pediatrics,,,,,,,,"26101366",,,0,10,0,0,0,,,
3912,99,"Adamina et al., 2010",journal,"Adamina M, Rosenthal R, Weber WP, Frey DM, Viehl CT, Bolli M, Huegli RW, Jacob AL, Heberer M, Oertli D, Marti W, Spagnoli GC, Zajac P",Intranodal immunization with a vaccinia virus encoding multiple antigenic epitopes and costimulatory molecules in metastatic melanoma,"2010","18","3","651-659",Molecular therapy : the journal of the American Society of Gene Therapy,,,,,,,,"19935776",,,0,10,0,0,0,,,
3913,99,"Snook et al., 2008",journal,"Snook AE, Stafford BJ, Li P, Tan G, Huang L, Birbe R, Schulz S, Schnell MJ, Thakur M, Rothstein JL, Eisenlohr LC, Waldman SA",Guanylyl cyclase C-induced immunotherapeutic responses opposing tumor metastases without autoimmunity,"2008","100","13","950-961",Journal of the National Cancer Institute,,,,,,,,"18577748",,,0,10,0,0,0,,,
3914,99,"Mehendale et al., 2008",journal,"Mehendale S, van Lunzen J, Clumeck N, Rockstroh J, Vets E, Johnson PR, Anklesaria P, Barin B, Boaz M, Kochhar S, Lehrman J, Schmidt C, Peeters M, Schwarze-Zander C, Kabamba K, Glaunsinger T, Sahay S, Thakar M, Paranjape R, Gilmour J, Excler JL, Fast P, Heald AE",A phase 1 study to evaluate the safety and immunogenicity of a recombinant HIV type 1 subtype C adeno-associated virus vaccine,"2008","24","6","873-880",AIDS research and human retroviruses,,,,,,,,"18544020",,,0,10,0,0,0,,,
3915,99,"Svane et al., 2004",journal,"Svane IM, Pedersen AE, Johnsen HE, Nielsen D, Kamby C, Gaarsdal E, Nikolajsen K, Buus S, Claesson MH","Vaccination with p53-peptide-pulsed dendritic cells, of patients with advanced breast cancer: report from a phase I study","2004","53","7","633-641","Cancer immunology, immunotherapy : CII",,,,,,,,"14985857",,,0,10,0,0,0,,,
3916,99,"Lin et al., 2016",journal,"Lin HC, Chao YH, Wu KH, Yen TY, Hsu YL, Hsieh TH, Wei HM, Wu JL, Muo CH, Hwang KP, Peng CT, Lin CC, Li TC",Increased risk of herpes zoster in children with cancer: A nationwide population-based cohort study,"2016","95","30",e4037,Medicine,,,,,,,,"27472677",,,0,10,0,0,0,,,
3917,99,"Fulco et al., 2014",journal,"Fulco I, Miot S, Haug MD, Barbero A, Wixmerten A, Feliciano S, Wolf F, Jundt G, Marsano A, Farhadi J, Heberer M, Jakob M, Schaefer DJ, Martin I",Engineered autologous cartilage tissue for nasal reconstruction after tumour resection: an observational first-in-human trial,"2014","384","9940","337-346","Lancet (London, England)",,,,,,,,"24726477",,,0,10,0,0,0,,,
3918,99,"Snape et al., 2010",journal,"Snape MD, Dawson T, Oster P, Evans A, John TM, Ohene-Kena B, Findlow J, Yu LM, Borrow R, Ypma E, Toneatto D, Pollard AJ",Immunogenicity of two investigational serogroup B meningococcal vaccines in the first year of life: a randomized comparative trial,"2010","29","11","71-79",The Pediatric infectious disease journal,,,,,,,,"20844462",,,0,10,0,0,0,,,
3919,99,"Czerniecki et al., 2007",journal,"Czerniecki BJ, Roses RE, Koski GK",Development of vaccines for high-risk ductal carcinoma in situ of the breast,"2007","67","14","6531-6534",Cancer research,,,,,,,,"17638860",,,0,10,0,0,0,,,
3920,99,"Moulton et al., 2002",journal,"Moulton HM, Yoshihara PH, Mason DH, Iversen PL, Triozzi PL",Active specific immunotherapy with a beta-human chorionic gonadotropin peptide vaccine in patients with metastatic colorectal cancer: antibody response is associated with improved survival,"2002","8","7","2044-2051",Clinical cancer research : an official journal of the American Association for Cancer Research,,,,,,,,"12114402",,,0,10,0,0,0,,,
3921,99,"Duggan et al., 2016",journal,"Duggan MC, Jochems C, Donahue RN, Richards J, Karpa V, Foust E, Paul B, Brooks T, Tridandapani S, Olencki T, Pan X, Lesinski GB, Schlom J, Carson Iii WE",A phase I study of recombinant (r) vaccinia-CEA(6D)-TRICOM and rFowlpox-CEA(6D)-TRICOM vaccines with GM-CSF and IFN--2b in patients with CEA-expressing carcinomas,"2016","65","11","1353-1364","Cancer immunology, immunotherapy : CII",,,,,,,,"27581603",,,0,10,0,0,0,,,
3922,99,"Flores et al., 2007",journal,"Flores RM, Zakowski M, Venkatraman E, Krug L, Rosenzweig K, Dycoco J, Lee C, Yeoh C, Bains M, Rusch V",Prognostic factors in the treatment of malignant pleural mesothelioma at a large tertiary referral center,"2007","2","10","957-965",Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer,,,,,,,,"17909360",,,0,10,0,0,0,,,
3923,99,"Rapoport et al., 2011",journal,"Rapoport AP, Aqui NA, Stadtmauer EA, Vogl DT, Fang HB, Cai L, Janofsky S, Chew A, Storek J, Akpek G, Badros A, Yanovich S, Tan MT, Veloso E, Pasetti MF, Cross A, Philip S, Murphy H, Bhagat R, Zheng Z, Milliron T, Cotte J, Cannon A, Levine BL, Vonderheide RH, June CH",Combination immunotherapy using adoptive T-cell transfer and tumor antigen vaccination on the basis of hTERT and survivin after ASCT for myeloma,"2011","117","3","788-797",Blood,,,,,,,,"21030558",,,0,10,0,0,0,,,
3924,99,"Yoo et al., 2009",journal,"Yoo GH, Moon J, Leblanc M, Lonardo F, Urba S, Kim H, Hanna E, Tsue T, Valentino J, Ensley J, Wolf G","A phase 2 trial of surgery with perioperative INGN 201 (Ad5CMV-p53) gene therapy followed by chemoradiotherapy for advanced, resectable squamous cell carcinoma of the oral cavity, oropharynx, hypopharynx, and larynx: report of the Southwest Oncology Group","2009","135","9","869-874",Archives of otolaryngology--head &amp; neck surgery,,,,,,,,"19770418",,,0,10,0,0,0,,,
3925,99,"Weber et al., 2003",journal,"Weber J, Sondak VK, Scotland R, Phillip R, Wang F, Rubio V, Stuge TB, Groshen SG, Gee C, Jeffery GG, Sian S, Lee PP",Granulocyte-macrophage-colony-stimulating factor added to a multipeptide vaccine for resected Stage II melanoma,"2003","97","1","186-200",Cancer,,,,,,,,"12491520",,,0,10,0,0,0,,,
3926,99,"Tarhini et al., 2012",journal,"Tarhini AA, Leng S, Moschos SJ, Yin Y, Sander C, Lin Y, Gooding WE, Kirkwood JM","Safety and immunogenicity of vaccination with MART-1 (26-35, 27L), gp100 (209-217, 210M), and tyrosinase (368-376, 370D) in adjuvant with PF-3512676 and GM-CSF in metastatic melanoma","2012","35","4","359-366","Journal of immunotherapy (Hagerstown, Md. : 1997)",,,,,,,,"22495394",,,0,10,0,0,0,,,
3927,99,"Luxembourg et al., 2015",journal,"Luxembourg A, Moreira ED Jr, Samakoses R, Kim KH, Sun X, Maansson R, Moeller E, Christiano S, Chen J","Phase III, randomized controlled trial in girls 9-15 years old to evaluate lot consistency of a novel nine-valent human papillomavirus L1 virus-like particle vaccine","2015","11","6","1306-1312",Human vaccines &amp; immunotherapeutics,,,,,,,,"26086587",,,0,10,0,0,0,,,
3928,99,"Charoensit et al., 2008",journal,"Charoensit P, Kawakami S, Higuchi Y, Hashida M",Incorporation of all-trans retinoic acid into lipoplexes inhibits nuclear factor kappaB activation mediated liver injury induced by lipoplexes in mice,"2008","10","1","61-69",The journal of gene medicine,,,,,,,,"18001002",,,0,10,0,0,0,,,
3929,99,"Aspord et al., 2012",journal,"Aspord C, Leccia MT, Salameire D, Laurin D, Chaperot L, Charles J, Plumas J",HLA-A(*)0201(+) plasmacytoid dendritic cells provide a cell-based immunotherapy for melanoma patients,"2012","132","10","2395-2406",The Journal of investigative dermatology,,,,,,,,"22696054",,,0,10,0,0,0,,,
3930,99,"Kemp et al., 2011",journal,"Kemp TJ, Hildesheim A, Safaeian M, Dauner JG, Pan Y, Porras C, Schiller JT, Lowy DR, Herrero R, Pinto LA",HPV16/18 L1 VLP vaccine induces cross-neutralizing antibodies that may mediate cross-protection,"2011","29","11","2011-2014",Vaccine,,,,,,,,"21241731",,,0,10,0,0,0,,,
3931,99,"Muderspach et al., 2000",journal,"Muderspach L, Wilczynski S, Roman L, Bade L, Felix J, Small LA, Kast WM, Fascio G, Marty V, Weber J",A phase I trial of a human papillomavirus (HPV) peptide vaccine for women with high-grade cervical and vulvar intraepithelial neoplasia who are HPV 16 positive,"2000","6","9","3406-3416",Clinical cancer research : an official journal of the American Association for Cancer Research,,,,,,,,"10999722",,,0,10,0,0,0,,,
3932,99,"Manegold and Thatcher, 2007",journal,"Manegold C, Thatcher N",Survival improvement in thoracic cancer: progress from the last decade and beyond,"2007","57 Suppl 2","",S3-5,"Lung cancer (Amsterdam, Netherlands)",,,,,,,,"17686443",,,0,10,0,0,0,,,
3933,99,"Marshall et al., 2005",journal,"Marshall JL, Gulley JL, Arlen PM, Beetham PK, Tsang KY, Slack R, Hodge JW, Doren S, Grosenbach DW, Hwang J, Fox E, Odogwu L, Park S, Panicali D, Schlom J","Phase I study of sequential vaccinations with fowlpox-CEA(6D)-TRICOM alone and sequentially with vaccinia-CEA(6D)-TRICOM, with and without granulocyte-macrophage colony-stimulating factor, in patients with carcinoembryonic antigen-expressing carcinomas","2005","23","4","720-731",Journal of clinical oncology : official journal of the American Society of Clinical Oncology,,,,,,,,"15613691",,,0,10,0,0,0,,,
3934,99,"Kanehira et al., 2007",journal,"Kanehira M, Harada Y, Takata R, Shuin T, Miki T, Fujioka T, Nakamura Y, Katagiri T",Involvement of upregulation of DEPDC1 (DEP domain containing 1) in bladder carcinogenesis,"2007","26","44","6448-6455",Oncogene,,,,,,,,"17452976",,,0,10,0,0,0,,,
3935,99,"Chen et al., 2014",journal,"Chen G, Gupta R, Petrik S, Laiko M, Leatherman JM, Asquith JM, Daphtary MM, Garrett-Mayer E, Davidson NE, Hirt K, Berg M, Uram JN, Dauses T, Fetting J, Duus EM, Atay-Rosenthal S, Ye X, Wolff AC, Stearns V, Jaffee EM, Emens LA","A feasibility study of cyclophosphamide, trastuzumab, and an allogeneic GM-CSF-secreting breast tumor vaccine for HER2+ metastatic breast cancer","2014","2","10","949-961",Cancer immunology research,,,,,,,,"25116755",,,0,10,0,0,0,,,
3936,99,"Dijkgraaf et al., 2015",journal,"Dijkgraaf EM, Santegoets SJ, Reyners AK, Goedemans R, Nijman HW, van Poelgeest MI, van Erkel AR, Smit VT, Daemen TA, van der Hoeven JJ, Melief CJ, Welters MJ, Kroep JR, van der Burg SH","A phase 1/2 study combining gemcitabine, Pegintron and p53 SLP vaccine in patients with platinum-resistant ovarian cancer","2015","6","31","32228-32243",Oncotarget,,,,,,,,"26334096",,,0,10,0,0,0,,,
3937,99,"Felizardo et al., 2011",journal,"Felizardo TC, Wang JC, McGray RA, Evelegh C, Spaner DE, Fowler DH, Bramson JL, Medin JA",Differential immune responses mediated by adenovirus- and lentivirus-transduced DCs in a HER-2/neu overexpressing tumor model,"2011","18","10","986-995",Gene therapy,,,,,,,,"21490686",,,0,10,0,0,0,,,
3938,99,"Van et al., 2016",journal,"Van Damme P, Bonanni P, Bosch FX, Joura E, Kjaer SK, Meijer CJ, Petry KU, Soubeyrand B, Verstraeten T, Stanley M",Use of the nonavalent HPV vaccine in individuals previously fully or partially vaccinated with bivalent or quadrivalent HPV vaccines,"2016","34","6","757-761",Vaccine,,,,,,,,"26772631",,,0,10,0,0,0,,,
3939,99,"Schoof et al., 1998",journal,"Schoof DD, Smith JW 2nd, Disis ML, Brant-Zawadski P, Wood W, Doran T, Johnson E, Urba WJ",Immunization of metastatic breast cancer patients with CD80-modified breast cancer cells and GM-CSF,"1998","451","","511-518",Advances in experimental medicine and biology,,,,,,,,"10026920",,,0,10,0,0,0,,,
3940,99,"Greenberg et al., 2009",journal,"Greenberg ME, Lai MH, Hartel GF, Wichems CH, Gittleson C, Bennet J, Dawson G, Hu W, Leggio C, Washington D, Basser RL",Response to a monovalent 2009 influenza A (H1N1) vaccine,"2009","361","25","2405-2413",The New England journal of medicine,,,,,,,,"19745216",,,0,10,0,0,0,,,
3941,99,"Reinartz et al., 2004",journal,"Reinartz S, Khler S, Schlebusch H, Krista K, Giffels P, Renke K, Huober J, Mbus V, Kreienberg R, DuBois A, Sabbatini P, Wagner U",Vaccination of patients with advanced ovarian carcinoma with the anti-idiotype ACA125: immunological response and survival (phase Ib/II),"2004","10","5","1580-1587",Clinical cancer research : an official journal of the American Association for Cancer Research,,,,,,,,"15014007",,,0,10,0,0,0,,,
3942,99,"Pujol et al., 2016",journal,"Pujol JL, De Pas T, Rittmeyer A, Vallires E, Kubisa B, Levchenko E, Wiesemann S, Masters GA, Shen R, Tjulandin SA, Hofmann HS, Vanhoutte N, Salaun B, Debois M, Jarnjak S, De Sousa Alves PM, Louahed J, Brichard VG, Lehmann FF",Safety and Immunogenicity of the PRAME Cancer Immunotherapeutic in Patients with Resected Non-Small Cell Lung Cancer: A Phase I Dose Escalation Study,"2016","11","12","2208-2217",Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer,,,,,,,,"27544054",,,0,10,0,0,0,,,
3943,99,"Khong et al., 2004",journal,"Khong HT, Yang JC, Topalian SL, Sherry RM, Mavroukakis SA, White DE, Rosenberg SA",Immunization of HLA-A*0201 and/or HLA-DPbeta1*04 patients with metastatic melanoma using epitopes from the NY-ESO-1 antigen,"2004","27","6","472-477","Journal of immunotherapy (Hagerstown, Md. : 1997)",,,,,,,,"15534491",,,0,10,0,0,0,,,
3944,99,"Borrello et al., 2009",journal,"Borrello IM, Levitsky HI, Stock W, Sher D, Qin L, DeAngelo DJ, Alyea EP, Stone RM, Damon LE, Linker CA, Maslyar DJ, Hege KM",Granulocyte-macrophage colony-stimulating factor (GM-CSF)-secreting cellular immunotherapy in combination with autologous stem cell transplantation (ASCT) as postremission therapy for acute myeloid leukemia (AML),"2009","114","9","1736-1745",Blood,,,,,,,,"19556425",,,0,10,0,0,0,,,
3945,99,"Garcia et al., 2004",journal,"Garcia F, Petry KU, Muderspach L, Gold MA, Braly P, Crum CP, Magill M, Silverman M, Urban RG, Hedley ML, Beach KJ",ZYC101a for treatment of high-grade cervical intraepithelial neoplasia: a randomized controlled trial,"2004","103","2","317-326",Obstetrics and gynecology,,,,,,,,"14754702",,,0,10,0,0,0,,,
3946,99,"Fakhrai et al., 2006",journal,"Fakhrai H, Mantil JC, Liu L, Nicholson GL, Murphy-Satter CS, Ruppert J, Shawler DL",Phase I clinical trial of a TGF-beta antisense-modified tumor cell vaccine in patients with advanced glioma,"2006","13","12","1052-1060",Cancer gene therapy,,,,,,,,"16826191",,,0,10,0,0,0,,,
3947,99,"Lu et al., 2016",journal,"Lu S, Ren J, Li Q, Jiang Z, Chen Y, Xu K, Ruan B, Yang S, Xie T, Yang L, Li J, Yao J",Effects of hepatitis B vaccine boosters on anti-HBs-negative children after primary immunization,"2016","","","0",Human vaccines &amp; immunotherapeutics,,,,,,,,"27905821",,,0,10,0,0,0,,,
3948,99,"Oertli et al., 2002",journal,"Oertli D, Marti WR, Zajac P, Noppen C, Kocher T, Padovan E, Adamina M, Schumacher R, Harder F, Heberer M, Spagnoli GC",Rapid induction of specific cytotoxic T lymphocytes against melanoma-associated antigens by a recombinant vaccinia virus vector expressing multiple immunodominant epitopes and costimulatory molecules in vivo,"2002","13","4","569-575",Human gene therapy,,,,,,,,"11874634",,,0,10,0,0,0,,,
3949,99,"Tolcher et al., 2006",journal,"Tolcher AW, Hao D, de Bono J, Miller A, Patnaik A, Hammond LA, Smetzer L, Van Wart Hood J, Merritt J, Rowinsky EK, Takimoto C, Von Hoff D, Eckhardt SG","Phase I, pharmacokinetic, and pharmacodynamic study of intravenously administered Ad5CMV-p53, an adenoviral vector containing the wild-type p53 gene, in patients with advanced cancer","2006","24","13","2052-2058",Journal of clinical oncology : official journal of the American Society of Clinical Oncology,,,,,,,,"16648505",,,0,10,0,0,0,,,
3950,99,"James et al., 2014",journal,"James BR, Anderson KG, Brincks EL, Kucaba TA, Norian LA, Masopust D, Griffith TS",CpG-mediated modulation of MDSC contributes to the efficacy of Ad5-TRAIL therapy against renal cell carcinoma,"2014","63","11","1213-1227","Cancer immunology, immunotherapy : CII",,,,,,,,"25143233",,,0,10,0,0,0,,,
3951,99,"Parkinson and Sznol, 1995",journal,"Parkinson DR, Sznol M",High-dose interleukin-2 in the therapy of metastatic renal-cell carcinoma,"1995","22","1","61-66",Seminars in oncology,,,,,,,,"7855620",,,0,10,0,0,0,,,
3952,99,"Lotem et al., 2004",journal,"Lotem M, Shiloni E, Pappo I, Drize O, Hamburger T, Weitzen R, Isacson R, Kaduri L, Merims S, Frankenburg S, Peretz T",Interleukin-2 improves tumour response to DNP-modified autologous vaccine for the treatment of metastatic malignant melanoma,"2004","90","4","773-780",British journal of cancer,,,,,,,,"14970852",,,0,10,0,0,0,,,
3953,99,"Paff et al., 2014",journal,"Paff M, Alexandru-Abrams D, Hsu FP, Bota DA",The evolution of the EGFRvIII (rindopepimut) immunotherapy for glioblastoma multiforme patients,"2014","10","11","3322-3331",Human vaccines &amp; immunotherapeutics,,,,,,,,"25625931",,,0,10,0,0,0,,,
3954,99,"Curigliano et al., 2016",journal,"Curigliano G, Romieu G, Campone M, Dorval T, Duck L, Canon JL, Roemer-Becuwe C, Roselli M, Neciosup S, Burny W, Callegaro A, de Sousa Alves PM, Louahed J, Brichard V, Lehmann FF",A phase I/II trial of the safety and clinical activity of a HER2-protein based immunotherapeutic for treating women with HER2-positive metastatic breast cancer,"2016","156","2","301-310",Breast cancer research and treatment,,,,,,,,"26975189",,,0,10,0,0,0,,,
3955,99,"Slovin et al., 2005",journal,"Slovin SF, Ragupathi G, Fernandez C, Jefferson MP, Diani M, Wilton AS, Powell S, Spassova M, Reis C, Clausen H, Danishefsky S, Livingston P, Scher HI",A bivalent conjugate vaccine in the treatment of biochemically relapsed prostate cancer: a study of glycosylated MUC-2-KLH and Globo H-KLH conjugate vaccines given with the new semi-synthetic saponin immunological adjuvant GPI-0100 OR QS-21,"2005","23","24","3114-3122",Vaccine,,,,,,,,"15837210",,,0,10,0,0,0,,,
3956,99,"Zangwill et al., 2008",journal,"Zangwill KM, Eriksen E, Lee M, Lee J, Marcy SM, Friedland LR, Weston W, Howe B, Ward JI","A population-based, postlicensure evaluation of the safety of a combination diphtheria, tetanus, acellular pertussis, hepatitis B, and inactivated poliovirus vaccine in a large managed care organization","2008","122","6","1179-1185",Pediatrics,,,,,,,,"19047220",,,0,10,0,0,0,,,
3957,99,"Brockstedt et al., 2004",journal,"Brockstedt DG, Giedlin MA, Leong ML, Bahjat KS, Gao Y, Luckett W, Liu W, Cook DN, Portnoy DA, Dubensky TW Jr",Listeria-based cancer vaccines that segregate immunogenicity from toxicity,"2004","101","38","13832-13837",Proceedings of the National Academy of Sciences of the United States of America,,,,,,,,"15365184",,,0,10,0,0,0,,,
3958,99,"Dessy et al., 2008",journal,"Dessy FJ, Giannini SL, Bougelet CA, Kemp TJ, David MP, Poncelet SM, Pinto LA, Wettendorff MA","Correlation between direct ELISA, single epitope-based inhibition ELISA and pseudovirion-based neutralization assay for measuring anti-HPV-16 and anti-HPV-18 antibody response after vaccination with the AS04-adjuvanted HPV-16/18 cervical cancer vaccine","2008","4","6","425-434",Human vaccines,,,,,,,,"18948732",,,0,10,0,0,0,,,
3959,99,"Bjoern et al., 2016",journal,"Bjoern J, Iversen TZ, Nitschke NJ, Andersen MH, Svane IM","Safety, immune and clinical responses in metastatic melanoma patients vaccinated with a long peptide derived from indoleamine 2,3-dioxygenase in combination with ipilimumab","2016","18","8","1043-1055",Cytotherapy,,,,,,,,"27378345",,,0,10,0,0,0,,,
3960,99,"Trck et al., 2014",journal,"Trck J, Snape MD, Tatangeli F, Voysey M, Yu LM, Faust SN, Heath PT, Finn A, Pollard AJ",Pneumococcal serotype-specific antibodies persist through early childhood after infant immunization: follow-up from a randomized controlled trial,"2014","9","3",e91413,PloS one,,,,,,,,"24618837",,,0,10,0,0,0,,,
3961,99,"Ragupathi et al., 2000",journal,"Ragupathi G, Meyers M, Adluri S, Howard L, Musselli C, Livingston PO",Induction of antibodies against GD3 ganglioside in melanoma patients by vaccination with GD3-lactone-KLH conjugate plus immunological adjuvant QS-21,"2000","85","5","659-666",International journal of cancer,,,,,,,,"10699946",,,0,10,0,0,0,,,
3962,99,"Miller et al., 2014",journal,"Miller MJ, Foy KC, Overholser JP, Nahta R, Kaumaya PT","HER-3 peptide vaccines/mimics: Combined therapy with IGF-1R, HER-2, and HER-1 peptides induces synergistic antitumor effects against breast and pancreatic cancer cells","2014","3","11",e956012,Oncoimmunology,,,,,,,,"25941588",,,0,10,0,0,0,,,
3963,99,"Toretsky et al., 1995",journal,"Toretsky JA, Neckers L, Wexler LH",Detection of (11;22)(q24;q12) translocation-bearing cells in peripheral blood progenitor cells of patients with Ewing's sarcoma family of tumors,"1995","87","5","385-386",Journal of the National Cancer Institute,,,,,,,,"7853420",,,0,10,0,0,0,,,
3964,99,"Higashihara et al., 2014",journal,"Higashihara Y, Kato J, Nagahara A, Izumi K, Konishi M, Kodani T, Serizawa N, Osada T, Watanabe S",Phase I clinical trial of peptide vaccination with URLC10 and VEGFR1 epitope peptides in patients with advanced gastric cancer,"2014","44","3","662-668",International journal of oncology,,,,,,,,"24398900",,,0,10,0,0,0,,,
3965,99,"Ferrara et al., 2009",journal,"Ferrara TA, Hodge JW, Gulley JL",Combining radiation and immunotherapy for synergistic antitumor therapy,"2009","11","1","37-42",Current opinion in molecular therapeutics,,,,,,,,"19169958",,,0,10,0,0,0,,,
3966,99,"Zajac et al., 2003",journal,"Zajac P, Oertli D, Marti W, Adamina M, Bolli M, Guller U, Noppen C, Padovan E, Schultz-Thater E, Heberer M, Spagnoli G",Phase I/II clinical trial of a nonreplicative vaccinia virus expressing multiple HLA-A0201-restricted tumor-associated epitopes and costimulatory molecules in metastatic melanoma patients,"2003","14","16","1497-1510",Human gene therapy,,,,,,,,"14577912",,,0,10,0,0,0,,,
3967,99,"Hegmans et al., 2005",journal,"Hegmans JP, Hemmes A, Aerts JG, Hoogsteden HC, Lambrecht BN",Immunotherapy of murine malignant mesothelioma using tumor lysate-pulsed dendritic cells,"2005","171","10","1168-1177",American journal of respiratory and critical care medicine,,,,,,,,"15764728",,,0,10,0,0,0,,,
3968,99,"Correale et al., 2005",journal,"Correale P, Cusi MG, Del Vecchio MT, Aquino A, Prete SP, Tsang KY, Micheli L, Nencini C, La Placa M, Montagnani F, Terrosi C, Caraglia M, Formica V, Giorgi G, Bonmassar E, Francini G","Dendritic cell-mediated cross-presentation of antigens derived from colon carcinoma cells exposed to a highly cytotoxic multidrug regimen with gemcitabine, oxaliplatin, 5-fluorouracil, and leucovorin, elicits a powerful human antigen-specific CTL response with antitumor activity in vitro","2005","175","2","820-828","Journal of immunology (Baltimore, Md. : 1950)",,,,,,,,"16002679",,,0,10,0,0,0,,,
3969,99,"Weber et al., 2013",journal,"Weber JS, Kudchadkar RR, Yu B, Gallenstein D, Horak CE, Inzunza HD, Zhao X, Martinez AJ, Wang W, Gibney G, Kroeger J, Eysmans C, Sarnaik AA, Chen YA","Safety, efficacy, and biomarkers of nivolumab with vaccine in ipilimumab-refractory or -naive melanoma","2013","31","34","4311-4318",Journal of clinical oncology : official journal of the American Society of Clinical Oncology,,,,,,,,"24145345",,,0,10,0,0,0,,,
3970,99,"Patel et al., 2013",journal,"Patel JD, Socinski MA, Garon EB, Reynolds CH, Spigel DR, Olsen MR, Hermann RC, Jotte RM, Beck T, Richards DA, Guba SC, Liu J, Frimodt-Moller B, John WJ, Obasaju CK, Pennella EJ, Bonomi P, Govindan R",PointBreak: a randomized phase III study of pemetrexed plus carboplatin and bevacizumab followed by maintenance pemetrexed and bevacizumab versus paclitaxel plus carboplatin and bevacizumab followed by maintenance bevacizumab in patients with stage IIIB or IV nonsquamous non-small-cell lung cancer,"2013","31","34","4349-4357",Journal of clinical oncology : official journal of the American Society of Clinical Oncology,,,,,,,,"24145346",,,0,10,0,0,0,,,
3971,99,"Sears et al., 2011",journal,"Sears AK, Perez SA, Clifton GT, Benavides LC, Gates JD, Clive KS, Holmes JP, Shumway NM, Van Echo DC, Carmichael MG, Ponniah S, Baxevanis CN, Mittendorf EA, Papamichail M, Peoples GE",AE37: a novel T-cell-eliciting vaccine for breast cancer,"2011","11","11","1543-1550",Expert opinion on biological therapy,,,,,,,,"21895539",,,0,10,0,0,0,,,
3972,99,"Tummers et al., 2016",journal,"Tummers QR, Hoogstins CE, Gaarenstroom KN, de Kroon CD, van Poelgeest MI, Vuyk J, Bosse T, Smit VT, van de Velde CJ, Cohen AF, Low PS, Burggraaf J, Vahrmeijer AL",Intraoperative imaging of folate receptor alpha positive ovarian and breast cancer using the tumor specific agent EC17,"2016","7","22","32144-32155",Oncotarget,,,,,,,,"27014973",,,0,10,0,0,0,,,
3973,99,"Sabbatini et al., 2006",journal,"Sabbatini P, Dupont J, Aghajanian C, Derosa F, Poynor E, Anderson S, Hensley M, Livingston P, Iasonos A, Spriggs D, McGuire W, Reinartz S, Schneider S, Grande C, Lele S, Rodabaugh K, Kepner J, Ferrone S, Odunsi K","Phase I study of abagovomab in patients with epithelial ovarian, fallopian tube, or primary peritoneal cancer","2006","12","18","5503-5510",Clinical cancer research : an official journal of the American Association for Cancer Research,,,,,,,,"17000686",,,0,10,0,0,0,,,
3974,99,"Nagabhushan et al., 2007",journal,"Nagabhushan TL, Maneval DC, Benedict WF, Wen SF, Ihnat PM, Engler H, Connor RJ",Enhancement of intravesical delivery with Syn3 potentiates interferon-alpha2b gene therapy for superficial bladder cancer,"2007","18","5-6","389-394",Cytokine &amp; growth factor reviews,,,,,,,,"17692556",,,0,10,0,0,0,,,
3975,99,"Mittendorf et al., 2011",journal,"Mittendorf EA, Alatrash G, Xiao H, Clifton GT, Murray JL, Peoples GE",Breast cancer vaccines: ongoing National Cancer Institute-registered clinical trials,"2011","10","6","755-774",Expert review of vaccines,,,,,,,,"21692698",,,0,10,0,0,0,,,
3976,99,"Ahlers et al., 2006",journal,"Ahlers CM, Camphausen K, Citrin D, Arlen PM, Gulley JL",A pilot trial of a carcinoembryonic antigen/ TRICOM-based vaccine and radiation to liver metastases in patients with carcinoembryonic antigen-positive solid tumors,"2006","6","1","72-75",Clinical colorectal cancer,,,,,,,,"16796796",,,0,10,0,0,0,,,
3977,99,"Prince et al., 2015",journal,"Prince HE, Seaton BL, Matud JL, Batterman HJ",Chikungunya virus RNA and antibody testing at a National Reference Laboratory since the emergence of Chikungunya virus in the Americas,"2015","22","3","291-297",Clinical and vaccine immunology : CVI,,,,,,,,"25540275",,,0,10,0,0,0,,,
3978,99,"Heimberger et al., 2003",journal,"Heimberger AB, Crotty LE, Archer GE, Hess KR, Wikstrand CJ, Friedman AH, Friedman HS, Bigner DD, Sampson JH",Epidermal growth factor receptor VIII peptide vaccination is efficacious against established intracerebral tumors,"2003","9","11","4247-4254",Clinical cancer research : an official journal of the American Association for Cancer Research,,,,,,,,"14519652",,,0,10,0,0,0,,,
3979,99,"Stadtmauer et al., 2011",journal,"Stadtmauer EA, Vogl DT, Luning Prak E, Boyer J, Aqui NA, Rapoport AP, McDonald KR, Hou X, Murphy H, Bhagat R, Mangan PA, Chew A, Veloso EA, Levine BL, Vonderheide RH, Jawad AF, June CH, Sullivan KE",Transfer of influenza vaccine-primed costimulated autologous T cells after stem cell transplantation for multiple myeloma leads to reconstitution of influenza immunity: results of a randomized clinical trial,"2011","117","1","63-71",Blood,,,,,,,,"20864577",,,0,10,0,0,0,,,
3980,99,"Koski et al., 2012",journal,"Koski GK, Koldovsky U, Xu S, Mick R, Sharma A, Fitzpatrick E, Weinstein S, Nisenbaum H, Levine BL, Fox K, Zhang P, Czerniecki BJ",A novel dendritic cell-based immunization approach for the induction of durable Th1-polarized anti-HER-2/neu responses in women with early breast cancer,"2012","35","1","54-65","Journal of immunotherapy (Hagerstown, Md. : 1997)",,,,,,,,"22130160",,,0,10,0,0,0,,,
3981,99,"Chaise et al., 2008",journal,"Chaise C, Buchan SL, Rice J, Marquet J, Rouard H, Kuentz M, Vittes GE, Molinier-Frenkel V, Farcet JP, Stauss HJ, Delfau-Larue MH, Stevenson FK",DNA vaccination induces WT1-specific T-cell responses with potential clinical relevance,"2008","112","7","2956-2964",Blood,,,,,,,,"18502835",,,0,10,0,0,0,,,
3982,99,"Hirschowitz et al., 2011",journal,"Hirschowitz EA, Mullins A, Prajapati D, Baeker T, Kloecker G, Foody T, Damron K, Love C, Yannelli JR",Pilot study of 1650-G: a simplified cellular vaccine for lung cancer,"2011","6","1","169-173",Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer,,,,,,,,"21150468",,,0,10,0,0,0,,,
3983,99,"Kudela et al., 2011",journal,"Kudela P, Sun Z, Fourcade J, Janjic B, Kirkwood JM, Maillere B, Zarour HM",Epitope hierarchy of spontaneous CD4+ T cell responses to LAGE-1,"2011","186","1","312-322","Journal of immunology (Baltimore, Md. : 1950)",,,,,,,,"21131422",,,0,10,0,0,0,,,
3984,99,"Gruslova et al., 2015",journal,"Gruslova A, Cavazos DA, Miller JR, Breitbart E, Cohen YC, Bangio L, Yakov N, Soundararajan A, Floyd JR, Brenner AJ",VB-111: a novel anti-vascular therapeutic for glioblastoma multiforme,"2015","124","3","365-372",Journal of neuro-oncology,,,,,,,,"26108658",,,0,10,0,0,0,,,
3985,99,"Beebe et al., 2008",journal,"Beebe M, Qin M, Moi M, Wu S, Heiati H, Walker L, Newman M, Fikes J, Ishioka GY","Formulation and characterization of a ten-peptide single-vial vaccine, EP-2101, designed to induce cytotoxic T-lymphocyte responses for cancer immunotherapy","2008","4","3","210-218",Human vaccines,,,,,,,,"18382135",,,0,10,0,0,0,,,
3986,99,"Clark et al., 2009",journal,"Clark TW, Pareek M, Hoschler K, Dillon H, Nicholson KG, Groth N, Stephenson I",Trial of 2009 influenza A (H1N1) monovalent MF59-adjuvanted vaccine,"2009","361","25","2424-2435",The New England journal of medicine,,,,,,,,"19745215",,,0,10,0,0,0,,,
3987,99,"Saeki et al., 2004",journal,"Saeki A, Nakao K, Nagayama Y, Yanagi K, Matsumoto K, Hayashi T, Ishikawa H, Hamasaki K, Ishii N, Eguchi K",Diverse efficacy of vaccination therapy using the alpha-fetoprotein gene against mouse hepatocellular carcinoma,"2004","13","1","111-116",International journal of molecular medicine,,,,,,,,"14654980",,,0,10,0,0,0,,,
3988,99,"Fulco et al., 2013",journal,"Fulco I, Largo RD, Miot S, Wixmerten A, Martin I, Schaefer DJ, Haug MD",Toward clinical application of tissue-engineered cartilage,"2013","29","2","99-105",Facial plastic surgery : FPS,,,,,,,,"23564241",,,0,10,0,0,0,,,
3989,99,"Parmiani et al., 2014",journal,"Parmiani G, Pilla L, Corti A, Doglioni C, Cimminiello C, Bellone M, Parolini D, Russo V, Capocefalo F, Maccalli C",A pilot Phase I study combining peptide-based vaccination and NGR-hTNF vessel targeting therapy in metastatic melanoma,"2014","3","11",e963406,Oncoimmunology,,,,,,,,"25941591",,,0,10,0,0,0,,,
3990,99,"Moreira et al., 2016",journal,"Moreira ED Jr, Block SL, Ferris D, Giuliano AR, Iversen OE, Joura EA, Kosalaraksa P, Schilling A, Van Damme P, Bornstein J, Bosch FX, Pils S, Cuzick J, Garland SM, Huh W, Kjaer SK, Qi H, Hyatt D, Martin J, Moeller E, Ritter M, Baudin M, Luxembourg A",Safety Profile of the 9-Valent HPV Vaccine: A Combined Analysis of 7 Phase III Clinical Trials,"2016","138","2","",Pediatrics,,,,,,,,"27422279",,,0,10,0,0,0,,,
3991,99,"Hutson et al., 2008",journal,"Hutson TE, Figlin RA, Kuhn JG, Motzer RJ",Targeted therapies for metastatic renal cell carcinoma: an overview of toxicity and dosing strategies,"2008","13","10","1084-1096",The oncologist,,,,,,,,"18838439",,,0,10,0,0,0,,,
3992,99,"Luxembourg et al., 2015",journal,"Luxembourg A, Brown D, Bouchard C, Giuliano AR, Iversen OE, Joura EA, Penny ME, Restrepo JA, Romaguera J, Maansson R, Moeller E, Ritter M, Chen J",Phase II studies to select the formulation of a multivalent HPV L1 virus-like particle (VLP) vaccine,"2015","11","6","1313-1322",Human vaccines &amp; immunotherapeutics,,,,,,,,"25912208",,,0,10,0,0,0,,,
3993,99,"Sharma et al., 2012",journal,"Sharma A, Koldovsky U, Xu S, Mick R, Roses R, Fitzpatrick E, Weinstein S, Nisenbaum H, Levine BL, Fox K, Zhang P, Koski G, Czerniecki BJ",HER-2 pulsed dendritic cell vaccine can eliminate HER-2 expression and impact ductal carcinoma in situ,"2012","118","17","4354-4362",Cancer,,,,,,,,"22252842",,,0,10,0,0,0,,,
3994,99,"Embree et al., 2015",journal,"Embree J, Law B, Voloshen T, Tomovici A","Immunogenicity, safety, and antibody persistence at 3, 5, and 10 years postvaccination in adolescents randomized to booster immunization with a combined tetanus, diphtheria, 5-component acellular pertussis, and inactivated poliomyelitis vaccine administered with a hepatitis B virus vaccine concurrently or 1 month apart","2015","22","3","282-290",Clinical and vaccine immunology : CVI,,,,,,,,"25540274",,,0,10,0,0,0,,,
3995,99,"Bartal and Robinson, 1987",journal,"Bartal AH, Robinson E",Novel approach to MER/BCG administration in cancer patients,"1987","5","1","1-5",Cancer investigation,,,,,,,,"3580942",,,0,10,0,0,0,,,
3996,99,"D'Souza et al., 2016",journal,"D'Souza G, Westra WH, Wang SJ, van Zante A, Wentz A, Kluz N, Rettig E, Ryan WR, Ha PK, Kang H, Bishop J, Quon H, Kiess AP, Richmon JD, Eisele DW, Fakhry C","Differences in the Prevalence of Human Papillomavirus (HPV) in Head and Neck Squamous Cell Cancers by Sex, Race, Anatomic Tumor Site, and HPV Detection Method","2016","","","",JAMA oncology,,,,,,,,"27930766",,,0,10,0,0,0,,,
3997,99,"Rice et al., 2008",journal,"Rice J, Ottensmeier CH, Stevenson FK",DNA vaccines: precision tools for activating effective immunity against cancer,"2008","8","2","108-120",Nature reviews. Cancer,,,,,,,,"18219306",,,0,10,0,0,0,,,
3998,99,"Czerniecki et al., 2007",journal,"Czerniecki BJ, Koski GK, Koldovsky U, Xu S, Cohen PA, Mick R, Nisenbaum H, Pasha T, Xu M, Fox KR, Weinstein S, Orel SG, Vonderheide R, Coukos G, DeMichele A, Araujo L, Spitz FR, Rosen M, Levine BL, June C, Zhang PJ",Targeting HER-2/neu in early breast cancer development using dendritic cells with staged interleukin-12 burst secretion,"2007","67","4","1842-1852",Cancer research,,,,,,,,"17293384",,,0,10,0,0,0,,,
3999,99,"Hodge et al., 1999",journal,"Hodge JW, Sabzevari H, Yafal AG, Gritz L, Lorenz MG, Schlom J",A triad of costimulatory molecules synergize to amplify T-cell activation,"1999","59","22","5800-5807",Cancer research,,,,,,,,"10582702",,,0,10,0,0,0,,,
4000,99,"Veltman et al., 2010",journal,"Veltman JD, Lambers ME, van Nimwegen M, de Jong S, Hendriks RW, Hoogsteden HC, Aerts JG, Hegmans JP",Low-dose cyclophosphamide synergizes with dendritic cell-based immunotherapy in antitumor activity,"2010","2010","","798467",Journal of biomedicine &amp; biotechnology,,,,,,,,"20508851",,,0,10,0,0,0,,,
4001,99,"Dauer et al., 2005",journal,"Dauer M, Herten J, Bauer C, Renner F, Schad K, Schnurr M, Endres S, Eigler A",Chemosensitization of pancreatic carcinoma cells to enhance T cell-mediated cytotoxicity induced by tumor lysate-pulsed dendritic cells,"2005","28","4","332-342","Journal of immunotherapy (Hagerstown, Md. : 1997)",,,,,,,,"16000951",,,0,10,0,0,0,,,
4002,99,"Ramesh et al., 2010",journal,"Ramesh R, Ioannides CG, Roth JA, Chada S",Adenovirus-mediated interleukin (IL)-24 immunotherapy for cancer,"2010","651","","241-270","Methods in molecular biology (Clifton, N.J.)",,,,,,,,"20686970",,,0,10,0,0,0,,,
4003,99,"Hirschowitz et al., 2004",journal,"Hirschowitz EA, Foody T, Kryscio R, Dickson L, Sturgill J, Yannelli J",Autologous dendritic cell vaccines for non-small-cell lung cancer,"2004","22","14","2808-2815",Journal of clinical oncology : official journal of the American Society of Clinical Oncology,,,,,,,,"15254048",,,0,10,0,0,0,,,
4004,99,"Jamshed et al., 2016",journal,"Jamshed S, Walsh EE, Dimitroff LJ, Santelli JS, Falsey AR",Improved immunogenicity of high-dose influenza vaccine compared to standard-dose influenza vaccine in adult oncology patients younger than 65 years receiving chemotherapy: A pilot randomized clinical trial,"2016","34","5","630-635",Vaccine,,,,,,,,"26721330",,,0,10,0,0,0,,,
4005,99,"Hegmans et al., 2010",journal,"Hegmans JP, Veltman JD, Lambers ME, de Vries IJ, Figdor CG, Hendriks RW, Hoogsteden HC, Lambrecht BN, Aerts JG",Consolidative dendritic cell-based immunotherapy elicits cytotoxicity against malignant mesothelioma,"2010","181","12","1383-1390",American journal of respiratory and critical care medicine,,,,,,,,"20167848",,,0,10,0,0,0,,,
4006,99,"Corrales-Rodriguez et al., 2011",journal,"Corrales-Rodriguez L, Blais N, Soulires D",Emepepimut-S for non-small cell lung cancer,"2011","11","8","1091-1097",Expert opinion on biological therapy,,,,,,,,"21689064",,,0,10,0,0,0,,,
4007,99,"Akbulut et al., 2010",journal,"Akbulut H, Tang Y, Akbulut KG, Maynard J, Deisseroth A",Addition of adenoviral vector targeting of chemotherapy to the MUC-1/ecdCD40L VPPP vector prime protein boost vaccine prolongs survival of mice carrying growing subcutaneous deposits of Lewis lung cancer cells,"2010","17","11","1333-1340",Gene therapy,,,,,,,,"20596057",,,0,10,0,0,0,,,
4008,99,"Ochiai et al., 2014",journal,"Ochiai RL, Khan MI, Soofi SB, Sur D, Kanungo S, You YA, Habib MA, Sahito SM, Manna B, Dutta S, Acosta CJ, Ali M, Bhattacharya SK, Bhutta ZA, Clemens JD","Immune responses to Vi capsular polysaccharide typhoid vaccine in children 2 to 16 years old in Karachi, Pakistan, and Kolkata, India","2014","21","5","661-666",Clinical and vaccine immunology : CVI,,,,,,,,"24599532",,,0,10,0,0,0,,,
4009,99,"Kafi et al., 2009",journal,"Kafi K, Betting DJ, Yamada RE, Bacica M, Steward KK, Timmerman JM",Maleimide conjugation markedly enhances the immunogenicity of both human and murine idiotype-KLH vaccines,"2009","46","3","448-456",Molecular immunology,,,,,,,,"19046770",,,0,10,0,0,0,,,
4010,99,"Tamminga et al., 1985",journal,"Tamminga CA, Foster NL, Chase TN",Reduced brain somatostatin levels in Alzheimer's disease,"1985","313","20","1294-1295",The New England journal of medicine,,,,,,,,"2865676",,,0,10,0,0,0,,,
4011,99,"Clerici et al., 1991",journal,"Clerici M, Lucey DR, Zajac RA, Boswell RN, Gebel HM, Takahashi H, Berzofsky JA, Shearer GM",Detection of cytotoxic T lymphocytes specific for synthetic peptides of gp160 in HIV-seropositive individuals,"1991","146","7","2214-2219","Journal of immunology (Baltimore, Md. : 1950)",,,,,,,,"1826020",,,0,10,0,0,0,,,
4012,99,"Wilgenhof et al., 2013",journal,"Wilgenhof S, Van Nuffel AM, Benteyn D, Corthals J, Aerts C, Heirman C, Van Riet I, Bonehill A, Thielemans K, Neyns B",A phase IB study on intravenous synthetic mRNA electroporated dendritic cell immunotherapy in pretreated advanced melanoma patients,"2013","24","10","2686-2693",Annals of oncology : official journal of the European Society for Medical Oncology,,,,,,,,"23904461",,,0,10,0,0,0,,,
4013,99,"La et al., 2017",journal,"La Rosa C, Longmate J, Martinez J, Zhou Q, Kaltcheva TI, Tsai W, Drake J, Carroll M, Wussow F, Chiuppesi F, Hardwick N, Dadwal S, Aldoss I, Nakamura R, Zaia JA, Diamond DJ",MVA vaccine encoding CMV antigens safely induces durable expansion of CMV-specific T cells in healthy adults,"2017","129","1","114-125",Blood,,,,,,,,"27760761",,,0,10,0,0,0,,,
4014,99,"Bartholomew et al., 2002",journal,"Bartholomew A, Sturgeon C, Siatskas M, Ferrer K, McIntosh K, Patil S, Hardy W, Devine S, Ucker D, Deans R, Moseley A, Hoffman R",Mesenchymal stem cells suppress lymphocyte proliferation in vitro and prolong skin graft survival in vivo,"2002","30","1","42-48",Experimental hematology,,,,,,,,"11823036",,,0,10,0,0,0,,,
4015,99,"Trimble et al., 2009",journal,"Trimble CL, Peng S, Kos F, Gravitt P, Viscidi R, Sugar E, Pardoll D, Wu TC",A phase I trial of a human papillomavirus DNA vaccine for HPV16+ cervical intraepithelial neoplasia 2/3,"2009","15","1","361-367",Clinical cancer research : an official journal of the American Association for Cancer Research,,,,,,,,"19118066",,,0,10,0,0,0,,,
4016,99,"Arlen et al., 2003",journal,"Arlen PM, Gulley JL, Palena C, Marshall J, Schlom J, Tsang KY",A novel ELISPOT assay to enhance detection of antigen-specific T cells employing antigen-presenting cells expressing vector-driven human B7-1,"2003","279","1-2","183-192",Journal of immunological methods,,,,,,,,"12969559",,,0,10,0,0,0,,,
4017,99,"Le et al., 2012",journal,"Le DT, Dubenksy TW Jr, Brockstedt DG",Clinical development of Listeria monocytogenes-based immunotherapies,"2012","39","3","311-322",Seminars in oncology,,,,,,,,"22595054",,,0,10,0,0,0,,,
4018,99,"Rivoltini et al., 1999",journal,"Rivoltini L, Squarcina P, Loftus DJ, Castelli C, Tarsini P, Mazzocchi A, Rini F, Viggiano V, Belli F, Parmiani G",A superagonist variant of peptide MART1/Melan A27-35 elicits anti-melanoma CD8+ T cells with enhanced functional characteristics: implication for more effective immunotherapy,"1999","59","2","301-306",Cancer research,,,,,,,,"9927036",,,0,10,0,0,0,,,
4019,99,"Aragon-Ching et al., 2007",journal,"Aragon-Ching JB, Williams KM, Gulley JL",Impact of androgen-deprivation therapy on the immune system: implications for combination therapy of prostate cancer,"2007","12","","4957-4971",Frontiers in bioscience : a journal and virtual library,,,,,,,,"17569623",,,0,10,0,0,0,,,
4020,99,"Keller et al., 2015",journal,"Keller M, Ebstein F, Brger E, Textoris-Taube K, Gorny X, Urban S, Zhao F, Dannenberg T, Sucker A, Keller C, Saveanu L, Krger E, Rothktter HJ, Dahlmann B, Henklein P, Voigt A, Kuckelkorn U, Paschen A, Kloetzel PM, Seifert U","The proteasome immunosubunits, PA28 and ER-aminopeptidase 1 protect melanoma cells from efficient MART-126-35 -specific T-cell recognition","2015","45","12","3257-3268",European journal of immunology,,,,,,,,"26399368",,,0,10,0,0,0,,,
4021,99,"Hirschowitz et al., 2006",journal,"Hirschowitz EA, Hiestand DM, Yannelli JR",Vaccines for lung cancer,"2006","1","1","93-104",Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer,,,,,,,,"17409835",,,0,10,0,0,0,,,
4022,99,"Beachler et al., 2016",journal,"Beachler DC, Kreimer AR, Schiffman M, Herrero R, Wacholder S, Rodriguez AC, Lowy DR, Porras C, Schiller JT, Quint W, Jimenez S, Safaeian M, Struijk L, Schussler J, Hildesheim A, Gonzalez P","Multisite HPV16/18 Vaccine Efficacy Against Cervical, Anal, and Oral HPV Infection","2016","108","1","",Journal of the National Cancer Institute,,,,,,,,"26467666",,,0,10,0,0,0,,,
4023,99,"Berinstein et al., 2012",journal,"Berinstein NL, Karkada M, Morse MA, Nemunaitis JJ, Chatta G, Kaufman H, Odunsi K, Nigam R, Sammatur L, MacDonald LD, Weir GM, Stanford MM, Mansour M","First-in-man application of a novel therapeutic cancer vaccine formulation with the capacity to induce multi-functional T cell responses in ovarian, breast and prostate cancer patients","2012","10","","156",Journal of translational medicine,,,,,,,,"22862954",,,0,10,0,0,0,,,
4024,99,"Wagner et al., 2001",journal,"Wagner U, Khler S, Reinartz S, Giffels P, Huober J, Renke K, Schlebusch H, Biersack HJ, Mbus V, Kreienberg R, Bauknecht T, Krebs D, Wallwiener D","Immunological consolidation of ovarian carcinoma recurrences with monoclonal anti-idiotype antibody ACA125: immune responses and survival in palliative treatment. See The biology behind: K. A. Foon and M. Bhattacharya-Chatterjee, Are solid tumor anti-idiotype vaccines ready for prime time? Clin. Cancer Res., 7:1112-1115, 2001","2001","7","5","1154-1162",Clinical cancer research : an official journal of the American Association for Cancer Research,,,,,,,,"11350879",,,0,10,0,0,0,,,
4025,99,"Meng et al., 2001",journal,"Meng WS, Butterfield LH, Ribas A, Dissette VB, Heller JB, Miranda GA, Glaspy JA, McBride WH, Economou JS",alpha-Fetoprotein-specific tumor immunity induced by plasmid prime-adenovirus boost genetic vaccination,"2001","61","24","8782-8786",Cancer research,,,,,,,,"11751399",,,0,10,0,0,0,,,
4026,99,"van et al., 1991",journal,"van der Bruggen P, Traversari C, Chomez P, Lurquin C, De Plaen E, Van den Eynde B, Knuth A, Boon T",A gene encoding an antigen recognized by cytolytic T lymphocytes on a human melanoma,"1991","254","5038","1643-1647","Science (New York, N.Y.)",,,,,,,,"1840703",,,0,10,0,0,0,,,
4027,99,"Nau, 2015",journal,Nau JY,"[Zona vaccine, molecular screening of lung cancer]","2015","11","477","1258-1259",Revue medicale suisse,,,,,,,,"26211288",,,0,10,0,0,0,,,
4028,99,"Qiao et al., 2005",journal,"Qiao H, Qian XP, Zhang HG, Tian C, Chen WF",[Estimation of an NY-ESO-1 expressing HCC cell line by NY-ESO-1b specific CD8+T cells in vitro induced by HLA-A2 restricted NY-ESO-1b peptide],"2005","37","6","565-568",Beijing da xue xue bao. Yi xue ban = Journal of Peking University. Health sciences,,,,,,,,"16378102",,,0,10,0,0,0,,,
4029,99,"Heiser et al., 2002",journal,"Heiser A, Coleman D, Dannull J, Yancey D, Maurice MA, Lallas CD, Dahm P, Niedzwiecki D, Gilboa E, Vieweg J",Autologous dendritic cells transfected with prostate-specific antigen RNA stimulate CTL responses against metastatic prostate tumors,"2002","109","3","409-417",The Journal of clinical investigation,,,,,,,,"11828001",,,0,10,0,0,0,,,
4030,99,"Deans and Moseley, 2000",journal,"Deans RJ, Moseley AB",Mesenchymal stem cells: biology and potential clinical uses,"2000","28","8","875-884",Experimental hematology,,,,,,,,"10989188",,,0,10,0,0,0,,,
4031,99,"Raez et al., 2003",journal,"Raez LE, Cassileth PA, Schlesselman JJ, Padmanabhan S, Fisher EZ, Baldie PA, Sridhar K, Podack ER",Induction of CD8 T-cell-Ifn-gamma response and positive clinical outcome after immunization with gene-modified allogeneic tumor cells in advanced non-small-cell lung carcinoma,"2003","10","11","850-858",Cancer gene therapy,,,,,,,,"14605671",,,0,10,0,0,0,,,
4032,99,"Krishnadas et al., 2015",journal,"Krishnadas DK, Shusterman S, Bai F, Diller L, Sullivan JE, Cheerva AC, George RE, Lucas KG","A phase I trial combining decitabine/dendritic cell vaccine targeting MAGE-A1, MAGE-A3 and NY-ESO-1 for children with relapsed or therapy-refractory neuroblastoma and sarcoma","2015","64","10","1251-1260","Cancer immunology, immunotherapy : CII",,,,,,,,"26105625",,,0,10,0,0,0,,,
4033,99,"Vogel et al., 2010",journal,"Vogel TU, Visan L, Ljutic B, Gajewska B, Caterini J, Salha D, Wen T, He L, Parrington M, Cao SX, McNeil B, Sandhu D, Scollard N, Zhang L, Bradley B, Tang M, Lovitt C, Oomen R, Dunn P, Tartaglia J, Berinstein NL",Preclinical qualification of a new multi-antigen candidate vaccine for metastatic melanoma,"2010","33","8","743-758","Journal of immunotherapy (Hagerstown, Md. : 1997)",,,,,,,,"20842062",,,0,10,0,0,0,,,
4034,99,"Daley et al., 1978",journal,"Daley MJ, Gebel HM, Lynch RG",Idiotype-specific transplantation resistance to MOPC-315: abrogation by post-immunization thymectomy,"1978","120","5","1620-1624","Journal of immunology (Baltimore, Md. : 1950)",,,,,,,,"77876",,,0,10,0,0,0,,,
4035,99,"Kharfan-Dabaja et al., 2012",journal,"Kharfan-Dabaja MA, Boeckh M, Wilck MB, Langston AA, Chu AH, Wloch MK, Guterwill DF, Smith LR, Rolland AP, Kenney RT","A novel therapeutic cytomegalovirus DNA vaccine in allogeneic haemopoietic stem-cell transplantation: a randomised, double-blind, placebo-controlled, phase 2 trial","2012","12","4","290-299",The Lancet. Infectious diseases,,,,,,,,"22237175",,,0,10,0,0,0,,,
4036,99,"Li et al., 2016",journal,"Li Y, Li RC, Ye Q, Li C, Liu YP, Ma X, Li Y, Zhao H, Chen X, Assudani D, Karkada N, Han HH, Van Der Meeren O, Mesaros N","Safety, immunogenicity and persistence of immune response to the combined diphtheria, tetanus, acellular pertussis, poliovirus and Haemophilus influenzae type b conjugate vaccine (DTPa-IPV/Hib) administered in Chinese infants","2016","","","1-11",Human vaccines &amp; immunotherapeutics,,,,,,,,"27768515",,,0,10,0,0,0,,,
4037,99,"Gatson et al., 2016",journal,"Gatson NT, Weathers SP, de Groot JF",ReACT Phase II trial: a critical evaluation of the use of rindopepimut plus bevacizumab to treat EGFRvIII-positive recurrent glioblastoma,"2016","5","1","11-26",CNS oncology,,,,,,,,"26670466",,,0,10,0,0,0,,,
4038,99,"Zachariae et al., 1991",journal,"Zachariae H, Aslam HM, Bjerring P, Sgaard H, Zachariae E, Heickendorff L",Serum aminoterminal propeptide of type III procollagen in psoriasis and psoriatic arthritis: relation to liver fibrosis and arthritis,"1991","25","1 Pt 1","50-53",Journal of the American Academy of Dermatology,,,,,,,,"1880254",,,0,10,0,0,0,,,
4039,99,"Juric et al., 2010",journal,"Juric D, Mahovli V, Rajhvajn S, Ovanin-Raki A, Skopljanac-Macina L, Barisi A, Proji IS, Babi D, Susa M, Corusi A, Oreskovi S",Liquid-based cytology--new possibilities in the diagnosis of cervical lesions,"2010","34","1","19-24",Collegium antropologicum,,,,,,,,"20432728",,,0,10,0,0,0,,,
4040,99,"Carter and Plosker, 2008",journal,"Carter NJ, Plosker GL","Prepandemic influenza vaccine H5N1 (split virion, inactivated, adjuvanted) [Prepandrix]: a review of its use as an active immunization against influenza A subtype H5N1 virus","2008","22","5","279-292","BioDrugs : clinical immunotherapeutics, biopharmaceuticals and gene therapy",,,,,,,,"18778110",,,0,10,0,0,0,,,
4041,99,"Olivares et al., 2011",journal,"Olivares J, Kumar P, Yu Y, Maples PB, Senzer N, Bedell C, Barve M, Tong A, Pappen BO, Kuhn J, Magee M, Wallraven G, Nemunaitis J",Phase I trial of TGF-beta 2 antisense GM-CSF gene-modified autologous tumor cell (TAG) vaccine,"2011","17","1","183-192",Clinical cancer research : an official journal of the American Association for Cancer Research,,,,,,,,"21208907",,,0,10,0,0,0,,,
4042,99,"Rouxel et al., 2016",journal,"Rouxel RN, Mrour E, Biacchesi S, Brmont M",Complete Protection against Influenza Virus H1N1 Strain A/PR/8/34 Challenge in Mice Immunized with Non-Adjuvanted Novirhabdovirus Vaccines,"2016","11","10",e0164245,PloS one,,,,,,,,"27711176",,,0,10,0,0,0,,,
4043,99,"Ishizaki et al., 2006",journal,"Ishizaki H, Tsunoda T, Wada S, Yamauchi M, Shibuya M, Tahara H",Inhibition of tumor growth with antiangiogenic cancer vaccine using epitope peptides derived from human vascular endothelial growth factor receptor 1,"2006","12","19","5841-5849",Clinical cancer research : an official journal of the American Association for Cancer Research,,,,,,,,"17020992",,,0,10,0,0,0,,,
4044,99,"Derr et al., 2016",journal,"Derr L, Cesson V, Lucca I, Cerantola Y, Valerio M, Fritschi U, Vlamopoulos Y, Burruni R, Legris AS, Dartiguenave F, Gharbi D, Martin V, Vaucher L, Speiser DE, Romero P, Jichlinski P, Nardelli-Haefliger D",Intravesical Bacillus Calmette Guerin Combined with a Cancer Vaccine Increases Local T-Cell Responses in Non-muscle-Invasive Bladder Cancer Patients,"2016","","","",Clinical cancer research : an official journal of the American Association for Cancer Research,,,,,,,,"27521445",,,0,10,0,0,0,,,
4045,99,"Di et al., 2014",journal,"Di Y, Seymour L, Fisher K",Activity of a group B oncolytic adenovirus (ColoAd1) in whole human blood,"2014","21","4","440-443",Gene therapy,,,,,,,,"24553347",,,0,10,0,0,0,,,
4046,99,"Boczkowski et al., 2009",journal,"Boczkowski D, Lee J, Pruitt S, Nair S",Dendritic cells engineered to secrete anti-GITR antibodies are effective adjuvants to dendritic cell-based immunotherapy,"2009","16","12","900-911",Cancer gene therapy,,,,,,,,"19498460",,,0,10,0,0,0,,,
4047,99,NCIt: C48373,website,"",NCIt vaccine Alpha Fetoprotein Plasmid DNA Vaccine,"","","","","","","","","","","","","",https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=C48373,"",0,10,0,0,0,,,
4048,50,FDA: GSK H1N1,website,"",FDA: Influenza A (H1N1) 2009 Monovalent Vaccine (GlaxoSmithKline),"","","","","","","","","","","","","",https://www.fda.gov/downloads/BiologicsBloodVaccines/Vaccines/ApprovedProducts/UCM190377.pdf,"",0,10,0,0,0,,,
4049,50,FDA: H5N1 GSK,website,"","Influenza A (H5N1) Virus Monovalent Vaccine, Adjuvanted","","","","","","","","","","","","","",https://www.fda.gov/downloads/BiologicsBloodVaccines/SafetyAvailability/VaccineSafety/UCM376464.pdf,"",0,10,0,0,0,,,
4050,50,FDA: Afluria Quadrivalent,website,"",FDA: Afluria Quadrivalent vaccine information,"","","","","","","","","","","","","",https://www.fda.gov/downloads/BiologicsBloodVaccines/Vaccines/ApprovedProducts/UCM518295.pdf,"",0,10,0,0,0,,,
4051,50,FDA: Flublok,website,"",FDA: Flublok vaccine information,"","","","","","","","","","","","","",https://www.fda.gov/downloads/BiologicsBloodVaccines/Vaccines/ApprovedProducts/UCM336020.pdf,"",0,10,0,0,0,,,
4052,50,FDA: Flublok Quadrivalent,website,"",FDA: Flublok Quadrivalent vaccine information,"","","","","","","","","","","","","",https://www.fda.gov/downloads/BiologicsBloodVaccines/Vaccines/ApprovedProducts/UCM524684.pdf,"",0,10,0,0,0,,,
4053,50,FDA: Flucelvax,website,"",FDA: Flucelvax vaccine information,"","","","","","","","","","","","","",https://www.fda.gov/downloads/BiologicsBloodVaccines/Vaccines/ApprovedProducts/UCM329134.pdf,"",0,10,0,0,0,,,
4054,50,FDA: Flucelvax Quadrivalent,website,"",FDA: Flucelvax Quadrivalent vaccine information,"","","","","","","","","","","","","",https://www.fda.gov/downloads/BiologicsBloodVaccines/Vaccines/ApprovedProducts/UCM502899.pdf,"",0,10,0,0,0,,,
4055,50,FDA: Flulaval Quadrivalent,website,"",FDA: Flulaval Quadrivalent vaccine information,"","","","","","","","","","","","","",https://www.fda.gov/downloads/BiologicsBloodVaccines/Vaccines/ApprovedProducts/UCM404086.pdf,"",0,10,0,0,0,,,
4056,50,GSK: FluLaval Tetra,website,"",GSK: FluLaval Tetra vaccine information,"","","","","","","","","","","","","",http://ca.gsk.com/media/590283/flulaval-tetra.pdf,"",0,10,0,0,0,,,
4057,50,FDA: FluMist Quadrivalent,website,"",FDA: FluMist Quadrivalent vaccine information,"","","","","","","","","","","","","",https://www.fda.gov/downloads/BiologicsBloodVaccines/Vaccines/ApprovedProducts/UCM294307.pdf,"",0,10,0,0,0,,,
4058,50,FDA: Fluarix Quadrivalent,website,"",FDA: Fluarix Quadrivalent vaccine information,"","","","","","","","","","","","","",https://www.fda.gov/downloads/BiologicsBloodVaccines/Vaccines/ApprovedProducts/UCM220624.pdf,"",0,10,0,0,0,,,
4059,50,FDA: Fluzone Quadrivalent,website,"",FDA: Fluzone Quadrivalent vaccine information,"","","","","","","","","","","","","",https://www.fda.gov/downloads/BiologicsBloodVaccines/Vaccines/ApprovedProducts/UCM356094.pdf,"",0,10,0,0,0,,,
4060,50,FDA: Fluzone ID Quadrivalent,website,"",FDA: Fluzone Intradermal Quadrivalent vaccine information,"","","","","","","","","","","","","",https://www.fda.gov/downloads/BiologicsBloodVaccines/Vaccines/ApprovedProducts/UCM426679.pdf,"",0,10,0,0,0,,,
4061,50,FDA: Fluzone Quadrivalent SH,website,"",FDA: Fluzone Quadrivalent Southern Hemisphere formulation vaccine information,"","","","","","","","","","","","","",https://www.fda.gov/downloads/BiologicsBloodVaccines/Vaccines/ApprovedProducts/UCM513242.pdf,"",0,10,0,0,0,,,
4062,50,Mylan: Abbott Influvac,website,"",Mylan: Abbott Influvac vaccine information,"","","","","","","","","","","","","",http://www.mylan.ca/-/media/mylanca/documents/english/product%20pdf/influvac-pm-2016-06-01.pdf,"",0,10,0,0,0,,,
4063,102,Product Monograph: Dukoral,website,"",Product Monograph: Dukoral vaccine information,"","","","","","","","","","","","","",http://healthsensetravelclinic.ca/wp-content/uploads/dukoral.pdf,"",0,10,0,0,0,,,
4064,102,FDA: Vaxchora,website,"",FDA: Vaxchora vaccine information,"","","","","","","","","","","","","",https://www.fda.gov/downloads/BiologicsBloodVaccines/Vaccines/ApprovedProducts/UCM506235.pdf,"",0,10,0,0,0,,,
4065,104,Valneva: Dukoral,website,"",Valneava Dukoral vaccine information,"","","","","","","","","","","","","",http://healthsensetravelclinic.ca/wp-content/uploads/dukoral.pdf,,0,0,0,0,0,,,
4066,25,Product Monograph: Dukoral,website,"",Product Monograph: Dukoral vaccine information,"","","","","","","","","","","","","",http://healthsensetravelclinic.ca/wp-content/uploads/dukoral.pdf,,0,0,0,0,0,,,
4067,55,Product Monograph: Adacel-Polio,website,"",Product Monograph: Adacel-Polio vaccine information,"","","","","","","","","","","","","",https://www.vaccineshoppecanada.com/document.cfm?file=adacel-polio_e.pdf,"",0,10,0,0,0,,,
4068,62,Product Monograph: Adacel-Polio,website,"",Product Monograph: Adacel-Polio vaccine information,"","","","","","","","","","","","","",https://www.vaccineshoppecanada.com/document.cfm?file=adacel-polio_e.pdf,"",0,10,0,0,0,,,
4069,55,GSK: Boostrix-Polio,website,"",GSK: Boostrix-Polio vaccine information,"","","","","","","","","","","","","",https://ca.gsk.com/media/589683/boostrix-polio.pdf,"",0,10,0,0,0,,,
4070,62,GSK: Boostrix-Polio,website,"",GSK:Boostrix-Polio vaccine information,"","","","","","","","","","","","","",https://ca.gsk.com/media/589683/boostrix-polio.pdf,"",0,10,0,0,0,,,
4071,62,Product Monograph: Td Adsorbed,website,"",Product Monograph: Td Adsorbed vaccine information,"","","","","","","","","","","","","",https://www.vaccineshoppecanada.com/document.cfm?file=td_adsorbed_e.pdf,"",0,10,0,0,0,,,
4072,62,FDA: Tetanus and Diphtheria Toxoids Adsorbed,website,"",FDA: Tetanus and Diphtheria Toxoids Adsorbed vaccine information,"","","","","","","","","","","","","",https://www.fda.gov/downloads/BiologicsBloodVaccines/Vaccines/ApprovedProducts/UCM164127.pdf,"",0,10,0,0,0,,,
4073,62,Product Monograph: Td Polio Adsorbed,website,"",Product Monograph: Td Polio Adsorbed vaccine information,"","","","","","","","","","","","","",https://www.vaccineshoppecanada.com/document.cfm?file=td_polio_adsorbed_e.pdf,"",0,10,0,0,0,,,
4074,55,GSK: Infanrix-IPV,website,"",GSK: Infanrix-IPV vaccine information,"","","","","","","","","","","","","",http://ca.gsk.com/media/590851/infanrix-ipv.pdf,"",0,10,0,0,0,,,
4075,62,GSK: Infanrix-IPV,website,"",GSK: Infanrix-IPV vaccine information,"","","","","","","","","","","","","",http://ca.gsk.com/media/590851/infanrix-ipv.pdf,"",0,10,0,0,0,,,
4076,55,FDA: KINRIX,website,"",FDA: KINRIX vaccine information,"","","","","","","","","","","","","",https://www.fda.gov/downloads/BiologicsBloodVaccines/Vaccines/ApprovedProducts/UCM241453.pdf,"",0,10,0,0,0,,,
4077,55,FDA: Quadracel,website,"",FDA: Quadracel vaccine information,"","","","","","","","","","","","","",https://www.fda.gov/downloads/BiologicsBloodVaccines/Vaccines/ApprovedProducts/UCM439903.pdf,"",0,10,0,0,0,,,
4078,62,FDA: Quadracel,website,"",FDA: Quadracel vaccine information,"","","","","","","","","","","","","",https://www.fda.gov/downloads/BiologicsBloodVaccines/Vaccines/ApprovedProducts/UCM439903.pdf,"",0,10,0,0,0,,,
4079,55,GSK: Infanrix-IPV/Hib,website,"",GSK: Infanrix-IPV/Hib vaccine information,"","","","","","","","","","","","","",http://ca.gsk.com/media/590970/infanrix-ipv-hib.pdf,"",0,10,0,0,0,,,
4080,62,GSK: Infanrix-IPV/Hib,website,"",GSK: Infanrix-IPV/Hib vaccine information,"","","","","","","","","","","","","",http://ca.gsk.com/media/590970/infanrix-ipv-hib.pdf,"",0,10,0,0,0,,,
4081,62,Product Monograph: Pediacel,website,"",Product Monograph: Pediacel vaccine information,"","","","","","","","","","","","","",https://www.vaccineshoppecanada.com/document.cfm?file=Pediacel_E.pdf,"",0,10,0,0,0,,,
4082,55,Product Monograph: Pediacel,website,"",Product Monograph: Pediacel vaccine information,"","","","","","","","","","","","","",https://www.vaccineshoppecanada.com/document.cfm?file=Pediacel_E.pdf,"",0,10,0,0,0,,,
4083,62,GSK: Infanrix-hexa,website,"",GSK: Infanrix-hexa vaccine information,"","","","","","","","","","","","","",http://ca.gsk.com/media/537989/infanrix-hexa.pdf,"",0,10,0,0,0,,,
4084,55,GSK: Infanrix-hexa,website,"",GSK: Infanrix-hexa vaccine information,"","","","","","","","","","","","","",http://ca.gsk.com/media/537989/infanrix-hexa.pdf,"",0,10,0,0,0,,,
4085,31,FDA: ActHIB,website,"",FDA: ActHIB vaccine information,"","","","","","","","","","","","","",https://www.fda.gov/downloads/BiologicsBloodVaccines/Vaccines/ApprovedProducts/UCM109841.pdf,,0,0,0,0,0,,,
4086,31,FDA: Hiberix,website,"",FDA: Hiberix vaccine information,"","","","","","","","","","","","","",https://www.fda.gov/downloads/BiologicsBloodVaccines/Vaccines/ApprovedProducts/UCM179530.pdf,,0,0,0,0,0,,,
4087,31,GSK: Infanrix-IPV/Hib,website,"",GSK: Infanrix-IPV/Hib vaccine information,"","","","","","","","","","","","","",http://ca.gsk.com/media/590970/infanrix-ipv-hib.pdf,,0,0,0,0,0,,,
4088,31,GSK: Infanrix-hexa,website,"",GSK: Infanrix-hexa vaccine information,"","","","","","","","","","","","","",http://ca.gsk.com/media/537989/infanrix-hexa.pdf,,0,0,0,0,0,,,
4089,29,FDA: BCG Vaccine,website,"",FDA: BCG Vaccine vaccine information,"","","","","","","","","","","","","",https://www.fda.gov/downloads/BiologicsBloodVaccines/Vaccines/ApprovedProducts/UCM202934.pdf,,0,0,0,0,0,,,
4090,46,GSK: Menjugate,website,"",GSK: Menjugate vaccine information,"","","","","","","","","","","","","",https://ca.gsk.com/media/1213633/menjugate.pdf,"",0,10,0,0,0,,,
4091,46,Pfizer: NeisVac-C,website,"",Pfizer: NeisVac-C vaccine information,"","","","","","","","","","","","","",http://www.pfizer.ca/sites/g/files/g10017036/f/201505/NeisVac-C_PM_182023_31Mar2015_EN.pdf,"",0,10,0,0,0,,,
4092,46,FDA: BEXSERO,website,"",FDA: BEXSERO vaccine information,"","","","","","","","","","","","","",https://www.fda.gov/downloads/BiologicsBloodVaccines/Vaccines/ApprovedProducts/UCM431447.pdf,"",0,10,0,0,0,,,
4093,46,FDA: TRUMENBA,website,"",FDA: TRUMENBA vaccine information,"","","","","","","","","","","","","",https://www.fda.gov/downloads/BiologicsBloodVaccines/Vaccines/ApprovedProducts/UCM421139.pdf,"",0,10,0,0,0,,,
4094,46,Pfizer: NIMENRIX,website,"",Pfizer: NIMENRIX vaccine information,"","","","","","","","","","","","","",http://www.pfizer.ca/sites/g/files/g10028126/f/201604/Nimenrix_PM_184020_23Mar2016_E.pdf,"",0,10,0,0,0,,,
4095,109,Product Monograph: Adacel-Polio,website,"",Product Monograph: Adacel-Polio vaccine information,"","","","","","","","","","","","","",https://www.vaccineshoppecanada.com/document.cfm?file=adacel-polio_e.pdf,"",0,10,0,0,0,,,
4096,109,GSK: Boostrix-Polio,website,"",GSK: Boostrix-Polio vaccine information,"","","","","","","","","","","","","",https://ca.gsk.com/media/589683/boostrix-polio.pdf,"",0,10,0,0,0,,,
4097,109,GSK: Infanrix-IPV,website,"",GSK: Infanrix-IPV vaccine information,"","","","","","","","","","","","","",http://ca.gsk.com/media/590851/infanrix-ipv.pdf,"",0,10,0,0,0,,,
4098,109,FDA: KINRIX,website,"",FDA: KINRIX vaccine information,"","","","","","","","","","","","","",https://www.fda.gov/downloads/BiologicsBloodVaccines/Vaccines/ApprovedProducts/UCM241453.pdf,"",0,10,0,0,0,,,
4099,109,FDA: Quadracel,website,"",FDA: Quadracel vaccine information,"","","","","","","","","","","","","",https://www.fda.gov/downloads/BiologicsBloodVaccines/Vaccines/ApprovedProducts/UCM439903.pdf,"",0,10,0,0,0,,,
4100,109,GSK: Infanrix-IPV/Hib,website,"",GSK: Infanrix-IPV/Hib vaccine information,"","","","","","","","","","","","","",http://ca.gsk.com/media/590970/infanrix-ipv-hib.pdf,"",0,10,0,0,0,,,
4101,109,Product Monograph: Pediacel,website,"",Product Monograph: Pediacel vaccine information,"","","","","","","","","","","","","",https://www.vaccineshoppecanada.com/document.cfm?file=Pediacel_E.pdf,"",0,10,0,0,0,,,
4102,109,GSK: Infanrix-hexa,website,"",GSK: Infanrix-hexa vaccine information,"","","","","","","","","","","","","",http://ca.gsk.com/media/537989/infanrix-hexa.pdf,"",0,10,0,0,0,,,
4103,41,FDA: Tetanus and Diptheria Toxoids Adsorbed,website,"",FDA: Tetanus and Diphtheria Toxoids Adsorbed vaccine information,"","","","","","","","","","","","","",https://www.fda.gov/downloads/BiologicsBloodVaccines/Vaccines/ApprovedProducts/UCM164127.pdf,"",0,10,0,0,0,,,
4104,41,Product Monograph: Td Adsorbed,website,"",Product Monograph: Td Adsorbed vaccine information,"","","","","","","","","","","","","",https://www.vaccineshoppecanada.com/document.cfm?file=td_adsorbed_e.pdf,"",0,10,0,0,0,,,
4105,41,Product Monograph: Td Polio Adsorbed,website,"",Product Monograph: Td Polio Adsorbed vaccine information,"","","","","","","","","","","","","",https://www.vaccineshoppecanada.com/document.cfm?file=td_polio_adsorbed_e.pdf,"",0,10,0,0,0,,,
4106,41,Product Monograph: Adacel-Polio,website,"",Product Monograph: Adacel-Polio vaccine information,"","","","","","","","","","","","","",https://www.vaccineshoppecanada.com/document.cfm?file=adacel-polio_e.pdf,"",0,10,0,0,0,,,
4107,41,GSK: Boostrix-Polio,website,"",GSK: Boostrix-Polio vaccine information,"","","","","","","","","","","","","",https://ca.gsk.com/media/589683/boostrix-polio.pdf,"",0,10,0,0,0,,,
4108,41,GSK: Infanrix-IPV,website,"",GSK: Infanrix-IPV vaccine information,"","","","","","","","","","","","","",http://ca.gsk.com/media/590851/infanrix-ipv.pdf,"",0,10,0,0,0,,,
4109,41,FDA: Quadracel,website,"",FDA: Quadracel vaccine information,"","","","","","","","","","","","","",https://www.fda.gov/downloads/BiologicsBloodVaccines/Vaccines/ApprovedProducts/UCM439903.pdf,"",0,10,0,0,0,,,
4110,41,GSK: Infanrix-IPV/Hib,website,"",GSK: Infanrix-IPV/Hib vaccine information,"","","","","","","","","","","","","",http://ca.gsk.com/media/590970/infanrix-ipv-hib.pdf,"",0,10,0,0,0,,,
4111,41,GSK: Infanrix-hexa,website,"",GSK: Infanrix-hexa vaccine information,"","","","","","","","","","","","","",http://ca.gsk.com/media/537989/infanrix-hexa.pdf,"",0,10,0,0,0,,,
4112,41,Product Monograph: Pediacel,website,"",Product Monograph: Pediacel vaccine information,"","","","","","","","","","","","","",https://www.vaccineshoppecanada.com/document.cfm?file=Pediacel_E.pdf,"",0,10,0,0,0,,,
4113,48,Product Monograph: ViVaxim,website,"",Product Monograph: ViVaxim vaccine information,"","","","","","","","","","","","","",https://www.vaccineshoppecanada.com/document.cfm?file=vivaxim_e.pdf,,0,0,0,0,0,,,
4114,42,Product Monograph: ViVaxim,website,"",Product Monograph: ViVaxim vaccine information,"","","","","","","","","","","","","",https://www.vaccineshoppecanada.com/document.cfm?file=vivaxim_e.pdf,,0,0,0,0,0,,,
4115,42,GSK: Typherix,website,"",GSK: Typherix vaccine information,"","","","","","","","","","","","","",https://ca.gsk.com/media/592159/typherix.pdf,,0,0,0,0,0,,,
4116,99,NCIT_C117725,website,,,,,,,,,,,,,,,,https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=C117725,,0,10,0,0,0,,,
4117,99,NCIT_C121777,website,,,,,,,,,,,,,,,,https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=C121777,,0,10,0,0,0,,,
4118,99,NCIT_C91719,website,,,,,,,,,,,,,,,,https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=C91719,,0,10,0,0,0,,,
4119,99,NCIT_C2643,website,,,,,,,,,,,,,,,,https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=C2643,,0,10,0,0,0,,,
4120,99,NCIT_C2640,website,,,,,,,,,,,,,,,,https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=C2640,,0,10,0,0,0,,,
4121,99,NCIT_C2761,website,,,,,,,,,,,,,,,,https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=C2761,,0,10,0,0,0,,,
4122,99,NCIT_C2760,website,,,,,,,,,,,,,,,,https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=C2760,,0,10,0,0,0,,,
4123,99,NCIT_C2763,website,,,,,,,,,,,,,,,,https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=C2763,,0,10,0,0,0,,,
4124,99,NCIT_C2762,website,,,,,,,,,,,,,,,,https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=C2762,,0,10,0,0,0,,,
4125,99,NCIT_C2764,website,,,,,,,,,,,,,,,,https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=C2764,,0,10,0,0,0,,,
4126,99,NCIT_C2648,website,,,,,,,,,,,,,,,,https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=C2648,,0,10,0,0,0,,,
4127,99,NCIT_C2766,website,,,,,,,,,,,,,,,,https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=C2766,,0,10,0,0,0,,,
4128,99,NCIT_C11915,website,,,,,,,,,,,,,,,,https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=C11915,,0,10,0,0,0,,,
4129,99,NCIT_C123381,website,,,,,,,,,,,,,,,,https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=C123381,,0,10,0,0,0,,,
4130,99,NCIT_C114755,website,,,,,,,,,,,,,,,,https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=C114755,,0,10,0,0,0,,,
4131,99,NCIT_C2798,website,,,,,,,,,,,,,,,,https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=C2798,,0,10,0,0,0,,,
4132,99,NCIT_C101262,website,,,,,,,,,,,,,,,,https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=C101262,,0,10,0,0,0,,,
4133,99,NCIT_C95741,website,,,,,,,,,,,,,,,,https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=C95741,,0,10,0,0,0,,,
4134,99,NCIT_C95211,website,,,,,,,,,,,,,,,,https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=C95211,,0,10,0,0,0,,,
4135,99,NCIT_C95212,website,,,,,,,,,,,,,,,,https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=C95212,,0,10,0,0,0,,,
4136,99,NCIT_C95213,website,,,,,,,,,,,,,,,,https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=C95213,,0,10,0,0,0,,,
4137,99,NCIT_C53290,website,,,,,,,,,,,,,,,,https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=C53290,,0,10,0,0,0,,,
4138,99,NCIT_C29982,website,,,,,,,,,,,,,,,,https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=C29982,,0,10,0,0,0,,,
4139,99,NCIT_C71162,website,,,,,,,,,,,,,,,,https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=C71162,,0,10,0,0,0,,,
4140,99,NCIT_C116740,website,,,,,,,,,,,,,,,,https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=C116740,,0,10,0,0,0,,,
4141,99,NCIT_C90540,website,,,,,,,,,,,,,,,,https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=C90540,,0,10,0,0,0,,,
4142,99,NCIT_C88279,website,,,,,,,,,,,,,,,,https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=C88279,,0,10,0,0,0,,,
4143,99,NCIT_C29945,website,,,,,,,,,,,,,,,,https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=C29945,,0,10,0,0,0,,,
4144,99,NCIT_C121570,website,,,,,,,,,,,,,,,,https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=C121570,,0,10,0,0,0,,,
4145,99,NCIT_C124054,website,,,,,,,,,,,,,,,,https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=C124054,,0,10,0,0,0,,,
4146,99,NCIT_C112206,website,,,,,,,,,,,,,,,,https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=C112206,,0,10,0,0,0,,,
4147,99,NCIT_C28682,website,,,,,,,,,,,,,,,,https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=C28682,,0,10,0,0,0,,,
4148,99,NCIT_C61077,website,,,,,,,,,,,,,,,,https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=C61077,,0,10,0,0,0,,,
4149,99,NCIT_C61076,website,,,,,,,,,,,,,,,,https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=C61076,,0,10,0,0,0,,,
4150,99,NCIT_C78861,website,,,,,,,,,,,,,,,,https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=C78861,,0,10,0,0,0,,,
4151,99,NCIT_C61073,website,,,,,,,,,,,,,,,,https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=C61073,,0,10,0,0,0,,,
4152,99,NCIT_C28330,website,,,,,,,,,,,,,,,,https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=C28330,,0,10,0,0,0,,,
4153,99,NCIT_C71533,website,,,,,,,,,,,,,,,,https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=C71533,,0,10,0,0,0,,,
4154,99,NCIT_C48411,website,,,,,,,,,,,,,,,,https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=C48411,,0,10,0,0,0,,,
4155,99,NCIT_C48412,website,,,,,,,,,,,,,,,,https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=C48412,,0,10,0,0,0,,,
4156,99,NCIT_C48414,website,,,,,,,,,,,,,,,,https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=C48414,,0,10,0,0,0,,,
4157,99,NCIT_C96393,website,,,,,,,,,,,,,,,,https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=C96393,,0,10,0,0,0,,,
4158,99,NCIT_C90572,website,,,,,,,,,,,,,,,,https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=C90572,,0,10,0,0,0,,,
4159,99,NCIT_C104419,website,,,,,,,,,,,,,,,,https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=C104419,,0,10,0,0,0,,,
4160,99,NCIT_C90570,website,,,,,,,,,,,,,,,,https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=C90570,,0,10,0,0,0,,,
4161,99,NCIT_C90571,website,,,,,,,,,,,,,,,,https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=C90571,,0,10,0,0,0,,,
4162,99,NCIT_C11845,website,,,,,,,,,,,,,,,,https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=C11845,,0,10,0,0,0,,,
4163,99,NCIT_C2767,website,,,,,,,,,,,,,,,,https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=C2767,,0,10,0,0,0,,,
4164,99,NCIT_C79799,website,,,,,,,,,,,,,,,,https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=C79799,,0,10,0,0,0,,,
4165,99,NCIT_C96397,website,,,,,,,,,,,,,,,,https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=C96397,,0,10,0,0,0,,,
4166,99,NCIT_C2501,website,,,,,,,,,,,,,,,,https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=C2501,,0,10,0,0,0,,,
4167,99,NCIT_C120129,website,,,,,,,,,,,,,,,,https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=C120129,,0,10,0,0,0,,,
4168,99,NCIT_C74000,website,,,,,,,,,,,,,,,,https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=C74000,,0,10,0,0,0,,,
4169,99,NCIT_C49275,website,,,,,,,,,,,,,,,,https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=C49275,,0,10,0,0,0,,,
4170,99,NCIT_C70985,website,,,,,,,,,,,,,,,,https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=C70985,,0,10,0,0,0,,,
4171,99,NCIT_C85462,website,,,,,,,,,,,,,,,,https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=C85462,,0,10,0,0,0,,,
4172,99,NCIT_C85463,website,,,,,,,,,,,,,,,,https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=C85463,,0,10,0,0,0,,,
4173,99,NCIT_C2464,website,,,,,,,,,,,,,,,,https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=C2464,,0,10,0,0,0,,,
4174,99,NCIT_C2465,website,,,,,,,,,,,,,,,,https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=C2465,,0,10,0,0,0,,,
4175,99,NCIT_C85466,website,,,,,,,,,,,,,,,,https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=C85466,,0,10,0,0,0,,,
4176,99,NCIT_C85464,website,,,,,,,,,,,,,,,,https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=C85464,,0,10,0,0,0,,,
4177,99,NCIT_C113794,website,,,,,,,,,,,,,,,,https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=C113794,,0,10,0,0,0,,,
4178,99,NCIT_C91373,website,,,,,,,,,,,,,,,,https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=C91373,,0,10,0,0,0,,,
4179,99,NCIT_C96041,website,,,,,,,,,,,,,,,,https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=C96041,,0,10,0,0,0,,,
4180,99,NCIT_C96042,website,,,,,,,,,,,,,,,,https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=C96042,,0,10,0,0,0,,,
4181,99,NCIT_C91377,website,,,,,,,,,,,,,,,,https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=C91377,,0,10,0,0,0,,,
4182,99,NCIT_C38587,website,,,,,,,,,,,,,,,,https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=C38587,,0,10,0,0,0,,,
4183,99,NCIT_C91379,website,,,,,,,,,,,,,,,,https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=C91379,,0,10,0,0,0,,,
4184,99,NCIT_C91378,website,,,,,,,,,,,,,,,,https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=C91378,,0,10,0,0,0,,,
4185,99,NCIT_C53443,website,,,,,,,,,,,,,,,,https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=C53443,,0,10,0,0,0,,,
4186,99,NCIT_C61088,website,,,,,,,,,,,,,,,,https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=C61088,,0,10,0,0,0,,,
4187,99,NCIT_C38124,website,,,,,,,,,,,,,,,,https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=C38124,,0,10,0,0,0,,,
4188,99,NCIT_C38123,website,,,,,,,,,,,,,,,,https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=C38123,,0,10,0,0,0,,,
4189,99,NCIT_C38122,website,,,,,,,,,,,,,,,,https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=C38122,,0,10,0,0,0,,,
4190,99,NCIT_C38121,website,,,,,,,,,,,,,,,,https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=C38121,,0,10,0,0,0,,,
4191,99,NCIT_C61082,website,,,,,,,,,,,,,,,,https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=C61082,,0,10,0,0,0,,,
4192,99,NCIT_C113647,website,,,,,,,,,,,,,,,,https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=C113647,,0,10,0,0,0,,,
4193,99,NCIT_C61087,website,,,,,,,,,,,,,,,,https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=C61087,,0,10,0,0,0,,,
4194,99,NCIT_C77878,website,,,,,,,,,,,,,,,,https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=C77878,,0,10,0,0,0,,,
4195,99,NCIT_C28860,website,,,,,,,,,,,,,,,,https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=C28860,,0,10,0,0,0,,,
4196,99,NCIT_C77874,website,,,,,,,,,,,,,,,,https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=C77874,,0,10,0,0,0,,,
4197,99,NCIT_C97666,website,,,,,,,,,,,,,,,,https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=C97666,,0,10,0,0,0,,,
4198,99,NCIT_C97665,website,,,,,,,,,,,,,,,,https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=C97665,,0,10,0,0,0,,,
4199,99,NCIT_C77877,website,,,,,,,,,,,,,,,,https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=C77877,,0,10,0,0,0,,,
4200,99,NCIT_C104738,website,,,,,,,,,,,,,,,,https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=C104738,,0,10,0,0,0,,,
4201,99,NCIT_C74090,website,,,,,,,,,,,,,,,,https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=C74090,,0,10,0,0,0,,,
4202,99,NCIT_C61327,website,,,,,,,,,,,,,,,,https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=C61327,,0,10,0,0,0,,,
4203,99,NCIT_C2214,website,,,,,,,,,,,,,,,,https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=C2214,,0,10,0,0,0,,,
4204,99,NCIT_C2606,website,,,,,,,,,,,,,,,,https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=C2606,,0,10,0,0,0,,,
4205,99,NCIT_C104734,website,,,,,,,,,,,,,,,,https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=C104734,,0,10,0,0,0,,,
4206,99,NCIT_C104737,website,,,,,,,,,,,,,,,,https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=C104737,,0,10,0,0,0,,,
4207,99,NCIT_C92573,website,,,,,,,,,,,,,,,,https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=C92573,,0,10,0,0,0,,,
4208,99,NCIT_C61495,website,,,,,,,,,,,,,,,,https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=C61495,,0,10,0,0,0,,,
4209,99,NCIT_C88326,website,,,,,,,,,,,,,,,,https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=C88326,,0,10,0,0,0,,,
4210,99,NCIT_C114293,website,,,,,,,,,,,,,,,,https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=C114293,,0,10,0,0,0,,,
4211,99,NCIT_C29187,website,,,,,,,,,,,,,,,,https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=C29187,,0,10,0,0,0,,,
4212,99,NCIT_C82352,website,,,,,,,,,,,,,,,,https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=C82352,,0,10,0,0,0,,,
4213,99,NCIT_C2781,website,,,,,,,,,,,,,,,,https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=C2781,,0,10,0,0,0,,,
4214,99,NCIT_C91710,website,,,,,,,,,,,,,,,,https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=C91710,,0,10,0,0,0,,,
4215,99,NCIT_C2732,website,,,,,,,,,,,,,,,,https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=C2732,,0,10,0,0,0,,,
4216,99,NCIT_C97122,website,,,,,,,,,,,,,,,,https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=C97122,,0,10,0,0,0,,,
4217,99,NCIT_C91717,website,,,,,,,,,,,,,,,,https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=C91717,,0,10,0,0,0,,,
4218,99,NCIT_C91716,website,,,,,,,,,,,,,,,,https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=C91716,,0,10,0,0,0,,,
4219,99,NCIT_C78448,website,,,,,,,,,,,,,,,,https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=C78448,,0,10,0,0,0,,,
4220,99,NCIT_C91718,website,,,,,,,,,,,,,,,,https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=C91718,,0,10,0,0,0,,,
4221,99,NCIT_C48816,website,,,,,,,,,,,,,,,,https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=C48816,,0,10,0,0,0,,,
4222,99,NCIT_C71758,website,,,,,,,,,,,,,,,,https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=C71758,,0,10,0,0,0,,,
4223,99,NCIT_C67082,website,,,,,,,,,,,,,,,,https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=C67082,,0,10,0,0,0,,,
4224,99,NCIT_C49290,website,,,,,,,,,,,,,,,,https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=C49290,,0,10,0,0,0,,,
4225,99,NCIT_C67086,website,,,,,,,,,,,,,,,,https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=C67086,,0,10,0,0,0,,,
4226,99,NCIT_C67089,website,,,,,,,,,,,,,,,,https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=C67089,,0,10,0,0,0,,,
4227,99,NCIT_C111991,website,,,,,,,,,,,,,,,,https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=C111991,,0,10,0,0,0,,,
4228,99,NCIT_C121640,website,,,,,,,,,,,,,,,,https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=C121640,,0,10,0,0,0,,,
4229,99,NCIT_C111998,website,,,,,,,,,,,,,,,,https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=C111998,,0,10,0,0,0,,,
4230,99,NCIT_C38761,website,,,,,,,,,,,,,,,,https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=C38761,,0,10,0,0,0,,,
4231,99,NCIT_C117235,website,,,,,,,,,,,,,,,,https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=C117235,,0,10,0,0,0,,,
4232,99,NCIT_C121947,website,,,,,,,,,,,,,,,,https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=C121947,,0,10,0,0,0,,,
4233,99,NCIT_C99228,website,,,,,,,,,,,,,,,,https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=C99228,,0,10,0,0,0,,,
4234,99,NCIT_C29334,website,,,,,,,,,,,,,,,,https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=C29334,,0,10,0,0,0,,,
4235,99,NCIT_C37448,website,,,,,,,,,,,,,,,,https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=C37448,,0,10,0,0,0,,,
4236,99,NCIT_C67085,website,,,,,,,,,,,,,,,,https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=C67085,,0,10,0,0,0,,,
4237,99,NCIT_C29338,website,,,,,,,,,,,,,,,,https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=C29338,,0,10,0,0,0,,,
4238,99,NCIT_C2237,website,,,,,,,,,,,,,,,,https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=C2237,,0,10,0,0,0,,,
4239,99,NCIT_C82675,website,,,,,,,,,,,,,,,,https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=C82675,,0,10,0,0,0,,,
4240,99,NCIT_C74070,website,,,,,,,,,,,,,,,,https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=C74070,,0,10,0,0,0,,,
4241,99,NCIT_C113807,website,,,,,,,,,,,,,,,,https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=C113807,,0,10,0,0,0,,,
4242,99,NCIT_C118851,website,,,,,,,,,,,,,,,,https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=C118851,,0,10,0,0,0,,,
4243,99,NCIT_C118852,website,,,,,,,,,,,,,,,,https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=C118852,,0,10,0,0,0,,,
4244,99,NCIT_C68839,website,,,,,,,,,,,,,,,,https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=C68839,,0,10,0,0,0,,,
4245,99,NCIT_C2423,website,,,,,,,,,,,,,,,,https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=C2423,,0,10,0,0,0,,,
4246,99,NCIT_C2426,website,,,,,,,,,,,,,,,,https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=C2426,,0,10,0,0,0,,,
4247,99,NCIT_C2424,website,,,,,,,,,,,,,,,,https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=C2424,,0,10,0,0,0,,,
4248,99,NCIT_C38119,website,,,,,,,,,,,,,,,,https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=C38119,,0,10,0,0,0,,,
4249,99,NCIT_C38117,website,,,,,,,,,,,,,,,,https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=C38117,,0,10,0,0,0,,,
4250,99,NCIT_C2428,website,,,,,,,,,,,,,,,,https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=C2428,,0,10,0,0,0,,,
4251,99,NCIT_C116321,website,,,,,,,,,,,,,,,,https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=C116321,,0,10,0,0,0,,,
4252,99,NCIT_C2816,website,,,,,,,,,,,,,,,,https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=C2816,,0,10,0,0,0,,,
4253,99,NCIT_C2815,website,,,,,,,,,,,,,,,,https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=C2815,,0,10,0,0,0,,,
4254,99,NCIT_C2814,website,,,,,,,,,,,,,,,,https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=C2814,,0,10,0,0,0,,,
4255,99,NCIT_C1455,website,,,,,,,,,,,,,,,,https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=C1455,,0,10,0,0,0,,,
4256,99,NCIT_C101777,website,,,,,,,,,,,,,,,,https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=C101777,,0,10,0,0,0,,,
4257,99,NCIT_C48376,website,,,,,,,,,,,,,,,,https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=C48376,,0,10,0,0,0,,,
4258,99,NCIT_C77910,website,,,,,,,,,,,,,,,,https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=C77910,,0,10,0,0,0,,,
4259,99,NCIT_C85452,website,,,,,,,,,,,,,,,,https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=C85452,,0,10,0,0,0,,,
4260,99,NCIT_C28878,website,,,,,,,,,,,,,,,,https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=C28878,,0,10,0,0,0,,,
4261,99,NCIT_C111900,website,,,,,,,,,,,,,,,,https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=C111900,,0,10,0,0,0,,,
4262,99,NCIT_C111903,website,,,,,,,,,,,,,,,,https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=C111903,,0,10,0,0,0,,,
4263,99,NCIT_C64773,website,,,,,,,,,,,,,,,,https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=C64773,,0,10,0,0,0,,,
4264,99,NCIT_C78830,website,,,,,,,,,,,,,,,,https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=C78830,,0,10,0,0,0,,,
4265,99,NCIT_C125692,website,,,,,,,,,,,,,,,,https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=C125692,,0,10,0,0,0,,,
4266,99,NCIT_C26450,website,,,,,,,,,,,,,,,,https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=C26450,,0,10,0,0,0,,,
4267,99,NCIT_C85451,website,,,,,,,,,,,,,,,,https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=C85451,,0,10,0,0,0,,,
4268,99,NCIT_C74057,website,,,,,,,,,,,,,,,,https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=C74057,,0,10,0,0,0,,,
4269,99,NCIT_C74056,website,,,,,,,,,,,,,,,,https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=C74056,,0,10,0,0,0,,,
4270,99,NCIT_C73438,website,,,,,,,,,,,,,,,,https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=C73438,,0,10,0,0,0,,,
4271,99,NCIT_C28780,website,,,,,,,,,,,,,,,,https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=C28780,,0,10,0,0,0,,,
4272,99,NCIT_C120118,website,,,,,,,,,,,,,,,,https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=C120118,,0,10,0,0,0,,,
4273,99,NCIT_C2497,website,,,,,,,,,,,,,,,,https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=C2497,,0,10,0,0,0,,,
4274,99,NCIT_C49087,website,,,,,,,,,,,,,,,,https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=C49087,,0,10,0,0,0,,,
4275,99,NCIT_C113296,website,,,,,,,,,,,,,,,,https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=C113296,,0,10,0,0,0,,,
4276,99,NCIT_C2492,website,,,,,,,,,,,,,,,,https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=C2492,,0,10,0,0,0,,,
4277,99,NCIT_C49082,website,,,,,,,,,,,,,,,,https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=C49082,,0,10,0,0,0,,,
4278,99,NCIT_C116848,website,,,,,,,,,,,,,,,,https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=C116848,,0,10,0,0,0,,,
4279,99,NCIT_C114380,website,,,,,,,,,,,,,,,,https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=C114380,,0,10,0,0,0,,,
4280,99,NCIT_C114385,website,,,,,,,,,,,,,,,,https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=C114385,,0,10,0,0,0,,,
4281,99,NCIT_C77900,website,,,,,,,,,,,,,,,,https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=C77900,,0,10,0,0,0,,,
4282,99,NCIT_C121544,website,,,,,,,,,,,,,,,,https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=C121544,,0,10,0,0,0,,,
4283,99,NCIT_C77907,website,,,,,,,,,,,,,,,,https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=C77907,,0,10,0,0,0,,,
4284,99,NCIT_C79832,website,,,,,,,,,,,,,,,,https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=C79832,,0,10,0,0,0,,,
4285,99,NCIT_C74015,website,,,,,,,,,,,,,,,,https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=C74015,,0,10,0,0,0,,,
4286,99,NCIT_C2675,website,,,,,,,,,,,,,,,,https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=C2675,,0,10,0,0,0,,,
4287,99,NCIT_C2674,website,,,,,,,,,,,,,,,,https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=C2674,,0,10,0,0,0,,,
4288,99,NCIT_C2772,website,,,,,,,,,,,,,,,,https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=C2772,,0,10,0,0,0,,,
4289,99,NCIT_C2773,website,,,,,,,,,,,,,,,,https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=C2773,,0,10,0,0,0,,,
4290,99,NCIT_C2771,website,,,,,,,,,,,,,,,,https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=C2771,,0,10,0,0,0,,,
4291,99,NCIT_C2776,website,,,,,,,,,,,,,,,,https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=C2776,,0,10,0,0,0,,,
4292,99,NCIT_C2774,website,,,,,,,,,,,,,,,,https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=C2774,,0,10,0,0,0,,,
4293,99,NCIT_C2775,website,,,,,,,,,,,,,,,,https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=C2775,,0,10,0,0,0,,,
4294,99,NCIT_C100099,website,,,,,,,,,,,,,,,,https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=C100099,,0,10,0,0,0,,,
4295,99,NCIT_C70968,website,,,,,,,,,,,,,,,,https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=C70968,,0,10,0,0,0,,,
4296,99,NCIT_C71741,website,,,,,,,,,,,,,,,,https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=C71741,,0,10,0,0,0,,,
4297,99,NCIT_C95751,website,,,,,,,,,,,,,,,,https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=C95751,,0,10,0,0,0,,,
4298,99,NCIT_C95759,website,,,,,,,,,,,,,,,,https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=C95759,,0,10,0,0,0,,,
4299,99,NCIT_C29065,website,,,,,,,,,,,,,,,,https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=C29065,,0,10,0,0,0,,,
4300,99,NCIT_C64846,website,,,,,,,,,,,,,,,,https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=C64846,,0,10,0,0,0,,,
4301,99,NCIT_C29476,website,,,,,,,,,,,,,,,,https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=C29476,,0,10,0,0,0,,,
4302,99,NCIT_C71760,website,,,,,,,,,,,,,,,,https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=C71760,,0,10,0,0,0,,,
4303,99,NCIT_C71761,website,,,,,,,,,,,,,,,,https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=C71761,,0,10,0,0,0,,,
4304,99,NCIT_C2807,website,,,,,,,,,,,,,,,,https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=C2807,,0,10,0,0,0,,,
4305,99,NCIT_C111036,website,,,,,,,,,,,,,,,,https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=C111036,,0,10,0,0,0,,,
4306,99,NCIT_C84844,website,,,,,,,,,,,,,,,,https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=C84844,,0,10,0,0,0,,,
4307,99,NCIT_C96519,website,,,,,,,,,,,,,,,,https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=C96519,,0,10,0,0,0,,,
4308,99,NCIT_C88320,website,,,,,,,,,,,,,,,,https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=C88320,,0,10,0,0,0,,,
4309,99,NCIT_C88289,website,,,,,,,,,,,,,,,,https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=C88289,,0,10,0,0,0,,,
4310,99,NCIT_C88288,website,,,,,,,,,,,,,,,,https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=C88288,,0,10,0,0,0,,,
4311,99,NCIT_C90569,website,,,,,,,,,,,,,,,,https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=C90569,,0,10,0,0,0,,,
4312,99,NCIT_C123923,website,,,,,,,,,,,,,,,,https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=C123923,,0,10,0,0,0,,,
4313,99,NCIT_C78862,website,,,,,,,,,,,,,,,,https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=C78862,,0,10,0,0,0,,,
4314,99,NCIT_C90560,website,,,,,,,,,,,,,,,,https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=C90560,,0,10,0,0,0,,,
4315,99,NCIT_C64635,website,,,,,,,,,,,,,,,,https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=C64635,,0,10,0,0,0,,,
4316,99,NCIT_C116879,website,,,,,,,,,,,,,,,,https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=C116879,,0,10,0,0,0,,,
4317,99,NCIT_C29558,website,,,,,,,,,,,,,,,,https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=C29558,,0,10,0,0,0,,,
4318,99,NCIT_C116777,website,,,,,,,,,,,,,,,,https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=C116777,,0,10,0,0,0,,,
4319,99,NCIT_C28810,website,,,,,,,,,,,,,,,,https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=C28810,,0,10,0,0,0,,,
4320,99,NCIT_C48368,website,,,,,,,,,,,,,,,,https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=C48368,,0,10,0,0,0,,,
4321,99,NCIT_C2512,website,,,,,,,,,,,,,,,,https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=C2512,,0,10,0,0,0,,,
4322,99,NCIT_C62756,website,,,,,,,,,,,,,,,,https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=C62756,,0,10,0,0,0,,,
4323,99,NCIT_C2510,website,,,,,,,,,,,,,,,,https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=C2510,,0,10,0,0,0,,,
4324,99,NCIT_C119617,website,,,,,,,,,,,,,,,,https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=C119617,,0,10,0,0,0,,,
4325,99,NCIT_C28784,website,,,,,,,,,,,,,,,,https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=C28784,,0,10,0,0,0,,,
4326,99,NCIT_C74016,website,,,,,,,,,,,,,,,,https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=C74016,,0,10,0,0,0,,,
4327,99,NCIT_C62452,website,,,,,,,,,,,,,,,,https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=C62452,,0,10,0,0,0,,,
4328,99,NCIT_C85479,website,,,,,,,,,,,,,,,,https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=C85479,,0,10,0,0,0,,,
4329,99,NCIT_C29068,website,,,,,,,,,,,,,,,,https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=C29068,,0,10,0,0,0,,,
4330,99,NCIT_C85470,website,,,,,,,,,,,,,,,,https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=C85470,,0,10,0,0,0,,,
4331,99,NCIT_C49042,website,,,,,,,,,,,,,,,,https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=C49042,,0,10,0,0,0,,,
4332,99,NCIT_C113786,website,,,,,,,,,,,,,,,,https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=C113786,,0,10,0,0,0,,,
4333,99,NCIT_C123918,website,,,,,,,,,,,,,,,,https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=C123918,,0,10,0,0,0,,,
4334,99,NCIT_C123919,website,,,,,,,,,,,,,,,,https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=C123919,,0,10,0,0,0,,,
4335,99,NCIT_C61098,website,,,,,,,,,,,,,,,,https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=C61098,,0,10,0,0,0,,,
4336,99,NCIT_C113653,website,,,,,,,,,,,,,,,,https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=C113653,,0,10,0,0,0,,,
4337,99,NCIT_C113651,website,,,,,,,,,,,,,,,,https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=C113651,,0,10,0,0,0,,,
4338,99,NCIT_C113432,website,,,,,,,,,,,,,,,,https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=C113432,,0,10,0,0,0,,,
4339,99,NCIT_C112005,website,,,,,,,,,,,,,,,,https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=C112005,,0,10,0,0,0,,,
4340,99,NCIT_C74066,website,,,,,,,,,,,,,,,,https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=C74066,,0,10,0,0,0,,,
4341,99,NCIT_C2204,website,,,,,,,,,,,,,,,,https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=C2204,,0,10,0,0,0,,,
4342,99,NCIT_C62527,website,,,,,,,,,,,,,,,,https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=C62527,,0,10,0,0,0,,,
4343,99,NCIT_C48418,website,,,,,,,,,,,,,,,,https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=C48418,,0,10,0,0,0,,,
4344,99,NCIT_C82361,website,,,,,,,,,,,,,,,,https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=C82361,,0,10,0,0,0,,,
4345,99,NCIT_C48419,website,,,,,,,,,,,,,,,,https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=C48419,,0,10,0,0,0,,,
4346,99,NCIT_C82416,website,,,,,,,,,,,,,,,,https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=C82416,,0,10,0,0,0,,,
4347,99,NCIT_C29786,website,,,,,,,,,,,,,,,,https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=C29786,,0,10,0,0,0,,,
4348,99,NCIT_C2680,website,,,,,,,,,,,,,,,,https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=C2680,,0,10,0,0,0,,,
4349,99,NCIT_C2686,website,,,,,,,,,,,,,,,,https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=C2686,,0,10,0,0,0,,,
4350,99,NCIT_C28877,website,,,,,,,,,,,,,,,,https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=C28877,,0,10,0,0,0,,,
4351,99,NCIT_C84854,website,,,,,,,,,,,,,,,,https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=C84854,,0,10,0,0,0,,,
4352,99,NCIT_C96737,website,,,,,,,,,,,,,,,,https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=C96737,,0,10,0,0,0,,,
4353,99,NCIT_C96738,website,,,,,,,,,,,,,,,,https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=C96738,,0,10,0,0,0,,,
4354,99,NCIT_C78865,website,,,,,,,,,,,,,,,,https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=C78865,,0,10,0,0,0,,,
4355,99,NCIT_C48410,website,,,,,,,,,,,,,,,,https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=C48410,,0,10,0,0,0,,,
4356,99,NCIT_C2709,website,,,,,,,,,,,,,,,,https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=C2709,,0,10,0,0,0,,,
4357,99,NCIT_C30000,website,,,,,,,,,,,,,,,,https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=C30000,,0,10,0,0,0,,,
4358,99,NCIT_C77895,website,,,,,,,,,,,,,,,,https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=C77895,,0,10,0,0,0,,,
4359,99,NCIT_C73999,website,,,,,,,,,,,,,,,,https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=C73999,,0,10,0,0,0,,,
4360,99,NCIT_C2339,website,,,,,,,,,,,,,,,,https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=C2339,,0,10,0,0,0,,,
4361,99,NCIT_C67098,website,,,,,,,,,,,,,,,,https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=C67098,,0,10,0,0,0,,,
4362,99,NCIT_C73997,website,,,,,,,,,,,,,,,,https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=C73997,,0,10,0,0,0,,,
4363,99,NCIT_C73995,website,,,,,,,,,,,,,,,,https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=C73995,,0,10,0,0,0,,,
4364,99,NCIT_C29086,website,,,,,,,,,,,,,,,,https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=C29086,,0,10,0,0,0,,,
4365,99,NCIT_C77863,website,,,,,,,,,,,,,,,,https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=C77863,,0,10,0,0,0,,,
4366,99,NCIT_C61434,website,,,,,,,,,,,,,,,,https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=C61434,,0,10,0,0,0,,,
4367,99,NCIT_C77869,website,,,,,,,,,,,,,,,,https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=C77869,,0,10,0,0,0,,,
4368,99,NCIT_C28550,website,,,,,,,,,,,,,,,,https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=C28550,,0,10,0,0,0,,,
4369,99,NCIT_C26681,website,,,,,,,,,,,,,,,,https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=C26681,,0,10,0,0,0,,,
4370,99,NCIT_C26680,website,,,,,,,,,,,,,,,,https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=C26680,,0,10,0,0,0,,,
4371,99,NCIT_C1126,website,,,,,,,,,,,,,,,,https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=C1126,,0,10,0,0,0,,,
4372,99,NCIT_C102541,website,,,,,,,,,,,,,,,,https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=C102541,,0,10,0,0,0,,,
4373,99,NCIT_C95722,website,,,,,,,,,,,,,,,,https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=C95722,,0,10,0,0,0,,,
4374,99,NCIT_C1690,website,,,,,,,,,,,,,,,,https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=C1690,,0,10,0,0,0,,,
4375,99,NCIT_C95727,website,,,,,,,,,,,,,,,,https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=C95727,,0,10,0,0,0,,,
4376,99,NCIT_C2783,website,,,,,,,,,,,,,,,,https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=C2783,,0,10,0,0,0,,,
4377,99,NCIT_C66985,website,,,,,,,,,,,,,,,,https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=C66985,,0,10,0,0,0,,,
4378,99,NCIT_C2023,website,,,,,,,,,,,,,,,,https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=C2023,,0,10,0,0,0,,,
4379,99,NCIT_C82661,website,,,,,,,,,,,,,,,,https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=C82661,,0,10,0,0,0,,,
4380,99,NCIT_C106242,website,,,,,,,,,,,,,,,,https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=C106242,,0,10,0,0,0,,,
4381,99,NCIT_C98287,website,,,,,,,,,,,,,,,,https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=C98287,,0,10,0,0,0,,,
4382,99,NCIT_C125631,website,,,,,,,,,,,,,,,,https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=C125631,,0,10,0,0,0,,,
4383,99,NCIT_C2419,website,,,,,,,,,,,,,,,,https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=C2419,,0,10,0,0,0,,,
4384,99,NCIT_C51978,website,,,,,,,,,,,,,,,,https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=C51978,,0,10,0,0,0,,,
4385,99,NCIT_C116332,website,,,,,,,,,,,,,,,,https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=C116332,,0,10,0,0,0,,,
4386,99,NCIT_C116331,website,,,,,,,,,,,,,,,,https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=C116331,,0,10,0,0,0,,,
4387,99,NCIT_C96398,website,,,,,,,,,,,,,,,,https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=C96398,,0,10,0,0,0,,,
4388,99,NCIT_C96399,website,,,,,,,,,,,,,,,,https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=C96399,,0,10,0,0,0,,,
4389,99,NCIT_C96391,website,,,,,,,,,,,,,,,,https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=C96391,,0,10,0,0,0,,,
4390,99,NCIT_C96392,website,,,,,,,,,,,,,,,,https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=C96392,,0,10,0,0,0,,,
4391,99,NCIT_C28503,website,,,,,,,,,,,,,,,,https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=C28503,,0,10,0,0,0,,,
4392,99,NCIT_C74064,website,,,,,,,,,,,,,,,,https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=C74064,,0,10,0,0,0,,,
4393,99,NCIT_C70674,website,,,,,,,,,,,,,,,,https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=C70674,,0,10,0,0,0,,,
4394,99,NCIT_C90592,website,,,,,,,,,,,,,,,,https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=C90592,,0,10,0,0,0,,,
4395,99,NCIT_C84755,website,,,,,,,,,,,,,,,,https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=C84755,,0,10,0,0,0,,,
4396,99,NCIT_C64785,website,,,,,,,,,,,,,,,,https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=C64785,,0,10,0,0,0,,,
4397,99,NCIT_C26446,website,,,,,,,,,,,,,,,,https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=C26446,,0,10,0,0,0,,,
4398,99,NCIT_C26445,website,,,,,,,,,,,,,,,,https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=C26445,,0,10,0,0,0,,,
4399,99,NCIT_C26444,website,,,,,,,,,,,,,,,,https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=C26444,,0,10,0,0,0,,,
4400,99,NCIT_C69076,website,,,,,,,,,,,,,,,,https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=C69076,,0,10,0,0,0,,,
4401,99,NCIT_C26449,website,,,,,,,,,,,,,,,,https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=C26449,,0,10,0,0,0,,,
4402,99,NCIT_C74023,website,,,,,,,,,,,,,,,,https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=C74023,,0,10,0,0,0,,,
4403,99,NCIT_C2241,website,,,,,,,,,,,,,,,,https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=C2241,,0,10,0,0,0,,,
4404,99,NCIT_C85445,website,,,,,,,,,,,,,,,,https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=C85445,,0,10,0,0,0,,,
4405,99,NCIT_C2569,website,,,,,,,,,,,,,,,,https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=C2569,,0,10,0,0,0,,,
4406,99,NCIT_C2485,website,,,,,,,,,,,,,,,,https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=C2485,,0,10,0,0,0,,,
4407,99,NCIT_C62768,website,,,,,,,,,,,,,,,,https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=C62768,,0,10,0,0,0,,,
4408,99,NCIT_C62767,website,,,,,,,,,,,,,,,,https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=C62767,,0,10,0,0,0,,,
4409,99,NCIT_C116847,website,,,,,,,,,,,,,,,,https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=C116847,,0,10,0,0,0,,,
4410,99,NCIT_C29337,website,,,,,,,,,,,,,,,,https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=C29337,,0,10,0,0,0,,,
4411,99,NCIT_C2805,website,,,,,,,,,,,,,,,,https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=C2805,,0,10,0,0,0,,,
4412,99,NCIT_C2806,website,,,,,,,,,,,,,,,,https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=C2806,,0,10,0,0,0,,,
4413,99,NCIT_C82420,website,,,,,,,,,,,,,,,,https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=C82420,,0,10,0,0,0,,,
4414,99,NCIT_C79842,website,,,,,,,,,,,,,,,,https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=C79842,,0,10,0,0,0,,,
4415,99,NCIT_C123928,website,,,,,,,,,,,,,,,,https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=C123928,,0,10,0,0,0,,,
4416,99,NCIT_C2493,website,,,,,,,,,,,,,,,,https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=C2493,,0,10,0,0,0,,,
4417,99,NCIT_C1830,website,,,,,,,,,,,,,,,,https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=C1830,,0,10,0,0,0,,,
4418,99,NCIT_C2809,website,,,,,,,,,,,,,,,,https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=C2809,,0,10,0,0,0,,,
4419,99,NCIT_C123921,website,,,,,,,,,,,,,,,,https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=C123921,,0,10,0,0,0,,,
4420,99,NCIT_C107243,website,,,,,,,,,,,,,,,,https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=C107243,,0,10,0,0,0,,,
4421,99,NCIT_C2746,website,,,,,,,,,,,,,,,,https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=C2746,,0,10,0,0,0,,,
4422,99,NCIT_C49177,website,,,,,,,,,,,,,,,,https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=C49177,,0,10,0,0,0,,,
4423,99,NCIT_C2743,website,,,,,,,,,,,,,,,,https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=C2743,,0,10,0,0,0,,,
4424,99,NCIT_C2742,website,,,,,,,,,,,,,,,,https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=C2742,,0,10,0,0,0,,,
4425,99,NCIT_C2741,website,,,,,,,,,,,,,,,,https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=C2741,,0,10,0,0,0,,,
4426,99,NCIT_C2740,website,,,,,,,,,,,,,,,,https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=C2740,,0,10,0,0,0,,,
4427,99,NCIT_C29785,website,,,,,,,,,,,,,,,,https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=C29785,,0,10,0,0,0,,,
4428,99,NCIT_C103830,website,,,,,,,,,,,,,,,,https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=C103830,,0,10,0,0,0,,,
4429,99,NCIT_C2666,website,,,,,,,,,,,,,,,,https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=C2666,,0,10,0,0,0,,,
4430,99,NCIT_C2667,website,,,,,,,,,,,,,,,,https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=C2667,,0,10,0,0,0,,,
4431,99,NCIT_C2660,website,,,,,,,,,,,,,,,,https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=C2660,,0,10,0,0,0,,,
4432,99,NCIT_C99378,website,,,,,,,,,,,,,,,,https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=C99378,,0,10,0,0,0,,,
4433,99,NCIT_C78489,website,,,,,,,,,,,,,,,,https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=C78489,,0,10,0,0,0,,,
4434,99,NCIT_C78487,website,,,,,,,,,,,,,,,,https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=C78487,,0,10,0,0,0,,,
4435,99,NCIT_C71520,website,,,,,,,,,,,,,,,,https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=C71520,,0,10,0,0,0,,,
4436,99,NCIT_C29918,website,,,,,,,,,,,,,,,,https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=C29918,,0,10,0,0,0,,,
4437,99,NCIT_C78466,website,,,,,,,,,,,,,,,,https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=C78466,,0,10,0,0,0,,,
4438,99,NCIT_C114496,website,,,,,,,,,,,,,,,,https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=C114496,,0,10,0,0,0,,,
4439,99,NCIT_C91076,website,,,,,,,,,,,,,,,,https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=C91076,,0,10,0,0,0,,,
4440,99,NCIT_C91077,website,,,,,,,,,,,,,,,,https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=C91077,,0,10,0,0,0,,,
4441,99,NCIT_C121856,website,,,,,,,,,,,,,,,,https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=C121856,,0,10,0,0,0,,,
4442,99,NCIT_C29564,website,,,,,,,,,,,,,,,,https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=C29564,,0,10,0,0,0,,,
4443,99,NCIT_C2341,website,,,,,,,,,,,,,,,,https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=C2341,,0,10,0,0,0,,,
4444,99,NCIT_C29409,website,,,,,,,,,,,,,,,,https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=C29409,,0,10,0,0,0,,,
4445,99,NCIT_C29561,website,,,,,,,,,,,,,,,,https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=C29561,,0,10,0,0,0,,,
4446,99,NCIT_C29560,website,,,,,,,,,,,,,,,,https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=C29560,,0,10,0,0,0,,,
4447,99,NCIT_C29563,website,,,,,,,,,,,,,,,,https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=C29563,,0,10,0,0,0,,,
4448,99,NCIT_C29402,website,,,,,,,,,,,,,,,,https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=C29402,,0,10,0,0,0,,,
4449,99,NCIT_C2063,website,,,,,,,,,,,,,,,,https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=C2063,,0,10,0,0,0,,,
4450,99,NCIT_C2060,website,,,,,,,,,,,,,,,,https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=C2060,,0,10,0,0,0,,,
4451,99,NCIT_C29401,website,,,,,,,,,,,,,,,,https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=C29401,,0,10,0,0,0,,,
4452,99,NCIT_C116736,website,,,,,,,,,,,,,,,,https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=C116736,,0,10,0,0,0,,,
4453,99,NCIT_C1648,website,,,,,,,,,,,,,,,,https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=C1648,,0,10,0,0,0,,,
4454,99,NCIT_C1643,website,,,,,,,,,,,,,,,,https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=C1643,,0,10,0,0,0,,,
4455,99,NCIT_C99116,website,,,,,,,,,,,,,,,,https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=C99116,,0,10,0,0,0,,,
4456,99,NCIT_C28549,website,,,,,,,,,,,,,,,,https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=C28549,,0,10,0,0,0,,,
4457,99,NCIT_C115105,website,,,,,,,,,,,,,,,,https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=C115105,,0,10,0,0,0,,,
4458,99,NCIT_C116893,website,,,,,,,,,,,,,,,,https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=C116893,,0,10,0,0,0,,,
4459,99,NCIT_C82654,website,,,,,,,,,,,,,,,,https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=C82654,,0,10,0,0,0,,,
4460,99,NCIT_C115106,website,,,,,,,,,,,,,,,,https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=C115106,,0,10,0,0,0,,,
4461,99,NCIT_C1985,website,,,,,,,,,,,,,,,,https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=C1985,,0,10,0,0,0,,,
4462,99,NCIT_C1986,website,,,,,,,,,,,,,,,,https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=C1986,,0,10,0,0,0,,,
4463,99,NCIT_C1980,website,,,,,,,,,,,,,,,,https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=C1980,,0,10,0,0,0,,,
4464,99,NCIT_C1981,website,,,,,,,,,,,,,,,,https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=C1981,,0,10,0,0,0,,,
4465,99,NCIT_C1982,website,,,,,,,,,,,,,,,,https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=C1982,,0,10,0,0,0,,,
4466,99,NCIT_C1983,website,,,,,,,,,,,,,,,,https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=C1983,,0,10,0,0,0,,,
4467,99,NCIT_C62801,website,,,,,,,,,,,,,,,,https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=C62801,,0,10,0,0,0,,,
4468,99,NCIT_C1988,website,,,,,,,,,,,,,,,,https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=C1988,,0,10,0,0,0,,,
4469,99,NCIT_C97265,website,,,,,,,,,,,,,,,,https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=C97265,,0,10,0,0,0,,,
4470,99,NCIT_C85456,website,,,,,,,,,,,,,,,,https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=C85456,,0,10,0,0,0,,,
4471,99,NCIT_C90558,website,,,,,,,,,,,,,,,,https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=C90558,,0,10,0,0,0,,,
4472,99,NCIT_C29317,website,,,,,,,,,,,,,,,,https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=C29317,,0,10,0,0,0,,,
4473,99,NCIT_C90555,website,,,,,,,,,,,,,,,,https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=C90555,,0,10,0,0,0,,,
4474,99,NCIT_C116868,website,,,,,,,,,,,,,,,,https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=C116868,,0,10,0,0,0,,,
4475,99,NCIT_C48371,website,,,,,,,,,,,,,,,,https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=C48371,,0,10,0,0,0,,,
4476,99,NCIT_C80834,website,,,,,,,,,,,,,,,,https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=C80834,,0,10,0,0,0,,,
4477,99,NCIT_C48372,website,,,,,,,,,,,,,,,,https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=C48372,,0,10,0,0,0,,,
4478,99,NCIT_C48377,website,,,,,,,,,,,,,,,,https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=C48377,,0,10,0,0,0,,,
4479,99,NCIT_C2531,website,,,,,,,,,,,,,,,,https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=C2531,,0,10,0,0,0,,,
4480,99,NCIT_C120039,website,,,,,,,,,,,,,,,,https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=C120039,,0,10,0,0,0,,,
4481,99,NCIT_C122396,website,,,,,,,,,,,,,,,,https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=C122396,,0,10,0,0,0,,,
4482,99,NCIT_C53410,website,,,,,,,,,,,,,,,,https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=C53410,,0,10,0,0,0,,,
4483,99,NCIT_C2445,website,,,,,,,,,,,,,,,,https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=C2445,,0,10,0,0,0,,,
4484,99,NCIT_C96739,website,,,,,,,,,,,,,,,,https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=C96739,,0,10,0,0,0,,,
4485,99,NCIT_C2442,website,,,,,,,,,,,,,,,,https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=C2442,,0,10,0,0,0,,,
4486,99,NCIT_C2534,website,,,,,,,,,,,,,,,,https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=C2534,,0,10,0,0,0,,,
4487,99,NCIT_C2830,website,,,,,,,,,,,,,,,,https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=C2830,,0,10,0,0,0,,,
4488,99,NCIT_C2521,website,,,,,,,,,,,,,,,,https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=C2521,,0,10,0,0,0,,,
4489,99,NCIT_C2520,website,,,,,,,,,,,,,,,,https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=C2520,,0,10,0,0,0,,,
4490,99,NCIT_C29566,website,,,,,,,,,,,,,,,,https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=C29566,,0,10,0,0,0,,,
4491,99,NCIT_C70644,website,,,,,,,,,,,,,,,,https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=C70644,,0,10,0,0,0,,,
4492,99,NCIT_C105806,website,,,,,,,,,,,,,,,,https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=C105806,,0,10,0,0,0,,,
4493,99,NCIT_C97344,website,,,,,,,,,,,,,,,,https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=C97344,,0,10,0,0,0,,,
4494,99,NCIT_C111688,website,,,,,,,,,,,,,,,,https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=C111688,,0,10,0,0,0,,,
4495,99,NCIT_C1979,website,,,,,,,,,,,,,,,,https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=C1979,,0,10,0,0,0,,,
4496,99,NCIT_C1978,website,,,,,,,,,,,,,,,,https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=C1978,,0,10,0,0,0,,,
4497,99,NCIT_C101892,website,,,,,,,,,,,,,,,,https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=C101892,,0,10,0,0,0,,,
4498,99,NCIT_C101891,website,,,,,,,,,,,,,,,,https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=C101891,,0,10,0,0,0,,,
4499,99,NCIT_C119759,website,,,,,,,,,,,,,,,,https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=C119759,,0,10,0,0,0,,,
4500,99,NCIT_C29112,website,,,,,,,,,,,,,,,,https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=C29112,,0,10,0,0,0,,,
4501,99,NCIT_C1977,website,,,,,,,,,,,,,,,,https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=C1977,,0,10,0,0,0,,,
4502,99,NCIT_C2620,website,,,,,,,,,,,,,,,,https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=C2620,,0,10,0,0,0,,,
4503,99,NCIT_C2622,website,,,,,,,,,,,,,,,,https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=C2622,,0,10,0,0,0,,,
4504,99,NCIT_C62531,website,,,,,,,,,,,,,,,,https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=C62531,,0,10,0,0,0,,,
4505,99,NCIT_C77909,website,,,,,,,,,,,,,,,,https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=C77909,,0,10,0,0,0,,,
4506,99,NCIT_C2628,website,,,,,,,,,,,,,,,,https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=C2628,,0,10,0,0,0,,,
4507,99,NCIT_C66972,website,,,,,,,,,,,,,,,,https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=C66972,,0,10,0,0,0,,,
4508,99,NCIT_C97126,website,,,,,,,,,,,,,,,,https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=C97126,,0,10,0,0,0,,,
4509,99,NCIT_C97127,website,,,,,,,,,,,,,,,,https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=C97127,,0,10,0,0,0,,,
4510,99,NCIT_C2787,website,,,,,,,,,,,,,,,,https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=C2787,,0,10,0,0,0,,,
4511,99,NCIT_C2786,website,,,,,,,,,,,,,,,,https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=C2786,,0,10,0,0,0,,,
4512,99,NCIT_C114295,website,,,,,,,,,,,,,,,,https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=C114295,,0,10,0,0,0,,,
4513,99,NCIT_C97123,website,,,,,,,,,,,,,,,,https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=C97123,,0,10,0,0,0,,,
4514,99,NCIT_C123283,website,,,,,,,,,,,,,,,,https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=C123283,,0,10,0,0,0,,,
4515,99,NCIT_C2232,website,,,,,,,,,,,,,,,,https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=C2232,,0,10,0,0,0,,,
4516,99,NCIT_C126797,website,,,,,,,,,,,,,,,,https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=C126797,,0,10,0,0,0,,,
4517,99,NCIT_C2236,website,,,,,,,,,,,,,,,,https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=C2236,,0,10,0,0,0,,,
4518,99,NCIT_C2235,website,,,,,,,,,,,,,,,,https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=C2235,,0,10,0,0,0,,,
4519,99,NCIT_C78193,website,,,,,,,,,,,,,,,,https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=C78193,,0,10,0,0,0,,,
4520,99,NCIT_C82371,website,,,,,,,,,,,,,,,,https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=C82371,,0,10,0,0,0,,,
4521,99,NCIT_C82407,website,,,,,,,,,,,,,,,,https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=C82407,,0,10,0,0,0,,,
4522,99,NCIT_C2403,website,,,,,,,,,,,,,,,,https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=C2403,,0,10,0,0,0,,,
4523,99,NCIT_C97951,website,,,,,,,,,,,,,,,,https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=C97951,,0,10,0,0,0,,,
4524,99,NCIT_C84845,website,,,,,,,,,,,,,,,,https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=C84845,,0,10,0,0,0,,,
4525,99,NCIT_C111037,website,,,,,,,,,,,,,,,,https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=C111037,,0,10,0,0,0,,,
4526,99,NCIT_C107159,website,,,,,,,,,,,,,,,,https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=C107159,,0,10,0,0,0,,,
4527,99,NCIT_C2657,website,,,,,,,,,,,,,,,,https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=C2657,,0,10,0,0,0,,,
4528,99,NCIT_C73998,website,,,,,,,,,,,,,,,,https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=C73998,,0,10,0,0,0,,,
4529,99,NCIT_C2718,website,,,,,,,,,,,,,,,,https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=C2718,,0,10,0,0,0,,,
4530,99,NCIT_C2650,website,,,,,,,,,,,,,,,,https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=C2650,,0,10,0,0,0,,,
4531,99,NCIT_C2710,website,,,,,,,,,,,,,,,,https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=C2710,,0,10,0,0,0,,,
4532,99,NCIT_C76227,website,,,,,,,,,,,,,,,,https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=C76227,,0,10,0,0,0,,,
4533,99,NCIT_C29091,website,,,,,,,,,,,,,,,,https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=C29091,,0,10,0,0,0,,,
4534,99,NCIT_C29090,website,,,,,,,,,,,,,,,,https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=C29090,,0,10,0,0,0,,,
4535,99,NCIT_C61442,website,,,,,,,,,,,,,,,,https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=C61442,,0,10,0,0,0,,,
4536,99,NCIT_C79833,website,,,,,,,,,,,,,,,,https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=C79833,,0,10,0,0,0,,,
4537,99,NCIT_C68842,website,,,,,,,,,,,,,,,,https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=C68842,,0,10,0,0,0,,,
4538,99,NCIT_C71526,website,,,,,,,,,,,,,,,,https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=C71526,,0,10,0,0,0,,,
4539,99,NCIT_C77867,website,,,,,,,,,,,,,,,,https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=C77867,,0,10,0,0,0,,,
4540,99,NCIT_C114990,website,,,,,,,,,,,,,,,,https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=C114990,,0,10,0,0,0,,,
4541,99,NCIT_C102787,website,,,,,,,,,,,,,,,,https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=C102787,,0,10,0,0,0,,,
4542,99,NCIT_C102782,website,,,,,,,,,,,,,,,,https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=C102782,,0,10,0,0,0,,,
4543,99,NCIT_C68999,website,,,,,,,,,,,,,,,,https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=C68999,,0,10,0,0,0,,,
4544,99,NCIT_C78819,website,,,,,,,,,,,,,,,,https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=C78819,,0,10,0,0,0,,,
4545,99,NCIT_C106257,website,,,,,,,,,,,,,,,,https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=C106257,,0,10,0,0,0,,,
4546,99,NCIT_C122399,website,,,,,,,,,,,,,,,,https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=C122399,,0,10,0,0,0,,,
4547,99,NCIT_C99129,website,,,,,,,,,,,,,,,,https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=C99129,,0,10,0,0,0,,,
4548,99,NCIT_C38132,website,,,,,,,,,,,,,,,,https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=C38132,,0,10,0,0,0,,,
4549,99,NCIT_C101094,website,,,,,,,,,,,,,,,,https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=C101094,,0,10,0,0,0,,,
4550,99,NCIT_C88341,website,,,,,,,,,,,,,,,,https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=C88341,,0,10,0,0,0,,,
4551,99,NCIT_C1479,website,,,,,,,,,,,,,,,,https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=C1479,,0,10,0,0,0,,,
4552,99,NCIT_C2382,website,,,,,,,,,,,,,,,,https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=C2382,,0,10,0,0,0,,,
4553,99,NCIT_C48396,website,,,,,,,,,,,,,,,,https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=C48396,,0,10,0,0,0,,,
4554,99,NCIT_C48395,website,,,,,,,,,,,,,,,,https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=C48395,,0,10,0,0,0,,,
4555,99,NCIT_C48394,website,,,,,,,,,,,,,,,,https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=C48394,,0,10,0,0,0,,,
4556,99,NCIT_C48393,website,,,,,,,,,,,,,,,,https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=C48393,,0,10,0,0,0,,,
4557,99,NCIT_C103192,website,,,,,,,,,,,,,,,,https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=C103192,,0,10,0,0,0,,,
4558,99,NCIT_C48390,website,,,,,,,,,,,,,,,,https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=C48390,,0,10,0,0,0,,,
4559,99,NCIT_C102879,website,,,,,,,,,,,,,,,,https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=C102879,,0,10,0,0,0,,,
4560,99,NCIT_C102978,website,,,,,,,,,,,,,,,,https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=C102978,,0,10,0,0,0,,,
4561,99,NCIT_C94217,website,,,,,,,,,,,,,,,,https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=C94217,,0,10,0,0,0,,,
4562,99,NCIT_C94216,website,,,,,,,,,,,,,,,,https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=C94216,,0,10,0,0,0,,,
4563,99,NCIT_C94215,website,,,,,,,,,,,,,,,,https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=C94215,,0,10,0,0,0,,,
4564,99,NCIT_C29088,website,,,,,,,,,,,,,,,,https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=C29088,,0,10,0,0,0,,,
4565,99,NCIT_C94210,website,,,,,,,,,,,,,,,,https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=C94210,,0,10,0,0,0,,,
4566,99,NCIT_C94218,website,,,,,,,,,,,,,,,,https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=C94218,,0,10,0,0,0,,,
4567,99,NCIT_C87436,website,,,,,,,,,,,,,,,,https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=C87436,,0,10,0,0,0,,,
4568,99,NCIT_C2576,website,,,,,,,,,,,,,,,,https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=C2576,,0,10,0,0,0,,,
4569,99,NCIT_C74036,website,,,,,,,,,,,,,,,,https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=C74036,,0,10,0,0,0,,,
4570,99,NCIT_C62478,website,,,,,,,,,,,,,,,,https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=C62478,,0,10,0,0,0,,,
4571,99,NCIT_C62479,website,,,,,,,,,,,,,,,,https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=C62479,,0,10,0,0,0,,,
4572,99,NCIT_C29778,website,,,,,,,,,,,,,,,,https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=C29778,,0,10,0,0,0,,,
4573,99,NCIT_C104743,website,,,,,,,,,,,,,,,,https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=C104743,,0,10,0,0,0,,,
4574,99,NCIT_C99902,website,,,,,,,,,,,,,,,,https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=C99902,,0,10,0,0,0,,,
4575,99,NCIT_C116067,website,,,,,,,,,,,,,,,,https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=C116067,,0,10,0,0,0,,,
4576,99,NCIT_C2474,website,,,,,,,,,,,,,,,,https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=C2474,,0,10,0,0,0,,,
4577,99,NCIT_C49064,website,,,,,,,,,,,,,,,,https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=C49064,,0,10,0,0,0,,,
4578,99,NCIT_C2471,website,,,,,,,,,,,,,,,,https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=C2471,,0,10,0,0,0,,,
4579,99,NCIT_C49063,website,,,,,,,,,,,,,,,,https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=C49063,,0,10,0,0,0,,,
4580,99,NCIT_C2473,website,,,,,,,,,,,,,,,,https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=C2473,,0,10,0,0,0,,,
4581,99,NCIT_C49023,website,,,,,,,,,,,,,,,,https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=C49023,,0,10,0,0,0,,,
4582,99,NCIT_C118364,website,,,,,,,,,,,,,,,,https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=C118364,,0,10,0,0,0,,,
4583,99,NCIT_C88334,website,,,,,,,,,,,,,,,,https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=C88334,,0,10,0,0,0,,,
4584,99,NCIT_C119664,website,,,,,,,,,,,,,,,,https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=C119664,,0,10,0,0,0,,,
4585,99,NCIT_C123930,website,,,,,,,,,,,,,,,,https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=C123930,,0,10,0,0,0,,,
4586,99,NCIT_C120183,website,,,,,,,,,,,,,,,,https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=C120183,,0,10,0,0,0,,,
4587,99,NCIT_C29316,website,,,,,,,,,,,,,,,,https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=C29316,,0,10,0,0,0,,,
4588,99,NCIT_C2754,website,,,,,,,,,,,,,,,,https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=C2754,,0,10,0,0,0,,,
4589,99,NCIT_C2757,website,,,,,,,,,,,,,,,,https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=C2757,,0,10,0,0,0,,,
4590,99,NCIT_C102751,website,,,,,,,,,,,,,,,,https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=C102751,,0,10,0,0,0,,,
4591,99,NCIT_C102753,website,,,,,,,,,,,,,,,,https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=C102753,,0,10,0,0,0,,,
4592,99,NCIT_C103823,website,,,,,,,,,,,,,,,,https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=C103823,,0,10,0,0,0,,,
4593,99,NCIT_C2619,website,,,,,,,,,,,,,,,,https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=C2619,,0,10,0,0,0,,,
4594,99,NCIT_C74087,website,,,,,,,,,,,,,,,,https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=C74087,,0,10,0,0,0,,,
4595,99,NCIT_C74088,website,,,,,,,,,,,,,,,,https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=C74088,,0,10,0,0,0,,,
4596,99,NCIT_C74089,website,,,,,,,,,,,,,,,,https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=C74089,,0,10,0,0,0,,,
4597,99,NCIT_C28776,website,,,,,,,,,,,,,,,,https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=C28776,,0,10,0,0,0,,,
4598,99,NCIT_C28775,website,,,,,,,,,,,,,,,,https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=C28775,,0,10,0,0,0,,,
4599,99,NCIT_C29192,website,,,,,,,,,,,,,,,,https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=C29192,,0,10,0,0,0,,,
4600,99,NCIT_C95024,website,,,,,,,,,,,,,,,,https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=C95024,,0,10,0,0,0,,,
4601,99,NCIT_C102982,website,,,,,,,,,,,,,,,,https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=C102982,,0,10,0,0,0,,,
4602,99,NCIT_C1159,website,,,,,,,,,,,,,,,,https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=C1159,,0,10,0,0,0,,,
4603,99,NCIT_C29908,website,,,,,,,,,,,,,,,,https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=C29908,,0,10,0,0,0,,,
4604,99,NCIT_C95771,website,,,,,,,,,,,,,,,,https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=C95771,,0,10,0,0,0,,,
4605,99,NCIT_C121848,website,,,,,,,,,,,,,,,,https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=C121848,,0,10,0,0,0,,,
4606,99,NCIT_C2057,website,,,,,,,,,,,,,,,,https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=C2057,,0,10,0,0,0,,,
4607,99,NCIT_C2545,website,,,,,,,,,,,,,,,,https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=C2545,,0,10,0,0,0,,,
4608,99,NCIT_C2055,website,,,,,,,,,,,,,,,,https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=C2055,,0,10,0,0,0,,,
4609,99,NCIT_C91707,website,,,,,,,,,,,,,,,,https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=C91707,,0,10,0,0,0,,,
4610,99,NCIT_C2195,website,,,,,,,,,,,,,,,,https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=C2195,,0,10,0,0,0,,,
4611,99,NCIT_C71748,website,,,,,,,,,,,,,,,,https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=C71748,,0,10,0,0,0,,,
4612,99,NCIT_C119614,website,,,,,,,,,,,,,,,,https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=C119614,,0,10,0,0,0,,,
4613,99,NCIT_C26645,website,,,,,,,,,,,,,,,,https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=C26645,,0,10,0,0,0,,,
4614,99,NCIT_C29555,website,,,,,,,,,,,,,,,,https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=C29555,,0,10,0,0,0,,,
4615,99,NCIT_C91715,website,,,,,,,,,,,,,,,,https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=C91715,,0,10,0,0,0,,,
4616,99,NCIT_C29559,website,,,,,,,,,,,,,,,,https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=C29559,,0,10,0,0,0,,,
4617,99,NCIT_C113174,website,,,,,,,,,,,,,,,,https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=C113174,,0,10,0,0,0,,,
4618,99,NCIT_C48373,website,,,,,,,,,,,,,,,,https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=C48373,,0,10,0,0,0,,,
4619,99,NCIT_C49289,website,,,,,,,,,,,,,,,,https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=C49289,,0,10,0,0,0,,,
4620,99,NCIT_C116888,website,,,,,,,,,,,,,,,,https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=C116888,,0,10,0,0,0,,,
4621,99,NCIT_C124652,website,,,,,,,,,,,,,,,,https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=C124652,,0,10,0,0,0,,,
4622,99,NCIT_C48465,website,,,,,,,,,,,,,,,,https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=C48465,,0,10,0,0,0,,,
4623,99,NCIT_C116880,website,,,,,,,,,,,,,,,,https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=C116880,,0,10,0,0,0,,,
4624,99,NCIT_C28551,website,,,,,,,,,,,,,,,,https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=C28551,,0,10,0,0,0,,,
4625,99,NCIT_C115976,website,,,,,,,,,,,,,,,,https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=C115976,,0,10,0,0,0,,,
4626,99,NCIT_C61146,website,,,,,,,,,,,,,,,,https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=C61146,,0,10,0,0,0,,,
4627,99,NCIT_C37515,website,,,,,,,,,,,,,,,,https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=C37515,,0,10,0,0,0,,,
4628,99,NCIT_C90542,website,,,,,,,,,,,,,,,,https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=C90542,,0,10,0,0,0,,,
4629,99,NCIT_C38715,website,,,,,,,,,,,,,,,,https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=C38715,,0,10,0,0,0,,,
4630,99,NCIT_C119616,website,,,,,,,,,,,,,,,,https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=C119616,,0,10,0,0,0,,,
4631,99,NCIT_C95705,website,,,,,,,,,,,,,,,,https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=C95705,,0,10,0,0,0,,,
4632,99,NCIT_C82688,website,,,,,,,,,,,,,,,,https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=C82688,,0,10,0,0,0,,,
4633,99,NCIT_C29910,website,,,,,,,,,,,,,,,,https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=C29910,,0,10,0,0,0,,,
4634,99,NCIT_C116709,website,,,,,,,,,,,,,,,,https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=C116709,,0,10,0,0,0,,,
4635,99,NCIT_C38708,website,,,,,,,,,,,,,,,,https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=C38708,,0,10,0,0,0,,,
4636,99,NCIT_C2430,website,,,,,,,,,,,,,,,,https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=C2430,,0,10,0,0,0,,,
4637,99,NCIT_C2433,website,,,,,,,,,,,,,,,,https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=C2433,,0,10,0,0,0,,,
4638,99,NCIT_C85450,website,,,,,,,,,,,,,,,,https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=C85450,,0,10,0,0,0,,,
4639,99,NCIT_C115101,website,,,,,,,,,,,,,,,,https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=C115101,,0,10,0,0,0,,,
4640,99,NCIT_C2436,website,,,,,,,,,,,,,,,,https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=C2436,,0,10,0,0,0,,,
4641,99,NCIT_C2439,website,,,,,,,,,,,,,,,,https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=C2439,,0,10,0,0,0,,,
4642,99,NCIT_C2438,website,,,,,,,,,,,,,,,,https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=C2438,,0,10,0,0,0,,,
4643,99,NCIT_C2824,website,,,,,,,,,,,,,,,,https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=C2824,,0,10,0,0,0,,,
4644,99,NCIT_C99903,website,,,,,,,,,,,,,,,,https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=C99903,,0,10,0,0,0,,,
4645,99,NCIT_C2822,website,,,,,,,,,,,,,,,,https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=C2822,,0,10,0,0,0,,,
4646,99,NCIT_C2821,website,,,,,,,,,,,,,,,,https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=C2821,,0,10,0,0,0,,,
4647,99,NCIT_C96402,website,,,,,,,,,,,,,,,,https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=C96402,,0,10,0,0,0,,,
4648,99,NCIT_C96405,website,,,,,,,,,,,,,,,,https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=C96405,,0,10,0,0,0,,,
4649,99,NCIT_C48640,website,,,,,,,,,,,,,,,,https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=C48640,,0,10,0,0,0,,,
4650,99,NCIT_C1325,website,,,,,,,,,,,,,,,,https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=C1325,,0,10,0,0,0,,,
4651,99,NCIT_C38681,website,,,,,,,,,,,,,,,,https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=C38681,,0,10,0,0,0,,,
4652,99,NCIT_C71723,website,,,,,,,,,,,,,,,,https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=C71723,,0,10,0,0,0,,,
4653,99,NCIT_C122678,website,,,,,,,,,,,,,,,,https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=C122678,,0,10,0,0,0,,,
4654,99,NCIT_C78820,website,,,,,,,,,,,,,,,,https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=C78820,,0,10,0,0,0,,,
4655,99,NCIT_C78821,website,,,,,,,,,,,,,,,,https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=C78821,,0,10,0,0,0,,,
4656,99,NCIT_C91085,website,,,,,,,,,,,,,,,,https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=C91085,,0,10,0,0,0,,,
4657,99,NCIT_C119745,website,,,,,,,,,,,,,,,,https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=C119745,,0,10,0,0,0,,,
4658,99,NCIT_C116920,website,,,,,,,,,,,,,,,,https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=C116920,,0,10,0,0,0,,,
4659,99,NCIT_C2811,website,,,,,,,,,,,,,,,,https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=C2811,,0,10,0,0,0,,,
4660,99,NCIT_C114289,website,,,,,,,,,,,,,,,,https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=C114289,,0,10,0,0,0,,,
4661,99,NCIT_C2227,website,,,,,,,,,,,,,,,,https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=C2227,,0,10,0,0,0,,,
4662,99,NCIT_C104747,website,,,,,,,,,,,,,,,,https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=C104747,,0,10,0,0,0,,,
4663,99,NCIT_C80055,website,,,,,,,,,,,,,,,,https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=C80055,,0,10,0,0,0,,,
4664,99,NCIT_C2384,website,,,,,,,,,,,,,,,,https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=C2384,,0,10,0,0,0,,,
4665,99,NCIT_C114285,website,,,,,,,,,,,,,,,,https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=C114285,,0,10,0,0,0,,,
4666,99,NCIT_C123378,website,,,,,,,,,,,,,,,,https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=C123378,,0,10,0,0,0,,,
4667,99,NCIT_C48632,website,,,,,,,,,,,,,,,,https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=C48632,,0,10,0,0,0,,,
4668,99,NCIT_C48637,website,,,,,,,,,,,,,,,,https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=C48637,,0,10,0,0,0,,,
4669,99,NCIT_C48638,website,,,,,,,,,,,,,,,,https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=C48638,,0,10,0,0,0,,,
4670,99,NCIT_C48639,website,,,,,,,,,,,,,,,,https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=C48639,,0,10,0,0,0,,,
4671,99,NCIT_C74042,website,,,,,,,,,,,,,,,,https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=C74042,,0,10,0,0,0,,,
4672,99,NCIT_C2540,website,,,,,,,,,,,,,,,,https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=C2540,,0,10,0,0,0,,,
4673,99,NCIT_C82388,website,,,,,,,,,,,,,,,,https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=C82388,,0,10,0,0,0,,,
4674,99,NCIT_C82381,website,,,,,,,,,,,,,,,,https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=C82381,,0,10,0,0,0,,,
4675,99,NCIT_C71757,website,,,,,,,,,,,,,,,,https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=C71757,,0,10,0,0,0,,,
4676,99,NCIT_C91714,website,,,,,,,,,,,,,,,,https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=C91714,,0,10,0,0,0,,,
4678,25,"Zeinalzadeh et al., 2017",journal,"Zeinalzadeh N, Salmanian AH, Goujani G, Amani J, Ahangari G, Akhavian A, Jafari M","A Chimeric protein of CFA/I, CS6 subunits and LTB/STa toxoid protects immunized mice against enterotoxigenic Escherichia coli","2017","61","7","272-279",Microbiology and immunology,,,,,,,,"28543534",,,0,10,0,0,0,,,"2018 Protegen Update Autogenerated"
4679,37,"Wang et al., 2013",journal,"Wang X, Xiong X, Graves S, Stenos J, Wen B",Protein array of Coxiella burnetii probed with Q fever sera,"2013","56","5","453-459",Science China. Life sciences,,,,,,,,"23633077",,,0,10,0,0,0,,,"2018 Protegen Update Autogenerated"
4680,135,"Floden et al., 2013",journal,"Floden AM, Gonzalez T, Gaultney RA, Brissette CA","Evaluation of RevA, a fibronectin-binding protein of Borrelia burgdorferi, as a potential vaccine candidate for lyme disease","2013","20","6","892-899",Clinical and vaccine immunology : CVI,,,,,,,,"23595502",,,0,10,0,0,0,,,"2018 Protegen Update Autogenerated"
4681,113,"Tifrea et al., 2016",journal,"Tifrea DF, Barta ML, Pal S, Hefty PS, de la Maza LM",Computational modeling of TC0583 as a putative component of the Chlamydia muridarum V-type ATP synthase complex and assessment of its protective capabilities as a vaccine antigen,"2016","18","4","245-253",Microbes and infection,,,,,,,,"26706820",,,0,10,0,0,0,,,"2018 Protegen Update Autogenerated"
4682,25,"Lin et al., 2017",journal,"Lin R, Zhu B, Zhang Y, Bai Y, Zhi F, Long B, Li Y, Wu Y, Wu X, Fan H",Intranasal immunization with novel EspA-Tir-M fusion protein induces protective immunity against enterohemorrhagic Escherichia coli O157:H7 challenge in mice,"2017","105","","19-24",Microbial pathogenesis,,,,,,,,"28163157",,,0,10,0,0,0,,,"2018 Protegen Update Autogenerated"
4683,139,"Santi et al., 2007",journal,"Santi I, Scarselli M, Mariani M, Pezzicoli A, Masignani V, Taddei A, Grandi G, Telford JL, Soriani M",BibA: a novel immunogenic bacterial adhesin contributing to group B Streptococcus survival in human blood,"2007","63","3","754-767",Molecular microbiology,,,,,,,,"17212592",,,0,10,0,0,0,,,"2018 Protegen Update Autogenerated"
4684,82,"Hchard et al., 2004",journal,"Hchard C, Grpinet O, Rodolakis A",Molecular cloning of the Chlamydophila abortus groEL gene and evaluation of its protective efficacy in a murine model by genetic vaccination,"2004","53",Pt 9,"861-868",Journal of medical microbiology,,,,,,,,"15314192",,,0,10,0,0,0,,,"2018 Protegen Update Autogenerated"
4685,208,"Pal et al., 1997",journal,"Pal S, Theodor I, Peterson EM, de la Maza LM",Immunization with an acellular vaccine consisting of the outer membrane complex of Chlamydia trachomatis induces protection against a genital challenge,"1997","65","8","3361-3369",Infection and immunity,,,,,,,,"9234798",,,0,10,0,0,0,,,"2018 Protegen Update Autogenerated"
4686,137,"Hamaoka et al., 2017",journal,"Hamaoka S, Naito Y, Katoh H, Shimizu M, Kinoshita M, Akiyama K, Kainuma A, Moriyama K, Ishii KJ, Sawa T",Efficacy comparison of adjuvants in PcrV vaccine against Pseudomonas aeruginosa pneumonia,"2017","61","2","64-74",Microbiology and immunology,,,,,,,,"28370521",,,0,10,0,0,0,,,"2018 Protegen Update Autogenerated"
4687,139,"Xue et al., 2010",journal,"Xue G, Yu L, Li S, Shen X",Intranasal immunization with GBS surface protein Sip and ScpB induces specific mucosal and systemic immune responses in mice,"2010","58","2","202-210",FEMS immunology and medical microbiology,,,,,,,,"19912341",,,0,10,0,0,0,,,"2018 Protegen Update Autogenerated"
4688,11,"Uchida et al., 2012",journal,"Uchida M, Harada T, Enkhtuya J, Kusumoto A, Kobayashi Y, Chiba S, Shyaka A, Kawamoto K",Protective effect of Bacillus anthracis surface protein EA1 against anthrax in mice,"2012","421","2","323-328",Biochemical and biophysical research communications,,,,,,,,"22507985",,,0,10,0,0,0,,,"2018 Protegen Update Autogenerated"
4689,112,"Lu et al., 2012",journal,"Lu X, Xia M, Endresz V, Faludi I, Szabo A, Gonczol E, Mundkur L, Chen D, Kakkar V","Impact of multiple antigenic epitopes from ApoB100, hHSP60 and Chlamydophila pneumoniae on atherosclerotic lesion development in Apob(tm2Sgy)Ldlr(tm1Her)J mice","2012","225","1","56-68",Atherosclerosis,,,,,,,,"22959702",,,0,10,0,0,0,,,"2018 Protegen Update Autogenerated"
4690,43,"Heine et al., 2014",journal,"Heine SJ, Diaz-McNair J, Andar AU, Drachenberg CB, van de Verg L, Walker R, Picking WL, Pasetti MF","Intradermal delivery of Shigella IpaB and IpaD type III secretion proteins: kinetics of cell recruitment and antigen uptake, mucosal and systemic immunity, and protection across serotypes","2014","192","4","1630-1640","Journal of immunology (Baltimore, Md. : 1950)",,,,,,,,"24453241",,,0,10,0,0,0,,,"2018 Protegen Update Autogenerated"
4691,108,"Gong et al., 2014",journal,"Gong W, Xiong X, Qi Y, Jiao J, Duan C, Wen B",Identification of novel surface-exposed proteins of Rickettsia rickettsii by affinity purification and proteomics,"2014","9","6",e100253,PloS one,,,,,,,,"24950252",,,0,10,0,0,0,,,"2018 Protegen Update Autogenerated"
4692,102,"Aktar et al., 2016",journal,"Aktar A, Rahman MA, Afrin S, Faruk MO, Uddin T, Akter A, Sami MIN, Yasmin T, Chowdhury F, Khan AI, Leung DT, LaRocque RC, Charles RC, Bhuiyan TR, Mandlik A, Kelly M, Kov P, Xu P, Calderwood SB, Harris JB, Qadri F, Ryan ET","O-Specific Polysaccharide-Specific Memory B Cell Responses in Young Children, Older Children, and Adults Infected with Vibrio cholerae O1 Ogawa in Bangladesh","2016","23","5","427-435",Clinical and vaccine immunology : CVI,,,,,,,,"27009211",,,0,10,0,0,0,,,"2018 Protegen Update Autogenerated"
4693,301,"Lee et al., 2014",journal,"Lee TH, Kim MH, Lee CS, Lee JH, Rhee JH, Chung KM",Protection against Vibrio vulnificus infection by active and passive immunization with the C-terminal region of the RtxA1/MARTXVv protein,"2014","32","2","271-276",Vaccine,,,,,,,,"24252692",,,0,10,0,0,0,,,"2018 Protegen Update Autogenerated"
4694,25,"Luo et al., 2016",journal,"Luo Q, Vickers TJ, Fleckenstein JM","Immunogenicity and Protective Efficacy against Enterotoxigenic Escherichia coli Colonization following Intradermal, Sublingual, or Oral Vaccination with EtpA Adhesin","2016","23","7","628-637",Clinical and vaccine immunology : CVI,,,,,,,,"27226279",,,0,10,0,0,0,,,"2018 Protegen Update Autogenerated"
4695,86,"Chung et al., 2012",journal,"Chung JW, Kster-Schck E, Gibbs BF, Jacques M, Coulton JW",Immunoproteomic analyses of outer membrane antigens of Actinobacillus pleuropneumoniae grown under iron-restricted conditions,"2012","159","1-2","187-194",Veterinary microbiology,,,,,,,,"22541161",,,0,10,0,0,0,,,"2018 Protegen Update Autogenerated"
4696,86,"Hur et al., 2016",journal,"Hur J, Eo SK, Park SY, Choi Y, Lee JH","Immunological study of an attenuated Salmonella Typhimurium expressing ApxIA, ApxIIA, ApxIIIA and OmpA of Actinobacillus pleuropneumoniae in a mouse model","2016","77","12","1693-1696",The Journal of veterinary medical science,,,,,,,,"26227587",,,0,10,0,0,0,,,"2018 Protegen Update Autogenerated"
4697,102,"Sharma et al., 2008",journal,"Sharma MK, Singh NK, Jani D, Sisodia R, Thungapathra M, Gautam JK, Meena LS, Singh Y, Ghosh A, Tyagi AK, Sharma AK",Expression of toxin co-regulated pilus subunit A (TCPA) of Vibrio cholerae and its immunogenic epitopes fused to cholera toxin B subunit in transgenic tomato (Solanum lycopersicum),"2008","27","2","307-318",Plant cell reports,,,,,,,,"17962948",,,0,10,0,0,0,,,"2018 Protegen Update Autogenerated"
4698,25,"Wang et al., 2017",journal,"Wang X, Teng D, Guan Q, Mao R, Hao Y, Wang X, Yao J, Wang J",Escherichia coli outer membrane protein F (OmpF): an immunogenic protein induces cross-reactive antibodies against Escherichia coli and Shigella,"2017","7","1","155",AMB Express,,,,,,,,"28728309",,,0,10,0,0,0,,,"2018 Protegen Update Autogenerated"
4699,86,"Liu et al., 2011",journal,"Liu J, Chen Y, Yuan F, Hu L, Bei W, Chen H","Cloning, expression, and characterization of TonB2 from Actinobacillus pleuropneumoniae and potential use as an antigenic vaccine candidate and diagnostic marker","2011","75","3","183-190",Canadian journal of veterinary research = Revue canadienne de recherche veterinaire,,,,,,,,"22210994",,,0,10,0,0,0,,,"2018 Protegen Update Autogenerated"
4700,140,"Radcliff et al., 2015",journal,"Radcliff FJ, Fraser JD, Proft T",Vaccination with Streptococcus pyogenes nuclease A stimulates a high antibody response but no protective immunity in a mouse model of infection,"2015","204","2","185-191",Medical microbiology and immunology,,,,,,,,"25119670",,,0,10,0,0,0,,,"2018 Protegen Update Autogenerated"
4701,200,"Simionatto et al., 2012",journal,"Simionatto S, Marchioro SB, Galli V, Brum CB, Klein CS, Rebelatto R, Silva EF, Borsuk S, Conceio FR, Dellagostin OA",Immunological characterization of Mycoplasma hyopneumoniae recombinant proteins,"2012","35","2","209-216","Comparative immunology, microbiology and infectious diseases",,,,,,,,"22304900",,,0,10,0,0,0,,,"2018 Protegen Update Autogenerated"
4702,134,"Li et al., 2017",journal,"Li B, Yuan H, Chen L, Sun H, Hu J, Wei S, Zhao Z, Zou Q, Wu C",The influence of adjuvant on UreB protection against &lt;i&gt;Helicobacter pylori&lt;/i&gt; through the diversity of CD4+ T-cell epitope repertoire,"2017","8","40","68138-68152",Oncotarget,,,,,,,,"28978104",,,0,10,0,0,0,,,"2018 Protegen Update Autogenerated"
4703,81,"Waller et al., 2007",journal,"Waller A, Flock M, Smith K, Robinson C, Mitchell Z, Karlstrm A, Lannergrd J, Bergman R, Guss B, Flock JI",Vaccination of horses against strangles using recombinant antigens from Streptococcus equi,"2007","25","18","3629-3635",Vaccine,,,,,,,,"17321016",,,0,10,0,0,0,,,"2018 Protegen Update Autogenerated"
4704,7,"Balderas et al., 2016",journal,"Balderas MA, Nguyen CT, Terwilliger A, Keitel WA, Iniguez A, Torres R, Palacios F, Goulding CW, Maresso AW",Progress toward the Development of a NEAT Protein Vaccine for Anthrax Disease,"2016","84","12","3408-3422",Infection and immunity,,,,,,,,"27647868",,,0,10,0,0,0,,,"2018 Protegen Update Autogenerated"
4705,43,"Gupta et al., 2011",journal,"Gupta P, Singh MK, Singh Y, Gautam V, Kumar S, Kumar O, Dhaked RK",Recombinant Shiga toxin B subunit elicits protection against Shiga toxin via mixed Th type immune response in mice,"2011","29","45","8094-8100",Vaccine,,,,,,,,"21856355",,,0,10,0,0,0,,,"2018 Protegen Update Autogenerated"
4706,11,"Makam et al., 2014",journal,"Makam SS, Kingston JJ, Harischandra MS, Batra HV",Protective antigen and extractable antigen 1 based chimeric protein confers protection against Bacillus anthracis in mouse model,"2014","59","1","91-99",Molecular immunology,,,,,,,,"24513572",,,0,10,0,0,0,,,"2018 Protegen Update Autogenerated"
4707,138,"Yang et al., 2017",journal,"Yang Y, Yu R, Yang X, Liu S, Fang T, Song X, Hou L, Yu C, Xu J, Fu L, Yi S, Chen W",Protection against Staphylococcus aureus and tetanus infections by a combined vaccine containing SasA and TeNTHc in mice,"2017","15","4","2369-2373",Molecular medicine reports,,,,,,,,"28259925",,,0,10,0,0,0,,,"2018 Protegen Update Autogenerated"
4708,24,"Huang et al., 2007",journal,"Huang S, Sahin O, Zhang Q",Infection-induced antibodies against the major outer membrane protein of Campylobacter jejuni mainly recognize conformational epitopes,"2007","272","2","137-143",FEMS microbiology letters,,,,,,,,"17521366",,,0,10,0,0,0,,,"2018 Protegen Update Autogenerated"
4709,25,"Lin et al., 2013",journal,"Lin J, Mateo KS, Zhao M, Erickson AK, Garcia N, He D, Moxley RA, Francis DH",Protection of piglets against enteric colibacillosis by intranasal immunization with K88ac (F4ac) fimbriae and heat labile enterotoxin of Escherichia coli,"2013","162","2-4","731-739",Veterinary microbiology,,,,,,,,"23089483",,,0,10,0,0,0,,,"2018 Protegen Update Autogenerated"
4710,195,"Lin et al., 2016",journal,"Lin X, Xiao G, Luo D, Kong L, Chen X, Sun D, Yan J",Chimeric epitope vaccine against Leptospira interrogans infection and induced specific immunity in guinea pigs,"2016","16","1","241",BMC microbiology,,,,,,,,"27737644",,,0,10,0,0,0,,,"2018 Protegen Update Autogenerated"
4711,25,"Won and John, 2017",journal,"Won G, John Hwa L","Potent immune responses induced by a Salmonella ghost delivery system that expresses the recombinant Stx2eB, FedF, and FedA proteins of the Escherichia coli-producing F18 and Shiga toxin in a murine model and evaluation of its protective effect as a porcine vaccine candidate","2017","37","1","81-90",The Veterinary quarterly,,,,,,,,"28317440",,,0,10,0,0,0,,,"2018 Protegen Update Autogenerated"
4712,140,"Dale et al., 2015",journal,"Dale JB, Niedermeyer SE, Agbaosi T, Hysmith ND, Penfound TA, Hohn CM, Pullen M, Bright MI, Murrell DS, Shenep LE, Courtney HS",Protective immunogenicity of group A streptococcal M-related proteins,"2015","22","3","344-350",Clinical and vaccine immunology : CVI,,,,,,,,"25630406",,,0,10,0,0,0,,,"2018 Protegen Update Autogenerated"
4713,25,"Ahmed et al., 2014",journal,"Ahmed B, Loos M, Vanrompay D, Cox E",Oral immunization with Lactococcus lactis-expressing EspB induces protective immune responses against Escherichia coli O157:H7 in a murine model of colonization,"2014","32","31","3909-3916",Vaccine,,,,,,,,"24877767",,,0,10,0,0,0,,,"2018 Protegen Update Autogenerated"
4714,141,"Lithgow et al., 2017",journal,"Lithgow KV, Hof R, Wetherell C, Phillips D, Houston S, Cameron CE",A defined syphilis vaccine candidate inhibits dissemination of Treponema pallidum subspecies pallidum,"2017","8","","14273",Nature communications,,,,,,,,"28145405",,,0,10,0,0,0,,,"2018 Protegen Update Autogenerated"
4715,134,"Li et al., 2015",journal,"Li B, Chen L, Sun H, Yang W, Hu J, He Y, Wei S, Zhao Z, Zhang J, Li H, Zou Q, Wu C",Immunodominant epitope-specific Th1 but not Th17 responses mediate protection against Helicobacter pylori infection following UreB vaccination of BALB/c mice,"2015","5","","14793",Scientific reports,,,,,,,,"26434384",,,0,10,0,0,0,,,"2018 Protegen Update Autogenerated"
4716,208,"Bartolini et al., 2013",journal,"Bartolini E, Ianni E, Frigimelica E, Petracca R, Galli G, Berlanda Scorza F, Norais N, Laera D, Giusti F, Pierleoni A, Donati M, Cevenini R, Finco O, Grandi G, Grifantini R",Recombinant outer membrane vesicles carrying Chlamydia muridarum HtrA induce antibodies that neutralize chlamydial infection in vitro,"2013","2","","",Journal of extracellular vesicles,,,,,,,,"24009891",,,0,10,0,0,0,,,"2018 Protegen Update Autogenerated"
4717,209,"Jin et al., 2012",journal,"Jin RP, Hu YH, Sun BG, Zhang XH, Sun L",Edwardsiella tarda sialidase: pathogenicity involvement and vaccine potential,"2012","33","3","514-521",Fish &amp; shellfish immunology,,,,,,,,"22705341",,,0,10,0,0,0,,,"2018 Protegen Update Autogenerated"
4718,121,"Druar et al., 2008",journal,"Druar C, Yu F, Barnes JL, Okinaka RT, Chantratita N, Beg S, Stratilo CW, Olive AJ, Soltes G, Russell ML, Limmathurotsakul D, Norton RE, Ni SX, Picking WD, Jackson PJ, Stewart DI, Tsvetnitsky V, Picking WL, Cherwonogrodzky JW, Ketheesan N, Peacock SJ, Wiersma EJ",Evaluating Burkholderia pseudomallei Bip proteins as vaccines and Bip antibodies as detection agents,"2008","52","1","78-87",FEMS immunology and medical microbiology,,,,,,,,"17995960",,,0,10,0,0,0,,,"2018 Protegen Update Autogenerated"
4719,137,"Thomas et al., 2009",journal,"Thomas LD, Cripps AW, Kyd JM",Immune response mechanisms against Pseudomonas aeruginosa associated with mucosal immunization with protein antigens in a rat model of acute lung infection,"2009","27","25-26","3324-3330",Vaccine,,,,,,,,"19200832",,,0,10,0,0,0,,,"2018 Protegen Update Autogenerated"
4720,138,"Reddy et al., 2015",journal,"Reddy PN, Paul S, Sripathy MH, Batra HV",Evaluation of recombinant SEA-TSST fusion toxoid for protection against superantigen induced toxicity in mouse model,"2015","103","","106-113",Toxicon : official journal of the International Society on Toxinology,,,,,,,,"26091873",,,0,10,0,0,0,,,"2018 Protegen Update Autogenerated"
4721,141,"Brautigam et al., 2016",journal,"Brautigam CA, Deka RK, Liu WZ, Norgard MV",The Tp0684 (MglB-2) Lipoprotein of Treponema pallidum: A Glucose-Binding Protein with Divergent Topology,"2016","11","8",e0161022,PloS one,,,,,,,,"27536942",,,0,10,0,0,0,,,"2018 Protegen Update Autogenerated"
4722,24,"Islam et al., 2010",journal,"Islam A, Raghupathy R, Albert MJ","Recombinant PorA, the major outer membrane protein of Campylobacter jejuni, provides heterologous protection in an adult mouse intestinal colonization model","2010","17","11","1666-1671",Clinical and vaccine immunology : CVI,,,,,,,,"20861330",,,0,10,0,0,0,,,"2018 Protegen Update Autogenerated"
4723,25,"McNeilly et al., 2015",journal,"McNeilly TN, Mitchell MC, Corbishley A, Nath M, Simmonds H, McAteer SP, Mahajan A, Low JC, Smith DG, Huntley JF, Gally DL","Optimizing the Protection of Cattle against Escherichia coli O157:H7 Colonization through Immunization with Different Combinations of H7 Flagellin, Tir, Intimin-531 or EspA","2015","10","5",e0128391,PloS one,,,,,,,,"26020530",,,0,10,0,0,0,,,"2018 Protegen Update Autogenerated"
4724,137,"Wu et al., 2012",journal,"Wu W, Huang J, Duan B, Traficante DC, Hong H, Risech M, Lory S, Priebe GP",Th17-stimulating protein vaccines confer protection against Pseudomonas aeruginosa pneumonia,"2012","186","5","420-427",American journal of respiratory and critical care medicine,,,,,,,,"22723292",,,0,10,0,0,0,,,"2018 Protegen Update Autogenerated"
4725,140,"Guerino et al., 2011",journal,"Guerino MT, Postol E, Demarchi LM, Martins CO, Mundel LR, Kalil J, Guilherme L","HLA class II transgenic mice develop a safe and long lasting immune response against StreptInCor, an anti-group A streptococcus vaccine candidate","2011","29","46","8250-8256",Vaccine,,,,,,,,"21907752",,,0,10,0,0,0,,,"2018 Protegen Update Autogenerated"
4726,200,"Chen et al., 2006",journal,"Chen AY, Fry SR, Forbes-Faulkner J, Daggard GE, Mukkur TK",Comparative immunogenicity of M. hyopneumoniae NrdF encoded in different expression systems delivered orally via attenuated S. typhimurium aroA in mice,"2006","114","3-4","252-259",Veterinary microbiology,,,,,,,,"16426773",,,0,10,0,0,0,,,"2018 Protegen Update Autogenerated"
4727,14,"Webb et al., 2017",journal,"Webb RP, Smith TJ, Smith LA, Wright PM, Guernieri RL, Brown JL, Skerry JC",Recombinant Botulinum Neurotoxin Hc Subunit (BoNT Hc) and Catalytically Inactive Clostridium botulinum Holoproteins (ciBoNT HPs) as Vaccine Candidates for the Prevention of Botulism,"2017","9","9","",Toxins,,,,,,,,"28869522",,,0,10,0,0,0,,,"2018 Protegen Update Autogenerated"
4728,47,"Xu et al., 2017",journal,"Xu Q, Pryharski K, Pichichero ME",Trivalent pneumococcal protein vaccine protects against experimental acute otitis media caused by Streptococcus pneumoniae in an infant murine model,"2017","35","2","337-344",Vaccine,,,,,,,,"27919628",,,0,10,0,0,0,,,"2018 Protegen Update Autogenerated"
4729,102,"Ekong et al., 2009",journal,"Ekong EE, Okenu DN, Mania-Pramanik J, He Q, Igietseme JU, Ananaba GA, Lyn D, Black C, Eko FO","A Vibrio cholerae ghost-based subunit vaccine induces cross-protective chlamydial immunity that is enhanced by CTA2B, the nontoxic derivative of cholera toxin","2009","55","2","280-291",FEMS immunology and medical microbiology,,,,,,,,"19040663",,,0,10,0,0,0,,,"2018 Protegen Update Autogenerated"
4730,140,"Niedermeyer et al., 2014",journal,"Niedermeyer SE, Penfound TA, Hohn C, Li Y, Homayouni R, Zhao J, Dale JB",Group A streptococcus expresses a trio of surface proteins containing protective epitopes,"2014","21","10","1421-1425",Clinical and vaccine immunology : CVI,,,,,,,,"25080552",,,0,10,0,0,0,,,"2018 Protegen Update Autogenerated"
4731,138,"Mamo et al., 2000",journal,"Mamo W, Frman G, Mller HP",Protection induced in mice vaccinated with recombinant collagen-binding protein (CnBP) and alpha-toxoid against intramammary infection with Staphylococcus aureus,"2000","44","5","381-384",Microbiology and immunology,,,,,,,,"10888356",,,0,10,0,0,0,,,"2018 Protegen Update Autogenerated"
4732,108,"Gong et al., 2014",journal,"Gong W, Xiong X, Qi Y, Jiao J, Duan C, Wen B",Surface protein Adr2 of Rickettsia rickettsii induced protective immunity against Rocky Mountain spotted fever in C3H/HeN mice,"2014","32","18","2027-2033",Vaccine,,,,,,,,"24582636",,,0,10,0,0,0,,,"2018 Protegen Update Autogenerated"
4733,12,"Sinha and Bhatnagar, 2013",journal,"Sinha K, Bhatnagar R",Recombinant GroEL enhances protective antigen-mediated protection against Bacillus anthracis spore challenge,"2013","202","2","153-165",Medical microbiology and immunology,,,,,,,,"23263010",,,0,10,0,0,0,,,"2018 Protegen Update Autogenerated"
4734,113,"Yu et al., 2014",journal,"Yu H, Karunakaran KP, Jiang X, Brunham RC",Evaluation of a multisubunit recombinant polymorphic membrane protein and major outer membrane protein T cell vaccine against Chlamydia muridarum genital infection in three strains of mice,"2014","32","36","4672-4680",Vaccine,,,,,,,,"24992718",,,0,10,0,0,0,,,"2018 Protegen Update Autogenerated"
4735,134,"O'Riordan et al., 2012",journal,"O'Riordan AA, Morales VA, Mulligan L, Faheem N, Windle HJ, Kelleher DP",Alkyl hydroperoxide reductase: a candidate Helicobacter pylori vaccine,"2012","30","26","3876-3884",Vaccine,,,,,,,,"22512976",,,0,10,0,0,0,,,"2018 Protegen Update Autogenerated"
4736,209,"Hu et al., 2012",journal,"Hu YH, Dang W, Deng T, Sun L","Edwardsiella tarda DnaK: expression, activity, and the basis for the construction of a bivalent live vaccine against E. tarda and Streptococcus iniae","2012","32","4","616-620",Fish &amp; shellfish immunology,,,,,,,,"22281608",,,0,10,0,0,0,,,"2018 Protegen Update Autogenerated"
4737,137,"Soldatenkova et al., 2013",journal,"Soldatenkova AV, Gederova LA, Akhmatova NK, Mikhalova NA",[Pseudomonas aeruginosa recombinant proteins: effect on mice cytokine profile],"2013","","6","80-87","Zhurnal mikrobiologii, epidemiologii, i immunobiologii",,,,,,,,"24605680",,,0,10,0,0,0,,,"2018 Protegen Update Autogenerated"
4738,43,"Pore and Chakrabarti, 2013",journal,"Pore D, Chakrabarti MK",Outer membrane protein A (OmpA) from Shigella flexneri 2a: a promising subunit vaccine candidate,"2013","31","36","3644-3650",Vaccine,,,,,,,,"23764536",,,0,10,0,0,0,,,"2018 Protegen Update Autogenerated"
4739,31,"Tabatabaee et al., 2016",journal,"Tabatabaee Bafroee AS, Siadat SD, Mousavi SF, Aghasadeghi MR, Khorsand H, Nejati M, Sadat SM, Mahdavi M",Recombinant C-terminal 311 amino acids of HapS adhesin as a vaccine candidate for nontypeable Haemophilus influenzae: A study on immunoreactivity in Balb/C mouse,"2016","98","","106-111",Microbial pathogenesis,,,,,,,,"27377430",,,0,10,0,0,0,,,"2018 Protegen Update Autogenerated"
4740,81,"Nally et al., 2000",journal,"Nally JE, Artiushin S, Sheoran AS, Burns PJ, Simon B, Gilley RM, Gibson J, Sullivan S, Timoney JF",Induction of mucosal and systemic antibody specific for SeMF3 of Streptococcus equi by intranasal vaccination using a sucrose acetate isobutyrate based delivery system,"2000","19","4-5","492-497",Vaccine,,,,,,,,"11027813",,,0,10,0,0,0,,,"2018 Protegen Update Autogenerated"
4741,140,"Morefield et al., 2014",journal,"Morefield G, Touhey G, Lu F, Dunham A, HogenEsch H",Development of a recombinant fusion protein vaccine formulation to protect against Streptococcus pyogenes,"2014","32","30","3810-3815",Vaccine,,,,,,,,"24837509",,,0,10,0,0,0,,,"2018 Protegen Update Autogenerated"
4742,195,"Humphryes et al., 2014",journal,"Humphryes PC, Weeks ME, AbuOun M, Thomson G, Nez A, Coldham NG",Vaccination with leptospiral outer membrane lipoprotein LipL32 reduces kidney invasion of Leptospira interrogans serovar canicola in hamsters,"2014","21","4","546-551",Clinical and vaccine immunology : CVI,,,,,,,,"24521782",,,0,10,0,0,0,,,"2018 Protegen Update Autogenerated"
4743,195,"Fernandes et al., 2017",journal,"Fernandes LGV, Teixeira AF, Filho AFS, Souza GO, Vasconcellos SA, Heinemann MB, Romero EC, Nascimento ALTO",Immune response and protective profile elicited by a multi-epitope chimeric protein derived from Leptospira interrogans,"2017","57","","61-69",International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases,,,,,,,,"28161462",,,0,10,0,0,0,,,"2018 Protegen Update Autogenerated"
4744,137,"Behrouz et al., 2016",journal,"Behrouz B, Mahdavi M, Amirmozafari N, Fatemi MJ, Irajian G, Bahroudi M, Hashemi FB",Immunogenicity of Pseudomonas aeruginosa recombinant b-type fagellin as a vaccine candidate: Protective efficacy in a murine burn wound sepsis model,"2016","","","",Burns : journal of the International Society for Burn Injuries,,,,,,,,"27156804",,,0,10,0,0,0,,,"2018 Protegen Update Autogenerated"
4745,121,"Haque et al., 2006",journal,"Haque A, Chu K, Easton A, Stevens MP, Galyov EE, Atkins T, Titball R, Bancroft GJ","A live experimental vaccine against Burkholderia pseudomallei elicits CD4+ T cell-mediated immunity, priming T cells specific for 2 type III secretion system proteins","2006","194","9","1241-1248",The Journal of infectious diseases,,,,,,,,"17041850",,,0,10,0,0,0,,,"2018 Protegen Update Autogenerated"
4746,209,"Jiao et al., 2010",journal,"Jiao XD, Zhang M, Cheng S, Sun L","Analysis of Edwardsiella tarda DegP, a serine protease and a protective immunogen","2010","28","4","672-677",Fish &amp; shellfish immunology,,,,,,,,"20060910",,,0,10,0,0,0,,,"2018 Protegen Update Autogenerated"
4747,138,"Rauch et al., 2014",journal,"Rauch S, Gough P, Kim HK, Schneewind O, Missiakas D",Vaccine protection of leukopenic mice against Staphylococcus aureus bloodstream infection,"2014","82","11","4889-4898",Infection and immunity,,,,,,,,"25183728",,,0,10,0,0,0,,,"2018 Protegen Update Autogenerated"
4748,139,"Liu et al., 2013",journal,"Liu G, Zhang W, Lu C",Identification of immunoreactive proteins of Streptococcus agalactiae isolated from cultured tilapia in China,"2013","69","3","223-231",Pathogens and disease,,,,,,,,"23929656",,,0,10,0,0,0,,,"2018 Protegen Update Autogenerated"
4749,134,"Zhang et al., 2015",journal,"Zhang X, Zhang J, Yang F, Wu W, Sun H, Xie Q, Si W, Zou Q, Yang Z",Immunization with Heat Shock Protein A and -Glutamyl Transpeptidase Induces Reduction on the Helicobacter pylori Colonization in Mice,"2015","10","6",e0130391,PloS one,,,,,,,,"26102080",,,0,10,0,0,0,,,"2018 Protegen Update Autogenerated"
4750,141,"Borenstein et al., 1988",journal,"Borenstein LA, Radolf JD, Fehniger TE, Blanco DR, Miller JN, Lovett MA",Immunization of rabbits with recombinant Treponema pallidum surface antigen 4D alters the course of experimental syphilis,"1988","140","7","2415-2421","Journal of immunology (Baltimore, Md. : 1950)",,,,,,,,"2450921",,,0,10,0,0,0,,,"2018 Protegen Update Autogenerated"
4751,209,"Song et al., 2013",journal,"Song M, Xie J, Peng X, Li H",Identification of protective immunogens from extracellular secretome of Edwardsiella tarda,"2013","35","6","1932-1936",Fish &amp; shellfish immunology,,,,,,,,"24099803",,,0,10,0,0,0,,,"2018 Protegen Update Autogenerated"
4752,141,"Centurion-Lara et al., 1997",journal,"Centurion-Lara A, Arroll T, Castillo R, Shaffer JM, Castro C, Van Voorhis WC, Lukehart SA",Conservation of the 15-kilodalton lipoprotein among Treponema pallidum subspecies and strains and other pathogenic treponemes: genetic and antigenic analyses,"1997","65","4","1440-1444",Infection and immunity,,,,,,,,"9119485",,,0,10,0,0,0,,,"2018 Protegen Update Autogenerated"
4753,47,"Anderson et al., 2016",journal,"Anderson RJ, Guru S, Weeratna R, Makinen S, Falconer DJ, Sheppard NC, Lang S, Chang B, Goenaga AL, Green BA, Merson JR, Gracheck SJ, Eyles JE",In vivo screen of genetically conserved Streptococcus pneumoniae proteins for protective immunogenicity,"2016","34","50","6292-6300",Vaccine,,,,,,,,"27816374",,,0,10,0,0,0,,,"2018 Protegen Update Autogenerated"
4754,108,"Gong et al., 2015",journal,"Gong W, Qi Y, Xiong X, Jiao J, Duan C, Wen B",Rickettsia rickettsii outer membrane protein YbgF induces protective immunity in C3H/HeN mice,"2015","11","3","642-649",Human vaccines &amp; immunotherapeutics,,,,,,,,"25714655",,,0,10,0,0,0,,,"2018 Protegen Update Autogenerated"
4755,195,"Umthong et al., 2015",journal,"Umthong S, Buaklin A, Jacquet A, Sangjun N, Kerdkaew R, Patarakul K, Palaga T",Immunogenicity of a DNA and Recombinant Protein Vaccine Combining LipL32 and Loa22 for Leptospirosis Using Chitosan as a Delivery System,"2015","25","4","526-536",Journal of microbiology and biotechnology,,,,,,,,"25348693",,,0,10,0,0,0,,,"2018 Protegen Update Autogenerated"
4756,81,"Fu et al., 2013",journal,"Fu Q, Wei Z, Liu X, Xiao P, Lu Z, Chen Y","Glyceraldehyde-3-phosphate dehydrogenase, an immunogenic Streptococcus equi ssp. zooepidemicus adhesion protein and protective antigen","2013","23","4","579-585",Journal of microbiology and biotechnology,,,,,,,,"23568215",,,0,10,0,0,0,,,"2018 Protegen Update Autogenerated"
4757,86,"Hu et al., 2015",journal,"Hu X, Yan H, Liu K, Hu J, Qi C, Yang J, Liu Y, Zhao J, Liu J",Identification and characterization of a novel stress-responsive outer membrane protein Lip40 from Actinobacillus pleuropneumoniae,"2015","15","","106",BMC biotechnology,,,,,,,,"26608465",,,0,10,0,0,0,,,"2018 Protegen Update Autogenerated"
4758,12,"Ashtekar et al., 2012",journal,"Ashtekar AR, Katz J, Xu Q, Michalek SM",A mucosal subunit vaccine protects against lethal respiratory infection with Francisella tularensis LVS,"2012","7","11",e50460,PloS one,,,,,,,,"23209745",,,0,10,0,0,0,,,"2018 Protegen Update Autogenerated"
4759,25,"Liu et al., 2012",journal,"Liu C, Chen Z, Tan C, Liu W, Xu Z, Zhou R, Chen H",Immunogenic characterization of outer membrane porins OmpC and OmpF of porcine extraintestinal pathogenic Escherichia coli,"2012","337","2","104-111",FEMS microbiology letters,,,,,,,,"23003111",,,0,10,0,0,0,,,"2018 Protegen Update Autogenerated"
4760,140,"Lei et al., 2004",journal,"Lei B, Liu M, Chesney GL, Musser JM",Identification of new candidate vaccine antigens made by Streptococcus pyogenes: purification and characterization of 16 putative extracellular lipoproteins,"2004","189","1","79-89",The Journal of infectious diseases,,,,,,,,"14702157",,,0,10,0,0,0,,,"2018 Protegen Update Autogenerated"
4761,25,"Habibi et al., 2015",journal,"Habibi M, Asadi Karam MR, Bouzari S",Evaluation of the effect of MPL and delivery route on immunogenicity and protectivity of different formulations of FimH and MrpH from uropathogenic Escherichia coli and Proteus mirabilis in a UTI mouse model,"2015","28","1","70-78",International immunopharmacology,,,,,,,,"26033493",,,0,10,0,0,0,,,"2018 Protegen Update Autogenerated"
4762,86,"van and Frey, 2003",journal,"van den Bosch H, Frey J",Interference of outer membrane protein PalA with protective immunity against Actinobacillus pleuropneumoniae infections in vaccinated pigs,"2003","21","25-26","3601-3607",Vaccine,,,,,,,,"12922088",,,0,10,0,0,0,,,"2018 Protegen Update Autogenerated"
4763,200,"King et al., 1997",journal,"King KW, Faulds DH, Rosey EL, Yancey RJ Jr",Characterization of the gene encoding Mhp1 from Mycoplasma hyopneumoniae and examination of Mhp1's vaccine potential,"1997","15","1","25-35",Vaccine,,,,,,,,"9041663",,,0,10,0,0,0,,,"2018 Protegen Update Autogenerated"
4764,209,"Sun et al., 2010",journal,"Sun Y, Liu CS, Sun L",Identification of an Edwardsiella tarda surface antigen and analysis of its immunoprotective potential as a purified recombinant subunit vaccine and a surface-anchored subunit vaccine expressed by a fish commensal strain,"2010","28","40","6603-6608",Vaccine,,,,,,,,"20673823",,,0,10,0,0,0,,,"2018 Protegen Update Autogenerated"
4765,140,"Severin et al., 2007",journal,"Severin A, Nickbarg E, Wooters J, Quazi SA, Matsuka YV, Murphy E, Moutsatsos IK, Zagursky RJ, Olmsted SB",Proteomic analysis and identification of Streptococcus pyogenes surface-associated proteins,"2007","189","5","1514-1522",Journal of bacteriology,,,,,,,,"17142387",,,0,10,0,0,0,,,"2018 Protegen Update Autogenerated"
4766,111,"Branger et al., 2009",journal,"Branger CG, Torres-Escobar A, Sun W, Perry R, Fetherston J, Roland KL, Curtiss R 3rd",Oral vaccination with LcrV from Yersinia pestis KIM delivered by live attenuated Salmonella enterica serovar Typhimurium elicits a protective immune response against challenge with Yersinia pseudotuberculosis and Yersinia enterocolitica,"2009","27","39","5363-5370",Vaccine,,,,,,,,"19596407",,,0,10,0,0,0,,,"2018 Protegen Update Autogenerated"
4767,200,"Chen et al., 2006",journal,"Chen AY, Fry SR, Forbes-Faulkner J, Daggard G, Mukkur TK",Evaluation of the immunogenicity of the P97R1 adhesin of Mycoplasma hyopneumoniae as a mucosal vaccine in mice,"2006","55",Pt 7,"923-929",Journal of medical microbiology,,,,,,,,"16772421",,,0,10,0,0,0,,,"2018 Protegen Update Autogenerated"
4768,112,"Atanu et al., 2013",journal,"Atanu FO, Oviedo-Orta E, Watson KA",A novel transport mechanism for MOMP in Chlamydophila pneumoniae and its putative role in immune-therapy,"2013","8","4",e61139,PloS one,,,,,,,,"23637791",,,0,10,0,0,0,,,"2018 Protegen Update Autogenerated"
4769,24,"Theoret et al., 2012",journal,"Theoret JR, Cooper KK, Zekarias B, Roland KL, Law BF, Curtiss R 3rd, Joens LA",The Campylobacter jejuni Dps homologue is important for in vitro biofilm formation and cecal colonization of poultry and may serve as a protective antigen for vaccination,"2012","19","9","1426-1431",Clinical and vaccine immunology : CVI,,,,,,,,"22787197",,,0,10,0,0,0,,,"2018 Protegen Update Autogenerated"
4770,141,"Centurion-Lara et al., 1999",journal,"Centurion-Lara A, Castro C, Barrett L, Cameron C, Mostowfi M, Van Voorhis WC, Lukehart SA",Treponema pallidum major sheath protein homologue Tpr K is a target of opsonic antibody and the protective immune response,"1999","189","4","647-656",The Journal of experimental medicine,,,,,,,,"9989979",,,0,10,0,0,0,,,"2018 Protegen Update Autogenerated"
4771,208,"Tsai et al., 2007",journal,"Tsai PY, Hsu MC, Huang CT, Li SY",Human antibody and antigen response to IncA antibody of Chlamydia trachomatis,"2007","20","1","156-161",International journal of immunopathology and pharmacology,,,,,,,,"17346439",,,0,10,0,0,0,,,"2018 Protegen Update Autogenerated"
4772,140,"Zhang et al., 2017",journal,"Zhang X, Song Y, Li Y, Cai M, Meng Y, Zhu H",Immunization with Streptococcal Heme Binding Protein (Shp) Protects Mice Against Group A Streptococcus Infection,"2017","973","","115-124",Advances in experimental medicine and biology,,,,,,,,"28190144",,,0,10,0,0,0,,,"2018 Protegen Update Autogenerated"
4773,134,"Liu et al., 2004",journal,"Liu XL, Li SQ, Liu CJ, Tao HX, Zhang ZS",Antigen epitope of Helicobacter pylori vacuolating cytotoxin A,"2004","10","16","2340-2343",World journal of gastroenterology,,,,,,,,"15285016",,,0,10,0,0,0,,,"2018 Protegen Update Autogenerated"
4774,138,"Nilsson et al., 1999",journal,"Nilsson IM, Verdrengh M, Ulrich RG, Bavari S, Tarkowski A",Protection against Staphylococcus aureus sepsis by vaccination with recombinant staphylococcal enterotoxin A devoid of superantigenicity,"1999","180","4","1370-1373",The Journal of infectious diseases,,,,,,,,"10479175",,,0,10,0,0,0,,,"2018 Protegen Update Autogenerated"
4775,14,"Prisilla et al., 2016",journal,"Prisilla A, Prathiviraj R, Sasikala R, Chellapandi P",Structural constraints-based evaluation of immunogenic avirulent toxins from Clostridium botulinum C2 and C3 toxins as subunit vaccines,"2016","44","","17-27","Infection, genetics and evolution : journal of molecular epidemiology and evolutionary genetics in infectious diseases",,,,,,,,"27320793",,,0,10,0,0,0,,,"2018 Protegen Update Autogenerated"
4776,62,"Khrustaleva et al., 2015",journal,"Khrustaleva TA, Khrustalev VV, Barkovsky EV, Kolodkina VL, Astapov AA",Structural and antigenic features of the synthetic SF23 peptide corresponding to the receptor binding fragment of diphtheria toxin,"2015","63","2","235-244",Molecular immunology,,,,,,,,"25062832",,,0,10,0,0,0,,,"2018 Protegen Update Autogenerated"
4777,209,"Jiao et al., 2010",journal,"Jiao XD, Hu YH, Sun L",Dissection and localization of the immunostimulating domain of Edwardsiella tarda FliC,"2010","28","34","5635-5640",Vaccine,,,,,,,,"20580470",,,0,10,0,0,0,,,"2018 Protegen Update Autogenerated"
4778,178,"Barasuol et al., 2017",journal,"Barasuol BM, Guizzo JA, Fegan JE, Martnez-Martnez S, Rodrguez-Ferri EF, Gutirrez-Martn CB, Kreutz LC, Schryvers AB, Frandoloso R",New insights about functional and cross-reactive properties of antibodies generated against recombinant TbpBs of Haemophilus parasuis,"2017","7","1","10377",Scientific reports,,,,,,,,"28871190",,,0,10,0,0,0,,,"2018 Protegen Update Autogenerated"
4779,112,"Faludi and Szab, 2011",journal,"Faludi I, Szab M",Vaccination with DNA vector expressing chlamydial low calcium response protein E (LcrE) against Chlamydophila pneumoniae infection,"2011","58","2","123-134",Acta microbiologica et immunologica Hungarica,,,,,,,,"21715282",,,0,10,0,0,0,,,"2018 Protegen Update Autogenerated"
4780,25,"Dziva et al., 2007",journal,"Dziva F, Vlisidou I, Crepin VF, Wallis TS, Frankel G, Stevens MP","Vaccination of calves with EspA, a key colonisation factor of Escherichia coli O157:H7, induces antigen-specific humoral responses but does not confer protection against intestinal colonisation","2007","123","1-3","254-261",Veterinary microbiology,,,,,,,,"17374460",,,0,10,0,0,0,,,"2018 Protegen Update Autogenerated"
4781,102,"Vishwakarma et al., 2015",journal,"Vishwakarma V, Sahoo SS, Das S, Ray S, Hardt WD, Suar M",Cholera toxin-B (ctxB) antigen expressing Salmonella Typhimurium polyvalent vaccine exerts protective immune response against Vibrio cholerae infection,"2015","33","15","1880-1889",Vaccine,,,,,,,,"25701672",,,0,10,0,0,0,,,"2018 Protegen Update Autogenerated"
4782,134,"Guo et al., 2017",journal,"Guo L, Yang H, Tang F, Yin R, Liu H, Gong X, Wei J, Zhang Y, Xu G, Liu K","Oral Immunization with a Multivalent Epitope-Based Vaccine, Based on NAP, Urease, HSP60, and HpaA, Provides Therapeutic Effect on &lt;i&gt;H. pylori&lt;/i&gt; Infection in Mongolian gerbils","2017","7","","349",Frontiers in cellular and infection microbiology,,,,,,,,"28824883",,,0,10,0,0,0,,,"2018 Protegen Update Autogenerated"
4783,140,"Ma et al., 2014",journal,"Ma C, Liu Z, Li W, Qian X, Zhang S, Gao X, Jiang S, Wei L",FbaA- and M protein-based multi-epitope vaccine elicits strong protective immune responses against group A streptococcus in mouse model,"2014","16","5","409-418",Microbes and infection,,,,,,,,"24704476",,,0,10,0,0,0,,,"2018 Protegen Update Autogenerated"
4784,135,"Bryksin et al., 2005",journal,"Bryksin AV, Godfrey HP, Carbonaro CA, Wormser GP, Aguero-Rosenfeld ME, Cabello FC","Borrelia burgdorferi BmpA, BmpB, and BmpD proteins are expressed in human infection and contribute to P39 immunoblot reactivity in patients with Lyme disease","2005","12","8","935-940",Clinical and diagnostic laboratory immunology,,,,,,,,"16085911",,,0,10,0,0,0,,,"2018 Protegen Update Autogenerated"
4785,8,"Suryanarayana et al., 2016",journal,"Suryanarayana N, Verma M, Thavachelvam K, Saxena N, Mankere B, Tuteja U, Hmuaka V",Generation of a novel chimeric PALFn antigen of Bacillus anthracis and its immunological characterization in mouse model,"2016","100","19","8439-8451",Applied microbiology and biotechnology,,,,,,,,"27364624",,,0,10,0,0,0,,,"2018 Protegen Update Autogenerated"
4786,208,"Starnbach et al., 2003",journal,"Starnbach MN, Loomis WP, Ovendale P, Regan D, Hess B, Alderson MR, Fling SP",An inclusion membrane protein from Chlamydia trachomatis enters the MHC class I pathway and stimulates a CD8+ T cell response,"2003","171","9","4742-4749","Journal of immunology (Baltimore, Md. : 1950)",,,,,,,,"14568950",,,0,10,0,0,0,,,"2018 Protegen Update Autogenerated"
4787,138,"Karauzum et al., 2013",journal,"Karauzum H, Adhikari RP, Sarwar J, Devi VS, Abaandou L, Haudenschild C, Mahmoudieh M, Boroun AR, Vu H, Nguyen T, Warfield KL, Shulenin S, Aman MJ",Structurally designed attenuated subunit vaccines for S. aureus LukS-PV and LukF-PV confer protection in a mouse bacteremia model,"2013","8","6",e65384,PloS one,,,,,,,,"23762356",,,0,10,0,0,0,,,"2018 Protegen Update Autogenerated"
4788,31,"Thornton et al., 2017",journal,"Thornton RB, Kirkham LS, Corscadden KJ, Wiertsema SP, Fuery A, Jones BJ, Coates HL, Vijayasekaran S, Zhang G, Keil A, Richmond PC",Australian Aboriginal Children with Otitis Media Have Reduced Antibody Titers to Specific Nontypeable Haemophilus influenzae Vaccine Antigens,"2017","24","4","",Clinical and vaccine immunology : CVI,,,,,,,,"28151410",,,0,10,0,0,0,,,"2018 Protegen Update Autogenerated"
4789,43,"Malaei et al., 2013",journal,"Malaei F, Hesaraki M, Saadati M, Ahdi AM, Sadraeian M, Honari H, Nazarian S",Immunogenicity of a new recombinant IpaC from Shigella dysenteriae type I in guinea pig as a vaccine candidate,"2013","10","2","110-117",Iranian journal of immunology : IJI,,,,,,,,"23811550",,,0,10,0,0,0,,,"2018 Protegen Update Autogenerated"
4790,208,"Gervassi et al., 2004",journal,"Gervassi AL, Grabstein KH, Probst P, Hess B, Alderson MR, Fling SP",Human CD8+ T cells recognize the 60-kDa cysteine-rich outer membrane protein from Chlamydia trachomatis,"2004","173","11","6905-6913","Journal of immunology (Baltimore, Md. : 1950)",,,,,,,,"15557186",,,0,10,0,0,0,,,"2018 Protegen Update Autogenerated"
4791,195,"Vijayachari et al., 2015",journal,"Vijayachari P, Vedhagiri K, Mallilankaraman K, Mathur PP, Sardesai NY, Weiner DB, Ugen KE, Muthumani K",Immunogenicity of a novel enhanced consensus DNA vaccine encoding the leptospiral protein LipL45,"2015","11","8","1945-1953",Human vaccines &amp; immunotherapeutics,,,,,,,,"26020621",,,0,10,0,0,0,,,"2018 Protegen Update Autogenerated"
4792,178,"Li et al., 2017",journal,"Li M, Cai RJ, Song S, Jiang ZY, Li Y, Gou HC, Chu PP, Li CL, Qiu HJ",Evaluation of immunogenicity and protective efficacy of recombinant outer membrane proteins of Haemophilus parasuis serovar 5 in a murine model,"2017","12","4",e0176537,PloS one,,,,,,,,"28448603",,,0,10,0,0,0,,,"2018 Protegen Update Autogenerated"
4793,137,"Hassan et al., 2018",journal,"Hassan R, El-Naggar W, Abd El-Aziz AM, Shaaban M, Kenawy HI, Ali YM",Immunization with outer membrane proteins (OprF and OprI) and flagellin Bprotects mice from pulmonary infection with mucoid and nonmucoid Pseudomonas aeruginosa,"2018","51","3","312-320","Journal of microbiology, immunology, and infection = Wei mian yu gan ran za zhi",,,,,,,,"28291719",,,0,10,0,0,0,,,"2018 Protegen Update Autogenerated"
4794,81,"Flock et al., 2004",journal,"Flock M, Jacobsson K, Frykberg L, Hirst TR, Franklin A, Guss B, Flock JI",Recombinant Streptococcus equi proteins protect mice in challenge experiments and induce immune response in horses,"2004","72","6","3228-3236",Infection and immunity,,,,,,,,"15155624",,,0,10,0,0,0,,,"2018 Protegen Update Autogenerated"
4795,25,"Harris et al., 2011",journal,"Harris JA, Roy K, Woo-Rasberry V, Hamilton DJ, Kansal R, Qadri F, Fleckenstein JM",Directed evaluation of enterotoxigenic Escherichia coli autotransporter proteins as putative vaccine candidates,"2011","5","12",e1428,PLoS neglected tropical diseases,,,,,,,,"22163060",,,0,10,0,0,0,,,"2018 Protegen Update Autogenerated"
4796,25,"Van et al., 2017",journal,"Van Goor A, Stromberg ZR, Mellata M",A recombinant multi-antigen vaccine with broad protection potential against avian pathogenic Escherichia coli,"2017","12","8",e0183929,PloS one,,,,,,,,"28837660",,,0,10,0,0,0,,,"2018 Protegen Update Autogenerated"
4797,134,"Li et al., 2012",journal,"Li HB, Zhang JY, He YF, Chen L, Li B, Liu KY, Yang WC, Zhao Z, Zou QM, Wu C",Systemic immunization with an epitope-based vaccine elicits a Th1-biased response and provides protection against Helicobacter pylori in mice,"2012","31","1","120-126",Vaccine,,,,,,,,"23137845",,,0,10,0,0,0,,,"2018 Protegen Update Autogenerated"
4798,208,"Goodall et al., 2001",journal,"Goodall JC, Yeo G, Huang M, Raggiaschi R, Gaston JS",Identification of Chlamydia trachomatis antigens recognized by human CD4+ T lymphocytes by screening an expression library,"2001","31","5","1513-1522",European journal of immunology,,,,,,,,"11465108",,,0,10,0,0,0,,,"2018 Protegen Update Autogenerated"
4799,141,"Morgan et al., 2002",journal,"Morgan CA, Lukehart SA, Van Voorhis WC",Immunization with the N-terminal portion of Treponema pallidum repeat protein K attenuates syphilitic lesion development in the rabbit model,"2002","70","12","6811-6816",Infection and immunity,,,,,,,,"12438357",,,0,10,0,0,0,,,"2018 Protegen Update Autogenerated"
4800,140,"Reglinski et al., 2016",journal,"Reglinski M, Lynskey NN, Choi YJ, Edwards RJ, Sriskandan S",Development of a multicomponent vaccine for Streptococcus pyogenes based on the antigenic targets of IVIG,"2016","72","4","450-459",The Journal of infection,,,,,,,,"26880087",,,0,10,0,0,0,,,"2018 Protegen Update Autogenerated"
4801,134,"Guo et al., 2017",journal,"Guo L, Yin R, Xu G, Gong X, Chang Z, Hong D, Liu H, Ding S, Han X, Li Y, Tang F, Liu K","Immunologic properties and therapeutic efficacy of a multivalent epitope-based vaccine against four Helicobacter pylori adhesins (urease, Lpp20, HpaA, and CagL) in Mongolian gerbils","2017","22","6","",Helicobacter,,,,,,,,"28851031",,,0,10,0,0,0,,,"2018 Protegen Update Autogenerated"
4802,209,"Liu et al., 2016",journal,"Liu F, Tang X, Sheng X, Xing J, Zhan W",DNA vaccine encoding molecular chaperone GroEL of Edwardsiella tarda confers protective efficacy against edwardsiellosis,"2016","79","","55-65",Molecular immunology,,,,,,,,"27701022",,,0,10,0,0,0,,,"2018 Protegen Update Autogenerated"
4803,137,"Campodnico et al., 2010",journal,"Campodnico VL, Llosa NJ, Grout M, Dring G, Maira-Litrn T, Pier GB",Evaluation of flagella and flagellin of Pseudomonas aeruginosa as vaccines,"2010","78","2","746-755",Infection and immunity,,,,,,,,"19995892",,,0,10,0,0,0,,,"2018 Protegen Update Autogenerated"
4804,25,"Hu et al., 2014",journal,"Hu JC, Mathias-Santos C, Greene CJ, King-Lyons ND, Rodrigues JF, Hajishengallis G, Ferreira LC, Connell TD",Intradermal administration of the Type II heat-labile enterotoxins LT-IIb and LT-IIc of enterotoxigenic Escherichia coli enhances humoral and CD8+ T cell immunity to a co-administered antigen,"2014","9","12",e113978,PloS one,,,,,,,,"25536061",,,0,10,0,0,0,,,"2018 Protegen Update Autogenerated"
4805,108,"Gazi et al., 2013",journal,"Gazi M, Caro-Gomez E, Goez Y, Cespedes MA, Hidalgo M, Correa P, Valbuena G","Discovery of a protective Rickettsia prowazekii antigen recognized by CD8+ T cells, RP884, using an in vivo screening platform","2013","8","10",e76253,PloS one,,,,,,,,"24146844",,,0,10,0,0,0,,,"2018 Protegen Update Autogenerated"
4806,141,"Cameron et al., 1998",journal,"Cameron CE, Castro C, Lukehart SA, Van Voorhis WC",Function and protective capacity of Treponema pallidum subsp. pallidum glycerophosphodiester phosphodiesterase,"1998","66","12","5763-5770",Infection and immunity,,,,,,,,"9826352",,,0,10,0,0,0,,,"2018 Protegen Update Autogenerated"
4807,195,"Atzingen et al., 2012",journal,"Atzingen MV, Vieira ML, Oliveira R, Domingos RF, Mendes RS, Barros AT, Gonales AP, de Morais ZM, Vasconcellos SA, Nascimento AL",Evaluation of immunoprotective activity of six leptospiral proteins in the hamster model of leptospirosis,"2012","6","","79-87",The open microbiology journal,,,,,,,,"23173023",,,0,10,0,0,0,,,"2018 Protegen Update Autogenerated"
4808,209,"Wang et al., 2010",journal,"Wang B, Mo ZL, Xiao P, Li J, Zou YX, Hao B, Li GY","EseD, a putative T3SS translocon component of Edwardsiella tarda, contributes to virulence in fish and is a candidate for vaccine development","2010","12","6","678-685","Marine biotechnology (New York, N.Y.)",,,,,,,,"20072793",,,0,10,0,0,0,,,"2018 Protegen Update Autogenerated"
4809,121,"Harland et al., 2007",journal,"Harland DN, Chu K, Haque A, Nelson M, Walker NJ, Sarkar-Tyson M, Atkins TP, Moore B, Brown KA, Bancroft G, Titball RW, Atkins HS","Identification of a LolC homologue in Burkholderia pseudomallei, a novel protective antigen for melioidosis","2007","75","8","4173-4180",Infection and immunity,,,,,,,,"17517877",,,0,10,0,0,0,,,"2018 Protegen Update Autogenerated"
4810,141,"Kao et al., 2017",journal,"Kao WA, Ptroov H, Ebady R, Lithgow KV, Rojas P, Zhang Y, Kim YE, Kim YR, Odisho T, Gupta N, Moter A, Cameron CE, Moriarty TJ",Identification of Tp0751 (Pallilysin) as a Treponema pallidum Vascular Adhesin by Heterologous Expression in the Lyme disease Spirochete,"2017","7","1","1538",Scientific reports,,,,,,,,"28484210",,,0,10,0,0,0,,,"2018 Protegen Update Autogenerated"
4811,112,"Finco et al., 2005",journal,"Finco O, Bonci A, Agnusdei M, Scarselli M, Petracca R, Norais N, Ferrari G, Garaguso I, Donati M, Sambri V, Cevenini R, Ratti G, Grandi G",Identification of new potential vaccine candidates against Chlamydia pneumoniae by multiple screenings,"2005","23","9","1178-1188",Vaccine,,,,,,,,"15629361",,,0,10,0,0,0,,,"2018 Protegen Update Autogenerated"
4812,79,"Bergh et al., 2013",journal,"Bergh PV, Burr SE, Benedicenti O, von Siebenthal B, Frey J, Wahli T",Antigens of the type-three secretion system of Aeromonas salmonicida subsp. salmonicida prevent protective immunity in rainbow trout,"2013","31","45","5256-5261",Vaccine,,,,,,,,"24012573",,,0,10,0,0,0,,,"2018 Protegen Update Autogenerated"
4813,140,"Chen et al., 2016",journal,"Chen X, Li N, Bi S, Wang X, Wang B",Co-Activation of Th17 and Antibody Responses Provides Efficient Protection against Mucosal Infection by Group A Streptococcus,"2016","11","12",e0168861,PloS one,,,,,,,,"28030629",,,0,10,0,0,0,,,"2018 Protegen Update Autogenerated"
4814,135,"Brandt et al., 2014",journal,"Brandt KS, Patton TG, Allard AS, Caimano MJ, Radolf JD, Gilmore RD",Evaluation of the Borrelia burgdorferi BBA64 protein as a protective immunogen in mice,"2014","21","4","526-533",Clinical and vaccine immunology : CVI,,,,,,,,"24501342",,,0,10,0,0,0,,,"2018 Protegen Update Autogenerated"
4815,140,"Kawabata et al., 2001",journal,"Kawabata S, Kunitomo E, Terao Y, Nakagawa I, Kikuchi K, Totsuka K, Hamada S",Systemic and mucosal immunizations with fibronectin-binding protein FBP54 induce protective immune responses against Streptococcus pyogenes challenge in mice,"2001","69","2","924-930",Infection and immunity,,,,,,,,"11159987",,,0,10,0,0,0,,,"2018 Protegen Update Autogenerated"
4816,140,"Schulze et al., 2017",journal,"Schulze K, Ebensen T, Chandrudu S, Skwarczynski M, Toth I, Olive C, Guzman CA",Bivalent mucosal peptide vaccines administered using the LCP carrier system stimulate protective immune responses against Streptococcus pyogenes infection,"2017","13","8","2463-2474","Nanomedicine : nanotechnology, biology, and medicine",,,,,,,,"28887213",,,0,10,0,0,0,,,"2018 Protegen Update Autogenerated"
4817,137,"Yang et al., 2017",journal,"Yang F, Gu J, Yang L, Gao C, Jing H, Wang Y, Zeng H, Zou Q, Lv F, Zhang J",Protective Efficacy of the Trivalent Pseudomonas aeruginosa Vaccine Candidate PcrV-OprI-Hcp1 in Murine Pneumonia and Burn Models,"2017","7","1","3957",Scientific reports,,,,,,,,"28638106",,,0,10,0,0,0,,,"2018 Protegen Update Autogenerated"
4818,47,"Gonzlez-Miro et al., 2017",journal,"Gonzlez-Miro M, Rodrguez-Noda L, Farias-Medina M, Garca-Rivera D, Vrez-Bencomo V, Rehm BHA",Self-assembled particulate PsaA as vaccine against &lt;i&gt;Streptococcus pneumoniae&lt;/i&gt; infection,"2017","3","4",e00291,Heliyon,,,,,,,,"28435909",,,0,10,0,0,0,,,"2018 Protegen Update Autogenerated"
4819,47,"Tostes et al., 2017",journal,"Tostes RO, Rodrigues TC, da Silva JB, Schanoski AS, Oliveira ML, Miyaji EN",Protection Elicited by Nasal Immunization with Recombinant Pneumococcal Surface Protein A (rPspA) Adjuvanted with Whole-Cell Pertussis Vaccine (wP) against Co-Colonization of Mice with Streptococcus pneumoniae,"2017","12","1",e0170157,PloS one,,,,,,,,"28103277",,,0,10,0,0,0,,,"2018 Protegen Update Autogenerated"
4820,108,"Sears et al., 2012",journal,"Sears KT, Ceraul SM, Gillespie JJ, Allen ED Jr, Popov VL, Ammerman NC, Rahman MS, Azad AF",Surface proteome analysis and characterization of surface cell antigen (Sca) or autotransporter family of Rickettsia typhi,"2012","8","8",e1002856,PLoS pathogens,,,,,,,,"22912578",,,0,10,0,0,0,,,"2018 Protegen Update Autogenerated"
4821,137,"Ahmadi et al., 2012",journal,"Ahmadi H, Tabaraie B, Maleknia S, Pormirzagholi F, Nejati M, Hedayati MH",Immunological evaluation of OMP-F of native Iranian Pseudomonas aeruginosa as a protective vaccine,"2012","6","10","721-726",Journal of infection in developing countries,,,,,,,,"23103894",,,0,10,0,0,0,,,"2018 Protegen Update Autogenerated"
4822,138,"Veloso et al., 2015",journal,"Veloso TR, Mancini S, Giddey M, Vouillamoz J, Que YA, Moreillon P, Entenza JM",Vaccination against Staphylococcus aureus experimental endocarditis using recombinant Lactococcus lactis expressing ClfA or FnbpA,"2015","33","30","3512-3517",Vaccine,,,,,,,,"26048778",,,0,10,0,0,0,,,"2018 Protegen Update Autogenerated"
4823,108,"Caro-Gomez et al., 2014",journal,"Caro-Gomez E, Gazi M, Goez Y, Valbuena G",Discovery of novel cross-protective Rickettsia prowazekii T-cell antigens using a combined reverse vaccinology and in vivo screening approach,"2014","32","39","4968-4976",Vaccine,,,,,,,,"25010827",,,0,10,0,0,0,,,"2018 Protegen Update Autogenerated"
4824,86,"Zhang et al., 2016",journal,"Zhang F, Cao S, Zhu Z, Yang Y, Wen X, Chang YF, Huang X, Wu R, Wen Y, Yan Q, Huang Y, Ma X, Zhao Q",Immunoprotective Efficacy of Six &lt;i&gt;In vivo&lt;/i&gt;-Induced Antigens against &lt;i&gt;Actinobacillus pleuropneumoniae&lt;/i&gt; as Potential Vaccine Candidates in Murine Model,"2016","7","","1623",Frontiers in microbiology,,,,,,,,"27818646",,,0,10,0,0,0,,,"2018 Protegen Update Autogenerated"
4825,25,"Nesta et al., 2012",journal,"Nesta B, Spraggon G, Alteri C, Moriel DG, Rosini R, Veggi D, Smith S, Bertoldi I, Pastorello I, Ferlenghi I, Fontana MR, Frankel G, Mobley HL, Rappuoli R, Pizza M, Serino L, Soriani M","FdeC, a novel broadly conserved Escherichia coli adhesin eliciting protection against urinary tract infections","2012","3","2","",mBio,,,,,,,,"22496310",,,0,10,0,0,0,,,"2018 Protegen Update Autogenerated"
4826,47,"Chen et al., 2015",journal,"Chen A, Mann B, Gao G, Heath R, King J, Maissoneuve J, Alderson M, Tate A, Hollingshead SK, Tweten RK, Briles DE, Tuomanen EI, Paton JC",Multivalent Pneumococcal Protein Vaccines Comprising Pneumolysoid with Epitopes/Fragments of CbpA and/or PspA Elicit Strong and Broad Protection,"2015","22","10","1079-1089",Clinical and vaccine immunology : CVI,,,,,,,,"26245351",,,0,10,0,0,0,,,"2018 Protegen Update Autogenerated"
4827,140,"Courtney et al., 2017",journal,"Courtney HS, Niedermeyer SE, Penfound TA, Hohn CM, Greeley A, Dale JB",Trivalent M-related protein as a component of next generation group A streptococcal vaccines,"2017","6","1","45-49",Clinical and experimental vaccine research,,,,,,,,"28168173",,,0,10,0,0,0,,,"2018 Protegen Update Autogenerated"
4828,140,"Tsao et al., 2013",journal,"Tsao N, Cheng MH, Yang HC, Wang YC, Liu YL, Kuo CF",Determining antibody-binding site of streptococcal pyrogenic exotoxin B to protect mice from group a streptococcus infection,"2013","8","1",e55028,PloS one,,,,,,,,"23383045",,,0,10,0,0,0,,,"2018 Protegen Update Autogenerated"
4829,134,"L et al., 2009",journal,"L L, Cao HD, Zeng HQ, Wang PL, Wang LJ, Liu SN, Xiang TX",Recombinant Mycobacterium smegmatis mc(2)155 vaccine expressing outer membrane protein 26 kDa antigen affords therapeutic protection against Helicobacter pylori infection,"2009","27","7","972-978",Vaccine,,,,,,,,"19111590",,,0,10,0,0,0,,,"2018 Protegen Update Autogenerated"
4830,178,"Macedo et al., 2016",journal,"Macedo N, Oliveira S, Torremorell M, Rovira A",Immune response to oligopeptide permease A (OppA) protein in pigs naturally and experimentally infected with Haemophilus parasuis,"2016","107","","62-67",Research in veterinary science,,,,,,,,"27473976",,,0,10,0,0,0,,,"2018 Protegen Update Autogenerated"
4831,200,"Leal et al., 2016",journal,"Leal FM, Virginio VG, Martello CL, Paes JA, Borges TJ, Jaeger N, Bonorino C, Ferreira HB",Mycoplasma hyopneumoniae and Mycoplasma flocculare differential domains from orthologous surface proteins induce distinct cellular immune responses in mice,"2016","190","","50-57",Veterinary microbiology,,,,,,,,"27283856",,,0,10,0,0,0,,,"2018 Protegen Update Autogenerated"
4832,209,"Trung et al., 2014",journal,"Trung Cao T, Tsai MA, Yang CD, Wang PC, Kuo TY, Gabriel Chen HC, Chen SC",Vaccine efficacy of glyceraldehyde-3-phosphate dehydrogenase (GAPDH) from Edwardsiella ictaluri against E. tarda in tilapia,"2014","60","6","241-250",The Journal of general and applied microbiology,,,,,,,,"25742975",,,0,10,0,0,0,,,"2018 Protegen Update Autogenerated"
4833,137,"Korpi et al., 2015",journal,"Korpi F, Irajian G, Mahadavi M, Motamedifar M, Mousavi M, Laghaei P, Raei N, Behrouz B",Active Immunization with Recombinant PilA protein Protects Against Pseudomonas aeruginosa Infection in a Mouse Burn Wound Model,"2015","","","",Journal of microbiology and biotechnology,,,,,,,,"26387817",,,0,10,0,0,0,,,"2018 Protegen Update Autogenerated"
4834,136,"Orgun and Way, 2008",journal,"Orgun NN, Way SS",A critical role for phospholipase C in protective immunity conferred by listeriolysin O-deficient Listeria monocytogenes,"2008","44","2","159-163",Microbial pathogenesis,,,,,,,,"17888620",,,0,10,0,0,0,,,"2018 Protegen Update Autogenerated"
4835,13,"Garufi et al., 2012",journal,"Garufi G, Wang YT, Oh SY, Maier H, Missiakas DM, Schneewind O",Sortase-conjugation generates a capsule vaccine that protects guinea pigs against Bacillus anthracis,"2012","30","23","3435-3444",Vaccine,,,,,,,,"22449424",,,0,10,0,0,0,,,"2018 Protegen Update Autogenerated"
4836,140,"Mansour and Abdelaziz, 2016",journal,"Mansour NM, Abdelaziz SA",Oral immunization of mice with engineered Lactobacillus gasseri NM713 strain expressing Streptococcus pyogenes M6 antigen,"2016","60","8","527-532",Microbiology and immunology,,,,,,,,"27301486",,,0,10,0,0,0,,,"2018 Protegen Update Autogenerated"
4837,82,"Bandholtz et al., 2002",journal,"Bandholtz L, Kreuger MR, Svanholm C, Wigzell H, Rottenberg ME",Adjuvant modulation of the immune responses and the outcome of infection with Chlamydia pneumoniae,"2002","130","3","393-403",Clinical and experimental immunology,,,,,,,,"12452828",,,0,10,0,0,0,,,"2018 Protegen Update Autogenerated"
4838,137,"Laghaei et al., 2016",journal,"Laghaei P, Hashemi FB, Irajian G, Korpi F, Amirmozafari N, Behrouz B",Immunogenicity and protective efficacy of Pseudomonas aeruginosa type a and b flagellin vaccines in a burned mouse model,"2016","74","","71-81",Molecular immunology,,,,,,,,"27152476",,,0,10,0,0,0,,,"2018 Protegen Update Autogenerated"
4839,141,"Wicher et al., 1991",journal,"Wicher K, Schouls LM, Wicher V, Van Embden JD, Nakeeb SS",Immunization of guinea pigs with recombinant TmpB antigen induces protection against challenge infection with Treponema pallidum Nichols,"1991","59","12","4343-4348",Infection and immunity,,,,,,,,"1937794",,,0,10,0,0,0,,,"2018 Protegen Update Autogenerated"
4840,139,"Suvorov et al., 2010",journal,"Suvorov AN, Grabovskaia KB, Leont'eva GF, Meringova LF, Koroleva IN, Duplik NV, Totolian AA",[Recombinant fragments of conservative proteins of group B streptococci as a basis of specific vaccine],"2010","","2","44-50","Zhurnal mikrobiologii, epidemiologii, i immunobiologii",,,,,,,,"20465000",,,0,10,0,0,0,,,"2018 Protegen Update Autogenerated"
4841,141,"McGill et al., 2010",journal,"McGill MA, Edmondson DG, Carroll JA, Cook RG, Orkiszewski RS, Norris SJ",Characterization and serologic analysis of the Treponema pallidum proteome,"2010","78","6","2631-2643",Infection and immunity,,,,,,,,"20385758",,,0,10,0,0,0,,,"2018 Protegen Update Autogenerated"
4842,141,"Tomson et al., 2007",journal,"Tomson FL, Conley PG, Norgard MV, Hagman KE",Assessment of cell-surface exposure and vaccinogenic potentials of Treponema pallidum candidate outer membrane proteins,"2007","9","11","1267-1275",Microbes and infection,,,,,,,,"17890130",,,0,10,0,0,0,,,"2018 Protegen Update Autogenerated"
4843,135,"Ulbrandt et al., 2001",journal,"Ulbrandt ND, Cassatt DR, Patel NK, Roberts WC, Bachy CM, Fazenbaker CA, Hanson MS",Conformational nature of the Borrelia burgdorferi decorin binding protein A epitopes that elicit protective antibodies,"2001","69","8","4799-4807",Infection and immunity,,,,,,,,"11447153",,,0,10,0,0,0,,,"2018 Protegen Update Autogenerated"
4844,111,"Daniel et al., 2009",journal,"Daniel C, Sebbane F, Poiret S, Goudercourt D, Dewulf J, Mullet C, Simonet M, Pot B",Protection against Yersinia pseudotuberculosis infection conferred by a Lactococcus lactis mucosal delivery vector secreting LcrV,"2009","27","8","1141-1144",Vaccine,,,,,,,,"19135495",,,0,10,0,0,0,,,"2018 Protegen Update Autogenerated"
4845,138,"Zhao et al., 2014",journal,"Zhao Z, Li B, Sun HQ, Zhang JY, Wang YL, Chen L, Hu J, He YF, Zeng H, Zou QM, Wu C",Fine-mapping of immunodominant linear B-cell epitopes of the Staphylococcus aureus SEB antigen using short overlapping peptides,"2014","9","3",e90445,PloS one,,,,,,,,"24599257",,,0,10,0,0,0,,,"2018 Protegen Update Autogenerated"
4846,25,"Kumar et al., 2015",journal,"Kumar A, Hays M, Lim F, Foster LJ, Zhou M, Zhu G, Miesner T, Hardwidge PR",Protective Enterotoxigenic Escherichia coli Antigens in a Murine Intranasal Challenge Model,"2015","9","8",e0003924,PLoS neglected tropical diseases,,,,,,,,"26244636",,,0,10,0,0,0,,,"2018 Protegen Update Autogenerated"
4847,134,"Mori et al., 2012",journal,"Mori J, Vranac T, Smrekar B, Cernilec M, Serbec V, Horvat S, Ihan A, Benina M, Jerala R",Chimeric flagellin as the self-adjuvanting antigen for the activation of immune response against Helicobacter pylori,"2012","30","40","5856-5863",Vaccine,,,,,,,,"22819990",,,0,10,0,0,0,,,"2018 Protegen Update Autogenerated"
4848,141,"Jiang et al., 2013",journal,"Jiang C, Zhao F, Xiao J, Zeng T, Yu J, Ma X, Wu H, Wu Y",Evaluation of the recombinant protein TpF1 of Treponema pallidum for serodiagnosis of syphilis,"2013","20","10","1563-1568",Clinical and vaccine immunology : CVI,,,,,,,,"23945159",,,0,10,0,0,0,,,"2018 Protegen Update Autogenerated"
4849,37,"Xiong et al., 2014",journal,"Xiong X, Qi Y, Jiao J, Gong W, Duan C, Wen B",Exploratory study on Th1 epitope-induced protective immunity against Coxiella burnetii infection,"2014","9","1",e87206,PloS one,,,,,,,,"24498044",,,0,10,0,0,0,,,"2018 Protegen Update Autogenerated"
4850,108,"Wang et al., 2017",journal,"Wang P, Xiong X, Jiao J, Yang X, Jiang Y, Wen B, Gong W",Th1 epitope peptides induce protective immunity against Rickettsia rickettsii infection in C3H/HeN mice,"2017","35","51","7204-7212",Vaccine,,,,,,,,"29032899",,,0,10,0,0,0,,,"2018 Protegen Update Autogenerated"
4851,178,"Hong et al., 2011",journal,"Hong M, Ahn J, Yoo S, Hong J, Lee E, Yoon I, Jung JK, Lee H",Identification of novel immunogenic proteins in pathogenic Haemophilus parasuis based on genome sequence analysis,"2011","148","1","89-92",Veterinary microbiology,,,,,,,,"20817421",,,0,10,0,0,0,,,"2018 Protegen Update Autogenerated"
4852,178,"Olvera et al., 2011",journal,"Olvera A, Pina S, Prez-Sim M, Aragn V, Segals J, Bensaid A",Immunogenicity and protection against Haemophilus parasuis infection after vaccination with recombinant virulence associated trimeric autotransporters (VtaA),"2011","29","15","2797-2802",Vaccine,,,,,,,,"21320547",,,0,10,0,0,0,,,"2018 Protegen Update Autogenerated"
4853,138,"Narita et al., 2015",journal,"Narita K, Hu DL, Asano K, Nakane A",Vaccination with non-toxic mutant toxic shock syndrome toxin-1 induces IL-17-dependent protection against Staphylococcus aureus infection,"2015","73","4","",Pathogens and disease,,,,,,,,"25857736",,,0,10,0,0,0,,,"2018 Protegen Update Autogenerated"
4854,140,"McNeil et al., 2005",journal,"McNeil SA, Halperin SA, Langley JM, Smith B, Warren A, Sharratt GP, Baxendale DM, Reddish MA, Hu MC, Stroop SD, Linden J, Fries LF, Vink PE, Dale JB",Safety and immunogenicity of 26-valent group a streptococcus vaccine in healthy adult volunteers,"2005","41","8","1114-1122",Clinical infectious diseases : an official publication of the Infectious Diseases Society of America,,,,,,,,"16163629",,,0,10,0,0,0,,,"2018 Protegen Update Autogenerated"
4855,24,"Heimesaat et al., 2014",journal,"Heimesaat MM, Alutis M, Grundmann U, Fischer A, Tegtmeyer N, Bhm M, Khl AA, Gbel UB, Backert S, Bereswill S",The role of serine protease HtrA in acute ulcerative enterocolitis and extra-intestinal immune responses during Campylobacter jejuni infection of gnotobiotic IL-10 deficient mice,"2014","4","","77",Frontiers in cellular and infection microbiology,,,,,,,,"24959425",,,0,10,0,0,0,,,"2018 Protegen Update Autogenerated"
4856,134,"Stent et al., 2012",journal,"Stent A, Every AL, Ng GZ, Chionh YT, Ong LS, Edwards SJ, Sutton P",Helicobacter pylori thiolperoxidase as a protective antigen in single- and multi-component vaccines,"2012","30","50","7214-7220",Vaccine,,,,,,,,"23084846",,,0,10,0,0,0,,,"2018 Protegen Update Autogenerated"
4857,178,"Wen et al., 2016",journal,"Wen Y, Yan X, Wen Y, Cao S, He L, Ding L, Zhang L, Zhou P, Huang X, Wu R, Wen X",Immunogenicity of the recombinant HxuCBA proteins encoded by hxuCBA gene cluster of Haemophilus parasuis in mice,"2016","591","2","478-483",Gene,,,,,,,,"27378742",,,0,10,0,0,0,,,"2018 Protegen Update Autogenerated"
4858,139,"Li et al., 2016",journal,"Li W, Wang HQ, He RZ, Li YW, Su YL, Li AX",Major surfome and secretome profile of Streptococcus agalactiae from Nile tilapia (Oreochromis niloticus): Insight into vaccine development,"2016","55","","737-746",Fish &amp; shellfish immunology,,,,,,,,"27327442",,,0,10,0,0,0,,,"2018 Protegen Update Autogenerated"
4859,178,"Tian et al., 2011",journal,"Tian H, Fu F, Li X, Chen X, Wang W, Lang Y, Cong F, Liu C, Tong G, Li X",Identification of the immunogenic outer membrane protein A antigen of Haemophilus parasuis by a proteomics approach and passive immunization with monoclonal antibodies in mice,"2011","18","10","1695-1701",Clinical and vaccine immunology : CVI,,,,,,,,"21832103",,,0,10,0,0,0,,,"2018 Protegen Update Autogenerated"
4860,121,"Gourlay et al., 2015",journal,"Gourlay LJ, Thomas RJ, Peri C, Conchillo-Sol O, Ferrer-Navarro M, Nithichanon A, Vila J, Daura X, Lertmemongkolchai G, Titball R, Colombo G, Bolognesi M",From crystal structure to in silico epitope discovery in the Burkholderia pseudomallei flagellar hook-associated protein FlgK,"2015","282","7","1319-1333",The FEBS journal,,,,,,,,"25645451",,,0,10,0,0,0,,,"2018 Protegen Update Autogenerated"
4861,140,"Okamoto et al., 2005",journal,"Okamoto S, Tamura Y, Terao Y, Hamada S, Kawabata S",Systemic immunization with streptococcal immunoglobulin-binding protein Sib 35 induces protective immunity against group: a Streptococcus challenge in mice,"2005","23","40","4852-4859",Vaccine,,,,,,,,"15990202",,,0,10,0,0,0,,,"2018 Protegen Update Autogenerated"
4862,140,"Bensi et al., 2012",journal,"Bensi G, Mora M, Tuscano G, Biagini M, Chiarot E, Bombaci M, Capo S, Falugi F, Manetti AG, Donato P, Swennen E, Gallotta M, Garibaldi M, Pinto V, Chiappini N, Musser JM, Janulczyk R, Mariani M, Scarselli M, Telford JL, Grifantini R, Norais N, Margarit I, Grandi G",Multi high-throughput approach for highly selective identification of vaccine candidates: the Group A Streptococcus case,"2012","11","6",M111.015693,Molecular &amp; cellular proteomics : MCP,,,,,,,,"22286755",,,0,10,0,0,0,,,"2018 Protegen Update Autogenerated"
4863,135,"Labandeira-Rey et al., 2001",journal,"Labandeira-Rey M, Baker EA, Skare JT",VraA (BBI16) protein of Borrelia burgdorferi is a surface-exposed antigen with a repetitive motif that confers partial protection against experimental Lyme borreliosis,"2001","69","3","1409-1419",Infection and immunity,,,,,,,,"11179306",,,0,10,0,0,0,,,"2018 Protegen Update Autogenerated"
4864,138,"Yu et al., 2015",journal,"Yu S, Zhang H, Yao D, Liu W, Wang X, Chen X, Wei Y, Zhang Z, Wang J, Yu L, Sun H, Wu Z, Yu Y, Song B, Ma J, Tong C, Cui Y",Identification of CD4+ T-cell epitopes on iron-regulated surface determinant B of Staphylococcus aureus,"2015","89","","108-113",Microbial pathogenesis,,,,,,,,"26423555",,,0,10,0,0,0,,,"2018 Protegen Update Autogenerated"
4865,86,"Zhou et al., 2013",journal,"Zhou Y, Li L, Chen Z, Yuan H, Chen H, Zhou R",Adhesion protein ApfA of Actinobacillus pleuropneumoniae is required for pathogenesis and is a potential target for vaccine development,"2013","20","2","287-294",Clinical and vaccine immunology : CVI,,,,,,,,"23269417",,,0,10,0,0,0,,,"2018 Protegen Update Autogenerated"
4866,138,"Clarke et al., 2006",journal,"Clarke SR, Brummell KJ, Horsburgh MJ, McDowell PW, Mohamad SA, Stapleton MR, Acevedo J, Read RC, Day NP, Peacock SJ, Mond JJ, Kokai-Kun JF, Foster SJ",Identification of in vivo-expressed antigens of Staphylococcus aureus and their use in vaccinations for protection against nasal carriage,"2006","193","8","1098-1108",The Journal of infectious diseases,,,,,,,,"16544250",,,0,10,0,0,0,,,"2018 Protegen Update Autogenerated"
4867,141,"Clark et al., 1993",journal,"Clark KL, Halay ED, Lai E, Burley SK",Co-crystal structure of the HNF-3/fork head DNA-recognition motif resembles histone H5,"1993","364","6436","412-420",Nature,,,,,,,,"8332212",,,0,10,0,0,0,,,"2018 Protegen Update Autogenerated"
4868,138,"Yu et al., 2014",journal,"Yu L, Fan Z, Ma J, Tong C, Song B, Zhu Z, Cui Y",Cross-protective effect of a novel multi-antigen-chimeric vaccine against Streptococcus and Staphylococcus aureus infection in mice,"2014","63",Pt 12,"1732-1740",Journal of medical microbiology,,,,,,,,"25288644",,,0,10,0,0,0,,,"2018 Protegen Update Autogenerated"
4869,81,"Lin et al., 2011",journal,"Lin HX, Huang DY, Wang Y, Lu CP, Fan HJ",A novel vaccine against Streptococcus equi ssp. zooepidemicus infections: the recombinant swinepox virus expressing M-like protein,"2011","29","40","7027-7034",Vaccine,,,,,,,,"21807055",,,0,10,0,0,0,,,"2018 Protegen Update Autogenerated"
4870,209,"Sun et al., 2012",journal,"Sun Y, Zheng WJ, Hu YH, Sun BG, Sun L","Edwardsiella tarda Eta1, an in vivo-induced antigen that is involved in host infection","2012","80","8","2948-2955",Infection and immunity,,,,,,,,"22585967",,,0,10,0,0,0,,,"2018 Protegen Update Autogenerated"
4871,209,"Liu et al., 2017",journal,"Liu F, Tang X, Sheng X, Xing J, Zhan W",Comparative study of the vaccine potential of six outer membrane proteins of Edwardsiella tarda and the immune responses of flounder (Paralichthys olivaceus) after vaccination,"2017","185","","38-47",Veterinary immunology and immunopathology,,,,,,,,"28242001",,,0,10,0,0,0,,,"2018 Protegen Update Autogenerated"
4872,138,"Bagnoli et al., 2015",journal,"Bagnoli F, Fontana MR, Soldaini E, Mishra RP, Fiaschi L, Cartocci E, Nardi-Dei V, Ruggiero P, Nosari S, De Falco MG, Lofano G, Marchi S, Galletti B, Mariotti P, Bacconi M, Torre A, Maccari S, Scarselli M, Rinaudo CD, Inoshima N, Savino S, Mori E, Rossi-Paccani S, Baudner B, Pallaoro M, Swennen E, Petracca R, Brettoni C, Liberatori S, Norais N, Monaci E, Bubeck Wardenburg J, Schneewind O, O'Hagan DT, Valiante NM, Bensi G, Bertholet S, De Gregorio E, Rappuoli R, Grandi G",Vaccine composition formulated with a novel TLR7-dependent adjuvant induces high and broad protection against Staphylococcus aureus,"2015","112","12","3680-3685",Proceedings of the National Academy of Sciences of the United States of America,,,,,,,,"25775551",,,0,10,0,0,0,,,"2018 Protegen Update Autogenerated"
4873,81,"Wei et al., 2013",journal,"Wei Z, Fu Q, Chen Y, Li M, Cong P, Mo D, Liu X","Streptococcus equi ssp. zooepidemicus C5a peptidase, a putative invasin, induces protective immune response in mice","2013","95","2","444-450",Research in veterinary science,,,,,,,,"23632199",,,0,10,0,0,0,,,"2018 Protegen Update Autogenerated"
4874,7,"Mikshis et al., 2014",journal,"Mikshis NI, Popova PIu, Kudriavtseva OM, Semakova AP, Novikova LN, Kravtsov AL, Bugorkova SA, Shchukovskaia TN, Popov IuA, Kutyrev VV",[Immunogenicity and safety of a prototype chemical anthrax vaccine in laboratory animal models],"2014","","4","22-30","Zhurnal mikrobiologii, epidemiologii, i immunobiologii",,,,,,,,"25286524",,,0,10,0,0,0,,,"2018 Protegen Update Autogenerated"
4875,113,"Mosolyg et al., 2014",journal,"Mosolyg T, Szab AM, Balogh EP, Faludi I, Virk DP, Endrsz V, Samu A, Krencs T, Burin K",Protection promoted by pGP3 or pGP4 against Chlamydia muridarum is mediated by CD4(+) cells in C57BL/6N mice,"2014","32","40","5228-5233",Vaccine,,,,,,,,"25077421",,,0,10,0,0,0,,,"2018 Protegen Update Autogenerated"
4876,178,"Yuan et al., 2012",journal,"Yuan F, Fu S, Hu J, Li J, Chang H, Hu L, Chen H, Tian Y, Bei W",Evaluation of recombinant proteins of Haemophilus parasuis strain SH0165 as vaccine candidates in a mouse model,"2012","93","1","51-56",Research in veterinary science,,,,,,,,"21596404",,,0,10,0,0,0,,,"2018 Protegen Update Autogenerated"
4877,209,"Liu et al., 2017",journal,"Liu F, Tang X, Sheng X, Xing J, Zhan W",Construction and evaluation of an Edwardsiella tarda DNA vaccine encoding outer membrane protein C,"2017","104","","238-247",Microbial pathogenesis,,,,,,,,"28137507",,,0,10,0,0,0,,,"2018 Protegen Update Autogenerated"
4878,81,"Velineni and Timoney, 2013",journal,"Velineni S, Timoney JF",Characterization and protective immunogenicity of the SzM protein of Streptococcus zooepidemicus NC78 from a clonal outbreak of equine respiratory disease,"2013","20","8","1181-1188",Clinical and vaccine immunology : CVI,,,,,,,,"23740925",,,0,10,0,0,0,,,"2018 Protegen Update Autogenerated"
4879,139,"Yang et al., 2007",journal,"Yang HH, Madoff LC, Guttormsen HK, Liu YD, Paoletti LC",Recombinant group B streptococcus Beta C protein and a variant with the deletion of its immunoglobulin A-binding site are protective mouse maternal vaccines and effective carriers in conjugate vaccines,"2007","75","7","3455-3461",Infection and immunity,,,,,,,,"17470542",,,0,10,0,0,0,,,"2018 Protegen Update Autogenerated"
4880,178,"Li et al., 2015",journal,"Li M, Song S, Yang D, Li C, Li G",Identification of secreted proteins as novel antigenic vaccine candidates of Haemophilus parasuis serovar 5,"2015","33","14","1695-1701",Vaccine,,,,,,,,"25704800",,,0,10,0,0,0,,,"2018 Protegen Update Autogenerated"
4881,137,"Rehm et al., 1994",journal,"Rehm BH, Grabert E, Hein J, Winkler UK",Antibody response of rabbits and cystic fibrosis patients to an alginate-specific outer membrane protein of a mucoid strain of Pseudomonas aeruginosa,"1994","16","1","43-51",Microbial pathogenesis,,,,,,,,"8057826",,,0,10,0,0,0,,,"2018 Protegen Update Autogenerated"
4882,24,"Yeh et al., 2015",journal,"Yeh HY, Hiett KL, Line JE",Reactions of chicken sera to recombinant Campylobacter jejuni flagellar proteins,"2015","197","2","353-358",Archives of microbiology,,,,,,,,"25413671",,,0,10,0,0,0,,,"2018 Protegen Update Autogenerated"
4883,139,"Pannaraj et al., 2008",journal,"Pannaraj PS, Kelly JK, Rench MA, Madoff LC, Edwards MS, Baker CJ",Alpha C protein-specific immunity in humans with group B streptococcal colonization and invasive disease,"2008","26","4","502-508",Vaccine,,,,,,,,"18155812",,,0,10,0,0,0,,,"2018 Protegen Update Autogenerated"
4884,138,"Cui et al., 2005",journal,"Cui JC, Hu DL, Lin YC, Qian AD, Nakane A",Immunization with glutathione S-transferase and mutant toxic shock syndrome toxin 1 fusion protein protects against Staphylococcus aureus infection,"2005","45","1","45-51",FEMS immunology and medical microbiology,,,,,,,,"15985222",,,0,10,0,0,0,,,"2018 Protegen Update Autogenerated"
4885,200,"Feng et al., 2014",journal,"Feng ZX, Bai Y, Yao JT, Pharr GT, Wan XF, Xiao SB, Chi LZ, Gan Y, Wang HY, Wei YN, Liu MJ, Xiong QY, Bai FF, Li B, Wu XS, Shao GQ","Use of serological and mucosal immune responses to Mycoplasma hyopneumoniae antigens P97R1, P46 and P36 in the diagnosis of infection","2014","202","1","128-133","Veterinary journal (London, England : 1997)",,,,,,,,"25066030",,,0,10,0,0,0,,,"2018 Protegen Update Autogenerated"
4886,140,"Pandey et al., 2015",journal,"Pandey M, Langshaw E, Hartas J, Lam A, Batzloff MR, Good MF",A synthetic M protein peptide synergizes with a CXC chemokine protease to induce vaccine-mediated protection against virulent streptococcal pyoderma and bacteremia,"2015","194","12","5915-5925","Journal of immunology (Baltimore, Md. : 1950)",,,,,,,,"25980008",,,0,10,0,0,0,,,"2018 Protegen Update Autogenerated"
4887,178,"Huang et al., 2013",journal,"Huang X, Li Y, Fu Y, Ji Y, Lian K, Zheng H, Wei J, Cai X, Zhu Q",Cross-protective efficacy of recombinant transferrin-binding protein A of Haemophilus parasuis in guinea pigs,"2013","20","6","912-919",Clinical and vaccine immunology : CVI,,,,,,,,"23616407",,,0,10,0,0,0,,,"2018 Protegen Update Autogenerated"
4888,121,"Woo et al., 2001",journal,"Woo PC, Leung PK, Wong SS, Ho PL, Yuen KY",groEL encodes a highly antigenic protein in Burkholderia pseudomallei,"2001","8","4","832-836",Clinical and diagnostic laboratory immunology,,,,,,,,"11427437",,,0,10,0,0,0,,,"2018 Protegen Update Autogenerated"
4889,138,"Kuipers et al., 2016",journal,"Kuipers A, Stapels DA, Weerwind LT, Ko YP, Ruyken M, Lee JC, van Kessel KP, Rooijakkers SH",The Staphylococcus aureus polysaccharide capsule and Efb-dependent fibrinogen shield act in concert to protect against phagocytosis,"2016","162","7","1185-1194","Microbiology (Reading, England)",,,,,,,,"27112346",,,0,10,0,0,0,,,"2018 Protegen Update Autogenerated"
4890,25,"Byrd et al., 2017",journal,"Byrd W, Ruiz-Perez F, Setty P, Zhu C, Boedeker EC",Secretion of the Shiga toxin B subunit (Stx1B) via an autotransporter protein optimizes the protective immune response to the antigen expressed in an attenuated E. coli (rEPEC E22ler) vaccine strain,"2017","211","","180-188",Veterinary microbiology,,,,,,,,"29102116",,,0,10,0,0,0,,,"2018 Protegen Update Autogenerated"
4891,178,"Li et al., 2016",journal,"Li M, Li C, Song S, Kang H, Yang D, Li G",Development and antigenic characterization of three recombinant proteins with potential for Glsser's disease prevention,"2016","34","19","2251-2258",Vaccine,,,,,,,,"26993332",,,0,10,0,0,0,,,"2018 Protegen Update Autogenerated"
4892,140,"Zhang et al., 2006",journal,"Zhang S, Green NM, Sitkiewicz I, Lefebvre RB, Musser JM",Identification and characterization of an antigen I/II family protein produced by group A Streptococcus,"2006","74","7","4200-4213",Infection and immunity,,,,,,,,"16790795",,,0,10,0,0,0,,,"2018 Protegen Update Autogenerated"
4893,140,"Mortensen et al., 2016",journal,"Mortensen R, Nissen TN, Fredslund S, Rosenkrands I, Christensen JP, Andersen P, Dietrich J",Identifying protective Streptococcus pyogenes vaccine antigens recognized by both B and T cells in human adults and children,"2016","6","","22030",Scientific reports,,,,,,,,"26911649",,,0,10,0,0,0,,,"2018 Protegen Update Autogenerated"
4894,14,"Gil et al., 2013",journal,"Gil LA, da Cunha CE, Moreira GM, Salvarani FM, Assis RA, Lobato FC, Mendona M, Dellagostin OA, Conceio FR",Production and evaluation of a recombinant chimeric vaccine against clostridium botulinum neurotoxin types C and D,"2013","8","7",e69692,PloS one,,,,,,,,"23936080",,,0,10,0,0,0,,,"2018 Protegen Update Autogenerated"
4895,25,"Lu et al., 2014",journal,"Lu X, Skurnik D, Pozzi C, Roux D, Cywes-Bentley C, Ritchie JM, Munera D, Gening ML, Tsvetkov YE, Nifantiev NE, Waldor MK, Pier GB",A Poly-N-acetylglucosamine-Shiga toxin broad-spectrum conjugate vaccine for Shiga toxin-producing Escherichia coli,"2014","5","2","00974-00914",mBio,,,,,,,,"24667709",,,0,10,0,0,0,,,"2018 Protegen Update Autogenerated"
4896,178,"Guo et al., 2017",journal,"Guo L, Xu L, Wu T, Fu S, Qiu Y, Hu CA, Ren X, Liu R, Ye M",Evaluation of recombinant protein superoxide dismutase of Haemophilus parasuis strain SH0165 as vaccine candidate in a mouse model,"2017","63","4","312-320",Canadian journal of microbiology,,,,,,,,"28177794",,,0,10,0,0,0,,,"2018 Protegen Update Autogenerated"
4897,209,"Beck et al., 2017",journal,"Beck BR, Lee SH, Kim D, Park JH, Lee HK, Kwon SS, Lee KH, Lee JI, Song SK",A Lactococcus lactis BFE920 feed vaccine expressing a fusion protein composed of the OmpA and FlgD antigens from Edwardsiella tarda was significantly better at protecting olive flounder (Paralichthys olivaceus) from edwardsiellosis than single antigen vaccines,"2017","68","","19-28",Fish &amp; shellfish immunology,,,,,,,,"28687358",,,0,10,0,0,0,,,"2018 Protegen Update Autogenerated"
4898,208,"Paes et al., 2016",journal,"Paes W, Brown N, Brzozowski AM, Coler R, Reed S, Carter D, Bland M, Kaye PM, Lacey CJN","Recombinant polymorphic membrane protein D in combination with a novel, second-generation lipid adjuvant protects against intra-vaginal Chlamydia trachomatis infection in mice","2016","34","35","4123-4131",Vaccine,,,,,,,,"27389169",,,0,10,0,0,0,,,"2018 Protegen Update Autogenerated"
4899,37,"Jiao et al., 2014",journal,"Jiao J, Xiong X, Qi Y, Gong W, Duan C, Yang X, Wen B",Serological characterization of surface-exposed proteins of Coxiella burnetii,"2014","160",Pt 12,"2718-2731","Microbiology (Reading, England)",,,,,,,,"25298245",,,0,10,0,0,0,,,"2018 Protegen Update Autogenerated"
4900,84,"Wijesurendra et al., 2017",journal,"Wijesurendra DS, Kanci A, Tivendale KA, Devlin JM, Wawegama NK, Bacci B, Noormohammadi AH, Markham PF, Browning GF",Immune responses to vaccination and infection with Mycoplasma gallisepticum in turkeys,"2017","46","5","464-473",Avian pathology : journal of the W.V.P.A,,,,,,,,"28345962",,,0,10,0,0,0,,,"2018 Protegen Update Autogenerated"
4901,139,"Santillan et al., 2011",journal,"Santillan DA, Rai KK, Santillan MK, Krishnamachari Y, Salem AK, Hunter SK",Efficacy of polymeric encapsulated C5a peptidase-based group B streptococcus vaccines in a murine model,"2011","205","3","249.e1-8",American journal of obstetrics and gynecology,,,,,,,,"21802065",,,0,10,0,0,0,,,"2018 Protegen Update Autogenerated"
4902,140,"Kagawa et al., 2009",journal,"Kagawa TF, O'Connell MR, Mouat P, Paoli M, O'Toole PW, Cooney JC",Model for substrate interactions in C5a peptidase from Streptococcus pyogenes: A 1.9 A crystal structure of the active form of ScpA,"2009","386","3","754-772",Journal of molecular biology,,,,,,,,"19152799",,,0,10,0,0,0,,,"2018 Protegen Update Autogenerated"
4903,111,"Tsybul'ski et al., 2011",journal,"Tsybul'ski AV, Popov AM, Sanina NM, Mazeka AN, Portniagina OIu, Novikova OD, Timchenko NF, Kostetski Ia",[Immunogenic and protective properties of nanosized constructs based on tubular immunostimulating complexes and pore forming protein of Yersinia pseudotuberculosis],"2011","","2","43-47","Zhurnal mikrobiologii, epidemiologii, i immunobiologii",,,,,,,,"21598614",,,0,10,0,0,0,,,"2018 Protegen Update Autogenerated"
4904,111,"Zhang et al., 2012",journal,"Zhang Y, Mena P, Romanov G, Lin JS, Smiley ST, Bliska JB",A protective epitope in type III effector YopE is a major CD8 T cell antigen during primary infection with Yersinia pseudotuberculosis,"2012","80","1","206-214",Infection and immunity,,,,,,,,"22064714",,,0,10,0,0,0,,,"2018 Protegen Update Autogenerated"
4905,111,"Zhang and Bliska, 2010",journal,"Zhang Y, Bliska JB","YopJ-promoted cytotoxicity and systemic colonization are associated with high levels of murine interleukin-18, gamma interferon, and neutrophils in a live vaccine model of Yersinia pseudotuberculosis infection","2010","78","5","2329-2341",Infection and immunity,,,,,,,,"20231414",,,0,10,0,0,0,,,"2018 Protegen Update Autogenerated"
4906,140,"Rodrguez-Ortega et al., 2006",journal,"Rodrguez-Ortega MJ, Norais N, Bensi G, Liberatori S, Capo S, Mora M, Scarselli M, Doro F, Ferrari G, Garaguso I, Maggi T, Neumann A, Covre A, Telford JL, Grandi G",Characterization and identification of vaccine candidate proteins through analysis of the group A Streptococcus surface proteome,"2006","24","2","191-197",Nature biotechnology,,,,,,,,"16415855",,,0,10,0,0,0,,,"2018 Protegen Update Autogenerated"
4907,141,"Cameron et al., 2000",journal,"Cameron CE, Lukehart SA, Castro C, Molini B, Godornes C, Van Voorhis WC","Opsonic potential, protective capacity, and sequence conservation of the Treponema pallidum subspecies pallidum Tp92","2000","181","4","1401-1413",The Journal of infectious diseases,,,,,,,,"10762571",,,0,10,0,0,0,,,"2018 Protegen Update Autogenerated"
4908,121,"Tippayawat et al., 2009",journal,"Tippayawat P, Saenwongsa W, Mahawantung J, Suwannasaen D, Chetchotisakd P, Limmathurotsakul D, Peacock SJ, Felgner PL, Atkins HS, Titball RW, Bancroft GJ, Lertmemongkolchai G",Phenotypic and functional characterization of human memory T cell responses to Burkholderia pseudomallei,"2009","3","4",e407,PLoS neglected tropical diseases,,,,,,,,"19352426",,,0,10,0,0,0,,,"2018 Protegen Update Autogenerated"
4909,139,"Brzychczy-Wloch et al., 2013",journal,"Brzychczy-Wloch M, Gorska S, Brzozowska E, Gamian A, Heczko PB, Bulanda M",Identification of high immunoreactive proteins from Streptococcus agalactiae isolates recognized by human serum antibodies,"2013","349","1","61-70",FEMS microbiology letters,,,,,,,,"24152143",,,0,10,0,0,0,,,"2018 Protegen Update Autogenerated"
4910,112,"Tammiruusu et al., 2007",journal,"Tammiruusu A, Penttil T, Lahesmaa R, Sarvas M, Puolakkainen M, Vuola JM",Intranasal administration of chlamydial outer protein N (CopN) induces protection against pulmonary Chlamydia pneumoniae infection in a mouse model,"2007","25","2","283-290",Vaccine,,,,,,,,"16949182",,,0,10,0,0,0,,,"2018 Protegen Update Autogenerated"
4911,141,"Sun et al., 2004",journal,"Sun ES, Molini BJ, Barrett LK, Centurion-Lara A, Lukehart SA, Van Voorhis WC",Subfamily I Treponema pallidum repeat protein family: sequence variation and immunity,"2004","6","8","725-737",Microbes and infection,,,,,,,,"15207819",,,0,10,0,0,0,,,"2018 Protegen Update Autogenerated"
4912,121,"Casey et al., 2016",journal,"Casey WT, Spink N, Cia F, Collins C, Romano M, Berisio R, Bancroft GJ, McClean S","Identification of an OmpW homologue in Burkholderia pseudomallei, a protective vaccine antigen against melioidosis","2016","34","23","2616-2621",Vaccine,,,,,,,,"27091689",,,0,10,0,0,0,,,"2018 Protegen Update Autogenerated"
4913,208,"Patel et al., 2014",journal,"Patel AL, Mishra PK, Sachdev D, Chaudhary U, Patton DL, Saluja D","Seroprevalence of antibodies against Pkn1, a novel potential immunogen, in Chlamydia trachomatis-infected Macaca nemestrina and human patients","2014","2014","","245483",BioMed research international,,,,,,,,"25032212",,,0,10,0,0,0,,,"2018 Protegen Update Autogenerated"
4914,209,"Jiao et al., 2009",journal,"Jiao XD, Dang W, Hu YH, Sun L",Identification and immunoprotective analysis of an in vivo-induced Edwardsiella tarda antigen,"2009","27","5","633-638",Fish &amp; shellfish immunology,,,,,,,,"19706328",,,0,10,0,0,0,,,"2018 Protegen Update Autogenerated"
4915,209,"Wang et al., 2013",journal,"Wang C, Hu YH, Chi H, Sun L","The major fimbrial subunit protein of Edwardsiella tarda: vaccine potential, adjuvant effect, and involvement in host infection","2013","35","3","858-865",Fish &amp; shellfish immunology,,,,,,,,"23811351",,,0,10,0,0,0,,,"2018 Protegen Update Autogenerated"
4916,86,"Shakarji et al., 2006",journal,"Shakarji L, Mikael LG, Srikumar R, Kobisch M, Coulton JW, Jacques M","Fhua and HgbA, outer membrane proteins of Actinobacillus pleuropneumoniae: their role as virulence determinants","2006","52","4","391-396",Canadian journal of microbiology,,,,,,,,"16699590",,,0,10,0,0,0,,,"2018 Protegen Update Autogenerated"
4917,25,"Asadi et al., 2016",journal,"Asadi Karam MR, Habibi M, Bouzari S",Use of flagellin and cholera toxin as adjuvants in intranasal vaccination of mice to enhance protective immune responses against uropathogenic Escherichia coli antigens,"2016","44","5","378-386",Biologicals : journal of the International Association of Biological Standardization,,,,,,,,"27461240",,,0,10,0,0,0,,,"2018 Protegen Update Autogenerated"
4918,120,"Zhang et al., 2013",journal,"Zhang XX, Yu H, Wang XH, Li XZ, Zhu YP, Li HX, Luo SJ, Yuan ZG",Protective efficacy against Chlamydophila psittaci by oral immunization based on transgenic rice expressing MOMP in mice,"2013","31","4","698-703",Vaccine,,,,,,,,"23196208",,,0,10,0,0,0,,,"2018 Protegen Update Autogenerated"
4919,208,"Skwor et al., 2010",journal,"Skwor T, Kandel RP, Basravi S, Khan A, Sharma B, Dean D","Characterization of humoral immune responses to chlamydial HSP60, CPAF, and CT795 in inflammatory and severe trachoma","2010","51","10","5128-5136",Investigative ophthalmology &amp; visual science,,,,,,,,"20463311",,,0,10,0,0,0,,,"2018 Protegen Update Autogenerated"
4920,81,"Wei et al., 2012",journal,"Wei Z, Fu Q, Liu X, Xiao P, Lu Z, Chen Y",Identification of Streptococcus equi ssp. zooepidemicus surface associated proteins by enzymatic shaving,"2012","159","3-4","519-525",Veterinary microbiology,,,,,,,,"22613253",,,0,10,0,0,0,,,"2018 Protegen Update Autogenerated"
4921,139,"Kvam et al., 2011",journal,"Kvam AI, Mavenyengwa RT, Radtke A, Maeland JA",Streptococcus agalactiae alpha-like protein 1 possesses both cross-reacting and Alp1-specific epitopes,"2011","18","8","1365-1370",Clinical and vaccine immunology : CVI,,,,,,,,"21653744",,,0,10,0,0,0,,,"2018 Protegen Update Autogenerated"
4922,43,"Oany et al., 2017",journal,"Oany AR, Pervin T, Mia M, Hossain M, Shahnaij M, Mahmud S, Kibria KMK",Vaccinomics Approach for Designing Potential Peptide Vaccine by Targeting &lt;i&gt;Shigella&lt;/i&gt; spp. Serine Protease Autotransporter Subfamily Protein SigA,"2017","2017","","6412353",Journal of immunology research,,,,,,,,"29082265",,,0,10,0,0,0,,,"2018 Protegen Update Autogenerated"
4923,195,"Conrad et al., 2017",journal,"Conrad NL, Cruz McBride FW, Souza JD, Silveira MM, Flix S, Mendona KS, Santos CS, Athanazio DA, Medeiros MA, Reis MG, Dellagostin OA, McBride AJ",LigB subunit vaccine confers sterile immunity against challenge in the hamster model of leptospirosis,"2017","11","3",e0005441,PLoS neglected tropical diseases,,,,,,,,"28301479",,,0,10,0,0,0,,,"2018 Protegen Update Autogenerated"
4924,102,"Eko et al., 2000",journal,"Eko FO, Mayr UB, Attridge SR, Lubitz W",Characterization and immunogenicity of Vibrio cholerae ghosts expressing toxin-coregulated pili,"2000","83","1-2","115-123",Journal of biotechnology,,,,,,,,"11000467",,,0,10,0,0,0,,,"2018 Protegen Update Autogenerated"
4925,24,"Chintoan-Uta et al., 2015",journal,"Chintoan-Uta C, Cassady-Cain RL, Al-Haideri H, Watson E, Kelly DJ, Smith DG, Sparks NH, Kaiser P, Stevens MP",Superoxide dismutase SodB is a protective antigen against Campylobacter jejuni colonisation in chickens,"2015","33","46","6206-6211",Vaccine,,,,,,,,"26458797",,,0,10,0,0,0,,,"2018 Protegen Update Autogenerated"
4926,209,"Li et al., 2012",journal,"Li MF, Hu YH, Zheng WJ, Sun BG, Wang CL, Sun L",Inv1: an Edwardsiella tarda invasin and a protective immunogen that is required for host infection,"2012","32","4","586-592",Fish &amp; shellfish immunology,,,,,,,,"22289712",,,0,10,0,0,0,,,"2018 Protegen Update Autogenerated"
4927,302,"Gong et al., 2015",journal,"Gong W, Wang P, Xiong X, Jiao J, Yang X, Wen B",Chloroform-Methanol Residue of Coxiella burnetii Markedly Potentiated the Specific Immunoprotection Elicited by a Recombinant Protein Fragment rOmpB-4 Derived from Outer Membrane Protein B of Rickettsia rickettsii in C3H/HeN Mice,"2015","10","4",e0124664,PloS one,,,,,,,,"25909586",,,0,10,0,0,0,,,"2018 Protegen Update Autogenerated"
4928,86,"Chen et al., 2012",journal,"Chen X, Xu Z, Li L, Chen H, Zhou R",Identification of conserved surface proteins as novel antigenic vaccine candidates of Actinobacillus pleuropneumoniae,"2012","50","6","978-986","Journal of microbiology (Seoul, Korea)",,,,,,,,"23274984",,,0,10,0,0,0,,,"2018 Protegen Update Autogenerated"
4929,12,"Jia et al., 2010",journal,"Jia Q, Lee BY, Bowen R, Dillon BJ, Som SM, Horwitz MA","A Francisella tularensis live vaccine strain (LVS) mutant with a deletion in capB, encoding a putative capsular biosynthesis protein, is significantly more attenuated than LVS yet induces potent protective immunity in mice against F. tularensis challenge","2010","78","10","4341-4355",Infection and immunity,,,,,,,,"20643859",,,0,10,0,0,0,,,"2018 Protegen Update Autogenerated"
4930,25,"Mobley and Alteri, 2015",journal,"Mobley HL, Alteri CJ",Development of a Vaccine against Escherichia coli Urinary Tract Infections,"2015","5","1","","Pathogens (Basel, Switzerland)",,,,,,,,"26729174",,,0,10,0,0,0,,,"2018 Protegen Update Autogenerated"
4931,178,"Zhou et al., 2009",journal,"Zhou M, Guo Y, Zhao J, Hu Q, Hu Y, Zhang A, Chen H, Jin M",Identification and characterization of novel immunogenic outer membrane proteins of Haemophilus parasuis serovar 5,"2009","27","38","5271-5277",Vaccine,,,,,,,,"19576561",,,0,10,0,0,0,,,"2018 Protegen Update Autogenerated"
4932,195,"Evangelista et al., 2017",journal,"Evangelista KV, Lourdault K, Matsunaga J, Haake DA",Immunoprotective properties of recombinant LigA and LigB in a hamster model of acute leptospirosis,"2017","12","7",e0180004,PloS one,,,,,,,,"28704385",,,0,10,0,0,0,,,"2018 Protegen Update Autogenerated"
4933,47,"Zhang et al., 2017",journal,"Zhang J, Cui YL, Jiang YM",[Immunoprotective effect of combined pneumococcal endopeptidase O and pneumococcal surface adhesin A vaccines against Streptococcus pneumoniae infection],"2017","19","5","583-589",Zhongguo dang dai er ke za zhi = Chinese journal of contemporary pediatrics,,,,,,,,"28506354",,,0,10,0,0,0,,,"2018 Protegen Update Autogenerated"
4934,108,"Jiao et al., 2005",journal,"Jiao Y, Wen B, Chen M, Niu D, Zhang J, Qiu L",Analysis of immunoprotectivity of the recombinant OmpA of Rickettsia heilongjiangensis,"2005","1063","","261-265",Annals of the New York Academy of Sciences,,,,,,,,"16481525",,,0,10,0,0,0,,,"2018 Protegen Update Autogenerated"
4935,9,"Khler et al., 2015",journal,"Khler SM, Baillie LW, Beyer W",BclA and toxin antigens augment each other to protect NMRI mice from lethal Bacillus anthracis challenge,"2015","33","24","2771-2777",Vaccine,,,,,,,,"25917676",,,0,10,0,0,0,,,"2018 Protegen Update Autogenerated"
4936,47,"Jang et al., 2017",journal,"Jang AY, Seo HS, Lin S, Chung GH, Kim HW, Lim S, Zhao L, Park IH, Lim JH, Kim KH","Molecular characterization of pneumococcal surface protein K, a potential pneumococcal vaccine antigen","2017","8","6","875-890",Virulence,,,,,,,,"28059611",,,0,10,0,0,0,,,"2018 Protegen Update Autogenerated"
4937,138,"Yang et al., 2016",journal,"Yang HJ, Zhang JY, Wei C, Yang LY, Zuo QF, Zhuang Y, Feng YJ, Srinivas S, Zeng H, Zou QM",Immunisation With Immunodominant Linear B Cell Epitopes Vaccine of Manganese Transport Protein C Confers Protection against Staphylococcus aureus Infection,"2016","11","2",e0149638,PloS one,,,,,,,,"26895191",,,0,10,0,0,0,,,"2018 Protegen Update Autogenerated"
4938,208,"Jiang et al., 2017",journal,"Jiang P, Cai Y, Chen J, Ye X, Mao S, Zhu S, Xue X, Chen S, Zhang L",Evaluation of tandem Chlamydia trachomatis MOMP multi-epitopes vaccine in BALB/c mice model,"2017","35","23","3096-3103",Vaccine,,,,,,,,"28456528",,,0,10,0,0,0,,,"2018 Protegen Update Autogenerated"
4939,138,"Delfani et al., 2016",journal,"Delfani S, Mohabati Mobarez A, Imani Fooladi AA, Amani J, Emaneini M",Protection of mice against Staphylococcus aureus infection by a recombinant protein ClfA-IsdB-Hlg as a vaccine candidate,"2016","205","1","47-55",Medical microbiology and immunology,,,,,,,,"26155981",,,0,10,0,0,0,,,"2018 Protegen Update Autogenerated"
4940,140,"Sagar et al., 2012",journal,"Sagar V, Bergmann R, Nerlich A, McMillan DJ, Nitsche Schmitz DP, Chhatwal GS","Variability in the distribution of genes encoding virulence factors and putative extracellular proteins of Streptococcus pyogenes in India, a region with high streptococcal disease burden, and implication for development of a regional multisubunit vaccine","2012","19","11","1818-1825",Clinical and vaccine immunology : CVI,,,,,,,,"22971782",,,0,10,0,0,0,,,"2018 Protegen Update Autogenerated"
4941,138,"Lacey et al., 2017",journal,"Lacey KA, Leech JM, Lalor SJ, McCormack N, Geoghegan JA, McLoughlin RM",The Staphylococcus aureus Cell Wall-Anchored Protein Clumping Factor A Is an Important T Cell Antigen,"2017","85","12","",Infection and immunity,,,,,,,,"28947645",,,0,10,0,0,0,,,"2018 Protegen Update Autogenerated"
4942,113,"Yu et al., 2009",journal,"Yu H, Jiang X, Shen C, Karunakaran KP, Brunham RC",Novel Chlamydia muridarum T cell antigens induce protective immunity against lung and genital tract infection in murine models,"2009","182","3","1602-1608","Journal of immunology (Baltimore, Md. : 1950)",,,,,,,,"19155509",,,0,10,0,0,0,,,"2018 Protegen Update Autogenerated"
4943,137,"Banadkoki et al., 2016",journal,"Banadkoki AZ, Keshavarzmehr M, Afshar Z, Aleyasin N, Fatemi MJ, Behrouz B, Hashemi FB",Protective effect of pilin protein with alum+naloxone adjuvant against acute pulmonary Pseudomonas aeruginosa infection,"2016","44","5","367-373",Biologicals : journal of the International Association of Biological Standardization,,,,,,,,"27427517",,,0,10,0,0,0,,,"2018 Protegen Update Autogenerated"
4944,208,"Wang et al., 2009",journal,"Wang J, Chen L, Chen F, Zhang X, Zhang Y, Baseman J, Perdue S, Yeh IT, Shain R, Holland M, Bailey R, Mabey D, Yu P, Zhong G",A chlamydial type III-secreted effector protein (Tarp) is predominantly recognized by antibodies from humans infected with Chlamydia trachomatis and induces protective immunity against upper genital tract pathologies in mice,"2009","27","22","2967-2980",Vaccine,,,,,,,,"19428908",,,0,10,0,0,0,,,"2018 Protegen Update Autogenerated"
4945,138,"Pozzi et al., 2015",journal,"Pozzi C, Lofano G, Mancini F, Soldaini E, Speziale P, De Gregorio E, Rappuoli R, Bertholet S, Grandi G, Bagnoli F",Phagocyte subsets and lymphocyte clonal deletion behind ineffective immune response to Staphylococcus aureus,"2015","39","5","750-763",FEMS microbiology reviews,,,,,,,,"25994610",,,0,10,0,0,0,,,"2018 Protegen Update Autogenerated"
4946,140,"Rivera-Hernandez et al., 2016",journal,"Rivera-Hernandez T, Pandey M, Henningham A, Cole J, Choudhury B, Cork AJ, Gillen CM, Ghaffar KA, West NP, Silvestri G, Good MF, Moyle PM, Toth I, Nizet V, Batzloff MR, Walker MJ",Differing Efficacies of Lead Group A Streptococcal Vaccine Candidates and Full-Length M Protein in Cutaneous and Invasive Disease Models,"2016","7","3","",mBio,,,,,,,,"27302756",,,0,10,0,0,0,,,"2018 Protegen Update Autogenerated"
4947,81,"Fu et al., 2013",journal,"Fu Q, Wei Z, Chen Y, Xiao P, Lu Z, Liu X","Identification of a surface protective antigen, CSP of Streptococcus equi ssp. zooepidemicus","2013","31","10","1400-1405",Vaccine,,,,,,,,"23306366",,,0,10,0,0,0,,,"2018 Protegen Update Autogenerated"
4948,145,"Zhang et al., 2014",journal,"Zhang J, Chen XW, Tong TZ, Ye Y, Liao M, Fan HY",BacMam virus-based surface display of the infectious bronchitis virus (IBV) S1 glycoprotein confers strong protection against virulent IBV challenge in chickens,"2014","32","6","664-670",Vaccine,,,,,,,,"24342247",,,0,10,0,0,0,,,"2018 Protegen Update Autogenerated"
4949,184,"Wen et al., 2015",journal,"Wen X, Wei X, Ran X, Ni H, Cao S, Zhang Y","Immunogenicity of porcine P[6], P[7]-specific VP8* rotavirus subunit vaccines with a tetanus toxoid universal T cell epitope","2015","33","36","4533-4539",Vaccine,,,,,,,,"26192360",,,0,10,0,0,0,,,"2018 Protegen Update Autogenerated"
4950,153,"McCabe and Spibey, 2005",journal,"McCabe VJ, Spibey N",Potential for broad-spectrum protection against feline calicivirus using an attenuated myxoma virus expressing a chimeric FCV capsid protein,"2005","23","46-47","5380-5388",Vaccine,,,,,,,,"16176851",,,0,10,0,0,0,,,"2018 Protegen Update Autogenerated"
4951,165,"Legisa et al., 2015",journal,"Legisa DM, Perez Aguirreburualde MS, Gonzalez FN, Marin-Lopez A, Ruiz V, Wigdorovitz A, Martinez-Escribano JA, Ortego J, Dus Santos MJ","An experimental subunit vaccine based on Bluetongue virus 4 VP2 protein fused to an antigen-presenting cells single chain antibody elicits cellular and humoral immune responses in cattle, guinea pigs and IFNAR(-/-) mice","2015","33","22","2614-2619",Vaccine,,,,,,,,"25858859",,,0,10,0,0,0,,,"2018 Protegen Update Autogenerated"
4952,73,"Qiao et al., 2005",journal,"Qiao J, Xia XZ, Yang ST, Hu GX, Xie ZJ",[Construction of recombinant canine adenovirus type 2 expressing Canine coronavirus spike glycoprotein and its immunogenicity],"2005","45","4","588-592",Wei sheng wu xue bao = Acta microbiologica Sinica,,,,,,,,"16245877",,,0,10,0,0,0,,,"2018 Protegen Update Autogenerated"
4953,101,"Larsen et al., 2013",journal,"Larsen A, Gonzalez ET, Serena MS, Echeverra MG, Mortola E",Expression of p24 gag protein of bovine leukemia virus in insect cells and its use in immunodetection of the disease,"2013","54","2","475-483",Molecular biotechnology,,,,,,,,"22829115",,,0,10,0,0,0,,,"2018 Protegen Update Autogenerated"
4954,283,"Rutkowska et al., 2011",journal,"Rutkowska DA, Meyer QC, Maree F, Vosloo W, Fick W, Huismans H",The use of soluble African horse sickness viral protein 7 as an antigen delivery and presentation system,"2011","156","1-2","35-48",Virus research,,,,,,,,"21195731",,,0,10,0,0,0,,,"2018 Protegen Update Autogenerated"
4955,122,"Phillips et al., 2014",journal,"Phillips AT, Schountz T, Toth AM, Rico AB, Jarvis DL, Powers AM, Olson KE",Liposome-antigen-nucleic acid complexes protect mice from lethal challenge with western and eastern equine encephalitis viruses,"2014","88","3","1771-1780",Journal of virology,,,,,,,,"24257615",,,0,10,0,0,0,,,"2018 Protegen Update Autogenerated"
4956,175,"Takano et al., 2014",journal,"Takano T, Tomizawa K, Morioka H, Doki T, Hohdatsu T",Evaluation of protective efficacy of the synthetic peptide vaccine containing the T-helper 1 epitope with CpG oligodeoxynucleotide against feline infectious peritonitis virus infection in cats,"2014","19","7","645-650",Antiviral therapy,,,,,,,,"24458025",,,0,10,0,0,0,,,"2018 Protegen Update Autogenerated"
4957,283,"Manning et al., 2017",journal,"Manning NM, Bachanek-Bankowska K, Mertens PPC, Castillo-Olivares J",Vaccination with recombinant Modified Vaccinia Ankara (MVA) viruses expressing single African horse sickness virus VP2 antigens induced cross-reactive virus neutralising antibodies (VNAb) in horses when administered in combination,"2017","35","44","6024-6029",Vaccine,,,,,,,,"28438410",,,0,10,0,0,0,,,"2018 Protegen Update Autogenerated"
4958,210,"O'Shaughnessy et al., 2011",journal,"O'Shaughnessy L, Carr M, Crowley B, Carberry S, Doyle S",Recombinant expression and immunological characterisation of proteins derived from human metapneumovirus,"2011","52","3","236-243",Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology,,,,,,,,"21920812",,,0,10,0,0,0,,,"2018 Protegen Update Autogenerated"
4959,64,"Ding et al., 2017",journal,"Ding P, Zhang T, Li Y, Teng M, Sun Y, Liu X, Chai S, Zhou E, Jin Q, Zhang G",Nanoparticle orientationally displayed antigen epitopes improve neutralizing antibody level in a model of porcine circovirus type 2,"2017","12","","5239-5254",International journal of nanomedicine,,,,,,,,"28769561",,,0,10,0,0,0,,,"2018 Protegen Update Autogenerated"
4960,210,"Ms et al., 2016",journal,"Ms V, Rodriguez L, Olmedillas E, Cano O, Palomo C, Terrn MC, Luque D, Melero JA, McLellan JS","Engineering, Structure and Immunogenicity of the Human Metapneumovirus F Protein in the Postfusion Conformation","2016","12","9",e1005859,PLoS pathogens,,,,,,,,"27611367",,,0,10,0,0,0,,,"2018 Protegen Update Autogenerated"
4961,183,"Subramaniam et al., 2017",journal,"Subramaniam S, Pieyro P, Derscheid RJ, Madson DM, Magstadt DR, Meng XJ",Dendritic cell-targeted porcine reproductive and respiratory syndrome virus (PRRSV) antigens adjuvanted with polyinosinic-polycytidylic acid (poly (I:C)) induced non-protective immune responses against heterologous type 2 PRRSV challenge in pigs,"2017","190","","18-25",Veterinary immunology and immunopathology,,,,,,,,"28778318",,,0,10,0,0,0,,,"2018 Protegen Update Autogenerated"
4962,156,"Maeda et al., 1996",journal,"Maeda K, Ono M, Kawaguchi Y, Niikura M, Okazaki K, Yokoyama N, Tokiyoshi Y, Tohya Y, Mikami T",Expression and properties of feline herpesvirus type 1 gD (hemagglutinin) by a recombinant baculovirus,"1996","46","1-2","75-80",Virus research,,,,,,,,"9029779",,,0,10,0,0,0,,,"2018 Protegen Update Autogenerated"
4963,128,"Faburay et al., 2014",journal,"Faburay B, Lebedev M, McVey DS, Wilson W, Morozov I, Young A, Richt JA",A glycoprotein subunit vaccine elicits a strong Rift Valley fever virus neutralizing antibody response in sheep,"2014","14","10","746-756","Vector borne and zoonotic diseases (Larchmont, N.Y.)",,,,,,,,"25325319",,,0,10,0,0,0,,,"2018 Protegen Update Autogenerated"
4964,155,"Yang et al., 2008",journal,"Yang S, Xia X, Qiao J, Liu Q, Chang S, Xie Z, Ju H, Zou X, Gao Y",Complete protection of cats against feline panleukopenia virus challenge by a recombinant canine adenovirus type 2 expressing VP2 from FPV,"2008","26","11","1482-1487",Vaccine,,,,,,,,"18313810",,,0,10,0,0,0,,,"2018 Protegen Update Autogenerated"
4965,268,"Zhao et al., 2014",journal,"Zhao W, Spatz S, Zhang Z, Wen G, Garcia M, Zsak L, Yu Q",Newcastle disease virus (NDV) recombinants expressing infectious laryngotracheitis virus (ILTV) glycoproteins gB and gD protect chickens against ILTV and NDV challenges,"2014","88","15","8397-8406",Journal of virology,,,,,,,,"24829337",,,0,10,0,0,0,,,"2018 Protegen Update Autogenerated"
4966,71,"Marciani et al., 1991",journal,"Marciani DJ, Kensil CR, Beltz GA, Hung CH, Cronier J, Aubert A",Genetically-engineered subunit vaccine against feline leukaemia virus: protective immune response in cats,"1991","9","2","89-96",Vaccine,,,,,,,,"1647576",,,0,10,0,0,0,,,"2018 Protegen Update Autogenerated"
4967,165,"Bouet-Cararo et al., 2014",journal,"Bouet-Cararo C, Contreras V, Caruso A, Top S, Szelechowski M, Bergeron C, Viarouge C, Desprat A, Relmy A, Guibert JM, Dubois E, Thiery R, Brard E, Bertagnoli S, Richardson J, Foucras G, Meyer G, Schwartz-Cornil I, Zientara S, Klonjkowski B","Expression of VP7, a Bluetongue virus group specific antigen by viral vectors: analysis of the induced immune responses and evaluation of protective potential in sheep","2014","9","11",e111605,PloS one,,,,,,,,"25364822",,,0,10,0,0,0,,,"2018 Protegen Update Autogenerated"
4968,56,"Kang et al., 2015",journal,"Kang H, Qi Y, Wang H, Zheng X, Gao Y, Li N, Yang S, Xia X",Chimeric rabies virus-like particles containing membrane-anchored GM-CSF enhances the immune response against rabies virus,"2015","7","3","1134-1152",Viruses,,,,,,,,"25768031",,,0,10,0,0,0,,,"2018 Protegen Update Autogenerated"
4969,160,"Zhao et al., 2011",journal,"Zhao K, He W, Gao W, Lu H, Han T, Li J, Zhang X, Zhang B, Wang G, Su G, Zhao Z, Song D, Gao F",Orf virus DNA vaccines expressing ORFV 011 and ORFV 059 chimeric protein enhances immunogenicity,"2011","8","","562",Virology journal,,,,,,,,"22204310",,,0,10,0,0,0,,,"2018 Protegen Update Autogenerated"
4970,106,"Stenkova et al., 2017",journal,"Stenkova AM, Chopenko NS, Davydova LA, Mazeika AN, Bystritskaya EP, Portnyagina OY, Anastyuk SD, Kulbatskii DS, Lyukmanova EN, Dolgikh DA, Kostetsky EY, Sanina NM",Engineering of Chimeric Protein Based on E Protein Domain III of Tick- Borne Encephalitis Virus and OmpF Porin of Yersinia pseudotuberculosis,"2017","24","10","974-981",Protein and peptide letters,,,,,,,,"28741465",,,0,10,0,0,0,,,"2018 Protegen Update Autogenerated"
4971,101,"Kabeya et al., 1996",journal,"Kabeya H, Ohashi K, Ohishi K, Sugimoto C, Amanuma H, Onuma M",An effective peptide vaccine to eliminate bovine leukaemia virus (BLV) infected cells in carrier sheep,"1996","14","12","1118-1122",Vaccine,,,,,,,,"8911007",,,0,10,0,0,0,,,"2018 Protegen Update Autogenerated"
4972,233,"Guo et al., 2016",journal,"Guo H, Zhu J, Tan Y, Li C, Chen Z, Sun S, Liu G",Self-assembly of virus-like particles of rabbit hemorrhagic disease virus capsid protein expressed in Escherichia coli and their immunogenicity in rabbits,"2016","131","","85-91",Antiviral research,,,,,,,,"27118636",,,0,10,0,0,0,,,"2018 Protegen Update Autogenerated"
4973,51,"Hua et al., 2014",journal,"Hua RH, Liu LK, Huo H, Li YN, Guo LP, Wang XL, Qin CF, Bu ZG",Comprehensive mapping of a novel NS1 epitope conserved in flaviviruses within the Japanese encephalitis virus serocomplex,"2014","185","","103-109",Virus research,,,,,,,,"24631788",,,0,10,0,0,0,,,"2018 Protegen Update Autogenerated"
4974,193,"Jagu et al., 2011",journal,"Jagu S, Malandro N, Kwak K, Yuan H, Schlegel R, Palmer KE, Huh WK, Campo MS, Roden RB",A multimeric L2 vaccine for prevention of animal papillomavirus infections,"2011","420","1","43-50",Virology,,,,,,,,"21920572",,,0,10,0,0,0,,,"2018 Protegen Update Autogenerated"
4975,129,"Demurtas et al., 2016",journal,"Demurtas OC, Massa S, Illiano E, De Martinis D, Chan PK, Di Bonito P, Franconi R",Antigen Production in Plant to Tackle Infectious Diseases Flare Up: The Case of SARS,"2016","7","","54",Frontiers in plant science,,,,,,,,"26904039",,,0,10,0,0,0,,,"2018 Protegen Update Autogenerated"
4976,169,"Mahony et al., 2015",journal,"Mahony D, Mody KT, Cavallaro AS, Hu Q, Mahony TJ, Qiao S, Mitter N","Immunisation of Sheep with Bovine Viral Diarrhoea Virus, E2 Protein Using a Freeze-Dried Hollow Silica Mesoporous Nanoparticle Formulation","2015","10","11",e0141870,PloS one,,,,,,,,"26535891",,,0,10,0,0,0,,,"2018 Protegen Update Autogenerated"
4977,175,"Satoh et al., 2011",journal,"Satoh R, Furukawa T, Kotake M, Takano T, Motokawa K, Gemma T, Watanabe R, Arai S, Hohdatsu T",Screening and identification of T helper 1 and linear immunodominant antibody-binding epitopes in the spike 2 domain and the nucleocapsid protein of feline infectious peritonitis virus,"2011","29","9","1791-1800",Vaccine,,,,,,,,"21216312",,,0,10,0,0,0,,,"2018 Protegen Update Autogenerated"
4978,145,"Leyson et al., 2016",journal,"Leyson C, Frana M, Jackwood M, Jordan B",Polymorphisms in the S1 spike glycoprotein of Arkansas-type infectious bronchitis virus (IBV) show differential binding to host tissues and altered antigenicity,"2016","498","","218-225",Virology,,,,,,,,"27619927",,,0,10,0,0,0,,,"2018 Protegen Update Autogenerated"
4979,150,"Sawant et al., 2015",journal,"Sawant PM, Dhama K, Rawool DB, Wani MY, Tiwari R, Singh SD, Singh RK",Development of a DNA vaccine for chicken infectious anemia and its immunogenicity studies using high mobility group box 1 protein as a novel immunoadjuvant indicated induction of promising protective immune responses,"2015","33","2","333-340",Vaccine,,,,,,,,"25448094",,,0,10,0,0,0,,,"2018 Protegen Update Autogenerated"
4980,199,"Ji et al., 2017",journal,"Ji P, Liu Y, Chen Y, Wang A, Jiang D, Zhao B, Wang J, Chai S, Zhou E, Zhang G",Porcine parvovirus capsid protein expressed in Escherichia coli self-assembles into virus-like particles with high immunogenicity in mice and guinea pigs,"2017","139","","146-152",Antiviral research,,,,,,,,"28063996",,,0,10,0,0,0,,,"2018 Protegen Update Autogenerated"
4981,233,"Zhang et al., 2017",journal,"Zhang S, Sun F, Ren T, Duan Y, Gu H, Lai C, Wang Z, Zhang P, Wang X, Yang P",Immunogenicity of an influenza virus-vectored vaccine carrying the hepatitis C virus protein epitopes in mice,"2017","145","","168-174",Antiviral research,,,,,,,,"28778831",,,0,10,0,0,0,,,"2018 Protegen Update Autogenerated"
4982,199,"Xie et al., 2010",journal,"Xie HL, Wang Z, Cui SJ, Zhang CF, Cui YD",The epitope of the VP1 protein of porcine parvovirus,"2010","7","","161",Virology journal,,,,,,,,"20637107",,,0,10,0,0,0,,,"2018 Protegen Update Autogenerated"
4983,283,"de et al., 2015",journal,"de la Poza F, Marn-Lpez A, Castillo-Olivares J, Calvo-Pinilla E, Ortego J",Identification of CD8 T cell epitopes in VP2 and NS1 proteins of African horse sickness virus in IFNAR(-/-) mice,"2015","210","","149-153",Virus research,,,,,,,,"26272673",,,0,10,0,0,0,,,"2018 Protegen Update Autogenerated"
4984,192,"Mou et al., 2016",journal,"Mou C, Zhu L, Xing X, Lin J, Yang Q",Immune responses induced by recombinant Bacillus subtilis expressing the spike protein of transmissible gastroenteritis virus in pigs,"2016","131","","74-84",Antiviral research,,,,,,,,"26988122",,,0,10,0,0,0,,,"2018 Protegen Update Autogenerated"
4985,191,"Balasuriya et al., 2002",journal,"Balasuriya UB, Heidner HW, Davis NL, Wagner HM, Hullinger PJ, Hedges JF, Williams JC, Johnston RE, David Wilson W, Liu IK, James MacLachlan N",Alphavirus replicon particles expressing the two major envelope proteins of equine arteritis virus induce high level protection against challenge with virulent virus in vaccinated horses,"2002","20","11-12","1609-1617",Vaccine,,,,,,,,"11858869",,,0,10,0,0,0,,,"2018 Protegen Update Autogenerated"
4986,53,"antak et al., 2015",journal,"antak M, rvell C, Gulija TK",Identification of conformational neutralization sites on the fusion protein of mumps virus,"2015","96",Pt 5,"982-990",The Journal of general virology,,,,,,,,"25614584",,,0,10,0,0,0,,,"2018 Protegen Update Autogenerated"
4987,198,"Nasiri et al., 2016",journal,"Nasiri K, Nassiri M, Tahmoorespur M, Haghparast A, Zibaee S",Design and Construction of Chimeric VP8-S2 Antigen for Bovine Rotavirus and Bovine Coronavirus,"2016","6","1","91-98",Advanced pharmaceutical bulletin,,,,,,,,"27123423",,,0,10,0,0,0,,,"2018 Protegen Update Autogenerated"
4988,156,"Sato et al., 2000",journal,"Sato E, Yokoyama N, Miyazawa T, Maeda K, Ikeda Y, Nishimura Y, Fujita K, Kohmoto M, Takahashi E, Mikami T",Efficient expression of the envelope protein of feline immunodeficiency virus in a recombinant feline herpesvirus type 1 (FHV-1) using the gC promoter of FHV-1,"2000","70","1-2","13-23",Virus research,,,,,,,,"11074121",,,0,10,0,0,0,,,"2018 Protegen Update Autogenerated"
4989,54,"Pouyanfard et al., 2018",journal,"Pouyanfard S, Spagnoli G, Bulli L, Balz K, Yang F, Odenwald C, Seitz H, Mariz FC, Bolchi A, Ottonello S, Mller M",Minor Capsid Protein L2 Polytope Induces Broad Protection against Oncogenic and Mucosal Human Papillomaviruses,"2018","92","4","",Journal of virology,,,,,,,,"29212932",,,0,10,0,0,0,,,"2018 Protegen Update Autogenerated"
4990,162,"Mikalsen et al., 2005",journal,"Mikalsen AB, Sindre H, Torgersen J, Rimstad E",Protective effects of a DNA vaccine expressing the infectious salmon anemia virus hemagglutinin-esterase in Atlantic salmon,"2005","23","41","4895-4905",Vaccine,,,,,,,,"16005119",,,0,10,0,0,0,,,"2018 Protegen Update Autogenerated"
4991,183,"Mokhtar et al., 2017",journal,"Mokhtar H, Biffar L, Somavarapu S, Frossard JP, McGowan S, Pedrera M, Strong R, Edwards JC, Garcia-Durn M, Rodriguez MJ, Stewart GR, Steinbach F, Graham SP",Evaluation of hydrophobic chitosan-based particulate formulations of porcine reproductive and respiratory syndrome virus vaccine candidate T cell antigens,"2017","209","","66-74",Veterinary microbiology,,,,,,,,"28228336",,,0,10,0,0,0,,,"2018 Protegen Update Autogenerated"
4992,57,"Afchangi et al., 2018",journal,"Afchangi A, Arashkia A, Shahosseini Z, Jalilvand S, Marashi SM, Roohvand F, Mohajel N, Shoja Z",Immunization of Mice by Rotavirus NSP4-VP6 Fusion Protein Elicited Stronger Responses Compared to VP6 Alone,"2018","31","3","233-241",Viral immunology,,,,,,,,"29185875",,,0,10,0,0,0,,,"2018 Protegen Update Autogenerated"
4993,232,"Joshi and Arankalle, 2016",journal,"Joshi SS, Arankalle VA",Differential Immune Responses in Mice Immunized with Recombinant Neutralizing Epitope Protein of Hepatitis E Virus Formulated with Liposome and Alum Adjuvants,"2016","29","6","350-360",Viral immunology,,,,,,,,"27285290",,,0,10,0,0,0,,,"2018 Protegen Update Autogenerated"
4994,51,"Qian et al., 2015",journal,"Qian P, Zhi X, Wang B, Zhang H, Chen H, Li X",Construction and immune efficacy of recombinant pseudorabies virus expressing PrM-E proteins of Japanese encephalitis virus genotype ,"2015","12","","214",Virology journal,,,,,,,,"26651827",,,0,10,0,0,0,,,"2018 Protegen Update Autogenerated"
4995,122,"Wu et al., 2007",journal,"Wu JQ, Barab ND, Chau D, Wong C, Rayner GR, Hu WG, Nagata LP",Complete protection of mice against a lethal dose challenge of western equine encephalitis virus after immunization with an adenovirus-vectored vaccine,"2007","25","22","4368-4375",Vaccine,,,,,,,,"17467858",,,0,10,0,0,0,,,"2018 Protegen Update Autogenerated"
4996,232,"Li et al., 2009",journal,"Li S, Tang X, Seetharaman J, Yang C, Gu Y, Zhang J, Du H, Shih JW, Hew CL, Sivaraman J, Xia N",Dimerization of hepatitis E virus capsid protein E2s domain is essential for virus-host interaction,"2009","5","8",e1000537,PLoS pathogens,,,,,,,,"19662165",,,0,10,0,0,0,,,"2018 Protegen Update Autogenerated"
4997,143,"Blodrn et al., 2014",journal,"Blodrn K, Hgglund S, Fix J, Dubuquoy C, Makabi-Panzu B, Thom M, Karlsson P, Roque JL, Karlstam E, Pringle J, Elout JF, Riffault S, Taylor G, Valarcher JF","Vaccine safety and efficacy evaluation of a recombinant bovine respiratory syncytial virus (BRSV) with deletion of the SH gene and subunit vaccines based on recombinant human RSV proteins: N-nanorings, P and M2-1, in calves with maternal antibodies","2014","9","6",e100392,PloS one,,,,,,,,"24945377",,,0,10,0,0,0,,,"2018 Protegen Update Autogenerated"
4998,143,"Gershwin et al., 2017",journal,"Gershwin LJ, Behrens NE, McEligot HA, Carvallo-Chaigneau FR, Crum LT, Gunnarson BM, Corbeil LB",A recombinant subunit vaccine for bovine RSV and Histophilus somni protects calves against dual pathogen challenge,"2017","35","15","1954-1963",Vaccine,,,,,,,,"28274639",,,0,10,0,0,0,,,"2018 Protegen Update Autogenerated"
4999,191,"Hedges et al., 1998",journal,"Hedges JF, Balasuriya UB, Ahmad S, Timoney PJ, McCollum WH, Yilma T, MacLachlan NJ","Detection of antibodies to equine arteritis virus by enzyme linked immunosorbant assays utilizing G(L), M and N proteins expressed from recombinant baculoviruses","1998","76","1-2","127-137",Journal of virological methods,,,,,,,,"9923747",,,0,10,0,0,0,,,"2018 Protegen Update Autogenerated"
5000,165,"Wang et al., 2013",journal,"Wang WS, Sun EC, Liu NH, Yang T, Xu QY, Qin YL, Zhao J, Feng YF, Li JP, Wei P, Zhang CY, Wu DL",Identification of three novel linear B-cell epitopes on the VP5 protein of BTV16,"2013","162","2-4","631-642",Veterinary microbiology,,,,,,,,"23290575",,,0,10,0,0,0,,,"2018 Protegen Update Autogenerated"
5001,220,"Gimnez-Lirola et al., 2016",journal,"Gimnez-Lirola LG, Mur L, Rivera B, Mogler M, Sun Y, Lizano S, Goodell C, Harris DL, Rowland RR, Gallardo C, Snchez-Vizcano JM, Zimmerman J",Detection of African Swine Fever Virus Antibodies in Serum and Oral Fluid Specimens Using a Recombinant Protein 30 (p30) Dual Matrix Indirect ELISA,"2016","11","9",e0161230,PloS one,,,,,,,,"27611939",,,0,10,0,0,0,,,"2018 Protegen Update Autogenerated"
5002,230,"Standish et al., 2016",journal,"Standish IF, Millard EV, Brenden TO, Faisal M","A DNA vaccine encoding the viral hemorrhagic septicemia virus genotype IVb glycoprotein confers protection in muskellunge (Esox masquinongy), rainbow trout (Oncorhynchus mykiss), brown trout (Salmo trutta), and lake trout (Salvelinus namaycush)","2016","13","1","203",Virology journal,,,,,,,,"27912771",,,0,10,0,0,0,,,"2018 Protegen Update Autogenerated"
5003,183,"An et al., 2018",journal,"An CH, Nazki S, Park SC, Jeong YJ, Lee JH, Park SJ, Khatun A, Kim WI, Park YI, Jeong JC, Kim CY",Plant synthetic GP4 and GP5 proteins from porcine reproductive and respiratory syndrome virus elicit immune responses in pigs,"2018","247","4","973-985",Planta,,,,,,,,"29313103",,,0,10,0,0,0,,,"2018 Protegen Update Autogenerated"
5004,184,"Hu and Wang, 2008",journal,"Hu J, Wang C",[Expression and immunogenicity analysis of recombinant plasmid pW425et-Vp7 of porcine rotavirus A in Lactobacillus],"2008","48","11","1514-1519",Wei sheng wu xue bao = Acta microbiologica Sinica,,,,,,,,"19149168",,,0,10,0,0,0,,,"2018 Protegen Update Autogenerated"
5005,232,"Al-Ayoubi et al., 2018",journal,"Al-Ayoubi J, Behrendt P, Bremer B, Suneetha PV, Gisa A, Rinker F, Manns MP, Cornberg M, Wedemeyer H, Kraft ARM",Hepatitis E virus ORF 1 induces proliferative and functional T-cell responses in patients with ongoing and resolved hepatitis E,"2018","38","2","266-277",Liver international : official journal of the International Association for the Study of the Liver,,,,,,,,"28718943",,,0,10,0,0,0,,,"2018 Protegen Update Autogenerated"
5006,176,"Pacchioni et al., 2013",journal,"Pacchioni SM, Bissa M, Zanotto C, Morghen Cde G, Illiano E, Radaelli A","L1R, A27L, A33R and B5R vaccinia virus genes expressed by fowlpox recombinants as putative novel orthopoxvirus vaccines","2013","11","","95",Journal of translational medicine,,,,,,,,"23578094",,,0,10,0,0,0,,,"2018 Protegen Update Autogenerated"
5007,278,"Lam et al., 2015",journal,"Lam S, Nyo M, Phuektes P, Yew CW, Tan YJ, Chu JJ",A potent neutralizing IgM mAb targeting the N218 epitope on E2 protein protects against Chikungunya virus pathogenesis,"2015","7","6","1178-1194",mAbs,,,,,,,,"26305993",,,0,10,0,0,0,,,"2018 Protegen Update Autogenerated"
5008,233,"Pierce et al., 2017",journal,"Pierce BG, Boucher EN, Piepenbrink KH, Ejemel M, Rapp CA, Thomas WD Jr, Sundberg EJ, Weng Z, Wang Y",Structure-Based Design of Hepatitis C Virus Vaccines That Elicit Neutralizing Antibody Responses to a Conserved Epitope,"2017","91","20","",Journal of virology,,,,,,,,"28794021",,,0,10,0,0,0,,,"2018 Protegen Update Autogenerated"
5009,58,"Nagieva et al., 2011",journal,"Nagieva FG, Nikulina VG, Barkova EP, Zubkov AV, Kuz'mina NS, Desiatskova RG, Tkachnko AV, Iunasova TN",[Monoclonal antibodies to rubella virus glycoprotein E1],"2011","","1","61-67","Zhurnal mikrobiologii, epidemiologii, i immunobiologii",,,,,,,,"21446169",,,0,10,0,0,0,,,"2018 Protegen Update Autogenerated"
5010,193,"Mdolo et al., 2017",journal,"Mdolo DG, Araldi RP, Mazzuchelli-de-Souza J, Pereira A, Pimenta DC, Zanphorlin LM, Beak W, Menossi M, de Cassia Stocco R, de Carvalho RF",Integrated analysis of recombinant BPV-1 L1 protein for the production of a bovine papillomavirus VLP vaccine,"2017","35","12","1590-1593",Vaccine,,,,,,,,"28222997",,,0,10,0,0,0,,,"2018 Protegen Update Autogenerated"
5011,106,"Dmitriev et al., 1996",journal,"Dmitriev IP, Khromykh AA, Ignatyev GM, Gainullina MN, Ageenko VA, Dryga SA, Vorobyeva MS, Sandakhchiev LS",Immunization with recombinant vaccinia viruses expressing structural and part of the nonstructural region of tick-borne encephalitis virus cDNA protect mice against lethal encephalitis,"1996","44","1-3","97-103",Journal of biotechnology,,,,,,,,"8717392",,,0,10,0,0,0,,,"2018 Protegen Update Autogenerated"
5012,220,"Burmakina et al., 2016",journal,"Burmakina G, Malogolovkin A, Tulman ER, Zsak L, Delhon G, Diel DG, Shobogorov NM, Morgunov YP, Morgunov SY, Kutish GF, Kolbasov D, Rock DL",African swine fever virus serotype-specific proteins are significant protective antigens for African swine fever,"2016","97","7","1670-1675",The Journal of general virology,,,,,,,,"27114233",,,0,10,0,0,0,,,"2018 Protegen Update Autogenerated"
5013,286,"Hashimoto et al., 2003",journal,"Hashimoto Y, Chen HS, Cunningham C, Malik TH, Lai PK",Two major histocompatibility complex class I-restricted epitopes of the Borna disease virus p10 protein identified by cytotoxic T lymphocytes induced by DNA-based immunization,"2003","77","10","6076-6081",Journal of virology,,,,,,,,"12719601",,,0,10,0,0,0,,,"2018 Protegen Update Autogenerated"
5014,54,"Khan et al., 2017",journal,"Khan S, Oosterhuis K, Wunderlich K, Bunnik EM, Bhaggoe M, Boedhoe S, Karia S, Steenbergen RDM, Bosch L, Serroyen J, Janssen S, Schuitemaker H, Vellinga J, Scheper G, Zahn R, Custers J",Development of a replication-deficient adenoviral vector-based vaccine candidate for the interception of HPV16- and HPV18-induced infections and disease,"2017","141","2","393-404",International journal of cancer,,,,,,,,"28263390",,,0,10,0,0,0,,,"2018 Protegen Update Autogenerated"
5015,220,"Heimerman et al., 2018",journal,"Heimerman ME, Murgia MV, Wu P, Lowe AD, Jia W, Rowland RR",Linear epitopes in African swine fever virus p72 recognized by monoclonal antibodies prepared against baculovirus-expressed antigen,"2018","30","3","406-412","Journal of veterinary diagnostic investigation : official publication of the American Association of Veterinary Laboratory Diagnosticians, Inc",,,,,,,,"29327672",,,0,10,0,0,0,,,"2018 Protegen Update Autogenerated"
5016,59,"Zhang et al., 2013",journal,"Zhang W, Li X, Lin Y, Tian D",Identification of three H-2K(d) restricted CTL epitopes of NS4A and NS4B protein from Yellow fever 17D vaccine,"2013","187","2","304-313",Journal of virological methods,,,,,,,,"23123122",,,0,10,0,0,0,,,"2018 Protegen Update Autogenerated"
5017,71,"Clark et al., 1991",journal,"Clark N, Kushner NN, Barrett CB, Kensil CR, Salsbury D, Cotter S",Efficacy and safety field trials of a recombinant DNA vaccine against feline leukemia virus infection,"1991","199","10","1433-1443",Journal of the American Veterinary Medical Association,,,,,,,,"1666099",,,0,10,0,0,0,,,"2018 Protegen Update Autogenerated"
5018,229,"Kobayashi et al., 2013",journal,"Kobayashi H, Iwatsuki-Horimoto K, Kiso M, Uraki R, Ichiko Y, Takimoto T, Kawaoka Y",A replication-incompetent influenza virus bearing the HN glycoprotein of human parainfluenza virus as a bivalent vaccine,"2013","31","52","6239-6246",Vaccine,,,,,,,,"24144478",,,0,10,0,0,0,,,"2018 Protegen Update Autogenerated"
5019,227,"Wang et al., 2015",journal,"Wang H, Huang C, Dong J, Yao Y, Xie Z, Liu X, Zhang W, Fang F, Chen Z","Complete protection of mice against lethal murine cytomegalovirus challenge by immunization with DNA vaccines encoding envelope glycoprotein complex III antigens gH, gL and gO","2015","10","3",e0119964,PloS one,,,,,,,,"25803721",,,0,10,0,0,0,,,"2018 Protegen Update Autogenerated"
5020,59,"Barros et al., 2011",journal,"Barros MC, Galasso TG, Chaib AJ, Degallier N, Nagata T, Ribeiro BM",Yellow fever virus envelope protein expressed in insect cells is capable of syncytium formation in lepidopteran cells and could be used for immunodetection of YFV in human sera,"2011","8","","261",Virology journal,,,,,,,,"21619598",,,0,10,0,0,0,,,"2018 Protegen Update Autogenerated"
5021,13,"Meln et al., 2017",journal,"Meln K, Kakkola L, He F, Airenne K, Vapalahti O, Karlberg H, Mirazimi A, Julkunen I","Production, purification and immunogenicity of recombinant Ebola virus proteins - A comparison of Freund's adjuvant and adjuvant system 03","2017","242","","35-45",Journal of virological methods,,,,,,,,"28025125",,,0,10,0,0,0,,,"2018 Protegen Update Autogenerated"
5022,151,"Ma et al., 2014",journal,"Ma J, Wang H, Zheng X, Xue X, Wang B, Wu H, Zhang K, Fan S, Wang T, Li N, Zhao Y, Gao Y, Yang S, Xia X",CpG/Poly (I:C) mixed adjuvant priming enhances the immunogenicity of a DNA vaccine against eastern equine encephalitis virus in mice,"2014","19","1","74-80",International immunopharmacology,,,,,,,,"24440303",,,0,10,0,0,0,,,"2018 Protegen Update Autogenerated"
5023,210,"Aerts et al., 2015",journal,"Aerts L, Rhaume C, Carbonneau J, Lavigne S, Couture C, Hamelin M, Boivin G",Adjuvant effect of the human metapneumovirus (HMPV) matrix protein in HMPV subunit vaccines,"2015","96",Pt 4,"767-774",The Journal of general virology,,,,,,,,"25519171",,,0,10,0,0,0,,,"2018 Protegen Update Autogenerated"
5024,18,"Maksiutov and Shchelkunov, 2011",journal,"Maksiutov RA, Shchelkunov SN",[Comparison of protective properties of the smallpox DNA-vaccine based on the variola virus A30L gene and its variant with modified codon usage],"2011","","2","30-34","Molekuliarnaia genetika, mikrobiologiia i virusologiia",,,,,,,,"21786633",,,0,10,0,0,0,,,"2018 Protegen Update Autogenerated"
5025,220,"Lokhandwala et al., 2016",journal,"Lokhandwala S, Waghela SD, Bray J, Martin CL, Sangewar N, Charendoff C, Shetti R, Ashley C, Chen CH, Berghman LR, Mwangi D, Dominowski PJ, Foss DL, Rai S, Vora S, Gabbert L, Burrage TG, Brake D, Neilan J, Mwangi W",Induction of Robust Immune Responses in Swine by Using a Cocktail of Adenovirus-Vectored African Swine Fever Virus Antigens,"2016","23","11","888-900",Clinical and vaccine immunology : CVI,,,,,,,,"27628166",,,0,10,0,0,0,,,"2018 Protegen Update Autogenerated"
5026,146,"Ge et al., 2015",journal,"Ge J, An Q, Song S, Gao D, Ping W",Construction of Recombinant Baculoviruses Expressing Infectious Bursal Disease Virus Main Protective Antigen and Their Immune Effects on Chickens,"2015","10","7",e0132993,PloS one,,,,,,,,"26167907",,,0,10,0,0,0,,,"2018 Protegen Update Autogenerated"
5027,191,"Balasuriya et al., 2004",journal,"Balasuriya UB, Dobbe JC, Heidner HW, Smalley VL, Navarrette A, Snijder EJ, MacLachlan NJ",Characterization of the neutralization determinants of equine arteritis virus using recombinant chimeric viruses and site-specific mutagenesis of an infectious cDNA clone,"2004","321","2","235-246",Virology,,,,,,,,"15051384",,,0,10,0,0,0,,,"2018 Protegen Update Autogenerated"
5028,142,"Wu et al., 2005",journal,"Wu H, Williams Y, Gunn KS, Singh NK, Locy RD, Giambrone JJ",Yeast-derived sigma C protein-induced immunity against avian reovirus,"2005","49","2","281-284",Avian diseases,,,,,,,,"16094835",,,0,10,0,0,0,,,"2018 Protegen Update Autogenerated"
5029,285,"Khandelwal et al., 2004",journal,"Khandelwal A, Renukaradhya GJ, Rajasekhar M, Sita GL, Shaila MS",Systemic and oral immunogenicity of hemagglutinin protein of rinderpest virus expressed by transgenic peanut plants in a mouse model,"2004","323","2","284-291",Virology,,,,,,,,"15193924",,,0,10,0,0,0,,,"2018 Protegen Update Autogenerated"
5030,128,"Kalbina et al., 2016",journal,"Kalbina I, Lagerqvist N, Moiane B, Ahlm C, Andersson S, Strid , Falk KI",Arabidopsis thaliana plants expressing Rift Valley fever virus antigens: Mice exhibit systemic immune responses as the result of oral administration of the transgenic plants,"2016","127","","61-67",Protein expression and purification,,,,,,,,"27402440",,,0,10,0,0,0,,,"2018 Protegen Update Autogenerated"
5031,231,"Tang et al., 2017",journal,"Tang A, Freed DC, Li F, Meschino S, Prokop M, Bett A, Casimiro D, Wang D, Fu TM",Functionally inactivated dominant viral antigens of human cytomegalovirus delivered in replication incompetent adenovirus type 6 vectors as vaccine candidates,"2017","13","12","2763-2771",Human vaccines &amp; immunotherapeutics,,,,,,,,"28494195",,,0,10,0,0,0,,,"2018 Protegen Update Autogenerated"
5032,199,"Qi and Cui, 2009",journal,"Qi T, Cui SJ","Expression, purification, and characterization of recombinant NS-1, the porcine parvovirus non-structural protein","2009","157","1","93-97",Journal of virological methods,,,,,,,,"19101593",,,0,10,0,0,0,,,"2018 Protegen Update Autogenerated"
5033,123,"Askari et al., 2016",journal,"Askari N, Shayan P, Mokhber-Dezfouli MR, Ebrahimzadeh E, Lotfollahzadeh S, Rostami A, Amininia N, Ragh MJ",Evaluation of recombinant P23 protein as a vaccine for passive immunization of newborn calves against Cryptosporidium parvum,"2016","38","5","282-289",Parasite immunology,,,,,,,,"27012710",,,0,10,0,0,0,,,"2018 Protegen Update Autogenerated"
5034,264,"Liu et al., 2017",journal,"Liu CY, Song YY, Ren HN, Sun GG, Liu RD, Jiang P, Long SR, Zhang X, Wang ZQ, Cui J",Cloning and expression of a Trichinella spiralis putative glutathione S-transferase and its elicited protective immunity against challenge infections,"2017","10","1","448",Parasites &amp; vectors,,,,,,,,"28962639",,,0,10,0,0,0,,,"2018 Protegen Update Autogenerated"
5035,97,"Singh et al., 2018",journal,"Singh MK, Jamal F, Dubey AK, Shivam P, Kumari S, Pushpanjali, Ahmed G, Dikhit MR, Narayan S, Das VNR, Pandey K, Sinha KK, Das P, Singh SK",Co-factor-independent phosphoglycerate mutase of Leishmania donovani modulates macrophage signalling and promotes T-cell repertoires bearing epitopes for both MHC-I and MHC-II,"2018","145","3","292-306",Parasitology,,,,,,,,"29140228",,,0,10,0,0,0,,,"2018 Protegen Update Autogenerated"
5036,93,"Yang et al., 2015",journal,"Yang D, Liu J, Hao P, Wang J, Lei T, Shan D, Liu Q","MIC3, a novel cross-protective antigen expressed in Toxoplasma gondii and Neospora caninum","2015","114","10","3791-3799",Parasitology research,,,,,,,,"26141436",,,0,10,0,0,0,,,"2018 Protegen Update Autogenerated"
5037,118,"Knight et al., 2014",journal,"Knight JM, Zingales B, Bottazzi ME, Hotez P, Zhan B",Limited antigenic variation in the Trypanosoma cruzi candidate vaccine antigen TSA-1,"2014","36","12","708-712",Parasite immunology,,,,,,,,"25040249",,,0,10,0,0,0,,,"2018 Protegen Update Autogenerated"
5038,93,"Nishimura et al., 2013",journal,"Nishimura M, Kohara J, Kuroda Y, Hiasa J, Tanaka S, Muroi Y, Kojima N, Furuoka H, Nishikawa Y",Oligomannose-coated liposome-entrapped dense granule protein 7 induces protective immune response to Neospora caninum in cattle,"2013","31","35","3528-3535",Vaccine,,,,,,,,"23742998",,,0,10,0,0,0,,,"2018 Protegen Update Autogenerated"
5039,115,"Ramirez et al., 2014",journal,"Ramirez L, Corvo L, Duarte MC, Chvez-Fumagalli MA, Valadares DG, Santos DM, de Oliveira CI, Escutia MR, Alonso C, Bonay P, Tavares CA, Coelho EA, Soto M",Cross-protective effect of a combined L5 plus L3 Leishmania major ribosomal protein based vaccine combined with a Th1 adjuvant in murine cutaneous and visceral leishmaniasis,"2014","7","","3",Parasites &amp; vectors,,,,,,,,"24382098",,,0,10,0,0,0,,,"2018 Protegen Update Autogenerated"
5040,98,"Jang et al., 2010",journal,"Jang SI, Lillehoj HS, Lee SH, Lee KW, Park MS, Cha SR, Lillehoj EP, Subramanian BM, Sriraman R, Srinivasan VA",Eimeria maxima recombinant Gam82 gametocyte antigen vaccine protects against coccidiosis and augments humoral and cell-mediated immunity,"2010","28","17","2980-2985",Vaccine,,,,,,,,"20178868",,,0,10,0,0,0,,,"2018 Protegen Update Autogenerated"
5041,98,"Witcombe et al., 2004",journal,"Witcombe DM, Ferguson DJ, Belli SI, Wallach MG, Smith NC",Eimeria maxima TRAP family protein EmTFP250: subcellular localisation and induction of immune responses by immunisation with a recombinant C-terminal derivative,"2004","34","7","861-872",International journal for parasitology,,,,,,,,"15157769",,,0,10,0,0,0,,,"2018 Protegen Update Autogenerated"
5042,98,"Huang et al., 2015",journal,"Huang J, Zhang Z, Li M, Song X, Yan R, Xu L, Li X",Immune protection of microneme 7 (EmMIC7) against Eimeria maxima challenge in chickens,"2015","44","5","392-400",Avian pathology : journal of the W.V.P.A,,,,,,,,"26181095",,,0,10,0,0,0,,,"2018 Protegen Update Autogenerated"
5043,242,"Ke et al., 2017",journal,"Ke XD, Shen S, Song LJ, Yu CX, Kikuchi M, Hirayama K, Gao H, Wang J, Yin X, Yao Y, Liu Q, Zhou W",Characterization of Schistosoma japonicum CP1412 protein as a novel member of the ribonuclease T2 molecule family with immune regulatory function,"2017","10","1","89",Parasites &amp; vectors,,,,,,,,"28212670",,,0,10,0,0,0,,,"2018 Protegen Update Autogenerated"
5044,97,"Kumar et al., 2017",journal,"Kumar M, Ranjan K, Singh V, Pathak C, Pappachan A, Singh DD","Hydrophilic Acylated Surface Protein A (HASPA) of Leishmania donovani: Expression, Purification and Biophysico-Chemical Characterization","2017","36","4","343-351",The protein journal,,,,,,,,"28634775",,,0,10,0,0,0,,,"2018 Protegen Update Autogenerated"
5045,303,"Zhu et al., 2012",journal,"Zhu H, Xu L, Yan R, Song X, Tang F, Wang S, Li X",Identification and characterization of a cDNA clone-encoding antigen of Eimeria acervulina,"2012","139","13","1711-1719",Parasitology,,,,,,,,"23036233",,,0,10,0,0,0,,,"2018 Protegen Update Autogenerated"
5046,88,"Lai et al., 2011",journal,"Lai L, Bumstead J, Liu Y, Garnett J, Campanero-Rhodes MA, Blake DP, Palma AS, Chai W, Ferguson DJ, Simpson P, Feizi T, Tomley FM, Matthews S",The role of sialyl glycan recognition in host tissue tropism of the avian parasite Eimeria tenella,"2011","7","10",e1002296,PLoS pathogens,,,,,,,,"22022267",,,0,10,0,0,0,,,"2018 Protegen Update Autogenerated"
5047,264,"Yang et al., 2018",journal,"Yang Z, Li W, Yang Z, Pan A, Liao W, Zhou X",A novel antigenic cathepsin B protease induces protective immunity in Trichinella-infected mice,"2018","36","2","248-255",Vaccine,,,,,,,,"29199042",,,0,10,0,0,0,,,"2018 Protegen Update Autogenerated"
5048,95,"Elsheikha and Mansfield, 2004",journal,"Elsheikha HM, Mansfield LS",Sarcocystis neurona major surface antigen gene 1 (SAG1) shows evidence of having evolved under positive selection pressure,"2004","94","6","452-459",Parasitology research,,,,,,,,"15517384",,,0,10,0,0,0,,,"2018 Protegen Update Autogenerated"
5049,118,"Egui et al., 2012",journal,"Egui A, Thomas MC, Morell M, Maran C, Carrilero B, Segovia M, Puerta CJ, Pinazo MJ, Rosas F, Gascn J, Lpez MC",Trypanosoma cruzi paraflagellar rod proteins 2 and 3 contain immunodominant CD8(+) T-cell epitopes that are recognized by cytotoxic T cells from Chagas disease patients,"2012","52","3-4","289-298",Molecular immunology,,,,,,,,"22750229",,,0,10,0,0,0,,,"2018 Protegen Update Autogenerated"
5050,117,"Duarte et al., 2017",journal,"Duarte MC, Lage DP, Martins VT, Costa LE, Carvalho AMRS, Ludolf F, Santos TTO, Vale DL, Roatt BM, Menezes-Souza D, Fernandes AP, Tavares CAP, Coelho EAF",A vaccine composed of a hypothetical protein and the eukaryotic initiation factor 5a from Leishmania braziliensis cross-protection against Leishmania amazonensis infection,"2017","222","2","251-260",Immunobiology,,,,,,,,"27693018",,,0,10,0,0,0,,,"2018 Protegen Update Autogenerated"
5051,116,"Mortazavidehkordi et al., 2016",journal,"Mortazavidehkordi N, Farjadfar A, Khanahmad H, Ghayour Najafabadi Z, Hashemi N, Fallah A, Najafi A, Kia V, Hejazi SH",Evaluation of a novel lentiviral vaccine expressing KMP11-HASPB fusion protein against Leishmania infantum in BALB/c mice,"2016","38","11","670-677",Parasite immunology,,,,,,,,"27540714",,,0,10,0,0,0,,,"2018 Protegen Update Autogenerated"
5052,118,"Barry et al., 2016",journal,"Barry MA, Wang Q, Jones KM, Heffernan MJ, Buhaya MH, Beaumier CM, Keegan BP, Zhan B, Dumonteil E, Bottazzi ME, Hotez PJ",A therapeutic nanoparticle vaccine against Trypanosoma cruzi in a BALB/c mouse model of Chagas disease,"2016","12","4","976-987",Human vaccines &amp; immunotherapeutics,,,,,,,,"26890466",,,0,10,0,0,0,,,"2018 Protegen Update Autogenerated"
5053,131,"He, 2012",journal,He GZ,"Entamoeba histolytica: cloning, expression and evaluation of the efficacy of a recombinant amebiasis cysteine proteinase gene (ACP1) antigen in minipig","2012","130","2","126-129",Experimental parasitology,,,,,,,,"22154977",,,0,10,0,0,0,,,"2018 Protegen Update Autogenerated"
5054,92,"Terkawi et al., 2013",journal,"Terkawi MA, Ratthanophart J, Salama A, AbouLaila M, Asada M, Ueno A, Alhasan H, Guswanto A, Masatani T, Yokoyama N, Nishikawa Y, Xuan X, Igarashi I",Molecular characterization of a new Babesia bovis thrombospondin-related anonymous protein (BbTRAP2),"2013","8","12",e83305,PloS one,,,,,,,,"24349483",,,0,10,0,0,0,,,"2018 Protegen Update Autogenerated"
5055,131,"Priest et al., 2010",journal,"Priest JW, Kwon JP, Montgomery JM, Bern C, Moss DM, Freeman AR, Jones CC, Arrowood MJ, Won KY, Lammie PJ, Gilman RH, Mead JR","Cloning and characterization of the acidic ribosomal protein P2 of Cryptosporidium parvum, a new 17-kilodalton antigen","2010","17","6","954-965",Clinical and vaccine immunology : CVI,,,,,,,,"20410328",,,0,10,0,0,0,,,"2018 Protegen Update Autogenerated"
5056,91,"Picchio et al., 2018",journal,"Picchio MS, Snchez VR, Arcon N, Soto AS, Perrone Sibilia M, Aldirico MLA, Urrutia M, Moretta R, Fenoy IM, Goldman A, Martin V","Vaccine potential of antigen cocktails composed of recombinant Toxoplasma gondii TgPI-1, ROP2 and GRA4 proteins against chronic toxoplasmosis in C3H mice","2018","185","","62-70",Experimental parasitology,,,,,,,,"29309783",,,0,10,0,0,0,,,"2018 Protegen Update Autogenerated"
5057,242,"Chen et al., 2016",journal,"Chen L, Chen Y, Zhang D, Hou M, Yang B, Zhang F, Zhang W, Luo X, Ji M, Wu G",Protection and immunological study on two tetraspanin-derived vaccine candidates against schistosomiasis japonicum,"2016","38","10","589-598",Parasite immunology,,,,,,,,"27189226",,,0,10,0,0,0,,,"2018 Protegen Update Autogenerated"
5058,92,"Ishizaki et al., 2017",journal,"Ishizaki T, Sivakumar T, Hayashida K, Takemae H, Tuvshintulga B, Munkhjargal T, Guswanto A, Igarashi I, Yokoyama N","Babesia bovis BOV57, a Theileria parva P67 homolog, is an invasion-related, neutralization-sensitive antigen","2017","54","","138-145","Infection, genetics and evolution : journal of molecular epidemiology and evolutionary genetics in infectious diseases",,,,,,,,"28668608",,,0,10,0,0,0,,,"2018 Protegen Update Autogenerated"
5059,91,"Ching et al., 2017",journal,"Ching XT, Fong MY, Lau YL",Evaluation of the Protective Effect of Deoxyribonucleic Acid Vaccines Encoding Granule Antigen 2 and 5 Against Acute Toxoplasmosis in BALB/c Mice,"2017","96","6","1441-1447",The American journal of tropical medicine and hygiene,,,,,,,,"28719288",,,0,10,0,0,0,,,"2018 Protegen Update Autogenerated"
5060,98,"Huang et al., 2015",journal,"Huang J, Zhang Z, Li M, Song X, Yan R, Xu L, Li X",Eimeria maxima microneme protein 2 delivered as DNA vaccine and recombinant protein induces immunity against experimental homogenous challenge,"2015","64","5","408-416",Parasitology international,,,,,,,,"26072304",,,0,10,0,0,0,,,"2018 Protegen Update Autogenerated"
5061,89,"Graham et al., 2006",journal,"Graham SP, Pell R, Honda Y, Mwangi DM, Tonukari NJ, Yamage M, Glew EJ, de Villiers EP, Shah T, Bishop R, Abuya E, Awino E, Gachanja J, Luyai AE, Mbwika F, Muthiani AM, Ndegwa DM, Njahira M, Nyanjui JK, Onono FO, Osaso J, Saya RM, Wildmann C, Fraser CM, Maudlin I, Gardner MJ, Morzaria SP, Loosmore S, Gilbert SC, Audonnet JC, van der Bruggen P, Nene V, Taracha EL",Theileria parva candidate vaccine antigens recognized by immune bovine cytotoxic T lymphocytes,"2006","103","9","3286-3291",Proceedings of the National Academy of Sciences of the United States of America,,,,,,,,"16492763",,,0,10,0,0,0,,,"2018 Protegen Update Autogenerated"
5062,123,"Roche et al., 2013",journal,"Roche JK, Rojo AL, Costa LB, Smeltz R, Manque P, Woehlbier U, Bartelt L, Galen J, Buck G, Guerrant RL",Intranasal vaccination in mice with an attenuated Salmonella enterica Serovar 908htr A expressing Cp15 of Cryptosporidium: impact of malnutrition with preservation of cytokine secretion,"2013","31","6","912-918",Vaccine,,,,,,,,"23246541",,,0,10,0,0,0,,,"2018 Protegen Update Autogenerated"
5063,92,"Antonio et al., 2010",journal,"Antonio Alvarez J, Lopez U, Rojas C, Borgonio VM, Sanchez V, Castaeda R, Vargas P, Figueroa JV","Immunization of Bos taurus steers with Babesia bovis recombinant antigens MSA-1, MSA-2c and 12D3","2010","57","1-2","87-90",Transboundary and emerging diseases,,,,,,,,"20537116",,,0,10,0,0,0,,,"2018 Protegen Update Autogenerated"
5064,91,"Czarnewski et al., 2017",journal,"Czarnewski P, Arajo ECB, Oliveira MC, Mineo TWP, Silva NM",Recombinant &lt;i&gt;Tg&lt;/i&gt;HSP70 Immunization Protects against &lt;i&gt;Toxoplasma gondii&lt;/i&gt; Brain Cyst Formation by Enhancing Inducible Nitric Oxide Expression,"2017","7","","142",Frontiers in cellular and infection microbiology,,,,,,,,"28487847",,,0,10,0,0,0,,,"2018 Protegen Update Autogenerated"
5065,91,"Liu et al., 2017",journal,"Liu Y, Cao A, Li Y, Li X, Cong H, He S, Zhou H",Immunization with a DNA vaccine encoding Toxoplasma gondii Superoxide dismutase (TgSOD) induces partial immune protection against acute toxoplasmosis in BALB/c mice,"2017","17","1","403",BMC infectious diseases,,,,,,,,"28592247",,,0,10,0,0,0,,,"2018 Protegen Update Autogenerated"
5066,97,"McAtee et al., 2017",journal,"McAtee CP, Seid CA, Hammond M, Hudspeth E, Keegan BP, Liu Z, Wei J, Zhan B, Arjona-Sabido R, Cruz-Chan V, Dumonteil E, Hotez PJ, Bottazzi ME","Expression, purification, immunogenicity and protective efficacy of a recombinant nucleoside hydrolase from Leishmania donovani, a vaccine candidate for preventing cutaneous leishmaniasis","2017","130","","129-136",Protein expression and purification,,,,,,,,"27773761",,,0,10,0,0,0,,,"2018 Protegen Update Autogenerated"
5067,116,"Dias et al., 2018",journal,"Dias DS, Ribeiro PAF, Martins VT, Lage DP, Ramos FF, Dias ALT, Rodrigues MR, Portela SB, Costa LE, Caligiorne RB, Steiner BT, Chvez-Fumagalli MA, Salles BCS, Santos TTO, Silveira JAG, Magalhes-Soares DF, Roatt BM, Machado-de-vila RA, Duarte MC, Menezes-Souza D, Silva ES, Galdino AS, Coelho EAF",Recombinant prohibitin protein of Leishmania infantum acts as a vaccine candidate and diagnostic marker against visceral leishmaniasis,"2018","323","","59-69",Cellular immunology,,,,,,,,"29128045",,,0,10,0,0,0,,,"2018 Protegen Update Autogenerated"
5068,242,"Gao et al., 2017",journal,"Gao Y, Zhou X, Wang H, Liu R, Ye Q, Zhao Q, Ming Z, Dong H",Immunization with recombinant schistosome adenylate kinase 1 partially protects mice against Schistosoma japonicum infection,"2017","116","6","1665-1674",Parasitology research,,,,,,,,"28455627",,,0,10,0,0,0,,,"2018 Protegen Update Autogenerated"
5069,90,"Schnittger et al., 2002",journal,"Schnittger L, Katzer F, Biermann R, Shayan P, Boguslawski K, McKellar S, Beyer D, Shiels BR, Ahmed JS",Characterization of a polymorphic Theileria annulata surface protein (TaSP) closely related to PIM of Theileria parva: implications for use in diagnostic tests and subunit vaccines,"2002","120","2","247-256",Molecular and biochemical parasitology,,,,,,,,"11897130",,,0,10,0,0,0,,,"2018 Protegen Update Autogenerated"
5070,98,"Xu et al., 2013",journal,"Xu J, Zhang Y, Tao J",Efficacy of a DNA vaccine carrying Eimeria maxima Gam56 antigen gene against coccidiosis in chickens,"2013","51","2","147-154",The Korean journal of parasitology,,,,,,,,"23710081",,,0,10,0,0,0,,,"2018 Protegen Update Autogenerated"
5071,225,"Tallima et al., 2017",journal,"Tallima H, Dvok J, Kareem S, Abou El Dahab M, Abdel Aziz N, Dalton JP, El Ridi R",Protective immune responses against Schistosoma mansoni infection by immunization with functionally active gut-derived cysteine peptidases alone and in combination with glyceraldehyde 3-phosphate dehydrogenase,"2017","11","3",e0005443,PLoS neglected tropical diseases,,,,,,,,"28346516",,,0,10,0,0,0,,,"2018 Protegen Update Autogenerated"
5072,225,"Mossallam et al., 2015",journal,"Mossallam SF, Amer EI, Ewaisha RE, Khalil AM, Aboushleib HM, Bahey-El-Din M","Fusion protein comprised of the two schistosomal antigens, Sm14 and Sm29, provides significant protection against Schistosoma mansoni in murine infection model","2015","15","","147",BMC infectious diseases,,,,,,,,"25887456",,,0,10,0,0,0,,,"2018 Protegen Update Autogenerated"
5073,95,"Crowdus et al., 2008",journal,"Crowdus CA, Marsh AE, Saville WJ, Lindsay DS, Dubey JP, Granstrom DE, Howe DK",SnSAG5 is an alternative surface antigen of Sarcocystis neurona strains that is mutually exclusive to SnSAG1,"2008","158","1-2","36-43",Veterinary parasitology,,,,,,,,"18829171",,,0,10,0,0,0,,,"2018 Protegen Update Autogenerated"
5074,0,"Hu et al., 2014",journal,"Hu JC, Mathias-Santos C, Greene CJ, King-Lyons ND, Rodrigues JF, Hajishengallis G, Ferreira LC, Connell TD",Intradermal administration of the Type II heat-labile enterotoxins LT-IIb and LT-IIc of enterotoxigenic Escherichia coli enhances humoral and CD8+ T cell immunity to a co-administered antigen,"2014","9","12",e113978,PloS one,"","","","","","","","25536061","","",0,10,110,0,0,,,
5075,0,"Ekong et al., 2009",journal,"Ekong EE, Okenu DN, Mania-Pramanik J, He Q, Igietseme JU, Ananaba GA, Lyn D, Black C, Eko FO","A Vibrio cholerae ghost-based subunit vaccine induces cross-protective chlamydial immunity that is enhanced by CTA2B, the nontoxic derivative of cholera toxin","2009","55","2","280-291",FEMS immunology and medical microbiology,"","","","","","","","19040663","","",0,10,111,0,0,,,
5076,29,"Bertholet et al., 2010",journal,"Bertholet S, Ireton GC, Ordway DJ, Windish HP, Pine SO, Kahn M, Phan T, Orme IM, Vedvick TS, Baldwin SL, Coler RN, Reed SG",A defined tuberculosis vaccine candidate boosts BCG and protects against multidrug-resistant Mycobacterium tuberculosis,"2010","2","53","53ra74",Science translational medicine,"","","","","","","","20944089","",,0,10,0,0,0,,,
5091,47,"Khan et al., 2006",journal,"Khan MN, Bansal A, Shukla D, Paliwal P, Sarada SK, Mustoori SR, Banerjee PK",Immunogenicity and protective efficacy of DnaJ (hsp40) of Streptococcus pneumoniae against lethal infection in mice,"2006","24","37-39","6225-6231",Vaccine,"","","","","","","","16797798","","",0,10,0,0,0,,,
5090,31,"DeMaria et al., 1996",journal,"DeMaria TF, Murwin DM, Leake ER",Immunization with outer membrane protein P6 from nontypeable Haemophilus influenzae induces bactericidal antibody and affords protection in the chinchilla model of otitis media,"1996","64","12","5187-5192",Infection and immunity,"","","","","","","","8945564","","",0,10,0,0,0,,,
5092,47,"McNeil et al., 2005",journal,"McNeil SA, Halperin SA, Langley JM, Smith B, Warren A, Sharratt GP, Baxendale DM, Reddish MA, Hu MC, Stroop SD, Linden J, Fries LF, Vink PE, Dale JB",Safety and immunogenicity of 26-valent group a streptococcus vaccine in healthy adult volunteers,"2005","41","8","1114-1122",Clinical infectious diseases : an official publication of the Infectious Diseases Society of America,"","","","","","","","16163629","","",0,10,0,0,0,,,
5093,47,"Salha et al., 2012",journal,"Salha D, Szeto J, Myers L, Claus C, Sheung A, Tang M, Ljutic B, Hanwell D, Ogilvie K, Ming M, Messham B, van den Dobbelsteen G, Hopfer R, Ochs MM, Gallichan S","Neutralizing antibodies elicited by a novel detoxified pneumolysin derivative, PlyD1, provide protection against both pneumococcal infection and lung injury","2012","80","6","2212-2220",Infection and immunity,"","","","","","","","22473606","","",0,10,0,0,0,,,
5094,37,"Bohai Wen,et al 2015",journal,"",Rickettsia rickettsii outer membrane protein YbgF induces protective immunity in C3H/HeN mice,"","","","","","","","","","","","","25714655","",,0,0,0,0,0,,,
5095,97,"Osman et al., 2017",journal,"Osman M, Mistry A, Keding A, Gabe R, Cook E, Forrester S, Wiggins R, Di Marco S, Colloca S, Siani L, Cortese R, Smith DF, Aebischer T, Kaye PM, Lacey CJ",A third generation vaccine for human visceral leishmaniasis and post kala azar dermal leishmaniasis: First-in-human trial of ChAd63-KH,"2017","11","5",e0005527,PLoS neglected tropical diseases,"","","","","","","","28498840","","",0,10,0,0,0,,,
5096,99,"Weide et al., 2012",journal,"Weide B, Zelba H, Derhovanessian E, Pflugfelder A, Eigentler TK, Di Giacomo AM, Maio M, Aarntzen EH, de Vries IJ, Sucker A, Schadendorf D, Bttner P, Garbe C, Pawelec G",Functional T cells targeting NY-ESO-1 or Melan-A are predictive for survival of patients with distant melanoma metastasis,"2012","30","15","1835-1841",Journal of clinical oncology : official journal of the American Society of Clinical Oncology,"","","","","","","","22529253","","",0,10,0,0,0,,,
5097,99,"Moehler et al., 2019",journal,"Moehler M, Heo J, Lee HC, Tak WY, Chao Y, Paik SW, Yim HJ, Byun KS, Baron A, Ungerechts G, Jonker D, Ruo L, Cho M, Kaubisch A, Wege H, Merle P, Ebert O, Habersetzer F, Blanc JF, Rosmorduc O, Lencioni R, Patt R, Leen AM, Foerster F, Homerin M, Stojkowitz N, Lusky M, Limacher JM, Hennequi M, Gaspar N, McFadden B, De Silva N, Shen D, Pelusio A, Kirn DH, Breitbach CJ, Burke JM",Vaccinia-based oncolytic immunotherapy Pexastimogene Devacirepvec in patients with advanced hepatocellular carcinoma after sorafenib failure: a randomized multicenter Phase IIb trial (TRAVERSE),"2019","8","8","1615817",Oncoimmunology,"","","","","","","","31413923","","",0,10,0,0,0,,,
5098,319,"Deng et al., 2018",journal,"Deng Y, Lan J, Bao L, Huang B, Ye F, Chen Y, Yao Y, Wang W, Qin C, Tan W",Enhanced protection in mice induced by immunization with inactivated whole viruses compare to spike protein of middle east respiratory syndrome coronavirus,"2018","7","1","60",Emerging microbes & infections,"","","","","","","","29618723","","",0,10,0,0,0,,,
5099,319,"Wang et al., 2015",journal,"Wang L, Shi W, Joyce MG, Modjarrad K, Zhang Y, Leung K, Lees CR, Zhou T, Yassine HM, Kanekiyo M, Yang ZY, Chen X, Becker MM, Freeman M, Vogel L, Johnson JC, Olinger G, Todd JP, Bagci U, Solomon J, Mollura DJ, Hensley L, Jahrling P, Denison MR, Rao SS, Subbarao K, Kwong PD, Mascola JR, Kong WP, Graham BS",Evaluation of candidate vaccine approaches for MERS-CoV,"2015","6","","7712",Nature communications,"","","","","","","","26218507","","",0,10,0,0,0,,,
5100,319,"Chi et al., 2017",journal,"Chi H, Zheng X, Wang X, Wang C, Wang H, Gai W, Perlman S, Yang S, Zhao J, Xia X",DNA vaccine encoding Middle East respiratory syndrome coronavirus S1 protein induces protective immune responses in mice,"2017","35","16","2069-2075",Vaccine,"","","","","","","","28314561","","",0,10,0,0,0,,,
5101,319,"Chen et al., 2017",journal,"Chen Y, Lu S, Jia H, Deng Y, Zhou J, Huang B, Yu Y, Lan J, Wang W, Lou Y, Qin K, Tan W",A novel neutralizing monoclonal antibody targeting the N-terminal domain of the MERS-CoV spike protein,"2017","6","5",e37,Emerging microbes & infections,"","","","","","","","28536429","","",0,10,0,0,0,,,
5102,319,"Kim et al., 2014",journal,"Kim E, Okada K, Kenniston T, Raj VS, AlHajri MM, Farag EA, AlHajri F, Osterhaus AD, Haagmans BL, Gambotto A",Immunogenicity of an adenoviral-based Middle East Respiratory Syndrome coronavirus vaccine in BALB/c mice,"2014","32","45","5975-5982",Vaccine,"","","","","","","","25192975","","",0,10,0,0,0,,,
5103,319,"Liu et al., 2018",journal,"Liu R, Wang J, Shao Y, Wang X, Zhang H, Shuai L, Ge J, Wen Z, Bu Z",A recombinant VSV-vectored MERS-CoV vaccine induces neutralizing antibody and T cell responses in rhesus monkeys after single dose immunization,"2018","150","","30-38",Antiviral research,"","","","","","","","29246504","","",0,10,0,0,0,,,
5104,129,"Woo et al., 2005",journal,"Woo PC, Lau SK, Tsoi HW, Chen ZW, Wong BH, Zhang L, Chan JK, Wong LP, He W, Ma C, Chan KH, Ho DD, Yuen KY",SARS coronavirus spike polypeptide DNA vaccine priming with recombinant spike polypeptide from Escherichia coli as booster induces high titer of neutralizing antibody against SARS coronavirus,"2005","23","42","4959-4968",Vaccine,"","","","","","","","15993989","","",0,10,0,0,0,,,
5105,129,"Shi et al., 2006",journal,"Shi SQ, Peng JP, Li YC, Qin C, Liang GD, Xu L, Yang Y, Wang JL, Sun QH",The expression of membrane protein augments the specific responses induced by SARS-CoV nucleocapsid DNA immunization,"2006","43","11","1791-1798",Molecular immunology,"","","","","","","","16423399","","",0,10,0,0,0,,,
5106,129,"See et al., 2006",journal,"See RH, Zakhartchouk AN, Petric M, Lawrence DJ, Mok CP, Hogan RJ, Rowe T, Zitzow LA, Karunakaran KP, Hitt MM, Graham FL, Prevec L, Mahony JB, Sharon C, Auperin TC, Rini JM, Tingle AJ, Scheifele DW, Skowronski DM, Patrick DM, Voss TG, Babiuk LA, Gauldie J, Roper RL, Brunham RC, Finlay BB",Comparative evaluation of two severe acute respiratory syndrome (SARS) vaccine candidates in mice challenged with SARS coronavirus,"2006","87",Pt 3,"641-650",The Journal of general virology,"","","","","","","","16476986","","",0,10,0,0,0,,,
5107,129,"Graham et al., 2012",journal,"Graham RL, Becker MM, Eckerle LD, Bolles M, Denison MR, Baric RS","A live, impaired-fidelity coronavirus vaccine protects in an aged, immunocompromised mouse model of lethal disease","2012","18","12","1820-1826",Nature medicine,"","","","","","","","23142821","","",0,10,0,0,0,,,
5108,129,"Fett et al., 2013",journal,"Fett C, DeDiego ML, Regla-Nava JA, Enjuanes L, Perlman S",Complete protection against severe acute respiratory syndrome coronavirus-mediated lethal respiratory disease in aged mice by immunization with a mouse-adapted virus lacking E protein,"2013","87","12","6551-6559",Journal of virology,"","","","","","","","23576515","","",0,10,0,0,0,,,
5109,129,"Chen et al., 2005",journal,"Chen Z, Zhang L, Qin C, Ba L, Yi CE, Zhang F, Wei Q, He T, Yu W, Yu J, Gao H, Tu X, Gettie A, Farzan M, Yuen KY, Ho DD",Recombinant modified vaccinia virus Ankara expressing the spike glycoprotein of severe acute respiratory syndrome coronavirus induces protective neutralizing antibodies primarily targeting the receptor binding region,"2005","79","5","2678-2688",Journal of virology,"","","","","","","","15708987","","",0,10,0,0,0,,,
5110,129,"Bisht et al., 2004",journal,"Bisht H, Roberts A, Vogel L, Bukreyev A, Collins PL, Murphy BR, Subbarao K, Moss B",Severe acute respiratory syndrome coronavirus spike protein expressed by attenuated vaccinia virus protectively immunizes mice,"2004","101","17","6641-6646",Proceedings of the National Academy of Sciences of the United States of America,"","","","","","","","15096611","","",0,10,0,0,0,,,
5111,129,"Liu et al., 2018",journal,"Liu R, Wang J, Shao Y, Wang X, Zhang H, Shuai L, Ge J, Wen Z, Bu Z",A recombinant VSV-vectored MERS-CoV vaccine induces neutralizing antibody and T cell responses in rhesus monkeys after single dose immunization,"2018","150","","30-38",Antiviral research,"","","","","","","","29246504","",,0,0,0,0,0,,,
5112,129,"Zhao et al., 2005",journal,"Zhao P, Cao J, Zhao LJ, Qin ZL, Ke JS, Pan W, Ren H, Yu JG, Qi ZT",Immune responses against SARS-coronavirus nucleocapsid protein induced by DNA vaccine,"2005","331","1","128-135",Virology,"","","","","","","","15582659","","",0,10,0,0,0,,,
5113,99,"Mitchell et al., 2018",journal,"Mitchell D, Chintala S, Dey M",Plasmacytoid dendritic cell in immunity and cancer,"2018","322","","63-73",Journal of neuroimmunology,"","","","","","","","30049538","","",0,10,0,0,0,,,
5114,99,"Bahy et al., 2016",journal,"Bahy RH, Hamouda HM, Shahat AS, Yassin AS, Amin MA",Development and evaluation of a novel vaccine against prevalent invasive multi-drug resistant strains of <i>Streptococcus pneumoniae</i>,"2016","4","",e2737,PeerJ,"","","","","","","","27917323","","",0,10,0,0,0,,,
5115,99,"Suzuki et al., 2019",journal,"Suzuki S, Osato R, Wajima T, Hasebe T, Ishikawa H, Mitsumori H, Nakaminami H, Noguchi N",Impact of the introduction of a 13-valent pneumococcal vaccine on pneumococcal serotypes in non-invasive isolates from 2007 to 2016 at a teaching hospital in Japan,"2019","68","6","903-909",Journal of medical microbiology,"","","","","","","","31090535","","",0,10,0,0,0,,,
5116,99,"Griguolo et al., 2019",journal,"Griguolo G, Pascual T, Dieci MV, Guarneri V, Prat A",Interaction of host immunity with HER2-targeted treatment and tumor heterogeneity in HER2-positive breast cancer,"2019","7","1","90",Journal for immunotherapy of cancer,"","","","","","","","30922362","","",0,10,0,0,0,,,
5117,99,"Alvarez et al., 2016",journal,"Alvarez RD, Huh WK, Bae S, Lamb LS Jr, Conner MG, Boyer J, Wang C, Hung CF, Sauter E, Paradis M, Adams EA, Hester S, Jackson BE, Wu TC, Trimble CL",A pilot study of pNGVL4a-CRT/E7(detox) for the treatment of patients with HPV16+ cervical intraepithelial neoplasia 2/3 (CIN2/3),"2016","140","2","245-252",Gynecologic oncology,"","","","","","","","26616223","","",0,10,0,0,0,,,
5118,99,"Lee et al., 2018",journal,"Lee SJ, Kim HJ, Huh YM, Kim IW, Jeong JH, Kim JC, Kim JD",Functionalized Magnetic PLGA Nanospheres for Targeting and Bioimaging of Breast Cancer,"2018","18","3","1542-1547",Journal of nanoscience and nanotechnology,"","","","","","","","29448628","","",0,10,0,0,0,,,
5119,99,"Hardwick et al., 2018",journal,"Hardwick NR, Frankel P, Ruel C, Kilpatrick J, Tsai W, Kos F, Kaltcheva T, Leong L, Morgan R, Chung V, Tinsley R, Eng M, Wilczynski S, Ellenhorn JDI, Diamond DJ, Cristea M",p53-Reactive T Cells Are Associated with Clinical Benefit in Patients with Platinum-Resistant Epithelial Ovarian Cancer After Treatment with a p53 Vaccine and Gemcitabine Chemotherapy,"2018","24","6","1315-1325",Clinical cancer research : an official journal of the American Association for Cancer Research,"","","","","","","","29301826","","",0,10,0,0,0,,,
5120,99,"Qazilbash et al., 2017",journal,"Qazilbash MH, Wieder E, Thall PF, Wang X, Rios R, Lu S, Kanodia S, Ruisaard KE, Giralt SA, Estey EH, Cortes J, Komanduri KV, Clise-Dwyer K, Alatrash G, Ma Q, Champlin RE, Molldrem JJ",PR1 peptide vaccine induces specific immunity with clinical responses in myeloid malignancies,"2017","31","3","697-704",Leukemia,"","","","","","","","27654852","","",0,10,0,0,0,,,
5121,99,"Mohammadzadeh et al., 2018",journal,"Mohammadzadeh M, Shirmohammadi M, Ghojazadeh M, Nikniaz L, Raeisi M, Aghdas SAM",Dendritic cells pulsed with prostate-specific membrane antigen in metastatic castration-resistant prostate cancer patients: a systematic review and meta-analysis,"2018","6","4","119-125",Prostate international,"","","","","","","","30505813","","",0,10,0,0,0,,,
5122,99,"Hannu et al., 2014",journal,"Hannu K, Johanna M, Ulf-Hkan S",KLK-targeted Therapies for Prostate Cancer,"2014","25","2","207-218",EJIFCC,"","","","","","","","27683469","","",0,10,0,0,0,,,
5123,99,"Correale et al., 1998",journal,"Correale P, Walmsley K, Zaremba S, Zhu M, Schlom J, Tsang KY",Generation of human cytolytic T lymphocyte lines directed against prostate-specific antigen (PSA) employing a PSA oligoepitope peptide,"1998","161","6","3186-3194","Journal of immunology (Baltimore, Md. : 1950)","","","","","","","","9743387","","",0,10,0,0,0,,,
5124,99,"Onaitis et al., 2002",journal,"Onaitis M, Kalady MF, Pruitt S, Tyler DS",Dendritic cell gene therapy,"2002","11","3","645-660",Surgical oncology clinics of North America,"","","","","","","","12487060","","",0,10,0,0,0,,,
5125,99,"Fujio et al., 2015",journal,"Fujio K, Watanabe M, Ueki H, Li SA, Kinoshita R, Ochiai K, Futami J, Watanabe T, Nasu Y, Kumon H",A vaccine strategy with multiple prostatic acid phosphatase-fused cytokines for prostate cancer treatment,"2015","33","4","1585-1592",Oncology reports,"","","","","","","","25632844","","",0,10,0,0,0,,,
5126,99,"Johnson et al., 2007",journal,"Johnson LE, Frye TP, Chinnasamy N, Chinnasamy D, McNeel DG",Plasmid DNA vaccine encoding prostatic acid phosphatase is effective in eliciting autologous antigen-specific CD8+ T cells,"2007","56","6","885-895","Cancer immunology, immunotherapy : CII","","","","","","","","17102977","","",0,10,0,0,0,,,
5127,99,"Rijnkels and Rosen, 2001",journal,"Rijnkels M, Rosen JM",Adenovirus-Cre-mediated recombination in mammary epithelial early progenitor cells,"2001","114",Pt 17,"3147-3153",Journal of cell science,"","","","","","","","11590241","","",0,10,0,0,0,,,
5128,99,"Park et al., 2010",journal,"Park MY, Kim DR, Jung HW, Yoon HI, Lee JH, Lee CT",Genetic immunotherapy of lung cancer using conditionally replicating adenovirus and adenovirus-interferon-beta,"2010","17","5","356-364",Cancer gene therapy,"","","","","","","","19893592","","",0,10,0,0,0,,,
5129,99,"Sugiyama, 2017",journal,Sugiyama H,WT1 peptide cancer vaccine,"2017","75","2","263-269",Nihon rinsho. Japanese journal of clinical medicine,"","","","","","","","30562862","","",0,10,0,0,0,,,
5130,99,"Wang et al., 2003",journal,"Wang T, Fan L, Watanabe Y, McNeill PD, Moulton GG, Bangur C, Fanger GR, Okada M, Inoue Y, Persing DH, Reed SG","L523S, an RNA-binding protein as a potential therapeutic target for lung cancer","2003","88","6","887-894",British journal of cancer,"","","","","","","","12644826","","",0,10,0,0,0,,,
5131,99,"Kass et al., 2001",journal,"Kass E, Panicali DL, Mazzara G, Schlom J, Greiner JW",Granulocyte/macrophage-colony stimulating factor produced by recombinant avian poxviruses enriches the regional lymph nodes with antigen-presenting cells and acts as an immunoadjuvant,"2001","61","1","206-214",Cancer research,"","","","","","","","11196163","","",0,10,0,0,0,,,
5132,99,"Hodge et al., 2003",journal,"Hodge JW, Grosenbach DW, Aarts WM, Poole DJ, Schlom J",Vaccine therapy of established tumors in the absence of autoimmunity,"2003","9","5","1837-1849",Clinical cancer research : an official journal of the American Association for Cancer Research,"","","","","","","","12738742","","",0,10,0,0,0,,,
5133,99,"DiPaola et al., 2006",journal,"DiPaola RS, Plante M, Kaufman H, Petrylak DP, Israeli R, Lattime E, Manson K, Schuetz T","A phase I trial of pox PSA vaccines (PROSTVAC-VF) with B7-1, ICAM-1, and LFA-3 co-stimulatory molecules (TRICOM) in patients with prostate cancer","2006","4","","1",Journal of translational medicine,"","","","","","","","16390546","","",0,10,0,0,0,,,
5134,99,"Xing et al., 2018",journal,"Xing P, Wang H, Yang S, Han X, Sun Y, Shi Y",Therapeutic cancer vaccine: phase I clinical tolerance study of Hu-rhEGF-rP64k/Mont in patients with newly diagnosed advanced non-small cell lung cancer,"2018","19","1","14",BMC immunology,"","","","","","","","29661145","","",0,10,0,0,0,,,
5135,99,"Halin et al., 2003",journal,"Halin C, Gafner V, Villani ME, Borsi L, Berndt A, Kosmehl H, Zardi L, Neri D","Synergistic therapeutic effects of a tumor targeting antibody fragment, fused to interleukin 12 and to tumor necrosis factor alpha","2003","63","12","3202-3210",Cancer research,"","","","","","","","12810649","","",0,10,0,0,0,,,
5136,99,"Wang et al., 2003",journal,"Wang XY, Chen X, Manjili MH, Repasky E, Henderson R, Subjeck JR",Targeted immunotherapy using reconstituted chaperone complexes of heat shock protein 110 and melanoma-associated antigen gp100,"2003","63","10","2553-2560",Cancer research,"","","","","","","","12750279","","",0,10,0,0,0,,,
5137,99,"McKenzie et al., 1998",journal,"McKenzie IF, Apostolopoulos V, Lees C, Xing PX, Lofthouse S, Osinski C, Popovski V, Acres B, Pietersz G",Oxidised mannan antigen conjugates preferentially stimulate T1 type immune responses,"1998","63","1-2","185-190",Veterinary immunology and immunopathology,"","","","","","","","9656453","","",0,10,0,0,0,,,
5138,99,"Tykodi and Thompson, 2008",journal,"Tykodi SS, Thompson JA",Development of modified vaccinia Ankara-5T4 as specific immunotherapy for advanced human cancer,"2008","8","12","1947-1953",Expert opinion on biological therapy,"","","","","","","","18990081","","",0,10,0,0,0,,,
5139,99,"Bernstein et al., 2008",journal,"Bernstein MB, Chakraborty M, Wansley EK, Guo Z, Franzusoff A, Mostbck S, Sabzevari H, Schlom J, Hodge JW",Recombinant Saccharomyces cerevisiae (yeast-CEA) as a potent activator of murine dendritic cells,"2008","26","4","509-521",Vaccine,"","","","","","","","18155327","","",0,10,0,0,0,,,
5140,99,"Rochlitz et al., 2003",journal,"Rochlitz C, Figlin R, Squiban P, Salzberg M, Pless M, Herrmann R, Tartour E, Zhao Y, Bizouarne N, Baudin M, Acres B",Phase I immunotherapy with a modified vaccinia virus (MVA) expressing human MUC1 as antigen-specific immunotherapy in patients with MUC1-positive advanced cancer,"2003","5","8","690-699",The journal of gene medicine,"","","","","","","","12898638","","",0,10,0,0,0,,,
5141,99,"Eder et al., 2000",journal,"Eder JP, Kantoff PW, Roper K, Xu GX, Bubley GJ, Boyden J, Gritz L, Mazzara G, Oh WK, Arlen P, Tsang KY, Panicali D, Schlom J, Kufe DW",A phase I trial of a recombinant vaccinia virus expressing prostate-specific antigen in advanced prostate cancer,"2000","6","5","1632-1638",Clinical cancer research : an official journal of the American Association for Cancer Research,"","","","","","","","10815880","","",0,10,0,0,0,,,
5142,99,"Rosenberg et al., 2003",journal,"Rosenberg SA, Yang JC, Schwartzentruber DJ, Hwu P, Topalian SL, Sherry RM, Restifo NP, Wunderlich JR, Seipp CA, Rogers-Freezer L, Morton KE, Mavroukakis SA, Gritz L, Panicali DL, White DE",Recombinant fowlpox viruses encoding the anchor-modified gp100 melanoma antigen can generate antitumor immune responses in patients with metastatic melanoma,"2003","9","8","2973-2980",Clinical cancer research : an official journal of the American Association for Cancer Research,"","","","","","","","12912944","","",0,10,0,0,0,,,
5143,99,"Guo et al., 2019",journal,"Guo ZS, Lu B, Guo Z, Giehl E, Feist M, Dai E, Liu W, Storkus WJ, He Y, Liu Z, Bartlett DL",Vaccinia virus-mediated cancer immunotherapy: cancer vaccines and oncolytics,"2019","7","1","6",Journal for immunotherapy of cancer,"","","","","","","","30626434","","",0,10,0,0,0,,,
5144,99,"Lattanzi et al., 2018",journal,"Lattanzi M, Han J, Moran U, Utter K, Tchack J, Sabado RL, Berman R, Shapiro R, Huang HH, Osman I, Bhardwaj N, Pavlick AC",Adjuvant NY-ESO-1 vaccine immunotherapy in high-risk resected melanoma: a retrospective cohort analysis,"2018","6","1","38",Journal for immunotherapy of cancer,"","","","","","","","29773080","","",0,10,0,0,0,,,
5145,99,"Yaddanapudi and Eaton, 2012",journal,"Yaddanapudi K, Eaton JW",Multi-peptide immunotherapeutic vaccine for renal cell carcinoma: getting the troops all worked up,"2012","1","4","229-233",Translational andrology and urology,"","","","","","","","25221745","","",0,10,0,0,0,,,
5146,99,"Holmberg and Sandmaier, 2001",journal,"Holmberg LA, Sandmaier BM",Theratope vaccine (STn-KLH),"2001","1","5","881-891",Expert opinion on biological therapy,"","","","","","","","11728222","","",0,10,0,0,0,,,
5147,99,"Weber et al., 2011",journal,"Weber JS, Vogelzang NJ, Ernstoff MS, Goodman OB, Cranmer LD, Marshall JL, Miles S, Rosario D, Diamond DC, Qiu Z, Obrocea M, Bot A",A phase 1 study of a vaccine targeting preferentially expressed antigen in melanoma and prostate-specific membrane antigen in patients with advanced solid tumors,"2011","34","7","556-567","Journal of immunotherapy (Hagerstown, Md. : 1997)","","","","","","","","21760528","","",0,10,0,0,0,,,
5148,99,"Ayyoub et al., 2001",journal,"Ayyoub M, Migliaccio M, Guillaume P, Linard D, Cerottini JC, Romero P, Lvy F, Speiser DE, Valmori D",Lack of tumor recognition by hTERT peptide 540-548-specific CD8(+) T cells from melanoma patients reveals inefficient antigen processing,"2001","31","9","2642-2651",European journal of immunology,"","","","","","","","11536162","","",0,10,0,0,0,,,
5149,99,"Li et al., 2017",journal,"Li J, Chen J, Li X, Qian Y",Vaccination efficacy with marrow mesenchymal stem cell against cancer was enhanced under simulated microgravity,"2017","485","3","606-613",Biochemical and biophysical research communications,"","","","","","","","28238782","","",0,10,0,0,0,,,
5150,99,"SAUER and TUCKER, 1954",journal,"SAUER LW, TUCKER WH","Immune responses to diphtheria, tetanus, and pertussis, aluminum phosphate adsorbed","1954","44","6","784-788",American journal of public health and the nation's health,"","","","","","","","13158668","","",0,10,0,0,0,,,
5151,99,"Winthrop et al., 2018",journal,"Winthrop KL, Korman N, Abramovits W, Rottinghaus ST, Tan H, Gardner A, Mukwaya G, Kaur M, Valdez H",T-cell-mediated immune response to pneumococcal conjugate vaccine (PCV-13) and tetanus toxoid vaccine in patients with moderate-to-severe psoriasis during tofacitinib treatment,"2018","78","6","1149-1155.e1",Journal of the American Academy of Dermatology,"","","","","","","","29080806","","",0,10,0,0,0,,,
5152,99,"Pektor et al., 2018",journal,"Pektor S, Hilscher L, Walzer KC, Miederer I, Bausbacher N, Loquai C, Schreckenberger M, Sahin U, Diken M, Miederer M",In vivo imaging of the immune response upon systemic RNA cancer vaccination by FDG-PET,"2018","8","1","80",EJNMMI research,"","","","","","","","30112704","","",0,10,0,0,0,,,
5153,99,"Svatek et al., 2018",journal,"Svatek RS, Tangen C, Delacroix S, Lowrance W, Lerner SP","Background and Update for S1602 ""A Phase III Randomized Trial to Evaluate the Influence of BCG Strain Differences and T Cell Priming with Intradermal BCG Before Intravesical Therapy for BCG-nave High-grade Non-muscle-invasive Bladder Cancer","2018","4","4","522-524",European urology focus,"","","","","","","","30197040","","",0,10,0,0,0,,,
5154,99,"Ragupathi et al., 1998",journal,"Ragupathi G, Koganty RR, Qiu D, Lloyd KO, Livingston PO",A novel and efficient method for synthetic carbohydrate conjugate vaccine preparation: synthesis of sialyl Tn-KLH conjugate using a 4-(4-N-maleimidomethyl) cyclohexane-1-carboxyl hydrazide (MMCCH) linker arm,"1998","15","3","217-221",Glycoconjugate journal,"","","","","","","","9579798","","",0,10,0,0,0,,,
5155,99,"Angsantikul et al., 2018",journal,"Angsantikul P, Fang RH, Zhang L",Toxoid Vaccination against Bacterial Infection Using Cell Membrane-Coated Nanoparticles,"2018","29","3","604-612",Bioconjugate chemistry,"","","","","","","","29241006","","",0,10,0,0,0,,,
5156,99,"Tang et al., 2007",journal,"Tang Y, Lin Z, Ni B, Wei J, Han J, Wang H, Wu Y",An altered peptide ligand for nave cytotoxic T lymphocyte epitope of TRP-2(180-188) enhanced immunogenicity,"2007","56","3","319-329","Cancer immunology, immunotherapy : CII","","","","","","","","16906394","","",0,10,0,0,0,,,
5157,99,"Ravindranathan et al., 2018",journal,"Ravindranathan S, Nguyen KG, Kurtz SL, Frazier HN, Smith SG, Koppolu BP, Rajaram N, Zaharoff DA",Tumor-derived granulocyte colony-stimulating factor diminishes efficacy of breast tumor cell vaccines,"2018","20","1","126",Breast cancer research : BCR,"","","","","","","","30348199","","",0,10,0,0,0,,,
5158,99,"Khan et al., 2015",journal,"Khan MI, Pach A 3rd, Khan GM, Bajracharya D, Sahastrabuddhe S, Bhutta W, Tahir R, Soofi S, Thapa CB, Joshi N, Puri MK, Shrestha P, Upreti SR, Clemens JD, Bhutta Z, Ochiai RL",Typhoid vaccine introduction: An evidence-based pilot implementation project in Nepal and Pakistan,"2015","33 Suppl 3","",C62-67,Vaccine,"","","","","","","","25937612","","",0,10,0,0,0,,,
5159,99,"Karyampudi and Ghosh, 2008",journal,"Karyampudi L, Ghosh SK",Mycobacterial HSP70 as an adjuvant in the design of an idiotype vaccine against a murine lymphoma,"2008","254","1","74-80",Cellular immunology,"","","","","","","","18715553","","",0,10,0,0,0,,,
5160,99,"Rini et al., 2016",journal,"Rini BI, Stenzl A, Zdrojowy R, Kogan M, Shkolnik M, Oudard S, Weikert S, Bracarda S, Crabb SJ, Bedke J, Ludwig J, Maurer D, Mendrzyk R, Wagner C, Mahr A, Fritsche J, Weinschenk T, Walter S, Kirner A, Singh-Jasuja H, Reinhardt C, Eisen T","IMA901, a multipeptide cancer vaccine, plus sunitinib versus sunitinib alone, as first-line therapy for advanced or metastatic renal cell carcinoma (IMPRINT): a multicentre, open-label, randomised, controlled, phase 3 trial","2016","17","11","1599-1611",The Lancet. Oncology,"","","","","","","","27720136","","",0,10,0,0,0,,,
5161,99,"Iinuma et al., 2014",journal,"Iinuma H, Fukushima R, Inaba T, Tamura J, Inoue T, Ogawa E, Horikawa M, Ikeda Y, Matsutani N, Takeda K, Yoshida K, Tsunoda T, Ikeda T, Nakamura Y, Okinaga K",Phase I clinical study of multiple epitope peptide vaccine combined with chemoradiation therapy in esophageal cancer patients,"2014","12","","84",Journal of translational medicine,"","","","","","","","24708624","","",0,10,0,0,0,,,
5162,99,"Lilleby et al., 2017",journal,"Lilleby W, Gaudernack G, Brunsvig PF, Vlatkovic L, Schulz M, Mills K, Hole KH, Inderberg EM",Phase I/IIa clinical trial of a novel hTERT peptide vaccine in men with metastatic hormone-naive prostate cancer,"2017","66","7","891-901","Cancer immunology, immunotherapy : CII","","","","","","","","28391357","","",0,10,0,0,0,,,
5163,99,"Downs-Canner et al., 2016",journal,"Downs-Canner S, Guo ZS, Ravindranathan R, Breitbach CJ, O'Malley ME, Jones HL, Moon A, McCart JA, Shuai Y, Zeh HJ, Bartlett DL",Phase 1 Study of Intravenous Oncolytic Poxvirus (vvDD) in Patients With Advanced Solid Cancers,"2016","24","8","1492-1501",Molecular therapy : the journal of the American Society of Gene Therapy,"","","","","","","","27203445","","",0,10,0,0,0,,,
5164,99,"Qin and Chatterjee, 1996",journal,"Qin H, Chatterjee SK",Cancer gene therapy using tumor cells infected with recombinant vaccinia virus expressing GM-CSF,"1996","7","15","1853-1860",Human gene therapy,"","","","","","","","8894677","","",0,10,0,0,0,,,
5165,99,"Schmitz-Winnenthal et al., 2018",journal,"Schmitz-Winnenthal FH, Hohmann N, Schmidt T, Podola L, Friedrich T, Lubenau H, Springer M, Wieckowski S, Breiner KM, Mikus G, Bchler MW, Keller AV, Koc R, Springfeld C, Knebel P, Bucur M, Grenacher L, Haefeli WE, Beckhove P","A phase 1 trial extension to assess immunologic efficacy and safety of prime-boost vaccination with VXM01, an oral T cell vaccine against VEGFR2, in patients with advanced pancreatic cancer","2018","7","4",e1303584,Oncoimmunology,"","","","","","","","29632710","","",0,10,0,0,0,,,
5166,99,"Nagayama et al., 2010",journal,"Nagayama H, Matsumoto K, Isoo N, Ohno H, Takahashi N, Nakaoka T, Shinozaki M, Watanabe M, Inoue Y, Nagamura F, Oyaizu N, Yamashita N",Gastrointestinal bleeding during anti-angiogenic peptide vaccination in combination with gemcitabine for advanced pancreatic cancer,"2010","3","6","307-317",Clinical journal of gastroenterology,"","","","","","","","26190488","","",0,10,0,0,0,,,
5167,99,"Palefsky et al., 2006",journal,"Palefsky JM, Berry JM, Jay N, Krogstad M, Da Costa M, Darragh TM, Lee JY",A trial of SGN-00101 (HspE7) to treat high-grade anal intraepithelial neoplasia in HIV-positive individuals,"2006","20","8","1151-1155","AIDS (London, England)","","","","","","","","16691066","","",0,10,0,0,0,,,
5168,99,"Rahma et al., 2010",journal,"Rahma OE, Ashtar E, Ibrahim R, Toubaji A, Gause B, Herrin VE, Linehan WM, Steinberg SM, Grollman F, Grimes G, Bernstein SA, Berzofsky JA, Khleif SN",A pilot clinical trial testing mutant von Hippel-Lindau peptide as a novel immune therapy in metastatic renal cell carcinoma,"2010","8","","8",Journal of translational medicine,"","","","","","","","20109232","","",0,10,0,0,0,,,
5169,99,"Fromm et al., 2016",journal,"Fromm G, de Silva S, Giffin L, Xu X, Rose J, Schreiber TH","Gp96-Ig/Costimulator (OX40L, ICOSL, or 4-1BBL) Combination Vaccine Improves T-cell Priming and Enhances Immunity, Memory, and Tumor Elimination","2016","4","9","766-778",Cancer immunology research,"","","","","","","","27364122","","",0,10,0,0,0,,,
5170,99,"Hersey et al., 1986",journal,"Hersey P, Edwards A, D'Alessandro G, MacDonald M",Phase II study of vaccinia melanoma cell lysates (VMCL) as adjuvant to surgical treatment of stage II melanoma. II. Effects on cell mediated cytotoxicity and leucocyte dependent antibody activity: immunological effects of VMCL in melanoma patients,"1986","22","3","221-231","Cancer immunology, immunotherapy : CII","","","","","","","","3460702","","",0,10,0,0,0,,,
5171,99,"Kobayashi et al., 2006",journal,"Kobayashi H, Nagato T, Aoki N, Sato K, Kimura S, Tateno M, Celis E",Defining MHC class II T helper epitopes for WT1 tumor antigen,"2006","55","7","850-860","Cancer immunology, immunotherapy : CII","","","","","","","","16220325","","",0,10,0,0,0,,,
5172,99,"Brooks et al., 2015",journal,"Brooks SE, Bonney SA, Lee C, Publicover A, Khan G, Smits EL, Sigurdardottir D, Arno M, Li D, Mills KI, Pulford K, Banham AH, van Tendeloo V, Mufti GJ, Rammensee HG, Elliott TJ, Orchard KH, Guinn BA",Application of the pMHC Array to Characterise Tumour Antigen Specific T Cell Populations in Leukaemia Patients at Disease Diagnosis,"2015","10","10",e0140483,PloS one,"","","","","","","","26492414","","",0,10,0,0,0,,,
5173,99,"Brayer et al., 2015",journal,"Brayer J, Lancet JE, Powers J, List A, Balducci L, Komrokji R, Pinilla-Ibarz J",WT1 vaccination in AML and MDS: A pilot trial with synthetic analog peptides,"2015","90","7","602-607",American journal of hematology,"","","","","","","","25802083","","",0,10,0,0,0,,,
5174,99,"Kobayashi et al., 2017",journal,"Kobayashi Y, Sakura T, Miyawaki S, Toga K, Sogo S, Heike Y",A new peptide vaccine OCV-501: in vitro pharmacology and phase 1 study in patients with acute myeloid leukemia,"2017","66","7","851-863","Cancer immunology, immunotherapy : CII","","","","","","","","28321480","","",0,10,0,0,0,,,
5175,99,"Sugiyama, 2005",journal,Sugiyama H,Cancer immunotherapy targeting Wilms' tumor gene WT1 product,"2005","4","4","503-512",Expert review of vaccines,"","","","","","","","16117707","","",0,10,0,0,0,,,
5176,99,"Nooka et al., 2018",journal,"Nooka AK, Wang ML, Yee AJ, Kaufman JL, Bae J, Peterkin D, Richardson PG, Raje NS",Assessment of Safety and Immunogenicity of PVX-410 Vaccine With or Without Lenalidomide in Patients With Smoldering Multiple Myeloma: A Nonrandomized Clinical Trial,"2018","4","12",e183267,JAMA oncology,"","","","","","","","30128502","","",0,10,0,0,0,,,
5177,99,"Flickinger et al., 2018",journal,"Flickinger JC Jr, Rodeck U, Snook AE",<i>Listeria monocytogenes</i> as a Vector for Cancer Immunotherapy: Current Understanding and Progress,"2018","6","3","",Vaccines,"","","","","","","","30044426","","",0,10,0,0,0,,,
5178,99,"Dalet et al., 2011",journal,"Dalet A, Stroobant V, Vigneron N, Van den Eynde BJ",Differences in the production of spliced antigenic peptides by the standard proteasome and the immunoproteasome,"2011","41","1","39-46",European journal of immunology,"","","","","","","","21182075","","",0,10,0,0,0,,,
5179,99,"Fagerberg et al., 2014",journal,"Fagerberg L, Hallstrm BM, Oksvold P, Kampf C, Djureinovic D, Odeberg J, Habuka M, Tahmasebpoor S, Danielsson A, Edlund K, Asplund A, Sjstedt E, Lundberg E, Szigyarto CA, Skogs M, Takanen JO, Berling H, Tegel H, Mulder J, Nilsson P, Schwenk JM, Lindskog C, Danielsson F, Mardinoglu A, Sivertsson A, von Feilitzen K, Forsberg M, Zwahlen M, Olsson I, Navani S, Huss M, Nielsen J, Ponten F, Uhln M",Analysis of the human tissue-specific expression by genome-wide integration of transcriptomics and antibody-based proteomics,"2014","13","2","397-406",Molecular & cellular proteomics : MCP,"","","","","","","","24309898","","",0,10,0,0,0,,,
5180,99,"Bollard et al., 2011",journal,"Bollard CM, Gottschalk S, Helen Huls M, Leen AM, Gee AP, Rooney CM",Good manufacturing practice-grade cytotoxic T lymphocytes specific for latent membrane proteins (LMP)-1 and LMP2 for patients with Epstein-Barr virus-associated lymphoma,"2011","13","5","518-522",Cytotherapy,"","","","","","","","21361747","","",0,10,0,0,0,,,
5181,99,"Saito et al., 2017",journal,"Saito H, Kitagawa K, Yoneda T, Fukui Y, Fujsawa M, Bautista D, Shirakawa T",Combination of p53-DC vaccine and rAd-p53 gene therapy induced CTLs cytotoxic against p53-deleted human prostate cancer cells in vitro,"2017","24","7","289-296",Cancer gene therapy,"","","","","","","","28621316","","",0,10,0,0,0,,,
5182,99,"Lubaroff et al., 2009",journal,"Lubaroff DM, Konety BR, Link B, Gerstbrein J, Madsen T, Shannon M, Howard J, Paisley J, Boeglin D, Ratliff TL, Williams RD",Phase I clinical trial of an adenovirus/prostate-specific antigen vaccine for prostate cancer: safety and immunologic results,"2009","15","23","7375-7380",Clinical cancer research : an official journal of the American Association for Cancer Research,"","","","","","","","19920098","","",0,10,0,0,0,,,
5183,99,"Kakudo et al., 2013",journal,"Kakudo N, Tanaka Y, Morimoto N, Ogawa T, Kushida S, Hara T, Kusumoto K",Adipose-derived regenerative cell (ADRC)-enriched fat grafting: optimal cell concentration and effects on grafted fat characteristics,"2013","11","","254",Journal of translational medicine,"","","","","","","","24107489","","",0,10,0,0,0,,,
5184,99,"Li et al., 2013",journal,"Li L, Yang G, Ren C, Tanimoto R, Hirayama T, Wang J, Hawke D, Kim SM, Lee JS, Goltsov AA, Park S, Ittmann MM, Troncoso P, Thompson TC",Glioma pathogenesis-related protein 1 induces prostate cancer cell death through Hsc70-mediated suppression of AURKA and TPX2,"2013","7","3","484-496",Molecular oncology,"","","","","","","","23333597","","",0,10,0,0,0,,,
5185,99,"Saeterdal et al., 2001",journal,"Saeterdal I, Bjrheim J, Lislerud K, Gjertsen MK, Bukholm IK, Olsen OC, Nesland JM, Eriksen JA, Mller M, Lindblom A, Gaudernack G",Frameshift-mutation-derived peptides as tumor-specific antigens in inherited and spontaneous colorectal cancer,"2001","98","23","13255-13260",Proceedings of the National Academy of Sciences of the United States of America,"","","","","","","","11687624","","",0,10,0,0,0,,,
5186,99,"McCormick et al., 2016",journal,"McCormick KA, Coveler AL, Rossi GR, Vahanian NN, Link C, Chiorean EG",Pancreatic cancer: Update on immunotherapies and algenpantucel-L,"2016","12","3","563-575",Human vaccines & immunotherapeutics,"","","","","","","","26619245","","",0,10,0,0,0,,,
5187,99,"Gyurkocza et al., 2017",journal,"Gyurkocza B, Lazarus HM, Giralt S",Allogeneic hematopoietic cell transplantation in patients with AML not achieving remission: potentially curative therapy,"2017","52","8","1083-1090",Bone marrow transplantation,"","","","","","","","28244979","","",0,10,0,0,0,,,
5188,99,"Procaccio et al., 2017",journal,"Procaccio L, Schirripa M, Fassan M, Vecchione L, Bergamo F, Prete AA, Intini R, Manai C, Dadduzio V, Boscolo A, Zagonel V, Lonardi S",Immunotherapy in Gastrointestinal Cancers,"2017","2017","","4346576",BioMed research international,"","","","","","","","28758114","","",0,10,0,0,0,,,
5189,99,"Avril et al., 2012",journal,"Avril T, Vauleon E, Hamlat A, Saikali S, Etcheverry A, Delmas C, Diabira S, Mosser J, Quillien V",Human glioblastoma stem-like cells are more sensitive to allogeneic NK and T cell-mediated killing compared with serum-cultured glioblastoma cells,"2012","22","2","159-174","Brain pathology (Zurich, Switzerland)","","","","","","","","21790828","","",0,10,0,0,0,,,
5190,99,"Kwiatkowska-Borowczyk et al., 2018",journal,"Kwiatkowska-Borowczyk E, Czerwiska P, Mackiewicz J, Gryska K, Kazimierczak U, Tomela K, Przybya A, Kozowska AK, Galus , Kwinta , Dondajewska E, Gbka-Buszek A, akowska M, Mackiewicz A",Whole cell melanoma vaccine genetically modified to stem cells like phenotype generates specific immune responses to ALDH1A1 and long-term survival in advanced melanoma patients,"2018","7","11",e1509821,Oncoimmunology,"","","","","","","","30377573","","",0,10,0,0,0,,,
5191,99,"LoGuidice et al., 2016",journal,"LoGuidice A, Houlihan A, Deans R",Multipotent adult progenitor cells on an allograft scaffold facilitate the bone repair process,"2016","7","","2041731416656148",Journal of tissue engineering,"","","","","","","","27493716","","",0,10,0,0,0,,,
5192,99,"Volz et al., 2016",journal,"Volz B, Schmidt M, Heinrich K, Kapp K, Schroff M, Wittig B","Design and characterization of the tumor vaccine MGN1601, allogeneic fourfold gene-modified vaccine cells combined with a TLR-9 agonist","2016","3","","15023",Molecular therapy oncolytics,"","","","","","","","27119114","","",0,10,0,0,0,,,
5193,99,"Hofman et al., 2010",journal,"Hofman FM, Stathopoulos A, Kruse CA, Chen TC, Schijns VE",Immunotherapy of malignant gliomas using autologous and allogeneic tissue cells,"2010","10","6","462-470",Anti-cancer agents in medicinal chemistry,"","","","","","","","20879986","","",0,10,0,0,0,,,
5194,99,"Berzofsky et al., 2004",journal,"Berzofsky JA, Terabe M, Oh S, Belyakov IM, Ahlers JD, Janik JE, Morris JC",Progress on new vaccine strategies for the immunotherapy and prevention of cancer,"2004","113","11","1515-1525",The Journal of clinical investigation,"","","","","","","","15173875","","",0,10,0,0,0,,,
5195,99,"Butterfield et al., 2006",journal,"Butterfield LH, Ribas A, Dissette VB, Lee Y, Yang JQ, De la Rocha P, Duran SD, Hernandez J, Seja E, Potter DM, McBride WH, Finn R, Glaspy JA, Economou JS",A phase I/II trial testing immunization of hepatocellular carcinoma patients with dendritic cells pulsed with four alpha-fetoprotein peptides,"2006","12","9","2817-2825",Clinical cancer research : an official journal of the American Association for Cancer Research,"","","","","","","","16675576","","",0,10,0,0,0,,,
5196,99,"Escrib-Garcia et al., 2017",journal,"Escrib-Garcia L, Alvarez-Fernndez C, Tellez-Gabriel M, Sierra J, Briones J","Dendritic cells combined with tumor cells and -galactosylceramide induce a potent, therapeutic and NK-cell dependent antitumor immunity in B cell lymphoma","2017","15","1","115",Journal of translational medicine,"","","","","","","","28549432","","",0,10,0,0,0,,,
5197,99,"Mailliard et al., 2004",journal,"Mailliard RB, Wankowicz-Kalinska A, Cai Q, Wesa A, Hilkens CM, Kapsenberg ML, Kirkwood JM, Storkus WJ, Kalinski P",alpha-type-1 polarized dendritic cells: a novel immunization tool with optimized CTL-inducing activity,"2004","64","17","5934-5937",Cancer research,"","","","","","","","15342370","","",0,10,0,0,0,,,
5198,99,"Kaufman et al., 2008",journal,"Kaufman HL, Lenz HJ, Marshall J, Singh D, Garett C, Cripps C, Moore M, von Mehren M, Dalfen R, Heim WJ, Conry RM, Urba WJ, Benson AB 3rd, Yu M, Caterini J, Kim-Schulze S, Debenedette M, Salha D, Vogel T, Elias I, Berinstein NL",Combination chemotherapy and ALVAC-CEA/B7.1 vaccine in patients with metastatic colorectal cancer,"2008","14","15","4843-4849",Clinical cancer research : an official journal of the American Association for Cancer Research,"","","","","","","","18676757","","",0,10,0,0,0,,,
5199,99,"Thomas et al., 2018",journal,"Thomas R, Al-Khadairi G, Roelands J, Hendrickx W, Dermime S, Bedognetti D, Decock J",NY-ESO-1 Based Immunotherapy of Cancer: Current Perspectives,"2018","9","","947",Frontiers in immunology,"","","","","","","","29770138","","",0,10,0,0,0,,,
5200,99,"Gulley et al., 2008",journal,"Gulley JL, Arlen PM, Tsang KY, Yokokawa J, Palena C, Poole DJ, Remondo C, Cereda V, Jones JL, Pazdur MP, Higgins JP, Hodge JW, Steinberg SM, Kotz H, Dahut WL, Schlom J",Pilot study of vaccination with recombinant CEA-MUC-1-TRICOM poxviral-based vaccines in patients with metastatic carcinoma,"2008","14","10","3060-3069",Clinical cancer research : an official journal of the American Association for Cancer Research,"","","","","","","","18483372","","",0,10,0,0,0,,,
5201,99,"Marshall, 2003",journal,Marshall J,Carcinoembryonic antigen-based vaccines,"2003","30","3 Suppl 8","30-36",Seminars in oncology,"","","","","","","","12881810","","",0,10,0,0,0,,,
5202,99,"Triozzi et al., 2005",journal,"Triozzi PL, Allen KO, Carlisle RR, Craig M, LoBuglio AF, Conry RM",Phase I study of the intratumoral administration of recombinant canarypox viruses expressing B7.1 and interleukin 12 in patients with metastatic melanoma,"2005","11","11","4168-4175",Clinical cancer research : an official journal of the American Association for Cancer Research,"","","","","","","","15930353","","",0,10,0,0,0,,,
5203,99,"Desai et al., 2018",journal,"Desai S, Rathi N, Kawade A, Venkatramanan P, Kundu R, Lalwani SK, Dubey AP, Venkateswara Rao J, Narayanappa D, Ghildiyal R, Gogtay NJ, Venugopal P, Palkar S, Munshi R, Bavdekar A, Juvekar S, Ganguly N, Niyogi P, Uttam KG, Kondekar A, Kumbhar D, Mohanlal S, Agarwal MC, Shetty P, Antony K, Gunale B, Dharmadhikari A, Deshpande J, Nalavade U, Sharma D, Bansal A, Tang Y, Flores J, Kulkarni PS",Non-interference of Bovine-Human reassortant pentavalent rotavirus vaccine ROTASIIL with the immunogenicity of infant vaccines in comparison with a licensed rotavirus vaccine,"2018","36","37","5519-5523",Vaccine,"","","","","","","","30104114","","",0,10,0,0,0,,,
5204,99,"Reusch et al., 2015",journal,"Reusch U, Duell J, Ellwanger K, Herbrecht C, Knackmuss SH, Fucek I, Eser M, McAleese F, Molkenthin V, Gall FL, Topp M, Little M, Zhukovsky EA","A tetravalent bispecific TandAb (CD19/CD3), AFM11, efficiently recruits T cells for the potent lysis of CD19(+) tumor cells","2015","7","3","584-604",mAbs,"","","","","","","","25875246","","",0,10,0,0,0,,,
5205,99,"Gall et al., 2005",journal,"Gall JM, Davol PA, Grabert RC, Deaver M, Lum LG",T cells armed with anti-CD3 x anti-CD20 bispecific antibody enhance killing of CD20+ malignant B cells and bypass complement-mediated rituximab resistance in vitro,"2005","33","4","452-459",Experimental hematology,"","","","","","","","15781336","","",0,10,0,0,0,,,
5206,99,"Parkhurst et al., 2011",journal,"Parkhurst MR, Yang JC, Langan RC, Dudley ME, Nathan DA, Feldman SA, Davis JL, Morgan RA, Merino MJ, Sherry RM, Hughes MS, Kammula US, Phan GQ, Lim RM, Wank SA, Restifo NP, Robbins PF, Laurencot CM, Rosenberg SA",T cells targeting carcinoembryonic antigen can mediate regression of metastatic colorectal cancer but induce severe transient colitis,"2011","19","3","620-626",Molecular therapy : the journal of the American Society of Gene Therapy,"","","","","","","","21157437","","",0,10,0,0,0,,,
5207,99,"Zaidi et al., 2019",journal,"Zaidi N, Quezada SA, Kuroiwa JMY, Zhang L, Jaffee EM, Steinman RM, Wang B",Anti-CTLA-4 synergizes with dendritic cell-targeted vaccine to promote IL-3-dependent CD4<sup>+</sup> effector T cell infiltration into murine pancreatic tumors,"2019","1445","1","62-73",Annals of the New York Academy of Sciences,"","","","","","","","30945313","","",0,10,0,0,0,,,
5208,99,"Triozzi et al., 2005",journal,"Triozzi PL, Bolger GB, Neidhart J, Rinehart JJ, Saleh M, Allen KO, Sellers S, Waddell MJ",Effect of docetaxel chemotherapy on the activity of a gonadotropin releasing hormone vaccine in patients with advanced prostate cancer,"2005","65","4","316-321",The Prostate,"","","","","","","","16015596","","",0,10,0,0,0,,,
5209,99,"Wilkinson et al., 2000",journal,"Wilkinson RW, Ross EL, Lee-MacAry AE, Laylor R, Burchell J, Taylor-Papadimitriou J, Snary D",A transgenic mouse model for tumour immunotherapy: induction of an anti-idiotype response to human MUC1,"2000","83","9","1202-1208",British journal of cancer,"","","","","","","","11027434","","",0,10,0,0,0,,,
5210,99,"Wettendorff et al., 1989",journal,"Wettendorff M, Iliopoulos D, Tempero M, Kay D, DeFreitas E, Koprowski H, Herlyn D",Idiotypic cascades in cancer patients treated with monoclonal antibody CO17-1A,"1989","86","10","3787-3791",Proceedings of the National Academy of Sciences of the United States of America,"","","","","","","","2786203","","",0,10,0,0,0,,,
5211,99,"Garfall and Stadtmauer, 2016",journal,"Garfall AL, Stadtmauer EA",Cellular and vaccine immunotherapy for multiple myeloma,"2016","2016","1","521-527",Hematology. American Society of Hematology. Education Program,"","","","","","","","27913524","","",0,10,0,0,0,,,
5212,99,"von et al., 2001",journal,"von Mehren M, Arlen P, Gulley J, Rogatko A, Cooper HS, Meropol NJ, Alpaugh RK, Davey M, McLaughlin S, Beard MT, Tsang KY, Schlom J, Weiner LM",The influence of granulocyte macrophage colony-stimulating factor and prior chemotherapy on the immunological response to a vaccine (ALVAC-CEA B7.1) in patients with metastatic carcinoma,"2001","7","5","1181-1191",Clinical cancer research : an official journal of the American Association for Cancer Research,"","","","","","","","11350882","","",0,10,0,0,0,,,
5213,99,"Alvarez-Salas, 2008",journal,Alvarez-Salas LM,"Amolimogene bepiplasmid, a DNA-based therapeutic encoding the E6 and E7 epitopes from HPV, for cervical and anal dysplasia","2008","10","6","622-628",Current opinion in molecular therapeutics,"","","","","","","","19051140","","",0,10,0,0,0,,,
5214,99,"McCaffery et al., 1996",journal,"McCaffery M, Yao TJ, Williams L, Livingston PO, Houghton AN, Chapman PB",Immunization of melanoma patients with BEC2 anti-idiotypic monoclonal antibody that mimics GD3 ganglioside: enhanced immunogenicity when combined with adjuvant,"1996","2","4","679-686",Clinical cancer research : an official journal of the American Association for Cancer Research,"","","","","","","","9816218","","",0,10,0,0,0,,,
5215,99,"Yuan et al., 2008",journal,"Yuan J, Gnjatic S, Li H, Powel S, Gallardo HF, Ritter E, Ku GY, Jungbluth AA, Segal NH, Rasalan TS, Manukian G, Xu Y, Roman RA, Terzulli SL, Heywood M, Pogoriler E, Ritter G, Old LJ, Allison JP, Wolchok JD",CTLA-4 blockade enhances polyfunctional NY-ESO-1 specific T cell responses in metastatic melanoma patients with clinical benefit,"2008","105","51","20410-20415",Proceedings of the National Academy of Sciences of the United States of America,"","","","","","","","19074257","","",0,10,0,0,0,,,
5216,99,"Rapoport et al., 2015",journal,"Rapoport AP, Stadtmauer EA, Binder-Scholl GK, Goloubeva O, Vogl DT, Lacey SF, Badros AZ, Garfall A, Weiss B, Finklestein J, Kulikovskaya I, Sinha SK, Kronsberg S, Gupta M, Bond S, Melchiori L, Brewer JE, Bennett AD, Gerry AB, Pumphrey NJ, Williams D, Tayton-Martin HK, Ribeiro L, Holdich T, Yanovich S, Hardy N, Yared J, Kerr N, Philip S, Westphal S, Siegel DL, Levine BL, Jakobsen BK, Kalos M, June CH",NY-ESO-1-specific TCR-engineered T cells mediate sustained antigen-specific antitumor effects in myeloma,"2015","21","8","914-921",Nature medicine,"","","","","","","","26193344","","",0,10,0,0,0,,,
5217,99,"Cohen et al., 2005",journal,"Cohen CJ, Zheng Z, Bray R, Zhao Y, Sherman LA, Rosenberg SA, Morgan RA",Recognition of fresh human tumor by human peripheral blood lymphocytes transduced with a bicistronic retroviral vector encoding a murine anti-p53 TCR,"2005","175","9","5799-5808","Journal of immunology (Baltimore, Md. : 1950)","","","","","","","","16237072","","",0,10,0,0,0,,,
5218,99,"Zhang et al., 2017",journal,"Zhang X, Sharma PK, Peter Goedegebuure S, Gillanders WE",Personalized cancer vaccines: Targeting the cancer mutanome,"2017","35","7","1094-1100",Vaccine,"","","","","","","","27449681","","",0,10,0,0,0,,,
5219,99,"Harzstark and Small, 2007",journal,"Harzstark AL, Small EJ",Immunotherapy for prostate cancer using antigen-loaded antigen-presenting cells: APC8015 (Provenge),"2007","7","8","1275-1280",Expert opinion on biological therapy,"","","","","","","","17696825","","",0,10,0,0,0,,,
5220,99,"Park et al., 2011",journal,"Park MH, Yang DH, Kim MH, Jang JH, Jang YY, Lee YK, Jin CJ, Pham TN, Thi TA, Lim MS, Lee HJ, Hong CY, Yoon JH, Lee JJ",Alpha-Type 1 Polarized Dendritic Cells Loaded with Apoptotic Allogeneic Breast Cancer Cells Can Induce Potent Cytotoxic T Lymphocytes against Breast Cancer,"2011","43","1","56-66",Cancer research and treatment : official journal of Korean Cancer Association,"","","","","","","","21509164","","",0,10,0,0,0,,,
5221,99,"Mahmud et al., 2018",journal,"Mahmud SM, Bozat-Emre S, Mostao-Guidolin LC, Marrie RA","Registry Cohort Study to Determine Risk for Multiple Sclerosis after Vaccination for Pandemic Influenza A(H1N1) with Arepanrix, Manitoba, Canada","2018","24","7","1267-1274",Emerging infectious diseases,"","","","","","","","29912696","","",0,10,0,0,0,,,
5222,99,"Jia et al., 2017",journal,"Jia YY, Tan WJ, Duan FF, Pan ZM, Chen X, Yin YL, Jiao XA",A Genetically Modified attenuated <i>Listeria</i> Vaccine Expressing HPV16 E7 Kill Tumor Cells in Direct and Antigen-Specific Manner,"2017","7","","279",Frontiers in cellular and infection microbiology,"","","","","","","","28706878","","",0,10,0,0,0,,,
5223,99,"Pal et al., 2006",journal,"Pal R, Venzon D, Santra S, Kalyanaraman VS, Montefiori DC, Hocker L, Hudacik L, Rose N, Nacsa J, Edghill-Smith Y, Moniuszko M, Hel Z, Belyakov IM, Berzofsky JA, Parks RW, Markham PD, Letvin NL, Tartaglia J, Franchini G",Systemic immunization with an ALVAC-HIV-1/protein boost vaccine strategy protects rhesus macaques from CD4+ T-cell loss and reduces both systemic and mucosal simian-human immunodeficiency virus SHIVKU2 RNA levels,"2006","80","8","3732-3742",Journal of virology,"","","","","","","","16571790","","",0,10,0,0,0,,,
5224,99,"Johnson et al., 2009",journal,"Johnson LA, Morgan RA, Dudley ME, Cassard L, Yang JC, Hughes MS, Kammula US, Royal RE, Sherry RM, Wunderlich JR, Lee CC, Restifo NP, Schwarz SL, Cogdill AP, Bishop RJ, Kim H, Brewer CC, Rudy SF, VanWaes C, Davis JL, Mathur A, Ripley RT, Nathan DA, Laurencot CM, Rosenberg SA",Gene therapy with human and mouse T-cell receptors mediates cancer regression and targets normal tissues expressing cognate antigen,"2009","114","3","535-546",Blood,"","","","","","","","19451549","","",0,10,0,0,0,,,
5225,99,"Chodon et al., 2014",journal,"Chodon T, Comin-Anduix B, Chmielowski B, Koya RC, Wu Z, Auerbach M, Ng C, Avramis E, Seja E, Villanueva A, McCannel TA, Ishiyama A, Czernin J, Radu CG, Wang X, Gjertson DW, Cochran AJ, Cornetta K, Wong DJ, Kaplan-Lefko P, Hamid O, Samlowski W, Cohen PA, Daniels GA, Mukherji B, Yang L, Zack JA, Kohn DB, Heath JR, Glaspy JA, Witte ON, Baltimore D, Economou JS, Ribas A",Adoptive transfer of MART-1 T-cell receptor transgenic lymphocytes and dendritic cell vaccination in patients with metastatic melanoma,"2014","20","9","2457-2465",Clinical cancer research : an official journal of the American Association for Cancer Research,"","","","","","","","24634374","","",0,10,0,0,0,,,
5226,99,"Qi et al., 2012",journal,"Qi CJ, Ning YL, Han YS, Min HY, Ye H, Zhu YL, Qian KQ",Autologous dendritic cell vaccine for estrogen receptor (ER)/progestin receptor (PR) double-negative breast cancer,"2012","61","9","1415-1424","Cancer immunology, immunotherapy : CII","","","","","","","","22290073","","",0,10,0,0,0,,,
5227,99,"Rousseau et al., 2006",journal,"Rousseau RF, Biagi E, Dutour A, Yvon ES, Brown MP, Lin T, Mei Z, Grilley B, Popek E, Heslop HE, Gee AP, Krance RA, Popat U, Carrum G, Margolin JF, Brenner MK",Immunotherapy of high-risk acute leukemia with a recipient (autologous) vaccine expressing transgenic human CD40L and IL-2 after chemotherapy and allogeneic stem cell transplantation,"2006","107","4","1332-1341",Blood,"","","","","","","","16249392","","",0,10,0,0,0,,,
5228,99,"Gao et al., 2014",journal,"Gao D, Li C, Xie X, Zhao P, Wei X, Sun W, Liu HC, Alexandrou AT, Jones J, Zhao R, Li JJ",Autologous tumor lysate-pulsed dendritic cell immunotherapy with cytokine-induced killer cells improves survival in gastric and colorectal cancer patients,"2014","9","4",e93886,PloS one,"","","","","","","","24699863","","",0,10,0,0,0,,,
5229,99,"Weinstock et al., 2017",journal,"Weinstock M, Rosenblatt J, Avigan D",Dendritic Cell Therapies for Hematologic Malignancies,"2017","5","","66-75",Molecular therapy. Methods & clinical development,"","","","","","","","28480306","","",0,10,0,0,0,,,
5230,99,"Sonpavde et al., 2017",journal,"Sonpavde G, McMannis JD, Bai Y, Seethammagari MR, Bull JMC, Hawkins V, Dancsak TK, Lapteva N, Levitt JM, Moseley A, Spencer DM, Slawin KM",Phase I trial of antigen-targeted autologous dendritic cell-based vaccine with in vivo activation of inducible CD40 for advanced prostate cancer,"2017","66","10","1345-1357","Cancer immunology, immunotherapy : CII","","","","","","","","28608115","","",0,10,0,0,0,,,
5231,99,"Lee et al., 2017",journal,"Lee JM, Lee MH, Garon E, Goldman JW, Salehi-Rad R, Baratelli FE, Schaue D, Wang G, Rosen F, Yanagawa J, Walser TC, Lin Y, Park SJ, Adams S, Marincola FM, Tumeh PC, Abtin F, Suh R, Reckamp KL, Lee G, Wallace WD, Lee S, Zeng G, Elashoff DA, Sharma S, Dubinett SM",Phase I Trial of Intratumoral Injection of <i>CCL21</i> Gene-Modified Dendritic Cells in Lung Cancer Elicits Tumor-Specific Immune Responses and CD8<sup>+</sup> T-cell Infiltration,"2017","23","16","4556-4568",Clinical cancer research : an official journal of the American Association for Cancer Research,"","","","","","","","28468947","","",0,10,0,0,0,,,
5232,99,"Chiappori et al., 2010",journal,"Chiappori AA, Soliman H, Janssen WE, Antonia SJ, Gabrilovich DI",INGN-225: a dendritic cell-based p53 vaccine (Ad.p53-DC) in small cell lung cancer: observed association between immune response and enhanced chemotherapy effect,"2010","10","6","983-991",Expert opinion on biological therapy,"","","","","","","","20420527","","",0,10,0,0,0,,,
5233,99,"Ardon et al., 2010",journal,"Ardon H, Van Gool S, Lopes IS, Maes W, Sciot R, Wilms G, Demaerel P, Bijttebier P, Claes L, Goffin J, Van Calenbergh F, De Vleeschouwer S",Integration of autologous dendritic cell-based immunotherapy in the primary treatment for patients with newly diagnosed glioblastoma multiforme: a pilot study,"2010","99","2","261-272",Journal of neuro-oncology,"","","","","","","","20146084","","",0,10,0,0,0,,,
5234,99,"Rosenblatt et al., 2011",journal,"Rosenblatt J, Vasir B, Uhl L, Blotta S, Macnamara C, Somaiya P, Wu Z, Joyce R, Levine JD, Dombagoda D, Yuan YE, Francoeur K, Fitzgerald D, Richardson P, Weller E, Anderson K, Kufe D, Munshi N, Avigan D",Vaccination with dendritic cell/tumor fusion cells results in cellular and humoral antitumor immune responses in patients with multiple myeloma,"2011","117","2","393-402",Blood,"","","","","","","","21030562","","",0,10,0,0,0,,,
5235,99,"Purner et al., 1994",journal,"Purner MB, Berens RL, Krug EC, Curiel TJ","Epstein-Barr virus-transformed B cells, a potentially convenient source of autologous antigen-presenting cells for the propagation of certain human cytotoxic T lymphocytes","1994","1","6","696-700",Clinical and diagnostic laboratory immunology,"","","","","","","","8556523","","",0,10,0,0,0,,,
5236,99,"Kubuschok et al., 2000",journal,"Kubuschok B, Cochlovius C, Jung W, Schmits R, Trmper L, Hartmann F, Renner C, Pfreundschuh M",Gene-modified spontaneous Epstein-Barr virus-transformed lymphoblastoid cell lines as autologous cancer vaccines: mutated p21 ras oncogene as a model,"2000","7","9","1231-1240",Cancer gene therapy,"","","","","","","","11023195","","",0,10,0,0,0,,,
5237,99,"Battiwalla and Hematti, 2009",journal,"Battiwalla M, Hematti P",Mesenchymal stem cells in hematopoietic stem cell transplantation,"2009","11","5","503-515",Cytotherapy,"","","","","","","","19728189","","",0,10,0,0,0,,,
5238,99,"Gupta and Emens, 2010",journal,"Gupta R, Emens LA",GM-CSF-secreting vaccines for solid tumors: moving forward,"2010","10","50","52-60",Discovery medicine,"","","","","","","","20670599","","",0,10,0,0,0,,,
5239,99,"Lutz et al., 2011",journal,"Lutz E, Yeo CJ, Lillemoe KD, Biedrzycki B, Kobrin B, Herman J, Sugar E, Piantadosi S, Cameron JL, Solt S, Onners B, Tartakovsky I, Choi M, Sharma R, Illei PB, Hruban RH, Abrams RA, Le D, Jaffee E, Laheru D","A lethally irradiated allogeneic granulocyte-macrophage colony stimulating factor-secreting tumor vaccine for pancreatic adenocarcinoma. A Phase II trial of safety, efficacy, and immune activation","2011","253","2","328-335",Annals of surgery,"","","","","","","","21217520","","",0,10,0,0,0,,,
5240,99,"Savvateeva et al., 2015",journal,"Savvateeva LV, Schwartz AM, Gorshkova LB, Gorokhovets NV, Makarov VA, Reddy VP, Aliev G, Zamyatnin AA Jr",Prophylactic Admission of an In Vitro Reconstructed Complexes of Human Recombinant Heat Shock Proteins and Melanoma Antigenic Peptides Activates Anti-Melanoma Responses in Mice,"2015","15","5","462-468",Current molecular medicine,"","","","","","","","26122656","","",0,10,0,0,0,,,
5241,99,"Baudard et al., 2007",journal,"Baudard M, Comte F, Conge AM, Mariano-Goulart D, Klein B, Rossi JF",Importance of [18F]fluorodeoxyglucose-positron emission tomography scanning for the monitoring of responses to immunotherapy in follicular lymphoma,"2007","48","2","381-388",Leukemia & lymphoma,"","","","","","","","17325900","","",0,10,0,0,0,,,
5242,99,"Parkhurst et al., 2003",journal,"Parkhurst MR, DePan C, Riley JP, Rosenberg SA, Shu S",Hybrids of dendritic cells and tumor cells generated by electrofusion simultaneously present immunodominant epitopes from multiple human tumor-associated antigens in the context of MHC class I and class II molecules,"2003","170","10","5317-5325","Journal of immunology (Baltimore, Md. : 1950)","","","","","","","","12734382","","",0,10,0,0,0,,,
5243,99,"Reed et al., 2015",journal,"Reed CM, Cresce ND, Mauldin IS, Slingluff CL Jr, Olson WC",Vaccination with Melanoma Helper Peptides Induces Antibody Responses Associated with Improved Overall Survival,"2015","21","17","3879-3887",Clinical cancer research : an official journal of the American Association for Cancer Research,"","","","","","","","25967144","","",0,10,0,0,0,,,
5244,99,"de et al., 2014",journal,"de Rosa F, Ridolfi L, Ridolfi R, Gentili G, Valmorri L, Nanni O, Petrini M, Fiammenghi L, Granato AM, Ancarani V, Pancisi E, Soldati V, Cassan S, Riccobon A, Parisi E, Romeo A, Turci L, Guidoboni M","Vaccination with autologous dendritic cells loaded with autologous tumor lysate or homogenate combined with immunomodulating radiotherapy and/or preleukapheresis IFN- in patients with metastatic melanoma: a randomised ""proof-of-principle"" phase II study","2014","12","","209",Journal of translational medicine,"","","","","","","","25053129","","",0,10,0,0,0,,,
5245,99,"Mastelic-Gavillet et al., 2019",journal,"Mastelic-Gavillet B, Balint K, Boudousquie C, Gannon PO, Kandalaft LE",Personalized Dendritic Cell Vaccines-Recent Breakthroughs and Encouraging Clinical Results,"2019","10","","766",Frontiers in immunology,"","","","","","","","31031762","","",0,10,0,0,0,,,
5246,99,"Borch et al., 2016",journal,"Borch TH, Engell-Noerregaard L, Zeeberg Iversen T, Ellebaek E, Met , Hansen M, Andersen MH, Thor Straten P, Svane IM",mRNA-transfected dendritic cell vaccine in combination with metronomic cyclophosphamide as treatment for patients with advanced malignant melanoma,"2016","5","9",e1207842,Oncoimmunology,"","","","","","","","27757300","","",0,10,0,0,0,,,
5247,99,"Kandalaft et al., 2013",journal,"Kandalaft LE, Powell DJ Jr, Chiang CL, Tanyi J, Kim S, Bosch M, Montone K, Mick R, Levine BL, Torigian DA, June CH, Coukos G",Autologous lysate-pulsed dendritic cell vaccination followed by adoptive transfer of vaccine-primed ex vivo co-stimulated T cells in recurrent ovarian cancer,"2013","2","1",e22664,Oncoimmunology,"","","","","","","","23482679","","",0,10,0,0,0,,,
5248,99,"Millman and Pagliuca, 2017",journal,"Millman JR, Pagliuca FW",Autologous Pluripotent Stem Cell-Derived -Like Cells for Diabetes Cellular Therapy,"2017","66","5","1111-1120",Diabetes,"","","","","","","","28507211","","",0,10,0,0,0,,,
5249,99,"Saxena and Bhardwaj, 2018",journal,"Saxena M, Bhardwaj N",Re-Emergence of Dendritic Cell Vaccines for Cancer Treatment,"2018","4","2","119-137",Trends in cancer,"","","","","","","","29458962","","",0,10,0,0,0,,,
5250,99,"Elster et al., 2016",journal,"Elster JD, Krishnadas DK, Lucas KG",Dendritic cell vaccines: A review of recent developments and their potential pediatric application,"2016","12","9","2232-2239",Human vaccines & immunotherapeutics,"","","","","","","","27245943","","",0,10,0,0,0,,,
5251,99,"Burkhardt et al., 2013",journal,"Burkhardt UE, Hainz U, Stevenson K, Goldstein NR, Pasek M, Naito M, Wu D, Ho VT, Alonso A, Hammond NN, Wong J, Sievers QL, Brusic A, McDonough SM, Zeng W, Perrin A, Brown JR, Canning CM, Koreth J, Cutler C, Armand P, Neuberg D, Lee JS, Antin JH, Mulligan RC, Sasada T, Ritz J, Soiffer RJ, Dranoff G, Alyea EP, Wu CJ",Autologous CLL cell vaccination early after transplant induces leukemia-specific T cells,"2013","123","9","3756-3765",The Journal of clinical investigation,"","","","","","","","23912587","","",0,10,0,0,0,,,
5252,99,"Rubinstein et al., 2000",journal,"Rubinstein A, Mizrachi Y, Bernstein L, Shliozberg J, Golodner M, Liu GQ, Ochs HD","Progressive specific immune attrition after primary, secondary and tertiary immunizations with bacteriophage phi X174 in asymptomatic HIV-1 infected patients","2000","14","4",F55-62,"AIDS (London, England)","","","","","","","","10770533","","",0,10,0,0,0,,,
5253,99,"Leitner et al., 2004",journal,"Leitner WW, Hwang LN, Bergmann-Leitner ES, Finkelstein SE, Frank S, Restifo NP",Apoptosis is essential for the increased efficacy of alphaviral replicase-based DNA vaccines,"2004","22","11-12","1537-1544",Vaccine,"","","","","","","","15063579","","",0,10,0,0,0,,,
5254,99,"Carbone et al., 2005",journal,"Carbone DP, Ciernik IF, Kelley MJ, Smith MC, Nadaf S, Kavanaugh D, Maher VE, Stipanov M, Contois D, Johnson BE, Pendleton CD, Seifert B, Carter C, Read EJ, Greenblatt J, Top LE, Kelsey MI, Minna JD, Berzofsky JA",Immunization with mutant p53- and K-ras-derived peptides in cancer patients: immune response and clinical outcome,"2005","23","22","5099-5107",Journal of clinical oncology : official journal of the American Society of Clinical Oncology,"","","","","","","","15983396","","",0,10,0,0,0,,,
5255,99,"Matheson and Goa, 2000",journal,"Matheson AJ, Goa KL",Diphtheria-tetanus-acellular pertussis vaccine adsorbed (Triacelluvax; DTaP3-CB): a review of its use in the prevention of Bordetella pertussis infection,"2000","2","2","139-159",Paediatric drugs,"","","","","","","","10937466","","",0,10,0,0,0,,,
5256,99,"Kim and Liau, 2010",journal,"Kim W, Liau LM",Dendritic cell vaccines for brain tumors,"2010","21","1","139-157",Neurosurgery clinics of North America,"","","","","","","","19944973","","",0,10,0,0,0,,,
5257,99,"Ma et al., 2012",journal,"Ma Y, Xu YC, Tang L, Zhang Z, Wang J, Wang HX",Cytokine-induced killer (CIK) cell therapy for patients with hepatocellular carcinoma: efficacy and safety,"2012","1","1","11",Experimental hematology & oncology,"","","","","","","","23210562","","",0,10,0,0,0,,,
5258,99,"Ridolfi et al., 2018",journal,"Ridolfi L, de Rosa F, Fiammenghi L, Petrini M, Granato AM, Ancarani V, Pancisi E, Soldati V, Cassan S, Bulgarelli J, Riccobon A, Gentili G, Nanni O, Framarini M, Tauceri F, Guidoboni M",Complementary vaccination protocol with dendritic cells pulsed with autologous tumour lysate in patients with resected stage III or IV melanoma: protocol for a phase II randomised trial (ACDC Adjuvant Trial),"2018","8","8",e021701,BMJ open,"","","","","","","","30082356","","",0,10,0,0,0,,,
5259,99,"Lesterhuis et al., 2006",journal,"Lesterhuis WJ, de Vries IJ, Schuurhuis DH, Boullart AC, Jacobs JF, de Boer AJ, Scharenborg NM, Brouwer HM, van de Rakt MW, Figdor CG, Ruers TJ, Adema GJ, Punt CJ",Vaccination of colorectal cancer patients with CEA-loaded dendritic cells: antigen-specific T cell responses in DTH skin tests,"2006","17","6","974-980",Annals of oncology : official journal of the European Society for Medical Oncology,"","","","","","","","16600979","","",0,10,0,0,0,,,
5260,99,"Timmerman et al., 2009",journal,"Timmerman JM, Vose JM, Czerwinski DK, Weng WK, Ingolia D, Mayo M, Denney DW, Levy R",Tumor-specific recombinant idiotype immunisation after chemotherapy as initial treatment for follicular non-Hodgkin lymphoma,"2009","50","1","37-46",Leukemia & lymphoma,"","","","","","","","19125383","","",0,10,0,0,0,,,
5261,99,"Panelli et al., 2000",journal,"Panelli MC, Wunderlich J, Jeffries J, Wang E, Mixon A, Rosenberg SA, Marincola FM",Phase 1 study in patients with metastatic melanoma of immunization with dendritic cells presenting epitopes derived from the melanoma-associated antigens MART-1 and gp100,"2000","23","4","487-498","Journal of immunotherapy (Hagerstown, Md. : 1997)","","","","","","","","10916759","","",0,10,0,0,0,,,
5262,99,"Deacon et al., 1982",journal,"Deacon SP, Langford DT, Shepherd WM, Knight PA",A comparative clinical study of Adsorbed Tetanus Vaccine and Adult-type Tetanus-Diphtheria Vaccine,"1982","89","3","513-519",The Journal of hygiene,"","","","","","","","7153515","","",0,10,0,0,0,,,
5263,99,"Halperin et al., 2011",journal,"Halperin SA, McNeil S, Langley J, Blatter M, Dionne M, Embree J, Johnson R, Latiolais T, Meekison W, Noya F, Senders S, Zickler P, Johnson DR","Tolerability and antibody response in adolescents and adults revaccinated with tetanus toxoid, reduced diphtheria toxoid, and acellular pertussis vaccine adsorbed (Tdap) 4-5 years after a previous dose","2011","29","46","8459-8465",Vaccine,"","","","","","","","21803091","","",0,10,0,0,0,,,
5264,99,"Okada et al., 2011",journal,"Okada H, Kalinski P, Ueda R, Hoji A, Kohanbash G, Donegan TE, Mintz AH, Engh JA, Bartlett DL, Brown CK, Zeh H, Holtzman MP, Reinhart TA, Whiteside TL, Butterfield LH, Hamilton RL, Potter DM, Pollack IF, Salazar AM, Lieberman FS",Induction of CD8+ T-cell responses against novel glioma-associated antigen peptides and clinical activity by vaccinations with {alpha}-type 1 polarized dendritic cells and polyinosinic-polycytidylic acid stabilized by lysine and carboxymethylcellulose in patients with recurrent malignant glioma,"2011","29","3","330-336",Journal of clinical oncology : official journal of the American Society of Clinical Oncology,"","","","","","","","21149657","","",0,10,0,0,0,,,
5265,99,"Mpendo et al., 2015",journal,"Mpendo J, Mutua G, Nyombayire J, Ingabire R, Nanvubya A, Anzala O, Karita E, Hayes P, Kopycinski J, Dally L, Hannaman D, Egan MA, Eldridge JH, Syvertsen K, Lehrman J, Rasmussen B, Gilmour J, Cox JH, Fast PE, Schmidt C","A Phase I Double Blind, Placebo-Controlled, Randomized Study of the Safety and Immunogenicity of Electroporated HIV DNA with or without Interleukin 12 in Prime-Boost Combinations with an Ad35 HIV Vaccine in Healthy HIV-Seronegative African Adults","2015","10","8",e0134287,PloS one,"","","","","","","","26252526","","",0,10,0,0,0,,,
5266,99,"Brun et al., 2018",journal,"Brun JL, Rajaonarison J, Nocart N, Hoarau L, Brun S, Garrigue I",Targeted immunotherapy of high-grade cervical intra-epithelial neoplasia: Expectations from clinical trials,"2018","8","2","227-235",Molecular and clinical oncology,"","","","","","","","29435283","","",0,10,0,0,0,,,
5267,99,"Kim et al., 2015",journal,"Kim JH, Lee JO, Kim N, Lee HJ, Lee YW, Kim HI, Kim SJ, Park SH, Kim HS",Paclitaxel suppresses the viability of breast tumor MCF7 cells through the regulation of EF1 and FOXO3a by AMPK signaling,"2015","47","5","1874-1880",International journal of oncology,"","","","","","","","26397839","","",0,10,0,0,0,,,
5268,99,"Wei et al., 2013",journal,"Wei H, Bera TK, Wayne AS, Xiang L, Colantonio S, Chertov O, Pastan I",A modified form of diphthamide causes immunotoxin resistance in a lymphoma cell line with a deletion of the WDR85 gene,"2013","288","17","12305-12312",The Journal of biological chemistry,"","","","","","","","23486472","","",0,10,0,0,0,,,
5269,99,"Zebertavage et al., 2019",journal,"Zebertavage L, Bambina S, Shugart J, Alice A, Zens KD, Lauer P, Hanson B, Gough MJ, Crittenden MR, Bahjat KS",A microbial-based cancer vaccine for induction of EGFRvIII-specific CD8+ T cells and anti-tumor immunity,"2019","14","1",e0209153,PloS one,"","","","","","","","30601871","","",0,10,0,0,0,,,
5270,99,"Nowicki et al., 2019",journal,"Nowicki TS, Berent-Maoz B, Cheung-Lau G, Huang RR, Wang X, Tsoi J, Kaplan-Lefko P, Cabrera P, Tran J, Pang J, Macabali M, Garcilazo IP, Carretero IB, Kalbasi A, Cochran AJ, Grasso CS, Hu-Lieskovan S, Chmielowski B, Comin-Anduix B, Singh A, Ribas A",A Pilot Trial of the Combination of Transgenic NY-ESO-1-reactive Adoptive Cellular Therapy with Dendritic Cell Vaccination with or without Ipilimumab,"2019","25","7","2096-2108",Clinical cancer research : an official journal of the American Association for Cancer Research,"","","","","","","","30573690","","",0,10,0,0,0,,,
5271,99,"Robbins et al., 2015",journal,"Robbins PF, Kassim SH, Tran TL, Crystal JS, Morgan RA, Feldman SA, Yang JC, Dudley ME, Wunderlich JR, Sherry RM, Kammula US, Hughes MS, Restifo NP, Raffeld M, Lee CC, Li YF, El-Gamil M, Rosenberg SA",A pilot trial using lymphocytes genetically engineered with an NY-ESO-1-reactive T-cell receptor: long-term follow-up and correlates with response,"2015","21","5","1019-1027",Clinical cancer research : an official journal of the American Association for Cancer Research,"","","","","","","","25538264","","",0,10,0,0,0,,,
5272,99,"Lu et al., 2006",journal,"Lu Y, Xu LC, Parker N, Westrick E, Reddy JA, Vetzel M, Low PS, Leamon CP","Preclinical pharmacokinetics, tissue distribution, and antitumor activity of a folate-hapten conjugate-targeted immunotherapy in hapten-immunized mice","2006","5","12","3258-3267",Molecular cancer therapeutics,"","","","","","","","17172429","","",0,10,0,0,0,,,
5273,99,"Bertino et al., 2013",journal,"Bertino P, Panigada M, Soprana E, Bianchi V, Bertilaccio S, Sanvito F, Rose AH, Yang H, Gaudino G, Hoffmann PR, Siccardi A, Carbone M",Fowlpox-based survivin vaccination for malignant mesothelioma therapy,"2013","133","3","612-623",International journal of cancer,"","","","","","","","23335100","","",0,10,0,0,0,,,
5274,99,"Tsang et al., 2005",journal,"Tsang KY, Palena C, Yokokawa J, Arlen PM, Gulley JL, Mazzara GP, Gritz L, Yafal AG, Ogueta S, Greenhalgh P, Manson K, Panicali D, Schlom J",Analyses of recombinant vaccinia and fowlpox vaccine vectors expressing transgenes for two human tumor antigens and three human costimulatory molecules,"2005","11","4","1597-1607",Clinical cancer research : an official journal of the American Association for Cancer Research,"","","","","","","","15746065","","",0,10,0,0,0,,,
5275,99,"Odunsi et al., 2012",journal,"Odunsi K, Matsuzaki J, Karbach J, Neumann A, Mhawech-Fauceglia P, Miller A, Beck A, Morrison CD, Ritter G, Godoy H, Lele S, duPont N, Edwards R, Shrikant P, Old LJ, Gnjatic S, Jger E",Efficacy of vaccination with recombinant vaccinia and fowlpox vectors expressing NY-ESO-1 antigen in ovarian cancer and melanoma patients,"2012","109","15","5797-5802",Proceedings of the National Academy of Sciences of the United States of America,"","","","","","","","22454499","","",0,10,0,0,0,,,
5276,99,"Herbert et al., 2010",journal,"Herbert N, Haferkamp A, Schmitz-Winnenthal HF, Zller M",Concomitant tumor and autoantigen vaccination supports renal cell carcinoma rejection,"2010","185","2","902-916","Journal of immunology (Baltimore, Md. : 1950)","","","","","","","","20548033","","",0,10,0,0,0,,,
5277,99,"Gahry-Sgard et al., 2003",journal,"Gahry-Sgard H, Pialoux G, Figueiredo S, Iga C, Surenaud M, Gaston J, Gras-Masse H, Lvy JP, Guillet JG",Long-term specific immune responses induced in humans by a human immunodeficiency virus type 1 lipopeptide vaccine: characterization of CD8+-T-cell epitopes recognized,"2003","77","20","11220-11231",Journal of virology,"","","","","","","","14512570","","",0,10,0,0,0,,,
5278,99,"Chen et al., 2017",journal,"Chen J, Guo XZ, Li HY, Zhao JJ, Xu WD",Dendritic cells engineered to secrete anti-DcR3 antibody augment cytotoxic T lymphocyte response against pancreatic cancer <i>in vitro</i>,"2017","23","5","817-829",World journal of gastroenterology,"","","","","","","","28223726","","",0,10,0,0,0,,,
5279,99,"Kong et al., 2018",journal,"Kong Z, Wang Y, Ma W",Vaccination in the immunotherapy of glioblastoma,"2018","14","2","255-268",Human vaccines & immunotherapeutics,"","","","","","","","29087782","","",0,10,0,0,0,,,
5280,99,"Sabbatini et al., 2007",journal,"Sabbatini PJ, Ragupathi G, Hood C, Aghajanian CA, Juretzka M, Iasonos A, Hensley ML, Spassova MK, Ouerfelli O, Spriggs DR, Tew WP, Konner J, Clausen H, Abu Rustum N, Dansihefsky SJ, Livingston PO","Pilot study of a heptavalent vaccine-keyhole limpet hemocyanin conjugate plus QS21 in patients with epithelial ovarian, fallopian tube, or peritoneal cancer","2007","13","14","4170-4177",Clinical cancer research : an official journal of the American Association for Cancer Research,"","","","","","","","17634545","","",0,10,0,0,0,,,
5281,99,"Sawada et al., 2013",journal,"Sawada Y, Yoshikawa T, Fujii S, Mitsunaga S, Nobuoka D, Mizuno S, Takahashi M, Yamauchi C, Endo I, Nakatsura T",Remarkable tumor lysis in a hepatocellular carcinoma patient immediately following glypican-3-derived peptide vaccination: an autopsy case,"2013","9","6","1228-1233",Human vaccines & immunotherapeutics,"","","","","","","","23466818","","",0,10,0,0,0,,,
5282,99,"Perricone et al., 2004",journal,"Perricone MA, Smith KA, Claussen KA, Plog MS, Hempel DM, Roberts BL, St George JA, Kaplan JM",Enhanced efficacy of melanoma vaccines in the absence of B lymphocytes,"2004","27","4","273-281","Journal of immunotherapy (Hagerstown, Md. : 1997)","","","","","","","","15235388","","",0,10,0,0,0,,,
5283,99,"Cassaday et al., 2007",journal,"Cassaday RD, Sondel PM, King DM, Macklin MD, Gan J, Warner TF, Zuleger CL, Bridges AJ, Schalch HG, Kim KM, Hank JA, Mahvi DM, Albertini MR",A phase I study of immunization using particle-mediated epidermal delivery of genes for gp100 and GM-CSF into uninvolved skin of melanoma patients,"2007","13","2 Pt 1","540-549",Clinical cancer research : an official journal of the American Association for Cancer Research,"","","","","","","","17255276","","",0,10,0,0,0,,,
5284,99,"Cochlovius et al., 1999",journal,"Cochlovius B, Linnebacher M, Zewe-Welschof M, Zller M",Recombinant gp100 protein presented by dendritic cells elicits a T-helper-cell response in vitro and in vivo,"1999","83","4","547-554",International journal of cancer,"","","","","","","","10508493","","",0,10,0,0,0,,,
5285,99,"Smith et al., 2009",journal,"Smith FO, Klapper JA, Wunderlich JR, Rosenberg SA, Dudley ME",Impact of a recombinant fowlpox vaccine on the efficacy of adoptive cell therapy with tumor infiltrating lymphocytes in a patient with metastatic melanoma,"2009","32","8","870-874","Journal of immunotherapy (Hagerstown, Md. : 1997)","","","","","","","","19752747","","",0,10,0,0,0,,,
5286,99,"Yang et al., 2002",journal,"Yang S, Linette GP, Longerich S, Haluska FG",Antimelanoma activity of CTL generated from peripheral blood mononuclear cells after stimulation with autologous dendritic cells pulsed with melanoma gp100 peptide G209-2M is correlated to TCR avidity,"2002","169","1","531-539","Journal of immunology (Baltimore, Md. : 1950)","","","","","","","","12077285","","",0,10,0,0,0,,,
5287,99,"Lotem et al., 2009",journal,"Lotem M, Machlenkin A, Hamburger T, Nissan A, Kadouri L, Frankenburg S, Gimmon Z, Elias O, David IB, Kuznetz A, Shiloni E, Peretz T",Autologous melanoma vaccine induces antitumor and self-reactive immune responses that affect patient survival and depend on MHC class II expression on vaccine cells,"2009","15","15","4968-4977",Clinical cancer research : an official journal of the American Association for Cancer Research,"","","","","","","","19602547","","",0,10,0,0,0,,,
5288,99,"Sosman et al., 2008",journal,"Sosman JA, Carrillo C, Urba WJ, Flaherty L, Atkins MB, Clark JI, Dutcher J, Margolin KA, Mier J, Gollob J, Kirkwood JM, Panka DJ, Crosby NA, O'Boyle K, LaFleur B, Ernstoff MS",Three phase II cytokine working group trials of gp100 (210M) peptide plus high-dose interleukin-2 in patients with HLA-A2-positive advanced melanoma,"2008","26","14","2292-2298",Journal of clinical oncology : official journal of the American Society of Clinical Oncology,"","","","","","","","18467720","","",0,10,0,0,0,,,
5289,99,"Thompson et al., 2004",journal,"Thompson LW, Garbee CF, Hibbitts S, Brinckerhoff LH, Pierce RA, Chianese-Bullock KA, Deacon DH, Engelhard VH, Slingluff CL Jr",Competition among peptides in melanoma vaccines for binding to MHC molecules,"2004","27","6","425-431","Journal of immunotherapy (Hagerstown, Md. : 1997)","","","","","","","","15534486","","",0,10,0,0,0,,,
5290,99,"Phan et al., 2003",journal,"Phan GQ, Touloukian CE, Yang JC, Restifo NP, Sherry RM, Hwu P, Topalian SL, Schwartzentruber DJ, Seipp CA, Freezer LJ, Morton KE, Mavroukakis SA, White DE, Rosenberg SA",Immunization of patients with metastatic melanoma using both class I- and class II-restricted peptides from melanoma-associated antigens,"2003","26","4","349-356","Journal of immunotherapy (Hagerstown, Md. : 1997)","","","","","","","","12843797","","",0,10,0,0,0,,,
5291,99,"Keehn et al., 2016",journal,"Keehn A, Gartrell B, Schoenberg MP",Vesigenurtacel-L (HS-410) in the management of high-grade nonmuscle invasive bladder cancer,"2016","12","23","2673-2682","Future oncology (London, England)","","","","","","","","27609194","","",0,10,0,0,0,,,
5292,99,"Simons and Sacks, 2006",journal,"Simons JW, Sacks N",Granulocyte-macrophage colony-stimulating factor-transduced allogeneic cancer cellular immunotherapy: the GVAX vaccine for prostate cancer,"2006","24","5","419-424",Urologic oncology,"","","","","","","","16962494","","",0,10,0,0,0,,,
5293,99,"Nemunaitis, 2003",journal,Nemunaitis J,GVAX (GMCSF gene modified tumor vaccine) in advanced stage non small cell lung cancer,"2003","91","1-2","225-231",Journal of controlled release : official journal of the Controlled Release Society,"","","","","","","","12932654","","",0,10,0,0,0,,,
5294,99,"Le et al., 2013",journal,"Le DT, Lutz E, Uram JN, Sugar EA, Onners B, Solt S, Zheng L, Diaz LA Jr, Donehower RC, Jaffee EM, Laheru DA",Evaluation of ipilimumab in combination with allogeneic pancreatic tumor cells transfected with a GM-CSF gene in previously treated pancreatic cancer,"2013","36","7","382-389","Journal of immunotherapy (Hagerstown, Md. : 1997)","","","","","","","","23924790","","",0,10,0,0,0,,,
5295,99,"Roohvand and Kossari, 2012",journal,"Roohvand F, Kossari N","Advances in hepatitis C virus vaccines, part two: advances in hepatitis C virus vaccine formulations and modalities","2012","22","4","391-415",Expert opinion on therapeutic patents,"","","","","","","","22455502","","",0,10,0,0,0,,,
5296,99,"Mullane et al., 2013",journal,"Mullane KM, Winston DJ, Wertheim MS, Betts RF, Poretz DM, Camacho LH, Pergam SA, Mullane MR, Stek JE, Sterling TM, Zhao Y, Manoff SB, Annunziato PW",Safety and immunogenicity of heat-treated zoster vaccine (ZVHT) in immunocompromised adults,"2013","208","9","1375-1385",The Journal of infectious diseases,"","","","","","","","23908479","","",0,10,0,0,0,,,
5297,99,"Nothdurft, 2008",journal,Nothdurft HD,Hepatitis A vaccines,"2008","7","5","535-545",Expert review of vaccines,"","","","","","","","18564009","","",0,10,0,0,0,,,
5298,99,"Roldo et al., 2010",journal,"Roldo A, Mellado MC, Castilho LR, Carrondo MJ, Alves PM",Virus-like particles in vaccine development,"2010","9","10","1149-1176",Expert review of vaccines,"","","","","","","","20923267","","",0,10,0,0,0,,,
5299,99,"Delhem et al., 1998",journal,"Delhem N, Hadida F, Gorochov G, Carpentier F, de Cavel JP, Andrani JF, Autran B, Cesbron JY",Primary Th1 cell immunization against HIVgp160 in SCID-hu mice coengrafted with peripheral blood lymphocytes and skin,"1998","161","4","2060-2069","Journal of immunology (Baltimore, Md. : 1950)","","","","","","","","9712080","","",0,10,0,0,0,,,
5300,99,"Alves et al., 2003",journal,"Alves PM, Faure O, Graff-Dubois S, Gross DA, Cornet S, Chouaib S, Miconnet I, Lemonnier FA, Kosmatopoulos K",EphA2 as target of anticancer immunotherapy: identification of HLA-A*0201-restricted epitopes,"2003","63","23","8476-8480",Cancer research,"","","","","","","","14679012","","",0,10,0,0,0,,,
5301,99,"Reker et al., 2004",journal,"Reker S, Becker JC, Svane IM, Ralfkiaer E, Straten PT, Andersen MH",HLA-B35-restricted immune responses against survivin in cancer patients,"2004","108","6","937-941",International journal of cancer,"","","","","","","","14712500","","",0,10,0,0,0,,,
5302,99,"Osanto, 1997",journal,Osanto S,Vaccine Trials for the Clinician: Prospects for Tumor Antigens,"1997","2","5","284-299",The oncologist,"","","","","","","","10388061","","",0,10,0,0,0,,,
5303,99,"Ueda et al., 2010",journal,"Ueda R, Ohkusu-Tsukada K, Fusaki N, Soeda A, Kawase T, Kawakami Y, Toda M",Identification of HLA-A2- and A24-restricted T-cell epitopes derived from SOX6 expressed in glioma stem cells for immunotherapy,"2010","126","4","919-929",International journal of cancer,"","","","","","","","19728337","","",0,10,0,0,0,,,
5304,99,"Mevorach et al., 2014",journal,"Mevorach D, Zuckerman T, Reiner I, Shimoni A, Samuel S, Nagler A, Rowe JM, Or R",Single infusion of donor mononuclear early apoptotic cells as prophylaxis for graft-versus-host disease in myeloablative HLA-matched allogeneic bone marrow transplantation: a phase I/IIa clinical trial,"2014","20","1","58-65",Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation,"","","","","","","","24140121","","",0,10,0,0,0,,,
5305,99,"Kim et al., 2014",journal,"Kim TJ, Jin HT, Hur SY, Yang HG, Seo YB, Hong SR, Lee CW, Kim S, Woo JW, Park KS, Hwang YY, Park J, Lee IH, Lim KT, Lee KH, Jeong MS, Surh CD, Suh YS, Park JS, Sung YC",Clearance of persistent HPV infection and cervical lesion by therapeutic DNA vaccine in CIN3 patients,"2014","5","","5317",Nature communications,"","","","","","","","25354725","","",0,10,0,0,0,,,
5306,99,"Zhu et al., 2013",journal,"Zhu Y, Zheng Y, Mei L, Liu M, Li S, Xiao H, Zhu H, Wu S, Chen H, Huang L",Enhanced immunotherapeutic effect of modified HPV16 E7-pulsed dendritic cell vaccine by an adeno-shRNA-SOCS1 virus,"2013","43","4","1151-1159",International journal of oncology,"","","","","","","","23877655","","",0,10,0,0,0,,,
5307,99,"Suso et al., 2011",journal,"Suso EM, Dueland S, Rasmussen AM, Vetrhus T, Aamdal S, Kvalheim G, Gaudernack G",hTERT mRNA dendritic cell vaccination: complete response in a pancreatic cancer patient associated with response against several hTERT epitopes,"2011","60","6","809-818","Cancer immunology, immunotherapy : CII","","","","","","","","21365467","","",0,10,0,0,0,,,
5308,99,"Fenoglio et al., 2013",journal,"Fenoglio D, Traverso P, Parodi A, Tomasello L, Negrini S, Kalli F, Battaglia F, Ferrera F, Sciallero S, Murdaca G, Setti M, Sobrero A, Boccardo F, Cittadini G, Puppo F, Criscuolo D, Carmignani G, Indiveri F, Filaci G","A multi-peptide, dual-adjuvant telomerase vaccine (GX301) is highly immunogenic in patients with prostate and renal cancer","2013","62","6","1041-1052","Cancer immunology, immunotherapy : CII","","","","","","","","23591981","","",0,10,0,0,0,,,
5309,99,"Relitti et al., 2020",journal,"Relitti N, Saraswati AP, Federico S, Khan T, Brindisi M, Zisterer D, Brogi S, Gemma S, Butini S, Campiani G",Telomerase-based cancer therapeutics: a review on their clinical trials,"2020","","","",Current topics in medicinal chemistry,"","","","","","","","31894749","","",0,10,0,0,0,,,
5310,99,"Bae et al., 2012",journal,"Bae J, Smith R, Daley J, Mimura N, Tai YT, Anderson KC, Munshi NC",Myeloma-specific multiple peptides able to generate cytotoxic T lymphocytes: a potential therapeutic application in multiple myeloma and other plasma cell disorders,"2012","18","17","4850-4860",Clinical cancer research : an official journal of the American Association for Cancer Research,"","","","","","","","22753586","","",0,10,0,0,0,,,
5311,99,"Kyte et al., 2016",journal,"Kyte JA, Aamdal S, Dueland S, Sbe-Larsen S, Inderberg EM, Madsbu UE, Skovlund E, Gaudernack G, Kvalheim G",Immune response and long-term clinical outcome in advanced melanoma patients vaccinated with tumor-mRNA-transfected dendritic cells,"2016","5","11",e1232237,Oncoimmunology,"","","","","","","","27999747","","",0,10,0,0,0,,,
5312,99,"Karamitros et al., 2018",journal,"Karamitros D, Stoilova B, Aboukhalil Z, Hamey F, Reinisch A, Samitsch M, Quek L, Otto G, Repapi E, Doondeea J, Usukhbayar B, Calvo J, Taylor S, Goardon N, Six E, Pflumio F, Porcher C, Majeti R, Gttgens B, Vyas P",Single-cell analysis reveals the continuum of human lympho-myeloid progenitor cells,"2018","19","1","85-97",Nature immunology,"","","","","","","","29167569","","",0,10,0,0,0,,,
5313,99,"Vesikari et al., 2015",journal,"Vesikari T, Brodszki N, van Damme P, Diez-Domingo J, Icardi G, Petersen LK, Tran C, Thomas S, Luxembourg A, Baudin M","A Randomized, Double-Blind, Phase III Study of the Immunogenicity and Safety of a 9-Valent Human Papillomavirus L1 Virus-Like Particle Vaccine (V503) Versus Gardasil in 9-15-Year-Old Girls","2015","34","9","992-998",The Pediatric infectious disease journal,"","","","","","","","26090572","","",0,10,0,0,0,,,
5314,99,"Muthumani et al., 2017",journal,"Muthumani K, Marnin L, Kudchodkar SB, Perales-Puchalt A, Choi H, Agarwal S, Scott VL, Reuschel EL, Zaidi FI, Duperret EK, Wise MC, Kraynyak KA, Ugen KE, Sardesai NY, Joseph Kim J, Weiner DB",Novel prostate cancer immunotherapy with a DNA-encoded anti-prostate-specific membrane antigen monoclonal antibody,"2017","66","12","1577-1588","Cancer immunology, immunotherapy : CII","","","","","","","","28819703","","",0,10,0,0,0,,,
5315,99,"Wentink et al., 2016",journal,"Wentink MQ, Hackeng TM, Tabruyn SP, Puijk WC, Schwamborn K, Altschuh D, Meloen RH, Schuurman T, Griffioen AW, Timmerman P",Targeted vaccination against the bevacizumab binding site on VEGF using 3D-structured peptides elicits efficient antitumor activity,"2016","113","44","12532-12537",Proceedings of the National Academy of Sciences of the United States of America,"","","","","","","","27791128","","",0,10,0,0,0,,,
5316,99,"Pellegatta et al., 2015",journal,"Pellegatta S, Valletta L, Corbetta C, Patan M, Zucca I, Riccardi Sirtori F, Bruzzone MG, Fogliatto G, Isacchi A, Pollo B, Finocchiaro G",Effective immuno-targeting of the IDH1 mutation R132H in a murine model of intracranial glioma,"2015","3","","4",Acta neuropathologica communications,"","","","","","","","25849072","","",0,10,0,0,0,,,
5317,99,"Kamran et al., 2016",journal,"Kamran N, Calinescu A, Candolfi M, Chandran M, Mineharu Y, Asad AS, Koschmann C, Nunez FJ, Lowenstein PR, Castro MG",Recent advances and future of immunotherapy for glioblastoma,"2016","16","10","1245-1264",Expert opinion on biological therapy,"","","","","","","","27411023","","",0,10,0,0,0,,,
5318,99,"Lacy et al., 2009",journal,"Lacy MQ, Mandrekar S, Dispenzieri A, Hayman S, Kumar S, Buadi F, Dingli D, Litzow M, Wettstein P, Padley D, Kabat B, Gastineau D, Rajkumar SV, Gertz MA",Idiotype-pulsed antigen-presenting cells following autologous transplantation for multiple myeloma may be associated with prolonged survival,"2009","84","12","799-802",American journal of hematology,"","","","","","","","19899131","","",0,10,0,0,0,,,
5319,99,"Seo et al., 2011",journal,"Seo SH, Kim KS, Park SH, Suh YS, Kim SJ, Jeun SS, Sung YC",The effects of mesenchymal stem cells injected via different routes on modified IL-12-mediated antitumor activity,"2011","18","5","488-495",Gene therapy,"","","","","","","","21228885","","",0,10,0,0,0,,,
5320,99,"Haight et al., 2000",journal,"Haight AE, Bowman LC, Ng CY, Vanin EF, Davidoff AM",Humoral response to vaccination with interleukin-2-expressing allogeneic neuroblastoma cells after primary therapy,"2000","35","6","712-715",Medical and pediatric oncology,"","","","","","","","11107153","","",0,10,0,0,0,,,
5321,99,"Holt et al., 2011",journal,"Holt GE, Podack ER, Raez LE",Immunotherapy as a strategy for the treatment of non-small-cell lung cancer,"2011","8","1","43-54","Therapy (London, England : 2004)","","","","","","","","21359153","","",0,10,0,0,0,,,
5322,99,"Lohmueller et al., 2016",journal,"Lohmueller JJ, Sato S, Popova L, Chu IM, Tucker MA, Barberena R, Innocenti GM, Cudic M, Ham JD, Cheung WC, Polakiewicz RD, Finn OJ",Antibodies elicited by the first non-viral prophylactic cancer vaccine show tumor-specificity and immunotherapeutic potential,"2016","6","","31740",Scientific reports,"","","","","","","","27545199","","",0,10,0,0,0,,,
5323,99,"Kim et al., 2019",journal,"Kim KH, Kim CS, Kim HM, Kim JD, Ma SH, Kim DH, Hwang PH, Han JW, Lee TJ, Kim JH, Karkada N, Mesaros N, Sohn WY, Kim JH","Immunogenicity and safety of a combined DTPa-IPV/Hib vaccine administered as a three-dose primary vaccination course in healthy Korean infants: phase III, randomized study","2019","15","2","317-326",Human vaccines & immunotherapeutics,"","","","","","","","30431387","","",0,10,0,0,0,,,
5324,99,"Turner et al., 1970",journal,"Turner GS, Squires EJ, Murray HG",Inactivated smallpox vaccine. A comparison of inactivation methods,"1970","68","2","197-210",The Journal of hygiene,"","","","","","","","4988047","","",0,10,0,0,0,,,
5325,99,"Halpern et al., 1992",journal,"Halpern SE, Dillman RO, Amox D, Hagan PL, Burks R, Dillman J, Perdikakis B, Merchant B, Frincke J, Schweighardt S",Detection of occult tumor using indium 111-labeled anticarcinoembryonic antigen antibodies,"1992","127","9","1094-1100","Archives of surgery (Chicago, Ill. : 1960)","","","","","","","","1514913","","",0,10,0,0,0,,,
5326,99,"Ascher et al., 1979",journal,"Ascher NL, Ahrenholz DH, Simmons RL, Weiblen B, Gomez L, Forstrom LA, Frick MP, Henke C, McCullough J",Indium 111 autologous tagged leukocytes in the diagnosis of intraperitoneal sepsis,"1979","114","4","386-392","Archives of surgery (Chicago, Ill. : 1960)","","","","","","","","107925","","",0,10,0,0,0,,,
5327,99,"Nitschke et al., 2017",journal,"Nitschke NJ, Bjoern J, Iversen TZ, Andersen MH, Svane IM","Indoleamine 2,3-dioxygenase and survivin peptide vaccine combined with temozolomide in metastatic melanoma","2017","4","","77",Stem cell investigation,"","","","","","","","29057249","","",0,10,0,0,0,,,
5328,99,"Siegel et al., 2001",journal,"Siegel F, Lu M, Roggendorf M",Coadministration of gamma interferon with DNA vaccine expressing woodchuck hepatitis virus (WHV) core antigen enhances the specific immune response and protects against WHV infection,"2001","75","11","5036-5042",Journal of virology,"","","","","","","","11333883","","",0,10,0,0,0,,,
5329,99,"Lee et al., 2007",journal,"Lee ST, Neelapu SS, Kwak LW",Therapeutic vaccine for lymphoma,"2007","48","1","1-10",Yonsei medical journal,"","","","","","","","17326239","","",0,10,0,0,0,,,
5330,99,"Ragupathi et al., 2009",journal,"Ragupathi G, Damani P, Srivastava G, Srivastava O, Sucheck SJ, Ichikawa Y, Livingston PO","Synthesis of sialyl Lewis(a) (sLe (a), CA19-9) and construction of an immunogenic sLe(a) vaccine","2009","58","9","1397-1405","Cancer immunology, immunotherapy : CII","","","","","","","","19190907","","",0,10,0,0,0,,,
5331,99,"Peethambaram et al., 2009",journal,"Peethambaram PP, Melisko ME, Rinn KJ, Alberts SR, Provost NM, Jones LA, Sims RB, Lin LR, Frohlich MW, Park JW",A phase I trial of immunotherapy with lapuleucel-T (APC8024) in patients with refractory metastatic tumors that express HER-2/neu,"2009","15","18","5937-5944",Clinical cancer research : an official journal of the American Association for Cancer Research,"","","","","","","","19723649","","",0,10,0,0,0,,,
5332,99,"Kitawaki et al., 2011",journal,"Kitawaki T, Kadowaki N, Fukunaga K, Kasai Y, Maekawa T, Ohmori K, Itoh T, Shimizu A, Kuzushima K, Kondo T, Ishikawa T, Uchiyama T",Cross-priming of CD8(+) T cells in vivo by dendritic cells pulsed with autologous apoptotic leukemic cells in immunotherapy for elderly patients with acute myeloid leukemia,"2011","39","4","424-433.e2",Experimental hematology,"","","","","","","","21216276","","",0,10,0,0,0,,,
5333,99,"Lauer et al., 2018",journal,"Lauer UM, Schell M, Beil J, Berchtold S, Koppenhfer U, Glatzle J, Knigsrainer A, Mhle R, Nann D, Fend F, Pfannenberg C, Bitzer M, Malek NP",Phase I Study of Oncolytic Vaccinia Virus GL-ONC1 in Patients with Peritoneal Carcinomatosis,"2018","24","18","4388-4398",Clinical cancer research : an official journal of the American Association for Cancer Research,"","","","","","","","29773661","","",0,10,0,0,0,,,
5334,99,"Vici et al., 2016",journal,"Vici P, Pizzuti L, Mariani L, Zampa G, Santini D, Di Lauro L, Gamucci T, Natoli C, Marchetti P, Barba M, Maugeri-Sacc M, Sergi D, Tomao F, Vizza E, Di Filippo S, Paolini F, Curzio G, Corrado G, Michelotti A, Sanguineti G, Giordano A, De Maria R, Venuti A",Targeting immune response with therapeutic vaccines in premalignant lesions and cervical cancer: hope or reality from clinical studies,"2016","15","10","1327-1336",Expert review of vaccines,"","","","","","","","27063030","","",0,10,0,0,0,,,
5335,99,"Hossain et al., 2019",journal,"Hossain MK, Vartak A, Sucheck SJ, Wall KA",Liposomal Fc Domain Conjugated to a Cancer Vaccine Enhances Both Humoral and Cellular Immunity,"2019","4","3","5204-5208",ACS omega,"","","","","","","","30949616","","",0,10,0,0,0,,,
5336,99,"Mohn et al., 2018",journal,"Mohn KG, Smith I, Sjursen H, Cox RJ",Immune responses after live attenuated influenza vaccination,"2018","14","3","571-578",Human vaccines & immunotherapeutics,"","","","","","","","28933664","","",0,10,0,0,0,,,
5337,99,"Deng et al., 2018",journal,"Deng W, Lira V, Hudson TE, Lemmens EE, Hanson WG, Flores R, Barajas G, Katibah GE, Desbien AL, Lauer P, Leong ML, Portnoy DA, Dubensky TW Jr",Recombinant <i>Listeria</i> promotes tumor rejection by CD8<sup>+</sup> T cell-dependent remodeling of the tumor microenvironment,"2018","115","32","8179-8184",Proceedings of the National Academy of Sciences of the United States of America,"","","","","","","","30038013","","",0,10,0,0,0,,,
5338,99,"Hung et al., 2008",journal,"Hung CF, Wu TC, Monie A, Roden R",Antigen-specific immunotherapy of cervical and ovarian cancer,"2008","222","","43-69",Immunological reviews,"","","","","","","","18363994","","",0,10,0,0,0,,,
5339,99,"Sun et al., 2018",journal,"Sun L, Hao Y, Wang Z, Zeng Y",Constructing TC-1-GLUC-LMP2 Model Tumor Cells to Evaluate the Anti-Tumor Effects of LMP2-Related Vaccines,"2018","10","4","",Viruses,"","","","","","","","29570629","","",0,10,0,0,0,,,
5340,99,"Quandt et al., 2018",journal,"Quandt J, Schlude C, Bartoschek M, Will R, Cid-Arregui A, Schlch S, Reissfelder C, Weitz J, Schneider M, Wiemann S, Momburg F, Beckhove P",Long-peptide vaccination with driver gene mutations in p53 and Kras induces cancer mutation-specific effector as well as regulatory T cell responses,"2018","7","12",e1500671,Oncoimmunology,"","","","","","","","30524892","","",0,10,0,0,0,,,
5341,99,"Tomita et al., 2014",journal,"Tomita Y, Yuno A, Tsukamoto H, Senju S, Kuroda Y, Hirayama M, Imamura Y, Yatsuda J, Sayem MA, Irie A, Hamada A, Jono H, Yoshida K, Tsunoda T, Daigo Y, Kohrogi H, Yoshitake Y, Nakamura Y, Shinohara M, Nishimura Y",Identification of immunogenic LY6K long peptide encompassing both CD4<sup>+</sup> and CD8<sup>+</sup> T-cell epitopes and eliciting CD4<sup>+</sup> T-cell immunity in patients with malignant disease,"2014","3","",e28100,Oncoimmunology,"","","","","","","","25340007","","",0,10,0,0,0,,,
5342,99,"Meleshko et al., 2017",journal,"Meleshko AN, Petrovskaya NA, Savelyeva N, Vashkevich KP, Doronina SN, Sachivko NV",Phase I clinical trial of idiotypic DNA vaccine administered as a complex with polyethylenimine to patients with B-cell lymphoma,"2017","13","6","1-6",Human vaccines & immunotherapeutics,"","","","","","","","28272989","","",0,10,0,0,0,,,
5343,99,"Kampf et al., 2007",journal,"Kampf G, Steinmann J, Rabenau H",Suitability of vaccinia virus and bovine viral diarrhea virus (BVDV) for determining activities of three commonly-used alcohol-based hand rubs against enveloped viruses,"2007","7","","5",BMC infectious diseases,"","","","","","","","17291338","","",0,10,0,0,0,,,
5344,99,"Thurner et al., 1999",journal,"Thurner B, Haendle I, Rder C, Dieckmann D, Keikavoussi P, Jonuleit H, Bender A, Maczek C, Schreiner D, von den Driesch P, Brcker EB, Steinman RM, Enk A, Kmpgen E, Schuler G","Vaccination with mage-3A1 peptide-pulsed mature, monocyte-derived dendritic cells expands specific cytotoxic T cells and induces regression of some metastases in advanced stage IV melanoma","1999","190","11","1669-1678",The Journal of experimental medicine,"","","","","","","","10587357","","",0,10,0,0,0,,,
5345,99,"Wei et al., 2019",journal,"Wei X, Chen F, Xin K, Wang Q, Yu L, Liu B, Liu Q",Cancer-Testis Antigen Peptide Vaccine for Cancer Immunotherapy: Progress and Prospects,"2019","12","5","733-738",Translational oncology,"","","","","","","","30877975","","",0,10,0,0,0,,,
5346,99,"Rapoport et al., 2014",journal,"Rapoport AP, Aqui NA, Stadtmauer EA, Vogl DT, Xu YY, Kalos M, Cai L, Fang HB, Weiss BM, Badros A, Yanovich S, Akpek G, Tsao P, Cross A, Mann D, Philip S, Kerr N, Brennan A, Zheng Z, Ruehle K, Milliron T, Strome SE, Salazar AM, Levine BL, June CH",Combination immunotherapy after ASCT for multiple myeloma using MAGE-A3/Poly-ICLC immunizations followed by adoptive transfer of vaccine-primed and costimulated autologous T cells,"2014","20","5","1355-1365",Clinical cancer research : an official journal of the American Association for Cancer Research,"","","","","","","","24520093","","",0,10,0,0,0,,,
5347,99,"Pol et al., 2019",journal,"Pol JG, Acuna SA, Yadollahi B, Tang N, Stephenson KB, Atherton MJ, Hanwell D, El-Warrak A, Goldstein A, Moloo B, Turner PV, Lopez R, LaFrance S, Evelegh C, Denisova G, Parsons R, Millar J, Stoll G, Martin CG, Pomoransky J, Breitbach CJ, Bramson JL, Bell JC, Wan Y, Stojdl DF, Lichty BD, McCart JA",Preclinical evaluation of a MAGE-A3 vaccination utilizing the oncolytic Maraba virus currently in first-in-human trials,"2019","8","1",e1512329,Oncoimmunology,"","","","","","","","30546947","","",0,10,0,0,0,,,
5348,99,"Yu et al., 2004",journal,"Yu JS, Liu G, Ying H, Yong WH, Black KL, Wheeler CJ","Vaccination with tumor lysate-pulsed dendritic cells elicits antigen-specific, cytotoxic T-cells in patients with malignant glioma","2004","64","14","4973-4979",Cancer research,"","","","","","","","15256471","","",0,10,0,0,0,,,
5349,99,"Kim et al., 2016",journal,"Kim SW, Goedegebuure P, Gillanders WE",Mammaglobin-A is a target for breast cancer vaccination,"2016","5","2",e1069940,Oncoimmunology,"","","","","","","","27057470","","",0,10,0,0,0,,,
5350,99,"Lindsey et al., 2006",journal,"Lindsey KR, Gritz L, Sherry R, Abati A, Fetsch PA, Goldfeder LC, Gonzales MI, Zinnack KA, Rogers-Freezer L, Haworth L, Mavroukakis SA, White DE, Steinberg SM, Restifo NP, Panicali DL, Rosenberg SA, Topalian SL",Evaluation of prime/boost regimens using recombinant poxvirus/tyrosinase vaccines for the treatment of patients with metastatic melanoma,"2006","12","8","2526-2537",Clinical cancer research : an official journal of the American Association for Cancer Research,"","","","","","","","16638862","","",0,10,0,0,0,,,
5351,99,"Schtz et al., 2001",journal,"Schtz A, Oertli D, Marti WR, Noppen C, Padovan E, Spagnoli GC, Heberer M, Zajac P",Immunogenicity of nonreplicating recombinant vaccinia expressing HLA-A201 targeted or complete MART-1/Melan-A antigen,"2001","8","9","655-661",Cancer gene therapy,"","","","","","","","11593334","","",0,10,0,0,0,,,
5352,99,"Mitchell et al., 1994",journal,"Mitchell MS, Jakowatz J, Harel W, Dean G, Stevenson L, Boswell WD, Groshen S",Increased effectiveness of interferon alfa-2b following active specific immunotherapy for melanoma,"1994","12","2","402-411",Journal of clinical oncology : official journal of the American Society of Clinical Oncology,"","","","","","","","8113848","","",0,10,0,0,0,,,
5353,99,"Melssen et al., 2019",journal,"Melssen MM, Petroni GR, Chianese-Bullock KA, Wages NA, Grosh WW, Varhegyi N, Smolkin ME, Smith KT, Galeassi NV, Deacon DH, Gaughan EM, Slingluff CL Jr",A multipeptide vaccine plus toll-like receptor agonists LPS or polyICLC in combination with incomplete Freund's adjuvant in melanoma patients,"2019","7","1","163",Journal for immunotherapy of cancer,"","","","","","","","31248461","","",0,10,0,0,0,,,
5354,99,"Nasser et al., 2020",journal,"Nasser R, Rakedzon S, Dickstein Y, Mousa A, Solt I, Peterisel N, Feldman T, Neuberger A",Are all vaccines safe for the pregnant traveller? A systematic review and meta-analysis,"2020","27","2","",Journal of travel medicine,"","","","","","","","31616947","","",0,10,0,0,0,,,
5355,99,"Cornelissen et al., 2016",journal,"Cornelissen R, Hegmans JP, Maat AP, Kaijen-Lambers ME, Bezemer K, Hendriks RW, Hoogsteden HC, Aerts JG",Extended Tumor Control after Dendritic Cell Vaccination with Low-Dose Cyclophosphamide as Adjuvant Treatment in Patients with Malignant Pleural Mesothelioma,"2016","193","9","1023-1031",American journal of respiratory and critical care medicine,"","","","","","","","26652184","","",0,10,0,0,0,,,
5356,99,"Perloff et al., 1977",journal,"Perloff M, Holland JF, Lumb GJ, Bekesi JG",Effects of methanol extraction residue of Bacillus calmette-Gurin in humans,"1977","37","4","1191-1196",Cancer research,"","","","","","","","321117","","",0,10,0,0,0,,,
5357,99,"van et al., 2015",journal,"van der Waart AB, Fredrix H, van der Voort R, Schaap N, Hobo W, Dolstra H",siRNA silencing of PD-1 ligands on dendritic cell vaccines boosts the expansion of minor histocompatibility antigen-specific CD8(+) T cells in NOD/SCID/IL2Rg(null) mice,"2015","64","5","645-654","Cancer immunology, immunotherapy : CII","","","","","","","","25724840","","",0,10,0,0,0,,,
5358,99,"Hutchins et al., 2017",journal,"Hutchins LF, Makhoul I, Emanuel PD, Pennisi A, Siegel ER, Jousheghany F, Guo X, Pashov AD, Monzavi-Karbassi B, Kieber-Emmons T",Targeting tumor-associated carbohydrate antigens: a phase I study of a carbohydrate mimetic-peptide vaccine in stage IV breast cancer subjects,"2017","8","58","99161-99178",Oncotarget,"","","","","","","","29228761","","",0,10,0,0,0,,,
5359,99,"Song et al., 2011",journal,"Song GY, Srivastava T, Ishizaki H, Lacey SF, Diamond DJ, Ellenhorn JD",Recombinant modified vaccinia virus ankara (MVA) expressing wild-type human p53 induces specific antitumor CTL expansion,"2011","29","8","501-510",Cancer investigation,"","","","","","","","21843052","","",0,10,0,0,0,,,
5360,99,"Ullenhag et al., 2008",journal,"Ullenhag GJ, Spendlove I, Watson NF, Kallmeyer C, Pritchard-Jones K, Durrant LG","T-cell responses in osteosarcoma patients vaccinated with an anti-idiotypic antibody, 105AD7, mimicking CD55","2008","128","2","148-154","Clinical immunology (Orlando, Fla.)","","","","","","","","18508409","","",0,10,0,0,0,,,
5361,99,"Saha et al., 2006",journal,"Saha A, Baral RN, Chatterjee SK, Mohanty K, Pal S, Foon KA, Primus FJ, Krieg AM, Weiner GJ, Bhattacharya-Chatterjee M",CpG oligonucleotides enhance the tumor antigen-specific immune response of an anti-idiotype antibody-based vaccine strategy in CEA transgenic mice,"2006","55","5","515-527","Cancer immunology, immunotherapy : CII","","","","","","","","16044253","","",0,10,0,0,0,,,
5362,99,"Gajdosik, 2014",journal,Gajdosik Z,Racotumomab - a novel anti-idiotype monoclonal antibody vaccine for the treatment of cancer,"2014","50","4","301-307","Drugs of today (Barcelona, Spain : 1998)","","","","","","","","24918647","","",0,10,0,0,0,,,
5363,99,"Eger et al., 2016",journal,"Eger C, Siebert N, Seidel D, Zumpe M, Jttner M, Brandt S, Mller HP, Lode HN",Generation and Characterization of a Human/Mouse Chimeric GD2-Mimicking Anti-Idiotype Antibody Ganglidiximab for Active Immunotherapy against Neuroblastoma,"2016","11","3",e0150479,PloS one,"","","","","","","","26967324","","",0,10,0,0,0,,,
5364,99,"Parker et al., 2000",journal,"Parker LL, Do MT, Westwood JA, Wunderlich JR, Dudley ME, Rosenberg SA, Hwu P",Expansion and characterization of T cells transduced with a chimeric receptor against ovarian cancer,"2000","11","17","2377-2387",Human gene therapy,"","","","","","","","11096442","","",0,10,0,0,0,,,
5365,99,"Kato, 2014",journal,Kato Y,[Efficacy of WT1 peptide-/MUC-1 peptide-pulsed dendritic cell therapy in 313 patients with a wide range of cancers],"2014","41","10","1280-1282",Gan to kagaku ryoho. Cancer & chemotherapy,"","","","","","","","25335717","","",0,10,0,0,0,,,
5366,99,"Tang et al., 2017",journal,"Tang Y, Cui X, Xiao H, Qi S, Hu X, Yu Q, Shi G, Zhang X, Gu J, Yu Y, Wang L, Li Y",Binding of circulating anti-MUC1 antibody and serum MUC1 antigen in stage IV breast cancer,"2017","15","5","2659-2664",Molecular medicine reports,"","","","","","","","28447743","","",0,10,0,0,0,,,
5367,99,"Kalli et al., 2018",journal,"Kalli KR, Block MS, Kasi PM, Erskine CL, Hobday TJ, Dietz A, Padley D, Gustafson MP, Shreeder B, Puglisi-Knutson D, Visscher DW, Mangskau TK, Wilson G, Knutson KL",Folate Receptor Alpha Peptide Vaccine Generates Immunity in Breast and Ovarian Cancer Patients,"2018","24","13","3014-3025",Clinical cancer research : an official journal of the American Association for Cancer Research,"","","","","","","","29545464","","",0,10,0,0,0,,,
5368,99,"Hui et al., 2013",journal,"Hui EP, Taylor GS, Jia H, Ma BB, Chan SL, Ho R, Wong WL, Wilson S, Johnson BF, Edwards C, Stocken DD, Rickinson AB, Steven NM, Chan AT",Phase I trial of recombinant modified vaccinia ankara encoding Epstein-Barr viral tumor antigens in nasopharyngeal carcinoma patients,"2013","73","6","1676-1688",Cancer research,"","","","","","","","23348421","","",0,10,0,0,0,,,
5369,99,"Hillman et al., 2017",journal,"Hillman GG, Reich LA, Rothstein SE, Abernathy LM, Fountain MD, Hankerd K, Yunker CK, Rakowski JT, Quemeneur E, Slos P",Radiotherapy and MVA-MUC1-IL-2 vaccine act synergistically for inducing specific immunity to MUC-1 tumor antigen,"2017","5","","4",Journal for immunotherapy of cancer,"","","","","","","","28116088","","",0,10,0,0,0,,,
5370,99,"Vivier et al., 2008",journal,"Vivier E, Tomasello E, Baratin M, Walzer T, Ugolini S",Functions of natural killer cells,"2008","9","5","503-510",Nature immunology,"","","","","","","","18425107","","",0,10,0,0,0,,,
5371,99,"Odunsi et al., 2007",journal,"Odunsi K, Qian F, Matsuzaki J, Mhawech-Fauceglia P, Andrews C, Hoffman EW, Pan L, Ritter G, Villella J, Thomas B, Rodabaugh K, Lele S, Shrikant P, Old LJ, Gnjatic S",Vaccination with an NY-ESO-1 peptide of HLA class I/II specificities induces integrated humoral and T cell responses in ovarian cancer,"2007","104","31","12837-12842",Proceedings of the National Academy of Sciences of the United States of America,"","","","","","","","17652518","","",0,10,0,0,0,,,
5372,99,"Parvanova et al., 2011",journal,"Parvanova I, Rettig L, Knuth A, Pascolo S",The form of NY-ESO-1 antigen has an impact on the clinical efficacy of anti-tumor vaccination,"2011","29","22","3832-3836",Vaccine,"","","","","","","","21470580","","",0,10,0,0,0,,,
5373,99,"Lopes et al., 2006",journal,"Lopes L, Fletcher K, Ikeda Y, Collins M",Lentiviral vector expression of tumour antigens in dendritic cells as an immunotherapeutic strategy,"2006","55","8","1011-1016","Cancer immunology, immunotherapy : CII","","","","","","","","16311731","","",0,10,0,0,0,,,
5374,99,"Mahipal et al., 2019",journal,"Mahipal A, Ejadi S, Gnjatic S, Kim-Schulze S, Lu H, Ter Meulen JH, Kenney R, Odunsi K",First-in-human phase 1 dose-escalating trial of G305 in patients with advanced solid tumors expressing NY-ESO-1,"2019","68","7","1211-1222","Cancer immunology, immunotherapy : CII","","","","","","","","31069460","","",0,10,0,0,0,,,
5375,99,"Liu et al., 2017",journal,"Liu Z, Yang Y, Zhang X, Wang H, Xu W, Wang H, Xiao F, Bai Z, Yao H, Ma X, Jin L, Wu C, Seth P, Zhang Z, Wang L",An Oncolytic Adenovirus Encoding Decorin and Granulocyte Macrophage Colony Stimulating Factor Inhibits Tumor Growth in a Colorectal Tumor Model by Targeting Pro-Tumorigenic Signals and via Immune Activation,"2017","28","8","667-680",Human gene therapy,"","","","","","","","28530155","","",0,10,0,0,0,,,
5376,99,"Cohen and Rudin, 2001",journal,"Cohen EE, Rudin CM",ONYX-015. Onyx Pharmaceuticals,"2001","2","12","1770-1775","Current opinion in investigational drugs (London, England : 2000)","","","","","","","","11892945","","",0,10,0,0,0,,,
5377,99,"Karkada et al., 2010",journal,"Karkada M, Weir GM, Quinton T, Sammatur L, MacDonald LD, Grant A, Liwski R, Juskevicius R, Sinnathamby G, Philip R, Mansour M",A novel breast/ovarian cancer peptide vaccine platform that promotes specific type-1 but not Treg/Tr1-type responses,"2010","33","3","250-261","Journal of immunotherapy (Hagerstown, Md. : 1997)","","","","","","","","20445345","","",0,10,0,0,0,,,
5378,99,"Schuler et al., 2014",journal,"Schuler PJ, Harasymczuk M, Visus C, Deleo A, Trivedi S, Lei Y, Argiris A, Gooding W, Butterfield LH, Whiteside TL, Ferris RL",Phase I dendritic cell p53 peptide vaccine for head and neck cancer,"2014","20","9","2433-2444",Clinical cancer research : an official journal of the American Association for Cancer Research,"","","","","","","","24583792","","",0,10,0,0,0,,,
5379,99,"Freeman et al., 1995",journal,"Freeman SM, McCune C, Robinson W, Abboud CN, Abraham GN, Angel C, Marrogi A",The treatment of ovarian cancer with a gene modified cancer vaccine: a phase I study,"1995","6","7","927-939",Human gene therapy,"","","","","","","","7578411","","",0,10,0,0,0,,,
5380,99,"Pinto et al., 1999",journal,"Pinto LA, Berzofsky JA, Fowke KR, Little RF, Merced-Galindez F, Humphrey R, Ahlers J, Dunlop N, Cohen RB, Steinberg SM, Nara P, Shearer GM, Yarchoan R",HIV-specific immunity following immunization with HIV synthetic envelope peptides in asymptomatic HIV-infected patients,"1999","13","15","2003-2012","AIDS (London, England)","","","","","","","","10546852","","",0,10,0,0,0,,,
5381,86,"Hur and Lee, 2014",journal,"Hur J, Lee JH","Optimization of immune strategy for a construct of Salmonella-delivered ApxIA, ApxIIA, ApxIIIA and OmpA antigens of Actinobacillus pleuropneumoniae for prevention of porcine pleuropneumonia using a murine model","2014","38","1","87-91",Veterinary research communications,"","","","","","","","24307459","","",0,10,0,0,0,,,
5382,129,"Tseng et al., 2012",journal,"Tseng CT, Sbrana E, Iwata-Yoshikawa N, Newman PC, Garron T, Atmar RL, Peters CJ, Couch RB",Immunization with SARS coronavirus vaccines leads to pulmonary immunopathology on challenge with the SARS virus,"2012","7","4",e35421,PloS one,"","","","","","","","22536382","","",0,10,0,0,0,,,
5383,129,"Iwata-Yoshikawa et al., 2014",journal,"Iwata-Yoshikawa N, Uda A, Suzuki T, Tsunetsugu-Yokota Y, Sato Y, Morikawa S, Tashiro M, Sata T, Hasegawa H, Nagata N",Effects of Toll-like receptor stimulation on eosinophilic infiltration in lungs of BALB/c mice immunized with UV-inactivated severe acute respiratory syndrome-related coronavirus vaccine,"2014","88","15","8597-8614",Journal of virology,"","","","","","","","24850731","","",0,10,0,0,0,,,
5384,129,"Zhou et al., 2006",journal,"Zhou Z, Post P, Chubet R, Holtz K, McPherson C, Petric M, Cox M",A recombinant baculovirus-expressed S glycoprotein vaccine elicits high titers of SARS-associated coronavirus (SARS-CoV) neutralizing antibodies in mice,"2006","24","17","3624-3631",Vaccine,"","","","","","","","16497416","","",0,10,0,0,0,,,
5385,319,"Kato et al., 2019",journal,"Kato H, Takayama-Ito M, Iizuka-Shiota I, Fukushi S, Posadas-Herrera G, Horiya M, Satoh M, Yoshikawa T, Yamada S, Harada S, Fujii H, Shibamura M, Inagaki T, Morimoto K, Saijo M, Lim CK",Development of a recombinant replication-deficient rabies virus-based bivalent-vaccine against MERS-CoV and rabies virus and its humoral immunogenicity in mice,"2019","14","10",e0223684,PloS one,"","","","","","","","31589656","","",0,10,0,0,0,,,
5386,319,"Ng et al., 2016",journal,"Ng OW, Chia A, Tan AT, Jadi RS, Leong HN, Bertoletti A, Tan YJ",Memory T cell responses targeting the SARS coronavirus persist up to 11 years post-infection,"2016","34","17","2008-2014",Vaccine,"","","","","","","","26954467","","",0,10,0,0,0,,,
5387,319,"Zhao et al., 2016",journal,"Zhao J, Zhao J, Mangalam AK, Channappanavar R, Fett C, Meyerholz DK, Agnihothram S, Baric RS, David CS, Perlman S",Airway Memory CD4(+) T Cells Mediate Protective Immunity against Emerging Respiratory Coronaviruses,"2016","44","6","1379-1391",Immunity,"","","","","","","","27287409","","",0,10,0,0,0,,,
5388,129,"Zhao et al., 2016",journal,"Zhao J, Zhao J, Mangalam AK, Channappanavar R, Fett C, Meyerholz DK, Agnihothram S, Baric RS, David CS, Perlman S",Airway Memory CD4(+) T Cells Mediate Protective Immunity against Emerging Respiratory Coronaviruses,"2016","44","6","1379-1391",Immunity,"","","","","","","","27287409","","",0,10,0,0,0,,,
5389,319,"Munster et al., 2017",journal,"Munster VJ, Wells D, Lambe T, Wright D, Fischer RJ, Bushmaker T, Saturday G, van Doremalen N, Gilbert SC, de Wit E, Warimwe GM",Protective efficacy of a novel simian adenovirus vaccine against lethal MERS-CoV challenge in a transgenic human DPP4 mouse model,"2017","2","","28",NPJ vaccines,"","","","","","","","29263883","","",0,10,0,0,0,,,
5390,319,"Folegatti et al., 2020",journal,"Folegatti PM, Bittaye M, Flaxman A, Lopez FR, Bellamy D, Kupke A, Mair C, Makinson R, Sheridan J, Rohde C, Halwe S, Jeong Y, Park YS, Kim JO, Song M, Boyd A, Tran N, Silman D, Poulton I, Datoo M, Marshal J, Themistocleous Y, Lawrie A, Roberts R, Berrie E, Becker S, Lambe T, Hill A, Ewer K, Gilbert S","Safety and immunogenicity of a candidate Middle East respiratory syndrome coronavirus viral-vectored vaccine: a dose-escalation, open-label, non-randomised, uncontrolled, phase 1 trial","2020","","","",The Lancet. Infectious diseases,"","","","","","","","32325038","","",0,10,0,0,0,,,
5391,319,"Song et al., 2013",journal,"Song F, Fux R, Provacia LB, Volz A, Eickmann M, Becker S, Osterhaus AD, Haagmans BL, Sutter G",Middle East respiratory syndrome coronavirus spike protein delivered by modified vaccinia virus Ankara efficiently induces virus-neutralizing antibodies,"2013","87","21","11950-11954",Journal of virology,"","","","","","","","23986586","","",0,10,0,0,0,,,
5392,319,"Koch et al., 2020",journal,"Koch T, Dahlke C, Fathi A, Kupke A, Krhling V, Okba NMA, Halwe S, Rohde C, Eickmann M, Volz A, Hesterkamp T, Jambrecina A, Borregaard S, Ly ML, Zinser ME, Bartels E, Poetsch JSH, Neumann R, Fux R, Schmiedel S, Lohse AW, Haagmans BL, Sutter G, Becker S, Addo MM","Safety and immunogenicity of a modified vaccinia virus Ankara vector vaccine candidate for Middle East respiratory syndrome: an open-label, phase 1 trial","2020","","","",The Lancet. Infectious diseases,"","","","","","","","32325037","","",0,10,0,0,0,,,
5393,129,"Kim et al., 2004",journal,"Kim TW, Lee JH, Hung CF, Peng S, Roden R, Wang MC, Viscidi R, Tsai YC, He L, Chen PJ, Boyd DA, Wu TC",Generation and characterization of DNA vaccines targeting the nucleocapsid protein of severe acute respiratory syndrome coronavirus,"2004","78","9","4638-4645",Journal of virology,"","","","","","","","15078946","","",0,10,0,0,0,,,
5394,319,"Malczyk et al., 2015",journal,"Malczyk AH, Kupke A, Prfer S, Scheuplein VA, Hutzler S, Kreuz D, Beissert T, Bauer S, Hubich-Rau S, Tondera C, Eldin HS, Schmidt J, Vergara-Alert J, Szer Y, Seifried J, Hanschmann KM, Kalinke U, Herold S, Sahin U, Cichutek K, Waibler Z, Eickmann M, Becker S, Mhlebach MD",A Highly Immunogenic and Protective Middle East Respiratory Syndrome Coronavirus Vaccine Based on a Recombinant Measles Virus Vaccine Platform,"2015","89","22","11654-11667",Journal of virology,"","","","","","","","26355094","","",0,10,0,0,0,,,
5395,319,"Bodmer et al., 2018",journal,"Bodmer BS, Fiedler AH, Hanauer JRH, Prfer S, Mhlebach MD",Live-attenuated bivalent measles virus-derived vaccines targeting Middle East respiratory syndrome coronavirus induce robust and multifunctional T cell responses against both viruses in an appropriate mouse model,"2018","521","","99-9107",Virology,"","","","","","","","29902727","","",0,10,0,0,0,,,
5396,319,"Guo et al., 2015",journal,"Guo X, Deng Y, Chen H, Lan J, Wang W, Zou X, Hung T, Lu Z, Tan W",Systemic and mucosal immunity in mice elicited by a single immunization with human adenovirus type 5 or 41 vector-based vaccines carrying the spike protein of Middle East respiratory syndrome coronavirus,"2015","145","4","476-484",Immunology,"","","","","","","","25762305","","",0,10,0,0,0,,,
5397,321,"Gao et al., 2020",journal,"Gao Q, Bao L, Mao H, Wang L, Xu K, Yang M, Li Y, Zhu L, Wang N, Lv Z, Gao H, Ge X, Kan B, Hu Y, Liu J, Cai F, Jiang D, Yin Y, Qin C, Li J, Gong X, Lou X, Shi W, Wu D, Zhang H, Zhu L, Deng W, Li Y, Lu J, Li C, Wang X, Yin W, Zhang Y, Qin C",Rapid development of an inactivated vaccine candidate for SARS-CoV-2,"2020","","","","Science (New York, N.Y.)","","","","","","","","32376603","","",0,10,0,0,0,,,
5398,129,"Liniger et al., 2008",journal,"Liniger M, Zuniga A, Tamin A, Azzouz-Morin TN, Knuchel M, Marty RR, Wiegand M, Weibel S, Kelvin D, Rota PA, Naim HY",Induction of neutralising antibodies and cellular immune responses against SARS coronavirus by recombinant measles viruses,"2008","26","17","2164-2174",Vaccine,"","","","","","","","18346823","","",0,10,0,0,0,,,
5399,129,"Weingartl et al., 2004",journal,"Weingartl H, Czub M, Czub S, Neufeld J, Marszal P, Gren J, Smith G, Jones S, Proulx R, Deschambault Y, Grudeski E, Andonov A, He R, Li Y, Copps J, Grolla A, Dick D, Berry J, Ganske S, Manning L, Cao J",Immunization with modified vaccinia virus Ankara-based recombinant vaccine against severe acute respiratory syndrome is associated with enhanced hepatitis in ferrets,"2004","78","22","12672-12676",Journal of virology,"","","","","","","","15507655","","",0,10,0,0,0,,,
5400,99,"Pitel, 1988",journal,Pitel ML,Use of a cantilevered acrylic splint in the autogenous transplantation of a third molar: report of case,"1988","117","2","329-331",Journal of the American Dental Association (1939),"","","","","","","","3166476","","",0,10,0,0,0,,,
5401,99,"Sang et al., 2011",journal,"Sang M, Wang L, Ding C, Zhou X, Wang B, Wang L, Lian Y, Shan B",Melanoma-associated antigen genes - an update,"2011","302","2","85-90",Cancer letters,"","","","","","","","21093980","","",0,10,0,0,0,,,
5402,99,"Braga et al., 2009",journal,"Braga CJ, Rittner GM, Muoz Henao JE, Teixeira AF, Massis LM, Sbrogio-Almeida ME, Taborda CP, Travassos LR, Ferreira LC",Paracoccidioides brasiliensis vaccine formulations based on the gp43-derived P10 sequence and the Salmonella enterica FliC flagellin,"2009","77","4","1700-1707",Infection and immunity,"","","","","","","","19204092","","",0,10,0,0,0,,,
5403,99,"Archer, Gary",website,Gary Archer,PEP-CMV in Recurrent MEdulloblastoma/Malignant Glioma (PRiME),"","","","","","","","","","","","",PEP-CMV in Recurrent MEdu,https://clinicaltrials.gov/ct2/show/NCT03299309,"",0,10,0,0,0,,,
5404,99,"Juszczyk et al., 1987",journal,"Juszczyk Z, Szydlo W, Jakubw H, Ziecik S",[Ultrasonographic control of the positioning of the catheter and intracardiac electrode],"1987","42","10","309-311","Polski tygodnik lekarski (Warsaw, Poland : 1960)","","","","","","","","03299309","","",0,10,0,0,0,,,
5405,99,MFGS-MOv18-gamma,website,"",Retroviral Vector MFGS-MOv18-gamma,"","","","","","","","","","","","","",https://www.ncbi.nlm.nih.gov/medgen/271119,"",0,10,0,0,0,,,
5406,99,"Benagiano et al., 1973",journal,"Benagiano A, Firu P, Zarnea L",[Old and new methods in the prevention of dental caries],"1973","20","1","1-18",Stomatologia,"","","","","","","","4510871","","",0,10,0,0,0,,,
5407,99,"Mitchell et al., 2015",journal,"Mitchell DA, Batich KA, Gunn MD, Huang MN, Sanchez-Perez L, Nair SK, Congdon KL, Reap EA, Archer GE, Desjardins A, Friedman AH, Friedman HS, Herndon JE 2nd, Coan A, McLendon RE, Reardon DA, Vredenburgh JJ, Bigner DD, Sampson JH",Tetanus toxoid and CCL3 improve dendritic cell vaccines in mice and glioblastoma patients,"2015","519","7543","366-369",Nature,"","","","","","","","25762141","","",0,10,0,0,0,,,
5408,99,"Robins et al., 1991",journal,"Robins RA, Denton GW, Hardcastle JD, Austin EB, Baldwin RW, Durrant LG",Antitumor immune response and interleukin 2 production induced in colorectal cancer patients by immunization with human monoclonal anti-idiotypic antibody,"1991","51","19","5425-5429",Cancer research,"","","","","","","","1913661","","",0,10,0,0,0,,,
5409,99,"Wen et al., 2019",journal,"Wen PY, Reardon DA, Armstrong TS, Phuphanich S, Aiken RD, Landolfi JC, Curry WT, Zhu JJ, Glantz M, Peereboom DM, Markert JM, LaRocca R, O'Rourke DM, Fink K, Kim L, Gruber M, Lesser GJ, Pan E, Kesari S, Muzikansky A, Pinilla C, Santos RG, Yu JS",A Randomized Double-Blind Placebo-Controlled Phase II Trial of Dendritic Cell Vaccine ICT-107 in Newly Diagnosed Patients with Glioblastoma,"2019","25","19","5799-5807",Clinical cancer research : an official journal of the American Association for Cancer Research,"","","","","","","","31320597","","",0,10,0,0,0,,,
5410,99,"Correa, 1988",journal,Correa A,[Impressions in relation to periodontal tissue],"1988","38","164","55-63",Revista de la Federacion Odontologica Colombiana,"","","","","","","","3077513","","",0,10,0,0,0,,,
5411,321,"Zha, et al., 2020",journal,"Lisha Zha, Hongxin Zhao, Mona O. Mohsen, Liang Hong, Yuhang Zhou, Chuankai Yao, Lijie Guo, Zehua Li, Hongquan Chen, Xuelan Liu, Xinyue Chang, Jie Zhang, Dong Li, Ke Wu, Monique Vogel, Martin F Bachmann, Junfeng Wang",Development of a COVID-19 vaccine based on the receptor binding domain displayed on virus-like particles,"","","","","","","","","","","","","",https://www.biorxiv.org/content/10.1101/2020.05.06.079830v1,"",0,10,0,0,0,,,
5412,319,"Wang et al., 2017",journal,"Wang C, Zheng X, Gai W, Zhao Y, Wang H, Wang H, Feng N, Chi H, Qiu B, Li N, Wang T, Gao Y, Yang S, Xia X",MERS-CoV virus-like particles produced in insect cells induce specific humoural and cellular imminity in rhesus macaques,"2017","8","8","12686-12694",Oncotarget,"","","","","","","","27050368",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5355045/,"",0,10,0,0,0,,,
5413,129,"DiNapoli et al., 2007",journal,"DiNapoli JM, Kotelkin A, Yang L, Elankumaran S, Murphy BR, Samal SK, Collins PL, Bukreyev A","Newcastle disease virus, a host range-restricted virus, as a vaccine vector for intranasal immunization against emerging pathogens","2007","104","23","9788-9793",Proceedings of the National Academy of Sciences of the United States of America,"","","","","","","","17535926",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1887550/,"",0,10,0,0,0,,,
5414,321,"Zhu et al., 2020",journal,"Zhu FC, Li YH, Guan XH, Hou LH, Wang WJ, Li JX, Wu SP, Wang BS, Wang Z, Wang L, Jia SY, Jiang HD, Wang L, Jiang T, Hu Y, Gou JB, Xu SB, Xu JJ, Wang XW, Wang W, Chen W","Safety, tolerability, and immunogenicity of a recombinant adenovirus type-5 vectored COVID-19 vaccine: a dose-escalation, open-label, non-randomised, first-in-human trial","2020","395","10240","1845-1854","Lancet (London, England)","","","","","","","","32450106","","",0,10,0,0,0,,,
5415,319,"Modjarrad et al., 2019",journal,"Modjarrad K, Roberts CC, Mills KT, Castellano AR, Paolino K, Muthumani K, Reuschel EL, Robb ML, Racine T, Oh MD, Lamarre C, Zaidi FI, Boyer J, Kudchodkar SB, Jeong M, Darden JM, Park YK, Scott PT, Remigio C, Parikh AP, Wise MC, Patel A, Duperret EK, Kim KY, Choi H, White S, Bagarazzi M, May JM, Kane D, Lee H, Kobinger G, Michael NL, Weiner DB, Thomas SJ, Maslow JN","Safety and immunogenicity of an anti-Middle East respiratory syndrome coronavirus DNA vaccine: a phase 1, open-label, single-arm, dose-escalation trial","2019","19","9","1013-1022",The Lancet. Infectious diseases,"","","","","","","","31351922","","",0,10,0,0,0,,,
5416,129,"Martin et al., 2008",journal,"Martin JE, Louder MK, Holman LA, Gordon IJ, Enama ME, Larkin BD, Andrews CA, Vogel L, Koup RA, Roederer M, Bailer RT, Gomez PL, Nason M, Mascola JR, Nabel GJ, Graham BS",A SARS DNA vaccine induces neutralizing antibody and cellular immune responses in healthy adults in a Phase I clinical trial,"2008","26","50","6338-6343",Vaccine,"","","","","","","","18824060","",,0,0,0,0,0,,,
5417,321,"Bourinbayar, 2020",website,Aldar Bourinbayar,Tableted COVID-19 Therapeutic Vaccine (COVID-19),"","","","","","","","","","","","","",https://clinicaltrials.gov/ct2/show/NCT04380532,"",0,10,0,0,0,,,
5418,321,"McKay et al., 2020",journal,"McKay PF, Hu K, Blakney AK, Samnuan K, Brown JC, Penn R, Zhou J, Bouton CR, Rogers P, Polra K, Lin PJC, Barbosa C, Tam YK, Barclay WS, Shattock RJ",Self-amplifying RNA SARS-CoV-2 lipid nanoparticle vaccine candidate induces high neutralizing antibody titers in mice,"2020","11","1","3523",Nature communications,"","","","","","","","32647131","","",0,10,0,0,0,,,
5419,99,"Rodriguez and Jungery, 1987",journal,"Rodriguez MH, Jungery M",Glycoprotein recognition mediates attachment of Plasmodium chabaudi to mouse erythrocytes,"1987","55","1","187-192",Infection and immunity,"","","","","","","","3539801","","",0,10,0,0,0,,,
5420,99,"Schleiss, 2009",journal,Schleiss MR,"VCL-CB01, an injectable bivalent plasmid DNA vaccine for potential protection against CMV disease and infection","2009","11","5","572-578",Current opinion in molecular therapeutics,"","","","","","","","19806506","","",0,10,0,0,0,,,
5421,323,"Weiss and Scott, 1981",journal,"Weiss RC, Scott FW",Antibody-mediated enhancement of disease in feline infectious peritonitis: comparisons with dengue hemorrhagic fever,"1981","4","2","175-189","Comparative immunology, microbiology and infectious diseases","","","","","","","","6754243","",,0,0,0,0,0,,,
5422,175,"Weiss and Scott, 1981",journal,"Weiss RC, Scott FW",Antibody-mediated enhancement of disease in feline infectious peritonitis: comparisons with dengue hemorrhagic fever,"1981","4","2","175-189","Comparative immunology, microbiology and infectious diseases","","","","","","","","6754243","",,0,0,0,0,0,,,
5423,319,"Agrawal et al., 2016",journal,"Agrawal AS, Tao X, Algaissi A, Garron T, Narayanan K, Peng BH, Couch RB, Tseng CT",Immunization with inactivated Middle East Respiratory Syndrome coronavirus vaccine leads to lung immunopathology on challenge with live virus,"2016","12","9","2351-2356",Human vaccines & immunotherapeutics,"","","","","","","","27269431","",,0,0,0,0,0,,,
5424,129,"Wang et al., 2014",journal,"Wang SF, Tseng SP, Yen CH, Yang JY, Tsao CH, Shen CW, Chen KH, Liu FT, Liu WT, Chen YM, Huang JC",Antibody-dependent SARS coronavirus infection is mediated by antibodies against spike proteins,"2014","451","2","208-214",Biochemical and biophysical research communications,"","","","","","","","25073113","",,0,0,0,0,0,,,
5425,321,"Folegatti et al., 2020",journal,"Folegatti PM, Ewer KJ, Aley PK, Angus B, Becker S, Belij-Rammerstorfer S, Bellamy D, Bibi S, Bittaye M, Clutterbuck EA, Dold C, Faust SN, Finn A, Flaxman AL, Hallis B, Heath P, Jenkin D, Lazarus R, Makinson R, Minassian AM, Pollock KM, Ramasamy M, Robinson H, Snape M, Tarrant R, Voysey M, Green C, Douglas AD, Hill AVS, Lambe T, Gilbert SC, Pollard AJ","Safety and immunogenicity of the ChAdOx1 nCoV-19 vaccine against SARS-CoV-2: a preliminary report of a phase 1/2, single-blind, randomised controlled trial","2020","","","","Lancet (London, England)","","","","","","","","32702298","","",0,10,0,0,0,,,
5426,321,"Xia et al., 2020",journal,"Xia S, Duan K, Zhang Y, Zhao D, Zhang H, Xie Z, Li X, Peng C, Zhang Y, Zhang W, Yang Y, Chen W, Gao X, You W, Wang X, Wang Z, Shi Z, Wang Y, Yang X, Zhang L, Huang L, Wang Q, Lu J, Yang Y, Guo J, Zhou W, Wan X, Wu C, Wang W, Huang S, Du J, Meng Z, Pan A, Yuan Z, Shen S, Guo W, Yang X",Effect of an Inactivated Vaccine Against SARS-CoV-2 on Safety and Immunogenicity Outcomes: Interim Analysis of 2 Randomized Clinical Trials,"2020","","","",JAMA,"","","","","","","","32789505","","",0,10,0,0,0,,,
5427,321,NCT04313127,website,"",Phase I Clinical Trial of a COVID-19 Vaccine in 18-60 Healthy Adults (CTCOVID-19),"2020","","","","","","","","","","","","",https://clinicaltrials.gov/ct2/show/NCT04313127,"",0,10,0,0,0,,,
5428,321,NCT04436471,website,"","An Open Study of the Safety, Tolerability and Immunogenicity of the Drug ""Gam-COVID-Vac"" Vaccine Against COVID-19","2020","","","","","","","","","","","","",https://clinicaltrials.gov/ct2/show/NCT04436471?term=NCT04436471&draw=2&rank=1,"",0,10,0,0,0,,,
5429,321,NCT04437875,website,"","An Open Study of the Safety, Tolerability and Immunogenicity of ""Gam-COVID-Vac Lyo"" Vaccine Against COVID-19","","","","","","","","","","","","",NCT04437875,https://clinicaltrials.gov/ct2/show/NCT04437875,"",0,10,0,0,0,,,
5430,321,NCT04463472,website,"",Study of COVID-19 DNA Vaccine (AG0301-COVID19),"2020","","","","","","","","","","","","",https://clinicaltrials.gov/ct2/show/NCT04463472,"",0,10,0,0,0,,,
5431,321,NCT04480957,website,"",Ascending Dose Study of Investigational SARS-CoV-2 Vaccine ARCT-021 in Healthy Adult Subjects,"2020","","","","","","","","","","","","",https://clinicaltrials.gov/ct2/show/NCT04480957,"",0,10,0,0,0,,,
5432,321,NCT04436276,website,"",A Study of Ad26.COV2.S in Adults (COVID-19),"","","","","","","","","","","","","",https://clinicaltrials.gov/ct2/show/NCT04436276,"",0,10,0,0,0,,,
5433,321,NCT04368988,website,"",Evaluation of the Safety and Immunogenicity of a SARS-CoV-2 rS (COVID-19) Nanoparticle Vaccine With/Without Matrix-M Adjuvant,"2020","","","","","","","","","","","","",https://clinicaltrials.gov/ct2/show/NCT04368988,"",0,10,0,0,0,,,
5434,321,NCT04412538,website,"",Safety and Immunogenicity Study of an Inactivated SARS-CoV-2 Vaccine for Preventing Against COVID-19,"2020","","","","","","","","","","","","",https://clinicaltrials.gov/ct2/show/NCT04412538,"",0,10,0,0,0,,,
5435,321,NCT04471519,website,"",Whole-Virion Inactivated SARS-CoV-2 Vaccine (BBV152) for COVID-19 in Healthy Volunteers (BBV152),"2020","","","","","","","","","","","","",https://clinicaltrials.gov/ct2/show/NCT04471519,"",0,10,0,0,0,,,
5436,321,NCT04336410,website,"","Safety, Tolerability and Immunogenicity of INO-4800 for COVID-19 in Healthy Volunteers","2020","","","","","","","","","","","","",https://clinicaltrials.gov/ct2/show/NCT04336410,"",0,10,0,0,0,,,
5437,321,NCT04449276,website,"","A Study to Evaluate the Safety, Reactogenicity and Immunogenicity of Vaccine CVnCoV in Healthy Adults","2020","","","","","","","","","","","",NCT04449276,https://clinicaltrials.gov/ct2/show/NCT04449276,"",0,10,0,0,0,,,
5438,321,NCT04445389,website,"","Safety and Immunogenicity Study of GX-19, a COVID-19 Preventive DNA Vaccine in Healthy Adults","2020","","","","","","","","","","","","",https://clinicaltrials.gov/ct2/show/NCT04445389,"",0,10,0,0,0,,,
5439,321,NCT04497298,website,"",Clinical Trial to Evaluate the Safety and Immunogenicitiy of the COVID-19 Vaccine (COVID-19-101),"2020","","","","","","","","","","","","",https://clinicaltrials.gov/ct2/show/NCT04497298,"",0,10,0,0,0,,,
5440,321,NCT04405908,website,"",SCB-2019 as COVID-19 Vaccine,"2020","","","","","","","","","","","","",https://clinicaltrials.gov/ct2/show/NCT04405908,"",0,10,0,0,0,,,
5441,321,NCT04453852,website,"",Monovalent Recombinant COVID19 Vaccine (COVAX19),"2020","","","","","","","","","","","","",https://clinicaltrials.gov/ct2/show/NCT04453852,"",0,10,0,0,0,,,
5442,321,NCT04450004,website,"","Safety, Tolerability and Immunogenicinity of a Coronavirus-Like Particle COVID-19 Vaccine in Adults Aged 18-55 Years.","2020","","","","","","","","","","","","",https://clinicaltrials.gov/ct2/show/NCT04450004,"",0,10,0,0,0,,,
5443,321,NCT04473690,website,"",KBP-201 COVID-19 Vaccine Trial in Healthy Volunteers,"2020","","","","","","","","","","","","",https://clinicaltrials.gov/ct2/show/NCT04473690,"",0,10,0,0,0,,,
5444,321,NCT04487210,website,"","A Phase I, Prospective, Open-Labeled Study to Evaluate the Safety and Immunogenicity of MVC-COV1901","2020","","","","","","","","","","","","",https://clinicaltrials.gov/ct2/show/NCT04487210,"",0,10,0,0,0,,,
5445,321,ChiCTR2000032459,website,"","Evaluation of the safety and immunogenicity of inactivated novel coronavirus (2019-CoV) vaccine (Vero cells) in healthy population aged 3 years and above: a randomized, double-blind, placebo parallel-controlled phase I/II clinical trial","2020","","","","","","","","","","","","",www.chictr.org.cn/hvshowproject.aspx?id=48144,"",0,10,0,0,0,,,
5446,321,CTRI/2020/07/026352,website,"","A prospective, randomized, adaptive, phase I/II clinical study to evaluate the safety andimmunogenicity of Novel Corona Virus -2019-nCov vaccine candidate of M/s Cadila HealthcareLimited by intradermal route in healthy subject","2020","","","","","","","","","","","","","http://ctri.nic.in/Clinicaltrials/pdf_generate.php?trialid=45306&EncHid=&modid=&compid=%27,%2745306det%27","",0,10,0,0,0,,,
5447,321,ISRCTN17072692,website,"",Clinical trial to assess the safety of a coronavirus vaccine in healthy men and women,"2020","","","","","","","","","","","","",http://www.isrctn.com/ISRCTN17072692,"",0,10,0,0,0,,,
5448,321,ChiCTR2000034112,website,"","A Phase I clinical trial to evaluate the safety, tolerance and preliminary immunogenicity of different doses of a SARS-CoV-2 mRNA vaccine in population aged 18-59 years and 60 years and above","2020","","","","","","","","","","","","",http://www.chictr.org.cn/historyversionpuben.aspx?regno=ChiCTR2000034112,"",0,10,0,0,0,,,
5449,321,GRAd-COV2,website,"",GRAd-COV2,"2020","","","","","","","","","","","","",https://www.covidx.eu/grad-cov2,"",0,10,0,0,0,,,
5450,321,ACTRN12620000674932,website,"","A Phase 1 Randomised, Double-Blind, Placebo-Controlled, Dosage-Escalation, Single Centre Study To Evaluate The Safety And Immunogenicity Of An Adjuvanted SARS-CoV-2 Sclamp Protein Subunit Vaccine (COVID-19 vaccine) In Healthy Adults Aged 18 To 55 Years Old","2020","","","","","","","","","","","","",https://www.anzctr.org.au/Trial/Registration/TrialReview.aspx?id=379861&isReview=true,"",0,10,0,0,0,,,
5451,321,"Mercado et al., 2020",journal,"Mercado NB, Zahn R, Wegmann F, Loos C, Chandrashekar A, Yu J, Liu J, Peter L, McMahan K, Tostanoski LH, He X, Martinez DR, Rutten L, Bos R, van Manen D, Vellinga J, Custers J, Langedijk JP, Kwaks T, Bakkers MJG, Zuijdgeest D, Rosendahl Huber SK, Atyeo C, Fischinger S, Burke JS, Feldman J, Hauser BM, Caradonna TM, Bondzie EA, Dagotto G, Gebre MS, Hoffman E, Jacob-Dolan C, Kirilova M, Li Z, Lin Z, Mahrokhian SH, Maxfield LF, Nampanya F, Nityanandam R, Nkolola JP, Patel S, Ventura JD, Verrington K, Wan H, Pessaint L, Van Ry A, Blade K, Strasbaugh A, Cabus M, Brown R, Cook A, Zouantchangadou S, Teow E, Andersen H, Lewis MG, Cai Y, Chen B, Schmidt AG, Reeves RK, Baric RS, Lauffenburger DA, Alter G, Stoffels P, Mammen M, Van Hoof J, Schuitemaker H, Barouch DH",Single-shot Ad26 vaccine protects against SARS-CoV-2 in rhesus macaques,"2020","","","",Nature,"","","","","","","","32731257","","",0,10,0,0,0,,,
5452,321,"Zhang et al., 2020",journal,"Zhang NN, Li XF, Deng YQ, Zhao H, Huang YJ, Yang G, Huang WJ, Gao P, Zhou C, Zhang RR, Guo Y, Sun SH, Fan H, Zu SL, Chen Q, He Q, Cao TS, Huang XY, Qiu HY, Nie JH, Jiang Y, Yan HY, Ye Q, Zhong X, Xue XL, Zha ZY, Zhou D, Yang X, Wang YC, Ying B, Qin CF",A Thermostable mRNA Vaccine against COVID-19,"2020","182","5","1271-1283.e16",Cell,"","","","","","","","32795413","","",0,10,0,0,0,,,
5453,321,"Walsh et al., 2020",journal,"Walsh EE, Frenck R, Falsey AR, Kitchin N, Absalon J, Gurtman A, Lockhart S, Neuzil K, Mulligan MJ, Bailey R, Swanson KA, Li P, Koury K, Kalina W, Cooper D, Fontes-Garfias C, Shi PY, Treci , Thompkins KR, Lyke KE, Raabe V, Dormitzer PR, Jansen KU, Sahin U, Gruber WC",RNA-Based COVID-19 Vaccine BNT162b2 Selected for a Pivotal Efficacy Study,"2020","","","",medRxiv : the preprint server for health sciences,"","","","","","","","32839784","","",0,10,0,0,0,,,
5454,321,"Mulligan et al., 2020",journal,"Mulligan MJ, Lyke KE, Kitchin N, Absalon J, Gurtman A, Lockhart S, Neuzil K, Raabe V, Bailey R, Swanson KA, Li P, Koury K, Kalina W, Cooper D, Fontes-Garfias C, Shi PY, Treci , Tompkins KR, Walsh EE, Frenck R, Falsey AR, Dormitzer PR, Gruber WC, ahin U, Jansen KU",Phase1/2 study of COVID-19 RNA vaccine BNT162b1 in adults,"2020","","","",Nature,"","","","","","","","32785213","","",0,10,0,0,0,,,
5455,321,"Jackson et al., 2020",journal,"Jackson LA, Anderson EJ, Rouphael NG, Roberts PC, Makhene M, Coler RN, McCullough MP, Chappell JD, Denison MR, Stevens LJ, Pruijssers AJ, McDermott A, Flach B, Doria-Rose NA, Corbett KS, Morabito KM, O'Dell S, Schmidt SD, Swanson PA 2nd, Padilla M, Mascola JR, Neuzil KM, Bennett H, Sun W, Peters E, Makowski M, Albert J, Cross K, Buchanan W, Pikaart-Tautges R, Ledgerwood JE, Graham BS, Beigel JH",An mRNA Vaccine against SARS-CoV-2 - Preliminary Report,"2020","","","",The New England journal of medicine,"","","","","","","","32663912","","",0,10,0,0,0,,,
5456,321,"Wang et al., 2020",journal,"Wang F, Kream RM, Stefano GB",An Evidence Based Perspective on mRNA-SARS-CoV-2 Vaccine Development,"2020","26","",e924700,Medical science monitor : international medical journal of experimental and clinical research,"","","","","","","","32366816","","",0,10,0,0,0,,,
5457,321,"Kaur and Gupta, 2020",journal,"Kaur SP, Gupta V",COVID-19 Vaccine: A comprehensive status report,"2020","288","","198114",Virus research,"","","","","","","","32800805","","",0,10,0,0,0,,,
5458,321,"Logunov et al., 2020",journal,"Logunov DY, Dolzhikova IV, Zubkova OV, Tukhvatullin AI, Shcheblyakov DV, Dzharullaeva AS, Grousova DM, Erokhova AS, Kovyrshina AV, Botikov AG, Izhaeva FM, Popova O, Ozharovskaya TA, Esmagambetov IB, Favorskaya IA, Zrelkin DI, Voronina DV, Shcherbinin DN, Semikhin AS, Simakova YV, Tokarskaya EA, Lubenets NL, Egorova DA, Shmarov MM, Nikitenko NA, Morozova LF, Smolyarchuk EA, Kryukov EV, Babira VF, Borisevich SV, Naroditsky BS, Gintsburg AL","Safety and immunogenicity of an rAd26 and rAd5 vector-based heterologous prime-boost COVID-19 vaccine in two formulations: two open, non-randomised phase 1/2 studies from Russia","2020","396","10255","887-897","Lancet (London, England)","","","","","","","","32896291","","",0,10,0,0,0,,,
5459,321,NCT04528641,website,ReiThera Srl,GRAd-COV2 Vaccine Against COVID-19,"2020","","","","","","","","","","","","",https://www.clinicaltrials.gov/ct2/show/NCT04528641?term=GRAd-COV2&draw=2&rank=1,"",0,10,0,0,0,,,
5460,321,"Saha et al., 2020",journal,"Saha RP, Sharma AR, Singh MK, Samanta S, Bhakta S, Mandal S, Bhattacharya M, Lee SS, Chakraborty C","Repurposing Drugs, Ongoing Vaccine, and New Therapeutic Development Initiatives Against COVID-19","2020","11","","1258",Frontiers in pharmacology,"","","","","","","","32973505","","",0,10,0,0,0,,,
5461,321,"Keech et al., 2020",journal,"Keech C, Albert G, Cho I, Robertson A, Reed P, Neal S, Plested JS, Zhu M, Cloney-Clark S, Zhou H, Smith G, Patel N, Frieman MB, Haupt RE, Logue J, McGrath M, Weston S, Piedra PA, Desai C, Callahan K, Lewis M, Price-Abbott P, Formica N, Shinde V, Fries L, Lickliter JD, Griffin P, Wilkinson B, Glenn GM",Phase 1-2 Trial of a SARS-CoV-2 Recombinant Spike Protein Nanoparticle Vaccine,"2020","","","",The New England journal of medicine,"","","","","","","","32877576","","",0,10,0,0,0,,,
5462,321,"Smith et al., 2020",journal,"Smith TRF, Patel A, Ramos S, Elwood D, Zhu X, Yan J, Gary EN, Walker SN, Schultheis K, Purwar M, Xu Z, Walters J, Bhojnagarwala P, Yang M, Chokkalingam N, Pezzoli P, Parzych E, Reuschel EL, Doan A, Tursi N, Vasquez M, Choi J, Tello-Ruiz E, Maricic I, Bah MA, Wu Y, Amante D, Park DH, Dia Y, Ali AR, Zaidi FI, Generotti A, Kim KY, Herring TA, Reeder S, Andrade VM, Buttigieg K, Zhao G, Wu JM, Li D, Bao L, Liu J, Deng W, Qin C, Brown AS, Khoshnejad M, Wang N, Chu J, Wrapp D, McLellan JS, Muthumani K, Wang B, Carroll MW, Kim JJ, Boyer J, Kulp DW, Humeau LMPF, Weiner DB, Broderick KE",Immunogenicity of a DNA vaccine candidate for COVID-19,"2020","11","1","2601",Nature communications,"","","","","","","","32433465","","",0,10,0,0,0,,,
5463,321,NCT04505722,website,"",Ad26COVS1 clinical trial,"","","","","","","","","","","","","",https://clinicaltrials.gov/ct2/show/NCT04505722,"",0,10,0,0,0,,,
5464,321,"Dai et al., 2020",journal,"Dai L, Zheng T, Xu K, Han Y, Xu L, Huang E, An Y, Cheng Y, Li S, Liu M, Yang M, Li Y, Cheng H, Yuan Y, Zhang W, Ke C, Wong G, Qi J, Qin C, Yan J, Gao GF","A Universal Design of Betacoronavirus Vaccines against COVID-19, MERS, and SARS","2020","182","3","722-733.e11",Cell,"","","","","","","","32645327","","",0,10,0,0,0,,,
5465,321,"Corbett et al., 2020",journal,"Corbett KS, Flynn B, Foulds KE, Francica JR, Boyoglu-Barnum S, Werner AP, Flach B, O'Connell S, Bock KW, Minai M, Nagata BM, Andersen H, Martinez DR, Noe AT, Douek N, Donaldson MM, Nji NN, Alvarado GS, Edwards DK, Flebbe DR, Lamb E, Doria-Rose NA, Lin BC, Louder MK, O'Dell S, Schmidt SD, Phung E, Chang LA, Yap C, Todd JM, Pessaint L, Van Ry A, Browne S, Greenhouse J, Putman-Taylor T, Strasbaugh A, Campbell TA, Cook A, Dodson A, Steingrebe K, Shi W, Zhang Y, Abiona OM, Wang L, Pegu A, Yang ES, Leung K, Zhou T, Teng IT, Widge A, Gordon I, Novik L, Gillespie RA, Loomis RJ, Moliva JI, Stewart-Jones G, Himansu S, Kong WP, Nason MC, Morabito KM, Ruckwardt TJ, Ledgerwood JE, Gaudinski MR, Kwong PD, Mascola JR, Carfi A, Lewis MG, Baric RS, McDermott A, Moore IN, Sullivan NJ, Roederer M, Seder RA, Graham BS",Evaluation of the mRNA-1273 Vaccine against SARS-CoV-2 in Nonhuman Primates,"2020","383","16","1544-1555",The New England journal of medicine,"","","","","","","","32722908",https://pubmed.ncbi.nlm.nih.gov/32722908/,"",0,10,0,0,0,,,
5466,321,"Anderson et al., 2020",journal,"Anderson EJ, Rouphael NG, Widge AT, Jackson LA, Roberts PC, Makhene M, Chappell JD, Denison MR, Stevens LJ, Pruijssers AJ, McDermott AB, Flach B, Lin BC, Doria-Rose NA, O'Dell S, Schmidt SD, Corbett KS, Swanson PA 2nd, Padilla M, Neuzil KM, Bennett H, Leav B, Makowski M, Albert J, Cross K, Edara VV, Floyd K, Suthar MS, Martinez DR, Baric R, Buchanan W, Luke CJ, Phadke VK, Rostad CA, Ledgerwood JE, Graham BS, Beigel JH",Safety and Immunogenicity of SARS-CoV-2 mRNA-1273 Vaccine in Older Adults,"2020","383","25","2427-2438",The New England journal of medicine,"","","","","","","","32991794",https://pubmed.ncbi.nlm.nih.gov/32991794/,"",0,10,0,0,0,,,
5467,321,"Walsh et al., 2020",journal,"Walsh EE, Frenck RW Jr, Falsey AR, Kitchin N, Absalon J, Gurtman A, Lockhart S, Neuzil K, Mulligan MJ, Bailey R, Swanson KA, Li P, Koury K, Kalina W, Cooper D, Fontes-Garfias C, Shi PY, Treci , Tompkins KR, Lyke KE, Raabe V, Dormitzer PR, Jansen KU, ahin U, Gruber WC",Safety and Immunogenicity of Two RNA-Based Covid-19 Vaccine Candidates,"2020","383","25","2439-2450",The New England journal of medicine,"","","","","","","","33053279","","",0,10,0,0,0,,,
5468,321,"King et al., 2020",journal,"King RG, Silva-Sanchez A, Peel JN, Botta D, Meza-Perez S, Allie R, Schultz MD, Liu M, Bradley JE, Qiu S, Yang G, Zhou F, Zumaquero E, Simpler TS, Mousseau B, Killian JT, Dean B, Shang Q, Tipper JL, Risley C, Harrod KS, Feng R, Lee Y, Shiberu B, Krishnan V, Peguillet I, Zhang J, Green T, Randall TD, Georges B, Lund FE, Roberts S",Single-dose intranasal administration of AdCOVID elicits systemic and mucosal immunity against SARS-CoV-2 in mice,"2020","","","",bioRxiv : the preprint server for biology,"","","","","","","","33052351",https://pubmed.ncbi.nlm.nih.gov/33052351/,"",0,10,0,0,0,,,
5469,321,"Wang et al., 2020",journal,"Wang H, Zhang Y, Huang B, Deng W, Quan Y, Wang W, Xu W, Zhao Y, Li N, Zhang J, Liang H, Bao L, Xu Y, Ding L, Zhou W, Gao H, Liu J, Niu P, Zhao L, Zhen W, Fu H, Yu S, Zhang Z, Xu G, Li C, Lou Z, Xu M, Qin C, Wu G, Gao GF, Tan W, Yang X","Development of an Inactivated Vaccine Candidate, BBIBP-CorV, with Potent Protection against SARS-CoV-2","2020","182","3","713-721.e9",Cell,"","","","","","","","32778225",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7275151/,"",0,10,0,0,0,,,
5470,321,"Polack et al., 2020",journal,"Polack FP, Thomas SJ, Kitchin N, Absalon J, Gurtman A, Lockhart S, Perez JL, Prez Marc G, Moreira ED, Zerbini C, Bailey R, Swanson KA, Roychoudhury S, Koury K, Li P, Kalina WV, Cooper D, Frenck RW Jr, Hammitt LL, Treci , Nell H, Schaefer A, nal S, Tresnan DB, Mather S, Dormitzer PR, ahin U, Jansen KU, Gruber WC",Safety and Efficacy of the BNT162b2 mRNA Covid-19 Vaccine,"2020","383","27","2603-2615",The New England journal of medicine,"","","","","","","","33301246",https://www.nejm.org/doi/10.1056/NEJMoa2034577?url_ver=Z39.88-2003&rfr_id=ori:rid:crossref.org&rfr_dat=cr_pub%20%200pubmed,"",0,10,0,0,0,,,
5471,321,"Zhang et al., 2020",journal,"Zhang Y, Zeng G, Pan H, Li C, Hu Y, Chu K, Han W, Chen Z, Tang R, Yin W, Chen X, Hu Y, Liu X, Jiang C, Li J, Yang M, Song Y, Wang X, Gao Q, Zhu F","Safety, tolerability, and immunogenicity of an inactivated SARS-CoV-2 vaccine in healthy adults aged 18-59 years: a randomised, double-blind, placebo-controlled, phase 1/2 clinical trial","2020","","","",The Lancet. Infectious diseases,"","","","","","","","33217362",https://www.thelancet.com/journals/laninf/article/PIIS1473-3099(20)30843-4/fulltext,"",0,10,0,0,0,,,
5472,321,"Tebas et al., 2020",journal,"Tebas P, Yang S, Boyer JD, Reuschel EL, Patel A, Christensen-Quick A, Andrade VM, Morrow MP, Kraynyak K, Agnes J, Purwar M, Sylvester A, Gillespie E, Maricic I, Zaidi FI, Kim KY, Dia Y, Frase D, Pezzoli P, Schultheis K, Smith TRF, Ramos SJ, McMullan T, Buttigieg K, Carroll MW, Ervin J, Diehl MC, Blackwood E, Mammen MP, Lee J, Dallas MJ, Brown AS, Shea JE, Kim JJ, Weiner DB, Broderick KE, Humeau LM","Safety and immunogenicity of INO-4800 DNA vaccine against SARS-CoV-2: A preliminary report of an open-label, Phase 1 clinical trial","2020","","","100689",EClinicalMedicine,"","","","","","","","33392485",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7759123/,"",0,10,0,0,0,,,
5473,321,"Tian et al., 2021",journal,"Tian JH, Patel N, Haupt R, Zhou H, Weston S, Hammond H, Logue J, Portnoff AD, Norton J, Guebre-Xabier M, Zhou B, Jacobson K, Maciejewski S, Khatoon R, Wisniewska M, Moffitt W, Kluepfel-Stahl S, Ekechukwu B, Papin J, Boddapati S, Jason Wong C, Piedra PA, Frieman MB, Massare MJ, Fries L, Bengtsson KL, Stertman L, Ellingsworth L, Glenn G, Smith G",SARS-CoV-2 spike glycoprotein vaccine candidate NVX-CoV2373 immunogenicity in baboons and protection in mice,"2021","12","1","372",Nature communications,"","","","","","","","33446655",https://www.nature.com/articles/s41467-020-20653-8,"",0,10,0,0,0,,,
5474,50,"Barra et al., 2013",journal,"Barra MI, Garrido JL, Stein C, Scher E, Ge Y, Engel SM, Kraus TA, Banach D, Moran TM",Localized mucosal response to intranasal live attenuated influenza vaccine in adults,"2013","207","1","115-124",The Journal of infectious diseases,"","","","","","","","23087433","","",0,10,0,0,0,,,
5475,321,"van et al., 2020",journal,"van Doremalen N, Lambe T, Spencer A, Belij-Rammerstorfer S, Purushotham JN, Port JR, Avanzato VA, Bushmaker T, Flaxman A, Ulaszewska M, Feldmann F, Allen ER, Sharpe H, Schulz J, Holbrook M, Okumura A, Meade-White K, Prez-Prez L, Edwards NJ, Wright D, Bissett C, Gilbride C, Williamson BN, Rosenke R, Long D, Ishwarbhai A, Kailath R, Rose L, Morris S, Powers C, Lovaglio J, Hanley PW, Scott D, Saturday G, de Wit E, Gilbert SC, Munster VJ",ChAdOx1nCoV-19 vaccine prevents SARS-CoV-2 pneumonia in rhesus macaques,"2020","586","7830","578-582",Nature,"","","","","","","","32731258","","",0,10,0,0,0,,,
5476,321,"Sun et al., 2020",journal,"Sun W, Leist SR, McCroskery S, Liu Y, Slamanig S, Oliva J, Amanat F, Schfer A, Dinnon KH 3rd, Garca-Sastre A, Krammer F, Baric RS, Palese P",Newcastle disease virus (NDV) expressing the spike protein of SARS-CoV-2 as a live virus vaccine candidate,"2020","62","","103132",EBioMedicine,"","","","","","","","33232870","","",0,10,0,0,0,,,
5477,321,NCT04773665,website,"","Safety, Tolerability, and Immunogenicity of the COVID-19 Vaccine Candidate (VBI-2902a)","","","","","","","","","","","","","",https://clinicaltrials.gov/ct2/show/NCT04773665,"",0,10,0,0,0,,,
5478,321,NCT04591184,website,"",A Clinical Trial of a Plasmid DNA Vaccine for COVID-19 [Covigenix VAX-001] in Adults,"","","","","","","","","","","","","",https://clinicaltrials.gov/ct2/show/NCT04591184,"",0,10,0,0,0,,,
5479,321,NCT04798001,website,"",Safety and Immunogenicity of an Intranasal RSV Vaccine Expressing SARS-CoV-2 Spike Protein (COVID-19 Vaccine) in Adults,"2021","","","","","","","","","","","","",https://clinicaltrials.gov/ct2/show/NCT04798001?term=covid-19+vaccine&draw=2,"",0,10,0,0,0,,,
5480,321,"Sahin et al., 2020",website,"Sahin U, Muik A, Vogler I, Derhovanessian E, Kranz LM, Vormehr M, Quandt J, Bidmon N, Ulges A, Baum A, Pascal K, Maurus D, Brachtendorf S, Lrks V, Sikorski J, Koch P, Hilker R, Becker D, Eller A, Grtzner J, Tonigold M, Boesler C, Rosenbaum C, Heesen L, Khnle M, Poran A, Dong JZ, Luxemburger U, Kemmer-Brck A, Langer D, Bexon M, Bolte S, Palanche T, Schultz A, Baumann S, Mahiny AJ, Boros G, Reinholz J, Szab GT, Karik K, Shi P, Fontes-Garfias C, Perez JL, Cutler M, Cooper D, Kyratsous CA, Dormitzer PR, Jansen KU, Treci ",BNT162b2 induces SARS-CoV-2-neutralising antibodies and T cells in humans,"2020","","","","","","","","","","","","",https://www.medrxiv.org/content/10.1101/2020.12.09.20245175v1.full?fbclid=IwAR2Drk0yoZUvLdve1MCKeMXm4s7lVqUD2BmPnJ07Og7eE3rOQgWDdwwAEdA,"",0,10,0,0,0,,,
5481,321,"Vogel et al., 2020",website,"Vogel AB, Kanevsky I, Che Y, Swanson KA, Muik A, Vormehr M, Kranz LM, Walzer KC, Hein S, Gler A, Loschko J, Maddur MS, Tompkins K, Cole J, Lui BG, Ziegenhals T, Plaschke A, Eisel D, Dany SC, Fesser S, Erbar S, Bates F, Schneider D, Jesionek B, Snger B, Wallisch A-K, Feuchter Y, Junginger H, Krumm SA, Heinen AP, Adams-Quack P, Schlereth J, Krner C, Hall-Ursone S, Brasky K, Griffor MC, Han S, Lees JA, Mashalidis EH, Sahasrabudhe PV, Tan CY, Pavliakova D, Singh G, Fontes-Garfias C, Pride M, Scully IL, Ciolino T, Obregon J, Gazi M, Carrion R Jr, Alfson KJ, Kalina WV, Kaushal D, Shi P-Y, Klamp T, Rosenbaum C, Kuhn AN, Treci , Dormitzer PR, Jansen KU, Sahin U",A prefusion SARS-CoV-2 spike RNA vaccine is highly immunogenic and prevents lung infection in non-human primates,"2020","","","","","","","","","","","","",https://www.biorxiv.org/content/10.1101/2020.09.08.280818v1.full?fbclid=IwAR1hGehYH9pEO70RRGT56XB_aJ2O5NFux9YN6XBzmCkXzNsjREuo11q5ub4,"",0,10,0,0,0,,,
5482,99,"He et al., 1997",journal,"He Z, He YS, Kim Y, Chu L, Ohmstede C, Biron KK, Coen DM",The human cytomegalovirus UL97 protein is a protein kinase that autophosphorylates on serines and threonines,"1997","71","1","405-411",Journal of virology,"","","","","","","","8985364","","",0,10,0,0,0,,,
5483,321,"Chappell et al., 2021",journal,"Chappell KJ, Mordant FL, Li Z, Wijesundara DK, Ellenberg P, Lackenby JA, Cheung STM, Modhiran N, Avumegah MS, Henderson CL, Hoger K, Griffin P, Bennet J, Hensen L, Zhang W, Nguyen THO, Marrero-Hernandez S, Selva KJ, Chung AW, Tran MH, Tapley P, Barnes J, Reading PC, Nicholson S, Corby S, Holgate T, Wines BD, Hogarth PM, Kedzierska K, Purcell DFJ, Ranasinghe C, Subbarao K, Watterson D, Young PR, Munro TP","Safety and immunogenicity of an MF59-adjuvanted spike glycoprotein-clamp vaccine for SARS-CoV-2: a randomised, double-blind, placebo-controlled, phase 1 trial","2021","","","",The Lancet. Infectious diseases,"","","","","","","","33887208","","",0,10,0,0,0,,,
5484,321,"Erasmus et al., 2020",journal,"Erasmus JH, Khandhar AP, O'Connor MA, Walls AC, Hemann EA, Murapa P, Archer J, Leventhal S, Fuller JT, Lewis TB, Draves KE, Randall S, Guerriero KA, Duthie MS, Carter D, Reed SG, Hawman DW, Feldmann H, Gale M Jr, Veesler D, Berglund P, Fuller DH",An Alphavirus-derived replicon RNA vaccine induces SARS-CoV-2 neutralizing antibody and T cell responses in mice and nonhuman primates,"2020","12","555","",Science translational medicine,"","","","","","","","32690628","","",0,10,0,0,0,,,
5485,99,"Felder et al., 2014",journal,"Felder M, Kapur A, Gonzalez-Bosquet J, Horibata S, Heintz J, Albrecht R, Fass L, Kaur J, Hu K, Shojaei H, Whelan RJ, Patankar MS","MUC16 (CA125): tumor biomarker to cancer therapy, a work in progress","2014","13","","129",Molecular cancer,"","","","","","","","24886523","","",0,10,0,0,0,,,
5486,99,Clinical trial NCT03544723,website,"",Safety and Efficacy of p53 Gene Therapy Combined With Immune Checkpoint Inhibitors in Solid Tumors,"","","","","","","","","","","","","",https://clinicaltrials.gov/ct2/show/NCT03544723,"",0,10,0,0,0,,,
5487,99,"Kozowska et al., 2013",journal,"Kozowska A, Mackiewicz J, Mackiewicz A",Therapeutic gene modified cell based cancer vaccines,"2013","525","2","200-207",Gene,"","","","","","","","23566846","","",0,10,0,0,0,,,
5488,0,"Ella et al., 2021",journal,"Ella R, Vadrevu KM, Jogdand H, Prasad S, Reddy S, Sarangi V, Ganneru B, Sapkal G, Yadav P, Abraham P, Panda S, Gupta N, Reddy P, Verma S, Kumar Rai S, Singh C, Redkar SV, Gillurkar CS, Kushwaha JS, Mohapatra S, Rao V, Guleria R, Ella K, Bhargava B","Safety and immunogenicity of an inactivated SARS-CoV-2 vaccine, BBV152: a double-blind, randomised, phase 1 trial","2021","21","5","637-646",The Lancet. Infectious diseases,"","","","","","","","33485468","","",0,10,113,0,0,,,
5489,321,"Ella et al., 2021",journal,"Ella R, Vadrevu KM, Jogdand H, Prasad S, Reddy S, Sarangi V, Ganneru B, Sapkal G, Yadav P, Abraham P, Panda S, Gupta N, Reddy P, Verma S, Kumar Rai S, Singh C, Redkar SV, Gillurkar CS, Kushwaha JS, Mohapatra S, Rao V, Guleria R, Ella K, Bhargava B","Safety and immunogenicity of an inactivated SARS-CoV-2 vaccine, BBV152: a double-blind, randomised, phase 1 trial","2021","21","5","637-646",The Lancet. Infectious diseases,"","","","","","","","33485468","","",0,10,0,0,0,,,
5490,99,"DeMeritt et al., 2004",journal,"DeMeritt IB, Milford LE, Yurochko AD",Activation of the NF-kappaB pathway in human cytomegalovirus-infected cells is necessary for efficient transactivation of the major immediate-early promoter,"2004","78","9","4498-4507",Journal of virology,"","","","","","","","15078930","","",0,10,0,0,0,,,
5491,99,"Blalock et al., 2012",journal,"Blalock LT, Landsberg J, Messmer M, Shi J, Pardee AD, Haskell R, Vujanovic L, Kirkwood JM, Butterfield LH",Human dendritic cells adenovirally-engineered to express three defined tumor antigens promote broad adaptive and innate immunity,"2012","1","3","287-357",Oncoimmunology,"","","","","","","","22737604","","",0,10,0,0,0,,,
5492,99,"Unfer et al., 2003",journal,"Unfer RC, Hellrung D, Link CJ Jr","Immunity to the alpha(1,3)galactosyl epitope provides protection in mice challenged with colon cancer cells expressing alpha(1,3)galactosyl-transferase: a novel suicide gene for cancer gene therapy","2003","63","5","987-993",Cancer research,"","","","","","","","12615713","","",0,10,0,0,0,,,
5493,99,"Motta et al., 2001",journal,"Motta I, Andr F, Lim A, Tartaglia J, Cox WI, Zitvogel L, Angevin E, Kourilsky P",Cross-presentation by dendritic cells of tumor antigen expressed in apoptotic recombinant canarypox virus-infected dendritic cells,"2001","167","3","1795-1802","Journal of immunology (Baltimore, Md. : 1950)","","","","","","","","11466405","","",0,10,0,0,0,,,
5494,99,"Bol et al., 2015",journal,"Bol KF, Figdor CG, Aarntzen EH, Welzen ME, van Rossum MM, Blokx WA, van de Rakt MW, Scharenborg NM, de Boer AJ, Pots JM, Olde Nordkamp MA, van Oorschot TG, Mus RD, Croockewit SA, Jacobs JF, Schuler G, Neyns B, Austyn JM, Punt CJ, Schreibelt G, de Vries IJ",Intranodal vaccination with mRNA-optimized dendritic cells in metastatic melanoma patients,"2015","4","8",e1019197,Oncoimmunology,"","","","","","","","26405571","","",0,10,0,0,0,,,
5495,99,"Okur et al., 2011",journal,"Okur FV, Yvon E, Biagi E, Dotti G, Carrum G, Heslop H, Mims MP, Fratantoni JC, Peshwa MV, Li L, Brenner MK",Comparison of two CD40-ligand/interleukin-2 vaccines in patients with chronic lymphocytic leukemia,"2011","13","9","1128-1139",Cytotherapy,"","","","","","","","21745159","","",0,10,0,0,0,,,
5496,99,"Connerotte et al., 2008",journal,"Connerotte T, Van Pel A, Godelaine D, Tartour E, Schuler-Thurner B, Lucas S, Thielemans K, Schuler G, Coulie PG",Functions of Anti-MAGE T-cells induced in melanoma patients under different vaccination modalities,"2008","68","10","3931-3940",Cancer research,"","","","","","","","18483279","","",0,10,0,0,0,,,
5497,321,"Thiagarajan, 2021",website,Kamala Thiagarajan,What do we know about Indias Covaxin vaccine?,"2021","","","","","","","","","","","","",https://www.bmj.com/content/373/bmj.n997,"",0,10,0,0,0,,,
5498,321,"LABline, 2021",website,LABline,Adjuvant enhances efficacy of Indias COVID-19 vaccine,"2021","","","","","","","","","","","","",https://www.mlo-online.com/disease/infectious-disease/article/21228745/adjuvant-enhances-efficacy-of-indias-covid19-vaccine,"",0,10,0,0,0,,,
5499,99,"Morera et al., 2017",journal,"Morera Y, Snchez J, Bequet-Romero M, Selman-Housein KH, de la Torre A, Hernndez-Bernal F, Martn Y, Garabito A, Piero J, Bermdez C, de la Torre J, Ayala M, Gavilondo JV",Specific humoral and cellular immune responses in cancer patients undergoing chronic immunization with a VEGF-based therapeutic vaccine,"2017","35","28","3582-3590",Vaccine,"","","","","","","","28536029","","",0,10,0,0,0,,,
5500,99,"Geynisman et al., 2013",journal,"Geynisman DM, Zha Y, Kunnavakkam R, Aklilu M, Catenacci DV, Polite BN, Rosenbaum C, Namakydoust A, Karrison T, Gajewski TF, Kindler HL",A randomized pilot phase I study of modified carcinoembryonic antigen (CEA) peptide (CAP1-6D)/montanide/GM-CSF-vaccine in patients with pancreatic adenocarcinoma,"2013","1","","8",Journal for immunotherapy of cancer,"","","","","","","","24829746","","",0,10,0,0,0,,,
5501,99,"Morse et al., 2010",journal,"Morse MA, Hobeika AC, Osada T, Berglund P, Hubby B, Negri S, Niedzwiecki D, Devi GR, Burnett BK, Clay TM, Smith J, Lyerly HK",An alphavirus vector overcomes the presence of neutralizing antibodies and elevated numbers of Tregs to induce immune responses in humans with advanced cancer,"2010","120","9","3234-3241",The Journal of clinical investigation,"","","","","","","","20679728","","",0,10,0,0,0,,,
5502,99,"Kim et al., 2008",journal,"Kim SG, Park MY, Kim CH, Sohn HJ, Kim HS, Park JS, Kim HJ, Oh ST, Kim TG",Modification of CEA with both CRT and TAT PTD induces potent anti-tumor immune responses in RNA-pulsed DC vaccination,"2008","26","50","6433-6440",Vaccine,"","","","","","","","18812201","","",0,10,0,0,0,,,
5503,99,"Di et al., 2006",journal,"Di Pucchio T, Pilla L, Capone I, Ferrantini M, Montefiore E, Urbani F, Patuzzo R, Pennacchioli E, Santinami M, Cova A, Sovena G, Arienti F, Lombardo C, Lombardi A, Caporaso P, D'Atri S, Marchetti P, Bonmassar E, Parmiani G, Belardelli F, Rivoltini L",Immunization of stage IV melanoma patients with Melan-A/MART-1 and gp100 peptides plus IFN-alpha results in the activation of specific CD8(+) T cells and monocyte/dendritic cell precursors,"2006","66","9","4943-4951",Cancer research,"","","","","","","","16651452","","",0,10,0,0,0,,,
5504,99,"Prabakaran et al., 2002",journal,"Prabakaran I, Menon C, Xu S, Gmez-Yafal A, Czerniecki BJ, Fraker DL",Mature CD83(+) dendritic cells infected with recombinant gp100 vaccinia virus stimulate potent antimelanoma T cells,"2002","9","4","411-418",Annals of surgical oncology,"","","","","","","","11986195","","",0,10,0,0,0,,,
5505,99,"Phuphanich et al., 2013",journal,"Phuphanich S, Wheeler CJ, Rudnick JD, Mazer M, Wang H, Nuo MA, Richardson JE, Fan X, Ji J, Chu RM, Bender JG, Hawkins ES, Patil CG, Black KL, Yu JS",Phase I trial of a multi-epitope-pulsed dendritic cell vaccine for patients with newly diagnosed glioblastoma,"2013","62","1","125-135","Cancer immunology, immunotherapy : CII","","","","","","","","22847020","","",0,10,0,0,0,,,
5506,99,"Trimble et al., 2015",journal,"Trimble CL, Morrow MP, Kraynyak KA, Shen X, Dallas M, Yan J, Edwards L, Parker RL, Denny L, Giffear M, Brown AS, Marcozzi-Pierce K, Shah D, Slager AM, Sylvester AJ, Khan A, Broderick KE, Juba RJ, Herring TA, Boyer J, Lee J, Sardesai NY, Weiner DB, Bagarazzi ML","Safety, efficacy, and immunogenicity of VGX-3100, a therapeutic synthetic DNA vaccine targeting human papillomavirus 16 and 18 E6 and E7 proteins for cervical intraepithelial neoplasia 2/3: a randomised, double-blind, placebo-controlled phase 2b trial","2015","386","10008","2078-2088","Lancet (London, England)","","","","","","","","26386540","","",0,10,0,0,0,,,
5507,99,"Schaller and Sampson, 2017",journal,"Schaller TH, Sampson JH",Advances and challenges: dendritic cell vaccination strategies for glioblastoma,"2017","16","1","27-36",Expert review of vaccines,"","","","","","","","27500911","","",0,10,0,0,0,,,
5508,99,"Feyen et al., 2020",journal,"Feyen DAM, McKeithan WL, Bruyneel AAN, Spiering S, Hrmann L, Ulmer B, Zhang H, Briganti F, Schweizer M, Hegyi B, Liao Z, Plnen RP, Ginsburg KS, Lam CK, Serrano R, Wahlquist C, Kreymerman A, Vu M, Amatya PL, Behrens CS, Ranjbarvaziri S, Maas RGC, Greenhaw M, Bernstein D, Wu JC, Bers DM, Eschenhagen T, Metallo CM, Mercola M",Metabolic Maturation Media Improve Physiological Function of Human iPSC-Derived Cardiomyocytes,"2020","32","3","107925",Cell reports,"","","","","","","","32697997","","",0,10,0,0,0,,,
5509,99,"Walter et al., 2012",journal,"Walter S, Weinschenk T, Stenzl A, Zdrojowy R, Pluzanska A, Szczylik C, Staehler M, Brugger W, Dietrich PY, Mendrzyk R, Hilf N, Schoor O, Fritsche J, Mahr A, Maurer D, Vass V, Trautwein C, Lewandrowski P, Flohr C, Pohla H, Stanczak JJ, Bronte V, Mandruzzato S, Biedermann T, Pawelec G, Derhovanessian E, Yamagishi H, Miki T, Hongo F, Takaha N, Hirakawa K, Tanaka H, Stevanovic S, Frisch J, Mayer-Mokler A, Kirner A, Rammensee HG, Reinhardt C, Singh-Jasuja H",Multipeptide immune response to cancer vaccine IMA901 after single-dose cyclophosphamide associates with longer patient survival,"2012","18","8","1254-1261",Nature medicine,"","","","","","","","22842478","","",0,10,0,0,0,,,
5510,99,"Plotkin and Bouveret-Le, 1995",journal,"Plotkin SA, Bouveret-Le Cam N",A new typhoid vaccine composed of the Vi capsular polysaccharide,"1995","155","21","2293-2299",Archives of internal medicine,"","","","","","","","7487253","","",0,10,0,0,0,,,
5511,99,"New et al., 1988",journal,"New JH, Eggleston AK, Fennewald M",Binding of the Tn3 transposase to the inverted repeats of Tn3,"1988","201","3","589-599",Journal of molecular biology,"","","","","","","","2843651","","",0,10,0,0,0,,,
5512,99,"Tamanaka et al., 2012",journal,"Tamanaka T, Oka Y, Fujiki F, Tsuboi A, Katsuhara A, Nakajima H, Hosen N, Nishida S, Lin YH, Tachino S, Akatsuka Y, Kuzushima K, Oji Y, Kumanogoh A, Sugiyama H",Recognition of a natural WT1 epitope by a modified WT1 peptide-specific T-cell receptor,"2012","32","12","5201-5209",Anticancer research,"","","","","","","","23225417","","",0,10,0,0,0,,,
5513,99,"Toso et al., 2002",journal,"Toso JF, Lapointe R, Hwu P",CD40 ligand and lipopolysaccharide enhance the in vitro generation of melanoma-reactive T-cells,"2002","259","1-2","181-190",Journal of immunological methods,"","","","","","","","11730853","","",0,10,0,0,0,,,
5514,0,"(Carson, 2021)",website,"",Vaccine Adjuvant Compendium (VAC),"2021","","","","","","","","","","","","",https://vac.niaid.nih.gov/view?id=6,"",0,10,114,0,0,,,
5515,0,"(Carson, 2021)",website,"",Vaccine Adjuvant Compendium (VAC),"2021","","","","","","","","","","","","",https://vac.niaid.nih.gov/view?id=7,"",0,10,115,0,0,,,
5516,0,"(Carson, 2021)",website,"",Vaccine Adjuvant Compendium (VAC),"2021","","","","","","","","","","","","",https://vac.niaid.nih.gov/view?id=9,"",0,10,116,0,0,,,
5517,0,"(Carson, 2021)",website,"",Vaccine Adjuvant Compendium (VAC),"2021","","","","","","","","","","","","",https://vac.niaid.nih.gov/view?id=8,"",0,10,117,0,0,,,
5518,0,"(Suresh, 2021)",website,Marulasiddappa Suresh,Vaccine Adjuvant Compendium (VAC),"2021","","","","","","","","","","","","",https://vac.niaid.nih.gov/view?id=15,"",0,10,118,0,0,,,
5519,0,"(Petrovsky, 2021)",website,Nikolai Petrovsky,Vaccine Adjuvant Compendium (VAC),"2021","","","","","","","","","","","","",https://vac.niaid.nih.gov/view?id=37,"",0,10,119,0,0,,,
5520,0,"(Petrovsky, 2021)",website,Nikolai Petrovsky,Vaccine Adjuvant Compendium (VAC),"2021","","","","","","","","","","","","",https://vac.niaid.nih.gov/view?id=38,"",0,10,120,0,0,,,
5521,0,"(Carter, 2021)",website,Darrick Carter,Vaccine Adjuvant Compendium (VAC),"2021","","","","","","","","","","","","",https://vac.niaid.nih.gov/view?id=21,"",0,10,121,0,0,,,
5522,0,"(Carter, 2021)",website,Darrick Carter,Vaccine Adjuvant Compendium (VAC),"2021","","","","","","","","","","","","",https://vac.niaid.nih.gov/view?id=19,"",0,10,122,0,0,,,
5523,0,"(Ernst, 2021)",website,Robert Ernst,Vaccine Adjuvant Compendium (VAC),"2021","","","","","","","","","","","","",https://vac.niaid.nih.gov/view?id=31,"",0,10,123,0,0,,,
5524,0,"(Ernst, 2021)",website,Robert Ernst,Vaccine Adjuvant Compendium (VAC),"2021","","","","","","","","","","","","",https://vac.niaid.nih.gov/view?id=33,"",0,10,124,0,0,,,
5525,0,"(Ernst, 2021)",website,Robert Ernst,Vaccine Adjuvant Compendium (VAC),"2021","","","","","","","","","","","","",https://vac.niaid.nih.gov/view?id=32,"",0,10,125,0,0,,,
5526,0,"(Morcol, 2021)",website,Tulin Morcol,Vaccine Adjuvant Compendium (VAC),"2021","","","","","","","","","","","","",https://vac.niaid.nih.gov/view?id=11,"",0,10,126,0,0,,,
5527,0,"(Vetro, 2021)",website,Joseph Vetro,Vaccine Adjuvant Compendium (VAC),"2021","","","","","","","","","","","","",https://vac.niaid.nih.gov/view?id=39,"",0,10,127,0,0,,,
5528,0,"(Lopez, 2021)",website,Carolina Lopez,Vaccine Adjuvant Compendium (VAC),"2021","","","","","","","","","","","","",https://vac.niaid.nih.gov/view?id=30,"",0,10,128,0,0,,,
5529,0,"(Norton, 2021)",website,Elizabeth Norton,Vaccine Adjuvant Compendium (VAC),"2021","","","","","","","","","","","","",https://vac.niaid.nih.gov/view?id=13,"",0,10,129,0,0,,,
5530,0,"(Carter, 2021)",website,Darrick Carter,Vaccine Adjuvant Compendium (VAC),"2021","","","","","","","","","","","","",https://vac.niaid.nih.gov/view?id=18,"",0,10,130,0,0,,,
5531,321,"Makar et al., 1975",journal,"Makar AB, McMartin KE, Palese M, Tephly TR",Formate assay in body fluids: application in methanol poisoning,"1975","13","2","117-126",Biochemical medicine,"","","","","","","","1","","",0,11,0,0,0,,,
5532,247,"Makar et al., 1975",journal,"Makar AB, McMartin KE, Palese M, Tephly TR",Formate assay in body fluids: application in methanol poisoning,"1975","13","2","117-126",Biochemical medicine,"","","","","","","","1","","",0,11,0,0,0,,,
5533,50,"Sato-Kaneko et al., 2020",journal,"Sato-Kaneko F, Yao S, Lao FS, Shpigelman J, Messer K, Pu M, Shukla NM, Cottam HB, Chan M, Chu PJ, Burkhart D, Schoener R, Matsutani T, Carson DA, Corr M, Hayashi T",A Novel Synthetic Dual Agonistic Liposomal TLR4/7 Adjuvant Promotes Broad Immune Responses in an Influenza Vaccine With Minimal Reactogenicity,"2020","11","","1207",Frontiers in immunology,"","","","","","","","32636840","","",0,10,0,0,0,,,
5534,50,"Goff et al., 2015",journal,"Goff PH, Hayashi T, Martnez-Gil L, Corr M, Crain B, Yao S, Cottam HB, Chan M, Ramos I, Eggink D, Heshmati M, Krammer F, Messer K, Pu M, Fernandez-Sesma A, Palese P, Carson DA","Synthetic Toll-like receptor 4 (TLR4) and TLR7 ligands as influenza virus vaccine adjuvants induce rapid, sustained, and broadly protective responses","2015","89","6","3221-3235",Journal of virology,"","","","","","","","25568203","","",0,10,0,0,0,,,
5535,50,"Shukla et al., 2018",journal,"Shukla NM, Arimoto KI, Yao S, Fan JB, Zhang Y, Sato-Kaneko F, Lao FS, Hosoya T, Messer K, Pu M, Cottam HB, Carson DA, Hayashi T, Zhang DE, Corr M",Identification of Compounds That Prolong Type I Interferon Signaling as Potential Vaccine Adjuvants,"2018","23","9","960-973",SLAS discovery : advancing life sciences R & D,"","","","","","","","29751735","","",0,10,0,0,0,,,
5536,50,"Marinaik et al., 2020",journal,"Marinaik CB, Kingstad-Bakke B, Lee W, Hatta M, Sonsalla M, Larsen A, Neldner B, Gasper DJ, Kedl RM, Kawaoka Y, Suresh M",Programming Multifaceted Pulmonary T Cell Immunity by Combination Adjuvants,"2020","1","6","100095",Cell reports. Medicine,"","","","","","","","32984856","","",0,10,0,0,0,,,
5537,50,"Honda-Okubo et al., 2012",journal,"Honda-Okubo Y, Saade F, Petrovsky N","Advax, a polysaccharide adjuvant derived from delta inulin, provides improved influenza vaccine protection through broad-based enhancement of adaptive immune responses","2012","30","36","5373-5381",Vaccine,"","","","","","","","22728225","","",0,10,0,0,0,,,
5538,0,VAC #12,website,"","","","","","","","","","","","","","","",https://vac.niaid.nih.gov/view?id=12,,0,10,113,0,0,,,
5539,30,"Laurens, 2020",journal,Laurens MB,"RTS,S/AS01 vaccine (Mosquirix): an overview","2020","16","3","480-489",Human vaccines & immunotherapeutics,"","","","","","","","31545128","","",0,10,0,0,0,,,
5540,30,"Zavala et al., 1985",journal,"Zavala F, Tam JP, Hollingdale MR, Cochrane AH, Quakyi I, Nussenzweig RS, Nussenzweig V",Rationale for development of a synthetic vaccine against Plasmodium falciparum malaria,"1985","228","4706","1436-1440","Science (New York, N.Y.)","","","","","","","","2409595","","",0,10,0,0,0,,,
5541,0,"Laurens, 2020",journal,Laurens MB,"RTS,S/AS01 vaccine (Mosquirix): an overview","2020","16","3","480-489",Human vaccines & immunotherapeutics,"","","","","","","","31545128","",,0,0,136,0,0,,,
5542,30,"Mensah et al., 2016",journal,"Mensah VA, Gueye A, Ndiaye M, Edwards NJ, Wright D, Anagnostou NA, Syll M, Ndaw A, Abiola A, Bliss C, Gomis JF, Petersen I, Ogwang C, Dieye T, Viebig NK, Lawrie AM, Roberts R, Nicosia A, Faye B, Gaye O, Leroy O, Imoukhuede EB, Ewer KJ, Bejon P, Hill AV, Cisse B","Safety, Immunogenicity and Efficacy of Prime-Boost Vaccination with ChAd63 and MVA Encoding ME-TRAP against Plasmodium falciparum Infection in Adults in Senegal","2016","11","12",e0167951,PloS one,"","","","","","","","27978537","","",0,10,0,0,0,,,
5543,212,"Falsey et al., 2022",journal,"Falsey AR, Walsh EE, Scott DA, Gurtman A, Zareba A, Jansen KU, Gruber WC, Dormitzer PR, Swanson KA, Jiang Q, Gomme E, Cooper D, Schmoele-Thoma B","Phase 1/2 Randomized Study of the Immunogenicity, Safety, and Tolerability of a Respiratory Syncytial Virus Prefusion F Vaccine in Adults With Concomitant Inactivated Influenza Vaccine","2022","225","12","2056-2066",The Journal of infectious diseases,"","","","","","","","34931667","","",0,10,0,0,0,,,
5544,30,"Oneko et al., 2021",journal,"Oneko M, Steinhardt LC, Yego R, Wiegand RE, Swanson PA, Kc N, Akach D, Sang T, Gutman JR, Nzuu EL, Dungani A, Kim Lee Sim B, Oloo PN, Otieno K, Bii DK, Billingsley PF, James ER, Kariuki S, Samuels AM, Jongo S, Chebore W, Abdulla S, Daubenberger C, Mpina M, Styers D, Potter GE, Abarbanell G, Richie TL, Hoffman SL, Seder RA","Safety, immunogenicity and efficacy of PfSPZ Vaccine against malaria in infants in western Kenya: a double-blind, randomized, placebo-controlled phase 2 trial","2021","27","9","1636-1645",Nature medicine,"","","","","","","","34518679","","",0,10,0,0,0,,,
5545,30,"Seder et al., 2013",journal,"Seder RA, Chang LJ, Enama ME, Zephir KL, Sarwar UN, Gordon IJ, Holman LA, James ER, Billingsley PF, Gunasekera A, Richman A, Chakravarty S, Manoj A, Velmurugan S, Li M, Ruben AJ, Li T, Eappen AG, Stafford RE, Plummer SH, Hendel CS, Novik L, Costner PJ, Mendoza FH, Saunders JG, Nason MC, Richardson JH, Murphy J, Davidson SA, Richie TL, Sedegah M, Sutamihardja A, Fahle GA, Lyke KE, Laurens MB, Roederer M, Tewari K, Epstein JE, Sim BK, Ledgerwood JE, Graham BS, Hoffman SL",Protection against malaria by intravenous immunization with a nonreplicating sporozoite vaccine,"2013","341","6152","1359-1365","Science (New York, N.Y.)","","","","","","","","23929949","","",0,10,0,0,0,,,
5546,30,"Mulamba et al., 2022",journal,"Mulamba C, Williams C, Kreppel K, Ouedraogo JB, Olotu AI",Evaluation of the Pfs25-IMX313/Matrix-M malaria transmission-blocking candidate vaccine in endemic settings,"2022","21","1","159",Malaria journal,"","","","","","","","35655174","","",0,10,0,0,0,,,
5547,30,"Mikolajczak et al., 2014",journal,"Mikolajczak SA, Lakshmanan V, Fishbaugher M, Camargo N, Harupa A, Kaushansky A, Douglass AN, Baldwin M, Healer J, O'Neill M, Phuong T, Cowman A, Kappe SH",A next-generation genetically attenuated Plasmodium falciparum parasite created by triple gene deletion,"2014","22","9","1707-1715",Molecular therapy : the journal of the American Society of Gene Therapy,"","","","","","","","24827907","","",0,10,0,0,0,,,
5548,30,"Coelho et al., 2021",journal,"Coelho CH, Tang WK, Burkhardt M, Galson JD, Muratova O, Salinas ND, Alves E Silva TL, Reiter K, MacDonald NJ, Nguyen V, Herrera R, Shimp R, Narum DL, Byrne-Steele M, Pan W, Hou X, Brown B, Eisenhower M, Han J, Jenkins BJ, Doritchamou JYA, Smelkinson MG, Vega-Rodrguez J, Trck J, Taylor JJ, Sagara I, Healy SA, Renn JP, Tolia NH, Duffy PE",A human monoclonal antibody blocks malaria transmission and defines a highly conserved neutralizing epitope on gametes,"2021","12","1","1750",Nature communications,"","","","","","","","33741942","","",0,10,0,0,0,,,
5549,126,"Thomas and Yoon, 2019",journal,"Thomas SJ, Yoon IK",A review of Dengvaxia: development to deployment,"2019","15","10","2295-2314",Human vaccines & immunotherapeutics,"","","","","","","","31589551","","",0,10,0,0,0,,,
5550,126,"Wollner et al., 2021",journal,"Wollner CJ, Richner M, Hassert MA, Pinto AK, Brien JD, Richner JM",A Dengue Virus Serotype 1 mRNA-LNP Vaccine Elicits Protective Immune Responses,"2021","95","12","",Journal of virology,"","","","","","","","33762420","","",0,10,0,0,0,,,
5551,30,"Alves et al., 2017",journal,"Alves E, Salman AM, Leoratti F, Lopez-Camacho C, Viveros-Sandoval ME, Lall A, El-Turabi A, Bachmann MF, Hill AV, Janse CJ, Khan SM, Reyes-Sandoval A",Evaluation of Plasmodium vivax Cell-Traversal Protein for Ookinetes and Sporozoites as a Preerythrocytic P. vivax Vaccine,"2017","24","4","",Clinical and vaccine immunology : CVI,"","","","","","","","28179403","","",0,10,0,0,0,,,
5552,115,"Naggan et al., 1972",journal,"Naggan L, Gunders AE, Michaeli D",Follow-up study of a vaccination programme against cutaneous leishmaniasis. II. Vaccination with a recently isolated strain of L. tropica from Jericho,"1972","66","2","239-243",Transactions of the Royal Society of Tropical Medicine and Hygiene,"","","","","","","","5048790","",,0,0,0,0,0,,,
5553,30,Duffy et al. 2021,website,"",Study of the Transmission-Blocking Vaccine Pfs230D1-EPA/Matrix-M Against Malaria in Adults in Mali,"","","","","","","","","","","","","",https://clinicaltrials.gov/ct2/show/NCT05135273?term=vaccine&cond=Malaria%2CFalciparum&draw=2&rank=2,"",0,10,0,0,0,,,
5554,30,"Spring et al., 2013",journal,"Spring M, Murphy J, Nielsen R, Dowler M, Bennett JW, Zarling S, Williams J, de la Vega P, Ware L, Komisar J, Polhemus M, Richie TL, Epstein J, Tamminga C, Chuang I, Richie N, O'Neil M, Heppner DG, Healer J, O'Neill M, Smithers H, Finney OC, Mikolajczak SA, Wang R, Cowman A, Ockenhouse C, Krzych U, Kappe SH",First-in-human evaluation of genetically attenuated Plasmodium falciparum sporozoites administered by bite of Anopheles mosquitoes to adult volunteers,"2013","31","43","4975-4983",Vaccine,"","","","","","","","24029408","","",0,10,0,0,0,,,
5555,30,"Spring et al., 2009",website,"",Phase 1/2a Trial of Pf GAP p52-/p36- Sporozoite Malaria Vaccine,"","","","","","","","","","","","","",https://clinicaltrials.gov/ct2/show/NCT01024686?term=vaccine&cond=malaria&draw=9&rank=31,"",0,10,0,0,0,,,
5556,30,"Thera et al., 2022",website,"",MSP3-CRM-Vac4All/ Alhydrogel Malaria Vaccine (MSP3CRMV4All),"","","","","","","","","","","","","",https://clinicaltrials.gov/ct2/show/NCT05197751?term=vaccine&cond=Malaria%2CFalciparum&draw=1&rank=10,"",0,10,0,0,0,,,
5557,30,"Aw et al., 2021",journal,"Aw R, Ashik MR, Islam AAZM, Khan I, Mainuddin M, Islam MA, Ahasan MM, Polizzi KM",Production and purification of an active CRM197 in Pichia pastoris and its immunological characterization using a Vi-typhoid antigen vaccine,"2021","39","51","7379-7386",Vaccine,"","","","","","","","34774362","","",0,10,0,0,0,,,
5558,30,"Coelho et al., 2019",journal,"Coelho CH, Gazzinelli-Guimaraes PH, Howard J, Barnafo E, Alani NAH, Muratova O, McCormack A, Kelnhofer E, Urban JF Jr, Narum DL, Anderson C, Langhorne J, Nutman TB, Duffy PE",Chronic helminth infection does not impair immune response to malaria transmission blocking vaccine Pfs230D1-EPA/Alhydrogel in mice,"2019","37","8","1038-1045",Vaccine,"","","","","","","","30685251","","",0,10,0,0,0,,,
5559,30,"He et al., 2015",journal,"He P, Zou Y, Hu Z",Advances in aluminum hydroxide-based adjuvant research and its mechanism,"2015","11","2","477-488",Human vaccines & immunotherapeutics,"","","","","","","","25692535","","",0,10,0,0,0,,,
5560,30,"Bennett et al., 2014",website,"",Phase 1 Clinical Trial With Controlled Human Malaria Infection (CHMI) to Evaluate the Safety and Efficacy of the Plasmodium Falciparum Vaccine Candidate FMP012 Administered Intramuscularly With AS01B Adjuvant System in Healthy Malaria-Nave Adults,"","","","","","","","","","","","","",https://clinicaltrials.gov/ct2/show/NCT02174978?term=vaccine&cond=malaria&draw=2&rank=32,"",0,10,0,0,0,,,
5561,126,"Hadinegoro et al., 2015",journal,"Hadinegoro SR, Arredondo-Garca JL, Capeding MR, Deseda C, Chotpitayasunondh T, Dietze R, Muhammad Ismail HI, Reynales H, Limkittikul K, Rivera-Medina DM, Tran HN, Bouckenooghe A, Chansinghakul D, Corts M, Fanouillere K, Forrat R, Frago C, Gailhardou S, Jackson N, Noriega F, Plennevaux E, Wartel TA, Zambrano B, Saville M",Efficacy and Long-Term Safety of a Dengue Vaccine in Regions of Endemic Disease,"2015","373","13","1195-1206",The New England journal of medicine,"","","","","","","","26214039","","",0,10,0,0,0,,,
5562,54,"Iwata et al., 2017",journal,"Iwata S, Murata S, Rong Han S, Wakana A, Sawata M, Tanaka Y",Safety and Immunogenicity of a 9-Valent Human Papillomavirus Vaccine Administered to 9- to 15-Year-Old Japanese Girls,"2017","70","4","368-373",Japanese journal of infectious diseases,"","","","","","","","28003597","","",0,10,0,0,0,,,
5563,54,"Chatterjee, 2014",journal,Chatterjee A,The next generation of HPV vaccines: nonavalent vaccine V503 on the horizon,"2014","13","11","1279-1290",Expert review of vaccines,"","","","","","","","25256262","","",0,10,0,0,0,,,
5564,54,"Vesikari et al., 2015",journal,"Vesikari T, Brodszki N, van Damme P, Diez-Domingo J, Icardi G, Petersen LK, Tran C, Thomas S, Luxembourg A, Baudin M","A Randomized, Double-Blind, Phase III Study of the Immunogenicity and Safety of a 9-Valent Human Papillomavirus L1 Virus-Like Particle Vaccine (V503) Versus Gardasil in 9-15-Year-Old Girls","2015","34","9","992-998",The Pediatric infectious disease journal,"","","","","","","","26090572","","",0,10,0,0,0,,,
5565,126,"Torres-Flores et al., 2022",journal,"Torres-Flores JM, Reyes-Sandoval A, Salazar MI",Dengue Vaccines: An Update,"2022","36","3","325-336","BioDrugs : clinical immunotherapeutics, biopharmaceuticals and gene therapy","","","","","","","","35608749","","",0,10,0,0,0,,,
5566,126,"Biswal et al., 2019",journal,"Biswal S, Reynales H, Saez-Llorens X, Lopez P, Borja-Tabora C, Kosalaraksa P, Sirivichayakul C, Watanaveeradej V, Rivera L, Espinoza F, Fernando L, Dietze R, Luz K, Venncio da Cunha R, Jimeno J, Lpez-Medina E, Borkowski A, Brose M, Rauscher M, LeFevre I, Bizjajeva S, Bravo L, Wallace D",Efficacy of a Tetravalent Dengue Vaccine in Healthy Children and Adolescents,"2019","381","21","2009-2019",The New England journal of medicine,"","","","","","","","31693803","","",0,10,0,0,0,,,
5567,277,"York, 2021",journal,York A,A vaccine for Crimean-Congo haemorrhagic fever?,"2021","19","2","75",Nature reviews. Microbiology,"","","","","","","","33303929","",,0,0,0,0,0,,,
5568,172,"Yang et al., 2021",journal,"Yang F, Liu P, Li X, Liu R, Gao L, Cui H, Zhang Y, Liu C, Qi X, Pan Q, Liu A, Wang X, Gao Y, Li K",Recombinant Duck Enteritis Virus-Vectored Bivalent Vaccine Effectively Protects Against Duck Hepatitis A Virus Infection in Ducks,"2021","12","","813010",Frontiers in microbiology,"","","","","","","","35003046","",,0,0,0,0,0,,,
5569,30,"Sheehy et al., 2011",journal,"Sheehy SH, Duncan CJ, Elias SC, Collins KA, Ewer KJ, Spencer AJ, Williams AR, Halstead FD, Moretz SE, Miura K, Epp C, Dicks MD, Poulton ID, Lawrie AM, Berrie E, Moyle S, Long CA, Colloca S, Cortese R, Gilbert SC, Nicosia A, Hill AV, Draper SJ",Phase Ia clinical evaluation of the Plasmodium falciparum blood-stage antigen MSP1 in ChAd63 and MVA vaccine vectors,"2011","19","12","2269-2276",Molecular therapy : the journal of the American Society of Gene Therapy,"","","","","","","","21862998","","",0,10,0,0,0,,,
5570,30,"Hill et al., 2009",website,"",A Study of the Safety and Effectiveness of Two New Malaria Vaccines,"","","","","","","","","","","","","",https://clinicaltrials.gov/ct2/show/NCT01003314?term=NCT01003314&draw=2&rank=1,"",0,10,0,0,0,,,
5571,30,"Sheehy et al., 2012",journal,"Sheehy SH, Duncan CJ, Elias SC, Biswas S, Collins KA, O'Hara GA, Halstead FD, Ewer KJ, Mahungu T, Spencer AJ, Miura K, Poulton ID, Dicks MD, Edwards NJ, Berrie E, Moyle S, Colloca S, Cortese R, Gantlett K, Long CA, Lawrie AM, Gilbert SC, Doherty T, Nicosia A, Hill AV, Draper SJ",Phase Ia clinical evaluation of the safety and immunogenicity of the Plasmodium falciparum blood-stage antigen AMA1 in ChAd63 and MVA vaccine vectors,"2012","7","2",e31208,PloS one,"","","","","","","","22363582","","",0,10,0,0,0,,,
5572,30,"Arvalo-Herrera et al., 2022",journal,"Arvalo-Herrera M, Gaitn X, Larmat-Delgado M, Caicedo MA, Herrera SM, Henao-Giraldo J, Castellanos A, Devaud JC, Pannatier A, Oate J, Corradin G, Herrera S",Randomized clinical trial to assess the protective efficacy of a Plasmodium vivax CS synthetic vaccine,"2022","13","1","1603",Nature communications,"","","","","","","","35338131","","",0,10,0,0,0,,,
5573,221,"Umer et al., 2020",journal,"Umer M, Jesse FFA, Mohammed Saleh WM, Chung ELT, Haron AW, Saharee AA, Mohd Lila MA, Ariff AB, Mohammad K, Sharif A",Histopathological changes of reproductive organs of goats immunized with Corynebacterium pseudotuberculosis killed vaccine,"2020","149","","104539",Microbial pathogenesis,"","","","","","","","33007431","",,0,0,0,0,0,,,
5574,190,"Yang et al., 2021",journal,"Yang F, Liu P, Li X, Liu R, Gao L, Cui H, Zhang Y, Liu C, Qi X, Pan Q, Liu A, Wang X, Gao Y, Li K",Recombinant Duck Enteritis Virus-Vectored Bivalent Vaccine Effectively Protects Against Duck Hepatitis A Virus Infection in Ducks,"2021","12","","813010",Frontiers in microbiology,"","","","","","","","35003046","",,0,0,0,0,0,,,
5575,126,"Villar et al., 2015",journal,"Villar L, Dayan GH, Arredondo-Garca JL, Rivera DM, Cunha R, Deseda C, Reynales H, Costa MS, Morales-Ramrez JO, Carrasquilla G, Rey LC, Dietze R, Luz K, Rivas E, Miranda Montoya MC, Corts Supelano M, Zambrano B, Langevin E, Boaz M, Tornieporth N, Saville M, Noriega F",Efficacy of a tetravalent dengue vaccine in children in Latin America,"2015","372","2","113-123",The New England journal of medicine,"","","","","","","","25365753","","",0,10,0,0,0,,,
5576,30,"Aucouturier et al., 2002",journal,"Aucouturier J, Dupuis L, Deville S, Ascarateil S, Ganne V",Montanide ISA 720 and 51: a new generation of water in oil emulsions as adjuvants for human vaccines,"2002","1","1","111-118",Expert review of vaccines,"","","","","","","","12908518","","",0,10,0,0,0,,,
5577,115,"Casella and Mitchell, 2008",journal,"Casella CR, Mitchell TC",Putting endotoxin to work for us: monophosphoryl lipid A as a safe and effective vaccine adjuvant,"2008","65","20","3231-3240",Cellular and molecular life sciences : CMLS,"","","","","","","","18668203","",,0,0,0,0,0,,,
5578,115,"Coler et al., 2002",journal,"Coler RN, Skeiky YA, Bernards K, Greeson K, Carter D, Cornellison CD, Modabber F, Campos-Neto A, Reed SG","Immunization with a polyprotein vaccine consisting of the T-Cell antigens thiol-specific antioxidant, Leishmania major stress-inducible protein 1, and Leishmania elongation initiation factor protects against leishmaniasis","2002","70","8","4215-4225",Infection and immunity,"","","","","","","","12117930","",,0,0,0,0,0,,,
5579,115,"Nascimento et al., 2010",journal,"Nascimento E, Fernandes DF, Vieira EP, Campos-Neto A, Ashman JA, Alves FP, Coler RN, Bogatzki LY, Kahn SJ, Beckmann AM, Pine SO, Cowgill KD, Reed SG, Piazza FM",A clinical trial to evaluate the safety and immunogenicity of the LEISH-F1+MPL-SE vaccine when used in combination with meglumine antimoniate for the treatment of cutaneous leishmaniasis,"2010","28","40","6581-6587",Vaccine,"","","","","","","","20688040","",,0,0,0,0,0,,,
5580,115,"Mou et al., 2015",journal,"Mou Z, Li J, Boussoffara T, Kishi H, Hamana H, Ezzati P, Hu C, Yi W, Liu D, Khadem F, Okwor I, Jia P, Shitaoka K, Wang S, Ndao M, Petersen C, Chen J, Rafati S, Louzir H, Muraguchi A, Wilkins JA, Uzonna JE",Identification of broadly conserved cross-species protective Leishmania antigen and its responding CD4+ T cells,"2015","7","310","310ra167",Science translational medicine,"","","","","","","","26491077","",,0,0,0,0,0,,,
5581,54,"Liu et al., 2015",journal,"Liu C, Yao Y, Yang X, Bai H, Huang W, Xia Y, Ma Y",Production of Recombinant Human Papillomavirus Type 52 L1 Protein in Hansenula polymorpha Formed Virus-Like Particles,"2015","25","6","936-940",Journal of microbiology and biotechnology,"","","","","","","","25639723","","",0,10,0,0,0,,,
5582,54,NCT04436133,website,"Chengdu Institute of Biological Products Co.,Ltd. Simoon Record Pharma Information Consulting Co., Ltd. Guangxi Center for Disease Control and Prevention Beijing Kantorico Statistical Technology Co., Ltd.",Immunogenicity AND Safety Study of the 11 Valent Recombinant Human Papillomavirus Vaccine (Hansenulapolymorpha),"2022","","","","","","","","","","","","",https://clinicaltrials.gov/ct2/show/NCT04436133,"",0,11,0,0,0,,,
5583,126,"Manoff et al., 2019",journal,"Manoff SB, Sausser M, Falk Russell A, Martin J, Radley D, Hyatt D, Roberts CC, Lickliter J, Krishnarajah J, Bett A, Dubey S, Finn T, Coller BA",Immunogenicity and safety of an investigational tetravalent recombinant subunit vaccine for dengue: results of a Phase I randomized clinical trial in flavivirus-nave adults,"2019","15","9","2195-2204",Human vaccines & immunotherapeutics,"","","","","","","","30427741","","",0,10,0,0,0,,,
5584,115,"Louis et al., 2019",journal,"Louis L, Clark M, Wise MC, Glennie N, Wong A, Broderick K, Uzonna J, Weiner DB, Scott P",Intradermal Synthetic DNA Vaccination Generates <i>Leishmania</i>-Specific T Cells in the Skin and Protection against Leishmania major,"2019","87","8","",Infection and immunity,"","","","","","","","31182618","",,0,0,0,0,0,,,
5585,277,"Hawman et al., 2021",journal,"Hawman DW, Ahln G, Appelberg KS, Meade-White K, Hanley PW, Scott D, Monteil V, Devignot S, Okumura A, Weber F, Feldmann H, Sllberg M, Mirazimi A",A DNA-based vaccine protects against Crimean-Congo haemorrhagic fever virus disease in a Cynomolgus macaque model,"2021","6","2","187-195",Nature microbiology,"","","","","","","","33257849","",,0,0,0,0,0,,,
5586,30,"Minassian et al., 2019",website,"","Safety, Immunogenicity and Efficacy of the Blood-stage Plasmodium Vivax Malaria Vaccine Candidate PvDBPII in Matrix M1","","","","","","","","","","","","","",https://clinicaltrials.gov/ct2/show/NCT04201431?term=vaccine&cond=Malaria%2C+Vivax&draw=2&rank=1,"",0,10,0,0,0,,,
5587,30,"Hou et al., 2022",journal,"Hou MM, Barrett JR, Themistocleous Y, Rawlinson TA, Diouf A, Martinez FJ, Nielsen CM, Lias AM, King LDW, Edwards NJ, Greenwood NM, Kingham L, Poulton ID, Khozoee B, Goh C, Mac Lochlainn DJ, Salkeld J, Guilotte-Blisnick M, Huon C, Mohring F, Reimer JM, Chauhan VS, Mukherjee P, Biswas S, Taylor IJ, Lawrie AM, Cho JS, Nugent FL, Long CA, Moon RW, Miura K, Silk SE, Chitnis CE, Minassian AM, Draper SJ",Impact of a blood-stage vaccine on <i>Plasmodium vivax</i> malaria,"2022","","","",medRxiv : the preprint server for health sciences,"","","","","","","","35664997","","",0,10,0,0,0,,,
5588,115,"Salehi-Sangani et al., 2019",journal,"Salehi-Sangani G, Mohebali M, Jajarmi V, Khamesipour A, Bandehpour M, Mahmoudi M, Zahedi-Zavaram H","Immunization against <i>Leishmania major</i> infection in BALB/c mice using a subunit-based DNA vaccine derived from TSA, LmSTI1, KMP11, and LACK predominant antigens","2019","22","12","1493-1501",Iranian journal of basic medical sciences,"","","","","","","","32133069","",,0,0,0,0,0,,,
5589,54,"Galicia-Carmona et al., 2021",journal,"Galicia-Carmona T, Arango-Bravo E, Serrano-Olvera JA, Flores-de La Torre C, Cruz-Esquivel I, Villalobos-Valencia R, Morn-Mendoza A, Castro-Eguiluz D, Cetina-Prez L",ADXS11-001 LM-LLO as specific immunotherapy in cervical cancer,"2021","17","8","2617-2625",Human vaccines & immunotherapeutics,"","","","","","","","33793380","","",0,10,0,0,0,,,
5590,30,"Minassian et al., 2022",website,"",A Study of the Plasmodium Falciparum Malaria Vaccine Candidate Pfs48/45 in Matrix-M Adjuvant in the UK,"","","","","","","","","","","","","",https://clinicaltrials.gov/ct2/show/NCT05400746?term=vaccine&cond=Plasmodium&draw=8&rank=70,"",0,10,0,0,0,,,
5591,30,"Theisen et al., 2017",journal,"Theisen M, Jore MM, Sauerwein R",Towards clinical development of a Pfs48/45-based transmission blocking malaria vaccine,"2017","16","4","329-336",Expert review of vaccines,"","","","","","","","28043178","","",0,10,0,0,0,,,
5592,54,"Hasan et al., 2020",journal,"Hasan Y, Furtado L, Tergas A, Lee N, Brooks R, McCall A, Golden D, Jolly S, Fleming G, Morrow M, Kraynyak K, Sylvester A, Arif F, Levin M, Schwartz D, Boyer J, Skolnik J, Esser M, Kumar R, Bagarazzi M, Weichselbaum R, Spiotto M",A Phase 1 Trial Assessing the Safety and Tolerability of a Therapeutic DNA Vaccination Against HPV16 and HPV18 E6/E7 Oncogenes After Chemoradiation for Cervical Cancer,"2020","107","3","487-498","International journal of radiation oncology, biology, physics","","","","","","","","32151670","","",0,10,0,0,0,,,
5593,30,"NIAID, 2006",website,"",Phase I Study of Safety and Immunogenicity of AMA1-C1Alhydrogel + CPG 7909 Vaccine for Malaria,"","","","","","","","","","","","","",https://clinicaltrials.gov/ct2/show/NCT00414336?term=vaccine&cond=malaria&draw=6,"",0,10,0,0,0,,,
5594,30,"Cooper et al., 2004",journal,"Cooper CL, Davis HL, Morris ML, Efler SM, Adhami MA, Krieg AM, Cameron DW, Heathcote J","CPG 7909, an immunostimulatory TLR9 agonist oligodeoxynucleotide, as adjuvant to Engerix-B HBV vaccine in healthy adults: a double-blind phase I/II study","2004","24","6","693-701",Journal of clinical immunology,"","","","","","","","15622454","","",0,10,0,0,0,,,
5595,30,"Malkin et al., 2005",journal,"Malkin EM, Diemert DJ, McArthur JH, Perreault JR, Miles AP, Giersing BK, Mullen GE, Orcutt A, Muratova O, Awkal M, Zhou H, Wang J, Stowers A, Long CA, Mahanty S, Miller LH, Saul A, Durbin AP",Phase 1 clinical trial of apical membrane antigen 1: an asexual blood-stage vaccine for Plasmodium falciparum malaria,"2005","73","6","3677-3685",Infection and immunity,"","","","","","","","15908397","","",0,10,0,0,0,,,
5596,30,"Hodder et al., 2001",journal,"Hodder AN, Crewther PE, Anders RF",Specificity of the protective antibody response to apical membrane antigen 1,"2001","69","5","3286-3294",Infection and immunity,"","","","","","","","11292751","","",0,10,0,0,0,,,
5597,30,"University of Oxford, 2014",website,"",A Phase Ia Clinical Trial to Assess the Safety and Immunogenicity of New Plasmodium Falciparum Malaria Vaccine Candidates ChAd63 RH5 Alone and With MVA RH5,"","","","","","","","","","","","","",https://clinicaltrials.gov/ct2/show/NCT02181088?term=vaccine&cond=Malaria%2CFalciparum&draw=6,"",0,10,0,0,0,,,
5598,30,"Payne et al., 2017",journal,"Payne RO, Silk SE, Elias SC, Miura K, Diouf A, Galaway F, de Graaf H, Brendish NJ, Poulton ID, Griffiths OJ, Edwards NJ, Jin J, Labb GM, Alanine DG, Siani L, Di Marco S, Roberts R, Green N, Berrie E, Ishizuka AS, Nielsen CM, Bardelli M, Partey FD, Ofori MF, Barfod L, Wambua J, Murungi LM, Osier FH, Biswas S, McCarthy JS, Minassian AM, Ashfield R, Viebig NK, Nugent FL, Douglas AD, Vekemans J, Wright GJ, Faust SN, Hill AV, Long CA, Lawrie AM, Draper SJ",Human vaccination against RH5 induces neutralizing antimalarial antibodies that inhibit RH5 invasion complex interactions,"2017","2","21","",JCI insight,"","","","","","","","29093263","","",0,10,0,0,0,,,
5599,271,"Endt et al., 2022",journal,"Endt K, Wollmann Y, Haug J, Bernig C, Feigl M, Heiseke A, Kalla M, Hochrein H, Suter M, Chaplin P, Volkmann A",A Recombinant MVA-Based RSV Vaccine Induces T-Cell and Antibody Responses That Cooperate in the Protection Against RSV Infection,"2022","13","","841471",Frontiers in immunology,"","","","","","","","35774800","",,0,0,0,0,0,,,
5600,271,"McFarland et al., 2020",journal,"McFarland EJ, Karron RA, Muresan P, Cunningham CK, Libous J, Perlowski C, Thumar B, Gnanashanmugam D, Moye J, Schappell E, Barr E, Rexroad V, Fearn L, Spector SA, Aziz M, Cielo M, Beneri C, Wiznia A, Luongo C, Collins P, Buchholz UJ",Live Respiratory Syncytial Virus Attenuated by M2-2 Deletion and Stabilized Temperature Sensitivity Mutation 1030s Is a Promising Vaccine Candidate in Children,"2020","221","4","534-543",The Journal of infectious diseases,"","","","","","","","31758177","",,0,0,0,0,0,,,
5601,30,"Minassian et al., 2022",website,"",Safety and Immunogenicity of Pvs25-IMX313/Matrix-M1 Vaccine,"","","","","","","","","","","","","",https://clinicaltrials.gov/ct2/show/NCT05270265?term=vaccine&cond=Malaria%2C+Vivax&draw=2&rank=4,"",0,10,0,0,0,,,
5602,30,"Sauerwein et al., 2017",website,"",Safety and Protective Efficacy of Pb(PfCS@UIS4) (PbVac),"","","","","","","","","","","","","",https://clinicaltrials.gov/ct2/show/study/NCT03138096?cond=Pb%28PfCS%40UIS4%29&draw=2&rank=1,"",0,10,0,0,0,,,
5603,30,"Reuling et al., 2020",journal,"Reuling IJ, Mendes AM, de Jong GM, Fabra-Garca A, Nunes-Cabao H, van Gemert GJ, Graumans W, Coffeng LE, de Vlas SJ, Yang ASP, Lee C, Wu Y, Birkett AJ, Ockenhouse CF, Koelewijn R, van Hellemond JJ, van Genderen PJJ, Sauerwein RW, Prudncio M",An open-label phase 1/2a trial of a genetically modified rodent malaria parasite for immunization against Plasmodium falciparum malaria,"2020","12","544","",Science translational medicine,"","","","","","","","32434846","","",0,10,0,0,0,,,
5604,115,"Ricardo-Carter et al., 2013",journal,"Ricardo-Carter C, Favila M, Polando RE, Cotton RN, Bogard Horner K, Condon D, Ballhorn W, Whitcomb JP, Yadav M, Geister RL, Schorey JS, McDowell MA",Leishmania major inhibits IL-12 in macrophages by signalling through CR3 (CD11b/CD18) and down-regulation of ETS-mediated transcription,"2013","35","12","409-420",Parasite immunology,"","","","","","","","23834512","",,0,0,0,0,0,,,
5605,266,"Jenikova et al., 2011",journal,"Jenikova G, Hruz P, Andersson MK, Tejman-Yarden N, Ferreira PC, Andersen YS, Davids BJ, Gillin FD, Svrd SG, Curtiss R 3rd, Eckmann L",1-giardin based live heterologous vaccine protects against Giardia lamblia infection in a murine model,"2011","29","51","9529-9537",Vaccine,"","","","","","","","22001876","",,0,0,0,0,0,,,
5606,13,"Ledgerwood et al., 2017",journal,"Ledgerwood JE, DeZure AD, Stanley DA, Coates EE, Novik L, Enama ME, Berkowitz NM, Hu Z, Joshi G, Ploquin A, Sitar S, Gordon IJ, Plummer SA, Holman LA, Hendel CS, Yamshchikov G, Roman F, Nicosia A, Colloca S, Cortese R, Bailer RT, Schwartz RM, Roederer M, Mascola JR, Koup RA, Sullivan NJ, Graham BS",Chimpanzee Adenovirus Vector Ebola Vaccine,"2017","376","10","928-938",The New England journal of medicine,"","","","","","","","25426834",https://pubmed.ncbi.nlm.nih.gov/25426834/,,0,0,0,0,0,,,
5607,266,"Radunovic et al., 2017",journal,"Radunovic M, Klotz C, Saghaug CS, Brattbakk HR, Aebischer T, Langeland N, Hanevik K",Genetic variation in potential Giardia vaccine candidates cyst wall protein 2 and 1-giardin,"2017","116","8","2151-2158",Parasitology research,"","","","","","","","28578460","",,0,0,0,0,0,,,
5608,266,"Castillo-Romero et al., 2012",journal,"Castillo-Romero A, Davids BJ, Lauwaet T, Gillin FD",Importance of enolase in Giardia lamblia differentiation,"2012","184","2","122-125",Molecular and biochemical parasitology,"","","","","","","","22569588","",,0,0,0,0,0,,,
5609,266,"Ljungstrm et al., 1985",journal,"Ljungstrm I, Holmgren J, Svennerholm AM, Ferrante A",Changes in intestinal fluid and mucosal immune responses to cholera toxin in Giardia muris infection and binding of cholera toxin to Giardia muris trophozoites,"1985","50","1","243-249",Infection and immunity,"","","","","","","","4044038","",,0,0,0,0,0,,,
5610,30,"Rajeshwari et al., 2004",journal,"Rajeshwari K, Patel K, Nambeesan S, Mehta M, Sehgal A, Chakraborty T, Sharma S",The P domain of the P0 protein of Plasmodium falciparum protects against challenge with malaria parasites,"2004","72","9","5515-5521",Infection and immunity,"","","","","","","","15322057","","",0,10,0,0,0,,,
5611,30,"Dub et al., 2020",journal,"Dub JY, McIntosh F, Zarruk JG, David S, Nigou J, Behr MA",Synthetic mycobacterial molecular patterns partially complete Freund's adjuvant,"2020","10","1","5874",Scientific reports,"","","","","","","","32246076","","",0,10,0,0,0,,,
5612,30,"Loughney et al., 2014",journal,"Loughney JW, Lancaster C, Ha S, Rustandi RR",Residual bovine serum albumin (BSA) quantitation in vaccines using automated Capillary Western technology,"2014","461","","49-56",Analytical biochemistry,"","","","","","","","24841366","","",0,10,0,0,0,,,
5613,212,"Endt et al., 2022",journal,"Endt K, Wollmann Y, Haug J, Bernig C, Feigl M, Heiseke A, Kalla M, Hochrein H, Suter M, Chaplin P, Volkmann A",A Recombinant MVA-Based RSV Vaccine Induces T-Cell and Antibody Responses That Cooperate in the Protection Against RSV Infection,"2022","13","","841471",Frontiers in immunology,"","","","","","","","35774800","","",0,10,0,0,0,,,
5614,212,"Eyles et al., 2013",journal,"Eyles JE, Johnson JE, Megati S, Roopchand V, Cockle PJ, Weeratna R, Makinen S, Brown TP, Lang S, Witko SE, Kotash CS, Li J, West K, Maldonado O, Falconer DJ, Lees C, Smith GJ, White P, Wright P, Loudon PT, Merson JR, Jansen KU, Sidhu MK",Nonreplicating vaccines can protect african green monkeys from the memphis 37 strain of respiratory syncytial virus,"2013","208","2","319-329",The Journal of infectious diseases,"","","","","","","","23596321","","",0,10,0,0,0,,,
5615,212,"Haller et al., 2003",journal,"Haller AA, Mitiku M, MacPhail M",Bovine parainfluenza virus type 3 (PIV3) expressing the respiratory syncytial virus (RSV) attachment and fusion proteins protects hamsters from challenge with human PIV3 and RSV,"2003","84",Pt 8,"2153-2162",The Journal of general virology,"","","","","","","","12867647","","",0,10,0,0,0,,,
5616,212,"Johnson et al., 2013",journal,"Johnson JE, McNeil LK, Megati S, Witko SE, Roopchand VS, Obregon JH, Illenberger DM, Kotash CS, Nowak RM, Braunstein E, Yurgelonis I, Jansen KU, Kalyan NK, Sidhu MK","Non-propagating, recombinant vesicular stomatitis virus vectors encoding respiratory syncytial virus proteins generate potent humoral and cellular immunity against RSV and are protective in mice","2013","150","1-2","134-144",Immunology letters,"","","","","","","","23261719","","",0,10,0,0,0,,,
5617,212,"Kim et al., 2014",journal,"Kim E, Okada K, Beeler JA, Crim RL, Piedra PA, Gilbert BE, Gambotto A","Development of an adenovirus-based respiratory syncytial virus vaccine: preclinical evaluation of efficacy, immunogenicity, and enhanced disease in a cotton rat model","2014","88","9","5100-5108",Journal of virology,"","","","","","","","24574396","","",0,10,0,0,0,,,
5618,212,"Liang et al., 2014",journal,"Liang B, Munir S, Amaro-Carambot E, Surman S, Mackow N, Yang L, Buchholz UJ, Collins PL, Schaap-Nutt A","Chimeric bovine/human parainfluenza virus type 3 expressing respiratory syncytial virus (RSV) F glycoprotein: effect of insert position on expression, replication, immunogenicity, stability, and protection against RSV infection","2014","88","8","4237-4250",Journal of virology,"","","","","","","","24478424","","",0,10,0,0,0,,,
5619,212,"McFarland et al., 2020",journal,"McFarland EJ, Karron RA, Muresan P, Cunningham CK, Libous J, Perlowski C, Thumar B, Gnanashanmugam D, Moye J, Schappell E, Barr E, Rexroad V, Fearn L, Spector SA, Aziz M, Cielo M, Beneri C, Wiznia A, Luongo C, Collins P, Buchholz UJ",Live Respiratory Syncytial Virus Attenuated by M2-2 Deletion and Stabilized Temperature Sensitivity Mutation 1030s Is a Promising Vaccine Candidate in Children,"2020","221","4","534-543",The Journal of infectious diseases,"","","","","","","","31758177","","",0,10,0,0,0,,,
5620,212,"Schmidt et al., 2001",journal,"Schmidt AC, McAuliffe JM, Murphy BR, Collins PL",Recombinant bovine/human parainfluenza virus type 3 (B/HPIV3) expressing the respiratory syncytial virus (RSV) G and F proteins can be used to achieve simultaneous mucosal immunization against RSV and HPIV3,"2001","75","10","4594-4603",Journal of virology,"","","","","","","","11312329","","",0,10,0,0,0,,,
5621,212,"Tang et al., 2003",journal,"Tang RS, Schickli JH, MacPhail M, Fernandes F, Bicha L, Spaete J, Fouchier RA, Osterhaus AD, Spaete R, Haller AA",Effects of human metapneumovirus and respiratory syncytial virus antigen insertion in two 3' proximal genome positions of bovine/human parainfluenza virus type 3 on virus replication and immunogenicity,"2003","77","20","10819-10828",Journal of virology,"","","","","","","","14512532","","",0,10,0,0,0,,,
5622,266,"Jensen et al., 1998",journal,"Jensen FC, Savary JR, Diveley JP, Chang JC",Adjuvant activity of incomplete Freund's adjuvant,"1998","32","3","173-186",Advanced drug delivery reviews,"","","","","","","","10837643","",,0,0,0,0,0,,,
5623,212,"Drachev et al., 1976",journal,"Drachev LA, Jasaitis AA, Mikelsaar H, Nemecek IB, Semenov AY, Semenova EG, Severina II, Skulachev VP",Reconstitution of biological molecular generators of electric current. H+-ATPase,"1976","251","22","7077-7082",The Journal of biological chemistry,"","","","","","","","11215","","",0,10,0,0,0,,,
5624,266,"Abdul-Wahid and Faubert, 2007",journal,"Abdul-Wahid A, Faubert G",Mucosal delivery of a transmission-blocking DNA vaccine encoding Giardia lamblia CWP2 by Salmonella typhimurium bactofection vehicle,"2007","25","50","8372-8383",Vaccine,"","","","","","","","17996337","",,0,0,0,0,0,,,
5625,123,"Benitez et al., 2011",journal,"Benitez A, Priest JW, Ehigiator HN, McNair N, Mead JR",Evaluation of DNA encoding acidic ribosomal protein P2 of Cryptosporidium parvum as a potential vaccine candidate for cryptosporidiosis,"2011","29","49","9239-9245",Vaccine,"","","","","","","","21968447","",,0,0,0,0,0,,,
5626,266,"Feng et al., 2016",journal,"Feng XM, Zheng WY, Zhang HM, Shi WY, Li Y, Cui BJ, Wang HY",Vaccination with Bivalent DNA Vaccine of 1-Giardin and CWP2 Delivered by Attenuated Salmonella typhimurium Reduces Trophozoites and Cysts in the Feces of Mice Infected with Giardia lamblia,"2016","11","6",e0157872,PloS one,"","","","","","","","27332547","",,0,0,0,0,0,,,
5627,266,"Mller et al., 1996",journal,"Mller N, Stger S, Gottstein B",Serological analysis of antigenic heterogeneity of Giardia lamblia variant surface proteins,"1996","64","4","1385-1390",Infection and immunity,"","","","","","","","8606105","",,0,0,0,0,0,,,
5628,266,"Stger et al., 1997",journal,"Stger S, Gottstein B, Mller N",Systemic and local antibody response in mice induced by a recombinant peptide fragment from Giardia lamblia variant surface protein (VSP) H7 produced by a Salmonella typhimurium vaccine strain,"1997","27","8","965-971",International journal for parasitology,"","","","","","","","9292314","",,0,0,0,0,0,,,
5629,118,"Gamba et al., 2021",journal,"Gamba JC, Roldn C, Prochetto E, Lupi G, Bontempi I, Poncini CV, Vermeulen M, Prez AR, Marcipar I, Cabrera G",Targeting Myeloid-Derived Suppressor Cells to Enhance a Trans-Sialidase-Based Vaccine Against Trypanosoma cruzi,"2021","11","","671104",Frontiers in cellular and infection microbiology,"","","","","","","","34295832","","",0,10,0,0,0,,,
5630,17,"Cashman et al., 2017",journal,"Cashman KA, Wilkinson ER, Shaia CI, Facemire PR, Bell TM, Bearss JJ, Shamblin JD, Wollen SE, Broderick KE, Sardesai NY, Schmaljohn CS",A DNA vaccine delivered by dermal electroporation fully protects cynomolgus macaques against Lassa fever,"2017","13","12","2902-2911",Human vaccines & immunotherapeutics,"","","","","","","","29045192","",,0,0,0,0,0,,,
5631,17,"Salami et al., 2019",journal,"Salami K, Gouglas D, Schmaljohn C, Saville M, Tornieporth N",A review of Lassa fever vaccine candidates,"2019","37","","105-111",Current opinion in virology,"","","","","","","","31472333","",,0,0,0,0,0,,,
5632,17,"Zapata et al., 2013",journal,"Zapata JC, Poonia B, Bryant J, Davis H, Ateh E, George L, Crasta O, Zhang Y, Slezak T, Jaing C, Pauza CD, Goicochea M, Moshkoff D, Lukashevich IS, Salvato MS",An attenuated Lassa vaccine in SIV-infected rhesus macaques does not persist or cause arenavirus disease but does elicit Lassa virus-specific immunity,"2013","10","","52",Virology journal,"","","","","","","","23402317","",,0,0,0,0,0,,,
5633,17,"Abreu-Mota et al., 2018",journal,"Abreu-Mota T, Hagen KR, Cooper K, Jahrling PB, Tan G, Wirblich C, Johnson RF, Schnell MJ",Non-neutralizing antibodies elicited by recombinant Lassa-Rabies vaccine are critical for protection against Lassa fever,"2018","9","1","4223",Nature communications,"","","","","","","","30310067","",,0,0,0,0,0,,,
5634,123,"Yu et al., 2010",journal,"Yu Q, Li J, Zhang X, Gong P, Zhang G, Li S, Wang H",Induction of immune responses in mice by a DNA vaccine encoding Cryptosporidium parvum Cp12 and Cp21 and its effect against homologous oocyst challenge,"2010","172","1-2","1-7",Veterinary parasitology,"","","","","","","","20541869","",,0,0,0,0,0,,,
5635,123,"Yao et al., 2007",journal,"Yao L, Yin J, Zhang X, Liu Q, Li J, Chen L, Zhao Y, Gong P, Liu C",Cryptosporidium parvum: identification of a new surface adhesion protein on sporozoite and oocyst by screening of a phage-display cDNA library,"2007","115","4","333-338",Experimental parasitology,"","","","","","","","17097085","",,0,0,0,0,0,,,
5636,123,"Bode et al., 2011",journal,"Bode C, Zhao G, Steinhagen F, Kinjo T, Klinman DM",CpG DNA as a vaccine adjuvant,"2011","10","4","499-511",Expert review of vaccines,"","","","","","","","21506647","",,0,0,0,0,0,,,
5637,118,"Barry et al., 2019",journal,"Barry MA, Versteeg L, Wang Q, Pollet J, Zhan B, Gusovsky F, Bottazzi ME, Hotez PJ, Jones KM",A therapeutic vaccine prototype induces protective immunity and reduces cardiac fibrosis in a mouse model of chronic Trypanosoma cruzi infection,"2019","13","5",e0007413,PLoS neglected tropical diseases,"","","","","","","","31145733","","",0,10,0,0,0,,,
5638,118,"Arnal et al., 2020",journal,"Arnal A, Villanueva-Lizama L, Teh-Poot C, Herrera C, Dumonteil E",Extent of polymorphism and selection pressure on the Trypanosoma cruzi vaccine candidate antigen Tc24,"2020","13","10","2663-2672",Evolutionary applications,"","","","","","","","33294015","","",0,10,0,0,0,,,
5639,212,"Sadoff et al., 2021",journal,"Sadoff J, De Paepe E, Haazen W, Omoruyi E, Bastian AR, Comeaux C, Heijnen E, Strout C, Schuitemaker H, Callendret B",Safety and Immunogenicity of the Ad26.RSV.preF Investigational Vaccine Coadministered With an Influenza Vaccine in Older Adults,"2021","223","4","699-708",The Journal of infectious diseases,"","","","","","","","32851411","","",0,10,0,0,0,,,
5640,212,"McFarland et al., 2020",journal,"McFarland EJ, Karron RA, Muresan P, Cunningham CK, Perlowski C, Libous J, Oliva J, Jean-Philippe P, Moye J, Schappell E, Barr E, Rexroad V, Fearn L, Cielo M, Wiznia A, Deville JG, Yang L, Luongo C, Collins PL, Buchholz UJ",Live-Attenuated Respiratory Syncytial Virus Vaccine With M2-2 Deletion and With Small Hydrophobic Noncoding Region Is Highly Immunogenic in Children,"2020","221","12","2050-2059",The Journal of infectious diseases,"","","","","","","","32006006","","",0,10,0,0,0,,,
5641,123,"Wang et al., 2010",journal,"Wang C, Luo J, Amer S, Guo Y, Hu Y, Lu Y, Wang H, Duan M, He H",Multivalent DNA vaccine induces protective immune responses and enhanced resistance against Cryptosporidium parvum infection,"2010","29","2","323-328",Vaccine,"","","","","","","","21029808","",,0,0,0,0,0,,,
5642,123,"Vignali and Kuchroo, 2012",journal,"Vignali DA, Kuchroo VK",IL-12 family cytokines: immunological playmakers,"2012","13","8","722-728",Nature immunology,"","","","","","","","22814351","",,0,0,0,0,0,,,
5643,17,"Cheng et al., 2017",journal,"Cheng BYH, Nogales A, de la Torre JC, Martnez-Sobrido L",Development of live-attenuated arenavirus vaccines based on codon deoptimization of the viral glycoprotein,"2017","501","","35-46",Virology,"","","","","","","","27855284","",,0,0,0,0,0,,,
5644,212,"Karron et al., 2020",journal,"Karron RA, Luongo C, Mateo JS, Wanionek K, Collins PL, Buchholz UJ",Safety and Immunogenicity of the Respiratory Syncytial Virus Vaccine RSV/NS2/1313/I1314L in RSV-Seronegative Children,"2020","222","1","82-91",The Journal of infectious diseases,"","","","","","","","31605113","","",0,10,0,0,0,,,
5645,123,"Liu et al., 2010",journal,"Liu K, Zai D, Zhang D, Wei Q, Han G, Gao H, Huang B",Divalent Cp15-23 vaccine enhances immune responses and protection against Cryptosporidium parvum infection,"2010","32","5","335-344",Parasite immunology,"","","","","","","","20500662","",,0,0,0,0,0,,,
5646,123,"Dub et al., 2020",journal,"Dub JY, McIntosh F, Zarruk JG, David S, Nigou J, Behr MA",Synthetic mycobacterial molecular patterns partially complete Freund's adjuvant,"2020","10","1","5874",Scientific reports,"","","","","","","","32246076","",,0,0,0,0,0,,,
5647,17,"Carnec et al., 2018",journal,"Carnec X, Mateo M, Page A, Reynard S, Hortion J, Picard C, Yekwa E, Barrot L, Barron S, Vallve A, Raoul H, Carbonnelle C, Ferron F, Baize S",A Vaccine Platform against Arenaviruses Based on a Recombinant Hyperattenuated Mopeia Virus Expressing Heterologous Glycoproteins,"2018","92","12","",Journal of virology,"","","","","","","","29593043","",,0,0,0,0,0,,,
5648,91,"Tian et al., 2022",journal,"Tian X, Wang M, Xie T, Wan G, Sun H, Mei X, Zhang Z, Li X, Wang S",A recombinant protein vaccine encoding Toxoplasma gondii Cyst wall 2 (dense granule protein 47) provides partial protection against acute and chronic T. gondii infection in BALB/c mice,"2022","232","","106514",Acta tropica,"","","","","","","","35580637","",,0,0,0,0,0,,,
5649,91,"Dar et al., 2013",journal,"Dar P, Kalaivanan R, Sied N, Mamo B, Kishore S, Suryanarayana VV, Kondabattula G",Montanide ISA 201 adjuvanted FMD vaccine induces improved immune responses and protection in cattle,"2013","31","33","3327-3332",Vaccine,"","","","","","","","23735678","",,0,0,0,0,0,,,
5650,99,"NCBI, 2023",website,"","E1M184V peptide, HIV vaccine peptide CID 24204505","","","","","","","","","","","","","",https://pubchem.ncbi.nlm.nih.gov/compound/24204505,"",0,10,0,0,0,,,
5651,91,"Zhou et al., 2019",journal,"Zhou J, Li C, Luo Y, Wang L",Antigenic Epitope Analysis and Efficacy Evaluation of GRA41 DNA Vaccine Against T. gondii Infection,"2019","64","3","471-478",Acta parasitologica,"","","","","","","","31187386","",,0,0,0,0,0,,,
5652,212,"Domachowske et al., 2018",journal,"Domachowske JB, Khan AA, Esser MT, Jensen K, Takas T, Villafana T, Dubovsky F, Griffin MP","Safety, Tolerability and Pharmacokinetics of MEDI8897, an Extended Half-life Single-dose Respiratory Syncytial Virus Prefusion F-targeting Monoclonal Antibody Administered as a Single Dose to Healthy Preterm Infants","2018","37","9","886-892",The Pediatric infectious disease journal,"","","","","","","","29373476","","",0,10,0,0,0,,,
5653,91,"Lu et al., 2017",journal,"Lu G, Zhou J, Zhou A, Han Y, Guo J, Song P, Zhou H, Cong H, Hou M, Wang L, He S",SAG5B and SAG5C combined vaccine protects mice against Toxoplasma gondii infection,"2017","66","5","596-602",Parasitology international,"","","","","","","","28602862","",,0,0,0,0,0,,,
5654,233,"Wu et al., 2016",journal,"Wu X, Chen P, Lin H, Hao X, Liang Z",Hepatitis E virus: Current epidemiology and vaccine,"2016","12","10","2603-2610",Human vaccines & immunotherapeutics,"","","","","","","","27184971","","",0,10,0,0,0,,,
5655,232,"Wu et al., 2016",journal,"Wu X, Chen P, Lin H, Hao X, Liang Z",Hepatitis E virus: Current epidemiology and vaccine,"2016","12","10","2603-2610",Human vaccines & immunotherapeutics,"","","","","","","","27184971","",,0,0,0,0,0,,,
5656,91,"Foroutan et al., 2020",journal,"Foroutan M, Ghaffarifar F, Sharifi Z, Dalimi A",Vaccination with a novel multi-epitope ROP8 DNA vaccine against acute Toxoplasma gondii infection induces strong B and T cell responses in mice,"2020","69","","101413","Comparative immunology, microbiology and infectious diseases","","","","","","","","31954995","",,0,0,0,0,0,,,
5657,91,"Xu et al., 2014",journal,"Xu Y, Zhang NZ, Tan QD, Chen J, Lu J, Xu QM, Zhu XQ",Evaluation of immuno-efficacy of a novel DNA vaccine encoding Toxoplasma gondii rhoptry protein 38 (TgROP38) against chronic toxoplasmosis in a murine model,"2014","14","","525",BMC infectious diseases,"","","","","","","","25267356","",,0,0,0,0,0,,,
5658,91,"Li et al., 2015",journal,"Li XZ, Wang XH, Xia LJ, Weng YB, Hernandez JA, Tu LQ, Li LT, Li SJ, Yuan ZG",Protective efficacy of recombinant canine adenovirus type-2 expressing TgROP18 (CAV-2-ROP18) against acute and chronic Toxoplasma gondii infection in mice,"2015","15","","114",BMC infectious diseases,"","","","","","","","25886737","",,0,0,0,0,0,,,
5659,91,"Zhu et al., 2022",journal,"Zhu Y, Xu J, Lian S, Zhang R, Hou J, Wang M, Yan X",Difference Analysis Between Canine Adenovirus Types 1 And 2,"2022","12","","854876",Frontiers in cellular and infection microbiology,"","","","","","","","35360116","",,0,0,0,0,0,,,
5660,118,"Gupta et al., 2019",journal,"Gupta S, Salgado-Jimnez B, Lokugamage N, Vzquez-Chagoyn JC, Garg NJ",TcG2/TcG4 DNA Vaccine Induces Th1 Immunity Against Acute Trypanosoma cruzi Infection: Adjuvant and Antigenic Effects of Heterologous T. rangeli Booster Immunization,"2019","10","","1456",Frontiers in immunology,"","","","","","","","31293599","","",0,10,0,0,0,,,
5661,118,"Araujo and Morein, 1991",journal,"Araujo FG, Morein B",Immunization with Trypanosoma cruzi epimastigote antigens incorporated into iscoms protects against lethal challenge in mice,"1991","59","9","2909-2914",Infection and immunity,"","","","","","","","1908826","","",0,10,0,0,0,,,
5662,118,"Aparicio-Burgos et al., 2015",journal,"Aparicio-Burgos JE, Zepeda-Escobar JA, de Oca-Jimenez RM, Estrada-Franco JG, Barbabosa-Pliego A, Ochoa-Garca L, Alejandre-Aguilar R, Rivas N, Peuelas-Rivas G, Val-Arreola M, Gupta S, Salazar-Garca F, Garg NJ, Vzquez-Chagoyn JC",Immune protection against Trypanosoma cruzi induced by TcVac4 in a canine model,"2015","9","4",e0003625,PLoS neglected tropical diseases,"","","","","","","","25853654","","",0,10,0,0,0,,,
5663,118,"Bhatia et al., 2004",journal,"Bhatia V, Sinha M, Luxon B, Garg N",Utility of the Trypanosoma cruzi sequence database for identification of potential vaccine candidates by in silico and in vitro screening,"2004","72","11","6245-6254",Infection and immunity,"","","","","","","","15501750","","",0,10,0,0,0,,,
5664,212,"Bastos et al., 2009",journal,"Bastos RG, Borsuk S, Seixas FK, Dellagostin OA",Recombinant Mycobacterium bovis BCG,"2009","27","47","6495-6503",Vaccine,"","","","","","","","19720367","",,0,0,0,0,0,,,
5665,212,"Abarca et al., 2020",journal,"Abarca K, Rey-Jurado E, Muoz-Durango N, Vzquez Y, Soto JA, Glvez NMS, Valds-Ferrada J, Iturriaga C, Urza M, Borzutzky A, Cerda J, Villarroel L, Madrid V, Gonzlez PA, Gonzlez-Aramundiz JV, Bueno SM, Kalergis AM","Safety and immunogenicity evaluation of recombinant BCG vaccine against respiratory syncytial virus in a randomized, double-blind, placebo-controlled phase I clinical trial","2020","27","","100517",EClinicalMedicine,"","","","","","","","33073219","","",0,10,0,0,0,,,
5666,91,"Li et al., 2016",journal,"Li XZ, Lv L, Zhang X, Anchang KY, Abdullahi AY, Tu L, Wang X, Xia L, Zhang XX, Feng W, Lu C, Li S, Yuan ZG",Recombinant canine adenovirus type-2 expressing TgROP16 provides partial protection against acute Toxoplasma gondii infection in mice,"2016","45","","447-453","Infection, genetics and evolution : journal of molecular epidemiology and evolutionary genetics in infectious diseases","","","","","","","","27742446","",,0,0,0,0,0,,,
5667,118,"Gupta and Garg, 2013",journal,"Gupta S, Garg NJ",TcVac3 induced control of Trypanosoma cruzi infection and chronic myocarditis in mice,"2013","8","3",e59434,PloS one,"","","","","","","","23555672","","",0,10,0,0,0,,,
5668,118,"Gupta and Garg, 2010",journal,"Gupta S, Garg NJ",Prophylactic efficacy of TcVac2 against Trypanosoma cruzi in mice,"2010","4","8",e797,PLoS neglected tropical diseases,"","","","","","","","20706586","","",0,10,0,0,0,,,
5669,13,Planty et al. 2020,journal,"Camille Planty 1, Guillaume Chevalier 2, Marie-ve Duclos 2, Clmentine Chalmey 2, Catherine Thirion-Delalande 2, Ccile Sobry , Ann-Muriel Steff 3, Eric Destexhe 1",Nonclinical safety assessment of repeated administration and biodistribution of ChAd3-EBO-Z Ebola candidate vaccine,"2020","","","",PubMed,"","","","","","","","31965598",https://pubmed.ncbi.nlm.nih.gov/31965598/,,0,0,0,0,0,,,
5670,13,Venkatraman et al.,journal,"Navin Venkatraman 1, Birahim Pierre Ndiaye 2, Georgina Bowyer 1, Djibril Wade 2, Saranya Sridhar 1, Daniel Wright 1, Jonathan Powlson 1, Ibrahima Ndiaye 2, Siry Diye 2, Craig Thompson 1, Momar Bakhoum 2, Richard Morter 1, Stefania Capone 3, Mariarosaria Del Sorbo 3, Sophie Jamieson 1, Tommy Rampling 1, Mehreen Datoo 1, Rachel Roberts 1, Ian Poulton 1, Oliver Griffiths 1, W Ripley Ballou 4, Franois Roman 4, David J M Lewis 5, Alison Lawrie 1, Egeruan Imoukhuede 1, Sarah C Gilbert 1, Tandakha N Dieye 2, Katie J Ewer 1, Souleymane Mboup 2, Adrian V S Hill 1",Safety and Immunogenicity of a Heterologous Prime-Boost Ebola Virus Vaccine Regimen in Healthy Adults in the United Kingdom and Senegal,"2019","","","","","","","","","","","","30407513",https://pubmed.ncbi.nlm.nih.gov/30407513/,,0,0,0,0,0,,,
5671,91,"Chen et al., 2014",journal,"Chen J, Li ZY, Huang SY, Petersen E, Song HQ, Zhou DH, Zhu XQ",Protective efficacy of Toxoplasma gondii calcium-dependent protein kinase 1 (TgCDPK1) adjuvated with recombinant IL-15 and IL-21 against experimental toxoplasmosis in mice,"2014","14","","487",BMC infectious diseases,"","","","","","","","25192845","",,0,0,0,0,0,,,
5672,321,NCT04655625,website,"",Clinical trial for vaccine AG0302-COVID19,"","","","","","","","","","","","","",https://clinicaltrials.gov/ct2/show/NCT04655625,"",0,10,0,0,0,,,
5673,212,"Chatterjee et al., 2017",journal,"Chatterjee S, Luthra P, Esaulova E, Agapov E, Yen BC, Borek DM, Edwards MR, Mittal A, Jordan DS, Ramanan P, Moore ML, Pappu RV, Holtzman MJ, Artyomov MN, Basler CF, Amarasinghe GK, Leung DW",Structural basis for human respiratory syncytial virus NS1-mediated modulation of host responses,"2017","2","","17101",Nature microbiology,"","","","","","","","28665409","","",0,10,0,0,0,,,
5674,91,"Chen et al., 2016",journal,"Chen J, Li ZY, Petersen E, Liu WG, Zhu XQ",Co-administration of interleukins 7 and 15 with DNA vaccine improves protective immunity against Toxoplasma gondii,"2016","162","","18-23",Experimental parasitology,"","","","","","","","26706605","",,0,0,0,0,0,,,
5675,212,"Gan et al., 2012",journal,"Gan SW, Tan E, Lin X, Yu D, Wang J, Tan GM, Vararattanavech A, Yeo CY, Soon CH, Soong TW, Pervushin K, Torres J",The small hydrophobic protein of the human respiratory syncytial virus forms pentameric ion channels,"2012","287","29","24671-24689",The Journal of biological chemistry,"","","","","","","","22621926","","",0,10,0,0,0,,,
5676,212,"Oliveira et al., 2013",journal,"Oliveira AP, Simabuco FM, Tamura RE, Guerrero MC, Ribeiro PG, Libermann TA, Zerbini LF, Ventura AM","Human respiratory syncytial virus N, P and M protein interactions in HEK-293T cells","2013","177","1","108-112",Virus research,"","","","","","","","23892143","","",0,10,0,0,0,,,
5677,28,"Volkova et al., 2021",journal,"Volkova NV, Pyankov OV, Ivanova AV, Isaeva AA, Zybkina AV, Kazachinskaya EI, Shcherbakov DN",Prototype of a DNA Vaccine against Marburg Virus,"2021","170","4","475-478",Bulletin of experimental biology and medicine,"","","","","","","","33713231","","",0,10,0,0,0,,,
5678,212,"Pei et al., 2021",journal,"Pei J, Wagner ND, Zou AJ, Chatterjee S, Borek D, Cole AR, Kim PJ, Basler CF, Otwinowski Z, Gross ML, Amarasinghe GK, Leung DW",Structural basis for IFN antagonism by human respiratory syncytial virus nonstructural protein 2,"2021","118","10","",Proceedings of the National Academy of Sciences of the United States of America,"","","","","","","","33649232","","",0,10,0,0,0,,,
5679,212,"Simabuco et al., 2011",journal,"Simabuco FM, Asara JM, Guerrero MC, Libermann TA, Zerbini LF, Ventura AM",Structural analysis of human respiratory syncytial virus p protein: identification of intrinsically disordered domains,"2011","42","1","340-345",Brazilian journal of microbiology : [publication of the Brazilian Society for Microbiology],"","","","","","","","24031640","","",0,10,0,0,0,,,
5680,321,"Nakagami et al,, 2022",journal,"Hironori Nakagami,  Hiroki Hayashi , Jiao Sun , Yuka Yanagida , Takako Otera , Futoshi Nakagami , Shigeto Hamaguchi , Hisao Yoshida , Hideo Okuno , Shota Yoshida , Ryo Nakamaru , Serina Yokoyama , Taku Fujimoto , Kazuhiro Hongyo , Yukihiro Akeda , Ryuichi Morishita , Kazunori Tomono , Hiromi Rakugi",Study to Assess the Safety and Immunogenicity of an Intradermal COVID-19 DNA Vaccine Administered Using a Pyro-Drive Jet Injector in Healthy Adults,"2022","","","","","","","","","","","","36146505",https://pubmed.ncbi.nlm.nih.gov/36146505/,"",0,10,0,0,0,,,
5681,91,"Zheng et al., 2017",journal,"Zheng L, Hu Y, Hua Q, Luo F, Xie G, Li X, Lin J, Wan Y, Ren S, Pan C, Tan F",Protective immune response in mice induced by a suicidal DNA vaccine encoding NTPase-II gene of Toxoplasma gondii,"2017","166","","336-342",Acta tropica,"","","","","","","","27940233","",,0,0,0,0,0,,,
5682,91,"Chen et al., 2018",journal,"Chen Y, Yu M, Hemandez JA, Li J, Yuan ZG, Yan H",Immuno-efficacy of DNA vaccines encoding PLP1 and ROP18 against experimental Toxoplasma gondii infection in mice,"2018","188","","73-78",Experimental parasitology,"","","","","","","","29626423","",,0,0,0,0,0,,,
5683,91,"Yan et al., 2012",journal,"Yan HK, Yuan ZG, Song HQ, Petersen E, Zhou Y, Ren D, Zhou DH, Li HX, Lin RQ, Yang GL, Zhu XQ",Vaccination with a DNA vaccine coding for perforin-like protein 1 and MIC6 induces significant protective immunity against Toxoplasma gondii,"2012","19","5","684-689",Clinical and vaccine immunology : CVI,"","","","","","","","22379063","",,0,0,0,0,0,,,
5684,28,"Tiemessen et al., 2022",journal,"Tiemessen MM, Solforosi L, Dekking L, Czapska-Casey D, Serroyen J, Sullivan NJ, Volkmann A, Pau MG, Callendret B, Schuitemaker H, Luhn K, Zahn R, Roozendaal R",Protection against Marburg Virus and Sudan Virus in NHP by an Adenovector-Based Trivalent Vaccine Regimen Is Correlated to Humoral Immune Response Levels,"2022","10","8","",Vaccines,"","","","","","","","36016151","","",0,10,0,0,0,,,
5685,212,"Tiong-Yip et al., 2014",journal,"Tiong-Yip CL, Aschenbrenner L, Johnson KD, McLaughlin RE, Fan J, Challa S, Xiong H, Yu Q",Characterization of a respiratory syncytial virus L protein inhibitor,"2014","58","7","3867-3873",Antimicrobial agents and chemotherapy,"","","","","","","","24777090","","",0,10,0,0,0,,,
5686,212,"Shahriari et al., 2018",journal,"Shahriari S, Wei KJ, Ghildyal R",Respiratory Syncytial Virus Matrix (M) Protein Interacts with Actin In Vitro and in Cell Culture,"2018","10","10","",Viruses,"","","","","","","","30274351","","",0,10,0,0,0,,,
5687,212,"Oomens et al., 2006",journal,"Oomens AG, Bevis KP, Wertz GW",The cytoplasmic tail of the human respiratory syncytial virus F protein plays critical roles in cellular localization of the F protein and infectious progeny production,"2006","80","21","10465-10477",Journal of virology,"","","","","","","","16928754","","",0,10,0,0,0,,,
5688,212,"Tripp et al., 2018",journal,"Tripp RA, Power UF, Openshaw PJM, Kauvar LM",Respiratory Syncytial Virus: Targeting the G Protein Provides a New Approach for an Old Problem,"2018","92","3","",Journal of virology,"","","","","","","","29118126","","",0,10,0,0,0,,,
5689,28,"Dye et al., 2016",journal,"Dye JM, Warfield KL, Wells JB, Unfer RC, Shulenin S, Vu H, Nichols DK, Aman MJ, Bavari S",Virus-Like Particle Vaccination Protects Nonhuman Primates from Lethal Aerosol Exposure with Marburgvirus (VLP Vaccination Protects Macaques against Aerosol Challenges),"2016","8","4","94",Viruses,"","","","","","","","27070636","","",0,10,0,0,0,,,
5690,212,"Gilman et al., 2019",journal,"Gilman MSA, Furmanova-Hollenstein P, Pascual G, B van 't Wout A, Langedijk JPM, McLellan JS",Transient opening of trimeric prefusion RSV F proteins,"2019","10","1","2105",Nature communications,"","","","","","","","31068578","","",0,10,0,0,0,,,
5691,118,"Gupta and Garg, 2012",journal,"Gupta S, Garg NJ",Delivery of antigenic candidates by a DNA/MVA heterologous approach elicits effector CD8(+)T cell mediated immunity against Trypanosoma cruzi,"2012","30","50","7179-7186",Vaccine,"","","","","","","","23079191","","",0,10,0,0,0,,,
5692,91,"Xu et al., 2015",journal,"Xu Y, Zhang NZ, Wang M, Dong H, Feng SY, Guo HC, Zhu XQ",A long-lasting protective immunity against chronic toxoplasmosis in mice induced by recombinant rhoptry proteins encapsulated in poly (lactide-co-glycolide) microparticles,"2015","114","11","4195-4203",Parasitology research,"","","","","","","","26243574","",,0,0,0,0,0,,,
5693,91,"Wang et al., 2014",journal,"Wang HL, Zhang TE, Yin LT, Pang M, Guan L, Liu HL, Zhang JH, Meng XL, Bai JZ, Zheng GP, Yin GR",Partial protective effect of intranasal immunization with recombinant Toxoplasma gondii rhoptry protein 17 against toxoplasmosis in mice,"2014","9","9",e108377,PloS one,"","","","","","","","25255141","",,0,0,0,0,0,,,
5694,91,"Wang et al., 2016",journal,"Wang HL, Wen LM, Pei YJ, Wang F, Yin LT, Bai JZ, Guo R, Wang CF, Yin GR",Recombinant Toxoplasma gondii phosphoglycerate mutase 2 confers protective immunity against toxoplasmosis in BALB/c mice,"2016","23","","12","Parasite (Paris, France)","","","","","","","","26984115","",,0,0,0,0,0,,,
5695,118,"Moraschi et al., 2021",journal,"Moraschi BF, Noronha IH, Ferreira CP, Cariste LM, Monteiro CB, Denapoli P, Vrechi T, Pereira GJS, Gazzinelli RT, Lannes-Vieira J, Rodrigues MM, Bortoluci KR, Vasconcelos JRC",Rapamycin Improves the Response of Effector and Memory CD8(+) T Cells Induced by Immunization With ASP2 of Trypanosoma cruzi,"2021","11","","676183",Frontiers in cellular and infection microbiology,"","","","","","","","34123875","","",0,10,0,0,0,,,
5696,118,"Arce-Fonseca et al., 2018",journal,"Arce-Fonseca M, Gonzlez-Vzquez MC, Rodrguez-Morales O, Graullera-Rivera V, Aranda-Fraustro A, Reyes PA, Carabarin-Lima A, Rosales-Encina JL",Recombinant Enolase of Trypanosoma cruzi as a Novel Vaccine Candidate against Chagas Disease in a Mouse Model of Acute Infection,"2018","2018","","8964085",Journal of immunology research,"","","","","","","","29854848","","",0,10,0,0,0,,,
5697,118,"Rigato et al., 2011",journal,"Rigato PO, de Alencar BC, de Vasconcelos JR, Dominguez MR, Arajo AF, Machado AV, Gazzinelli RT, Bruna-Romero O, Rodrigues MM","Heterologous plasmid DNA prime-recombinant human adenovirus 5 boost vaccination generates a stable pool of protective long-lived CD8(+) T effector memory cells specific for a human parasite, Trypanosoma cruzi","2011","79","5","2120-2130",Infection and immunity,"","","","","","","","21357719","","",0,10,0,0,0,,,
5698,321,Zhang et. al,journal,"Zheng M, Wang P, Song W, Lau SY, Liu S, Huang X, Mok BW, Liu YC, Chen Y, Yuen KY, Chen H. An",A14U Substitution in the 3' Noncoding Region of the M Segment of Viral RNA Supports Replication of Influenza Virus with an NS1 Deletion by Modulating Alternative Splicing of M Segment mRNAs,"2015","","","","","","","","","","","","26223635",https://pubmed.ncbi.nlm.nih.gov/26223635/,"",0,10,0,0,0,,,
5699,321,Spencer et. al 2022 [PubMed ID: 35228013],journal,"Alexandra J Spencer,, Susan Morris , Marta Ulaszewska , Claire Powers , Reshma Kailath , Cameron Bissett, Adam Truby, Nazia Thakur, Joseph Newman, Elizabeth R Allen , Indra Rudiansyah, Chang Liu, Wanwisa Dejnirattisai, Juthathip Mongkolsapaya, Hannah Davies, Francesca R Donnellan, David Pulido, Thomas P Peacock, Wendy S Barclay, Helen Bright, Kuishu Ren, Gavin Screaton, Patrick McTamney, Dalan Bailey, Sarah C Gilbert, Teresa Lambe","The ChAdOx1 vectored vaccine, AZD2816, induces strong immunogenicity against SARS-CoV-2 beta (B.1.351) and other variants of concern in preclinical studies","2022","","","","","","","","","","","","35228013",https://pubmed.ncbi.nlm.nih.gov/35228013/,"",0,10,0,0,0,,,
5700,321,Hassan et. al 2020,journal,"Hassan AO, Kafai NM, Dmitriev IP, Fox JM, Smith BK, Harvey IB, Chen RE, Winkler ES, Wessel AW, Case JB, Kashentseva E, McCune BT, Bailey AL, Zhao H, VanBlargan LA, Dai YN, Ma M, Adams LJ, Shrihari S, Danis JE, Gralinski LE, Hou YJ, Schafer A, Kim AS, Keeler SP, Weiskopf D, Baric RS, Holtzman MJ, Fremont DH, Curiel DT, Diamond MS",A Single-Dose Intranasal ChAd Vaccine Protects Upper and Lower Respiratory Tracts against SARS-CoV-2,"2020","","","","","","","","","","","","32931734",https://pubmed.ncbi.nlm.nih.gov/32931734/,"",0,10,0,0,0,,,
5701,321,Agrati et. al 2021,journal,"Chiara Agrati , Stefania Capone , Concetta Castilletti, Eleonora Cimini, Giulia Matusali, Silvia Meschi, Eleonora Tartaglia, Roberto Camerini, Simone Lanini, Stefano Milleri, Stefano Colloca, Alessandra Vitelli, Antonella Folgori",Strong immunogenicity of heterologous prime-boost immunizations with the experimental vaccine GRAd-COV2 and BNT162b2 or ChAdOx1-nCOV19,"","","","","","","","","","","","","34737309",https://pubmed.ncbi.nlm.nih.gov/34737309/,"",0,10,0,0,0,,,
5702,321,Ahn et. al 2022,journal,"Jin Young Ahn, Jeongsoo Lee, You Suk Suh, Young Goo Song, Yoon-Jeong Choi, Kyoung Hwa Lee, Sang Hwan Seo, Manki Song, Jong-Won Oh, Minwoo Kim, Han Yeong Seo, Jeong-Eun Kwak, Jin Won Youn, Jung Won Woo, Eui-Cheol Shin, Young Chul Sung, Su-Hyung Park, Jun Yong Choi","afety and immunogenicity of two recombinant DNA COVID-19 vaccines containing the coding regions of the spike or spike and nucleocapsid proteins: an interim analysis of two open-label, non-randomised, phase 1 trials in healthy adults","2022","","","","","","","","","","","","35156068/",https://pubmed.ncbi.nlm.nih.gov/35156068,"",0,10,0,0,0,,,
5703,321,NCT04751682,website,"",Safety and Immunogenicity of an Intranasal SARS-CoV-2 Vaccine (BBV154) for COVID-19,"","","","","","","","","","","","","",https://clinicaltrials.gov/ct2/show/NCT04751682,"",0,10,0,0,0,,,
5704,118,"Gupta et al., 2015",journal,"Gupta S, Smith C, Auclair S, Delgadillo Ade J, Garg NJ",Therapeutic Efficacy of a Subunit Vaccine in Controlling Chronic Trypanosoma cruzi Infection and Chagas Disease Is Enhanced by Glutathione Peroxidase Over-Expression,"2015","10","6",e0130562,PloS one,"","","","","","","","26075398","","",0,10,0,0,0,,,
5705,91,"Tanaka et al., 2014",journal,"Tanaka S, Kuroda Y, Ihara F, Nishimura M, Hiasa J, Kojima N, Nishikawa Y",Vaccination with profilin encapsulated in oligomannose-coated liposomes induces significant protective immunity against Toxoplasma gondii,"2014","32","16","1781-1785",Vaccine,"","","","","","","","24530937","",,0,0,0,0,0,,,
5706,91,"Liu et al., 2016",journal,"Liu Z, Yin L, Li Y, Yuan F, Zhang X, Ma J, Liu H, Wang Y, Zheng K, Cao J",Intranasal immunization with recombinant Toxoplasma gondii actin depolymerizing factor confers protective efficacy against toxoplasmosis in mice,"2016","17","1","37",BMC immunology,"","","","","","","","27716047","",,0,0,0,0,0,,,
5707,91,"Wang et al., 2014",journal,"Wang HL, Pang M, Yin LT, Zhang JH, Meng XL, Yu BF, Guo R, Bai JZ, Zheng GP, Yin GR",Intranasal immunisation of the recombinant Toxoplasma gondii receptor for activated C kinase 1 partly protects mice against T. gondii infection,"2014","137","","58-66",Acta tropica,"","","","","","","","24813415","",,0,0,0,0,0,,,
5708,212,"Yang et al., 2013",journal,"Yang CF, Wang CK, Malkin E, Schickli JH, Shambaugh C, Zuo F, Galinski MS, Dubovsky F, Tang RS","Implication of respiratory syncytial virus (RSV) F transgene sequence heterogeneity observed in Phase 1 evaluation of MEDI-534, a live attenuated parainfluenza type 3 vectored RSV vaccine","2013","31","26","2822-2827",Vaccine,"","","","","","","","23602668","",,0,0,0,0,0,,,
5709,91,"Zhang et al., 2016",journal,"Zhang NZ, Xu Y, Wang M, Chen J, Huang SY, Gao Q, Zhu XQ",Vaccination with Toxoplasma gondii calcium-dependent protein kinase 6 and rhoptry protein 18 encapsulated in poly(lactide-co-glycolide) microspheres induces long-term protective immunity in mice,"2016","16","","168",BMC infectious diseases,"","","","","","","","27090890","",,0,0,0,0,0,,,
5710,212,"Ivanov et al., 2021",journal,"Ivanov V, Oomens AGP, Papin JF, Staats R, Reuter DN, Yu Z, Piedra PA, Wellliver RC Sr",Intranasal and intrapulmonary vaccination with an M protein-deficient respiratory syncytial virus (RSV) vaccine improves clinical signs and reduces viral replication in infant baboons after an RSV challenge infection,"2021","39","30","4063-4071",Vaccine,"","","","","","","","34140172","",,0,0,0,0,0,,,
5711,118,"Bivona et al., 2018",journal,"Bivona AE, Snchez Alberti A, Matos MN, Cerny N, Cardoso AC, Morales C, Gonzlez G, Cazorla SI, Malchiodi EL",Trypanosoma cruzi 80 kDa prolyl oligopeptidase (Tc80) as a novel immunogen for Chagas disease vaccine,"2018","12","3",e0006384,PLoS neglected tropical diseases,"","","","","","","","29601585","","",0,10,0,0,0,,,
5712,91,"El et al., 2016",journal,"El Temsahy MM, El Kerdany ED, Eissa MM, Shalaby TI, Talaat IM, Mogahed NM",The effect of chitosan nanospheres on the immunogenicity of Toxoplasma lysate vaccine in mice,"2016","40","3","611-626",Journal of parasitic diseases : official organ of the Indian Society for Parasitology,"","","","","","","","27605755","",,0,0,0,0,0,,,
5713,91,"El et al., 2014",journal,"El Bissati K, Zhou Y, Dasgupta D, Cobb D, Dubey JP, Burkhard P, Lanar DE, McLeod R",Effectiveness of a novel immunogenic nanoparticle platform for Toxoplasma peptide vaccine in HLA transgenic mice,"2014","32","26","3243-3248",Vaccine,"","","","","","","","24736000","",,0,0,0,0,0,,,
5714,91,"Lee et al., 2016",journal,"Lee DH, Kim AR, Lee SH, Quan FS",Cross-protection induced by Toxoplasma gondii virus-like particle vaccine upon intraperitoneal route challenge,"2016","164","","77-83",Acta tropica,"","","","","","","","27586039","",,0,0,0,0,0,,,
5715,91,"Lagal et al., 2015",journal,"Lagal V, Dinis M, Cannella D, Bargieri D, Gonzalez V, Andenmatten N, Meissner M, Tardieux I",AMA1-deficient Toxoplasma gondii parasites transiently colonize mice and trigger an innate immune response that leads to long-lasting protective immunity,"2015","83","6","2475-2486",Infection and immunity,"","","","","","","","25847964","",,0,0,0,0,0,,,
5716,54,"Nieto et al., 2012",journal,"Nieto K, Weghofer M, Sehr P, Ritter M, Sedlmeier S, Karanam B, Seitz H, Mller M, Kellner M, Hrer M, Michaelis U, Roden RB, Gissmann L, Kleinschmidt JA",Development of AAVLP(HPV16/31L2) particles as broadly protective HPV vaccine candidate,"2012","7","6",e39741,PloS one,"","","","","","","","22761884","","",0,10,0,0,0,,,
5717,28,"Zhu et al., 2022",journal,"Zhu W, Liu G, Cao W, He S, Leung A, Strher U, Fairchild MJ, Nichols R, Crowell J, Fusco J, Banadyga L","A Cloned Recombinant Vesicular Stomatitis Virus-Vectored Marburg Vaccine, PHV01, Protects Guinea Pigs from Lethal Marburg Virus Disease","2022","10","7","",Vaccines,"","","","","","","","35891170","",,0,0,0,0,0,,,
5718,277,"Berber et al., 2021",journal,"Berber E, anakolu N, Tonbak , Ozdarendeli A",Development of a protective inactivated vaccine against Crimean-Congo hemorrhagic fever infection,"2021","7","10",e08161,Heliyon,"","","","","","","","34703927","",,0,0,0,0,0,,,
5719,28,"Woolsey et al., 2022",journal,"Woolsey C, Cross RW, Agans KN, Borisevich V, Deer DJ, Geisbert JB, Gerardi C, Latham TE, Fenton KA, Egan MA, Eldridge JH, Geisbert TW, Matassov D",A highly attenuated Vesiculovax vaccine rapidly protects nonhuman primates against lethal Marburg virus challenge,"2022","16","5",e0010433,PLoS neglected tropical diseases,"","","","","","","","35622847","",,0,0,0,0,0,,,
5720,321,"Li et al.,",journal,"Jianglong Li, Qi Liu, Jun Liu, Zihui Fang, Liping Luo,, Shuang Li, Yixin Lei, Zhi Li, Jing Jin, Ronglin Xie, Yucai Peng",Development of Bivalent mRNA Vaccines against SARS-CoV-2 Variants,"2022","","","","","","","","","","","","36366316",https://pubmed.ncbi.nlm.nih.gov/36366316/,"",0,10,0,0,0,,,
5721,321,Tran et. al 2021,journal,"Thi Nhu Mai Tran, Bruce Pearson May, Trong Thuan Ung, Mai Khoi Nguyen, Thi Thuy Trang Nguyen, Van Long Dinh, Chinh Chung Doan 1, The Vinh Tran 1, Hiep Khong 1, Thi Thanh Truc Nguyen 1, Hoang Quoc Huy Hua 1, Viet Anh Nguyen 1, Tan Phat Ha 1, Dang Luu Phan 1, Truong An Nguyen 1, Thi Ngoc Bui 1, Tieu My Tu 1, Thi Theo Nguyen 1, Thi Thuy Hang Le 1, Thi Lan Dong 1, Trong Hieu Huynh 1, Phien Huong Ho 1, Nguyen Thanh Thao Le 1, Cong Thao Truong 1, Hoang Phi Pham 1, Cong Y Luong 1, Nie Lim Y 1, Minh Ngoc Cao 1, Duy Khanh Nguyen 1, Thi Thanh Le 2, Duc Cuong Vuong 2, Le Khanh Hang Nguyen 2, Minh Si Do 1",Preclinical Immune Response and Safety Evaluation of the Protein Subunit Vaccine Nanocovax for COVID-19,"2021","","","","","","","","","","","","34938290",https://pubmed.ncbi.nlm.nih.gov/34938290/,"",0,10,0,0,0,,,
5722,321,"Gonzlez-Domnguez et al., 2022",journal,"Irene Gonzlez-Domnguez 1, Jose Luis Martnez 1, Stefan Slamanig 1, Nicholas Lemus 1, Yonghong Liu 1, Tsoi Ying Lai 1, Juan Manuel Carreo 1, Gagandeep Singh A 1, Gagandeep Singh B 1 2, Michael Schotsaert 1 2, Ignacio Mena 1 2, Stephen McCroskery 1, Lynda Coughlan 3 4, Florian Krammer 1 5, Adolfo Garca-Sastre 1 2 5 6 7, Peter Palese 1 6, Weina Sun 1",Trivalent NDV-HXP-S vaccine protects against phylogenetically distant SARS-CoV-2 variants of concern in mice,"","","","","","","","","","","","","35350201",https://pubmed.ncbi.nlm.nih.gov/35350201/,"",0,10,0,0,0,,,
5723,321,Wang et al. 2022,journal,"Xuan-Yi Wang 1 2 3, Syed Faisal Mahmood 4, Fang Jin 5 6, Wee Kooi Cheah 7, Muhammad Ahmad 8, Mian Amjad Sohail 9, Waheed Ahmad 10, Vijaya K Suppan 11, Muneeba Ahsan Sayeed 12, Shobha Luxmi 13, Aik-Howe Teo 14, Li Yuan Lee 15, Yang-Yang Qi 1 2, Rong-Juan Pei 16, Wei Deng 6, Zhong-Hui Xu 17, Jia-Ming Yang 17, Yan Zhang 17, Wu-Xiang Guan 16, Xiong Yu 18","Efficacy of heterologous boosting against SARS-CoV-2 using a recombinant interferon-armed fusion protein vaccine (V-01): a randomized, double-blind and placebo-controlled phase III trial","2022","","","","","","","","","","","","35686572",https://pubmed.ncbi.nlm.nih.gov/35686572/,"",0,10,0,0,0,,,
5724,321,Guirakhoo et. al 2022,journal,"Farshad Guirakhoo 1, Shixia Wang 1, Chang Yi Wang 2, Hui Kai Kuo 2, Wen Jiun Peng 2, Hope Liu 2, Lixia Wang 1, Marina Johnson 3, Adam Hunt 3, Mei Mei Hu 1, Thomas P Monath 1, Alexander Rumyantsev 1, David Goldblatt 3",High Neutralizing Antibody Levels Against Severe Acute Respiratory Syndrome Coronavirus 2 Omicron BA.1 and BA.2 After UB-612 Vaccine Booster,"2022","","","","","","","","","","","","35723969",https://pubmed.ncbi.nlm.nih.gov/35723969/,"",0,10,0,0,0,,,
5725,321,"Hashimoto et al., 2022",journal,"Masayuki Hashimoto 1, Noriyo Nagata 2, Tomoyuki Homma 3, Hiroki Maeda 4, Keiji Dohi 5, Naomi M Seki 6, Ken Yoshihara 7, Naoko Iwata-Yoshikawa 8, Nozomi Shiwa-Sudo 9, Yusuke Sakai 10, Masayuki Shirakura 11, Noriko Kishida 12, Tomoko Arita 13, Yasushi Suzuki 14, Shinji Watanabe 15, Hideki Asanuma 16, Takuhiro Sonoyama 17, Tadaki Suzuki 18, Shinya Omoto 19, Hideki Hasegawa 20",Immunogenicity and protective efficacy of SARS-CoV-2 recombinant S-protein vaccine S-268019-b in cynomolgus monkeys,"2022","","","","","","","","","","","","35691872",https://pubmed.ncbi.nlm.nih.gov/35691872/,"",0,10,0,0,0,,,
5726,321,"Richmond et al., 2021",journal,"Peter Richmond 1, Lara Hatchuel 2, Min Dong 3, Brenda Ma 3, Branda Hu 3, Igor Smolenov 3, Ping Li 3, Peng Liang 3, Htay Htay Han 3, Joshua Liang 3, Ralf Clemens 4","Safety and immunogenicity of S-Trimer (SCB-2019), a protein subunit vaccine candidate for COVID-19 in healthy adults: a phase 1, randomised, double-blind, placebo-controlled trial","2021","","","","","","","","","","","","33524311",https://pubmed.ncbi.nlm.nih.gov/33524311/,"",0,10,0,0,0,,,
5727,321,NCT05125926,website,"",A Phase  Trial to Evaluate the Safety and Immunogenicity of SARS-CoV-2 Vaccine LYB001,"2021","","","","","","","","","","","","",https://clinicaltrials.gov/ct2/show/NCT05125926,"",0,10,0,0,0,,,
5728,99,"Mosaheb et al., 2020",journal,"Mosaheb MM, Dobrikova EY, Brown MC, Yang Y, Cable J, Okada H, Nair SK, Bigner DD, Ashley DM, Gromeier M",Genetically stable poliovirus vectors activate dendritic cells and prime antitumor CD8 T cell immunity,"2020","11","1","524",Nature communications,"","","","","","","","31988324","","",0,10,0,0,79,,,
5729,277,"Appelberg et al., 2022",journal,"Appelberg S, John L, Pardi N, Vgvri , Bereczky S, Ahln G, Monteil V, Abdurahman S, Mikaeloff F, Beattie M, Tam Y, Sllberg M, Neogi U, Weissman D, Mirazimi A",Nucleoside-Modified mRNA Vaccines Protect IFNAR(-/-) Mice against Crimean-Congo Hemorrhagic Fever Virus Infection,"2022","96","3",e0156821,Journal of virology,"","","","","","","","34817199","",,0,0,0,0,0,,,
5730,17,"Fischer et al., 2021",journal,"Fischer RJ, Purushotham JN, van Doremalen N, Sebastian S, Meade-White K, Cordova K, Letko M, Jeremiah Matson M, Feldmann F, Haddock E, LaCasse R, Saturday G, Lambe T, Gilbert SC, Munster VJ",ChAdOx1-vectored Lassa fever vaccine elicits a robust cellular and humoral immune response and protects guinea pigs against lethal Lassa virus challenge,"2021","6","1","32",NPJ vaccines,"","","","","","","","33654106","",,0,0,0,0,0,,,
5731,118,"Katae et al., 2002",journal,"Katae M, Miyahira Y, Takeda K, Matsuda H, Yagita H, Okumura K, Takeuchi T, Kamiyama T, Ohwada A, Fukuchi Y, Aoki T",Coadministration of an interleukin-12 gene and a Trypanosoma cruzi gene improves vaccine efficacy,"2002","70","9","4833-4840",Infection and immunity,"","","","","","","","12183527","","",0,10,0,0,0,,,
5732,118,"Gherardi et al., 2001",journal,"Gherardi MM, Ramrez JC, Esteban M",Towards a new generation of vaccines: the cytokine IL-12 as an adjuvant to enhance cellular immune responses to pathogens during prime-booster vaccination regimens,"2001","16","2","655-667",Histology and histopathology,"","","","","","","","11332721","","",0,10,0,0,0,,,
5733,118,"Rodrigues et al., 1999",journal,"Rodrigues MM, Ribeiro M, Pereira-Chioccola V, Renia L, Costa F",Predominance of CD4 Th1 and CD8 Tc1 cells revealed by characterization of the cellular immune response generated by immunization with a DNA vaccine containing a Trypanosoma cruzi gene,"1999","67","8","3855-3863",Infection and immunity,"","","","","","","","10417149","","",0,10,0,0,0,,,
5734,118,"Costa et al., 1998",journal,"Costa F, Franchin G, Pereira-Chioccola VL, Ribeiro M, Schenkman S, Rodrigues MM",Immunization with a plasmid DNA containing the gene of trans-sialidase reduces Trypanosoma cruzi infection in mice,"1998","16","8","768-774",Vaccine,"","","","","","","","9627933","","",0,10,0,0,0,,,
5735,118,"Caeiro et al., 2020",journal,"Caeiro LD, Masip YE, Rizzi M, Rodrguez ME, Pueblas Castro C, Snchez DO, Coria ML, Cassataro J, Tekiel V",The Trypanosoma cruzi TcTASV-C protein subfamily administrated with U-Omp19 promotes a protective response against a lethal challenge in mice,"2020","38","48","7645-7653",Vaccine,"","","","","","","","33071003","","",0,10,0,0,0,,,
5736,118,"Coria et al., 2016",journal,"Coria LM, Ibaez AE, Tkach M, Sabbione F, Bruno L, Carabajal MV, Berguer PM, Barrionuevo P, Schillaci R, Trevani AS, Giambartolomei GH, Pasquevich KA, Cassataro J","A Brucella spp. Protease Inhibitor Limits Antigen Lysosomal Proteolysis, Increases Cross-Presentation, and Enhances CD8+ T Cell Responses","2016","196","10","4014-4029","Journal of immunology (Baltimore, Md. : 1950)","","","","","","","","27084100","","",0,10,0,0,0,,,
5737,118,"Caeiro et al., 2018",journal,"Caeiro LD, Alba-Soto CD, Rizzi M, Solana ME, Rodriguez G, Chidichimo AM, Rodriguez ME, Snchez DO, Levy GV, Tekiel V",The protein family TcTASV-C is a novel Trypanosoma cruzi virulence factor secreted in extracellular vesicles by trypomastigotes and highly expressed in bloodstream forms,"2018","12","5",e0006475,PLoS neglected tropical diseases,"","","","","","","","29727453","","",0,10,0,0,0,,,
5738,91,"Wang et al., 2017",journal,"Wang JL, Elsheikha HM, Zhu WN, Chen K, Li TT, Yue DM, Zhang XX, Huang SY, Zhu XQ",Immunization with Toxoplasma gondii GRA17 Deletion Mutant Induces Partial Protection and Survival in Challenged Mice,"2017","8","","730",Frontiers in immunology,"","","","","","","","28706518","",,0,0,0,0,0,,,
5739,91,"Wang et al., 2018",journal,"Wang JL, Li TT, Elsheikha HM, Chen K, Cong W, Yang WB, Bai MJ, Huang SY, Zhu XQ","Live Attenuated Pru:cdpk2 Strain of Toxoplasma gondii Protects Against Acute, Chronic, and Congenital Toxoplasmosis","2018","218","5","768-777",The Journal of infectious diseases,"","","","","","","","29669003","",,0,0,0,0,0,,,
5740,277,"Spengler et al., 2019",journal,"Spengler JR, Welch SR, Scholte FEM, Coleman-McCray JD, Harmon JR, Nichol ST, Bergeron , Spiropoulou CF",Heterologous protection against Crimean-Congo hemorrhagic fever in mice after a single dose of replicon particle vaccine,"2019","170","","104573",Antiviral research,"","","","","","","","31377243","",,0,0,0,0,0,,,
5741,321,"Khorattanakulchai et al., 2022",journal,"Narach Khorattanakulchai 1 2, Kanjana Srisutthisamphan 3, Balamurugan Shanmugaraj 4, Suwimon Manopwisedjaroen 5, Kaewta Rattanapisit 4, Chalisa Panapitakkul 1 2, Taratorn Kemthong 6, Nutchanat Suttisan 6, Suchinda Malaivijitnond 6, Arunee Thitithanyanont 5, Anan Jongkaewwattana 3, Waranyoo Phoolcharoen 1 2",A recombinant subunit vaccine candidate produced in plants elicits neutralizing antibodies against SARS-CoV-2 variants in macaques,"2022","","","","","","","","","","","","36247553",https://pubmed.ncbi.nlm.nih.gov/36247553/,"",0,10,0,0,0,,,
5742,321,"Wuertz et al., 2021",journal,"",A SARS-CoV-2 spike ferritin nanoparticle vaccine protects hamsters against Alpha and Beta virus variant challenge,"","","","","","","","","","","","","34711815",https://pubmed.ncbi.nlm.nih.gov/34711815/,"",0,10,0,0,0,,,
5743,118,"Arce-Fonseca et al., 2011",journal,"Arce-Fonseca M, Ramos-Ligonio A, Lpez-Monten A, Salgado-Jimnez B, Talams-Rohana P, Rosales-Encina JL",A DNA vaccine encoding for TcSSP4 induces protection against acute and chronic infection in experimental Chagas disease,"2011","7","9","1230-1238",International journal of biological sciences,"","","","","","","","22110377","","",0,10,0,0,0,,,
5744,118,"Planelles et al., 2001",journal,"Planelles L, Thomas MC, Alonso C, Lpez MC",DNA immunization with Trypanosoma cruzi HSP70 fused to the KMP11 protein elicits a cytotoxic and humoral immune response against the antigen and leads to protection,"2001","69","10","6558-6563",Infection and immunity,"","","","","","","","11553607","","",0,10,0,0,0,,,
5745,91,"Abdelbaset et al., 2017",journal,"Abdelbaset AE, Fox BA, Karram MH, Abd Ellah MR, Bzik DJ, Igarashi M","Lactate dehydrogenase in Toxoplasma gondii controls virulence, bradyzoite differentiation, and chronic infection","2017","12","3",e0173745,PloS one,"","","","","","","","28323833","",,0,0,0,0,0,,,
5746,321,"Ali et al., 2021",journal,"Kashif Ali 1, Gary Berman 1, Honghong Zhou 1, Weiping Deng 1, Veronica Faughnan 1, Maria Coronado-Voges 1, Baoyu Ding 1, Jacqueline Dooley 1, Bethany Girard 1, William Hillebrand 1, Rolando Pajon 1, Jacqueline M Miller 1, Brett Leav 1, Roderick McPhee 1",Evaluation of mRNA-1273 SARS-CoV-2 Vaccine in Adolescents,"2021","","","","","","","","","","","","34379915",https://pubmed.ncbi.nlm.nih.gov/34379915/,"",0,10,0,0,0,,,
5747,321,"Chalkias et al., 2022",journal,"Spyros Chalkias 1, Charles Harper 1, Keith Vrbicky 1, Stephen R Walsh 1, Brandon Essink 1, Adam Brosz 1, Nichole McGhee 1, Joanne E Tomassini 1, Xing Chen 1, Ying Chang 1, Andrea Sutherland 1, David C Montefiori 1, Bethany Girard 1, Darin K Edwards 1, Jing Feng 1, Honghong Zhou 1, Lindsey R Baden 1, Jacqueline M Miller 1, Rituparna Das 1",A Bivalent Omicron-Containing Booster Vaccine against Covid-19,"2022","","","","","","","","","","","","36112399",https://pubmed.ncbi.nlm.nih.gov/36112399/,"",0,10,0,0,0,,,
5748,321,"Ying et al., 2022",journal,"Baoling Ying 1, Suzanne M Scheaffer 1, Bradley Whitener 1, Chieh-Yu Liang 2, Oleksandr Dmytrenko 1, Samantha Mackin 2, Kai Wu 3, Diana Lee 3, Laura E Avena 3, Zhenlu Chong 1, James Brett Case 1, LingZhi Ma 3, Thu T M Kim 3, Caralyn E Sein 3, Angela Woods 3, Daniela Montes Berrueta 3, Gwo-Yu Chang 3, Guillaume Stewart-Jones 3, Isabella Renzi 3, Yen-Ting Lai 3, Agata Malinowski 3, Andrea Carfi 3, Sayda M Elbashir 3, Darin K Edwards 3, Larissa B Thackray 4, Michael S Diamond 5",Boosting with variant-matched or historical mRNA vaccines protects against Omicron infection in mice,"","","","","","","","","","","","","35452622",https://pubmed.ncbi.nlm.nih.gov/35452622/,"",0,10,0,0,0,,,
5749,118,"Morell et al., 2006",journal,"Morell M, Thomas MC, Caballero T, Alonso C, Lpez MC",The genetic immunization with paraflagellar rod protein-2 fused to the HSP70 confers protection against late Trypanosoma cruzi infection,"2006","24","49-50","7046-7055",Vaccine,"","","","","","","","16901590","","",0,10,0,0,0,,,
5750,321,"Johnson et al., 2022",journal,"Susan Johnson 1, Clarissa I Martinez 1, Sarah N Tedjakusuma 1, Nadine Peinovich 1, Emery G Dora 1, Sharla M Birch 2, Adriana E Kajon 2, Adam D Werts 2, Sean N Tucker 1",Oral Vaccination Protects Against Severe Acute Respiratory Syndrome Coronavirus 2 in a Syrian Hamster Challenge Model,"2022","","","","","","","","","","","","34758086",https://pubmed.ncbi.nlm.nih.gov/34758086/,"",0,10,0,0,0,,,
5751,321,"Fluckiger et al., 2021",journal,"Anne-Catherine Fluckiger 1, Barthelemy Ontsouka 2, Jasminka Bozic 2, Abebaw Diress 2, Tanvir Ahmed 2, Tamara Berthoud 2, Anh Tran 3, Diane Duque 3, Mingmin Liao 4, Michael McCluskie 3, Francisco Diaz-Mitoma 5, David E Anderson 5, Catalina Soare 2",An enveloped virus-like particle vaccine expressing a stabilized prefusion form of the SARS-CoV-2 spike protein elicits highly potent immunity,"2021","","","","","","","","","","","","34304928",https://pubmed.ncbi.nlm.nih.gov/34304928/,"",0,10,0,0,0,,,
5752,118,"Wrightsman and Manning, 2000",journal,"Wrightsman RA, Manning JE",Paraflagellar rod proteins administered with alum and IL-12 or recombinant adenovirus expressing IL-12 generates antigen-specific responses and protective immunity in mice against Trypanosoma cruzi,"2000","18","14","1419-1427",Vaccine,"","","","","","","","10618540","","",0,10,0,0,0,,,
5753,321,"Zhang et al., 2022",journal,"Zhiren Zhang 1, Qiaren He 2, Wei Zhao 1, Yong Li 1, Jiaming Yang 3, Zhenxiang Hu 3, Xi Chen 3, Hua Peng 4, Yang-Xin Fu 5, Long Chen 2, Ligong Lu 1",A Heterologous V-01 or Variant-Matched Bivalent V-01D-351 Booster following Primary Series of Inactivated Vaccine Enhances the Neutralizing Capacity against SARS-CoV-2 Delta and Omicron Strains,"","","","","","","","","","","","","35887928",https://pubmed.ncbi.nlm.nih.gov/35887928/,"",0,10,0,0,0,,,
5754,321,"Xu et al., 2023",journal,"Ke Xu 1, Wenwen Lei 1, Bin Kang 2 3, Hanyu Yang 2 3, Yajuan Wang 2 3, Yanli Lu 2 3, Lu Lv 2 3, Yufei Sun 2 3, Jing Zhang 1, Xiaolin Wang 2 3, Mengjie Yang 1, Mo Dan 2 3, Guizhen Wu 1","A novel mRNA vaccine, SYS6006, against SARS-CoV-2","","","","","","","","","","","","","36685587",https://pubmed.ncbi.nlm.nih.gov/36685587/,"",0,10,0,0,0,,,
5755,321,NCT05047445 - COVIDITY,website,Scancell Ltd,A First Time in Human Phase 1 Open-Label Study of the COVIDITY Vaccine Administered by Needle-free Injection,"2021","","","","","","","","","","","","",https://clinicaltrials.gov/ct2/show/NCT05047445,"",0,10,0,0,0,,,
5756,321,NCT05434585,journal,"","A Study to Evaluate Safety, Tolerability, and Immunogenicity of SARS-CoV-2 Variant mRNA Vaccines","2022","","","","","","","","","","","",NCT05434585,https://clinicaltrials.gov/ct2/show/NCT05434585,,0,0,0,0,0,,,
5757,321,NCT05385991,journal,"",Booster Dose Study to Assess the Safety and Immunogenicity of ACM-001 Administered Intramuscularly or Intranasally.,"2022","","","","","","","","","","","",NCT05385991,https://clinicaltrials.gov/ct2/show/NCT05385991,,0,0,0,0,0,,,
5758,91,"Zorgi et al., 2016",journal,"Zorgi NE, Galisteo AJ Jr, Sato MN, do Nascimento N, de Andrade HF Jr",Immunity in the spleen and blood of mice immunized with irradiated Toxoplasma gondii tachyzoites,"2016","205","4","297-314",Medical microbiology and immunology,"","","","","","","","26732075","",,0,0,0,0,0,,,
5759,91,"Li et al., 2018",journal,"Li X, Wu Y, Huang S, Lu F",Disodium cromoglycate may act as a novel adjuvant for UV-attenuated Toxoplasma gondii vaccine in mouse model,"2018","67","3","351-356",Parasitology international,"","","","","","","","29421521","",,0,0,0,0,0,,,
5760,321,NCT05171946,website,"",Phase-I Study to Evaluate the Safety and Immunogenicity of a Prophylactic pDNA Vaccine Candidate Against COVID-19 in Healthy Adults,"","","","","","","","","","","","","",https://clinicaltrials.gov/ct2/show/NCT05171946,,0,0,0,0,0,,,
5761,321,NCT04334980,website,"","Evaluating the Safety, Tolerability and Immunogenicity of bacTRL-Spike Vaccine for Prevention of COVID-19","2020","","","","","","","","","","","","",https://clinicaltrials.gov/ct2/show/NCT04334980,,0,0,0,0,0,,,
5762,321,NCT04953078,website,"","A Study to Evaluate Safety, Tolerability, and Reactogenicity of an RBD-Fc-based Vaccine to Prevent COVID-19","","","","","","","","","","","","","",https://clinicaltrials.gov/ct2/show/NCT04953078,,0,0,0,0,0,,,
5763,321,NCT04776317,website,"",Chimpanzee Adenovirus and Self-Amplifying mRNA Prime-Boost Prophylactic Vaccines Against SARS-CoV-2 in Healthy Adults,"2021","","","","","","","","","","","","",https://clinicaltrials.gov/ct2/show/NCT04776317,,0,0,0,0,0,,,
5764,321,NCT05094609,website,"",Phase 1 Trial of ChAd68 and Ad5 Adenovirus COVID-19 Vaccines Delivered by Aerosol,"2021","","","","","","","","","","","","",https://clinicaltrials.gov/ct2/show/NCT05094609,,0,0,0,0,0,,,
5765,321,NCT04627675,website,"",CORVax12: SARS-CoV-2 Spike (S) Protein Plasmid DNA Vaccine Trial for COVID-19 (SARS-CoV-2) (CORVax12),"2020","","","","","","","","","","","","",https://clinicaltrials.gov/ct2/show/NCT04627675,,0,0,0,0,0,,,
5766,321,NCT04758962,website,"",A Study of the Safety of and Immune Response to Varying Doses of a Vaccine Against COVID-19 in Healthy Adults,"2021","","","","","","","","","","","","",https://clinicaltrials.gov/ct2/show/study/NCT04758962,,0,0,0,0,0,,,
5767,321,NCT04893512,website,"",First-In-Human Study Of Orally Administered CoV2-OGEN1 In Healthy Subjects,"2021","","","","","","","","","","","","",https://clinicaltrials.gov/ct2/show/study/NCT04893512,,0,0,0,0,0,,,
5768,91,"Tao et al., 2013",journal,"Tao Q, Fang R, Zhang W, Wang Y, Cheng J, Li Y, Fang K, Khan MK, Hu M, Zhou Y, Zhao J",Protective immunity induced by a DNA vaccine-encoding Toxoplasma gondii microneme protein 11 against acute toxoplasmosis in BALB/c mice,"2013","112","8","2871-2877",Parasitology research,"","","","","","","","23749087","",,0,0,0,0,0,,,
5769,91,"Mavi et al., 2019",journal,"Mavi SA, Modarressi MH, Mohebali M, Shojaee S, Zeraati H, Teimouri A, Keshavarz H","Assessment of the immunogenicity and protective efficiency of a novel dual-promoter DNA vaccine, harboring SAG1 and GRA7 genes, from RH strain of Toxoplasma gondii in BALB/c mice","2019","12","","2519-2530",Infection and drug resistance,"","","","","","","","31616167","",,0,0,0,0,0,,,
5770,91,"Xu et al., 2019",journal,"Xu XP, Liu WG, Xu QM, Zhu XQ, Chen J","Evaluation of immune protection against Toxoplasma gondii infection in mice induced by a multi-antigenic DNA vaccine containing TgGRA24, TgGRA25 and TgMIC6","2019","26","","58","Parasite (Paris, France)","","","","","","","","31535970","",,0,0,0,0,0,,,
5771,321,"Wang et al., 2021",journal,"Ying Wang 1, Chen Yang 1, Yutong Song 1, J Robert Coleman 1, Marcin Stawowczyk 1, Juliana Tafrova 1, Sybil Tasker 1, David Boltz 2, Robert Baker 2, Liliana Garcia 2, Olivia Seale 2, Anna Kushnir 1, Eckard Wimmer 3, Steffen Mueller 4",Scalable live-attenuated SARS-CoV-2 vaccine candidate demonstrates preclinical safety and efficacy,"2021","","","","","","","","","","","","34193524",https://pubmed.ncbi.nlm.nih.gov/34193524/,,0,0,0,0,0,,,
5772,321,"Zaman et al., 2019",journal,"Khalequ Zaman 1, Robert Kingma 2, Md Yunus 3, Ineke van Straaten 2, Dirk Mekkes 2, Xandra Bouwstra 2, Bhagwat Gunale 4, Prasad S Kulkarni 4","Safety, immunogenicity and lot-to-lot consistency of a new Bivalent Oral Polio Vaccine (bOPV) in healthy Infants: Results of a Phase III, observer blind, randomized, controlled clinical study","2019","","","","","","","","","","","","31235374",https://pubmed.ncbi.nlm.nih.gov/31235374/,,0,0,0,0,0,,,
5773,321,"Liu et al., 2022",journal,"Jun Liu 1, Patrick Budylowski 1 2, Reuben Samson 3 4, Bryan D Griffin 5, Giorgi Babuadze 5, Bhavisha Rathod 4, Karen Colwill 4, Jumai A Abioye 6, Jordan A Schwartz 6, Ryan Law 7, Lily Yip 5, Sang Kyun Ahn 3, Serena Chau 7, Maedeh Naghibosadat 5, Yuko Arita 6, Queenie Hu 4, Feng Yun Yue 1, Arinjay Banerjee 8 9 10, W Rod Hardy 4, Karen Mossman 11, Samira Mubareka 5 12, Robert A Kozak 5, Michael S Pollanen 12, Natalia Martin Orozco 6, Anne-Claude Gingras 3 4, Eric G Marcusson 6 13, Mario A Ostrowski 1 7 14",Preclinical evaluation of a SARS-CoV-2 mRNA vaccine PTX-COVID19-B,"2022","","","","","","","","","","","","35044832",https://pubmed.ncbi.nlm.nih.gov/35044832/,,0,0,0,0,0,,,
5774,321,"Kim et al., 2023",journal,"Woo Joo Kim 1, Christine C Roberts 2, Joon Young Song 1, Jin Gu Yoon 1, Hye Seong 1, Hak-Jun Hyun 1, Hyojin Lee 2, Areum Gil 2, Yeeun Oh 2, Ji-Eun Park 2, Bohyun Jeon 2, Ji-Eun Lee 2, Sang Kyu Choi 3, Sun Kyung Yoon 3, Sunhee Lee 3, Byoungguk Kim 3, Deborah Kane 2, Susan Spruill 4, Sagar B Kudchodkar 2, Kar Muthumani 2, Young K Park 2, Ijoo Kwon 2, Moonsup Jeong 2, Joel N Maslow 5",Safety and immunogenicity of the bi-cistronic GLS-5310 COVID-19 DNA vaccine delivered with the GeneDerm suction device,"2023","","","","","","","","","","","","36592685",https://pubmed.ncbi.nlm.nih.gov/36592685/,,0,0,0,0,0,,,
5775,321,"Lovell et al., 2022",journal,"Jonathan F Lovell 1, Yeong Ok Baik 2, Seuk Keun Choi 2, Chankyu Lee 2, Jeong-Yoon Lee 2, Kazutoyo Miura 3, Wei-Chiao Huang 4 5, Young-Shin Park 6, Sun-Je Woo 6, Sang Hwan Seo 6, Jae-Ouk Kim 6, Manki Song 6, Chung-Jong Kim 7, Jae-Ki Choi 8, Jieun Kim 9, Eun Ju Choo 10, Jung-Hyun Choi 11",Interim analysis from a phase 2 randomized trial of EuCorVac-19: a recombinant protein SARS-CoV-2 RBD nanoliposome vaccine,"2022","","","","","","","","","","","","36447243",https://pubmed.ncbi.nlm.nih.gov/36447243/,,0,0,0,0,0,,,
5776,91,"Pinzan et al., 2015",journal,"Pinzan CF, Sardinha-Silva A, Almeida F, Lai L, Lopes CD, Loureno EV, Panunto-Castelo A, Matthews S, Roque-Barreira MC",Vaccination with Recombinant Microneme Proteins Confers Protection against Experimental Toxoplasmosis in Mice,"2015","10","11",e0143087,PloS one,"","","","","","","","26575028","",,0,0,0,0,0,,,
5777,91,"Sun et al., 2011",journal,"Sun XM, Zou J, A A ES, Yan WC, Liu XY, Suo X, Wang H, Chen QJ",DNA vaccination with a gene encoding Toxoplasma gondii GRA6 induces partial protection against toxoplasmosis in BALB/c mice,"2011","4","","213",Parasites & vectors,"","","","","","","","22070984","",,0,0,0,0,0,,,
5778,91,"Chu et al., 2018",journal,"Chu JQ, Huang S, Ye W, Fan XY, Huang R, Ye SC, Yu CY, Wu WY, Zhou Y, Zhou W, Lee YH, Quan JH",Evaluation of Protective Immune Response Induced by a DNA Vaccine Encoding GRA8 against Acute Toxoplasmosis in a Murine Model,"2018","56","4","325-334",The Korean journal of parasitology,"","","","","","","","30196664","",,0,0,0,0,0,,,
5779,91,"Hu et al., 2017",journal,"Hu LY, Zhang NZ, Zhang FK, Wang M, Gao Q, Wang JL, Zhu XQ",Resistance to Chronic Toxoplasma gondii Infection Induced by a DNA Vaccine Expressing GRA16,"2017","2017","","1295038",BioMed research international,"","","","","","","","28875149","",,0,0,0,0,0,,,
5780,91,"Zhu et al., 2017",journal,"Zhu WN, Wang JL, Chen K, Yue DM, Zhang XX, Huang SY, Zhu XQ",Evaluation of protective immunity induced by DNA vaccination with genes encoding Toxoplasma gondii GRA17 and GRA23 against acute toxoplasmosis in mice,"2017","179","","20-27",Experimental parasitology,"","","","","","","","28625894","",,0,0,0,0,0,,,
5781,91,"Gold et al., 2015",journal,"Gold DA, Kaplan AD, Lis A, Bett GC, Rosowski EE, Cirelli KM, Bougdour A, Sidik SM, Beck JR, Lourido S, Egea PF, Bradley PJ, Hakimi MA, Rasmusson RL, Saeij JP",The Toxoplasma Dense Granule Proteins GRA17 and GRA23 Mediate the Movement of Small Molecules between the Host and the Parasitophorous Vacuole,"2015","17","5","642-652",Cell host & microbe,"","","","","","","","25974303","",,0,0,0,0,0,,,
5782,99,NCIt_C96042,website,"",NA-17/MAGE-3.A2/NY-ESO-1 Peptide Vaccine (Code C96042),"","","","","","","","","","","","","",https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI%20Thesaurus&code=C96042,"",0,10,0,0,0,,,
5783,99,"Trakatelli et al., 2006",journal,"Trakatelli M, Toungouz M, Blocklet D, Dodoo Y, Gordower L, Laporte M, Vereecken P, Sales F, Mortier L, Mazouz N, Lambermont M, Goldman S, Coulie P, Goldman M, Velu T",A new dendritic cell vaccine generated with interleukin-3 and interferon-beta induces CD8+ T cell responses against NA17-A2 tumor peptide in melanoma patients,"2006","55","4","469-474","Cancer immunology, immunotherapy : CII","","","","","","","","16133111",https://pubmed.ncbi.nlm.nih.gov/16133111/,"",0,10,0,0,0,,,
5784,99,NCT00900809,website,"",QUILT-3.018: Neukoplast (NK-92) for the Treatment of Refractory or Relapsed Acute Myeloid Leukemia,"","","","","","","","","","","","","",https://clinicaltrials.gov/ct2/show/NCT00900809,"",0,10,0,0,0,,,
5785,99,NCT01307618,website,"",Vaccine Therapy With or Without Recombinant Interleukin-12 Followed by Daclizumab in Treating Patients With Metastatic Melanoma,"","","","","","","","","","","","","",https://clinicaltrials.gov/ct2/show/NCT01307618,"",0,10,0,0,0,,,
5786,99,"Chick et al., 2021",journal,"Chick RC, Clifton GT, Hale DF, Vreeland TJ, Hickerson AT, Kemp Bohan PM, McCarthy PM, Litton JK, Alatrash G, Murthy RK, Qiao N, Philips A, Lukas J, Holmes JP, Mittendorf EA, Peoples GE","Subgroup analysis of nelipepimut-S plus GM-CSF combined with trastuzumab versus trastuzumab alone to prevent recurrences in patients with high-risk, HER2 low-expressing breast cancer","2021","225","","108679","Clinical immunology (Orlando, Fla.)","","","","","","","","33485895",https://pubmed.ncbi.nlm.nih.gov/33485895/,"",0,10,0,0,0,,,
5787,99,NCT02636582,website,"",Nelipepimut-S Plus GM-CSF Vaccine Therapy in Treating Patients With Breast Cancer,"","","","","","","","","","","","","",https://clinicaltrials.gov/ct2/show/NCT02636582,"",0,10,0,0,0,,,
5788,99,"Bowen et al., 2002",journal,"Bowen GP, Borgland SL, Lam M, Libermann TA, Wong NC, Muruve DA",Adenovirus vector-induced inflammation: capsid-dependent induction of the C-C chemokine RANTES requires NF-kappa B,"2002","13","3","367-379",Human gene therapy,"","","","","","","","11860704","","",0,10,0,0,0,,,
5789,99,"Barton et al., 2021",journal,"Barton KN, Siddiqui F, Pompa R, Freytag SO, Khan G, Dobrosotskaya I, Ajlouni M, Zhang Y, Cheng J, Movsas B, Kwon D",Phase I trial of oncolytic adenovirus-mediated cytotoxic and interleukin-12 gene therapy for the treatment of metastatic pancreatic cancer,"2021","20","","94-9104",Molecular therapy oncolytics,"","","","","","","","33575474","","",0,10,0,0,0,,,
5790,99,"Sato-Dahlman et al., 2020",journal,"Sato-Dahlman M, LaRocca CJ, Yanagiba C, Yamamoto M",Adenovirus and Immunotherapy: Advancing Cancer Treatment by Combination,"2020","12","5","",Cancers,"","","","","","","","32455560","","",0,10,0,0,0,,,
5791,99,"McKenzie et al., 2004",journal,"McKenzie T, Liu Y, Fanale M, Swisher SG, Chada S, Hunt KK",Combination therapy of Ad-mda7 and trastuzumab increases cell death in Her-2/neu-overexpressing breast cancer cells,"2004","136","2","437-442",Surgery,"","","","","","","","15300212","","",0,10,0,0,0,,,
5792,99,"Balint et al., 2015",journal,"Balint JP, Gabitzsch ES, Rice A, Latchman Y, Xu Y, Messerschmidt GL, Chaudhry A, Morse MA, Jones FR","Extended evaluation of a phase 1/2 trial on dosing, safety, immunogenicity, and overall survival after immunizations with an advanced-generation Ad5 [E1-, E2b-]-CEA(6D) vaccine in late-stage colorectal cancer","2015","64","8","977-987","Cancer immunology, immunotherapy : CII","","","","","","","","25956394","","",0,10,0,0,0,,,
5793,99,"Loskog et al., 2004",journal,"Loskog A, Dzojic H, Vikman S, Ninalga C, Essand M, Korsgren O, Totterman TH",Adenovirus CD40 ligand gene therapy counteracts immune escape mechanisms in the tumor Microenvironment,"2004","172","11","7200-7205","Journal of immunology (Baltimore, Md. : 1950)","","","","","","","","15153545","","",0,10,0,0,0,,,
5794,99,"Gupta et al., 2006",journal,"Gupta V, Wang W, Sosnowski BA, Hofman FM, Chen TC",Fibroblast growth factor-2-retargeted adenoviral vector for selective transduction of primary glioblastoma multiforme endothelial cells,"2006","20","4",E26,Neurosurgical focus,"","","","","","","","16709032","","",0,10,0,0,0,,,
5795,99,"Morris et al., 2000",journal,"Morris JC, Ramsey WJ, Wildner O, Muslow HA, Aguilar-Cordova E, Blaese RM",A phase I study of intralesional administration of an adenovirus vector expressing the HSV-1 thymidine kinase gene (AdV.RSV-TK) in combination with escalating doses of ganciclovir in patients with cutaneous metastatic malignant melanoma,"2000","11","3","487-503",Human gene therapy,"","","","","","","","10697123","","",0,10,0,0,0,,,
5796,99,"Soliman et al., 2018",journal,"Soliman H, Khambati F, Han HS, Ismail-Khan R, Bui MM, Sullivan DM, Antonia S",A phase-1/2 study of adenovirus-p53 transduced dendritic cell vaccine in combination with indoximod in metastatic solid tumors and invasive breast cancer,"2018","9","11","10110-10117",Oncotarget,"","","","","","","","29515795","","",0,10,0,0,0,,,
5797,99,"Brown et al., 2020",journal,"Brown TA 2nd, Mittendorf EA, Hale DF, Myers JW 3rd, Peace KM, Jackson DO, Greene JM, Vreeland TJ, Clifton GT, Ardavanis A, Litton JK, Shumway NM, Symanowski J, Murray JL, Ponniah S, Anastasopoulou EA, Pistamaltzian NF, Baxevanis CN, Perez SA, Papamichail M, Peoples GE","Prospective, randomized, single-blinded, multi-center phase II trial of two HER2 peptide vaccines, GP2 and AE37, in breast cancer patients to prevent recurrence","2020","181","2","391-401",Breast cancer research and treatment,"","","","","","","","32323103","","",0,10,0,0,0,,,
5798,99,"Coveler et al., 2016",journal,"Coveler AL, Rossi GR, Vahanian NN, Link C, Chiorean EG",Algenpantucel-L immunotherapy in pancreatic adenocarcinoma,"2016","8","2","117-125",Immunotherapy,"","","","","","","","26787078","","",0,10,0,0,0,,,
5799,99,"Raez et al., 2004",journal,"Raez LE, Cassileth PA, Schlesselman JJ, Sridhar K, Padmanabhan S, Fisher EZ, Baldie PA, Podack ER",Allogeneic vaccination with a B7.1 HLA-A gene-modified adenocarcinoma cell line in patients with advanced non-small-cell lung cancer,"2004","22","14","2800-2807",Journal of clinical oncology : official journal of the American Society of Clinical Oncology,"","","","","","","","15254047","","",0,10,0,0,0,,,
5800,99,"Hu et al., 2022",journal,"Hu JL, Omofoye OA, Rudnick JD, Kim S, Tighiouart M, Phuphanich S, Wang H, Mazer M, Ganaway T, Chu RM, Patil CG, Black KL, Shiao SL, Wang R, Yu JS",A Phase I Study of Autologous Dendritic Cell Vaccine Pulsed with Allogeneic Stem-like Cell Line Lysate in Patients with Newly Diagnosed or Recurrent Glioblastoma,"2022","28","4","689-696",Clinical cancer research : an official journal of the American Association for Cancer Research,"","","","","","","","34862245","","",0,10,0,0,0,,,
5801,99,"Czerwinska et al., 2020",journal,"Czerwinska P, Rucinski M, Wlodarczyk N, Jaworska A, Grzadzielewska I, Gryska K, Galus L, Mackiewicz J, Mackiewicz A",Therapeutic melanoma vaccine with cancer stem cell phenotype represses exhaustion and maintains antigen-specific T cell stemness by up-regulating BCL6,"2020","9","1","1710063",Oncoimmunology,"","","","","","","","32002306","","",0,10,0,0,0,,,
5802,99,"Olin et al., 2014",journal,"Olin MR, Low W, McKenna DH, Haines SJ, Dahlheimer T, Nascene D, Gustafson MP, Dietz AB, Clark HB, Chen W, Blazar B, Ohlfest JR, Moertel C",Vaccination with dendritic cells loaded with allogeneic brain tumor cells for recurrent malignant brain tumors induces a CD4(+)IL17(+) response,"2014","2","","4",Journal for immunotherapy of cancer,"","","","","","","","24829761","","",0,10,0,0,0,,,
5803,99,"He et al., 2014",journal,"He Y, Hong Y, Mizejewski GJ",Engineering -fetoprotein-based gene vaccines to prevent and treat hepatocellular carcinoma: review and future prospects,"2014","6","6","725-736",Immunotherapy,"","","","","","","","25041030","","",0,10,0,0,0,,,
5804,99,"Toyoda et al., 2020",journal,"Toyoda T, Kamata T, Tanaka K, Ihara F, Takami M, Suzuki H, Nakajima T, Ikeuchi T, Kawasaki Y, Hanaoka H, Nakayama T, Yoshino I, Motohashi S",Phase II study of -galactosylceramide-pulsed antigen-presenting cells in patients with advanced or recurrent non-small cell lung cancer,"2020","8","1","",Journal for immunotherapy of cancer,"","","","","","","","32188702","","",0,10,0,0,0,,,
5805,99,"van et al., 2005",journal,"van Baren N, Bonnet MC, Drno B, Khammari A, Dorval T, Piperno-Neumann S, Linard D, Speiser D, Marchand M, Brichard VG, Escudier B, Ngrier S, Dietrich PY, Maraninchi D, Osanto S, Meyer RG, Ritter G, Moingeon P, Tartaglia J, van der Bruggen P, Coulie PG, Boon T",Tumoral and immunologic response after vaccination of melanoma patients with an ALVAC virus encoding MAGE antigens recognized by T cells,"2005","23","35","9008-9021",Journal of clinical oncology : official journal of the American Society of Clinical Oncology,"","","","","","","","16061912","","",0,10,0,0,0,,,
5806,99,"van et al., 2002",journal,"van der Burg SH, Menon AG, Redeker A, Bonnet MC, Drijfhout JW, Tollenaar RA, van de Velde CJ, Moingeon P, Kuppen PJ, Offringa R, Melief CJ",Induction of p53-specific immune responses in colorectal cancer patients receiving a recombinant ALVAC-p53 candidate vaccine,"2002","8","5","1019-1027",Clinical cancer research : an official journal of the American Association for Cancer Research,"","","","","","","","12006514","","",0,10,0,0,0,,,
5807,99,"Kyriakopoulos et al., 2020",journal,"Kyriakopoulos CE, Eickhoff JC, Ferrari AC, Schweizer MT, Wargowski E, Olson BM, McNeel DG","Multicenter Phase I Trial of a DNA Vaccine Encoding the Androgen Receptor Ligand-binding Domain (pTVG-AR, MVI-118) in Patients with Metastatic Prostate Cancer","2020","26","19","5162-5171",Clinical cancer research : an official journal of the American Association for Cancer Research,"","","","","","","","32513836","","",0,10,0,0,0,,,
5808,99,"de et al., 2004",journal,"de Bono JS, Rha SY, Stephenson J, Schultes BC, Monroe P, Eckhardt GS, Hammond LA, Whiteside TL, Nicodemus CF, Cermak JM, Rowinsky EK, Tolcher AW",Phase I trial of a murine antibody to MUC1 in patients with metastatic cancer: evidence for the activation of humoral and cellular antitumor immunity,"2004","15","12","1825-1833",Annals of oncology : official journal of the European Society for Medical Oncology,"","","","","","","","15550589","","",0,10,0,0,0,,,
5809,99,"Ju et al., 2022",journal,"Ju M, Fan J, Zou Y, Yu M, Jiang L, Wei Q, Bi J, Hu B, Guan Q, Song X, Dong M, Wang L, Yu L, Wang Y, Kang H, Xin W, Zhao L","Computational Recognition of a Regulatory T-cell-specific Signature With Potential Implications in Prognosis, Immunotherapy, and Therapeutic Resistance of Prostate Cancer","2022","13","","807840",Frontiers in immunology,"","","","","","","","35812443","","",0,10,0,0,0,,,
5810,99,"Small et al., 2014",journal,"Small EJ, Higano CS, Kantoff PW, Whitmore JB, Frohlich MW, Petrylak DP",Time to disease-related pain and first opioid use in patients with metastatic castration-resistant prostate cancer treated with sipuleucel-T,"2014","17","3","259-264",Prostate cancer and prostatic diseases,"","","","","","","","24957547","","",0,10,0,0,0,,,
5811,99,"Chung et al., 2022",journal,"Chung DJ, Sharma S, Rangesa M, DeWolf S, Elhanati Y, Perica K, Young JW",Langerhans dendritic cell vaccine bearing mRNA-encoded tumor antigens induces antimyeloma immunity after autotransplant,"2022","6","5","1547-1558",Blood advances,"","","","","","","","35100339","","",0,10,0,0,0,,,
5812,99,"Sarivalasis et al., 2019",journal,"Sarivalasis A, Boudousqui C, Balint K, Stevenson BJ, Gannon PO, Iancu EM, Rossier L, Martin Lluesma S, Mathevet P, Sempoux C, Coukos G, Dafni U, Harari A, Bassani-Sternberg M, Kandalaft LE",A Phase I/II trial comparing autologous dendritic cell vaccine pulsed either with personalized peptides (PEP-DC) or with tumor lysate (OC-DC) in patients with advanced high-grade ovarian serous carcinoma,"2019","17","1","391",Journal of translational medicine,"","","","","","","","31771601","","",0,10,0,0,0,,,
5813,99,"Barth et al., 2010",journal,"Barth RJ Jr, Fisher DA, Wallace PK, Channon JY, Noelle RJ, Gui J, Ernstoff MS",A randomized trial of ex vivo CD40L activation of a dendritic cell vaccine in colorectal cancer patients: tumor-specific immune responses are associated with improved survival,"2010","16","22","5548-5556",Clinical cancer research : an official journal of the American Association for Cancer Research,"","","","","","","","20884622","","",0,10,0,0,0,,,
5814,99,"Rosenblatt et al., 2013",journal,"Rosenblatt J, Avivi I, Vasir B, Uhl L, Munshi NC, Katz T, Dey BR, Somaiya P, Mills H, Campigotto F, Weller E, Joyce R, Levine JD, Tzachanis D, Richardson P, Laubach J, Raje N, Boussiotis V, Yuan YE, Bisharat L, Held V, Rowe J, Anderson K, Kufe D, Avigan D",Vaccination with dendritic cell/tumor fusions following autologous stem cell transplant induces immunologic and clinical responses in multiple myeloma patients,"2013","19","13","3640-3648",Clinical cancer research : an official journal of the American Association for Cancer Research,"","","","","","","","23685836","","",0,10,0,0,0,,,
5815,99,"Sato et al., 1997",journal,"Sato T, Bullock TN, Eisenlohr LC, Mastrangelo MJ, Berd D","Dinitrophenyl-modified autologous melanoma vaccine induces a T cell response to hapten-modified, melanoma peptides","1997","85","3","265-272",Clinical immunology and immunopathology,"","","","","","","","9400626","","",0,10,0,0,0,,,
5816,99,"Hanna, 2012",journal,Hanna MG Jr,Immunotherapy with autologous tumor cell vaccines for treatment of occult disease in early stage colon cancer,"2012","8","8","1156-1160",Human vaccines & immunotherapeutics,"","","","","","","","22854664","","",0,10,0,0,0,,,
5817,99,"Frank et al., 2020",journal,"Frank MJ, Khodadoust MS, Czerwinski DK, Haabeth OAW, Chu MP, Miklos DB, Advani RH, Alizadeh AA, Gupta NK, Maeda LS, Reddy SA, Laport GG, Meyer EH, Negrin RS, Rezvani AR, Weng WK, Sheehan K, Faham M, Okada A, Moore AH, Phillips DL, Wapnir IL, Brody JD, Levy R",Autologous tumor cell vaccine induces antitumor T cell immune responses in patients with mantle cell lymphoma: A phase I/II trial,"2020","217","9","",The Journal of experimental medicine,"","","","","","","","32558897","","",0,10,0,0,0,,,
5818,99,"Redman et al., 2008",journal,"Redman BG, Chang AE, Whitfield J, Esper P, Jiang G, Braun T, Roessler B, Mul JJ","Phase Ib trial assessing autologous, tumor-pulsed dendritic cells as a vaccine administered with or without IL-2 in patients with metastatic melanoma","2008","31","6","591-598","Journal of immunotherapy (Hagerstown, Md. : 1997)","","","","","","","","18528294","","",0,10,0,0,0,,,
5819,99,"Clarke et al., 1995",journal,"Clarke MF, Apel IJ, Benedict MA, Eipers PG, Sumantran V, Gonzlez-Garca M, Doedens M, Fukunaga N, Davidson B, Dick JE, Minn AJ, Boise LH, Thompson CB, Wicha M, Nez G",A recombinant bcl-x s adenovirus selectively induces apoptosis in cancer cells but not in normal bone marrow cells,"1995","92","24","11024-11028",Proceedings of the National Academy of Sciences of the United States of America,"","","","","","","","7479929","","",0,10,0,0,0,,,
5820,99,"Rijavec et al., 2015",journal,"Rijavec E, Biello F, Genova C, Barletta G, Maggioni C, Dal Bello MG, Coco S, Truini A, Vanni I, Alama A, Beltramini S, Grassi MA, Boccardo F, Grossi F",Belagenpumatucel-L for the treatment of non-small cell lung cancer,"2015","15","9","1371-1379",Expert opinion on biological therapy,"","","","","","","","26211534","","",0,10,0,0,0,,,
5821,99,NCT05479045,website,"",A Combination Therapy Strategy to Prevent Anti-PD-1 Therapy Resistance in Metastatic Ovarian Cancer Patients,"","","","","","","","","","","","","",https://clinicaltrials.gov/ct2/show/NCT05479045,"",0,10,0,0,0,,,
5822,99,"Mizote et al., 2014",journal,"Mizote Y, Uenaka A, Isobe M, Wada H, Kakimi K, Saika T, Kita S, Koide Y, Oka M, Nakayama E",Production of NY-ESO-1 peptide/DRB1*08:03 tetramers and ex vivo detection of CD4 T-cell responses in vaccinated cancer patients,"2014","32","8","957-964",Vaccine,"","","","","","","","24397899",https://pubmed.ncbi.nlm.nih.gov/24397899/,"",0,10,0,0,0,,,
5823,99,NCT00199849,website,"",NY-ESO-1 Plasmid DNA (pPJV7611) Cancer Vaccine,"","","","","","","","","","","","","",https://clinicaltrials.gov/ct2/show/NCT00199849,"",0,10,0,0,0,,,
5824,99,"Liu et al., 2011",journal,"Liu Y, Tian X, Leitner WW, Aldridge ME, Zheng J, Yu Z, Restifo NP, Weiss R, Scheiblhofer S, Xie C, Sun R, Cheng G, Zeng G",Polymeric structure and host Toll-like receptor 4 dictate immunogenicity of NY-ESO-1 antigen in vivo,"2011","286","43","37077-37084",The Journal of biological chemistry,"","","","","","","","21900253",https://pubmed.ncbi.nlm.nih.gov/21900253/,"",0,10,0,0,0,,,
5825,99,NCIT_C113432,website,"",NY-ESO-1/GLA-SE Vaccine ID-G305 (Code C113432),"","","","","","","","","","","","","",https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI%20Thesaurus&code=C113432,"",0,10,0,0,0,,,
5826,99,NCT00616291,website,"","Vaccine Therapy in Treating Patients With Metastatic, Progressive Prostate Cancer","","","","","","","","","","","","","",https://clinicaltrials.gov/ct2/show/NCT00616291,"",0,10,0,0,0,,,
5827,99,"Shang et al., 2004",journal,"Shang XY, Chen HS, Zhang HG, Pang XW, Qiao H, Peng JR, Qin LL, Fei R, Mei MH, Leng XS, Gnjatic S, Ritter G, Simpson AJ, Old LJ, Chen WF",The spontaneous CD8+ T-cell response to HLA-A2-restricted NY-ESO-1b peptide in hepatocellular carcinoma patients,"2004","10","20","6946-6955",Clinical cancer research : an official journal of the American Association for Cancer Research,"","","","","","","","15501973",https://pubmed.ncbi.nlm.nih.gov/15501973/,"",0,10,0,0,0,,,
5828,99,NCT00199836,website,"",A Pilot Study of NY-ESO-1b Peptide Plus CpG 7909 and Montanide ISA-51 in Patients With Cancer,"","","","","","","","","","","","","",https://clinicaltrials.gov/ct2/show/NCT00199836,"",0,10,0,0,0,,,
5829,99,NCT00109655,website,"",Dose-Escalation Study of CG0070 for Bladder Cancer After BCG (Bacillus Calmette-Guerin) Failure,"","","","","","","","","","","","","",https://clinicaltrials.gov/ct2/show/NCT00109655,"",0,10,0,0,0,,,
5830,99,NCT00006106,website,"",ONYX-015 With Cisplatin and Fluorouracil in Treating Patients With Advanced Head and Neck Cancer,"","","","","","","","","","","","","",https://clinicaltrials.gov/ct2/show/NCT00006106,"",0,10,0,0,0,,,
5831,99,"Ottensmeier et al., 2016",journal,"Ottensmeier C, Bowers M, Hamid D, Maishman T, Regan S, Wood W, Cazaly A, Stanton L",Wilms tumour antigen 1 Immunity via DNA fusion gene vaccination in haematological malignancies by intramuscular injection followed by intramuscular electroporation: a Phase II non-randomised clinical trial (WIN),"2016","","","",NIHR Journals Library,"","","","","","","","27099895",https://pubmed.ncbi.nlm.nih.gov/27099895/,"",0,10,0,0,0,,,
5832,99,NCT00001827,website,"",p53 Vaccine for Ovarian Cancer,"","","","","","","","","","","","","",https://clinicaltrials.gov/ct2/show/NCT00001827,"",0,10,0,0,0,,,
5833,99,NCIT_C82420,website,"",P53-Synthetic Long Peptides Vaccine (Code C82420),"","","","","","","","","","","","","",https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI%20Thesaurus&code=C82420,"",0,10,0,0,0,,,
5834,99,"Rodeberg et al., 2005",journal,"Rodeberg DA, Nuss RA, Heppelmann CJ, Celis E",Lack of effective T-lymphocyte response to the PAX3/FKHR translocation area in alveolar rhabdomyosarcoma,"2005","54","6","526-534","Cancer immunology, immunotherapy : CII","","","","","","","","15838707",https://pubmed.ncbi.nlm.nih.gov/15838707/,"",0,10,0,0,0,,,
5835,99,NCT02864368,website,"",Peptide Targets for Glioblastoma Against Novel Cytomegalovirus Antigens (PERFORMANCE),"","","","","","","","","","","","","",https://clinicaltrials.gov/ct2/show/NCT02864368,"",0,10,0,0,0,,,
5836,99,NCIT_C107243,website,"",PEP-CMV Vaccine (Code C107243),"","","","","","","","","","","","","",https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI%20Thesaurus&code=C107243,"",0,10,0,0,0,,,
5837,99,"Sampson et al., 2020",journal,"Sampson JH, Gunn MD, Fecci PE, Ashley DM",Brain immunology and immunotherapy in brain tumours,"2020","20","1","12-25",Nature reviews. Cancer,"","","","","","","","31806885",https://pubmed.ncbi.nlm.nih.gov/31806885/,"",0,10,0,0,0,,,
5838,99,NCT02562755,website,"",Hepatocellular Carcinoma Study Comparing Vaccinia Virus Based Immunotherapy Plus Sorafenib vs Sorafenib Alone (PHOCUS),"","","","","","","","","","","","","",https://clinicaltrials.gov/ct2/show/NCT02562755,"",0,10,0,0,0,,,
5839,99,"Weller et al., 2017",journal,"Weller M, Butowski N, Tran DD, Recht LD, Lim M, Hirte H, Ashby L, Mechtler L, Goldlust SA, Iwamoto F, Drappatz J, O'Rourke DM, Wong M, Hamilton MG, Finocchiaro G, Perry J, Wick W, Green J, He Y, Turner CD, Yellin MJ, Keler T, Davis TA, Stupp R, Sampson JH","Rindopepimut with temozolomide for patients with newly diagnosed, EGFRvIII-expressing glioblastoma (ACT IV): a randomised, double-blind, international phase 3 trial","2017","18","10","1373-1385",The Lancet. Oncology,"","","","","","","","28844499",https://pubmed.ncbi.nlm.nih.gov/28844499/,"",0,10,0,0,0,,,
5840,99,NCT05163223,website,"","Therapeutic Cancer Vaccine (AST-301, pNGVL3-hICD) in Patients With Breast Cancer (Cornerstone001)","","","","","","","","","","","","","",https://clinicaltrials.gov/ct2/show/NCT05163223,"",0,10,0,0,0,,,
5841,99,"Qiu et al., 2018",journal,"Qiu J, Peng S, Ma Y, Yang A, Farmer E, Cheng MA, Roden RBS, Wu TC, Chang YN, Hung CF",Epithelial boost enhances antigen expression by vaccinia virus for the generation of potent CD8+ T cell-mediated antitumor immunity following DNA priming vaccination,"2018","525","","205-215",Virology,"","","","","","","","30296681",https://pubmed.ncbi.nlm.nih.gov/30296681/,"",0,10,0,0,0,,,
5842,99,NCIT_C2235,website,"",PR1 Leukemia Peptide Vaccine (Code C2235),"","","","","","","","","","","","","",https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI%20Thesaurus&code=C2235,"",0,10,0,0,0,,,
5843,99,NCT00345293,website,"",Dendritic Cell Vaccine Study (DC/PC3) for Prostate Cancer,"","","","","","","","","","","","","",https://clinicaltrials.gov/ct2/show/NCT00345293,"",0,10,0,0,0,,,
5844,99,NCT02111577,website,"",Phase III Study of DCVAC/PCa Added to Standard Chemotherapy for Men With Metastatic Castration Resistant Prostate Cancer (VIABLE),"","","","","","","","","","","","","",https://clinicaltrials.gov/ct2/show/NCT02111577,"",0,10,0,0,0,,,
5845,99,"Arlen et al., 2003",journal,"Arlen PM, Gulley JL, Tsang KY, Schlom J",Strategies for the development of PSA-based vaccines for the treatment of advanced prostate cancer,"2003","2","4","483-493",Expert review of vaccines,"","","","","","","","14711334",https://pubmed.ncbi.nlm.nih.gov/14711334/,"",0,10,0,0,0,,,
5846,99,NCT02058680,website,"",Phase 1A/1B Study of PSA/IL-2/GM-CSF Vaccine for Recurrent Prostate Cancer in Hormone Naive and Hormone Independent Patients (PSA),"","","","","","","","","","","","","",https://clinicaltrials.gov/ct2/show/NCT02058680,"",0,10,0,0,0,,,
5847,99,"Shore et al., 2020",journal,"Shore ND, Morrow MP, McMullan T, Kraynyak KA, Sylvester A, Bhatt K, Cheung J, Boyer JD, Liu L, Sacchetta B, Rosencranz S, Heath EI, Nordquist L, Cheng HH, Tagawa ST, Appleman LJ, Tutrone R, Garcia JA, Whang YE, Kelly WK, Weiner DB, Bagarazzi ML, Skolnik JM",CD8(+) T Cells Impact Rising PSA in Biochemically Relapsed Cancer Patients Using Immunotherapy Targeting Tumor-Associated Antigens,"2020","28","5","1238-1250",Molecular therapy : the journal of the American Society of Gene Therapy,"","","","","","","","32208168",https://pubmed.ncbi.nlm.nih.gov/32208168/,"",0,10,0,0,0,,,
5848,99,NCIT_C29338,website,"",PSA:154-163(155L) Peptide Vaccine (Code C29338),"","","","","","","","","","","","","",https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI%20Thesaurus&code=C29338,"",0,10,0,0,0,,,
5849,99,"Teplensky et al., 2021",journal,"Teplensky MH, Dittmar JW, Qin L, Wang S, Evangelopoulos M, Zhang B, Mirkin CA",Spherical Nucleic Acid Vaccine Structure Markedly Influences Adaptive Immune Responses of Clinically Utilized Prostate Cancer Targets,"2021","10","22",e2101262,Advanced healthcare materials,"","","","","","","","34494382",https://pubmed.ncbi.nlm.nih.gov/34494382/,"",0,10,0,0,0,,,
5850,99,"Garland et al., 2022",journal,"Garland SM, Anagani M, Bhatla N, Chatterjee S, Lalwani S, Ross C, Group T, Lin J, Luxembourg A, Walia A, Tu Y",Immunogenicity and safety of quadrivalent and 9-valent human papillomavirus vaccines in Indian clinical trial participants,"2022","18","6","2105067",Human vaccines & immunotherapeutics,"","","","","","","","35997582",https://pubmed.ncbi.nlm.nih.gov/35997582/,"",0,10,0,0,0,,,
5851,99,"Gabri et al., 2016",journal,"Gabri MR, Cacciavillano W, Chantada GL, Alonso DF",Racotumomab for treating lung cancer and pediatric refractory malignancies,"2016","16","4","573-578",Expert opinion on biological therapy,"","","","","","","","26903265",https://pubmed.ncbi.nlm.nih.gov/26903265/,"",0,10,0,0,0,,,
5852,99,"Cafri et al., 2020",journal,"Cafri G, Gartner JJ, Zaks T, Hopson K, Levin N, Paria BC, Parkhurst MR, Yossef R, Lowery FJ, Jafferji MS, Prickett TD, Goff SL, McGowan CT, Seitter S, Shindorf ML, Parikh A, Chatani PD, Robbins PF, Rosenberg SA",mRNA vaccine-induced neoantigen-specific T cell immunity in patients with gastrointestinal cancer,"2020","130","11","5976-5988",The Journal of clinical investigation,"","","","","","","","33016924",https://pubmed.ncbi.nlm.nih.gov/33016924/,"",0,10,0,0,0,,,
5853,99,NCT00019591,website,"",Vaccine Therapy With or Without Interleukin-2 in Treating Patients With Locally Advanced or Metastatic Colorectal Cancer,"","","","","","","","","","","","","",https://clinicaltrials.gov/ct2/show/NCT00019591,"",0,10,0,0,0,,,
5854,99,"Shore et al., 2017",journal,"Shore ND, Boorjian SA, Canter DJ, Ogan K, Karsh LI, Downs TM, Gomella LG, Kamat AM, Lotan Y, Svatek RS, Bivalacqua TJ, Grubb RL 3rd, Krupski TL, Lerner SP, Woods ME, Inman BA, Milowsky MI, Boyd A, Treasure FP, Gregory G, Sawutz DG, Yla-Herttuala S, Parker NR, Dinney CPN","Intravesical rAd-IFN/Syn3 for Patients With High-Grade, Bacillus Calmette-Guerin-Refractory or Relapsed Non-Muscle-Invasive Bladder Cancer: A Phase II Randomized Study","2017","35","30","3410-3416",Journal of clinical oncology : official journal of the American Society of Clinical Oncology,"","","","","","","","28834453",https://pubmed.ncbi.nlm.nih.gov/28834453/,"",0,10,0,0,0,,,
5855,99,"Reali et al., 2005",journal,"Reali E, Canter D, Zeytin H, Schlom J, Greiner JW",Comparative studies of Avipox-GM-CSF versus recombinant GM-CSF protein as immune adjuvants with different vaccine platforms,"2005","23","22","2909-2921",Vaccine,"","","","","","","","15780740",https://pubmed.ncbi.nlm.nih.gov/15780740/,"",0,10,0,0,0,,,
5856,99,"Arlen et al., 2007",journal,"Arlen PM, Skarupa L, Pazdur M, Seetharam M, Tsang KY, Grosenbach DW, Feldman J, Poole DJ, Litzinger M, Steinberg SM, Jones E, Chen C, Marte J, Parnes H, Wright J, Dahut W, Schlom J, Gulley JL",Clinical safety of a viral vector based prostate cancer vaccine strategy,"2007","178","4 Pt 1","1515-1520",The Journal of urology,"","","","","","","","17707059",https://pubmed.ncbi.nlm.nih.gov/17707059/,"",0,10,0,0,0,,,
5857,99,NCT00924092,website,"","Open Label Phase I Study to Evaluate the Safety and Tolerability of Vaccine (GI-6207) Consisting of Whole, Heat-Killed Recombinant Saccharomyces Cerevisiae Genetically Modified to Express CEA Protein in Adults With Metastatic CEA-Expressing Carcinoma","","","","","","","","","","","","","",https://clinicaltrials.gov/ct2/show/NCT00924092,"",0,10,0,0,0,,,
5858,99,"Gulley et al., 2002",journal,"Gulley J, Chen AP, Dahut W, Arlen PM, Bastian A, Steinberg SM, Tsang K, Panicali D, Poole D, Schlom J, Michael Hamilton J",Phase I study of a vaccine using recombinant vaccinia virus expressing PSA (rV-PSA) in patients with metastatic androgen-independent prostate cancer,"2002","53","2","109-117",The Prostate,"","","","","","","","12242725",https://pubmed.ncbi.nlm.nih.gov/12242725/,"",0,10,0,0,0,,,
5859,99,"Tsang et al., 1995",journal,"Tsang KY, Zaremba S, Nieroda CA, Zhu MZ, Hamilton JM, Schlom J",Generation of human cytotoxic T cells specific for human carcinoembryonic antigen epitopes from patients immunized with recombinant vaccinia-CEA vaccine,"1995","87","13","982-990",Journal of the National Cancer Institute,"","","","","","","","7629885",https://pubmed.ncbi.nlm.nih.gov/7629885/,"",0,10,0,0,0,,,
5860,99,NCT00217373,website,"","Vaccine Therapy, GM-CSF, and Interferon Alfa-2b in Treating Patients With Locally Advanced or Metastatic Cancer That Expresses Carcinoembryonic Antigen (CEA)","","","","","","","","","","","","","",https://clinicaltrials.gov/ct2/show/NCT00217373,"",0,10,0,0,0,,,
5861,99,"Nagorsen et al., 2004",journal,"Nagorsen D, Servis C, Lvy N, Provenzano M, Dudley ME, Marincola FM, Lvy F",Proteasomal cleavage does not determine immunogenicity of gp100-derived peptides gp100 209-217 and gp100 209-217T210M,"2004","53","9","817-824","Cancer immunology, immunotherapy : CII","","","","","","","","15133631",https://pubmed.ncbi.nlm.nih.gov/15133631/,"",0,10,0,0,0,,,
5862,99,"Saenger et al., 2008",journal,"Saenger YM, Li Y, Chiou KC, Chan B, Rizzuto G, Terzulli SL, Merghoub T, Houghton AN, Wolchok JD",Improved tumor immunity using anti-tyrosinase related protein-1 monoclonal antibody combined with DNA vaccines in murine melanoma,"2008","68","23","9884-9891",Cancer research,"","","","","","","","19047169",https://pubmed.ncbi.nlm.nih.gov/19047169/,"",0,10,0,0,0,,,
5863,99,"Kurtzberg et al., 2020",journal,"Kurtzberg J, Abdel-Azim H, Carpenter P, Chaudhury S, Horn B, Mahadeo K, Nemecek E, Neudorf S, Prasad V, Prockop S, Quigg T, Satwani P, Cheng A, Burke E, Hayes J, Skerrett D","A Phase 3, Single-Arm, Prospective Study of Remestemcel-L, Ex Vivo Culture-Expanded Adult Human Mesenchymal Stromal Cells for the Treatment of Pediatric Patients Who Failed to Respond to Steroid Treatment for Acute Graft-versus-Host Disease","2020","26","5","845-854",Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation,"","","","","","","","32018062",https://pubmed.ncbi.nlm.nih.gov/32018062/,"",0,10,0,0,0,,,
5864,99,"Bedke and Stenzl, 2013",journal,"Bedke J, Stenzl A",IMA901: a peptide vaccine in renal cell carcinoma,"2013","22","10","1329-1336",Expert opinion on investigational drugs,"","","","","","","","23899354",https://pubmed.ncbi.nlm.nih.gov/23899354/,"",0,10,0,0,0,,,
5865,99,"Amin et al., 2015",journal,"Amin A, Dudek AZ, Logan TF, Lance RS, Holzbeierlein JM, Knox JJ, Master VA, Pal SK, Miller WH Jr, Karsh LI, Tcherepanova IY, DeBenedette MA, Williams WL, Plessinger DC, Nicolette CA, Figlin RA","Survival with AGS-003, an autologous dendritic cell-based immunotherapy, in combination with sunitinib in unfavorable risk patients with advanced renal cell carcinoma (RCC): Phase 2 study results","2015","3","","14",Journal for immunotherapy of cancer,"","","","","","","","25901286",https://pubmed.ncbi.nlm.nih.gov/25901286/,"",0,10,0,0,0,,,
5866,99,"Li et al., 2021",journal,"Li T, Zhao L, Yang Y, Wang Y, Zhang Y, Guo J, Chen G, Qin P, Xu B, Ma B, Zhang F, Shang Y, Li Q, Zhang K, Yuan D, Feng C, Ma Y, Liu Z, Tian Z, Li H, Wang S, Gao Q",T Cells Expanded from PD-1(+) Peripheral Blood Lymphocytes Share More Clones with Paired Tumor-Infiltrating Lymphocytes,"2021","81","8","2184-2194",Cancer research,"","","","","","","","33408117",https://pubmed.ncbi.nlm.nih.gov/33408117/,"",0,10,0,0,0,,,
5867,99,NCT00505271,website,"",Safety and Efficacy Study Using Rexin-G for Breast Cancer,"","","","","","","","","","","","","",https://clinicaltrials.gov/ct2/show/NCT00505271,"",0,10,0,0,0,,,
5868,99,"Gupta et al., 2015",journal,"Gupta S, Termini JM, Rivas Y, Otero M, Raffa FN, Bhat V, Farooq A, Stone GW",A multi-trimeric fusion of CD40L and gp100 tumor antigen activates dendritic cells and enhances survival in a B16-F10 melanoma DNA vaccine model,"2015","33","38","4798-4806",Vaccine,"","","","","","","","26241951",https://pubmed.ncbi.nlm.nih.gov/26241951/,"",0,10,0,0,0,,,
5869,99,"Ibrahim et al., 2013",journal,"Ibrahim NK, Murray JL, Zhou D, Mittendorf EA, Sample D, Tautchin M, Miles D",Survival Advantage in Patients with Metastatic Breast Cancer Receiving Endocrine Therapy plus Sialyl Tn-KLH Vaccine: Post Hoc Analysis of a Large Randomized Trial,"2013","4","7","577-584",Journal of Cancer,"","","","","","","","23983823",https://pubmed.ncbi.nlm.nih.gov/23983823/,"",0,10,0,0,0,,,
5870,99,"Kantoff et al., 2010",journal,"Kantoff PW, Higano CS, Shore ND, Berger ER, Small EJ, Penson DF, Redfern CH, Ferrari AC, Dreicer R, Sims RB, Xu Y, Frohlich MW, Schellhammer PF",Sipuleucel-T immunotherapy for castration-resistant prostate cancer,"2010","363","5","411-422",The New England journal of medicine,"","","","","","","","20818862",https://pubmed.ncbi.nlm.nih.gov/20818862/,"",0,10,0,0,0,,,
5871,99,"Longenecker et al., 1993",journal,"Longenecker BM, Reddish M, Koganty R, MacLean GD",Immune responses of mice and human breast cancer patients following immunization with synthetic sialyl-Tn conjugated to KLH plus detox adjuvant,"1993","690","","276-291",Annals of the New York Academy of Sciences,"","","","","","","","7690215",https://pubmed.ncbi.nlm.nih.gov/7690215/,"",0,10,0,0,0,,,
5872,99,NCIT_C97951,website,"",Maveropepimut-S (Code C97951),"","","","","","","","","","","","","",https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI%20Thesaurus&code=C97951,"",0,10,0,0,0,,,
5873,99,"Berinstein et al., 2015",journal,"Berinstein NL, Karkada M, Oza AM, Odunsi K, Villella JA, Nemunaitis JJ, Morse MA, Pejovic T, Bentley J, Buyse M, Nigam R, Weir GM, MacDonald LD, Quinton T, Rajagopalan R, Sharp K, Penwell A, Sammatur L, Burzykowski T, Stanford MM, Mansour M",Survivin-targeted immunotherapy drives robust polyfunctional T cell generation and differentiation in advanced ovarian cancer patients,"2015","4","8",e1026529,Oncoimmunology,"","","","","","","","26405584",https://pubmed.ncbi.nlm.nih.gov/26405584/,"",0,10,0,0,0,,,
5874,99,"Lo et al., 2005",journal,"Lo HW, Day CP, Hung MC",Cancer-specific gene therapy,"2005","54","","235-255",Advances in genetics,"","","","","","","","16096014",https://pubmed.ncbi.nlm.nih.gov/16096014/,"",0,10,0,0,0,,,
5875,99,"Fenstermaker et al., 2016",journal,"Fenstermaker RA, Ciesielski MJ, Qiu J, Yang N, Frank CL, Lee KP, Mechtler LR, Belal A, Ahluwalia MS, Hutson AD",Clinical study of a survivin long peptide vaccine (SurVaxM) in patients with recurrent malignant glioma,"2016","65","11","1339-1352","Cancer immunology, immunotherapy : CII","","","","","","","","27576783",https://pubmed.ncbi.nlm.nih.gov/27576783/,"",0,10,0,0,0,,,
5876,99,NCT02960594,website,"",hTERT Immunotherapy Alone or in Combination With IL-12 DNA Followed by Electroporation in Adults With Solid Tumors at High Risk of Relapse (TRT-001),"","","","","","","","","","","","","",https://clinicaltrials.gov/ct2/show/NCT02960594,"",0,10,0,0,0,,,
5877,99,"Vonderheide et al., 2021",journal,"Vonderheide RH, Kraynyak KA, Shields AF, McRee AJ, Johnson JM, Sun W, Chintakuntlawar AV, Pawlicki J, Sylvester AJ, McMullan T, Samuels R, Kim JJ, Weiner D, Boyer JD, Morrow MP, Humeau L, Skolnik JM","Phase 1 study of safety, tolerability and immunogenicity of the human telomerase (hTERT)-encoded DNA plasmids INO-1400 and INO-1401 with or without IL-12 DNA plasmid INO-9012 in adult patients with solid tumors","2021","9","7","",Journal for immunotherapy of cancer,"","","","","","","","34230114",https://pubmed.ncbi.nlm.nih.gov/34230114/,"",0,10,0,0,0,,,
5878,99,"Wood et al., 2016",journal,"Wood LV, Fojo A, Roberson BD, Hughes MS, Dahut W, Gulley JL, Madan RA, Arlen PM, Sabatino M, Stroncek DF, Castiello L, Trepel JB, Lee MJ, Parnes HL, Steinberg SM, Terabe M, Wilkerson J, Pastan I, Berzofsky JA",TARP vaccination is associated with slowing in PSA velocity and decreasing tumor growth rates in patients with Stage D0 prostate cancer,"2016","5","8",e1197459,Oncoimmunology,"","","","","","","","27622067",https://pubmed.ncbi.nlm.nih.gov/27622067/,"",0,10,0,0,0,,,
5879,99,NCT02362464,website,"",Long-Term TARP Vaccination Using a Multi-Epitope TARP Peptide Autologous Dendritic Cell Vaccination in Previously Vaccinated Men on NCI 09-C-0139,"","","","","","","","","","","","","",https://clinicaltrials.gov/ct2/show/NCT02362464,"",0,10,0,0,0,,,
5880,99,"Gosavi et al., 2022",journal,"Gosavi D, Wower I, Beckmann IK, Hofacker IL, Wower J, Wolfinger MT, Sztuba-Solinska J",Insights into the secondary and tertiary structure of the Bovine Viral Diarrhea Virus Internal Ribosome Entry Site,"2022","19","1","496-506",RNA biology,"","","","","","","","35380920",https://pubmed.ncbi.nlm.nih.gov/35380920/,"",0,10,0,0,0,,,
5881,99,NCT02855892,website,"",A Phase II Clinical Trial to Evaluate the Efficacy and Safety of GV1001 in Patients With BPH,"","","","","","","","","","","","","",https://clinicaltrials.gov/ct2/show/NCT02855892,"",0,10,0,0,0,,,
5882,99,"Kim et al., 2016",journal,"Kim H, Seo EH, Lee SH, Kim BJ",The Telomerase-Derived Anticancer Peptide Vaccine GV1001 as an Extracellular Heat Shock Protein-Mediated Cell-Penetrating Peptide,"2016","17","12","",International journal of molecular sciences,"","","","","","","","27941629",https://pubmed.ncbi.nlm.nih.gov/27941629/,"",0,10,0,0,0,,,
5883,99,"Jimnez-Cervantes et al., 1994",journal,"Jimnez-Cervantes C, Solano F, Kobayashi T, Urabe K, Hearing VJ, Lozano JA, Garca-Borrn JC","A new enzymatic function in the melanogenic pathway. The 5,6-dihydroxyindole-2-carboxylic acid oxidase activity of tyrosinase-related protein-1 (TRP1)","1994","269","27","17993-18000",The Journal of biological chemistry,"","","","","","","","8027058",https://pubmed.ncbi.nlm.nih.gov/8027058/,"",0,10,0,0,0,,,
5884,99,NCT00028431,website,"",Novel Adjuvants for Peptide-Based Melanoma Vaccines,"","","","","","","","","","","","","",https://clinicaltrials.gov/ct2/show/NCT00028431,"",0,10,0,0,0,,,
5885,99,NCT00681577,website,"",Histocompatibility Leukocyte Antigen (HLA)-A*2402 Restricted Peptide Vaccine Therapy in Patients With Gastric Cancer,"","","","","","","","","","","","","",https://clinicaltrials.gov/ct2/show/NCT00681577,"",0,10,0,0,0,,,
5886,99,NCT00632333,website,"",Combination of Chemoradiation Therapy and Epitope Peptide Vaccine Therapy in Treating Patients With Esophageal Cancer,"","","","","","","","","","","","","",https://clinicaltrials.gov/ct2/show/NCT00632333,"",0,10,0,0,0,,,
5887,99,"Wallack et al., 1987",journal,"Wallack MK, Bash JA, McNally KR, Leftheriotis E",Serological evaluation of melanoma patients in a phase I/II trial of vaccinia melanoma oncolysate (VMO) immunotherapy,"1987","1","","351-359","Cancer detection and prevention. Supplement : official publication of the International Society for Preventive Oncology, Inc","","","","","","","","3155379",https://pubmed.ncbi.nlm.nih.gov/3155379/,"",0,10,0,0,0,,,
5888,99,NCT00655785,website,"",Antiangiogenic Peptide Vaccine Therapy With Gemcitabine in Treating Patient With Pancreatic Cancer (Phase1/2),"","","","","","","","","","","","","",https://clinicaltrials.gov/ct2/show/NCT00655785,"",0,10,0,0,0,,,
5889,99,NCT03294564,website,"","Cognitive, Emotional, and Neural Responses to Acute Inflammation","","","","","","","","","","","","","",https://clinicaltrials.gov/ct2/show/NCT03294564,"",0,10,0,0,0,,,
5890,99,NCT01718899,website,"",Phase 1/2a Study of Cancer Vaccine to Treat Smoldering Multiple Myeloma,"","","","","","","","","","","","","",https://clinicaltrials.gov/ct2/show/NCT01718899,"",0,10,0,0,0,,,
5891,99,"Yost, 1985",journal,Yost WA,"Click stimuli do produce masking-level differences, sometimes","1985","77","6","2191-2192",The Journal of the Acoustical Society of America,"","","","","","","","4019903",https://pubmed.ncbi.nlm.nih.gov/4019903/,"",0,10,0,0,0,,,
5892,216,"Liu et al., 2018",journal,"Liu T, Zhou Z, Tian X, Liu W, Xu D, Fan Y, Liao J, Gu S, Li X, Zhou R","A recombinant trivalent vaccine candidate against human adenovirus types 3, 7, and 55","2018","36","16","2199-2206",Vaccine,"","","","","","","","29548605","",,0,0,0,0,0,,,
5893,216,"Guo et al., 2021",journal,"Guo J, Zhang Y, Zhang Y, Zhang C, Zhu C, Xing M, Wang X, Zhou D",A bivalent live-attenuated vaccine candidate elicits protective immunity against human adenovirus types 4 and 7,"2021","10","1","1947-1959",Emerging microbes & infections,"","","","","","","","34520320","",,0,0,0,0,0,,,
5894,278,"Wang et al., 2011",journal,"Wang D, Suhrbier A, Penn-Nicholson A, Woraratanadharm J, Gardner J, Luo M, Le TT, Anraku I, Sakalian M, Einfeld D, Dong JY",A complex adenovirus vaccine against chikungunya virus provides complete protection against viraemia and arthritis,"2011","29","15","2803-2809",Vaccine,"","","","","","","","21320541","",,0,0,0,0,0,,,
5895,17,"Maruyama et al., 2019",journal,"Maruyama J, Mateer EJ, Manning JT, Sattler R, Seregin AV, Bukreyeva N, Jones FR, Balint JP, Gabitzsch ES, Huang C, Paessler S",Adenoviral vector-based vaccine is fully protective against lethal Lassa fever challenge in Hartley guinea pigs,"2019","37","45","6824-6831",Vaccine,"","","","","","","","31561999","",,0,0,0,0,0,,,
5896,13,"Wong et al., 2015",journal,"Wong G, Richardson JS, Pillet S, Racine T, Patel A, Soule G, Ennis J, Turner J, Qiu X, Kobinger GP",Adenovirus-Vectored Vaccine Provides Postexposure Protection to Ebola Virus-Infected Nonhuman Primates,"2015","212 Suppl 2",Suppl 2,S379-383,The Journal of infectious diseases,"","","","","","","","25957963","",,0,0,0,0,0,,,
5897,278,"Rossi et al., 2019",journal,"Rossi SL, Comer JE, Wang E, Azar SR, Lawrence WS, Plante JA, Ramsauer K, Schrauf S, Weaver SC",Immunogenicity and Efficacy of a Measles Virus-Vectored Chikungunya Vaccine in Nonhuman Primates,"2019","220","5","735-742",The Journal of infectious diseases,"","","","","","","","31053842","",,0,0,0,0,0,,,
5898,278,"Brandler et al., 2013",journal,"Brandler S, Ruffi C, Combredet C, Brault JB, Najburg V, Prevost MC, Habel A, Tauber E, Desprs P, Tangy F",A recombinant measles vaccine expressing chikungunya virus-like particles is strongly immunogenic and protects mice from lethal challenge with chikungunya virus,"2013","31","36","3718-3725",Vaccine,"","","","","","","","23742993","",,0,0,0,0,0,,,
5899,278,"Ramsauer et al., 2015",journal,"Ramsauer K, Schwameis M, Firbas C, Mllner M, Putnak RJ, Thomas SJ, Desprs P, Tauber E, Jilma B, Tangy F","Immunogenicity, safety, and tolerability of a recombinant measles-virus-based chikungunya vaccine: a randomised, double-blind, placebo-controlled, active-comparator, first-in-man trial","2015","15","5","519-527",The Lancet. Infectious diseases,"","","","","","","","25739878","",,0,0,0,0,0,,,
5900,278,"Reisinger et al., 2019",journal,"Reisinger EC, Tschismarov R, Beubler E, Wiedermann U, Firbas C, Loebermann M, Pfeiffer A, Muellner M, Tauber E, Ramsauer K","Immunogenicity, safety, and tolerability of the measles-vectored chikungunya virus vaccine MV-CHIK: a double-blind, randomised, placebo-controlled and active-controlled phase 2 trial","2019","392","10165","2718-2727","Lancet (London, England)","","","","","","","","30409443","",,0,0,0,0,0,,,
5901,126,"Lin et al., 2020",journal,"Lin TH, Chen HW, Hsiao YJ, Yan JY, Chiang CY, Chen MY, Hu HM, Wu SH, Pan CH",Immunodomination of Serotype-Specific CD4+ T-Cell Epitopes Contributed to the Biased Immune Responses Induced by a Tetravalent Measles-Vectored Dengue Vaccine,"2020","11","","546",Frontiers in immunology,"","","","","","","","32300346","",,0,0,0,0,0,,,
5902,283,"O'Kennedy et al., 2022",journal,"O'Kennedy MM, Coetzee P, Koekemoer O, du Plessis L, Lourens CW, Kwezi L, du Preez I, Mamputha S, Mokoena NB, Rutkowska DA, Verschoor JA, Lemmer Y",Protective immunity of plant-produced African horse sickness virus serotype 5 chimaeric virus-like particles (VLPs) and viral protein 2 (VP2) vaccines in IFNAR(-/-) mice,"2022","40","35","5160-5169",Vaccine,"","","","","","","","35902279","",,0,0,0,0,0,,,
5903,220,"Chen et al., 2020",journal,"Chen W, Zhao D, He X, Liu R, Wang Z, Zhang X, Li F, Shan D, Chen H, Zhang J, Wang L, Wen Z, Wang X, Guan Y, Liu J, Bu Z",A seven-gene-deleted African swine fever virus is safe and effective as a live attenuated vaccine in pigs,"2020","63","5","623-634",Science China. Life sciences,"","","","","","","","32124180","",,0,0,0,0,0,,,
5904,168,"Ritchie et al., 1996",journal,"Ritchie BW, Niagro FD, Latimer KS, Pritchard N, Campagnoli RP, Lukert PD",An inactivated avian polyomavirus vaccine is safe and immunogenic in various Psittaciformes,"1996","14","12","1103-1107",Vaccine,"","","","","","","","8911004","",,0,0,0,0,0,,,
5905,286,"Hausmann et al., 2005",journal,"Hausmann J, Baur K, Engelhardt KR, Fischer T, Rziha HJ, Staeheli P",Vaccine-induced protection against Borna disease in wild-type and perforin-deficient mice,"2005","86",Pt 2,"399-403",The Journal of general virology,"","","","","","","","15659759","",,0,0,0,0,0,,,
5906,101,"Surez et al., 2022",journal,"Surez Archilla G, Gutirrez G, Camussone C, Calvinho L, Abdala A, Alvarez I, Petersen M, Franco L, Destefano G, Monti G, Jacques JR, Joris T, Willems L, Trono K",A safe and effective vaccine against bovine leukemia virus,"2022","13","","980514",Frontiers in immunology,"","","","","","","","36032174","",,0,0,0,0,0,,,
5907,193,"Avki et al., 2004",journal,"Avki S, Turutoglu H, Simsek A, Unsal A",Clinical and immunological effects of Newcastle disease virus vaccine on bovine papillomatosis,"2004","98","1-2","9-16",Veterinary immunology and immunopathology,"","","","","","","","15127837","",,0,0,0,0,0,,,
5908,256,"Zimmerman et al., 2006",journal,"Zimmerman AD, Boots RE, Valli JL, Chase CC",Evaluation of protection against virulent bovine viral diarrhea virus type 2 in calves that had maternal antibodies and were vaccinated with a modified-live vaccine,"2006","228","11","1757-1761",Journal of the American Veterinary Medical Association,"","","","","","","","16740078","",,0,0,0,0,0,,,
5909,59,"Julander et al., 2018",journal,"Julander JG, Testori M, Cheminay C, Volkmann A",Immunogenicity and Protection After Vaccination With a Modified Vaccinia Virus Ankara-Vectored Yellow Fever Vaccine in the Hamster Model,"2018","9","","1756",Frontiers in immunology,"","","","","","","","30116244","",,0,0,0,0,0,,,
5910,52,"Gillet et al., 2009",journal,"Gillet Y, Habermehl P, Thomas S, Eymin C, Fiquet A","Immunogenicity and safety of concomitant administration of a measles, mumps and rubella vaccine (M-M-RvaxPro) and a varicella vaccine (VARIVAX) by intramuscular or subcutaneous routes at separate injection sites: a randomised clinical trial","2009","7","","16",BMC medicine,"","","","","","","","19366435","","",0,10,0,0,0,,,
5911,177,"Fu et al., 2022",journal,"Fu Y, Sun J, Lian S, Deng X, Zhang L, Shao J, Yu H, Yan X, Zhu Y",Immunogenicity of an Inactivated Canine Adenovirus Type 1 Vaccine for Foxes,"2022","9","","678671",Frontiers in veterinary science,"","","","","","","","35242832","",,0,0,0,0,0,,,
5912,17,"Watrobska-Swietlikowska, 2019",journal,Watrobska-Swietlikowska D,Compatibility of Maximum Inorganic and Organic Calcium and Phosphate Content in Neonatal Parenteral Solutions,"2019","9","1","10525",Scientific reports,"","","","","","","","31324864","","",0,10,0,0,0,,,
5913,50,"Watrobska-Swietlikowska, 2019",journal,Watrobska-Swietlikowska D,Compatibility of Maximum Inorganic and Organic Calcium and Phosphate Content in Neonatal Parenteral Solutions,"2019","9","1","10525",Scientific reports,"","","","","","","","31324864","","",0,10,0,0,0,,,
5914,50,"Fisher et al., 2022",journal,"Fisher DG, Gnazzo V, Holthausen DJ, Lpez CB",Non-standard viral genome-derived RNA activates TLR3 and type I IFN signaling to induce cDC1-dependent CD8+T-cell responses during vaccination in mice,"2022","40","50","7270-7279",Vaccine,"","","","","","","","36333225","","",0,10,0,0,0,,,
5915,281,"Marinaro et al., 2012",journal,"Marinaro M, Rezza G, Del Giudice G, Colao V, Tarsitano E, Camero M, Losurdo M, Buonavoglia C, Tempesta M",A caprine herpesvirus 1 vaccine adjuvanted with MF59 protects against vaginal infection and interferes with the establishment of latency in goats,"2012","7","4",e34913,PloS one,"","","","","","","","22511971","",,0,0,0,0,0,,,
5916,64,"Xu et al., 2013",journal,"Xu J, Huang D, Xu J, Liu S, Lin H, Zhu H, Liu B, Chen W, Lu C",Immune responses and protective efficacy of a recombinant swinepox virus co-expressing HA1 genes of H3N2 and H1N1 swine influenza virus in mice and pigs,"2013","162","1","259-264",Veterinary microbiology,"","","","","","","","23265244","","",0,11,0,0,0,,,
5917,150,"Zhang et al., 2015",journal,"Zhang X, Wu B, Liu Y, Chen W, Dai Z, Bi Y, Xie Q",Assessing the efficacy of an inactivated chicken anemia virus vaccine,"2015","33","16","1916-1922",Vaccine,"","","","","","","","25758933","",,0,0,0,0,0,,,
5918,154,"Kusuhara et al., 2005",journal,"Kusuhara H, Hohdatsu T, Okumura M, Sato K, Suzuki Y, Motokawa K, Gemma T, Watanabe R, Huang C, Arai S, Koyama H",Dual-subtype vaccine (Fel-O-Vax FIV) protects cats against contact challenge with heterologous subtype B FIV infected cats,"2005","108","3-4","155-165",Veterinary microbiology,"","","","","","","","15899558","",,0,0,0,0,0,,,
5919,230,"Edupuganti et al., 2013",journal,"Edupuganti S, Eidex RB, Keyserling H, Akondy RS, Lanciotti R, Orenstein W, del Rio C, Pan Y, Querec T, Lipman H, Barrett A, Ahmed R, Teuwen D, Cetron M, Mulligan MJ","A randomized, double-blind, controlled trial of the 17D yellow fever virus vaccine given in combination with immune globulin or placebo: comparative viremia and immunogenicity","2013","88","1","172-177",The American journal of tropical medicine and hygiene,"","","","","","","","23208880","",,0,0,0,0,0,,,
5920,18,"Kim et al., 2013",journal,"Kim NH, Kang YM, Kim G, Choe PG, Song JS, Lee KH, Seong BL, Park WB, Kim NJ, Oh MD","An open-label, single arm, phase III clinical study to evaluate the efficacy and safety of CJ smallpox vaccine in previously vaccinated healthy adults","2013","31","45","5239-5242",Vaccine,"","","","","","","","24021303","",,0,0,0,0,0,,,
5921,175,"Hohdatsu et al., 2003",journal,"Hohdatsu T, Yamato H, Ohkawa T, Kaneko M, Motokawa K, Kusuhara H, Kaneshima T, Arai S, Koyama H",Vaccine efficacy of a cell lysate with recombinant baculovirus-expressed feline infectious peritonitis (FIP) virus nucleocapsid protein against progression of FIP,"2003","97","1-2","31-44",Veterinary microbiology,"","","","","","","","14637036","",,0,0,0,0,0,,,
5922,206,"Dhanesh et al., 2020",journal,"Dhanesh VV, Hosamani M, Basagoudanavar SH, Saravanan P, Biswal JK, Tamil Selvan RP, Madhavan A, Sehrish K, Sanyal A, Sreenivasa BP",Immunogenicity and protective efficacy of 3A truncated negative marker foot-and-mouth disease virus serotype A vaccine,"2020","104","6","2589-2602",Applied microbiology and biotechnology,"","","","","","","","32002597","",,0,0,0,0,0,,,
5923,48,"Emerson et al., 1996",journal,"Emerson SU, Tsarev SA, Govindarajan S, Shapiro M, Purcell RH","A simian strain of hepatitis A virus, AGM-27, functions as an attenuated vaccine for chimpanzees","1996","173","3","592-597",The Journal of infectious diseases,"","","","","","","","8627022","",,0,0,0,0,0,,,
5924,234,"Jin et al., 2021",journal,"Jin WP, Lu J, Zhang XY, Wu J, Wei ZN, Mai JY, Qian SS, Yu YT, Meng SL, Wang ZJ, Shen S",Efficacy of Coxsackievirus A5 Vaccine Candidates in an Actively Immunized Mouse Model,"2021","95","6","",Journal of virology,"","","","","","","","33408178","",,0,0,0,0,0,,,
5925,210,"Lvy et al., 2013",journal,"Lvy C, Aerts L, Hamelin M, Granier C, Szcsi J, Lavillette D, Boivin G, Cosset FL",Virus-like particle vaccine induces cross-protection against human metapneumovirus infections in mice,"2013","31","25","2778-2785",Vaccine,"","","","","","","","23583815","",,0,0,0,0,0,,,
5926,245,"Duan et al., 2022",journal,"Duan K, Tang X, Zhao J, Ren G, Shao Y, Lu T, He B, Xu L",An inactivated vaccine against infectious pancreatic necrosis virus in rainbow trout (Oncorhynchus mykiss),"2022","127","","48-55",Fish & shellfish immunology,"","","","","","","","35697270","",,0,0,0,0,0,,,
5927,106,"Salat et al., 2020",journal,"Salat J, Mikulasek K, Larralde O, Pokorna Formanova P, Chrdle A, Haviernik J, Elsterova J, Teislerova D, Palus M, Eyer L, Zdrahal Z, Petrik J, Ruzek D",Tick-Borne Encephalitis Virus Vaccines Contain Non-Structural Protein 1 Antigen and may Elicit NS1-Specific Antibody Responses in Vaccinated Individuals,"2020","8","1","",Vaccines,"","","","","","","","32059489","",,0,0,0,0,0,,,
5928,58,"Rampa et al., 2020",journal,"Rampa JE, Askling HH, Lang P, Zens KD, Gltekin N, Stanga Z, Schlagenhauf P",Immunogenicity and safety of the tick-borne encephalitis vaccination (2009-2019): A systematic review,"2020","37","","101876",Travel medicine and infectious disease,"","","","","","","","32931931","",,0,0,0,0,0,,,
5929,59,"Bonaldo et al., 2014",journal,"Bonaldo MC, Sequeira PC, Galler R",The yellow fever 17D virus as a platform for new live attenuated vaccines,"2014","10","5","1256-1265",Human vaccines & immunotherapeutics,"","","","","","","","24553128","","",0,10,0,0,0,,,
5930,59,"Montalvo et al., 2022",journal,"Montalvo Zurbia-Flores G, Rollier CS, Reyes-Sandoval A",Re-thinking yellow fever vaccines: fighting old foes with new generation vaccines,"2022","18","1","1895644",Human vaccines & immunotherapeutics,"","","","","","","","33974507","",,0,0,0,0,0,,,
5931,68,"Van et al., 2016",journal,"Van Hoeven N, Joshi SW, Nana GI, Bosco-Lauth A, Fox C, Bowen RA, Clements DE, Martyak T, Parks DE, Baldwin S, Reed SG, Coler RN",A Novel Synthetic TLR-4 Agonist Adjuvant Increases the Protective Response to a Clinical-Stage West Nile Virus Vaccine Antigen in Multiple Formulations,"2016","11","2",e0149610,PloS one,"","","","","","","","26901122","",,0,0,0,0,0,,,
5932,68,"Durbin et al., 2013",journal,"Durbin AP, Wright PF, Cox A, Kagucia W, Elwood D, Henderson S, Wanionek K, Speicher J, Whitehead SS, Pletnev AG",The live attenuated chimeric vaccine rWN/DEN430 is well-tolerated and immunogenic in healthy flavivirus-nave adult volunteers,"2013","31","48","5772-5777",Vaccine,"","","","","","","","23968769","",,0,0,0,0,0,,,
5933,68,"Arroyo et al., 2004",journal,"Arroyo J, Miller C, Catalan J, Myers GA, Ratterree MS, Trent DW, Monath TP","ChimeriVax-West Nile virus live-attenuated vaccine: preclinical evaluation of safety, immunogenicity, and efficacy","2004","78","22","12497-12507",Journal of virology,"","","","","","","","15507637","",,0,0,0,0,0,,,
5934,18,"Wilck et al., 2010",journal,"Wilck MB, Seaman MS, Baden LR, Walsh SR, Grandpre LE, Devoy C, Giri A, Kleinjan JA, Noble LC, Stevenson KE, Kim HT, Dolin R",Safety and immunogenicity of modified vaccinia Ankara (ACAM3000): effect of dose and route of administration,"2010","201","9","1361-1370",The Journal of infectious diseases,"","","","","","","","20350191","",,0,0,0,0,0,,,
5935,162,"Lauscher et al., 2011",journal,"Lauscher A, Krossy B, Frost P, Grove S, Knig M, Bohlin J, Falk K, Austb L, Rimstad E",Immune responses in Atlantic salmon (Salmo salar) following protective vaccination against infectious salmon anemia (ISA) and subsequent ISA virus infection,"2011","29","37","6392-6401",Vaccine,"","","","","","","","21554914","",,0,0,0,0,0,,,
5936,226,"Krolik et al., 2021",journal,"Krolik M, Csepregi L, Hartmann F, Engetschwiler C, Flatz L",Recombinant lymphocytic choriomeningitis virus-based vaccine vector protects type I interferon receptor deficient mice from viral challenge,"2021","39","8","1257-1264",Vaccine,"","","","","","","","33518468","",,0,0,0,0,0,,,
5937,227,"Wang et al., 2014",journal,"Wang H, Yao Y, Huang C, Fu X, Chen Q, Zhang H, Chen J, Fang F, Xie Z, Chen Z",An adjuvanted inactivated murine cytomegalovirus (MCMV) vaccine induces potent and long-term protective immunity against a lethal challenge with virulent MCMV,"2014","14","","195",BMC infectious diseases,"","","","","","","","24720840","",,0,0,0,0,0,,,
5938,127,"Foster et al., 2022",journal,"Foster SL, Woolsey C, Borisevich V, Agans KN, Prasad AN, Deer DJ, Geisbert JB, Dobias NS, Fenton KA, Cross RW, Geisbert TW",A recombinant VSV-vectored vaccine rapidly protects nonhuman primates against lethal Nipah virus disease,"2022","119","12",e2200065119,Proceedings of the National Academy of Sciences of the United States of America,"","","","","","","","35286211","",,0,0,0,0,0,,,
5939,160,"Wassie et al., 2019",journal,"Wassie T, Fanmei Z, Jiang X, Liu G, Girmay S, Min Z, Chenhui L, Bo DD, Ahmed S",Recombinant B2L and Kisspeptin-54 DNA Vaccine Induces Immunity Against Orf Virus and Inhibits Spermatogenesis In Rats,"2019","9","1","16262",Scientific reports,"","","","","","","","31700161","",,0,0,0,0,0,,,
5940,128,"Pittman et al., 1999",journal,"Pittman PR, Liu CT, Cannon TL, Makuch RS, Mangiafico JA, Gibbs PH, Peters CJ",Immunogenicity of an inactivated Rift Valley fever vaccine in humans: a 12-year experience,"1999","18","1-2","181-189",Vaccine,"","","","","","","","10501248","",,0,0,0,0,0,,,
5941,128,"Ikegami et al., 2015",journal,"Ikegami T, Hill TE, Smith JK, Zhang L, Juelich TL, Gong B, Slack OA, Ly HJ, Lokugamage N, Freiberg AN","Rift Valley Fever Virus MP-12 Vaccine Is Fully Attenuated by a Combination of Partial Attenuations in the S, M, and L Segments","2015","89","14","7262-7276",Journal of virology,"","","","","","","","25948740","",,0,0,0,0,0,,,
5942,128,"Jenkin et al., 2023",journal,"Jenkin D, Wright D, Folegatti PM, Platt A, Poulton I, Lawrie A, Tran N, Boyd A, Turner C, Gitonga JN, Karanja HK, Mugo D, Ewer KJ, Bowden TA, Gilbert SC, Charleston B, Kaleebu P, Hill AVS, Warimwe GM","Safety and immunogenicity of a ChAdOx1 vaccine against Rift Valley fever in UK adults: an open-label, non-randomised, first-in-human phase 1 clinical trial","2023","","","",The Lancet. Infectious diseases,"","","","","","","","37060917","",,0,0,0,0,0,,,
5943,184,"Li et al., 2022",journal,"Li W, Lei M, Li Z, Li H, Liu Z, He Q, Luo R",Development of a Genetically Engineered Bivalent Vaccine against Porcine Epidemic Diarrhea Virus and Porcine Rotavirus,"2022","14","8","",Viruses,"","","","","","","","36016368","",,0,0,0,0,0,,,
5944,257,"Zheng et al., 2016",journal,"Zheng X, Wang S, Zhang W, Liu X, Yi Y, Yang S, Xia X, Li Y, Zhang Z",Development of a VLP-based vaccine in silkworm pupae against rabbit hemorrhagic disease virus,"2016","40","","164-169",International immunopharmacology,"","","","","","","","27598862","",,0,0,0,0,0,,,
5945,258,"Ren et al., 2018",journal,"Ren Z, Meng F, Li Q, Wang Y, Liu X, Cui Z, Chang S, Zhao P",Protection induced by a gp90 protein-based vaccine derived from a Reticuloendotheliosis virus strain isolated from a contaminated IBD vaccine,"2018","15","1","42",Virology journal,"","","","","","","","29530099","",,0,0,0,0,0,,,
5946,229,"Englund et al., 2013",journal,"Englund JA, Karron RA, Cunningham CK, Larussa P, Melvin A, Yogev R, Handelsman E, Siberry GK, Thumar B, Schappell E, Bull CV, Chu HY, Schaap-Nutt A, Buchholz U, Collins PL, Schmidt AC",Safety and infectivity of two doses of live-attenuated recombinant cold-passaged human parainfluenza type 3 virus vaccine rHPIV3cp45 in HPIV3-seronegative young children,"2013","31","48","5706-5712",Vaccine,"","","","","","","","24103895","",,0,0,0,0,0,,,
5947,229,"August et al., 2022",journal,"August A, Shaw CA, Lee H, Knightly C, Kalidindia S, Chu L, Essink BJ, Seger W, Zaks T, Smolenov I, Panther L",Safety and Immunogenicity of an mRNA-Based Human Metapneumovirus and Parainfluenza Virus Type 3 Combined Vaccine in Healthy Adults,"2022","9","7",ofac206,Open forum infectious diseases,"","","","","","","","35794943","",,0,0,0,0,0,,,
5948,229,"Gomez et al., 2009",journal,"Gomez M, Mufson MA, Dubovsky F, Knightly C, Zeng W, Losonsky G","Phase-I study MEDI-534, of a live, attenuated intranasal vaccine against respiratory syncytial virus and parainfluenza-3 virus in seropositive children","2009","28","7","655-658",The Pediatric infectious disease journal,"","","","","","","","19483659","",,0,0,0,0,0,,,
5949,285,"Kamata et al., 2001",journal,"Kamata H, Ohishi K, Hulskotte E, Osterhaus AD, Inui K, Shaila MS, Yamanouchi K, Barrett T",Rinderpest virus (RPV) ISCOM vaccine induces protection in cattle against virulent RPV challenge,"2001","19","25-26","3355-3359",Vaccine,"","","","","","","","11348698","",,0,0,0,0,0,,,
5950,127,"Geisbert et al., 2021",journal,"Geisbert TW, Bobb K, Borisevich V, Geisbert JB, Agans KN, Cross RW, Prasad AN, Fenton KA, Yu H, Fouts TR, Broder CC, Dimitrov AS",A single dose investigational subunit vaccine for human use against Nipah virus and Hendra virus,"2021","6","1","23",NPJ vaccines,"","","","","","","","33558494","",,0,0,0,0,0,,,
5951,127,"Freeman and Levenson, 1966",journal,"Freeman V, Levenson G",Salaries paid by public health nursing services--1966,"1966","14","12","60-63",Nursing outlook,"","","","","","","","05178901","",,0,0,0,0,0,,,
5952,229,"Makula et al., 1978",journal,"Makula RA, Torregrossa RE, Isle HB",Identification and synthesis of acyl-phosphatidylglycerol in Acinetobacter sp. HO1-N,"1978","133","3","1530-1532",Journal of bacteriology,"","","","","","","","00641017","",,0,0,0,0,0,,,
5953,56,"Yu et al., 2012",journal,"Yu P, Huang Y, Zhang Y, Tang Q, Liang G",Production and evaluation of a chromatographically purified Vero cell rabies vaccine (PVRV) in China using microcarrier technology,"2012","8","9","1230-1235",Human vaccines & immunotherapeutics,"","","","","","","","22894963","",,0,0,0,0,0,,,
5954,56,"Napolitano et al., 2020",journal,"Napolitano F, Merone R, Abbate A, Ammendola V, Horncastle E, Lanzaro F, Esposito M, Contino AM, Sbrocchi R, Sommella A, Duncan JD, Hinds J, Urbanowicz RA, Lahm A, Colloca S, Folgori A, Ball JK, Nicosia A, Wizel B, Capone S, Vitelli A",A next generation vaccine against human rabies based on a single dose of a chimpanzee adenovirus vector serotype C,"2020","14","7",e0008459,PLoS neglected tropical diseases,"","","","","","","","32667913","",,0,0,0,0,0,,,
5955,56,"Saxena et al., 2008",journal,"Saxena S, Dahiya SS, Sonwane AA, Patel CL, Saini M, Rai A, Gupta PK",A sindbis virus replicon-based DNA vaccine encoding the rabies virus glycoprotein elicits immune responses and complete protection in mice from lethal challenge,"2008","26","51","6592-6601",Vaccine,"","","","","","","","18848857","",,0,0,0,0,0,,,
5956,151,"Roy et al., 2013",journal,"Roy CJ, Adams AP, Wang E, Leal G, Seymour RL, Sivasubramani SK, Mega W, Frolov I, Didier PJ, Weaver SC",A chimeric Sindbis-based vaccine protects cynomolgus macaques against a lethal aerosol challenge of eastern equine encephalitis virus,"2013","31","11","1464-1470",Vaccine,"","","","","","","","23333212","",,0,0,0,0,0,,,
5957,106,"Tang et al., 2023",journal,"Tang J, Fu M, Xu C, Xue B, Zhou A, Chen S, Zhao H, Zhou Y, Chen J, Yang Q, Chen X",Development of a novel virus-like particle-based vaccine for preventing tick-borne encephalitis virus infection,"2023","","","",Virologica Sinica,"","","","","","","","37328107","",,0,0,0,0,0,,,
5958,57,"Ribes et al., 2011",journal,"Ribes JM, Ortego J, Ceriani J, Montava R, Enjuanes L, Buesa J",Transmissible gastroenteritis virus (TGEV)-based vectors with engineered murine tropism express the rotavirus VP7 protein and immunize mice against rotavirus,"2011","410","1","107-118",Virology,"","","","","","","","21094967","",,0,0,0,0,0,,,
5959,243,"Reeman et al., 2017",journal,"Reeman S, Gates AJ, Pulford DJ, Krieg A, Ulaeto DO",Protection of Mice from Lethal Vaccinia Virus Infection by Vaccinia Virus Protein Subunits with a CpG Adjuvant,"2017","9","12","",Viruses,"","","","","","","","29232844","",,0,0,0,0,0,,,
5960,60,"Heineman et al., 2019",journal,"Heineman TC, Cunningham A, Levin M","Understanding the immunology of Shingrix, a recombinant glycoprotein E adjuvanted herpes zoster vaccine","2019","59","","42-48",Current opinion in immunology,"","","","","","","","31003070","",,0,0,0,0,0,,,
5961,56,"Wang et al., 2018",journal,"Wang C, Dulal P, Zhou X, Xiang Z, Goharriz H, Banyard A, Green N, Brunner L, Ventura R, Collin N, Draper SJ, Hill AVS, Ashfield R, Fooks AR, Ertl HC, Douglas AD",A simian-adenovirus-vectored rabies vaccine suitable for thermostabilisation and clinical development for low-cost single-dose pre-exposure prophylaxis,"2018","12","10",e0006870,PLoS neglected tropical diseases,"","","","","","","","30372438","",,0,0,0,0,0,,,
5962,56,"Aldrich et al., 2021",journal,"Aldrich C, Leroux-Roels I, Huang KB, Bica MA, Loeliger E, Schoenborn-Kellenberger O, Walz L, Leroux-Roels G, von Sonnenburg F, Oostvogels L",Proof-of-concept of a low-dose unmodified mRNA-based rabies vaccine formulated with lipid nanoparticles in human volunteers: A phase 1 trial,"2021","39","8","1310-1318",Vaccine,"","","","","","","","33487468","",,0,0,0,0,0,,,
5963,56,"Zhang et al., 2016",journal,"Zhang Y, Zhang S, Li W, Hu Y, Zhao J, Liu F, Lin H, Liu Y, Wang L, Xu S, Hu R, Shao H, Li L",A novel rabies vaccine based-on toll-like receptor 3 (TLR3) agonist PIKA adjuvant exhibiting excellent safety and efficacy in animal studies,"2016","489","","165-172",Virology,"","","","","","","","26765968","",,0,0,0,0,0,,,
5964,56,"Giesen et al., 2015",journal,"Giesen A, Gniel D, Malerczyk C","30 Years of rabies vaccination with Rabipur: a summary of clinical data and global experience","2015","14","3","351-367",Expert review of vaccines,"","","","","","","","25683583","","",0,10,0,0,0,,,
5965,49,"Horta et al., 2022",journal,"Horta D, Forn M, Agust A, Raga A, Martn-Cardona A, Hernndez-Soto JM, Ruiz-Ramrez P, Esteve-Comas M",Efficacy of Hepatitis B Virus Vaccines HBVaxpro40 and Fendrix in Patients with Chronic Liver Disease in Clinical Practice,"2022","10","8","",Vaccines,"","","","","","","","36016211","",,0,0,0,0,0,,,
5966,55,"Capeding et al., 2022",journal,"Capeding MR, Gomez-Go GD, Oberdorfer P, Borja-Tabora C, Bravo L, Carlos J, Tangsathapornpong A, Uppala R, Laoprasopwattana K, Yang Y, Han S, Wittawatmongkol O","Safety and Immunogenicity of a New Inactivated Polio Vaccine Made From Sabin Strains: A Randomized, Double-Blind, Active-Controlled, Phase 2/3 Seamless Study","2022","226","2","308-318",The Journal of infectious diseases,"","","","","","","","33351072","",,0,0,0,0,0,,,
5967,220,"Borca et al., 2021",journal,"Borca MV, Ramirez-Medina E, Silva E, Vuono E, Rai A, Pruitt S, Espinoza N, Velazquez-Salinas L, Gay CG, Gladue DP",ASFV-G-I177L as an Effective Oral Nasal Vaccine against the Eurasia Strain of Africa Swine Fever,"2021","13","5","",Viruses,"","","","","","","","33925435","",,0,0,0,0,0,,,
5968,220,"McDowell et al., 2022",journal,"McDowell CD, Bold D, Trujillo JD, Meekins DA, Keating C, Cool K, Kwon T, Madden DW, Artiaga BL, Balaraman V, Ankhanbaatar U, Zayat B, Retallick J, Dodd K, Chung CJ, Morozov I, Gaudreault NN, Souza-Neto JA, Richt JA",Experimental Infection of Domestic Pigs with African Swine Fever Virus Isolated in 2019 in Mongolia,"2022","14","12","",Viruses,"","","","","","","","36560702","",,0,0,0,0,0,,,
5969,230,"Jung et al., 2022",journal,"Jung MH, Jung SJ, Kim T",Saponin and chitosan-based oral vaccine against viral haemorrhagic septicaemia virus (VHSV) provides protective immunity in olive flounder (Paralichthys olivaceus),"2022","126","","336-346",Fish & shellfish immunology,"","","","","","","","35643353","",,0,0,0,0,0,,,
5970,56,NCT03741270,website,"",Safety of Rabivax-S for Pre-exposure Prophylaxis,"2019","","","","","","","","","","","","",https://clinicaltrials.gov/study/NCT03741270?tab=results,"",0,10,0,0,0,,,
5971,233,NCT01070407,website,"",A Study of a New Candidate Vaccine Against Hepatitis C Virus (HCV),"2015","","","","","","","","","","","","",https://classic.clinicaltrials.gov/ct2/show/NCT01070407,"",0,10,0,0,0,,,
5972,321,"Sanchez-Felipe et al., 2021",journal,"Sanchez-Felipe L, Vercruysse T, Sharma S, Ma J, Lemmens V, Van Looveren D, Arkalagud Javarappa MP, Boudewijns R, Malengier-Devlies B, Liesenborghs L, Kaptein SJF, De Keyzer C, Bervoets L, Debaveye S, Rasulova M, Seldeslachts L, Li LH, Jansen S, Yakass MB, Verstrepen BE, Bszrmnyi KP, Kiemenyi-Kayere G, van Driel N, Quaye O, Zhang X, Ter Horst S, Mishra N, Deboutte W, Matthijnssens J, Coelmont L, Vandermeulen C, Heylen E, Vergote V, Schols D, Wang Z, Bogers W, Kuiken T, Verschoor E, Cawthorne C, Van Laere K, Opdenakker G, Vande Velde G, Weynand B, Teuwen DE, Matthys P, Neyts J, Jan Thibaut H, Dallmeier K",A single-dose live-attenuated YF17D-vectored SARS-CoV-2 vaccine candidate,"2021","590","7845","320-325",Nature,"","","","","","","","33260195","",,0,0,0,0,0,,,
5973,59,"Ma et al., 2022",journal,"Ma J, Yakass MB, Jansen S, Malengier-Devlies B, Van Looveren D, Sanchez-Felipe L, Vercruysse T, Weynand B, Javarappa MPA, Quaye O, Matthys P, Roskams T, Neyts J, Thibaut HJ, Dallmeier K",Live-attenuated YF17D-vectored COVID-19 vaccine protects from lethal yellow fever virus infection in mouse and hamster models,"2022","83","","104240",EBioMedicine,"","","","","","","","36041265","",,0,0,0,0,0,,,
5974,206,NCT04182932,website,"",Safety and Immunogenicity of CJ-40010 in Healthy Subjects,"","","","","","","","","","","","","",https://classic.clinicaltrials.gov/ct2/show/NCT04182932,,0,0,0,0,0,,,
5975,268,"Loncoman et al., 2018",journal,"Loncoman CA, Hartley CA, Coppo MJC, Browning GF, Beltrn G, Riblet S, Freitas CO, Garca M, Devlin JM",Single Nucleotide Polymorphism Genotyping Analysis Shows That Vaccination Can Limit the Number and Diversity of Recombinant Progeny of Infectious Laryngotracheitis Viruses from the United States,"2018","84","23","",Applied and environmental microbiology,"","","","","","","","30242009","",,0,0,0,0,0,,,
5976,199,"Snchez-Matamoros et al., 2019",journal,"Snchez-Matamoros A, Camprodon A, Maldonado J, Pedrazuela R, Miranda J",Safety and long-lasting immunity of the combined administration of a modified-live virus vaccine against porcine reproductive and respiratory syndrome virus 1 and an inactivated vaccine against porcine parvovirus and Erysipelothrix rhusiopathiae in breeding pigs,"2019","5","","11",Porcine health management,"","","","","","","","31057805","",,0,0,0,0,0,,,
5977,199,"van et al., 2020",journal,"van den Born E, van den Elzen PPM, van Kilsdonk E, Hoeijmakers MJH, Segers RPAM",An octavalent vaccine provides pregnant gilts protection against a highly virulent porcine parvovirus strain,"2020","16","1","55",BMC veterinary research,"","","","","","","","32050969","",,0,0,0,0,0,,,
5978,199,"Garcia-Morante et al., 2019",journal,"Garcia-Morante B, Noguera M, Kraft C, Bridger P",Field evaluation of the safety and compatibility of a combined vaccine against porcine parvovirus 1 and porcine reproductive and respiratory syndrome virus in breeding animals,"2019","5","","28",Porcine health management,"","","","","","","","31890252","",,0,0,0,0,0,,,
5979,126,"Hou et al., 2022",journal,"Hou R, Tomalin LE, Silva JP, Kim-Schulze S, Whitehead SS, Fernandez-Sesma A, Durbin AP, Surez-Farias M",The innate immune response following multivalent dengue vaccination and implications for protection against dengue challenge,"2022","7","11","",JCI insight,"","","","","","","","35511431","",,0,0,0,0,0,,,
5980,145,"Zhao et al., 2019",journal,"Zhao Y, Xie D, Zhang K, Cheng J, Xu G, Zhang G",Pathogenicity of a GI-22 genotype infectious bronchitis virus isolated in China and protection against it afforded by GI-19 vaccine,"2019","267","","59-66",Virus research,"","","","","","","","31082454","",,0,0,0,0,0,,,
5981,182,Merck Animal Health USA,website,"Merck & Co., Inc.",PP-Vax(TM),"2023","","","","","","","","","","","","",https://www.merck-animal-health-usa.com/species/poultry/products/pp-vac,"",0,10,0,0,0,,,
5982,13,"Bergren et al., 2018",journal,"Bergren NA, Miller MR, Monath TP, Kading RC",Assessment of the ability of V920 recombinant vesicular stomatitis-Zaire ebolavirus vaccine to replicate in relevant arthropod cell cultures and vector species,"2018","14","4","994-991002",Human vaccines & immunotherapeutics,"","","","","","","","29206076","","",0,10,0,0,0,,,
5983,91,"Zhou and Wang, 2017",journal,"Zhou J, Wang L",SAG4 DNA and Peptide Vaccination Provides Partial Protection against T. gondii Infection in BALB/c Mice,"2017","8","","1733",Frontiers in microbiology,"","","","","","","","28936207","",,0,0,0,0,0,,,
5984,99,"Mazumder et al., 2017",journal,"Mazumder S, Johnson JM, Swank V, Dvorina N, Martelli E, Ko J, Tuohy VK",Primary Immunoprevention of Epithelial Ovarian Carcinoma by Vaccination against the Extracellular Domain of Anti-Mllerian Hormone Receptor II,"2017","10","11","612-624","Cancer prevention research (Philadelphia, Pa.)","","","","","","","","29093011","","",0,10,0,0,0,,,
5985,99,"Mazumder et al., 2022",journal,"Mazumder S, Swank V, Dvorina N, Johnson JM, Tuohy VK",Formulation of an ovarian cancer vaccine with the squalene-based AddaVax adjuvant inhibits the growth of murine epithelial ovarian carcinomas,"2022","11","2","163-172",Clinical and experimental vaccine research,"","","","","","","","35799868","","",0,10,0,0,0,,,
5986,321,"Winokur et al., 2023",journal,"Winokur P, Gayed J, Fitz-Patrick D, Thomas SJ, Diya O, Lockhart S, Xu X, Zhang Y, Bangad V, Schwartz HI, Denham D, Cardona JF, Usdan L, Ginis J, Mensa FJ, Zou J, Xie X, Shi PY, Lu C, Buitrago S, Scully IL, Cooper D, Koury K, Jansen KU, Treci , ahin U, Swanson KA, Gruber WC, Kitchin N",Bivalent Omicron BA.1-Adapted BNT162b2 Booster in Adults Older than 55 Years,"2023","388","3","214-227",The New England journal of medicine,"","","","","","","","36652353","",,0,0,0,0,0,,,
5987,99,"Takeda et al., 2018",journal,"Takeda K, Kitaura K, Suzuki R, Owada Y, Muto S, Okabe N, Hasegawa T, Osugi J, Hoshino M, Tsunoda T, Okumura K, Suzuki H",Quantitative T-cell repertoire analysis of peripheral blood mononuclear cells from lung cancer patients following long-term cancer peptide vaccination,"2018","67","6","949-964","Cancer immunology, immunotherapy : CII","","","","","","","","29568993","","",0,10,0,0,0,,,
5988,327,"Marinaik et al., 2020",journal,"Marinaik CB, Kingstad-Bakke B, Lee W, Hatta M, Sonsalla M, Larsen A, Neldner B, Gasper DJ, Kedl RM, Kawaoka Y, Suresh M",Programming Multifaceted Pulmonary T Cell Immunity by Combination Adjuvants,"2020","1","6","100095",Cell reports. Medicine,"","","","","","","","32984856","",,0,0,0,0,0,,,
5989,327,"Blake et al., 2021",journal,"Blake S, Bremer PT, Zhou B, Petrovsky N, Smith LC, Hwang CS, Janda KD",Developing Translational Vaccines against Heroin and Fentanyl through Investigation of Adjuvants and Stability,"2021","18","1","228-235",Molecular pharmaceutics,"","","","","","","","33301675","",,0,0,0,0,0,,,
5990,50,"Sato-Kaneko et al., 2021",journal,"Sato-Kaneko F, Yao S, Lao FS, Nan J, Shpigelman J, Cheng A, Saito T, Messer K, Pu M, Shukla NM, Cottam HB, Chan M, Molina AJ, Corr M, Hayashi T, Carson DA",Mitochondria-dependent synthetic small-molecule vaccine adjuvants for influenza virus infection,"2021","118","23","",Proceedings of the National Academy of Sciences of the United States of America,"","","","","","","","34078669","","",0,10,0,0,0,,,
5991,312,"Chhibber et al., 2005",journal,"Chhibber S, Rani M, Vanashree Y",Immunoprotective potential of polysaccharide-tetanus toxoid conjugate in Klebsiella pneumoniae induced lobar pneumonia in rats,"2005","43","1","40-45",Indian journal of experimental biology,"","","","","","","","15691064","","",0,10,0,0,0,,,
5992,312,"Feldman et al., 2019",journal,"Feldman MF, Mayer Bridwell AE, Scott NE, Vinogradov E, McKee SR, Chavez SM, Twentyman J, Stallings CL, Rosen DA, Harding CM",A promising bioconjugate vaccine against hypervirulent Klebsiella pneumoniae,"2019","116","37","18655-18663",Proceedings of the National Academy of Sciences of the United States of America,"","","","","","","","31455739","","",0,10,0,0,0,,,
5993,312,"Chhibber and Bajaj, 1995",journal,"Chhibber S, Bajaj J",Polysaccharide-iron-regulated cell surface protein conjugate vaccine: its role in protection against Klebsiella pneumoniae-induced lobar pneumonia,"1995","13","2","179-184",Vaccine,"","","","","","","","7625113","","",0,10,0,0,0,,,
5994,312,"Hegerle et al., 2018",journal,"Hegerle N, Choi M, Sinclair J, Amin MN, Ollivault-Shiflett M, Curtis B, Laufer RS, Shridhar S, Brammer J, Toapanta FR, Holder IA, Pasetti MF, Lees A, Tennant SM, Cross AS, Simon R",Development of a broad spectrum glycoconjugate vaccine to prevent wound and disseminated infections with Klebsiella pneumoniae and Pseudomonas aeruginosa,"2018","13","9",e0203143,PloS one,"","","","","","","","30188914","","",0,10,0,0,0,,,
5995,312,"Jain et al., 2015",journal,"Jain RR, Mehta MR, Bannalikar AR, Menon MD",Alginate microparticles loaded with lipopolysaccharide subunit antigen for mucosal vaccination against Klebsiella pneumoniae,"2015","43","3","195-201",Biologicals : journal of the International Association of Biological Standardization,"","","","","","","","25737397","","",0,10,0,0,0,,,
5996,312,"Nimier et al., 1999",journal,"Nimier K, Wolff F, Allouch PY, Guy-Grand D, Bloy C","Protective effects of RU 41740, a bacterial immunomodulator, against experimental infections: induction of cytokine and immunoglobulin release in mice after oral administration","1999","21","9","561-574",International journal of immunopharmacology,"","","","","","","","10501625","","",0,10,0,0,0,,,
5997,312,"Peng et al., 2021",journal,"Peng Z, Wu J, Wang K, Li X, Sun P, Zhang L, Huang J, Liu Y, Hua X, Yu Y, Pan C, Wang H, Zhu L",Production of a Promising Biosynthetic Self-Assembled Nanoconjugate Vaccine against Klebsiella Pneumoniae Serotype O2 in a General Escherichia Coli Host,"2021","8","14",e2100549,"Advanced science (Weinheim, Baden-Wurttemberg, Germany)","","","","","","","","34032027","","",0,10,0,0,0,,,
5998,312,"Ravinder et al., 2020",journal,"Ravinder M, Liao KS, Cheng YY, Pawar S, Lin TL, Wang JT, Wu CY",A Synthetic Carbohydrate-Protein Conjugate Vaccine Candidate against Klebsiella pneumoniae Serotype K2,"2020","85","24","15964-15997",The Journal of organic chemistry,"","","","","","","","33108196","","",0,10,0,0,0,,,
5999,312,"Seeberger et al., 2017",journal,"Seeberger PH, Pereira CL, Khan N, Xiao G, Diago-Navarro E, Reppe K, Opitz B, Fries BC, Witzenrath M",A Semi-Synthetic Glycoconjugate Vaccine Candidate for Carbapenem-Resistant Klebsiella pneumoniae,"2017","56","45","13973-13978",Angewandte Chemie (International ed. in English),"","","","","","","","28815890","","",0,10,0,0,0,,,
6000,312,"Babu et al., 2017",journal,"Babu L, Uppalapati SR, Sripathy MH, Reddy PN",Evaluation of Recombinant Multi-Epitope Outer Membrane Protein-Based Klebsiella pneumoniae Subunit Vaccine in Mouse Model,"2017","8","","1805",Frontiers in microbiology,"","","","","","","","28979250","","",0,10,0,0,0,,,
6001,312,"Hussein et al., 2018",journal,"Hussein KE, Bahey-El-Din M, Sheweita SA",Immunization with the outer membrane proteins OmpK17 and OmpK36 elicits protection against Klebsiella pneumoniae in the murine infection model,"2018","119","","12-18",Microbial pathogenesis,"","","","","","","","29626658","","",0,10,0,0,0,,,
6002,312,"Kumar et al., 2020",journal,"Kumar A, Harjai K, Chhibber S",Early cytokine response to lethal challenge of Klebsiella pneumoniae averted the prognosis of pneumonia in FyuA immunized mice,"2020","144","","104161",Microbial pathogenesis,"","","","","","","","32194179","","",0,10,0,0,0,,,
6003,312,"Lavender et al., 2005",journal,"Lavender H, Jagnow JJ, Clegg S",Klebsiella pneumoniae type 3 fimbria-mediated immunity to infection in the murine model of respiratory disease,"2005","295","3","153-159",International journal of medical microbiology : IJMM,"","","","","","","","16047414","","",0,10,0,0,0,,,
6004,312,"Robert et al., 1982",journal,"Robert D, Bienvenu P, Lafont S, Jouanneteau B, Normier G, Dussourd D'Hinterland L, Fontanges R",An attempt to localize the vaccinating power of Klebsiella pneumoniae ribosomal preparations using saccharose-gradient ultracentrifugation,"1982","26","10","941-950",Microbiology and immunology,"","","","","","","","6761558","","",0,10,0,0,0,,,
6005,312,"Robert et al., 1981",journal,"Robert D, Michel S, Ivanoff B, Cozzone AJ, Fontanges R",On the immunogenicity of ribosomes and ribosomal proteins isolated from Klebsiella pneumoniae and Streptococcus pneumoniae,"1981","25","2","183-194",Microbiology and immunology,"","","","","","","","7015078","","",0,10,0,0,0,,,
6006,312,"Rodrigues et al., 2020",journal,"Rodrigues MX, Yang Y, de Souza Meira EB Jr, do Carmo Silva J, Bicalho RC",Development and evaluation of a new recombinant protein vaccine (YidR) against Klebsiella pneumoniae infection,"2020","38","29","4640-4648",Vaccine,"","","","","","","","32444194","","",0,10,0,0,0,,,
6007,312,"Singh and Sharma, 2001",journal,"Singh BR, Sharma VD",Potential of Klebsiella pneumoniae cytotoxin toxoid as vaccine against klebsiellosis in rabbits and mice,"2001","19","31","4505-4510",Vaccine,"","","","","","","","11483277","","",0,10,0,0,0,,,
6008,312,"Cryz et al., 1986",journal,"Cryz SJ Jr, Frer E, Germanier R",Immunization against fatal experimental Klebsiella pneumoniae pneumonia,"1986","54","2","403-407",Infection and immunity,"","","","","","","","3533779","","",0,10,0,0,0,,,
6009,312,"Cryz et al., 1984",journal,"Cryz SJ Jr, Frer E, Germanier R",Protection against fatal Klebsiella pneumoniae burn wound sepsis by passive transfer of anticapsular polysaccharide,"1984","45","1","139-142",Infection and immunity,"","","","","","","","6376353","","",0,10,0,0,0,,,
6010,312,"Malachowa et al., 2019",journal,"Malachowa N, Kobayashi SD, Porter AR, Freedman B, Hanley PW, Lovaglio J, Saturday GA, Gardner DJ, Scott DP, Griffin A, Cordova K, Long D, Rosenke R, Sturdevant DE, Bruno D, Martens C, Kreiswirth BN, DeLeo FR",Vaccine Protection against Multidrug-Resistant Klebsiella pneumoniae in a Nonhuman Primate Model of Severe Lower Respiratory Tract Infection,"2019","10","6","",mBio,"","","","","","","","31848292","","",0,10,0,0,0,,,
6011,312,"Roe et al., 1989",journal,"Roe EA, Jones RJ, Saunders JR","Immunoprotective extracellular polysaccharides of Klebsiella aerogenes capsular type K1, expressed in Escherichia coli","1989","1","5","253-261",FEMS microbiology immunology,"","","","","","","","2517220","","",0,10,0,0,0,,,
6012,312,"Roe and Jones, 1984",journal,"Roe EA, Jones RJ",Vaccination against Klebsiella aerogenes,"1984","93","2","355-363",The Journal of hygiene,"","","","","","","","6389699","","",0,10,0,0,0,,,
6013,312,"Chathley et al., 1996",journal,"Chathley UC, Sharma S, Chhibber S",Lipopolysaccharide-induced resistance in mice against ascending urinary tract infection with Klebsiella pneumoniae,"1996","41","4","373-376",Folia microbiologica,"","","","","","","","9131794","","",0,10,0,0,0,,,
6014,312,"Clements et al., 2008",journal,"Clements A, Jenney AW, Farn JL, Brown LE, Deliyannis G, Hartland EL, Pearse MJ, Maloney MB, Wesselingh SL, Wijburg OL, Strugnell RA",Targeting subcapsular antigens for prevention of Klebsiella pneumoniae infections,"2008","26","44","5649-5653",Vaccine,"","","","","","","","18725260","","",0,10,0,0,0,,,
6015,312,"Rani et al., 1990",journal,"Rani M, Gupta RK, Chhibber S",Protection against Klebsiella pneumoniae induced lobar pneumonia in rats with lipopolysaccharide and related antigens,"1990","36","12","885-890",Canadian journal of microbiology,"","","","","","","","2081334","","",0,10,0,0,0,,,
6016,312,"Cooper and Rowley, 1982",journal,"Cooper JM, Rowley D",Resistance to Klebsiella pneumoniae and the importance of two bacterial antigens,"1982","60","6","629-641",The Australian journal of experimental biology and medical science,"","","","","","","","6820634","","",0,10,0,0,0,,,
6017,312,"Kuenen et al., 1994",journal,"Kuenen JD, van Dijke EE, Hol C, Bootsma HJ, Verhoef J, van Dijk H","Protective effects of orally administered, Klebsiella-containing bacterial lysates in mice","1994","8","1","69-75",FEMS immunology and medical microbiology,"","","","","","","","8156053","","",0,10,0,0,0,,,
6018,312,"Deng et al., 2004",journal,"Deng JC, Moore TA, Newstead MW, Zeng X, Krieg AM, Standiford TJ",CpG oligodeoxynucleotides stimulate protective innate immunity against pulmonary Klebsiella infection,"2004","173","8","5148-5155","Journal of immunology (Baltimore, Md. : 1950)","","","","","","","","15470059","","",0,10,0,0,0,,,
6019,312,"Karaolis et al., 2007",journal,"Karaolis DK, Newstead MW, Zeng X, Hyodo M, Hayakawa Y, Bhan U, Liang H, Standiford TJ",Cyclic di-GMP stimulates protective innate immunity in bacterial pneumonia,"2007","75","10","4942-4950",Infection and immunity,"","","","","","","","17646358","","",0,10,0,0,0,,,
6020,312,"Lee et al., 2015",journal,"Lee WH, Choi HI, Hong SW, Kim KS, Gho YS, Jeon SG",Vaccination with Klebsiella pneumoniae-derived extracellular vesicles protects against bacteria-induced lethality via both humoral and cellular immunity,"2015","47","9",e183,Experimental & molecular medicine,"","","","","","","","26358222","","",0,10,0,0,0,,,
6021,312,"Wu et al., 2020",journal,"Wu G, Ji H, Guo X, Li Y, Ren T, Dong H, Liu J, Liu Y, Shi X, He B",Nanoparticle reinforced bacterial outer-membrane vesicles effectively prevent fatal infection of carbapenem-resistant Klebsiella pneumoniae,"2020","24","","102148","Nanomedicine : nanotechnology, biology, and medicine","","","","","","","","31887427","","",0,10,0,0,0,,,
6022,312,"Ahmad et al., 2012",journal,"Ahmad TA, Haroun M, Hussein AA, El Ashry el SH, El-Sayed LH",Development of a new trend conjugate vaccine for the prevention of Klebsiella pneumoniae,"2012","4","2",e33,Infectious disease reports,"","","","","","","","24470947","","",0,10,0,0,0,,,
6023,312,"Hsieh et al., 2013",journal,"Hsieh PF, Liu JY, Pan YJ, Wu MC, Lin TL, Huang YT, Wang JT","Klebsiella pneumoniae peptidoglycan-associated lipoprotein and murein lipoprotein contribute to serum resistance, antiphagocytosis, and proinflammatory cytokine stimulation","2013","208","10","1580-1589",The Journal of infectious diseases,"","","","","","","","23911714","","",0,10,0,0,0,,,
6024,312,"Kurupati et al., 2011",journal,"Kurupati P, Ramachandran NP, Poh CL",Protective efficacy of DNA vaccines encoding outer membrane protein A and OmpK36 of Klebsiella pneumoniae in mice,"2011","18","1","82-88",Clinical and vaccine immunology : CVI,"","","","","","","","21048001","","",0,10,0,0,0,,,
6025,312,"Twentyman et al., 2020",journal,"Twentyman J, Morffy Smith C, Nims JS, Dahler AA, Rosen DA",A murine model demonstrates capsule-independent adaptive immune protection in survivors of Klebsiella pneumoniae respiratory tract infection,"2020","13","3","",Disease models & mechanisms,"","","","","","","","32298236","","",0,10,0,0,0,,,
6026,99,NCT01174082,website,M.D. Anderson Cancer Center,Trial of ID-Specific Donor Vaccinated Lymphocyte Infusion for Patients With Myeloma Relapsing or Failing to Achieve a Complete Remission After an Allogenic Transplant,"2018","69","1","171-174",FEBS letters,"","","","","","","","11124",https://clinicaltrials.gov/study/NCT01174082,"",0,10,0,0,0,,,
6027,99,NCT01898039,website,Hadassah Medical Organization,Modified Melanoma Vaccine for High Risk or Low Residual Disease Patients,"2018","","","","","","","","","","","","",https://clinicaltrials.gov/study/NCT01898039,"",0,10,0,0,0,,,
6028,99,NCT02688673,website,Affiliated Hospital to Academy of Military Medical Sciences,DC Vaccine Combined With CIK Cells in Patients With SCLC,"2016","","","","","","","","","","","","",https://clinicaltrials.gov/study/NCT02688673,"",0,10,0,0,0,,,
6029,99,NCT00911560,website,Memorial Sloan Kettering Cancer Center,"Bivalent Vaccine With Escalating Doses of the Immunological Adjuvant OPT-821, in Combination With Oral -glucan for High-Risk Neuroblastoma","2023","","","","","","","","","","","","",https://clinicaltrials.gov/study/NCT00911560,"",0,10,0,0,0,,,
6030,99,NCT04418219,website,Thomas Jefferson University,"Breast Cancer Vaccine in Combination With Pembrolizumab for Treatment of Persistent, Recurrent, or Metastatic Breast Cancer","2021","","","","","","","","","","","","",https://clinicaltrials.gov/study/NCT04418219,"",0,11,0,0,0,,,
6031,99,NCT04348747,website,Roswell Park Cancer Institute,Dendritic Cell Vaccines Against Her2/Her3 and Pembrolizumab for the Treatment of Brain Metastasis From Triple Negative Breast Cancer or HER2+ Breast Cancer,"2023","","","","","","","","","","","","",https://clinicaltrials.gov/study/NCT04348747,"",0,10,0,0,0,,,
6032,99,NCT01209871,website,M.D. Anderson Cancer Center,Vaccine Therapy in Treating Patients With Lymphoplasmacytic Lymphoma,"2023","","","","","","","","","","","","",https://clinicaltrials.gov/study/NCT01209871,"",0,10,0,0,0,,,
6033,99,NCT02493829,website,King's College London,B7.1/IL-2 Leukaemia Cell Vaccine for Non-Transplant AML RFUSIN2-AML2 (NTX),"2017","","","","","","","","","","","","",https://clinicaltrials.gov/study/NCT02493829,"",0,10,0,0,0,,,
6034,99,NCT03226236,website,Istituto Scientifico Romagnolo per lo Studio e la cura dei Tumori,Vaccination With Dendritic Cells Pulsed With Autologous Tumor Homogenate in Combination With HD-IL2 and Immunomodulating Radiotherapy in Metastatic RCC (RENALVax-2),"2018","","","","","","","","","","","","",https://clinicaltrials.gov/study/NCT03226236,"",0,10,0,0,0,,,
6035,99,NCT05195619,website,Centre Hospitalier Universitaire Vaudois,Autologous dendritic cell vaccine loaded with personalized peptides (PEP-DC vaccine),"2023","","","","","","","","","","","","",https://clinicaltrials.gov/study/NCT05195619,"",0,10,0,0,0,,,
6036,99,NCT01241162,website,University of Louisville,Decitabine Followed by a Cancer Antigen Vaccine for Patients With Neuroblastoma and Sarcoma,"2017","","","","","","","","","","","","",https://clinicaltrials.gov/study/NCT01241162,"",0,10,0,0,0,,,
6037,99,NCT00048386,website,"Malcolm Brenner, Baylor College of Medicine",Neuroblastoma Vaccine for Treatment of High-Risk Neuroblastoma After Chemotherapy (CYCHE2),"2012","","","","","","","","","","","","",https://clinicaltrials.gov/study/NCT00048386,"",0,10,0,0,0,,,
6038,99,NCT04573140,website,University of Florida,A Study of RNA-lipid Particle (RNA-LP) Vaccines for Newly Diagnosed Pediatric High-Grade Gliomas (pHGG) and Adult Glioblastoma (GBM) (PNOC020),"2023","","","","","","","","","","","","",https://clinicaltrials.gov/study/NCT04573140,"",0,10,0,0,0,,,
6039,99,NCT00101101,website,H. Lee Moffitt Cancer Center and Research Institute,Universal Granulocyte Macrophage-colony Stimulating Factor (GM-CSF)-Producing and GM.CD40L for Autologous Tumor Vaccine in Mantle Cell Lymphoma,"2023","","","","","","","","","","","","",https://clinicaltrials.gov/study/NCT00101101,"",0,10,0,0,0,,,
6040,99,NCT03412786,website,Herlev Hospital,Bcl-XL_42-CAF09b Vaccination for Patients With Prostate Cancer With Lymph Node Metastases,"2022","","","","","","","","","","","","",https://clinicaltrials.gov/study/NCT03412786,"",0,10,0,0,0,,,
6041,99,NCT01413087,website,Anchiano Therapeutics Israel Ltd.,Efficacy and Safety of BC-819 and Gemcitabine in Patients With Locally Advanced Pancreatic Adenocarcinoma (LAPC-BC-819),"2019","","","","","","","","","","","","",https://clinicaltrials.gov/study/NCT01413087,"",0,10,0,0,0,,,
6042,99,NCT00466726,website,Gruppo Italiano Malattie EMatologiche dell'Adulto,Vaccine Therapy in Treating Patients With Philadelphia Chromosome-Positive Chronic Myelogenous Leukemia (CML0206),"2018","","","","","","","","","","","","",https://clinicaltrials.gov/study/NCT00466726,"",0,10,0,0,0,,,
6043,99,NCT01349647,website,Memorial Sloan Kettering Cancer Center,"Immunization With a Pentavalent Vaccine Composed of KLH-conjugates of GD2L, GD3L, Globo H, Fucosyl GM1, and N-Propionylated Polysialic Acid","2016","","","","","","","","","","","","",https://clinicaltrials.gov/study/NCT01349647,"",0,10,0,0,0,,,
6044,99,NCT02074046,website,"Fuda Cancer Hospital, Guangzhou",Safety Study of Cancer Stem Cell Vaccine to Treat Pancreatic Cancer,"2015","","","","","","","","","","","","",https://clinicaltrials.gov/study/NCT02074046,"",0,10,0,0,0,,,
6045,99,NCT01094496,website,Celldex Therapeutics,"A Study of the CDX-1307 Vaccine Regimen in Patients With Newly Diagnosed Muscle-Invasive Bladder Cancer (The ""N-ABLE"" Study)","2020","","","","","","","","","","","","",https://clinicaltrials.gov/study/NCT01094496,"",0,10,0,0,0,,,
6046,99,NCT05559177,website,Shanghai Pudong Hospital,"An Open, Dose-escalation Clinical Study of Chimeric Exosomal Tumor Vaccines for Recurrent or Metastatic Bladder Cancer","2022","","","","","","","","","","","","",https://clinicaltrials.gov/study/NCT05559177,"",0,10,0,0,0,,,
6047,99,NCT00038415,website,M.D. Anderson Cancer Center,A Phase I/II Trial of Idiotypic Vaccination for Chronic Lymphocytic Leukemia Using a Genetic Approach,"2018","","","","","","","","","","","","",https://clinicaltrials.gov/study/NCT00038415,"",0,10,0,0,0,,,
6048,99,NCT01622933,website,"Lisa H. Butterfield, Ph.D.",Multiple Antigen-Engineered DC Vaccine for Melanoma,"2017","","","","","","","","","","","","",https://clinicaltrials.gov/study/NCT01622933,"",0,10,0,0,0,,,
6049,99,NCT04147078,website,"Zhen-Yu Ding, Sichuan University",Personalized DC Vaccine for Postoperative Cancer,"2019","","","","","","","","","","","","",https://clinicaltrials.gov/study/NCT04147078,"",0,10,0,0,0,,,
6050,99,NCT05457959,website,Jonsson Comprehensive Cancer Center,"Peptide-Pulsed Dendritic Cell Vaccination in Combination With Nivolumab and Ipilimumab for the Treatment of Recurrent and/or Progressive Diffuse Hemispheric Glioma, H3 G34-mutant","2023","","","","","","","","","","","","",https://clinicaltrials.gov/study/NCT05457959,"",0,10,0,0,0,,,
6051,99,NCT00056134,website,University Hospital Erlangen,Vaccine Therapy in Treating Patients With Stage III or Stage IV Melanoma,"2018","","","","","","","","","","","","",https://clinicaltrials.gov/study/NCT00056134,"",0,10,0,0,0,,,
6052,99,NCT00004880,website,Jonsson Comprehensive Cancer Center,Vaccine Therapy in Treating Patients With Advanced Kidney Cancer,"2020","","","","","","","","","","","","",https://clinicaltrials.gov/study/NCT00004880,"",0,10,0,0,0,,,
6053,99,NCT01759810,website,NeuroVita Clinic,Proteome-based Personalized Immunotherapy of Glioblastoma,"2017","","","","","","","","","","","","",https://clinicaltrials.gov/study/NCT01759810,"",0,10,0,0,0,,,
6054,99,NCT00625755,website,Beth Israel Deaconess Medical Center,A Phase I/II Study to Assess the Safety and Efficacy of Vaccinations With Allogeneic Dendritic Cells: Autologous Tumor-Derived Cells Subjected to Electrofusions in Patients With AJCC Stage IV Renal Cell Carcinoma,"2017","","","","","","","","","","","","",https://clinicaltrials.gov/study/NCT00625755,,0,0,0,0,0,,,
6055,99,NCT02018458,website,Baylor Research Institute,Safety Study Of Chemotherapy Combined With Dendritic Cell Vaccine to Treat Breast Cancer,"2021","","","","","","","","","","","","",https://clinicaltrials.gov/study/NCT02018458,"",0,10,0,0,0,,,
6056,99,NCT04270149,website,"Herbert Lyerly, Duke University",Cancer Peptides Plus GM-CSF and Adjuvant in Breast Cancer,"2023","","","","","","","","","","","","",https://clinicaltrials.gov/study/NCT04270149,"",0,10,0,0,0,,,
6057,99,NCT00530140,website,"Clinica Universidad de Navarra, Universidad de Navarra",Idiotypic Vaccination for Follicular Lymphoma Patients (FLIDVAX2006),"2011","","","","","","","","","","","","",https://clinicaltrials.gov/study/NCT00530140,"",0,10,0,0,0,,,
6058,99,NCT04998474,website,Frame Pharmaceuticals B.V.,FRAME-001 Personalized Vaccine in NSCLC,"2021","","","","","","","","","","","","",https://clinicaltrials.gov/study/NCT04998474,"",0,10,0,0,0,,,
6059,99,NCT00002637,website,Memorial Sloan Kettering Cancer Center,Biological Therapy in Treating Patients With Prostate Cancer,"2013","","","","","","","","","","","","",https://clinicaltrials.gov/study/NCT00002637,"",0,10,0,0,0,,,
6060,99,NCT00301093,website,Dana-Farber Cancer Institute,Vaccine Therapy and Imatinib Mesylate in Treating Patients With Chronic Phase Chronic Myelogenous Leukemia,"2020","","","","","","","","","","","","",https://clinicaltrials.gov/study/NCT00301093,"",0,10,0,0,0,,,
6061,99,NCT00809250,website,Dana-Farber Cancer Institute,Vaccination With GM-K562 Cells in Patients With Advanced Myelodysplastic Syndrome (MDS) or Acute Myeloid Leukemia (AML) After Allogeneic Hematopoetic Stem Cell Transplantation,"2020","","","","","","","","","","","","",https://clinicaltrials.gov/study/NCT00809250,"",0,10,0,0,0,,,
6062,99,NCT00442130,website,Dana-Farber Cancer Institute,Reduced Intensity Stem Cell Transplantation for Chronic Lymphocytic Leukemia Followed by Vaccination,"2020","","","","","","","","","","","","",https://clinicaltrials.gov/study/NCT00442130,"",0,10,0,0,0,,,
6063,99,NCT00727441,website,Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins,Vaccine Therapy With or Without Cyclophosphamide in Treating Patients Undergoing Chemotherapy and Radiation Therapy for Stage I or Stage II Pancreatic Cancer That Can Be Removed by Surgery,"2020","","","","","","","","","","","","",https://clinicaltrials.gov/study/NCT00727441,"",0,10,0,0,0,,,
6064,99,NCT00091286,website,"Craig L Slingluff, Jr, University of Virginia","Vaccine Therapy in Treating Patients With Stage IIB, Stage III, or Stage IV Colorectal Cancer","2020","","","","","","","","","","","","",https://clinicaltrials.gov/study/NCT00091286,"",0,10,0,0,0,,,
6065,99,NCT04749641,website,"Yang Zhang, Beijing Tiantan Hospital",Neoantigen Vaccine Therapy Against H3.3-K27M Diffuse Intrinsic Pontine Glioma (ENACTING),"2023","","","","","","","","","","","","",https://clinicaltrials.gov/study/NCT04749641,"",0,10,0,0,0,,,
6066,99,NCT00478062,website,Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins,Vaccine Therapy in Treating Patients Who Have Received First-Line Therapy for Hodgkin's Lymphoma,"2018","","","","","","","","","","","","",https://clinicaltrials.gov/study/NCT00478062,"",0,10,0,0,0,,,
6067,99,NCT00090480,website,NewLink Genetics Corporation,Vaccine Treatment for Advanced Breast Cancer,"2020","","","","","","","","","","","","",https://clinicaltrials.gov/study/NCT00090480,"",0,10,0,0,0,,,
6068,99,NCT00300612,website,NewLink Genetics Corporation,Vaccine Treatment for Advanced Malignant Melanoma,"2020","","","","","","","","","","","","",https://clinicaltrials.gov/study/NCT00300612,"",0,10,0,0,0,,,
6069,99,NCT00105053,website,NewLink Genetics Corporation,Vaccine Treatment for Hormone Refractory Prostate Cancer,"2020","","","","","","","","","","","","",https://clinicaltrials.gov/study/NCT00105053,"",0,10,0,0,0,,,
6070,99,NCT01189383,website,Baylor Research Institute,"IL15 Dendritic Cell Vaccine for Patients With Resected Stage III (A, B or C) or Stage IV Melanoma","2016","","","","","","","","","","","","",https://clinicaltrials.gov/study/NCT01189383,"",0,10,0,0,0,,,
6071,99,NCT03914768,website,Shenzhen Geno-Immune Medical Institute,Immune Modulatory DC Vaccine Against Brain Tumor,"2020","","","","","","","","","","","","",https://clinicaltrials.gov/study/NCT03914768,"",0,10,0,0,0,,,
6072,99,NCT00000105,website,"Masonic Cancer Center, University of Minnesota",Vaccination With Tetanus and KLH to Assess Immune Responses.,"2017","","","","","","","","","","","","",https://clinicaltrials.gov/study/NCT00000105,"",0,10,0,0,0,,,
6073,99,NCT02745756,website,H. Lee Moffitt Cancer Center and Research Institute,A Combined Cell Therapy Approach to the Treatment of Neuroblastoma,"2017","","","","","","","","","","","","",https://clinicaltrials.gov/study/NCT02745756,"",0,10,0,0,0,,,
6074,99,NCT00868114,website,Leo W. Jenkins Cancer Center,Direct Tumor Injection KLH-Pulsed Dendritic Cells in Unresectable Pancreatic Cancer,"2018","","","","","","","","","","","","",https://clinicaltrials.gov/study/NCT00868114,"",0,10,0,0,0,,,
6075,99,NCT02115126,website,"David Rizzieri, MD, Duke University",Phase II Trial to Evaluate an EBV-derived Dendritic Cell Vaccine in Autologous Stem Cell Transplant,"2016","","","","","","","","","","","","",https://clinicaltrials.gov/study/NCT02115126,"",0,10,0,0,0,,,
6076,99,NCT00373217,website,"Craig L Slingluff, Jr, University of Virginia","Vaccine Therapy, Paclitaxel, and Carboplatin in Treating Patients Who Are Undergoing Surgery for Stage III or Stage IV Ovarian Cancer, Primary Peritoneal Cancer, or Fallopian Tube Cancer","2022","","","","","","","","","","","","",https://clinicaltrials.gov/study/NCT00373217,"",0,10,0,0,0,,,
6077,99,NCT03092453,website,University of Pennsylvania,Dendritic Cell Vaccination in Patients With Advanced Melanoma,"2023","","","","","","","","","","","","",https://clinicaltrials.gov/study/NCT03092453,"",0,10,0,0,0,,,
6078,99,NCT00683670,website,University of Pennsylvania,Dendritic Cells (White Blood Cells) Vaccination for Advanced Melanoma,"2017","","","","","","","","","","","","",https://clinicaltrials.gov/study/NCT00683670,"",0,10,0,0,0,,,
6079,99,NCT00094653,website,Bristol-Myers Squibb,"MDX-010 Antibody, MDX-1379 Melanoma Vaccine, or MDX-010/MDX-1379 Combination Treatment for Patients With Unresectable or Metastatic Melanoma","2017","","","","","","","","","","","","",https://clinicaltrials.gov/study/NCT00094653,"",0,10,0,0,0,,,
6080,99,NCT00028431,website,University of Southern California,Novel Adjuvants for Peptide-Based Melanoma Vaccines,"2014","","","","","","","","","","","","",https://clinicaltrials.gov/study/NCT00028431,"",0,10,0,0,0,,,
6081,99,NCT00071981,website,Eastern Cooperative Oncology Group,Vaccine Therapy Using Melanoma Peptides for Cytotoxic T Cells and Helper T Cells in Treating Patients With Metastatic Melanoma,"2023","","","","","","","","","","","","",https://clinicaltrials.gov/study/NCT00071981,"",0,10,0,0,0,,,
6082,99,NCT00928902,website,University of Virginia,"Trial for the Evaluation of the Effect of Systemic Low-dose Interleukin-2 (IL-2) on the Immunogenicity of a Vaccine Comprising Synthetic Melanoma Peptides Administered With Granulocyte-macrophage Colony-stimulating Factor (GM-CSF)-In-Adjuvant, in Patients With High Risk Melanoma (MEL36)","2010","","","","","","","","","","","","",https://clinicaltrials.gov/study/NCT00928902,"",0,10,0,0,0,,,
6083,99,NCT01861938,website,Hadassah Medical Organization,Modified Melanoma Vaccine for High Risk or Low Residual Disease Patients,"2013","","","","","","","","","","","","",https://clinicaltrials.gov/study/NCT01861938,"",0,10,0,0,0,,,
6084,99,NCT00623831,website,Ludwig Institute for Cancer Research,A Phase 1 Study of Mixed Bacteria Vaccine (MBV) in Patients With Tumors Expressing NY-ESO-1 Antigen,"2022","","","","","","","","","","","","",https://clinicaltrials.gov/study/NCT00623831,"",0,10,0,0,0,,,
6085,99,NCT04741984,website,Michael Gunn,Monocyte Antigen Carrier Cells for Newly Diagnosed GBM (DEMAND),"2023","","","","","","","","","","","","",https://clinicaltrials.gov/study/NCT04741984,"",0,10,0,0,0,,,
6086,99,NCT00986609,website,"Joseph Baar, MD, PhD, Case Comprehensive Cancer Center",MUC1 Vaccine for Triple-negative Breast Cancer,"2018","","","","","","","","","","","","",https://clinicaltrials.gov/study/NCT00986609,"",0,10,0,0,0,,,
6087,99,NCT03300817,website,National Cancer Institute (NCI),MUC1 Vaccine in Preventing Lung Cancer in Current and Former Smokers at High Risk for Lung Cancer,"2024","","","","","","","","","","","","",https://clinicaltrials.gov/study/NCT03300817,"",0,10,0,0,0,,,
6088,99,NCT04197687,website,Academic and Community Cancer Research United,"TPIV100 and Sargramostim for the Treatment of HER2 Positive, Stage II-III Breast Cancer in Patients With Residual Disease After Chemotherapy and Surgery","2023","","","","","","","","","","","","",https://clinicaltrials.gov/study/NCT04197687,"",0,10,0,0,0,,,
6089,99,NCT00085189,website,University of Southern California,Vaccine Therapy in Treating Patients With Stage IIC-IV Melanoma,"2014","","","","","","","","","","","","",https://clinicaltrials.gov/study/NCT00085189,"",0,10,0,0,0,,,
6090,99,NCT04688385,website,University Hospital Tuebingen,Personalized Multi-peptide Vaccination in CLL Patients,"2023","","","","","","","","","","","","",https://clinicaltrials.gov/study/NCT04688385,"",0,10,0,0,0,,,
6091,99,NCT04317248,website,Yuehua Huang,"""Cocktail"" Therapy for Hepatitis B Related Hepatocellular Carcinoma","2020","","","","","","","","","","","","",https://clinicaltrials.gov/study/NCT04317248,"",0,10,0,0,0,,,
6092,99,NCT04574583,website,National Cancer Institute (NCI),"Phase I/II Trial Investigating the Safety, Tolerability, Pharmacokinetics, Immune and Clinical Activity of SX-682 in Combination With BinTrafusp Alfa (M7824 or TGF-beta ""Trap""/PD-L1) With CV301 TRICOM in Advanced Solid Tumors (STAT)","2023","","","","","","","","","","","","",https://clinicaltrials.gov/study/NCT04574583,"",0,10,0,0,0,,,
6093,99,NCT00017537,website,University of Alabama at Birmingham,Vaccine Therapy in Treating Patients With Metastatic or Recurrent Cancer,"2023","","","","","","","","","","","","",https://clinicaltrials.gov/study/NCT00017537,"",0,10,0,0,0,,,
6094,99,NCT02728102,website,"National Heart, Lung, and Blood Institute (NHLBI)",Dendritic Cell/Myeloma Fusion Vaccine for Multiple Myeloma (BMT CTN 1401),"2023","","","","","","","","","","","","",https://clinicaltrials.gov/study/NCT02728102,"",0,10,0,0,0,,,
6095,99,NCT03480152,website,National Cancer Institute (NCI),"Messenger RNA (mRNA)-Based, Personalized Cancer Vaccine Against Neoantigens Expressed by the Autologous Cancer","2020","9","12","833-844",Nature reviews. Immunology,"","","","","","","","19935803",https://clinicaltrials.gov/study/NCT03480152,"",0,10,0,0,0,,,
6096,99,NCT03166254,website,Washington University School of Medicine,Personalized Therapeutic Anti-tumor Vaccine With Pembrolizumab and Standard of Care Chemotherapy in Squamous Non-Small Cell Lung Cancer and Extensive Stage Small Cell Lung Cancer,"2019","","","","","","","","","","","","",https://clinicaltrials.gov/study/NCT03166254,"",0,10,0,0,0,,,
6097,99,NCT03598816,website,Washington University School of Medicine,PolyImmune {Durvalumab (MEDI4736) and Tremelimumab} & Vaccine Orchestrated Treatment for Patients With Advanced/Metastatic Renal Cell Carcinoma (PIVOT-RCC),"2020","","","","","","","","","","","","",https://clinicaltrials.gov/study/NCT03598816,"",0,10,0,0,0,,,
6098,99,NCT05098210,website,Fred Hutchinson Cancer Center,Personalized Neo-Antigen Peptide Vaccine for the Treatment of Stage IIIC-IV Melanoma or Hormone Receptor Positive Her2 Negative Metastatic Refractory Breast Cancer,"2024","","","","","","","","","","","","",https://clinicaltrials.gov/study/NCT05098210,"",0,10,0,0,0,,,
6099,99,NCT05227378,website,"Shen Lin, Peking University",Safety and Efficacy of Personalized Neoantigen Vaccine in Advanced Gastric Cancer,"2022","","","","","","","","","","","","",https://clinicaltrials.gov/study/NCT05227378,"",0,10,0,0,0,,,
6100,99,NCT02750995,website,"Daniel El Fassi, Herlev Hospital",Peptide Vaccination in Combination With Azacitidine for Patients With MDS and AML (AZACTA),"2020","","","","","","","","","","","","",https://clinicaltrials.gov/study/NCT02750995,"",0,10,0,0,0,,,
6101,99,NCT01312376,website,Abramson Cancer Center at Penn Medicine,Autologous T-Cells Combined With Autologous OC-DC Vaccine in Ovarian Cancer,"2020","","","","","","","","","","","","",https://clinicaltrials.gov/study/NCT01312376,"",0,10,0,0,0,,,
6102,99,NCT05317325,website,Sichuan University,A Translational Study of Tumor Antigen-pulsed DC Vaccine for ESCC,"2022","","","","","","","","","","","","",https://clinicaltrials.gov/study/NCT05317325,"",0,10,0,0,0,,,
6103,99,NCT05111353,website,Washington University School of Medicine,Neoantigen Vaccines in Pancreatic Cancer in the Window Prior to Surgery,"2024","","","","","","","","","","","","",https://clinicaltrials.gov/study/NCT05111353,"",0,10,0,0,0,,,
6104,99,NCT03042182,website,Immunitor LLC,Trial of Therapeutic Vaccine in Patients With Cholangiocarcinoma (cholangio),"2019","","","","","","","","","","","","",https://clinicaltrials.gov/study/NCT03042182,"",0,10,0,0,0,,,
6105,99,NCT00660101,website,AVAX Technologies,"Trial of Autologous, Hapten-Modified Vaccine, OVAX, in Patients With Relapsed Stage III or IV Ovarian Cancer","2015","","","","","","","","","","","","",https://clinicaltrials.gov/study/NCT00660101,"",0,10,0,0,0,,,
6106,99,NCT00148928,website,GlaxoSmithKline,Safety & Activity of P501-AS15 Vaccine as a First-line Treatment for Patients With Hormone-sensitive Prostate Cancer Who Show Rising PSA,"2017","","","","","","","","","","","","",https://clinicaltrials.gov/study/NCT00148928,"",0,10,0,0,0,,,
6107,99,NCT00836407,website,Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins,"Ipilimumab +/- Vaccine Therapy in Treating Patients With Locally Advanced, Unresectable or Metastatic Pancreatic Cancer","2020","","","","","","","","","","","","",https://clinicaltrials.gov/study/NCT00836407,"",0,10,0,0,0,,,
6108,99,NCT03047928,website,"Inge Marie Svane, Herlev Hospital",Combination Therapy With Nivolumab and PD-L1/IDO Peptide Vaccine to Patients With Metastatic Melanoma,"2022","","","","","","","","","","","","",https://clinicaltrials.gov/study/NCT03047928,"",0,10,0,0,0,,,
6109,99,NCIT_C148154,website,"",PD-L1/IDO Peptide Vaccine IO102-103,"","","","","","","","","","","","","",https://ncithesaurus.nci.nih.gov/ncitbrowser/pages/home.jsf,"",0,10,0,0,0,,,
6110,99,NCT03042793,website,"Lene Meldgaard Knudsen, Herlev Hospital",Vaccination With PD-L1 Peptide Against Multiple Myeloma,"2020","","","","","","","","","","","","",https://clinicaltrials.gov/study/NCT03042793,"",0,10,0,0,0,,,
6111,99,NCIT_C148146,website,"",PD-L1 Peptide Vaccine,"","","","","","","","","","","","","",https://ncithesaurus.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&ns=ncit&code=C148146,"",0,10,0,0,0,,,
6112,99,NCT02808416,website,Guangdong 999 Brain Hospital,Personalized Cellular Vaccine for Brain Metastases (PERCELLVAC3) (PerCellVac3),"2022","","","","","","","","","","","","",https://clinicaltrials.gov/study/NCT02808416,"",0,10,0,0,0,,,
6113,99,NCT02419170,website,Washington University School of Medicine,Mature Dendritic Cell Vaccination Against Unique Immunogenic Peptides in Patients With Non Small Cell Lung Cancer (NSCLC),"2016","","","","","","","","","","","","",https://clinicaltrials.gov/study/NCT02419170,"",0,10,0,0,0,,,
6114,99,NCT03558945,website,"Anda Biopharmaceutical Development (Shenzhen) Co., Ltd.",Clinical Trial on Personalized Neoantigen Vaccine for Pancreatic Tumor,"2023","","","","","","","","","","","","",https://clinicaltrials.gov/study/NCT03558945,"",0,10,0,0,0,,,
6115,99,NCT03121677,website,Washington University School of Medicine,Personalized Tumor Vaccine Strategy and PD-1 Blockade in Patients With Follicular Lymphoma,"2023","","","","","","","","","","","","",https://clinicaltrials.gov/study/NCT03121677,"",0,10,0,0,0,,,
6116,99,NCIT_C154278,website,"",Colorectal Cancer Peptide Vaccine PolyPEPI1018,"","","","","","","","","","","","","",https://ncithesaurus.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&ns=ncit&code=C154278,"",0,10,0,0,0,,,
6117,99,NCT03391232,website,Treos Bio Zrt,PolyPEPI1018 Vaccine and CDx for the Treatment of Metastatic Colorectal Cancer (OBERTO) (OBERTO),"2022","","","","","","","","","","","","",https://clinicaltrials.gov/study/NCT03391232,"",0,10,0,0,0,,,
6118,99,NCT00004104,website,NYU Langone Health,Vaccine Therapy Plus Interleukin-2 With or Without Interferon Alfa-2b in Treating Patients With Stage III Melanoma,"2016","","","","","","","","","","","","",https://clinicaltrials.gov/study/NCT00004104,"",0,10,0,0,0,,,
6119,99,NCIT_C1633,website,"",Polyvalent Melanoma Vaccine,"","","","","","","","","","","","","",https://ncithesaurus.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&ns=ncit&code=C1633,"",0,10,0,0,0,,,
6120,99,NCT05533203,website,Shanghai Humantech Biotechnology Co. Ltd,Safety of Prodencel in the Treatment of Metastatic Castration-resistant Prostate Cancer (mCRPC),"2023","","","","","","","","","","","","",https://clinicaltrials.gov/study/NCT05533203,"",0,10,0,0,0,,,
6121,99,NCIT_C192174,website,"",Prodencel,"","","","","","","","","","","","","",https://ncithesaurus.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&ns=ncit&code=C192174,"",0,10,0,0,0,,,
6122,99,NCT02780401,website,University of Washington,"Vaccine Therapy in Preventing Cancer Recurrence in Patients With Non-Metastatic, Node Positive, HER2 Negative Breast Cancer That is in Remission (WOKVAC)","2022","","","","","","","","","","","","",https://clinicaltrials.gov/study/NCT02780401,"",0,10,0,0,0,,,
6123,99,NCIT_C127910,website,"",pUMVC3-IGFBP2-HER2-IGF1R Plasmid DNA Vaccine,"","","","","","","","","","","","","",https://ncithesaurus.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&ns=ncit&code=C127910,"",0,10,0,0,0,,,
6124,99,NCT00626483,website,"Gary Archer Ph.D., Duke University",Basiliximab in Treating Patients With Newly Diagnosed Glioblastoma Multiforme Undergoing Targeted Immunotherapy and Temozolomide-Caused Lymphopenia (REGULATe),"2021","","","","","","","","","","","","",https://clinicaltrials.gov/study/NCT00626483,"",0,10,0,0,0,,,
6125,99,NCIT_C156067,website,"",Autologous CMV-pp65-flLAMP mRNA Loaded Dendritic Cell Vaccine,"","","","","","","","","","","","","",https://ncithesaurus.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&ns=ncit&code=C156067,"",0,10,0,0,0,,,
6126,99,NCT05202561,website,First Affiliated Hospital Bengbu Medical College,A Study of RNA Tumor Vaccine in Patients With Advanced Solid Tumors,"2022","","","","","","","","","","","","",https://clinicaltrials.gov/study/NCT05202561,"",0,10,0,0,0,,,
6127,99,NCIT_C162186,website,"",mRNA-derived KRAS-targeted Vaccine V941,"","","","","","","","","","","","","",https://ncithesaurus.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&ns=ncit&code=C162186,"",0,10,0,0,0,,,
6128,99,NCT04079166,website,Scancell Ltd,SCIB1 in Melanoma Patients Receiving Either Nivolumab With Ipilimumab or Pembrolizumab (The SCOPE Study),"2024","","","","","","","","","","","","",https://clinicaltrials.gov/study/NCT04079166,"",0,10,0,0,0,,,
6129,99,NCIT_C91380,website,"",Melanoma TRP2 CTL Epitope Vaccine SCIB1,"","","","","","","","","","","","","",https://ncithesaurus.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&ns=ncit&code=C91380,"",0,10,0,0,0,,,
6130,99,NCT00470574,website,Memorial Sloan Kettering Cancer Center,Vaccine Therapy and QS21 in Treating Patients With Metastatic Breast Cancer,"2020","","","","","","","","","","","","",https://clinicaltrials.gov/study/NCT00470574,"",0,10,0,0,0,,,
6131,99,NCIT_C69000,website,"",Sialyl Lewis-Keyhole Limpet Hemocyanin Conjugate Vaccine,"","","","","","","","","","","","","",https://ncithesaurus.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&ns=ncit&code=C69000,"",0,10,0,0,0,,,
6132,99,NCT02851056,website,H. Lee Moffitt Cancer Center and Research Institute,Survivin Vaccine : Multiple Myeloma Autologous Hematopoietic Cell Transplant (HCT),"2022","","","","","","","","","","","","",https://clinicaltrials.gov/study/NCT02851056,"",0,10,0,0,0,,,
6133,99,NCT00343109,website,University of Washington,Vaccine Therapy in Treating Patients Receiving Trastuzumab For HER2-Positive Stage IIIB-IV Breast Cancer,"2020","","","","","","","","","","","","",https://clinicaltrials.gov/study/NCT00343109,"",0,10,0,0,0,,,
6134,99,NCT00267085,website,M.D. Anderson Cancer Center,Synthetic Vaccine in Patients With Chronic Myeloid Leukemia and Minimal Residual Disease,"2012","","","","","","","","","","","","",https://clinicaltrials.gov/study/NCT00267085,"",0,10,0,0,0,,,
6135,99,NCIT_C61309,website,"",Bcr-Abl (b2a2)-Derived Peptide Vaccine,"","","","","","","","","","","","","",https://ncithesaurus.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&ns=ncit&code=C61309,"",0,10,0,0,0,,,
6136,99,NCT03556566,website,Immunitor LLC,Open Label Immunotherapy Trial for Ovarian Cancer (V3-OVA),"2019","","","","","","","","","","","","",https://clinicaltrials.gov/study/NCT03556566,"",0,10,0,0,0,,,
6137,99,NCIT_C159540,website,"",Oral Cancer Vaccine V3-OVA,"","","","","","","","","","","","","",https://ncithesaurus.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&ns=ncit&code=C159540,"",0,10,0,0,0,,,
6138,99,NCIT_C2468,website,"",Tetanus Peptide Melanoma Vaccine,"","","","","","","","","","","","","",https://ncithesaurus.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&ns=ncit&code=C2468,"",0,10,0,0,0,,,
6139,99,NCT05638698,website,University of Kansas Medical Center,Tg01 Vaccine / Qs-21 Stimulon With Or Without Balstilimab As Maintenance Therapy Following Adjuvant Chemotherapy In Patients With Resected Pancreatic Cancer (TESLA),"2023","","","","","","","","","","","","",https://clinicaltrials.gov/study/NCT05638698,"",0,10,0,0,0,,,
6140,99,NCIT_C200465,website,"",RAS Peptide Cancer Vaccine TG01,"","","","","","","","","","","","","",https://ncithesaurus.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&ns=ncit&code=C200465,"",0,10,0,0,0,,,
6141,99,NCT00684294,website,Mary Crowley Medical Research Center,Phase I Trial of TGFB2-Antisense-GMCSF Gene Modified Autologous Tumor Cell (TAG) Vaccine for Advanced Cancer (Auto TAG),"2020","","","","","","","","","","","","",https://clinicaltrials.gov/study/NCT00684294,"",0,10,0,0,0,,,
6142,99,"Zanetti, 2003",journal,Zanetti M,"Protocol #0207-545: a phase I/II, escalating dose, open-label evaluation of safety, feasibility, and tolerability of transgenic lymphocyte immunization (TLI) vaccine subjects with histologically proven prostate adenocarcinoma","2003","14","3","301-302",Human gene therapy,"","","","","","","","12653092","","",0,10,0,0,0,,,
6143,99,NCT00061035,website,Cosmo Bioscience,Evaluation of Transgenic Lymphocyte Immunization Vaccine in Subjects With Prostate Adenocarcinoma,"2008","","","","","","","","","","","","",https://clinicaltrials.gov/study/NCT00061035,"",0,10,0,0,0,,,
6144,99,NCIT_C38720,website,"",Transgenic Lymphocyte Immunization Vaccine,"","","","","","","","","","","","","",https://ncithesaurus.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&ns=ncit&code=C38720,"",0,10,0,0,0,,,
6145,99,NCT04247282,website,National Cancer Institute (NCI),Anti-PD-L1/TGF-beta Trap (M7824) Alone and in Combination With TriAd Vaccine and N-803 for Resectable Head and Neck Squamous Cell Carcinoma Not Associated With Human Papillomavirus Infection,"2023","","","","","","","","","","","","",https://clinicaltrials.gov/study/NCT04247282,"",0,10,0,0,0,,,
6146,99,NCIT_C91373,website,"",Adenoviral Vector Ad5-CEA(6D) Vaccine,"","","","","","","","","","","","","",ttps://ncithesaurus.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&ns=ncit&code=C91373,"",0,10,0,0,0,,,
6147,99,NCIT_C143034,website,"",Adenoviral Brachyury Vaccine ETBX-051,"","","","","","","","","","","","","",https://ncithesaurus.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&ns=ncit&code=C143034,"",0,10,0,0,0,,,
6148,99,NCIT_C143035,website,"",Adenoviral MUC1 Vaccine ETBX-061,"","","","","","","","","","","","","",https://ncithesaurus.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&ns=ncit&code=C143035,"",0,10,0,0,0,,,
6149,99,NCT03396575,website,University of Florida,Brain Stem Gliomas Treated With Adoptive Cellular Therapy During Focal Radiotherapy Recovery Alone or With Dose-intensified Temozolomide (Phase I) (BRAVO),"2023","","","","","","","","","","","","",https://clinicaltrials.gov/study/NCT03396575,"",0,10,0,0,0,,,
6150,99,NCIT_C116913,website,"",Total Tumor RNA-loaded Dendritic Cell Vaccine,"","","","","","","","","","","","","",https://ncithesaurus.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&ns=ncit&code=C116913,"",0,10,0,0,0,,,
6151,99,NCT05023928,website,Sichuan University,Tumor Antigen-sensitized DC Vaccine as an Adjuvant Therapy for Esophagus Cancer,"2021","","","","","","","","","","","","",https://clinicaltrials.gov/study/NCT05023928,"",0,10,0,0,0,,,
6152,99,NCT05235607,website,Sichuan University,Personalized Immune Cell Therapy Targeting Neoantigen of Malignant Solid Tumors,"2022","","","","","","","","","","","","",https://clinicaltrials.gov/study/NCT05235607,"",0,10,0,0,0,,,
6153,99,NCT05283109,website,"Mustafa Khasraw, MBChB, MD, FRCP, FRACP, Duke University",ETAPA I: Peptide-based Tumor Associated Antigen Vaccine in GBM (ETAPA I),"2023","","","","","","","","","","","","",https://clinicaltrials.gov/study/NCT05283109,"",0,10,0,0,0,,,
6154,99,NCIT_C187131,website,"",P30-linked EphA2/CMV pp65/Survivin Peptide Vaccine P30-EPS,"","","","","","","","","","","","","",https://ncithesaurus.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&ns=ncit&code=C187131,"",0,10,0,0,0,,,
6155,30,"VanBuskirk et al., 2009",journal,"VanBuskirk KM, O'Neill MT, De La Vega P, Maier AG, Krzych U, Williams J, Dowler MG, Sacci JB Jr, Kangwanrangsan N, Tsuboi T, Kneteman NM, Heppner DG Jr, Murdock BA, Mikolajczak SA, Aly AS, Cowman AF, Kappe SH","Preerythrocytic, live-attenuated Plasmodium falciparum vaccine candidates by design","2009","106","31","13004-13009",Proceedings of the National Academy of Sciences of the United States of America,"","","","","","","","19625622","","",0,10,0,0,0,,,
6156,99,NCT02944357,website,Mayo Clinic,"Gemcitabine Hydrochloride, Cisplatin, and AGS-003-BLD in Treating Patients With Muscle-Invasive Bladder Cancer Undergoing Surgery","2017","","","","","","","","","","","","",https://clinicaltrials.gov/study/NCT02944357,"",0,10,0,0,0,,,
6157,99,NCIT_C129522,website,"",Autologous Bladder Cell Carcinoma RNAs/CD40L RNA Electroporated Autologous Matured Dendritic Cells,"","","","","","","","","","","","","",https://ncithesaurus.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&ns=ncit&code=C129522,"",0,10,0,0,0,,,
6158,99,NCT00002505,website,Hoag Memorial Hospital Presbyterian,Tumor Cell Vaccine in Treating Patients With Advanced Cancer,"2011","","","","","","","","","","","","",https://clinicaltrials.gov/study/NCT00002505,"",0,10,0,0,0,,,
6159,99,NCT00923351,website,National Cancer Institute (NCI),"Therapy to Treat Ewing's Sarcoma, Rhabdomyosarcoma or Neuroblastoma","2018","","","","","","","","","","","","",https://clinicaltrials.gov/study/NCT00923351,"",0,10,0,0,0,,,
6160,99,NCT00405327,website,University of Michigan Rogel Cancer Center,A Pilot Study of Tumor Cell Vaccine for High-risk Solid Tumor Patients Following Stem Cell Transplantation,"2017","","","","","","","","","","","","",https://clinicaltrials.gov/study/NCT00405327,"",0,10,0,0,0,,,
6161,99,NCIT_C1988,website,"",Dendritic Cell Tumor Cell Lysate Vaccine,"","","","","","","","","","","","","",https://ncithesaurus.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&ns=ncit&code=C1988,"",0,10,0,0,0,,,
6162,99,NCT02332889,website,University of Louisville,Phase I/II: Decitabine/Vaccine Therapy in Relapsed/Refractory Pediatric High Grade Gliomas/Medulloblastomas/CNS PNETs,"2018","","","","","","","","","","","","",https://clinicaltrials.gov/study/NCT02332889,"",0,10,0,0,0,,,
6163,99,NCT02077114,website,Herlev Hospital,Vaccination With Peptides in Combination With Either Ipilimumab or Vemurafenib for the Treatment of Unresectable Stage III or IV Malignant Melanoma,"2014","","","","","","","","","","","","",https://clinicaltrials.gov/study/NCT02077114,"",0,10,0,0,0,,,
6164,99,NCIT_C159498,website,"",IDO Peptide Vaccine IO102,"","","","","","","","","","","","","",https://ncithesaurus.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&ns=ncit&code=C159498,"",0,10,0,0,0,,,
6165,99,NCT03141463,website,University Medical Center Groningen,Vvax001 Cancer Vaccine in (Pre) Malignant Cervical Lesions,"2018","","","","","","","","","","","","",https://clinicaltrials.gov/study/NCT03141463,"",0,10,0,0,0,,,
6166,99,NCIT_C148539,website,"",HPV E6/E7-encoding Semliki Forest Virus Vaccine Vvax001,"","","","","","","","","","","","","",https://ncithesaurus.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&ns=ncit&code=C148539,"",0,10,0,0,0,,,
6167,99,NCT00938223,website,"Craig L Slingluff, Jr, University of Virginia","Evaluation of the Immunogenicity of Vaccination With Multiple Synthetic Melanoma Peptides With Granulocyte-macrophage Colony-stimulating Factor (GM-CSF)-In-Adjuvant, in Patients With Advanced Melanoma (MEL39)","2018","","","","","","","","","","","","",https://clinicaltrials.gov/study/NCT00938223,"",0,10,0,0,0,,,
6168,99,NCT00515528,website,University of Chicago,Vaccination Plus Ontak in Patients With Metastatic Melanoma,"2021","","","","","","","","","","","","",https://clinicaltrials.gov/study/NCT00515528,"",0,10,0,0,0,,,
6169,99,NCIT_C91722,website,"","4-Peptide Melanoma Vaccine","","","","","","","","","","","","","",https://ncithesaurus.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&ns=ncit&code=C91722,"",0,10,0,0,0,,,
6170,99,NCT00610311,website,National Cancer Institute (NCI),Anti-gp100 Cells Plus ALVAC gp100 Vaccine to Treat Advanced Melanoma,"2015","","","","","","","","","","","","",https://clinicaltrials.gov/study/NCT00610311,"",0,10,0,0,0,,,
6171,99,NCIT_C180518,website,"",ALVAC gp100 Vaccine,"","","","","","","","","","","","","",https://ncithesaurus.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&ns=ncit&code=C180518,"",0,10,0,0,0,,,
6172,99,NCIT_C78832,website,"",LV.IL-2/B7.1-Transduced AML Blast Vaccine RFUSIN2-AML1,"","","","","","","","","","","","","",https://ncithesaurus.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&ns=ncit&code=C78832,"",0,10,0,0,0,,,
6173,99,NCIT_C170932,website,"",Anti-HER2/HER3 Dendritic Cell Vaccine,"","","","","","","","","","","","","",https://ncithesaurus.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&ns=ncit&code=C170932,"",0,10,0,0,0,,,
6174,99,NCT03300843,website,National Cancer Institute (NCI),Ability of a Dendritic Cell Vaccine to Immunize Melanoma or Epithelial Cancer Patients Against Defined Mutated Neoantigens Expressed by the Autologous Cancer,"2019","","","","","","","","","","","","",https://clinicaltrials.gov/study/NCT03300843,"",0,10,0,0,0,,,
6175,99,NCIT_C179254,website,"",Personalized Peptides-loaded Autologous Dendritic Cell Vaccine,"","","","","","","","","","","","","",https://ncithesaurus.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&ns=ncit&code=C179254,"",0,10,0,0,0,,,
6176,99,NCIT_C116733,website,"",Autologous Lymphoma Immunoglobulin-derived scFv-chemokine DNA Vaccine,"","","","","","","","","","","","","",https://ncithesaurus.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&ns=ncit&code=C116733,"",0,10,0,0,0,,,
6177,99,NCT05264974,website,University of Florida,Novel RNA-nanoparticle Vaccine for the Treatment of Early Melanoma Recurrence Following Adjuvant Anti-PD-1 Antibody Therapy,"2024","","","","","","","","","","","","",https://clinicaltrials.gov/study/NCT05264974,"",0,10,0,0,0,,,
6178,99,NCIT_C178432,website,"",Autologous Total Tumor mRNA and CMV-pp65-flLAMP mRNA Loaded Liposome Vaccine,"","","","","","","","","","","","","",https://ncithesaurus.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&ns=ncit&code=C178432,"",0,10,0,0,0,,,
6179,99,NCIT_C48391,website,"",GM.CD40L Cell Vaccine,"","","","","","","","","","","","","",https://ncithesaurus.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&ns=ncit&code=C48391,"",0,10,0,0,0,,,
6180,99,NCT00101166,website,H. Lee Moffitt Cancer Center and Research Institute,Universal Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF)-Producing and CD40L Expressing Bystander Cell Line for Tumor Vaccine in Melanoma,"2018","","","","","","","","","","","","",https://clinicaltrials.gov/study/NCT00101166,"",0,10,0,0,0,,,
6181,99,NCT00840931,website,H. Lee Moffitt Cancer Center and Research Institute,Immunotherapy Using Lenalidomide + Bystander Vaccine in High Risk Myelodysplastic Syndrome (MDS),"2019","","","","","","","","","","","","",https://clinicaltrials.gov/study/NCT00840931,"",0,10,0,0,0,,,
6182,99,NCT00455221,website,Tehran University of Medical Sciences,Safety Assessment of a Multipeptide-gene Vaccine in CML,"2012","","","","","","","","","","","","",https://clinicaltrials.gov/study/NCT00455221,"",0,10,0,0,0,,,
6183,99,NCT00004052,website,Memorial Sloan Kettering Cancer Center,Vaccine Therapy in Treating Patients With Chronic Myelogenous Leukemia,"2013","","","","","","","","","","","","",https://clinicaltrials.gov/study/NCT00004052,"",0,10,0,0,0,,,
6184,99,NCIT_C2205,website,"",BCR-ABL Peptide Vaccine,"","","","","","","","","","","","","",https://ncithesaurus.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&ns=ncit&code=C2205,"",0,10,0,0,0,,,
6185,99,NCIT_C61310,website,"",Bcr-Abl (b3a2)-Derived Peptide Vaccine,"","","","","","","","","","","","","",https://ncithesaurus.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&ns=ncit&code=C61310,"",0,10,0,0,0,,,
6186,99,NCIT_C107685,website,"",BC-819 Plasmid/Polyethylenimine Complex,"","","","","","","","","","","","","",https://ncithesaurus.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&ns=ncit&code=C107685,"",0,10,0,0,0,,,
6187,99,NCIT_C97034,website,"",Pentavalent KLH Conjugate Vaccine,"","","","","","","","","","","","","",https://ncithesaurus.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&ns=ncit&code=C97034,"",0,10,0,0,0,,,
6188,99,NCT01081223,website,TVAX Biomedical,Phase I/II Study To Test The Safety and Efficacy of TVI-Brain-1 As A Treatment For Recurrent Grade IV Glioma,"2023","","","","","","","","","","","","",https://clinicaltrials.gov/study/NCT01081223,"",0,10,0,0,0,,,
6189,99,NCIT_C199632,website,"",Autologous Vaccine-enhanced Ex Vivo Activated Cancer Neoantigens-specific T-cells TVI-Brain-1,"","","","","","","","","","","","","",https://ncithesaurus.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&ns=ncit&code=C199632,"",0,10,0,0,0,,,
6190,99,NCIT_C77858,website,"",Human Monoclonal Antibody B11-hCG Beta Fusion Protein CDX-1307,"","","","","","","","","","","","","",https://ncithesaurus.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&ns=ncit&code=C77858,"",0,10,0,0,0,,,
6191,99,NCT03059485,website,Beth Israel Deaconess Medical Center,DC/AML Fusion Cell Vaccine vs Observation in Patients Who Achieve a Chemotherapy-induced Remission,"2023","","","","","","","","","","","","",https://clinicaltrials.gov/study/NCT03059485,"",0,10,0,0,0,,,
6192,99,NCT01096602,website,Beth Israel Deaconess Medical Center,Blockade of PD-1 in Conjunction With the Dendritic Cell/AML Vaccine Following Chemotherapy Induced Remission,"2023","","","","","","","","","","","","",https://clinicaltrials.gov/study/NCT01096602,"",0,10,0,0,0,,,
6193,99,NCIT_C148214,website,"",Autologous AML/Dendritic Cell Fusion Vaccine,"","","","","","","","","","","","","",https://ncithesaurus.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&ns=ncit&code=C148214,"",0,10,0,0,0,,,
6194,99,NCIT_C1987,website,"",Dendritic Cell Tumor Peptide Vaccine,"","","","","","","","","","","","","",https://ncithesaurus.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&ns=ncit&code=C1987,"",0,10,0,0,0,,,
6195,99,"Hu et al., 2021",journal,"Hu Z, Leet DE, Allese RL, Oliveira G, Li S, Luoma AM, Liu J, Forman J, Huang T, Iorgulescu JB, Holden R, Sarkizova S, Gohil SH, Redd RA, Sun J, Elagina L, Giobbie-Hurder A, Zhang W, Peter L, Ciantra Z, Rodig S, Olive O, Shetty K, Pyrdol J, Uduman M, Lee PC, Bachireddy P, Buchbinder EI, Yoon CH, Neuberg D, Pentelute BL, Hacohen N, Livak KJ, Shukla SA, Olsen LR, Barouch DH, Wucherpfennig KW, Fritsch EF, Keskin DB, Wu CJ, Ott PA",Personal neoantigen vaccines induce persistent memory T cell responses and epitope spreading in patients with melanoma,"2021","27","3","515-525",Nature medicine,"","","","","","","","33479501","","",0,10,0,0,0,,,
6196,99,NCT01970358,website,"Patrick Ott, MD",A Phase I Study With a Personalized NeoAntigen Cancer Vaccine in Melanoma,"2020","","","","","","","","","","","","",https://clinicaltrials.gov/study/NCT01970358,"",0,10,0,0,0,,,
6197,99,"Mahoney et al., 2019",journal,"Mahoney KM, Shukla SA, Patsoukis N, Chaudhri A, Browne EP, Arazi A, Eisenhaure TM, Pendergraft WF 3rd, Hua P, Pham HC, Bu X, Zhu B, Hacohen N, Fritsch EF, Boussiotis VA, Wu CJ, Freeman GJ",A secreted PD-L1 splice variant that covalently dimerizes and mediates immunosuppression,"2019","68","3","421-432","Cancer immunology, immunotherapy : CII","","","","","","","","30564891","","",0,10,0,0,0,,,
6198,99,"Ott et al., 2017",journal,"Ott PA, Hu Z, Keskin DB, Shukla SA, Sun J, Bozym DJ, Zhang W, Luoma A, Giobbie-Hurder A, Peter L, Chen C, Olive O, Carter TA, Li S, Lieb DJ, Eisenhaure T, Gjini E, Stevens J, Lane WJ, Javeri I, Nellaiappan K, Salazar AM, Daley H, Seaman M, Buchbinder EI, Yoon CH, Harden M, Lennon N, Gabriel S, Rodig SJ, Barouch DH, Aster JC, Getz G, Wucherpfennig K, Neuberg D, Ritz J, Lander ES, Fritsch EF, Hacohen N, Wu CJ",An immunogenic personal neoantigen vaccine for patients with melanoma,"2017","547","7662","217-221",Nature,"","","","","","","","28678778","","",0,10,0,0,0,,,
6199,99,"Kuai et al., 2020",journal,"Kuai R, Singh PB, Sun X, Xu C, Najafabadi AH, Scheetz L, Yuan W, Xu Y, Hong H, Keskin DB, Wu CJ, Jain R, Schwendeman A, Moon JJ",Robust anti-tumor T cell response with efficient intratumoral infiltration by nanodisc cancer immunotherapy,"2020","3","9","",Advanced therapeutics,"","","","","","","","38317797","","",0,10,0,0,0,,,
6200,99,NCIT_C141422,website,"",Neoantigen-loaded Autologous Dendritic Cell Vaccine,"","","","","","","","","","","","","",https://ncithesaurus.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&ns=ncit&code=C141422,"",0,10,0,0,0,,,
6201,99,NCT03674073,website,Chinese PLA General Hospital,A Study Combining Personalized Neoantigen-based Dendritic Cell Vaccine With Microwave Ablation for the Treatment of Hepatocellular Carcinoma,"2018","","","","","","","","","","","","",https://clinicaltrials.gov/study/NCT03674073,"",0,10,0,0,0,,,
6202,99,NCT03871205,website,Shenzhen People's Hospital,Neoantigen-primed DC Vaccines Therapy for Refractory Lung Cancer,"2019","","","","","","","","","","","","",https://clinicaltrials.gov/study/NCT03871205,"",0,10,0,0,0,,,
6203,99,NCT04912765,website,"National Cancer Centre, Singapore",Neoantigen Dendritic Cell Vaccine and Nivolumab in HCC and Liver Metastases From CRC,"2024","","","","","","","","","","","","",https://clinicaltrials.gov/study/NCT04912765,"",0,10,0,0,0,,,
6204,99,"Wang et al., 2024",journal,"Wang Y, Cho JW, Kastrunes G, Buck A, Razimbaud C, Culhane AC, Sun J, Braun DA, Choueiri TK, Wu CJ, Jones K, Nguyen QD, Zhu Z, Wei K, Zhu Q, Signoretti S, Freeman GJ, Hemberg M, Marasco WA",Immune-restoring CAR-T cells display antitumor activity and reverse immunosuppressive TME in a humanized ccRCC mouse model,"2024","27","2","108879",iScience,"","","","","","","","38327771","","",0,10,0,0,0,,,
6205,99,"Kaczanowska et al., 2024",journal,"Kaczanowska S, Murty T, Alimadadi A, Contreras CF, Duault C, Subrahmanyam PB, Reynolds W, Gutierrez NA, Baskar R, Wu CJ, Michor F, Altreuter J, Liu Y, Jhaveri A, Duong V, Anbunathan H, Ong C, Zhang H, Moravec R, Yu J, Biswas R, Van Nostrand S, Lindsay J, Pichavant M, Sotillo E, Bernstein D, Carbonell A, Derdak J, Klicka-Skeels J, Segal JE, Dombi E, Harmon SA, Turkbey B, Sahaf B, Bendall S, Maecker H, Highfill SL, Stroncek D, Glod J, Merchant M, Hedrick CC, Mackall CL, Ramakrishna S, Kaplan RN",Immune determinants of CAR-T cell expansion in solid tumor patients receiving GD2 CAR-T cell therapy,"2024","42","1","35-51.e8",Cancer cell,"","","","","","","","38134936","","",0,10,0,0,0,,,
6206,99,NCT02107963,website,National Cancer Institute (NCI),A Phase I Trial of T Cells Expressing an Anti-GD2 Chimeric Antigen Receptor in Children and Young Adults With GD2+ Solid Tumors,"2023","","","","","","","","","","","","",https://clinicaltrials.gov/study/NCT02107963,"",0,10,0,0,0,,,
6207,99,"Mota et al., 2023",journal,"Mota I, Patrucco E, Mastini C, Mahadevan NR, Thai TC, Bergaggio E, Cheong TC, Leonardi G, Karaca-Atabay E, Campisi M, Poggio T, Menotti M, Ambrogio C, Longo DL, Klaeger S, Keshishian H, Sztupinszki ZM, Szallasi Z, Keskin DB, Duke-Cohan JS, Reinhold B, Carr SA, Wu CJ, Moynihan KD, Irvine DJ, Barbie DA, Reinherz EL, Voena C, Awad MM, Blasco RB, Chiarle R",ALK peptide vaccination restores the immunogenicity of ALK-rearranged non-small cell lung cancer,"2023","4","7","1016-1035",Nature cancer,"","","","","","","","37430060","","",0,10,0,0,0,,,
6208,99,"Wang et al., 2022",journal,"Wang J, Weiss T, Neidert MC, Toussaint NC, Naghavian R, Sells Moreno C, Foege M, Tomas Ojer P, Medici G, Jelcic I, Schulz D, Rushing E, Dettwiler S, Schrrs B, Shin JH, McKay R, Wu CJ, Lutterotti A, Sospedra M, Moch H, Greiner EF, Bodenmiller B, Regli L, Weller M, Roth P, Martin R","Vaccination with Designed Neopeptides Induces Intratumoral, Cross-reactive CD4+ T-cell Responses in Glioblastoma","2022","28","24","5368-5382",Clinical cancer research : an official journal of the American Association for Cancer Research,"","","","","","","","36228153","","",0,10,0,0,0,,,
6209,99,"Backlund et al., 2022",journal,"Backlund CM, Holden RL, Moynihan KD, Garafola D, Farquhar C, Mehta NK, Maiorino L, Pham S, Iorgulescu JB, Reardon DA, Wu CJ, Pentelute BL, Irvine DJ",Cell-penetrating peptides enhance peptide vaccine accumulation and persistence in lymph nodes to drive immunogenicity,"2022","119","32",e2204078119,Proceedings of the National Academy of Sciences of the United States of America,"","","","","","","","35914154","",,0,0,0,0,0,,,
6210,99,"Ho et al., 2022",journal,"Ho VT, Kim HT, Brock J, Galinsky I, Daley H, Reynolds C, Weber A, Pozdnyakova O, Severgnini M, Nikiforow S, Cutler C, Koreth J, Alyea EP, Antin JH, Gooptu M, Romee R, Shapiro R, Chen YB, Rosenblatt J, Avigan D, Hodi FS, Dranoff G, Wu CJ, Ritz J, Soiffer RJ","GM-CSF secreting leukemia cell vaccination for MDS/AML after allogeneic HSCT: a randomized, double-blinded, phase 2 trial","2022","6","7","2183-2194",Blood advances,"","","","","","","","34807983","","",0,10,0,0,0,,,
6211,99,NCT01773395,website,Dana-Farber Cancer Institute,GVAX vs. Placebo for MDS/AML After Allo HSCT,"2022","6","7","2183-2194",Blood advances,"","","","","","","","34807983",https://clinicaltrials.gov/study/NCT01773395,"",0,10,0,0,0,,,
6212,99,"Keskin et al., 2019",journal,"Keskin DB, Anandappa AJ, Sun J, Tirosh I, Mathewson ND, Li S, Oliveira G, Giobbie-Hurder A, Felt K, Gjini E, Shukla SA, Hu Z, Li L, Le PM, Allese RL, Richman AR, Kowalczyk MS, Abdelrahman S, Geduldig JE, Charbonneau S, Pelton K, Iorgulescu JB, Elagina L, Zhang W, Olive O, McCluskey C, Olsen LR, Stevens J, Lane WJ, Salazar AM, Daley H, Wen PY, Chiocca EA, Harden M, Lennon NJ, Gabriel S, Getz G, Lander ES, Regev A, Ritz J, Neuberg D, Rodig SJ, Ligon KL, Suv ML, Wucherpfennig KW, Hacohen N, Fritsch EF, Livak KJ, Ott PA, Wu CJ, Reardon DA",Neoantigen vaccine generates intratumoral T cell responses in phase Ib glioblastoma trial,"2019","565","7738","234-239",Nature,"","","","","","","","30568305","","",0,10,0,0,0,,,
6213,312,"Rafi et al., 2023",journal,"Rafi MO, Al-Khafaji K, Mandal SM, Meghla NS, Biswas PK, Rahman MS",A subunit vaccine against pneumonia: targeting Streptococcus pneumoniae and Klebsiella pneumoniae,"2023","12","1","21",Network modeling and analysis in health informatics and bioinformatics,"","","","","","","","37096010","",,0,0,0,0,0,,,
6214,99,"Fritsch et al., 2014",journal,"Fritsch EF, Hacohen N, Wu CJ",Personal neoantigen cancer vaccines: The momentum builds,"2014","3","",e29311,Oncoimmunology,"","","","","","","","25101225","","",0,10,0,0,0,,,
6215,99,"Burkhardt and Wu, 2013",journal,"Burkhardt UE, Wu CJ",Boosting leukemia-specific T cell responses in patients following stem cell transplantation,"2013","2","11",e26587,Oncoimmunology,"","","","","","","","24482749","","",0,10,0,0,0,,,
6216,99,NCIT_C175590,website,"",ESR1 Peptides/GM-CSF/Montanide ISA Vaccine,"","","","","","","","","","","","","",https://ncithesaurus.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&ns=ncit&code=C175590,"",0,10,0,0,0,,,
6217,99,NCIT_C71036,website,"",Autologous Follicular Lymphoma-Derived Idiotype Vaccine,"","","","","","","","","","","","","",https://ncithesaurus.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&ns=ncit&code=C71036,"",0,10,0,0,0,,,
6218,99,NCIT_C52190,website,"",GM-K562 Cell Vaccine,"","","","","","","","","","","","","",https://ncithesaurus.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&ns=ncit&code=C52190,"",0,10,0,0,0,,,
6219,99,NCT00361296,website,Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins,Vaccine Therapy in Treating Patients With Myelodysplastic Syndromes,"2023","","","","","","","","","","","","",https://clinicaltrials.gov/study/NCT00361296,"",0,10,0,0,0,,,
6220,30,"Talaat et al., 2016",journal,"Talaat KR, Ellis RD, Hurd J, Hentrich A, Gabriel E, Hynes NA, Rausch KM, Zhu D, Muratova O, Herrera R, Anderson C, Jones D, Aebig J, Brockley S, MacDonald NJ, Wang X, Fay MP, Healy SA, Durbin AP, Narum DL, Wu Y, Duffy PE","Safety and Immunogenicity of Pfs25-EPA/Alhydrogel, a Transmission Blocking Vaccine against Plasmodium falciparum: An Open Label Study in Malaria Nave Adults","2016","11","10",e0163144,PloS one,"","","","","","","","27749907","","",0,10,0,0,0,,,
6221,30,"Moreno et al., 2008",journal,"Moreno A, Caro-Aguilar I, Yazdani SS, Shakri AR, Lapp S, Strobert E, McClure H, Chitnis CE, Galinski MR",Preclinical assessment of the receptor-binding domain of Plasmodium vivax Duffy-binding protein as a vaccine candidate in rhesus macaques,"2008","26","34","4338-4344",Vaccine,"","","","","","","","18573299","","",0,10,0,0,0,,,
6222,30,"Day et al., 2024",website,Nicholas Day,"A Safety, Immunogenicity and Efficacy Study of PvRII/Matrix-M in Healthy Thai Adults Living in Thailand","2024","","","","","","","","","","","","",https://clinicaltrials.gov/study/NCT05380388,"",0,10,0,0,0,,,
6223,30,"Vandepapelire et al., 2005",journal,"Vandepapelire P, Rehermann B, Koutsoukos M, Moris P, Garon N, Wettendorff M, Leroux-Roels G",Potent enhancement of cellular and humoral immune responses against recombinant hepatitis B antigens using AS02A adjuvant in healthy adults,"2005","23","20","2591-2601",Vaccine,"","","","","","","","15780441","","",0,10,0,0,0,,,
6224,30,"Stertman et al., 2023",journal,"Stertman L, Palm AE, Zarnegar B, Carow B, Lunderius Andersson C, Magnusson SE, Carnrot C, Shinde V, Smith G, Glenn G, Fries L, Lvgren Bengtsson K",The Matrix-M adjuvant: A critical component of vaccines for the 21(st) century,"2023","19","1","2189885",Human vaccines & immunotherapeutics,"","","","","","","","37113023","","",0,10,0,0,0,,,
6225,30,"Asante et al., 2011",journal,"Asante KP, Abdulla S, Agnandji S, Lyimo J, Vekemans J, Soulanoudjingar S, Owusu R, Shomari M, Leach A, Jongert E, Salim N, Fernandes JF, Dosoo D, Chikawe M, Issifou S, Osei-Kwakye K, Lievens M, Paricek M, Mller T, Apanga S, Mwangoka G, Dubois MC, Madi T, Kwara E, Minja R, Hounkpatin AB, Boahen O, Kayan K, Adjei G, Chandramohan D, Carter T, Vansadia P, Sillman M, Savarese B, Loucq C, Lapierre D, Greenwood B, Cohen J, Kremsner P, Owusu-Agyei S, Tanner M, Lell B","Safety and efficacy of the RTS,S/AS01E candidate malaria vaccine given with expanded-programme-on-immunisation vaccines: 19 month follow-up of a randomised, open-label, phase 2 trial","2011","11","10","741-749",The Lancet. Infectious diseases,"","","","","","","","21782519","","",0,10,0,0,0,,,
6226,30,"Genton et al., 2007",journal,"Genton B, Pluschke G, Degen L, Kammer AR, Westerfeld N, Okitsu SL, Schroller S, Vounatsou P, Mueller MM, Tanner M, Zurbriggen R",A randomized placebo-controlled phase Ia malaria vaccine trial of two virosome-formulated synthetic peptides in healthy adult volunteers,"2007","2","10",e1018,PloS one,"","","","","","","","17925866","","",0,10,0,0,0,,,
6227,30,"Cao et al., 2022",journal,"Cao Y, Hayashi CTH, Zavala F, Tripathi AK, Simonyan H, Young CN, Clark LC, Usuda Y, Van Parys JM, Kumar N",Effective Functional Immunogenicity of a DNA Vaccine Combination Delivered via In Vivo Electroporation Targeting Malaria Infection and Transmission,"2022","10","7","",Vaccines,"","","","","","","","35891298","","",0,10,0,0,0,,,
6228,30,"Rausch et al., 2023",journal,"Rausch KM, Barnafo EK, Lambert LE, Muratova O, Gorres JP, Anderson C, Narum DL, Wu Y, Morrison RD, Zaidi I, Duffy PE",Preclinical evaluations of Pfs25-EPA and Pfs230D1-EPA in AS01 for a vaccine to reduce malaria transmission,"2023","26","7","107192",iScience,"","","","","","","","37485364","","",0,10,0,0,0,,,
6229,30,"Chichester et al., 2018",journal,"Chichester JA, Green BJ, Jones RM, Shoji Y, Miura K, Long CA, Lee CK, Ockenhouse CF, Morin MJ, Streatfield SJ, Yusibov V",Safety and immunogenicity of a plant-produced Pfs25 virus-like particle as a transmission blocking vaccine against malaria: A Phase 1 dose-escalation study in healthy adults,"2018","36","39","5865-5871",Vaccine,"","","","","","","","30126674","","",0,10,0,0,0,,,
6230,99,NCIT_C48392,website,"","HER-2-neu, CEA Peptides, GM-CSF, Montanide ISA-51 Vaccine","","","","","","","","","","","","","",https://ncithesaurus.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&ns=ncit&code=C48392,"",0,10,0,0,0,,,
6231,99,NCIT_C132684,website,"",H3.3K27M-specific Peptide Vaccine,"","","","","","","","","","","","","",https://ncithesaurus.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&ns=ncit&code=C132684,"",0,10,0,0,0,,,
6232,99,NCIT_C61592,website,"",Hodgkin's Antigens-GM-CSF-Expressing Cell Vaccine,"","","","","","","","","","","","","",https://ncithesaurus.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&ns=ncit&code=C61592,"",0,10,0,0,0,,,
6233,99,https://clinicaltrials.gov/study/NCT00134082,website,Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins,Rituximab and Cyclophosphamide Followed by Vaccine Therapy in Treating Patients With Relapsed Hodgkin Lymphoma,"2019","","","","","","","","","","","","",https://clinicaltrials.gov/study/NCT00134082,,0,0,0,0,0,,,
6234,99,NCIT_C62775,website,"","MAGE-A1, Her-2/neu, FBP Peptides Cancer Vaccine","","","","","","","","","","","","","",https://ncithesaurus.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&ns=ncit&code=C62775,"",0,10,0,0,0,,,
6235,99,NCIT_C162250,website,"",Autologous mDC3 Vaccine,"","","","","","","","","","","","","",https://ncithesaurus.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&ns=ncit&code=C162250,"",0,10,0,0,0,,,
6236,99,NCIT_C38700,website,"",Melanoma Helper Peptide Vaccine,"","","","","","","","","","","","","",https://ncithesaurus.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&ns=ncit&code=C38700,"",0,10,0,0,0,,,
6237,99,NCIT_C107169,website,"",Allogeneic HLA-A2/4-1BB ligand-expressing Melanoma Vaccine,"","","","","","","","","","","","","",https://ncithesaurus.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&ns=ncit&code=C107169,"",0,10,0,0,0,,,
6238,99,NCIT_C74063,website,"",Mixed Bacteria Vaccine,"","","","","","","","","","","","","",https://ncithesaurus.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&ns=ncit&code=C74063,"",0,10,0,0,0,,,
6239,99,NCIT_C179670,website,"",Autologous CMV-pp65-LAMP mRNA Loaded Monocyte Vaccine MT-201-GBM,"","","","","","","","","","","","","",https://ncithesaurus.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&ns=ncit&code=C179670,"",0,10,0,0,0,,,
6240,99,NCIT_C82417,website,"",MUC1 Peptide-Poly-ICLC Vaccine,"","","","","","","","","","","","","",https://ncithesaurus.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&ns=ncit&code=C82417,"",0,10,0,0,0,,,
6241,99,NCIT_C173525,website,"",Multi-epitope HER2 Peptide Vaccine TPIV100,"","","","","","","","","","","","","",https://ncithesaurus.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&ns=ncit&code=C173525,"",0,10,0,0,0,,,
6242,99,NCIT_C38695,website,"",Multi-epitope Melanoma Peptide Vaccine,"","","","","","","","","","","","","",https://ncithesaurus.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&ns=ncit&code=C38695,"",0,10,0,0,0,,,
6243,99,NCT05014607,website,University Hospital Tuebingen,Personalized Multi-peptide Vaccination in Combination With the TLR1/2 Ligand XS15 in Cancer Patients (InHeVac01),"2021","","","","","","","","","","","","",https://clinicaltrials.gov/study/NCT05014607,"",0,10,0,0,0,,,
6244,99,NCIT_C179595,website,"",TLR1/2 Agonist Pam3Cys-GDPKHPKSF,"","","","","","","","","","","","","",https://ncithesaurus.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&ns=ncit&code=C179595,"",0,10,0,0,0,,,
6245,99,NCIT_C143059,website,"",Prime Cancer Vaccine MVA-BN-CV301,"","","","","","","","","","","","","",https://ncithesaurus.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&ns=ncit&code=C143059,"",0,10,0,0,0,,,
6246,99,NCIT_C2637,website,"",MVF-HER-2(628-647)-CRL 1005 Vaccine,"","","","","","","","","","","","","",https://ncithesaurus.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&ns=ncit&code=C2637,"",0,10,0,0,0,,,
6247,99,NCIT_C158480,website,"",Autologous Dendritic Cell/Myeloma Fusion Vaccine,"","","","","","","","","","","","","",https://ncithesaurus.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&ns=ncit&code=C158480,"",0,10,0,0,0,,,
6248,30,"Yazdani et al., 2006",journal,"Yazdani SS, Shakri AR, Pattnaik P, Rizvi MM, Chitnis CE",Improvement in yield and purity of a recombinant malaria vaccine candidate based on the receptor-binding domain of Plasmodium vivax Duffy binding protein by codon optimization,"2006","28","14","1109-1114",Biotechnology letters,"","","","","","","","16794771","","",0,10,0,0,0,,,
6249,99,NCIT_C148239,website,"",mRNA-based Personalized Cancer Vaccine NCI-4650,"","","","","","","","","","","","","",https://ncithesaurus.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&ns=ncit&code=C148239,"",0,10,0,0,0,,,
6250,99,NCIT_C129935,website,"",Personalized Peptide Cancer Vaccine NEO-PV-01,"","","","","","","","","","","","","",https://ncithesaurus.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&ns=ncit&code=C129935,"",0,10,0,0,0,,,
6251,99,NCIT_C165508,website,"",Neoantigen Peptide Vaccine,"","","","","","","","","","","","","",https://ncithesaurus.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&ns=ncit&code=C165508,"",0,10,0,0,0,,,
6252,99,NCIT_C127125,website,"",NY-ESO-1/PRAME/MAGE-A3/WT-1 Peptide Vaccine,"","","","","","","","","","","","","",https://ncithesaurus.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&ns=ncit&code=C127125,"",0,10,0,0,0,,,
6253,99,NCIT_C122402,website,"",Autologous Oxidized Ovarian Tumor Cell Lysate Vaccine,"","","","","","","","","","","","","",https://ncithesaurus.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&ns=ncit&code=C122402,"",0,10,0,0,0,,,
6254,99,NCIT_C150471,website,"",Personalized Synthetic Long Peptide Vaccine,"","","","","","","","","","","","","",https://ncithesaurus.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&ns=ncit&code=C150471,"",0,10,0,0,0,,,
6255,99,NCIT_C148144,website,"",Oral Therapeutic Vaccine V3-X,"","","","","","","","","","","","","",https://ncithesaurus.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&ns=ncit&code=C148144,"",0,10,0,0,0,,,
6256,99,NCIT_C153334,website,"",Allogeneic GM-CSF-secreting Lethally Irradiated Pancreatic Tumor Cell Vaccine,"","","","","","","","","","","","","",https://ncithesaurus.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&ns=ncit&code=C153334,"",0,10,0,0,0,,,
6257,99,NCT00305760,website,Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins,"Vaccine Therapy, Cyclophosphamide, and Cetuximab in Treating Patients With Metastatic or Locally Advanced Pancreatic Cancer","2020","","","","","","","","","","","","",https://clinicaltrials.gov/study/NCT00305760,"",0,10,0,0,0,,,
6258,99,NCT03468244,website,Changhai Hospital,Clinical Study of Personalized mRNA Vaccine Encoding Neoantigen in Patients With Advanced Digestive System Neoplasms,"2019","","","","","","","","","","","","",https://clinicaltrials.gov/study/NCT03468244,"",0,10,0,0,0,,,
6259,99,NCT05359354,website,"YueJuan Cheng, Peking Union Medical College Hospital",Safety and Efficacy of Personalized Neoantigen Vaccine in Advanced Solid Tumors,"2023","","","","","","","","","","","","",https://clinicaltrials.gov/study/NCT05359354,"",0,10,0,0,0,,,
6260,99,NCT02510950,website,Washington University School of Medicine,Neoepitope-based Personalized Vaccine Approach in Patients With Newly Diagnosed Glioblastoma,"2017","","","","","","","","","","","","",https://clinicaltrials.gov/study/NCT02510950,"",0,10,0,0,0,,,
6261,30,"Kunkeaw et al., 2023",journal,"Kunkeaw N, Nguitragool W, Takashima E, Kangwanrangsan N, Muramatsu H, Tachibana M, Ishino T, Lin PJC, Tam YK, Pichyangkul S, Tsuboi T, Pardi N, Sattabongkot J",A Pvs25 mRNA vaccine induces complete and durable transmission-blocking immunity to Plasmodium vivax,"2023","8","1","187",NPJ vaccines,"","","","","","","","38092803","","",0,10,0,0,0,,,
6262,30,"Wu et al., 2008",journal,"Wu Y, Ellis RD, Shaffer D, Fontes E, Malkin EM, Mahanty S, Fay MP, Narum D, Rausch K, Miles AP, Aebig J, Orcutt A, Muratova O, Song G, Lambert L, Zhu D, Miura K, Long C, Saul A, Miller LH, Durbin AP",Phase 1 trial of malaria transmission blocking vaccine candidates Pfs25 and Pvs25 formulated with montanide ISA 51,"2008","3","7",e2636,PloS one,"","","","","","","","18612426","","",0,10,0,0,0,,,
6263,30,"Thera et al., 2016",journal,"Thera MA, Coulibaly D, Kone AK, Guindo AB, Traore K, Sall AH, Diarra I, Daou M, Traore IM, Tolo Y, Sissoko M, Niangaly A, Arama C, Baby M, Kouriba B, Sissoko MS, Sagara I, Toure OB, Dolo A, Diallo DA, Remarque E, Chilengi R, Noor R, Sesay S, Thomas A, Kocken CH, Faber BW, Imoukhuede EB, Leroy O, Doumbo OK",Phase 1 randomized controlled trial to evaluate the safety and immunogenicity of recombinant Pichia pastoris-expressed Plasmodium falciparum apical membrane antigen 1 (PfAMA1-FVO [25-545]) in healthy Malian adults in Bandiagara,"2016","15","1","442",Malaria journal,"","","","","","","","27577237","","",0,10,0,0,0,,,
6264,30,"de Graaf et al., 2021",journal,"de Graaf H, Payne RO, Taylor I, Miura K, Long CA, Elias SC, Zaric M, Minassian AM, Silk SE, Li L, Poulton ID, Baker M, Draper SJ, Gbesemete D, Brendish NJ, Martins F, Marini A, Mekhaiel D, Edwards NJ, Roberts R, Vekemans J, Moyle S, Faust SN, Berrie E, Lawrie AM, Hill F, Hill AVS, Biswas S",Safety and Immunogenicity of ChAd63/MVA Pfs25-IMX313 in a Phase I First-in-Human Trial,"2021","12","","694759",Frontiers in immunology,"","","","","","","","34335606","","",0,10,0,0,0,,,
6265,30,"Renn et al., 2021",journal,"Renn JP, Doritchamou JYA, Tentokam BCN, Morrison RD, Cowles MV, Burkhardt M, Ma R, Mahamar A, Attaher O, Diarra BS, Traore M, Dicko A, Tolia NH, Fried M, Duffy PE","Allelic variants of full-length VAR2CSA, the placental malaria vaccine candidate, differ in antigenicity and receptor binding affinity","2021","4","1","1309",Communications biology,"","","","","","","","34799664","","",0,10,0,0,0,,,
6266,30,"Mendes et al., 2018",journal,"Mendes AM, Reuling IJ, Andrade CM, Otto TD, Machado M, Teixeira F, Pissarra J, Gonalves-Rosa N, Bonaparte D, Sinfrnio J, Sanders M, Janse CJ, Khan SM, Newbold CI, Berriman M, Lee CK, Wu Y, Ockenhouse CF, Sauerwein RW, Prudncio M",Pre-clinical evaluation of a P. berghei-based whole-sporozoite malaria vaccine candidate,"2018","3","","54",NPJ vaccines,"","","","","","","","30510775","","",0,10,0,0,0,,,
6267,30,"Takashima et al., 2022",journal,"Takashima E, Nagaoka H, Correia R, Alves PM, Roldo A, Christensen D, Guderian JA, Fukushima A, Viebig NK, Depraetere H, Tsuboi T",A novel asexual blood-stage malaria vaccine candidate: PfRipr5 formulated with human-use adjuvants induces potent growth inhibitory antibodies,"2022","13","","1002430",Frontiers in immunology,"","","","","","","","36389677","","",0,10,0,0,0,,,
6268,30,"Bjerkan et al., 2021",journal,"Bjerkan L, Visweswaran GRR, Gudjonsson A, Labb GM, Quinkert D, Pattinson DJ, Spng HCL, Draper SJ, Bogen B, Braathen R",APC-Targeted DNA Vaccination Against Reticulocyte-Binding Protein Homolog 5 Induces Plasmodium falciparum-Specific Neutralizing Antibodies and T Cell Responses,"2021","12","","720550",Frontiers in immunology,"","","","","","","","34733274","","",0,10,0,0,0,,,
6269,30,"Fantin et al., 2021",journal,"Fantin RF, Fraga VG, Lopes CA, de Azevedo IC, Reis-Cunha JL, Pereira DB, Lobo FP, de Oliveira MM, Dos Santos AC, Bartholomeu DC, Fujiwara RT, Bueno LL",New highly antigenic linear B cell epitope peptides from PvAMA-1 as potential vaccine candidates,"2021","16","11",e0258637,PloS one,"","","","","","","","34727117","",,0,0,0,0,0,,,
6270,30,"Lefebvre et al., 2021",journal,"Lefebvre MN, Drewry LL, Pewe LL, Hancox LS, Reyes-Sandoval A, Harty JT",Cutting Edge: Subunit Booster Vaccination Confers Sterilizing Immunity against Liver-Stage Malaria in Mice Initially Primed with a Weight-Normalized Dose of Radiation-Attenuated Sporozoites,"2021","207","11","2631-2635","Journal of immunology (Baltimore, Md. : 1950)","","","","","","","","34716185","",,0,0,0,0,0,,,
6271,30,"Stanisic et al., 2021",journal,"Stanisic DI, Ho MF, Nevagi R, Cooper E, Walton M, Islam MT, Hussein WM, Skwarczynski M, Toth I, Good MF",Development and Evaluation of a Cryopreserved Whole-Parasite Vaccine in a Rodent Model of Blood-Stage Malaria,"2021","12","5",e0265721,mBio,"","","","","","","","34663097","",,0,0,0,0,0,,,
6272,30,"Howard et al., 2021",journal,"Howard GP, Bender NG, Khare P, Lpez-Gutirrez B, Nyasembe V, Weiss WJ, Simecka JW, Hamerly T, Mao HQ, Dinglasan RR",Immunopotentiation by Lymph-Node Targeting of a Malaria Transmission-Blocking Nanovaccine,"2021","12","","729086",Frontiers in immunology,"","","","","","","","34512663","",,0,0,0,0,0,,,
6273,30,"Virnik et al., 2021",journal,"Virnik K, Zhou W, Medvedev A, Walsh G, Perry-Anderson J, Majam V, Felber BK, Kumar S, Berkower I",Live attenuated rubella vectors expressing Plasmodium falciparum circumsporozoite protein (Pf-CSP) provide a novel malaria vaccine platform in the rhesus macaque,"2021","577","","58-63",Biochemical and biophysical research communications,"","","","","","","","34507066","",,0,0,0,0,0,,,
6274,30,"Zhang et al., 2021",journal,"Zhang Y, Liu F, Zhao Y, Yang F, Bai J, Jia X, Roobsoong W, Sattabongkot J, Cui L, Cao Y, Luo E, Wang M",Evaluation of two Plasmodium vivax sexual stage antigens as transmission-blocking vaccine candidates,"2021","14","1","407",Parasites & vectors,"","","","","","","","34399829","",,0,0,0,0,0,,,
6275,30,"Mian et al., 2022",journal,"Mian SY, Somanathan A, Chaddha K, Pandey AK, Singh H, Krishna S, Chaturvedi N, Uchoi S, Shukla MM, Bharti PK, Singh N, Chauhan VS, Gaur D",Plasmodium falciparum Cysteine-Rich Protective Antigen (CyRPA) Elicits Detectable Levels of Invasion-Inhibitory Antibodies during Natural Infection in Humans,"2022","90","1",e0037721,Infection and immunity,"","","","","","","","34694918","",,0,0,0,0,0,,,
6276,50,NCT04363359,website,"",Clinical Trial of Quadrivalent Influenza Virus Split Vaccine,"2023","","","","","","","","","","","","",https://clinicaltrials.gov/study/NCT04363359,,0,0,0,0,0,,,
6277,99,"Oji et al., 2023",journal,"Oji Y, Kagawa N, Arita H, Naka N, Hamada KI, Outani H, Shintani Y, Takeda Y, Morii E, Shimazu K, Suzuki M, Nishida S, Nakata J, Tsuboi A, Iwai M, Hayashi S, Imanishi R, Ikejima S, Kanegae M, Iwamoto M, Ikeda M, Yagi K, Shimokado H, Nakajima H, Hasegawa K, Morimoto S, Fujiki F, Nagahara A, Tanemura A, Ueda Y, Mizushima T, Ohmi M, Ishida T, Fujimoto M, Nonomura N, Kimura T, Inohara H, Okada S, Kishima H, Hosen N, Kumanogoh A, Oka Y, Sugiyama H",WT1 Trio Peptide-Based Cancer Vaccine for Rare Cancers Expressing Shared Target WT1,"2023","15","2","",Cancers,"","","","","","","","36672344","",,0,0,0,0,0,,,
